Citrus Sinensis ID: 014140

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430
Protein Sequence
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHccccccEEEEccccccccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEEEEHHHHHHHcccccccccccccccccccccccHHHHHHcccccccccccccccEEEEEEEccccccEEEEEEcccccccccHHcccccccccccHHHHHHHHHHHHccccccccccEEEEEcccEEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHccccccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccEEEccccccccccEEEEccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccccEEEEEEEcccccccHHHEEcccccccHHHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEcccccccHHcHccHHEEccccccEEEEEEEEEEcccccHHHHHcccccccccHHHHHEEEEEEHcccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLglkessggkstivgQRFLTTTSRILAagrggsrdrrpiifsplikeedlAFLEKEDYFASLEKIRScwngevykaelpgssgrviTIKKIIQPLKsgaelikkdseplhhKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYlhmshrpriihrdiqpanvlidDDMEARISEFglakripdghtrtttwslagtvgyiapechqtvalsdtcdiysFGVLLAVLVIgkfpsddffqhTKEMSLVQWMRNVmtsenpnrainsKLLGNGYEEQMLLVLKIACFctlddpnkrpnskdVRCMLSQIQH
Flexible Loop (DISEMBL)
mvkinkvlddaiekqtkeesVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLglkessggkstivgqrfltttsrilaagrggsrdrrpiIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAelpgssgrviTIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSeiitagqvrhrNIVPLLARMVRRDCDLLVYEFrrngslqdilYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFglakripdghtRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTlddpnkrpnskdVRCMLSQIQH
Low Complexity Region (SEG)
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH
Disordered region (IsUnstruct)
*******************SVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKD*EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD********************
Disordered Region (DISOPRED)
****NKV*DDA******EESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLL*****************DIAWQINVLGLKESSGGKSTIVGQRFLTTTSR***************IFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQ****************HHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD**QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ*
Disordered Region (DISEMBL)
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH
Disordered Region (DISPRO)
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQ**D*************DIAWQINVLGLKESSGGKSTIVGQRFLTTTS*****************FSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	430	2.2.26 [Sep-21-2011]
Q9SKB2	641	Leucine-rich repeat recep	yes	no	0.825	0.553	0.625	1e-126
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.602	0.235	0.396	6e-45
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.672	0.239	0.363	6e-43
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.672	0.239	0.363	1e-42
Q9SSL9	1123	Leucine-rich repeat recep	no	no	0.613	0.235	0.361	1e-42
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.704	0.254	0.346	1e-42
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.620	0.256	0.360	2e-42
Q9LJF3	1164	Receptor-like protein kin	no	no	0.679	0.250	0.356	4e-42
Q9FZ59	1088	Leucine-rich repeat recep	no	no	0.593	0.234	0.388	7e-42
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.681	0.251	0.348	9e-42

>sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1

 Score =  453 bits (1165), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 225/360 (62%), Positives = 272/360 (75%), Gaps = 5/360 (1%)

Query: 72  AWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKE-EDLAFL 130
           AW   +LG    + G  TI G  F      I+ A RG  +   P IFSPLIK+ EDLAFL
Sbjct: 286 AW---ILGFVVGAIG-GTISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFL 341

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           E E+  ASLE I     GEV+KAELPGS+G++I +KK+IQP K   EL  +DS+ L+ KM
Sbjct: 342 ENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKM 401

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
            QIRSEI T G +RHRN++PLLA + R +C  LVYE+   GSLQDIL DV  G +EL W 
Sbjct: 402 RQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWP 461

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           ARH+IA GIA+GLEYLHM H PRIIHRD++PANVL+DDDMEARIS+FGLAK +PD  T  
Sbjct: 462 ARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHI 521

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           TT  +AGTVGYIAPE +QT   +D CDIYSFGV+L +LVIGK PSD+FFQHT EMSL++W
Sbjct: 522 TTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKW 581

Query: 371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           MRN++TSENP+ AI+ KL+  G++EQMLLVLKIAC+CTLDDP +RPNSKDVR MLSQI+H
Sbjct: 582 MRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  182 bits (461), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 113/285 (39%), Positives = 165/285 (57%), Gaps = 26/285 (9%)

Query: 148  GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            G VYKAE+ G  G VI +KK    L S  E    D+          R+EI T G++RHRN
Sbjct: 811  GTVYKAEMSG--GEVIAVKK----LNSRGEGASSDN--------SFRAEISTLGKIRHRN 856

Query: 208  IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE--LDWLARHRIAQGIASGLEY 265
            IV L      ++ +LL+YE+   GSL +    + +G +   LDW AR+RIA G A GL Y
Sbjct: 857  IVKLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDWNARYRIALGAAEGLCY 913

Query: 266  LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
            LH   RP+I+HRDI+  N+L+D+  +A + +FGLAK I   ++++ + ++AG+ GYIAPE
Sbjct: 914  LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPE 972

Query: 326  CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN-RAI 384
               T+ +++ CDIYSFGV+L  L+ GK P     Q      LV W+R  + +  P     
Sbjct: 973  YAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG---DLVNWVRRSIRNMIPTIEMF 1029

Query: 385  NSKLLGNGYE--EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ 427
            +++L  N      +M LVLKIA FCT + P  RP  ++V  M+++
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  175 bits (444), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 114/314 (36%), Positives = 173/314 (55%), Gaps = 25/314 (7%)

Query: 120  PLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            PL K      LE  + F +   + S   G+VYKA+L    G V+ IKK+I     G    
Sbjct: 872  PLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIHVSGQGDR-- 927

Query: 180  KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD 239
                        +  +E+ T G+++HRN+VPLL      +  LLVYE+ + GSL+D+L+D
Sbjct: 928  ------------EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHD 975

Query: 240  VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
              +   +L+W AR +IA G A GL +LH +  P IIHRD++ +NVL+D+++EAR+S+FG+
Sbjct: 976  RKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGM 1035

Query: 300  AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--D 357
            A+ +    T  +  +LAGT GY+ PE +Q+   S   D+YS+GV+L  L+ GK P+D  D
Sbjct: 1036 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSAD 1095

Query: 358  FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGN--GYEEQMLLVLKIACFCTLDDPNKR 415
            F     + +LV W++ +          + +LL      E ++L  LK+AC C  D   KR
Sbjct: 1096 F----GDNNLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKR 1150

Query: 416  PNSKDVRCMLSQIQ 429
            P    V  M  +IQ
Sbjct: 1151 PTMIQVMAMFKEIQ 1164

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  174 bits (442), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 114/314 (36%), Positives = 173/314 (55%), Gaps = 25/314 (7%)

Query: 120  PLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            PL K      LE  + F +   + S   G+VYKA+L    G V+ IKK+I     G    
Sbjct: 872  PLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLIHVSGQGDR-- 927

Query: 180  KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD 239
                        +  +E+ T G+++HRN+VPLL      +  LLVYE+ + GSL+D+L+D
Sbjct: 928  ------------EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHD 975

Query: 240  VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
              +   +L+W AR +IA G A GL +LH +  P IIHRD++ +NVL+D+++EAR+S+FG+
Sbjct: 976  RKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGM 1035

Query: 300  AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--D 357
            A+ +    T  +  +LAGT GY+ PE +Q+   S   D+YS+GV+L  L+ GK P+D  D
Sbjct: 1036 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSAD 1095

Query: 358  FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGN--GYEEQMLLVLKIACFCTLDDPNKR 415
            F     + +LV W++ +          + +LL      E ++L  LK+AC C  D   KR
Sbjct: 1096 F----GDNNLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKR 1150

Query: 416  PNSKDVRCMLSQIQ 429
            P    V  M  +IQ
Sbjct: 1151 PTMIQVMAMFKEIQ 1164

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score =  174 bits (442), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/293 (36%), Positives = 159/293 (54%), Gaps = 29/293 (9%)

Query: 148  GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            G VY+A L   SG+V  +K+++      A  I+ +       M++   EI T G+VRHRN
Sbjct: 839  GIVYRASL--GSGKVYAVKRLVF-----ASHIRAN-----QSMMR---EIDTIGKVRHRN 883

Query: 208  IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            ++ L    +R+D  L++Y +   GSL D+L+ VS     LDW AR+ +A G+A GL YLH
Sbjct: 884  LIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLH 943

Query: 268  MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                P I+HRDI+P N+L+D D+E  I +FGLA+ + D    T T  + GT GYIAPE  
Sbjct: 944  YDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTAT--VTGTTGYIAPENA 1001

Query: 328  QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN------ 381
                     D+YS+GV+L  LV  K   D  F  + +  +V W+R+ ++S N N      
Sbjct: 1002 FKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTD--IVSWVRSALSSSNNNVEDMVT 1059

Query: 382  ----RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
                  +  +LL +   EQ++ V ++A  CT  DP  RP  +D   +L  ++H
Sbjct: 1060 TIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLEDVKH 1112

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  174 bits (441), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 113/326 (34%), Positives = 165/326 (50%), Gaps = 23/326 (7%)

Query: 109  GSRDRRPIIFS------PLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRV 162
            GSR R P+  +      PL+K      +E  D+F+    I     G VYKA LPG   + 
Sbjct: 884  GSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGE--KT 941

Query: 163  ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDL 222
            + +KK+ +    G                +  +E+ T G+V+H N+V LL      +  L
Sbjct: 942  VAVKKLSEAKTQGNR--------------EFMAEMETLGKVKHPNLVSLLGYCSFSEEKL 987

Query: 223  LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            LVYE+  NGSL   L + +     LDW  R +IA G A GL +LH    P IIHRDI+ +
Sbjct: 988  LVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKAS 1047

Query: 283  NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
            N+L+D D E ++++FGLA+ I    +  +T  +AGT GYI PE  Q+   +   D+YSFG
Sbjct: 1048 NILLDGDFEPKVADFGLARLISACESHVST-VIAGTFGYIPPEYGQSARATTKGDVYSFG 1106

Query: 343  VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK 402
            V+L  LV GK P+   F+ ++  +LV W    +        I+  L+    +   L +L+
Sbjct: 1107 VILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQ 1166

Query: 403  IACFCTLDDPNKRPNSKDVRCMLSQI 428
            IA  C  + P KRPN  DV   L +I
Sbjct: 1167 IAMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  173 bits (439), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/286 (36%), Positives = 161/286 (56%), Gaps = 19/286 (6%)

Query: 148  GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            G VYKAE+P  +G +I +KK+    K   ++ ++ S         + +E+   G VRHRN
Sbjct: 731  GTVYKAEMP--NGEIIAVKKLWGKNKENGKIRRRKS--------GVLAEVDVLGNVRHRN 780

Query: 208  IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIAQGIASGLEYL 266
            IV LL     RDC +L+YE+  NGSL D+L+   +      +W A ++IA G+A G+ YL
Sbjct: 781  IVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYL 840

Query: 267  HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
            H    P I+HRD++P+N+L+D D EAR+++FG+AK I    T  +   +AG+ GYIAPE 
Sbjct: 841  HHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QTDESMSVVAGSYGYIAPEY 897

Query: 327  HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
              T+ +    DIYS+GV+L  ++ GK   +  F      S+V W+R+ + ++     +  
Sbjct: 898  AYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGN--SIVDWVRSKLKTKEDVEEVLD 955

Query: 387  KLLGNGYE---EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            K +G       E+M  +L+IA  CT   P  RP  +DV  +L + +
Sbjct: 956  KSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAK 1001

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  172 bits (437), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 172/311 (55%), Gaps = 19/311 (6%)

Query: 120  PLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            PL K      LE  + F++   I S   G+VYKA+L  + G V+ IKK+IQ    G    
Sbjct: 842  PLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLIQVTGQGDR-- 897

Query: 180  KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD 239
                        +  +E+ T G+++HRN+VPLL      +  LLVYE+ + GSL+ +L++
Sbjct: 898  ------------EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHE 945

Query: 240  -VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 298
               +G   LDW AR +IA G A GL +LH S  P IIHRD++ +NVL+D D  AR+S+FG
Sbjct: 946  KTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFG 1005

Query: 299  LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            +A+ +    T  +  +LAGT GY+ PE +Q+   +   D+YS+GV+L  L+ GK P D  
Sbjct: 1006 MARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP- 1064

Query: 359  FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEE-QMLLVLKIACFCTLDDPNKRPN 417
             +  ++ +LV W + +   +     ++ +L+ +   + ++L  LKIA  C  D P KRP 
Sbjct: 1065 EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPT 1124

Query: 418  SKDVRCMLSQI 428
               V  M  ++
Sbjct: 1125 MIQVMTMFKEL 1135

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1

 Score =  171 bits (434), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 110/283 (38%), Positives = 156/283 (55%), Gaps = 28/283 (9%)

Query: 148  GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            G VY+A L   SG    +KK+I      AE I+ +          ++ EI T G VRHRN
Sbjct: 806  GVVYRASL--GSGEEYAVKKLIF-----AEHIRANQ--------NMKREIETIGLVRHRN 850

Query: 208  IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            ++ L    +R++  L++Y++  NGSL D+L+  +QG   LDW AR  IA GI+ GL YLH
Sbjct: 851  LIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLH 910

Query: 268  MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                P IIHRDI+P N+L+D DME  I +FGLA+ + D    T T  + GT GYIAPE  
Sbjct: 911  HDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDSTVSTAT--VTGTTGYIAPENA 968

Query: 328  QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS-----ENPNR 382
                 S   D+YS+GV+L  LV GK   D  F   +++++V W+R+V++S     +    
Sbjct: 969  YKTVRSKESDVYSYGVVLLELVTGKRALDRSFP--EDINIVSWVRSVLSSYEDEDDTAGP 1026

Query: 383  AINSK----LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             ++ K    LL     EQ + V  +A  CT   P  RP+ +DV
Sbjct: 1027 IVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDV 1069

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  171 bits (433), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 109/313 (34%), Positives = 174/313 (55%), Gaps = 20/313 (6%)

Query: 120  PLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            PL K      LE  + F++   + S   GEVYKA+L    G V+ IKK+I+    G    
Sbjct: 843  PLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQL--RDGSVVAIKKLIRITGQGDR-- 898

Query: 180  KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD 239
                        +  +E+ T G+++HRN+VPLL      +  LLVYE+ + GSL+ +L++
Sbjct: 899  ------------EFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHE 946

Query: 240  VS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 297
             S  +G   L+W AR +IA G A GL +LH S  P IIHRD++ +NVL+D+D EAR+S+F
Sbjct: 947  KSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDF 1006

Query: 298  GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            G+A+ +    T  +  +LAGT GY+ PE +Q+   +   D+YS+GV+L  L+ GK P D 
Sbjct: 1007 GMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDP 1066

Query: 358  FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEE-QMLLVLKIACFCTLDDPNKRP 416
              +  ++ +LV W + +   +     ++ +L+ +   + ++   LKIA  C  D P KRP
Sbjct: 1067 -GEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRP 1125

Query: 417  NSKDVRCMLSQIQ 429
                +  M  +++
Sbjct: 1126 TMIQLMAMFKEMK 1138

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	430
255540437	633	BRASSINOSTEROID INSENSITIVE 1-associated	0.795	0.540	0.683	1e-136
224133744	630	predicted protein [Populus trichocarpa]	0.765	0.522	0.703	1e-136
356508750	636	PREDICTED: leucine-rich repeat receptor-	0.848	0.573	0.632	1e-132
224119518	627	predicted protein [Populus trichocarpa]	0.848	0.582	0.616	1e-131
24421095	633	receptor-like protein kinase [Nicotiana	0.753	0.511	0.68	1e-130
356516603	631	PREDICTED: leucine-rich repeat receptor-	0.762	0.519	0.671	1e-127
449440606	643	PREDICTED: leucine-rich repeat receptor-	0.765	0.511	0.651	1e-126
15225153	641	putative leucine-rich repeat transmembra	0.825	0.553	0.625	1e-125
297822929	641	hypothetical protein ARALYDRAFT_482113 [	0.825	0.553	0.622	1e-124
16648755	641	At2g31880/F20M17.8 [Arabidopsis thaliana	0.825	0.553	0.625	1e-124

>gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  491 bits (1264), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 235/344 (68%), Positives = 283/344 (82%), Gaps = 2/344 (0%)

Query: 89  TIVGQRFLTTTSRILAAGRGGSRDRRPIIFSP-LIKE-EDLAFLEKEDYFASLEKIRSCW 146
           ++ G  F      ILA  RGG +D  P IFSP LIK+ E+LAFLEKED  ++LE I    
Sbjct: 290 SMSGFVFSVMFKLILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGG 349

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
            GEVYKAELPGS+G++I IKKI+QP +  AEL ++D++ L+ KM QIRSEI T GQ+RHR
Sbjct: 350 CGEVYKAELPGSNGKMIAIKKIVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHR 409

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           N++PLLA + R DC  LVYEF +NGSLQDIL DV QG+RELDWLARHRIA G+ASGLEYL
Sbjct: 410 NLLPLLAHVSRPDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYL 469

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H SH PRIIHRD++PANVL+DDDMEARI++FGLAK +PD +T  TT ++AGTVGYIAPE 
Sbjct: 470 HTSHSPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEY 529

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
           HQT+  +D CDIYSFGVLL VLV+GK PSD+FFQ T+EMSLV+WMRN+MTSENP++AI+ 
Sbjct: 530 HQTLKFTDKCDIYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDP 589

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           K+ GNG+EEQMLLVLKIACFCTLDDP +RPNSKD+RCMLSQI+H
Sbjct: 590 KMNGNGFEEQMLLVLKIACFCTLDDPRQRPNSKDIRCMLSQIKH 633

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa]

 Score =  489 bits (1260), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 232/330 (70%), Positives = 275/330 (83%), Gaps = 1/330 (0%)

Query: 102 ILAAGRGGSRDRRPIIFSPLIKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSG 160
           +LAA +GG RD  P IFSPLIK  EDLAFLEK+D  A+LE I     GEVYKAELPGS+G
Sbjct: 301 VLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSNG 360

Query: 161 RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDC 220
           ++I IKKIIQP K  AEL ++DS+ LH KM QI+SEI T G +RHRN++PLLA + R DC
Sbjct: 361 KMIAIKKIIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDC 420

Query: 221 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
             LVYE  +NGSLQD L  V++GRRELDWLARHRIA G+ASGLEYLH+SH PRIIHRD++
Sbjct: 421 HYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRDLK 480

Query: 281 PANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
           PANVL+DD MEARI++FGLAK +PD  T  TT ++AGTVGYIAPE HQT+  +D CDIYS
Sbjct: 481 PANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYS 540

Query: 341 FGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLV 400
           FGV+L VLV+GK PSD+FFQ+T+EMSLV+WMRN+MTSENP +AI+ KL+GNG EEQMLLV
Sbjct: 541 FGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQMLLV 600

Query: 401 LKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           LKIACFCT+DDP +RPNSKDVRCMLSQI+H
Sbjct: 601 LKIACFCTIDDPKQRPNSKDVRCMLSQIKH 630

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max]

 Score =  478 bits (1230), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/370 (63%), Positives = 287/370 (77%), Gaps = 5/370 (1%)

Query: 62  KEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPL 121
           K  +++ + + W   +LG    + G  T+ G  F       LA  +G  R   P I+SPL
Sbjct: 271 KHKHSKRKLLGW---ILGFVAGALG-GTLSGFVFSLMFKLALALIKGRGRKAGPDIYSPL 326

Query: 122 IKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           IK+ EDLAFLEKE+  ASLE I     GEVYKAELPGS+G++I IKKI+QP K GAEL +
Sbjct: 327 IKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSNGKMIAIKKIVQPPKDGAELAE 386

Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           +DS+ L+ KM QIRSEI T GQ+RHRN++PLLA + R +C  LVYEF +NGSLQD L  V
Sbjct: 387 EDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPECHYLVYEFMKNGSLQDTLSKV 446

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            +G  ELDWL+RH+I+ G+A+GLEYLHM+H PRIIHRD++PAN+L+DDDMEARI++FGLA
Sbjct: 447 ERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDLKPANILLDDDMEARIADFGLA 506

Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
           K +PD  T  TT ++AGTVGYIAPE HQ +  +D CDIYS+GV+L VLVIGK PSDDFFQ
Sbjct: 507 KAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSYGVILGVLVIGKLPSDDFFQ 566

Query: 361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
           HT+EMSLV+WMR  ++SENP  AINSKLLGNGYEEQMLLVLKIACFCT+DDP +RPNSKD
Sbjct: 567 HTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLLVLKIACFCTMDDPKERPNSKD 626

Query: 421 VRCMLSQIQH 430
           VRCMLSQI+H
Sbjct: 627 VRCMLSQIKH 636

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa]

 Score =  475 bits (1222), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 228/370 (61%), Positives = 290/370 (78%), Gaps = 5/370 (1%)

Query: 62  KEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPL 121
           K  N++ +   W +  L    +     ++ G  F      +LAA +GG RD  P IFSPL
Sbjct: 262 KHKNSKRKLAGWLLGFL----AGSVAGSLSGFVFSLLFKIVLAAVKGGGRDVGPAIFSPL 317

Query: 122 IKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           IK+ EDLAFLEK++  A+LE I     GEV+KAELPGS+G++I +KKIIQP K  AEL +
Sbjct: 318 IKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELPGSNGKMIAVKKIIQPPKDAAELSE 377

Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           +DS+ L+ KM QI+SEI T G +RHRN++PLLA + R DC  LVYEF +NGSLQD+L  V
Sbjct: 378 EDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCHYLVYEFMKNGSLQDVLNQV 437

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
           ++G+RELDWLARH+IA G+ASGLEYLH+SH P+IIHRD++PANVL+DDDMEARI++FGLA
Sbjct: 438 TEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRDLKPANVLLDDDMEARIADFGLA 497

Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
           K +PD  T  TT ++AGTVGYIAPE HQT+  ++ CDIYSFGV+L VLV+GK PSD FFQ
Sbjct: 498 KAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDIYSFGVVLGVLVMGKLPSDAFFQ 557

Query: 361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
            T+E+SLV+WMRN+M SENP++AI+ KL+G+G EEQMLLVLKIACFCT+DDP +RP+SKD
Sbjct: 558 STRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQMLLVLKIACFCTIDDPKQRPSSKD 617

Query: 421 VRCMLSQIQH 430
           VRCMLSQI+H
Sbjct: 618 VRCMLSQIKH 627

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum]

 Score =  469 bits (1208), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 221/325 (68%), Positives = 269/325 (82%), Gaps = 1/325 (0%)

Query: 107 RGGSRDRRPIIFSPLIKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITI 165
           R G  D    I+SPLIK+ EDLAFLEKED  ASLE I     GEVY+AELPGS+G++I I
Sbjct: 309 RKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGSNGKIIAI 368

Query: 166 KKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVY 225
           KKI+QP    AEL ++D++ L+ KM Q++SEI   GQ+RHRN++PLLA M R DC  LVY
Sbjct: 369 KKILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRPDCHYLVY 428

Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E+ +NGSLQDIL  V++G RELDWL RHRIA GIA+GLEYLH++H   IIHRD++PANVL
Sbjct: 429 EYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRDLKPANVL 488

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +DDDMEARI++FGLAK +PD HT  TT ++AGTVGYIAPE HQT+  +D CDIYSFGV+L
Sbjct: 489 LDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVVL 548

Query: 346 AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIAC 405
           AVLVIGK PSD+FFQHT EMSLV+W+RNVMTSE+P RAI+ KL+G+G+EEQMLLVLKIAC
Sbjct: 549 AVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQMLLVLKIAC 608

Query: 406 FCTLDDPNKRPNSKDVRCMLSQIQH 430
           FCTL++P +RPNSKDVRCML+QI+H
Sbjct: 609 FCTLENPKERPNSKDVRCMLTQIKH 633

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max]

 Score =  461 bits (1187), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 221/329 (67%), Positives = 267/329 (81%), Gaps = 1/329 (0%)

Query: 103 LAAGRGGSRDRRPIIFSPLIKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGR 161
           LA  +G  R   P I+SPLIK+ EDLAFLEKE+  ASLE I     GEVYKAELPGS+G+
Sbjct: 303 LALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSNGK 362

Query: 162 VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD 221
           +I IKKIIQP K GAEL ++DS+ L+ KM QIRSEI T GQ+RHRN++PLLA + R  C 
Sbjct: 363 MIAIKKIIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPGCH 422

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
            LVYEF +NGSL D L  V  G  ELDWL+RH+IA G+A+GLEYLH++H PRIIHRD++P
Sbjct: 423 YLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDLKP 482

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           AN+L+DDDMEARI++FGLAK +PD  T  TT ++AGTVGYIAPE HQ +  +D CDIYSF
Sbjct: 483 ANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSF 542

Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVL 401
           GV+L VLVIGK PS +FFQHT+EMSLV+WMR +++SENP  AI++KLLGNGYE+QMLLVL
Sbjct: 543 GVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLLVL 602

Query: 402 KIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           KIACFCT+DDP +RPNSKDV CMLSQI+H
Sbjct: 603 KIACFCTMDDPKERPNSKDVWCMLSQIKH 631

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus]

 Score =  457 bits (1176), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 215/330 (65%), Positives = 265/330 (80%), Gaps = 1/330 (0%)

Query: 102 ILAAGRGGSRDRRPIIFSP-LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSG 160
           ++AA +GGS++  P IF+P LIK +DLAFLE+++  ASL+ I     GEVYKAELP  SG
Sbjct: 304 VIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELPEKSG 363

Query: 161 RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDC 220
           ++  IKKI QP K  AELI+++S  +  KM QI+SEI T G++RHRN++PL+A + R DC
Sbjct: 364 KMFAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRPDC 423

Query: 221 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
             LVYE  +NGSLQD+L  VS G +ELDWL RH IA G+ASGLEYLHM+H PRIIHRD++
Sbjct: 424 HYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRDLK 483

Query: 281 PANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
           PANVL+DD MEARI++FGLAK +PD  T  T  ++AGTVGYIAPE HQT+  +D CDIY 
Sbjct: 484 PANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDIYG 543

Query: 341 FGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLV 400
           FGVLL VLVIGK PSD+FFQ+T EMSLV+WM+NVMTS+NP  AI+ KLLGNG+EEQMLL 
Sbjct: 544 FGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQMLLA 603

Query: 401 LKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           LKIACFCT+D+P +RPNSKDVRCMLSQI+H
Sbjct: 604 LKIACFCTMDNPKERPNSKDVRCMLSQIKH 633

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana]

 Score =  453 bits (1165), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 225/360 (62%), Positives = 272/360 (75%), Gaps = 5/360 (1%)

Query: 72  AWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKE-EDLAFL 130
           AW   +LG    + G  TI G  F      I+ A RG  +   P IFSPLIK+ EDLAFL
Sbjct: 286 AW---ILGFVVGAIG-GTISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFL 341

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           E E+  ASLE I     GEV+KAELPGS+G++I +KK+IQP K   EL  +DS+ L+ KM
Sbjct: 342 ENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKM 401

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
            QIRSEI T G +RHRN++PLLA + R +C  LVYE+   GSLQDIL DV  G +EL W 
Sbjct: 402 RQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWP 461

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           ARH+IA GIA+GLEYLHM H PRIIHRD++PANVL+DDDMEARIS+FGLAK +PD  T  
Sbjct: 462 ARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHI 521

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           TT  +AGTVGYIAPE +QT   +D CDIYSFGV+L +LVIGK PSD+FFQHT EMSL++W
Sbjct: 522 TTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKW 581

Query: 371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           MRN++TSENP+ AI+ KL+  G++EQMLLVLKIAC+CTLDDP +RPNSKDVR MLSQI+H
Sbjct: 582 MRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata]

 Score =  452 bits (1163), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 224/360 (62%), Positives = 273/360 (75%), Gaps = 5/360 (1%)

Query: 72  AWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKE-EDLAFL 130
           AW   +LG    + G  TI G  F      I+ A RG  +   P IFSPLIK+ EDLAFL
Sbjct: 286 AW---ILGFVVGAIG-GTISGFVFSVLFKLIIQAIRGSGKPSGPSIFSPLIKKAEDLAFL 341

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           E E+  ASLE I     GEV+KAELPGS+G++I +KK+IQP K   EL  +DS+ ++ KM
Sbjct: 342 ENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFMNKKM 401

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
            QIRSEI T GQ+RHRN++PLLA + R +C  LVYE+   GSLQDIL DV  G +EL W 
Sbjct: 402 RQIRSEISTVGQIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWP 461

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           ARH+IA GIA+GLEYLHM H PRIIHRD++PANVL+DDDMEARIS+FGLAK +PD  T  
Sbjct: 462 ARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKVMPDAVTHI 521

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           TT ++AGTVGYIAPE +QT   +  CDIYSFGV+L +LVIGK PSD+FFQHT EMSL++W
Sbjct: 522 TTSNVAGTVGYIAPEFYQTHKFTAKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKW 581

Query: 371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           MRN++TSENP+ AI+ KL+  G++EQMLLVLKIAC+CTLDDP +RPNSKDVR MLSQI+H
Sbjct: 582 MRNIITSENPSLAIDPKLMEQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana]

 Score =  452 bits (1162), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 225/360 (62%), Positives = 271/360 (75%), Gaps = 5/360 (1%)

Query: 72  AWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPIIFSPLIKE-EDLAFL 130
           AW   +LG    + G  TI G  F      I+ A RG  +   P IFSPLIK+ EDLAFL
Sbjct: 286 AW---ILGFVVGAIG-GTISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFL 341

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           E E+  ASLE I     GEV+KAELPGS+G++I +KK+IQP K   EL  +DS+ L+ KM
Sbjct: 342 ENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKM 401

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
            QIRSEI T G +RHRN++PLLA + R +C  LVYE+   GSLQDIL DV  G +EL W 
Sbjct: 402 RQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWP 461

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           ARH+IA GIA+GLEYLHM H PRIIHRD +PANVL+DDDMEARIS+FGLAK +PD  T  
Sbjct: 462 ARHKIALGIAAGLEYLHMDHNPRIIHRDSKPANVLLDDDMEARISDFGLAKAMPDAVTHI 521

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           TT  +AGTVGYIAPE +QT   +D CDIYSFGV+L +LVIGK PSD+FFQHT EMSL++W
Sbjct: 522 TTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKW 581

Query: 371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           MRN++TSENP+ AI+ KL+  G++EQMLLVLKIAC+CTLDDP +RPNSKDVR MLSQI+H
Sbjct: 582 MRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	430
TAIR|locus:2045228	641	SOBIR1 "SUPPRESSOR OF BIR1 1"	0.858	0.575	0.606	4.5e-114
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.613	0.235	0.380	1.9e-42
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.602	0.235	0.4	5.1e-42
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.606	0.270	0.379	2.1e-41
TAIR|locus:2025545	1029	AT1G08590 [Arabidopsis thalian	0.637	0.266	0.367	3.3e-41
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.616	0.254	0.362	4.1e-41
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.632	0.272	0.369	4.7e-41
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.613	0.235	0.362	1.7e-40
TAIR|locus:2183906	401	CRN "CORYNE" [Arabidopsis thal	0.686	0.735	0.343	2e-40
TAIR|locus:2007918	1088	PEPR2 "PEP1 receptor 2" [Arabi	0.593	0.234	0.392	5.4e-40

TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1125 (401.1 bits), Expect = 4.5e-114, P = 4.5e-114
 Identities = 227/374 (60%), Positives = 279/374 (74%)

Query:    58 MSKVKEVNARLQDIAWQINVLGLKESSGGKSTIVGQRFLTTTSRILAAGRGGSRDRRPII 117
             + K K+ + + +  AW   +LG    + G  TI G  F      I+ A RG  +   P I
Sbjct:   272 LKKKKKKSKKKKVAAW---ILGFVVGAIG-GTISGFVFSVLFKLIIQAIRGSEKPPGPSI 327

Query:   118 FSPLIKE-EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA 176
             FSPLIK+ EDLAFLE E+  ASLE I     GEV+KAELPGS+G++I +KK+IQP K   
Sbjct:   328 FSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDAD 387

Query:   177 ELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI 236
             EL  +DS+ L+ KM QIRSEI T G +RHRN++PLLA + R +C  LVYE+   GSLQDI
Sbjct:   388 ELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDI 447

Query:   237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
             L DV  G +EL W ARH+IA GIA+GLEYLHM H PRIIHRD++PANVL+DDDMEARIS+
Sbjct:   448 LTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISD 507

Query:   297 FGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
             FGLAK +PD  T  TT  +AGTVGYIAPE +QT   +D CDIYSFGV+L +LVIGK PSD
Sbjct:   508 FGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSD 567

Query:   357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP 416
             +FFQHT EMSL++WMRN++TSENP+ AI+ KL+  G++EQMLLVLKIAC+CTLDDP +RP
Sbjct:   568 EFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRP 627

Query:   417 NSKDVRCMLSQIQH 430
             NSKDVR MLSQI+H
Sbjct:   628 NSKDVRTMLSQIKH 641

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010942 "positive regulation of cell death" evidence=IMP

GO:0031349 "positive regulation of defense response" evidence=IMP

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0060862 "negative regulation of floral organ abscission" evidence=IGI

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 448 (162.8 bits), Expect = 1.9e-42, Sum P(2) = 1.9e-42
 Identities = 108/284 (38%), Positives = 166/284 (58%)

Query:   148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             G+VYKA+L    G+V+ IKK+I     G      D E          +E+ T G+++HRN
Sbjct:   819 GDVYKAQL--KDGKVVAIKKLIHVSGQG------DRE--------FTAEMETIGKIKHRN 862

Query:   208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
             +VPLL      +  LLVY++ + GSL+D+L+D  +  ++L+W AR +IA G A GL +LH
Sbjct:   863 LVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLH 922

Query:   268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
              +  P IIHRD++ +NVLID+ +EAR+S+FG+A+ +    T  +  +LAGT GY+ PE +
Sbjct:   923 HNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYY 982

Query:   328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
             Q+   +   D+YS+GV+L  L+ GK P+D      ++ +LV W++   T        + +
Sbjct:   983 QSFRCTTKGDVYSYGVVLLELLTGKPPTDSA-DFGEDNNLVGWVKQ-HTKLKITDVFDPE 1040

Query:   388 LLGN--GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
             LL      E ++L  LKIAC C  D P++RP    V  M  +IQ
Sbjct:  1041 LLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMFKEIQ 1084

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 5.1e-42, P = 5.1e-42
 Identities = 114/285 (40%), Positives = 165/285 (57%)

Query:   148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             G VYKAE+ G  G VI +KK    L S  E    D+          R+EI T G++RHRN
Sbjct:   811 GTVYKAEMSG--GEVIAVKK----LNSRGEGASSDNS--------FRAEISTLGKIRHRN 856

Query:   208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE--LDWLARHRIAQGIASGLEY 265
             IV L      ++ +LL+YE+   GSL + L    +G +   LDW AR+RIA G A GL Y
Sbjct:   857 IVKLYGFCYHQNSNLLLYEYMSKGSLGEQL---QRGEKNCLLDWNARYRIALGAAEGLCY 913

Query:   266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
             LH   RP+I+HRDI+  N+L+D+  +A + +FGLAK I   ++++ + ++AG+ GYIAPE
Sbjct:   914 LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPE 972

Query:   326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN-RAI 384
                T+ +++ CDIYSFGV+L  L+ GK P     Q      LV W+R  + +  P     
Sbjct:   973 YAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG---DLVNWVRRSIRNMIPTIEMF 1029

Query:   385 NSKLLGNGYE--EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ 427
             +++L  N      +M LVLKIA FCT + P  RP  ++V  M+++
Sbjct:  1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 449 (163.1 bits), Expect = 2.1e-41, P = 2.1e-41
 Identities = 105/277 (37%), Positives = 155/277 (55%)

Query:   147 NGEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
             +G VY+ EL   SG V+ +KK+  Q  K  A      SE   H   ++++E+ T G +RH
Sbjct:   667 SGTVYRVEL--KSGEVVAVKKLWSQSNKDSA------SEDKMHLNKELKTEVETLGSIRH 718

Query:   206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
             +NIV L +     DC LLVYE+  NG+L D L+   +G   L+W  RH+IA G+A GL Y
Sbjct:   719 KNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALH---KGFVHLEWRTRHQIAVGVAQGLAY 775

Query:   266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
             LH    P IIHRDI+  N+L+D + + ++++FG+AK +      +TT  +AGT GY+APE
Sbjct:   776 LHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPE 835

Query:   326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN-VMTSENPNRAI 384
                +   +  CD+YSFGV+L  L+ GK P D  F   K  ++V W+   + T E     +
Sbjct:   836 YAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENK--NIVNWVSTKIDTKEGLIETL 893

Query:   385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             + K L    +  M+  L++A  CT   P  RP   +V
Sbjct:   894 D-KRLSESSKADMINALRVAIRCTSRTPTIRPTMNEV 929

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)]

 Score = 436 (158.5 bits), Expect = 3.3e-41, Sum P(2) = 3.3e-41
 Identities = 104/283 (36%), Positives = 159/283 (56%)

Query:   148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             G VYKAE+       + +KK+ +      ++  +D      +   I  E+   G +RHRN
Sbjct:   726 GIVYKAEVMRRPLLTVAVKKLWRSPSPQNDI--EDHHQEEDEEDDILREVNLLGGLRHRN 783

Query:   208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
             IV +L  +      ++VYE+  NG+L   L+   +     DWL+R+ +A G+  GL YLH
Sbjct:   784 IVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLH 843

Query:   268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 P IIHRDI+  N+L+D ++EARI++FGLAK +   H   T   +AG+ GYIAPE  
Sbjct:   844 NDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMML--HKNETVSMVAGSYGYIAPEYG 901

Query:   328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN-VMTSENPNRAINS 386
              T+ + +  DIYS GV+L  LV GK P D  F+ +  + +V+W+R  V  +E+    I++
Sbjct:   902 YTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDS--IDVVEWIRRKVKKNESLEEVIDA 959

Query:   387 KLLGNGYE--EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ 427
              + G+     E+MLL L+IA  CT   P  RP+ +DV  ML++
Sbjct:   960 SIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAE 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 447 (162.4 bits), Expect = 4.1e-41, P = 4.1e-41
 Identities = 103/284 (36%), Positives = 160/284 (56%)

Query:   148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             G VYKAE+P  +G +I +KK+    K   ++ ++ S  L        +E+   G VRHRN
Sbjct:   731 GTVYKAEMP--NGEIIAVKKLWGKNKENGKIRRRKSGVL--------AEVDVLGNVRHRN 780

Query:   208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIAQGIASGLEYL 266
             IV LL     RDC +L+YE+  NGSL D+L+   +      +W A ++IA G+A G+ YL
Sbjct:   781 IVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYL 840

Query:   267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
             H    P I+HRD++P+N+L+D D EAR+++FG+AK I    + +    +AG+ GYIAPE 
Sbjct:   841 HHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESMSV---VAGSYGYIAPEY 897

Query:   327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
               T+ +    DIYS+GV+L  ++ GK   +  F      S+V W+R+ + ++     +  
Sbjct:   898 AYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGN--SIVDWVRSKLKTKEDVEEVLD 955

Query:   387 KLLGNG---YEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ 427
             K +G       E+M  +L+IA  CT   P  RP  +DV  +L +
Sbjct:   956 KSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 4.7e-41, Sum P(2) = 4.7e-41
 Identities = 105/284 (36%), Positives = 160/284 (56%)

Query:   147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
             +G+VYK EL G  G V+ +KK+ + +K G +    DS  L+  +    +E+ T G +RH+
Sbjct:   694 SGKVYKVELRG--GEVVAVKKLNKSVKGGDDEYSSDS--LNRDVFA--AEVETLGTIRHK 747

Query:   207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
             +IV L       DC LLVYE+  NGSL D+L+   +G   L W  R RIA   A GL YL
Sbjct:   748 SIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYL 807

Query:   267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGHTRTTTWSLAGTVGYIAP 324
             H    P I+HRD++ +N+L+D D  A++++FG+AK  ++    T      +AG+ GYIAP
Sbjct:   808 HHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAP 867

Query:   325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
             E   T+ +++  DIYSFGV+L  LV GK P+D      K+M+  +W+   +        I
Sbjct:   868 EYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD-KDMA--KWVCTALDKCGLEPVI 924

Query:   385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
             + KL    ++E++  V+ I   CT   P  RP+ + V  ML ++
Sbjct:   925 DPKL-DLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEV 967

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 442 (160.7 bits), Expect = 1.7e-40, P = 1.7e-40
 Identities = 107/295 (36%), Positives = 163/295 (55%)

Query:   147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
             +G VY+A L   SG+V  +K+++      A  I+ +   +         EI T G+VRHR
Sbjct:   838 HGIVYRASL--GSGKVYAVKRLVF-----ASHIRANQSMMR--------EIDTIGKVRHR 882

Query:   207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
             N++ L    +R+D  L++Y +   GSL D+L+ VS     LDW AR+ +A G+A GL YL
Sbjct:   883 NLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYL 942

Query:   267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
             H    P I+HRDI+P N+L+D D+E  I +FGLA+ + D    T T  + GT GYIAPE 
Sbjct:   943 HYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTAT--VTGTTGYIAPEN 1000

Query:   326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN---- 381
               +TV   ++ D+YS+GV+L  LV  K   D  F  + +  +V W+R+ ++S N N    
Sbjct:  1001 AFKTVRGRES-DVYSYGVVLLELVTRKRAVDKSFPESTD--IVSWVRSALSSSNNNVEDM 1057

Query:   382 ------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
                     +  +LL +   EQ++ V ++A  CT  DP  RP  +D   +L  ++H
Sbjct:  1058 VTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLEDVKH 1112

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2183906 CRN "CORYNE" [Arabidopsis thaliana (taxid:3702)]

 Score = 430 (156.4 bits), Expect = 2.0e-40, P = 2.0e-40
 Identities = 109/317 (34%), Positives = 177/317 (55%)

Query:   115 PIIFSPLIKEEDL-AFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
             P++FSP I  + L A L        ++ + S  NG+ YK  L   +G V+ +K++   L+
Sbjct:   101 PVVFSPKITPKSLHAALSN-----GIQLLGSDLNGKYYKMVL--DNGLVVAVKRL-GSLE 152

Query:   174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL 233
              G    +  S     + +Q   E++ AG +RHRN++ L A +   D   LVY++  NGSL
Sbjct:   153 -GVGSPESSSSKSVKRRLQKELELL-AG-LRHRNLMSLRAYVRESDEFSLVYDYMPNGSL 209

Query:   234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
             +D++  V     EL W  R R+A GI  GL+YLH S   +I+H +++P NV++D + E R
Sbjct:   210 EDVMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFEPR 269

Query:   294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF 353
             +++ GLAK +P  HT  + +S        APE  Q+   +D  DI+SFG++L VL+ G+ 
Sbjct:   270 LADCGLAKIMPSSHTAVSCYS--------APESSQSNRYTDKSDIFSFGMILGVLLTGRD 321

Query:   354 PSDDFFQHTKEM-SLVQWMRNVMTSENPNRAINSKLLGNGYEE-QMLLVLKIACFCTLDD 411
             P+  F + +    SL QW++++  S     A++  +LG   EE +ML+ L+I   C  D 
Sbjct:   322 PTHPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALRITIICLSDF 381

Query:   412 PNKRPNSKDVRCMLSQI 428
             P  RP+S ++  ML+Q+
Sbjct:   382 PADRPSSDELVHMLTQL 398

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009909 "regulation of flower development" evidence=RCA;IMP

GO:0010073 "meristem maintenance" evidence=IGI;RCA

GO:0010082 "regulation of root meristem growth" evidence=IGI

GO:0010075 "regulation of meristem growth" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0019900 "kinase binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0006406 "mRNA export from nucleus" evidence=RCA

GO:0007155 "cell adhesion" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010074 "maintenance of meristem identity" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0016570 "histone modification" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048449 "floral organ formation" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 5.4e-40, P = 5.4e-40
 Identities = 112/285 (39%), Positives = 164/285 (57%)

Query:   147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
             +G VY+A L   SG    +KK+I      AE I+ +          ++ EI T G VRHR
Sbjct:   805 HGVVYRASL--GSGEEYAVKKLIF-----AEHIRANQN--------MKREIETIGLVRHR 849

Query:   207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
             N++ L    +R++  L++Y++  NGSL D+L+  +QG   LDW AR  IA GI+ GL YL
Sbjct:   850 NLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYL 909

Query:   267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
             H    P IIHRDI+P N+L+D DME  I +FGLA+ + D    T T  + GT GYIAPE 
Sbjct:   910 HHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDSTVSTAT--VTGTTGYIAPEN 967

Query:   326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS--ENPNRA 383
              ++TV   ++ D+YS+GV+L  LV GK   D  F   +++++V W+R+V++S  +  + A
Sbjct:   968 AYKTVRSKES-DVYSYGVVLLELVTGKRALDRSFP--EDINIVSWVRSVLSSYEDEDDTA 1024

Query:   384 ---INSKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                ++ KL    L     EQ + V  +A  CT   P  RP+ +DV
Sbjct:  1025 GPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDV 1069

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0042277 "peptide binding" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	430
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-26
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-17
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.002
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.002
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  141 bits (358), Expect = 2e-39
 Identities = 83/274 (30%), Positives = 122/274 (44%), Gaps = 38/274 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VY A     +G+++ IK I           KK       +  +I  EI    +++H N
Sbjct: 13  GKVYLARD-KKTGKLVAIKVI-----------KKKKIKKDRE--RILREIKILKKLKHPN 58

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L       D   LV E+   G L D+L    +GR   D  AR  + Q I S LEYLH
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDE-ARFYLRQ-ILSALEYLH 114

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            S    I+HRD++P N+L+D+D   ++++FGLA+++  G   TT     GT  Y+APE  
Sbjct: 115 -SKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVL 168

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
                    DI+S GV+L  L+ GK P   F    + + L + +        P     S 
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPPFPPPEWDIS- 224

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                  E   L+ K        DP KR  +++ 
Sbjct: 225 ------PEAKDLIRK--LLVK--DPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  125 bits (316), Expect = 3e-33
 Identities = 86/277 (31%), Positives = 127/277 (45%), Gaps = 34/277 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYKA+  G+   V  +K +           KK SE    K    R EI    ++ H N
Sbjct: 13  GTVYKAKHKGTGKIVA-VKIL-----------KKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+     +D   LV E+   G L D L     G   L      +IA  I  GLEYLH
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGP--LSEDEAKKIALQILRGLEYLH 115

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            S+   IIHRD++P N+L+D++   +I++FGLAK++    +  TT    GT  Y+APE  
Sbjct: 116 -SNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVL 170

Query: 328 QTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
                     D++S GV+L  L+ GK P    F     +  +Q +R ++         + 
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLE---FDE 223

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC 423
               +G EE   L+ K        DP+KRP ++++  
Sbjct: 224 PKWSSGSEEAKDLIKKCLNK----DPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  123 bits (310), Expect = 6e-33
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
            G VY A    + G+ + IK I +   S               + ++  EI    ++ H 
Sbjct: 6   FGTVYLARDKKT-GKKVAIKIIKKEDSS-------------SLLEELLREIEILKKLNHP 51

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV L       +   LV E+   GSL+D+L    +   +L      RI   I  GLEYL
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYL 108

Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           H S+   IIHRD++P N+L+D D+ + ++++FGL+K +    +   T  + GT  Y+APE
Sbjct: 109 H-SNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPE 163

Query: 326 CH-QTVALSDTCDIYSFGVLLAVL 348
                   S+  DI+S GV+L  L
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  111 bits (280), Expect = 4e-28
 Identities = 79/267 (29%), Positives = 121/267 (45%), Gaps = 37/267 (13%)

Query: 157 GSSG---RVITIK-KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL 212
           GSSG   +V       I  LK     I  D +    K  Q+  E+ T        +V   
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKK----IHVDGDEEFRK--QLLRELKTLRSCESPYVVKCY 65

Query: 213 ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR 271
                ++ ++ +V E+   GSL D+L  V     E   LA   IA+ I  GL+YLH    
Sbjct: 66  G-AFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPV-LAY--IARQILKGLDYLHTKRH 120

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA 331
             IIHRDI+P+N+LI+   E +I++FG++K + +   +  T+   GTV Y++PE  Q  +
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGES 176

Query: 332 LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGN 391
            S   DI+S G+ L    +GKFP    F    + S  + M+ +     P+      L   
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICDGPPPS------LPAE 226

Query: 392 GYEEQMLLVLK--IACFCTLDDPNKRP 416
            +  +     +  I+  C   DP KRP
Sbjct: 227 EFSPEF----RDFISA-CLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 72/220 (32%), Positives = 106/220 (48%), Gaps = 24/220 (10%)

Query: 135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIR 194
            F  LEKI     GEVYKA     +G+ + IK I   L+S     K+  E +        
Sbjct: 1   LFEILEKIGKGGFGEVYKA-RHKRTGKEVAIKVI--KLES-----KEKKEKII------- 45

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +EI    + +H NIV      +++D   +V EF   GSL+D+L   +        +A   
Sbjct: 46  NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAY-- 102

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +  GLEYLH S+   IIHRDI+ AN+L+  D E ++ +FGL+ ++ D   R T   
Sbjct: 103 VCKELLKGLEYLH-SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM-- 157

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             GT  ++APE           DI+S G+    L  GK P
Sbjct: 158 -VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  105 bits (265), Expect = 5e-26
 Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY A     +G ++ +K +            + S     ++  +  EI     ++H N
Sbjct: 14  GSVYLALD-KDTGELMAVKSV------------ELSGDSEEELEALEREIRILSSLQHPN 60

Query: 208 IVPLLARMVRRDCD-LLVY-EFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLE 264
           IV         + + L ++ E+   GSL  +L     G+  E   + R    Q I  GL 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEP--VIRKYTRQ-ILEGLA 115

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YLH S+   I+HRDI+ AN+L+D D   ++++FG AKR+ D  T   T S+ GT  ++AP
Sbjct: 116 YLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
           E  +        DI+S G  +  +  GK P   + +    M+ +   +   + E P   I
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAAL--YKIGSSGEPPE--I 225

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
              L      E+    L+  C     DP KRP 
Sbjct: 226 PEHLS-----EEAKDFLR-KCLRR--DPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  102 bits (258), Expect = 4e-25
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 22/201 (10%)

Query: 148 GEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEVYK  L      +   + +K     LK GA            +  +   E     ++ 
Sbjct: 13  GEVYKGTLKGDGEGTETKVAVKT----LKEGAS---------EEEREEFLEEASIMKKLS 59

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NIV LL    + +   +V E+   G L D L        +L      ++A  IA G+E
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGME 116

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YL  S     +HRD+   N L+ +++  +IS+FGL++ I +             + ++AP
Sbjct: 117 YLE-SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Query: 325 ECHQTVALSDTCDIYSFGVLL 345
           E  +    +   D++SFGVLL
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLL 194

Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (260), Expect = 8e-25
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 33/282 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-R 206
           GEVY A       +++ +K +            K  E    ++ +   EI     + H  
Sbjct: 14  GEVYLARDR----KLVALKVL-----------AKKLESKSKEVERFLREIQILASLNHPP 58

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV L           LV E+   GSL+D+L  + +     +  A   +AQ I S LEYL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ-ILSALEYL 117

Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTW----SLAGTVGY 321
           H      IIHRDI+P N+L+D D    ++ +FGLAK +PD  + ++      +  GT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 322 IAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE 378
           +APE          S + DI+S G+ L  L+ G  P +     +     ++ +  + T  
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
             +  ++        +    L+ K        DP  R +S  
Sbjct: 235 LAS-PLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  101 bits (255), Expect = 1e-24
 Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 39/221 (17%)

Query: 140 EKIRSCWNGEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI 197
           +K+     GEVYK +L G  G+     +K     LK  A   ++              E 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEER---------KDFLKEA 47

Query: 198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----YDVSQGRRELDWLAR 252
               ++ H N+V LL      +   LV E+   G L D L        S  +  L     
Sbjct: 48  RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
              A  IA G+EYL      + +HRD+   N L+ +D+  +IS+FGL++ + D       
Sbjct: 108 LSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164

Query: 313 --------WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                   W        +APE  +    +   D++SFGVLL
Sbjct: 165 TGGKLPIRW--------MAPESLKDGIFTSKSDVWSFGVLL 197

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (254), Expect = 2e-24
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 22/201 (10%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEVYK  L G          +K +           K+D+     +      E     ++ 
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTL-----------KEDASEQQIEEF--LREARIMRKLD 59

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NIV LL      +  ++V E+   G L D L       +EL        A  IA G+E
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGME 117

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YL  S     IHRD+   N L+ +++  +IS+FGL++ + D             + ++AP
Sbjct: 118 YLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAP 173

Query: 325 ECHQTVALSDTCDIYSFGVLL 345
           E  +    +   D++SFGVLL
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLL 194

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  100 bits (252), Expect = 2e-24
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 23/201 (11%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEVYK +L G  G+      +K +           K+D+     +      E     ++ 
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTL-----------KEDASEQQIEEF--LREARIMRKLD 59

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H N+V LL      +   +V E+   G L   L    + R +L        A  IA G+E
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGME 116

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YL  S     IHRD+   N L+ +++  +IS+FGL++ + D             + ++AP
Sbjct: 117 YLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAP 172

Query: 325 ECHQTVALSDTCDIYSFGVLL 345
           E  +    +   D++SFGVLL
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLL 193

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (253), Expect = 6e-23
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 20/230 (8%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SEI   G+++H NIV L+          L++E+    +L ++L       R L W  R +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           IA GIA  L +LH    P ++  ++ P  ++ID   E       L   +P      T   
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCF 839

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHTKEMSLVQWMRN 373
           ++    Y+APE  +T  +++  DIY FG++L  L+ GK P+D +F  H    S+V+W R 
Sbjct: 840 ISS--AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG---SIVEWARY 894

Query: 374 VMTSENPNRAINSKLLGNG--YEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             +  + +  I+  + G+    + +++ V+ +A  CT  DP  RP + DV
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
            G VYK  L   +G  + IK+I         L K   E     +  I  EI     ++H 
Sbjct: 13  FGVVYKG-LNLETGDFVAIKQI--------SLEKIKEE----ALKSIMQEIDLLKNLKHP 59

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV  +  +   D   ++ E+  NGSL+ I+     G      +A + + Q +  GL YL
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVY-VYQ-VLQGLAYL 115

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      +IHRDI+ AN+L   D   ++++FG+A ++ D      +  + GT  ++APE 
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            +    S   DI+S G  +  L+ G  P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 9e-21
 Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 8/107 (7%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I   LEYLH      II+RD++P N+L+D D   ++++FGLAK +    +RT T    GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
             Y+APE           D +S GVLL  ++ GK P   F+   ++ 
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 19/218 (8%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ-IRSEIITAGQVRHR 206
           G VY   +  SSG ++ +K++  P       +   S+     M+  +  EI    +++H 
Sbjct: 14  GSVYLG-MNASSGELMAVKQVELPS------VSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV  L   +  D   +  E+   GS+  +L +   G  E + L R+ + Q I  GL YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFVRQ-ILKGLNYL 122

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW----SLAGTVGYI 322
           H      IIHRDI+ AN+L+D+    +IS+FG++K++      T T     SL G+V ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
           APE  +  + +   DI+S G L+  ++ GK P  D  Q
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 139 LEKIRSCWNGEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMI-QIRSE 196
             KI     G+VY A +   +G ++ +K+I IQ                  K I +I  E
Sbjct: 5   GNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDND--------------PKTIKEIADE 49

Query: 197 IITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA 256
           +     ++H N+V      V R+   +  E+   G+L+++L    +  R LD        
Sbjct: 50  MKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYT 105

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW--S 314
             +  GL YLH      I+HRDI+PAN+ +D +   ++ +FG A ++ +  T       S
Sbjct: 106 LQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 315 LAGTVGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFP 354
           LAGT  Y+APE              DI+S G ++  +  GK P
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 25/226 (11%)

Query: 139 LEKIRSCWNGEVYKAE-LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI 197
           +E I       VY A  LP      + IK+I        +L K  +      + ++R E+
Sbjct: 6   IEVIGVGATAVVYAAICLPN--NEKVAIKRI--------DLEKCQTS-----VDELRKEV 50

Query: 198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQGRRELDWLARHRIA 256
               Q  H N+V      V  D   LV  +   GSL DI+     +G  +   +A   + 
Sbjct: 51  QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--VL 108

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT--TTWS 314
           + +  GLEYLH       IHRDI+  N+L+ +D   +I++FG++  + DG  RT     +
Sbjct: 109 KEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 315 LAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF 359
             GT  ++APE   Q        DI+SFG+    L  G  P   + 
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 25/175 (14%)

Query: 194 RSEIITAGQVRH----RNIV-----PLLARMVR--RDCDLLVY---EFRRNGSLQDILYD 239
           +  I+  GQ  H    + I+     P + ++ R  +D    +Y   E+   G L  IL D
Sbjct: 28  KRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGELWTILRD 86

Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
              G  + ++ AR  IA  +    EYLH      II+RD++P N+L+D +   ++ +FG 
Sbjct: 87  R--GLFD-EYTARFYIAC-VVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGF 139

Query: 300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           AK++  G     TW+  GT  Y+APE         + D +S G+LL  L+ G+ P
Sbjct: 140 AKKLKSG---QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 34/219 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VYKA     +GR++ IKKI    K G    K+  + ++     +R EI    +++H N
Sbjct: 14  AVVYKAR-DKETGRIVAIKKI----KLGER--KEAKDGIN--FTALR-EIKLLQELKHPN 63

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH--RIAQGIASGLEY 265
           I+ LL     +    LV+EF     L+ ++ D     + +                GLEY
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKD-----KSIVLTPADIKSYMLMTLRGLEY 117

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      I+HRD++P N+LI  D   ++++FGLA+     + + T      T  Y APE
Sbjct: 118 LH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVVTRWYRAPE 172

Query: 326 C-----HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                 H  V      D++S G + A L++     P D 
Sbjct: 173 LLFGARHYGVG----VDMWSVGCIFAELLLRVPFLPGDS 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 74/228 (32%), Positives = 105/228 (46%), Gaps = 31/228 (13%)

Query: 202 QVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHR----IA 256
           +V  R IV L A   +   DL LV      G L+  +Y+V +   E       R     A
Sbjct: 49  KVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE---ENPGFPEPRACFYTA 104

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
           Q I SGLE+LH     RII+RD++P NVL+D+D   RIS+ GLA  + DG ++T  +  A
Sbjct: 105 Q-IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY--A 158

Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           GT G++APE  Q      + D ++ GV L  ++  + P    F+   E         V  
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP----FRARGE--------KVEN 206

Query: 377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD-DPNKRPNSKDVRC 423
            E   R +N  +    Y ++     K  C   L  DP KR   +D  C
Sbjct: 207 KELKQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 50/145 (34%), Positives = 73/145 (50%), Gaps = 13/145 (8%)

Query: 223 LVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
           LV      G L+  +Y+V + G  E    A    AQ I  GLE+LH   + RI++RD++P
Sbjct: 70  LVMTLMNGGDLKYHIYNVGEPGFPEAR--AIFYAAQ-IICGLEHLH---QRRIVYRDLKP 123

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
            NVL+DD    RIS+ GLA  +  G         AGT GY+APE  Q      + D ++ 
Sbjct: 124 ENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMS 366
           G  L  ++ G+ P   F Q  +++ 
Sbjct: 181 GCTLYEMIAGRSP---FRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 79.8 bits (198), Expect = 6e-17
 Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 55/284 (19%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VY      S G++  +K+I   L + +E  ++D+           +E+    ++ H N
Sbjct: 14  GKVYLVR-RKSDGKLYVLKEI--DLSNMSEKEREDAL----------NEVKILKKLNHPN 60

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI----AQGIASGL 263
           I+        +    +V E+   G L   +    + ++E       +I     Q +   L
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILDWFVQ-LCLAL 116

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VG-- 320
           +YLH S +  I+HRDI+P N+ +  +   ++ +FG++K        ++T  LA T VG  
Sbjct: 117 KYLH-SRK--ILHRDIKPQNIFLTSNGLVKLGDFGISK------VLSSTVDLAKTVVGTP 167

Query: 321 -YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            Y++PE  Q    +   DI+S G +L  L   K P    F+    + L      ++  + 
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLEL---ALKILKGQY 220

Query: 380 PNRAINSKLLGNGYEEQML-LVLKIACFCTLD-DPNKRPNSKDV 421
           P   I S+     Y  ++  LV  +     L  DP +RP+   +
Sbjct: 221 P--PIPSQ-----YSSELRNLVSSL-----LQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 8e-17
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 30/199 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ-IRSEIITAGQVRHR 206
           G+V   +     G+ + +K +            KD         Q   +E      +RH 
Sbjct: 20  GDVMLGDY---RGQKVAVKCL------------KD----DSTAAQAFLAEASVMTTLRHP 60

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           N+V LL  +++ +   +V E+   GSL D L   S+GR  +    +   A  +  G+EYL
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYL 118

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                   +HRD+   NVL+ +D+ A++S+FGLAK    G       S    V + APE 
Sbjct: 119 EEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEA 170

Query: 327 HQTVALSDTCDIYSFGVLL 345
            +    S   D++SFG+LL
Sbjct: 171 LREKKFSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 38/284 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V K  L  + G +  +K            I  D  P   K  QI  E+      +   
Sbjct: 15  GSVTKCRLKNT-GMIFALK-----------TITTDPNPDLQK--QILRELEINKSCKSPY 60

Query: 208 IVPLL-ARMVRRDCDL-LVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIAQGIASGLE 264
           IV    A +      + +  E+   GSL  I   V  +G R  + +   +IA+ +  GL 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVLKGLS 119

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YLH     +IIHRDI+P+N+L+    + ++ +FG++  + +    T T    GT  Y+AP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAP 172

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL--VQWMRNVMTSENPNR 382
           E  Q    S T D++S G+ L  +   +FP    F    E  L  ++ +  ++   NP  
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNMPNP-E 227

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
             +    G  + E+    +     C   DP +RP   D   ML 
Sbjct: 228 LKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWD---MLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           ++ +  +++I S   G+VYKA    ++G ++ IK I   L+ G +               
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVI--KLEPGDDFE------------I 46

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I+ EI    + RH NIV      +RRD   +V E+   GSLQDI Y V++G      +A 
Sbjct: 47  IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAY 105

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             + +    GL YLH + +   IHRDI+ AN+L+ +D + ++++FG++ ++    T    
Sbjct: 106 --VCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKR 158

Query: 313 WSLAGTVGYIAPECHQTVALSD---TCDIYSFGV 343
            S  GT  ++APE             CDI++ G+
Sbjct: 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 148 GEVYKAELPGSSGRVITIK--KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G VY+  L    G    +K   +    ++G E +K           Q+  EI    +++H
Sbjct: 14  GSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVK-----------QLEQEIALLSKLQH 61

Query: 206 RNIVPLLARMVRRDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
            NIV  L    R + +L ++ E    GSL  +L         +    R    Q I  GLE
Sbjct: 62  PNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQ-ILLGLE 116

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YLH  +    +HRDI+ AN+L+D +   ++++FG+AK++      +   S  G+  ++AP
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAP 170

Query: 325 E-CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
           E   Q        DI+S G  +  +  GK P      
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 36/274 (13%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKD---SEPLHHKMIQIRSEIITAGQVRHRNIVPLLA 213
           GS G V    + ++    G  L+ K+         +  Q+ SE+    +++H NIV    
Sbjct: 11  GSFGTV----RKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 214 RMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLEYLH- 267
           R++ R    L  V E+   G L  +   + + ++E  ++      RI   +   L   H 
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 268 -MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                  ++HRD++PAN+ +D +   ++ +FGLAK +    +   T+   GT  Y++PE 
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMSPEQ 181

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
              ++  +  DI+S G L+  L     P    F    ++ L   ++       P R    
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQLASKIKEGKFRRIPYR---- 233

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
                 Y  ++  V+K        DP+KRP++++
Sbjct: 234 ------YSSELNEVIK---SMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 7/120 (5%)

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 294
           D+ Y +SQ  +  +   +  I + I   LEYLH S    IIHRDI+P N+L+D+     I
Sbjct: 86  DLRYHLSQKVKFSEEQVKFWICE-IVLALEYLH-SKG--IIHRDIKPDNILLDEQGHVHI 141

Query: 295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           ++F +A ++      T+T   +GT GY+APE       S   D +S GV     + GK P
Sbjct: 142 TDFNIATKVTPDTLTTST---SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 19/199 (9%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV +  L     + I +   I+ LK+G+   K+  + L         E    GQ  H N
Sbjct: 18  GEVCRGRLKLPGKKEIDVA--IKTLKAGSS-DKQRLDFLT--------EASIMGQFDHPN 66

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL- 266
           I+ L   + +    +++ E+  NGSL   L    +   +        + +GIASG++YL 
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
            M++    +HRD+   N+L++ ++  ++S+FGL++R+ D     TT      + + APE 
Sbjct: 124 EMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 327 HQTVALSDTCDIYSFGVLL 345
                 +   D++SFG+++
Sbjct: 180 IAYRKFTSASDVWSFGIVM 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.2 bits (191), Expect = 9e-16
 Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 28/180 (15%)

Query: 196 EIITAGQVRH----RNIV-----PLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQ 242
           +I+   QV H    + I+     P L  +     D     LV E+   G L   L     
Sbjct: 38  KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKS 95

Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
           GR      AR   AQ +   LEYLH      I++RD++P N+L+D D   +I++FG AKR
Sbjct: 96  GRFPEPV-ARFYAAQ-VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR 150

Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
           +        T++L GT  Y+APE   +       D ++ G+L+  ++ G  P   FF   
Sbjct: 151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP---FFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
            + + +LEKI    +GEVYKA    + G+ + IKK+          ++K ++ L      
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRAT-GKEVAIKKMR---------LRKQNKEL------ 61

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY--DVSQGRRELDWL 250
           I +EI+     +H NIV      +  D   +V E+   GSL DI+    V         +
Sbjct: 62  IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------M 113

Query: 251 ARHRIA---QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
              +IA   + +  GLEYLH  +    IHRDI+  N+L+  D   ++++FG A ++    
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           ++    S+ GT  ++APE  +        DI+S G++ 
Sbjct: 171 SKRN--SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMC 206

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 35/174 (20%)

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
            H  I+ L       +    V E+  NG L   +     G  +     R   A+ I   L
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLAL 115

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK------------------RIPD 305
           EYLH      IIHRD++P N+L+D DM  +I++FG AK                      
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGKFP 354
              R    S  GT  Y++PE      L++       D+++ G ++  ++ GK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPEL-----LNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 12/163 (7%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +V  R +V L      +D   LV      G L+  +Y + +   E      +  A  I  
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEICC 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GLE LH   + RI++RD++P N+L+DD    RIS+ GLA  +P+G T        GTVGY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRVGTVGY 167

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           +APE  +    + + D ++ G LL  ++ G+ P    FQ  K+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQRKK 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 45/129 (34%), Positives = 70/129 (54%), Gaps = 9/129 (6%)

Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E+   GSL D +    QGR     L +  IA  +  GL YLH  H+  IIHRD++P+N+L
Sbjct: 79  EYMDGGSL-DKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIHRDVKPSNIL 133

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           ++   + ++ +FG++ ++ +   +T      GT  Y+APE  Q    S   DI+S G+ L
Sbjct: 134 VNSRGQIKLCDFGVSGQLVNSLAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSL 189

Query: 346 AVLVIGKFP 354
             L  G+FP
Sbjct: 190 IELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII 198
           LE++     G+VYK EL G + R+      I+ LK  AE   +          + R E  
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---------EFRQEAE 60

Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRE 246
               ++H NIV LL    +     +++E+  +G L + L                  +  
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           LD      IA  IA+G+EYL   H    +HRD+   N L+ + +  +IS+FGL++ I   
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            + R  + SL   V ++ PE       +   DI+SFGV+L
Sbjct: 178 DYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 31/214 (14%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E+ F  LEK+     G VYKA +   +G+V+ IK +  P++   + I K           
Sbjct: 2   EEVFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVV--PVEEDLQEIIK----------- 47

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
              EI    Q     IV       +     +V E+   GS+ DI+      +     L  
Sbjct: 48  ---EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM------KITNKTLTE 98

Query: 253 HRIA---QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
             IA        GLEYLH +   + IHRDI+  N+L++++ +A++++FG++ ++    T 
Sbjct: 99  EEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTM 153

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
               ++ GT  ++APE  Q +  ++  DI+S G+
Sbjct: 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 15/213 (7%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY A L  ++G ++ +K++  P    A +  +        +  +RSEI T   + H N
Sbjct: 15  GRVYLA-LNVTTGEMMAVKQVELP----ATIAGRHDSRQKDMVKALRSEIETLKDLDHLN 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV  L      +   +  E+   GS+   L   + GR E   L R    Q +  GL YLH
Sbjct: 70  IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQ-LVRFFTEQ-VLEGLAYLH 125

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 I+HRD++  N+L+D D   +IS+FG++K+  D +      S+ G+V ++APE  
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 328 QT--VALSDTCDIYSFGVLLAVLVIGKFP-SDD 357
            +     S   DI+S G ++  +  G+ P SD+
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 41/294 (13%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F    K+ S + GEV++          I I             +K D   L  +  Q   
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKI-------------LKSDDL-LKQQDFQ--K 51

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E+    ++RH++++ L A     +   ++ E    GSL   L    +G+  L   +   +
Sbjct: 52  EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLIDM 109

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
           A  +A G+ YL   +    IHRD+   N+L+ +D+  ++++FGLA+ I +    ++   +
Sbjct: 110 ACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNV 374
                + APE       S   D++SFG+LL  +   G+ P      H     +    R  
Sbjct: 167 P--YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP 224

Query: 375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
             ++ P               Q +  + + C+    +P  RP+ K +R  L  I
Sbjct: 225 CPAKCP---------------QEIYKIMLECWAA--EPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 64/233 (27%), Positives = 96/233 (41%), Gaps = 41/233 (17%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  L KI     G VYKA     +G ++ IKKI    +S                  +R 
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLRFESEG-----------IPKTALR- 47

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NI+ LL     +    LV+EF     +   LY + + R+    L    I
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF-----MDTDLYKLIKDRQRG--LPESLI 100

Query: 256 A---QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRT- 310
                 +  GL + H SH   I+HRD++P N+LI+ +   ++++FGLA+         T 
Sbjct: 101 KSYLYQLLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157

Query: 311 ---TTWSLAGTVGYIAPECHQTVALSDT-CDIYSFGVLLAVLVIGK--FPSDD 357
              T W       Y APE         T  DI+S G + A L+  +  FP   
Sbjct: 158 YVVTRW-------YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 45/133 (33%), Positives = 64/133 (48%), Gaps = 25/133 (18%)

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI--------AQGIASGLEYLHMSHRPR 273
            L+ E+   GSL              D+L +H++        AQ I  G+ YLH  H   
Sbjct: 84  QLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH--- 127

Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVAL 332
            IHRD+   NVL+D+D   +I +FGLAK +P+GH          + V + A EC +    
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187

Query: 333 SDTCDIYSFGVLL 345
           S   D++SFGV L
Sbjct: 188 SYASDVWSFGVTL 200

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 43/144 (29%), Positives = 65/144 (45%), Gaps = 7/144 (4%)

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H N++ L   +V     ++V E    GSL D L   + G   +  L     A  IA+G
Sbjct: 53  LDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTL--CDYAVQIANG 109

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGY 321
           + YL      R IHRD+   N+L+  D + +I +FGL + +P           L     +
Sbjct: 110 MRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166

Query: 322 IAPECHQTVALSDTCDIYSFGVLL 345
            APE  +T   S   D++ FGV L
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 7/154 (4%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A     +   +V E+   GSL D L      +  L  L    +A  IA 
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD--MAAQIAE 114

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ YL        IHRD+   N+L+ +++  +I++FGLA+ I D    T        + +
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKW 170

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 24/228 (10%)

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E+ F  LE+I     GEVYK  +   +  V+ IK I             D E    ++
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII-------------DLEEAEDEI 46

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I+ EI    Q     I       ++     ++ E+   GS  D+L     G  E  ++
Sbjct: 47  EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYI 103

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A   I + I  GL+YLH     R IHRDI+ ANVL+ +  + ++++FG+A ++ D   + 
Sbjct: 104 AT--ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            T+   GT  ++APE  +  A     DI+S G+    L  G+ P+ D 
Sbjct: 159 NTF--VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 17/173 (9%)

Query: 179 IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL--LARMVRRDCDLLVYEFRRNGSLQDI 236
           +    E  H        EI     + H NIV    +          L+ E+  +GSL+D 
Sbjct: 41  LNHSGEEQH--RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDY 98

Query: 237 LYDVSQGRRELDWLARHRI---AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
           L      +R  D +   R+   +  I  G++YL      R IHRD+   N+L++ +   +
Sbjct: 99  L------QRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVK 149

Query: 294 ISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSFGVLL 345
           IS+FGLAK +P+            + + + APEC +T   S   D++SFGV L
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 44/109 (40%), Positives = 61/109 (55%), Gaps = 10/109 (9%)

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
           A  I  GLE LH   R RI++RD++P N+L+DD    RIS+ GLA  IP+G    T    
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGR 161

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
            GTVGY+APE  +    + + D +  G L+  ++ GK P    F+  KE
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 48/136 (35%), Positives = 72/136 (52%), Gaps = 8/136 (5%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV      G L+  +Y+V +   E++ +  H  AQ I  G+  LH+ H   I++RD++P 
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVI-HYSAQ-ITCGI--LHL-HSMDIVYRDMKPE 124

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           NVL+DD    R+S+ GLA  + DG T T     AGT GY+APE  +    S   D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVDWFAMG 181

Query: 343 VLLAVLVIGKFPSDDF 358
             +  +V G+ P  D 
Sbjct: 182 CSIYEMVAGRTPFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 31/223 (13%)

Query: 126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP 185
           DL+    ++ F  +++I S   G+VYKA    ++G +  IK I   L+ G +        
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIKVI--KLEPGEDFA------ 51

Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR 245
                  ++ EII     +H NIV      +RRD   +  EF   GSLQDI Y V+    
Sbjct: 52  ------VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGPLS 104

Query: 246 ELD--WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           E    +++R  +      GL YLH   +   +HRDI+ AN+L+ D+   ++++FG++ +I
Sbjct: 105 ESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI 156

Query: 304 PDGHTRTTTWSLAGTVGYIAPE---CHQTVALSDTCDIYSFGV 343
               T     S  GT  ++APE     +    +  CDI++ G+
Sbjct: 157 --TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 10/167 (5%)

Query: 179 IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY 238
           +K+D+  +     +   E     +++H N+V LL    R     ++ EF   G+L D L 
Sbjct: 39  LKEDTMEVE----EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 94

Query: 239 DVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 298
           +    R+E++ +    +A  I+S +EYL   +    IHRD+   N L+ ++   ++++FG
Sbjct: 95  EC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 149

Query: 299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           L+ R+  G T T        + + APE       S   D+++FGVLL
Sbjct: 150 LS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 12/162 (7%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           +E     Q+RH N+V LL  +V     L +V E+   GSL D L   S+GR  L      
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLL 105

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           + +  +   +EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T 
Sbjct: 106 KFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG 159

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            L   V + APE  +    S   D++SFG+LL  +   G+ P
Sbjct: 160 KLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 12/154 (7%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++ H+N+V LL  ++      +V E    G+L + L   ++GR  +  +   + +  +A 
Sbjct: 55  KLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAE 111

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+EYL      +++HRD+   N+L+ +D  A++S+FGLA+    G   +        V +
Sbjct: 112 GMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKW 163

Query: 322 IAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            APE  +    S   D++S+GVLL  V   G+ P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 12/163 (7%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +V  R +V L      +D   LV      G L+  +Y++  G    D       A  +  
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCC 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GLE L    R RI++RD++P N+L+DD    RIS+ GLA +IP+G    T     GTVGY
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGY 167

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           +APE       + + D +  G L+  ++ G+ P    F+  KE
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 42/236 (17%)

Query: 148 GEVYKAEL----PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V+  E     P +   ++ +K            +K+ +     K  +  +E++T  Q 
Sbjct: 19  GKVFLGECYHLEPENDKELVAVK-----------TLKETASNDARKDFEREAELLTNFQ- 66

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQD----------ILYDVSQGRRELDWLARH 253
            H NIV         D  ++V+E+  +G L             L        EL      
Sbjct: 67  -HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  IASG+ YL   H    +HRD+   N L+  D+  +I +FG+++ +      T  +
Sbjct: 126 QIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDYY 178

Query: 314 SLAGT----VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKE 364
            + G     + ++ PE       +   D++SFGV+L  +   GK P   ++  + E
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 19/180 (10%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  +  GL YL+  HR  I+HRDI+P+N+L++   + ++ +FG++  + +    T   
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--- 161

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP----SDDFFQHTKEMSLVQ 369
              GT  Y++PE  Q    +   D++S G+ +  L +GKFP    + D       M ++ 
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220

Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            ++ ++    P      +L  + + E +   +     C L DP +RP  + +  M   IQ
Sbjct: 221 LLQQIVQEPPP------RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 24/196 (12%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           +V E+  NG L  +L    Q  R L      R    I  GL +LH     +I+HRDI+  
Sbjct: 76  IVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSL 130

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           N+ +D     +I + G+AK + D      T  + GT  Y++PE  +    ++  D+++ G
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALG 188

Query: 343 VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK 402
           V+L     GK P    F    + +L+     ++    P        +   Y +Q+  ++ 
Sbjct: 189 VVLYECCTGKHP----FDANNQGALI---LKIIRGVFPP-------VSQMYSQQLAQLID 234

Query: 403 IACFCTLDDPNKRPNS 418
               C   D  +RP++
Sbjct: 235 Q---CLTKDYRQRPDT 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 24/227 (10%)

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E+ F  LE+I     GEV+K  +   + +V+ IK I             D E    ++
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII-------------DLEEAEDEI 46

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I+ EI    Q     +       ++     ++ E+   GS  D+L          D  
Sbjct: 47  EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEF 101

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               + + I  GL+YLH   +   IHRDI+ ANVL+ +  + ++++FG+A ++ D   + 
Sbjct: 102 QIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            T+   GT  ++APE  Q  A     DI+S G+    L  G+ P+ D
Sbjct: 159 NTF--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 44/287 (15%)

Query: 148 GEVYKA--ELPGSSGRVITIKKIIQPLKSG-AELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEV++   ++PG     + IK     LK G  E  ++D            SE    GQ  
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKT----LKPGYTEKQRQD----------FLSEASIMGQFS 64

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ L   + +    +++ E+  NG+L   L D   G  E        + +GIA+G++
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDG--EFSSYQLVGMLRGIAAGMK 121

Query: 265 YL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYI 322
           YL  M++    +HRD+   N+L++ ++E ++S+FGL++ + D    T T S     + + 
Sbjct: 122 YLSDMNY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN 381
           APE       +   D++SFG+++  V+  G+ P  D   H    ++    R     + P+
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPS 237

Query: 382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
            A+   +L                 C   D  +RP   D+  +L ++
Sbjct: 238 -AVYQLMLQ----------------CWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 20/170 (11%)

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDW 249
            QI  EI     V H N+V     M   + ++ ++ EF   GSL+        G    D 
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLLEFMDGGSLE--------GTHIADE 167

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
                +A+ I SG+ YLH  H   I+HRDI+P+N+LI+     +I++FG+++ +    T 
Sbjct: 168 QFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTM 222

Query: 310 TTTWSLAGTVGYIAPECHQT---VALSDTC--DIYSFGVLLAVLVIGKFP 354
               S  GT+ Y++PE   T       D    DI+S GV +    +G+FP
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 8/154 (5%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +VPL A +V  +   +V EF   GSL D L +      +L  L    +A  IA 
Sbjct: 57  KLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIAD 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   IHRD++ AN+L+ D++  +I++FGLA+ I D +  T        + +
Sbjct: 114 GMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKW 169

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  LV  G+ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 30/255 (11%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSE-IITAGQVRHRNIVPLLARM 215
           G+ G V   KK         +++KK      +++  +++E  I   Q     +  L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRII 275
             +D   LV E+   G    ++  +  G    DW A+  IA+ +  G+E LH      II
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDW-AKQYIAE-VVLGVEDLHQRG---II 119

Query: 276 HRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           HRDI+P N+LID     ++++FGL+ R    + +       GT  Y+APE    V     
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLS-RNGLENKK-----FVGTPDYLAPETILGVGDDKM 173

Query: 336 CDIYSFGVLLAVLVIGKFP-----SDDFFQHTKEMSLVQWMRNVMTSENP------NRAI 384
            D +S G ++   + G  P      D  F +      + W   V    +P      NR +
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-LSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 385 ----NSKLLGNGYEE 395
                 +L  NGY+E
Sbjct: 233 CMDPAKRLGANGYQE 247

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 27/219 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V  AEL G  G    +K     LK    LI  D E     M++ R   + A    +  
Sbjct: 9   GKVLLAELKGK-GEYFAVKA----LKKDVVLIDDDVEC---TMVEKR---VLALAWENPF 57

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS-QGRRELDWLARHRIAQGIASGLEYL 266
           +  L      ++    V EF   G   D+++ +  +GR +L + A    A+ I  GL++L
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDL-YRATFYAAE-IVCGLQFL 112

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      II+RD++  NV++D D   +I++FG+ K    G  R +T+   GT  YIAPE 
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF--CGTPDYIAPEI 167

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFP-----SDDFFQ 360
            Q +  + + D +SFGVLL  ++IG+ P      D+ F+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 25/213 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSG-AELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           GEV +  L     R I +   I+ LKSG  E  ++D            SE    GQ  H 
Sbjct: 18  GEVCRGRLKLPGKREIFVA--IKTLKSGYTEKQRRD----------FLSEASIMGQFDHP 65

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NI+ L   + +    +++ EF  NG+L   L    Q   +   +    + +GIA+G++YL
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 267 -HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT-TWSLAGT--VGYI 322
             M++    +HRD+   N+L++ ++  ++S+FGL++ + D  +  T T SL G   + + 
Sbjct: 123 SEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 323 APECHQTVALSDTCDIYSFG-VLLAVLVIGKFP 354
           APE       +   D++S+G V+  V+  G+ P
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 8/153 (5%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +V  + +V L      +D   LV      G L+  +Y++     E +    +  A  I  
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY--AAEILC 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GLE LH   R   ++RD++P N+L+DD    RIS+ GLA +IP+G    +     GTVGY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGY 167

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE       + + D +  G L+  ++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 34/96 (35%), Positives = 58/96 (60%), Gaps = 8/96 (8%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I   LEYLH S    I++RD++P N+L+D +   ++++FG AK++ D      TW+L GT
Sbjct: 110 IVCALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGT 161

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y+APE  Q+   +   D ++ G+L+  +++G  P
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 32/216 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V K     ++G ++ IKK             K+SE           E+    Q+RH N
Sbjct: 15  GVVLKCR-NKATGEIVAIKKF------------KESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L     R+    LV+E+     L+ +  + S G   L   A       +   + Y H
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLELL--EASPG--GLPPDAVRSYIWQLLQAIAYCH 117

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 IIHRDI+P N+L+ +    ++ +FG A+ +        T     T  Y APE  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPE-- 171

Query: 328 QTVALSDT-----CDIYSFGVLLAVLVIGK--FPSD 356
             + + DT      D+++ G ++A L+ G+  FP D
Sbjct: 172 --LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.0 bits (168), Expect = 5e-13
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E+ F  LEKI     GEV+K  +   + +V+ IK I             D E    ++
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDEI 46

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I+ EI    Q     +       ++     ++ E+   GS  D+L         LD  
Sbjct: 47  EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDET 101

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               I + I  GL+YLH   +   IHRDI+ ANVL+ +  E ++++FG+A ++ D   + 
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            T+   GT  ++APE  +  A     DI+S G+    L  G+ P  + 
Sbjct: 159 NTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 45/131 (34%), Positives = 74/131 (56%), Gaps = 9/131 (6%)

Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           V E+   G   D+++ +    R  +  AR   A+ I  GL++LH      II+RD++  N
Sbjct: 74  VMEYLNGG---DLMFHIQSSGRFDEARARFYAAE-IICGLQFLHKKG---IIYRDLKLDN 126

Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
           VL+D D   +I++FG+ K   +G  + +T+   GT  YIAPE  +    +++ D +SFGV
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIAPEILKGQKYNESVDWWSFGV 184

Query: 344 LLAVLVIGKFP 354
           LL  ++IG+ P
Sbjct: 185 LLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 53/151 (35%), Positives = 74/151 (49%), Gaps = 20/151 (13%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   G L  +L +V  G  + D  AR  IA+ I   LEYLH S+   IIHRD++P 
Sbjct: 70  LVMEYLPGGDLASLLENV--GSLDEDV-ARIYIAE-IVLALEYLH-SNG--IIHRDLKPD 122

Query: 283 NVLIDDDMEARISEFGLAK--------RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           N+LID +   ++++FGL+K         + D         + GT  YIAPE       S 
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR--IVGTPDYIAPEVILGQGHSK 180

Query: 335 TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           T D +S G +L   ++G  P   F   T E 
Sbjct: 181 TVDWWSLGCILYEFLVGIPP---FHGETPEE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 7/153 (4%)

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A + + +   ++ E+   GSL D L     G+  L  L     +  IA G
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEG 115

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + Y+    R   IHRD++ ANVL+ + +  +I++FGLA+ I D    T        + + 
Sbjct: 116 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWT 171

Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE     + +   D++SFG+LL  ++  GK P
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  ++     L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 16  GNGGVVTKVQHKPSGLIMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 69

Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L +  +   E+  L +  IA  +  GL YL   H+ 
Sbjct: 70  GAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI--LGKVSIA--VLRGLAYLREKHQ- 124

Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D        S  GT  Y++PE  Q    
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHY 179

Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  L IG++P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 8/154 (5%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L D      +L  L    +A  +A+
Sbjct: 57  KLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD--MAAQVAA 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   IHRD++ AN+L+ D +  +I++FGLA+ I D +  T        + +
Sbjct: 114 GMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKW 169

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  LV  G+ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+SG V T   +    +   + I    +P    +I   +EI+   ++++ NIV  L   +
Sbjct: 30  GASGTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLDSFL 86

Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D   +V E+   GSL D++ +      ++  + R  +       LE+LH +   ++IH
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVIH 138

Query: 277 RDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  NVL+  D   ++++FG   +I P+   R+T   + GT  ++APE     A    
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPK 195

Query: 336 CDIYSFGVLLAVLVIGKFP 354
            DI+S G++   +V G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 5/96 (5%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +A  L++LH      II+RD++P N+L+D++   ++++FGL+K   D   +   +S  GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGT 161

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           V Y+APE       + + D +SFGVL+  ++ G  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 34/215 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY A    S+   I IK+I  P +       +  +PLH        EI     ++HRN
Sbjct: 22  GIVYAAR-DLSTQVRIAIKEI--PERD-----SRYVQPLHE-------EIALHSYLKHRN 66

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG-----IASG 262
           IV  L          +  E    GSL  +L      R +   L  +          I  G
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEG 120

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           L+YLH +   +I+HRDI+  NVL++      +IS+FG +KR+   +  T T++  GT+ Y
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--GTLQY 175

Query: 322 IAPEC--HQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE             DI+S G  +  +  GK P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 11/99 (11%)

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           EYLH      II+RD++P N+L+D+    ++++FG AK++PD      T++L GT  Y+A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLA 183

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
           PE  Q+       D ++ GVLL   + G  P   FF  T
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP---FFDDT 219

Length = 329

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 67/307 (21%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSE----PLHHKMIQIRSEIITAGQV 203
           G+VYKA     +G ++ +KKI           + ++E    P     I    EI    ++
Sbjct: 13  GQVYKAR-NKKTGELVALKKI-----------RMENEKEGFP-----ITAIREIKLLQKL 55

Query: 204 RHRNIVPLLARMVRRDCD--LLVYEFRR---NGSLQDILYDVSQGRRELDWLARHRIAQG 258
           RH NIV L   +  +      +V+E+      G L       ++ +       +    + 
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ------IKC-YMKQ 108

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  GL+YLH      I+HRDI+ +N+LI++D   ++++FGLA+     ++   T +   T
Sbjct: 109 LLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT-NRVIT 164

Query: 319 VGYIAPECHQTVALSDT-----CDIYSFGVLLAVLVIGK--FP-SDDFFQHTK------- 363
           + Y  PE    + L  T      D++S G +LA L +GK  F  S +  Q  K       
Sbjct: 165 LWYRPPE----LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS 220

Query: 364 -------EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP 416
                   +S + W  N+   +   R +            + L+ K+       DP KR 
Sbjct: 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL----DPKKRI 276

Query: 417 NSKDVRC 423
           ++     
Sbjct: 277 SADQALQ 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 27/220 (12%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + IK++    +   ELI               +
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQPKKELII--------------N 65

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + +H NIV  L   +  D   +V E+   GSL D++ +      ++  + R   
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-- 123

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +    +IHRDI+  N+L+  D   ++++FG   +I P+   R+T   
Sbjct: 124 ---CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 174

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   +V G+ P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 45/281 (16%)

Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR 218
           +G+++ IKK ++             +    K I +R EI    Q+RH N+V L+    R+
Sbjct: 25  TGQIVAIKKFLE-----------SEDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRK 72

Query: 219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD 278
               LV+EF  +     +L D+ +    LD     +    I  G+E+ H SH   IIHRD
Sbjct: 73  KRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-SHN--IIHRD 125

Query: 279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT--- 335
           I+P N+L+      ++ +FG A+ +       T +    T  Y APE    + + DT   
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY--VATRWYRAPE----LLVGDTKYG 179

Query: 336 --CDIYSFGVLLAVLVIGK--FPSD-DFFQHTKEM----SLVQWMRNVMTSENPNRAI-- 384
              DI++ G L+  ++ G+  FP D D  Q    +    +L+   + +   +NP  A   
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKNPLFAGMR 238

Query: 385 -----NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
                  + L   + +   LVL +A  C   DP+ RP+S  
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 31/224 (13%)

Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           S+GR + +KK+        +L K+    L      + +E++     +H NIV + +  + 
Sbjct: 42  STGRQVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHPNIVEMYSSYLV 87

Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R   + +A   +   +   L +LH      +IHR
Sbjct: 88  GDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT--VCLAVLKALSFLHAQ---GVIHR 139

Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R    SL GT  ++APE    +      D
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEVISRLPYGTEVD 197

Query: 338 IYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN 381
           I+S G+++  +V G+ P   +F        +Q M+ +  +  P 
Sbjct: 198 IWSLGIMVIEMVDGEPP---YFNE----PPLQAMKRIRDNLPPK 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 72/228 (31%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 2   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 48

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S        L + 
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKS 104

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            + Q +  GL + H SHR  ++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 105 YLFQ-LLQGLAFCH-SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 157

Query: 312 TWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE        S   DI+S G + A +V  +  FP D
Sbjct: 158 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 67/252 (26%), Positives = 111/252 (44%), Gaps = 65/252 (25%)

Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR 218
           +G+ + IKKI++P  +   L K           +   E+     +RH NI+ L       
Sbjct: 34  TGQNVAIKKIMKPFSTPV-LAK-----------RTYRELKLLKHLRHENIISL------- 74

Query: 219 DCDLLVYEFRRNGSLQDI----------LYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
             D+ +        L+DI          L+ +   R       ++ + Q I  GL+Y+H 
Sbjct: 75  -SDIFI------SPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ-ILRGLKYVHS 126

Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG---YIAPE 325
           +    ++HRD++P+N+LI+++ + +I +FGLA RI D         + G V    Y APE
Sbjct: 127 AG---VVHRDLKPSNILINENCDLKICDFGLA-RIQDPQ-------MTGYVSTRYYRAPE 175

Query: 326 CHQTVALSDT-CDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLVQWMR--------NV 374
              T    D   DI+S G + A ++ GK  FP  D   H  + S++  +         N 
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD---HVNQFSIITDLLGTPPDDVINT 232

Query: 375 MTSENPNRAINS 386
           + SEN  R + S
Sbjct: 233 ICSENTLRFVQS 244

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 14/166 (8%)

Query: 193 IRSEIITAGQVRHRNIVPLLARM---VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD 248
           IR++II   QV H    P +         D ++ +  E    GSL  +L     GR    
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 103

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            L +  IA  +  GL YL   H+  I+HRD++P+N+L++   E ++ +FG++ ++ D   
Sbjct: 104 ILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                S  GT  Y++PE  Q    S   DI+S G+ L  + IG++P
Sbjct: 160 N----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  ++ L A     +   +V E  + GSL + L   +    +L  L    +A  +AS
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVAS 114

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           G+ YL   +    IHRD+   NVL+ ++   ++++FGLA+ I +           G    
Sbjct: 115 GMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFP 167

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
           + + APE       S   D++SFG+LL  +V  G+ P
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 31/213 (14%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  ++++ S   G+VYKA     +G +  +K I        +L   D   L      I+ 
Sbjct: 11  YELIQRVGSGTYGDVYKAR-NLHTGELAAVKII--------KLEPGDDFSL------IQQ 55

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD--WLARH 253
           EI    + +H NIV      + R+   +  E+   GSLQDI Y V+    EL   ++ R 
Sbjct: 56  EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRE 114

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            +      GL YLH   +   +HRDI+ AN+L+ D+ + ++++FG+A +I    T     
Sbjct: 115 TL-----QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRK 164

Query: 314 SLAGTVGYIAPE---CHQTVALSDTCDIYSFGV 343
           S  GT  ++APE     +    +  CDI++ G+
Sbjct: 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 39/273 (14%)

Query: 149 EVYKAELPGSSGRVITIKKI----IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
            VYKA      GRV+ +KK+    +   K+  + +K               EI    Q+ 
Sbjct: 17  VVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLK---------------EIDLLKQLD 60

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H N++  LA  +  +   +V E    G L  ++    + +R +      +    + S LE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           ++H S R  I+HRDI+PANV I      ++ + GL  R     T T   SL GT  Y++P
Sbjct: 121 HMH-SKR--IMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKT-TAAHSLVGTPYYMSP 175

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
           E       +   DI+S G LL  +   + P   F+    +M+L    + +   + P    
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYG--DKMNLYSLCKKIEKCDYP---- 226

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
              L  + Y E++  ++     C   DP KRP+
Sbjct: 227 --PLPADHYSEELRDLVSR---CINPDPEKRPD 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 47/132 (35%), Positives = 67/132 (50%), Gaps = 20/132 (15%)

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA----KRIPDGHTRTT 311
           A  I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA    K+ P       
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156

Query: 312 TWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQ 369
                GT GY+APE  Q  VA   + D +S G +L  L+ G  P   F QH TK+   + 
Sbjct: 157 -----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEID 208

Query: 370 WMRNVMTSENPN 381
            M   M  E P+
Sbjct: 209 RMTLTMAVELPD 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 63/244 (25%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V  A    + GR + IKK+ +P +S           +H K  +   E+     + H N
Sbjct: 29  GQVCSAFDTKT-GRKVAIKKLSRPFQS----------AIHAK--RTYRELRLLKHMDHEN 75

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDI-------------LYDVSQGRRELDWLARHR 254
           ++ LL      D       F    SL+D              L ++ + ++  D   +  
Sbjct: 76  VIGLL------DV------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR--TTT 312
           + Q I  GL+Y+H +    IIHRD++P+N+ +++D E +I +FGLA+   D  T    T 
Sbjct: 124 VYQ-ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179

Query: 313 WSLAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF-QHTKE 364
           W       Y APE      H       T DI+S G ++A L+ GK  FP  D   Q  + 
Sbjct: 180 W-------YRAPEIMLNWMHYN----QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228

Query: 365 MSLV 368
           M+LV
Sbjct: 229 MNLV 232

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 10/129 (7%)

Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E    GSL  +L     GR   + L +  IA  +  GL YL   H+  I+HRD++P+N+L
Sbjct: 79  EHMDGGSLDQVLKKA--GRIPENILGKISIA--VLRGLTYLREKHK--IMHRDVKPSNIL 132

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           ++   E ++ +FG++ ++ D        S  GT  Y++PE  Q    +   DI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 346 AVLVIGKFP 354
             + IG++P
Sbjct: 189 VEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           +V E+   G L   +    + R+ +      RI   +  GL+ LH     +I+HRD++ A
Sbjct: 76  IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSA 132

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           N+L+  +   +I + G++K +     +T      GT  Y+APE  +    S   DI+S G
Sbjct: 133 NILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGRPYSYKSDIWSLG 188

Query: 343 VLLAVLVIGKFP 354
            LL  +     P
Sbjct: 189 CLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 10/168 (5%)

Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           +  +R EI    ++ H +I+ +L          L  E+   GS+  +L      +  +  
Sbjct: 47  VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII 106

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRIPDGHT 308
               ++ +G++    YLH +   +IIHRD++ AN+LID      RI++FG A R+    T
Sbjct: 107 NYTEQLLRGLS----YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159

Query: 309 RTTTW--SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
               +   L GT+ ++APE  +      +CD++S G ++  +   K P
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 65.2 bits (160), Expect = 8e-12
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 57/228 (25%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYKA     +G ++ +KKI   L +  E I   +         +R EI    +++H N
Sbjct: 13  GVVYKARDK-KTGEIVALKKI--RLDNEEEGIPSTA---------LR-EISLLKELKHPN 59

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH-------RIAQGIA 260
           IV LL  +       LV+E+           D+   ++ LD             I   + 
Sbjct: 60  IVKLLDVIHTERKLYLVFEY--------CDMDL---KKYLDKRPGPLSPNLIKSIMYQLL 108

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDG---HTRTTTWSL 315
            GL Y H SHR  I+HRD++P N+LI+ D   ++++FGLA+   IP     H   T W  
Sbjct: 109 RGLAYCH-SHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-- 163

Query: 316 AGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSD 356
                Y APE    + L         DI+S G + A ++ GK  FP D
Sbjct: 164 -----YRAPE----ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 40/232 (17%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  +EKI     G VYKA     +G ++ +KKI           + ++E        IR 
Sbjct: 1   YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKKI-----------RLETEDEGVPSTAIR- 47

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ---DILYDVSQGRRELDWLAR 252
           EI    ++ H NIV LL  +   +   LV+EF  +  L+   D              L +
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPP----LIK 102

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRT 310
             + Q +  G+ Y H SHR  ++HRD++P N+LID +   ++++FGLA+   +P    RT
Sbjct: 103 SYLYQ-LLQGIAYCH-SHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVP---VRT 155

Query: 311 TTWSLAGTVGYIAPE----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
            T  +  T+ Y APE      Q    S   DI+S G + A +V  +  FP D
Sbjct: 156 YTHEVV-TLWYRAPEILLGSRQ---YSTPVDIWSIGCIFAEMVNRRPLFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 57  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 114 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 169

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + IK++    +   ELI               +
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELII--------------N 65

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  L++LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+T   
Sbjct: 126 -----QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 174

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   +V G+ P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 24/225 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AEL G+  +   IK     LK    L+  D E     M++ R   + +    H  
Sbjct: 9   GKVFLAELKGT-NQFFAIKA----LKKDVVLMDDDVEC---TMVEKR---VLSLAWEHPF 57

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +  L      ++    V E+   G   D+++ + Q   + D       A  I  GL++LH
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGG---DLMFHI-QSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 I++RD++  N+L+D D   +I++FG+ K    G  +T T+   GT  YIAPE  
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--CGTPDYIAPEIL 168

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR 372
                + + D +SFGVLL  ++IG+ P    F    E  L Q +R
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSP----FHGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 8/154 (5%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H  +V L A +V ++   ++ E+  NGSL D L      +  ++ L    +A  IA 
Sbjct: 57  QLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID--MAAQIAE 113

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++    R   IHRD++ AN+L+ + +  +I++FGLA R+ + +  T        + +
Sbjct: 114 GMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIKW 169

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 41/109 (37%), Positives = 62/109 (56%), Gaps = 15/109 (13%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTV 319
           GL+Y+H +    IIHRD++P+NV +++D E RI +FGLA++  D  T    T W      
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW------ 180

Query: 320 GYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
            Y APE     +  + T DI+S G ++A L+ GK  FP +D+    K +
Sbjct: 181 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 51/224 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGA---ELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G+V KAE  G      T    ++ LK  A   +L    SE    KMI            +
Sbjct: 26  GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----------K 74

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI--------- 255
           H+NI+ LL    +     +V E+  +G+L+D L    + RR     A             
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLT 130

Query: 256 -------AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DG 306
                  A  +A G+E+L      + IHRD+   NVL+ +D   +I++FGLA+ I   D 
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187

Query: 307 HTRTTTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
           + +TT   L   V ++APE     AL D       D++SFGVLL
Sbjct: 188 YRKTTNGRLP--VKWMAPE-----ALFDRVYTHQSDVWSFGVLL 224

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 28/293 (9%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMIQIR 194
           +A LE + S   G VYK     +   ++ +K+I +     G +  ++D       +  I 
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-----IGDIV 56

Query: 195 SEI-ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           SE+ I   Q+RH NIV      +  D   +V +      L +    + + ++        
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L YLH     RI+HRD+ P N+++ +D +  I++FGLAK+       T   
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT--- 171

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
           S+ GT+ Y  PE  +     +  D+++FG +L  +   + P    F  T  +SL    + 
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLA--TKI 225

Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
           V     P   +   +    Y E +  V+     C   D   RP+   V  M+S
Sbjct: 226 VEAVYEP---LPEGM----YSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 16/147 (10%)

Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           V E+   G   D+++ + +  R  +  AR   A+ I  GL++LH      II+RD++  N
Sbjct: 74  VMEYVNGG---DLMFHIQRSGRFDEPRARFYAAE-IVLGLQFLH-ERG--IIYRDLKLDN 126

Query: 284 VLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           VL+D +   +I++FG+ K  I  G T +T     GT  YIAPE           D ++ G
Sbjct: 127 VLLDSEGHIKIADFGMCKEGILGGVTTST---FCGTPDYIAPEILSYQPYGPAVDWWALG 183

Query: 343 VLLAVLVIGKFP-----SDDFFQHTKE 364
           VLL  ++ G+ P      D+ FQ   E
Sbjct: 184 VLLYEMLAGQSPFEGDDEDELFQSILE 210

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 32/107 (29%), Positives = 44/107 (41%), Gaps = 27/107 (25%)

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT--------------- 310
           L   H+   IHRDI+P N+LID D   ++++FGL K++     R                
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 311 ---TTW---------SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                          S  GT  YIAPE  +       CD +S GV+L
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 24/197 (12%)

Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 43  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 88

Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 89  GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R    SL GT  ++APE    +      D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPEVD 198

Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 9/105 (8%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           ++   I   L YL   H   +IHRD++P+N+L+D     ++ +FG++ R+ D   +T + 
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS- 174

Query: 314 SLAGTVGYIAPECHQTVALSDTCDI----YSFGVLLAVLVIGKFP 354
             AG   Y+APE       +   DI    +S G+ L  L  G+FP
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 40/214 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--- 204
           G VYKA    + GR + +KK+  PL        ++  P    +  +R EI    Q+    
Sbjct: 13  GTVYKARDLNT-GRFVALKKVRVPLS-------EEGIP----LSTLR-EIALLKQLESFE 59

Query: 205 HRNIVPLL----ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIAQG 258
           H NIV LL         R+  L LV+E   +  L   L    +    L     +  + Q 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPK--PGLPPETIKDLMRQ- 115

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+++LH SHR  I+HRD++P N+L+  D + +I++FGLA RI       T  S+  T
Sbjct: 116 LLRGVDFLH-SHR--IVHRDLKPQNILVTSDGQVKIADFGLA-RIYSFEMALT--SVVVT 169

Query: 319 VGYIAPECHQTVALSDT----CDIYSFGVLLAVL 348
           + Y APE    V L  +     D++S G + A L
Sbjct: 170 LWYRAPE----VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 16/145 (11%)

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V EF   G   D+++ + + RR  +  AR   A+ I S L +LH      II+RD++ 
Sbjct: 72  FFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-ITSALMFLH---DKGIIYRDLKL 124

Query: 282 ANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
            NVL+D +   ++++FG+ K  I +G    TT +  GT  YIAPE  Q +    + D ++
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWA 181

Query: 341 FGVLLAVLVIGKFP-----SDDFFQ 360
            GVLL  ++ G  P      DD F+
Sbjct: 182 MGVLLYEMLCGHAPFEAENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 19/234 (8%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    Q+ H N++  L   +  +   +V E    G L  ++    + +R +      + 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              + S +E++H     R++HRDI+PANV I      ++ + GL +        T   SL
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM 375
            GT  Y++PE       +   DI+S G LL  +   + P      +  +M+L    + + 
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIE 221

Query: 376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
             + P       L    Y E++    ++   C   DP++RP+   V  +  Q+ 
Sbjct: 222 QCDYP------PLPTEHYSEKL---RELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 50/209 (23%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIK-KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM 215
           G+ G+V   +     L + A++I+ +  E L   M++I  +I++  + +H NIV L    
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI--DILS--ECKHPNIVGLYEAY 71

Query: 216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRE--LDWLARHRIAQGIASGLEYLHMSHRPR 273
              +   ++ EF   G+L  I+ ++ +G  E  + ++ R      +   L +LH     +
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLH---SHK 123

Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +IHRD++  N+L+  D + ++++FG++ +  +  T     +  GT  ++APE        
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 334 DT-----CDIYSFGVLLAVLVIGKFPSDD 357
           D       DI+S G+ L  L   + P  +
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 28/203 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V K      SG+ + +   ++ LK       K          +   E     Q+ H  
Sbjct: 9   GSVVKGVYLMKSGKEVEVA--VKTLKQEHIAAGKK---------EFLREASVMAQLDHPC 57

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+  + + +  +LV E    G L   L    + RRE+       +A  +A G+ YL 
Sbjct: 58  IVRLIG-VCKGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT--RTTT---WSLAGTVGYI 322
             H    +HRD+   NVL+ +  +A+IS+FG+++ +  G    R TT   W L     + 
Sbjct: 113 SKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----WY 165

Query: 323 APECHQTVALSDTCDIYSFGVLL 345
           APEC      S   D++S+GV L
Sbjct: 166 APECINYGKFSSKSDVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 66

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+   +
Sbjct: 127 -----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---T 175

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 21/178 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+KA     +G  + +KK+          +++    + ++ ++   EI      +H  
Sbjct: 14  GIVFKA-KDRETGETVALKKV---------ALRRLEGGIPNQALR---EIKALQACQHPY 60

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL         +LV E+     L ++L D     R L         + +  G+ Y+H
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
            +    I+HRD++PAN+LI  D   +I++FGLA R+              T  Y APE
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLA-RLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 43/128 (33%), Positives = 66/128 (51%), Gaps = 12/128 (9%)

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
           A  I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA       ++    + 
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHAS 155

Query: 316 AGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQWMRN 373
            GT GY+APE  Q   A   + D +S G +L  L+ G  P   F QH TK+   +  M  
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTL 212

Query: 374 VMTSENPN 381
            +  E P+
Sbjct: 213 TVNVELPD 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 52/279 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVYKA +   + +V+ IK I             D E    ++  I+ EI    Q R   
Sbjct: 15  GEVYKA-IDKRTNQVVAIKVI-------------DLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 208 IVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           I       ++    L ++ E+   GS  D+L     G+ +  ++A   I + +  GLEYL
Sbjct: 61  ITKYYGSFLK-GSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF--ILREVLLGLEYL 114

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H       IHRDI+ AN+L+ ++ + ++++FG++ ++    ++  T+   GT  ++APE 
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT---SENPNRA 383
            +     +  DI+S G+    L  G+ P          +S +  MR V+      NP   
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP----------LSDLHPMR-VLFLIPKNNP--- 215

Query: 384 INSKLLGNGYEEQMLLVLK--IACFCTLDDPNKRPNSKD 420
               L GN + +      K  ++  C   DP +RP++K+
Sbjct: 216 --PSLEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 12/118 (10%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  I   LEYLH   +  +IHRD++P+NVLI+ + + ++ +FG++  + D   +T   
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163

Query: 314 SLAGTVGYIAPE----CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF---FQHTKE 364
             AG   Y+APE               D++S G+ +  L  G+FP D +   FQ  K+
Sbjct: 164 --AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 25/195 (12%)

Query: 155 LPGSSGRVITIKKIIQPLKSGAELIKKDSE---PLHHKMIQIRSEIITAGQVRHRNIVPL 211
           L  ++G V+ +KK+           +++ E    L H  I           V+++ +   
Sbjct: 28  LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI-----------VKYKGVCYS 76

Query: 212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR 271
             R   R    LV E+   GSL+D L    + R  LD       A  I  G+EYL     
Sbjct: 77  AGRRNLR----LVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK-- 127

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTV 330
            R +HRD+   N+L++ +   +I +FGL K +P D             + + APE     
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 331 ALSDTCDIYSFGVLL 345
             S   D++SFGV+L
Sbjct: 187 KFSVASDVWSFGVVL 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 46/231 (19%)

Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRH----RNIVPLLARMVRRDCDLLV---YEFRRNGS 232
           KKD+  ++   +  + EI+   +V H    RNI   L R +  +   +V   + F+ +  
Sbjct: 14  KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPFIVGLKFSFQTDSD 70

Query: 233 LQDILYDVSQGRRELDW-----------LARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
           L  +   +S G  EL W            A+  IA+ + + LE+LH   +  I++RD++P
Sbjct: 71  LYLVTDYMSGG--ELFWHLQKEGRFSEDRAKFYIAELVLA-LEHLH---KYDIVYRDLKP 124

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT-----C 336
            N+L+D      + +FGL+K   +     TT +  GT  Y+APE    V L +       
Sbjct: 125 ENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE----VLLDEKGYTKHV 178

Query: 337 DIYSFGVLLAVLVIGKFPSDDFFQHTKEM------SLVQWMRNVMTSENPN 381
           D +S GVL+  +  G  P   + + T++M        V++ +NV++ E   
Sbjct: 179 DFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 4/101 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW-SLAG 317
           I  G+EYLH      I+HRDI+ AN+L D     ++ +FG +KR+    +  T   S+ G
Sbjct: 113 ILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
           T  +++PE           D++S G  +  ++  K P  +F
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 19/222 (8%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    Q+ H N++   A  +  +   +V E    G L  ++    + +R +      + 
Sbjct: 52  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              + S LE++H     R++HRDI+PANV I      ++ + GL +        T   SL
Sbjct: 112 FVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM 375
            GT  Y++PE       +   DI+S G LL  +   + P      +  +M+L    + + 
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIE 221

Query: 376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
             + P       L  + Y E++    ++   C   DP KRP+
Sbjct: 222 QCDYP------PLPSDHYSEEL---RQLVNMCINPDPEKRPD 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 29/233 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYKA     + R++ +K I  PL    EL K           QI SE+    +     
Sbjct: 15  GTVYKAYHL-LTRRILAVKVI--PLDITVELQK-----------QIMSELEILYKCDSPY 60

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+         +   +  EF   GSL     DV    R++      RIA  +  GL YL 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-----DVY---RKIPEHVLGRIAVAVVKGLTYLW 112

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                +I+HRD++P+N+L++   + ++ +FG++ ++ +   +T      GT  Y+APE  
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERI 165

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
                    D++S G+    L +G+FP     ++   +  +Q ++ ++  + P
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 47/211 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKK-----DSEPLHHKMIQIRSEIITAGQ 202
           G+VYK  L                 K   E+  K         L  K +Q   E     Q
Sbjct: 9   GDVYKGVL-----------------KGNTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQ 48

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQ---GI 259
             H NIV L+   V++    +V E    GSL   L      R++ + L   ++ Q     
Sbjct: 49  YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDA 102

Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV 319
           A+G+EYL   +    IHRD+   N L+ ++   +IS+FG+++    G      ++++  +
Sbjct: 103 AAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGG-----IYTVSDGL 154

Query: 320 GYI-----APECHQTVALSDTCDIYSFGVLL 345
             I     APE       +   D++S+G+LL
Sbjct: 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILL 185

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 42/234 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKK--DSEPLHHKMIQIRSEIITAGQVR 204
           G+V KA     +G+++ IKK+ I  + +     ++      +H   ++   E+    +++
Sbjct: 23  GKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR---ELKIMNEIK 78

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQ------G 258
           H NI+ L+   V  D   LV +         +  D+   ++ +D   R   +Q       
Sbjct: 79  HENIMGLVDVYVEGDFINLVMDI--------MASDL---KKVVDRKIRLTESQVKCILLQ 127

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-----IPDGHTRTTTW 313
           I +GL  LH  +    +HRD+ PAN+ I+     +I++FGLA+R       D  ++  T 
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 314 SL-------AGTVGYIAPE-CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                      T+ Y APE            D++S G + A L+ GK  FP ++
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238

Length = 335

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 17/186 (9%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +E++     +H+N+V +    +  +   ++ EF + G+L DI   VSQ R     L   +
Sbjct: 67  NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTR-----LNEEQ 118

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           IA    S L+ L   H   +IHRDI+  ++L+  D   ++S+FG   +I     +    S
Sbjct: 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--S 176

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV 374
           L GT  ++APE           DI+S G+++  +V G+ P   +F  +     VQ M+ +
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSP----VQAMKRL 229

Query: 375 MTSENP 380
             S  P
Sbjct: 230 RDSPPP 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 28/210 (13%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNG 231
           +KK S P    +   R+  E+     ++H N++ LL     AR +    D+ +       
Sbjct: 47  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 106

Query: 232 SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 291
            L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++D E
Sbjct: 107 DLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158

Query: 292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVI 350
            +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A L+ 
Sbjct: 159 LKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Query: 351 GK--FPSDDFFQHTKEMSLVQWMRNVMTSE 378
           G+  FP  D   H  ++ L+  +R V T  
Sbjct: 214 GRTLFPGTD---HIDQLKLI--LRLVGTPG 238

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 16/148 (10%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D++Y + Q  R  +  A    A+ IA GL +LH      II+RD++  
Sbjct: 78  FVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAE-IAIGLFFLHSKG---IIYRDLKLD 130

Query: 283 NVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NV++D +   +I++FG+ K  + DG    TT +  GT  YIAPE         + D ++F
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 342 GVLLAVLVIGKFP-----SDDFFQHTKE 364
           GVLL  ++ G+ P      D+ FQ   E
Sbjct: 188 GVLLYEMLAGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 14/161 (8%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++ H N+V L     ++    +V E+  NG L + L +  +G+   +WL    +   +  
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCE 111

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
            +EYL        IHRD+   N L+ +D   ++S+FGLA+ + D    ++     GT   
Sbjct: 112 AMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFP 164

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
           V +  PE       S   D++SFGVL+  V   GK P + F
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 25/200 (12%)

Query: 149 EVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI 208
            V K   PGS GRV    K  QP     ++ +K +  +   ++Q          V H ++
Sbjct: 69  TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ---------NVNHPSV 119

Query: 209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
           + +   +V      +V     +    D+   +++  R L       I + I  GL YLH 
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA 175

Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAK---RIPDGHTRTTTWSLAGTVGYIAPE 325
               RIIHRD++  N+ I+D  +  I + G A+     P          LAGTV   APE
Sbjct: 176 Q---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA------FLGLAGTVETNAPE 226

Query: 326 CHQTVALSDTCDIYSFGVLL 345
                  +   DI+S G++L
Sbjct: 227 VLARDKYNSKADIWSAGIVL 246

Length = 357

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 10/163 (6%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + +    ++V E+  NGSL   L     G+  +  L    
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVG-- 110

Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT 312
           + +GIASG++YL  M +    +HRD+   N+L++ ++  ++S+FGL++ + D      TT
Sbjct: 111 MLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
                 + + APE       +   D++S+G+++  V+  G+ P
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 8/151 (5%)

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H  +V L     ++    +V EF  NG L + L    QG+   D L    + Q +  G+E
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLS--MCQDVCEGME 114

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           YL    R   IHRD+   N L+      ++S+FG+ + + D    T++      V +  P
Sbjct: 115 YLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170

Query: 325 ECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           E       S   D++SFGVL+  V   GK P
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 35/223 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDS----EPLHHKMIQIRSEIITAGQV 203
           G+V  AEL G+   V  IK           ++KKD     + +   M + R   I A   
Sbjct: 9   GKVMLAELKGTD-EVYAIK-----------VLKKDVILQDDDVDCTMTEKR---ILALAA 53

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           +H  +  L      +D    V E+   G   D+++ + + R+  +  +R   A+ +   L
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAE-VTLAL 109

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYI 322
            +LH   R  +I+RD++  N+L+D +   ++++FG+ K  I +G T TT     GT  YI
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT---FCGTPDYI 163

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP-----SDDFFQ 360
           APE  Q +    + D ++ GVL+  ++ G+ P      DD F+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 6/144 (4%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q  H NIV L+    ++    +V E  + G     L   ++G R L      ++ +  A+
Sbjct: 49  QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVENAAA 105

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+EYL   H    IHRD+   N L+ +    +IS+FG+++   DG   +T       V +
Sbjct: 106 GMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162

Query: 322 IAPECHQTVALSDTCDIYSFGVLL 345
            APE       S   D++SFG+LL
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 45/209 (21%), Positives = 84/209 (40%), Gaps = 20/209 (9%)

Query: 157 GSSGRVITIKKIIQPLKSGAEL------IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP 210
           G+ G V   K +  P     ++      +++++ P  +K  +I  E      V H ++V 
Sbjct: 18  GAFGTVY--KGVWIPEGEKVKIPVAIKVLREETSPKANK--EILDEAYVMASVDHPHVVR 73

Query: 211 LLA-RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS 269
           LL   +  +    L+ +    G L D    V   +  +           IA G+ YL   
Sbjct: 74  LLGICLSSQVQ--LITQLMPLGCLLDY---VRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
              R++HRD+   NVL+      +I++FGLAK +               + ++A E    
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 330 VALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              +   D++S+GV +  ++  G  P + 
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 45/146 (30%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--------- 300
           LAR  IA+ +   +E +H   +   IHRDI+P N+LID D   ++++FGL          
Sbjct: 102 LARFYIAE-LTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 301 --------------------------------KRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
                                           +R    H R    SL GT  YIAPE   
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217

Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFP 354
               +  CD +S GV+L  +++G+ P
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 178 LIKKDSEPLHHKMIQIRSEIITAG--------------QVRHRNIVPLLARMVRRDCDLL 223
           L+++ +   ++ M  +R E+I A                 RH  +  L       D    
Sbjct: 13  LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72

Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++RDI+  N
Sbjct: 73  VMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVYRDIKLEN 125

Query: 284 VLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           +++D D   +I++FGL K  I DG T  T     GT  Y+APE  +        D +  G
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 343 VLLAVLVIGKFP 354
           V++  ++ G+ P
Sbjct: 183 VVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 20/167 (11%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +E +T GQ  H NIV L   + R +  ++V E+  NG+L   L      R+    L   +
Sbjct: 55  AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL------RKHEGQLVAGQ 108

Query: 255 IA---QGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           +     G+ASG++YL  M +    +H+ +    VL++ D+  +IS F    R+ +  +  
Sbjct: 109 LMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEA 161

Query: 311 --TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             TT S    V + APE  Q    S   D++SFG+++  V+  G+ P
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 7/102 (6%)

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWS 314
           A  IA GL +LH      II+RD++  NV++D +   +I++FG+ K  I  G    TT +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRT 160

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
             GT  YIAPE         + D ++FGVLL  ++ G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 47/268 (17%)

Query: 177 ELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI 236
           +++K+++     ++  + SE     QV H +++ L     +    LL+ E+ + GSL+  
Sbjct: 36  KMLKENASSS--ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93

Query: 237 L--------------------YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
           L                    Y  +   R L        A  I+ G++YL      +++H
Sbjct: 94  LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVH 150

Query: 277 RDIQPANVLIDDDMEARISEFGLAKRI--PDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           RD+   NVL+ +  + +IS+FGL++ +   D + + +   +   V ++A E       + 
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP--VKWMAIESLFDHIYTT 208

Query: 335 TCDIYSFGVLLAVLV-IGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             D++SFGVLL  +V +G  P    +       L   ++     E P          N  
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNP----YPGIAPERLFNLLKTGYRMERPE---------NCS 255

Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           EE   L+L     C   +P+KRP   D+
Sbjct: 256 EEMYNLMLT----CWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 25/181 (13%)

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           +D+++   E L +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
               A  +A G+EYL      R IHRD+   NVL+ +D   +I++FGLA+ +   D + +
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGK-----FPSDDFFQHTK 363
           T+   L   V ++APE       +   D++SFG+L+  +  +G       P ++ F+  +
Sbjct: 193 TSNGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Query: 364 E 364
           E
Sbjct: 251 E 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 26/194 (13%)

Query: 236 ILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS 295
            +Y+V +     + L +  IA      L YL    +  IIHRD++P+N+L+D +   ++ 
Sbjct: 95  YVYEVLKSVIPEEILGK--IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLC 150

Query: 296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGK 352
           +FG++ ++ D   +T     AG   Y+APE     A        D++S G+ L  +  GK
Sbjct: 151 DFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Query: 353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQ--MLLVLKIACFCTLD 410
           FP   +       S+   +  V+  + P       +L N  E +     V  I   C + 
Sbjct: 208 FPYPKW------NSVFDQLTQVVKGDPP-------ILSNSEEREFSPSFVNFIN-LCLIK 253

Query: 411 DPNKRPNSKDVRCM 424
           D +KRP  K++   
Sbjct: 254 DESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 17/238 (7%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 6   GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 65

Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 66  THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 119

Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRA 176

Query: 336 CDIYSFGVLLAVLVIGKFPSDDFFQ--HTK--EMSLVQWMRNVMTSENPNRAINSKLL 389
            D +  GV++  ++ G+ P   F+   H K  E+ L++ +R   T     +++ S LL
Sbjct: 177 VDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLL 231

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.1 bits (144), Expect = 9e-10
 Identities = 69/305 (22%), Positives = 114/305 (37%), Gaps = 71/305 (23%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIK-KDSEPLHHKMIQIRSEIITAGQVRHR 206
           G VY A     +G ++ IKK+ +   S  E +  ++ + L     ++           H 
Sbjct: 13  GSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSL----RKLNE---------HP 58

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA---QGIASGL 263
           NIV L       D    V+E+     ++  LY + +  R+    +   I      I  GL
Sbjct: 59  NIVKLKEVFRENDELYFVFEY-----MEGNLYQLMK-DRKGKPFSESVIRSIIYQILQGL 112

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT----TTWSLAGTV 319
            ++H   +    HRD++P N+L+      +I++FGLA+ I      T    T W      
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW------ 163

Query: 320 GYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FP----SDDFFQ-------H 361
            Y APE    + L  T      DI++ G ++A L   +  FP     D  ++        
Sbjct: 164 -YRAPE----ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218

Query: 362 TKE-----MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP 416
           TK+       L   +        P      +L+ N   E + L+          DP KRP
Sbjct: 219 TKQDWPEGYKLASKLGFRFPQFAPTSL--HQLIPNASPEAIDLIKD----MLRWDPKKRP 272

Query: 417 NSKDV 421
            +   
Sbjct: 273 TASQA 277

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L G++    T    I+ LK  AE   ++         + + E +   +++H N
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE---------EFKHEAMMRSRLQHPN 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ----GRRELDWLAR---------HR 254
           IV LL  + +     +++ +  +  L + L   S     G  + D   +         H 
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + Q IA+G+E+L   H   ++H+D+   NVL+ D +  +IS+ GL + +          +
Sbjct: 130 VTQ-IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
               + +++PE       S   DI+S+GV+L
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 8/153 (5%)

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A +V ++   ++ EF   GSL D L      ++ L  L     +  IA G
Sbjct: 58  LQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 114

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + ++    +   IHRD++ AN+L+   +  +I++FGLA+ I D +  T        + + 
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT 170

Query: 323 APECHQTVALSDTCDIYSFGVLLA-VLVIGKFP 354
           APE     + +   D++SFG+LL  ++  G+ P
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 139 LEKIRSCWNGEVYKAEL--PG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +E++  C  G++YK  L  PG    +++ IK +           K  + P      Q  +
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-----------KDINNPQQWGEFQQEA 58

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY------DVSQGRRE--- 246
            ++   ++ H NIV LL  + +     +++E+   G L + L       DV     E   
Sbjct: 59  SLM--AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 247 ----LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
               LD      IA  IA+G+EYL  SH    +H+D+   N+LI + +  +IS+ GL++ 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL-SSHF--FVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 303 I-PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           I    + R    SL   + ++ PE       S   DI+SFGV+L
Sbjct: 174 IYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E  F  L +I     G VY A     +  V+ IKK+    K   E           K   
Sbjct: 14  EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE-----------KWQD 61

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I  E+    Q+RH N +      +R     LV E+   GS  DIL    +  +E++  A 
Sbjct: 62  IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA- 119

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             I  G   GL YLH SH    IHRDI+  N+L+ +    ++++FG A  +   +     
Sbjct: 120 --ICHGALQGLAYLH-SHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----- 169

Query: 313 WSLAGTVGYIAPECHQTVALS-------DTCDIYSFGV 343
            S  GT  ++APE    V L+          D++S G+
Sbjct: 170 -SFVGTPYWMAPE----VILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 69/240 (28%), Positives = 99/240 (41%), Gaps = 72/240 (30%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVYKA     +GRV+ +KKI+          +KD  P     I    EI    +++H N
Sbjct: 22  GEVYKAR-QIKTGRVVALKKILM-------HNEKDGFP-----ITALREIKILKKLKHPN 68

Query: 208 IVPLLARMVRR------------------DCDLLVYEFRRNGSL--QDILYDVSQGRREL 247
           +VPL+   V R                  D DL       +G L    +    SQ     
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL-------SGLLENPSVKLTESQ----- 116

Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA------- 300
               +  + Q +  G+ YLH +H   I+HRDI+ AN+LID+    +I++FGLA       
Sbjct: 117 ---IKCYMLQ-LLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 301 ---KRIPDGHTRTTTWSLAGTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGK 352
              K    G TR  T +L  T  Y  PE        T A+    DI+  G + A +   +
Sbjct: 170 PNPKGGGGGGTRKYT-NLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 45/230 (19%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  +EKI     G VYK      +G+++ +KKI   L+S  E +   +         IR 
Sbjct: 2   YTKIEKIGEGTYGVVYKGR-NKKTGQIVAMKKI--RLESEEEGVPSTA---------IR- 48

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR---RELDWLAR 252
           EI    +++H NIV L   +++     L++EF  +  L+  L  + +G+    EL     
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IP---DGH 307
           ++I QGI          H  R++HRD++P N+LID+    ++++FGLA+   IP     H
Sbjct: 108 YQILQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160

Query: 308 TRTTTWSLAGTVGYIAPECHQTVAL-----SDTCDIYSFGVLLAVLVIGK 352
              T W       Y APE    V L     S   DI+S G + A +   K
Sbjct: 161 EVVTLW-------YRAPE----VLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 177 ELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEFRRNGSLQ 234
           +L++ D+    H+  + R E     ++ H NIV LL         LL  V+E+    +L+
Sbjct: 9   KLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLR 67

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDME 291
           ++L   + G      L      + +   L+ L  +H   I+HRD++P N+++        
Sbjct: 68  EVL--AADGA-----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 292 ARISEFGLAKRIPDGH-----TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL- 345
           A++ +FG+   +P        T T T  + GT  Y APE  +   ++   D+Y++G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 346 -----AVLVIGKFPSDDFFQH--TKEMSLVQWM 371
                  +V G   ++  +Q     ++SL  W+
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         +++KK+      ++    +E       RH  +  L     
Sbjct: 6   GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ 65

Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +D    V E+   G L    + +S+ R   +   R   A+ I S L+YLH     +I++
Sbjct: 66  TKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAE-IVSALDYLHSG---KIVY 118

Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I D  T  T     GT  Y+APE  +       
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAPEVLEDNDYGRA 175

Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 10/160 (6%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +E++      H N+V +    +  D   +V EF   G+L DI   V+  R     +   +
Sbjct: 68  NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-----MNEEQ 119

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           IA    S L  L   H   +IHRDI+  ++L+  D   ++S+FG   ++     +    S
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK--S 177

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           L GT  ++APE    +      DI+S G+++  ++ G+ P
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 13/127 (10%)

Query: 205 HRNIVPLLARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG 258
           HRNI       +++      D   LV EF   GS+ D++ +      + DW+A   I + 
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICRE 129

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GL +LH      +IHRDI+  NVL+ ++ E ++ +FG++ ++     R  T+   GT
Sbjct: 130 ILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGT 184

Query: 319 VGYIAPE 325
             ++APE
Sbjct: 185 PYWMAPE 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 16/179 (8%)

Query: 189 KMIQIRS----EIITAGQV----RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           KMI+  S    E I   +V     H  +V L     ++    +V E+  NG L + L   
Sbjct: 34  KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--- 90

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            +  +         + + +  G+ YL  S +   IHRD+   N L+DD    ++S+FGL+
Sbjct: 91  REHGKRFQPSQLLEMCKDVCEGMAYLE-SKQ--FIHRDLAARNCLVDDQGCVKVSDFGLS 147

Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
           + + D    T++      V +  PE       S   D+++FGVL+  V  +GK P + F
Sbjct: 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 12/115 (10%)

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWS 314
           A  I+ GL +LH   R  II+RD++  NV++D +   +I++FG+ K  + DG    TT +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP-----SDDFFQHTKE 364
             GT  YIAPE         + D +++GVLL  ++ G+ P      D+ FQ   E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 33/238 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR 206
           G+V  AE  G     I   K  +P+    +++K D+      +  + SE+     + +H+
Sbjct: 26  GQVVMAEAIG-----IDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHK 78

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLARHR 254
           NI+ LL    +     ++ E+   G+L++ L           +D  +   E L +     
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTRTTT 312
            A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ +   D + +TT 
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGK-----FPSDDFFQHTKE 364
             L   V ++APE       +   D++SFGVLL  +  +G       P ++ F+  KE
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 31/184 (16%)

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRREL----D 248
           +H+NI+ LL    +     ++ E+   G+L++ L           Y+ +Q   E     D
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DG 306
            ++    A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D 
Sbjct: 142 LVS---CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195

Query: 307 HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQ 360
           + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F+
Sbjct: 196 YKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Query: 361 HTKE 364
             KE
Sbjct: 254 LLKE 257

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 22/169 (13%)

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-------QDILYDVSQGRRE 246
           + E+I   +++H NIV   A         +V E+   G L       + +L+   Q    
Sbjct: 47  KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ---I 103

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRIPD 305
           L W  +      I+ GL+++H     +I+HRDI+  N+ +  + M A++ +FG+A+++ D
Sbjct: 104 LSWFVQ------ISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154

Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             +    ++  GT  Y++PE  Q    ++  DI+S G +L  L   K P
Sbjct: 155 --SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 30/204 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYKA+        +   K+I+          K  E L   M++I  EI+      H  
Sbjct: 26  GKVYKAK--NKETGALAAAKVIE---------TKSEEELEDYMVEI--EILAT--CNHPY 70

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV LL          ++ EF   G++  I+ ++ +G      L   +I       LE L 
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVICRQMLEALQ 124

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGL-AKRIPDGHTRTTTWSLAGTVGYIAPEC 326
             H  +IIHRD++  NVL+  D + ++++FG+ AK +     R    S  GT  ++APE 
Sbjct: 125 YLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD---SFIGTPYWMAPEV 181

Query: 327 HQTVALSDT-----CDIYSFGVLL 345
                + DT      DI+S G+ L
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITL 205

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 157 GSSGRVITIK----------KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           GS G+V+  K          K++Q      + I K  E  H  ++  R+ ++    V+H 
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVLQ-----KKAILKKKEQKH--IMAERNVLLK--NVKHP 56

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            +V L       D    V ++   G L    + + + R   +  AR   A+ IAS L YL
Sbjct: 57  FLVGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYL 112

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      II+RD++P N+L+D      +++FGL K   +    T+T+   GT  Y+APE 
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF--CGTPEYLAPEV 167

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF-QHTKEM 365
            +      T D +  G +L  ++ G  P   F+ + T EM
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPP---FYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 42/243 (17%)

Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62

Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL      + +    D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

Query: 356 DDF 358
            D 
Sbjct: 228 TDH 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 31/115 (26%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT---------TT 312
           GL+YLH ++   +IHRD++P+N+L++ + + +I +FGLA R  D              T 
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLA-RGVDPDEDEKGFLTEYVVTR 170

Query: 313 WSLAGTVGYIAPE----CHQ-TVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQ 360
           W       Y APE      + T A+    DI+S G + A L+  K  FP  D+  
Sbjct: 171 W-------YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYID 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 7/128 (5%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           L+ EF  +GSL++ L    + + +++   + + A  I  G++YL      + +HRD+   
Sbjct: 85  LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAAR 138

Query: 283 NVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL++ + + +I +FGL K I  D    T    L   V + APEC          D++SF
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198

Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 199 GVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 48/181 (26%), Positives = 88/181 (48%), Gaps = 25/181 (13%)

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ +   D + +
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 196 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253

Query: 364 E 364
           E
Sbjct: 254 E 254

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 58/262 (22%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G V   +K+        + ++K    L +++  +++E     +  +  +V L     
Sbjct: 12  GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71

Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +D    V ++   G +  +L  +  G    D LAR  IA+   +    +   H+   IH
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLL--IRMGIFPED-LARFYIAELTCA----VESVHKMGFIH 124

Query: 277 RDIQPANVLIDDDMEARISEFGLA------------------------------------ 300
           RDI+P N+LID D   ++++FGL                                     
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184

Query: 301 ---------KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG 351
                    +R    H R    SL GT  YIAPE       +  CD +S GV+L  +++G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244

Query: 352 KFPSDDFFQHT---KEMSLVQW 370
           + P   F   T    +M ++ W
Sbjct: 245 QPP---FLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 37/211 (17%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRH 205
            G+VYKA     +G+++ IK  I         I +D E       +I+ E  I      H
Sbjct: 19  YGKVYKARHK-KTGQLVAIK--IMD-------IIEDEEE------EIKEEYNILRKYSNH 62

Query: 206 RNIVP------LLARMVRRDCDLLVYEFRRNGSLQDILYDV-SQGRR-ELDWLARHRIAQ 257
            NI                D   LV E    GS+ D++  +  +G+R + +W+A   I +
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILR 120

Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG 317
               GL YLH +    +IHRDI+  N+L+  + E ++ +FG++ ++    T     +  G
Sbjct: 121 ETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD--STLGRRNTFIG 175

Query: 318 TVGYIAPE---CHQTVALSDT--CDIYSFGV 343
           T  ++APE   C +    S     D++S G+
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 45/221 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A    +SG ++ +KK+    +   E   +D  P+      +R EI     +RH N
Sbjct: 21  GIVYRAR-DTTSGEIVALKKV----RMDNE---RDGIPIS----SLR-EITLLLNLRHPN 67

Query: 208 IVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           IV L   +V +  D   LV E+     L  +L ++     E        +   +  GL+Y
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES---QVKCLMLQLLRGLQY 123

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PDGH---TRTTTWSLAGTVG 320
           LH +    IIHRD++ +N+L+ D    +I++FGLA+    P         T W       
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW------- 173

Query: 321 YIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           Y APE        T A+    D+++ G +LA L+  K   P
Sbjct: 174 YRAPELLLGCTTYTTAI----DMWAVGCILAELLAHKPLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 18/187 (9%)

Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQD----- 235
           KD      K  Q  +E++T   ++H +IV         D  ++V+E+ ++G L       
Sbjct: 44  KDPTLAARKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 101

Query: 236 -----ILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
                IL D    Q + EL       IA  IASG+ YL   H    +HRD+   N L+  
Sbjct: 102 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGA 158

Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AV 347
           ++  +I +FG+++ +               + ++ PE       +   D++SFGV+L  +
Sbjct: 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Query: 348 LVIGKFP 354
              GK P
Sbjct: 219 FTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 19/114 (16%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  GL+Y+H +    IIHRD++P N+ +++D E +I +FGLA+      T +       T
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178

Query: 319 VGYIAPECHQTVALS-----DTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
             Y APE    V L+      T DI+S G ++A ++ GK  F   D      E+
Sbjct: 179 RWYRAPE----VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 29/235 (12%)

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIAQGIAS 261
           + H N++  L + +     LLV EF   G L++ L        ++       R+A  +AS
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA-KRIPDGHTRTTTWSLAGTVG 320
           GL +LH +     IH D+   N  +  D+  +I ++GLA ++ P+ +  T     A  + 
Sbjct: 112 GLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD-CHAVPLR 167

Query: 321 YIAPEC----HQ---TVALSDTCDIYSFGV-LLAVLVIGKFPSDDFFQHTKEMSLVQWMR 372
           ++APE      Q       +   +I+S GV +  +      P   +   + E  L Q +R
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP---YPDLSDEQVLKQVVR 224

Query: 373 NVMTS-ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
                   P        L   Y ++   V++   FC L DP  RP +++V  +L+
Sbjct: 225 EQDIKLPKPQ-------LDLKYSDRWYEVMQ---FCWL-DPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 47/238 (19%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           D +  +EKI     G VYKA     +   I +KKI          ++++ E +    I+ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKAR-DRVTNETIALKKI---------RLEQEDEGVPSTAIR- 50

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR- 252
             EI    +++H NIV L   +       LV+E+        +  D+ +        A+ 
Sbjct: 51  --EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY--------LDLDLKKHMDSSPDFAKN 100

Query: 253 HRIAQG----IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKR--IPD 305
            R+ +     I  G+ Y H SHR  ++HRD++P N+LID    A ++++FGLA+   IP 
Sbjct: 101 PRLIKTYLYQILRGIAYCH-SHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156

Query: 306 GHTRTTTWSLAGTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
              RT T  +  T+ Y APE      H     S   DI+S G + A +V  K  FP D
Sbjct: 157 --VRTFTHEVV-TLWYRAPEILLGSRH----YSTPVDIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 44/238 (18%)

Query: 149 EVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMIQI 193
           + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++    
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 194 RS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRR 245
           R+  E++    V H+NI+ LL      + +    D+ LV E       Q I       + 
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QM 114

Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+    
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---- 167

Query: 306 GHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
             T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP  D+
Sbjct: 168 --TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 41/135 (30%), Positives = 71/135 (52%), Gaps = 11/135 (8%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V EF   G   D+++ + + R+  +  AR   A+ I+  L +LH      II+RD++  
Sbjct: 73  FVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNFLH---ERGIIYRDLKLD 125

Query: 283 NVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL+D +   +++++G+ K  I  G T +T     GT  YIAPE  +      + D ++ 
Sbjct: 126 NVLLDAEGHIKLTDYGMCKEGIRPGDTTST---FCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 342 GVLLAVLVIGKFPSD 356
           GVL+  ++ G+ P D
Sbjct: 183 GVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 8/131 (6%)

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 294
           ++ Y + + R  L+  AR   A+ IAS L YLH  +   I++RD++P N+L+D      +
Sbjct: 82  ELFYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 137

Query: 295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           ++FGL K   + +  T+T+   GT  Y+APE         T D +  G +L  ++ G  P
Sbjct: 138 TDFGLCKENIEHNGTTSTF--CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Query: 355 SDDFFQHTKEM 365
              + ++T EM
Sbjct: 196 F--YSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 33/224 (14%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           + +  L KI     G V+K      +G+++ IKK ++           + +P+  K I +
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCR-NRETGQIVAIKKFVE----------SEDDPVIKK-IAL 48

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           R EI    Q++H N+V L+  + RR   L LV+E+  +     +L ++ +  R +     
Sbjct: 49  R-EIRMLKQLKHPNLVNLI-EVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVP---E 99

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
           H I + I   L+ ++  H+   IHRD++P N+LI    + ++ +FG A+ +       T 
Sbjct: 100 HLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159

Query: 313 WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLLAVLVIG 351
           +    T  Y APE    + + DT      D+++ G + A L+ G
Sbjct: 160 Y--VATRWYRAPE----LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 47/217 (21%)

Query: 157 GSSGRVITIKKIIQPLKSGAEL-----IKKDSEPLHHKMIQIRSEI---ITAGQVRHRNI 208
           G+ G+VI +++     K+  +      +KK+       +I  + E+   +T  +V     
Sbjct: 6   GTFGKVILVRE-----KATGKYYAMKILKKE-------VIIAKDEVAHTLTESRVLQNTR 53

Query: 209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW-LARHRI---------AQG 258
            P L          L Y F+ +  L  ++   + G  EL + L+R R+            
Sbjct: 54  HPFLTA--------LKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAE 103

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAG 317
           I S L YLH      +++RD++  N+++D D   +I++FGL K  I DG T  T     G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCG 157

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           T  Y+APE  +        D +  GV++  ++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 50/240 (20%), Positives = 95/240 (39%), Gaps = 37/240 (15%)

Query: 148 GEVYKAELPG---SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEV+ A+  G     G  + + K +Q         K   E   +   + R E+    ++ 
Sbjct: 19  GEVFLAKAKGIEEEGGETLVLVKALQ---------KTKDE---NLQSEFRRELDMFRKLS 66

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE------LDWLARHRIAQG 258
           H+N+V LL      +   ++ E+   G L+  L   ++ + E      L    +  +   
Sbjct: 67  HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PDGHTRTTTWSLA 316
           IA G+++L  +   R +HRD+   N L+    E ++S   L+K +   + +         
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-- 180

Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL------AVLVIGKFPSDDFFQHTKEMSLVQW 370
             + ++APE  Q    S   D++SFGVL+        L       ++     +   L + 
Sbjct: 181 -PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-EL 238

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 18/161 (11%)

Query: 205 HRNIVPLLARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG 258
           HRNI       +++      D   LV EF   GS+ D++ +      + +W+A   I + 
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICRE 119

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GL +LH   + ++IHRDI+  NVL+ ++ E ++ +FG++ ++     R  T+   GT
Sbjct: 120 ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGT 174

Query: 319 VGYIAPE---CHQT--VALSDTCDIYSFGVLLAVLVIGKFP 354
             ++APE   C +          D++S G+    +  G  P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 13/135 (9%)

Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E+   GSL D LY        +      RI   +  GL++L   H   IIHRD++P NVL
Sbjct: 79  EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE------CHQTVALSDTCDIY 339
           ++ + + ++ +FG++  +     +T      G   Y+APE       +Q    +   D++
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQNPTYTVQSDVW 191

Query: 340 SFGVLLAVLVIGKFP 354
           S G+ +  + +G++P
Sbjct: 192 SLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 45/229 (19%)

Query: 148 GEVYKAE----LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V+ AE    LP     ++ +K     LK  +E  ++D         Q  +E++T  Q 
Sbjct: 19  GKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQD--------FQREAELLTVLQ- 65

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY-------------DVSQGRRELDWL 250
            H++IV            L+V+E+ R+G L   L              DV+ G+  L  +
Sbjct: 66  -HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               IA  IASG+ YL   H    +HRD+   N L+   +  +I +FG+++ I      T
Sbjct: 125 LA--IASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YST 175

Query: 311 TTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + G     + ++ PE       +   DI+SFGV+L  +   GK P
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
            ++E      + H NI+      +     ++V E+   G+L + +    +    L  L  
Sbjct: 46  AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSL--LDE 100

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKRIPDGHTRTT 311
             I       L  LH  H   I+HRD++  N+L+D   M  +I +FG++K +    +++ 
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSK 157

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +++ GT  YI+PE  +    +   DI++ G +L
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 34/103 (33%), Positives = 61/103 (59%), Gaps = 10/103 (9%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSLAGT 318
           GL+Y+H ++   +IHRD++P+N+L+++D E RI +FG+A+ +   P  H    T  +A T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-T 174

Query: 319 VGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSDDF 358
             Y APE   ++    T  D++S G + A ++  +  FP  ++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 37/223 (16%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
              + K +    +  ++ +KKI         L     E     +  ++ EIIT+ Q++H 
Sbjct: 15  IVHLAKHK---PTNTLVAVKKI--------NLDSCSKE----DLKLLQQEIITSRQLQHP 59

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIAQGIASGLEY 265
           NI+P +   +      +V      GS +D+L     +G  E   LA   I + + + L+Y
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPE---LAIAFILKDVLNALDY 116

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEF---------GLAKRIPDGHTRTTTWSLA 316
           +H       IHR ++ +++L+  D +  +S           G  +R+     +++  +L 
Sbjct: 117 IHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 317 GTVGYIAPECHQTVALSDT--CDIYSFGVLLAVLVIGKFPSDD 357
               +++PE  Q          DIYS G+    L  G  P  D
Sbjct: 174 ----WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 26/179 (14%)

Query: 218 RDCDLLV---YEFRRNGSLQDILYDVSQG-------RRELDWLARHRIAQG-IASGLEYL 266
           R C  LV   Y F+ +  L  IL  V+ G       +RE    +  R+    I   L++L
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPE 325
           H   +  II+RDI+  N+L+D +    +++FGL+K  + +   R   +S  GT+ Y+APE
Sbjct: 122 H---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER--AYSFCGTIEYMAPE 176

Query: 326 C--HQTVALSDTCDIYSFGVLLAVLVIG--KFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
                +       D +S GVL   L+ G   F  D       E+S     R ++ S+ P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS-----RRILKSKPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 31/221 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AE          I   ++ LK  ++  +KD    H +     +E++T   ++H +
Sbjct: 19  GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD---FHRE-----AELLT--NLQHEH 68

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-------VSQGR--RELDWLARHRIAQG 258
           IV      V  D  ++V+E+ ++G L   L         +++G    EL       IAQ 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG- 317
           IA+G+ YL   H    +HRD+   N L+ +++  +I +FG+++ +      T  + + G 
Sbjct: 129 IAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDV----YSTDYYRVGGH 181

Query: 318 ---TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++ PE       +   D++S GV+L  +   GK P
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 14/160 (8%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++ H  +V L      R    LV+EF  +G L D L      R +        +   +  
Sbjct: 55  KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCE 111

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           G+ YL  S+   +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT   
Sbjct: 112 GMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFP 164

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
           V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 51/225 (22%)

Query: 148 GEVYKAE-LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G VYKA+   G  G+   IKK     +    +               R EI    +++H 
Sbjct: 14  GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI----------SQSACR-EIALLRELKHE 62

Query: 207 NIVPL----LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           N+V L    L    +     L++++  +   Q I +     R  +       +   I +G
Sbjct: 63  NVVSLVEVFLEHADK--SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEAR----ISEFGLAKRIPDGHTRT-------- 310
           + YLH +    ++HRD++PAN+L+  +   R    I + GLA R+ +   +         
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLADLDPVV 176

Query: 311 -TTWSLAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLV 349
            T W       Y APE      H T A+    DI++ G + A L+
Sbjct: 177 VTIW-------YRAPELLLGARHYTKAI----DIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 15/159 (9%)

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  SE     Q  H NIV L+    +R    +V E    G   D L  + + + EL   
Sbjct: 37  IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTK 93

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
              + A   A+G+ YL   +    IHRD+   N L+ ++   +IS+FG++++  DG    
Sbjct: 94  QLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---- 146

Query: 311 TTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVLL 345
             +S +G     + + APE       S   D++S+G+LL
Sbjct: 147 -IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
            EYL   +   I++RD++P N+L+D D   ++++FG AK +      T T++L GT  YI
Sbjct: 144 FEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYI 195

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE    V      D ++ G+ +  +++G  P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 30/91 (32%), Positives = 47/91 (51%)

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           +H  H   +IHRDI+ AN+L+  +   ++ +FG +K      +     +  GT  Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
             +    S   D++S GVLL  L+  K P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 36/137 (26%), Positives = 55/137 (40%), Gaps = 38/137 (27%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT---------- 308
           IA  +  +   H+   IHRDI+P N+L+D     ++S+FGL   +   H           
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 309 -----------------RTTTW---------SLAGTVGYIAPECHQTVALSDTCDIYSFG 342
                            +  TW         S  GT  YIAPE       +  CD +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 343 VLLAVLVIG--KFPSDD 357
           V++  +++G   F SD+
Sbjct: 227 VIMYEMLVGYPPFCSDN 243

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 48/269 (17%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMI 191
           + + Y  ++  S+  V+   + ++P+ SGA+                +KK S P  ++  
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63

Query: 192 QIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQG 243
             R+  E++    V H+NI+ LL      + +    D+ LV E       Q I  ++   
Sbjct: 64  AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE 123

Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           R  + +L        +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 124 R--MSYLLYQ-----MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-- 171

Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
               T  T + +   V    Y APE    +   +  DI+S G ++  LV G       FQ
Sbjct: 172 ----TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQ 223

Query: 361 HTKEMSLVQWMRNVMTSENPNRAINSKLL 389
            T  +   QW + +     P+    ++L 
Sbjct: 224 GTDHID--QWNKVIEQLGTPSAEFMNRLQ 250

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 10/178 (5%)

Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           KDSE           E+     ++  NIV L     RR    LV+E+     L+ +L ++
Sbjct: 35  KDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEM 93

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
             G      +   ++   I   ++ +H  H+  I+HRDI+P N+LI  +   ++ +FG A
Sbjct: 94  PNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA 147

Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
           + + +G     T  +A T  Y +PE           D++S G +L  L  G+  FP +
Sbjct: 148 RNLSEGSNANYTEYVA-TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 36/250 (14%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII-TAGQVRH 205
           N E+ K    G+ G+V  ++K+     SG      DS  L+   +  ++ I+  A    H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKV-----SG-----HDSGKLYAMKVLKKATIVQKAKTTEH 50

Query: 206 RNIVPLLARMVRRDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG----- 258
                 +   +R+   L  L Y F+ +  L  IL  ++ G        R R  +      
Sbjct: 51  TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110

Query: 259 ---IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              I   LE+LH   +  II+RDI+  N+L+D +    +++FGL+K   +       +S 
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSF 166

Query: 316 AGTVGYIAPECHQTVALSDT-----CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
            GT+ Y+AP+    V   D       D +S GVL+  L+ G  P   F    ++ S  + 
Sbjct: 167 CGTIEYMAPD---IVRGGDGGHDKAVDWWSMGVLMYELLTGASP---FTVDGEKNSQAEI 220

Query: 371 MRNVMTSENP 380
            R ++ SE P
Sbjct: 221 SRRILKSEPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 21/136 (15%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           +AR  IA+ + +    +H  H+   +HRDI+P NVL+D +   R+++FG   ++    T 
Sbjct: 103 MARFYIAEMVLA----IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158

Query: 310 TTTWSLAGTVGYIAPECHQTVALSD-------TCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
            ++ ++ GT  YI+PE  Q  A+ D        CD +S GV +  ++ G+ P   F+   
Sbjct: 159 QSSVAV-GTPDYISPEILQ--AMEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAE- 211

Query: 363 KEMSLVQWMRNVMTSE 378
              SLV+    +M  E
Sbjct: 212 ---SLVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 41/136 (30%), Positives = 71/136 (52%), Gaps = 11/136 (8%)

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
            LV E+   G   D+++ + + R+  +  AR   A+ I   L +LH      II+RD++ 
Sbjct: 72  FLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLH---ERGIIYRDLKL 124

Query: 282 ANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
            NVL+D D   +++++G+ K  +  G T +T     GT  YIAPE  +      + D ++
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 341 FGVLLAVLVIGKFPSD 356
            GVL+  ++ G+ P D
Sbjct: 182 LGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 35/213 (16%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV-----PL 211
           G  G+V  ++K+     +GA+  K  +  +  K   +R++  TA     RNI+     P 
Sbjct: 7   GGYGKVFQVRKV-----TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR------RE---LDWLARHRIAQGIASG 262
           +        DL +Y F+  G L  IL  +S G       RE   ++  A   +++ I+  
Sbjct: 62  I-------VDL-IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-ISLA 112

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGY 321
           LE+LH   +  II+RD++P N+L+D     ++++FGL K  I +G   T T +  GT+ Y
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEY 166

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE           D +S G L+  ++ G  P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 42/232 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY A  P  S RV  +KKI + L S   L+KK           +R   I A  + H  
Sbjct: 16  GEVYLAYDPVCSRRV-ALKKIREDL-SENPLLKKRF---------LREAKIAA-DLIHPG 63

Query: 208 IVPLLARMVRRDCDLLVYE--FRRNGSLQDILYDVSQGRRELDWLARH-------RIAQG 258
           IVP+ +  +  D D + Y   +    +L+ +L  V Q       LA          I   
Sbjct: 64  IVPVYS--ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--------------RIP 304
           I + +EY+H      ++HRD++P N+L+    E  I ++G A                  
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 305 DG--HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +    + T    + GT  Y+APE    V  S++ DIY+ GV+L  ++   FP
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           V+H  +V L       +    V +F   G L    + + + R   +  AR   A+ IAS 
Sbjct: 53  VKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAE-IASA 108

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGY 321
           L YLH      I++RD++P N+L+D      +++FGL K  I    T TT     GT  Y
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT---FCGTPEY 162

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE  +     +T D +  G +L  ++ G  P
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GL+YLH +    I+HRDI+P N+L++ +   +I +FGLA+      ++  T  +  T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167

Query: 319 VGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK 352
             Y APE      H T A+    DI+S G + A L+  +
Sbjct: 168 QYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           +R E++   ++ H+   P + RM+     +  +LV E    G L   L   S  + E+  
Sbjct: 38  VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---SGKKDEITV 94

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PDGH 307
                +   ++ G++YL   +    +HRD+   NVL+ +   A+IS+FGL+K +   D +
Sbjct: 95  SNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151

Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  +   W L     + APEC      S   D++S+G+ +
Sbjct: 152 YKARSAGKWPLK----WYAPECINFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 23/138 (16%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHT 308
           +AR  +A+ + +    +   H+   +HRDI+P NVL+D +   R+++FG   R+  DG  
Sbjct: 103 MARFYLAEMVLA----IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSD-------TCDIYSFGVLLAVLVIGKFPSDDFFQH 361
           ++      GT  YI+PE  Q  A+ D        CD +S GV +  ++ G+ P   F+  
Sbjct: 159 QSNV--AVGTPDYISPEILQ--AMEDGKGRYGPECDWWSLGVCMYEMLYGETP---FYAE 211

Query: 362 TKEMSLVQWMRNVMTSEN 379
               SLV+    +M  + 
Sbjct: 212 ----SLVETYGKIMNHKE 225

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 6/85 (7%)

Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
           H    IHRD++P N LID     ++++FGL+K I      T   S+ G+  Y+APE  + 
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAPEVLRG 172

Query: 330 VALSDTCDIYSFGVLLAVLVIGKFP 354
                T D +S G +L   + G FP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG-FP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 33/121 (27%), Positives = 55/121 (45%), Gaps = 34/121 (28%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR--------- 309
           I  GL+Y+H ++   ++HRD++P N+L++ D E +I +FGLA+   +             
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 310 TTTWSLAGTVGYIAPE-------CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQ 360
            T W       Y APE         + +      D++S G +LA L+  K  F   D+  
Sbjct: 171 ATRW-------YRAPEIMLSFQSYTKAI------DVWSVGCILAELLGRKPVFKGKDYVD 217

Query: 361 H 361
            
Sbjct: 218 Q 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 35/203 (17%)

Query: 172 LKSGAEL-IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCD------L 222
            ++G ++ IKK S P   ++   R+  E+     ++H N++ LL                
Sbjct: 37  KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV  + +   LQ I+     G    +   ++ + Q +  GL+Y+H +    IIHRD++P 
Sbjct: 97  LVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQ-MLCGLKYIHSAG---IIHRDLKPG 146

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS-----DTCD 337
           N+ +++D E +I +FGLA+     H          T  Y APE    V L+      T D
Sbjct: 147 NLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPE----VILNWMHYNQTVD 197

Query: 338 IYSFGVLLAVLVIGK--FPSDDF 358
           I+S G ++A ++ GK  F   D+
Sbjct: 198 IWSVGCIMAEMLTGKTLFKGKDY 220

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 36/225 (16%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLH-HKMIQIRSEIITAGQVRH 205
           N E+ K    G+ G+V  ++K+             D+  L+  K++Q  + +  A  V H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGH----------DTGKLYAMKVLQKAALVQKAKTVEH 50

Query: 206 ----RNIVPLLARMVRRDCDLLV---YEFRRNGSLQDILYDVSQG-------RRELDWLA 251
               RN++  +     R    LV   Y F+    L  IL  VS G       +R+     
Sbjct: 51  TRTERNVLEHV-----RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED 105

Query: 252 RHRIAQG-IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
             R   G I   LE+LH   +  I++RDI+  N+L+D +    +++FGL+K       + 
Sbjct: 106 EVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKE 161

Query: 311 TTWSLAGTVGYIAPE-CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            T+S  GT+ Y+APE            D +S G+L+  L+ G  P
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 30/106 (28%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGH---------TRTT 311
           GL+Y+H ++   ++HRD++PANV I+ +D+  +I +FGLA RI D H            T
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA-RIVDPHYSHKGYLSEGLVT 181

Query: 312 TWSLAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK 352
            W       Y +P       + T A+    D+++ G + A ++ GK
Sbjct: 182 KW-------YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 11/106 (10%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD---GHTRTTTWSL 315
           I  GL+Y+H ++   ++HRD++P+N+L++ + + +I +FGLA RI D    HT   T  +
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGFLTEYV 170

Query: 316 AGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGK--FPSDDF 358
           A T  Y APE        +   DI+S G +LA ++  +  FP  D+
Sbjct: 171 A-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 10/122 (8%)

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 294
           ++ + + + R  L+  AR   A+ +AS + YLH  +   II+RD++P N+L+D      +
Sbjct: 82  ELFFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN---IIYRDLKPENILLDSQGHVVL 137

Query: 295 SEFGLAKR--IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK 352
           ++FGL K    P+     TT +  GT  Y+APE  +      T D +  G +L  ++ G 
Sbjct: 138 TDFGLCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193

Query: 353 FP 354
            P
Sbjct: 194 PP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 157 GSSGRVI--TIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITA-GQVRHRNIVPLLA 213
           G+ G+VI   IKK    + +  +++K+ +    H+      E++   G   H NI+ LL 
Sbjct: 13  GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPNIINLLG 70

Query: 214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH------------RIAQGIAS 261
               R    +  E+   G+L D L        +  +   H            + A  +A+
Sbjct: 71  ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT 130

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G++YL      + IHRD+   NVL+ +++ ++I++FGL+ R  + + + T   L   V +
Sbjct: 131 GMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS-RGEEVYVKKTMGRLP--VRW 184

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLV 349
           +A E       +   D++SFGVLL  +V
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 9/103 (8%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAG 317
           +A  +  +H  H+   +HRDI+P NVLID     ++++FG A R+  +    +      G
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK--LPVG 165

Query: 318 TVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFP 354
           T  YIAPE   T+           CD +S GV+   ++ G+ P
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 63/181 (34%)

Query: 205 HRNIVPLLARMVRR---DCDL-LVYEFR--------RNGSLQDILYDVSQGRRELDWLAR 252
           H NIV LL   V +   D D+ LV+E+         R   L+D+                
Sbjct: 66  HPNIVKLLN--VIKAENDKDIYLVFEYMETDLHAVIRANILEDV---------------- 107

Query: 253 HR--IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGH 307
           H+  I   +   L+Y+H  +   +IHRD++P+N+L++ D   ++++FGLA+ +    +  
Sbjct: 108 HKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Query: 308 TR-------TTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--F 353
                     T W       Y APE    + L  T      D++S G +L  +++GK  F
Sbjct: 165 ENPVLTDYVATRW-------YRAPE----ILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Query: 354 P 354
           P
Sbjct: 214 P 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 27/176 (15%)

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW-LA 251
           IR EI    +++H NIV L   +   +  +LV+E+  +  L+  + D    R  LD    
Sbjct: 46  IR-EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTV 102

Query: 252 R---HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
           +   +++ +GIA         H  R++HRD++P N+LI+   E ++++FGLA+    G  
Sbjct: 103 KSFTYQLLKGIA-------FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIP 153

Query: 309 RTTTWSLAGTVGYIAPECHQTVAL-----SDTCDIYSFGVLLAVLVIGK--FPSDD 357
             T  +   T+ Y AP+    V L     S + DI+S G ++A ++ G+  FP  +
Sbjct: 154 VNTFSNEVVTLWYRAPD----VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 26/189 (13%)

Query: 172 LKSGAELIKKDSEPLHHKMIQ-------IRSEIITAGQVRHRNIVPLLARMV---RRDCD 221
           +K G   +KK  + +  K+++       ++ E++    V  +   P + RM+     +  
Sbjct: 11  VKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESW 70

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
           +LV E    G L   L    Q  + +       +   ++ G++YL  ++    +HRD+  
Sbjct: 71  MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAA 123

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG-----YIAPECHQTVALSDTC 336
            NVL+     A+IS+FGL+K +         +  A T G     + APEC      S   
Sbjct: 124 RNVLLVTQHYAKISDFGLSKAL----GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179

Query: 337 DIYSFGVLL 345
           D++SFGVL+
Sbjct: 180 DVWSFGVLM 188

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 32/223 (14%)

Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L  E+++  + ++     G+VYKA+       V+   K+I           K  E L   
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQ--NKETGVLAAAKVID---------TKSEEELEDY 49

Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           M++I  +I+ +    H NIV LL      +   ++ EF   G++  ++ ++ +       
Sbjct: 50  MVEI--DILAS--CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------ 99

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           L   +I       LE L+  H  +IIHRD++  N+L   D + ++++FG++ +    +TR
Sbjct: 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTR 155

Query: 310 TTTW--SLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
           T     S  GT  ++APE        D       D++S G+ L
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 7/98 (7%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL+YLH +   +I++RD++  N+L+D +   +I++FGL K       RT+T+   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF--CGTPEF 167

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           +APE     + +   D +  GVL+  +++G+  FP DD
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 34/188 (18%)

Query: 125 EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSE 184
            +  F ++   +  L KI     GEV+KA     + +++ +KK+         L++ + E
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKAR-HKKTKQIVALKKV---------LMENEKE 52

Query: 185 PLHHKMIQIRSEIITAGQVRHRNIVPLL------ARMVRRDCD--LLVYEFRRN---GSL 233
                 I    EI     ++H N+V L+      A    R      LV+EF  +   G L
Sbjct: 53  GFP---ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL 109

Query: 234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
            +     +    +       ++ + + +GL Y+H   R +I+HRD++ AN+LI  D   +
Sbjct: 110 SNKNVKFTLSEIK-------KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILK 159

Query: 294 ISEFGLAK 301
           +++FGLA+
Sbjct: 160 LADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 41/198 (20%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI 236
           IKK S P  +     R+  E++    V H+NI+ LL              F    SL++ 
Sbjct: 46  IKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN------------VFTPQKSLEEF 93

Query: 237 --LYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-------------HRPRIIHRDIQP 281
             +Y V +       L    + Q I   L++  MS             H   IIHRD++P
Sbjct: 94  QDVYLVME-------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           +N+++  D   +I +FGLA R        T + +  T  Y APE    +   +  DI+S 
Sbjct: 147 SNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSV 203

Query: 342 GVLLAVLVIGK--FPSDD 357
           G ++  ++ G   FP  D
Sbjct: 204 GCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 49/150 (32%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--------- 300
           LAR  IA+ +   +E +H   +   IHRDI+P N+LID D   ++++FGL          
Sbjct: 102 LARFYIAE-LTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157

Query: 301 ------------------------------------KRIPDGHTRTTTWSLAGTVGYIAP 324
                                               +R    H R    SL GT  YIAP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           E       +  CD +S GV+L  +++G+ P
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 48/211 (22%), Positives = 96/211 (45%), Gaps = 37/211 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAEL-------IKKDSEPLHHKMIQIRSEIIT 199
           G+V+KA    + GR + +K++ +Q  + G  L       + +  E   H  +    ++ T
Sbjct: 15  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74

Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNG----SLQDILYDVSQGRRELDWLARHRI 255
             +      + L+   V +D    + +    G    +++D+++ + +             
Sbjct: 75  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR------------- 121

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
                 GL++LH SH  R++HRD++P N+L+    + ++++FGLA RI       T  S+
Sbjct: 122 ------GLDFLH-SH--RVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT--SV 169

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
             T+ Y APE     + +   D++S G + A
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 37/172 (21%)

Query: 203 VRHRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQG---------RRELDWLA 251
           + H+NI+P+L  +   D +   ++Y +   G+L+  L     G          ++L  +A
Sbjct: 65  LSHQNILPIL-HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-P------ 304
                  IA G+ YLH   +  +IH+DI   N +ID++++ +I++  L++ + P      
Sbjct: 124 IQ-----IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 305 -DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV-IGKFP 354
            D   R   W        +A E       S   D++SFGVLL  L+ +G+ P
Sbjct: 176 GDNENRPVKW--------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 3/85 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IA G+EYL  S+R   IHRD+   N ++ +DM   +++FGL+K+I  G            
Sbjct: 122 IALGMEYL--SNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 319 VGYIAPECHQTVALSDTCDIYSFGV 343
           V +IA E       +   D+++FGV
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGV 203

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 33/118 (27%), Positives = 48/118 (40%), Gaps = 33/118 (27%)

Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH---------------------- 307
           H+   IHRDI+P N+L+D     ++S+FGL   +   H                      
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 308 --TRTTTW---------SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +  TW         S  GT  YIAPE       +  CD +S GV++  ++IG  P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 42/165 (25%), Positives = 63/165 (38%), Gaps = 40/165 (24%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           L+ EF   G +  +L        + D L        IA  +  +   H+   IHRDI+P 
Sbjct: 78  LIMEFLPGGDMMTLLM-------KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130

Query: 283 NVLIDDDMEARISEFGLAKRIPDGH------------------------TRTTTW----- 313
           N+L+D     ++S+FGL   +   H                         +  TW     
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190

Query: 314 ----SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
               S  GT  YIAPE       +  CD +S GV++  ++IG  P
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 19/163 (11%)

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS--- 261
           H NI+ LL     R    L  E+  +G+L D L        +  +   +  A  ++S   
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 262 ---------GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
                    G++YL    + + IHRD+   N+L+ ++  A+I++FGL+ R  + + + T 
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTM 182

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             L   V ++A E       +   D++S+GVLL  ++ +G  P
Sbjct: 183 GRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 39/223 (17%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G+V+ ++K             +D++ ++      ++ I++  +V H     L  R V
Sbjct: 4   GSFGKVMQVRK-------------RDTQRIYALKTIRKAHIVSRSEVTH----TLAERTV 46

Query: 217 --RRDCDLLV---YEFRRNGSLQDILYDVSQG------RRE---LDWLARHRIAQGIASG 262
             + +C  +V   + F+    L  +L  ++ G      +RE       AR   A+ +   
Sbjct: 47  LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAE-LLCA 105

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE LH   +  +I+RD++P N+L+D      + +FGL K       +T T+   GT  Y+
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYL 160

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE       +   D ++ GVLL  ++ G  P  D  ++  EM
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD--ENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 36/232 (15%)

Query: 121 LIKEEDLAFL----EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA 176
           ++K+ ++A L    + E+ F  L +I     G VY A     +  V+ +KK+     SG 
Sbjct: 4   VVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFAT-NSHTNEVVAVKKMSY---SGK 59

Query: 177 ELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI 236
           +         + K   I  E+    Q++H N +      ++     LV E+   GS  D+
Sbjct: 60  QT--------NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDL 110

Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    +  +E++  A   I  G   GL YLH SH   +IHRDI+  N+L+ +  + ++++
Sbjct: 111 LEVHKKPLQEVEIAA---ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLAD 164

Query: 297 FGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGV 343
           FG A +    +      S  GT  ++APE    +A+ +       D++S G+
Sbjct: 165 FGSASKSSPAN------SFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 23/203 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR 206
           G+V +A   G S     +K  ++ LK  A   ++++         + SE+     +  H 
Sbjct: 49  GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA---------LMSELKIMSHLGNHE 99

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV LL         L++ E+   G L + L    +    L+ L     +  +A G+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS--FSYQVAKGMAFL 157

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
              +    IHRD+   NVL+      +I +FGLA+ I +        +    V ++APE 
Sbjct: 158 ASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 326 ---CHQTVALSDTCDIYSFGVLL 345
              C  T       D++S+G+LL
Sbjct: 215 IFNCVYTF----ESDVWSYGILL 233

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           L+Y+H      +IHRDI+ AN+L+ +    ++ +FG+A  +    ++ +T    GT  ++
Sbjct: 114 LKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWM 168

Query: 323 APECHQTVALSDT-CDIYSFGVLLAVLVIGKFP 354
           APE        DT  DI+S G+ +  +  G  P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 48/237 (20%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G V+KA+    +  ++ +K++   L    E +   +         +R 
Sbjct: 2   YEKLEKIGEGTYGTVFKAK-NRETHEIVALKRV--RLDDDDEGVPSSA---------LR- 48

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    +++H+NIV L   +       LV+E+      QD+   +D   G  ++D     
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEY----CDQDLKKYFDSCNG--DID----P 98

Query: 254 RIAQG----IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPD-- 305
            I +     +  GL + H SH   ++HRD++P N+LI+ + E ++++FGLA+   IP   
Sbjct: 99  EIVKSFMFQLLKGLAFCH-SHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155

Query: 306 -GHTRTTTWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK---FPSDD 357
                 T W       Y  P+      L  T  D++S G + A L       FP +D
Sbjct: 156 YSAEVVTLW-------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 15/138 (10%)

Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++ 
Sbjct: 72  FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKL 124

Query: 282 ANVLIDDDMEARISEFGLAK---RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDI 338
            NVL+D +   +++++G+ K   R  D     TT +  GT  YIAPE  +      + D 
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 339 YSFGVLLAVLVIGKFPSD 356
           ++ GVL+  ++ G+ P D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 20/128 (15%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK-------- 301
           +AR   A+ + + LEYLH      I+HRD++P N+LI      ++++FGL+K        
Sbjct: 102 MARMYFAETVLA-LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 302 RIPDGHTRTTTW-----SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
            + +GH    T       + GT  YIAPE           D ++ G++L   ++G  P  
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP-- 215

Query: 357 DFFQHTKE 364
            FF  T E
Sbjct: 216 -FFGDTPE 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           + G++I +K++     S     +K+ E L  ++  ++S       ++H NIV  L   + 
Sbjct: 22  NQGQLIAVKQVELD-TSNVLAAEKEYEKLQEEVDLLKS-------LKHVNIVQYLGTCLD 73

Query: 218 RDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            D  + ++ EF   GS+  IL         L      +  + I  G+ YLH +    ++H
Sbjct: 74  -DNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVH 125

Query: 277 RDIQPANVLIDDDMEARISEFGLAKRIP----DGHTRTTTWSLAGTVGYIAPECHQTVAL 332
           RDI+  NV++  +   ++ +FG A+R+      G       S+ GT  ++APE       
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185

Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
               DI+S G  +  +  GK P
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 7e-07
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 22/213 (10%)

Query: 157 GSSGRVI--TIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR 214
           G+ G+V+   IKK    + +  + +K+ +    H+      E++      H NI+ LL  
Sbjct: 6   GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGHHPNIINLLGA 64

Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH------------RIAQGIASG 262
              R    L  E+  +G+L D L        +  +   +              A  +A G
Sbjct: 65  CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 124

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++YL    + + IHRD+   N+L+ ++  A+I++FGL+ R  + + + T   L   V ++
Sbjct: 125 MDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGRLP--VRWM 178

Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           A E       +   D++S+GVLL  ++ +G  P
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 28/165 (16%)

Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLH-MSHRPRIIHRDI 279
           +V E+   G L +++  YD+ +      W AR   A+ +   L+ +H M      IHRD+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAE-VVLALDAIHSMGF----IHRDV 168

Query: 280 QPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVA----LSD 334
           +P N+L+D     ++++FG   ++  +G  R  T    GT  YI+PE  ++         
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGR 226

Query: 335 TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            CD +S GV L  +++G  P   F+      SLV     +M  +N
Sbjct: 227 ECDWWSVGVFLYEMLVGDTP---FYAD----SLVGTYSKIMDHKN 264

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 36/242 (14%)

Query: 122 IKEEDLAFL----EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE 177
           +K+ ++A L    + E  F  L +I     G VY A     +  V+ IKK+    K   E
Sbjct: 9   LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE 67

Query: 178 LIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL 237
                      K   I  E+    +++H N +      +R     LV E+   GS  D+L
Sbjct: 68  -----------KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL 115

Query: 238 YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 297
               +  +E++  A   I  G   GL YLH SH   +IHRDI+  N+L+ +  + ++++F
Sbjct: 116 EVHKKPLQEVEIAA---ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLADF 169

Query: 298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGK 352
           G A      +      S  GT  ++APE    +A+ +       D++S G+    L   K
Sbjct: 170 GSASIASPAN------SFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERK 221

Query: 353 FP 354
            P
Sbjct: 222 PP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 3/87 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IASG+EYL        IHRD+   N +++++M   +++FGL+K+I +G            
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
           V +IA E       +   D++SFGV +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTM 204

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY       +GR + +K++  P    ++   K+   L         EI     +RH  
Sbjct: 16  GEVYLC-YDADTGRELAVKQV--PFDPDSQETSKEVNALE-------CEIQLLKNLRHDR 65

Query: 208 IVPL---LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           IV     L     +   + V E+   GS++D L    +    L      R  + I  G+ 
Sbjct: 66  IVQYYGCLRDPEEKKLSIFV-EYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVS 120

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH-TRTTTWSLAGTVGYIA 323
           YLH +    I+HRDI+ AN+L D     ++ +FG +KRI     + T   S+ GT  +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
           PE           D++S    +  ++  K P  ++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 148 GEVYKAELPG-SSGRVITIKKIIQPLKSGAEL-IKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G V++A  PG       T+  + + LK  A   ++ D +           E     +  H
Sbjct: 19  GRVFQARAPGLLPYEPFTMVAV-KMLKEEASADMQADFQ----------REAALMAEFDH 67

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS------------------QGRREL 247
            NIV LL          L++E+   G L + L   S                       L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
               +  IA+ +A+G+ YL  S R + +HRD+   N L+ ++M  +I++FGL++ I    
Sbjct: 128 SCTEQLCIAKQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
               + + A  + ++ PE       +   D++++GV+L
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E    GS+ +++  +    + LD      I  G   GL++LH +   RIIHRD++  
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGN 157

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE---CHQTVALS--DTCD 337
           N+L+  +   ++ +FG++ ++     R  T    GT  ++APE   C Q    S    CD
Sbjct: 158 NILLTTEGGVKLVDFGVSAQLTSTRLRRNT--SVGTPFWMAPEVIACEQQYDYSYDARCD 215

Query: 338 IYSFGVLLAVLVIGKFP 354
           ++S G+    L  G  P
Sbjct: 216 VWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 9e-07
 Identities = 35/113 (30%), Positives = 62/113 (54%), Gaps = 16/113 (14%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG-LAKRIPDGHT 308
           +AR  +A+ + + ++ +H  H    +HRDI+P N+L+D +   R+++FG   K + DG  
Sbjct: 103 MARFYLAEMVIA-IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSD-------TCDIYSFGVLLAVLVIGKFP 354
           +++     GT  YI+PE  Q  A+ D        CD +S GV +  ++ G+ P
Sbjct: 159 QSSV--AVGTPDYISPEILQ--AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 61/249 (24%)

Query: 205 HRNIVPLLARMVRRD--CDLLVYEFRRNGSLQDI-LYDVSQGRRELDWLARHRIAQGIAS 261
           H NI+ L+  +  R      LV+E      L D+ LY++ +GR+    L   R+   +  
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFE------LMDMNLYELIKGRKRP--LPEKRVKSYMYQ 108

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT----TTWSLAG 317
            L+ L   HR  I HRDI+P N+LI DD   ++++FG  + I      T    T W    
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW---- 163

Query: 318 TVGYIAPECHQTVALSD-----TCDIYSFG-VLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
              Y APEC     L+D       DI++ G V   +L +  FP    F  T E+  +  +
Sbjct: 164 ---YRAPEC----LLTDGYYGPKMDIWAVGCVFFEILSL--FP---LFPGTNELDQIAKI 211

Query: 372 RNVMTS--------ENPNRAIN-----------SKLLGNGYEEQMLLVLKIACFCTLDDP 412
            +V+ +           +R +N            KLL N   E + L+ K+  +    DP
Sbjct: 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAY----DP 267

Query: 413 NKRPNSKDV 421
           ++R  +K  
Sbjct: 268 DERITAKQA 276

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 16/109 (14%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL+Y+H ++   ++HRD++P+N+L++ + + +I +FGLA+   +     T + +  T  Y
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWY 174

Query: 322 IAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTK 363
            APE        T A+    D++S G + A L+  K  FP  D+    K
Sbjct: 175 RAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKPLFPGKDYVHQLK 219

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)

Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W AR   A+ + +    L   H    IHRD++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-ARFYTAEVVLA----LDAIHSMGFIHRDVK 169

Query: 281 PANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++  +G  R  T    GT  YI+PE  ++          
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 3/156 (1%)

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           RSE+       H  IV         D  LL+ E+   GS  D+   + Q  +E      +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDLNKQIKQRLKEHLPFQEY 169

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            +       +  L   H  +++HRD++ AN+ +      ++ +FG +K+  D  +     
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV 349
           S  GT  Y+APE  +    S   D++S GV+L  L+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 70/304 (23%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+   L G+ G++  +K + +      E+IK++   +    +    EI+    + H  
Sbjct: 15  GRVFLVRLKGT-GKLFALKVLDK-----KEMIKRNK--VKR--VLTEQEILAT--LDHPF 62

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +  L A         LV ++   G L  +L     G+   + +AR   A+ +   LEYLH
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAE-VLLALEYLH 120

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--------RIPDGHTRTTTW------ 313
           +     I++RD++P N+L+ +     +S+F L+K                +         
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 314 -------------SLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
                        S  GT  YIAPE           D ++ G+LL  ++ G  P   F  
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP---FKG 234

Query: 361 HTKEMSLVQWMRNVMTSE-----NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR 415
             ++ +      N++  E     +P  + +++ L        LLV          DP+KR
Sbjct: 235 SNRDETF----SNILKKEVTFPGSPPVSSSARDLIRK-----LLV---------KDPSKR 276

Query: 416 PNSK 419
             SK
Sbjct: 277 LGSK 280

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 21/171 (12%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IASG+EYL   +    IHRD+   N +++++M   +++FGL+K+I  G       +    
Sbjct: 122 IASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS 377
           V ++A E       +   D+++FGV +  ++  G+ P                   V  S
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP----------------YAGVENS 222

Query: 378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           E  N  I    L     + +  V ++ C C   +P  RP+ + +R  L  I
Sbjct: 223 EIYNYLIKGNRLKQP-PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 21/168 (12%)

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL------ 247
           R E +   +++H NIV             +V E+   G   D++  +   R +L      
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG---DLMQKIKLQRGKLFPEDTI 102

Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
             W  +      +  G++++H     R++HRDI+  N+ +  + + ++ +FG A+ +   
Sbjct: 103 LQWFVQ------MCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153

Query: 307 HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                T+   GT  Y+ PE  + +  ++  DI+S G +L  L   K P
Sbjct: 154 GAYACTY--VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + +    GL++LH +    I+HRD++P N+L+    + ++++FGLA RI       T   
Sbjct: 113 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALT--P 166

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
           +  T+ Y APE       +   D++S G + A
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 30/176 (17%)

Query: 191 IQIRSEIITAGQVRHRNIV--------PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           IQ+ +EI+  G++ H NI+             M+ +  D  +Y F  + +          
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-------W 260

Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA-- 300
             R L    R  I + +   +EY+H     ++IHRDI+  N+ ++ D +  + +FG A  
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 301 ---KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF 353
              +R          W   GTV   +PE        +  DI+S G++L  ++   F
Sbjct: 317 FEKEREA----FDYGW--VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)

Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E  F+ L +I     G VY A     +  V+ IKK+    K   E           K 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNE-----------KW 59

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I  E+    ++RH N +      +R     LV E+   GS  D+L    +  +E++  
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA 118

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A   +  G   GL YLH SH   +IHRD++  N+L+ +    ++ +FG A  +   +   
Sbjct: 119 A---VTHGALQGLAYLH-SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--- 169

Query: 311 TTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGV 343
                 GT  ++APE    +A+ +       D++S G+
Sbjct: 170 ---XFVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S + Y+H   +  I+HRDI+  N+ +      ++ +FG++K +   ++   T  + GT
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
             Y++PE  Q V  +   DI++ G +L
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 173 KSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHRNIVPLLARMVRRDCD-----LLVYE 226
           K+G++   K  +P+H    +I +E  I      H N+V       ++D        LV E
Sbjct: 41  KNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100

Query: 227 FRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
               GS+ D++   + +G R  + +  + + + +  GL++LH++   + IHRD++  N+L
Sbjct: 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM-GLQHLHVN---KTIHRDVKGNNIL 156

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE---CHQTV--ALSDTCDIYS 340
           +  +   ++ +FG++ ++     R  T    GT  ++APE   C Q +       CD++S
Sbjct: 157 LTTEGGVKLVDFGVSAQLTSTRLRRNT--SVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214

Query: 341 FGVLLAVLVIGKFPSDDF 358
            G+    L  G  P  D 
Sbjct: 215 LGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 39/224 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+    G  G  + ++  +   K+  E   +  E           E +   +  H+N
Sbjct: 20  GEVYEGLYRGRDGDAVELQVAV---KTLPESCSEQDE------SDFLMEALIMSKFNHQN 70

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQG 258
           IV L+     R    ++ E    G L+  L    + R            D L     A+ 
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLL---FCARD 124

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSL 315
           +A G +YL  +H    IHRDI   N L+        A+I++FG+A+ I     R + +  
Sbjct: 125 VAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI----YRASYYRK 177

Query: 316 AGT----VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            G     + ++ PE       +   D++SFGVLL  +  +G  P
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 30/228 (13%)

Query: 132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI 191
           K D +  LEK+       VYK +    +G+++ +K I         L +++  P      
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVI--------RLQEEEGTPF----T 49

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            IR   +  G ++H NIV L   +  ++   LV+E+      Q +  D   G    + + 
Sbjct: 50  AIREASLLKG-LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVK 106

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKRIPDGHTR 309
                  +  GL Y+H  +   I+HRD++P N+LI D  E ++++FGL  AK +P  HT 
Sbjct: 107 LFLFQ--LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIG--KFP 354
           +       T+ Y  P+         TC D++  G +   ++ G   FP
Sbjct: 161 SNE---VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 38/211 (18%)

Query: 156 PGSSGRV--------ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           PGS G V           KK+I    +G +   ++ + L  K I  R+ I      R ++
Sbjct: 102 PGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDIL--KTISHRAIINLIHAYRWKS 159

Query: 208 IVPLLARMVRRDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            V ++    +  CDL  Y  R     L+  +                 I + +   L YL
Sbjct: 160 TVCMVMPKYK--CDLFTYVDRSGPLPLEQAIT----------------IQRRLLEALAYL 201

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      IIHRD++  N+ +D+   A + +FG A ++         +  +GT+   +PE 
Sbjct: 202 HGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE- 257

Query: 327 HQTVALSDTC---DIYSFGVLLAVLVIGKFP 354
              +AL   C   DI+S G++L  + +    
Sbjct: 258 --LLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 20/207 (9%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKK------DSEPLHHKMIQIRSEIITAGQVRHRNIVP 210
           G+ GRV     +   + +G EL  K      +S     ++  +  EI     ++H  IV 
Sbjct: 13  GAFGRV----YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 211 LLARMVRRDCDLLV--YEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
               +  R    L    E+   GS++D L    +    L      +  + I  G+ YLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPECH 327
           +    I+HRDI+ AN+L D     ++ +FG +KR+     + T   S+ GT  +++PE  
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFP 354
                    D++S G  +  ++  K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.6 bits (115), Expect = 5e-06
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 31/202 (15%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDW 249
           Q+  E+    +++H+NIV  + R + +    L  + EF   G L   +    +   +++ 
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 250 LARHRIAQGIASGLEYLH-MSHRP---RIIHRDIQPANVLIDDDME-------------- 291
            A   I + +   L Y H +   P   R++HRD++P N+ +   +               
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 292 ---ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE--CHQTVALSDTCDIYSFGVLLA 346
              A+I +FGL+K I      +   S  GT  Y +PE   H+T +  D  D+++ G ++ 
Sbjct: 178 RPIAKIGDFGLSKNI---GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 347 VLVIGKFP---SDDFFQHTKEM 365
            L  GK P   +++F Q   E+
Sbjct: 235 ELCSGKTPFHKANNFSQLISEL 256

Length = 1021

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 16/164 (9%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E+     ++H NIV L   +    C  LV+E+  +  L+  L +        + ++ H +
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG------NLMSMHNV 105

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKRIPDGHTRTTTW 313
              +   L  L   H+ +I+HRD++P N+LI++  E ++++FGL  AK +P   T+T + 
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP---TKTYSN 162

Query: 314 SLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
            +  T+ Y  P+    +   S   D++  G +L  +  G+  FP
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 21/163 (12%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH-- 253
           EI    ++++ NI+ LL   V  D   ++ E+  NG L   L      +RE++    H  
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-----SQREIESTFTHAN 121

Query: 254 -----------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
                       +A  IASG++YL   +    +HRD+   N L+ +    +I++FG+++ 
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRN 178

Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +  G            + ++A E       +   D+++FGV L
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 36/155 (23%), Positives = 72/155 (46%), Gaps = 6/155 (3%)

Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +Q   E     ++ H  IV   A  + RD   ++ E+     L   L ++    + L   
Sbjct: 47  VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL--- 103

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           + +++ +     L  +H  H+ RI+HRD++  N+ + +++  +I +FG+++ +       
Sbjct: 104 SENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA 162

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           TT    GT  Y++PE  +        DI+S G +L
Sbjct: 163 TT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 38/163 (23%), Positives = 72/163 (44%), Gaps = 29/163 (17%)

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-------QDILYDVSQGRRE 246
           R E+     ++H NIV             +V ++   G L       + +L+      + 
Sbjct: 47  RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF---PEDQI 103

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           LDW  +      I   L+++H     +I+HRDI+  N+ +  D   ++ +FG+A+ +   
Sbjct: 104 LDWFVQ------ICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--- 151

Query: 307 HTRTTTWSLA----GTVGYIAPECHQTVALSDTCDIYSFGVLL 345
               +T  LA    GT  Y++PE  +    ++  DI++ G +L
Sbjct: 152 ---NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 8/101 (7%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAGTVG 320
            L+Y+H ++   + HRD++P N+L + D + +I +FGLA+   +       W+    T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 321 YIAPE-CHQTVA-LSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           Y APE C    +  +   DI+S G + A ++ GK  FP  +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 19/139 (13%)

Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W A+   A+ + +    L   H   +IHRD++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-AKFYTAEVVLA----LDAIHSMGLIHRDVK 169

Query: 281 PANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++ + G  R  T    GT  YI+PE  ++          
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 228 CDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 50/265 (18%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           D F  + +I     G+VYKA     +G ++ +KK+           + D+E     +  I
Sbjct: 7   DKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKV-----------RLDNEKEGFPITAI 54

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDL----------LVYEFRRN---GSLQDILYDV 240
           R EI    Q+ HRNIV L   +  +   L          LV+E+  +   G L+  L   
Sbjct: 55  R-EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF 113

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
           S+            I   +   LE L+  H+   +HRDI+ +N+L+++  + ++++FGLA
Sbjct: 114 SE----------DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163

Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGKFPS 355
           +      +R  T  +  T+ Y  PE    + L +       D++S G +L  L    F  
Sbjct: 164 RLYNSEESRPYTNKVI-TLWYRPPE----LLLGEERYGPAIDVWSCGCILGEL----FTK 214

Query: 356 DDFFQHTKEMSLVQWMRNVMTSENP 380
              FQ  +E++ ++ +  +  S  P
Sbjct: 215 KPIFQANQELAQLELISRLCGSPCP 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 48/189 (25%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           R +  +A G+++L   +    IHRD+   NVL+ D   A+I +FGLA+ I +        
Sbjct: 216 RFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 314 SLAGTVGYIAPE----CHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLV 368
           +    V ++APE    C  TV      D++S+G+LL  +  +GK P              
Sbjct: 273 NARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGKSPY------------- 315

Query: 369 QWMRNVMTSENPNRAINSK---LLGNGYEEQM-------LLVLKIACFCTLDDPNKRPNS 418
                      P   +NSK   ++  GY  QM         +  I   C   +P +RP  
Sbjct: 316 -----------PGILVNSKFYKMVKRGY--QMSRPDFAPPEIYSIMKMCWNLEPTERPTF 362

Query: 419 KDVRCMLSQ 427
             +  ++ +
Sbjct: 363 SQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 39/148 (26%), Positives = 60/148 (40%), Gaps = 16/148 (10%)

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIAQGIASGLE 264
           N+V L   +V  D   LV +    G L   +        E    W A   +A      L+
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
            LH   R  I+ RD+ P N+L+DD    +++ F     + D        ++     Y AP
Sbjct: 100 ALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGK 352
           E       ++ CD +S G +L  L+ GK
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 4/106 (3%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTT 312
           +  + I  G+ YLH +    I+HRDI+ AN+L D     ++ +FG +KR+     + T  
Sbjct: 110 KYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            S+ GT  +++PE           DI+S G  +  ++  K P  +F
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 37/144 (25%), Positives = 69/144 (47%), Gaps = 9/144 (6%)

Query: 205 HRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H N++ LL   +  +   L+V  + ++G L++ +   +      D +        +A G+
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGM 111

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--VGY 321
           EYL      + +HRD+   N ++D+    ++++FGLA+ I D    +          V +
Sbjct: 112 EYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 322 IAPECHQTVALSDTCDIYSFGVLL 345
           +A E  QT   +   D++SFGVLL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLL 192

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 21/51 (41%), Positives = 34/51 (66%), Gaps = 8/51 (15%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKRIPDGHTRT 310
           GL Y H   R R++HRD++P N+LI +  E ++++FGL  AK +P   ++T
Sbjct: 115 GLAYCH--QR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKT 159

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 16/164 (9%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E+     ++H NIV L   +       LV+E+  +  L+  L D        + +  H +
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG------NSINMHNV 106

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKRIPDGHTRTTTW 313
              +   L  L+  HR +++HRD++P N+LI++  E ++++FGL  AK IP   T+T + 
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSN 163

Query: 314 SLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
            +  T+ Y  P+    +   S   D++  G +   +  G+  FP
Sbjct: 164 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 9/90 (10%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L  + R + IHRD+   N+L+ ++   +I +FGLA+ I   PD + R     L
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARL 237

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
              + ++APE       +   D++SFGVLL
Sbjct: 238 P--LKWMAPESIFDKVYTTQSDVWSFGVLL 265

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 39/297 (13%)

Query: 140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT 199
           ++I + W G+V   E+  +SG     + +++ L+  A + ++         ++   E   
Sbjct: 1   KEIGNGWFGKVILGEV--NSG-YTPAQVVVKELRVSASVQEQ---------MKFLEEAQP 48

Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL---DWLARHRIA 256
              ++H N++  L +       LLV EF   G L+  L   S  + EL   D     R+A
Sbjct: 49  YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMA 106

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
             IA GL  LH+ H+   IH D+   N L+  D+  +I ++GL+          T   L 
Sbjct: 107 CEIALGL--LHL-HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163

Query: 317 GTVGYIAP----ECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
             + +IAP    E H  + + D     +++S GV +  L   +  S  +   + E  L  
Sbjct: 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLTY 221

Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
            +R     + P   +   L    YE        +  FC L  P +RP++++V  +LS
Sbjct: 222 TVRE-QQLKLPKPRLKLPLSDRWYE--------VMQFCWL-QPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 7/122 (5%)

Query: 225 YEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           Y+   +  ++++L D  S+G   LD L+       +A G+E+L   +    +HRD+   N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLS---FTYQVARGMEFLASKN---CVHRDLAARN 267

Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
           VL+      +I +FGLA+ I       +  S    V ++APE       +   D++S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 344 LL 345
           LL
Sbjct: 328 LL 329

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 24/104 (23%)

Query: 270 HRPRIIHRDIQPANVLIDDDMEA-RISEFGLAK--RIPDG---HTRTTTWSLAGTVGYIA 323
           H+  ++HRD++P N+L+D      +I++ GL +   IP     H   T W       Y A
Sbjct: 127 HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW-------YRA 179

Query: 324 PECHQTVAL-----SDTCDIYSFGVLLAVLVIGK--FPSDDFFQ 360
           PE    V L     S   DI+S G + A +   +  FP D   Q
Sbjct: 180 PE----VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 33/130 (25%), Positives = 48/130 (36%), Gaps = 45/130 (34%)

Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLA------------KRIPDGHTRTT------ 311
           H+   IHRDI+P N+LID     ++S+FGL+            +++  G +         
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 312 ------------------TW---------SLAGTVGYIAPECHQTVALSDTCDIYSFGVL 344
                             TW         S  GT  YIAPE          CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 345 LAVLVIGKFP 354
           +   +IG  P
Sbjct: 238 MFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 16/116 (13%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ ++   +I +FGLA+ I   PD + R  +  L
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL 238

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP------SDDFFQHTKE 364
              + ++APE       +   D++SFGVLL  +  +G  P      +++F Q  K+
Sbjct: 239 P--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 17/149 (11%)

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-- 318
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +    T  +   G   
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKGL 182

Query: 319 --VGYIAPECHQTVALSDTCDIYSFGVLL 345
             V ++APE  +    + + D++SFGV+L
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 31/156 (19%)

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR----------HRIA 256
           ++V LL  +      L+V E    G L+  L    + RR                  ++A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-------PDGHTR 309
             IA G+ YL        +HRD+   N ++ +D+  +I +FG+ + I         G   
Sbjct: 126 AEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                    V ++APE  +    +   D++SFGV+L
Sbjct: 183 L-------PVRWMAPESLKDGVFTTKSDVWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 10/112 (8%)

Query: 237 LYDVSQGRREL---DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
           LY     +R +   D LA   I + +   ++YLH +   RIIHRDI+  N+ I+   +  
Sbjct: 169 LYCYLAAKRNIAICDILA---IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222

Query: 294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +FG A   P        +  AGT+   APE           DI+S G++L
Sbjct: 223 LGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVL 273

Length = 391

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I +        
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                V +++PE  +    +   D++SFGV+L
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           R L       +A+ + S ++Y+H      IIHRDI+  NVL++   +  + +FG A    
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311

Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
              +    + +AGTV   APE       + + DI+S G+++
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352

Length = 461

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 63/295 (21%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP-LHHKMIQIRSEIITAGQVRHR 206
           G+VY+          + +    + +    +  K  + P +  K +Q   E     Q  H 
Sbjct: 20  GDVYQG---------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---EAYIMRQFDHP 67

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +IV L+  ++  +   +V E    G L+  L      +  LD  +    +  +++ L YL
Sbjct: 68  HIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                 R +HRDI   NVL+      ++ +FGL++ + D  +          + ++APE 
Sbjct: 124 ESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPES 179

Query: 327 HQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN---VMTSENPNR 382
                 +   D++ FGV +  +L++G  P              Q ++N   +   EN  R
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKP-------------FQGVKNNDVIGRIENGER 226

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLD---------DPNKRPNSKDVRCMLSQI 428
                           L +   C  TL          DP+KRP   +++  LS I
Sbjct: 227 ----------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.3 bits (104), Expect = 7e-05
 Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 4/99 (4%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IA G+ YL      R++HRD+   NVL+      +I++FGLA+ +               
Sbjct: 118 IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
           + ++A EC      +   D++S+GV +  ++  G  P D
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 27/223 (12%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           D +  L +I     G VY+A     +G ++ +KK+           K + E     +  +
Sbjct: 5   DEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKKL-----------KMEKEKEGFPITSL 52

Query: 194 RSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           R EI    +++H NIV +   +V     D   +V E+  +  L+ ++  + Q   + +  
Sbjct: 53  R-EINILLKLQHPNIVTV-KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE-- 107

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               +   + SG+ +LH      I+HRD++ +N+L+++    +I +FGLA+         
Sbjct: 108 -VKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 311 TTWSLAGTVGYIAPECHQTVALSDT-CDIYSFGVLLAVLVIGK 352
           T   L  T+ Y APE         T  D++S G + A L+  K
Sbjct: 164 T--QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 22/149 (14%)

Query: 202 QVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRREL-------DWLARH 253
           Q++H NIV         D  L +V  F   G   D+ + + + + +L       +W  + 
Sbjct: 55  QLKHPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQ- 110

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
                IA  L+YLH  H   I+HRD++  NV +      ++ + G+A+ + +     +T 
Sbjct: 111 -----IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST- 161

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFG 342
            L GT  Y++PE       +   D+++ G
Sbjct: 162 -LIGTPYYMSPELFSNKPYNYKSDVWALG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ ++   +I +FGLA+ I   PD + R     L
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARL 243

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
              + ++APE       +   D++SFGVLL
Sbjct: 244 P--LKWMAPETIFDRVYTIQSDVWSFGVLL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 21/52 (40%), Positives = 36/52 (69%), Gaps = 4/52 (7%)

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
           +A   I++ +A  L+YLH   R  IIHRD++P N+LI ++   ++++FGL+K
Sbjct: 105 MAVKYISE-VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 4/101 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +A+G+E+L   +    +HRD+   NVLI +    +I +FGLA+ I       +  S    
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
           + ++APE       +   D++SFG+LL  +  +G  P  + 
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/107 (28%), Positives = 58/107 (54%), Gaps = 9/107 (8%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           E+     ++H NIV L   +V  D  L LV+E+  +  L+  + D        + ++ H 
Sbjct: 54  EVSLLKDLKHANIVTL-HDIVHTDKSLTLVFEYL-DKDLKQYMDDCG------NIMSMHN 105

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
           +   +   L  L   HR +++HRD++P N+LI++  E ++++FGLA+
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 37/165 (22%), Positives = 77/165 (46%), Gaps = 25/165 (15%)

Query: 140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDS-----EPLHHKMIQIR 194
           ++I + W G+V  +E+   +G     + +++ LK+ A   +++      +P  ++++Q  
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDP--YRILQ-- 53

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
                     H NI+  L + V     LLV+E+   G L+  L      RR    L   R
Sbjct: 54  ----------HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
           +A  IA+G+ ++H  +    +H D+   N  +  D+  ++ ++G+
Sbjct: 104 MACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 12/98 (12%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KRIPDGHTRTTTWSLAGTV 319
           GL Y+H      I+HRD++P N+LI    E ++++FGLA  K IP      T  S   T+
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS----QTYSSEVVTL 167

Query: 320 GYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
            Y  P+        S   DI+  G +   ++ G+  FP
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 18/154 (11%)

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRE-------------LDWLA 251
           NI+ LL   V  D   ++ E+  NG L   L  + +                   + + +
Sbjct: 80  NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              +A  IASG++YL   +    +HRD+   N L+ +++  +I++FG+++ +  G     
Sbjct: 140 LLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                  + ++A EC      +   D+++FGV L
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 29/118 (24%), Positives = 54/118 (45%), Gaps = 10/118 (8%)

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-------VSQGRRELD 248
           EI    +++  NI+ LLA  +  D   ++ E+  NG L   L                + 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           +     +A  IASG++YL   +    +HRD+   N L+  +   +I++FG+++ +  G
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 4/101 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IA G+ YL      R++HRD+   NVL+      +I++FGLA+ +    T          
Sbjct: 118 IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
           + ++A E       +   D++S+GV +  ++  G  P D  
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 28/115 (24%), Positives = 50/115 (43%), Gaps = 10/115 (8%)

Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
            +  L+W  +      IA G+ YL       ++HRD+   NVL+      +I++FGLAK 
Sbjct: 108 SQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
           +               + ++A E       +   D++S+GV +  ++  G  P D
Sbjct: 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.5 bits (93), Expect = 0.002
 Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 10/90 (11%)

Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-ARIS 295
           L+D+ +   +L      +I + +   L  LH  +   IIH DI+  NVL D   +   + 
Sbjct: 96  LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152

Query: 296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           ++GL K I    T +      GT+ Y +PE
Sbjct: 153 DYGLCKII---GTPSC---YDGTLDYFSPE 176

Length = 267

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 18/151 (11%)

Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA---RHRIAQG 258
           QV H++IV L    VR   +++V EF   G L   +       R+ D L    + ++A+ 
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM------HRKSDVLTTPWKFKVAKQ 113

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +AS L YL       ++H ++   N+L+    E    E G   ++ D     T  S    
Sbjct: 114 LASALSYL---EDKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGIPITVLSRQEC 168

Query: 319 VG---YIAPEC-HQTVALSDTCDIYSFGVLL 345
           V    +IAPEC   +  LS   D +SFG  L
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTL 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 3/87 (3%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I +        +    
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
           V ++APE       +   D++S+G+LL
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILL 306

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	430
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.26
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
PRK09902	216	hypothetical protein; Provisional	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.72
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.36
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.31
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.24
PF01636	239	APH: Phosphotransferase enzyme family This family	98.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.13
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.07
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.98
PRK10593	297	hypothetical protein; Provisional	97.88
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.56
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.42
PRK05231	319	homoserine kinase; Provisional	97.38
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.33
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.27
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.02
KOG2270	520	consensus Serine/threonine protein kinase involved	96.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.88
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.8
PLN02756	418	S-methyl-5-thioribose kinase	96.8
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.45
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.22
PLN02236	344	choline kinase	96.15
COG2334	331	Putative homoserine kinase type II (protein kinase	96.15
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.02
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.92
PRK12396	409	5-methylribose kinase; Reviewed	95.92
PRK11768	325	serine/threonine protein kinase; Provisional	95.81
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.68
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.39
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	95.27
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.18
PTZ00384	383	choline kinase; Provisional	94.65
PRK06148	1013	hypothetical protein; Provisional	94.44
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.08

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-55  Score=420.14  Aligned_cols=278  Identities=35%  Similarity=0.563  Sum_probs=240.9

Q ss_pred             hcccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       131 ~~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++++|...+.||+||||.||+|.+.  +|..||||++......             . ..+|.+|+.++.+++|||+|+
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~-------------~-~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQ-------------G-EREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCc-------------c-hhHHHHHHHHHhcCCCcCccc
Confidence            47999999999999999999999987  7799999987432211             0 345999999999999999999


Q ss_pred             ceeEEEeCC-eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          211 LLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       211 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++|||.+.+ ..+||||||++|||.++|+.....  +++|..|++||.++|+||+|||+.+.++|+||||||+|||||++
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            999999999 599999999999999999763222  89999999999999999999999988899999999999999999


Q ss_pred             CceEEeecCCcccCCC-CCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +++||+|||+|+..+. ....... . .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+...+ .....++
T Consensus       214 ~~aKlsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~  290 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLV  290 (361)
T ss_pred             CCEEccCccCcccCCccccceeee-c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHH
Confidence            9999999999976654 2221111 1 799999999999999999999999999999999999988775442 3445599


Q ss_pred             HHHHHHhcCCCCchhcccccc-CCCcH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          369 QWMRNVMTSENPNRAINSKLL-GNGYE-EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +|+...+........+|+.+. ..+.. .+...+..++..|++.+|.+||+|.+|+++|+.+.
T Consensus       291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            999999999899999999987 55554 67888999999999999999999999999997653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-52  Score=376.58  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=214.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .++..+..||+|..|+||+++++. +++.+|+|.+.-.             ......+++.+|+++++..+|||||.+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~-------------~~~~~~~Qi~rEl~il~~~~spyIV~~yg  144 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKP-TGKIYALKVILLN-------------IDPALQKQILRELEILRSCQSPYIVGFYG  144 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcC-CCeEEEEEeeccc-------------CCHHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence            356778899999999999999874 9999999999322             22345688999999999999999999999


Q ss_pred             EEEeCCe-eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          214 RMVRRDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       214 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      .|+.++. .+|+||||++|||++++..    .+.+++...-.|+.+|++||.|||..  ++||||||||+|||++..|.+
T Consensus       145 aF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  145 AFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             EEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCE
Confidence            9999995 9999999999999999943    36799999999999999999999942  359999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||||||.+..+.+.    ...+++||..|||||.+.+..|+.++||||||++++|+.+|++||...  ........+.+.
T Consensus       219 KicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~  292 (364)
T KOG0581|consen  219 KICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLC  292 (364)
T ss_pred             EeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHH
Confidence            99999999988665    223578999999999999999999999999999999999999998764  233445566666


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..++.|...-      .   .....+.+++..||+.||.+|||+.|+++
T Consensus       293 ~Iv~~ppP~lP~------~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  293 AIVDEPPPRLPE------G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHhcCCCCCCCc------c---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            666544332111      1   12334889999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=381.15  Aligned_cols=257  Identities=31%  Similarity=0.423  Sum_probs=207.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCce-EEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRV-ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+...+.||+|+||+||+|.++   |+. ||||++.......            .....|.+|+.+|.+++|||||+++|
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~------------~~~~~f~~E~~il~~l~HpNIV~f~G  106 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDD------------ESRKAFRREASLLSRLRHPNIVQFYG  106 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcCh------------HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3455566999999999999994   555 9999995543221            11678999999999999999999999


Q ss_pred             EEEeCC-eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-c
Q 014140          214 RMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-E  291 (430)
Q Consensus       214 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~  291 (430)
                      +|.+.. .+++|||||++|+|.++++..  ....+++..++.++.|||+||.|||+.+.  ||||||||+|||++.++ +
T Consensus       107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~  182 (362)
T KOG0192|consen  107 ACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKT  182 (362)
T ss_pred             EEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCE
Confidence            999988 799999999999999999753  45789999999999999999999995531  99999999999999997 9


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ--TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +||+|||+++......  .......||+.|||||++.  ...|+.|+||||||+++|||+||..||....+       .+
T Consensus       183 ~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~  253 (362)
T KOG0192|consen  183 LKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQ  253 (362)
T ss_pred             EEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HH
Confidence            9999999998765432  1222367999999999999  55899999999999999999999999876532       22


Q ss_pred             HHHHHh-cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WMRNVM-TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .+.... ...++.          .+..+...+..++..||+.||..||++.+++..|+.+.
T Consensus       254 ~~~~v~~~~~Rp~----------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  254 VASAVVVGGLRPP----------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             HHHHHHhcCCCCC----------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            222222 122211          11113334888999999999999999999999998763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-51  Score=353.94  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=215.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|.+.+.||+|.||.||+++.. .+|..+|.|.+......            .+.......|+.+|++|+|||||++++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md------------~k~rq~~v~Ei~lLkQL~HpNIVqYy~   85 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMD------------AKARQDCVKEISLLKQLNHPNIVQYYA   85 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhcc------------HHHHHHHHHHHHHHHhcCCchHHHHHH
Confidence            46899999999999999999976 49999999999654333            244678999999999999999999999


Q ss_pred             -EEEeCCe-eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCcEEeCCCC
Q 014140          214 -RMVRRDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR-PRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       214 -~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~iiH~Dlkp~Nill~~~~  290 (430)
                       .+.+++. ++||||||.+|+|..++...+.....+++.++|+++.|++.||..+|+... ..|+||||||.||+++.+|
T Consensus        86 ~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g  165 (375)
T KOG0591|consen   86 HSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG  165 (375)
T ss_pred             HhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence             4555444 899999999999999999988888999999999999999999999997422 2399999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+++.+....+...  +.+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.       ++.+.
T Consensus       166 vvKLGDfGL~r~l~s~~tfA~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L  236 (375)
T KOG0591|consen  166 VVKLGDFGLGRFLSSKTTFAH--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSL  236 (375)
T ss_pred             ceeeccchhHhHhcchhHHHH--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHH
Confidence            999999999999876654433  579999999999999999999999999999999999999997642       44444


Q ss_pred             HHHHhcCCCCchhccccccCCCc-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGY-EEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      ...+...+-+          +.+ .-....+..|+..|+..||+.||+...++..+
T Consensus       237 ~~KI~qgd~~----------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  237 CKKIEQGDYP----------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHHHHcCCCC----------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            4444433211          112 23345688899999999999999965555443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-49  Score=377.52  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|...+.||+|||++||.++... +|+.||+|++.+.           ..........+.+|+++.++|+|||||++++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~-----------~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~   85 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKK-----------LLKKPKQREKVLNEIEIHRSLKHPNIVQFYH   85 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehH-----------HhcCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence            469999999999999999999743 9999999999432           2222345788999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.++++.|||.|+|+.|+|..++.    ..+++++.++..++.||+.||.|||+.+   |+|||||..|+||+++.++|
T Consensus        86 ~FEDs~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VK  158 (592)
T KOG0575|consen   86 FFEDSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVK  158 (592)
T ss_pred             EeecCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEE
Confidence            9999999999999999999999984    4568999999999999999999999554   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|..+........  ..+||+.|+|||++...+.+..+||||+||++|.||.|++||+..       .+.+-...
T Consensus       159 IgDFGLAt~le~~~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~  229 (592)
T KOG0575|consen  159 IGDFGLATQLEYDGERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNK  229 (592)
T ss_pred             ecccceeeeecCcccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHH
Confidence            999999999876544433  479999999999999999999999999999999999999998753       12222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.......           |........+||..+|+.||.+|||+++|+.
T Consensus       230 Ik~~~Y~~-----------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  230 IKLNEYSM-----------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHhcCccc-----------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22222111           1112233788999999999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-50  Score=366.33  Aligned_cols=260  Identities=26%  Similarity=0.355  Sum_probs=209.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.|-+|..+ .+|+.||||.+..........       .........+|+++|++|+|||||+++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~-------~~~~~~~v~~EieILkkL~HP~IV~~~  242 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSR-------AIAKTRDVQNEIEILKKLSHPNIVRIK  242 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccc-------cccchhhhHHHHHHHHhcCCCCEEEEe
Confidence            456888999999999999999766 499999999997654432221       011234467999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---  289 (430)
                      ++|...+..|||||||.||+|.+.+    -..+.+.+..-..++.|++.|+.|||   .+||+||||||+|||++.+   
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcc
Confidence            9999999999999999999999998    34567888888999999999999999   5559999999999999876   


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ..+||+|||+|+..+..   ..+...+||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.+...   ..+
T Consensus       316 ~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~s  389 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPS  389 (475)
T ss_pred             eEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---Ccc
Confidence            78999999999998644   3344679999999999998875   34578999999999999999999876543   233


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.+.+...-...          .............+|+.+||..||++|||+.|+++
T Consensus       390 l~eQI~~G~y~f----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 LKEQILKGRYAF----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHHhcCcccc----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            333332211110          11233455667899999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-48  Score=355.11  Aligned_cols=202  Identities=30%  Similarity=0.426  Sum_probs=179.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ..+|...+.||+|+||+||+|+++. ++..||||.+.....            ..+..+.+..|+.+|+.++|||||.++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l------------~~k~~e~L~~Ei~iLkel~H~nIV~l~   75 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKL------------NKKLVELLLSEIKILKELKHPNIVRLL   75 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc-CCceEEeeeehhhcc------------CHHHHHHHHHHHHHHHhcCCcceeeEE
Confidence            4578888999999999999999986 789999999943211            223467789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---  289 (430)
                      +++...+..|||||||+||+|.++++.    .+.+++.+...++.|+|.||++||+.+   ||||||||.||||+..   
T Consensus        76 d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   76 DCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             EEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCC
Confidence            999999999999999999999999964    457999999999999999999999666   9999999999999865   


Q ss_pred             ---CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          290 ---MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       290 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                         ..+||+|||+|+.+..+....   ..+|++-|||||++..++|+.|+|+||+|+++|+|++|+.||+.
T Consensus       149 ~~~~~LKIADFGfAR~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CCCceEEecccchhhhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence               568999999999997654433   46899999999999999999999999999999999999999874

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=369.79  Aligned_cols=257  Identities=26%  Similarity=0.363  Sum_probs=212.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.+..++.||+|.||.||.|.++  ....||+|.+......               ...|.+|+.+|.+|+|+|||+++
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV~l~  267 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLVKLY  267 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccccC---------------hhHHHHHHHHHHhCcccCeEEEE
Confidence            445677889999999999999996  5568999998543221               46788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|...+.+|||||||+.|||.++|+.  ..+..+.....+.++.|||+||+||++.+   +|||||.+.||||+++..+
T Consensus       268 gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~v  342 (468)
T KOG0197|consen  268 GVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVV  342 (468)
T ss_pred             EEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceE
Confidence            999999999999999999999999975  45677999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||+|+...++.+. ......-...|.|||.+..+.++.|||||||||+||||+| |+.||..+.    ....++.+
T Consensus       343 KIsDFGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----n~ev~~~l  417 (468)
T KOG0197|consen  343 KISDFGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----NEEVLELL  417 (468)
T ss_pred             EEcccccccccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----HHHHHHHH
Confidence            99999999955444332 2212334567999999999999999999999999999999 888876542    33444444


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....+.+.|             ..++..+.+++..||+.+|++|||+..+...|+.+.
T Consensus       418 e~GyRlp~P-------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  418 ERGYRLPRP-------------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             hccCcCCCC-------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            444433332             334455999999999999999999999999998763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.3e-48  Score=340.01  Aligned_cols=264  Identities=21%  Similarity=0.292  Sum_probs=207.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|+.+..+|+|+||.||+++.+. +|+.||||++..            ++......+-.++|+++|++|+|||+|.++.
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~-TgqIVAIKkF~E------------sedd~~VkKIAlREIrmLKqLkH~NLVnLiE   68 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD-TGQIVAIKKFVE------------SEDDPVVKKIALREIRMLKQLKHENLVNLIE   68 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC-cccEEEEEeecc------------CCccHHHHHHHHHHHHHHHhcccchHHHHHH
Confidence            357888999999999999999875 999999999943            2333455677899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.....++||+|||+. ++.+-+.   .....++......++.|++.|+.|+|+++   +|||||||+|||++.+|.+|
T Consensus        69 VFrrkrklhLVFE~~dh-TvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   69 VFRRKRKLHLVFEYCDH-TVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVK  141 (396)
T ss_pred             HHHhcceeEEEeeecch-HHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEE
Confidence            99999999999999988 5555553   34556999999999999999999999666   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |||||+|+.+....  .....++.|.+|+|||.+.| .+|+..+||||+||++.||++|.+-|.+...    .+..-.+.
T Consensus       142 LCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD----iDQLy~I~  215 (396)
T KOG0593|consen  142 LCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD----IDQLYLIR  215 (396)
T ss_pred             eccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch----HHHHHHHH
Confidence            99999999987422  22234688999999999998 5799999999999999999999988765332    11111111


Q ss_pred             HHhc-----------CCC------CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMT-----------SEN------PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+.           ...      ....-++.-.....+.....+++++..||+.||++|++.++++.
T Consensus       216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111           111      11111111122233444557999999999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=346.51  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=204.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+++.||.|+||+||.++.+ .+++.||+|++.+..           ...........+|..+|..++||.||+++
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~-----------iv~~~e~~~~~~Er~IL~~v~hPFiv~l~   91 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKK-----------IVEKKEVRHTKAERNILSKIKHPFIVKLI   91 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhH-----------hhhhhhHHHHHHHHHHHHhCCCCcEeeeE
Confidence            567999999999999999999977 599999999995432           22224478899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ..|++.+.+|||+||+.||.|...|+    ..+.+++..+.-++..|+.||.|||+.+   |+||||||+|||+|.+|++
T Consensus        92 ysFQt~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   92 YSFQTEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             EecccCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence            99999999999999999999999994    4567999999999999999999999555   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||+++..........  .++||+.|||||++.+.+|+..+|+||+|+++|||++|.+||...       +...+..
T Consensus       165 ~LtDFgL~k~~~~~~~~t~--tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~  235 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGDATR--TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYD  235 (357)
T ss_pred             EEeccccchhcccCCCccc--cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHH
Confidence            9999999996554433222  479999999999999999999999999999999999999997542       3344444


Q ss_pred             HHhcCC-CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC
Q 014140          373 NVMTSE-NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP  416 (430)
Q Consensus       373 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp  416 (430)
                      .+.... .....           -......+++...|+.||++|.
T Consensus       236 ~I~~~k~~~~p~-----------~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  236 KILKGKLPLPPG-----------YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHhcCcCCCCCc-----------cCCHHHHHHHHHHhccCHHHhc
Confidence            444433 11111           0122377888899999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=342.82  Aligned_cols=265  Identities=25%  Similarity=0.346  Sum_probs=210.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.....||.|..++||+|+... .+..||||++.-...             ......+.+|+..|+.++||||+++
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc-------------~~~ld~l~kE~~~msl~~HPNIv~~   89 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKC-------------NNDLDALRKEVQTMSLIDHPNIVTY   89 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhh-------------hhhHHHHHHHHHHhhhcCCCCcceE
Confidence            45679999999999999999999874 789999999943222             1236889999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +..|..++.+|+||+||.+||+.+++...  -...+++..+..|..++++||.|||   .+|.||||||+.||||+++|.
T Consensus        90 ~~sFvv~~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~  164 (516)
T KOG0582|consen   90 HCSFVVDSELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGT  164 (516)
T ss_pred             EEEEEecceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCc
Confidence            99999999999999999999999999763  3345999999999999999999999   555999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcce-e-eccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          292 ARISEFGLAKRIPDGHTRTT-T-WSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +||+|||.+..+........ . ..+.||++|||||++...  +|+.|+||||||++..||.+|..||....+       
T Consensus       165 VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------  237 (516)
T KOG0582|consen  165 VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------  237 (516)
T ss_pred             EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------
Confidence            99999999887765433222 2 456899999999995543  699999999999999999999999987543       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+.+-.-+.+..+... -..+...........+..++..||+.||.+|||++++++
T Consensus       238 mkvLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  238 MKVLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHHHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111122222222111 000101111122335889999999999999999999975

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-46  Score=345.80  Aligned_cols=266  Identities=24%  Similarity=0.315  Sum_probs=206.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|+.+++||+|+||.||+|+.. .+|+.||+|++..+....            .......+|+.+|++|+||||+++
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~------------~~~~t~~REI~ILr~l~HpNIikL  181 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKE------------GFPITAIREIKILRRLDHPNIIKL  181 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCC------------cchHHHHHHHHHHHhcCCCcccce
Confidence            4567899999999999999999976 499999999997654321            124567899999999999999999


Q ss_pred             eeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      .+..++.  ..+|||+|||++ +|..++.   ...-.|+...+..++.|++.||.|+|   .+||+|||||.+|||||++
T Consensus       182 ~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~  254 (560)
T KOG0600|consen  182 EEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNN  254 (560)
T ss_pred             eeEEEecCCceEEEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCC
Confidence            9999887  689999999998 8988883   34557999999999999999999999   5559999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |.+||+|||+|+++....... ..+.+-|.+|.|||.+.|. .|+..+|+||.||||.||++|++.|.+..    .....
T Consensus       255 G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t----EveQl  329 (560)
T KOG0600|consen  255 GVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT----EVEQL  329 (560)
T ss_pred             CCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc----HHHHH
Confidence            999999999999876554433 2356789999999999987 59999999999999999999998876532    22222


Q ss_pred             HHHHHHhcCCCCc----------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPN----------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.+-.+...+...                ......+ .+.........++|+..+|..||.+|.|+.++++
T Consensus       330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l-~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRL-RETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHHHHhCCCChhccccccCCcccccCCCCcccchH-HHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            2222222211110                0000000 0001112335778888999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.7e-45  Score=315.11  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=208.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|...+.||+|.||.||+|+... +|+.||||++......+            -......+|+..|+.++||||+.+++
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~kd------------Gi~~talREIK~Lqel~h~nIi~LiD   68 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNAKD------------GINRTALREIKLLQELKHPNIIELID   68 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC-CCcEEEEEEeecccccc------------CccHHHHHHHHHHHHccCcchhhhhh
Confidence            357788999999999999999764 99999999996553321            11356789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.+.+.+.||+|||+. +|+..+++   +...++...+..++.++++|++|||+..   |+||||||.|+|++++|.+|
T Consensus        69 ~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lK  141 (318)
T KOG0659|consen   69 VFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLK  141 (318)
T ss_pred             hccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEE
Confidence            99999999999999987 99999954   5667999999999999999999999776   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+|+.+.........  .+-|.+|.|||.+.|. .|+..+|+||.||++.||+.|.+-|.+    ..+.+....+-
T Consensus       142 iADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If  215 (318)
T KOG0659|consen  142 IADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIF  215 (318)
T ss_pred             eecccchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHH
Confidence            9999999998765544332  3679999999998887 599999999999999999999865433    22222222333


Q ss_pred             HHhcCCCCchhcc--------------ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          373 NVMTSENPNRAIN--------------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       373 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ..+..+.+...-+              ........+.+....++|+..+|..||.+|+++.|++++
T Consensus       216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            3333222211110              001111223344557999999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.3e-45  Score=349.73  Aligned_cols=265  Identities=22%  Similarity=0.293  Sum_probs=203.5

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||.|+||.||+|.+.    ..++..||||++.....             ......+.+|+.++..+ +|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~n   72 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-------------ASEHKALMSELKILIHIGNHLN   72 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-------------hHHHHHHHHHHHHHHHhccCcc
Confidence            467899999999999999999742    23567899998843211             12246789999999999 8999


Q ss_pred             cccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcCC-------------------------------------------
Q 014140          208 IVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQG-------------------------------------------  243 (430)
Q Consensus       208 iv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------  243 (430)
                      |++++++|... +..++||||+++|+|.+++......                                           
T Consensus        73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (338)
T cd05102          73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS  152 (338)
T ss_pred             eeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccc
Confidence            99999988764 4578999999999999999642110                                           


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCC
Q 014140          244 ---------------RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT  308 (430)
Q Consensus       244 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  308 (430)
                                     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       153 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~  229 (338)
T cd05102         153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD  229 (338)
T ss_pred             cCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc
Confidence                           23578889999999999999999954   599999999999999999999999999987644322


Q ss_pred             cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhcccc
Q 014140          309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK  387 (430)
Q Consensus       309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ........++..|+|||++.+..++.++|||||||++|||++ |..||.....   ...+..    ....+....     
T Consensus       230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~~----~~~~~~~~~-----  297 (338)
T cd05102         230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFCQ----RLKDGTRMR-----  297 (338)
T ss_pred             hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHH----HHhcCCCCC-----
Confidence            222223346788999999999899999999999999999997 9999865321   111111    111111110     


Q ss_pred             ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       388 ~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                          .+......+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       298 ----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         298 ----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                01112234889999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-45  Score=364.75  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=216.6

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ...+....+.||+|+||+||+|+..+    .+...||||.++...             ..+...+|++|+.+|+.++|||
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------------~~~~~~dF~REaeLla~l~H~n  550 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------------ENQARQDFRREAELLAELQHPN  550 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------------cHHHHHHHHHHHHHHHhccCCC
Confidence            34566778899999999999998753    234689999884321             2235688999999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------G----RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      ||+|+|+|.+++..+||+|||..|+|..+|+....      .    ..+++..+.+.||.|||.||.||-+.+   ++||
T Consensus       551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHR  627 (774)
T KOG1026|consen  551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHR  627 (774)
T ss_pred             eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---cccc
Confidence            99999999999999999999999999999974321      1    334889999999999999999999666   9999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||..+|+||.++..|||+|||+++..-..++......-.-..+|||||.+..+.||.+||||||||+|||+++ |..||.
T Consensus       628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~  707 (774)
T KOG1026|consen  628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY  707 (774)
T ss_pred             chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence            9999999999999999999999998766555543322334678999999999999999999999999999999 889987


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +...    ...++.++    .+..         -+.+..++..+..|+..||+.+|.+||+++||-..|+.+
T Consensus       708 glSn----~EVIe~i~----~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  708 GLSN----QEVIECIR----AGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ccch----HHHHHHHH----cCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            6543    22333332    2221         134455666799999999999999999999999999865

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.4e-45  Score=344.53  Aligned_cols=249  Identities=25%  Similarity=0.349  Sum_probs=212.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+.+ .+.+.||+|.+.+....            ++....+.+|+++++.++|||||.+++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~------------~k~l~~l~~ev~i~r~lkHpniv~m~e   68 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRN------------EKELKNLRQEVRILRSLKHPNIVEMLE   68 (808)
T ss_pred             cchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCc------------hHHHHHHHHHHHHHHhcCCcchhhHHH
Confidence            57899999999999999999866 48999999999554333            234678999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|....++|+|+||+.| +|..++.    ....+++..+..++.+++.||.|||+..   |+|||+||.|||++..+.+|
T Consensus        69 sfEt~~~~~vVte~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~K  140 (808)
T KOG0597|consen   69 SFETSAHLWVVTEYAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLK  140 (808)
T ss_pred             hhcccceEEEEehhhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCcee
Confidence            99999999999999977 9999994    4667999999999999999999999555   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +||||+|+.+..+....  ..+.||+.|||||+..+.+|+..+|.||+||++||+++|++||..       .++.+.++.
T Consensus       141 lcdFg~Ar~m~~~t~vl--tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~  211 (808)
T KOG0597|consen  141 LCDFGLARAMSTNTSVL--TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKS  211 (808)
T ss_pred             echhhhhhhcccCceee--eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHH
Confidence            99999999987654333  357899999999999999999999999999999999999999743       345556666


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...+...           +......+..++...|..||.+|.++.+++.
T Consensus       212 I~~d~v~~-----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKDPVKP-----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcCCCCC-----------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            66544322           1233345888999999999999999998864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-45  Score=335.41  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .++...+.||+|+||.||++.... +|...|||.+.....              .....+.+|+.+|.+++|||||+++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~--------------~~~~~l~~Ei~iL~~l~~p~IV~~~G   81 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDS--------------PTSESLEREIRILSRLNHPNIVQYYG   81 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC-CCcceeeeeeecccc--------------hhHHHHHHHHHHHHhCCCCCEEeeCC
Confidence            357778999999999999999764 699999998843210              11567899999999999999999999


Q ss_pred             EEEeCC--eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CC
Q 014140          214 RMVRRD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DM  290 (430)
Q Consensus       214 ~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~  290 (430)
                      ......  .+++.|||+++|||.+++..  ..+ .+++..+..++.||++||.|||+.   |++|+||||+|||++. ++
T Consensus        82 ~~~~~~~~~~~i~mEy~~~GsL~~~~~~--~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~  155 (313)
T KOG0198|consen   82 SSSSRENDEYNIFMEYAPGGSLSDLIKR--YGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNG  155 (313)
T ss_pred             ccccccCeeeEeeeeccCCCcHHHHHHH--cCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCC
Confidence            855544  68999999999999999964  222 799999999999999999999944   5999999999999999 79


Q ss_pred             ceEEeecCCcccCCC-CCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||++..... ...........||+.|||||++.++. ...++|||||||++.||+||+.||...      ....
T Consensus       156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~  229 (313)
T KOG0198|consen  156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEA  229 (313)
T ss_pred             eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchH
Confidence            999999999987764 22222333578999999999999633 335899999999999999999999864      1122


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      +++-.........         ..+........+++..|+..+|+.|||+.++++-
T Consensus       230 ~~~~~ig~~~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  230 EALLLIGREDSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             HHHHHHhccCCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            2222222222111         1122233458899999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=343.36  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ...+|...++||.|+|++|++|+... +++.||||++.+      +.+.+     +...+-+..|-.+|.+| .||.|++
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K------~~Iik-----e~KvkYV~~Ek~~l~~L~~hPgivk  138 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDK------RYIIK-----EKKVKYVTREKEALTQLSGHPGIVK  138 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecC-CCceeeHhhhhH------HHHHh-----hcccchhhHHHHHHHHhhCCCCeEE
Confidence            46789999999999999999999775 999999999833      11111     12245567788999999 8999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      |+.-|.+...+|+|+||+++|+|.++|+.    .+.|++.....++.+|+.||+|||+.   |||||||||+|||||++|
T Consensus       139 Ly~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dm  211 (604)
T KOG0592|consen  139 LYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDG  211 (604)
T ss_pred             EEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCC
Confidence            99999999999999999999999999954    46799999999999999999999955   599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCc-----------ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          291 EARISEFGLAKRIPDGHTR-----------TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      +++|+|||.|+.+......           .....++||-.|.+||++.....+..+|+|+|||++|+|+.|.+||....
T Consensus       212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N  291 (604)
T KOG0592|consen  212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN  291 (604)
T ss_pred             cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence            9999999999988643221           11135899999999999999999999999999999999999999987542


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +    ..+.+.+-.+-.  ....        ..+    ..+.+|+.+.|..||.+|+++.+|.+
T Consensus       292 e----yliFqkI~~l~y--~fp~--------~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  292 E----YLIFQKIQALDY--EFPE--------GFP----EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             H----HHHHHHHHHhcc--cCCC--------CCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence            2    111211111110  0111        111    34778888999999999999988754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=339.52  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=206.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .++|.+++.||.|+||.||+|+-. .+|..||||+++.....            .+ .-.-.+|+..|++|+ |||||++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s------------~e-e~~nLREvksL~kln~hpniikL   74 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYS------------WE-ECMNLREVKSLRKLNPHPNIIKL   74 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhcc------------HH-HHHHHHHHHHHHhcCCCCcchhh
Confidence            357999999999999999999866 48999999998543322            11 123467999999998 9999999


Q ss_pred             eeEEEeCC-eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ..++.+++ .+++|||||+. +|+.++..   .+..|++..+..|+.||++||+|+|   ..|+.|||+||+|||+..+.
T Consensus        75 ~Evi~d~~~~L~fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~  147 (538)
T KOG0661|consen   75 KEVIRDNDRILYFVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGND  147 (538)
T ss_pred             HHHhhccCceEeeeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccc
Confidence            99999988 99999999976 99999965   3678999999999999999999999   55699999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+|+.+.......   .++.|.+|+|||++... .|+.+.|+||+|||++|+.+-++-|.+.    .+.+-+-
T Consensus       148 ~iKiaDFGLARev~SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~----sE~Dqi~  220 (538)
T KOG0661|consen  148 VIKIADFGLAREVRSKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA----SEIDQIY  220 (538)
T ss_pred             eeEecccccccccccCCCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC----cHHHHHH
Confidence            99999999999886543332   45889999999987654 6899999999999999999998776543    3333333


Q ss_pred             HHHHHhcCCCCc---------hhccccc-------cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          370 WMRNVMTSENPN---------RAINSKL-------LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       370 ~~~~~~~~~~~~---------~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .+..++..+...         ..+...+       .....+.....+.+++..|++.||.+|||+.+.++.
T Consensus       221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            333333322111         1111111       011122345568899999999999999999998863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=315.23  Aligned_cols=239  Identities=25%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|..+..||.|+||+|.+++.+. +|..+|+|++.....           -.-++.++..+|..+|+.+.||+++++++
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~v-----------VklKQveH~~nEk~vL~~v~~PFlv~l~~  111 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKV-----------VKLKQVEHTHNEKRVLKAVSHPFLVKLYG  111 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEcc-CCceeehhhcCHHHH-----------HHHHHHHHHhhHHHHHhhccCceeEEEEE
Confidence            468889999999999999999875 799999999944322           22345788999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .|.+.+.+||||||.+||.|.++++.    .+.+++..+.-+|.+|+.||+|||+.+   |++|||||+|||+|.+|.+|
T Consensus       112 t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  112 TFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             eeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEE
Confidence            99999999999999999999999954    567999999999999999999999666   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|+.....     ++..+||+.|+|||++.+.+|+.++|.|||||++|||+.|.+||....+       .+....
T Consensus       185 itDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~K  252 (355)
T KOG0616|consen  185 ITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEK  252 (355)
T ss_pred             EEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHH
Confidence            9999999986433     4578999999999999999999999999999999999999999864322       111222


Q ss_pred             HhcCC-CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCC
Q 014140          374 VMTSE-NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR  415 (430)
Q Consensus       374 ~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R  415 (430)
                      ++... ..+..+            ...+.+|+...|+.|-.+|
T Consensus       253 I~~~~v~fP~~f------------s~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKVKFPSYF------------SSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcccCCccc------------CHHHHHHHHHHHhhhhHhh
Confidence            22211 111111            1237788888888888888

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-44  Score=339.20  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=205.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|..+..||+|+||.||+|+-+. +|..+|+|++.+...           ....++..++.|-.+|...++|+||+++
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~-Tg~iyAmK~LkKS~M-----------~~~~Qv~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKD-TGEIYAMKILKKSEM-----------LKKNQVEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             cccchhheeeccccceeEEEEEEcc-CCcEEeeecccHHHH-----------HhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence            4679999999999999999999764 999999999955332           2234578899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ..|.+.+.+||||||++||++..+|.    ....|++..+..++.+++.|+.-+|   +.|+|||||||+|+|||..|++
T Consensus       208 YsFQD~~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  208 YSFQDKEYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             EEecCCCeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence            99999999999999999999999994    4567999999999999999999999   4559999999999999999999


Q ss_pred             EEeecCCcccCCC----------------------CCCc-----c------------------eeecccccccccccccc
Q 014140          293 RISEFGLAKRIPD----------------------GHTR-----T------------------TTWSLAGTVGYIAPECH  327 (430)
Q Consensus       293 kl~Dfg~a~~~~~----------------------~~~~-----~------------------~~~~~~gt~~y~aPE~~  327 (430)
                      ||+|||++.-+..                      ....     .                  .....+|||.|+|||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            9999999863311                      0000     0                  01246799999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhc
Q 014140          328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFC  407 (430)
Q Consensus       328 ~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  407 (430)
                      .+.+|+..+|+||||||+||||.|.+||....+......++.|-..+.......              ......+||.+|
T Consensus       361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA~DLI~rl  426 (550)
T KOG0605|consen  361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEAKDLITRL  426 (550)
T ss_pred             hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHHHHHHHHH
Confidence            999999999999999999999999999987666555555555543332211110              113478889888


Q ss_pred             ccCCCCCCCC
Q 014140          408 TLDDPNKRPN  417 (430)
Q Consensus       408 l~~dp~~Rps  417 (430)
                      +. ||++|.-
T Consensus       427 l~-d~~~RLG  435 (550)
T KOG0605|consen  427 LC-DPENRLG  435 (550)
T ss_pred             hc-CHHHhcC
Confidence            88 9999976

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=340.60  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ....|.....||+|+.|.||.|...+ +++.||||++......              ..+-+.+|+.+|+..+|+|||.+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~Q~--------------~keLilnEi~Vm~~~~H~NiVnf  335 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKIS-TKQEVAIKRMDLRKQP--------------KKELLLNEILVMRDLHHPNIVNF  335 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeecc-CCceEEEEEEEeccCC--------------chhhhHHHHHHHHhccchHHHHH
Confidence            34578888999999999999998764 8999999999443222              13568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +..|...+.+|+|||||+||+|.|++.     ...+++.++..|+.+++.||+|||   ..||+|||||.+|||++.+|.
T Consensus       336 l~Sylv~deLWVVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~  407 (550)
T KOG0578|consen  336 LDSYLVGDELWVVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGS  407 (550)
T ss_pred             HHHhcccceeEEEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCc
Confidence            999999999999999999999999983     345999999999999999999999   556999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||++..+........  ..+||+.|||||+.....|+.|+||||||++++||+-|.+||=...      .+ .-+
T Consensus       408 vKltDFGFcaqi~~~~~KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------Pl-rAl  478 (550)
T KOG0578|consen  408 VKLTDFGFCAQISEEQSKRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PL-RAL  478 (550)
T ss_pred             EEEeeeeeeeccccccCccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hH-HHH
Confidence            99999999998876654333  4689999999999999999999999999999999999999974311      11 112


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+..++.+.-.        .+......+.+++.+||+.|+++||++.|+++
T Consensus       479 yLIa~ng~P~lk--------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  479 YLIATNGTPKLK--------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHhhcCCCCcC--------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            222223332211        11223344889999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=337.38  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=202.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .+.|.+.+.||+|+||+|++|.+.. +|..||+|.+......      .  .. ......+.+|+.+++.++ ||||+++
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~------~--~~-~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVS------S--KS-QKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeecc-CCCeEEEEEechhccc------c--cc-cccchhhHHHHHHHHHhccCCCEeEE
Confidence            5679999999999999999998764 8899999966332110      0  01 122455668999999999 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC-C
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-M  290 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~  290 (430)
                      +.++......++||||+.||+|.+++..    .+.+.+..+..++.|++.|++|||   +.||+||||||+|||++.+ +
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCC
Confidence            9999999999999999999999999943    567899999999999999999999   5559999999999999999 9


Q ss_pred             ceEEeecCCcccCC-CCCCcceeeccccccccccccccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          291 EARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVA-LS-DTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ++||+|||++.... ...   .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..       +.
T Consensus       159 ~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~  228 (370)
T KOG0583|consen  159 NLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NV  228 (370)
T ss_pred             CEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cH
Confidence            99999999999874 222   223569999999999999987 85 6799999999999999999998762       22


Q ss_pred             HHHHHHHhcCCC-CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          368 VQWMRNVMTSEN-PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       368 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ....+.+....- ....+.           ...+.+|+.+||..||.+|+++.+|+
T Consensus       229 ~~l~~ki~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  229 PNLYRKIRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHHhcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            222222222211 111110           23488999999999999999999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=341.87  Aligned_cols=241  Identities=28%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      ...++.||+|+-|-||+|++   .++.||||++.                     +.-..+++-|++|+||||+.|.|+|
T Consensus       126 IsELeWlGSGaQGAVF~Grl---~netVAVKKV~---------------------elkETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL---HNETVAVKKVR---------------------ELKETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhhhhhhccCcccceeeeec---cCceehhHHHh---------------------hhhhhhHHHHHhccCcceeeEeeee
Confidence            34567899999999999998   68999999882                     2223578889999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .....+|||||||+.|-|..+|    ..+..+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIs  254 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKIS  254 (904)
T ss_pred             cCCceeEEeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEec
Confidence            9999999999999999999999    45677899999999999999999999776   9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||-++.+...   .+...+.||..|||||++.+.+.+.|+|||||||+|||||||..||.+.....    ++-    .+
T Consensus       255 DFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw----GV  323 (904)
T KOG4721|consen  255 DFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW----GV  323 (904)
T ss_pred             cccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE----ec
Confidence            99999887655   33446799999999999999999999999999999999999999987643210    000    00


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..+.+.        -..+..++.-+.-|+.+||+..|..|||+++|+.-|.
T Consensus       324 GsNsL~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  324 GSNSLH--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cCCccc--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            111111        1122333444777888999999999999999998876

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.5e-43  Score=327.55  Aligned_cols=249  Identities=19%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe--
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR--  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  217 (430)
                      ..||+|++|.||+|.+   +|+.||||.+.....           ........+.+|+.+|.+++||||++++|++.+  
T Consensus        26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHK-----------GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             eEEeeCCceEEEEEEE---CCEEEEEEecccccc-----------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            5789999999999987   789999999854321           122335778899999999999999999999977  


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          218 --RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       218 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                        ....++||||+++|+|.+++..    ...+++.....++.+++.||.|||..  .+++||||||+||++++++.+||+
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEc
Confidence              3467899999999999999953    35689999999999999999999953  148899999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |||+++.......     ...|+..|+|||++.+  ..++.++|||||||++|||++|..||.....       .+....
T Consensus       166 dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~  233 (283)
T PHA02988        166 CHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDL  233 (283)
T ss_pred             ccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHH
Confidence            9999986543221     3467899999999976  6799999999999999999999999875321       122222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....... ..+        +......+.+++.+||+.||++|||+.++++.|++++
T Consensus       234 i~~~~~~-~~~--------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 IINKNNS-LKL--------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHhcCCC-CCC--------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2211111 001        1112335889999999999999999999999999876

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=333.30  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|...+.||+|.||.||+|.... +++.||+|.+.-             +.....+..+.+|+.+|.++++|||.++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~L-------------e~~~deIediqqei~~Ls~~~~~~it~yy   77 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNK-TKKVVAIKIIDL-------------EEAEDEIEDIQQEISVLSQCDSPNITEYY   77 (467)
T ss_pred             ccccccchhccccccceeeeeeecc-ccceEEEEEech-------------hhcchhhHHHHHHHHHHHhcCcchHHhhh
Confidence            4568888999999999999998764 899999999932             23334578899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |.+..+..++++||||.||++.+.+    ..+..+++....-++.+++.|+.|||+.+   .+|||||+.|||+..+|.+
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~v  150 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDV  150 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcE
Confidence            9999999999999999999999999    44555688888889999999999999555   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||.+..+.......  ..++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+ ....-+     
T Consensus       151 kl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlfl-----  222 (467)
T KOG0201|consen  151 KLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFL-----  222 (467)
T ss_pred             EEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEe-----
Confidence            999999999887665544  357999999999999988999999999999999999999999887655 111100     


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             +.....|.+.+.+    ...+.+++..||..||+.||++.++++
T Consensus       223 -------Ipk~~PP~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 -------IPKSAPPRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -------ccCCCCCcccccc----CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                   1111112222222    233889999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.2e-43  Score=331.31  Aligned_cols=268  Identities=19%  Similarity=0.290  Sum_probs=203.4

Q ss_pred             cccccccccccccCceEEEeecCC---------------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHH
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG---------------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII  198 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  198 (430)
                      ++|.+.+.||+|+||.||+|.+..               .++..||+|.+....             .......+.+|+.
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~   71 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------------NKNARNDFLKEVK   71 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------------CHHHHHHHHHHHH
Confidence            568889999999999999997531               134579999884321             1123567899999


Q ss_pred             HHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc---------------CCCCCCCHHHHHHHHHHHHHHH
Q 014140          199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS---------------QGRRELDWLARHRIAQGIASGL  263 (430)
Q Consensus       199 ~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~i~~~l  263 (430)
                      ++.+++||||+++++++.+.+..++||||+++|+|.+++....               .....+++...+.++.|++.||
T Consensus        72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  151 (304)
T cd05096          72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM  151 (304)
T ss_pred             HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999986421               1123578889999999999999


Q ss_pred             HHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHH
Q 014140          264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGV  343 (430)
Q Consensus       264 ~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  343 (430)
                      .|||+.   +++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+
T Consensus       152 ~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  228 (304)
T cd05096         152 KYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV  228 (304)
T ss_pred             HHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence            999955   49999999999999999999999999998765443322222345678899999999889999999999999


Q ss_pred             HHHHHHh--CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 014140          344 LLAVLVI--GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV  421 (430)
Q Consensus       344 ~l~ell~--g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev  421 (430)
                      ++|||++  +..||.....    ....................      ..++.++..+.+++.+||+.+|.+|||+.+|
T Consensus       229 ~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         229 TLWEILMLCKEQPYGELTD----EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             HHHHHHHccCCCCCCcCCH----HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            9999997  4567654321    22222222222211110000      0011123458899999999999999999999


Q ss_pred             HHHHhc
Q 014140          422 RCMLSQ  427 (430)
Q Consensus       422 ~~~L~~  427 (430)
                      .+.|++
T Consensus       299 ~~~l~~  304 (304)
T cd05096         299 HAFLTE  304 (304)
T ss_pred             HHHHhC
Confidence            999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.9e-43  Score=329.59  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||+|+||.||+|.... +|+.||+|.+......           .......+.+|+.++..++|||++++++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~iv~~~~~~   69 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIK-----------KRKGEAMALNEKRILEKVNSRFVVSLAYAY   69 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhh-----------hhhhHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            6788999999999999998764 8999999988432111           112234678899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .+.+..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+|||+++++.++|+
T Consensus        70 ~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          70 ETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             ccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999999999888542  334689999999999999999999954   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||++.........   ....||..|+|||++.+..++.++|||||||++|+|++|+.||......    ...+.+....
T Consensus       145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~  217 (285)
T cd05631         145 DLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER----VKREEVDRRV  217 (285)
T ss_pred             eCCCcEEcCCCCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHHh
Confidence            99999876433221   2347899999999999999999999999999999999999998753221    1111111111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      .....          ..+......+.+|+..||+.||.+||+     +.++++
T Consensus       218 ~~~~~----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         218 KEDQE----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hcccc----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11110          011112234788999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=321.08  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      -.|++.+.||.|.||+|-+|..+. .|+.||||.+.           ++....++..-.+.+|+++|..|+||||+.+|.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~-sgR~VAiKsIr-----------KdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE  120 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK-SGREVAIKSIR-----------KDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE  120 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc-CCcEeehhhhh-----------hhhcccHHHHHHHHHHHHHHhhcCCCceeehhh
Confidence            358899999999999999998654 89999999884           444455566788999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|...+...|||||..+|.|+|++    ...+.+++..+..++.||..|+.|+|   ..+++|||||.+|||+|.++++|
T Consensus       121 VFENkdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK  193 (668)
T KOG0611|consen  121 VFENKDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK  193 (668)
T ss_pred             hhcCCceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence            999999999999999999999999    44567999999999999999999999   55599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++..+......+   .++|++.|.+||++.|.+| +..+|.|||||+||.|+.|..||++..    ...++   +
T Consensus       194 IADFGLSNly~~~kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lv---r  263 (668)
T KOG0611|consen  194 IADFGLSNLYADKKFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLV---R  263 (668)
T ss_pred             eeccchhhhhccccHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHH---H
Confidence            99999998876654433   4699999999999999988 567999999999999999999998642    22233   3


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .+-+......        ..    +....-|+++||..||++|.|+.+|..-
T Consensus       264 QIs~GaYrEP--------~~----PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  264 QISRGAYREP--------ET----PSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HhhcccccCC--------CC----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            3322111100        01    1126678999999999999999998753

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-43  Score=340.88  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||+|+||.||+|....    .++..||+|++.....             ......+.+|+.+++.+ +|||
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~il~~l~~h~n  103 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------------TDEREALMSELKILSHLGQHKN  103 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------------HHHHHHHHHHHHHHHhhccCCc
Confidence            3578999999999999999997532    2446899999843211             12246788999999999 8999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC---------------------------------------------
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---------------------------------------------  242 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------  242 (430)
                      |++++++|...+..++||||+++|+|.++++....                                             
T Consensus       104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (374)
T cd05106         104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE  183 (374)
T ss_pred             eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence            99999999999999999999999999999864210                                             


Q ss_pred             ---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          243 ---------------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       243 ---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                                           ....+++..++.++.|++.||.|||+.   +++||||||+|||+++++.++|+|||+++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~  260 (374)
T cd05106         184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR  260 (374)
T ss_pred             cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeee
Confidence                                 113478889999999999999999954   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCCCC
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENP  380 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  380 (430)
                      ...............++..|+|||++.+..++.++|||||||++|+|++ |+.||......   ..+............ 
T Consensus       261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~~~~~~~~-  336 (374)
T cd05106         261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVKRGYQMSR-  336 (374)
T ss_pred             eccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHHcccCccC-
Confidence            7654332222212345678999999998899999999999999999997 99998653221   111111111110000 


Q ss_pred             chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          381 NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                           +   ..    ....+.+++..||+.||.+|||+.+|+++|+++
T Consensus       337 -----~---~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         337 -----P---DF----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             -----C---CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 0   01    123488999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3e-42  Score=330.45  Aligned_cols=201  Identities=26%  Similarity=0.405  Sum_probs=175.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+++... +|..+|+|.+....             .......+.+|+.++++++||||++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   69 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEI-------------KPAIRNQIIRELQVLHECNSPYIVGFY   69 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeeccc-------------CHHHHHHHHHHHHHHHHCCCCCCCeEE
Confidence            4679999999999999999999764 88999999884321             112356799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+  +++||||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~  143 (331)
T cd06649          70 GAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEI  143 (331)
T ss_pred             EEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcE
Confidence            999999999999999999999999853    346899999999999999999999542  59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +|+|||++........    ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       144 kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         144 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             EEccCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999986643321    234689999999999998999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=361.11  Aligned_cols=263  Identities=22%  Similarity=0.331  Sum_probs=212.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .......+.||+|+||.||.|...+.+|.    .||||.+...             ........|.+|..+|+.++||||
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-------------~~~~~~~~Fl~Ea~~m~~f~HpNi  757 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-------------SSEQEVSDFLKEALLMSKFDHPNI  757 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-------------CCHHHHHHHHHHHHHHhcCCCcce
Confidence            34556778999999999999999876665    3888887332             223457899999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      |+++|+|.+....++++|||.+|+|..+|+..+.   ....+.....+.++.|||+|+.||++.+   +|||||.++|+|
T Consensus       758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCL  834 (1025)
T KOG1095|consen  758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCL  834 (1025)
T ss_pred             eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhhee
Confidence            9999999999999999999999999999976322   2566899999999999999999999666   999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~  364 (430)
                      |+....+||+|||+|+.+....+........-...|||||.+..+.++.|+|||||||++||++| |..||....+    
T Consensus       835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----  910 (1025)
T KOG1095|consen  835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----  910 (1025)
T ss_pred             ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----
Confidence            99999999999999996654443332211123468999999999999999999999999999999 8899876432    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .   +.+..++..++.          ..+..++..+.++|..||+.+|++||++..|++.+.++
T Consensus       911 ~---~v~~~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  911 F---EVLLDVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             H---HHHHHHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            1   222223333322          22344555688999999999999999999999987765

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.6e-43  Score=328.27  Aligned_cols=269  Identities=17%  Similarity=0.194  Sum_probs=200.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +++.||+|++......            ......+.+|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~   67 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEEN------------EEVKETTLRELKMLRTLKQENIVELKE   67 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC-CCcEEEEEEEeccccc------------ccchhhHHHHHHHHHhCCCccccchhh
Confidence            368899999999999999999864 7899999998542211            122466788999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||++++++..+.    .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+|
T Consensus        68 ~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~k  140 (287)
T cd07848          68 AFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLK  140 (287)
T ss_pred             hEecCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEE
Confidence            999999999999999987766554    233568999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH----
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ----  369 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~----  369 (430)
                      |+|||++.......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............    
T Consensus       141 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         141 LCDFGFARNLSEGSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             EeeccCccccccccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999998765432211 1234689999999999998999999999999999999999999865321110000000    


Q ss_pred             ----HHHHHhcCCCCchhcccccc------CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 ----WMRNVMTSENPNRAINSKLL------GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                          ................+...      ..........+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                00000000000000000000      0011112345899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6e-43  Score=340.54  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=203.5

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||+|+||.||+|++.    ..++..||||++.....             ......+.+|+.++..+ +|||
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~Ei~il~~l~~Hpn  100 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------------LTEREALMSELKVLSYLGNHIN  100 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------------cHHHHHHHHHHHHHHHhcCCcc
Confidence            457899999999999999999742    23567899998843211             12245688999999999 8999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC---------------------------------------------
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---------------------------------------------  242 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------  242 (430)
                      |++++++|...+..++||||+++|+|.+++.....                                             
T Consensus       101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  180 (375)
T cd05104         101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP  180 (375)
T ss_pred             eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence            99999999999999999999999999999864211                                             


Q ss_pred             --------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEee
Q 014140          243 --------------------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE  296 (430)
Q Consensus       243 --------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D  296 (430)
                                                ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D  257 (375)
T cd05104         181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICD  257 (375)
T ss_pred             cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEec
Confidence                                      112578899999999999999999955   599999999999999999999999


Q ss_pred             cCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHh
Q 014140          297 FGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       297 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      ||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....   ...+...+....
T Consensus       258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~  334 (375)
T cd05104         258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMIKEGY  334 (375)
T ss_pred             CccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHHHhCc
Confidence            999987654332222212345678999999999999999999999999999998 8888765321   112222222111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ....      +       ......+.+++..||+.||++|||+.+|++.|++
T Consensus       335 ~~~~------~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 RMLS------P-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             cCCC------C-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            1000      0       0112348899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=339.52  Aligned_cols=260  Identities=27%  Similarity=0.343  Sum_probs=206.1

Q ss_pred             cccccccccccccCceEEEeecCCCCC---ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ++......||+|+||.||+|++...++   ..||||...-           ...........|.+|+++|++++|||||+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-----------~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-----------SSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-----------cccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            344556899999999999999975444   2389998742           12233456889999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +||++....++++|||+|+||+|.++|+.   ....++..++..++.+.|.||+|||+.+   ++||||-++|+|++.++
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCC
Confidence            99999999999999999999999999964   3336999999999999999999999666   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+++.-........  ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+...    .....
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~  373 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKA  373 (474)
T ss_pred             eEEeCccccccCCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HHHHH
Confidence            999999999877542111111  1134578999999999999999999999999999999 8889776432    23333


Q ss_pred             HH-HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WM-RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ++ ...+....+             ...+..+..++..||..+|++||+|.++.+.|+.+.
T Consensus       374 kI~~~~~r~~~~-------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  374 KIVKNGYRMPIP-------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHHhcCccCCCC-------------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            33 222211111             122334777888999999999999999999998763

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-43  Score=335.44  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=208.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +-|...+-||.|+.|.|-+|++. .+|+.+|||.+....           .........+-.|+.+|+.+.|||++++|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~-----------~~s~s~~~~IerEIviMkLi~HpnVl~Lyd   79 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRS-----------ELSSSQPAGIEREIVIMKLIEHPNVLRLYD   79 (786)
T ss_pred             cceeccccccCCCCceehhhhcc-cccceeEEEeecccc-----------ccccccccchhhhhHHHHHhcCCCeeeeee
Confidence            45788899999999999999986 499999999995431           222233566888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.+...+|+|.||++||.|.+++-    ..+++++..+.+++.||+.|+.|+|..+   ||||||||+|+|||..+++|
T Consensus        80 Vwe~~~~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   80 VWENKQHLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             eeccCceEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEe
Confidence            9999999999999999999999994    4578999999999999999999999666   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+|..-..+.-..+   -+|.+.|.+||++.|.+| +.++||||.|||||.||+|+.||++       .++...+.
T Consensus       153 IADFGMAsLe~~gklLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------dNir~LLl  222 (786)
T KOG0588|consen  153 IADFGMASLEVPGKLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLLL  222 (786)
T ss_pred             eeccceeecccCCccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------ccHHHHHH
Confidence            999999988766554443   489999999999999998 5689999999999999999999874       23333333


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..+.-           ..+.....++.+|+.+|+..||+.|.|+.||++
T Consensus       223 KV~~G~f-----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  223 KVQRGVF-----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHcCcc-----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            3332211           111223344889999999999999999999986

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=309.61  Aligned_cols=264  Identities=22%  Similarity=0.258  Sum_probs=204.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|..++.|++|+||.||+|+.+. +++.||+|+++.....         +..   ...-.+|+.+|.+++|||||.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~-t~eIVALKr~kmekek---------~GF---PItsLREIniLl~~~H~NIV~v  140 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEKEK---------EGF---PITSLREINILLKARHPNIVEV  140 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCC-cceeEEeeeccccccc---------CCC---cchhHHHHHHHHhcCCCCeeee
Confidence            45679999999999999999999764 9999999999654321         111   2346789999999999999999


Q ss_pred             eeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ..+..-  -+..|||||||+. +|.+++...   ..++....+..++.|+++|++|||..+   |+||||||+|+|++..
T Consensus       141 kEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~  213 (419)
T KOG0663|consen  141 KEVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHK  213 (419)
T ss_pred             EEEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccC
Confidence            998865  4578999999988 999999653   367999999999999999999999666   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |.+||+|||+|+.++.....  ....+-|.+|.|||.+.|. .|+...|+||+|||+.||+++++-|.+..    ..+..
T Consensus       214 G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s----E~dQl  287 (419)
T KOG0663|consen  214 GILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS----EIDQL  287 (419)
T ss_pred             CcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc----hHHHH
Confidence            99999999999998765332  2246789999999998887 59999999999999999999998765432    22223


Q ss_pred             HHHHHHhcCCCCchhccccc----------cCCCcH--------H--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKL----------LGNGYE--------E--QMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~--------~--~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+-..+..  |.+.+.+..          +...+.        .  ....-++|+..+|..||.+|.|+++.++
T Consensus       288 ~~If~llGt--Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  288 DKIFKLLGT--PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHHHHhCC--CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            333222221  111111110          000000        0  2245678889999999999999999875

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.2e-42  Score=318.12  Aligned_cols=265  Identities=23%  Similarity=0.294  Sum_probs=211.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|+... +++.||||.+.....           ........+.+|+.+++.++|||++++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEM-----------MDAKARQDCVKEIDLLKQLNHPNVIKYLD   69 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeecccc-----------CCHHHHHHHHHHHHHHHhCCCcceeeeee
Confidence            468899999999999999998764 889999998743211           11233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++|+||+++|+|.+++.........++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~  146 (267)
T cd08228          70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999865444456689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....     .........
T Consensus       147 l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~~  219 (267)
T cd08228         147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQK  219 (267)
T ss_pred             ECccccceeccchhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHHH
Confidence            99999988765432211  12468889999999998889999999999999999999999975321     112222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ......+.         .........+.+++.+||+.+|++||++.+|++.|++++
T Consensus       220 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         220 IEQCDYPP---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HhcCCCCC---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            22111111         011123345889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=325.98  Aligned_cols=267  Identities=24%  Similarity=0.320  Sum_probs=204.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -+.|.+...||+|.||+|-+|... .+++.||||++.+........+...........+...+|+.+|++|+|||||+++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            468999999999999999999865 4999999999965544332222222222223357899999999999999999999


Q ss_pred             eEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          213 ARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRE-LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       213 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      .+..+  .+.+|||+|||..|.+...     ....+ +++.+++.++.+++.||+|||.++   ||||||||+|+||+++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            98866  5679999999999887554     23344 999999999999999999999555   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCC---cceeeccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 014140          290 MEARISEFGLAKRIPDGHT---RTTTWSLAGTVGYIAPECHQTVA----LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT  362 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~  362 (430)
                      |.+||+|||.+..+..+..   .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..+   
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---  323 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---  323 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence            9999999999987743311   11122368999999999887742    3667999999999999999999985432   


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                          ..+....+.+.+         +.-+..+++...+.+|+.++|..||+.|.+..+|...
T Consensus       324 ----~~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  324 ----ELELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ----HHHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence                222233333221         1111222445568899999999999999999988643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=325.91  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=199.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.... +|+.||+|++......           .......+.+|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~   68 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVI-----------RLKQEQHVHNEKRVLKEVSHPFIIRLFW   68 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHh-----------hhHHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence            368889999999999999998764 7999999998432111           1123467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~k  141 (291)
T cd05612          69 TEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIK  141 (291)
T ss_pred             hhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence            99999999999999999999999853    34689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       ......
T Consensus       142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~  209 (291)
T cd05612         142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEK  209 (291)
T ss_pred             EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence            99999998764321     134689999999999998999999999999999999999999865321       111122


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      .......           .+......+.+++.+||+.||.+||+     +.++++
T Consensus       210 i~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         210 ILAGKLE-----------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHhCCcC-----------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            2211110           00111234789999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=335.29  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=204.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.+.+.+.||+|.||+||+|+|.+    .||||++.-....            .+..+.|++|+.++++-||-||+-|
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt------------~~qlqaFKnEVa~lkkTRH~NIlLF  453 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPT------------PEQLQAFKNEVAVLKKTRHENILLF  453 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc----ceEEEEEecCCCC------------HHHHHHHHHHHHHHhhcchhhheee
Confidence            45667888999999999999999964    3999999443222            2457899999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      .|+|..... .||+-+|.|-||+.+++..   ...|+..+.+.||+||++||.|||..+   |||||||..|||+.+++.
T Consensus       454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k  526 (678)
T KOG0193|consen  454 MGACMNPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK  526 (678)
T ss_pred             ehhhcCCce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence            999988777 9999999999999999753   356999999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |||+|||++................|...|||||++.-+   +|+..+||||||+++|||++|..||.....   +..+.
T Consensus       527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIif  603 (678)
T KOG0193|consen  527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQIIF  603 (678)
T ss_pred             EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheEE
Confidence            999999999765433222222234678899999987743   699999999999999999999999873211   01000


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                           .+..+..  ..|.   ......+...+.+|+..||..++++||.+.+|+..|+.+
T Consensus       604 -----mVGrG~l--~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  604 -----MVGRGYL--MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             -----Eeccccc--Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence                 0001100  0010   111223344588888999999999999999999987765

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-43  Score=320.14  Aligned_cols=259  Identities=24%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|...+++|+|+||.||.|.... +++.||||+..++...                  -..|+.+|+.++|||||++.-+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r~------------------knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKRY------------------KNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC-CCceeEEEEecCCCCc------------------CcHHHHHHHhcCCcCeeeEEEE
Confidence            47788999999999999999885 6899999999554332                  2469999999999999999998


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          215 MVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       215 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      |....     ...+|||||+. +|.++++.....+..++...+..++.|+++||+|||+.   +||||||||+|+|+|.+
T Consensus        86 f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~  161 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPD  161 (364)
T ss_pred             EEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCC
Confidence            87643     23589999987 99999987666677899999999999999999999954   59999999999999966


Q ss_pred             -CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 -MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                       |.+||||||.|+.+..+....   ++..|..|+|||.+.|. .|+.+.||||.||++.||+.|++-|.+..    ..+.
T Consensus       162 tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s----~~dQ  234 (364)
T KOG0658|consen  162 TGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS----SVDQ  234 (364)
T ss_pred             CCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC----HHHH
Confidence             899999999999987665543   35778999999998887 59999999999999999999998876522    2222


Q ss_pred             HHHHHHHhcCCCC--chhc--------cccccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENP--NRAI--------NSKLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~--~~~~--------~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...+-..+..+..  ...+        .+.+...     .......++.+|+.++|+.+|.+|.++.|++.
T Consensus       235 L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  235 LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            2222222221110  0000        0111110     11222345889999999999999999999874

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-43  Score=334.61  Aligned_cols=257  Identities=19%  Similarity=0.236  Sum_probs=201.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++.....           ........+.+|+.++..++||||+++++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~   68 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLL-----------FKLNEVRHVLTERDILTTTKSEWLVKLLY   68 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHH-----------hhhhHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            368899999999999999998764 789999999853211           11123567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k  141 (333)
T cd05600          69 AFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIK  141 (333)
T ss_pred             EEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999943    35689999999999999999999955   499999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.....    ......+..
T Consensus       142 L~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~  212 (333)
T cd05600         142 LTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWENLKY  212 (333)
T ss_pred             EEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHHHHh
Confidence            999999986543     11235789999999999999999999999999999999999999865322    111111111


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ....  ...    .............+.+++..||+.+|.+||++.++++.
T Consensus       213 ~~~~--~~~----~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         213 WKET--LQR----PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccc--ccC----CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1000  000    00000001223457889999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-42  Score=315.91  Aligned_cols=256  Identities=23%  Similarity=0.330  Sum_probs=207.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|..++.||+|..|+||++++++ ++..+|+|++.+.           .....+...+...|-.||+.++||.+..+|+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~-----------~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa  144 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKE-----------SLASRKKLKRAQTEREILSLLDHPFLPTLYA  144 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHH-----------HHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence            468889999999999999999986 6799999999432           2223455778899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .|..++..|+|||||+||+|..+++.  +....+++..+.-++..|+.||+|||   ..|||+|||||+||||-++|++.
T Consensus       145 ~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIM  219 (459)
T KOG0610|consen  145 SFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIM  219 (459)
T ss_pred             eeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEE
Confidence            99999999999999999999999875  66788999999999999999999999   66699999999999999999999


Q ss_pred             EeecCCcccCCCCC---------------------------------Cc---------------------ceeecccccc
Q 014140          294 ISEFGLAKRIPDGH---------------------------------TR---------------------TTTWSLAGTV  319 (430)
Q Consensus       294 l~Dfg~a~~~~~~~---------------------------------~~---------------------~~~~~~~gt~  319 (430)
                      |+||.++.......                                 ..                     .....++||-
T Consensus       220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh  299 (459)
T KOG0610|consen  220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH  299 (459)
T ss_pred             eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence            99999986542100                                 00                     0112467999


Q ss_pred             ccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHH
Q 014140          320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLL  399 (430)
Q Consensus       320 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (430)
                      .|+|||++.|.+.+.++|+|+|||++|||+.|..||.+....   .    -+.+++..+..        + ...+.....
T Consensus       300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~----Tl~NIv~~~l~--------F-p~~~~vs~~  363 (459)
T KOG0610|consen  300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---E----TLRNIVGQPLK--------F-PEEPEVSSA  363 (459)
T ss_pred             ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---h----hHHHHhcCCCc--------C-CCCCcchhH
Confidence            999999999999999999999999999999999999865331   1    12233322110        0 111134456


Q ss_pred             HHHHHHhcccCCCCCCCC----HHHHH
Q 014140          400 VLKIACFCTLDDPNKRPN----SKDVR  422 (430)
Q Consensus       400 l~~l~~~cl~~dp~~Rps----~~ev~  422 (430)
                      +.+||+..|..||.+|.-    +.||-
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhh
Confidence            899999999999999988    66654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-42  Score=331.19  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|.+......           .......+.+|+.++..++||||++++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~   84 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREIL-----------KMKQVQHVAQEKSILMELSHPFIVNMM   84 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHh-----------hhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3578999999999999999999864 7899999998532111           112356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  157 (329)
T PTZ00263         85 CSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHV  157 (329)
T ss_pred             EEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCE
Confidence            999999999999999999999999853    35688999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+...
T Consensus       158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~  225 (329)
T PTZ00263        158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYE  225 (329)
T ss_pred             EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHH
Confidence            999999998764322     135789999999999999999999999999999999999999864221       11112


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVR  422 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~  422 (430)
                      ..... .+.  + +   ..    ....+.+++..||+.||.+||+     +.+++
T Consensus       226 ~i~~~-~~~--~-p---~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        226 KILAG-RLK--F-P---NW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             HHhcC-CcC--C-C---CC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            22211 110  0 0   01    1234789999999999999997     56665

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.9e-42  Score=317.84  Aligned_cols=259  Identities=22%  Similarity=0.286  Sum_probs=202.8

Q ss_pred             ccccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|.+.  +..+..||+|.+.....             ......+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~   70 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------------DKQRRGFLAEALTLGQFDHSNIVR   70 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------------HHHHHHHHHHHHHHhcCCCCCcCe
Confidence            356899999999999999999764  22467899998843211             122467889999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++..++..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~  144 (266)
T cd05064          71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDL  144 (266)
T ss_pred             EEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCC
Confidence            99999999999999999999999999854   234689999999999999999999954   599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++++|||.+......... ......++..|+|||++.+..++.++|||||||++||+++ |..||.....    .....
T Consensus       145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~  219 (266)
T cd05064         145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIK  219 (266)
T ss_pred             cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHH
Confidence            9999999987654322111 1112345678999999999999999999999999999775 9999865322    11222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+.   .....          ..+...+..+.+++..||+.+|.+||++.+|.+.|+++
T Consensus       220 ~~~---~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 AVE---DGFRL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHH---CCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            221   11111          01112334588899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=314.27  Aligned_cols=266  Identities=25%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|...+.||.|++|.|..|.... +|+.||||++...+..            ....++..+|+.+|+.++|+||+.++
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~-t~~~VAIKKi~~~F~~------------~~~akRtlRElklLr~~~HeNIi~l~   87 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKR-TGEKVAIKKILNPFEN------------QIDAKRTLRELKLLRHLRHENIIGLL   87 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcC-CCCEeehhhhhhhhhc------------hHHHHHHHHHHHHHHHhcCCCcceEE
Confidence            4556668999999999999998774 8999999999644332            23367889999999999999999999


Q ss_pred             eEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++..     -+..|+|+|+|+. +|...++    .+..++......++.|+++||.|+|+.+   ++||||||+|+|++
T Consensus        88 di~~p~~~~~f~DvYiV~elMet-DL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n  159 (359)
T KOG0660|consen   88 DIFRPPSRDKFNDVYLVFELMET-DLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLN  159 (359)
T ss_pred             eecccccccccceeEEehhHHhh-HHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeec
Confidence            99876     3467999999954 9999983    4556999999999999999999999776   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccc------
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ------  360 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------  360 (430)
                      .+..+||+|||+|+..............+.|.+|.|||++... .|+...||||.|||+.||++|++-|.+...      
T Consensus       160 ~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l  239 (359)
T KOG0660|consen  160 ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL  239 (359)
T ss_pred             cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence            9999999999999998654222222356789999999987654 699999999999999999999977654211      


Q ss_pred             -----ccccccHHH-----HHHHHhcCCC-CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          361 -----HTKEMSLVQ-----WMRNVMTSEN-PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       361 -----~~~~~~l~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                           +........     .+++.+..-. ..+.-...++....    ...++|+.+||..||.+|+|++|.+.
T Consensus       240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~----p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN----PLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC----HHHHHHHHHHhccCccccCCHHHHhc
Confidence                 000000111     1111221111 11111112222333    34888999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-43  Score=299.51  Aligned_cols=268  Identities=21%  Similarity=0.268  Sum_probs=213.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||.|||+.||+++.. +++..||+|++.....              +..+..++|++..++++|||++++
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~~--------------~~~e~~~rEid~~rkf~s~~vl~l   83 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHSQ--------------EDIEEALREIDNHRKFNSPNVLRL   83 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeeccc-Ccccchhhheeeccch--------------HHHHHHHHHHHHHHhhCCcchHHH
Confidence            3568999999999999999999965 4899999999965432              336788999999999999999999


Q ss_pred             eeEEEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          212 LARMVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       212 ~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++++....     ..|++++|...|||.+.+......+..+++...+.|+.+|++||.+||+. .+++.||||||.|||+
T Consensus        84 ~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILl  162 (302)
T KOG2345|consen   84 VDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILL  162 (302)
T ss_pred             HHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEe
Confidence            99876543     48999999999999999998777777899999999999999999999977 4579999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcc-------eeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRT-------TTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      .+++.+++.|||.+....-.....       .......|..|.|||.+.-   ...+.++|||||||+||+|+.|..||+
T Consensus       163 s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  163 SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            999999999999998764221111       1112346899999998764   357899999999999999999999998


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..+...+...+.-..      +.        ..-+......+.+.+++.+|++.||.+||++.+++..+..+-
T Consensus       243 ~~~~~GgSlaLAv~n------~q--------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  243 RIYQQGGSLALAVQN------AQ--------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             HHhhcCCeEEEeeec------cc--------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            765533322221110      00        000000113445889999999999999999999999988763

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-42  Score=328.79  Aligned_cols=245  Identities=20%  Similarity=0.248  Sum_probs=194.3

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|+||.||+|+... +|+.||+|++.....           ........+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   68 (323)
T cd05571           1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVI-----------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD   68 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC
Confidence            368999999999998764 899999999853211           11223466789999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~  141 (323)
T cd05571          69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999999999843    45689999999999999999999955   599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN  379 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  379 (430)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.....       ........... 
T Consensus       142 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~-  211 (323)
T cd05571         142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEE-  211 (323)
T ss_pred             CcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC-
Confidence            875432211  12235799999999999999999999999999999999999999854211       11111111111 


Q ss_pred             CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .      .    .+......+.+++..||+.||++||     ++.++++
T Consensus       212 ~------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 I------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             C------C----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1      0    0111223478899999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-42  Score=321.79  Aligned_cols=262  Identities=27%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             cccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ++|.+.+.||.|+||.||+|.....    ....|++|.+....             .......+.+|+.++..++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------------~~~~~~~~~~ei~~l~~l~h~~i~   71 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------------EPKVQQEFRQEAELMSDLQHPNIV   71 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------------CHHHHHHHHHHHHHHHhcCCcccc
Confidence            4688899999999999999987532    22679999874221             122346789999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      ++++++...+..+++|||+++|+|.+++.....            ....+++...+.++.|++.||.|||+.   +++|+
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~  148 (283)
T cd05048          72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHR  148 (283)
T ss_pred             eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            999999999999999999999999999965311            114688999999999999999999955   59999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+||++++++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999986644332222223456788999999998899999999999999999998 999986


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....    ..+...+.    .....         ..+...+..+.+++..||+.+|.+||++.+|++.|+.+
T Consensus       229 ~~~~----~~~~~~i~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         229 GFSN----QEVIEMIR----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CCCH----HHHHHHHH----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            5322    12222221    11111         11122334588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-42  Score=330.98  Aligned_cols=250  Identities=20%  Similarity=0.225  Sum_probs=199.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||.|+||.||+|.+...++..||+|++.....           ........+.+|+.+++.++||||++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   97 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-----------IKQKQVDHVFSERKILNYINHPFCVNLY   97 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence            35689999999999999999987654557899999843211           1112356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+
T Consensus        98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426         98 GSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence            999999999999999999999999953    35689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||....+    .   ....
T Consensus       171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~---~~~~  238 (340)
T PTZ00426        171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L---LIYQ  238 (340)
T ss_pred             EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H---HHHH
Confidence            999999998764321     235799999999999998899999999999999999999999864321    1   1111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ........   +        +......+.+++.+||+.+|.+|+     ++.++++
T Consensus       239 ~i~~~~~~---~--------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        239 KILEGIIY---F--------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHhcCCCC---C--------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            22211110   0        011122377899999999999995     7888765

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.6e-42  Score=335.63  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=206.0

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp  206 (430)
                      ..+.|.+.+.||+|+||.||+|+..+    ..+..||||++.....             ......+.+|+.+++++. ||
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~Ei~~l~~l~~Hp  101 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------------SSEKQALMSELKIMTHLGPHL  101 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------------hHHHHHHHHHHHHHHhcCCCC
Confidence            46789999999999999999998632    1345799999843211             122467899999999996 99


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------------------------------------
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------------------------------------  242 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------  242 (430)
                      ||++++++|...+..++|||||++|+|.+++.....                                            
T Consensus       102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (400)
T cd05105         102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK  181 (400)
T ss_pred             CeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence            999999999999999999999999999999864211                                            


Q ss_pred             ------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 014140          243 ------------------------------------------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRI  274 (430)
Q Consensus       243 ------------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  274 (430)
                                                                      ....+++..+..++.|++.||.|||+.   ++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~i  258 (400)
T cd05105         182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NC  258 (400)
T ss_pred             cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence                                                            013478888999999999999999954   59


Q ss_pred             EecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 014140          275 IHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKF  353 (430)
Q Consensus       275 iH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~  353 (430)
                      +|+||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus       259 vH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~  338 (400)
T cd05105         259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGT  338 (400)
T ss_pred             eCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999987654332222223456788999999999899999999999999999997 889


Q ss_pred             CCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          354 PSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       354 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ||......   ..+...+   .....+.          .+......+.+++..||+.+|++||++.+|.++|+++-
T Consensus       339 P~~~~~~~---~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         339 PYPGMIVD---STFYNKI---KSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CCcccchh---HHHHHHH---hcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            97653221   1111111   1111110          11122345889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=326.16  Aligned_cols=245  Identities=22%  Similarity=0.239  Sum_probs=193.3

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||+|+||.||+|+... +++.||+|.+.....           ........+..|+.++.+++||||+++++++...+..
T Consensus         1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   68 (312)
T cd05585           1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHI-----------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL   68 (312)
T ss_pred             CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence            7999999999998764 789999999843211           1122356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++
T Consensus        69 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~  141 (312)
T cd05585          69 YLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK  141 (312)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence            999999999999999853    34689999999999999999999955   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....       ..+........... 
T Consensus       142 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~~-  211 (312)
T cd05585         142 LNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPLR-  211 (312)
T ss_pred             cCccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCC-
Confidence            64332221  123578999999999999999999999999999999999999986421       22222333322110 


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                                .+......+.+++..||+.||.+||+...+.+.|
T Consensus       212 ----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         212 ----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             ----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence                      0111223478899999999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-41  Score=325.86  Aligned_cols=201  Identities=26%  Similarity=0.417  Sum_probs=173.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|+||.||+|.+.. +|..+|+|.+.....             ......+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~   69 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGFY   69 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeecccC-------------HHHHHHHHHHHHHHHHCCCCccccee
Confidence            4679999999999999999998764 789999998743211             12346789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+..++||||+++|+|.+++..    ...+++.....++.+++.||.|||+.+  +++|+||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~  143 (333)
T cd06650          70 GAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI  143 (333)
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCE
Confidence            999999999999999999999999853    346899999999999999999999532  59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ||+|||++........    ....||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       144 kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         144 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             EEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999876543211    134689999999999998899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=315.34  Aligned_cols=265  Identities=24%  Similarity=0.296  Sum_probs=210.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|++|.||+|.... +|..++||.+.....           ........+.+|+.+++.++||||+++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   69 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL-DGVPVALKKVQIFDL-----------MDAKARADCIKEIDLLKQLNHPNVIKYYA   69 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC-CCceEEEEeeeehhh-----------hhHHHHHHHHHHHHHHHHccCCchhhhhh
Confidence            368889999999999999998754 889999998743211           11233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..++..+++|||+++++|.+++.........+++..++.++.+++.||.|||   +.+++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEE
Confidence            999999999999999999999998754444567899999999999999999999   45599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....|+..|+|||++.+..++.++|+||||+++|+|++|..||....     ....+....
T Consensus       147 l~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~  219 (267)
T cd08229         147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK  219 (267)
T ss_pred             ECcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc-----chHHHHhhh
Confidence            99999988765432211  13468899999999998889999999999999999999999975421     112222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ......+      ..   ........+.+++.+||+.+|++|||+.+|+++++++.
T Consensus       220 ~~~~~~~------~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 IEQCDYP------PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hhcCCCC------CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            2111110      00   01123345889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-41  Score=314.24  Aligned_cols=256  Identities=21%  Similarity=0.321  Sum_probs=204.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|++|.||+|...  ++..||+|.+....               .....+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~   67 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT---------------MSVQAFLEEANLMKTLQHDKLVRLY   67 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc---------------hhHHHHHHHHHHHHhCCCCCeeeEE
Confidence            457899999999999999999865  67889999874211               1146789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..+++|||+++|+|.+++..  .....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~  142 (261)
T cd05072          68 AVVTKEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMC  142 (261)
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcE
Confidence            999999999999999999999999864  2345688999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....    ......+
T Consensus       143 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~  217 (261)
T cd05072         143 KIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSAL  217 (261)
T ss_pred             EECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHHH
Confidence            999999998765432211 112345778999999998889999999999999999998 9999864321    1222222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..   .....      ....    ....+.+++.+||+.+|++||++.++.+.|+.+
T Consensus       218 ~~---~~~~~------~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         218 QR---GYRMP------RMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             Hc---CCCCC------CCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11   11110      0011    223488899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=333.20  Aligned_cols=246  Identities=23%  Similarity=0.281  Sum_probs=202.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      -++|..+.+||+|+||+|++|.+++ +++.+|||++.++           .....+.++..+.|.+++.... ||.++++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~-----------~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKG-----------DILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeecc-----------ceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            4679999999999999999999986 8899999999543           3333445788999999999885 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.|.+.+++|+||||+.||++..+.     ....+++..+.-++..|+.||.|||+++   |||||||.+|||||.+|+
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCc
Confidence            99999999999999999999944333     3467999999999999999999999555   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.-.....  .+..++||+.|+|||++.+..|+..+|+|||||++|||+.|..||.+.    +...+   .
T Consensus       507 ~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd----dEee~---F  577 (694)
T KOG0694|consen  507 VKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD----DEEEV---F  577 (694)
T ss_pred             EEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC----CHHHH---H
Confidence            99999999997653332  233579999999999999999999999999999999999999998643    22222   2


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ..++..+.           .++.-...+...++..+|..+|++|.-+
T Consensus       578 dsI~~d~~-----------~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEV-----------RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCC-----------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            22332221           1233344558889999999999999876

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.3e-41  Score=312.27  Aligned_cols=266  Identities=25%  Similarity=0.297  Sum_probs=211.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|... .+|+.+|+|.+......           .......+.+|+.++++++|+|++++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-----------~~~~~~~~~~ei~~l~~~~~~~i~~~~~   69 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMM-----------DAKARQDCLKEIDLLKQLDHPNVIKYLA   69 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeeccccc-----------chhhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            46889999999999999999876 48999999988432111           1123567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++|+|.+++.........+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~  146 (267)
T cd08224          70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEE
Confidence            9999999999999999999999987644445668999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....++..|+|||++.+..++.++|+||||+++|+|++|..||....     .++.+....
T Consensus       147 l~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~  219 (267)
T cd08224         147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK  219 (267)
T ss_pred             EeccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh
Confidence            99999988764432211  12468889999999998889999999999999999999999975321     222222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                      ......+.         .........+.+++.+||+.+|++||++.+|+++|++++.
T Consensus       220 ~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         220 IEKCDYPP---------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             hhcCCCCC---------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence            21111000         0011233458899999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=326.39  Aligned_cols=254  Identities=18%  Similarity=0.221  Sum_probs=212.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|..++.+|+|+||.+++.+++. ++..|++|.+.-.....            .......+|+.++++++|||||.+.+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~------------~~r~~A~~E~~lis~~~hP~iv~y~d   70 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTE------------PERRSAIQEMDLLSKLLHPNIVEYKD   70 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCc------------hhhHHHHHHHHHHHhccCCCeeeecc
Confidence            578999999999999999998875 88899999995543332            22457889999999999999999999


Q ss_pred             EEEeCCe-eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          214 RMVRRDC-DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       214 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      .|..++. .+|||+||+||+|.+.+.+  +.+..+++..++.++.|++.|+.|||+..   |+|||||+.|||++.++.+
T Consensus        71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~V  145 (426)
T KOG0589|consen   71 SFEEDGQLLCIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKV  145 (426)
T ss_pred             chhcCCceEEEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCce
Confidence            9999998 9999999999999999976  33677999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||+|+.+.......  ....||+.|+.||.+.+.+|+.|+|||||||++|||++-+.+|...    +...++..+.
T Consensus       146 kLgDfGlaK~l~~~~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li~ki~  219 (426)
T KOG0589|consen  146 KLGDFGLAKILNPEDSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELILKIN  219 (426)
T ss_pred             eecchhhhhhcCCchhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc----chHHHHHHHh
Confidence            999999999987765332  2478999999999999999999999999999999999999997653    2222332222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      +..             ..+.+......+..++..||+.+|..||++.+++..
T Consensus       220 ~~~-------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGL-------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hcc-------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            221             112223334458889999999999999999999865

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-41  Score=339.42  Aligned_cols=255  Identities=18%  Similarity=0.202  Sum_probs=203.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|.+.+.||+|++|.||+|......+..||+|.+...              .......+.+|+.+|+.++||||++++++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~  133 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------------DERQAAYARSELHCLAACDHFGIVKHFDD  133 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------------CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            4889999999999999999865433778888876221              11224567889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      |...+..|+||||+++|+|.+++........++++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       134 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             EEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEE
Confidence            999999999999999999999986544445678999999999999999999995   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..+.............||+.|+|||++.+..++.++|||||||++|+|++|+.||....       ..+.....
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~  283 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQV  283 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Confidence            99999987754433222334579999999999999999999999999999999999999986421       12222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......          .+......+.+++..||+.+|++||++.+++.
T Consensus       284 ~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGKYDP----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCCCCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            2211110          01112234889999999999999999999874

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-41  Score=312.07  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=199.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.+.  ++..+|+|.+.....               ....+.+|+.+++.++||||+++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~   66 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAM---------------SEEDFIEEAKVMMKLSHPKLVQLYG   66 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCc---------------cHHHHHHHHHHHHHCCCCCceeEEE
Confidence            45788899999999999999876  667899998742211               1356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        67 ~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05114          67 VCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVK  140 (256)
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEE
Confidence            99999999999999999999999854   224589999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.+.......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||....    .......  
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~--  213 (256)
T cd05114         141 VSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEM--  213 (256)
T ss_pred             ECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH--
Confidence            99999998764332211 112345678999999998889999999999999999999 899976432    1122222  


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                       ......+.   .+.       .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       214 -i~~~~~~~---~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         214 -ISRGFRLY---RPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -HHCCCCCC---CCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             22211111   011       11234889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=296.81  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=208.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||.|-||.||+|+.+. ++-.||+|++.+.           +........++.+|+.+.+.|+||||+++|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk-s~~IvalKVlfKs-----------qi~~~~v~~qlrREiEIqs~L~hpnilrlY   88 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKS-----------QILKTQVEHQLRREIEIQSHLRHPNILRLY   88 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc-CCcEEEEeeeeHH-----------HHHHhcchhhhhheeEeecccCCccHHhhh
Confidence            4578999999999999999999875 8899999999442           222234457899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.++...||++||.+.|+|...|+.  .....+++.....++.|+|.||.|+|..+   ++||||||+|+|++..+.+
T Consensus        89 ~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   89 GYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             hheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCe
Confidence            999999999999999999999999964  34567899999999999999999999555   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |++|||.+...+.+..    ...+||..|.|||...+..++..+|+|++|++.||++.|.+||+...    .......+.
T Consensus       164 kiAdfGwsV~~p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~  235 (281)
T KOG0580|consen  164 KIADFGWSVHAPSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIR  235 (281)
T ss_pred             eccCCCceeecCCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHH
Confidence            9999999987653322    24689999999999999999999999999999999999999987542    122222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..-       ..++       ......+.+++..|+..+|.+|.+..|+++
T Consensus       236 k~~-------~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  236 KVD-------LKFP-------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             Hcc-------ccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            211       1111       122234889999999999999999999876

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.5e-42  Score=317.21  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=194.2

Q ss_pred             cccccccccCceEEEeecC---CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          138 SLEKIRSCWNGEVYKAELP---GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      ..+.||.|.||.||+|.+.   ...+..|+||.+....             .......+.+|+..+++++||||++++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~   69 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------------SEEEEEEFLNEIQILRKLRHPNIVKLYGF   69 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------------SHHHHHHHHHHHHHHHTHSBTTBE-EEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------------ccccceeeeeccccccccccccccccccc
Confidence            4578999999999999986   2246789999983311             12236789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      |...+..++||||+++|+|.+++...  ....+++..+..|+.|++.||.|||+.+   ++|+||+++||++++++.+||
T Consensus        70 ~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl  144 (259)
T PF07714_consen   70 CIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKL  144 (259)
T ss_dssp             EESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEE
T ss_pred             cccccccccccccccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            99888899999999999999999752  3467999999999999999999999665   999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++................+...|+|||.+.+..++.++||||||+++||+++ |+.||....    ...+...+..
T Consensus       145 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----~~~~~~~~~~  220 (259)
T PF07714_consen  145 SDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----NEEIIEKLKQ  220 (259)
T ss_dssp             ESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----HHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccc
Confidence            99999988744333333333457789999999999889999999999999999999 678876542    1222222211


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      ..   .+.          .+......+.+++..||+.+|++|||+.+|++.|
T Consensus       221 ~~---~~~----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 GQ---RLP----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TE---ETT----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cc---cce----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11   110          0111223488999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-41  Score=324.27  Aligned_cols=245  Identities=21%  Similarity=0.264  Sum_probs=193.2

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|+||.||+++... +|..||+|.+......           .......+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~   68 (323)
T cd05595           1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   68 (323)
T ss_pred             CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            368999999999998764 8999999998532111           1123566788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|..++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        69 ~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  141 (323)
T cd05595          69 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHH
Confidence            99999999999999988843    34689999999999999999999955   599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN  379 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  379 (430)
                      +........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ............
T Consensus       142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~~~  212 (323)
T cd05595         142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI  212 (323)
T ss_pred             hccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCC
Confidence            875432211  11235689999999999999999999999999999999999999864321       111111111110


Q ss_pred             CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .       ....    ....+.+++..||+.||.+||     ++.++++
T Consensus       213 ~-------~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 R-------FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             C-------CCCC----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            0       0011    123478899999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.1e-41  Score=312.04  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|.+.+.||.|++|.||+|.... ++..+|+|.+....               .....+.+|+.+++.++||||+++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT---------------MEVEEFLKEAAVMKEIKHPNLVQLLG   69 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec-CCceEEEEEecCCc---------------hHHHHHHHHHHHHHhCCCCChhheEE
Confidence            458888999999999999998764 78999999874211               11456889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++..  .....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+|
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~k  144 (263)
T cd05052          70 VCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVK  144 (263)
T ss_pred             EEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEE
Confidence            99999999999999999999999854  233468999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++........... ....++..|+|||++.+..++.++|||||||++|||++ |..||....       ..+...
T Consensus       145 l~df~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~~~~  216 (263)
T cd05052         145 VADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYE  216 (263)
T ss_pred             eCCCccccccccceeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Confidence            999999987654322111 12234678999999999899999999999999999998 888875421       111122


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .......+      ..    +...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       217 ~~~~~~~~------~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         217 LLEKGYRM------ER----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHCCCCC------CC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            22111111      00    111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-41  Score=329.23  Aligned_cols=261  Identities=18%  Similarity=0.184  Sum_probs=196.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||.|+||.||+|.... +++.||+|...                    ...+.+|+.++++++||||++++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~--------------------~~~~~~E~~il~~l~HpnIv~~~  149 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQ--------------------RGGTATEAHILRAINHPSIIQLK  149 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECC-CCCEEEEechh--------------------hhhhHHHHHHHHhCCCCCCCCEe
Confidence            4679999999999999999998764 89999999651                    23467899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++|+|++. ++|..++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       150 ~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~v  221 (391)
T PHA03212        150 GTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDV  221 (391)
T ss_pred             EEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCE
Confidence            99999999999999995 689888843    34689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---ccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE---MSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~---~~l~~  369 (430)
                      ||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|..|+-........   .....
T Consensus       222 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~  300 (391)
T PHA03212        222 CLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK  300 (391)
T ss_pred             EEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence            99999999754332211 122457999999999999999999999999999999999999876432111100   01111


Q ss_pred             HHHHHhcCCCCchh------cc-------------ccccC--CCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRA------IN-------------SKLLG--NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~------~~-------------~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+............      ++             +....  .........+.+++.+||+.||.+|||+.|+++
T Consensus       301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11111100000000      00             00000  001123446889999999999999999999985

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-42  Score=339.81  Aligned_cols=259  Identities=20%  Similarity=0.248  Sum_probs=205.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .-.+.+.+.|.+|||+.||+|+... .|..||+|++...              ++.....+.+|+.+|++|+ |||||.+
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~--------------de~~L~~v~~EI~~MK~L~gh~nIV~y  100 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVN--------------DEEALNAVKREIDIMKLLSGHKNIVSY  100 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecC--------------CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence            3457889999999999999999873 4599999998543              2344678999999999997 9999999


Q ss_pred             eeEE-Ee---C---CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          212 LARM-VR---R---DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       212 ~~~~-~~---~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ++.. ..   +   -..+|.||||.||+|-|+++.+.+.  .|++.++++|+.|+++|+++||.+ .++|||||||-+||
T Consensus       101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENv  177 (738)
T KOG1989|consen  101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENV  177 (738)
T ss_pred             eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhhe
Confidence            9933 21   1   2467999999999999999875443  399999999999999999999988 78899999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcce-------eecccccccccccccc---CCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTT-------TWSLAGTVGYIAPECH---QTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      ||+.+++.||||||.+...........       .....-|+.|+|||++   .+.+.+.|+|||+|||+||-|+....|
T Consensus       178 Lls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~P  257 (738)
T KOG1989|consen  178 LLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTP  257 (738)
T ss_pred             EEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCC
Confidence            999999999999999986543331110       0112468999999974   466789999999999999999999999


Q ss_pred             CCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          355 SDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       355 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      |+....    .                ..++....-+..+.....+.+||..||+.||.+||++.+|+..+-.|.
T Consensus       258 Fe~sg~----l----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  258 FEESGK----L----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             cCcCcc----e----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence            986421    0                011111111122345566999999999999999999999999987764

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-41  Score=326.06  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||+|+||.||+|...+    .+++.||+|++.....             ......+..|+.++.++ +|||
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~~E~~~~~~l~~h~n   72 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------------ASEYKALMTELKILIHIGHHLN   72 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------------HHHHHHHHHHHHHHHhhccCcc
Confidence            4578999999999999999997532    2457899998843211             12245678899999999 8999


Q ss_pred             cccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcCC-------------------------------------------
Q 014140          208 IVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQG-------------------------------------------  243 (430)
Q Consensus       208 iv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------  243 (430)
                      |++++++|... ...+++|||+++|+|.+++......                                           
T Consensus        73 iv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (337)
T cd05054          73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKS  152 (337)
T ss_pred             hhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcc
Confidence            99999988654 5678999999999999998642110                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCc
Q 014140          244 --------------RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR  309 (430)
Q Consensus       244 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  309 (430)
                                    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++..+......
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~  229 (337)
T cd05054         153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  229 (337)
T ss_pred             hhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch
Confidence                          13689999999999999999999954   5999999999999999999999999999876543322


Q ss_pred             ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccc
Q 014140          310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKL  388 (430)
Q Consensus       310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||......   ..+...    ........      
T Consensus       230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~~~------  296 (337)
T cd05054         230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRR----LKEGTRMR------  296 (337)
T ss_pred             hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHH----HhccCCCC------
Confidence            22223456778999999999999999999999999999998 99998653221   111111    11111100      


Q ss_pred             cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          389 LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       389 ~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         .+......+.+++..||+.+|++||++.+|++.|+++
T Consensus       297 ---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         297 ---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-41  Score=317.62  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||+|+||+||++.... +|+.||+|.+......           .......+..|+.+++.++||||+++.+++...+..
T Consensus         1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   68 (280)
T cd05608           1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLK-----------KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL   68 (280)
T ss_pred             CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHh-----------hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence            6999999999998764 8899999998432111           112245678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++||||+++|+|.+.+.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  145 (280)
T cd05608          69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV  145 (280)
T ss_pred             EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccce
Confidence            999999999999988865444456799999999999999999999955   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      .+......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..............  
T Consensus       146 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~--  218 (280)
T cd05608         146 ELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILNDSV--  218 (280)
T ss_pred             ecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcccCC--
Confidence            76543322  123578999999999999999999999999999999999999986432111   11111111111110  


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                               ..+......+.+++..||+.||++||     ++.++++
T Consensus       219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 ---------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ---------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                     01112234478899999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-41  Score=311.67  Aligned_cols=251  Identities=24%  Similarity=0.298  Sum_probs=195.8

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|+||.||+|++.. +|+.+|+|.+....             .......+.+|+.+++.++||||++++++|...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   66 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETL-------------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ   66 (252)
T ss_pred             CccCcccCccEEEEEEec-CCceEEEEecCccC-------------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence            468999999999998764 78999999874221             1123467899999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        67 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  140 (252)
T cd05084          67 PIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGM  140 (252)
T ss_pred             CeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECcccc
Confidence            99999999999999999853   2346899999999999999999999   45599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      +................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....    .....   ......
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~---~~~~~~  213 (252)
T cd05084         141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTRE---AIEQGV  213 (252)
T ss_pred             CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHH---HHHcCC
Confidence            886543221111111123457999999999899999999999999999998 8888764321    11111   111111


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ..          ..+......+.+++.+||+.+|++|||+.+|.++|+.
T Consensus       214 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         214 RL----------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11          0111123458899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-41  Score=323.72  Aligned_cols=245  Identities=21%  Similarity=0.278  Sum_probs=194.1

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|+||.||+++... +|+.||+|++.....           ........+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   68 (328)
T cd05593           1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVI-----------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD   68 (328)
T ss_pred             CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            368999999999998764 899999999853211           11223567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        69 ~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~  141 (328)
T cd05593          69 RLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL  141 (328)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcC
Confidence            99999999999999988843    35689999999999999999999954   599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN  379 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  379 (430)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+..........
T Consensus       142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~  212 (328)
T cd05593         142 CKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEDI  212 (328)
T ss_pred             CccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCCc
Confidence            876432211  11235799999999999998999999999999999999999999864211       111222211111


Q ss_pred             CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .       +    +......+.+++..||+.||.+||     ++.++++
T Consensus       213 ~-------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 K-------F----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             c-------C----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            0       0    111223478899999999999997     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.9e-42  Score=321.19  Aligned_cols=263  Identities=17%  Similarity=0.230  Sum_probs=196.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|.... ++..||+|.+......             .....+.+|+.+++.++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~   70 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEE-------------GAPCTAIREVSLLKNLKHANIVTLHD   70 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC-CCCEEEEEEecccccC-------------CcchhHHHHHHHHHhCCCCCEeeEEE
Confidence            568999999999999999998764 8899999998432111             11245778999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++ +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        71 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~k  143 (288)
T cd07871          71 IIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELK  143 (288)
T ss_pred             EEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence            99999999999999975 99998853   234578999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++........  ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....    ......+.
T Consensus       144 l~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~  217 (288)
T cd07871         144 LADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV----KEELHLIF  217 (288)
T ss_pred             ECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            999999976543221  1123467999999998876 4689999999999999999999999864321    11111111


Q ss_pred             HHhcCCCC------------chhccccccCCC----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENP------------NRAINSKLLGNG----YEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~------------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........            .....+......    .+.....+.+++.+||+.||.+|||+.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111000            000000000000    0011234789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.5e-41  Score=321.05  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=200.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..+|...+.||+|+||.||+|++.. +|.    .||+|.+....             .......+.+|+.+++.++||||
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni   71 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-------------SPKANKEILDEAYVMASVDNPHV   71 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccC-------------CHHHHHHHHHHHHHHHhCCCCCC
Confidence            4569999999999999999998753 444    48999874211             11234678899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      ++++|+|... ..++|+||+++|+|.+++..   ....+++...+.++.|++.||+|||+.   +++||||||+|||++.
T Consensus        72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~  144 (316)
T cd05108          72 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKT  144 (316)
T ss_pred             CeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecC
Confidence            9999998764 56799999999999999854   234688999999999999999999955   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....    ..+
T Consensus       145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~  220 (316)
T cd05108         145 PQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEI  220 (316)
T ss_pred             CCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence            99999999999987754333222212334678999999999999999999999999999998 9999865321    111


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .....   ....+..          +..+...+.+++..||+.+|++||++.+++..|.++
T Consensus       221 ~~~~~---~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         221 SSILE---KGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             HHHHh---CCCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111   1111100          011123478899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-41  Score=309.84  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=202.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|++|.||+|...  +++.||+|.+.....               ....+.+|+.++++++||||++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~   67 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTM---------------DPKDFLAEAQIMKKLRHPKLIQLY   67 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCcc---------------cHHHHHHHHHHHHHCCCCCcccee
Confidence            456889999999999999999865  667899998843211               135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  142 (261)
T cd05068          68 AVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNIC  142 (261)
T ss_pred             EEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCE
Confidence            9999999999999999999999999642  235689999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++............ ....+..|+|||++.+..++.++||||||+++++|++ |+.||.....    ..+...+
T Consensus       143 ~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~  217 (261)
T cd05068         143 KVADFGLARVIKEDIYEARE-GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQV  217 (261)
T ss_pred             EECCcceEEEccCCcccccC-CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence            99999999877533221111 1223467999999999899999999999999999999 9999864321    1111111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         ......          ..+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       218 ---~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         218 ---DQGYRM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---HcCCCC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               111110          01112234588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-41  Score=319.46  Aligned_cols=264  Identities=20%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l  211 (430)
                      +|.+.+.||+|+||.||+|+....+|..||+|.+.......            .....+.+|+.+++.+   +||||+++
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~hpniv~~   69 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------------GMPLSTIREVAVLRHLETFEHPNVVRL   69 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------------CchHHHHHHHHHHHhhcccCCCCcceE
Confidence            58889999999999999998755467899999885432211            1123455666666655   69999999


Q ss_pred             eeEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          212 LARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       212 ~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++|..     ....++||||++ ++|.+++..  .....+++..+..++.|++.||.|||+.   +++||||||+|||+
T Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~  143 (290)
T cd07862          70 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILV  143 (290)
T ss_pred             EEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEE
Confidence            999863     346899999996 599999864  2334589999999999999999999955   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|..||.....    ..
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~  216 (290)
T cd07862         144 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VD  216 (290)
T ss_pred             cCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HH
Confidence            999999999999998765432   11234689999999999988999999999999999999999999875322    11


Q ss_pred             HHHHHHHHhcCCCC----------chhccccc---cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENP----------NRAINSKL---LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~----------~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+........+          ...+....   .....+.....+.+++.+||+.||++|||+.++++
T Consensus       217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11111111111000          00000000   00000122345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=317.32  Aligned_cols=255  Identities=26%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|++.+.||+|+||.||++.... +++.||+|++......           .......+.+|+.+++.++||||+++++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   68 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIK-----------KRKGEAMALNEKQILEKVNSRFVVSLAYA   68 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhh-----------hhhhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            37788999999999999998753 7899999998432111           11223567889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l  143 (285)
T cd05605          69 YETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRI  143 (285)
T ss_pred             ecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEE
Confidence            9999999999999999999998854  2335689999999999999999999955   4999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++.........   ....|+..|+|||++.+..++.++|||||||++|+|++|..||.....    ....+.+...
T Consensus       144 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~  216 (285)
T cd05605         144 SDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERR  216 (285)
T ss_pred             eeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHH
Confidence            999999876433221   134689999999999988899999999999999999999999875321    1111111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ......          ..+......+.+++..||+.||.+||     ++.++++
T Consensus       217 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         217 VKEDQE----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhhccc----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            111110          11112233478999999999999999     7878764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.4e-41  Score=313.67  Aligned_cols=262  Identities=19%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|++.+.||.|++|.||+|.+.+    .++..||+|.+....             .......+.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~i   71 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------------SMRERIEFLNEASVMKEFNCHHV   71 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------------CHHHHHHHHHHHHHHHhCCCCCe
Confidence            5679999999999999999997642    245789999873211             11224568899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      +++++++...+..++||||+++|+|.+++......      ...+++..+..++.|++.||.|||+   .+++|+||||+
T Consensus        72 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~  148 (277)
T cd05062          72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAAR  148 (277)
T ss_pred             eeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchh
Confidence            99999999999999999999999999998653211      2346788899999999999999995   45999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ||++++++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||..... 
T Consensus       149 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-  227 (277)
T cd05062         149 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-  227 (277)
T ss_pred             eEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            99999999999999999986654332222112345778999999998889999999999999999999 6888764321 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                         .   +..........+.          .+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       228 ---~---~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         228 ---E---QVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---H---HHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence               1   1111111111110          011122358899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-41  Score=317.89  Aligned_cols=265  Identities=20%  Similarity=0.231  Sum_probs=196.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|+||.||+|+... +|+.||||++......             .....+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~   69 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEEE-------------GTPFTAIREASLLKGLKHANIVLLH   69 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC-CCCEEEEEEecccccc-------------ccchhHHHHHHHHhhCCCCCcCeEE
Confidence            4679999999999999999998764 7899999998432111             1124567899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+. ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  142 (303)
T cd07869          70 DIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGEL  142 (303)
T ss_pred             EEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence            99999999999999996 588888753   335688999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......   ......+
T Consensus       143 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~  217 (303)
T cd07869         143 KLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERI  217 (303)
T ss_pred             EECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHH
Confidence            9999999875432211  11234689999999988764 5889999999999999999999998753221   1111111


Q ss_pred             HHHhcCCCC--------chhcccccc---CCCc-H------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENP--------NRAINSKLL---GNGY-E------EQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~--------~~~~~~~~~---~~~~-~------~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........        ...+.+...   .... .      .....+.+++..||+.||.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            111110000        000000000   0000 0      01134778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-41  Score=310.00  Aligned_cols=260  Identities=22%  Similarity=0.337  Sum_probs=204.8

Q ss_pred             ccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||.|+||.||+|.+...  +...||||.+....             .......+..|+.+++.++||||++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~   69 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------------SDKQRLDFLTEASIMGQFDHPNIIR   69 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------------ChHHHHHHHHHHHHHHhCCCCCcce
Confidence            35789999999999999999987532  34589999874321             1223467889999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++
T Consensus        70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~  143 (266)
T cd05033          70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNL  143 (266)
T ss_pred             EeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence            99999999999999999999999999854   23468999999999999999999995   4599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....    ..+..
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~  219 (266)
T cd05033         144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIK  219 (266)
T ss_pred             CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Confidence            999999999998753222222212345678999999999899999999999999999998 9999754321    12222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+....   ....          +......+.+++..||+.+|++||++.+|++.|+++
T Consensus       220 ~~~~~~---~~~~----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         220 AVEDGY---RLPP----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHcCC---CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222111   1100          111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.5e-41  Score=313.06  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=204.7

Q ss_pred             cccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ..|.+.+.||+|+||.||+|....    .++..||||.+.....             ......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i~   71 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-------------NDARKDFEREAELLTNFQHENIV   71 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-------------HHHHHHHHHHHHHHHhcCCCCch
Confidence            468889999999999999998642    2457899998843211             12356789999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVS----------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI  279 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  279 (430)
                      ++++++...+..++||||+++|+|.+++....          .....+++..+..++.|++.|+.|||+.   +++|+||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dl  148 (280)
T cd05049          72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDL  148 (280)
T ss_pred             heeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceecccc
Confidence            99999999999999999999999999996532          1234578999999999999999999954   5999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDF  358 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~  358 (430)
                      ||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       149 kp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             ccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322222223345788999999999999999999999999999998 99997543


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ..    ......+.    .+....         .+......+.+++..||+.||++||++.||++.|++
T Consensus       229 ~~----~~~~~~~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         229 SN----EEVIECIT----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CH----HHHHHHHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            21    12222222    111100         011122348899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-41  Score=332.17  Aligned_cols=256  Identities=22%  Similarity=0.300  Sum_probs=194.5

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|..++.||+|+||+||+|+... +++.||+|++.....           ........+.+|+.+++.++||||++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~   69 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDV-----------LNRNQVAHVKAERDILAEADNEWVVKLYYS   69 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEE
Confidence            58889999999999999998764 899999999843211           112335678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||..   +|+||||||+|||++.++.+||
T Consensus        70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL  142 (381)
T cd05626          70 FQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKL  142 (381)
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEE
Confidence            9999999999999999999999853    34689999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCC---------------------------------------------cceeeccccccccccccccCC
Q 014140          295 SEFGLAKRIPDGHT---------------------------------------------RTTTWSLAGTVGYIAPECHQT  329 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~  329 (430)
                      +|||++..+.....                                             ........||+.|+|||++.+
T Consensus       143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (381)
T cd05626         143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR  222 (381)
T ss_pred             eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence            99999764311000                                             000113469999999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHh--c
Q 014140          330 VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACF--C  407 (430)
Q Consensus       330 ~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c  407 (430)
                      ..++.++|||||||++|||++|..||......       .............. +.  .....+++    +.+++.+  |
T Consensus       223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~-~~--~~~~~s~~----~~dli~~ll~  288 (381)
T cd05626         223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT-------ETQLKVINWENTLH-IP--PQVKLSPE----AVDLITKLCC  288 (381)
T ss_pred             CCCCCccceeehhhHHHHHHhCCCCCcCCCHH-------HHHHHHHccccccC-CC--CCCCCCHH----HHHHHHHHcc
Confidence            89999999999999999999999998653221       11111111000000 00  00112222    5566655  5


Q ss_pred             ccCCCCCCCCHHHHHH
Q 014140          408 TLDDPNKRPNSKDVRC  423 (430)
Q Consensus       408 l~~dp~~Rps~~ev~~  423 (430)
                      +..+|..||++.+++.
T Consensus       289 ~~~~~~~R~~~~~~l~  304 (381)
T cd05626         289 SAEERLGRNGADDIKA  304 (381)
T ss_pred             CcccccCCCCHHHHhc
Confidence            6777778999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8e-41  Score=314.37  Aligned_cols=263  Identities=19%  Similarity=0.297  Sum_probs=204.9

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..+|.+.+.||.|+||+||++...    ..++..+|+|.+...              .......+.+|+.++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i   69 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------------SDNARKDFHREAELLTNLQHEHI   69 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------------CHHHHHHHHHHHHHHHhCCCCCc
Confidence            346889999999999999999752    224567899987321              11235678999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS---------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI  279 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  279 (430)
                      +++++++...+..++||||+++++|.+++....         .....+++..++.++.|++.||+|||+   .+++||||
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dl  146 (288)
T cd05093          70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDL  146 (288)
T ss_pred             ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccc
Confidence            999999999999999999999999999996432         122358999999999999999999994   45999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDF  358 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~  358 (430)
                      ||+||++++++.++|+|||++................++..|+|||++.+..++.++|||||||++++|++ |..||...
T Consensus       147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986643322222222345778999999998899999999999999999998 88887643


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..    .....   .........      .....    ...+.+++.+||+.+|.+|||+.++.+.|+++.
T Consensus       227 ~~----~~~~~---~i~~~~~~~------~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         227 SN----NEVIE---CITQGRVLQ------RPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             CH----HHHHH---HHHcCCcCC------CCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            22    11111   111111110      00111    234889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=332.60  Aligned_cols=255  Identities=23%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++......           .......+..|+.++..++||||+++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMI-----------KRNQIAHVRAERDILADADSPWIVKLYY   68 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHh-----------hccHHHHHHHHHHHHHhcCCCCccchhh
Confidence            368899999999999999998764 7999999998532111           1123567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~k  141 (350)
T cd05573          69 SFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIK  141 (350)
T ss_pred             heecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEE
Confidence            99999999999999999999999954    2568999999999999999999995   4599999999999999999999


Q ss_pred             EeecCCcccCCCCC---------------------------CcceeeccccccccccccccCCCCCCcchhHHHHHHHHH
Q 014140          294 ISEFGLAKRIPDGH---------------------------TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLA  346 (430)
Q Consensus       294 l~Dfg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~  346 (430)
                      |+|||++.......                           .........||+.|+|||++.+..++.++|||||||++|
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  221 (350)
T cd05573         142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY  221 (350)
T ss_pred             eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence            99999998765432                           001112356899999999999999999999999999999


Q ss_pred             HHHhCCCCCCccccccccccHHHHHHHHhcC-CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 014140          347 VLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS-ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-SKDVRC  423 (430)
Q Consensus       347 ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~ev~~  423 (430)
                      ||++|+.||.....       .......... .....  ..  ...    ....+.+++..|++ +|.+||+ +.++++
T Consensus       222 ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~--p~--~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         222 EMLYGFPPFYSDTL-------QETYNKIINWKESLRF--PP--DPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             hhccCCCCCCCCCH-------HHHHHHHhccCCcccC--CC--CCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            99999999865321       1111112110 00000  00  001    22347888999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.6e-41  Score=337.34  Aligned_cols=260  Identities=20%  Similarity=0.245  Sum_probs=205.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||+||+|+... +|+.||||.+......            ......+.+|+..+..++|+|++++
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~------------~~~~~~~~~Ei~~l~~~~h~~iv~~   96 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGMS------------EADKNRAQAEVCCLLNCDFFSIVKC   96 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccCC------------HHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            34689999999999999999998764 8999999998443211            2235678899999999999999999


Q ss_pred             eeEEEeCC--------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          212 LARMVRRD--------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       212 ~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      +..+...+        ..++||||+++|+|.+++.........+++..+..++.|++.||.|||   +.+|+||||||+|
T Consensus        97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~N  173 (496)
T PTZ00283         97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSAN  173 (496)
T ss_pred             ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHH
Confidence            88775432        367999999999999999764445567999999999999999999999   4559999999999


Q ss_pred             EEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ||++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....    
T Consensus       174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----  249 (496)
T PTZ00283        174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----  249 (496)
T ss_pred             EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----
Confidence            9999999999999999987654333223334679999999999999999999999999999999999999986421    


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                         ....+..........          .+......+.+++..||+.+|.+||++.++++.
T Consensus       250 ---~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        250 ---MEEVMHKTLAGRYDP----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ---HHHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence               222222222211110          111122348899999999999999999998763

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.1e-41  Score=316.81  Aligned_cols=262  Identities=20%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             cccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .+|.+.+.||.|+||.||+|+...    .++..+++|.+....              ......+.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~   70 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------------LAARKDFQREAELLTNLQHEHIV   70 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------------HHHHHHHHHHHHHHhcCCCCCcc
Confidence            458888999999999999997532    245678888873211              12246688999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      ++++++...+..++||||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~  147 (291)
T cd05094          71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHR  147 (291)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            999999999999999999999999999965321            124589999999999999999999944   59999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986644332222223456788999999999899999999999999999999 999975


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....    ....+.   .. .+....         .+...+..+.+++.+||+.+|++||++.+|+++|+++.
T Consensus       228 ~~~~----~~~~~~---~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         228 QLSN----TEVIEC---IT-QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             CCCH----HHHHHH---Hh-CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            4322    112221   11 111110         01112334889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-42  Score=332.26  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=197.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|+... +|+.||||++.....           ........+.+|+.++..++||||+++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~h~~iv~~~~   68 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEM-----------LEKEQVAHVRAERDILAEADNPWVVKLYY   68 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceEE
Confidence            368899999999999999999764 799999999853211           11123466889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+++..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  141 (364)
T cd05599          69 SFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIK  141 (364)
T ss_pred             EEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEE
Confidence            99999999999999999999999853    34689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcc------------------------------------eeeccccccccccccccCCCCCCcchh
Q 014140          294 ISEFGLAKRIPDGHTRT------------------------------------TTWSLAGTVGYIAPECHQTVALSDTCD  337 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  337 (430)
                      |+|||++..+.......                                    ......||+.|+|||++.+..++.++|
T Consensus       142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  221 (364)
T cd05599         142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD  221 (364)
T ss_pred             EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence            99999987653221100                                    001246999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC
Q 014140          338 IYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN  417 (430)
Q Consensus       338 v~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps  417 (430)
                      ||||||++|||++|..||.....       .+........... ..+...  ...    ...+.+++..|+. +|.+|++
T Consensus       222 iwSlG~il~el~~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~~~--~~~----s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFCSDNP-------QETYRKIINWKET-LQFPDE--VPL----SPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             eecchhHHHHhhcCCCCCCCCCH-------HHHHHHHHcCCCc-cCCCCC--CCC----CHHHHHHHHHHcc-CHhhcCC
Confidence            99999999999999999865322       1112222211100 000000  011    2246778888886 9999998


Q ss_pred             ---HHHHHH
Q 014140          418 ---SKDVRC  423 (430)
Q Consensus       418 ---~~ev~~  423 (430)
                         +.++++
T Consensus       287 ~~~~~~ll~  295 (364)
T cd05599         287 NNGVNEIKS  295 (364)
T ss_pred             CCCHHHHhc
Confidence               877765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-41  Score=324.06  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=193.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|+||.||+|.... +|..||||++......            ......+.+|+.+++.++||||++++++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~   67 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVFEH------------VSDATRILREIKLLRLLRHPDIVEIKHI   67 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhhcc------------chhHHHHHHHHHHHHhCCCCCEeeecce
Confidence            47888999999999999998764 8999999998432111            1124568899999999999999999998


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          215 MVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       215 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +...+     ..|+|||||. ++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        68 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~  139 (338)
T cd07859          68 MLPPSRREFKDIYVVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANAD  139 (338)
T ss_pred             EeccCCCCCceEEEEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC
Confidence            86533     4799999995 68999884    344689999999999999999999955   49999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCc-ceeeccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.+||+|||+++........ .......||..|+|||++.+  ..++.++|||||||++|+|++|+.||.....    ..
T Consensus       140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~~  215 (338)
T cd07859         140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VH  215 (338)
T ss_pred             CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----HH
Confidence            99999999999865432221 11123578999999999876  5789999999999999999999999864321    11


Q ss_pred             HHHHHHHHhcCCCC-----------chhc---ccc---ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENP-----------NRAI---NSK---LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~-----------~~~~---~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+.........           ...+   ...   ......+.....+.+++.+||+.||++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            11111111100000           0000   000   000000111234789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-41  Score=327.95  Aligned_cols=205  Identities=25%  Similarity=0.360  Sum_probs=174.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|.... +|+.||+|++.....           ........+..|+.++..++||||+++++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~il~~~~~~~iv~~~~   68 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADM-----------LEKEQVGHIRAERDILVEADSLWVVKMFY   68 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHH-----------HHhhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            468899999999999999998764 799999999843211           11223467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vk  141 (363)
T cd05628          69 SFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVK  141 (363)
T ss_pred             EEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEE
Confidence            99999999999999999999999953    35689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCc---------------------------------ceeeccccccccccccccCCCCCCcchhHHH
Q 014140          294 ISEFGLAKRIPDGHTR---------------------------------TTTWSLAGTVGYIAPECHQTVALSDTCDIYS  340 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  340 (430)
                      |+|||+++.+......                                 .......||+.|+|||++.+..++.++||||
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS  221 (363)
T cd05628         142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (363)
T ss_pred             EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence            9999998765321100                                 0012357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCc
Q 014140          341 FGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       341 lG~~l~ell~g~~p~~~  357 (430)
                      |||++|||++|..||..
T Consensus       222 lGvil~ell~G~~Pf~~  238 (363)
T cd05628         222 LGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             hHHHHHHHHhCCCCCCC
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-41  Score=334.76  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=193.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||+|+||.||+|.... +++.||||++....                  ....+|+.+|+.++||||++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~------------------~~~~~Ei~il~~l~h~niv~l~  125 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDP------------------QYKNRELLIMKNLNHINIIFLK  125 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecCc------------------chHHHHHHHHHhcCCCCCccee
Confidence            4679999999999999999998764 78999999884311                  1234699999999999999999


Q ss_pred             eEEEeC--------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          213 ARMVRR--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       213 ~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++...        ..+++||||+++ +|.+++.........+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus       126 ~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NI  201 (440)
T PTZ00036        126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL  201 (440)
T ss_pred             eeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHE
Confidence            987542        246789999975 888887654445667999999999999999999999554   99999999999


Q ss_pred             EeCCCC-ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 014140          285 LIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT  362 (430)
Q Consensus       285 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~  362 (430)
                      |++.++ .+||+|||+++.+......   ....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... 
T Consensus       202 Ll~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-  277 (440)
T PTZ00036        202 LIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-  277 (440)
T ss_pred             EEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence            999665 6999999999876543222   134689999999998764 6899999999999999999999998653221 


Q ss_pred             ccccHHHHHHHHhcCCCCc---------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          363 KEMSLVQWMRNVMTSENPN---------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ..+.. +..........               ......+....+......+.+|+.+||+.||.+|||+.++++
T Consensus       278 --~~~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        278 --DQLVR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             --HHHHH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence              11111 11111110000               000000000011112345889999999999999999999874

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-41  Score=305.01  Aligned_cols=268  Identities=22%  Similarity=0.238  Sum_probs=203.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC-cccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN-IVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~  212 (430)
                      ..|..+++||+|+||+||+|+... +|+.||+|++.-....+            -......+|+.+|+.|+|+| |+.++
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~E------------G~P~taiREisllk~L~~~~~iv~L~   77 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEEE------------GVPSTAIREISLLKRLSHANHIVRLH   77 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec-CCCEEEEEEEecccccc------------CCCchhhHHHHHHHHhCCCcceEEEE
Confidence            357788999999999999999875 89999999996543321            01345788999999999999 99999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+      .+++|+||++. +|..++.........++...+..++.|++.||+|||+.+   |+||||||.|||+
T Consensus        78 dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi  153 (323)
T KOG0594|consen   78 DVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLI  153 (323)
T ss_pred             eeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEE
Confidence            9999877      78999999976 999999654332246788999999999999999999555   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +++|.+||+|||+|+...-...  .....++|.+|.|||++.|. .|+...||||+||+++||++++.-|.+...    .
T Consensus       154 ~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~  227 (323)
T KOG0594|consen  154 SSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----I  227 (323)
T ss_pred             CCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----H
Confidence            9999999999999996653222  12245789999999999988 689999999999999999999877665332    2


Q ss_pred             cHHHHHHHHhcCCCCc----h----hccccccCC-----CcH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          366 SLVQWMRNVMTSENPN----R----AINSKLLGN-----GYE---EQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~----~----~~~~~~~~~-----~~~---~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      +....+-..+..+...    .    .........     ...   .......+++.+||+.+|.+|.|+...++.
T Consensus       228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            2222222332222110    0    000000000     001   111358899999999999999999999875

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.4e-41  Score=323.69  Aligned_cols=250  Identities=26%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|...+.||.|+||.||+|++.. +|+.||||.+....             .......+.+|+.+++.++||||+++++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~  139 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNH-------------EDTVRRQICREIEILRDVNHPNVVKCHD  139 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCC-------------cHHHHHHHHHHHHHHHhCCCCCcceeee
Confidence            467888999999999999998764 78999999984321             1123567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++|+|.+..        ...+.....++.|++.||.|||+.   +++||||||+|||+++++.+|
T Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  208 (353)
T PLN00034        140 MFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK  208 (353)
T ss_pred             EeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence            999999999999999999986532        356777889999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |+|||++..+......  .....||..|+|||++...     ..+.++|||||||++|||++|+.||.....    ....
T Consensus       209 L~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~  282 (353)
T PLN00034        209 IADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWA  282 (353)
T ss_pred             Ecccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHH
Confidence            9999999876433211  1235789999999987532     345689999999999999999999873211    1122


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ...........+.          ........+.+++..||+.||++||++.|+++.
T Consensus       283 ~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        283 SLMCAICMSQPPE----------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHhccCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2111111111110          111122348899999999999999999999863

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-40  Score=314.47  Aligned_cols=269  Identities=18%  Similarity=0.269  Sum_probs=201.6

Q ss_pred             ccccccccccccccCceEEEeecC---------------CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP---------------GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI  197 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  197 (430)
                      .++|++.+.||.|+||.||++...               ..++..+|+|++....             .......+.+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------------~~~~~~~~~~E~   70 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------------NKNARNDFLKEI   70 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------------CHHHHHHHHHHH
Confidence            356899999999999999998632               1234578999884321             112346789999


Q ss_pred             HHHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG-------RRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       198 ~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      .+++.++||||+++++++...+..++||||+++|+|.+++......       ...+++..+..++.|++.||+|||+.+
T Consensus        71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  150 (296)
T cd05095          71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN  150 (296)
T ss_pred             HHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999999999999999999653211       134788899999999999999999554


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                         ++|+||||+|||++.++.++|+|||++..+.............++..|+|||+..++.++.++|||||||++|||++
T Consensus       151 ---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~  227 (296)
T cd05095         151 ---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT  227 (296)
T ss_pred             ---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence               99999999999999999999999999987644322221112334678999999888889999999999999999998


Q ss_pred             --CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          351 --GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       351 --g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                        |..||.....    ....................      ..+..+...+.+++.+||+.||.+||++.+|++.|++
T Consensus       228 ~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         228 LCKEQPYSQLSD----EQVIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hCCCCCccccCh----HHHHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              6678754322    11111111111111000000      0011122458899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.5e-41  Score=314.14  Aligned_cols=272  Identities=23%  Similarity=0.285  Sum_probs=200.0

Q ss_pred             cccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          136 FASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      |...+.||.|+||+||++..   ...++..||+|.+.....             ......+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------------QQNTSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            48889999999999988653   223788999998843211             12246688999999999999999999


Q ss_pred             eEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          213 ARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       213 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++...  ...++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||||+||++++++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~  144 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR  144 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCC
Confidence            988764  457899999999999999843     3489999999999999999999955   599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++|+|||++........... .....++..|+|||.+.+..++.++||||||+++++|++|..|+.......  .....
T Consensus       145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~  222 (283)
T cd05080         145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIG  222 (283)
T ss_pred             cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhc
Confidence            999999999987654322111 112345667999999998889999999999999999999999975432100  00000


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                      ...............+.......+...+..+.+++..||+.+|++|||+.+|++.|+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~  283 (283)
T cd05080         223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH  283 (283)
T ss_pred             ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence            0000000000000000000111112233458899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.2e-41  Score=321.48  Aligned_cols=248  Identities=21%  Similarity=0.248  Sum_probs=191.5

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||+|.+......           .......+..|+.++.++ +||||+++++++...
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~   68 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVN-----------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   68 (329)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhc-----------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC
Confidence            468999999999998764 8899999998542211           112345678899988877 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|..++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        69 ~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          69 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999988843    35689999999999999999999955   49999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-ccccHHHHHHHHhcC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT-KEMSLVQWMRNVMTS  377 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~l~~~~~~~~~~  377 (430)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......++......
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~  219 (329)
T cd05618         142 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             ccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence            9875432211  1123578999999999999999999999999999999999999986432211 111222222222211


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ....          .+......+.+++.+||+.||.+||++
T Consensus       220 ~~~~----------~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         220 KQIR----------IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCC----------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1110          111122347899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.2e-41  Score=313.46  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=202.2

Q ss_pred             cccccccccccccCceEEEeecC---CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ..|++.+.||+|+||.||+|.+.   ..++..+++|.+....             .......+.+|+.+++.++||||++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~niv~   71 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------------NPQQWGEFQQEASLMAELHHPNIVC   71 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------------CHHHHHHHHHHHHHHhhCCCCCeee
Confidence            35788899999999999999852   2256789999884211             1123467889999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      +++++...+..++||||+++|+|.+++.....             ....+++.....++.|++.||.|||+.   +++|+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~  148 (283)
T cd05090          72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHK  148 (283)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehh
Confidence            99999999999999999999999999853211             123578899999999999999999955   59999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+|||+++++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999987654332222223446778999999998889999999999999999998 888875


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ....    ..+.+.+..   ...+.      ....    ....+.+++..||+.+|++||++.+|.+.|..
T Consensus       229 ~~~~----~~~~~~~~~---~~~~~------~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         229 GFSN----QEVIEMVRK---RQLLP------CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCH----HHHHHHHHc---CCcCC------CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            4321    122222211   11110      0011    22347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=331.92  Aligned_cols=256  Identities=20%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|+... +|+.||||++.....           ........+.+|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~hp~iv~~~~   68 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEM-----------FKKDQLAHVKAERDVLAESDSPWVVSLYY   68 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHH-----------HHhHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            368899999999999999998764 899999999843211           11233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~k  141 (377)
T cd05629          69 SFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIK  141 (377)
T ss_pred             EEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999853    35689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCc------------c---------------------------------eeeccccccccccccccC
Q 014140          294 ISEFGLAKRIPDGHTR------------T---------------------------------TTWSLAGTVGYIAPECHQ  328 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~  328 (430)
                      |+|||+++.+......            .                                 ......||+.|+|||++.
T Consensus       142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  221 (377)
T cd05629         142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL  221 (377)
T ss_pred             EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence            9999999643211000            0                                 001246999999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcc
Q 014140          329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCT  408 (430)
Q Consensus       329 ~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  408 (430)
                      +..++.++|||||||++|||++|..||.....       .+............. + +.     .......+.+++..||
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~-~-p~-----~~~~s~~~~dli~~lL  287 (377)
T cd05629         222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENS-------HETYRKIINWRETLY-F-PD-----DIHLSVEAEDLIRRLI  287 (377)
T ss_pred             cCCCCCceeeEecchhhhhhhcCCCCCCCCCH-------HHHHHHHHccCCccC-C-CC-----CCCCCHHHHHHHHHHh
Confidence            98999999999999999999999999864321       111111111100000 0 00     0011234778888899


Q ss_pred             cCCCCCC---CCHHHHHH
Q 014140          409 LDDPNKR---PNSKDVRC  423 (430)
Q Consensus       409 ~~dp~~R---ps~~ev~~  423 (430)
                      . +|.+|   |++.++++
T Consensus       288 ~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         288 T-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             c-CHhhcCCCCCHHHHhc
Confidence            7 66665   58888775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.5e-41  Score=319.14  Aligned_cols=248  Identities=22%  Similarity=0.269  Sum_probs=191.6

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHH---hccCCCCcccce
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITA---GQVRHRNIVPLL  212 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~l~  212 (430)
                      |.+.+.||+|+||.||+|.... +|+.||||++......           .......+..|..++   +.++||||++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~   68 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDII-----------ARDEVESLMCEKRIFETANSERHPFLVNLF   68 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhccccCCCChhcee
Confidence            5678999999999999998764 8999999998542211           112234566666554   567899999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..|+||||+++|+|...+.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~  140 (324)
T cd05589          69 ACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFV  140 (324)
T ss_pred             eEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcE
Confidence            99999999999999999999998873     24689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+...
T Consensus       141 kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~  211 (324)
T cd05589         141 KIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFD  211 (324)
T ss_pred             EeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            9999999875432221  11235789999999999999999999999999999999999999864321       11122


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      ........           .+......+.+++.+||+.||.+||+     +.++++
T Consensus       212 ~i~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         212 SIVNDEVR-----------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHhCCCC-----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            22211110           01111234788999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5e-41  Score=320.39  Aligned_cols=240  Identities=24%  Similarity=0.266  Sum_probs=189.4

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||||.+.....           ........+..|..++..+ +||||+++++++...
T Consensus         1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   68 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVI-----------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP   68 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHH-----------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC
Confidence            368999999999998764 789999999853211           1112245677888888877 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||
T Consensus        69 ~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          69 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             CEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            999999999999999998853    34689999999999999999999954   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       .+.........
T Consensus       142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~  212 (320)
T cd05590         142 MCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE  212 (320)
T ss_pred             CCeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC
Confidence            98764322211  2235789999999999998999999999999999999999999864321       11222222211


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ...           +......+.+++..||+.||.+||++
T Consensus       213 ~~~-----------~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 VVY-----------PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCC-----------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            110           01112347889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.3e-41  Score=320.12  Aligned_cols=248  Identities=22%  Similarity=0.252  Sum_probs=191.9

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||+|.+......           .......+..|..++..+ +||||+++++++.+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~-----------~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~   68 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVN-----------DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE   68 (329)
T ss_pred             CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC
Confidence            368999999999998764 8899999998542211           122346688899999998 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          69 SRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            999999999999999988843    35699999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-ccccHHHHHHHHhcC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT-KEMSLVQWMRNVMTS  377 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~l~~~~~~~~~~  377 (430)
                      ++........  ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||+...... .......+.......
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  219 (329)
T cd05588         142 MCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             cccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence            9875322111  1223578999999999999999999999999999999999999996422111 111222233222222


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ....  +        +......+.+++..||+.||.+||++
T Consensus       220 ~~~~--~--------p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         220 KQIR--I--------PRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCC--C--------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2111  0        01112347889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.5e-41  Score=316.30  Aligned_cols=262  Identities=21%  Similarity=0.264  Sum_probs=203.9

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||.|+||.||+|...    ..++..+|+|.+.....             ......+.+|+.+++++ +|||
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~~  100 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------------SSEREALMSELKIMSHLGNHEN  100 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------------hHHHHHHHHHHHHHHhccCCCC
Confidence            457899999999999999999742    22556899998743211             12246789999999999 7999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      |+++++++...+..++||||+++|+|.++++.  .....+++..+..++.+++.||.|||+.   +++|+||||+||+++
T Consensus       101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~  175 (302)
T cd05055         101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLT  175 (302)
T ss_pred             cceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEc
Confidence            99999999999999999999999999999964  2233489999999999999999999955   599999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMS  366 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~  366 (430)
                      .++.++++|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....   ...
T Consensus       176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~~  252 (302)
T cd05055         176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DSK  252 (302)
T ss_pred             CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hHH
Confidence            999999999999987654332222222346788999999999899999999999999999998 9999764321   111


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +.....    .+....         .+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       253 ~~~~~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         253 FYKLIK----EGYRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111111    111000         0011123488999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.1e-41  Score=322.68  Aligned_cols=246  Identities=20%  Similarity=0.256  Sum_probs=193.2

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|+||.||++.... +|..||+|.+......           .......+..|+.++..++||||+++++++...+
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~   68 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIV-----------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD   68 (325)
T ss_pred             CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC
Confidence            368999999999998764 8999999998532111           1123466788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+
T Consensus        69 ~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~  142 (325)
T cd05594          69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGL  142 (325)
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCC
Confidence            99999999999999998843    45689999999999999999999952  3599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN  379 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  379 (430)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       ............
T Consensus       143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~  213 (325)
T cd05594         143 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI  213 (325)
T ss_pred             CeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCC
Confidence            875432211  11235699999999999998999999999999999999999999864211       111111111110


Q ss_pred             CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .       .....    ...+.+++..||+.||.+|+     ++.++++
T Consensus       214 ~-------~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         214 R-------FPRTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             C-------CCCCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            0       00111    23478899999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.4e-41  Score=312.43  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=193.0

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||+|+||.||+++... +|+.||+|.+......           .......+..|+.+++.++||||+++++++......
T Consensus         1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~-----------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~   68 (277)
T cd05607           1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLK-----------KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL   68 (277)
T ss_pred             CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhh-----------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence            6999999999998764 7999999998432110           011123456799999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        69 ~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~  143 (277)
T cd05607          69 CLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAV  143 (277)
T ss_pred             EEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeee
Confidence            999999999999998854  233458899999999999999999995   459999999999999999999999999988


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      .......   .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......   ................
T Consensus       144 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  217 (277)
T cd05607         144 ELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDEVKF  217 (277)
T ss_pred             ecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhcccccc
Confidence            7654322   123468999999999999899999999999999999999999986532211   1112222222111000


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                         .   ..    .....+.+++..||+.||.+||++.|+++.
T Consensus       218 ---~---~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         218 ---E---HQ----NFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ---c---cc----cCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence               0   01    122347899999999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-40  Score=307.42  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=199.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|++|.||+|...  ++..+|+|.+.....               ....+.+|+.++.+++||||+++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~   66 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM---------------SEDEFIEEAKVMMKLSHEKLVQLYG   66 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCcc---------------cHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            46788899999999999999875  556799998743211               1356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+.+|+|.+++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~k  140 (256)
T cd05113          67 VCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK  140 (256)
T ss_pred             EEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEE
Confidence            99999999999999999999999854   23368999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....    ......  
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~--  213 (256)
T cd05113         141 VSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEK--  213 (256)
T ss_pred             ECCCccceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH--
Confidence            99999988664432211 112345678999999998889999999999999999998 9999764321    112221  


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                       .........   +   ..    ....+.+++..||+.+|.+||++.+|++.|+
T Consensus       214 -~~~~~~~~~---~---~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 -VSQGLRLYR---P---HL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -HhcCCCCCC---C---CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             221111100   0   01    1245889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.6e-41  Score=327.38  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=203.8

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp  206 (430)
                      +.++|.+.+.||+|+||.||+|++.+    ..+..||+|++.....             ......+.+|+.+|.++. ||
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~E~~~l~~l~~H~  101 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------------SSEKQALMSELKIMSHLGPHL  101 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------------hhHHHHHHHHHHHHHhcCCCC
Confidence            45678889999999999999998642    2457899999953211             112356889999999997 99


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------------------------------------
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------------------------------------  242 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------  242 (430)
                      ||++++++|...+..++||||+++|+|.++++....                                            
T Consensus       102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (401)
T cd05107         102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM  181 (401)
T ss_pred             CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence            999999999999999999999999999999964211                                            


Q ss_pred             --------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          243 --------------------------------------------------GRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       243 --------------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                                                                        ....+++...+.++.|++.||.|||   ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~  258 (401)
T cd05107         182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SK  258 (401)
T ss_pred             CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cC
Confidence                                                              1124677888999999999999999   55


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-C
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-G  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g  351 (430)
                      +++||||||+|||+++++.++|+|||+++...............++..|+|||++.+..++.++||||||++++||++ |
T Consensus       259 ~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g  338 (401)
T cd05107         259 NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG  338 (401)
T ss_pred             CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence            599999999999999999999999999986543322111122356788999999998889999999999999999998 8


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..||.....   ...+...   ......+.          .+......+.+++..||+.+|.+||++.+|++.|+++
T Consensus       339 ~~P~~~~~~---~~~~~~~---~~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         339 GTPYPELPM---NEQFYNA---IKRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCCCCCCc---hHHHHHH---HHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            889764321   0011111   11111110          0111224588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.4e-41  Score=314.62  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=202.9

Q ss_pred             ccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .|.+.+.||.|+||.||+|...+    ..+..||+|++....             .......+..|+.++..++||||++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~~~~l~h~~iv~   72 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------------EGPLREEFKHEAMMRSRLQHPNIVC   72 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------------CHHHHHHHHHHHHHHhcCCCCCcCe
Confidence            57888999999999999998642    235789999984321             1123467889999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      +++++...+..++++||+++++|.+++....            .....+++..+..++.|++.||.|||+.   +++|||
T Consensus        73 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~d  149 (283)
T cd05091          73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKD  149 (283)
T ss_pred             EEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            9999999999999999999999999985311            1124588899999999999999999944   599999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDD  357 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~  357 (430)
                      |||+||++++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         150 LATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             cchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999887654333222223456789999999988889999999999999999998 7888764


Q ss_pred             cccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ...       .+...........          ..+......+.+++..||+.+|.+||++.+|+..|+.
T Consensus       230 ~~~-------~~~~~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         230 YSN-------QDVIEMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCH-------HHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            321       1222222221111          0111223448899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-40  Score=311.61  Aligned_cols=261  Identities=23%  Similarity=0.307  Sum_probs=201.7

Q ss_pred             ccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      +|.+.+.||+|+||.||+|....    .....+++|.+....             .......+.+|+.+++.++||||++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~   67 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------------SSSELRDLLSEFNLLKQVNHPHVIK   67 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------------CHHHHHHHHHHHHHHhhCCCCCEee
Confidence            36788999999999999998642    123578888774321             1122467889999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------------GRRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      +++.|...+..++|+||+++|+|.+++.....                    ....+++..++.++.|++.||.|||+. 
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-  146 (290)
T cd05045          68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-  146 (290)
T ss_pred             EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-
Confidence            99999999999999999999999999864211                    123588999999999999999999954 


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                        +++||||||+|||+++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++++|++
T Consensus       147 --~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t  224 (290)
T cd05045         147 --KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             --CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence              599999999999999999999999999986643322211222345678999999988889999999999999999998


Q ss_pred             -CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          351 -GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       351 -g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                       |..||....+    ..+.+.........             .+......+.+++..||+.+|.+||++.++++.|+++
T Consensus       225 ~g~~p~~~~~~----~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         225 LGGNPYPGIAP----ERLFNLLKTGYRME-------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             cCCCCCCCCCH----HHHHHHHhCCCCCC-------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence             9999864321    12222222111110             0111223488999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.4e-41  Score=319.46  Aligned_cols=245  Identities=21%  Similarity=0.267  Sum_probs=192.0

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +|+.||+|++.....           ........+..|..++..+ +||||+++++++...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~   68 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVI-----------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK   68 (321)
T ss_pred             CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHh-----------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence            368999999999998764 789999999843211           1112345677889988876 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..|+||||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          69 DRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             CeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            999999999999999998853    34689999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       ...........
T Consensus       142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~  212 (321)
T cd05591         142 MCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDD  212 (321)
T ss_pred             cceecccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence            98764322221  1235689999999999998999999999999999999999999864321       11222222221


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-------NSKDVRC  423 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-------s~~ev~~  423 (430)
                      ...           +......+.+++..||+.||++||       ++.++++
T Consensus       213 ~~~-----------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 VLY-----------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCC-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            110           001123478899999999999999       6776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-40  Score=318.45  Aligned_cols=245  Identities=24%  Similarity=0.251  Sum_probs=192.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC-Cccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR-NIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~  213 (430)
                      +|.+.+.||+|+||.||+|+... +++.||||++......           .......+..|..++..+.|+ +|+++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~   68 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVII-----------QDDDVECTMVEKRVLALPGKPPFLTQLHS   68 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhcCCCCceeeeEE
Confidence            47889999999999999998764 7889999998542111           112346688899999999765 5888999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  141 (324)
T cd05587          69 CFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIK  141 (324)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEE
Confidence            99999999999999999999999843    34689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    ...   ...
T Consensus       142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~---~~~  212 (324)
T cd05587         142 IADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DEL---FQS  212 (324)
T ss_pred             EeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH---HHH
Confidence            999999875432211  12235799999999999999999999999999999999999999864321    111   112


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      .......       .    +......+.+++..||+.||.+||+.
T Consensus       213 i~~~~~~-------~----~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         213 IMEHNVS-------Y----PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHcCCCC-------C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2211100       0    01112347889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-40  Score=307.14  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=205.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|+||.||+|...  ++..+++|.+.....              .....+..|+.+++.++||||++++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~   68 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDDL--------------LKQQDFQKEVQALKRLRHKHLISLF   68 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccch--------------hhHHHHHHHHHHHhcCCCcchhhee
Confidence            456899999999999999999886  589999998843211              1245688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~  143 (261)
T cd05148          69 AVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVC  143 (261)
T ss_pred             eeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceE
Confidence            999999999999999999999999965  234568999999999999999999994   459999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||.+...........  ...++..|+|||++.+..++.++||||||+++++|++ |+.||.....    ......+
T Consensus       144 kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~  217 (261)
T cd05148         144 KVADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQI  217 (261)
T ss_pred             EEccccchhhcCCcccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH
Confidence            9999999987644322111  2346778999999988889999999999999999998 8999864321    1122222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .   .....          ..+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       218 ~---~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         218 T---AGYRM----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             H---hCCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1   11111          01112223488999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-40  Score=313.07  Aligned_cols=269  Identities=17%  Similarity=0.268  Sum_probs=205.7

Q ss_pred             ccccccccccccccCceEEEeecCCC---------------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS---------------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI  197 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  197 (430)
                      .++|.+.+.||+|+||.||+|.....               .+..||+|.+.....             ......+.+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~~e~   70 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------------DNAREDFLKEV   70 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------------HHHHHHHHHHH
Confidence            35789999999999999999986532               224589998743211             13357789999


Q ss_pred             HHHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-------GRRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       198 ~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      .++++++|||++++++++..++..++||||+++++|.+++.....       ....+++..++.++.|++.||.|||+. 
T Consensus        71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-  149 (296)
T cd05051          71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-  149 (296)
T ss_pred             HHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-
Confidence            999999999999999999999999999999999999999965321       123689999999999999999999955 


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                        +++|+||||+||++++++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++
T Consensus       150 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  227 (296)
T cd05051         150 --NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT  227 (296)
T ss_pred             --CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence              499999999999999999999999999987654433333334456789999999998889999999999999999998


Q ss_pred             --CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          351 --GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       351 --g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                        |..||....    ......................      .+...+..+.+++..||+.+|.+|||+.+|++.|++
T Consensus       228 ~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         228 LCREQPYEHLT----DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cCCCCCCCCcC----hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              667765432    1122222222211111111111      111122458999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.7e-41  Score=320.93  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=197.0

Q ss_pred             ccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      +|.+.+.||+|+||.||+++..  ..+|+.||+|++......          ........+..|+.++..+ +||||+++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~~i~~~   70 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----------QKAKTVEHTRTERNVLEHVRQSPFLVTL   70 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----------hhhhHHHHHHHHHHHHHhccCCCCcccE
Confidence            4788999999999999998753  236899999998532111          1112346688999999999 59999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~  143 (332)
T cd05614          71 HYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGH  143 (332)
T ss_pred             EEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCC
Confidence            9999999999999999999999999853    34689999999999999999999955   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++.......... .....||..|+|||++.+. .++.++|||||||++|||++|..||........   ....
T Consensus       144 ~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~  219 (332)
T cd05614         144 VVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEV  219 (332)
T ss_pred             EEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHH
Confidence            9999999998654332221 2245799999999998875 478899999999999999999999864322111   1111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ..........       .    +......+.+++..||+.||++||     ++.++++
T Consensus       220 ~~~~~~~~~~-------~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         220 SRRILKCDPP-------F----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHhcCCCC-------C----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1222211111       1    111223478899999999999999     6667654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=306.98  Aligned_cols=261  Identities=20%  Similarity=0.313  Sum_probs=201.8

Q ss_pred             cccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          136 FASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      |.+.+.||+|+||.||+|.+...  .+..||+|++.....            .......+.+|+..++.++||||+++++
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~   68 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------------TYSEIEEFLSEAACMKDFDHPNVMKLIG   68 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------------CHHHHHHHHHHHHHHHhCCCCCeeeEEe
Confidence            46778999999999999987532  347899999843211            1233567899999999999999999999


Q ss_pred             EEEeCCe------eEEEEEecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          214 RMVRRDC------DLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       214 ~~~~~~~------~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++...+.      .++|+||+++|+|..++....  .....+++.....++.|++.||.|||+.   +++|+||||+||+
T Consensus        69 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil  145 (273)
T cd05035          69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCM  145 (273)
T ss_pred             eeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEE
Confidence            9876554      789999999999999986532  1234689999999999999999999955   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~  364 (430)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----  221 (273)
T cd05035         146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----  221 (273)
T ss_pred             ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            99999999999999987654433222212335678999999988889999999999999999999 8888754321    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.+.   ......+.          .+......+.+++.+||+.||.+||++.++++.|+++
T Consensus       222 ~~~~~~---~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         222 HEIYDY---LRHGNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHH---HHcCCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            122222   22111110          1112234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=306.33  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|.+.+.||.|+||.||+|.+.  ++..+|+|.+......               ...+.+|+.+++.++||||+++++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMS---------------EDDFIEEAKVMMKLSHPNLVQLYG   66 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEEEEEE
Confidence            35788999999999999999875  6678999987432111               346788999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05059          67 VCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVK  140 (256)
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEE
Confidence            99999999999999999999999854   234689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+++.......... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.....    ......  
T Consensus       141 l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~--  213 (256)
T cd05059         141 VSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVVES--  213 (256)
T ss_pred             ECCcccceeccccccccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH--
Confidence            999999987643322111 11234567999999999899999999999999999999 7899864321    112221  


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                       ......+.          .+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       214 -~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         214 -VSAGYRLY----------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -HHcCCcCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             11111110          00112335889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-40  Score=316.66  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=188.5

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||+|.+......           .......+..|..++..+ +||||+++++++...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~   68 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVL-----------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK   68 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence            368999999999999764 7899999998542211           111234456666676654 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          69 EHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            999999999999999998843    34689999999999999999999954   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|..||.....       .+........ 
T Consensus       142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~-  211 (316)
T cd05592         142 MCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILND-  211 (316)
T ss_pred             CCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC-
Confidence            9986543322  12235789999999999998999999999999999999999999864321       1111122111 


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK-DVR  422 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~-ev~  422 (430)
                      .+.          .+......+.+++..||+.+|.+||++. +++
T Consensus       212 ~~~----------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 RPH----------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            110          0111123477899999999999999975 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-40  Score=317.52  Aligned_cols=247  Identities=20%  Similarity=0.251  Sum_probs=193.3

Q ss_pred             cccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||+|+||.||+++..  ..+++.||+|.+......          ........+.+|+.+|+.++||||+++++++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~   71 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----------RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT   71 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----------hhhhhHHHHHHHHHHHHhCCCCchhceeeEEec
Confidence            67999999999999753  236889999998532110          011224567899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ++..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  144 (323)
T cd05584          72 GGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDF  144 (323)
T ss_pred             CCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeC
Confidence            9999999999999999999843    35688889999999999999999955   5999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcC
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      |+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ..........
T Consensus       145 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~  215 (323)
T cd05584         145 GLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKG  215 (323)
T ss_pred             cCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC
Confidence            998754332221  1235689999999999998899999999999999999999999864321       1122222221


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ...   +        +......+.+++.+||+.+|++||     ++.++++
T Consensus       216 ~~~---~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 KLN---L--------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCC---C--------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            110   0        111123478999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-40  Score=316.88  Aligned_cols=245  Identities=23%  Similarity=0.275  Sum_probs=192.6

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||+||+|.+.. ++..||||.+.....           ........+..|..++..+ +||||+++++++...
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~   68 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVI-----------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK   68 (318)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHH-----------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence            368999999999998764 789999999854211           1112245677888999888 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||
T Consensus        69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          69 DRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            999999999999999998843    34699999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       ...........
T Consensus       142 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~  212 (318)
T cd05570         142 MCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDE  212 (318)
T ss_pred             CCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCC
Confidence            98753322211  1234689999999999999999999999999999999999999864321       11112222111


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS-----KDVRC  423 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~-----~ev~~  423 (430)
                      ..           .+......+.+++.+||+.||.+||++     .++++
T Consensus       213 ~~-----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 VR-----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CC-----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            10           011122347899999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-40  Score=317.37  Aligned_cols=247  Identities=21%  Similarity=0.242  Sum_probs=191.4

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||+||+|+... +++.||+|++.....           ........+..|..++.++ +||||+++++++...
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   68 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELV-----------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT   68 (327)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC
Confidence            368999999999998764 789999999954211           1123356788999999888 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|..++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          69 SRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            999999999999999998843    34699999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....+.........
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  218 (327)
T cd05617         142 MCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEK  218 (327)
T ss_pred             cceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhC
Confidence            9875332211  1223579999999999999999999999999999999999999996432211 111222222222111


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ...          .+......+.+++.+||+.||.+||++
T Consensus       219 ~~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 PIR----------IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            110          011112337789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-40  Score=311.94  Aligned_cols=263  Identities=23%  Similarity=0.308  Sum_probs=205.3

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||+|+||.||+|....    .....+|+|.+....             .......+.+|+.++..+ +|||
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h~~   77 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------------TEKDLSDLVSEMEMMKMIGKHKN   77 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------------CHHHHHHHHHHHHHHHhhcCCCC
Confidence            4578899999999999999998753    134689999884321             112346688999999999 7999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRII  275 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii  275 (430)
                      |+++++++...+..+++|||+++|+|.+++....            .....+++..++.++.|++.||.|||+.   +++
T Consensus        78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~iv  154 (293)
T cd05053          78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCI  154 (293)
T ss_pred             eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999999999996421            2345689999999999999999999954   599


Q ss_pred             ecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 014140          276 HRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP  354 (430)
Q Consensus       276 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p  354 (430)
                      |+||||+||++++++.++|+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus       155 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence            999999999999999999999999987654433222222345678999999998899999999999999999998 8888


Q ss_pred             CCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          355 SDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       355 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      |.....       .+..........+.          .+......+.+++..||+.+|++|||+.++++.|+.+
T Consensus       235 ~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         235 YPGIPV-------EELFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             CCCCCH-------HHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            754321       11111111111110          1111233488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-40  Score=324.28  Aligned_cols=256  Identities=19%  Similarity=0.241  Sum_probs=198.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|..||+|++.....           ........+.+|+.+++.++||||++++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            4578999999999999999998764 899999999843211           0112245578899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         110 YAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             EEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCE
Confidence            999999999999999999999999843     3478889999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ||+|||++.......... .....||+.|+|||++.+.    .++.++|||||||++|||++|..||.....       .
T Consensus       182 kL~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~  253 (370)
T cd05596         182 KLADFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------V  253 (370)
T ss_pred             EEEeccceeeccCCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------H
Confidence            999999998764332211 1235799999999998754    378899999999999999999999864321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~  423 (430)
                      .............. +.      ........+.+++..||+.+|.+  ||++.++++
T Consensus       254 ~~~~~i~~~~~~~~-~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         254 GTYSKIMDHKNSLT-FP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHHcCCCcCC-CC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            12222222111000 00      00112334788999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.3e-40  Score=307.95  Aligned_cols=257  Identities=21%  Similarity=0.270  Sum_probs=197.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCce----EEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRV----ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ++|.+.+.||.|+||.||+|.+.. +|..    +++|.+...             ........+..|+.+++.++||||+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~~~~l~~l~h~~iv   72 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDR-------------SGRQTFQEITDHMLAMGSLDHAYIV   72 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccc-------------cchHHHHHHHHHHHHHhcCCCCCcc
Confidence            467888999999999999998753 5553    666665211             1112346788899999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++. ....++++||+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.+
T Consensus        73 ~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~  145 (279)
T cd05111          73 RLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSD  145 (279)
T ss_pred             eEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC
Confidence            9999875 4557899999999999999954   234689999999999999999999954   59999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      +.+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||.....    ....
T Consensus       146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~  221 (279)
T cd05111         146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVP  221 (279)
T ss_pred             CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence            9999999999987654332222223456788999999998899999999999999999998 9999865422    1112


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +.+    ..+....  .+.   .    +...+.+++..||..+|++|||+.++++.|..+
T Consensus       222 ~~~----~~~~~~~--~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         222 DLL----EKGERLA--QPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             HHH----HCCCcCC--CCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            221    1111110  000   1    123477889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.8e-41  Score=329.22  Aligned_cols=205  Identities=24%  Similarity=0.350  Sum_probs=172.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|..++.||+|+||.||+|+... +++.||+|.+.....           ........+.+|+.+++.++||||++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~   69 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDV-----------LLRNQVAHVKAERDILAEADNEWVVRLYYS   69 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHh-----------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEE
Confidence            58889999999999999998764 889999999843211           112335678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++|||||++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL  142 (382)
T cd05625          70 FQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKL  142 (382)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999853    34688999999999999999999955   4999999999999999999999


Q ss_pred             eecCCcccCCCCC---------------------------------------------CcceeeccccccccccccccCC
Q 014140          295 SEFGLAKRIPDGH---------------------------------------------TRTTTWSLAGTVGYIAPECHQT  329 (430)
Q Consensus       295 ~Dfg~a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~  329 (430)
                      +|||++..+....                                             .........||+.|+|||++.+
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (382)
T cd05625         143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR  222 (382)
T ss_pred             eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence            9999975331000                                             0000113468999999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          330 VALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       330 ~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      ..++.++|||||||++|||++|+.||...
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             CCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-40  Score=308.05  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=206.7

Q ss_pred             ccccccccccccccCceEEEeecCCC---CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS---SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|.+...   .+..|++|.+....             .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni~   71 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------------SEIQVTLLLQESCLLYGLSHQNIL   71 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------------CHHHHHHHHHHHHHHHhCCCCCCC
Confidence            46789999999999999999987631   26889999874211             123357788999999999999999


Q ss_pred             cceeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          210 PLLARMVR-RDCDLLVYEFRRNGSLQDILYDVSQG----RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       210 ~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ++++++.. +...++++||+++|+|.+++......    ...+++..++.++.|++.||.|||+.   +++|+||||+||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~ni  148 (280)
T cd05043          72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNC  148 (280)
T ss_pred             eEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhE
Confidence            99998876 56789999999999999998653222    25689999999999999999999954   599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTK  363 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~  363 (430)
                      ++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+   
T Consensus       149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  225 (280)
T cd05043         149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---  225 (280)
T ss_pred             EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---
Confidence            999999999999999987654333222223346778999999998889999999999999999999 9999865321   


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                       ..+..++..   ...+..          ....+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       226 -~~~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         226 -FEMAAYLKD---GYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -HHHHHHHHc---CCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             222222221   111110          0111234889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-41  Score=295.08  Aligned_cols=259  Identities=26%  Similarity=0.364  Sum_probs=209.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  212 (430)
                      +.|...++||.|..+.|-++.++. +|..+|+|++......      +.++......+.-..|+.+|+++ -||||+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~-t~~e~a~kii~~~at~------~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKE-TGKEFAVKIIDVTATT------ESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcc-cccceeEEEEEecccc------cCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            357778999999999999998764 8899999998554332      23334556677888999999999 599999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.++...++|+|.|+.|.|.|++    .+.-.+++....+|+.|+..|+.|||..+   |+||||||+|||++++.++
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence            9999999999999999999999999    44567999999999999999999999555   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT------VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +|+|||++..+..+....   ..+||++|+|||.+.-      .+|+..+|+||+||++|.++.|.+||=...       
T Consensus       163 ~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------  232 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------  232 (411)
T ss_pred             EEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------
Confidence            999999999987765433   4689999999998653      368899999999999999999999964321       


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..-.++.++.+.-.       +.++...+......+|+.+||+.||.+|.|++|++.
T Consensus       233 QmlMLR~ImeGkyq-------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 QMLMLRMIMEGKYQ-------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHhcccc-------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11122333322211       112233444556889999999999999999999874

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-41  Score=324.93  Aligned_cols=256  Identities=20%  Similarity=0.241  Sum_probs=200.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|.... +|+.||+|++.....           ........+..|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~   68 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVL-----------LAQETVSFFEEERDILSISNSPWIPQLQY   68 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceee
Confidence            368899999999999999998764 899999999853211           11223567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~k  142 (330)
T cd05601          69 AFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIK  142 (330)
T ss_pred             EEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEE
Confidence            999999999999999999999999642   34699999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ------TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      |+|||++..+...... ......||+.|+|||++.      +..++.++|||||||++|+|++|..||.....       
T Consensus       143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------  214 (330)
T cd05601         143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------  214 (330)
T ss_pred             eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------
Confidence            9999999876543322 222346899999999987      45678999999999999999999999864321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ............... +.      ........+.+++..||+ +|.+||++.++++
T Consensus       215 ~~~~~~i~~~~~~~~-~~------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         215 AKTYNNIMNFQRFLK-FP------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHHcCCCccC-CC------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            112222222111100 00      001122347788889998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-40  Score=315.22  Aligned_cols=244  Identities=26%  Similarity=0.359  Sum_probs=189.3

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||||.+......           .......+..|..++... +||||+++++++.+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~   68 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVL-----------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK   68 (316)
T ss_pred             CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC
Confidence            368999999999999764 7899999998542110           011234566777777764 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          69 ENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            999999999999999999843    34689999999999999999999954   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++.........  .....||..|+|||++.+..++.++|||||||++|||++|..||.....    ..+...+.   .. 
T Consensus       142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~---~~-  211 (316)
T cd05619         142 MCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIR---MD-  211 (316)
T ss_pred             cceECCCCCCc--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH---hC-
Confidence            98754322211  1235789999999999998999999999999999999999999864321    11222111   11 


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK-DVR  422 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~-ev~  422 (430)
                      .+.  +        +......+.+++.+||+.+|.+||++. ++.
T Consensus       212 ~~~--~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 NPC--Y--------PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCC--C--------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            110  0        011123478899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-40  Score=306.86  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=200.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|++|.||+|...  ++..+|+|.+......               ...+.+|+.++++++|||+++++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~E~~~l~~l~~~~i~~~~   67 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS---------------PESFLEEAQIMKKLRHDKLVQLY   67 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC---------------HHHHHHHHHHHHhcCCCceEEEE
Confidence            346889999999999999999865  6778999988432211               24688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++. .+..+++|||+++++|.+++..  .....+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+
T Consensus        68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~  141 (260)
T cd05070          68 AVVS-EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVC  141 (260)
T ss_pred             eEEC-CCCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceE
Confidence            9875 4567899999999999999864  2334589999999999999999999955   49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||....    ....... 
T Consensus       142 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~-  215 (260)
T cd05070         142 KIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLEQ-  215 (260)
T ss_pred             EeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH-
Confidence            999999998765432211 112345678999999988889999999999999999999 888876432    1122222 


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        ......+          ..+......+.+++.+||+.+|.+|||+.++.+.|++.
T Consensus       216 --~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         216 --VERGYRM----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             --HHcCCCC----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence              2111111          01112234588999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-40  Score=316.87  Aligned_cols=245  Identities=24%  Similarity=0.238  Sum_probs=192.5

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  213 (430)
                      +|.+.+.||+|+||.||+|+... +++.||+|.+.....           ........+..|..++..+ +||+|+++++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~   68 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVV-----------IQDDDVECTMVEKRVLALSGKPPFLTQLHS   68 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhccCCCeEeeEEE
Confidence            47888999999999999998764 789999999854211           1112245567788888877 5899999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k  141 (323)
T cd05616          69 CFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             EEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEE
Confidence            99999999999999999999999843    34689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ..+..   .
T Consensus       142 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~---~  212 (323)
T cd05616         142 IADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQ---S  212 (323)
T ss_pred             EccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHH---H
Confidence            999999875432221  12235789999999999999999999999999999999999999865321    11222   2


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      .......           .+......+.+++.+||+.+|.+|++.
T Consensus       213 i~~~~~~-----------~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 IMEHNVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHhCCCC-----------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            2211110           011122347889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-41  Score=330.06  Aligned_cols=256  Identities=20%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||.||+|+... +|+.||||.+.....           ........+.+|+.+|+.++||||+++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~h~~iv~~~~   68 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADV-----------LMRNQAAHVKAERDILAEADNEWVVKLYY   68 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHH-----------HhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            368999999999999999998764 799999999843211           11122466889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+.+++..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ik  141 (376)
T cd05598          69 SFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK  141 (376)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999953    34688999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCC-----------------------------------------CcceeeccccccccccccccCCCCC
Q 014140          294 ISEFGLAKRIPDGH-----------------------------------------TRTTTWSLAGTVGYIAPECHQTVAL  332 (430)
Q Consensus       294 l~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~  332 (430)
                      |+|||++..+....                                         .........||+.|+|||++.+..+
T Consensus       142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  221 (376)
T cd05598         142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY  221 (376)
T ss_pred             EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC
Confidence            99999975331000                                         0000113469999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCC
Q 014140          333 SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDP  412 (430)
Q Consensus       333 ~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp  412 (430)
                      +.++|||||||++|||++|+.||......       +........... ..+  ........    .+.+++.+|+ .+|
T Consensus       222 ~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~-~~~--~~~~~~s~----~~~~li~~l~-~~p  286 (376)
T cd05598         222 TQLCDWWSVGVILYEMLVGQPPFLADTPA-------ETQLKVINWETT-LHI--PSQAKLSR----EASDLILRLC-CGA  286 (376)
T ss_pred             CcceeeeeccceeeehhhCCCCCCCCCHH-------HHHHHHhccCcc-ccC--CCCCCCCH----HHHHHHHHHh-cCH
Confidence            99999999999999999999998653221       111111110000 000  00011222    3556666665 499


Q ss_pred             CCCC---CHHHHHH
Q 014140          413 NKRP---NSKDVRC  423 (430)
Q Consensus       413 ~~Rp---s~~ev~~  423 (430)
                      .+|+   ++.++++
T Consensus       287 ~~R~~~~t~~ell~  300 (376)
T cd05598         287 EDRLGKNGADEIKA  300 (376)
T ss_pred             hhcCCCCCHHHHhC
Confidence            9999   7888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.7e-40  Score=305.88  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=197.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|+||.||+|.... ++..||+|.+....             .......+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   67 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDI-------------TVELQKQIMSELEILYKCDSPYIIGFYGA   67 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCC-------------ChHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            57888999999999999998764 88999999884321             11224678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++++|..+.        .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l  136 (279)
T cd06619          68 FFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKL  136 (279)
T ss_pred             EEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999996542        368888999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++........    ....||..|+|||++.+..++.++|+||||+++|+|++|..||...................
T Consensus       137 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (279)
T cd06619         137 CDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI  212 (279)
T ss_pred             eeCCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence            99999986643321    13468999999999999899999999999999999999999987644322222112222111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .....+ .     ...   ......+.+++.+||+.+|++||++.++++.
T Consensus       213 ~~~~~~-~-----~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDEDPP-V-----LPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccCCC-C-----CCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111111 0     000   1112347899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.3e-40  Score=304.06  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|...  +++.||+|.+.....               ....+.+|+.++++++|||+++++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~   67 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSM---------------SPEAFLAEANLMKQLQHPRLVRLY   67 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCC---------------cHHHHHHHHHHHHhcCCcCeeeEE
Confidence            456889999999999999999865  788999998843221               135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++ ..+..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+
T Consensus        68 ~~~-~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~  141 (260)
T cd05067          68 AVV-TQEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCC  141 (260)
T ss_pred             EEE-ccCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCE
Confidence            986 45678999999999999999864  234568999999999999999999994   459999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.......... .....++..|+|||++.+..++.++||||||++++|+++ |+.||.....    ......+
T Consensus       142 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~  216 (260)
T cd05067         142 KIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNL  216 (260)
T ss_pred             EEccCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHH
Confidence            999999998765322211 112345778999999998889999999999999999999 9999864321    1222222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....   .+.          .+......+.+++.+||+.+|++||+++++++.|+.+
T Consensus       217 ~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         217 ERGY---RMP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HcCC---CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            1111   110          0111223488999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-40  Score=306.19  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|++.  +...||+|.+.....               ....+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~~   67 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLY   67 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc---------------CHHHHHHHHHHHHhCCCCCcceEE
Confidence            456899999999999999999875  445699998843111               134688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++. .+..++||||+++|+|.+++..  .....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~  141 (262)
T cd05071          68 AVVS-EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVC  141 (262)
T ss_pred             EEEC-CCCcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcE
Confidence            9874 4567999999999999999964  2234679999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||.+..+....... .....++..|+|||+..+..++.++||||||+++|+|++ |..||.....    ....   
T Consensus       142 ~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~~~---  213 (262)
T cd05071         142 KVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL---  213 (262)
T ss_pred             EeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HHHH---
Confidence            999999998765433211 112346678999999988889999999999999999999 8888764321    1111   


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .........          ......+..+.+++..||+.+|++||++.+++++|+.+
T Consensus       214 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         214 DQVERGYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHhcCCCC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            111111111          11122344588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.9e-40  Score=305.19  Aligned_cols=260  Identities=21%  Similarity=0.334  Sum_probs=197.7

Q ss_pred             cccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      |.+.+.||+|+||.||+|++.. ++.  .+|+|.+.....            .......+..|+.+++.++||||+++++
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~-~~~~~~~a~k~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~   67 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQ-DDSILKVAVKTMKIAIC------------TRSEMEDFLSEAVCMKEFDHPNVMRLIG   67 (272)
T ss_pred             CccccccCcccCceEEEeEEcc-CCCeeeEEEEecccCcC------------CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3567899999999999998763 443  689998743211            1233577889999999999999999999


Q ss_pred             EEEeC------CeeEEEEEecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          214 RMVRR------DCDLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       214 ~~~~~------~~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++...      ...+++|||+++|+|.+++....  .....+++.....++.|++.||.|||+.   +++||||||+|||
T Consensus        68 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil  144 (272)
T cd05075          68 VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCM  144 (272)
T ss_pred             EEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheE
Confidence            87542      24689999999999999874321  2234589999999999999999999954   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~  364 (430)
                      ++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||.....    
T Consensus       145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  220 (272)
T cd05075         145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----  220 (272)
T ss_pred             EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence            99999999999999987654332211112345678999999999899999999999999999999 7888764221    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+..   .......+.          .+......+.+++..||+.+|++|||+.+|++.|+++
T Consensus       221 ~~~~~---~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         221 SEIYD---YLRQGNRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHH---HHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111   121111111          0111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=311.21  Aligned_cols=268  Identities=19%  Similarity=0.256  Sum_probs=200.8

Q ss_pred             ccccccccccccccCceEEEeecCCC-------------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHH
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS-------------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT  199 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  199 (430)
                      .++|.+.+.||+|+||.||++.....             ....||+|.+.....             ......+.+|+.+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~ei~~   70 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------------KTARNDFLKEIKI   70 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------------HHHHHHHHHHHHH
Confidence            35789999999999999999976421             123589998843211             1234678999999


Q ss_pred             HhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 014140          200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------GRRELDWLARHRIAQGIASGLEYLHMSHR  271 (430)
Q Consensus       200 l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  271 (430)
                      +++++|||++++++++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||.|||+.  
T Consensus        71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  148 (295)
T cd05097          71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--  148 (295)
T ss_pred             HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--
Confidence            9999999999999999999999999999999999999854211        112478899999999999999999955  


Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-
Q 014140          272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-  350 (430)
Q Consensus       272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-  350 (430)
                       +++|+||||+||++++++.+||+|||++................++..|+|||++.+..++.++||||||+++++|++ 
T Consensus       149 -~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         149 -NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             -CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence             599999999999999999999999999987644332222222345778999999998899999999999999999998 


Q ss_pred             -CCCCCCccccccccccHHHHHHHHhcCC-CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          351 -GKFPSDDFFQHTKEMSLVQWMRNVMTSE-NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       351 -g~~p~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                       |..||.....    .............. .....       ..+...+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       228 ~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         228 CKEQPYSLLSD----EQVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CCCCCCcccCh----HHHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             5567654321    11222211111110 00000       0011122358999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-40  Score=311.84  Aligned_cols=262  Identities=21%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||.|+||.||+|...+    .++..||+|.+....             .......+.+|+.+++.++||||
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~~~~~ei~~l~~l~h~~i   70 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------------SADMQADFQREAALMAEFDHPNI   70 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------------CHHHHHHHHHHHHHHHhcCCCch
Confidence            4678999999999999999998642    367899999884321             11234678899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS------------------QGRRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      +++++++...+..++||||+++|+|.+++....                  .....+++..++.++.|++.||.|||+  
T Consensus        71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--  148 (288)
T cd05050          71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--  148 (288)
T ss_pred             heEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--
Confidence            999999999999999999999999999996421                  112357889999999999999999994  


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                       .+++||||+|+||++++++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++
T Consensus       149 -~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  227 (288)
T cd05050         149 -RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  227 (288)
T ss_pred             -CCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence             4599999999999999999999999999876543322111112234677999999998899999999999999999998


Q ss_pred             -CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          351 -GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       351 -g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                       |..||.....       .+......... ...         .+......+.+++.+||+.+|.+|||+.|+++.|++
T Consensus       228 ~~~~p~~~~~~-------~~~~~~~~~~~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         228 YGMQPYYGMAH-------EEVIYYVRDGN-VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCCCCCH-------HHHHHHHhcCC-CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             7788754321       12222222111 110         011123458899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.1e-40  Score=306.89  Aligned_cols=259  Identities=21%  Similarity=0.260  Sum_probs=200.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..+|.+.+.||.|+||.||+|++.. +|.    .||+|.+....             .......+.+|+.++..++||||
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~-------------~~~~~~~~~~e~~~l~~~~~~~i   71 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENT-------------SPKANKEILDEAYVMAGVGSPYV   71 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCC-------------CHHHHHHHHHHHHHHHhcCCCCC
Confidence            4568899999999999999998653 454    48999884321             11234678899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++++.. ...++++||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+|||+++
T Consensus        72 ~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~  144 (279)
T cd05109          72 CRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKS  144 (279)
T ss_pred             ceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC
Confidence            999999875 456799999999999999853   235689999999999999999999955   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||+....    ..+
T Consensus       145 ~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~  220 (279)
T cd05109         145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REI  220 (279)
T ss_pred             CCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence            99999999999987754322211112235678999999999899999999999999999998 8899865322    122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ...+...   ..+..          +......+.+++..||+.||++||++.++++.|+.+.
T Consensus       221 ~~~~~~~---~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         221 PDLLEKG---ERLPQ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             HHHHHCC---CcCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2222211   11100          0112234788999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=306.22  Aligned_cols=258  Identities=21%  Similarity=0.273  Sum_probs=201.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|... .++..+|+|.+......         .........+.+|+.++++++||||+++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   71 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDS---------PETKKEVNALECEIQLLKNLQHERIVQYYG   71 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccc---------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence            46889999999999999999865 37899999988543211         111223567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        72 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~  144 (263)
T cd06625          72 CLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVK  144 (263)
T ss_pred             EEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999853    34688999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....       .....
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~  217 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIF  217 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHH
Confidence            999999976543221111 1234578899999999998999999999999999999999999864311       11111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ........         ...+......+.+++..||+.+|.+||++.++++.
T Consensus       218 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         218 KIATQPTN---------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHhccCCC---------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11111110         01111223348889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-40  Score=316.60  Aligned_cols=241  Identities=24%  Similarity=0.263  Sum_probs=187.5

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHH-HHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII-TAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||+||+|+... +|+.||+|.+......           .......+..|.. +++.++||||+++++++...
T Consensus         1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~   68 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAIL-----------KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA   68 (323)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHh-----------hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC
Confidence            368999999999998764 8999999998432111           1112344555544 56789999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          69 DKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             CEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            999999999999999999843    45689999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....       ..+.........
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~  212 (323)
T cd05575         142 LCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNKP  212 (323)
T ss_pred             CCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCC
Confidence            9875432221  1223578999999999999999999999999999999999999986421       122222222211


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      ..       +...    ....+.+++..||+.||.+||++.
T Consensus       213 ~~-------~~~~----~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 LR-------LKPN----ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC-------CCCC----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            10       0011    123488899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-40  Score=309.10  Aligned_cols=262  Identities=22%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             ccccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|++|.||+|.+...    .+..|++|.+....             .......+.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~i   71 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------------SEQDESDFLMEALIMSKFNHQNI   71 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------------CHHHHHHHHHHHHHHHhCCCCCE
Confidence            46789999999999999999988531    45788888773211             11224568899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++++.+.+..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil  148 (277)
T cd05036          72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCL  148 (277)
T ss_pred             eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEE
Confidence            9999999999999999999999999999965321   123589999999999999999999955   4999999999999


Q ss_pred             eCCCC---ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          286 IDDDM---EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       286 l~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ++.++   .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... 
T Consensus       149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-  227 (277)
T cd05036         149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-  227 (277)
T ss_pred             EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            98654   599999999987643322111112233568999999998899999999999999999997 9999864321 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                         ..+.   ..........          .+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       228 ---~~~~---~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         228 ---QEVM---EFVTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ---HHHH---HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence               1122   2222111111          011122358899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.6e-40  Score=310.57  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=205.1

Q ss_pred             ccccccccccccccCceEEEeecC------CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP------GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      ..+|.+.+.||.|+||.||+|+..      ..++..+|+|.+....             .......+.+|+.+++.+ +|
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h   80 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------------TEKDLSDLVSEMEMMKMIGKH   80 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------------chHHHHHHHHHHHHHHhhccC
Confidence            456888999999999999999752      1234579999874221             112356789999999999 89


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||+++++++...+..++||||+++|+|.+++.....            ....+++..+..++.|++.||.|||+.   +
T Consensus        81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---g  157 (304)
T cd05101          81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---K  157 (304)
T ss_pred             CCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            9999999999999999999999999999999975321            123578899999999999999999955   5


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      ++||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       158 ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987754333222223346778999999998889999999999999999998 77


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .||...       ...+............          .+......+.+++..||+.+|.+|||+.++++.|.++.
T Consensus       238 ~p~~~~-------~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         238 SPYPGI-------PVEELFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             CCcccC-------CHHHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            886532       1222222222111110          01122345888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-40  Score=314.88  Aligned_cols=244  Identities=25%  Similarity=0.332  Sum_probs=189.3

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +|+.||+|.+......           .......+..|..++..+ +||||+++++++.+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   68 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVL-----------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK   68 (316)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhh-----------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC
Confidence            368999999999999864 8899999998542110           011234567788888755 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             CEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            999999999999999999843    35689999999999999999999954   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|..||.....    ..+.+   .... .
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~~---~~~~-~  211 (316)
T cd05620         142 MCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFE---SIRV-D  211 (316)
T ss_pred             CCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHH---HHHh-C
Confidence            9875432221  12235789999999999999999999999999999999999999864311    11221   1111 1


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK-DVR  422 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~-ev~  422 (430)
                      .+.      .    +......+.+++..||+.||++||++. ++.
T Consensus       212 ~~~------~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 TPH------Y----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCC------C----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            110      0    001123478899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.3e-40  Score=301.74  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=202.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||+|++|.||+|.... +|..|++|.+......            ......+.+|+.+++.++|||+++++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMN------------RREREEAIDEARVLAKLDSSYIIRYYES   67 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC-CCcEEEEEEeehhhCC------------HHHHHHHHHHHHHHHhcCCCCeehheee
Confidence            36778999999999999998764 7899999988432111            2335678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++++|.+++...  ....+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l  142 (256)
T cd08529          68 FLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKI  142 (256)
T ss_pred             eccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEE
Confidence            99999999999999999999999652  24578999999999999999999994   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....|++.|+|||++.+..++.++|+||||+++++|++|+.||.....    ...   ....
T Consensus       143 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~~  213 (256)
T cd08529         143 GDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GAL---ILKI  213 (256)
T ss_pred             cccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH---HHHH
Confidence            9999988765432222  134688999999999998999999999999999999999999864321    111   1122


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+          ..+......+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         214 IRGVFP----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HcCCCC----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            211111          011122345889999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-40  Score=306.97  Aligned_cols=262  Identities=19%  Similarity=0.306  Sum_probs=204.2

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||.|+||.||+|....    ..+..||+|.+....             .......+.+|+.++..++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------------~~~~~~~~~~e~~~l~~~~~~~i   71 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------------SMRERIEFLNEASVMKEFNCHHV   71 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------------CHHHHHHHHHHHHHHHhCCCCce
Confidence            4578999999999999999998752    234789999873321             11224578899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      +++++++...+..++||||+++|+|.+++.....      ....+++..++.++.|++.||.|||+.   +++|+||||+
T Consensus        72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~  148 (277)
T cd05032          72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAAR  148 (277)
T ss_pred             eEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChh
Confidence            9999999999999999999999999999965322      123478899999999999999999954   5999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||..... 
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  227 (277)
T cd05032         149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-  227 (277)
T ss_pred             eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-
Confidence            99999999999999999987654332222223456789999999988889999999999999999998 8888754221 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                         ........   ....+.          .+......+.+++..||+.+|++|||+.++++.|+.
T Consensus       228 ---~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         228 ---EEVLKFVI---DGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ---HHHHHHHh---cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence               12222221   111110          011113458899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.7e-41  Score=318.98  Aligned_cols=242  Identities=21%  Similarity=0.275  Sum_probs=191.4

Q ss_pred             cccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||+|+||.||+++..  ..+|+.||+|++......            ......+..|+.++++++||||+++++++..
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT   69 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            57999999999998752  237899999998542111            1123557789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ++..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  142 (318)
T cd05582          70 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  142 (318)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeec
Confidence            9999999999999999999843    35689999999999999999999955   4999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcC
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ..........
T Consensus       143 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~  213 (318)
T cd05582         143 GLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKA  213 (318)
T ss_pred             cCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcC
Confidence            99886543322  12245789999999999998899999999999999999999999864321       1112222211


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD  420 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~e  420 (430)
                      ...           .+......+.+++..||+.||.+||++.+
T Consensus       214 ~~~-----------~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 KLG-----------MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCC-----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            110           01111234788999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.5e-40  Score=305.54  Aligned_cols=258  Identities=22%  Similarity=0.314  Sum_probs=190.8

Q ss_pred             cccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|.+.+ .++..+|+|.+.....             ......+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   67 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV   67 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            368999999999998642 2456799998743211             12235688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ...++||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus        68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~df  144 (269)
T cd05087          68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDY  144 (269)
T ss_pred             CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCc
Confidence            999999999999999999975322 223567788889999999999999955   5999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-------ALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      |++................++..|+|||++.+.       .++.++|+||||+++|||++ |..||......    ....
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~  220 (269)
T cd05087         145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLT  220 (269)
T ss_pred             cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHH
Confidence            999765433222222234578889999988643       35789999999999999996 99998653221    1111


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..   ... .......+......    ...+.+++..|| .+|++|||+.+|+..|+
T Consensus       221 ~~---~~~-~~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         221 YT---VRE-QQLKLPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HH---hhc-ccCCCCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11   111 01111111111111    223777888998 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-40  Score=324.27  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=196.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+...||.|+||.||+|.+.. +++.||||...                    ...+.+|+.+|++++|||||+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~--------------------~~~~~~E~~iL~~L~HpnIv~l~  226 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGW--------------------YASSVHEARLLRRLSHPAVLALL  226 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC-CCCEEEEeccc--------------------ccCHHHHHHHHHHCCCCCCCcEE
Confidence            4579999999999999999999874 78999999641                    12356899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++|||++. ++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       227 ~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~v  299 (461)
T PHA03211        227 DVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDI  299 (461)
T ss_pred             EEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCE
Confidence            99999999999999995 689888853   234699999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc----ccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT----KEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~----~~~~l~  368 (430)
                      +|+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+-......    ....+.
T Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~  379 (461)
T PHA03211        300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL  379 (461)
T ss_pred             EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence            9999999987654322222224579999999999999999999999999999999999886643211110    111122


Q ss_pred             HHHHHHhcC-CCCchhcc----------------ccccCCCc---HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          369 QWMRNVMTS-ENPNRAIN----------------SKLLGNGY---EEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~-~~~~~~~~----------------~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ..+...... ........                +.......   ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            222211100 00000000                00000000   0112247889999999999999999999863

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.3e-40  Score=304.07  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+...||.|++|.||+|.+.  .+..+|+|.+.....               ....+.+|+.+++.++|||++++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~   68 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTM---------------MPEAFLQEAQIMKKLRHDKLVPLYA   68 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCCc---------------cHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            45888899999999999999875  455799998743211               1356888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++. .+..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++
T Consensus        69 ~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~  142 (260)
T cd05069          69 VVS-EEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCK  142 (260)
T ss_pred             EEc-CCCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEE
Confidence            875 5568899999999999999964  233458999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.+.......... .....++..|+|||+..+..++.++||||||+++|+|++ |..||.....    ......+ 
T Consensus       143 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~-  216 (260)
T cd05069         143 IADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQV-  216 (260)
T ss_pred             ECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH-
Confidence            99999998764332211 112345778999999998889999999999999999999 8999865321    1122221 


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        .....+          ..+...+..+.+++.+||+.+|++||++.+|+++|+++
T Consensus       217 --~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         217 --ERGYRM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             --HcCCCC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              111111          01112234588999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-39  Score=305.46  Aligned_cols=260  Identities=21%  Similarity=0.272  Sum_probs=201.1

Q ss_pred             cccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .+|.....||+|+||.||++...    ..++..+++|.+...              .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~   70 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------------SESARQDFQREAELLTVLQHQHIV   70 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------------CHHHHHHHHHHHHHHhcCCCCCCc
Confidence            45788899999999999999642    235678899987321              123356799999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-----------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      ++++++...+..++||||+++|+|.+++.....           ....+++..++.++.|++.|++|||+.   +++|+|
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~d  147 (280)
T cd05092          71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRD  147 (280)
T ss_pred             eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            999999999999999999999999999965321           113588999999999999999999954   599999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDD  357 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~  357 (430)
                      |||+|||+++++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999999976543322222212345678999999999999999999999999999998 8899754


Q ss_pred             cccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ...    ......   ........      .....    +..+.+++.+||+.||++||++.+|++.|+.
T Consensus       228 ~~~----~~~~~~---~~~~~~~~------~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         228 LSN----TEAIEC---ITQGRELE------RPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             CCH----HHHHHH---HHcCccCC------CCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            322    111111   11111110      00111    2347899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=304.23  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=211.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ++-|.++.+||+|+||.||+|.++ .+|.++|||++.-                .....++..|+.+|++++.|++|++|
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV----------------~sDLQEIIKEISIMQQC~S~yVVKYY   94 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV----------------DTDLQEIIKEISIMQQCKSKYVVKYY   94 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc----------------cchHHHHHHHHHHHHHcCCchhhhhh
Confidence            456899999999999999999887 4999999998822                12267889999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |.+..+..+|+|||||-.||+.|+++.   ...++.+..+..++.+.++||+|||...   -+|||||+.|||++.+|.+
T Consensus        95 GSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~A  168 (502)
T KOG0574|consen   95 GSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIA  168 (502)
T ss_pred             hhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchh
Confidence            999999999999999999999999964   4568999999999999999999999554   8999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||.|..+.+.....+  ...||+-|||||++..-+|+.++||||||++..||..|++||.+..+-          +
T Consensus       169 KLADFGVAGQLTDTMAKRN--TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------R  236 (502)
T KOG0574|consen  169 KLADFGVAGQLTDTMAKRN--TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------R  236 (502)
T ss_pred             hhhhccccchhhhhHHhhC--ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------c
Confidence            9999999988765433333  468999999999999999999999999999999999999999876541          1


Q ss_pred             HHh-cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVM-TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+. -..+|...+      ..+......+-++++.||-.+|++|-|+.++++
T Consensus       237 AIFMIPT~PPPTF------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  237 AIFMIPTKPPPTF------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             eeEeccCCCCCCC------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            111 011111111      234556667999999999999999999999886

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-40  Score=306.82  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.+.+.||+|+||+||+++... +++.+|+|.+......            .........|+.++++++||||+++++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~   67 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEIE------------EEEREENIREIKILRRLRHPNIVQILDVF   67 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTHH------------HHHHHHHHHHHHHHHHHTBTTBCHEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC-CCeEEEEEEecccccc------------ccccchhhhhhhccccccccccccccccc
Confidence            5778999999999999999875 7889999999543221            12233445699999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .+.+..++||||+++++|.+++.    ....+++..++.++.|++.||.+||+.+   ++|+||||+||++++++.++|+
T Consensus        68 ~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~  140 (260)
T PF00069_consen   68 QDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLI  140 (260)
T ss_dssp             EESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEES
T ss_pred             ccccccccccccccccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence            99999999999999999999995    3456899999999999999999999665   9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      |||.+.......  .......++..|+|||++. +..++.++||||+|+++++|++|..||.....    .+........
T Consensus       141 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~----~~~~~~~~~~  214 (260)
T PF00069_consen  141 DFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS----DDQLEIIEKI  214 (260)
T ss_dssp             SGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH----HHHHHHHHHH
T ss_pred             cccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc----hhhhhhhhhc
Confidence            999997652211  2222457899999999998 77899999999999999999999999876411    1111111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........       .........+.+++..||+.||++||++.++++
T Consensus       215 ~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  215 LKRPLPSSS-------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTHHHHHT-------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccccc-------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110000000       000000145899999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-39  Score=301.08  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=195.7

Q ss_pred             ccccccCceEEEeecC-CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          141 KIRSCWNGEVYKAELP-GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      .||+|+||.||+|.+. ..++..+|+|++.....            .......+.+|+.+++.++||||+++++++. .+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   68 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN------------DPALKDELLREANVMQQLDNPYIVRMIGICE-AE   68 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC------------cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CC
Confidence            5899999999999753 23678999998843211            1233577899999999999999999999875 55


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~  141 (257)
T cd05116          69 SWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGL  141 (257)
T ss_pred             CcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCcc
Confidence            67899999999999999843    3468999999999999999999994   4599999999999999999999999999


Q ss_pred             cccCCCCCCcce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcC
Q 014140          300 AKRIPDGHTRTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       300 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      +........... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.....    ..+...+..   .
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~---~  214 (257)
T cd05116         142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIES---G  214 (257)
T ss_pred             ccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHC---C
Confidence            987654432211 112234678999999988889999999999999999998 9999865322    122222221   1


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.      .    +......+.+++..||+.||++||++.+|.+.|+++
T Consensus       215 ~~~~------~----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ERME------C----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCC------C----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1110      0    111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.4e-40  Score=301.57  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=195.3

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      ++||+|+||.||+|...  ++..+|+|.+.....             ......+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   65 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLP-------------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ   65 (250)
T ss_pred             CccCCCCCceEEEEEec--CCcEEEEEecCCcCC-------------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC
Confidence            36899999999999865  788999998743221             122456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++++|.+++..   ....+++..+..++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|||+
T Consensus        66 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~  139 (250)
T cd05085          66 PIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGM  139 (250)
T ss_pred             ccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCcc
Confidence            99999999999999999853   2345889999999999999999999   45599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      +............ ...++..|+|||++.+..++.++||||||+++|++++ |..||.....    .....   ......
T Consensus       140 ~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~~~~---~~~~~~  211 (250)
T cd05085         140 SRQEDDGIYSSSG-LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQARE---QVEKGY  211 (250)
T ss_pred             ceeccccccccCC-CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH---HHHcCC
Confidence            8765433221111 1234677999999998889999999999999999998 9999864321    11111   111111


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..          ..+......+.+++.+||+.+|++||++.++++.|.
T Consensus       212 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 RM----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11          001112345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.5e-40  Score=305.69  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=198.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|++.....              .....+.+|+.++++++||||++++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~ii~~~   72 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEPG--------------DDFSLIQQEIFMVKECKHCNIVAYF   72 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCcc--------------chHHHHHHHHHHHHhcCCCCeeeee
Confidence            4579999999999999999998754 889999999843211              1134678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+
T Consensus        73 ~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~  145 (267)
T cd06646          73 GSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDV  145 (267)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCE
Confidence            999999999999999999999999843    3468999999999999999999994   459999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||++.........  .....|+..|+|||.+.   ...++.++|+|||||+++||++|..||....+.....    
T Consensus       146 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----  219 (267)
T cd06646         146 KLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----  219 (267)
T ss_pred             EECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----
Confidence            99999999876432211  11346889999999875   3457889999999999999999999975432210000    


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                          .........   +..  .........+.+++..||+.+|++||++.++++.|
T Consensus       220 ----~~~~~~~~~---~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         220 ----LMSKSNFQP---PKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----eeecCCCCC---CCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                000000000   000  00111234588999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.5e-40  Score=310.65  Aligned_cols=263  Identities=23%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             ccccccccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      .++|.+.+.||+|+||.||+|+..+      .++..+|+|.+....             .......+..|+.++..+ +|
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~~h   83 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------------TEKDLSDLISEMEMMKMIGKH   83 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------------ChHHHHHHHHHHHHHHHhcCC
Confidence            4578999999999999999997642      123579999884321             112246788899999999 79


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||+++++++...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+   .+
T Consensus        84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~g  160 (307)
T cd05098          84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KK  160 (307)
T ss_pred             CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CC
Confidence            9999999999999999999999999999999975321            12358999999999999999999994   45


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      ++|+||||+||+++.++.++|+|||.+................+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999886643322111112234578999999998889999999999999999998 88


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .||....       ..+...........          ..+......+.+++..||+.+|.+|||+.+|++.|..+
T Consensus       241 ~p~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         241 SPYPGVP-------VEELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             CCCCcCC-------HHHHHHHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            8875321       11222222111110          01112234588899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-40  Score=339.44  Aligned_cols=258  Identities=20%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+++.||.|+||+||+|+... ++..+|+|.+......            ......+..|+.++++++|||||+++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l~------------e~~~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGLK------------EREKSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEeccccC------------HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            3579999999999999999999874 7889999988432211            12356789999999999999999999


Q ss_pred             eEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEecCCCCCcEEe
Q 014140          213 ARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR----PRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~Dlkp~Nill  286 (430)
                      ++|..  ...+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            98865  356899999999999999997644445679999999999999999999996431    459999999999999


Q ss_pred             CC-----------------CCceEEeecCCcccCCCCCCcceeeccccccccccccccCC--CCCCcchhHHHHHHHHHH
Q 014140          287 DD-----------------DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       287 ~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~e  347 (430)
                      +.                 .+.+||+|||++..+......   ....||+.|+|||++.+  ..++.++|||||||++|+
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence            64                 345899999999876433221   23478999999999865  358899999999999999


Q ss_pred             HHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          348 LVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       348 ll~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      |++|..||....      .....+..........       ....    ...+.+|+..||+.+|.+||++.+++.
T Consensus       236 LLTGk~PF~~~~------~~~qli~~lk~~p~lp-------i~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        236 LCSGKTPFHKAN------NFSQLISELKRGPDLP-------IKGK----SKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHCCCCCCcCC------cHHHHHHHHhcCCCCC-------cCCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999999986421      1222222222111110       0111    234889999999999999999999983

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.3e-40  Score=317.01  Aligned_cols=265  Identities=20%  Similarity=0.270  Sum_probs=200.5

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  207 (430)
                      .++|.+.+.||.|+||.||+|...    ..+++.||||++.....             ......+.+|+.++.++ +|||
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~n   72 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHHLN   72 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------------hHHHHHHHHHHHHHHhccCCcc
Confidence            457999999999999999999742    23678999999843211             12246788999999999 6899


Q ss_pred             cccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcC--------------------------------------------
Q 014140          208 IVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQ--------------------------------------------  242 (430)
Q Consensus       208 iv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------  242 (430)
                      |++++++|... ...++||||+++|+|.++++....                                            
T Consensus        73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (343)
T cd05103          73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGF  152 (343)
T ss_pred             HhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccc
Confidence            99999988654 467899999999999999864211                                            


Q ss_pred             -------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccC
Q 014140          243 -------------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       243 -------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  303 (430)
                                         ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             cCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence                               012478888899999999999999954   5999999999999999999999999999876


Q ss_pred             CCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCCCCch
Q 014140          304 PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR  382 (430)
Q Consensus       304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (430)
                      .............++..|+|||++.+..++.++||||||+++|+|++ |..||......   ..+...   ........ 
T Consensus       230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~~~~~~-  302 (343)
T cd05103         230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRR---LKEGTRMR-  302 (343)
T ss_pred             ccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHHH---HhccCCCC-
Confidence            43322222212345678999999998899999999999999999997 88997643211   111111   11111110 


Q ss_pred             hccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        .+   ...    ...+.+++..||+.+|.+|||+.+|++.|+.+-
T Consensus       303 --~~---~~~----~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         303 --AP---DYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             --CC---CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              00   011    124789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-40  Score=306.94  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             cccccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .+|.+.+.||+|+||.||+|..   ...++..||+|++....              ......+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~   69 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------------AEHLRDFEREIEILKSLQHDNIVK   69 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCCCeeE
Confidence            4688899999999999999974   23478899999984321              123567889999999999999999


Q ss_pred             ceeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++...  ...++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||++++
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~  143 (284)
T cd05081          70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVES  143 (284)
T ss_pred             EEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECC
Confidence            99987643  467899999999999999853   23458999999999999999999994   45999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc------
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH------  361 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~------  361 (430)
                      ++.++|+|||++.......... ......++..|+|||++.+..++.++||||||++++||++|..|+......      
T Consensus       144 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~  223 (284)
T cd05081         144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG  223 (284)
T ss_pred             CCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc
Confidence            9999999999998775433211 111122345699999999888999999999999999999987764321110      


Q ss_pred             --cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          362 --TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       362 --~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        .........+.........         ..........+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         224 NDKQGQMIVYHLIELLKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cccccccchHHHHHHHhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence              0000001111111111100         0011122345889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.3e-40  Score=308.77  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|..+    +..+..||+|.+....             .......+.+|+.+++.++||||
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~i   71 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------------SLRERIEFLNEASVMKGFTCHHV   71 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------------CHHHHHHHHHHHHHHHhCCCCCe
Confidence            467999999999999999999753    2245689999873221             11223567889999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      +++++++...+..++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||+   ++++||||||+
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~  148 (288)
T cd05061          72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAAR  148 (288)
T ss_pred             eeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChh
Confidence            9999999999999999999999999999975321      12446778889999999999999994   45999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ||++++++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... 
T Consensus       149 nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-  227 (288)
T cd05061         149 NCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-  227 (288)
T ss_pred             eEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999986544322222212345678999999998899999999999999999999 7888754221 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                            .+..........+..          +......+.+++..||+.+|.+|||+.++++.|.+.
T Consensus       228 ------~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         228 ------EQVLKFVMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------HHHHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  122222222111110          011124588999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.7e-40  Score=307.61  Aligned_cols=254  Identities=25%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |+..+.||.|+||.||+|.... +++.||+|.+......           .......+.+|+.+++.++|+|++++++.+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~   69 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIK-----------KRKGESMALNEKQILEKVNSRFVVSLAYAY   69 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhcc-----------chHHHHHHHHHHHHHHhCCCCCeeeeeEEE
Confidence            6777899999999999998875 8999999988432111           112235577899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .+.+..++||||+++|+|.+++..  .....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        70 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~  144 (285)
T cd05630          70 ETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS  144 (285)
T ss_pred             ecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999864  2334589999999999999999999954   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||++.........   ....|+..|+|||++.+..++.++||||||+++|+|++|..||........    ........
T Consensus       145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~~~  217 (285)
T cd05630         145 DLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLV  217 (285)
T ss_pred             eccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHhhh
Confidence            99998765433221   134689999999999998999999999999999999999999875322110    01111111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      ....      ......    ....+.+++..||+.||++|||     +.++++
T Consensus       218 ~~~~------~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 KEVQ------EEYSEK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhh------hhcCcc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1000      000111    1234788999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-40  Score=320.91  Aligned_cols=261  Identities=19%  Similarity=0.222  Sum_probs=197.8

Q ss_pred             ccccccccccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ...|.+.+.||.|+||.||+|...+ ..+..|++|.+..                   .....+|+.+|++++||||+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-------------------~~~~~~E~~il~~l~h~~iv~~  151 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-------------------GKTPGREIDILKTISHRAIINL  151 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc-------------------cccHHHHHHHHHhcCCCCccce
Confidence            3569999999999999999997542 2567899998732                   1234579999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++|||++. ++|.+++.    ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       152 ~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~  223 (392)
T PHA03207        152 IHAYRWKSTVCMVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPEN  223 (392)
T ss_pred             eeeEeeCCEEEEEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCC
Confidence            999999999999999995 58988883    345799999999999999999999955   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++................||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+
T Consensus       224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~  303 (392)
T PHA03207        224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII  303 (392)
T ss_pred             EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence            99999999987655433333334679999999999999999999999999999999999999986533211111111111


Q ss_pred             HHHh----------------------cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVM----------------------TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....                      ...++.......+..   ......+.+++.+||+.||++|||+.+++.
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            1110                      000000000000000   011234778999999999999999999985

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.5e-40  Score=337.40  Aligned_cols=265  Identities=25%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.... +|+.||+|++.....           .......++.+|+.+++.++||||+++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~-----------~~e~~~~rflrEi~ILs~L~HPNIVkl~~   69 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLS-----------ENPLLKKRFLREAKIAADLIHPGIVPVYS   69 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC-CCcEEEEEEECcccc-----------cCHHHHHHHHHHHHHHHhCCCcCcCeEEE
Confidence            468999999999999999998764 799999999843211           11233567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQG-------RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++.+++..++||||++||+|.+++......       ...+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILL  146 (932)
T PRK13184         70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILL  146 (932)
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEE
Confidence            999999999999999999999998642211       23456778899999999999999955   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCC----------------cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          287 DDDMEARISEFGLAKRIPDGHT----------------RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                      +.++.++|+|||++........                ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT  226 (932)
T PRK13184        147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT  226 (932)
T ss_pred             cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999999999999987621110                001112469999999999999999999999999999999999


Q ss_pred             CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcc
Q 014140          351 GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-NSKDVRCMLSQI  428 (430)
Q Consensus       351 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~ev~~~L~~l  428 (430)
                      |..||.....    .....  .....  .+... .      .....+..+.+++.+||+.||++|| ++.++.+.|+.+
T Consensus       227 G~~PF~~~~~----~ki~~--~~~i~--~P~~~-~------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        227 LSFPYRRKKG----RKISY--RDVIL--SPIEV-A------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCCCCCCcch----hhhhh--hhhcc--Chhhc-c------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999865211    11110  01110  01000 0      0012223478899999999999995 566777766643

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-40  Score=321.93  Aligned_cols=257  Identities=18%  Similarity=0.241  Sum_probs=196.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +++.+|+|.+.....           ........+.+|+.+++.++||||++++
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAFANSPWVVQLF  109 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4679999999999999999999864 789999999843211           1112245678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         110 CAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence            999999999999999999999999843     2488999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ||+|||++.......... .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||.....       .
T Consensus       182 kL~DFG~a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~  253 (370)
T cd05621         182 KLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------V  253 (370)
T ss_pred             EEEecccceecccCCcee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------H
Confidence            999999998764332211 12457999999999987643    78899999999999999999999864321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~~  424 (430)
                      .............. +.      ........+.+++..||..+|.+  ||++.++++.
T Consensus       254 ~~~~~i~~~~~~~~-~p------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         254 GTYSKIMDHKNSLN-FP------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHhCCcccC-CC------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            12222222111000 00      00112234778888888755543  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-40  Score=320.55  Aligned_cols=262  Identities=20%  Similarity=0.247  Sum_probs=195.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|+||.||+|... .+|+.||||++.....            .......+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~   67 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQ------------NLVSCKRVFRELKMLCFFKHDNVLSALDI   67 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEecccccc------------chHHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence            3778899999999999999875 3899999998843211            11224678899999999999999999999


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          215 MVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       215 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +...+     ..++|+||+. ++|.+.+.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.+
T Consensus        68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~  139 (372)
T cd07853          68 LQPPHIDPFEEIYVVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSN  139 (372)
T ss_pred             ecCCCccccceEEEEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCC
Confidence            98776     7899999996 58888873    345799999999999999999999955   59999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +.+||+|||++.......... .....+|..|+|||++.+. .++.++|||||||++|||++|+.||......    ...
T Consensus       140 ~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~  214 (372)
T cd07853         140 CVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI----QQL  214 (372)
T ss_pred             CCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH----HHH
Confidence            999999999998654332211 1134678999999998875 4799999999999999999999998653221    111


Q ss_pred             HHHHHHhcCCCC-------------------chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENP-------------------NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+......+..                   ........ ..........+.+++.+||+.||.+|||+.++++
T Consensus       215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            111111110000                   00000000 0001111345789999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=300.42  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=197.0

Q ss_pred             cccccccCceEEEeecCCCC--CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELPGSS--GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||+|+||.||+|.+...+  +..+|+|.+......             .....+.+|+.+++.+.|||++++++++. 
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   66 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------------AGKKEFLREASVMAQLDHPCIVRLIGVCK-   66 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-
Confidence            46899999999999875433  278999988432211             23567899999999999999999999875 


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      .+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||..   +++|+||||+||+++.++.++|+||
T Consensus        67 ~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df  139 (257)
T cd05060          67 GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDF  139 (257)
T ss_pred             CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccc
Confidence            5567999999999999999954    33689999999999999999999944   5999999999999999999999999


Q ss_pred             CCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHh
Q 014140          298 GLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       298 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |+++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....    ...+...+... 
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~~~~-  214 (257)
T cd05060         140 GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAMLESG-  214 (257)
T ss_pred             cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHcC-
Confidence            9998765433211 1111234568999999998899999999999999999998 999986532    12222222211 


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                        ...          ..+......+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       215 --~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~  257 (257)
T cd05060         215 --ERL----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE  257 (257)
T ss_pred             --CcC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence              110          0111122358899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.6e-40  Score=306.90  Aligned_cols=254  Identities=23%  Similarity=0.287  Sum_probs=197.2

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||.|+||+||+|.... +|+.+|+|.+.....           ........+.+|+.+++.++|+|++.+.+++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~   69 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRI-----------KKRKGESMALNEKQILEKVNSQFVVNLAYAY   69 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhh-----------hhhhHHHHHHHHHHHHHHcCCcCceeEEEEE
Confidence            6677899999999999998764 899999999843211           1112235578899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ..++..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+
T Consensus        70 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~  144 (285)
T cd05632          70 ETKDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             ecCCEEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEe
Confidence            999999999999999999998864  233469999999999999999999994   459999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||++.........   ....|+..|+|||++.+..++.++|+||||+++|+|++|..||.....    ......+....
T Consensus       145 Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~  217 (285)
T cd05632         145 DLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRV  217 (285)
T ss_pred             cCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhh
Confidence            99998765433221   234689999999999988999999999999999999999999865321    11111111111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      .....  .        ........+.+++..||+.||.+||+     +.+++.
T Consensus       218 ~~~~~--~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         218 LETEE--V--------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             hcccc--c--------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            11110  0        01112234788999999999999999     556654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.6e-39  Score=307.08  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=200.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.... +|..+|+|.+....             ......++.+|+.++.+++||||+++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~   66 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEI-------------KPAIRNQIIRELKVLHECNSPYIVGFYG   66 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC-CCeEEEEEEecccc-------------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            368899999999999999998764 78899999874321             1123467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|..++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.  .+++|+||+|+|||++.++.++
T Consensus        67 ~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~  140 (308)
T cd06615          67 AFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIK  140 (308)
T ss_pred             EEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEE
Confidence            99999999999999999999999953    35689999999999999999999953  2599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++........    ....|+..|+|||++.+..++.++|+||||+++++|++|..||.....    .........
T Consensus       141 l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~  212 (308)
T cd06615         141 LCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGR  212 (308)
T ss_pred             EccCCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcC
Confidence            999999876543221    134688999999999888899999999999999999999999853211    111111110


Q ss_pred             HhcCCCCch--------------------hcc----ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNR--------------------AIN----SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~--------------------~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .........                    ..+    ..............+.+++.+||+.+|++||++.+|++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000000                    000    000000000123358899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.9e-40  Score=309.86  Aligned_cols=258  Identities=22%  Similarity=0.273  Sum_probs=197.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ++|.+.+.||.|+||.||+|.... ++.  .+++|.+....             .......+.+|+.++.++ +||||++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~-------------~~~~~~~~~~E~~~l~~l~~hp~iv~   67 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFA-------------SENDHRDFAGELEVLCKLGHHPNIIN   67 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccC-------------CHHHHHHHHHHHHHHHhhcCCCchhh
Confidence            468889999999999999998753 443  46888763211             112246788999999999 7999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      +++++...+..++|+||+++|+|.+++.....            ....+++..++.++.|++.||+|||+   .+++|||
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~d  144 (297)
T cd05089          68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRD  144 (297)
T ss_pred             eEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCc
Confidence            99999999999999999999999999964211            12358899999999999999999995   4599999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDD  357 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~  357 (430)
                      |||+|||++.++.+||+|||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       145 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         145 LAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             CCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999864322111   111223567999999998889999999999999999997 9999864


Q ss_pred             cccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...       .+..........+          ..+......+.+++..||+.+|.+||++.++++.|..+
T Consensus       222 ~~~-------~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         222 MTC-------AELYEKLPQGYRM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             CCH-------HHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            321       1111112111110          00111223488999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=333.81  Aligned_cols=260  Identities=22%  Similarity=0.357  Sum_probs=214.2

Q ss_pred             cccccccccccccccCceEEEeecCCCC--CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ..+...+.++||.|.||.|++|+++...  ...||||-++...             .+++...|+.|+.||.++.||||+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------------tekqrrdFL~EAsIMGQFdHPNII  693 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------------TEKQRRDFLSEASIMGQFDHPNII  693 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------------cHHHHhhhhhhhhhcccCCCCcEE
Confidence            4567788899999999999999997432  3589999885432             235578899999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +|.|+.+.....+||+|||++|+|+.+|+.   ..+.+++.+..-++.+|+.||.||-   +++++||||.+.|||+|.+
T Consensus       694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsn  767 (996)
T KOG0196|consen  694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSN  767 (996)
T ss_pred             EEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccc
Confidence            999999999999999999999999999965   4466999999999999999999999   5569999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeecccc--ccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMS  366 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~  366 (430)
                      ..+||+|||+++.+.++.....+ ..-|  ...|.|||.+...++|.+|||||||+++||.++ |..||=++..    .+
T Consensus       768 LvCKVsDFGLSRvledd~~~~yt-t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----Qd  842 (996)
T KOG0196|consen  768 LVCKVSDFGLSRVLEDDPEAAYT-TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QD  842 (996)
T ss_pred             eEEEeccccceeecccCCCcccc-ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----HH
Confidence            99999999999988665422211 1222  578999999999999999999999999999988 8899755433    22


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .   ++.+...-++..          +.+++..+.+|++.||++|-.+||.+.+|+.+|.++
T Consensus       843 V---IkaIe~gyRLPp----------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  843 V---IKAIEQGYRLPP----------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             H---HHHHHhccCCCC----------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            2   333332333332          234456699999999999999999999999999876

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.5e-40  Score=313.49  Aligned_cols=241  Identities=22%  Similarity=0.247  Sum_probs=186.4

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH-HHHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||.|+||.||+|+... +|+.||+|++......           .......+..|. .+++.++||||+++++++.+.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~   68 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTIL-----------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA   68 (321)
T ss_pred             CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHH-----------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence            368999999999998764 8899999998432111           111233455555 467889999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|...+..    ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          69 EKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            999999999999999988843    35688899999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|..||....       ............
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~  212 (321)
T cd05603         142 LCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHKP  212 (321)
T ss_pred             CCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcCC
Confidence            9875432221  1223578999999999999899999999999999999999999986421       122222222211


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      ..           .+......+.+++.+||+.+|.+||++.
T Consensus       213 ~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 LQ-----------LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC-----------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            10           0111223478899999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.4e-40  Score=305.45  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=196.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      +++.|.+.+.||.|+||.||+|.... +++.+|+|.+.....               ....+..|+.++..+ +|||+++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~~   67 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTGD---------------EEEEIKQEINMLKKYSHHRNIAT   67 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcCCc---------------cHHHHHHHHHHHHHhcCCCCeee
Confidence            45678999999999999999998764 789999998843211               135678899999998 6999999


Q ss_pred             ceeEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          211 LLARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       211 l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++++...      ...++||||+++|+|.+++..  .....+++..+..++.|++.||+|||+.   +++|+||+|+||
T Consensus        68 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~ni  142 (272)
T cd06637          68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV  142 (272)
T ss_pred             EeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHE
Confidence            99998763      457899999999999999864  2335689999999999999999999955   499999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      ++++++.++|+|||++.........  .....|+..|+|||++.     +..++.++|||||||++|||++|..||....
T Consensus       143 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         143 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             EECCCCCEEEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999999999999999865432221  12356899999999986     3358889999999999999999999986432


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..      .... ...... .....        .......+.+++.+||+.+|.+|||+.++++
T Consensus       221 ~~------~~~~-~~~~~~-~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         221 PM------RALF-LIPRNP-APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HH------HHHH-HHhcCC-CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            21      1111 111111 00000        0112234889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-39  Score=302.72  Aligned_cols=258  Identities=22%  Similarity=0.341  Sum_probs=201.4

Q ss_pred             cccccccccccccCceEEEeecCCCCC---ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      +.|.+.+.||+|+||.||+|.+.. ++   ..||||.+....             .......+..|+.+++.++||||++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni~~   69 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKL-PGKREIFVAIKTLKSGY-------------TEKQRRDFLSEASIMGQFDHPNIIH   69 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEec-CCCCceeEEEEEcCCCC-------------CHHHHHHHHHHHHHHHhCCCcCcce
Confidence            357889999999999999998764 33   369999874211             1233577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++..++..++||||+++|+|.+++..   ..+.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~  143 (269)
T cd05065          70 LEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNL  143 (269)
T ss_pred             EEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCC
Confidence            99999999999999999999999999854   235689999999999999999999954   599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeec-cc--cccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWS-LA--GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMS  366 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~  366 (430)
                      .++|+|||++.............. ..  .+..|+|||++.+..++.++||||||+++||+++ |..||.....    ..
T Consensus       144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~  219 (269)
T cd05065         144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QD  219 (269)
T ss_pred             cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HH
Confidence            999999999887654322111111 11  2457999999999899999999999999999886 9999764321    12


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...++...   ....          .+.+.+..+.+++..||+.+|++||++.+|+..|+++
T Consensus       220 ~~~~i~~~---~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         220 VINAIEQD---YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHcC---CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            22222111   1110          0111223478899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-39  Score=306.21  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|++|+||+|.... +|..||+|.+.....             ......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~   70 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAK-------------SSVRKQILRELQIMHECRSPYIVSFYG   70 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecCc-------------chHHHHHHHHHHHHHHcCCCCcceEee
Confidence            568899999999999999998763 789999998743211             123567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++..    .+.+++.....++.+++.||.|||+.  .+++|+||+|+||++++++.++
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~  144 (284)
T cd06620          71 AFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIK  144 (284)
T ss_pred             eEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEE
Confidence            99999999999999999999998843    34689999999999999999999953  2599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc----ccccHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT----KEMSLVQ  369 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~----~~~~l~~  369 (430)
                      |+|||++........    ....|+..|+|||++.+..++.++|+|||||+++++++|..||.......    ....+..
T Consensus       145 l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~  220 (284)
T cd06620         145 LCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD  220 (284)
T ss_pred             EccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence            999999876533221    13468999999999988899999999999999999999999987543321    1112223


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      +.........+.      +   ........+.+++..||+.||++||++.|+++..
T Consensus       221 ~~~~~~~~~~~~------~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         221 LLQQIVQEPPPR------L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHhhccCCC------C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            333332221111      0   0011234588999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-39  Score=303.75  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=187.8

Q ss_pred             ccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          141 KIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      .||+|+||.||+|.... .....+++|.+....             .......+.+|+.+++.++||||+++++++...+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~   68 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI   68 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence            58999999999997532 234578888763211             1122467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      ..++||||+++|+|.+++...... ....++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||
T Consensus        69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          69 PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccc
Confidence            999999999999999999653321 23456788899999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-------VALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++................++..|+|||++..       ..++.++|||||||++|||++ |..||.....    ...   
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~---  218 (269)
T cd05042         146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQV---  218 (269)
T ss_pred             cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHH---
Confidence            9876543322211222345778999998643       356889999999999999999 7788764321    111   


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      .......... ....+.....    ....+.+++..|| .||++|||+.+|++.|.
T Consensus       219 ~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         219 LKQVVREQDI-KLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHhhccCc-cCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111111 1111111111    2234667888888 59999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.5e-40  Score=311.98  Aligned_cols=244  Identities=23%  Similarity=0.243  Sum_probs=191.3

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLAR  214 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  214 (430)
                      |...+.||+|+||.||+|+... +|+.||+|.+.....           ........+..|..++..+. ||+|++++++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVV-----------IQDDDVECTMVEKRVLALQDKPPFLTQLHSC   69 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhccCCCchhheeeE
Confidence            6778999999999999998764 899999999853211           11122456778899998885 5778889999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|
T Consensus        70 ~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL  142 (323)
T cd05615          70 FQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence            9999999999999999999999843    35699999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ...   ....
T Consensus       143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~---~~~i  213 (323)
T cd05615         143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DEL---FQSI  213 (323)
T ss_pred             eccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHH---HHHH
Confidence            99999876432221  12235689999999999998999999999999999999999999865321    111   1222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ......           .+......+.+++.+||+.+|.+|++.
T Consensus       214 ~~~~~~-----------~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         214 MEHNVS-----------YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HhCCCC-----------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            211110           011112347889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.4e-40  Score=314.09  Aligned_cols=244  Identities=23%  Similarity=0.246  Sum_probs=187.2

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH-HHHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|+... +++.||+|++......           .......+..|. .+++.++||||+++++++...
T Consensus         1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~   68 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAIL-----------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA   68 (325)
T ss_pred             CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHH-----------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC
Confidence            368999999999998764 7899999998532110           011123344444 456788999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...++......++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          69 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             CeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            999999999999999999843    34578888899999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+.........
T Consensus       142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~  212 (325)
T cd05602         142 LCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKP  212 (325)
T ss_pred             CCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC
Confidence            9976432221  12235799999999999999999999999999999999999999864321       11222222111


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ..   +.        +.....+.+++..||+.+|.+||++.+.+
T Consensus       213 ~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 LQ---LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             cC---CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            10   00        11223478899999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=314.91  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=216.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .....+.+.||+|-||.|.++...  .+..||||.++....             .+....|..|+++|.+|+|||||.++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~-------------~~~r~~F~kEIkiLsqLkhPNIveLv  601 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDAT-------------KNARNDFLKEIKILSRLKHPNIVELL  601 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccc-------------hhHHHHHHHHHHHHhccCCCCeeEEE
Confidence            456778899999999999999985  569999999954332             23368899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|..++.+++|+|||++|+|..++.....  ..+.-..-.+|+.||+.||+||.+.+   ++||||.+.|+|++.++++
T Consensus       602 GVC~~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~i  676 (807)
T KOG1094|consen  602 GVCVQDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTI  676 (807)
T ss_pred             eeeecCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccE
Confidence            999999999999999999999999965322  22444556779999999999999887   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccccccccHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI--GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ||+|||+++.+..+.+.......+-...|||||.+..++++.+||||+||+++||+++  ...||.....    ...++-
T Consensus       677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven  752 (807)
T KOG1094|consen  677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVEN  752 (807)
T ss_pred             EecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHh
Confidence            9999999998877776666555566789999999999999999999999999999876  5688776433    334444


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .............+      ..++.++..+.+++..||+.+..+||+++++...|++.
T Consensus       753 ~~~~~~~~~~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  753 AGEFFRDQGRQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhcCCCCcceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            44444433322211      22334445588999999999999999999999998764

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-39  Score=308.75  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             ccccccccccccccCceEEEeecC------CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP------GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      .++|.+.+.||+|+||.||+|+..      ...+..+|+|.+.....             ......+.+|+.+++.+ +|
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h   77 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------------DKDLADLISEMELMKLIGKH   77 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------------hHHHHHHHHHHHHHHhccCC
Confidence            457889999999999999999753      12356789998742211             12356788999999999 69


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||++++++|...+..++||||+++|+|.+++.....            ....+++..+..++.|++.||.|||+   .+
T Consensus        78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~g  154 (314)
T cd05099          78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RR  154 (314)
T ss_pred             CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CC
Confidence            9999999999999999999999999999999965321            12458999999999999999999994   45


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      ++|+||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       155 i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~  234 (314)
T cd05099         155 CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG  234 (314)
T ss_pred             eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987654322222212234567999999998889999999999999999999 88


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .||.....    ..+...+   . .....         ..+......+.+++.+||+.+|++||++.++++.|.++.
T Consensus       235 ~p~~~~~~----~~~~~~~---~-~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         235 SPYPGIPV----EELFKLL---R-EGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             CCCCCCCH----HHHHHHH---H-cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            88754211    1122211   1 11110         001112234778999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.5e-40  Score=314.62  Aligned_cols=244  Identities=23%  Similarity=0.253  Sum_probs=188.3

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHH-HHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII-TAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||.|+||.||+|+... +|+.+|+|++......           .......+..|.. +++.++||||+++++++...
T Consensus         1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~   68 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVL-----------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT   68 (325)
T ss_pred             CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC
Confidence            368999999999998764 8999999998432111           1122344555554 56778999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|..++.    ....+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          69 EKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             CEEEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            99999999999999998884    345689999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....       ..+.........
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~~  212 (325)
T cd05604         142 LCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHKP  212 (325)
T ss_pred             CcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcCC
Confidence            9875432211  1123578999999999999999999999999999999999999986421       112222222211


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ..   +.    ..    ....+.+++..|++.+|.+||++.+.+
T Consensus       213 ~~---~~----~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         213 LV---LR----PG----ASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             cc---CC----CC----CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            10   00    11    123477899999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.5e-40  Score=308.07  Aligned_cols=263  Identities=20%  Similarity=0.237  Sum_probs=191.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l  211 (430)
                      .|.+.+.||+|+||.||+|+... +|+.||+|.+.......            .....+.+|+.+++.+   +||||+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~h~ni~~~   67 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNED------------GLPLSTVREVALLKRLEAFDHPNIVRL   67 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCCC------------CCchHHHHHHHHHHHhhhcCCCCeeee
Confidence            47888999999999999998764 89999999885422110            0112345566666555   79999999


Q ss_pred             eeEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          212 LARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       212 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++++...     ...++||||+++ +|.+++..  .....+++..+..++.|++.||.|||+.   +++||||||+||++
T Consensus        68 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili  141 (288)
T cd07863          68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILV  141 (288)
T ss_pred             eeeeccccCCCCceEEEEEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            9988652     457899999975 89998854  2234589999999999999999999955   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||++.........   ....||..|+|||++.+..++.++|||||||++|+|++|.+||......    .
T Consensus       142 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~  214 (288)
T cd07863         142 TSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----D  214 (288)
T ss_pred             CCCCCEEECccCccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----H
Confidence            99999999999999876533221   1346799999999999989999999999999999999999998643211    1


Q ss_pred             HHHHHHHHhcCCC----C------chhcccc---ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSEN----P------NRAINSK---LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~----~------~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+........    +      ...+.+.   ......+.....+.+++.+||+.||++|||+.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         215 QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111110000    0      0000000   000011123345789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.6e-40  Score=318.14  Aligned_cols=257  Identities=18%  Similarity=0.237  Sum_probs=196.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +++.+|+|.+.....           ........+.+|..+++.++||||++++
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~-----------~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4679999999999999999999864 889999999843211           1112245678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..     ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCE
Confidence            999999999999999999999999843     3478889999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ||+|||++.......... .....||+.|+|||++.+..    ++.++|||||||++|||++|..||....       ..
T Consensus       182 kL~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~  253 (371)
T cd05622         182 KLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LV  253 (371)
T ss_pred             EEEeCCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HH
Confidence            999999998765332211 12357999999999987643    7889999999999999999999986421       12


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~~  424 (430)
                      .....+.........       .........+.+++..||+.++.+  ||++.++++.
T Consensus       254 ~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         254 GTYSKIMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            222333322111100       001112334778888999844433  6788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-39  Score=300.94  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCC---ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|...+.||+|++|.||+|.+.. ++   ..+++|.+....             .......+.+|+.+++.++|||++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~   69 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKM-PGRKEVAVAIKTLKPGY-------------TEKQRQDFLSEASIMGQFSHHNII   69 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEec-CCCCceEEEEEeccccC-------------CHHHHHHHHHHHHHHhcCCCCCee
Confidence            3468889999999999999998753 33   379999874321             112246788999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++.+++...+..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.+
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~  143 (268)
T cd05063          70 RLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSN  143 (268)
T ss_pred             EEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCC
Confidence            999999999999999999999999999853   335689999999999999999999955   59999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCccee-eccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTT-WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      +.++++|||++............ .....+..|+|||++.+..++.++|||||||++|||++ |..||.....    .  
T Consensus       144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~--  217 (268)
T cd05063         144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----H--  217 (268)
T ss_pred             CcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----H--
Confidence            99999999999876543222111 11223457999999998889999999999999999997 9999854321    1  


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                       +.............          .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       218 -~~~~~i~~~~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         218 -EVMKAINDGFRLPA----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -HHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             12222211111110          111223488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-39  Score=300.05  Aligned_cols=255  Identities=21%  Similarity=0.324  Sum_probs=201.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.+.  .+..+++|.+....               .....+.+|+.+++.++|+|+++++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~   67 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS---------------MSVEAFLAEANVMKTLQHDKLVKLH   67 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCCh---------------hHHHHHHHHHHHHHhcCCCCcceEE
Confidence            457899999999999999999865  66779999874211               1246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.. ...+++|||+++|+|.+++..  .....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~  141 (260)
T cd05073          68 AVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVC  141 (260)
T ss_pred             EEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcE
Confidence            99887 778999999999999999964  2345688999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||.+.......... .....++..|+|||++.+..++.++|+||||+++|++++ |..||....    .......+
T Consensus       142 ~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~  216 (260)
T cd05073         142 KIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRAL  216 (260)
T ss_pred             EECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence            999999998765432211 112345678999999998889999999999999999999 899976432    11222222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....   ..          .........+.+++.+||+.+|++||++.++.+.|+.+
T Consensus       217 ~~~~---~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         217 ERGY---RM----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             hCCC---CC----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            1111   10          00111233488999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-40  Score=323.28  Aligned_cols=206  Identities=25%  Similarity=0.371  Sum_probs=174.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|...+.||+|+||.||+|+... +|+.||+|.+.....           ........+..|+.++..++||||+++++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~   68 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADM-----------LEKEQVAHIRAERDILVEADGAWVVKMFY   68 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHH-----------hhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            368889999999999999998764 899999999853211           11223567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vk  141 (360)
T cd05627          69 SFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVK  141 (360)
T ss_pred             EEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999843    45689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCc---------------------------------ceeeccccccccccccccCCCCCCcchhHHH
Q 014140          294 ISEFGLAKRIPDGHTR---------------------------------TTTWSLAGTVGYIAPECHQTVALSDTCDIYS  340 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  340 (430)
                      |+|||++..+......                                 .......||+.|+|||++.+..++.++||||
T Consensus       142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS  221 (360)
T cd05627         142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (360)
T ss_pred             EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence            9999998755321100                                 0011346999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q 014140          341 FGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       341 lG~~l~ell~g~~p~~~~  358 (430)
                      |||++|||++|..||...
T Consensus       222 lGvilyel~tG~~Pf~~~  239 (360)
T cd05627         222 LGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccceeeecccCCCCCCCC
Confidence            999999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-39  Score=300.48  Aligned_cols=259  Identities=21%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             cccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .+|.+.+.||+|+||.||+|.+...  .+..+|+|.+....             .......+.+|+.++..++||||+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~   70 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------------TEKQRRDFLSEASIMGQFDHPNIIHL   70 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------------CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4688899999999999999987532  23478999874321             11235678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++..++..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  144 (267)
T cd05066          71 EGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLV  144 (267)
T ss_pred             EEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCe
Confidence            9999999999999999999999999954   234689999999999999999999954   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCccee-eccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTT-WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      ++++|||++............ ....++..|+|||++.+..++.++|+||||++++++++ |..||.....    .....
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~  220 (267)
T cd05066         145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIK  220 (267)
T ss_pred             EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHH
Confidence            999999999877543322111 11233568999999999899999999999999999886 9999865322    11222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+..   ...+..          +...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       221 ~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         221 AIEE---GYRLPA----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHhC---CCcCCC----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            2211   111100          011223478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=298.28  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=202.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|..   .|+.||+|.+.....               ...++.+|+.+++.++|||+++++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~   66 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST---------------AAQAFLAEASVMTTLRHPNLVQLL   66 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh---------------HHHHHHHHHHHHHhcCCcceeeeE
Confidence            35688899999999999999975   688999999843211               256789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~  141 (256)
T cd05039          67 GVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVA  141 (256)
T ss_pred             EEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCE
Confidence            999999999999999999999999964  2233689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||.++.......     ...++..|+|||++.+..++.++||||||++++++++ |..||.....    ..+...+
T Consensus       142 ~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~  212 (256)
T cd05039         142 KVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHV  212 (256)
T ss_pred             EEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence            9999999987643322     1234678999999998889999999999999999997 9999764321    1122111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..   .....          .+...+..+.+++.+||..+|++|||+.+++++|+++
T Consensus       213 ~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 EK---GYRME----------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             hc---CCCCC----------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11   11110          0111234588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=310.07  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=208.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      ...|.+.+.||.|.||.||+++.+. +|+.+|+|.+.......           ......+.+|+.+|+++. |||||.+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~-tg~~~A~K~i~k~~~~~-----------~~~~~~v~~Ev~il~~l~~hpniv~l  101 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS-TGKEVACKVIPKRKLRG-----------KEDREDVRREVAILQQLSGHPNIVQL  101 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC-CCceeEEEEeehhhccc-----------cccHHHHHHHHHHHHhccCCCCEEEE
Confidence            4678999999999999999999875 79999999995543321           113567999999999998 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC--
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--  289 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--  289 (430)
                      +++|.+.+..++|||++.||.|.+.+...     .+++..+..++.|++.++.|||+   .|++||||||+|+|+...  
T Consensus       102 ~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  102 KDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             EEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccC
Confidence            99999999999999999999999999653     39999999999999999999995   559999999999999643  


Q ss_pred             --CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 --MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                        +.+|++|||++.....+   ......+||+.|+|||++...+|+..+||||+|+++|.|++|..||......   ...
T Consensus       174 ~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~  247 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIF  247 (382)
T ss_pred             CCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHH
Confidence              47999999999988762   2333579999999999999999999999999999999999999998754321   111


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .    .+.....       .......+.....+.+++..|+..||.+|+|+.++++
T Consensus       248 ~----~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  248 L----AILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             H----HHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1    2221111       1222333444556889999999999999999999986

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-39  Score=300.41  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=187.9

Q ss_pred             ccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          141 KIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      .||+|+||.||+|+... .....+++|.+....             .......+.+|+.+++.++||||+++++.|....
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   68 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI   68 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC
Confidence            68999999999997542 123456666653211             1123567999999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++.........++......++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||+
T Consensus        69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~  145 (268)
T cd05086          69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI  145 (268)
T ss_pred             ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccc
Confidence            99999999999999999975333334577788889999999999999955   499999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQT-------VALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +................++..|+|||++..       ..++.++||||||+++|||++ |..||.....       .+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~  218 (268)
T cd05086         146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVL  218 (268)
T ss_pred             ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence            865332221112223467889999998753       245789999999999999997 4667654221       1122


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ....... .....++.......    ..+.+++..|| .+|++||++.+|++.|.
T Consensus       219 ~~~~~~~-~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         219 NHVIKDQ-QVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHhhc-ccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222111 11222222222222    34777888899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=299.48  Aligned_cols=256  Identities=22%  Similarity=0.322  Sum_probs=202.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|...  ++..+|||.+.....               ....+.+|+.+++.++|||+++++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~   67 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTM---------------SPEAFLQEAQIMKKLRHDKLVQLY   67 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCcc---------------CHHHHHHHHHHHhhCCCCCEeeee
Confidence            457899999999999999999875  668899998843221               135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++......++||||+++++|.+++..  .....+++..+..++.+++.|+.|||+.   +++|+||+|+||++++++.+
T Consensus        68 ~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~  142 (261)
T cd05034          68 AVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVC  142 (261)
T ss_pred             eeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCE
Confidence            999988999999999999999999964  2334689999999999999999999955   49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.......... .....++..|+|||.+.+..++.++|+||||++++++++ |+.||.....    ...... 
T Consensus       143 ~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~-  216 (261)
T cd05034         143 KIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQ-  216 (261)
T ss_pred             EECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH-
Confidence            999999998765422111 112234568999999998889999999999999999998 9999754321    112221 


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        ........          .+...+..+.+++.+||+.+|.+||++.++.+.|+.+
T Consensus       217 --~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         217 --VERGYRMP----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             --HHcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence              11111100          0011123588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.8e-40  Score=301.32  Aligned_cols=252  Identities=18%  Similarity=0.246  Sum_probs=201.0

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|+||.||+++... ++..+|+|.+.....             ......+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   66 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKS-------------SSAVEDSRKEAVLLAKMKHPNIVAFKES   66 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC-CCceEEEEEEEcCcc-------------hHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            47788999999999999998764 789999998843211             1235678889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++|+|.+++..  .....++......++.|++.||.|||+.   +++|+||+|+||++++++.+++
T Consensus        67 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l  141 (255)
T cd08219          67 FEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKL  141 (255)
T ss_pred             EEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEE
Confidence            9999999999999999999998854  2345689999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+..........  ....|+..|+|||++.+..++.++|+||||+++|+|++|..||....       ........
T Consensus       142 ~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~  212 (255)
T cd08219         142 GDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKV  212 (255)
T ss_pred             cccCcceeeccccccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHH
Confidence            9999997664432211  13468899999999999889999999999999999999999986421       11111222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ...... .         .+......+.+++.+||+.||++||++.+|+..
T Consensus       213 ~~~~~~-~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQGSYK-P---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hcCCCC-C---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            211111 0         011122347899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-39  Score=308.04  Aligned_cols=259  Identities=22%  Similarity=0.265  Sum_probs=198.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  209 (430)
                      .++|.+.+.||.|+||.||+|.+.. +|.  .+++|.+....             .......+.+|+.++.++ +||||+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~-------------~~~~~~~~~~Ei~~l~~l~~h~~iv   71 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA-------------SKDDHRDFAGELEVLCKLGHHPNII   71 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccC-------------CHHHHHHHHHHHHHHHHhcCCCCcc
Confidence            3578889999999999999998764 554  45777653211             112356788999999999 899999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      ++++++...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+   .+++||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~  148 (303)
T cd05088          72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHR  148 (303)
T ss_pred             eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence            999999999999999999999999999965321            12468999999999999999999994   459999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+|||++.++.++|+|||++........   .....++..|+|||++.+..++.++|||||||+++||++ |..||.
T Consensus       149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         149 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             ccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence            9999999999999999999999864321111   111234667999999988889999999999999999998 999986


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....    .   +............          .+......+.+++.+||+.+|++||++.++++.|.++
T Consensus       226 ~~~~----~---~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         226 GMTC----A---ELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             cCCh----H---HHHHHHhcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            4321    1   1111111111110          0011123478999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-39  Score=314.58  Aligned_cols=265  Identities=22%  Similarity=0.275  Sum_probs=194.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|..||+|++......            ......+.+|+.+++.++||||++++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~   86 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQN------------QTHAKRAYRELVLLKCVNHKNIISLL   86 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccccc------------hhHHHHHHHHHHHHHhCCCCCEeeee
Confidence            3579999999999999999998753 8999999998533211            12246678999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+      ..|+||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~  156 (359)
T cd07876          87 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV  156 (359)
T ss_pred             eeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            9986543      46999999975 6766663      2478889999999999999999955   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE--  364 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~--  364 (430)
                      +.++.+||+|||+++.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||.........  
T Consensus       157 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~  233 (359)
T cd07876         157 KSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK  233 (359)
T ss_pred             CCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999976543221   12346899999999999999999999999999999999999998753210000  


Q ss_pred             ---------ccH----HHHHHHHhcCCCCch--h----cccccc---CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          365 ---------MSL----VQWMRNVMTSENPNR--A----INSKLL---GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       365 ---------~~l----~~~~~~~~~~~~~~~--~----~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                               ..+    ...............  .    +.....   ..........+.+++.+||+.||++|||+.|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  313 (359)
T cd07876         234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL  313 (359)
T ss_pred             HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence                     000    000111111000000  0    000000   000111124578999999999999999999998


Q ss_pred             H
Q 014140          423 C  423 (430)
Q Consensus       423 ~  423 (430)
                      +
T Consensus       314 ~  314 (359)
T cd07876         314 R  314 (359)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=317.10  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=205.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +..|..++.||.|+||-||-|+... +.++||||++....+..           ...-..+..|+..|++++|||+|.+.
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs-----------~EKWqDIlKEVrFL~~l~HPntieYk   92 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQS-----------NEKWQDILKEVRFLRQLRHPNTIEYK   92 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccC-ccceeeeeecccccccc-----------HHHHHHHHHHHHHHHhccCCCccccc
Confidence            4568999999999999999998764 88999999996654432           22346789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|......|||||||- ||-.|++.-   -.+++.+..+..|+.+.+.||+|||+.+   .||||||+.|||+++.|.|
T Consensus        93 gCyLre~TaWLVMEYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~V  165 (948)
T KOG0577|consen   93 GCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLV  165 (948)
T ss_pred             ceeeccchHHHHHHHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCee
Confidence            99999999999999995 488888853   3457899999999999999999999776   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ||+|||.|......      .+++|||.|||||++..   +.|+.++||||||++..||.-.++|+-.+.       -..
T Consensus       166 KLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMS  232 (948)
T KOG0577|consen  166 KLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMS  232 (948)
T ss_pred             eeccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHH
Confidence            99999999876433      25799999999998764   579999999999999999999999954321       122


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      -+..+-.+..|.         -...+....+..++..||+.-|.+|||..+++.
T Consensus       233 ALYHIAQNesPt---------Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  233 ALYHIAQNESPT---------LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHhcCCCC---------CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            222332232221         113455566889999999999999999999875

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-40  Score=307.58  Aligned_cols=266  Identities=21%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             cccccccccccccCceEEEeecC---CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ..|.+++.||+|+||.||+|++.   ..++..||+|.+....             .......+.+|+.+++.++|||+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~   70 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------------GGNHIADLKKEIEILRNLYHENIVK   70 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------------cHHHHHHHHHHHHHHHhCCCCCeee
Confidence            35788999999999999999753   2368899999884221             1123467899999999999999999


Q ss_pred             ceeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++...  ...++||||+++++|.+++..   ....+++..++.++.|++.||.|||+   .+++||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~  144 (284)
T cd05079          71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVES  144 (284)
T ss_pred             eeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcC
Confidence            99998875  568899999999999999853   23468999999999999999999994   45999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc-------
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ-------  360 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-------  360 (430)
                      ++.++|+|||++..+....... ......++..|+|||++.+..++.++||||||+++|+|+++..|......       
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~  224 (284)
T cd05079         145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG  224 (284)
T ss_pred             CCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence            9999999999998765433221 11234567789999999888899999999999999999998766432110       


Q ss_pred             -ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          361 -HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       361 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                       ............... .....         ..+......+.+++..||+.+|.+||++.++++.|+.+
T Consensus       225 ~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         225 PTHGQMTVTRLVRVLE-EGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccccccHHHHHHHHH-cCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             001111111111111 11100         01112234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-39  Score=302.79  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=197.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ++.|.+.+.||.|+||.||+|.... ++..+++|.+....              ......+.+|+.+++.++|||+++++
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~ii~~~   68 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKS--------------EEELEDYMVEIDILASCDHPNIVKLL   68 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCCC--------------HHHHHHHHHHHHHHHHCCCCCeeeEE
Confidence            3457888999999999999998764 78899999883211              12356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++|+||+++++|..++..   ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~  142 (282)
T cd06643          69 DAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDI  142 (282)
T ss_pred             EEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCE
Confidence            999999999999999999999998753   235689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +|+|||++.........  .....++..|+|||++.     +..++.++|||||||++|+|++|+.||.....       
T Consensus       143 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------  213 (282)
T cd06643         143 KLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------  213 (282)
T ss_pred             EEccccccccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------
Confidence            99999998765432221  12346899999999974     34578899999999999999999999765321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..........+...        .+......+.+++..||+.+|.+||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         214 MRVLLKIAKSEPPTLA--------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHhhcCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111111111100        01112235889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.2e-39  Score=298.23  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=191.8

Q ss_pred             cccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||+|+||.||+|.+..  .++..+|+|.+....             .......+..|+.+++.++|||++++++++..
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   67 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP   67 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-------------CHHHHHHHHHHHHHHccCCCCCcceEEEEeec
Confidence            468999999999998642  244679999873211             11235678899999999999999999998764


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEee
Q 014140          218 -RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE  296 (430)
Q Consensus       218 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D  296 (430)
                       ++..++|+||+.+|+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|
T Consensus        68 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~d  141 (262)
T cd05058          68 SEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVAD  141 (262)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence             5567899999999999999954   233467888899999999999999954   599999999999999999999999


Q ss_pred             cCCcccCCCCCCcc--eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccccccccHHHHHHH
Q 014140          297 FGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG-KFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       297 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      ||+++.........  ......++..|+|||++.+..++.++||||||+++|||++| .+||....       .......
T Consensus       142 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~  214 (262)
T cd05058         142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVY  214 (262)
T ss_pred             ccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Confidence            99998654322111  11123457789999999988999999999999999999995 55554321       1122222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ......+..          +...+..+.+++..||+.+|++||++.+|++.|+++.
T Consensus       215 ~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         215 LLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            222111110          0011234889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-39  Score=314.52  Aligned_cols=193  Identities=24%  Similarity=0.296  Sum_probs=164.4

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ...+|.+.+.||+|+||.||+|+... ++..||+|....                    .....|+.++++++||||+++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~--------------------~~~~~E~~~l~~l~h~~iv~~  122 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQK--------------------GTTLIEAMLLQNVNHPSVIRM  122 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCc--------------------cccHHHHHHHHhCCCCCCcCh
Confidence            35679999999999999999999764 788999997421                    123468999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++|+||+. ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       123 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~  195 (357)
T PHA03209        123 KDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQ  195 (357)
T ss_pred             hheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCC
Confidence            999999999999999995 589888853   345689999999999999999999955   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      ++|+|||+++.......   .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       196 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        196 VCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             EEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99999999975432211   12356899999999999999999999999999999999966543

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-39  Score=297.87  Aligned_cols=249  Identities=26%  Similarity=0.365  Sum_probs=196.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|.+.+.||+|+||.||+|..   .|..+|+|.+...                .....+.+|+.++++++|||++++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----------------ATAQAFLAEASVMTQLRHSNLVQLLG   66 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCC----------------chHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            4688899999999999999976   5788999987321                11356889999999999999999999


Q ss_pred             EEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          214 RMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       214 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++.. .+..++|+||+++++|.+++..  .....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~  141 (256)
T cd05082          67 VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVA  141 (256)
T ss_pred             EEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcE
Confidence            7654 5678999999999999999864  233458999999999999999999994   459999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++........     ...++..|+|||++.+..++.++|||||||++|+|++ |+.||...       .+.+..
T Consensus       142 kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-------~~~~~~  209 (256)
T cd05082         142 KVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVV  209 (256)
T ss_pred             EecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHH
Confidence            9999999876543221     2234678999999998889999999999999999998 99987532       111222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..... +...     .    .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       210 ~~~~~-~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         210 PRVEK-GYKM-----D----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHhc-CCCC-----C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            22211 1110     0    0111233488999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-39  Score=301.57  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=201.0

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.+...||.|++|.||+|.... ++..+|+|.+.........     ..........+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASS-----KDRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             ccccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccch-----hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            6677899999999999998753 7899999988544322110     111223456788999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ...+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEec
Confidence            999999999999999999999953    35688999999999999999999955   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcc----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          296 EFGLAKRIPDGHTRT----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      |||.++.........    ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....       ...+
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~  221 (267)
T cd06628         149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAI  221 (267)
T ss_pred             ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHH
Confidence            999998775322111    11124578899999999998899999999999999999999999865321       1111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........      +    ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       222 ~~~~~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 FKIGENAS------P----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHhccCC------C----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            11111100      0    111122345889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=300.51  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..+|.+.+.||+|+||.||+|.... +|.    .+|+|.+.....             ......+.+|+.+++.++|||+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i   71 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREETS-------------PKANKEILDEAYVMASVDHPHV   71 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEec-CCCCcceEEEEEeccCCCC-------------HHHHHHHHHHHHHHHhCCCCCc
Confidence            4568889999999999999998753 343    588888743211             2335678899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++++.. ...++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+   .+++|+||+|+||++++
T Consensus        72 ~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~  144 (279)
T cd05057          72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKT  144 (279)
T ss_pred             ceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcC
Confidence            999999987 788999999999999999854   23458999999999999999999995   45999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.++|+|||.++...............++..|+|||.+.+..++.++|+||||++++|+++ |..||.....    ..+
T Consensus       145 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~  220 (279)
T cd05057         145 PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEI  220 (279)
T ss_pred             CCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHH
Confidence            99999999999987654322221112234568999999988889999999999999999998 9999865321    122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+.   .......          +......+.+++..||..+|++||++.++++.|.++
T Consensus       221 ~~~~~---~~~~~~~----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         221 PDLLE---KGERLPQ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             HHHHh---CCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            22221   1111100          001113478899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.5e-39  Score=297.79  Aligned_cols=267  Identities=23%  Similarity=0.329  Sum_probs=206.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhc-cCCCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQ-VRHRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~  213 (430)
                      +|.+.+.||.|+||.||+|.+....++.+|+|.+........    +...........+.+|+.++.+ ++||||+++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~----~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG----KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc----cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            478889999999999999998754678999998854332211    1111122345677889998875 79999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEE
Confidence            99999999999999999999999865444556799999999999999999999942  2599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||.+.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....       .......
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~~~  224 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLATK  224 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHHHH
Confidence            99999998765443   1223468899999999998889999999999999999999999975421       1112222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ....... .. .    .   ......+.+++.+||+.||++||++.|+..+|.
T Consensus       225 ~~~~~~~-~~-~----~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 IVEAVYE-PL-P----E---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HhhccCC-cC-C----c---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            2111110 00 0    0   011234888999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-39  Score=307.99  Aligned_cols=263  Identities=18%  Similarity=0.228  Sum_probs=195.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||.||+|+... +++.||+|.+......             .....+.+|+.++++++||||+++++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~   71 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEE-------------GAPCTAIREVSLLKDLKHANIVTLHD   71 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC-CCCeEEEEEeeccccC-------------CcchhHHHHHHHHHhCCCCCcceEEE
Confidence            568999999999999999998764 7899999998532211             11235678999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..++..++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        72 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~k  144 (309)
T cd07872          72 IVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELK  144 (309)
T ss_pred             EEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999975 88888753   234588999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.....    ......+.
T Consensus       145 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~~~~  218 (309)
T cd07872         145 LADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV----EDELHLIF  218 (309)
T ss_pred             ECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHH
Confidence            9999999765432211  112467899999998865 4589999999999999999999999864321    11111111


Q ss_pred             HHhcCCCCc-----------hhcc-ccc----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPN-----------RAIN-SKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~-----------~~~~-~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........           ...+ +..    ...........+.+++.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            111100000           0000 000    00001112335789999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=296.71  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             cccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||.|+||.||+|....  ..+..+++|.+......             .....+.+|+.++..++|||++++++++..
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   67 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------------EERKDFLKEARVMKKLGHPNVVRLLGVCTE   67 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------------hHHHHHHHHHHHHhhcCCCChheeeeeecC
Confidence            468999999999998863  12889999998443211             135778999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQG-----RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ....++||||+++++|.+++......     ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+
T Consensus        68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~  144 (262)
T cd00192          68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVV  144 (262)
T ss_pred             CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcE
Confidence            99999999999999999999653211     3679999999999999999999994   559999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||.+................++..|+|||.+.+..++.++||||||+++++|++ |..||.....    ..+... 
T Consensus       145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~-  219 (262)
T cd00192         145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEY-  219 (262)
T ss_pred             EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH-
Confidence            9999999988765432222223467889999999998899999999999999999999 6899865421    112222 


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                        .......          ..+......+.+++..||+.+|.+|||+.++++.|+
T Consensus       220 --~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         220 --LRKGYRL----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --HHcCCCC----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              2111111          111122345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-39  Score=310.75  Aligned_cols=202  Identities=23%  Similarity=0.288  Sum_probs=165.3

Q ss_pred             cccccccc--cCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          138 SLEKIRSC--WNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       138 ~~~~lg~G--~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      ++++||+|  +||+||++.... +|+.||+|++......            ......+.+|+.+++.++||||++++++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~hpniv~~~~~~   68 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEACT------------NEMVTFLQGELHVSKLFNHPNIVPYRATF   68 (327)
T ss_pred             hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhcc------------HHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            45789999  678999998764 8999999998432211            12346688899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ..++..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++++
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~  143 (327)
T cd08227          69 IADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS  143 (327)
T ss_pred             EECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEc
Confidence            9999999999999999999998542  234589999999999999999999955   49999999999999999999999


Q ss_pred             ecCCcccCCCCCCc-----ceeeccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          296 EFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       296 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ||+...........     .......++..|+|||++.+  ..++.++|||||||+++||++|..||..
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99875543221110     01112356788999999876  3589999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.3e-39  Score=296.43  Aligned_cols=251  Identities=20%  Similarity=0.231  Sum_probs=193.5

Q ss_pred             ccccccCceEEEeecCCC-CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          141 KIRSCWNGEVYKAELPGS-SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      .||.|+||.||+|.+... .+..||+|.+....             .......+.+|+.++++++||||+++++++. .+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~   67 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AE   67 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CC
Confidence            389999999999976522 45679999884321             1223467899999999999999999999875 55


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        68 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~  141 (257)
T cd05115          68 ALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGL  141 (257)
T ss_pred             CeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCc
Confidence            78999999999999999853   345689999999999999999999954   599999999999999999999999999


Q ss_pred             cccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcC
Q 014140          300 AKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       300 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      +.......... ......++..|+|||++.+..++.++||||||+++|++++ |..||.....    .   +........
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~~~~~  214 (257)
T cd05115         142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----P---EVMSFIEQG  214 (257)
T ss_pred             cccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----H---HHHHHHHCC
Confidence            98654432211 1111233578999999988889999999999999999996 9999865422    1   111111111


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.          .+......+.+++..||+.+|++||++.+|.+.|+.+
T Consensus       215 ~~~~----------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 KRLD----------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1110          1111234488899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-39  Score=302.75  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             cccccccCceEEEeecCC-----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          140 EKIRSCWNGEVYKAELPG-----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +.||.|+||.||+|+...     ..+..+|+|.+.....             ......+.+|+.+++.++||||++++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------------DQEKKEFLKEAHLMSNFNHPNIVKLLGV   67 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-------------hhhHHHHHHHHHHHHhcCCCCeeeEeee
Confidence            368999999999998752     2236789998733211             1224678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-  290 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-  290 (430)
                      +...+..++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++ 
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  144 (269)
T cd05044          68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGY  144 (269)
T ss_pred             ecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCC
Confidence            9999999999999999999999975322   224588999999999999999999954   599999999999999877 


Q ss_pred             ----ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccc
Q 014140          291 ----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEM  365 (430)
Q Consensus       291 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~  365 (430)
                          .++++|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....    .
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~  220 (269)
T cd05044         145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----Q  220 (269)
T ss_pred             CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----H
Confidence                899999999987654332222222345788999999999999999999999999999998 9999764321    1


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      .....+   .....+          ..+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       221 ~~~~~~---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         221 EVLQHV---TAGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHH---hcCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            222211   111111          0111223458899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-39  Score=302.42  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=199.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|...+.||.|+||.||+|.+.. ++..||+|.+.....             ......+.+|+.+++.++||||+++++
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYITRYYG   69 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEeccccc-------------hHHHHHHHHHHHHHHcCCCCccHhhhc
Confidence            457888999999999999998753 788999998742211             123467899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..++..++||||+++++|.+++.     ...+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~  141 (277)
T cd06642          70 SYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             ccccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEE
Confidence            9999999999999999999999883     2468999999999999999999994   5599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      ++|||++..........  ....|+..|+|||++.+..++.++|+||||++++||++|..|+....+.    ....   .
T Consensus       142 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~---~  212 (277)
T cd06642         142 LADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLF---L  212 (277)
T ss_pred             EccccccccccCcchhh--hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHh---h
Confidence            99999998765432211  1246788999999999988999999999999999999999997643221    1111   1


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       .....+     +..    .......+.+++..||+.+|++||++.++++
T Consensus       213 -~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         213 -IPKNSP-----PTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -hhcCCC-----CCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             111111     011    1122344889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.4e-39  Score=304.48  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ....|.+.+.||.|++|.||+|.... ++..|++|.+.....              .....+.+|+.+++.++|||++++
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~v~~~   82 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNY   82 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCc--------------chHHHHHHHHHHHHhCCCCCEeeE
Confidence            34679999999999999999998653 889999998843211              124668899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.+...+..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~  154 (296)
T cd06654          83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS  154 (296)
T ss_pred             EEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            9999999999999999999999999843     3578999999999999999999954   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++..........  ....|++.|+|||.+.+..++.++|||||||++|+|++|..||....+      .. ..
T Consensus       155 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~-~~  225 (296)
T cd06654         155 VKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LR-AL  225 (296)
T ss_pred             EEECccccchhcccccccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HH-hH
Confidence            9999999987654332111  124688999999999988899999999999999999999999864321      01 11


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+..        ..+......+.+++.+||..+|++||++.++++
T Consensus       226 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         226 YLIATNGTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHhcCCCCCC--------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11111111100        011122344888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=310.08  Aligned_cols=259  Identities=21%  Similarity=0.209  Sum_probs=194.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+++... +++.||+|.+.....           ........+.+|..++..++||||+++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEM-----------LKRAETACFREERDVLVNGDRRWITNLHY   68 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHH-----------hhhhhHHHHHHHHHHHHhCCCCCCCceEE
Confidence            368899999999999999998764 789999999843111           11123466889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+||||+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~k  142 (331)
T cd05597          69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIR  142 (331)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEE
Confidence            99999999999999999999999953   234689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |+|||++..+........ ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||....       ..
T Consensus       143 l~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-------~~  214 (331)
T cd05597         143 LADFGSCLRLLADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LV  214 (331)
T ss_pred             EEECCceeecCCCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-------HH
Confidence            999999876644322211 12468999999999873     357889999999999999999999986421       12


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD--DPNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~Rps~~ev~~~  424 (430)
                      +............. +.+ .....    ...+.+++..|+..  ++..||++.++++.
T Consensus       215 ~~~~~i~~~~~~~~-~~~-~~~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         215 ETYGKIMNHKEHFQ-FPP-DVTDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHcCCCccc-CCC-ccCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            22222222111100 000 01112    23366677666644  44447898888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.5e-39  Score=295.69  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=197.0

Q ss_pred             cccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.||+|++|.||+|.+....++  .+|||.+......             .....+.+|+.++++++||||+++++++..
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   67 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT   67 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC
Confidence            4689999999999987643443  6899988432211             346789999999999999999999999988


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                       ...++||||+++|+|.+++....  ...+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+||
T Consensus        68 -~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~df  141 (257)
T cd05040          68 -HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDF  141 (257)
T ss_pred             -CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccc
Confidence             88999999999999999996522  1568999999999999999999994   45999999999999999999999999


Q ss_pred             CCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHh
Q 014140          298 GLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       298 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |++..+...... .......++..|+|||++.+..++.++|||||||++++|++ |..||.....    ......   ..
T Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~---~~  214 (257)
T cd05040         142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKK---ID  214 (257)
T ss_pred             cccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---HH
Confidence            999877543221 11113457789999999999899999999999999999998 9999864321    111111   11


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ......         ..+...+..+.+++..||+.+|++||++.++++.|.
T Consensus       215 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         215 KEGERL---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             hcCCcC---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111000         001112345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-39  Score=315.61  Aligned_cols=266  Identities=23%  Similarity=0.270  Sum_probs=195.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|... .+++.||||++......            ......+.+|+.+++.++||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~   82 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccC------------hHHHHHHHHHHHHHHHhCCCchhcee
Confidence            467999999999999999999865 47899999998432211            12346678899999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++....      ..++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+   .+|+||||||+|||+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill  152 (355)
T cd07874          83 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV  152 (355)
T ss_pred             eeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEE
Confidence            9886543      46999999975 6777763      248889999999999999999994   559999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||+++........   ....||..|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  229 (355)
T cd07874         153 KSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_pred             CCCCCEEEeeCcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876433221   234689999999999998999999999999999999999999864321000000


Q ss_pred             HH---------------HHHHHHhcCC-CCchhcccc-----cc---CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          367 LV---------------QWMRNVMTSE-NPNRAINSK-----LL---GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       367 l~---------------~~~~~~~~~~-~~~~~~~~~-----~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ..               .......... .......+.     ..   ..........+.+++.+||+.||++|||+.|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell  309 (355)
T cd07874         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL  309 (355)
T ss_pred             HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence            00               0001110000 000000000     00   001111234578999999999999999999998


Q ss_pred             HH
Q 014140          423 CM  424 (430)
Q Consensus       423 ~~  424 (430)
                      +.
T Consensus       310 ~h  311 (355)
T cd07874         310 QH  311 (355)
T ss_pred             cC
Confidence            73

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.3e-39  Score=299.74  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|...+.||.|+||.||+|.... ++..||+|.+....             .......+.+|+.++++++||||+++++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEE-------------AEDEIEDIQQEITVLSQCDSPYVTKYYG   69 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc-CCEEEEEEEEeccc-------------cHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            457888999999999999998764 78999999884211             1123567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+++..++||||+++|+|.+++..     ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~  141 (277)
T cd06640          70 SYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEE
Confidence            99999999999999999999999842     3588899999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....++..|+|||++.+..++.++|+||||+++|||++|..||....+.    ....   .
T Consensus       142 l~dfg~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~---~  212 (277)
T cd06640         142 LADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLF---L  212 (277)
T ss_pred             EcccccceeccCCcccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhh---h
Confidence            99999998765433221  1346788999999999888999999999999999999999998653321    0110   1


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      . ....+         ..........+.+++..||+.+|.+||++.++++.
T Consensus       213 ~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 I-PKNNP---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             h-hcCCC---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1 01111         11222344568899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-39  Score=298.18  Aligned_cols=252  Identities=22%  Similarity=0.286  Sum_probs=192.8

Q ss_pred             cccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEE
Q 014140          140 EKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMV  216 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  216 (430)
                      +.||.|+||.||+|++.. +|.  .+++|.+....             .......+.+|+.++.++ +||||+++++++.
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   66 (270)
T cd05047           1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYA-------------SKDDHRDFAGELEVLCKLGHHPNIINLLGACE   66 (270)
T ss_pred             CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccC-------------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe
Confidence            368999999999998764 554  46888773211             112346788999999999 7999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          217 RRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       217 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ..+..++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~ni  143 (270)
T cd05047          67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  143 (270)
T ss_pred             cCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceE
Confidence            99999999999999999999964321            123588999999999999999999954   599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTK  363 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~  363 (430)
                      ++++++.+||+|||++.......   .......+..|+|||++.+..++.++||||||++++||++ |..||.....   
T Consensus       144 li~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---  217 (270)
T cd05047         144 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---  217 (270)
T ss_pred             EEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence            99999999999999986432111   1111233567999999988889999999999999999997 9999854321   


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                          .+............          .+......+.+++.+||+.+|.+|||+.+++..|.++
T Consensus       218 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         218 ----AELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----HHHHHHHhCCCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                11111221111110          0111223478999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.7e-39  Score=296.33  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=198.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|.+.+.||.|++|.||+|.+.  ++..+|+|.+......               ...+.+|+.++++++|||++++++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS---------------EEDFIEEAQVMMKLSHPKLVQLYG   66 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC---------------HHHHHHHHHHHHhCCCCCeeeEEE
Confidence            46788899999999999999875  5788999987432111               346889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++......++||||+++++|.+++..   ....+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~  140 (256)
T cd05112          67 VCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVK  140 (256)
T ss_pred             EEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEE
Confidence            99999999999999999999999853   234588999999999999999999955   499999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.+......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....    ..+.+   
T Consensus       141 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~---  212 (256)
T cd05112         141 VSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVE---  212 (256)
T ss_pred             ECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHH---
Confidence            9999998866433221 1112235678999999998899999999999999999998 8999764221    11222   


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ........   ..+..       ....+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~---~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         213 TINAGFRL---YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHhCCCCC---CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            11111111   11111       1235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=299.11  Aligned_cols=249  Identities=28%  Similarity=0.405  Sum_probs=199.5

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|+... +|+.+|+|.+....             .......+.+|+.+++.++|||+++++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEE-------------AEDEIEDIQQEIQFLSQCRSPYITKYYGS   67 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccc-------------cchHHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence            57888999999999999998764 88999999884321             11224568899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+....++|+||+++++|.+++..     ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l  139 (274)
T cd06609          68 FLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKL  139 (274)
T ss_pred             EEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999843     278999999999999999999994   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....++..|+|||++.+..++.++||||||+++|+|++|..||....+    .   ......
T Consensus       140 ~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~---~~~~~~  210 (274)
T cd06609         140 ADFGVSGQLTSTMSKR--NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----M---RVLFLI  210 (274)
T ss_pred             cccccceeeccccccc--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----H---HHHHHh
Confidence            9999998775432211  134688899999999998899999999999999999999999864321    1   111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ... .+..     ....   .....+.+++..||+.+|++||++.++++
T Consensus       211 ~~~-~~~~-----~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         211 PKN-NPPS-----LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             hhc-CCCC-----Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111 1110     0001   02234788999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-39  Score=303.16  Aligned_cols=266  Identities=23%  Similarity=0.256  Sum_probs=195.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|++|.||+|.... +|..||+|++......            ......+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESEE------------EGVPSTAIREISLLKELQHPNIVCLQDV   67 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC-CCcEEEEEEecccccc------------CCchHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            47888999999999999998764 7899999988432111            1123567889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +..++..++||||++ ++|.+++.... ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l  142 (285)
T cd07861          68 LMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKL  142 (285)
T ss_pred             EeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEE
Confidence            999999999999997 58988885422 235689999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++........  ......+++.|+|||++.+. .++.++||||||+++++|++|+.||.......   ........
T Consensus       143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~---~~~~~~~~  217 (285)
T cd07861         143 ADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID---QLFRIFRI  217 (285)
T ss_pred             CcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHH
Confidence            99999876543211  11123568899999988764 47899999999999999999999986432110   01110000


Q ss_pred             HhcCC-----------CCchhcc---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSE-----------NPNRAIN---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~-----------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....           .....+.   ..............+.+++.+||+.||.+|||+.+|++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         218 LGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000           0000000   00000001112334778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-38  Score=297.94  Aligned_cols=263  Identities=23%  Similarity=0.346  Sum_probs=202.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|...+.||.|++|.||+|.... +++.+|+|.+.....             ......+.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~   66 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPN-------------PDLQKQILRELEINKSCKSPYIVKYYG   66 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCc-------------hHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence            357888999999999999999864 789999998843211             123567899999999999999999999


Q ss_pred             EEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +|...  +..++||||+++++|.+++.........++......++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~  143 (287)
T cd06621          67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQ  143 (287)
T ss_pred             EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCe
Confidence            98654  468999999999999998865444556789999999999999999999954   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++.........    ...++..|+|||.+.+..++.++||||||+++|+|++|..||......  .....+..
T Consensus       144 ~~l~dfg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~  217 (287)
T cd06621         144 VKLCDFGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELL  217 (287)
T ss_pred             EEEeeccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHH
Confidence            999999998765432221    245788999999999989999999999999999999999998754221  11112222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+  .+.....  ........+.+++.+||+.+|.+|||+.|+++
T Consensus       218 ~~~~~~~~~--~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         218 SYIVNMPNP--ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHhcCCch--hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            222111111  1111100  00112345889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.2e-39  Score=348.83  Aligned_cols=260  Identities=27%  Similarity=0.458  Sum_probs=210.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|...+.||+|+||.||+|+... +|..||||++.....                  ....|+..+++++|||||+++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~l~~l~HpnIv~~~~  750 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNS------------------IPSSEIADMGKLQHPNIVKLIG  750 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCcc------------------ccHHHHHHHhhCCCCCcceEEE
Confidence            456777899999999999998753 889999998842110                  1124578899999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.+.+..++||||+++|+|.++++       .++|..+..++.|++.||+|||+.+.++++||||||+||+++.++..+
T Consensus       751 ~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~  823 (968)
T PLN00113        751 LCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH  823 (968)
T ss_pred             EEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceE
Confidence            9999999999999999999999994       389999999999999999999977677899999999999999998888


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +. ||.+.......      ...||..|+|||++.+..++.++|||||||++|||++|+.||+....  ....+.+|.+.
T Consensus       824 ~~-~~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~  894 (968)
T PLN00113        824 LR-LSLPGLLCTDT------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARY  894 (968)
T ss_pred             EE-eccccccccCC------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHH
Confidence            75 66554332111      23578999999999999999999999999999999999999864332  34557777766


Q ss_pred             HhcCCCCchhccccccC--CCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          374 VMTSENPNRAINSKLLG--NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..........+++.+..  .....+...+.+++.+||+.+|++||+|.+|++.|+++
T Consensus       895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            55444444444544422  23445666789999999999999999999999999876

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.2e-39  Score=307.51  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             cccccccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      .+|.+.+.||+|+||.||+|+..+      ..+..||+|.+....             .......+.+|+.+++++ +||
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h~   78 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------------TDKDLSDLVSEMEMMKMIGKHK   78 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------------CHHHHHHHHHHHHHHHhhcCCC
Confidence            468899999999999999997532      122478999774211             112356789999999999 799


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRI  274 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  274 (430)
                      ||++++++|...+..++++||+++|+|.+++.....            ....+++..+..++.|++.||.|||+   .++
T Consensus        79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi  155 (334)
T cd05100          79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKC  155 (334)
T ss_pred             CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCe
Confidence            999999999999999999999999999999965321            22358889999999999999999995   459


Q ss_pred             EecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 014140          275 IHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKF  353 (430)
Q Consensus       275 iH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~  353 (430)
                      +||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus       156 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  235 (334)
T cd05100         156 IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS  235 (334)
T ss_pred             eccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999987654332222222344578999999999899999999999999999998 888


Q ss_pred             CCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          354 PSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       354 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ||....       ..+............          .+......+.+++..||+.+|++||++.++++.|.++.
T Consensus       236 p~~~~~-------~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         236 PYPGIP-------VEELFKLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             CCCCCC-------HHHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            875421       222222222111110          01112234889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.5e-39  Score=298.31  Aligned_cols=256  Identities=20%  Similarity=0.280  Sum_probs=195.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .+|...+.||+|+||.||+|.... +|..|++|.+......         .........+.+|+.+++.++||||+++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   71 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPES---------PETSKEVSALECEIQLLKNLQHERIVQYYG   71 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCC---------chhHHHHHHHHHHHHHHHHcCCCCeeeEEE
Confidence            468899999999999999998764 7899999988543211         112234567899999999999999999999


Q ss_pred             EEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++..  .+..++++||+++++|.+++..    ...+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~  144 (266)
T cd06651          72 CLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGN  144 (266)
T ss_pred             EEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence            8875  3567899999999999999853    34588999999999999999999944   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCC-cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHT-RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++|+.||.....       ...
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~  217 (266)
T cd06651         145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAA  217 (266)
T ss_pred             EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHH
Confidence            99999999886543211 1111234588999999999998899999999999999999999999864321       111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +........     .+    ..+......+.+++ .||..+|++||++.+|++
T Consensus       218 ~~~~~~~~~-----~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         218 IFKIATQPT-----NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHhcCCC-----CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111111110     00    11111223355666 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5e-39  Score=312.29  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=194.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +++.||||++......            ......+.+|+.+++.++||||++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~ii~~~   89 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIIGLL   89 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccccC------------chhHHHHHHHHHHHHhcCCCCccccc
Confidence            3579999999999999999998653 7899999998432211            12245678899999999999999999


Q ss_pred             eEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...      ...|+||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus        90 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  159 (364)
T cd07875          90 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV  159 (364)
T ss_pred             eeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEE
Confidence            987643      357999999965 7877773      2478899999999999999999954   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||+++........   ....||..|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       160 ~~~~~~kL~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  236 (364)
T cd07875         160 KSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK  236 (364)
T ss_pred             CCCCcEEEEeCCCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999876433221   134689999999999999999999999999999999999999864321000000


Q ss_pred             H-----------HH----HHHHHhcCCCCchh-----ccccc----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          367 L-----------VQ----WMRNVMTSENPNRA-----INSKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       367 l-----------~~----~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      .           ..    .+............     +.+..    ...........+.+++.+||+.||.+|||+.+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L  316 (364)
T cd07875         237 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL  316 (364)
T ss_pred             HHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            0           00    00000000000000     00000    0000111223578999999999999999999998


Q ss_pred             H
Q 014140          423 C  423 (430)
Q Consensus       423 ~  423 (430)
                      +
T Consensus       317 ~  317 (364)
T cd07875         317 Q  317 (364)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-39  Score=302.79  Aligned_cols=268  Identities=19%  Similarity=0.252  Sum_probs=197.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.....||.|++|.||+|.... +|+.||+|++......            ......+.+|+.++++++|||++++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~~~~~   67 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDD------------PVIKKIALREIRMLKQLKHPNLVNLIE   67 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC-CCcEEEEEEEeecccC------------ccccHHHHHHHHHHHhCCCCCEeeeee
Confidence            368889999999999999998764 7899999988432111            011345789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|..++.    ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++
T Consensus        68 ~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~  140 (286)
T cd07847          68 VFRRKRKLHLVFEYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIK  140 (286)
T ss_pred             EEeeCCEEEEEEeccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEE
Confidence            9999999999999999988887763    33468999999999999999999995   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....++..|+|||++.+ ..++.++||||||+++++|++|..||.................
T Consensus       141 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (286)
T cd07847         141 LCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG  218 (286)
T ss_pred             ECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999877543321  112357889999999876 4578999999999999999999999875322111000000000


Q ss_pred             -------HHhcCCCC-chhccccccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 -------NVMTSENP-NRAINSKLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 -------~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             ........ .....+.....     ........+.+++..||+.+|++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                   00000000 00000000000     00112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.2e-39  Score=303.75  Aligned_cols=259  Identities=21%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|...+.||+|+||.||+|.+.. +|.    .+|+|.+.....             ......+.+|+.+++.++||||
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~ni   71 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTG-------------PKANVEFMDEALIMASMDHPHL   71 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCCc
Confidence            4578889999999999999998753 454    468887732211             1223468899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      ++++++|... ..++++||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||++++
T Consensus        72 v~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~  144 (303)
T cd05110          72 VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKS  144 (303)
T ss_pred             ccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecC
Confidence            9999998754 46799999999999999853   234589999999999999999999954   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....    ...
T Consensus       145 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~  220 (303)
T cd05110         145 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REI  220 (303)
T ss_pred             CCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHH
Confidence            99999999999987654332222212345778999999998899999999999999999997 8899764321    112


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..++..   ...+..      ...    ....+.+++..||..+|++||++.++++.|..+.
T Consensus       221 ~~~~~~---~~~~~~------~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         221 PDLLEK---GERLPQ------PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             HHHHHC---CCCCCC------CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            222211   111100      011    1234788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-39  Score=300.82  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +++.||+|.+.....              .....+.+|+.+++.++||||++++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~--------------~~~~~~~~e~~~~~~l~h~~ii~~~   72 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLEPG--------------EDFAVVQQEIIMMKDCKHSNIVAYF   72 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecCch--------------hHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            3578999999999999999998764 789999998843211              1235678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  145 (267)
T cd06645          73 GSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHV  145 (267)
T ss_pred             EEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999843    34689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||++........  ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+.   .....
T Consensus       146 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~~~  220 (267)
T cd06645         146 KLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFL  220 (267)
T ss_pred             EECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhHHh
Confidence            9999999876543221  112356899999999874   446889999999999999999999997543211   00100


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .   ......+. ....      .......+.+++.+||+.+|++||++.+|++
T Consensus       221 ~---~~~~~~~~-~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         221 M---TKSNFQPP-KLKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             h---hccCCCCC-cccc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   00000000 0000      0011234788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.9e-39  Score=299.81  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             cccccccccccccCceEEEeecC---CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ..|...+.||+|+||.||+|++.   ..++..+|||.+......             .....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~ei~~l~~l~~~~i~~   70 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------------QHRSDFEREIEILRTLDHENIVK   70 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------------HHHHHHHHHHHHHHhCCCCChhe
Confidence            35778899999999999999864   225789999998432111             23578999999999999999999


Q ss_pred             ceeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++..  ....++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~  144 (284)
T cd05038          71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVES  144 (284)
T ss_pred             EEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcC
Confidence            9999887  5578999999999999999954   233599999999999999999999954   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE---  364 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~---  364 (430)
                      ++.++|+|||.+.......... ......++..|+|||.+.+..++.++||||||++++||++|..|+.........   
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~  224 (284)
T cd05038         145 EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG  224 (284)
T ss_pred             CCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence            9999999999998876332211 111224466799999999889999999999999999999999987543211100   


Q ss_pred             ----ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          365 ----MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       365 ----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                          .................         ..+......+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         225 IAQGQMIVTRLLELLKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             cccccccHHHHHHHHHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence                00011111111111100         011122345889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=297.36  Aligned_cols=241  Identities=19%  Similarity=0.258  Sum_probs=183.7

Q ss_pred             ccccccCceEEEeecCCC-----------------------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH
Q 014140          141 KIRSCWNGEVYKAELPGS-----------------------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI  197 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  197 (430)
                      .||+|+||.||+|.+...                       ....|++|.+...              .......+.+|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------------~~~~~~~~~~~~   67 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------------HRDIALAFFETA   67 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------------HHHHHHHHHHHH
Confidence            689999999999985311                       1235777776321              112346788899


Q ss_pred             HHHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       198 ~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      .+++.++||||++++++|...+..++||||+++|+|..++..   ..+.+++..+..++.|++.||+|||   ..+++||
T Consensus        68 ~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~  141 (274)
T cd05076          68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLE---DKNLVHG  141 (274)
T ss_pred             HHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCC
Confidence            999999999999999999999999999999999999998853   3456899999999999999999999   4559999


Q ss_pred             CCCCCcEEeCCCC-------ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHH
Q 014140          278 DIQPANVLIDDDM-------EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLV  349 (430)
Q Consensus       278 Dlkp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell  349 (430)
                      ||||+|||++..+       .++++|||.+.......      ...++..|+|||.+.+ ..++.++||||||+++||++
T Consensus       142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             CCCcccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999997643       48999999876543221      2356788999998876 46899999999999999995


Q ss_pred             -hCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          350 -IGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       350 -~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                       +|..||....+.    .........   ....        ...    ...+.+++..||+.+|++|||+.+|++.|+
T Consensus       216 ~~g~~p~~~~~~~----~~~~~~~~~---~~~~--------~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         216 FDGEVPLKERTPS----EKERFYEKK---HRLP--------EPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             hCCCCCccccChH----HHHHHHHhc---cCCC--------CCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             688887653221    111111110   0000        011    123788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6e-39  Score=301.16  Aligned_cols=257  Identities=21%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ..++|.+.+.||+|+||.||+|.... +++.+|+|.+....               .....+.+|+.+++.+ +||||++
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIH---------------DIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECC-CCceeEEEeecccc---------------chHHHHHHHHHHHHHHhcCCCeee
Confidence            46789999999999999999998764 78999999873211               1124577899999999 6999999


Q ss_pred             ceeEEE-----eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          211 LLARMV-----RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       211 l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++.     .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil  156 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEE
Confidence            999885     3456899999999999999886543445678999999999999999999995   45999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ++.++.++|+|||++..........  ....|+..|+|||++.+     ..++.++|||||||++|+|++|..||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            9999999999999988764332211  13468999999998753     4578899999999999999999999865321


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .       .......... ......+       ......+.+++.+||+.+|++|||+.+|++.
T Consensus       235 ~-------~~~~~~~~~~-~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         235 M-------RALFKIPRNP-PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-------HHHhhccccC-CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0       1111111111 1111111       1112348889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.9e-39  Score=295.58  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|...+.||.|++|.||+|.... ++..+++|.+...                .....+.+|+.+++.++|||+++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~----------------~~~~~~~~e~~~~~~l~~~~i~~~~   64 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVE----------------EDLQEIIKEISILKQCDSPYIVKYY   64 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecH----------------HHHHHHHHHHHHHHhCCCCcEeeee
Confidence            4678999999999999999999864 6899999988321                1146799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++......++++||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+
T Consensus        65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~  138 (256)
T cd06612          65 GSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQA  138 (256)
T ss_pred             eeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcE
Confidence            999999999999999999999999853   345689999999999999999999955   49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++.........  .....++..|+|||++.+..++.++||||||+++++|++|+.||....+..       ...
T Consensus       139 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~  209 (256)
T cd06612         139 KLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIF  209 (256)
T ss_pred             EEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhh
Confidence            99999999876543321  113457899999999999899999999999999999999999987532211       011


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...... .. .+      ..+......+.+++..||+.+|++|||+.++++
T Consensus       210 ~~~~~~-~~-~~------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         210 MIPNKP-PP-TL------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhccCC-CC-CC------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111000 00 00      011122345889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.6e-39  Score=296.74  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=198.9

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|+||.||+|...  +|+.+|+|.+......        ..........+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~--------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSN--------VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccc--------hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            3678899999999999999864  8899999988532211        01112335678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++|+||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence            9999999999999999999999953    24588999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCC----cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          295 SEFGLAKRIPDGHT----RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +|||++........    ........|+..|+|||++.+..++.++||||||+++++|++|..||.....      ... 
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~-  216 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAA-  216 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHH-
Confidence            99999886532111    1111234689999999999998899999999999999999999999864321      000 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........    +..    +......+.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~----~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         217 MFYIGAHRGLM----PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHhhhccCCC----CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01111010000    011    1112344788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-38  Score=299.06  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||.|+||.||+|+... ++..+++|.+...              .......+..|+.+++.++|||+++++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   75 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETK--------------SEEELEDYMVEIEILATCNHPYIVKLL   75 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC-CCceEEEEEeccC--------------CHHHHHHHHHHHHHHHhCCCCcEeeeE
Confidence            4679999999999999999998764 7899999998431              122356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|..++..   ....+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~  149 (292)
T cd06644          76 GAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDI  149 (292)
T ss_pred             EEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCE
Confidence            999999999999999999999888753   2346899999999999999999999   4559999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +|+|||++.........  .....++..|+|||++.     ...++.++|||||||++|+|++|..||.....       
T Consensus       150 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------  220 (292)
T cd06644         150 KLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------  220 (292)
T ss_pred             EEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------
Confidence            99999998764332211  11346788999999985     33578899999999999999999999764321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ............+..        ..+......+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         221 MRVLLKIAKSEPPTL--------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHhcCCCccC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111222221111110        011122334788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-39  Score=305.29  Aligned_cols=263  Identities=17%  Similarity=0.220  Sum_probs=196.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||.|+||.||+|.... ++..||+|.+......             .....+.+|+.+++.++||||+++++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI~~~~~   71 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHEE-------------GAPCTAIREVSLLKDLKHANIVTLHD   71 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEeccccc-------------CchhHHHHHHHHHHhcCCCCcceEEE
Confidence            568999999999999999998764 7899999988432211             11245678999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||++ ++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~k  144 (301)
T cd07873          72 IIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELK  144 (301)
T ss_pred             EEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEE
Confidence            9999999999999997 589988854   23468899999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||.....    ......+.
T Consensus       145 l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~  218 (301)
T cd07873         145 LADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIF  218 (301)
T ss_pred             ECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            9999999765432211  1123578899999988764 578899999999999999999999864321    11111111


Q ss_pred             HHhcCCCC---chhcc---------ccccC----CCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENP---NRAIN---------SKLLG----NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~---~~~~~---------~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........   ...+.         +....    .........+.+++.+||+.||.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111000   00000         00000    001112335789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-39  Score=294.69  Aligned_cols=249  Identities=23%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||.|++|.||+|...  +++.|++|.+.....             ......+.+|+.++++++||||+++++++...+
T Consensus         1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   65 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLP-------------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ   65 (251)
T ss_pred             CccccCCCceEEEEEEe--CCCcEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Confidence            46899999999999875  489999998743211             123567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||+++++|.+++..   ....+++..+..++.+++.||.|||+.   +++||||+|+||+++.++.++|+|||+
T Consensus        66 ~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~  139 (251)
T cd05041          66 PIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGM  139 (251)
T ss_pred             CeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccc
Confidence            99999999999999999854   234688999999999999999999955   599999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      +................++..|+|||.+.++.++.++|+||||+++|+|++ |..||.....    ......+..   ..
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~~~~---~~  212 (251)
T cd05041         140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIES---GY  212 (251)
T ss_pred             cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHHHhc---CC
Confidence            987653322211112234567999999998899999999999999999999 7888754321    111111111   11


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..          ..+......+.+++.+||+.+|.+||++.+|++.|.
T Consensus       213 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 RM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            00          011122345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-38  Score=293.05  Aligned_cols=254  Identities=19%  Similarity=0.240  Sum_probs=203.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|++.+.||.|+||.||.++... ++..+++|.+......            ......+.+|+.++++++||||++++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~   67 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLS------------EKERRDALNEIVILSLLQHPNIIAYYNH   67 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccc------------hhHHHHHHHHHHHHHhCCCCCeeEEEeE
Confidence            47889999999999999998764 8899999988432211            1235678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..+++|||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        68 ~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl  142 (256)
T cd08221          68 FMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL  142 (256)
T ss_pred             EecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEE
Confidence            99999999999999999999998642  245689999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++.........  .....|++.|+|||++.+..++.++||||||+++++|++|..||....       ..+.....
T Consensus       143 ~d~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~  213 (256)
T cd08221         143 GDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKI  213 (256)
T ss_pred             CcCcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHH
Confidence            999999876544321  123468999999999998889999999999999999999999976421       12222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      .......          ........+.+++..||+.+|.+||++.++++.+
T Consensus       214 ~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         214 VQGNYTP----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HcCCCCC----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            2211111          0112233488899999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.1e-39  Score=308.89  Aligned_cols=259  Identities=20%  Similarity=0.204  Sum_probs=194.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||++++.. +++.+|+|.+.....           ........+..|+.++..++||||+++++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEM-----------LKRAETACFREERDVLVNGDNQWITTLHY   68 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHH-----------HHhhHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            368899999999999999999874 789999999843111           11122456888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~k  142 (332)
T cd05623          69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR  142 (332)
T ss_pred             EEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence            99999999999999999999999954   234689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |+|||++.......... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||...       +..
T Consensus       143 L~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-------~~~  214 (332)
T cd05623         143 LADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-------SLV  214 (332)
T ss_pred             EeecchheecccCCcce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-------CHH
Confidence            99999987654332221 11357999999999986     345889999999999999999999998642       122


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCC--CCCCCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDD--PNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--p~~Rps~~ev~~~  424 (430)
                      +............ .+ +.    ........+.+++.+|+..+  +..||++.++++.
T Consensus       215 ~~~~~i~~~~~~~-~~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         215 ETYGKIMNHKERF-QF-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHhCCCccc-cC-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            2223332221100 00 00    01112234677777777544  4447888888653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-38  Score=302.12  Aligned_cols=199  Identities=22%  Similarity=0.293  Sum_probs=159.8

Q ss_pred             ccccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      ...||+|+||.||+|+... .+++.||+|.+.....                ...+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISLQKVFLS   69 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------------cHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence            4689999999999998642 3668999998843211                2346789999999999999999998865


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----
Q 014140          218 --RDCDLLVYEFRRNGSLQDILYDVS-----QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI----  286 (430)
Q Consensus       218 --~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----  286 (430)
                        ....++||||+.+ +|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    
T Consensus        70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~  145 (317)
T cd07868          70 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  145 (317)
T ss_pred             CCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCC
Confidence              4567899999964 8988875321     1223589999999999999999999955   59999999999999    


Q ss_pred             CCCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            45678999999999876543221 122245789999999998874 589999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.3e-39  Score=296.25  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=203.8

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||+|.... +|..+|+|.+.....            .......+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNM------------TEKEKQQLVSEVNILRELKHPNIVRYYDR   67 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccC------------CHHHHHHHHHHHHHHHhcCCCccceeeee
Confidence            47788999999999999998764 889999998843221            12335678899999999999999999998


Q ss_pred             EEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEeCCCC
Q 014140          215 MVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH--RPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       215 ~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +..  ....+++|||+++++|.+++.........+++..++.++.+++.||.|||..+  ..+++|+||+|+||++++++
T Consensus        68 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~  147 (265)
T cd08217          68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN  147 (265)
T ss_pred             eecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC
Confidence            764  45678999999999999999765445667999999999999999999999443  44599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .++|+|||++...........  ...++..|+|||++.+..++.++|+||||+++++|++|..||....    ...+.+.
T Consensus       148 ~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~  221 (265)
T cd08217         148 NVKLGDFGLAKILGHDSSFAK--TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASK  221 (265)
T ss_pred             CEEEecccccccccCCccccc--ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHH
Confidence            999999999988765432111  2468999999999999889999999999999999999999986532    1112221


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         .. ....         ...+......+.+++..||+.+|++||++.+|++
T Consensus       222 ---~~-~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         222 ---IK-EGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---Hh-cCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               11 1111         0111223345889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=309.35  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=209.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ..+....++||-|.||.||.|.|+. ..-.||||-++.+.               ....+|+.|+.+|+.++|||+|+++
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKEDt---------------MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT---------------MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeec-cceeeehhhhhhcc---------------hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            3455667899999999999999985 67889999884322               3368899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|+.....|||+|||..|+|.++|+..  ....++....+.++.||..||.||...+   +|||||...|+|+.++..+
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiV  404 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIV  404 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceE
Confidence            9999999999999999999999999763  4456888889999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||+++.+..+.+.. .....-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+.    +-......+
T Consensus       405 KvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dlSqVY~LL  479 (1157)
T KOG4278|consen  405 KVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYGLL  479 (1157)
T ss_pred             EeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHH
Confidence            999999999987654321 111223578999999999999999999999999999998 77886543    212222223


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...++...             +..|+..++.|++.||+.+|.+||++.|+-+.|+.+
T Consensus       480 EkgyRM~~-------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  480 EKGYRMDG-------------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             hccccccC-------------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            33332222             223344589999999999999999999999998865

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.2e-39  Score=295.34  Aligned_cols=252  Identities=19%  Similarity=0.227  Sum_probs=198.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||++.... +++.+|+|++.....            .......+.+|+.++++++|||++++++.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNA------------SRRERKAAEQEAQLLSQLKHPNIVAYRES   67 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhc------------CHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            47889999999999999998764 788999999843211            11235668899999999999999999998


Q ss_pred             EEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          215 MVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       215 ~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +.. ....++||||+++++|.+++..  .....+++..++.++.+++.|+.|||+.   +++|+||+|+||+++.++.++
T Consensus        68 ~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~  142 (257)
T cd08223          68 WEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIK  142 (257)
T ss_pred             ecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEE
Confidence            764 4467899999999999999864  2345689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++.........  .....+++.|+|||++.+..++.++||||||+++++|++|+.||....       .......
T Consensus       143 l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~  213 (257)
T cd08223         143 VGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYR  213 (257)
T ss_pred             EecccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHH
Confidence            9999999876433221  123468899999999999999999999999999999999999976421       1122222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+          ..+......+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 IIEGKLP----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHhcCCC----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2211110          111223345889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.5e-39  Score=296.75  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||++..   +++.+|+|.+....                ....+.+|+.+++.++|||++++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~----------------~~~~~~~e~~~l~~~~~~~i~~~~~   66 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV----------------TAQAFLEETAVMTKLHHKNLVRLLG   66 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc----------------hHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4588899999999999999974   78889999873311                1356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..+ ..++||||+++|+|.+++..  .....+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++
T Consensus        67 ~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~k  140 (254)
T cd05083          67 VILHN-GLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAK  140 (254)
T ss_pred             EEcCC-CcEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEE
Confidence            98654 47999999999999999965  233468999999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++........     ....+..|+|||++.+..++.++|+||||+++|+|++ |..||.....       .+...
T Consensus       141 l~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~  208 (254)
T cd05083         141 VSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKE  208 (254)
T ss_pred             ECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHH
Confidence            999999876432211     1234567999999998899999999999999999998 8999764321       11111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      .......+.          .+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       209 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         209 CVEKGYRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHhCCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111111110          011223457899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-39  Score=310.19  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=193.4

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      -.+.|.+.+.||.|+||.||+|.... ++..||||++......            ......+.+|+.++++++||||+++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQS------------LIHARRTYRELRLLKHMKHENVIGL   79 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhhh------------hHHHHHHHHHHHHHHhcCCCchhhh
Confidence            35679999999999999999998764 7899999998432111            1224567789999999999999999


Q ss_pred             eeEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          212 LARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       212 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++++...      ...++++|++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil  150 (343)
T cd07878          80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVA  150 (343)
T ss_pred             hhhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEE
Confidence            9988643      3468999998 779988873     24599999999999999999999955   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      ++.++.+||+|||++.......     ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....    
T Consensus       151 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----  221 (343)
T cd07878         151 VNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY----  221 (343)
T ss_pred             ECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH----
Confidence            9999999999999998764322     13468999999999877 4689999999999999999999999864211    


Q ss_pred             ccHHHHHHHHhcCCCCch----------hcccccc-------CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNR----------AINSKLL-------GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+........+..          .....+.       ..........+.+++.+||+.||.+|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111111111111000000          0000000       0000001123678999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-38  Score=296.29  Aligned_cols=256  Identities=21%  Similarity=0.248  Sum_probs=197.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|... .+|..||+|.+......         .........+.+|+.+++.++||||+++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   71 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPES---------PETSKEVNALECEIQLLKNLLHERIVQYYG   71 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCC---------cccHHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence            56889999999999999999876 38999999988532211         111233578899999999999999999999


Q ss_pred             EEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.+.  ...++||||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  144 (265)
T cd06652          72 CLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGN  144 (265)
T ss_pred             EeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCC
Confidence            88763  467899999999999999853    24578899999999999999999955   4999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||.+......... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....      ... 
T Consensus       145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~-  217 (265)
T cd06652         145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAA-  217 (265)
T ss_pred             EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHH-
Confidence            999999998865432111 112234688999999999888899999999999999999999999864311      111 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......... .        ...+......+.+++..|+. +|.+||++.+|++
T Consensus       218 ~~~~~~~~~-~--------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         218 IFKIATQPT-N--------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHhcCCC-C--------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            111111110 0        11222334457788888985 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=308.65  Aligned_cols=257  Identities=19%  Similarity=0.282  Sum_probs=209.2

Q ss_pred             cccccccccccccCceEEEeecCCC-CC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGS-SG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      +.....++||.|.||.||.|.+... .|  -.||||..+.+-..             ...+.|+.|..+|+.++|||||+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------------d~tekflqEa~iMrnfdHphIik  455 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------------DDTEKFLQEASIMRNFDHPHIIK  455 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------------hhHHHHHHHHHHHHhCCCcchhh
Confidence            3445567899999999999998643 33  36788877443222             23688999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|+|.+ ...|+|||.++.|.|..+++.   +...++..+...++.||+.||+|||+..   ++||||...|||+.+..
T Consensus       456 LIGv~~e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~  528 (974)
T KOG4257|consen  456 LIGVCVE-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQ  528 (974)
T ss_pred             eeeeeec-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcc
Confidence            9999974 567999999999999999965   4456999999999999999999999666   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+++.+.+..+.... ...-...|||||.+....++.+||||.|||.+||++. |..||.+....+-.     
T Consensus       529 CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----  602 (974)
T KOG4257|consen  529 CVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----  602 (974)
T ss_pred             eeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----
Confidence            9999999999999877665554 3344678999999999999999999999999999998 89998865432111     


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                                  -.+...-.-+.++.++..+..|+.+||.++|.+||...++...|+.+
T Consensus       603 ------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  603 ------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                        11111112234555666689999999999999999999999998865

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-38  Score=297.44  Aligned_cols=254  Identities=20%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|+||.||+|.... +|..||+|.+....             .......+.+|+.++.+++||||++++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~-------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   67 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLEL-------------DESKFNQIIMELDILHKAVSPYIVDFYGA   67 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeeccc-------------CHHHHHHHHHHHHHHHhcCCCcHHhhhhh
Confidence            57889999999999999998764 78999999884321             11224678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++++|..++... .....+++..+..++.+++.||.|||+.  .+++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l  144 (286)
T cd06622          68 FFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKL  144 (286)
T ss_pred             eecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999988542 1134689999999999999999999953  25999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC------CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA------LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +|||++.........    ...++..|+|||++.+..      ++.++|+|||||++|+|++|..||.....    ....
T Consensus       145 ~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~  216 (286)
T cd06622         145 CDFGVSGNLVASLAK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIF  216 (286)
T ss_pred             eecCCcccccCCccc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHH
Confidence            999998766433221    235788999999986543      58899999999999999999999864211    1112


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........+          ..+......+.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         217 AQLSAIVDGDPP----------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHhhcCCC----------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            222222211111          111223445889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=298.47  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|.... ++..+|+|.+....              ......+..|+.++++++|||+++++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~~~   68 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIES--------------EEELEDFMVEIDILSECKHPNIVGLY   68 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCC--------------HHHHHHHHHHHHHHHhCCCCceeEEE
Confidence            4579999999999999999998764 78999999984321              12356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~  142 (280)
T cd06611          69 EAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDV  142 (280)
T ss_pred             EEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCE
Confidence            999999999999999999999999854   234699999999999999999999955   49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +|+|||++..........  ....+++.|+|||++.     +..++.++|+||||+++|+|++|..||.....       
T Consensus       143 ~l~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------  213 (280)
T cd06611         143 KLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------  213 (280)
T ss_pred             EEccCccchhhccccccc--ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------
Confidence            999999987654332211  1346899999999875     34578899999999999999999999865321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ............+..  .      .+......+.+++..||+.+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~--~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         214 MRVLLKILKSEPPTL--D------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHHhcCCCCCc--C------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111222222111110  0      011122347889999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-39  Score=312.18  Aligned_cols=258  Identities=20%  Similarity=0.214  Sum_probs=195.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+++... +++.||+|.+.....           ........+.+|..++..++||||+++++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~l~~   68 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEM-----------LKRAETACFREERNVLVNGDCQWITTLHY   68 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHH-----------HhhHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            468899999999999999998764 789999999843211           11123456888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+||||+++|+|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~k  142 (331)
T cd05624          69 AFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIR  142 (331)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEE
Confidence            99999999999999999999999954   23468999999999999999999995   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      |+|||++........... ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||....       ..
T Consensus       143 l~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~  214 (331)
T cd05624         143 LADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LV  214 (331)
T ss_pred             EEeccceeeccCCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-------HH
Confidence            999999987654332221 13469999999999876     467889999999999999999999986421       12


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~  423 (430)
                      +............ .+.. ..    ......+.+++.+|+...+.+  |+++.++++
T Consensus       215 ~~~~~i~~~~~~~-~~p~-~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         215 ETYGKIMNHEERF-QFPS-HI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHcCCCcc-cCCC-cc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            2222222211100 0111 11    112334778888888765543  457777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-39  Score=298.01  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|.... +|+.+|+|.+........    ..........+.+..|+.+++.++|||+++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAG----RHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecC-CCceeeeeeeechhhhhc----ccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            36778899999999999998653 789999998854322110    0111112235678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999999999854    35689999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA--LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|||++................|+..|+|||++.+..  ++.++|+||||++++++++|..||.....      . ....
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~-~~~~  222 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------I-AAMF  222 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------H-HHHH
Confidence            9999998764332222222346889999999987754  88999999999999999999999753211      1 1111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..... .....+....    .......+.+++..||+.+|.+||++.+|++
T Consensus       223 ~~~~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         223 KLGNK-RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             Hhhcc-ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111 1111111111    1122345888999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-39  Score=303.05  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=197.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|.... +|+.||+|++......            ......+.+|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~   67 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDD------------KMVKKIAMREIRMLKQLRHENLVNLIE   67 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCc------------chhhHHHHHHHHHHHhcCCcchhhHHH
Confidence            368889999999999999999764 7899999987432211            122456888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|..+..    ....+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        68 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~  140 (286)
T cd07846          68 VFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVK  140 (286)
T ss_pred             hcccCCeEEEEEecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEE
Confidence            9999999999999999998888763    234589999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....++..|+|||++.+. .++.++||||||+++++|++|..||...........+..+..
T Consensus       141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  218 (286)
T cd07846         141 LCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG  218 (286)
T ss_pred             EEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence            9999998876443221  1124578999999998764 478899999999999999999988753221000000111000


Q ss_pred             -------HHhcCCCCch-hcccccc-----CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 -------NVMTSENPNR-AINSKLL-----GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 -------~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             .......... ...+...     ....+.....+.+++..||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                   0000000000 0000000     0001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-38  Score=301.70  Aligned_cols=260  Identities=20%  Similarity=0.216  Sum_probs=199.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|.... +++.|++|.+.....           ........+.+|+.+++.++||||+++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNL-----------ILRNQIQQVFVERDILTFAENPFVVSMFC   68 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhh-----------hhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence            368889999999999999998764 789999998843211           11223467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+..++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~  141 (305)
T cd05609          69 SFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIK  141 (305)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEE
Confidence            99999999999999999999999943    34689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCC-------------cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          294 ISEFGLAKRIPDGHT-------------RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      |+|||+++.......             ........++..|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus       142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~  221 (305)
T cd05609         142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  221 (305)
T ss_pred             EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999874211100             0011123578899999999988899999999999999999999999853211


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                             .+.............    ..    .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 -------~~~~~~~~~~~~~~~----~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         222 -------EELFGQVISDDIEWP----EG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -------HHHHHHHHhcccCCC----Cc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                   112222221111000    00    00122347899999999999999997777776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=302.02  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=208.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +-|...+.||+|.|..|-+|++.- +|..||||++.+....+            ....++..|++.|+.++|||||++|.
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~------------~st~hlfqEVRCMKLVQHpNiVRLYE   84 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDT------------LSTGHLFQEVRCMKLVQHPNIVRLYE   84 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccch------------hhhhHHHHHHHHHHHhcCcCeeeeee
Confidence            568888999999999999999874 99999999995544332            22578999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC-CCCce
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEA  292 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~  292 (430)
                      +......+|||+|.-++|+|+|+|..+   ...+.+....+++.||+.|+.|+|+.+   ++||||||+|+.+. .-|-+
T Consensus        85 ViDTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlV  158 (864)
T KOG4717|consen   85 VIDTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLV  158 (864)
T ss_pred             hhcccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCce
Confidence            999999999999999999999999653   346999999999999999999999887   99999999998776 56889


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS-DTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||.|||++..+..+....+   .+|+..|-|||++.|..|+ +++||||||||||-|++|+.||+.......       +
T Consensus       159 KLTDFGFSNkf~PG~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------L  228 (864)
T KOG4717|consen  159 KLTDFGFSNKFQPGKKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------L  228 (864)
T ss_pred             EeeeccccccCCCcchhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------h
Confidence            9999999988876654443   5899999999999999986 469999999999999999999876432111       1


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                               .-.+|.  .-..+.-....+.+||..||..||.+|.+.++|..
T Consensus       229 ---------TmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  229 ---------TMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---------hhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                     111111  12334555667999999999999999999999875

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=293.00  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|.... +++.+++|.+.....              .....+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~i~~~~   66 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPG--------------DDFEIIQQEISMLKECRHPNIVAYF   66 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCch--------------hhHHHHHHHHHHHHhCCCCChhceE
Confidence            3578999999999999999998764 788999999843211              1256788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..+++|||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+
T Consensus        67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~  140 (262)
T cd06613          67 GSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDV  140 (262)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCE
Confidence            999999999999999999999999854   225689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||.+.........  .....++..|+|||.+.+.   .++.++|+||||+++++|++|..||......   .... 
T Consensus       141 ~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~-  214 (262)
T cd06613         141 KLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALF-  214 (262)
T ss_pred             EECccccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH-
Confidence            99999998876543211  1134678899999999877   7899999999999999999999998653221   0011 


Q ss_pred             HHHHHhcCC-CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSE-NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ...... .+..       ..........+.+++.+||+.+|.+||++.+|+.
T Consensus       215 ---~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         215 ---LISKSNFPPPK-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---HHHhccCCCcc-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               111110 0000       0112223445889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=294.96  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=203.0

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|.... +++.+++|.+.....             ......+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~   67 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEIN-------------EAIQKQILRELDILHKCNSPYIVGFYGA   67 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccC-------------hHHHHHHHHHHHHHHHCCCCchhhhhee
Confidence            57888999999999999998764 789999998843211             1235678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++|+||+++++|.+++...   ...+++.....++.|++.||.|||+.  .+++|+||+|+||++++++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l  142 (265)
T cd06605          68 FYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKL  142 (265)
T ss_pred             eecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999998642   25789999999999999999999940  46999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+.........    ...++..|+|||++.+..++.++||||||+++++|++|..||.....  ......+.+...
T Consensus       143 ~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~  216 (265)
T cd06605         143 CDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYI  216 (265)
T ss_pred             eecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHH
Confidence            999998765432221    15688899999999998999999999999999999999999865321  112223333333


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+..         ........+.+++..||..+|.+|||+.+++.
T Consensus       217 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         217 VNEPPPRL---------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcCCCCCC---------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            32221110         00013344889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-38  Score=295.62  Aligned_cols=261  Identities=20%  Similarity=0.310  Sum_probs=200.7

Q ss_pred             cccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ++|.+...||.|+||.||+|+....    +...+++|.+...             ........+.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv   71 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------------KDENLQSEFRRELDMFRKLSHKNVV   71 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------------cchHHHHHHHHHHHHHHhcCCccee
Confidence            5688999999999999999986421    3467899877321             1112356789999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG-----RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ++++++...+..++||||+++|+|.+++......     ...+++..+..++.|++.||.|||+.+   ++|+||||+||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Ni  148 (275)
T cd05046          72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNC  148 (275)
T ss_pred             eeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceE
Confidence            9999999999999999999999999999653211     126899999999999999999999554   99999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTK  363 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~  363 (430)
                      +++.++.++++|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.....   
T Consensus       149 li~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---  224 (275)
T cd05046         149 LVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---  224 (275)
T ss_pred             EEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---
Confidence            9999999999999998754322211 1112346778999999988889999999999999999999 7788754321   


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                       ........    ........        ....+..+.+++.+||+.+|.+||++.+++..|++
T Consensus       225 -~~~~~~~~----~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         225 -EEVLNRLQ----AGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -HHHHHHHH----cCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             11222111    11111000        01122358899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-38  Score=299.62  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||.|++|.||+|.... +|+.|++|.+.....              .....+.+|+.+++.++|||+++++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~   82 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQKQ--------------PKKELIINEILVMKELKNPNIVNFL   82 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcC-CCcEEEEEEEecccC--------------chHHHHHHHHHHHHhcCCCceeeee
Confidence            3569999999999999999998653 889999998843211              1245688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++|+||+++++|..++..     ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~  154 (296)
T cd06655          83 DSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSV  154 (296)
T ss_pred             eeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            999999999999999999999998842     3589999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++..........  ....++..|+|||.+.+..++.++|||||||++|+|++|..||....+       .....
T Consensus       155 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~  225 (296)
T cd06655         155 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALY  225 (296)
T ss_pred             EEccCccchhcccccccC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999988664432221  134688999999999998899999999999999999999999865322       11111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......+..        ..+......+.+++.+||..+|.+||++.++++
T Consensus       226 ~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         226 LIATNGTPEL--------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHhcCCccc--------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1111111100        011112234788999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=302.03  Aligned_cols=264  Identities=20%  Similarity=0.236  Sum_probs=199.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|++|.||+|.... +++.||+|++.....            .......+.+|+.++++++||||++++++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   68 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESED------------DEDVKKTALREVKVLRQLRHENIVNLKEA   68 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcc------------cccchhHHHHHHHHHHhcCCCCeeehhhe
Confidence            58889999999999999998764 789999998843211            11234678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||++++.+..+..    ....+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        69 ~~~~~~~~iv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl  141 (288)
T cd07833          69 FRRKGRLYLVFEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL  141 (288)
T ss_pred             EEECCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence            999999999999999876666552    334589999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++........... ....++..|+|||++.+. .++.++||||||+++|+|++|..||.....    .........
T Consensus       142 ~d~g~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~  216 (288)
T cd07833         142 CDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQK  216 (288)
T ss_pred             EeeecccccCCCccccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence            99999987765432111 234678999999999888 789999999999999999999999864321    111111111


Q ss_pred             HhcCCCC-----------------chhccccc-cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENP-----------------NRAINSKL-LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+                 ........ ....+......+.+++..||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         217 CLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            1100000                 00000000 00111122456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-38  Score=296.03  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|.... ++..+++|++......             .....+.+|+.+++.++|||++++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQ-------------TSVDELRKEVQAMSQCNHPNVVKYYT   66 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcc-------------hHHHHHHHHHHHHHhcCCCCEEEEEE
Confidence            368899999999999999998764 7899999988432111             13577899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+...+..++|+|++++++|.+++.... ....+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~  142 (267)
T cd06610          67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVK  142 (267)
T ss_pred             EEeeCCEEEEEEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEE
Confidence            9999999999999999999999996421 124689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcc--eeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          294 ISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |+|||++..+.......  ......|+..|+|||++... .++.++|+||||+++++|++|..||......   ..+.. 
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~-  218 (267)
T cd06610         143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLML-  218 (267)
T ss_pred             EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHH-
Confidence            99999998776443321  22345689999999998877 7899999999999999999999998654221   11111 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ......+.  ....   .........+.+++..||+.||++||++.+|++
T Consensus       219 ---~~~~~~~~--~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         219 ---TLQNDPPS--LETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---HhcCCCCC--cCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               11111110  0000   001123345889999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-38  Score=298.49  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=198.4

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ..++|.+.+.||.|+||.||+|.... +++.+|+|.+....               .....+.+|+.+++++ +|||+++
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~ni~~   83 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPIS---------------DVDEEIEAEYNILQSLPNHPNVVK   83 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEecccc---------------cHHHHHHHHHHHHHHhcCCCCeEE
Confidence            46789999999999999999998764 88999999884311               1135577899999999 7999999


Q ss_pred             ceeEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          211 LLARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       211 l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++...     +..++||||+++|+|.+++.........+++..++.++.|++.||.|||+   .+++|+||||+||+
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nil  160 (291)
T cd06639          84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEE
Confidence            99998754     35799999999999999986543445678999999999999999999994   45999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ++.++.++|+|||++..........  ....|+..|+|||++...     .++.++|||||||++|+|++|+.||.....
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            9999999999999988765332211  124688999999987654     368899999999999999999999865322


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             ...+....... +....+       +......+.+++.+||+.+|++||++.++++
T Consensus       239 -------~~~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         239 -------VKTLFKIPRNP-PPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -------HHHHHHHhcCC-CCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                   11111111111 111111       1122335889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=309.94  Aligned_cols=244  Identities=20%  Similarity=0.196  Sum_probs=185.0

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCcccceeEEEeC
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNIVPLLARMVRR  218 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~  218 (430)
                      ||+|+||+||+|+... +|+.||||++......           .......+..|..++..+   +||||+++++++...
T Consensus         1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~   68 (330)
T cd05586           1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIV-----------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD   68 (330)
T ss_pred             CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHh-----------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence            7999999999998764 7999999998432111           112234455666776655   699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          69 SDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             CeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            999999999999999998843    45689999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      ++.........  .....||..|+|||++.+. .++.++|||||||++|+|++|..||....       ..+........
T Consensus       142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~~  212 (330)
T cd05586         142 LSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAFG  212 (330)
T ss_pred             cCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHcC
Confidence            98764332221  1235799999999998765 48999999999999999999999985421       11222222211


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN----SKDVRC  423 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps----~~ev~~  423 (430)
                      ...   +..    .   .....+.+++..||+.||.+||+    +.++++
T Consensus       213 ~~~---~~~----~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 KVR---FPK----N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCC---CCC----c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            110   000    0   11234778999999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-38  Score=297.60  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|.... +++.+|+|.+.....           ........+.+|+.++++++||||+++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   68 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKI-----------VKLKQVEHVLNEKRILQSIRHPFLVNLYG   68 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCccceee
Confidence            368889999999999999998764 789999999843211           11223567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        69 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~k  141 (290)
T cd05580          69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIK  141 (290)
T ss_pred             EEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999854    35689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++......     .....|++.|+|||.+.+..++.++||||||+++++|++|..||.....       ......
T Consensus       142 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~  209 (290)
T cd05580         142 ITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEK  209 (290)
T ss_pred             EeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence            9999999876544     1234688999999999888899999999999999999999999864321       111111


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .... ...  +        +......+.+++.+||+.+|.+||     ++.++++
T Consensus       210 ~~~~-~~~--~--------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         210 ILEG-KVR--F--------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HhcC-Ccc--C--------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            1111 110  0        011123478999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-38  Score=300.45  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||.|++|.||+|.... +|+.||+|.+.....              .....+.+|+.+++.++|||+++++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~i~~~~   82 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNYL   82 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCcc--------------chHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4578999999999999999998653 889999998843211              1135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~  154 (297)
T cd06656          83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSV  154 (297)
T ss_pred             EEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            999999999999999999999999843     3578999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++..........  ....+++.|+|||.+.+..++.++|+||||+++|++++|..||....+...       ..
T Consensus       155 ~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~  225 (297)
T cd06656         155 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LY  225 (297)
T ss_pred             EECcCccceEccCCccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------ee
Confidence            999999987654432221  124688899999999998899999999999999999999999864321100       00


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+.+.        ...+......+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         226 LIATNGTPE--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             eeccCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            001011100        0011122344788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8e-39  Score=320.54  Aligned_cols=259  Identities=17%  Similarity=0.173  Sum_probs=187.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC------CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR------HR  206 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp  206 (430)
                      .++|.+.+.||.|+||+||+|.+.. +++.||||++....               .....+..|+.++..++      |+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~  191 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVP---------------KYTRDAKIEIQFMEKVRQADPADRF  191 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecch---------------hhHHHHHHHHHHHHHHhhcCcccCc
Confidence            5679999999999999999998764 78999999984211               11233455666666664      45


Q ss_pred             CcccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          207 NIVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       207 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++++++... ...|+|||++ +++|.+++..    ...+++..+..++.||+.||.|||+.  .+|+||||||+|||
T Consensus       192 ~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NIL  264 (467)
T PTZ00284        192 PLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENIL  264 (467)
T ss_pred             ceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEE
Confidence            688888888764 5788999998 7799998853    35699999999999999999999953  25999999999999


Q ss_pred             eCCCC----------------ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHH
Q 014140          286 IDDDM----------------EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV  349 (430)
Q Consensus       286 l~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell  349 (430)
                      ++.++                .+||+|||.+......     .....||+.|+|||++.+..|+.++|||||||++|||+
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence            98765                4999999987643221     12457999999999999999999999999999999999


Q ss_pred             hCCCCCCccccccccccHHHHHHHHhcC---------------------CCCchhccccc----cCCC---cHHHHHHHH
Q 014140          350 IGKFPSDDFFQHTKEMSLVQWMRNVMTS---------------------ENPNRAINSKL----LGNG---YEEQMLLVL  401 (430)
Q Consensus       350 ~g~~p~~~~~~~~~~~~l~~~~~~~~~~---------------------~~~~~~~~~~~----~~~~---~~~~~~~l~  401 (430)
                      +|+.||+....    ......+...+..                     .......++..    ....   .......+.
T Consensus       340 tG~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (467)
T PTZ00284        340 TGKLLYDTHDN----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC  415 (467)
T ss_pred             hCCCCCCCCCh----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence            99999875321    1111111111100                     00000000000    0000   001123578


Q ss_pred             HHHHhcccCCCCCCCCHHHHHH
Q 014140          402 KIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       402 ~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +|+..||+.||.+|||+.|+++
T Consensus       416 dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        416 DLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHHhCCcChhhCCCHHHHhc
Confidence            9999999999999999999986

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-38  Score=291.71  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||+|++|.||+|.... ++..|++|.+......         .........+.+|+.+++.++|||++++++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~---------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDG---------QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             ccccceeeecCCceEEEEEEcC-CCcEEEEEEEEEcccc---------ccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            6677899999999999998753 7899999988543211         11223457789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ...+..++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            999999999999999999999853    34588999999999999999999955   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      |||.+.......   ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||.....       .......
T Consensus       145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~  214 (258)
T cd06632         145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKI  214 (258)
T ss_pred             cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHH
Confidence            999988764433   112346889999999988776 89999999999999999999999865421       1111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...... .        ..+......+.+++.+||+.+|++||++.+++.
T Consensus       215 ~~~~~~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRSKEL-P--------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HhcccC-C--------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            110100 0        011112234788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-38  Score=291.81  Aligned_cols=252  Identities=18%  Similarity=0.244  Sum_probs=201.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|++.+.||.|+||.+|+++... +|+.||+|.+......            ......+.+|+.++++++||||++++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMS------------PKEREESRKEVAVLSNMKHPNIVQYQES   67 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCC------------hHHHHHHHHHHHHHHhCCCCCeeeeEee
Confidence            47889999999999999998764 8899999998432111            1224678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++|+||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l  142 (256)
T cd08218          68 FEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKL  142 (256)
T ss_pred             ecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999854  2234578999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....|++.|+|||++.+..++.++|+||||+++++|++|..||...       ...+.....
T Consensus       143 ~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~  213 (256)
T cd08218         143 GDFGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKI  213 (256)
T ss_pred             eeccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHH
Confidence            9999998765432221  1245788999999999988999999999999999999999997532       112222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+.          .+......+.+++.+||+.+|++||++.+|++
T Consensus       214 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         214 IRGSYPP----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             hcCCCCC----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2222111          11122334889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-38  Score=294.22  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=200.4

Q ss_pred             ccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||.|+||.||+|.+...  ....++||.......             ......+.+|+.+++.++||||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~i~~   71 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-------------PSVREKFLQEAYIMRQFDHPHIVK   71 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-------------HHHHHHHHHHHHHHHhCCCCchhc
Confidence            34688889999999999999987532  235789998743211             233567899999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.. +..++||||+++|+|.+++..   ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.++
T Consensus        72 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~  144 (270)
T cd05056          72 LIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPD  144 (270)
T ss_pred             eeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCC
Confidence            9998865 557899999999999999954   234589999999999999999999954   599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++|+|||++............ ...++..|+|||.+.+..++.++||||||++++|+++ |..||.....    .....
T Consensus       145 ~~~l~d~g~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~  219 (270)
T cd05056         145 CVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIG  219 (270)
T ss_pred             CeEEccCceeeecccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHH
Confidence            9999999999876544222111 2234568999999988889999999999999999996 9999865322    11111


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .+   .....+.          .+......+.+++.+|+..+|.+|||+.++++.|+.+.
T Consensus       220 ~~---~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         220 RI---ENGERLP----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HH---HcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11   1111110          01112235888999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.8e-39  Score=310.56  Aligned_cols=196  Identities=27%  Similarity=0.332  Sum_probs=170.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-C-----CCc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-H-----RNI  208 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pni  208 (430)
                      .|.+.+.||+|+||.|-+|...+ +++.||||+++..               .....+...|+.+|..|+ |     -|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~-T~e~VAIKIiKN~---------------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~  250 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK-TGEIVAIKIIKNK---------------KRFLRQAQIEIRILELLNKHDPDDKYNI  250 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC-CCcEEEEEeeccC---------------hHHHHHHHHHHHHHHHHhccCCCCCeeE
Confidence            68999999999999999997664 8999999999542               233677889999999997 4     489


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      |+++++|...++.|||+|.+.. +|++++..  +....++...+..|+.||+.||.+||+.+   |||+||||+||||.+
T Consensus       251 Vrm~d~F~fr~HlciVfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~  324 (586)
T KOG0667|consen  251 VRMLDYFYFRNHLCIVFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKD  324 (586)
T ss_pred             EEeeeccccccceeeeehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeecc
Confidence            9999999999999999999965 99999976  45566999999999999999999999555   999999999999975


Q ss_pred             C--CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          289 D--MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       289 ~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      .  ..+||+|||.|........     .+.-+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+
T Consensus       325 ~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  325 PKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            4  4799999999988655433     34567889999999999999999999999999999999866544

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=297.03  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ++++|.+.+.||.|++|.||+|.... +++.+++|.+....               .....+.+|+.+++++ .||||++
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~---------------~~~~~~~~e~~~l~~~~~h~~i~~   67 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIE---------------DEEEEIKEEYNILRKYSNHPNIAT   67 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCc---------------hhHHHHHHHHHHHHHhcCCCChhe
Confidence            46789999999999999999998764 78899999884321               1246788999999999 6999999


Q ss_pred             ceeEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          211 LLARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       211 l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++++....      ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||
T Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni  144 (275)
T cd06608          68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNI  144 (275)
T ss_pred             EEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHE
Confidence            999997654      48999999999999999876443456799999999999999999999954   599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      +++.++.++|+|||++.........  .....|+..|+|||++.+.     .++.++||||||+++++|++|..||....
T Consensus       145 ~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  222 (275)
T cd06608         145 LLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH  222 (275)
T ss_pred             EEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence            9999999999999998765433221  1234688999999987643     46789999999999999999999986432


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..   ..+    ....... ....       ..+......+.+++.+||..||++|||+.++++
T Consensus       223 ~~---~~~----~~~~~~~-~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         223 PM---RAL----FKIPRNP-PPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hH---HHH----HHhhccC-CCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11   111    1111111 1100       111223445889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.6e-38  Score=296.33  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=194.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHH-HhccCCCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT-AGQVRHRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~  212 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||+|++......             .....+..|+.. ++.++|||+++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~~iv~~~   66 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNS-------------QEQKRLLMDLDISMRSVDCPYTVTFY   66 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCc-------------HHHHHHHHHHHHHHHHcCCCCeeeee
Confidence            368889999999999999998764 7999999988432111             112344555554 6667899999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++..++..++||||++ |+|.+++.........+++..++.++.|++.||.|||+.  .+++||||||+||+++.++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~  143 (283)
T cd06617          67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQV  143 (283)
T ss_pred             EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCE
Confidence            99999999999999996 589998876444456799999999999999999999954  159999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT----VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ||+|||++.........   ....|+..|+|||++.+    ..++.++|+||||+++|+|++|+.||.....     .. 
T Consensus       144 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~-  214 (283)
T cd06617         144 KLCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PF-  214 (283)
T ss_pred             EEeeccccccccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CH-
Confidence            99999999876433211   12457889999998865    3568899999999999999999999864221     11 


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +..........+.  +.    .   ......+.+++..||+.+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~--~~----~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         215 QQLKQVVEEPSPQ--LP----A---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHhcCCCC--CC----c---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111111110  00    0   012234889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=294.14  Aligned_cols=241  Identities=18%  Similarity=0.246  Sum_probs=184.6

Q ss_pred             cccccccCceEEEeecCCCCC-------ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          140 EKIRSCWNGEVYKAELPGSSG-------RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +.||.|+||.||+|.... .+       ..+++|.+...              .......+..|+.+++.++|||+++++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~-~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~e~~~l~~~~h~~iv~~~   65 (258)
T cd05078           1 ESLGQGTFTKIFKGIRRE-VGDYGELHKTEVLLKVLDKS--------------HRNYSESFFEAASMMSQLSHKHLVLNY   65 (258)
T ss_pred             CCCCcccchhheeeeecc-cccccccccchhhHHhhcch--------------hHHHHHHHHHHHHHHHhCCCCChhhee
Confidence            468999999999998643 22       34777765211              123356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++..++..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++. 
T Consensus        66 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~  139 (258)
T cd05078          66 GVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDR  139 (258)
T ss_pred             eEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEeccccc
Confidence            999999999999999999999999854   234689999999999999999999954   5999999999999987765 


Q ss_pred             -------eEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCC-CCCCcccccc
Q 014140          292 -------ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGK-FPSDDFFQHT  362 (430)
Q Consensus       292 -------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~-~p~~~~~~~~  362 (430)
                             ++++|||++......      ....++..|+|||++.+. .++.++||||||+++|+|++|. .|+.....  
T Consensus       140 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--  211 (258)
T cd05078         140 KTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--  211 (258)
T ss_pred             ccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--
Confidence                   699999988655322      124578899999999874 5799999999999999999995 55443211  


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                        ........   .....            +......+.+++..||+.+|++|||+.++++.|+
T Consensus       212 --~~~~~~~~---~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         212 --QKKLQFYE---DRHQL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --HHHHHHHH---ccccC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              11111111   00000            0011134789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.6e-39  Score=299.82  Aligned_cols=264  Identities=19%  Similarity=0.212  Sum_probs=194.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||+|.... +|..+|+|.+......            ......+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~-~g~~~~~k~~~~~~~~------------~~~~~~~~~ei~~l~~l~h~~i~~~~~~   67 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLYDV   67 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC-CCcEEEEEEeeccccc------------ccCccchhHHHHHHHhcCCCCeeeHHHH
Confidence            37788999999999999998764 8999999998542211            1113457789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++|+||++ ++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l  140 (284)
T cd07839          68 LHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKL  140 (284)
T ss_pred             hccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEE
Confidence            999999999999997 488888743   235689999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++.........  .....++..|+|||++.+.. ++.++|||||||++|+|++|..|+.....   .......+..
T Consensus       141 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~~  215 (284)
T cd07839         141 ADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFR  215 (284)
T ss_pred             CccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHHH
Confidence            999999865432211  11235788999999987754 78999999999999999999988533211   1111111111


Q ss_pred             HhcCCC----------Cchhcccccc-----CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSEN----------PNRAINSKLL-----GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~----------~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......          +.....+...     ....+.....+.+++.+||+.||.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            110000          0000000000     0111122345789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=302.43  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=200.5

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|.... +++.||+|.+......           .......+..|+.+++.++||||+++++.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   69 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMI-----------KRNKVKRVLTEQEILATLDHPFLPTLYAS   69 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccc-----------hHHHHHHHHHHHHHHHhCCCCCchhheee
Confidence            58889999999999999998864 7899999998543211           12235678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+.+++|.+++..  .....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|
T Consensus        70 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          70 FQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             eecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEE
Confidence            9999999999999999999999854  234568999999999999999999994   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcc---------------------------eeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRT---------------------------TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +|||++..........                           ......||..|+|||++.+..++.++||||||+++|+
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            9999987653221100                           0112467889999999999889999999999999999


Q ss_pred             HHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 014140          348 LVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN----SKDVRC  423 (430)
Q Consensus       348 ll~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps----~~ev~~  423 (430)
                      |++|..||......   ..    ...........         .........+.+++.+||+.+|++||+    +.+++.
T Consensus       225 l~~g~~pf~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         225 MLYGTTPFKGSNRD---ET----FSNILKKEVTF---------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HhhCCCCCCCCchH---HH----HHHHhcCCccC---------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            99999998643221   11    11111111100         000113345899999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.1e-38  Score=291.17  Aligned_cols=242  Identities=21%  Similarity=0.285  Sum_probs=184.4

Q ss_pred             cccccccCceEEEeecCCC-----------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          140 EKIRSCWNGEVYKAELPGS-----------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      +.||.|+||.||+|.+...           ....+++|.+...              .......+..|+.+++.++||||
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------------~~~~~~~~~~~~~~l~~l~hp~i   66 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------------HRDISLAFFETASMMRQVSHKHI   66 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------------hhhHHHHHHHHHHHHHhCCCCCE
Confidence            3689999999999986421           1235777876321              11224568889999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++++......++||||+++|+|..++..   ....+++..++.++.|++.||+|||+   .+++||||||+|||++.
T Consensus        67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~  140 (262)
T cd05077          67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAR  140 (262)
T ss_pred             eeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEec
Confidence            9999999999999999999999999988753   23568999999999999999999994   55999999999999987


Q ss_pred             CCc-------eEEeecCCcccCCCCCCcceeeccccccccccccccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCccc
Q 014140          289 DME-------ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-TVALSDTCDIYSFGVLLAVLV-IGKFPSDDFF  359 (430)
Q Consensus       289 ~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell-~g~~p~~~~~  359 (430)
                      ++.       ++++|||++.......      ...++..|+|||++. +..++.++|||||||++|||+ +|..|+....
T Consensus       141 ~~~~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         141 EGIDGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCccCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            654       8999999987653221      235788899999887 456899999999999999998 5888865421


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      .       .+. .........       .....    ...+.+++.+||+.||.+||++.+|++.|+
T Consensus       215 ~-------~~~-~~~~~~~~~-------~~~~~----~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         215 L-------AEK-ERFYEGQCM-------LVTPS----CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-------hHH-HHHHhcCcc-------CCCCC----hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1       111 111111100       00111    234789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.9e-38  Score=292.91  Aligned_cols=261  Identities=21%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             cccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          136 FASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      |.+.+.||+|+||.||+|.+..  .++..+|||++.....            ......++.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~   68 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------------SSSDIEEFLREAACMKEFDHPNVIKLIG   68 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------------ChHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            5667899999999999998642  2578999999843221            1223567889999999999999999999


Q ss_pred             EEEeCC------eeEEEEEecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          214 RMVRRD------CDLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       214 ~~~~~~------~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++...+      ..++++||+.+|+|.+++....  .....+++...+.++.|++.||+|||+.   +++|+||||+||+
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nil  145 (273)
T cd05074          69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCM  145 (273)
T ss_pred             EEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEE
Confidence            886543      2478999999999998875321  1223578999999999999999999955   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~  364 (430)
                      +++++.++|+|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |..||.....    
T Consensus       146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----  221 (273)
T cd05074         146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----  221 (273)
T ss_pred             EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----
Confidence            99999999999999987654332222222345678999999998889999999999999999999 8888764321    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+...   .........          +......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       222 ~~~~~~---~~~~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         222 SEIYNY---LIKGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHH---HHcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            112221   111111110          011223588999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-38  Score=298.75  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      +.+.|.+.+.||.|+||.||+|.... +++.+|+|.+....               .....+..|+.++.++ +|||+++
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~~---------------~~~~~~~~e~~~l~~~~~h~~i~~   77 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTE---------------DEEEEIKLEINMLKKYSHHRNIAT   77 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecCh---------------HHHHHHHHHHHHHHHhcCCCcEEE
Confidence            45678999999999999999999864 88999999873211               1245678899999999 6999999


Q ss_pred             ceeEEEe------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          211 LLARMVR------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       211 l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++++..      .+..+++|||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~ni  152 (282)
T cd06636          78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV  152 (282)
T ss_pred             EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999853      45789999999999999998652  234588888999999999999999955   599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      ++++++.++|+|||++........  ......|+..|+|||.+.     +..++.++|+|||||++|+|++|..||....
T Consensus       153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999999999999999876543221  112356899999999876     3458889999999999999999999986532


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +..       ..........+.      .   ........+.+++..||+.||.+||++.+|++
T Consensus       231 ~~~-------~~~~~~~~~~~~------~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         231 PMR-------ALFLIPRNPPPK------L---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHh-------hhhhHhhCCCCC------C---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            210       001111111000      0   01112335889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.3e-38  Score=292.00  Aligned_cols=253  Identities=25%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.+.....||+|+||.||+|.... ++..|++|.+....              ......+.+|+.+++.++||||++++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~   71 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLS-TQVRIAIKEIPERD--------------SRYVQPLHEEIALHSYLKHRNIVQYL   71 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecC-CCcEEEEEEecCCC--------------HHHHHHHHHHHHHHHhcCCCCeeeee
Confidence            4455556789999999999998764 78899999873321              12356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-C
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-D  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~  289 (430)
                      +++..++..++|+||+++++|.+++...   ...+  ++..+..++.|++.||.|||+   .+++|+||||+||+++. +
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~  145 (268)
T cd06624          72 GSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYS  145 (268)
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCC
Confidence            9999999999999999999999999642   2234  788889999999999999994   45999999999999986 6


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA--LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +.++|+|||.+..........  ....|+..|+|||++.+..  ++.++||||||+++|+|++|..||.....    ...
T Consensus       146 ~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~~  219 (268)
T cd06624         146 GVVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQA  219 (268)
T ss_pred             CeEEEecchhheecccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hhh
Confidence            799999999987664332211  1245789999999987654  78899999999999999999999864321    001


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+........           ...+......+.+++.+||+.+|.+|||+.++++
T Consensus       220 ~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         220 AMFKVGMFKIH-----------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hHhhhhhhccC-----------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            11111000000           0111122344888999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-38  Score=291.48  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|+... +|+.|++|++......             .....+.+|+.++..++|||++++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDE-------------EFRKQLLRELKTLRSCESPYVVKCYG   66 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcch-------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            368889999999999999999875 7999999998432211             23577999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++..    ...+++..++.++.|++.|+.|||+.  .+++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~  140 (264)
T cd06623          67 AFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVK  140 (264)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999954    25689999999999999999999950  4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||.+..........  ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....    ....+....
T Consensus       141 l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~  214 (264)
T cd06623         141 IADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQA  214 (264)
T ss_pred             EccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHH
Confidence            99999998775433322  124678999999999998899999999999999999999999865432    122222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ......+.  ...    .   .....+.+++..||+.+|++||++.++++.
T Consensus       215 ~~~~~~~~--~~~----~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         215 ICDGPPPS--LPA----E---EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HhcCCCCC--CCc----c---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            22211111  110    1   023458899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-38  Score=292.89  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=201.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|... .+++.+|+|.+......        ..........+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~--------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNT--------SSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCC--------chhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            3777899999999999999875 48999999988532211        01112346789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-ceE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~k  293 (430)
                      +.+.+..++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .++
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999853    34688999999999999999999955   599999999999998776 599


Q ss_pred             EeecCCcccCCCCCCcc--eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      |+|||.+..........  ......|+..|+|||.+.+..++.++|+||+|+++++|++|..||.....    .......
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~  220 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALI  220 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHH
Confidence            99999998775432211  11134678999999999888899999999999999999999999864221    1111111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........         ...+......+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 FKIASATTA---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHhccCCC---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111110000         1112223345889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=284.47  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ++.|++.+.||+|.|+.||+..+. .+|+.+|+|.+......         .   ...+.+.+|+++-+.|+||||+++.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~---------~---~~~e~l~rEarIC~~LqHP~IvrL~   76 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLS---------A---RDFQKLEREARICRKLQHPNIVRLH   76 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhc---------c---ccHHHHHHHHHHHHhcCCCcEeehh
Confidence            467889999999999999999654 69999999988432221         1   1357789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---C
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---D  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~  289 (430)
                      ....+....|||+|+|.|++|..-+-.    ...+++..+-..++||+.+|.|+|..   +|+|||+||.|+++.+   .
T Consensus        77 ~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~  149 (355)
T KOG0033|consen   77 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKG  149 (355)
T ss_pred             hhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCC
Confidence            999999999999999999999876632    24578888889999999999999955   5999999999999963   3


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .-+||+|||+|..+..+   .......||++|||||++...+|+..+|||+.||+||-++.|.+||-+.    ....+.+
T Consensus       150 A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye  222 (355)
T KOG0033|consen  150 AAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYE  222 (355)
T ss_pred             CceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHH
Confidence            45899999999998733   3334578999999999999999999999999999999999999997642    2233333


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+...-..      ++    +...+.......+|+++||..||.+|.|+.|.++
T Consensus       223 ~I~~g~yd------~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  223 QIKAGAYD------YP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccccC------CC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            33222111      11    1122223344889999999999999999998764

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-38  Score=298.48  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.....||.|+||.||++.... ++..||||.+....              ......+.+|+.+++.++|||++++++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~ii~~~~   86 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKH-TGKQVAVKKMDLRK--------------QQRRELLFNEVVIMRDYHHENVVDMYN   86 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECC-CCCEEEEEEEecch--------------HHHHHHHHHHHHHHHhCCCCcHHHHHH
Confidence            445667789999999999998754 78999999873211              122466889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .+...+..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~k  158 (292)
T cd06658          87 SYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK  158 (292)
T ss_pred             heecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence            99999999999999999999998732     3588999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++.........  .....|+..|+|||++.+..++.++||||||+++|||++|..||.....    ......+..
T Consensus       159 L~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~  232 (292)
T cd06658         159 LSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIRD  232 (292)
T ss_pred             EccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Confidence            9999998765433221  1234688999999999888899999999999999999999999764221    111111111


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ...    .     ...  ........+.+++..||..+|.+|||+.++++.
T Consensus       233 ~~~----~-----~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 NLP----P-----RVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCC----C-----ccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            110    0     000  001122347889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=313.26  Aligned_cols=255  Identities=19%  Similarity=0.257  Sum_probs=207.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .+.....++||+|.||.|++|.|...+|+  .||||.+..+...             .....|.+|+.+|.+|+|||+|+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------------~~mddflrEas~M~~L~H~hliR  175 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------------AIMDDFLREASHMLKLQHPHLIR  175 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------------hhHHHHHHHHHHHHhccCcceeE
Confidence            34456778999999999999999876775  6899998543221             24788999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +||+..+ ....||||.++.|||.+.|+.  .....|.......++.|||.||.||.+..   +|||||...|+|+....
T Consensus       176 LyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllaspr  249 (1039)
T KOG0199|consen  176 LYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPR  249 (1039)
T ss_pred             Eeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccc
Confidence            9999987 778899999999999999976  34567888999999999999999999555   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCccee-eccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTT-WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||+.+-++.+...... ....-.+.|+|||.+....++.++|||+|||++|||++ |..||.+...    ..+.
T Consensus       250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL  325 (1039)
T KOG0199|consen  250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQIL  325 (1039)
T ss_pred             eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHH
Confidence            9999999999998765443332 12334678999999999999999999999999999999 6789876432    1122


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.+.   ...+          -..+..+.+.+++++..||..+|++||++..|.+
T Consensus       326 ~~iD---~~er----------LpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  326 KNID---AGER----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             Hhcc---cccc----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            2111   1111          1234456677999999999999999999999974

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.3e-38  Score=294.91  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|...+.||.|+||.||+|.... ++..+|+|.+....             .......+.+|+.++..++||||+++++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~   69 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEE-------------AEDEIEDIQQEITVLSQCDSPYVTKYYG   69 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECC-CCcEEEEEEecccc-------------chHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            457888999999999999998653 78999999873211             1123467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++..++..++||||+++++|.+++..     ..+++..+..++.+++.|+.|||+   .+++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~  141 (277)
T cd06641          70 SYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVK  141 (277)
T ss_pred             EEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEE
Confidence            99999999999999999999999842     358999999999999999999995   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....++..|+|||.+.+..++.++|+|||||++++|++|..||.....       ......
T Consensus       142 l~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~  212 (277)
T cd06641         142 LADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFL  212 (277)
T ss_pred             Eeecccceecccchhhh--ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHH
Confidence            99999987664432211  124678899999999988899999999999999999999999864321       111111


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+      .+    .......+.+++..||+.+|.+||++.++++
T Consensus       213 ~~~~~~~------~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         213 IPKNNPP------TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             HhcCCCC------CC----CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1111111      01    1112334788999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-38  Score=298.13  Aligned_cols=265  Identities=24%  Similarity=0.258  Sum_probs=195.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|+... +|..||||++......            ......+.+|+.++++++||||++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~   67 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTET------------EGVPSTAIREISLLKELNHPNIVKLLDV   67 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC-CCCEEEEEEccccccc------------cccchHHHHHHHHHHhcCCCCCcchhhh
Confidence            47888999999999999998764 7899999988432111            1123568899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+. ++|.+++..  .....+++..+..++.|++.||+|||.   .+++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l  141 (284)
T cd07860          68 IHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKL  141 (284)
T ss_pred             cccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999996 589998864  234568999999999999999999994   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++.........  .....++..|+|||++.+.. ++.++||||||+++|+|+||+.||.....   ...+.+....
T Consensus       142 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~  216 (284)
T cd07860         142 ADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRT  216 (284)
T ss_pred             eeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHH
Confidence            999998765433211  11235688999999887654 68899999999999999999999864211   1111111111


Q ss_pred             HhcCCCC-----------chhcc---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENP-----------NRAIN---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .-.....           ...+.   ........+.....+.+++.+||+.||.+||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000           00000   00000000112234778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-38  Score=287.98  Aligned_cols=251  Identities=19%  Similarity=0.264  Sum_probs=199.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|.... ++..+|+|.+......            ......+.+|+.+++.++|||++++++.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~   67 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMT------------KDERLAAQNECQVLKLLSHPNIIEYYEN   67 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC-CCcEEEEEEEeccccc------------cHHHHHHHHHHHHHhhCCCCchhheeee
Confidence            47888999999999999998764 8899999998432211            1235678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC-CceE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~k  293 (430)
                      +...+..++||||+++++|.+++...  ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.+ +.++
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~  142 (256)
T cd08220          68 FLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVK  142 (256)
T ss_pred             EecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            99999999999999999999999652  244589999999999999999999955   59999999999999855 4689


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||.+.........   ....|+..|+|||.+.+..++.++||||||+++++|++|..||.....       ......
T Consensus       143 l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~  212 (256)
T cd08220         143 IGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLK  212 (256)
T ss_pred             EccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHH
Confidence            9999999876543221   134688999999999988899999999999999999999999764311       111222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....... .         .+......+.+++..||+.+|.+|||+.++++
T Consensus       213 ~~~~~~~-~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         213 IMSGTFA-P---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHhcCCC-C---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            2211110 0         01112234889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.2e-38  Score=288.51  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=198.9

Q ss_pred             cccccccccccCceEEEeecCCCC---CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSS---GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +.+.+.||.|+||.||+|+.....   +..+|+|.+.....             ......+..|+.++..++|||+++++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i~~~~   67 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------------EQQIEEFLREARIMRKLDHPNIVKLL   67 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------------hHHHHHHHHHHHHHHhcCCCchheEE
Confidence            356789999999999999986422   48999999843211             11357889999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..+++|||+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        68 ~~~~~~~~~~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~  142 (258)
T smart00219       68 GVCTEEEPLMIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVV  142 (258)
T ss_pred             EEEcCCCeeEEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeE
Confidence            9999999999999999999999998542  112289999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++............ ...++..|+|||.+.+..++.++||||||+++++|++ |..||...    ....+.+. 
T Consensus       143 ~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~-  216 (258)
T smart00219      143 KISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEY-  216 (258)
T ss_pred             EEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHH-
Confidence            99999999877654332221 2346789999999988889999999999999999998 78887542    11122222 


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                        ......+.          .+......+.+++.+||+.+|++|||+.++++.|
T Consensus       217 --~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 --LKKGYRLP----------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --HhcCCCCC----------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              22111110          0011233588899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.6e-38  Score=300.42  Aligned_cols=199  Identities=21%  Similarity=0.294  Sum_probs=159.2

Q ss_pred             ccccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      ...||+|+||.||+|+... .++..||+|.+....                ....+.+|+.+++.++||||+++++++..
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----------------ISMSACREIALLRELKHPNVIALQKVFLS   69 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----------------CcHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            3579999999999998642 356889999884211                12357789999999999999999999854


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----
Q 014140          218 --RDCDLLVYEFRRNGSLQDILYDVS-----QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI----  286 (430)
Q Consensus       218 --~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----  286 (430)
                        ....++||||+.+ +|.+++....     .....+++..+..++.|++.||.|||+.   +++||||||+|||+    
T Consensus        70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~  145 (317)
T cd07867          70 HSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  145 (317)
T ss_pred             cCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCC
Confidence              4577899999965 8888875321     1233588999999999999999999954   59999999999999    


Q ss_pred             CCCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            56678999999999876543221 112235689999999998774 589999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=310.04  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=203.3

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      +.+.|.++..||.|+||+||+|..+ .++-..|-|++..              ........+.-|+.||..+.||+||++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIet--------------kseEELEDylVEIeILa~CdHP~ivkL   94 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIET--------------KSEEELEDYLVEIEILAECDHPVIVKL   94 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcc--------------cchhHHhhhhhhhhhhhcCCChHHHHH
Confidence            4556788899999999999999866 3666667777622              112346789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.|+..+.++|+.|||.||-+..++-.   -+..+.+..+..++.|++.||.|||+.+   |||||||+.|||+.-+|.
T Consensus        95 l~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGd  168 (1187)
T KOG0579|consen   95 LSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGD  168 (1187)
T ss_pred             HHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCc
Confidence            9999999999999999999999998853   4567999999999999999999999666   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ++|+|||.+.....  +......+.||+.|||||+..     ..+|+.++||||||++|.||..+.+|-...       +
T Consensus       169 irLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------n  239 (1187)
T KOG0579|consen  169 IRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------N  239 (1187)
T ss_pred             Eeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------c
Confidence            99999999765332  222233578999999999855     457999999999999999999999995433       2


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+-.+....+|. .+       .+......+.+++..||..||..||++.++++
T Consensus       240 pMRVllKiaKSePPT-Ll-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  240 PMRVLLKIAKSEPPT-LL-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hHHHHHHHhhcCCCc-cc-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            233333333333222 22       22334455889999999999999999999985

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.8e-38  Score=293.88  Aligned_cols=264  Identities=23%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||+|.... +|..||+|++......            ......+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~   67 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE-TGETVALKKVALRRLE------------GGIPNQALREIKALQACQHPYVVKLLDV   67 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC-CCceEEEEEEEccccc------------chhhHHHHHHHHHHHhCCCCCCcceeeE
Confidence            47888999999999999998764 7899999998543211            1224678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+ +++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l  140 (286)
T cd07832          68 FPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKI  140 (286)
T ss_pred             EecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEE
Confidence            99999999999999 9999999854   235699999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++......... ......|+..|+|||++.+.. ++.++||||||+++++|++|.+||.....    ......+..
T Consensus       141 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~  215 (286)
T cd07832         141 ADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFR  215 (286)
T ss_pred             eeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHH
Confidence            999999877544321 112346889999999987654 68999999999999999999877653211    111111111


Q ss_pred             HhcCCCCc------------hhcccc----ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPN------------RAINSK----LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~------------~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........            ....+.    ......++....+.+++.+||+.+|++||+++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11110000            000000    000001122356889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=296.90  Aligned_cols=264  Identities=19%  Similarity=0.243  Sum_probs=194.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||.|++|.||+|.... +++.||||.+......             .....+.+|+.+++.++||||+++++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~   70 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEE-------------GAPFTAIREASLLKDLKHANIVTLHD   70 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEeccccc-------------CCchhHHHHHHHHhhCCCcceeeEEE
Confidence            578999999999999999998753 7899999998542211             01234678999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++ +|.+++..   ....+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        71 ~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  143 (291)
T cd07844          71 IIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELK  143 (291)
T ss_pred             EEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEE
Confidence            99999999999999975 99998854   234689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+++.........  ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.....   .......+.
T Consensus       144 l~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~  218 (291)
T cd07844         144 LADFGLARAKSVPSKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD---VEDQLHKIF  218 (291)
T ss_pred             ECccccccccCCCCccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHH
Confidence            99999987543221111  12346788999998876 4588999999999999999999999864321   011111111


Q ss_pred             HHhcCCCCch----------------hccccccCCCcHHH--HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNR----------------AINSKLLGNGYEEQ--MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~----------------~~~~~~~~~~~~~~--~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+.......                ...+..........  ...+.+++..||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         219 RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            1111100000                00000000000001  145778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=301.10  Aligned_cols=253  Identities=27%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|..-++||+||||.||-++.+. +|+.||+|++.+      +.+++     ........+|-.+|.+++.|.||.+-
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvra-TGKMYAcKkL~K------KRiKk-----r~ge~maLnEk~iL~kV~s~FiVsla  251 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRA-TGKMYACKKLDK------KRIKK-----RKGETMALNEKQILEKVSSPFIVSLA  251 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEec-chhhHHHHHHHH------HHHHH-----hhhhHHhhHHHHHHHHhccCcEEEEe
Confidence            5678999999999999999998874 999999998832      11111     12235578999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      -.|.+.+.+|+|+..|.||+|.-+|++.  .++.+++..+..++.+|+.||.+||   +.+|++||+||+|||+|+.|++
T Consensus       252 YAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~Ghv  326 (591)
T KOG0986|consen  252 YAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHV  326 (591)
T ss_pred             eeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCe
Confidence            9999999999999999999999998763  4467999999999999999999999   6669999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|+|+|..++.+.....   .+||.+|||||++.+..|+...|+|||||++|||+.|+.||.......    -.+.+.
T Consensus       327 RISDLGLAvei~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k~eEvd  399 (591)
T KOG0986|consen  327 RISDLGLAVEIPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----KREEVD  399 (591)
T ss_pred             EeeccceEEecCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----hHHHHH
Confidence            9999999999987765543   489999999999999999999999999999999999999986533211    111121


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      .......          ..++......+.++....|+.||.+|.-.+
T Consensus       400 rr~~~~~----------~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLEDP----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhcch----------hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            1111110          112222334477777788999999997554

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-38  Score=292.61  Aligned_cols=251  Identities=23%  Similarity=0.256  Sum_probs=200.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|+||.||+|.... ++..||+|.+.....           ........+.+|+.++++++||||++++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   68 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKC-----------VEKGSVRNVLNERRILQELNHPFLVNLWYS   68 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhh-----------cchhHHHHHHHHHHHHHhCCCCChHHHHHh
Confidence            47889999999999999998753 789999999853221           111235789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +..++..++|+||+.+++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l  141 (258)
T cd05578          69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHI  141 (258)
T ss_pred             hcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEE
Confidence            9999999999999999999999843    35789999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++........   .....|+..|+|||++.+..++.++|+||||+++|+|++|..||......     ........
T Consensus       142 ~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~  213 (258)
T cd05578         142 TDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAK  213 (258)
T ss_pred             eecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHH
Confidence            99999887654321   12346888999999999888999999999999999999999998754321     11122222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS--KDVR  422 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~--~ev~  422 (430)
                      .....  .        ..+......+.+++.+||+.+|.+||++  .+++
T Consensus       214 ~~~~~--~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         214 QETAD--V--------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             hcccc--c--------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11110  0        1111223458899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=278.30  Aligned_cols=253  Identities=20%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ++...+..||+|+.|.|+++++++ +|..+|||.+.....             ....+++...++++...+ .|+||+.+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~N-------------kee~kRILmDldvv~~s~dcpyIV~c~  157 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGN-------------KEENKRILMDLDVVLKSHDCPYIVQCF  157 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcc-cceEEEEEeecccCC-------------HHHHHHHHHhhhHHhhccCCCeeeeee
Confidence            455667789999999999999985 899999999854322             233577888888888775 89999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|..+...++.||.|.. .++.++.+   ..+++++...-++...++.||.||...+  +|+|||+||+|||+|+.|++
T Consensus       158 GyFi~n~dV~IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni  231 (391)
T KOG0983|consen  158 GYFITNTDVFICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI  231 (391)
T ss_pred             eEEeeCchHHHHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence            999999999999999954 77777754   3456999999999999999999998776  89999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      |+||||++..+.+...+..   ..|.+.|||||.+...   .|+.++||||||++++||.||+.||..-.   .+   .+
T Consensus       232 KlCDFGIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~---td---Fe  302 (391)
T KOG0983|consen  232 KLCDFGISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK---TD---FE  302 (391)
T ss_pred             Eeecccccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC---cc---HH
Confidence            9999999998876655443   3789999999998765   58999999999999999999999987521   11   12


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..+++...  ..++...  .    ...++.+++..||+.|+.+||...++++
T Consensus       303 ~ltkvln~eP--P~L~~~~--g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  303 VLTKVLNEEP--PLLPGHM--G----FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhcCC--CCCCccc--C----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            2333443222  1121111  0    1234888999999999999999999875

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=310.53  Aligned_cols=245  Identities=27%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCe
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDC  220 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  220 (430)
                      +||.|.||+||.|++.. +...+|||-+..              .......-+..|+.+-++|+|.|||+++|.|.+++.
T Consensus       582 VLGKGTYG~VYA~RD~~-tqvrIaIKEIpe--------------kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf  646 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD-TQVRIAIKEIPE--------------KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF  646 (1226)
T ss_pred             EeecCceeEEEeecccc-ceeEEEeeeccc--------------ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe
Confidence            69999999999999874 777899998732              112235668899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CCceEEeec
Q 014140          221 DLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEF  297 (430)
Q Consensus       221 ~~lV~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Df  297 (430)
                      .-|.||-++||||.++++.   .=+++  .+.+.-.+..||++||.|||...   |+|||||-+|+|++. .|.+||+||
T Consensus       647 ~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDF  720 (1226)
T KOG4279|consen  647 FKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDF  720 (1226)
T ss_pred             EEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEeccc
Confidence            9999999999999999965   22455  77888889999999999999666   999999999999985 688999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |-++.+..-..-  +..+-||..|||||++..+  +|+.++|||||||++.||.||++||-+....     ....++-.+
T Consensus       721 GTsKRLAginP~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----qAAMFkVGm  793 (1226)
T KOG4279|consen  721 GTSKRLAGINPC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----QAAMFKVGM  793 (1226)
T ss_pred             ccchhhccCCcc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----hHhhhhhcc
Confidence            999887654332  2246799999999999877  4899999999999999999999998654321     011111111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .          +.-.+.+.+....+..++.+|+.++|.+||++.++++
T Consensus       794 y----------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 Y----------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             e----------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            0          1123455666777999999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-38  Score=288.70  Aligned_cols=239  Identities=20%  Similarity=0.285  Sum_probs=185.7

Q ss_pred             cccccccCceEEEeecCCCCC----------ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          140 EKIRSCWNGEVYKAELPGSSG----------RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      +.||+|+||.||+|.+.. ++          ..+++|.+....               .....+.+|+.+++.++||||+
T Consensus         1 ~~lg~G~~~~v~~~~~~~-~~~~~~~~~~~~~~v~~k~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~   64 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRV-QSDLDIVGPGQEVSVVLKVLGSDH---------------RDSLAFFETASLMSQLSHKHLV   64 (259)
T ss_pred             CcccccccceEEEEEEec-cCCccccCCccceeeeeeccccch---------------hhHHHHHHHHHHHHcCCCcchh
Confidence            468999999999999864 33          246777653211               1146788999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++.. +..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.+
T Consensus        65 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~  137 (259)
T cd05037          65 KLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARY  137 (259)
T ss_pred             heeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecC
Confidence            99999988 7789999999999999999642   2368999999999999999999994   459999999999999988


Q ss_pred             C-------ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 014140          290 M-------EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVI-GKFPSDDFF  359 (430)
Q Consensus       290 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~-g~~p~~~~~  359 (430)
                      +       .++|+|||++......      ....++..|+|||++.+.  .++.++||||||+++++|++ |..||....
T Consensus       138 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             ccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            7       7999999999876431      123567789999999877  78999999999999999999 567765432


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      .    ........   ......        ...    ...+.+++..||..+|.+||++.+|++.|+
T Consensus       212 ~----~~~~~~~~---~~~~~~--------~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         212 S----SEKERFYQ---DQHRLP--------MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             c----hhHHHHHh---cCCCCC--------CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1    11111111   111000        000    045889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-37  Score=287.56  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=200.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|++|.||+|.... +++.|++|.+......            ......+..|+.+++.++||||++++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~   67 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDND------------PKTIKEIADEMKVLELLKHPNLVKYYGV   67 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccc------------hHHHHHHHHHHHHHHhCCCCChhheeee
Confidence            47788999999999999998754 7899999998543211            2346789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++|+||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl  140 (264)
T cd06626          68 EVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKL  140 (264)
T ss_pred             EecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999843    34588999999999999999999955   4999999999999999999999


Q ss_pred             eecCCcccCCCCCCcce--eeccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          295 SEFGLAKRIPDGHTRTT--TWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|||++...........  .....++..|+|||++.+..   ++.++||||||++++++++|+.||.....   .   ..
T Consensus       141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~---~~  214 (264)
T cd06626         141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---E---FQ  214 (264)
T ss_pred             cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---h---HH
Confidence            99999987754332211  11246788999999998776   88999999999999999999999864321   0   11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........+.  +..      .......+.+++..||+.+|.+||++.+++.
T Consensus       215 ~~~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         215 IMFHVGAGHKPP--IPD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHhcCCCCC--CCc------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111111110  000      0111334778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=299.95  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=201.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  210 (430)
                      ....|++++.||+||.++||++..-  +.+.||+|++...            ........-|.+|+..|.+|+ |.+||+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~------------~~D~qtl~gy~nEI~lL~KLkg~~~IIq  424 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLL------------EADNQTLDGYRNEIALLNKLKGHDKIIQ  424 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHh------------hcCHHHHHHHHHHHHHHHHhcCCceEEE
Confidence            4456899999999999999999643  7788999887432            233456788999999999995 999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++|-..++.+||||||-+. +|..+|+..   ...++...+..+..|++.++.++|+.+   |||.||||.|+|+-. |
T Consensus       425 L~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G  496 (677)
T KOG0596|consen  425 LYDYEVTDGYLYMVMECGDI-DLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-G  496 (677)
T ss_pred             EeeeeccCceEEEEeecccc-cHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-e
Confidence            99999999999999999855 999999652   223332377889999999999999555   999999999999864 6


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-----------LSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      .+||+|||+|..+..+.+.......+||+.||+||.+....           .+.++||||||||||+|+.|+.||....
T Consensus       497 ~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  497 RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            89999999999998888877777889999999999876443           4578999999999999999999987542


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                            +....+..+...+.  ..-.+.. ...  .   .+.+++..||..||.+||++.++++
T Consensus       577 ------n~~aKl~aI~~P~~--~Iefp~~-~~~--~---~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 ------NQIAKLHAITDPNH--EIEFPDI-PEN--D---ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ------HHHHHHHhhcCCCc--cccccCC-CCc--h---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence                  12222222222111  1111111 111  1   1889999999999999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-38  Score=318.47  Aligned_cols=285  Identities=19%  Similarity=0.254  Sum_probs=193.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeeccccc---chhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKS---GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|.+++.||+|+||+||++.++...+...++|.+......   ....+.+...........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            367999999999999999999876545555554433211111   01111111112223456788999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      ++++++...+..|+|+|++. ++|.+++..... ............++.|++.||.|||+.   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999995 578887753211 122234566778999999999999955   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC-CCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF-PSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||++..+....... .....||..|+|||++.+..++.++|||||||++|||++|.. |+..... .....+
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~  380 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQL  380 (501)
T ss_pred             CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHH
Confidence            9999999999998775432221 123579999999999999999999999999999999999875 4432211 111111


Q ss_pred             HHHHHHHhc--CCCCc---h---hcccccc---CCCcH------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMT--SENPN---R---AINSKLL---GNGYE------EQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~--~~~~~---~---~~~~~~~---~~~~~------~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+.+...-.  ...+.   .   .++....   .....      .....+.+++.+||+.||.+|||+.|++.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111000  00000   0   0000000   00000      01224677889999999999999999986

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=298.00  Aligned_cols=209  Identities=22%  Similarity=0.291  Sum_probs=169.7

Q ss_pred             ccccccccccccCceEEEeecCCC-CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGS-SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .|.+...||+|++|.||+|..... ++..||+|.+.....           ........+.+|+.++..++||||+++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----------QYTGISQSACREIALLRELKHENVVSLVE   69 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----------cccCccHHHHHHHHHHHhcCCCCccceEE
Confidence            377889999999999999987632 689999999854321           01112356788999999999999999999


Q ss_pred             EEEeC--CeeEEEEEecCCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC--
Q 014140          214 RMVRR--DCDLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--  288 (430)
Q Consensus       214 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--  288 (430)
                      ++...  +..++||||+++ +|.+++...... ...++...++.++.|++.||.|||+.   +++||||||+||+++.  
T Consensus        70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~  145 (316)
T cd07842          70 VFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEG  145 (316)
T ss_pred             EEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCC
Confidence            99988  789999999975 787777543332 23789999999999999999999955   5999999999999999  


Q ss_pred             --CCceEEeecCCcccCCCCCC-cceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          289 --DMEARISEFGLAKRIPDGHT-RTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       289 --~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                        ++.+||+|||++........ ........++..|+|||++.+. .++.++||||||+++++|++|+.||...
T Consensus       146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence              99999999999987654322 1112234678999999988764 5789999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.8e-38  Score=296.80  Aligned_cols=251  Identities=26%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|...+.||.|+||.||+|.... +|+.||+|.+.....           ........+.+|+.+++.++|||+++++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~-----------~~~~~~~~~~~Ei~~l~~l~h~niv~~~   81 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGK-----------QSNEKWQDIIKEVRFLQQLRHPNTIEYK   81 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEecccc-----------CcHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            4568999999999999999998764 789999998843221           1123346788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|...+..++|+||++ |+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~  154 (307)
T cd06607          82 GCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTV  154 (307)
T ss_pred             EEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCE
Confidence            99999999999999997 588887743   234689999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||++.......      ...++..|+|||++.   ...++.++||||||+++|||++|..||.....       ..
T Consensus       155 kL~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~  221 (307)
T cd06607         155 KLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS  221 (307)
T ss_pred             EEeecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HH
Confidence            999999987654321      245788999999874   34688999999999999999999999754321       11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ..........+.         .........+.+++..||+.+|++||++.+|+..
T Consensus       222 ~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         222 ALYHIAQNDSPT---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHhcCCCCC---------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            111111111110         0111233458899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.5e-38  Score=295.77  Aligned_cols=264  Identities=21%  Similarity=0.220  Sum_probs=196.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|.... +++.+++|.+......            ......+.+|+.++++++||||+++++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~   71 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEK------------EGFPITSLREINILLKLQHPNIVTVKE   71 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeecccc------------ccchhhHHHHHHHHHhcCCCCEEEEEE
Confidence            468899999999999999999864 7899999998543211            112345778999999999999999999


Q ss_pred             EEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++...  +..++||||+++ +|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  144 (293)
T cd07843          72 VVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGI  144 (293)
T ss_pred             EEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCc
Confidence            99887  889999999975 99998854   223689999999999999999999955   4999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||++..........  ....++..|+|||.+.+.. ++.++|+||||+++++|++|..||......    .....
T Consensus       145 ~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~  218 (293)
T cd07843         145 LKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNK  218 (293)
T ss_pred             EEEeecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHH
Confidence            9999999998765432111  1235788999999987654 689999999999999999999998643211    11111


Q ss_pred             HHHHhcC-----------------CCCchhccccccCCCcHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTS-----------------ENPNRAINSKLLGNGYEE-QMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +......                 ..........+....+.. ....+.+++..||+.+|++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         219 IFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            1010000                 000000000000111111 2445789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.7e-38  Score=295.36  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|.....||.|+||.||+|.... +++.||+|.+.....              .....+.+|+.+++.++|||+++++++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i~~~~~~   86 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHQNVVEMYKS   86 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC-CCCEEEEEEEEeccc--------------chHHHHHHHHHHHHhCCCCchhhhhhh
Confidence            45566789999999999998753 789999999832111              113568889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +..++..++|+||+++++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        87 ~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL  158 (297)
T cd06659          87 YLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL  158 (297)
T ss_pred             eeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEE
Confidence            9999999999999999999998732     4589999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....|+..|+|||++.+..++.++||||||++++||++|..||.....       .+.....
T Consensus       159 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~  229 (297)
T cd06659         159 SDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRL  229 (297)
T ss_pred             eechhHhhcccccccc--cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            9999987654332211  135689999999999988899999999999999999999999864211       1111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........        ........+.+++..||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         230 RDSPPPKLK--------NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             hccCCCCcc--------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            111111000        00111234788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-38  Score=291.69  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=196.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l  211 (430)
                      .|...+.||.|+||.||+|.... +|+.+|+|.+.....             ......+.+|+.+++.++   |||++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~~~~vi~~   67 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDTP-------------DDDVSDIQREVALLSQLRQSQPPNITKY   67 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC-CCcEEEEEEecCCCC-------------chhHHHHHHHHHHHHHhccCCCCCeeeE
Confidence            47788999999999999998764 889999998843211             122456888999999997   9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++......++||||+++++|.+++..     ..+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~  139 (277)
T cd06917          68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGN  139 (277)
T ss_pred             eeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCC
Confidence            9999999999999999999999999843     3689999999999999999999954   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||++..........  ....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.....       ...
T Consensus       140 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~  210 (277)
T cd06917         140 VKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRA  210 (277)
T ss_pred             EEEccCCceeecCCCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhh
Confidence            9999999998775543222  234688999999988754 478999999999999999999999865321       111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..... ...+.     .+...   .....+.+++..||+.+|++||++.+++.
T Consensus       211 ~~~~~-~~~~~-----~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         211 MMLIP-KSKPP-----RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             hhccc-cCCCC-----CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111 11111     11111   12335889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-37  Score=292.08  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=197.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  213 (430)
                      +|...+.||+|+||.||++.... +|+.+|+|.+.....             ......+.+|+.++.++. ||||+++++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~~iv~~~~   70 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVD-------------EKEQKRLLMDLDVVMRSSDCPYIVKFYG   70 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccC-------------hHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            56778899999999999998764 789999998843211             123467889999999996 999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++...+..+++|||+.. +|.++.... ......+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~  147 (288)
T cd06616          71 ALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNI  147 (288)
T ss_pred             EEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcE
Confidence            99999999999999864 776654321 12345799999999999999999999954  259999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||++.........   ....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....      ...+
T Consensus       148 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~  218 (288)
T cd06616         148 KLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFD  218 (288)
T ss_pred             EEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHH
Confidence            99999999765433221   123578899999998876   68999999999999999999999986432      1222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .+........+.      +...........+.+++..||+.+|++|||+.+|+..
T Consensus       219 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         219 QLTQVVKGDPPI------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHhhhcCCCCCc------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            222222211111      1111111233458899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-37  Score=294.66  Aligned_cols=267  Identities=22%  Similarity=0.237  Sum_probs=197.0

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||.|++|.||+|.... +|+.||||.+.......         ........+..|+.+++.++||||++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKE---------AKDGINFTALREIKLLQELKHPNIIGLLDV   70 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC-CCcEEEEEEEecccccc---------ccchhhHHHHHHHHHHhhcCCCCChhhhhe
Confidence            36778899999999999998764 78999999985432210         011224567789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+ +|+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        71 ~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l  143 (298)
T cd07841          71 FGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKL  143 (298)
T ss_pred             eecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEE
Confidence            99999999999999 8899999953   223699999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++..........  ....++..|+|||.+.+ ..++.++|||||||++++|++|..||.....    .........
T Consensus       144 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~  217 (298)
T cd07841         144 ADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFE  217 (298)
T ss_pred             ccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHH
Confidence            9999998765432211  12356788999998865 3578999999999999999999777653221    111111111


Q ss_pred             HhcCCCCc---------hhccccccC-----CCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPN---------RAINSKLLG-----NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~---------~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ........         .........     .........+.+++..||+.+|.+|||+.++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11000000         000000000     0112224568899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2e-37  Score=287.05  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||.|++|.||+|+... +++.+++|.+.....           ........+.+|+.+++.++||||+++++++.+.+..
T Consensus         1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   68 (262)
T cd05572           1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHI-----------VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI   68 (262)
T ss_pred             CCCCCceEEEEEEECC-CCcEEEEEEEehhcc-----------hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence            6999999999999864 789999999843221           1122346799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        69 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~  141 (262)
T cd05572          69 YMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK  141 (262)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence            999999999999999953    34589999999999999999999954   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      ......   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....     +.............. 
T Consensus       142 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-  212 (262)
T cd05572         142 KLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGK-  212 (262)
T ss_pred             ccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCC-
Confidence            775442   11234688999999999888899999999999999999999999865321     112222222211100 


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                              ...+......+.+++..||+.+|++||+     +.|+++
T Consensus       213 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 --------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             --------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                    0111111345899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-39  Score=308.40  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=195.0

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEE
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  216 (430)
                      ....+||+|+|-+||+|.+. .+|-.||=-.+...          ..........+|..|+.+|+.|+|||||++|.+|.
T Consensus        43 k~~evLGrGafKtVYka~De-~~giEVAWnqvk~~----------d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~  111 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIR----------DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV  111 (632)
T ss_pred             ehhhhcccccceeeeecccc-ccchhhHHHHHhHH----------HhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence            45678999999999999764 47777763222111          11122344688999999999999999999999998


Q ss_pred             eCCe--eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CCceE
Q 014140          217 RRDC--DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEAR  293 (430)
Q Consensus       217 ~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~k  293 (430)
                      +...  ..+|+|.|..|+|..++..    .+.+.......|+.||++||.|||+. .|+|||||||.+||||+. .|.+|
T Consensus       112 d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  112 DTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             cCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCcee
Confidence            8655  7789999999999999954    45688999999999999999999998 789999999999999985 48999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|+|+|........    ....|||.|||||+.. ..|+..+||||||+.++||.|+..||..=.      +-.+.-+.
T Consensus       187 IGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKK  255 (632)
T KOG0584|consen  187 IGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKK  255 (632)
T ss_pred             ecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHH
Confidence            999999998754432    2468999999999887 689999999999999999999999986421      11222233


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.. +..+..+..    -..+    .+.++|.+||.. .++|||+.|+++
T Consensus       256 V~S-GiKP~sl~k----V~dP----evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  256 VTS-GIKPAALSK----VKDP----EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHc-CCCHHHhhc----cCCH----HHHHHHHHHhcC-chhccCHHHHhh
Confidence            332 222222111    1122    288899999999 999999999985

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-37  Score=290.30  Aligned_cols=248  Identities=26%  Similarity=0.306  Sum_probs=190.8

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||.|+||+||+|.... +|+.+|+|.+.....           ........+.+|+.+++.++|||++++++++...+..
T Consensus         1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   68 (277)
T cd05577           1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRL-----------KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL   68 (277)
T ss_pred             CCCCCceeEEEEEEcC-CCcEEEEEEEehhhh-----------hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence            6999999999998664 899999998843211           1112245677899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      |+||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        69 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~  143 (277)
T cd05577          69 CLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV  143 (277)
T ss_pred             EEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchh
Confidence            9999999999999998642  224689999999999999999999955   59999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      .......   .....++..|+|||++.+..++.++||||||+++++|++|+.||........    ...+........  
T Consensus       144 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--  214 (277)
T cd05577         144 ELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMA--  214 (277)
T ss_pred             hhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcccccc--
Confidence            6644221   1134678899999999888899999999999999999999999865322111    111111110000  


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                          .    ..+......+.+++..||+.+|.+||     ++.+++.
T Consensus       215 ----~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 ----V----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ----c----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                0    01111233478999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-37  Score=292.49  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=198.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|.+.+.||+|+||.||+|.... ++..+++|.+....              ......+.+|+.+++.++|||++++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~hp~i~~~~~   83 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA-TGQEVAIKQMNLQQ--------------QPKKELIINEILVMRENKHPNIVNYLD   83 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC-CCCEEEEEEecccc--------------chHHHHHHHHHHHHhhcCCCCeeehhh
Confidence            568899999999999999997653 78899999873211              112466889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++|+||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~k  155 (293)
T cd06647          84 SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  155 (293)
T ss_pred             eeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEE
Confidence            99999999999999999999999843     3478999999999999999999944   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++..........  ....|++.|+|||++.+..++.++|+||||+++|++++|..||.......       ....
T Consensus       156 L~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~  226 (293)
T cd06647         156 LTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYL  226 (293)
T ss_pred             EccCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heee
Confidence            99999987654432211  12468889999999988889999999999999999999999986432210       0000


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ....+.+.  +      .........+.+++..||..+|++||++.+++..
T Consensus       227 ~~~~~~~~--~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         227 IATNGTPE--L------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             hhcCCCCC--C------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111110  0      0111223358889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.4e-37  Score=291.16  Aligned_cols=266  Identities=19%  Similarity=0.203  Sum_probs=194.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      +.+.|.+.+.||+|+||.||+|.... +|..||+|.+......             .....+.+|+.+++.++|+||+++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~   68 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEE-------------GVPFTAIREASLLKGLKHANIVLL   68 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccCcC-------------CCcHHHHHHHHHHHhcCCCCEeEE
Confidence            35679999999999999999998764 7899999998432111             112356789999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+. ++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~  141 (291)
T cd07870          69 HDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGE  141 (291)
T ss_pred             EEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCc
Confidence            999999999999999996 688777643   234578888899999999999999955   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||+++.........  ....+++.|+|||++.+. .++.++||||||+++++|++|..||+.....   ......
T Consensus       142 ~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~  216 (291)
T cd07870         142 LKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEK  216 (291)
T ss_pred             EEEeccccccccCCCCCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHH
Confidence            9999999987653322111  123578899999998764 5788999999999999999999998753221   001000


Q ss_pred             HHHHhcCC------------CCchhccccccCCCc------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSE------------NPNRAINSKLLGNGY------EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~------------~~~~~~~~~~~~~~~------~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......+            ...............      ......+.+++.+|+..||.+|||+.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            10000000            000000000000000      001234778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-37  Score=285.62  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|+||.||+|.... +|..+|+|.+......            ......+.+|+.+++.++|||++++++.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~~~h~~i~~~~~~   67 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMP------------VKEKEASKKEVILLAKMKHPNIVTFFAS   67 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhcc------------chhhHHHHHHHHHHHhCCCCChhhhhhe
Confidence            47788999999999999998864 7899999988432111            1124567899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-ceE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~k  293 (430)
                      +...+..++|+||+++++|.+++..  .....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++ .++
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~  142 (257)
T cd08225          68 FQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAK  142 (257)
T ss_pred             eccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEE
Confidence            9999999999999999999999864  23345899999999999999999999554   99999999999999885 469


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||.+..........  ....|++.|+|||++.+..++.++|+||||+++++|++|..||....       ..+....
T Consensus       143 l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~  213 (257)
T cd08225         143 LGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLK  213 (257)
T ss_pred             ecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH
Confidence            99999998765432211  12468899999999988889999999999999999999999975421       2222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......          ...+.....+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         214 ICQGYFA----------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HhcccCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2221110          001112234889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=292.11  Aligned_cols=264  Identities=25%  Similarity=0.255  Sum_probs=194.3

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.+.+.||.|++|.||+|.... +|..||+|++......            ......+.+|+.+++.++|||++++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~   67 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETED------------EGVPSTAIREISLLKELNHPNIVRLLDVV   67 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC-CCCEEEEEEeeccccc------------ccchhHHHHHHHHHHhcCCCCccCHhhee
Confidence            5678899999999999998764 8999999988432111            11235678899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .+.+..+++|||++ ++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        68 ~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~  141 (283)
T cd07835          68 HSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLA  141 (283)
T ss_pred             ccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEe
Confidence            99999999999995 6999998542  224689999999999999999999954   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      |||++.........  .....++..|+|||++.+. .++.++|+||||+++|+|++|..||......   ..+.......
T Consensus       142 df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~  216 (283)
T cd07835         142 DFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTL  216 (283)
T ss_pred             ecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            99999765432211  1123568899999988765 4789999999999999999999998643211   1111111110


Q ss_pred             hcCC-----------CCchhcc---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSE-----------NPNRAIN---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~-----------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....           .....+.   ........+.....+.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000           0000000   00000011112245889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-37  Score=289.70  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||.|++|.||+|.+.. ++..+++|++.....               ....+.+|+.+++.++|||++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~   80 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ---------------NKELIINEILIMKDCKHPNIVDY   80 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch---------------hHHHHHHHHHHHHHCCCCCeeEE
Confidence            35678999999999999999998764 789999999843211               24678899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++|+||+++++|.+++....   ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~  154 (286)
T cd06614          81 YDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGS  154 (286)
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCC
Confidence            999999999999999999999999996521   379999999999999999999995   55999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++..........  ....++..|+|||++.+..++.++|+||||+++|+|++|..||....+       ....
T Consensus       155 ~~l~d~~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~  225 (286)
T cd06614         155 VKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRAL  225 (286)
T ss_pred             EEECccchhhhhccchhhh--ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence            9999999987654332211  134578899999999988899999999999999999999999764321       1111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+ ...       ........+.+++..||+.+|.+||++.++++
T Consensus       226 ~~~~~~~~~-~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         226 FLITTKGIP-PLK-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHhcCCC-CCc-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111111111 000       01112345889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=291.39  Aligned_cols=270  Identities=14%  Similarity=0.126  Sum_probs=187.4

Q ss_pred             ccccccccccccccCceEEEeecCCCC---CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSS---GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .+.|.+.+.||+|+||+||+|.... +   +..+|+|..........   .+..............+...+..+.|+|++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~~---~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETIV---METLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCchh---hHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            3579999999999999999998763 4   55677775422211100   000000000012233455566778999999


Q ss_pred             cceeEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          210 PLLARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       210 ~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++++++....    ..++++|++. .++.+.+..    ....++..+..++.|++.||.|||+.   +++||||||+|||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil  158 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM  158 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            9999776543    3467888874 477777632    23467888899999999999999955   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ++.++.++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||+++||++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999876432111     111234699999999999999999999999999999999999999976422


Q ss_pred             cccccc--HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          361 HTKEMS--LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       361 ~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ......  ..++...... +..    .   ....    +..+.+++..|++.+|++||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~-~~~----~---~~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHE-GKI----K---IKNA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHHhHHHHHHHhhh-hhh----c---cCCC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111000  0111111111 110    0   0111    244889999999999999999999999874

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.7e-38  Score=294.31  Aligned_cols=266  Identities=21%  Similarity=0.235  Sum_probs=193.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ++|.+.+.||+|+||.||+|.... +|+.||+|.+......            ......+.+|+.+++.++ ||||++++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~~i~~~~   67 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEMDE------------EGIPPTALREISLLQMLSESIYIVRLL   67 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhccc------------cCCchHHHHHHHHHHHccCCCCcccee
Confidence            358889999999999999999764 8999999987432111            112356788999999995 69999999


Q ss_pred             eEEEeCCe-----eEEEEEecCCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRDC-----DLLVYEFRRNGSLQDILYDVSQG-RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+.     .++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+   .+++||||+|+||++
T Consensus        68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~  143 (295)
T cd07837          68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLV  143 (295)
T ss_pred             eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEE
Confidence            99987665     7999999986 898888653222 3568999999999999999999994   459999999999999


Q ss_pred             CC-CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          287 DD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       287 ~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      +. ++.++|+|||++.........  .....+++.|+|||++.+. .++.++||||||+++|+|++|..||......   
T Consensus       144 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---  218 (295)
T cd07837         144 DKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---  218 (295)
T ss_pred             ecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence            98 889999999998865432111  1123568889999988654 5789999999999999999999998642211   


Q ss_pred             ccHHHHHHHHhcCCCCchhc---------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAI---------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+..... ....+. ....               .+.......+.....+.+++..||+.+|.+||++.+++.
T Consensus       219 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         219 QQLLHIFK-LLGTPT-EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHHH-HhCCCC-hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11111111 100000 0000               000000001123345889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-37  Score=286.98  Aligned_cols=252  Identities=22%  Similarity=0.251  Sum_probs=203.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||+++... +|..+++|.+......            ......+.+|+.+++.++||||++++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMS------------QKEREDAVNEIRILASVNHPNIISYKEA   67 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhcc------------HHHHHHHHHHHHHHHhCCCCCchhhhhh
Confidence            47788999999999999998764 8899999998432211            1235677889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +......++||||+++++|.+++.........+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl  144 (256)
T cd08530          68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKI  144 (256)
T ss_pred             hccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEE
Confidence            999999999999999999999987644445678999999999999999999994   45999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++........    ....++..|+|||.+.+..++.++|+||||+++++|++|+.||.....    ..+.   ...
T Consensus       145 ~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~---~~~  213 (256)
T cd08530         145 GDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLR---YKV  213 (256)
T ss_pred             eeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH---HHH
Confidence            99999987755421    124578899999999998899999999999999999999999864321    1111   111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .... .         ...+......+.+++..||+.+|++||++.++++
T Consensus       214 ~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         214 QRGK-Y---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hcCC-C---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111 1         1112233455899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-37  Score=289.82  Aligned_cols=264  Identities=21%  Similarity=0.275  Sum_probs=196.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|++.+.||.|++|.||+|+... +|..||||++......             .....+.+|+.+++.++||||++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~   66 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEE-------------GTPSTAIREISLMKELKHENIVRLHDV   66 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC-CCeEEEEEEecccccc-------------cchHHHHHHHHHHHhhcCCCEeeeeee
Confidence            47889999999999999999764 8999999998543211             113457789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++ +|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        67 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l  141 (284)
T cd07836          67 IHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKL  141 (284)
T ss_pred             EeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEE
Confidence            9999999999999985 8988885422 234689999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++..........  ....++..|+|||++.+. .++.++||||||+++|+|++|..||......    ........
T Consensus       142 ~d~g~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~  215 (284)
T cd07836         142 ADFGLARAFGIPVNTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFR  215 (284)
T ss_pred             eecchhhhhcCCcccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHH
Confidence            9999997654322111  123578899999988664 5788999999999999999999998653221    11111111


Q ss_pred             HhcCC------------CCchhcc---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSE------------NPNRAIN---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~------------~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....            .....+.   ........+.....+.+++..|++.+|.+||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11000            0000000   00000011122345889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4e-37  Score=293.28  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=196.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|...+.||+|+||.||+|+... +|..+|+|++.....           ........+.+|+.+++.++|||++++++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   92 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGK-----------QSNEKWQDIIKEVKFLQRIKHPNSIEYKG   92 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCC-----------CchHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            458889999999999999998764 789999998843211           12233567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++ +|.+++..   ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        93 ~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~k  165 (317)
T cd06635          93 CYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK  165 (317)
T ss_pred             EEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEE
Confidence            99999999999999975 88887743   235689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |+|||++.......      ...|+..|+|||++.   +..++.++|||||||++|+|++|..||.....       ...
T Consensus       166 l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~  232 (317)
T cd06635         166 LADFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA  232 (317)
T ss_pred             EecCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHH
Confidence            99999987653321      246788999999874   45688999999999999999999999754211       111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      .........+.         .........+.+++.+||+.+|.+||++.+|++.+
T Consensus       233 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         233 LYHIAQNESPT---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             HHHHHhccCCC---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            11111111111         01112233488999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=281.01  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=205.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++...+..||.|+||+|++-.++ .+|+..|||++.....             +....++..|..+..+- +.||||++
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~-------------~keq~rll~e~d~~mks~~cp~IVkf  128 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNI-------------EKEQKRLLMEHDTVMKSSNCPNIVKF  128 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccc-------------hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence            345677789999999999999887 4999999999954322             23456788888765554 78999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ||.+...+..|+.||.|+- ||..+... .......+++...-.|+.-.+.||.||-...  .|||||+||+|||++..|
T Consensus       129 yGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G  205 (361)
T KOG1006|consen  129 YGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG  205 (361)
T ss_pred             hhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence            9999999999999999965 87665432 2234567999999999999999999997543  599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||||||++..+.++....   .-.|...|||||.+...  +|+.+|||||||++|+|+.||..||...      .+..
T Consensus       206 ~vKLCDFGIcGqLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svf  276 (361)
T KOG1006|consen  206 DVKLCDFGICGQLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVF  276 (361)
T ss_pred             CEeeecccchHhHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHH
Confidence            99999999998775543222   23688899999988765  5899999999999999999999998653      3456


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      +.+..+.....+.-..+....     .....+..++..||..|.+.||+..++.++
T Consensus       277 eql~~Vv~gdpp~l~~~~~~~-----~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  277 EQLCQVVIGDPPILLFDKECV-----HYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHcCCCCeecCccccc-----ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            666666666555443333322     223348889999999999999999988753

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.2e-37  Score=287.29  Aligned_cols=259  Identities=22%  Similarity=0.246  Sum_probs=192.0

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLAR  214 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  214 (430)
                      |.+.+.||.|+||.||+|.... ++..||+|++......            .. ......|+.++.++. |||+++++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~------------~~-~~~~~~e~~~l~~l~~h~~i~~~~~~   66 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKS------------LE-QVNNLREIQALRRLSPHPNILRLIEV   66 (282)
T ss_pred             CceEeeccccccceEEEEEEcC-CCcEEEEEEehhccCC------------ch-hhhHHHHHHHHhhcCCCCCccceEEE
Confidence            5678899999999999998764 8899999988432211            01 123457888899885 9999999999


Q ss_pred             EEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          215 MVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       215 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +.+.  +..++||||++ |+|.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++. +.+
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~  138 (282)
T cd07831          67 LFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DIL  138 (282)
T ss_pred             EecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCe
Confidence            9987  88999999997 588888753   235689999999999999999999955   5999999999999999 999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++..........   ...++..|+|||++.+ ..++.++|||||||++|||++|..||.....    .....+.
T Consensus       139 kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~~  211 (282)
T cd07831         139 KLADFGSCRGIYSKPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAKI  211 (282)
T ss_pred             EEEecccccccccCCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHHH
Confidence            999999998765432221   2357889999997654 4578899999999999999999999864321    1222222


Q ss_pred             HHHhcCCCC-----------chhccccccC----CCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENP-----------NRAINSKLLG----NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~-----------~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........           .....+....    .........+.+++..||+.+|++||++.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            221111100           0000000000    001123456899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=291.20  Aligned_cols=267  Identities=27%  Similarity=0.392  Sum_probs=203.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc--CCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV--RHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l  211 (430)
                      ......+++|+|.||.||+|++   +++.||||++..                 .....|.+|-.+.+..  +|+||++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~-----------------~~kqs~~~Ek~Iy~lp~m~h~nIl~F  269 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPE-----------------QEKQSFQNEKNIYSLPGMKHENILQF  269 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc---cCceeEEEecCH-----------------HHHHHHHhHHHHHhccCccchhHHHh
Confidence            3456678999999999999998   679999999832                 3356788888887765  79999999


Q ss_pred             eeEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCC
Q 014140          212 LARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH------RPRIIHRDIQP  281 (430)
Q Consensus       212 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiH~Dlkp  281 (430)
                      +++-....    .++||+||.+.|||.++|..     ..++|....+|+..+++||+|||+..      +++|+|||||+
T Consensus       270 i~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS  344 (534)
T KOG3653|consen  270 IGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS  344 (534)
T ss_pred             hchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc
Confidence            99876555    78999999999999999943     56999999999999999999999753      56899999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-CC-----cchhHHHHHHHHHHHHhCCCCC
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LS-----DTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      .|||+.+|+.+.|+|||+|..+..+.........+||.+|||||++.|.. +.     .+.||||+|.+||||++...-+
T Consensus       345 kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  345 KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            99999999999999999999988766655555689999999999998753 22     2589999999999999965332


Q ss_pred             --------Ccccc-cc-ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          356 --------DDFFQ-HT-KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       356 --------~~~~~-~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                              .-.|. .. ..+.+-+ +...+-..+..+.+.+.- ..  ...+..+.+.+..||..||+.|.|+.=+-+.+
T Consensus       425 ~~~~vp~Yqlpfe~evG~hPt~e~-mq~~VV~kK~RP~~p~~W-~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  425 DPGPVPEYQLPFEAEVGNHPTLEE-MQELVVRKKQRPKIPDAW-RK--HAGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             cCCCCCcccCchhHHhcCCCCHHH-HHHHHHhhccCCCChhhh-hc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence                    21222 11 1122222 222222211111111111 11  13355688999999999999999999998888


Q ss_pred             hccc
Q 014140          426 SQIQ  429 (430)
Q Consensus       426 ~~l~  429 (430)
                      .++.
T Consensus       501 ~~l~  504 (534)
T KOG3653|consen  501 AELM  504 (534)
T ss_pred             HHHh
Confidence            7764

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-37  Score=289.73  Aligned_cols=246  Identities=22%  Similarity=0.244  Sum_probs=184.5

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHH---HHhccCCCCcccceeEEEe
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII---TAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~l~~~~~~  217 (430)
                      .||+|+||.||++.... +|+.+|+|.+......           .......+.+|..   ++...+|||++.+++++..
T Consensus         1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~   68 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIK-----------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT   68 (279)
T ss_pred             CcccCCCeEEEEEEECC-CCcEEEEEEEEccccc-----------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec
Confidence            48999999999998764 7899999988543211           0011122334443   3344479999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      .+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        69 ~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~df  141 (279)
T cd05633          69 PDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL  141 (279)
T ss_pred             CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccC
Confidence            9999999999999999998843    346999999999999999999999554   999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhc
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT  376 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~  376 (430)
                      |++........    ....||..|+|||.+.+ ..++.++|||||||++++|++|..||......    ... .......
T Consensus       142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~-~~~~~~~  212 (279)
T cd05633         142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKH-EIDRMTL  212 (279)
T ss_pred             CcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----CHH-HHHHHhh
Confidence            99876543321    12468999999998864 56899999999999999999999998653221    111 1111110


Q ss_pred             CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 014140          377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRCM  424 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~~  424 (430)
                      ...      ..    .+......+.+++..||+.||.+||     ++.++++.
T Consensus       213 ~~~------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 TVN------VE----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCC------cC----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            000      01    1112233488899999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.4e-37  Score=281.90  Aligned_cols=254  Identities=26%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||+|++|.||+|.... +++.+++|++......            ......+.+|+.++++++||||+++++.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDS------------EEELEALEREIRILSSLQHPNIVRYYGS   67 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccc------------hHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            36778999999999999998764 7999999998443211            2346788999999999999999999999


Q ss_pred             EEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          215 MVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       215 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +...  +..++|+||+++++|.+++..    ...+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~  140 (260)
T cd06606          68 ERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVV  140 (260)
T ss_pred             EecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCE
Confidence            9988  889999999999999999854    23799999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||.+................++..|+|||.+.+..++.++||||||+++++|++|..||....      .......
T Consensus       141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~  214 (260)
T cd06606         141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALY  214 (260)
T ss_pred             EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHH
Confidence            9999999988765543211223568899999999998889999999999999999999999987543      1111111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........         ...+......+.+++.+|++.+|++||++.++++
T Consensus       215 ~~~~~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         215 KIGSSGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hccccCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11110111         0111122345889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=284.70  Aligned_cols=256  Identities=21%  Similarity=0.245  Sum_probs=197.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|++|.||+|.... +|..||+|.+......         .........+.+|+.++++++||||+++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~---------~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   71 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDS---------QETSKEVNALECEIQLLKNLRHDRIVQYYG   71 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCccc---------chhhHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence            578999999999999999998764 8999999987432111         111234578899999999999999999999


Q ss_pred             EEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.+.  +..++|+||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~  144 (264)
T cd06653          72 CLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGN  144 (264)
T ss_pred             EEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence            98764  457899999999999999843    34588999999999999999999955   5999999999999999999


Q ss_pred             eEEeecCCcccCCCCCC-cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHT-RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||+++....... ........|+..|+|||++.+..++.++|+|||||++++|++|+.||.....      . ..
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~  217 (264)
T cd06653         145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------M-AA  217 (264)
T ss_pred             EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------H-HH
Confidence            99999999986543211 1111234688999999999998899999999999999999999999864311      1 11


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +......+.. .        ..+......+.+++..||+ +|..||++.+++.
T Consensus       218 ~~~~~~~~~~-~--------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         218 IFKIATQPTK-P--------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHcCCCC-C--------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111111110 0        1122233458899999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.4e-37  Score=294.36  Aligned_cols=263  Identities=19%  Similarity=0.273  Sum_probs=191.2

Q ss_pred             cccccc--cCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          140 EKIRSC--WNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G--~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      ..||.|  +||+||+|++. .+|+.||+|.+......            ....+.+.+|+.+++.++||||++++++|..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   70 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCT------------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTT   70 (328)
T ss_pred             HHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCCcceEeeeEec
Confidence            456666  89999999875 48999999988432211            1235788999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      .+..++|+||+.+++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        71 ~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~  145 (328)
T cd08226          71 GSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGL  145 (328)
T ss_pred             CCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEech
Confidence            99999999999999999998652  234589999999999999999999955   5999999999999999999999999


Q ss_pred             CCcccCCCCCCc-c----eeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          298 GLAKRIPDGHTR-T----TTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       298 g~a~~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +.+......... .    ......++..|+|||++.+.  .++.++|||||||++++|++|..||.......   .....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~  222 (328)
T cd08226         146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQK  222 (328)
T ss_pred             HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHH
Confidence            865433221110 0    01112346679999998764  47899999999999999999999987542210   00000


Q ss_pred             HHH----------------Hh----------------cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          371 MRN----------------VM----------------TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       371 ~~~----------------~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ...                ..                ............+...........+.+|+.+||+.||++|||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta  302 (328)
T cd08226         223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA  302 (328)
T ss_pred             hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH
Confidence            000                00                0000000000111111223445678999999999999999999


Q ss_pred             HHHHH
Q 014140          419 KDVRC  423 (430)
Q Consensus       419 ~ev~~  423 (430)
                      .++++
T Consensus       303 ~e~l~  307 (328)
T cd08226         303 SSLLS  307 (328)
T ss_pred             HHHhh
Confidence            99975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.7e-37  Score=283.21  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=204.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||++.... ++..+++|++......            ......+.+|+++++.++|||++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~   67 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMS------------EKEREDALNEVKILKKLNHPNIIKYYES   67 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccCC------------hHHHHHHHHHHHHHHhcCCCChhheEEE
Confidence            47888999999999999999764 7899999998432211            2335678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++|+||+++++|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l  144 (258)
T cd08215          68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKL  144 (258)
T ss_pred             EecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEE
Confidence            9999999999999999999999976433357799999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+........  ......|++.|+|||...+..++.++|+||+|+++++|++|..||....       ..+.....
T Consensus       145 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~  215 (258)
T cd08215         145 GDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKI  215 (258)
T ss_pred             CCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHH
Confidence            99999987655431  1223468899999999998889999999999999999999999975432       12222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...... .         .+......+.+++..||..+|++||++.++++
T Consensus       216 ~~~~~~-~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 LKGQYP-P---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             hcCCCC-C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            221111 0         11122244889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-37  Score=292.44  Aligned_cols=268  Identities=20%  Similarity=0.257  Sum_probs=194.6

Q ss_pred             hcccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       131 ~~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ..-++|.+...||.|+||.||+|.... +|+.||||.+......            ......+.+|+.++++++||||++
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~   75 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENEK------------EGFPITALREIKILQLLKHENVVN   75 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCCc------------CCchhHHHHHHHHHHhCCCCCccc
Confidence            345679999999999999999998764 8999999988432211            111245678999999999999999


Q ss_pred             ceeEEEeCC--------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          211 LLARMVRRD--------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       211 l~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      ++++|...+        ..++||||+.+ +|.+.+..   ....+++..++.++.|++.||.|||+.   +++|+||+|+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~  148 (310)
T cd07865          76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAA  148 (310)
T ss_pred             eEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            999987654        34999999964 88888743   334689999999999999999999955   5999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      ||+++.++.++|+|||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus       149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999876433221  111134578899999988765 47889999999999999999999986432


Q ss_pred             cccccccHHHHHHHHhcCCCCchhc---------cc-cccCCC---------cHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAI---------NS-KLLGNG---------YEEQMLLVLKIACFCTLDDPNKRPNSKD  420 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~---------~~-~~~~~~---------~~~~~~~l~~l~~~cl~~dp~~Rps~~e  420 (430)
                      .    ......+...... .+....         +. ......         .......+.+++..||+.||.+|||+.+
T Consensus       229 ~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e  303 (310)
T cd07865         229 E----QHQLTLISQLCGS-ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT  303 (310)
T ss_pred             H----HHHHHHHHHHhCC-CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence            1    1111111111110 000000         00 000000         0001234678999999999999999999


Q ss_pred             HHH
Q 014140          421 VRC  423 (430)
Q Consensus       421 v~~  423 (430)
                      +++
T Consensus       304 ~l~  306 (310)
T cd07865         304 ALN  306 (310)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.3e-37  Score=296.28  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=194.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... +|+.||+|.+......            ......+.+|+.+++.++||||++++
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPFQN------------VTHAKRAYRELVLMKLVNHKNIIGLL   81 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccccC------------hhHHHHHHHHHHHHHhcCCCCCccee
Confidence            4679999999999999999998764 8999999988432111            12245677899999999999999999


Q ss_pred             eEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...      ...++||||+.+ +|.+.+..      .++...+..++.|++.||.|||+.   +++||||||+||++
T Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~  151 (353)
T cd07850          82 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV  151 (353)
T ss_pred             eeeccCCCccccCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence            988654      346999999964 88888732      288899999999999999999955   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE--  364 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~--  364 (430)
                      +.++.++|+|||++........   .....++..|+|||.+.+..++.++|||||||++++|++|+.||.........  
T Consensus       152 ~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  228 (353)
T cd07850         152 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK  228 (353)
T ss_pred             CCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999987644322   11245788999999999999999999999999999999999998642110000  


Q ss_pred             ---------ccHHHHH----HHHhcCCC------Cchhcccccc----CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 014140          365 ---------MSLVQWM----RNVMTSEN------PNRAINSKLL----GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV  421 (430)
Q Consensus       365 ---------~~l~~~~----~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev  421 (430)
                               ..+....    ........      ....+.....    ..........+.+++.+||+.||++|||+.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence                     0000000    00000000      0000000000    00111234557899999999999999999999


Q ss_pred             HH
Q 014140          422 RC  423 (430)
Q Consensus       422 ~~  423 (430)
                      ++
T Consensus       309 L~  310 (353)
T cd07850         309 LQ  310 (353)
T ss_pred             hc
Confidence            85

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-37  Score=286.80  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=196.9

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|...+.||.|++|.||+|.... +++.+++|++....              ......+.+|+.+++.++|||+++++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~--------------~~~~~~~~~e~~~l~~~~h~~vv~~~~~   84 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLRK--------------QQRRELLFNEVVIMRDYQHPNIVEMYSS   84 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC-CCCEEEEEEEeccc--------------hhHHHHHHHHHHHHHHcCCCChheEEEE
Confidence            45667899999999999998654 78999999873211              1124568899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++|+||+++++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|
T Consensus        85 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l  156 (285)
T cd06648          85 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKL  156 (285)
T ss_pred             EEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEE
Confidence            9999999999999999999999843     4589999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+.........  .....|+..|+|||.+.+..++.++||||||+++++|++|..||....+       .......
T Consensus       157 ~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~  227 (285)
T cd06648         157 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRI  227 (285)
T ss_pred             cccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHH
Confidence            999988765433221  1234689999999999988899999999999999999999999754211       1222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+ ...       ........+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~-~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         228 RDNLPP-KLK-------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HhcCCC-CCc-------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            211110 000       01112235889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.2e-37  Score=291.89  Aligned_cols=264  Identities=24%  Similarity=0.224  Sum_probs=193.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|++|.||+|.... +|+.||+|.+......            ......+.+|+.++++++||||+++++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~   68 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQED------------EGVPSTAIREISLLKEMQHGNIVRLQD   68 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhcccc------------ccchHHHHHHHHHHHhccCCCEeeEEE
Confidence            468889999999999999998764 7899999987432211            122356888999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CCce
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEA  292 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~  292 (430)
                      ++...+..++||||++ ++|.+.+..  .....+++.....++.|++.||.|||+.   +++|+||+|+||+++. ++.+
T Consensus        69 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~  142 (294)
T PLN00009         69 VVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL  142 (294)
T ss_pred             EEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEE
Confidence            9999999999999996 588888743  2233468888899999999999999954   5999999999999985 5679


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++........  ......+++.|+|||++.+. .++.++||||||+++|+|++|..||......   ..+.. +
T Consensus       143 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~-~  216 (294)
T PLN00009        143 KLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFK-I  216 (294)
T ss_pred             EEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-H
Confidence            9999999976543211  11124578899999988764 5789999999999999999999998643211   01111 0


Q ss_pred             HHHhcCCCCchhc----------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAI----------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+. ....                .........+.....+.+++.+|++.+|++||++.++++
T Consensus       217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        217 FRILGTPN-EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHhCCCC-hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01110000 0000                000000001112334788999999999999999999985

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=296.83  Aligned_cols=265  Identities=21%  Similarity=0.255  Sum_probs=195.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|++|.||+|.... +|+.||+|++....             .......+..|+.+++.++||||++++
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~niv~~~   69 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFE-------------HQTFCQRTLREIKILRRFKHENIIGIL   69 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccc-------------cchhHHHHHHHHHHHHhCCCCCcCchh
Confidence            4679999999999999999998764 88999999884211             112245678899999999999999999


Q ss_pred             eEEEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++....     ..++|+||+.+ +|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~  140 (336)
T cd07849          70 DIIRPPSFESFNDVYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN  140 (336)
T ss_pred             heeecccccccceEEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEC
Confidence            9876543     57999999965 8888773     24689999999999999999999955   599999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      .++.++|+|||++.......... ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....    .
T Consensus       141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~----~  216 (336)
T cd07849         141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY----L  216 (336)
T ss_pred             CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            99999999999998764332211 1123468999999998755 4689999999999999999999999854211    1


Q ss_pred             cHHHHHHHHhcCCCCchh-----------c---c--ccc-cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRA-----------I---N--SKL-LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~-----------~---~--~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .....+...+..+.....           +   .  ... .....+.....+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         217 HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111111111110000           0   0  000 000001123458899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.2e-38  Score=277.93  Aligned_cols=208  Identities=22%  Similarity=0.315  Sum_probs=171.9

Q ss_pred             cccccccccccccCceEEEeecCCCCC---ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ..|+.+..||+|.+|.||+|.-...++   ..+|||++......+            -.....-+|+.+++.++|||++.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------------GiS~SAcREiaL~REl~h~nvi~   91 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------------GISMSACREIALLRELKHPNVIS   91 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------------CcCHHHHHHHHHHHHhcCCcchh
Confidence            368889999999999999995443232   379999985542211            11245678999999999999999


Q ss_pred             ceeEEEe-CCeeEEEEEecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVR-RDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +..++.. +...++++||.+. +|..+|+-.+. ....++..++..|+.||+.|+.|||++.   |+||||||.|||+..
T Consensus        92 Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmg  167 (438)
T KOG0666|consen   92 LVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMG  167 (438)
T ss_pred             HHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEec
Confidence            9999988 7789999999988 89999875432 3457999999999999999999999998   999999999999988


Q ss_pred             C----CceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          289 D----MEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       289 ~----~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +    |.+||+|||+++.+.+.-..- ....++-|.+|.|||.+.|. .||.+.||||.|||+.||++-.+-|..
T Consensus       168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            7    899999999999886543322 22245679999999999887 599999999999999999999887764

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.4e-37  Score=284.10  Aligned_cols=250  Identities=25%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||.|+||.||+++... +|+.+++|.+.....           ........+.+|+.++++++||||+++++.+...+..
T Consensus         1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   68 (265)
T cd05579           1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADM-----------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL   68 (265)
T ss_pred             CCCCCceEEEEEEECC-CCCEEEEEEecchhh-----------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence            6899999999999863 799999998843221           1123457789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.
T Consensus        69 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~  141 (265)
T cd05579          69 YLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK  141 (265)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccch
Confidence            999999999999999954    23689999999999999999999954   59999999999999999999999999988


Q ss_pred             cCCCCCCc------ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          302 RIPDGHTR------TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       302 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      ........      .......++..|+|||...+..++.++||||||++++++++|..||.....       .+......
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~  214 (265)
T cd05579         142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNIL  214 (265)
T ss_pred             hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh
Confidence            65433211      122234678899999999888899999999999999999999999864321       11122222


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ... ....   .   ..  .....+.+++..||+.+|.+||++.++.+.|+
T Consensus       215 ~~~-~~~~---~---~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         215 NGK-IEWP---E---DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCC-cCCC---c---cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            111 1000   0   00  01344889999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=283.80  Aligned_cols=248  Identities=22%  Similarity=0.265  Sum_probs=187.7

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHH-HhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT-AGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||.|++|.||+|.... +|+.||+|.+......           .......+..|..+ ....+|||++++++++..+
T Consensus         2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   69 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMI-----------AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK   69 (260)
T ss_pred             ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhh-----------HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC
Confidence            568999999999998764 7899999988432111           11112334455444 4455899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        70 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          70 DYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             CeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            999999999999999999853    34689999999999999999999955   59999999999999999999999999


Q ss_pred             CcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCC
Q 014140          299 LAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE  378 (430)
Q Consensus       299 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~  378 (430)
                      ++......      ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....    .   ......... 
T Consensus       143 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~~~~~~~~~-  208 (260)
T cd05611         143 LSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----D---AVFDNILSR-  208 (260)
T ss_pred             cceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----H---HHHHHHHhc-
Confidence            98765331      124578899999999988899999999999999999999999864321    1   111111111 


Q ss_pred             CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ...  .....    .......+.+++.+||+.+|++||++.++.+.|+
T Consensus       209 ~~~--~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         209 RIN--WPEEV----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccC--CCCcc----cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            100  00000    1112344889999999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-37  Score=317.59  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=188.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|+.++.||+||||.||+++.+ -||+.||||++.-..             .......+.+|+..|++|+|||||+++
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~-------------s~~~~skI~rEVk~LArLnHpNVVRYy  543 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKA-------------SDKLYSKILREVKLLARLNHPNVVRYY  543 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeec-ccchhhhhhhccCch-------------HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            357899999999999999999976 599999999994432             234467899999999999999999998


Q ss_pred             eEEEeCC-------------------------------------------------------------------------
Q 014140          213 ARMVRRD-------------------------------------------------------------------------  219 (430)
Q Consensus       213 ~~~~~~~-------------------------------------------------------------------------  219 (430)
                      ..|.+..                                                                         
T Consensus       544 sAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~  623 (1351)
T KOG1035|consen  544 SAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDS  623 (1351)
T ss_pred             hhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccc
Confidence            7543210                                                                         


Q ss_pred             ----------------------------------------------eeEEEEEecCCCCHHHHHhhhcCCCCCC-CHHHH
Q 014140          220 ----------------------------------------------CDLLVYEFRRNGSLQDILYDVSQGRREL-DWLAR  252 (430)
Q Consensus       220 ----------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l-~~~~~  252 (430)
                                                                    .+||-||||+..+|.+++.+    +... .....
T Consensus       624 dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~  699 (1351)
T KOG1035|consen  624 DEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEA  699 (1351)
T ss_pred             cccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHH
Confidence                                                          12678999998777777743    1112 46778


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCC----C------------CCCcceeeccc
Q 014140          253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP----D------------GHTRTTTWSLA  316 (430)
Q Consensus       253 ~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~  316 (430)
                      ++++.+|++||+|+|   .+|||||||||.|||++++..+||+|||+|....    .            +.........+
T Consensus       700 wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V  776 (1351)
T KOG1035|consen  700 WRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV  776 (1351)
T ss_pred             HHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence            999999999999999   5569999999999999999999999999998721    0            00111222568


Q ss_pred             cccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCc
Q 014140          317 GTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGY  393 (430)
Q Consensus       317 gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ||.-|+|||++.+..   |+.|+|+|||||+++||+.   ||.....      -+..+.. ++.+..+..  +.+    .
T Consensus       777 GTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~-LR~g~iP~~--~~f----~  840 (1351)
T KOG1035|consen  777 GTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTN-LRKGSIPEP--ADF----F  840 (1351)
T ss_pred             ceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHh-cccCCCCCC--ccc----c
Confidence            999999999988765   9999999999999999994   5544221      1111222 222222211  111    2


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       394 ~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......-.++++++++.||++|||+.|+++
T Consensus       841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  841 DPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            222333568999999999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=286.60  Aligned_cols=263  Identities=23%  Similarity=0.278  Sum_probs=196.2

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.+.+.||.|++|.||+|.... +|+.+|+|++.....            .......+.+|+.+++.++|||++++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   67 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK-TGELVALKKIRMENE------------KEGFPITAIREIKLLQKLRHPNIVRLKEIV   67 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC-CCeEEEEEEEecccc------------cccchHHHHHHHHHHHhccCCCeeeheeeE
Confidence            5678899999999999998764 789999999954321            112245688899999999999999999999


Q ss_pred             EeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          216 VRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       216 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ...  +..++|+||+++ +|.+++..   ....+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++
T Consensus        68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~  140 (287)
T cd07840          68 TSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLK  140 (287)
T ss_pred             ecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEE
Confidence            988  889999999975 89888843   225789999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.......... .....++..|+|||.+.+. .++.++||||||+++++|++|..||.....    ......+.
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~~  215 (287)
T cd07840         141 LADFGLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKIF  215 (287)
T ss_pred             EccccceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHH
Confidence            99999998775443211 1123568889999987654 578999999999999999999999864321    11111111


Q ss_pred             HHhcCCCCc-----------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPN-----------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........                 ......+.......+...+.+++..||+.+|.+||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111110000                 000000000000001445889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-36  Score=285.74  Aligned_cols=261  Identities=22%  Similarity=0.259  Sum_probs=199.9

Q ss_pred             ccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      +|.+.+.||.|++|.||+++..  ..++..||||.+.....          .........+.+|+.++.++ +||||+++
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~   70 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----------VQKAKTAEHTRTERQVLEAVRRCPFLVTL   70 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----------HhhhhHHHHHHHHHHHHHhccCCcchhhh
Confidence            3678899999999999999753  23678999998843211          11122356788999999999 59999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.+..++..++||||+++|+|.+++..    ...+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~  143 (288)
T cd05583          71 HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGH  143 (288)
T ss_pred             heeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCC
Confidence            9999999999999999999999999843    3468999999999999999999995   45999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA--LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ++|+|||++........... ....|+..|+|||.+.+..  .+.++||||||+++++|++|..||.....   ......
T Consensus       144 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~  219 (288)
T cd05583         144 VVLTDFGLSKEFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSE  219 (288)
T ss_pred             EEEEECcccccccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHH
Confidence            99999999887654322211 1346889999999987765  78899999999999999999999853211   111122


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ..........+           .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       220 ~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         220 ISRRILKSKPP-----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHccCCC-----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            22222211111           111122347889999999999999999988887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8e-37  Score=285.53  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=200.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ++|.+.+.||+|++|.||+|.... +|..+++|++.....           ........+.+|+.++++++ ||||++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~-----------~~~~~~~~~~~e~~~~~~l~~~~~i~~~~   68 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQL-----------IKEKKVKYVKIEKEVLTRLNGHPGIIKLY   68 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhc-----------cchHHHHHHHHHHHHHHhcccCCCchhHH
Confidence            368889999999999999998764 899999998843211           11123467889999999998 99999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~  141 (280)
T cd05581          69 YTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI  141 (280)
T ss_pred             HHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence            999999999999999999999999954    34699999999999999999999955   49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCc------------------ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          293 RISEFGLAKRIPDGHTR------------------TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      +++|||++.........                  .......++..|+|||++.+..++.++|+||||++++++++|..|
T Consensus       142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            99999999876543221                  112234678999999999888899999999999999999999999


Q ss_pred             CCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 014140          355 SDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS----KDVRC  423 (430)
Q Consensus       355 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~----~ev~~  423 (430)
                      |.....    ...   .........           ..+......+.+++..||+.+|.+||++    .++++
T Consensus       222 ~~~~~~----~~~---~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         222 FRGSNE----YLT---FQKILKLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCccH----HHH---HHHHHhcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            875321    111   111111110           0111113348899999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-36  Score=285.64  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=194.7

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.....||.|+||.||+|.... +|..+|||++....              ......+.+|+.+++.++|||++++++++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   86 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS-SGKLVAVKKMDLRK--------------QQRRELLFNEVVIMRDYQHENVVEMYNSY   86 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC-CCeEEEEEEecccc--------------hhHHHHHHHHHHHHHhcCCcchhheeeEE
Confidence            4445789999999999998764 89999999873211              12246688999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ..++..++||||+++++|.+++..     ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~  158 (292)
T cd06657          87 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS  158 (292)
T ss_pred             EeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEc
Confidence            999999999999999999998732     3589999999999999999999954   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||++.........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....    ......+....
T Consensus       159 dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~~  232 (292)
T cd06657         159 DFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNL  232 (292)
T ss_pred             ccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhC
Confidence            99998765433211  1234688999999999888899999999999999999999999764211    11112221111


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...         ..  ........+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~---------~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         233 PPK---------LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             Ccc---------cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            100         00  00111234778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.2e-37  Score=295.02  Aligned_cols=266  Identities=22%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||.|+||.||+|.... +|..+|+|++......            ......+..|+.+++++ +||||+++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~h~ni~~~   72 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRN------------ATDAQRTFREIMFLQELGDHPNIVKL   72 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeeccccCc------------chhhhhhhHHHHHHHHhcCCCCccce
Confidence            3578999999999999999998763 7899999988432111            11234577899999999 99999999


Q ss_pred             eeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +++|...  ...++||||++ ++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~  143 (337)
T cd07852          73 LNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSD  143 (337)
T ss_pred             eeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC
Confidence            9998654  36899999997 599988843     2688999999999999999999954   59999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCc---ceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTR---TTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++|+|||++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......    
T Consensus       144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~----  219 (337)
T cd07852         144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL----  219 (337)
T ss_pred             CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH----
Confidence            99999999999876543321   12223568999999998765 45788999999999999999999998643211    


Q ss_pred             cHHHHHHHHhcC-----------CCCchhcc------ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          366 SLVQWMRNVMTS-----------ENPNRAIN------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       366 ~l~~~~~~~~~~-----------~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ............           ......++      ........+.....+.+++.+||+.+|++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            111110000000           00000000      000000011123458899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.4e-37  Score=294.01  Aligned_cols=266  Identities=21%  Similarity=0.264  Sum_probs=195.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ..+|.+.+.||.|++|.||+|.... +|..||+|++......            ......+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~valK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~   70 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDV------------PTLAKRTLRELKILRHFKHDNIIAIR   70 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC-CCCEEEEEEecccccc------------ccchHHHHHHHHHHHhcCCCCccCHH
Confidence            3678999999999999999998764 7999999998532211            12245677899999999999999999


Q ss_pred             eEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          213 ARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       213 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++..    ....++||||+. |+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~  142 (334)
T cd07855          71 DILRPPGADFKDVYVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNE  142 (334)
T ss_pred             HhccccCCCCceEEEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC
Confidence            98763    346799999995 58998884    345599999999999999999999954   5999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcc--eeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      ++.+||+|||++..........  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....    .
T Consensus       143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~  218 (334)
T cd07855         143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----V  218 (334)
T ss_pred             CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----H
Confidence            9999999999997664322211  1113468899999998866 4588999999999999999999999865321    1


Q ss_pred             cHHHHHHHHhcCCC-----------Cchhccc-cccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSEN-----------PNRAINS-KLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~-----------~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+........           ....... .....     ..+.....+.+++..||+.+|.+||++.+++.
T Consensus       219 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111110000           0000000 00000     01122455899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-36  Score=282.71  Aligned_cols=243  Identities=20%  Similarity=0.227  Sum_probs=185.9

Q ss_pred             ccccccccc--ccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          134 DYFASLEKI--RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~l--g~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ++|.+.+.+  |.|+||.||++.... +|..+|+|.+......                 .  .|+.....+ +|||+++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~-----------------~--~e~~~~~~~~~h~~iv~   73 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFN-----------------A--IEPMVHQLMKDNPNFIK   73 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcC-CCcEEEEEEEehhhcc-----------------h--hhHHHHHHhhcCCCEEE
Confidence            455666665  999999999998764 8899999998432110                 0  022222222 6999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             EEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCC
Confidence            99999999999999999999999999953    2379999999999999999999995   4599999999999999998


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       .++|+|||++.......      ...++..|+|||++.+..++.++||||||+++++|++|..||.....  .......
T Consensus       147 ~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~  218 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLES  218 (267)
T ss_pred             CeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHH
Confidence             99999999987664322      23578999999999998999999999999999999999999874322  1122222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-SKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~ev~~  423 (430)
                      +.... ... .          .........+.+++..||+.+|.+||+ +.++++
T Consensus       219 ~~~~~-~~~-~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 LLKRQ-QKK-L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhh-ccc-C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            22222 110 0          001122334889999999999999996 588874

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-36  Score=277.16  Aligned_cols=250  Identities=31%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|...+.||+|++|.||++.... ++..+++|++.....              .....+.+|+.+++.++|||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~   65 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK--------------EKKEKIINEIQILKKCKHPNIVKYYGS   65 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch--------------hHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            36788999999999999998764 789999999843221              235778999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++++||+++++|.+++..   ....+++..+..++.+++.||.|||.   .+++|+||+|+||++++++.++|
T Consensus        66 ~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l  139 (253)
T cd05122          66 YLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKL  139 (253)
T ss_pred             EecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEE
Confidence            9999999999999999999999854   22578999999999999999999995   55999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+........   .....++..|+|||++.+..++.++|+||||+++++|++|..||.....       .......
T Consensus       140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~  209 (253)
T cd05122         140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKI  209 (253)
T ss_pred             eecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHH
Confidence            99999987765432   2235688999999999988899999999999999999999999764321       1111111


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .... ......       .......+.+++..||+.+|++|||+.++++
T Consensus       210 ~~~~-~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         210 ATNG-PPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HhcC-CCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111 100000       0111334889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=277.18  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|++|.||+|.... +++.|++|.+......            ......+.+|+.++++++|||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIK------------EEALKSIMQEIDLLKNLKHPNIVKYIGS   67 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC-CCcEEEEEEecccccC------------HHHHHHHHHHHHHHHhCCCCCccEEEEE
Confidence            37788999999999999998764 7889999998543211            2335789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  140 (254)
T cd06627          68 IETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKL  140 (254)
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999843    35689999999999999999999954   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+.........  .....++..|+|||...+..++.++||||||+++++|++|..||.....      ...... .
T Consensus       141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~-~  211 (254)
T cd06627         141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFR-I  211 (254)
T ss_pred             eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-H
Confidence            999999877654332  1234678999999999888889999999999999999999999764321      111111 1


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+  .        .+......+.+++.+||+.+|++||++.+++.
T Consensus       212 ~~~~~~--~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 VQDDHP--P--------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             hccCCC--C--------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111110  0        11112334889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=284.36  Aligned_cols=263  Identities=24%  Similarity=0.286  Sum_probs=193.6

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCcccce
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNIVPLL  212 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~  212 (430)
                      |.+.+.||.|++|.||+|+... ++..||+|++......            ......+.+|+.++.++   +|||+++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   67 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSE------------EGIPLSTLREIALLKQLESFEHPNIVRLL   67 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC-CCCEEEEEEecccccc------------chhhhhHHHHHHHHHHhhccCCCCcceEE
Confidence            5678899999999999999864 7899999998532211            11134456677766665   599999999


Q ss_pred             eEEEeCCe-----eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRRDC-----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...+.     .+++|||+++ +|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++
T Consensus        68 ~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~  141 (287)
T cd07838          68 DVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVT  141 (287)
T ss_pred             EEEeeccCCCCceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEc
Confidence            99998776     8999999975 899988542  223689999999999999999999955   599999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      .++.++|+|||++..........   ...++..|+|||++.+..++.++|+|||||++|+|++|..||......   ..+
T Consensus       142 ~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~  215 (287)
T cd07838         142 SDGQVKIADFGLARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQL  215 (287)
T ss_pred             cCCCEEEeccCcceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHH
Confidence            99999999999998765432211   235788999999999989999999999999999999999987643221   111


Q ss_pred             HHHHHHHhcCCCC---------chhccc---cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENP---------NRAINS---KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .............         ...+..   .......+.....+.+++..||+.||.+||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         216 DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            1111111000000         000000   0001111233456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-36  Score=287.93  Aligned_cols=265  Identities=24%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|+||.||+|.... +|+.||+|.+......            ......+.+|+.++++++|||+++++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNER------------DGIPISSLREITLLLNLRHPNIVELK   72 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccCC------------CCCcchhhHHHHHHHhCCCCCCcceE
Confidence            4679999999999999999998764 8999999998532211            01123456799999999999999999


Q ss_pred             eEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          213 ARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       213 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++...  +..++||||+.+ +|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  145 (309)
T cd07845          73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKG  145 (309)
T ss_pred             EEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            998765  568999999965 89888854   235689999999999999999999955   499999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++|+|||++..........  ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.....    .....
T Consensus       146 ~~kL~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~~~  219 (309)
T cd07845         146 CLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQLD  219 (309)
T ss_pred             CEEECccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence            99999999998765432111  12345788999999876 4578999999999999999999999864321    11111


Q ss_pred             HHHHHhcCCCCc-----------hhc--ccccc---CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPN-----------RAI--NSKLL---GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~-----------~~~--~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..........           ..+  .....   ..........+.+++..||+.||++|||+.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            111111100000           000  00000   0000112344778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.1e-36  Score=283.40  Aligned_cols=257  Identities=23%  Similarity=0.307  Sum_probs=196.2

Q ss_pred             ccccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      +|.+.+.||.|+||.||+|....  .+|..||+|++......          ........+.+|+.++.++ +||||+++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~~i~~~   70 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----------QKAKTTEHTRTERQVLEHIRQSPFLVTL   70 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----------hcchHHHHHHHHHHHHHhcccCCChhce
Confidence            37788999999999999998642  37899999998432110          1112346688899999999 59999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++..++..++||||+++++|.+++..    ...+++.....++.|++.||.|||+   .+++||||+|+|||++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~  143 (290)
T cd05613          71 HYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGH  143 (290)
T ss_pred             eeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCC
Confidence            9999999999999999999999999853    3468899999999999999999994   55999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ++|+|||++......... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....   ......
T Consensus       144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~  219 (290)
T cd05613         144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAE  219 (290)
T ss_pred             EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHH
Confidence            999999999876443221 12235688999999998764  468899999999999999999999863211   122222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ..........+           .+......+.+++..||+.+|.+||     ++.+++.
T Consensus       220 ~~~~~~~~~~~-----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         220 ISRRILKSEPP-----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHhhccCCC-----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            23333222111           1111223478999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-36  Score=286.52  Aligned_cols=255  Identities=21%  Similarity=0.352  Sum_probs=194.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      -++|.+.+.||+|++|.||+|.+.. +|+.||||.+.....             ......+..|+.++..+. ||||+++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~-------------~~~~~~~~~e~~~~~~~~~~~~i~~~   79 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGN-------------KEENKRILMDLDVVLKSHDCPYIVKC   79 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCC-------------hHHHHHHHHHHHHHHhccCCCchHhh
Confidence            4578999999999999999999864 689999999843211             112345666777676665 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|.+....++||||+. ++|.+++..   ....+++..+..++.|++.||.|||+.  .+++||||+|+||++++++.
T Consensus        80 ~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~  153 (296)
T cd06618          80 YGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGN  153 (296)
T ss_pred             heeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCC
Confidence            999999999999999985 488887754   234789999999999999999999953  25999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ++|+|||++..+.......   ...++..|+|||++.+..    ++.++||||||+++|+|++|+.||.....      -
T Consensus       154 ~kL~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~  224 (296)
T cd06618         154 VKLCDFGISGRLVDSKAKT---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------E  224 (296)
T ss_pred             EEECccccchhccCCCccc---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------H
Confidence            9999999988764432221   235788999999987654    78899999999999999999999864211      1


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .+..........+.  +...  .    .....+.+++.+||+.+|.+||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~--~~~~--~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         225 FEVLTKILQEEPPS--LPPN--E----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHhcCCCCC--CCCC--C----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11222222221111  0000  0    122348899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=283.01  Aligned_cols=262  Identities=24%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.+.+.||.|++|.||+|.... +|+.+++|.+......            ......+.+|+.+++.++||||+++++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   67 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFES------------EGIPKTALREIKLLKELNHPNIIKLLDVF   67 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC-CCcEEEEEEecccccc------------chhHHHHHHHHHHHHHhcCCCcchHHHhh
Confidence            5677899999999999998754 7899999988432211            12246788899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ..++..++|+||+++ +|.+++..   ....+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        68 ~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~  140 (283)
T cd05118          68 RHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLA  140 (283)
T ss_pred             ccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEe
Confidence            999999999999975 88888854   235789999999999999999999955   49999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      |||.+........  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.....    ......+...
T Consensus       141 df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~  214 (283)
T cd05118         141 DFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRT  214 (283)
T ss_pred             eeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHH
Confidence            9999987755431  11134578899999998877 789999999999999999999999754221    1111111111


Q ss_pred             hcCCCCch--hc--------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNR--AI--------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~--~~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+..  .+              .........+.....+.+++..||+.||.+||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11100000  00              000000111234556899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=284.93  Aligned_cols=261  Identities=22%  Similarity=0.273  Sum_probs=193.0

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLAR  214 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  214 (430)
                      |.+.+.||.|++|.||+|+... +++.|+||++......             .......+|+..+++++ |||+++++++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~h~~i~~~~~~   66 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYS-------------WEECMNLREVKSLRKLNEHPNIVKLKEV   66 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC-CCcEEEEEEehhhccc-------------hhHHHHHHHHHHHHhccCCCCchhHHHH
Confidence            5678899999999999999764 7899999988432111             11233456899999999 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +..++..++||||+ +|+|.+.+...  ....+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|
T Consensus        67 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l  140 (283)
T cd07830          67 FRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKI  140 (283)
T ss_pred             hhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEE
Confidence            99999999999999 78999988542  235689999999999999999999955   4999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      +|||++..........   ...++..|+|||++.+ ..++.++|+||||+++++|++|+.||......    ........
T Consensus       141 ~d~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~----~~~~~~~~  213 (283)
T cd07830         141 ADFGLAREIRSRPPYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI----DQLYKICS  213 (283)
T ss_pred             eecccceeccCCCCcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH----HHHHHHHH
Confidence            9999998765432211   2457889999998754 45799999999999999999999997543211    11111111


Q ss_pred             HhcC-------------CCCchhcc---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTS-------------ENPNRAIN---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~-------------~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....             ......+.   +.......+.....+.+++..||+.+|++||++.|++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         214 VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1000             00000000   00000001111345889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-37  Score=296.09  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=203.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+...||+|.|++|.+|.+.. +|..||||.+.+....           . .....+.+|+++|..++|||||++
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln-----------~-~~~~k~~rev~imk~l~HPnIvkl  120 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLN-----------P-SKRQKLGREVDIMKSLNHPNIVKL  120 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccC-----------h-HHHHHHHHHHHHHHhcCCcceeee
Confidence            45789999999999999999999875 8999999988443222           1 224558999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +.+......+|+||||+.+|.+++++..    .+......+..++.|+..+++|||+.+   |+|||||++||||+.+.+
T Consensus       121 ~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mn  193 (596)
T KOG0586|consen  121 FSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMN  193 (596)
T ss_pred             eeeeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccc
Confidence            9999999999999999999999999943    455666889999999999999999666   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++..+..+....   ..+|++.|.|||++.+..| +..+|+||+|+++|.|++|..||++..-    ..+.+ 
T Consensus       194 ikIaDfgfS~~~~~~~~lq---t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~-  265 (596)
T KOG0586|consen  194 IKIADFGFSTFFDYGLMLQ---TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRP-  265 (596)
T ss_pred             eeeeccccceeeccccccc---ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccc-
Confidence            9999999999887543333   4689999999999999987 5679999999999999999999885311    11111 


Q ss_pred             HHHHhc-CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMT-SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        +.+. .-+....            ....+.++++++|-.+|.+|+++.++.+
T Consensus       266 --rvl~gk~rIp~~------------ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  266 --RVLRGKYRIPFY------------MSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             --hheeeeecccce------------eechhHHHHHHhhccCccccCCHHHhhh
Confidence              1111 1111111            1223778999999999999999999865

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-36  Score=291.51  Aligned_cols=264  Identities=19%  Similarity=0.274  Sum_probs=195.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+...||.|+||+||+|+.. .+|..||||.+......            ......+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni~~~~   70 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDN------------RIDAKRTLREIKLLRHLDHENVIAIK   70 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccc------------cchhHHHHHHHHHHHhcCCCCccchH
Confidence            357899999999999999999876 48999999988432111            11235677899999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     ...++|+||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~  142 (337)
T cd07858          71 DIMPPPHREAFNDVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLN  142 (337)
T ss_pred             HheecccccccCcEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence            988654     34799999996 68988884    345699999999999999999999955   599999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      .++.+||+|||++.........  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....    ..
T Consensus       143 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~  216 (337)
T cd07858         143 ANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY----VH  216 (337)
T ss_pred             CCCCEEECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HH
Confidence            9999999999999876543211  113467889999998765 4689999999999999999999999864311    01


Q ss_pred             HHHHHHHHhcCCCCch------------------hccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          367 LVQWMRNVMTSENPNR------------------AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ....+...........                  ...... ....+.....+.+++.+||+.+|++|||+.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            1111111110000000                  000000 00011233458899999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7e-36  Score=284.15  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=193.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|...+.||.|+||+||+|+... +|..|++|++.....           ........+.+|+.+++.++|||++++++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   88 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGK-----------QTNEKWQDIIKEVKFLQQLKHPNTIEYKG   88 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECC-CCcEEEEEEEecccc-----------CchHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            346667889999999999998753 789999999843221           11233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+. |+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++
T Consensus        89 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~k  161 (313)
T cd06633          89 CYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK  161 (313)
T ss_pred             EEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEE
Confidence            9999999999999996 588888743   335689999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |+|||++......      ....|+..|+|||++.   +..++.++||||||+++|+|++|..||.....       ...
T Consensus       162 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~  228 (313)
T cd06633         162 LADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA  228 (313)
T ss_pred             EeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHH
Confidence            9999998653221      1346888999999974   45688899999999999999999999754321       111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........+..         ........+.+++.+||+.+|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         229 LYHIAQNDSPTL---------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHhcCCCCC---------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111110         00111234788999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5e-36  Score=280.34  Aligned_cols=245  Identities=22%  Similarity=0.235  Sum_probs=184.4

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHH---HHHHhccCCCCcccceeEEEe
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSE---IITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpniv~l~~~~~~  217 (430)
                      .||+|+||.||+|.... +|+.||+|.+.......           ......+..|   +..++...||||+.+++++..
T Consensus         1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~   68 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKM-----------KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT   68 (278)
T ss_pred             CcccCCCeEEEEEEEec-CCCEEEEEEeecccccc-----------chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence            48999999999998753 78999999885422110           0101123333   344555689999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      .+..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~v~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~df  141 (278)
T cd05606          69 PDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (278)
T ss_pred             CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999884    345699999999999999999999954   5999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhc
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT  376 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~  376 (430)
                      |++........    ....|+..|+|||++.++ .++.++||||+|+++|+|++|..||......    ..... .....
T Consensus       142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~~~-~~~~~  212 (278)
T cd05606         142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEI-DRMTL  212 (278)
T ss_pred             cCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc----chHHH-HHHhh
Confidence            99876543221    134689999999998754 6899999999999999999999998753221    11111 11111


Q ss_pred             CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ...+      ..    +......+.+++.+||..+|.+||     ++.++++
T Consensus       213 ~~~~------~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 TMAV------EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ccCC------CC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1000      01    111123488899999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.1e-36  Score=285.20  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=188.9

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      +.+.+|.|++  ||+++... +|+.||+|++.....            .......+..|+.+++.++||||+++++++..
T Consensus         6 i~~~~~~~~~--v~~~~~~~-~~~~~avK~~~~~~~------------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~   70 (314)
T cd08216           6 IGKCFEDLMI--VHLAKHKP-TNTLVAVKKINLDSC------------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV   70 (314)
T ss_pred             hhHhhcCCce--EEEEEecC-CCCEEEEEEEecccc------------chhHHHHHHHHHHHHHhcCCcchhhhhheeec
Confidence            3344444544  45554443 899999999854311            11235779999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      .+..+++|||+++|+|.+++...  ....+++.....++.|++.||.|||+.   +|+|+||||+||+++.++.++++||
T Consensus        71 ~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~  145 (314)
T cd08216          71 DSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGL  145 (314)
T ss_pred             CCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecC
Confidence            99999999999999999999652  234588999999999999999999955   4999999999999999999999999


Q ss_pred             CCcccCCCCCCc-----ceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          298 GLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       298 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |.+.........     .......++..|+|||++.+.  .++.++|+|||||+++||++|..||.....   ...+.+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~---~~~~~~~  222 (314)
T cd08216         146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA---TQMLLEK  222 (314)
T ss_pred             ccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence            988765432211     111234577889999998763  588999999999999999999999875321   1111111


Q ss_pred             HHHHhcC----C-------CCch----hccc----cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTS----E-------NPNR----AINS----KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~----~-------~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......    .       ....    ..+.    .............+.+++..||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            1100000    0       0000    0000    0001112233456889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=299.79  Aligned_cols=205  Identities=26%  Similarity=0.376  Sum_probs=173.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .+...+.||.||||.||+|+++ .+|+.||||.+....             .....+....|+++|++++|||||+++++
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~-------------~~r~~e~~~~EieilkKLnh~NIVk~f~i   79 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKES-------------SLRPRERWCREIEILKKLNHPNIVKLFDI   79 (732)
T ss_pred             ceeehhhhcCCccceeeeeccc-ccccchhHHhhhhhc-------------ccchHHHHHHHHHHHHHcCchhhhhhccc
Confidence            3566789999999999999876 499999999985432             12336778999999999999999999997


Q ss_pred             EEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC-
Q 014140          215 MVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-  287 (430)
Q Consensus       215 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-  287 (430)
                      -.+.      +...+|||||+||||...++.- .+...+++...+.+..+++.||.|||+++   |+||||||.||++- 
T Consensus        80 ee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~  155 (732)
T KOG4250|consen   80 EETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQI  155 (732)
T ss_pred             CCccccCcccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEee
Confidence            6543      3467999999999999999763 34567999999999999999999999665   99999999999984 


Q ss_pred             -CCC--ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          288 -DDM--EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       288 -~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                       .+|  ..||+|||.|+.+.++..   ..+++||..|++||+... ..|+..+|.|||||++|++.||..||.++..
T Consensus       156 Gedgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  156 GEDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cCCCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence             223  479999999999987753   335799999999999984 7789999999999999999999999977543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=273.14  Aligned_cols=254  Identities=20%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             ccccccc-ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcc
Q 014140          132 KEDYFAS-LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIV  209 (430)
Q Consensus       132 ~~~~~~~-~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  209 (430)
                      -+++|.+ ..+||-|-.|+|-.+.++ .+|+.+|+|++..                   ....++|+++--.. .|||||
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~D-------------------s~KARrEVeLHw~~s~h~~iV  118 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLD-------------------SPKARREVELHWMASGHPHIV  118 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEec-cchhhhHHHHHhc-------------------CHHHHhHhhhhhhhcCCCceE
Confidence            3566765 468999999999999876 4999999999843                   34567788776666 599999


Q ss_pred             cceeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          210 PLLARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       210 ~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      .+++++..    ...+.+|||+|+||.|...++.  .....+++..+-.|+.||+.|+.|||+.+   |.||||||+|+|
T Consensus       119 ~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLL  193 (400)
T KOG0604|consen  119 SIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLL  193 (400)
T ss_pred             EeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhhee
Confidence            99998864    3567899999999999999976  45567999999999999999999999666   999999999999


Q ss_pred             eCC---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 014140          286 IDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT  362 (430)
Q Consensus       286 l~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~  362 (430)
                      ...   +..+||+|||+|+.........   ..+-|+.|.|||++....|+..+|+||+||++|-|++|.+||-....  
T Consensus       194 yt~t~~na~lKLtDfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--  268 (400)
T KOG0604|consen  194 YTTTSPNAPLKLTDFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--  268 (400)
T ss_pred             eecCCCCcceEecccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--
Confidence            974   4579999999999865433322   34679999999999999999999999999999999999999864332  


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ..+...++.....+.-      .+..+-.....+...++++.+|..+|.+|.|+.++++
T Consensus       269 --~aispgMk~rI~~gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  269 --LAISPGMKRRIRTGQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             --ccCChhHHhHhhccCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence              2222222222222211      0112234556677999999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=326.11  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=200.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      ++.-...||.|.||.||.|... .+|...|+|-+......            ......+.+|+.++..|+|||+|+++|+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~------------~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSD------------HKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred             eeccccccCCcceeeeEEeecC-CccchhhhhhhhcCccc------------cccCcchHHHHHHHHhccCccccccCce
Confidence            4555678999999999999765 49999999988443222            2335668899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      -.+.+..+|.||||.+|+|.+.+.    -+...++.....+..|++.|++|||+.+   ||||||||.||+++.+|.+|+
T Consensus      1303 EvHRekv~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred             eecHHHHHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEe
Confidence            999999999999999999999994    3455778888889999999999999555   999999999999999999999


Q ss_pred             eecCCcccCCCCCC--cceeeccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          295 SEFGLAKRIPDGHT--RTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|||.|..+.++..  ........||+.|||||++.+..   -..+.||||+||++.||.||+.||..+..   ...+.-
T Consensus      1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy 1452 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMY 1452 (1509)
T ss_pred             ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHh
Confidence            99999998866531  11223568999999999998753   56789999999999999999999987533   111221


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+......             +.|......-.+++..||..||.+|.++.|+++
T Consensus      1453 ~V~~gh~P-------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKP-------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHhccCCC-------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            11111111             112223334678889999999999999988876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-36  Score=284.98  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=195.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|.... +|+.||+|.+......            ......+.+|+.+++.++|||+++++
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~------------~~~~~~~~~e~~~~~~l~h~~i~~~~   72 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEK------------EGFPITAIREIKILRQLNHRNIVNLK   72 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccc------------cCchHHHHHHHHHHHhCCCCCeeeee
Confidence            4678999999999999999999864 7899999998543211            11134577899999999999999999


Q ss_pred             eEEEeCC----------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          213 ARMVRRD----------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       213 ~~~~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      +++.+..          ..++|+||+++ ++.+.+..   ....+++..+..++.|++.||+|||+.   +++|+||+|+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~  145 (302)
T cd07864          73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCS  145 (302)
T ss_pred             heecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            9987655          78999999976 77777743   234689999999999999999999954   5999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~  361 (430)
                      ||++++++.+||+|||++......... ......++..|+|||.+.+. .++.++|||||||++++|++|+.||..... 
T Consensus       146 nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-  223 (302)
T cd07864         146 NILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-  223 (302)
T ss_pred             HEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence            999999999999999999876543321 11123467889999987654 578899999999999999999999864221 


Q ss_pred             cccccHHHHHHHHhcCCCCchh-----------ccccc-----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          362 TKEMSLVQWMRNVMTSENPNRA-----------INSKL-----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~-----------~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ......+........+...           .+...     ........+..+.+++..||+.+|.+||++.+++.
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         224 ---LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ---HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               1111111111111110000           00000     00000112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.1e-36  Score=285.12  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|...+.||.|++|.||+|+... ++..+++|.+.....           ........+.+|+.+++.++|||+++++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~   81 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGK-----------QSNEKWQDIIKEVRFLQKLRHPNTIQYR   81 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccc-----------cChHHHHHHHHHHHHHHhCCCCCcccEE
Confidence            3458888999999999999998764 789999998843211           1122346788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+. |+|.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~  154 (308)
T cd06634          82 GCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV  154 (308)
T ss_pred             EEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcE
Confidence            99999999999999996 588887743   234589999999999999999999955   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +|+|||++.......      ...++..|+|||++.   +..++.++|||||||++|+|++|..||.....       ..
T Consensus       155 kl~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~  221 (308)
T cd06634         155 KLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS  221 (308)
T ss_pred             EECCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HH
Confidence            999999987654321      245788999999875   34678899999999999999999999754311       11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ..........+.         .........+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         222 ALYHIAQNESPA---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHhhcCCCC---------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            111111111110         0011223448899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.6e-36  Score=278.33  Aligned_cols=256  Identities=18%  Similarity=0.246  Sum_probs=196.8

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|.+.+.||+|+||.||++.... .+..+++|.+......         ........++..|+.+++.++|||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVG---------ELNPNETVQANQEAQLLSKLDHPAIVKFHAS   70 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC-CCCcceEEEecccccc---------ccCcchHHHHHHHHHHHHhCCCCcHHHHHHH
Confidence            37788999999999999998763 4555666665332111         0011123457789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +.+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+   .+++|+||+|+||++++ +.++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l  146 (260)
T cd08222          71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKI  146 (260)
T ss_pred             HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEee
Confidence            999999999999999999999987644455679999999999999999999994   45999999999999975 56999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||.+..........  ....|+..|+|||.+.+..++.++|+||||+++++|++|..||....       ........
T Consensus       147 ~d~g~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~  217 (260)
T cd08222         147 GDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRI  217 (260)
T ss_pred             cccCceeecCCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH
Confidence            9999987764432211  13457889999999988889999999999999999999999975321       22222222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+.          .+......+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTPS----------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCCC----------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            2211111          11223345889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.6e-36  Score=287.83  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=194.3

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .+++|.+.+.||.|+||.||+|.... +|..||||++......            ......+..|+.+++.++|||++++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~   74 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFST------------PVLAKRTYRELKLLKHLRHENIISL   74 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECC-CCCEEEEEEecccccc------------cchhHHHHHHHHHHHhcCCCCeeeE
Confidence            46789999999999999999998664 8999999988432211            1224667889999999999999999


Q ss_pred             eeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++|.. .+..++|+||+ +++|.+++.     ...+++.....++.|++.||.|||+   .+++|+||+|+||++++++
T Consensus        75 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~  145 (328)
T cd07856          75 SDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENC  145 (328)
T ss_pred             eeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCC
Confidence            999876 56789999999 568988873     2357888889999999999999995   4599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .++|+|||.+.......     ....++..|+|||++.+ ..++.++||||||+++++|++|..||...........+.+
T Consensus       146 ~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~  220 (328)
T cd07856         146 DLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD  220 (328)
T ss_pred             CEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999987543221     12357889999998766 5689999999999999999999999864322100000010


Q ss_pred             --------HHHHHhcCCCCchhccc-cccCCCc-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          370 --------WMRNVMTSENPNRAINS-KLLGNGY-----EEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       370 --------~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                              +........ ....+.. ......+     +.....+.+++.+||+.+|++||++.+++..
T Consensus       221 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         221 LLGTPPDDVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhCCCCHHHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    000000000 0000000 0000000     1123458899999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.1e-36  Score=286.06  Aligned_cols=267  Identities=23%  Similarity=0.274  Sum_probs=193.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||.|++|.||+|+... +++.+|+|++.......            .....+.+|+.+++.++||||++++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~   73 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK-TGRVVALKKILMHNEKD------------GFPITALREIKILKKLKHPNVVPLI   73 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEEeccCCC------------CcchhHHHHHHHHHhcCCCCccchh
Confidence            4679999999999999999998764 78999999985432111            1123467899999999999999999


Q ss_pred             eEEEeCC--------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          213 ARMVRRD--------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       213 ~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++....        ..++|+||+.+ +|...+..   ....+++..+..++.|++.||.|||+.   +++|+||||+||
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~ni  146 (311)
T cd07866          74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANI  146 (311)
T ss_pred             hheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9876543        46899999965 78777743   345699999999999999999999955   599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcc---------eeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRT---------TTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      ++++++.++|+|||++..........         ......+++.|+|||++.+. .++.++||||||+++|+|++|+.|
T Consensus       147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence            99999999999999998664322111         11134568889999987654 578999999999999999999999


Q ss_pred             CCccccccccccHHHHHHHHhcCCCCch-------------hcccccc---CCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          355 SDDFFQHTKEMSLVQWMRNVMTSENPNR-------------AINSKLL---GNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       355 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------------~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      |.....    ....+.+........+..             .......   ..........+.+++.+||+.+|.+|||+
T Consensus       227 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         227 LQGKSD----IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             CCCCCH----HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence            864322    111111111111000000             0000000   00001112458899999999999999999


Q ss_pred             HHHHH
Q 014140          419 KDVRC  423 (430)
Q Consensus       419 ~ev~~  423 (430)
                      .+++.
T Consensus       303 ~ell~  307 (311)
T cd07866         303 SDALE  307 (311)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=289.20  Aligned_cols=277  Identities=22%  Similarity=0.221  Sum_probs=195.0

Q ss_pred             cccc-cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          134 DYFA-SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       134 ~~~~-~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ++|. +.+.||.|+||.||+|.... +|+.||||.+........................+.+|+.+++.++||||++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            3454 45779999999999998653 889999999854322210000000000000113577899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+. |+|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence            99999999999999996 599998843    44689999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCC------------cceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          293 RISEFGLAKRIPDGHT------------RTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      +|+|||++........            ........++..|+|||++.+. .++.++|+|||||++++|++|..||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999987652110            0111123467889999998765 46899999999999999999999986432


Q ss_pred             cccccccHHHHHHHHhcCCCCc---hh-----------ccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPN---RA-----------INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .    ......+..........   ..           ..+.............+.+++..||+.+|++||++.+++.
T Consensus       239 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 E----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            2    11111111111111100   00           0000000001112345889999999999999999999985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=273.86  Aligned_cols=245  Identities=22%  Similarity=0.252  Sum_probs=196.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|..+++||.|.||+|-+++-+ .+|+.||+|.+.+.           ..........-..|-++|+..+||.+..+.
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKe-----------viiakdEVAHTlTE~RVL~~~~HPFLt~LK  234 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKE-----------VIIAKDEVAHTLTENRVLQNCRHPFLTSLK  234 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeec-ccCceeehhhhhhh-----------heeehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence            367888999999999999999876 49999999998443           222234467788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      -.|...+.+|+||||..||.|.-.|.    ....+++.....+-..|+.||.|||+.+   |++||||.+|.|+|.+|++
T Consensus       235 YsFQt~drlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHI  307 (516)
T KOG0690|consen  235 YSFQTQDRLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHI  307 (516)
T ss_pred             hhhccCceEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCce
Confidence            99999999999999999999998884    3556888888889999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||.|||+++.-..  ....+..++||+.|+|||++....|+..+|+|.+||++|||++|+.||...    +...+.+.+-
T Consensus       308 KitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~----dh~kLFeLIl  381 (516)
T KOG0690|consen  308 KITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK----DHEKLFELIL  381 (516)
T ss_pred             Eeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc----chhHHHHHHH
Confidence            9999999986432  223444689999999999999999999999999999999999999997542    2222333221


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP  416 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp  416 (430)
                      .  ..-+..        ....+    ....|+...|..||.+|.
T Consensus       382 ~--ed~kFP--------r~ls~----eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  382 M--EDLKFP--------RTLSP----EAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             h--hhccCC--------ccCCH----HHHHHHHHHhhcChHhhc
Confidence            1  011111        11122    256677778888999995

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-36  Score=287.22  Aligned_cols=264  Identities=22%  Similarity=0.325  Sum_probs=193.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||.|++|.||+|.... +|..||||++.....            .......+.+|+.+++.++||||+++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPFQ------------SELFAKRAYRELRLLKHMKHENVIGL   79 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC-CCcEEEEEEeccccc------------chHHHHHHHHHHHHHHhcCCCCccce
Confidence            35679999999999999999998654 899999998843211            11234568899999999999999999


Q ss_pred             eeEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          212 LARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       212 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++++....      ..++||||+ +++|.+++.     ...+++..+..++.|++.||.|||.   .+++||||+|+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nil  150 (343)
T cd07880          80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLA  150 (343)
T ss_pred             eeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            99987654      358999999 779988873     2468999999999999999999994   55999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      ++.++.++|+|||++........     ...++..|+|||.+.+ ..++.++|+||||++++++++|..||.........
T Consensus       151 l~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  225 (343)
T cd07880         151 VNEDCELKILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL  225 (343)
T ss_pred             EcCCCCEEEeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999986543221     2457889999998876 35889999999999999999999998643210000


Q ss_pred             ccHH--------HHHHHHhcCCCCchhcc--ccc----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLV--------QWMRNVMTSENPNRAIN--SKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~--------~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+.        .+..... .........  +..    ...........+.+++.+|++.||.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         226 MEIMKVTGTPSKEFVQKLQ-SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhcCCCCHHHHHhhc-chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000        0000000 000000000  000    00001112334789999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9e-36  Score=286.90  Aligned_cols=259  Identities=24%  Similarity=0.319  Sum_probs=190.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+...||.|++|.||+|.... +|+.||||++......            ......+.+|+.+++.++||||++++
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQS------------EIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCC-CCcEEEEEEecCcccc------------ccchhHHHHHHHHHHhcCCCCccchh
Confidence            3578999999999999999998753 7899999988542211            11235678899999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++....      ..++|+||+.. +|..++      ...+++..+..++.|++.||+|||+.   +++||||+|+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll  150 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAV  150 (342)
T ss_pred             heecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence            9987543      45899999964 777765      23589999999999999999999954   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.++|+|||++........     ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....    .
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~  221 (342)
T cd07879         151 NEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----L  221 (342)
T ss_pred             CCCCCEEEeeCCCCcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            9999999999999876533211     2457889999999876 4688999999999999999999999864321    1


Q ss_pred             cHHHHHHHHhcCCCC-----------chhcc--ccc----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENP-----------NRAIN--SKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~-----------~~~~~--~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+........+           .....  +..    .....+.....+.+++..||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111111111000000           00000  000    00000112234789999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=272.16  Aligned_cols=240  Identities=24%  Similarity=0.271  Sum_probs=190.9

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||.|++|.||++.... +++.+++|.+.....           ........+..|+.+++.++|||++++++.+..++..
T Consensus         1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   68 (250)
T cd05123           1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKI-----------IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL   68 (250)
T ss_pred             CCCCCceEEEEEEECC-CCcEEEEEEeehhhh-----------cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence            6999999999998764 789999998844221           1123456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ++||||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        69 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~  141 (250)
T cd05123          69 YLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK  141 (250)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcce
Confidence            999999999999999953    34689999999999999999999954   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCc
Q 014140          302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN  381 (430)
Q Consensus       302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  381 (430)
                      .......  ......++..|+|||...+..++.++|+||||++++++++|..||.....       ............. 
T Consensus       142 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-  211 (250)
T cd05123         142 ELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLR-  211 (250)
T ss_pred             ecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCC-
Confidence            7654321  11234678899999999988899999999999999999999999854321       1112222211110 


Q ss_pred             hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 014140          382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD  420 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~e  420 (430)
                                .+......+.+++..||..||++||++.+
T Consensus       212 ----------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         212 ----------FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ----------CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                      00111234788999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-35  Score=285.52  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=191.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .+++|.+.+.||+|+||.||+|.... +|+.||+|++......            ......+.+|+.++.+++||||+++
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~Ei~~l~~l~h~~iv~~   81 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQS------------IIHAKRTYRELRLLKHMKHENVIGL   81 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchh------------hHHHHHHHHHHHHHHHcCCCcccce
Confidence            56789999999999999999998653 8899999988432111            1224567889999999999999999


Q ss_pred             eeEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          212 LARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       212 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++++...      ...+++++++ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl  152 (345)
T cd07877          82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA  152 (345)
T ss_pred             eeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence            9988643      3467888887 7799888742     3589999999999999999999954   5999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      +++++.++|+|||++.......     ....++..|+|||.+.+ ..++.++|||||||++++|++|+.||......   
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---  224 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---  224 (345)
T ss_pred             EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            9999999999999987653321     13467889999998876 46889999999999999999999998542211   


Q ss_pred             ccHHHHHHHHhcCCCCchhc---------------c---ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAI---------------N---SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       .....+....... +....               .   ..............+.+++..||+.+|.+||++.+++.
T Consensus       225 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         225 -DQLKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             -HHHHHHHHHhCCC-CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             1101010000000 00000               0   00000000011234789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=312.08  Aligned_cols=255  Identities=22%  Similarity=0.231  Sum_probs=200.6

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.++.+||+|+||.|.++++++ ++++||.|++.+...           ........|..|-.+|..-+.+=|+++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eM-----------lKr~~tA~F~EERDimv~~ns~Wiv~L  140 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEM-----------LKRAETACFREERDIMVFGNSEWIVQL  140 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHH-----------hhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence            35689999999999999999999875 899999999844221           112235779999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +-.|.+++++|+|||||+||+|..++..    ...+++.++..++..|+.||.-||   +.|+|||||||+|||+|.+|+
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCc
Confidence            9999999999999999999999999943    337999999999999999999999   556999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +||+|||.+-.+..+...... ..+|||.|++||++..     +.|+..+|+||+||++|||+.|..||-.       .+
T Consensus       214 ikLADFGsClkm~~dG~V~s~-~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-------ds  285 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADGTVRSS-VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-------DS  285 (1317)
T ss_pred             EeeccchhHHhcCCCCcEEec-cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-------HH
Confidence            999999999888755443333 5689999999999764     3589999999999999999999999742       34


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC---HHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN---SKDV  421 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps---~~ev  421 (430)
                      +++-...++........  |     ...+......+||+..+. +|+.|..   +.++
T Consensus       286 lveTY~KIm~hk~~l~F--P-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi  335 (1317)
T KOG0612|consen  286 LVETYGKIMNHKESLSF--P-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDI  335 (1317)
T ss_pred             HHHHHHHHhchhhhcCC--C-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence            55544455443211100  0     011133345666665444 6777877   5554

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-35  Score=285.13  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=198.9

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||.|++|.||+|+... +|..+|||++.....            .......+.+|+.+++.++||||++++++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFD------------DLIDAKRILREIKLLRHLRHENIIGLLDI   67 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC-CCcEEEEEeeccccc------------cchhhhhHHHHHHHHHhcCCcchhhhhhh
Confidence            47888999999999999998763 689999999854221            11224678899999999999999999999


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          215 MVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       215 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +...+     ..|+||||+++ +|.+++.    ....+++..++.++.+++.||.|||+.   +++|+||||+||+++.+
T Consensus        68 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~  139 (330)
T cd07834          68 LRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSN  139 (330)
T ss_pred             hcccCcccccceEEEecchhh-hHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            98775     78999999974 8988884    334799999999999999999999954   59999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +.++|+|||++......... .......++..|+|||++.+. .++.++|+||||+++++|++|..||.....    ...
T Consensus       140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~----~~~  215 (330)
T cd07834         140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY----IDQ  215 (330)
T ss_pred             CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH----HHH
Confidence            99999999999877554311 111234578899999999888 789999999999999999999999865321    111


Q ss_pred             HHHHHHHhcCCCCch-----------hcc------ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          368 VQWMRNVMTSENPNR-----------AIN------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~-----------~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ...+...........           .+.      ........+.....+.+++..||+.+|.+||++.+++..
T Consensus       216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111111111100000           000      000000111123458899999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-36  Score=304.61  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=207.6

Q ss_pred             ccccccccccccccCceEEEeecCCCC------CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSS------GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      .++..+.+.||+|+||.|++|...+..      ...||||.+.....             ......+..|+.+|..+ +|
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-------------~~~~~~~~~El~~m~~~g~H  361 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-------------SSEKKDLMSELNVLKELGKH  361 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-------------cHHHHHHHHHHHHHHHhcCC
Confidence            444566679999999999999865222      45799998843221             13468899999999999 69


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS---QG-------R--RELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||+.++|+|...+..++|+||+..|+|.++++..+   ..       .  ..++....+.++.|||.||+||++..   
T Consensus       362 ~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---  438 (609)
T KOG0200|consen  362 PNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---  438 (609)
T ss_pred             cchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---
Confidence            999999999999999999999999999999998754   00       1  23889999999999999999999554   


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeecccc--ccccccccccCCCCCCcchhHHHHHHHHHHHHh-
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-  350 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-  350 (430)
                      ++||||.++|||+..+..+||+|||+|+........... .-.|  ...|||||.+....|+.+|||||||++|||+++ 
T Consensus       439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence            999999999999999999999999999976554443322 1122  345999999999999999999999999999999 


Q ss_pred             CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          351 GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       351 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      |..||.+..   ....+.++++...+...|.             .+...+.++++.||+.+|++||+..++.+.|+.
T Consensus       518 G~~PYp~~~---~~~~l~~~l~~G~r~~~P~-------------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  518 GGTPYPGIP---PTEELLEFLKEGNRMEQPE-------------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCCCCCCCC---cHHHHHHHHhcCCCCCCCC-------------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            778986522   1233444444444333322             223448899999999999999999999999876

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=289.46  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=196.3

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeC
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  218 (430)
                      .+.||+|.||+||-|+++. +|+.||||++.+-...           . +...++++|+.+|++++||.||.+...|...
T Consensus       569 devLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp-----------~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~  635 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFP-----------T-KQESQLRNEVAILQNLHHPGIVNLECMFETP  635 (888)
T ss_pred             HhhccCCcceeeecceecc-cCceeeeeeeecccCC-----------C-chHHHHHHHHHHHHhcCCCCeeEEEEeecCC
Confidence            4689999999999999886 9999999999432221           1 2247899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---CceEEe
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---MEARIS  295 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~  295 (430)
                      +..++|||.+.| +..+++-.  ...+.+++.....++.||+.||.|||..+   |+|+||||+|||+.+.   ..+|||
T Consensus       636 ervFVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlC  709 (888)
T KOG4236|consen  636 ERVFVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLC  709 (888)
T ss_pred             ceEEEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeec
Confidence            999999999955 66666543  45678999999999999999999999666   9999999999999754   579999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH--
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN--  373 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~--  373 (430)
                      |||+|+.++......   ..+||+.|+|||++.+.+|+..-|+||.||++|.-++|.+||.+..      ++.+.+.+  
T Consensus       710 DFGfARiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------dIndQIQNAa  780 (888)
T KOG4236|consen  710 DFGFARIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------DINDQIQNAA  780 (888)
T ss_pred             cccceeecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------chhHHhhccc
Confidence            999999998765443   4689999999999999999999999999999999999999986532      12222211  


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ++....            ...+.....++|+...|+..-.+|-|...-+
T Consensus       781 FMyPp~------------PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  781 FMYPPN------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             cccCCC------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            111111            2233334478888888998999998877654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=275.34  Aligned_cols=265  Identities=25%  Similarity=0.346  Sum_probs=203.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc--CCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV--RHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l  211 (430)
                      ......+.||+|.||.||+|.+   .|+.||||.+....                 ...+.+|.++.+..  ||+||+.|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~srd-----------------E~SWfrEtEIYqTvmLRHENILgF  270 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSSRD-----------------ERSWFRETEIYQTVMLRHENILGF  270 (513)
T ss_pred             heeEEEEEecCccccceeeccc---cCCceEEEEecccc-----------------hhhhhhHHHHHHHHHhccchhhhh
Confidence            4567789999999999999999   68899999994321                 34566777777664  99999999


Q ss_pred             eeEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCC
Q 014140          212 LARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPA  282 (430)
Q Consensus       212 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp~  282 (430)
                      ++.-..++    .++||++|.+.|||+|+|.+     ..++....++++..+|.||++||..     ++|.|.|||||+.
T Consensus       271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK  345 (513)
T KOG2052|consen  271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK  345 (513)
T ss_pred             hhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence            98754433    57999999999999999953     5689999999999999999999953     5788999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCC--CCcceeeccccccccccccccCCCC----C-C-cchhHHHHHHHHHHHHhC---
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDG--HTRTTTWSLAGTVGYIAPECHQTVA----L-S-DTCDIYSFGVLLAVLVIG---  351 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~Dv~slG~~l~ell~g---  351 (430)
                      |||+..++.+.|+|+|+|......  .........+||..|||||++...-    + + ..+||||||.++||+...   
T Consensus       346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~  425 (513)
T KOG2052|consen  346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES  425 (513)
T ss_pred             cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence            999999999999999999876543  2222333568999999999987642    2 2 358999999999999763   


Q ss_pred             -------CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          352 -------KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       352 -------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                             +.||.+..+  .++++. .++.++...+..+.++++   -...+.+..+.+++..||..+|.-|.|+-.|-+.
T Consensus       426 ggi~eey~~Pyyd~Vp--~DPs~e-eMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKt  499 (513)
T KOG2052|consen  426 GGIVEEYQLPYYDVVP--SDPSFE-EMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKT  499 (513)
T ss_pred             CCEehhhcCCcccCCC--CCCCHH-HHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence                   256665543  223333 334444333333222222   1334567779999999999999999999999999


Q ss_pred             Hhccc
Q 014140          425 LSQIQ  429 (430)
Q Consensus       425 L~~l~  429 (430)
                      |.++.
T Consensus       500 l~~l~  504 (513)
T KOG2052|consen  500 LAKLS  504 (513)
T ss_pred             HHHHh
Confidence            98874

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-35  Score=285.46  Aligned_cols=264  Identities=19%  Similarity=0.235  Sum_probs=189.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ..+|.+.+.||.|+||.||+|.... +|..||+|.+.....              .....+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~~--------------~~~~~~~~Ei~~l~~l~h~~i~~~~   68 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKVY   68 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCCC--------------chHHHHHHHHHHHHhcCCCcchhhH
Confidence            3579999999999999999998764 899999998843221              2246688899999999999999999


Q ss_pred             eEEEeC--------------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          213 ARMVRR--------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       213 ~~~~~~--------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      +++...              ...++||||++ ++|.+++..     ..+++..+..++.|++.||.|||+.   +++|||
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~d  139 (342)
T cd07854          69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRD  139 (342)
T ss_pred             hhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            876553              35789999997 589888732     3588999999999999999999954   599999


Q ss_pred             CCCCcEEeC-CCCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          279 IQPANVLID-DDMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       279 lkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      |||+||+++ .++.++++|||.+..+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus       140 ikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             CCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999997 45678999999998654322111 1112357889999997654 46888999999999999999999998


Q ss_pred             CccccccccccHHHHHHHHhc----------CCCCchhccccccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 014140          356 DDFFQHTKEMSLVQWMRNVMT----------SENPNRAINSKLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKD  420 (430)
Q Consensus       356 ~~~~~~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~e  420 (430)
                      ........   ..........          ...+...........     ........+.+++.+||+.||.+|||+.+
T Consensus       220 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  296 (342)
T cd07854         220 AGAHELEQ---MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE  296 (342)
T ss_pred             CCCCHHHH---HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence            64322100   0000000000          000000000000000     00112234788999999999999999999


Q ss_pred             HHH
Q 014140          421 VRC  423 (430)
Q Consensus       421 v~~  423 (430)
                      ++.
T Consensus       297 ll~  299 (342)
T cd07854         297 ALM  299 (342)
T ss_pred             HhC
Confidence            974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=281.84  Aligned_cols=264  Identities=22%  Similarity=0.253  Sum_probs=201.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|-.+.+||+|||+.||+|.+. ...+.||||...-.....       .+..+...+...+|.++-+.|.||.||++|+
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~Wr-------dEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWR-------DEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchh-------hHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            46778889999999999999765 478899999764332111       1122345678889999999999999999999


Q ss_pred             EEE-eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC---CC
Q 014140          214 RMV-RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID---DD  289 (430)
Q Consensus       214 ~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~  289 (430)
                      +|. +.+..|-|+|||+|.+|.-+|.    ....+++..+..|+.||+.||.||.+. .++|||.||||.|||+-   ..
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence            996 4567899999999999998884    456689999999999999999999987 68999999999999995   45


Q ss_pred             CceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          290 MEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTV----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      |.+||.|||+++.+.+..+..     -+....||++|++||++.-+    ..+.|+||||+|||+|.++.|+.||.....
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            789999999999987654432     23356799999999987644    468999999999999999999999875322


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                         ..++.+.. .++......  +      +..+........+|++||++.-++|.+..++.
T Consensus       690 ---QQdILqeN-TIlkAtEVq--F------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  690 ---QQDILQEN-TILKATEVQ--F------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ---HHHHHhhh-chhcceecc--C------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence               11222211 111111110  0      11112223477899999999999998887764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=275.73  Aligned_cols=262  Identities=24%  Similarity=0.261  Sum_probs=195.7

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |.....||+|++|.||+|+... +++.+|+|.+.....            .......+..|+.+++.++|||++++++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   67 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNE------------EEGIPSTALREISLLKELKHPNIVKLLDVI   67 (282)
T ss_pred             CeeehcccccCcceEEEeeecC-CCcEEEEEEeccccc------------cccccHHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            4567889999999999998764 799999999854321            112245678899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ...+..++|+||++ ++|.+++...   ...+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+
T Consensus        68 ~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~  140 (282)
T cd07829          68 HTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLA  140 (282)
T ss_pred             hcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEe
Confidence            99999999999997 5999999542   24699999999999999999999955   59999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      |||.+..........  ....++..|+|||.+.+. .++.++||||||++++|+++|..||.....    ......+...
T Consensus       141 d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~  214 (282)
T cd07829         141 DFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQI  214 (282)
T ss_pred             cCCcccccCCCcccc--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHH
Confidence            999998765432211  123457789999998777 789999999999999999999999864321    1111111111


Q ss_pred             hcCCCC------------c---hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENP------------N---RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~------------~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......            .   ............+.....+.+++..||+.+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            100000            0   000000000001112345899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-36  Score=287.61  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=194.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+...||.|++|.||+|+... ++..||||++.....            .......+.+|+.++++++|||+++++
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQ------------SAIHAKRTYRELRLLKHMDHENVIGLL   80 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECC-CCcEEEEEecccccc------------hhhHHHHHHHHHHHHHhccCCCHHHHH
Confidence            5679999999999999999998864 789999998843211            112245677899999999999999999


Q ss_pred             eEEEeCCe------eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+.      .++|+||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill  151 (343)
T cd07851          81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAV  151 (343)
T ss_pred             HHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEE
Confidence            98876654      89999999 6699998842     4689999999999999999999954   59999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      ++++.++|+|||++.......     ....++..|+|||.+.+. .++.++||||||+++|++++|+.||.....    .
T Consensus       152 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~  222 (343)
T cd07851         152 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----I  222 (343)
T ss_pred             CCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence            999999999999998764331     134578899999988653 678999999999999999999999864321    1


Q ss_pred             cHHHHHHHHhcCCCC-----------chhccc------cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENP-----------NRAINS------KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~-----------~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+.........           ...+..      .............+.+++..||+.+|.+|||+.+|++
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            111111111110000           000000      0000000112345889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-35  Score=282.66  Aligned_cols=264  Identities=21%  Similarity=0.249  Sum_probs=190.0

Q ss_pred             ccccccccccccCceEEEeecCCCC--CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      +|.+.+.||.|+||.||+++... +  +..||+|++.....            .......+.+|+.++.++ .||||+++
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~~h~~iv~~   67 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFS------------KKILAKRALRELKLLRHFRGHKNITCL   67 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCC-CCcCceEEEEEeccccc------------cchhHHHHHHHHHHHHHhcCCCChhee
Confidence            37788999999999999999764 5  78999998843211            111245678899999999 59999999


Q ss_pred             eeEEEeC----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVRR----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++.+...    ...++++||+. ++|.+++.    ....+++..+..++.|++.||.|||+   .+++||||||+||+++
T Consensus        68 ~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~  139 (332)
T cd07857          68 YDMDIVFPGNFNELYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVN  139 (332)
T ss_pred             eeeeeeccccCCcEEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEc
Confidence            9976432    45688999985 58999883    34568999999999999999999994   4599999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCc--ceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .++.++|+|||++..+......  .......||..|+|||++.+ ..++.++|+||||+++++|++|..||.....    
T Consensus       140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~----  215 (332)
T cd07857         140 ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY----  215 (332)
T ss_pred             CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH----
Confidence            9999999999999876532211  11123468999999998766 4689999999999999999999999864221    


Q ss_pred             ccHHHHHHHHhcCCCC-----------chhc------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENP-----------NRAI------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~-----------~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+.........           ....      .........+.....+.+++.+||+.+|.+|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111111111100000           0000      000000000111345889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7e-35  Score=302.29  Aligned_cols=149  Identities=23%  Similarity=0.335  Sum_probs=130.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||.|+||.||+|.+.. +++.||||++.....           ........+..|+.++..++||||+++++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   71 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADM-----------INKNMVHQVQAERDALALSKSPFIVHLYY   71 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhc-----------cCHHHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence            578999999999999999998764 799999999843221           11233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..|+||||+.+++|.+++..    ...+++..++.++.||+.||.|||..   +|+||||||+|||++.++.++
T Consensus        72 ~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk  144 (669)
T cd05610          72 SLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK  144 (669)
T ss_pred             EEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence            99999999999999999999999853    34588999999999999999999955   599999999999999999999


Q ss_pred             EeecCCcc
Q 014140          294 ISEFGLAK  301 (430)
Q Consensus       294 l~Dfg~a~  301 (430)
                      |+|||+++
T Consensus       145 L~DFGls~  152 (669)
T cd05610         145 LTDFGLSK  152 (669)
T ss_pred             EEeCCCCc
Confidence            99999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=297.09  Aligned_cols=256  Identities=22%  Similarity=0.295  Sum_probs=206.5

Q ss_pred             ccccccccccccCceEEEeecCCCCC----ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSG----RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ......+||+|+||+||+|.+-- .|    .+||||++...             ...+...++..|+.+|.+++|||+++
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~P-ege~vKipVaiKvl~~~-------------t~~~~s~e~LdeAl~masldHpnl~R  762 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIP-EGENVKIPVAIKVLIEF-------------TSPKASIELLDEALRMASLDHPNLLR  762 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEec-CCceecceeEEEEeecc-------------CCchhhHHHHHHHHHHhcCCCchHHH
Confidence            45667899999999999999863 34    47888887432             12233578999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|+|..+. +.||++||+.|+|.|+++.   ....+.....+.|..|||+||.|||   .++++||||-.+|+|+.+-.
T Consensus       763 LLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~  835 (1177)
T KOG1025|consen  763 LLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPN  835 (1177)
T ss_pred             Hhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCC
Confidence            999998777 7899999999999999975   3456889999999999999999999   55599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+|+.|||+++.+......-......-.+.|||-|.+....|+.++|||||||++||++| |..|++....        +
T Consensus       836 hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~  907 (1177)
T KOG1025|consen  836 HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------E  907 (1177)
T ss_pred             eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------H
Confidence            999999999998875443332222334678999999999999999999999999999999 8999876532        1


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+...+..+.         .-..++.+..++.-++.+||..|+..||+++++...++++
T Consensus       908 eI~dlle~ge---------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  908 EIPDLLEKGE---------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             HhhHHHhccc---------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            1222222221         1133445566799999999999999999999999988754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=272.22  Aligned_cols=259  Identities=17%  Similarity=0.219  Sum_probs=202.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCC---
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRN---  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn---  207 (430)
                      .+.|.++..+|+|.||.|-.+..+. .+..||||++..-               ....+..+-|+++|.++.  .|+   
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V---------------~kYreAa~iEi~vLqki~~~DP~g~~  151 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNV---------------DKYREAALIEIEVLQKINESDPNGKF  151 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHH---------------HHHhhHHHHHHHHHHHHHhcCCCCce
Confidence            6789999999999999999997765 5899999988432               233567788999999994  233   


Q ss_pred             -cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          208 -IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       208 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                       +|++.++|...++.|+|+|.+ |-|+.+++..  ++..+++...+..++.|++++++|||+..   ++|.||||+|||+
T Consensus       152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILf  225 (415)
T KOG0671|consen  152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILF  225 (415)
T ss_pred             EEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEE
Confidence             688888899999999999999 6699999964  56678999999999999999999999555   9999999999998


Q ss_pred             CC--------------------CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHH
Q 014140          287 DD--------------------DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLA  346 (430)
Q Consensus       287 ~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~  346 (430)
                      .+                    +..++|+|||.|..-....+     ..+.|..|.|||++.+-+|+.++||||+||||.
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence            42                    33589999999988655442     457799999999999999999999999999999


Q ss_pred             HHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhcccc---------------------------------ccCCCc
Q 014140          347 VLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK---------------------------------LLGNGY  393 (430)
Q Consensus       347 ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~  393 (430)
                      |+.+|..-|....    +......+..++. +.|..++...                                 ..-...
T Consensus       301 ElytG~~LFqtHe----n~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~  375 (415)
T KOG0671|consen  301 ELYTGETLFQTHE----NLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD  375 (415)
T ss_pred             EeeccceecccCC----cHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence            9999998876432    2222233333332 2222221111                                 001122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       394 ~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +.+...+++|+..||..||.+|+|+.|++.
T Consensus       376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  376 DLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            345567999999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=240.68  Aligned_cols=198  Identities=24%  Similarity=0.323  Sum_probs=169.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.-.++||+|.+|+||+|+.. .+++.||+|++.-+...+            -......+|+.+|+.++|.|||+++++
T Consensus         3 ~ydkmekigegtygtvfkarn~-~t~eivalkrvrldddde------------gvpssalreicllkelkhknivrl~dv   69 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDV   69 (292)
T ss_pred             chHHHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCC------------CCcHHHHHHHHHHHHhhhcceeehhhh
Confidence            4667889999999999999876 489999999996543321            224668899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      ...+..+-+|+|||+. +|..+..   .-++.++......++.|+++||.|+|+.+   ++|||+||.|.|++.+|.+|+
T Consensus        70 lhsdkkltlvfe~cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkl  142 (292)
T KOG0662|consen   70 LHSDKKLTLVFEFCDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKL  142 (292)
T ss_pred             hccCceeEEeHHHhhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEe
Confidence            9999999999999965 8888874   34677999999999999999999999777   999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCC
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      +|||+++.++-..  ......+-|.+|.+|.++.|.. |+...|+||.||++.|+.....|
T Consensus       143 adfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  143 ADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             cccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            9999999875432  2222346799999999999876 89999999999999999985555

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=273.26  Aligned_cols=246  Identities=25%  Similarity=0.237  Sum_probs=193.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      ..+|..+.+||.|+||+|.+|..++ +.+.||||++..+..           ......+--+.|-++|+.. +.|.++++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDVi-----------iQdDDvectm~EKrvLAL~~kppFL~ql  415 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVI-----------IQDDDVECTMVEKRVLALPGKPPFLVQL  415 (683)
T ss_pred             ecccceEEEeccCccceeeeecccC-cchhhhhhhhcccee-----------eecCcccceehhhhheecCCCCchHHHH
Confidence            3467888999999999999998765 789999999855422           1122245567788888877 67899999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +.+|...+.+|+||||+.||+|--.+++    -+.+.+..+..+|..||.||-+||   +.|||+||||.+||+++.+|+
T Consensus       416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGH  488 (683)
T KOG0696|consen  416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGH  488 (683)
T ss_pred             HHHhhhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCc
Confidence            9999999999999999999999887744    456888888999999999999999   556999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||.|||+++.-..+.  .++..++||+.|+|||++...+|+..+|+|||||+||||+.|++||++..    ...+.+.+
T Consensus       489 iKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD----E~elF~aI  562 (683)
T KOG0696|consen  489 IKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQAI  562 (683)
T ss_pred             eEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHH
Confidence            9999999998643332  23446799999999999999999999999999999999999999987632    22222222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN  417 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps  417 (430)
                         ....           -.++.........+....|...|.+|.-
T Consensus       563 ---~ehn-----------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 ---MEHN-----------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---HHcc-----------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence               1111           0122223334556666677788988853

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.7e-35  Score=266.63  Aligned_cols=220  Identities=21%  Similarity=0.204  Sum_probs=173.3

Q ss_pred             ccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCeeEEE
Q 014140          145 CWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLV  224 (430)
Q Consensus       145 G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  224 (430)
                      |.+|+||+++... +|+.||+|++....                   .+..|...+....||||+++++++...+..++|
T Consensus         4 g~~~~v~~~~~~~-~~~~~~~K~i~~~~-------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   63 (237)
T cd05576           4 GVIDKVLLVMDTR-TQQTFILKGLRKSS-------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLV   63 (237)
T ss_pred             cccceEEEEEEcc-CCcEEEEEeecchh-------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEE
Confidence            8999999998764 89999999984321                   223344555566799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCC
Q 014140          225 YEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP  304 (430)
Q Consensus       225 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  304 (430)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++++|||.+....
T Consensus        64 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          64 LQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             EecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            999999999999854    235899999999999999999999   4559999999999999999999999999886654


Q ss_pred             CCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhc
Q 014140          305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI  384 (430)
Q Consensus       305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (430)
                      ....     ...++..|+|||...+..++.++|+||+|+++|||++|..|+......      .      .....    +
T Consensus       137 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~------~~~~~----~  195 (237)
T cd05576         137 DSCD-----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------I------NTHTT----L  195 (237)
T ss_pred             cccc-----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------c------ccccc----c
Confidence            3221     234577899999998888999999999999999999999886432110      0      00000    0


Q ss_pred             cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       385 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                            ..+......+.+++.+||+.||++||++
T Consensus       196 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         196 ------NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ------CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence                  0011122347889999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=282.97  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=198.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .++..+..||.||||.|-+.+.++ ....+|+|.+++           ...-...+.+.+.+|-.+|..++.|.||++|-
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK-----------~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr  487 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNS-QKATFALKILKK-----------KHIVDTKQQEHVFSERNIMMECRSDFIVRLYR  487 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecc-cchHHHHHHHhH-----------hhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence            456677789999999999999864 334588887733           22223345688999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      -|.++...|++||-|-||.|+..++.    .+.++..+...++..+++|++|||..+   ||+|||||+|++++.+|-+|
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~K  560 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLK  560 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceE
Confidence            99999999999999999999999954    567999999999999999999999555   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |.|||+|+.+..+   ..+|.++||+.|.|||++.+.+.+.++|.||||+++|||++|.+||....+    ......+-.
T Consensus       561 LVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktYn~ILk  633 (732)
T KOG0614|consen  561 LVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTYNLILK  633 (732)
T ss_pred             EeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHh
Confidence            9999999998655   345678999999999999999999999999999999999999999876433    111111111


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN  417 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps  417 (430)
                      .+..-            ..|........+|++..+..+|.+|.-
T Consensus       634 Gid~i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  634 GIDKI------------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhhh------------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence            11100            011222234677888888999999975

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=285.48  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      .+.-|++.+.||.|.+|+||+++... +|+..|+|........               -+++..|..+|+.+ .|||++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~~~d~---------------deEiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDPTEDE---------------EEEIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeee-cCceeeeEeecCCccc---------------cHHHHHHHHHHHhccCCCCcce
Confidence            35668999999999999999999875 8999999988554332               25577789999988 6999999


Q ss_pred             ceeEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          211 LLARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       211 l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++|++.-     ++.+|||||||.+||..|++....  +..+.|..+..|+..++.|+.+||...   ++|||+|-.|||
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiL  155 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVL  155 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEE
Confidence            9999975     567999999999999999998744  678999999999999999999999554   999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ++.++.+|++|||++..+........  ...||+.|||||++.-.     .|+..+|+||||++..||--|.+|+.++.+
T Consensus       156 LT~e~~VKLvDFGvSaQldsT~grRn--T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  156 LTENAEVKLVDFGVSAQLDSTVGRRN--TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EeccCcEEEeeeeeeeeeeccccccc--CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999999999999988765444333  46899999999998754     378899999999999999999999887765


Q ss_pred             ccccccHHHHHHHHhcCC-CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSE-NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                                ++.+...+ +|.    +.  -..+......+.+++..||..|-.+||++.++++
T Consensus       234 ----------mraLF~IpRNPP----Pk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 ----------MRALFLIPRNPP----PK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----------hhhhccCCCCCC----cc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                      22222111 111    11  1234556677999999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=244.81  Aligned_cols=224  Identities=23%  Similarity=0.357  Sum_probs=183.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      +.+....+..||+|++|.|-+-++. .+|...|+|++.....             .+...+...|+.+..+. .+|.+|.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn-------------~q~q~r~L~dldi~~r~~~CPf~V~  109 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVN-------------SQEQKRLLMDLDIIMRTVDCPFTVH  109 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcC-------------hHHHHHHHHhhhhhccCCCCCeEEE
Confidence            3445566788999999999999887 4999999999943322             23457788888887766 6999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      |||........++.||.|+. ||..+....-..+..+++...-+|+..+++||.|||+.-  .++|||+||+|||+|.+|
T Consensus       110 FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G  186 (282)
T KOG0984|consen  110 FYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG  186 (282)
T ss_pred             eehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence            99999999999999999976 999888776677888999999999999999999999763  599999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      .+|+||||.+..+.++.....   ..|...|||||.+..+    .|+.++||||||+++.||.+++.||+..+      .
T Consensus       187 qVKiCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~------t  257 (282)
T KOG0984|consen  187 QVKICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG------T  257 (282)
T ss_pred             cEEEcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC------C
Confidence            999999999988866543221   3578899999987654    68999999999999999999999987533      2


Q ss_pred             HHHHHHHHhcCCCCc
Q 014140          367 LVQWMRNVMTSENPN  381 (430)
Q Consensus       367 l~~~~~~~~~~~~~~  381 (430)
                      -.+.++.++..+.|.
T Consensus       258 pF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  258 PFQQLKQVVEEPSPQ  272 (282)
T ss_pred             HHHHHHHHhcCCCCC
Confidence            344455666555443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=257.80  Aligned_cols=257  Identities=21%  Similarity=0.281  Sum_probs=191.5

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  217 (430)
                      .++||+|+++.|-.+... .+|..||||++.+.              ......++.+|+.++.+++ |+||++++.+|.+
T Consensus        83 ~e~LGeGAyasVqtcv~i-~t~~EYAVKiidKq--------------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSI-QTGKEYAVKIIDKQ--------------PGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             HHHhcCccceeeeeeeee-ccchhhhhhhhhcC--------------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            468999999999988755 48999999998332              1234678999999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc---eEE
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME---ARI  294 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl  294 (430)
                      +...|||||.|.||+|...|+.    ...+++.++.++..+|+.||.|||   ..||.||||||+|||..+...   +||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999954    567999999999999999999999   666999999999999976554   799


Q ss_pred             eecCCcccCCC--CCCcc---eeeccccccccccccccC---CC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccc-
Q 014140          295 SEFGLAKRIPD--GHTRT---TTWSLAGTVGYIAPECHQ---TV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK-  363 (430)
Q Consensus       295 ~Dfg~a~~~~~--~~~~~---~~~~~~gt~~y~aPE~~~---~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-  363 (430)
                      |||.++.-+..  +.+..   .....+|+..|||||+..   +.  .|+.++|.||||||+|-|++|.+||.+.-.... 
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            99988765432  11111   112457888999999743   22  489999999999999999999999976422111 


Q ss_pred             ---cccHHHHHHH---HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          364 ---EMSLVQWMRN---VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       364 ---~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ...-..+...   ....+.-  .+.    ............+++...|-.++.+|.++.++++
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkY--eFP----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKY--EFP----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCC--cCC----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               1111111111   1111110  000    0112233445777888888899999999988765

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-36  Score=258.48  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=197.4

Q ss_pred             hcccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       131 ~~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ...+.|.-..++|+|.||.||+|+... +|+.||+|++......         +..   .....+|+.+|..|+|+|++.
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneK---------eGf---pitalreikiL~~lkHenv~n   80 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEK---------EGF---PITALREIKILQLLKHENVVN   80 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccc---------cCC---cHHHHHHHHHHHHhcchhHHH
Confidence            345678888999999999999998764 7888999877432211         111   345778999999999999999


Q ss_pred             ceeEEEeC--------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          211 LLARMVRR--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       211 l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      ++..|...        ...|+||.+|+. +|..++.   .....++..++.+++.++..||.|+|...   |+|||+||.
T Consensus        81 liEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaa  153 (376)
T KOG0669|consen   81 LIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAA  153 (376)
T ss_pred             HHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHh
Confidence            99988542        347999999987 8999983   33467999999999999999999999554   999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCC--cceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHT--RTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      |+||+.++.+||+|||+++.+.....  .....+.+-|.+|.+||.+.|. .|+.+.|||+.||++.||+||.+-+.+..
T Consensus       154 NvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  154 NVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             hEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            99999999999999999987653221  1222345679999999998887 58999999999999999999998765432


Q ss_pred             cccccccHHHHHHHHhcCCC-----------Cchhcccc-ccCC---CcHHH------HHHHHHHHHhcccCCCCCCCCH
Q 014140          360 QHTKEMSLVQWMRNVMTSEN-----------PNRAINSK-LLGN---GYEEQ------MLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~-~~~~---~~~~~------~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      .    ......+......-.           ....+..+ +...   ...+.      ....++|+..++..||.+||++
T Consensus       234 e----qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a  309 (376)
T KOG0669|consen  234 E----QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA  309 (376)
T ss_pred             H----HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence            2    222222222221100           01111000 0000   00111      1257788899999999999999


Q ss_pred             HHHHH
Q 014140          419 KDVRC  423 (430)
Q Consensus       419 ~ev~~  423 (430)
                      .+++.
T Consensus       310 d~aln  314 (376)
T KOG0669|consen  310 DQALN  314 (376)
T ss_pred             Hhhhc
Confidence            99875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=279.25  Aligned_cols=240  Identities=21%  Similarity=0.246  Sum_probs=189.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .+.|.....+|.|+|+.|-.+.+. .+++..++|.+...                  .....+|+.++... +||||+++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~------------------~~~~~~e~~~~~~~~~h~niv~~  381 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKR------------------ADDNQDEIPISLLVRDHPNIVKS  381 (612)
T ss_pred             chhhccccccCCCCccceeeeecc-ccccchhheecccc------------------ccccccccchhhhhcCCCcceee
Confidence            567888888999999999999876 48999999998432                  12234456555555 69999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe-CCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI-DDDM  290 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~  290 (430)
                      .+.+.+....|+|||.+.|+-|.+.+..    ...+. ..+..|+.+++.++.|||.   .|++||||||+|||+ ++.+
T Consensus       382 ~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g  453 (612)
T KOG0603|consen  382 HDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAG  453 (612)
T ss_pred             cceecCCceeeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCC
Confidence            9999999999999999999988888743    22233 6777899999999999995   459999999999999 6889


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +++|+|||.++......     ...+-|..|.|||++....|+.++|+||||++||+|++|+.||.....   +   .+ 
T Consensus       454 ~lrltyFG~a~~~~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---~---~e-  521 (612)
T KOG0603|consen  454 HLRLTYFGFWSELERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---G---IE-  521 (612)
T ss_pred             cEEEEEechhhhCchhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---h---HH-
Confidence            99999999999876551     123458899999999999999999999999999999999999865322   1   11 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...+..+...            ........+|+.+||+.||.+||++.++..
T Consensus       522 i~~~i~~~~~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  522 IHTRIQMPKFS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHhhcCCccc------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            12222222111            223344889999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-33  Score=286.14  Aligned_cols=265  Identities=20%  Similarity=0.228  Sum_probs=168.0

Q ss_pred             cccccccccccccccCceEEEeecCCCC----CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSS----GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..++|.+.+.||+|+||.||+|++.. +    +..||+|++.....                .....++  .+....+.+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~----------------~e~~~~e--~l~~~~~~~  190 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGA----------------VEIWMNE--RVRRACPNS  190 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccch----------------hHHHHHH--HHHhhchhh
Confidence            46789999999999999999999864 6    78999998732110                0111111  111122222


Q ss_pred             cccceeE------EEeCCeeEEEEEecCCCCHHHHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHH
Q 014140          208 IVPLLAR------MVRRDCDLLVYEFRRNGSLQDILYDVSQG----------------RRELDWLARHRIAQGIASGLEY  265 (430)
Q Consensus       208 iv~l~~~------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~  265 (430)
                      +..+...      +......++|+||+.+++|.+++......                ........+..++.|++.||.|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~y  270 (566)
T PLN03225        191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDG  270 (566)
T ss_pred             HHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHH
Confidence            2222221      23566789999999999999998642100                0011233456799999999999


Q ss_pred             HhhcCCCCeEecCCCCCcEEeCC-CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC--------------
Q 014140          266 LHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--------------  330 (430)
Q Consensus       266 LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------  330 (430)
                      ||+.   +|+||||||+|||++. ++.+||+|||+++.+........ ....+|+.|+|||.+...              
T Consensus       271 LH~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~  346 (566)
T PLN03225        271 LHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA  346 (566)
T ss_pred             HHHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCcccccccc
Confidence            9954   5999999999999985 57999999999987644322221 245789999999965322              


Q ss_pred             --------CCCcchhHHHHHHHHHHHHhCCCCCCcccc------ccccccHHHHHHHHhcCCCCchhccccccCCCcHHH
Q 014140          331 --------ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ------HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQ  396 (430)
Q Consensus       331 --------~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                              .++.++|||||||++|||+++..|++....      .....++..|.........+.  +.. .. ......
T Consensus       347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~-~~-~~~d~~  422 (566)
T PLN03225        347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPD--LRR-GF-EVLDLD  422 (566)
T ss_pred             ccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchh--hhh-hh-hhcccc
Confidence                    234567999999999999998777543110      001112222222111100000  000 00 000001


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          397 MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       397 ~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+|+..||+.||.+|||+.++++
T Consensus       423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        423 GGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             chHHHHHHHHHccCCcccCCCHHHHhC
Confidence            123558999999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.5e-33  Score=252.76  Aligned_cols=240  Identities=30%  Similarity=0.391  Sum_probs=189.6

Q ss_pred             cCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCeeEEEE
Q 014140          146 WNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVY  225 (430)
Q Consensus       146 ~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  225 (430)
                      +||.||+|.... +|..+++|++......             .....+.+|+..+++++|+|++++++++......++++
T Consensus         1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   66 (244)
T smart00220        1 SFGKVYLARDKK-TGKLVAIKVIKKEKIK-------------KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVM   66 (244)
T ss_pred             CceEEEEEEECC-CCcEEEEEEecccccc-------------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEE
Confidence            589999999864 6899999998443221             11467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCC
Q 014140          226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       226 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  305 (430)
                      ||+++++|.+++..    ...+++..++.++.+++.++.|||..   +++|+||+|+||++++++.++++|||.+.....
T Consensus        67 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       67 EYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             eCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            99999999999853    22389999999999999999999955   599999999999999999999999999988765


Q ss_pred             CCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhcc
Q 014140          306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN  385 (430)
Q Consensus       306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (430)
                      ..   ......++..|++||.+.+..++.++||||||++++++++|..||....   ......+....   ........ 
T Consensus       140 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~---~~~~~~~~-  209 (244)
T smart00220      140 GG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGK---PKPPFPPP-  209 (244)
T ss_pred             cc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhc---cCCCCccc-
Confidence            42   1123467889999999998889999999999999999999999986421   11112222111   11110000 


Q ss_pred             ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          386 SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       386 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             .......+.+++.+||..+|++||++.++++
T Consensus       210 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 -------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence                   0002245889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.9e-33  Score=273.73  Aligned_cols=278  Identities=19%  Similarity=0.235  Sum_probs=182.5

Q ss_pred             cccccccccccccccCceEEEeecC---------------CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHH
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELP---------------GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSE  196 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  196 (430)
                      ..++|.+.++||+|+||.||+|.+.               ...++.||||++..........+.+..............|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3678999999999999999999642               1245789999985432211111100000000112335567


Q ss_pred             HHHHhccCCCCc-----ccceeEEEe--------CCeeEEEEEecCCCCHHHHHhhhcC--------------------C
Q 014140          197 IITAGQVRHRNI-----VPLLARMVR--------RDCDLLVYEFRRNGSLQDILYDVSQ--------------------G  243 (430)
Q Consensus       197 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~  243 (430)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            888888876654     677887754        3567999999999999999864211                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeecccccccccc
Q 014140          244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA  323 (430)
Q Consensus       244 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  323 (430)
                      ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........... ....+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence            12356788899999999999999955   599999999999999999999999999976543322111 12345789999


Q ss_pred             ccccCCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCccccccc-----cccHHHHHHHHh
Q 014140          324 PECHQTVA--------------------L--SDTCDIYSFGVLLAVLVIGKF-PSDDFFQHTK-----EMSLVQWMRNVM  375 (430)
Q Consensus       324 PE~~~~~~--------------------~--~~~~Dv~slG~~l~ell~g~~-p~~~~~~~~~-----~~~l~~~~~~~~  375 (430)
                      ||.+....                    +  ..+.||||+||++++|++|.. |+........     ...+..|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            99876432                    1  234799999999999999985 6643211000     111111211  1


Q ss_pred             cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 014140          376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDP---NKRPNSKDVRC  423 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~Rps~~ev~~  423 (430)
                      ....    .+...    .........+++..||..+|   .+|+|+.|+++
T Consensus       457 ~~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111    11111    11123347788888998765   68999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=251.19  Aligned_cols=254  Identities=20%  Similarity=0.238  Sum_probs=197.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      -.+|..+++||+|+|.+|-++++.+ +.+.||+|++++....           ..+.+.-.+.|-.+..+- +||.+|-+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~n-----------ddedidwvqtek~vfe~asn~pflvgl  316 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVN-----------DDEDIDWVQTEKHVFEQASNNPFLVGL  316 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcc-cceeeehhhHHHHhcC-----------CcccchhHHhhHHHHHhccCCCeEEeh
Confidence            4579999999999999999999875 8899999998554332           222345566677776666 69999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ..+|.....+++|.||++||+|--.++    ....+++..+..+...|+.||.|||   .+|||+||||..|+|+|..|+
T Consensus       317 hscfqtesrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaegh  389 (593)
T KOG0695|consen  317 HSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGH  389 (593)
T ss_pred             hhhhcccceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCc
Confidence            999999999999999999999977773    3456999999999999999999999   556999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+.|+|+++.--...  ..+..++||+.|+|||++.|..|...+|+|+|||+++||+.|+.||+-.-......+..+++
T Consensus       390 ikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl  467 (593)
T KOG0695|consen  390 IKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL  467 (593)
T ss_pred             eeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence            9999999998643222  22335799999999999999999999999999999999999999998543333333444433


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN  417 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps  417 (430)
                      -.+.-....          ..+.........++..-|+.||.+|.-
T Consensus       468 fqvilekqi----------riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  468 FQVILEKQI----------RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHHHhhhcc----------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            333211110          011111223556777888999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-33  Score=267.81  Aligned_cols=219  Identities=22%  Similarity=0.371  Sum_probs=182.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      .-|..++.||-|+||.|.+++-.. +...||.|-+.+..           ..........+.|-.||..-..+-||+||-
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvD-T~~lYAmKTLrKaD-----------Vl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVD-TRALYAMKTLRKAD-----------VLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecc-hhhHHHHhhhHHHH-----------HHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            457888999999999999998653 68889999874321           222345678889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      .|.+.+++|+||+|++||++-.+|-+    -+.|++..+..++..+..|+++.|   +.|+|||||||+|||||.+|++|
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCcee
Confidence            99999999999999999999999843    456899999999999999999999   77799999999999999999999


Q ss_pred             EeecCCcccC---------CCCCCc-------------------------------ceeeccccccccccccccCCCCCC
Q 014140          294 ISEFGLAKRI---------PDGHTR-------------------------------TTTWSLAGTVGYIAPECHQTVALS  333 (430)
Q Consensus       294 l~Dfg~a~~~---------~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~  333 (430)
                      |.|||++.-+         ..+...                               ......+||+.|+|||++...+|+
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            9999998633         111000                               001246799999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          334 DTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       334 ~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ..+|+||.|||||||+.|+.||-...+......+..|-
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR  887 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence            99999999999999999999997766655555555553

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=275.82  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=189.8

Q ss_pred             cccccccccccccCc-eEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          134 DYFASLEKIRSCWNG-EVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g-~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      ..|...+++|.|..| .||+|.+   .|+.||||++..                 .-.....+|+..|+.- .|||||++
T Consensus       509 ~~~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~-----------------e~~~~A~rEi~lL~eSD~H~NviRy  568 (903)
T KOG1027|consen  509 LFFSPKEILGYGSNGTVVFRGVY---EGREVAVKRLLE-----------------EFFDFAQREIQLLQESDEHPNVIRY  568 (903)
T ss_pred             eeeccHHHcccCCCCcEEEEEee---CCceehHHHHhh-----------------HhHHHHHHHHHHHHhccCCCceEEE
Confidence            346677889999887 6899998   789999999832                 1235678999999998 59999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---  288 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---  288 (430)
                      ++.-.+....||..|.|.. ||.+++...........-...+.+..|++.||++||+.+   |+||||||.||||+.   
T Consensus       569 yc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~  644 (903)
T KOG1027|consen  569 YCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSA  644 (903)
T ss_pred             EeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCC
Confidence            9998899999999999965 999999642000001111345678999999999999766   999999999999975   


Q ss_pred             C--CceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccccc
Q 014140          289 D--MEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG-KFPSDDFFQHTKE  364 (430)
Q Consensus       289 ~--~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~  364 (430)
                      +  ..++|+|||+++.+..+... .......||.+|+|||.+....-+.++||||+||++|+.++| ..||......  +
T Consensus       645 ~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~  722 (903)
T KOG1027|consen  645 DGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--Q  722 (903)
T ss_pred             CcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--h
Confidence            3  46899999999998765432 233456799999999999999888999999999999999996 8998765431  1


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             .++++.......+.+      ..++  ...+||..|++++|..||++.+|+.
T Consensus       723 -------~NIl~~~~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  723 -------ANILTGNYTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -------hhhhcCccceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                   122222211111111      0111  5788999999999999999999973

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=245.92  Aligned_cols=264  Identities=18%  Similarity=0.239  Sum_probs=205.7

Q ss_pred             ccccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..++.....+.+|.||.||.|.++..    +.+.|-+|-+.+             ....-+...+..|...+..+.|||+
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-------------~AS~iQv~~~L~es~lly~~sH~nl  349 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-------------HASQIQVNLLLQESMLLYGASHPNL  349 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-------------cccHHHHHHHHHHHHHHhcCcCCCc
Confidence            45678888999999999999977521    223444444311             1122346778999999999999999


Q ss_pred             ccceeEEEe-CCeeEEEEEecCCCCHHHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          209 VPLLARMVR-RDCDLLVYEFRRNGSLQDILYDVS----QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       209 v~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      .++.+++.+ .+.++.+|.++..|+|..++...+    ...+.++-.....++.|++.|++|||   +.+++|.||..+|
T Consensus       350 l~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRN  426 (563)
T KOG1024|consen  350 LSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARN  426 (563)
T ss_pred             cceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhc
Confidence            999999876 457889999999999999997322    23345777788899999999999999   5569999999999


Q ss_pred             EEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 014140          284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHT  362 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~  362 (430)
                      ++|++...+||+|=.+++.+...+++.--.+-.....||+||.+.+..|+..+||||||+++|||+| |+.||.+..+. 
T Consensus       427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-  505 (563)
T KOG1024|consen  427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-  505 (563)
T ss_pred             ceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-
Confidence            9999999999999999998877666543333345678999999999999999999999999999999 88998765431 


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                            +....+..+.+...          +.+++.+++.++..||...|++||+..+++..|..++
T Consensus       506 ------Em~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  506 ------EMEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ------HHHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                  11122222222222          3344556999999999999999999999999998764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-33  Score=245.31  Aligned_cols=201  Identities=25%  Similarity=0.340  Sum_probs=167.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +....+.||-|+||.||..++.. +|+.||.|++..-...            -...+.+.+|+.+|..++|.|++..+++
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR-dgrrvalkK~pnvfq~------------L~s~krvFre~kmLcfFkHdNVLSaLDI  120 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR-SGKRVALKKMPNVFQN------------LASCKRVFREIKMLSSFRHDNVLSLLDI  120 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC-CccchhHhhcchHHHH------------HHHHHHHHHHHHHHHhhccccHHHHHHh
Confidence            34556899999999999999875 9999999998432221            1235789999999999999999999987


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          215 MVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       215 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ..-..     .+|+++|.|.. +|..++    -+...++...+.-+..||++||.|||+.+   |+||||||.|.|++++
T Consensus       121 LQPph~dfFqEiYV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSN  192 (449)
T KOG0664|consen  121 LQPANPSFFQELYVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSN  192 (449)
T ss_pred             cCCCCchHHHHHHHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccC
Confidence            75543     45789999976 888887    56788999999999999999999999665   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ..+||||||+++..........+ ..+-|..|.|||.+.|. .|+.+.||||.||++.|++..+.-|..
T Consensus       193 CvLKICDFGLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  193 CILKICDFGLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             ceEEecccccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            99999999999987654333222 34568899999999987 599999999999999999988877653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=7e-32  Score=255.95  Aligned_cols=205  Identities=26%  Similarity=0.329  Sum_probs=171.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~  210 (430)
                      ..|..+..+|.|+||.|++|.++. +...|+||.+.+..--      .+.--.....-.+-.|+.||..++   |+||++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL------~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK  633 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERIL------VDTWVRDRKLGTVPSEIQILATLNKHSHENILK  633 (772)
T ss_pred             ccceeeeeccccccceEEEeeecc-cceEEEeeehhhhhhh------hhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence            458999999999999999999875 6889999988543211      111111111234667999999997   999999


Q ss_pred             ceeEEEeCCeeEEEEEec-CCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          211 LLARMVRRDCDLLVYEFR-RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++|.+++.+||+||-. +|.+|.+++    ...+.+++..+..|+.||+.|+++||   +.||+|||||-+|+.++.+
T Consensus       634 lLdfFEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  634 LLDFFEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhheeecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecC
Confidence            999999999999999974 467899999    45677999999999999999999999   5559999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      |-+||+|||.|.....+...    .++||..|.|||++.|.+| +..-|||++|++||.++....||-
T Consensus       707 g~~klidfgsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999887655332    4689999999999999988 556899999999999999888863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=236.57  Aligned_cols=264  Identities=25%  Similarity=0.311  Sum_probs=194.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +.+|..+..+|.|.- .|--|-+ ...+++||+|+...+...            ..-.++..+|...+..+.|+||++++
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D-~v~~~~v~ikk~~~pf~n------------~~~akra~rel~l~~~v~~~nii~l~   81 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFD-QVLGRPVAIKKLSRPFQN------------QTHAKRAYRELKLMKCVNHKNIISLL   81 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecch-hhccCceehhhhcCcccc------------Cccchhhhhhhhhhhhhcccceeeee
Confidence            456778888999988 5665643 348999999999665222            11246788999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      .+|+-..      ..|+|||+|+. +|...+.      -.++-.+...|..|++.|+.|||   +.||+||||||+||++
T Consensus        82 n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv  151 (369)
T KOG0665|consen   82 NVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVV  151 (369)
T ss_pred             eccCccccHHHHHhHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCccccee
Confidence            9997644      46899999965 9999884      34778889999999999999999   5559999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc------
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ------  360 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------  360 (430)
                      ..++.+||.|||+|+.....   -....++.|..|.|||++.+.+|...+||||+||++.||++|..-|.+...      
T Consensus       152 ~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k  228 (369)
T KOG0665|consen  152 NSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK  228 (369)
T ss_pred             cchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence            99999999999999876544   122246789999999999999999999999999999999999977653111      


Q ss_pred             -----ccccccH----HHHHHHHhcCCC------Cchhcccccc---CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          361 -----HTKEMSL----VQWMRNVMTSEN------PNRAINSKLL---GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       361 -----~~~~~~l----~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                           +..+..+    ..-.+......+      ..+.+.+..+   ...+.-....+.+++.+||-.+|++|.|+.+++
T Consensus       229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL  308 (369)
T KOG0665|consen  229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL  308 (369)
T ss_pred             HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence                 0011111    111112221100      0111111111   112223345688999999999999999999987


Q ss_pred             H
Q 014140          423 C  423 (430)
Q Consensus       423 ~  423 (430)
                      .
T Consensus       309 ~  309 (369)
T KOG0665|consen  309 R  309 (369)
T ss_pred             c
Confidence            5

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=8.1e-31  Score=222.65  Aligned_cols=258  Identities=20%  Similarity=0.267  Sum_probs=192.3

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  210 (430)
                      ..++|++.+.+|+|-++.||.|... .+++.++||.+.+.                 ..+.+.+|+.+|..|+ ||||++
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPV-----------------kkkKIkREikIL~nL~gg~NIi~   97 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPV-----------------KKKKIKREIKILQNLRGGPNIIK   97 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhccccc-CCCceEEEeeechH-----------------HHHHHHHHHHHHHhccCCCCeee
Confidence            4568999999999999999999755 38889999998442                 2467999999999998 999999


Q ss_pred             ceeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      ++++..+  +..+.||+||+.+.+...+.       +.++...+..++.+++.||.|+|   ++||.|||+||.|+++|.
T Consensus        98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh  167 (338)
T KOG0668|consen   98 LLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDH  167 (338)
T ss_pred             hhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeech
Confidence            9999876  45678999999998777665       34777888899999999999999   555999999999999995


Q ss_pred             -CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          289 -DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       289 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                       .-.++|+|+|+|.+...+.....   .+.+..|--||.+..- .|+..-|+|||||++..|+..+.||-....  +...
T Consensus       168 ~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQ  242 (338)
T KOG0668|consen  168 ELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQ  242 (338)
T ss_pred             hhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHH
Confidence             45799999999998876654433   2567778899987765 588899999999999999999999743222  2222


Q ss_pred             HHHHHHHHhcCCC-----------Cchhccc-----------cccCCCcH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSEN-----------PNRAINS-----------KLLGNGYE-EQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~-----------~~~~~~~-----------~~~~~~~~-~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ++..++ ++....           ..+.++.           .+...... -.....++++...|..|-.+|||+.|.+.
T Consensus       243 LVkIak-VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  243 LVKIAK-VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHH-HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            322211 111100           1111111           00000000 01134778888999999999999999763

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-30  Score=239.89  Aligned_cols=134  Identities=25%  Similarity=0.321  Sum_probs=114.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-----C--
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-----H--  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h--  205 (430)
                      .++|.+.++||=|.|++||+|.+. .+.+.||+|+.+..               ....+....|+.+|++++     |  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKSA---------------qhYtEaAlDEIklL~~v~~~Dp~~~~  140 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKSA---------------QHYTEAALDEIKLLQQVREGDPNDPG  140 (590)
T ss_pred             CceEEEEEeccccccceeEEEeec-cCCeEEEEEEEehh---------------hHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            478999999999999999999654 58899999998432               234677889999999994     3  


Q ss_pred             -CCcccceeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 014140          206 -RNIVPLLARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ  280 (430)
Q Consensus       206 -pniv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  280 (430)
                       .+||+|++.|..    +.+.|||+|++ |.+|..+|..  ...+.++...+..|+.||+.||.|||..+  ||||.|||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlK  215 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLK  215 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCC
Confidence             369999999976    45789999999 7799999975  45677999999999999999999999887  89999999


Q ss_pred             CCcEEeC
Q 014140          281 PANVLID  287 (430)
Q Consensus       281 p~Nill~  287 (430)
                      |+|||+.
T Consensus       216 PENvLl~  222 (590)
T KOG1290|consen  216 PENVLLC  222 (590)
T ss_pred             cceeeee
Confidence            9999973

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=229.25  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=195.0

Q ss_pred             hhhhhhcccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-C
Q 014140          126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-R  204 (430)
Q Consensus       126 ~~~~~~~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  204 (430)
                      ++....-.+.|.+...||+|.||++-++++++ +++.+++|.+..+...               ...|.+|...--.| .
T Consensus        16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~tt---------------~~dF~rEfhY~~~Ls~   79 (378)
T KOG1345|consen   16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQTT---------------QADFVREFHYSFFLSP   79 (378)
T ss_pred             cccccchhhhhhHHHHhcccceeeEEeeeccC-CceEEEeeccCcchhh---------------HHHHHHHhccceeecc
Confidence            33333445779999999999999999999985 8899999988554433               57788998877777 5


Q ss_pred             CCCcccceeE-EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          205 HRNIVPLLAR-MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       205 hpniv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      |.||+.-|++ |...+.+.+++||++.|+|.+-+     ....+.+....+++.|++.|+.|+|+.+   ++|||||.+|
T Consensus        80 H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eN  151 (378)
T KOG1345|consen   80 HQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAEN  151 (378)
T ss_pred             chhhhHHHHHHhhcCceEEEeeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccce
Confidence            8999998875 56677888999999999999887     3356889999999999999999999777   9999999999


Q ss_pred             EEeC--CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC---C--CCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          284 VLID--DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---A--LSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       284 ill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      ||+.  +...+||||||+.+..+....     ...-+..|.+||.....   .  ..+.+|+|.||++++.++||.+||+
T Consensus       152 iLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  152 ILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             EEEecCCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            9995  445899999999876543221     23346779999975543   2  3667999999999999999999998


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..  ........+|..-..+...   . -|+.+....+.    +.++..+-|.++|++|-...++.++..
T Consensus       227 ka--~~~d~~Y~~~~~w~~rk~~---~-~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  227 KA--SIMDKPYWEWEQWLKRKNP---A-LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             hh--hccCchHHHHHHHhcccCc---c-CchhhcccCHH----HHHHHHHhcCCcccccchhHHHHHHHH
Confidence            42  2344555555432222111   1 11222233333    666777789999999976666665543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.2e-29  Score=223.93  Aligned_cols=213  Identities=32%  Similarity=0.455  Sum_probs=181.3

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCee
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD  221 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  221 (430)
                      ||.|++|.||++.... +|+.+++|.+.......             ....+.+|+..++.++|++++++++++......
T Consensus         1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   66 (215)
T cd00180           1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL   66 (215)
T ss_pred             CCcCCceEEEEEEecC-CCcEEEEEEeccccchh-------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE
Confidence            6899999999998753 68999999985432210             246799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CCceEEeecCCc
Q 014140          222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLA  300 (430)
Q Consensus       222 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~a  300 (430)
                      ++++||+++++|.+++...   ...+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+
T Consensus        67 ~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~  140 (215)
T cd00180          67 YLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLS  140 (215)
T ss_pred             EEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCce
Confidence            9999999999999998542   14689999999999999999999955   5999999999999999 899999999999


Q ss_pred             ccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCC
Q 014140          301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN  379 (430)
Q Consensus       301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  379 (430)
                      ........  ......+...|++||..... .++.++|+|++|++++++                               
T Consensus       141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence            87654431  11124578899999999887 788999999999999999                               


Q ss_pred             CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                                        ..+.+++..|++.+|++||++.++++.|
T Consensus       188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                              2377899999999999999999998643

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=254.63  Aligned_cols=253  Identities=27%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ...+|..+..+|+|++|.||+|+... +++..|+|++.-....              ...-++.|+-+++.++|||||.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~-s~elaavkvVkLep~d--------------d~~~iqqei~~~~dc~h~nivay   77 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLEPGD--------------DFSGIQQEIGMLRDCRHPNIVAY   77 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccc-cCchhhheeeeccCCc--------------cccccccceeeeecCCCcChHHH
Confidence            45678999999999999999999874 8999999998543222              24567889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +|.+...+.++++||||.+|+|.+..    ...+++++..+..++...++||.|||+   .+=+|||||-.||++++.|.
T Consensus        78 ~gsylr~dklwicMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gD  150 (829)
T KOG0576|consen   78 FGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGD  150 (829)
T ss_pred             HhhhhhhcCcEEEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCc
Confidence            99999999999999999999999987    457789999999999999999999994   45899999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeecccccccccccccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH---QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +|+.|||.+..+......  .+.+.||+.|||||+-   ..+.|...+|||++|+...|+---+.|.....+        
T Consensus       151 vklaDfgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------  220 (829)
T KOG0576|consen  151 VKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------  220 (829)
T ss_pred             eeecccCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------
Confidence            999999998876543221  2357899999999974   455799999999999999999888877433222        


Q ss_pred             HHHHHHhcC--CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTS--ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+-..+..  ..+...-|+       ......+.+++..|+..+|.+||+++.+++
T Consensus       221 mr~l~LmTkS~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  221 MRALFLMTKSGFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHhhccCCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            011111211  112222222       223344888999999999999999987654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.4e-30  Score=244.30  Aligned_cols=200  Identities=20%  Similarity=0.205  Sum_probs=168.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC------CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR------HR  206 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp  206 (430)
                      .+.|.+....|.|-|++|-.|.... .|..||||.+.....               ..+.=+.|+.+|.+|+      --
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnNE~---------------M~KtGl~EleiLkKL~~AD~Edk~  494 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNNEV---------------MHKTGLKELEILKKLNDADPEDKF  494 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecchH---------------HhhhhhHHHHHHHHhhccCchhhh
Confidence            5678888999999999999998764 778999999954322               2345578999999995      34


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      |.++++-.|...+++|||+|-+. .+|.++|..... .-.|....+..++.|++.||..|-.++   |+|.||||.|||+
T Consensus       495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV  569 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence            89999999999999999999985 499999976533 345888899999999999999999666   9999999999999


Q ss_pred             CCC-CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          287 DDD-MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       287 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ++. ..+||||||.|.....+...    .+.-+.-|.|||++.|.+|+...|+||.||+||||.||+.-|.+
T Consensus       570 NE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            966 46899999999887655321    12345569999999999999999999999999999999987765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.4e-28  Score=221.73  Aligned_cols=200  Identities=29%  Similarity=0.400  Sum_probs=169.6

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||.|++|.||++.... ++..+++|.+......             .....+.+|+..++.++|+|++++++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~   66 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTE-------------KQREEFLREIRILKKLKHPNIVKLYGVF   66 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccch-------------HHHHHHHHHHHHHHhCCCCChhhheeee
Confidence            4567899999999999999863 6899999998532211             2357888999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRE-LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      ......++++||+++++|.+++..    ... +++.....++.+++.++.+||..   +++|+|++|+||+++.++.++|
T Consensus        67 ~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l  139 (225)
T smart00221       67 EDPEPLYLVMEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKL  139 (225)
T ss_pred             ecCCceEEEEeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999999999999854    223 88999999999999999999955   5999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeecccccccccccccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +|||.+......... ......++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus       140 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      140 ADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999887654311 11234678899999998 666788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=8.4e-29  Score=228.05  Aligned_cols=199  Identities=25%  Similarity=0.344  Sum_probs=165.7

Q ss_pred             ccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  209 (430)
                      .+.|..+++||.|.|++||+|.+...  .++.||+|.+.....                ...+.+|+++|..+. +.||+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------------p~ri~~El~~L~~~gG~~ni~   98 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------------PSRILNELEMLYRLGGSDNII   98 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------------chHHHHHHHHHHHhccchhhh
Confidence            46789999999999999999998642  568999999955433                356899999999995 89999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-  288 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-  288 (430)
                      ++.+++..++...+|+||++.....++...       ++...+..++..++.||.++|   ..||+||||||+|+|.+. 
T Consensus        99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen   99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRR  168 (418)
T ss_pred             cchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccc
Confidence            999999999999999999999999999843       778889999999999999999   555999999999999984 


Q ss_pred             CCceEEeecCCcccCCCCC-------------C-----------------------------cceeeccccccccccccc
Q 014140          289 DMEARISEFGLAKRIPDGH-------------T-----------------------------RTTTWSLAGTVGYIAPEC  326 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~  326 (430)
                      .+.-.|.|||+|.......             .                             .....+..||++|.|||+
T Consensus       169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence            4678999999998211000             0                             000113569999999999


Q ss_pred             cCCCC-CCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          327 HQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       327 ~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +...+ -+.++||||.|++++.+++++.||-.
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhcccccccc
Confidence            88765 58899999999999999999999743

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.8e-28  Score=258.91  Aligned_cols=196  Identities=16%  Similarity=0.191  Sum_probs=137.2

Q ss_pred             ccCC-CCcccceeEE-------EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          202 QVRH-RNIVPLLARM-------VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       202 ~l~h-pniv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      .++| +||++++++|       ...+..++++||+ +++|.+++..   ....+++..++.++.||+.||.|||+.   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3556 6888888887       3345677889988 5599999953   245699999999999999999999954   5


Q ss_pred             eEecCCCCCcEEeCCCC-------------------ceEEeecCCcccCCCCCC--------------cceeeccccccc
Q 014140          274 IIHRDIQPANVLIDDDM-------------------EARISEFGLAKRIPDGHT--------------RTTTWSLAGTVG  320 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~  320 (430)
                      |+||||||+||||+..+                   .+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            99999999999996544                   455666666653211000              000012358899


Q ss_pred             cccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHH
Q 014140          321 YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLV  400 (430)
Q Consensus       321 y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  400 (430)
                      |+|||++.+..|+.++|||||||++|||++|..|+....      ..........   .+     +..     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~---~~-----~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRV---LP-----PQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhh---cC-----hhh-----hhcCHHH
Confidence            999999999999999999999999999999988754211      0111111110   00     000     0011225


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 014140          401 LKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       401 ~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..++.+||+++|.+||++.++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            57788999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.7e-26  Score=200.62  Aligned_cols=167  Identities=19%  Similarity=0.200  Sum_probs=124.9

Q ss_pred             CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcc
Q 014140          231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT  310 (430)
Q Consensus       231 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  310 (430)
                      |||.+++..   ....+++..++.++.|++.||.|||+.   +      ||+|||++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            689999953   245699999999999999999999944   3      999999999999999  99988764321   


Q ss_pred             eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccC
Q 014140          311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLG  390 (430)
Q Consensus       311 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                          ..||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+...... .....+..       .
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~-~~~~~~~~-------~  129 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNG-MPADDPRD-------R  129 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHH-hccCCccc-------c
Confidence                25889999999999999999999999999999999999998643221  1111111111 11111100       0


Q ss_pred             CCcHHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          391 NGYEEQML--LVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       391 ~~~~~~~~--~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ........  .+.+++..||+.+|.+||++.++++.+..+
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            01112222  589999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-24  Score=205.03  Aligned_cols=261  Identities=21%  Similarity=0.246  Sum_probs=190.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC----CCccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH----RNIVP  210 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~  210 (430)
                      .|.+.+.||+|+||.||++.........+|+|.........              ...+..|..++..+..    +++..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------------~~~l~~E~~vl~~l~~~~~~~~~~~   84 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------------PSVLKIEIQVLKKLEKKNGPSHFPK   84 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------------CccchhHHHHHHHHhhhcCCCCCCE
Confidence            79999999999999999998763224578888774322110              1157778888888863    68888


Q ss_pred             ceeEE-EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          211 LLARM-VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       211 l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +++.. ......++||+.+ |.||.++.....  ...++..+...|+.|++.+|.+||+.   |++||||||+|+++...
T Consensus        85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~  158 (322)
T KOG1164|consen   85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQS  158 (322)
T ss_pred             EEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCC
Confidence            88888 4777889999998 889999875432  57899999999999999999999955   59999999999999854


Q ss_pred             -----CceEEeecCCcc--cCCCCCC-----cce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          290 -----MEARISEFGLAK--RIPDGHT-----RTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       290 -----~~~kl~Dfg~a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                           ..+.|.|||+++  .......     ... .....||..|.++.++.+...+.+.|+||++.++.+++.|..||.
T Consensus       159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~  238 (322)
T KOG1164|consen  159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE  238 (322)
T ss_pred             CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence                 469999999999  3322111     111 223569999999999999999999999999999999999999996


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..........+........    ...      .....+.+   +.++...+-..+..++|....+...|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  239 ALEMTDLKSKFEKDPRKLL----TDR------FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             cccccchHHHHHHHhhhhc----ccc------ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            5433212111111111111    100      12223333   44444455557999999999999887654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.2e-25  Score=210.80  Aligned_cols=172  Identities=19%  Similarity=0.162  Sum_probs=129.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|...+.||+|+||+||+|.+...+++.+|||++......         .........+.+|+.+|++++|+|++..+
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~---------~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW---------WSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc---------cccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            467999999999999999999876547888999987421100         00112346699999999999999998633


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCcEEeCCCCc
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI-QPANVLIDDDME  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~  291 (430)
                      ..   .+..++||||++|++|.. +.   ..    .   ...++.+++.+|.|||+   .||+|||| ||+|||++.++.
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~~---~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-AR---PH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-hC---cc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCC
Confidence            22   246799999999999963 21   11    1   14678899999999994   55999999 999999999999


Q ss_pred             eEEeecCCcccCCCCCCcce------eeccccccccccccccCCC
Q 014140          292 ARISEFGLAKRIPDGHTRTT------TWSLAGTVGYIAPECHQTV  330 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  330 (430)
                      ++|+|||+|+.+........      .....+++.|+|||++...
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999997754322111      1245688899999997653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.9e-26  Score=196.68  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=188.2

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      .....+|.....|..|+|++.   |..+++|.+.-.            +........|..|.-.|+-+.||||+.++|.|
T Consensus       192 lnl~tkl~e~hsgelwrgrwq---gndivakil~vr------------~~t~risrdfneefp~lrifshpnilpvlgac  256 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ---GNDIVAKILNVR------------EVTARISRDFNEEFPALRIFSHPNILPVLGAC  256 (448)
T ss_pred             hhhhhhhccCCCccccccccc---Ccchhhhhhhhh------------hcchhhcchhhhhCcceeeecCCchhhhhhhc
Confidence            445567888899999999994   555667766322            22233356789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ....++.++..||+.|||+.+++.  +..-..+-.++.+++.++++|++|||+.. +-|.---|.+..+++|++..++|+
T Consensus       257 nsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  257 NSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             cCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            999999999999999999999975  44556788899999999999999999884 445556789999999999887764


Q ss_pred             --ecCCcccCCCCCCcceeeccccccccccccccCCCCC---CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          296 --EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL---SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       296 --Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                        |--++..         .....-.+.|++||.+...+-   -..+|+|||++++||+.|...||.+..+-....     
T Consensus       334 mad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----  399 (448)
T KOG0195|consen  334 MADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----  399 (448)
T ss_pred             cccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----
Confidence              2111111         001223678999999987753   346999999999999999999998765422111     


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                       +-.+..-+          -..++....-..+|+.-|...||.+||.+..|+-.|++++
T Consensus       400 -kialeglr----------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 -KIALEGLR----------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -hhhhcccc----------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             11111111          1122223334778888999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=8.5e-24  Score=189.23  Aligned_cols=260  Identities=22%  Similarity=0.261  Sum_probs=198.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      -+|.+.++||+|+||..+.|+.- -++++||||.-..  +              ...-++..|.+..+.|. .++|...+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPr--k--------------S~APQLrdEYr~YKlL~g~~GIP~vY   90 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPR--K--------------SEAPQLRDEYRTYKLLGGTEGIPQVY   90 (449)
T ss_pred             ccceeccccccCcceeeeccccc-ccCceEEEEeccc--c--------------CCcchHHHHHHHHHHHcCCCCCCcee
Confidence            36999999999999999999865 4899999996411  1              11457888999999995 69999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---  289 (430)
                      -+..++-+-.||+|.+ |.||+|++--   -+..|+..++..+|.|++.-++|+|+.+   +|+|||||+|+||...   
T Consensus        91 YFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k  163 (449)
T KOG1165|consen   91 YFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTK  163 (449)
T ss_pred             eeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCC
Confidence            8888888889999998 8899998743   3567999999999999999999999777   9999999999999643   


Q ss_pred             --CceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 014140          290 --MEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT  362 (430)
Q Consensus       290 --~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~  362 (430)
                        ..+.++|||+|+.+.+..+..     ..++..||..||+--...|..-+.+-|+-|+|-++++.|-|..||.+.....
T Consensus       164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence              458999999999886654432     2346779999999999999999999999999999999999999999865422


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ... -.+.      .+...+...........+++....+..++.   .+-.+-|+..-+...+..
T Consensus       244 nK~-kYeK------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  244 NKE-KYEK------IGETKRSTPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             hHH-HHHH------hccccccCCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHH
Confidence            111 1111      122222222222233345555555555554   377777888777666554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=9.6e-24  Score=181.06  Aligned_cols=261  Identities=23%  Similarity=0.264  Sum_probs=194.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-CCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-RNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l  211 (430)
                      .+.|.+++.||+|+||.+|+|.... +|..||||+-.....                ..++.-|..+.+.|++ ..|..+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a~----------------hpqL~yEskvY~iL~~g~GiP~i   76 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKAK----------------HPQLLYESKVYRILQGGVGIPHI   76 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeecc-CCceEEEEeecccCC----------------CcchhHHHHHHHHhccCCCCchh
Confidence            4679999999999999999998775 999999998633211                2457788999999975 778888


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---  288 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---  288 (430)
                      ..+..+.+.-.+||+.. |.||+++++-.   ...++..+++.++-|++.-++|+|..+   ++||||||+|+|..-   
T Consensus        77 ~~y~~e~~ynvlVMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh  149 (341)
T KOG1163|consen   77 RHYGTEKDYNVLVMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRH  149 (341)
T ss_pred             hhhccccccceeeeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccc
Confidence            88888999999999998 88999998642   346999999999999999999999555   999999999999863   


Q ss_pred             CCceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ...+.++|||+|+.+-+..+.     ....+..||..|.+--.+.+..-+.+.|+-|+|.+|.++.-|..||++......
T Consensus       150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            346899999999977543322     122356799999998888888888999999999999999999999998765332


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ...... +.+..-.-.+     ..++...|.+    +.-.+.-|-..--++-|+..-+.+.+.-
T Consensus       230 ~QKyEk-I~EkK~s~~i-----e~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  230 KQKYEK-ISEKKMSTPI-----EVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             HHHHHH-HHHhhcCCCH-----HHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            222211 1111101000     1122223322    4445556666677777887777666543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=6.9e-25  Score=221.90  Aligned_cols=261  Identities=18%  Similarity=0.199  Sum_probs=191.1

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEE
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  216 (430)
                      ....++|.|++|.|+.+.... .....+.|.+... ..       ..+........+..|+.+-..++|||++..+..+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~-~~-------~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVR-VK-------PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             CccceeeecccCceEEEEecC-CCccchhhhhhcc-cC-------CcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            456789999999888776542 4555555544211 00       11122233344888999999999999999888888


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEee
Q 014140          217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE  296 (430)
Q Consensus       217 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D  296 (430)
                      +.....-+||||++ +|..++.    ....+....+..++.|++.|+.|+|+.   |+.|||+|++|+++..+|.+||+|
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~D  463 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIID  463 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEee
Confidence            77776667999999 9999984    334688899999999999999999955   599999999999999999999999


Q ss_pred             cCCcccCCCCCCc--ceeeccccccccccccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          297 FGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       297 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      ||.+..+......  ......+|+..|+|||++.+..|... .||||.|+++..|++|+.||..........  .+    
T Consensus       464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~----  537 (601)
T KOG0590|consen  464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT----  537 (601)
T ss_pred             cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh----
Confidence            9999877654443  33446789999999999999999765 899999999999999999997543322111  00    


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ....................+.....++..+|+.+|.+|.|+.+|++
T Consensus       538 ---~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  538 ---NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               00000000000001112233445778899999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.8e-22  Score=191.84  Aligned_cols=264  Identities=28%  Similarity=0.364  Sum_probs=194.9

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC-CcccceeE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR-NIVPLLAR  214 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~  214 (430)
                      |.+...||.|+||.||++...    ..+++|.+.......           ......+.+|+.+++.+.|+ +++++.++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   66 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESK-----------SKEVERFLREIQILASLNHPPNIVKLYDF   66 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccc-----------hhHHHHHHHHHHHHHHccCCcceeeEEEE
Confidence            567789999999999999864    788999885433221           12367799999999999988 79999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-ceE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~k  293 (430)
                      +......+++++++.++++.+++...... ..++......++.+++.++.|+|..+   ++|||+||+||+++..+ .++
T Consensus        67 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~  142 (384)
T COG0515          67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVK  142 (384)
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEE
Confidence            97777789999999999999777431111 36899999999999999999999555   99999999999999988 799


Q ss_pred             EeecCCcccCCCCCCcc----eeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          294 ISEFGLAKRIPDGHTRT----TTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ++|||.+..........    ......||..|+|||.+.+   ..++...|+||+|++++++++|..||...........
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~  222 (384)
T COG0515         143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ  222 (384)
T ss_pred             EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence            99999998665443321    2235689999999999988   5788899999999999999999999654321100112


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+...... ........    .........+.+++..|+..+|..|.++.+...
T Consensus       223 ~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         223 TLKIILELPTP-SLASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HHHHHHhcCCc-ccccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            22222211111 00000000    000122245778888999999999999987664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-23  Score=210.02  Aligned_cols=251  Identities=22%  Similarity=0.259  Sum_probs=179.8

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      ++...+.||++.|=+|.+|+++  .|. |+||++......         ... ....+-..|++ ...++|||.+++.-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~---------~sL-~~~~qrL~~ik-~~l~~~pn~lPfqk~   89 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPT---------ISL-RPFKQRLEEIK-FALMKAPNCLPFQKV   89 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCC---------CCc-hHHHHHHHHHH-HHhhcCCcccchHHH
Confidence            5777899999999999999875  565 999999654322         111 11344444555 666799999999888


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      -......|||-+|..+ +|+|.+    ...+-+...+..-|+.|++.||.-+|   +.||+|||||.+|||+++=.-+.|
T Consensus        90 ~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~L  161 (1431)
T KOG1240|consen   90 LVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYL  161 (1431)
T ss_pred             HHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhh
Confidence            7778888999999976 999998    45566788888999999999999999   556999999999999999999999


Q ss_pred             eecCCccc--CCCCCCcceee---ccccccccccccccCCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCc
Q 014140          295 SEFGLAKR--IPDGHTRTTTW---SLAGTVGYIAPECHQTV----------A-LSDTCDIYSFGVLLAVLVI-GKFPSDD  357 (430)
Q Consensus       295 ~Dfg~a~~--~~~~~~~~~~~---~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~~l~ell~-g~~p~~~  357 (430)
                      +||...+.  ++.+......+   .-..-.+|+|||.+...          + .+++.||||+||+++|+++ |++||.-
T Consensus       162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            99977653  33333322221   12234689999976542          1 5778999999999999999 6777652


Q ss_pred             cccccccccHHHHHHHHhc-CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          358 FFQHTKEMSLVQWMRNVMT-SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                                .+.+...-. ...+...+.     ...   ...+..++..|++.||++|.|+++.++--
T Consensus       242 ----------SQL~aYr~~~~~~~e~~Le-----~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  242 ----------SQLLAYRSGNADDPEQLLE-----KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             ----------HHHHhHhccCccCHHHHHH-----hCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence                      111110000 000100000     000   01278899999999999999999998753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=2.7e-22  Score=182.94  Aligned_cols=238  Identities=17%  Similarity=0.164  Sum_probs=155.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC---------
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH---------  205 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---------  205 (430)
                      .+...+.||.|+++.||.+++.. +|+.+|+|++..+..           ......+++.+|......+.+         
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~-----------~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~   80 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPAD-----------ASANEYEQLKEEQLAITLFPGVKNPKEAYR   80 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEEESST-----------THTTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred             EEEEccccccCCceEEEEEEEcc-CCceEEEEEEecccc-----------cchHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence            35667899999999999999874 899999999965542           222346677777766655432         


Q ss_pred             -CCcccceeEEEe---------C---C-----eeEEEEEecCCCCHHHHHh---hhcCCCCCCCHHHHHHHHHHHHHHHH
Q 014140          206 -RNIVPLLARMVR---------R---D-----CDLLVYEFRRNGSLQDILY---DVSQGRRELDWLARHRIAQGIASGLE  264 (430)
Q Consensus       206 -pniv~l~~~~~~---------~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~l~  264 (430)
                       -.++..++...-         .   .     +.+++|+-+.+ +|.+++.   ........+....++.+..|+++.++
T Consensus        81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA  159 (288)
T PF14531_consen   81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVA  159 (288)
T ss_dssp             HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHH
Confidence             122222332221         1   1     23678888854 8888754   22222344666778888999999999


Q ss_pred             HHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC--------CCCCcch
Q 014140          265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT--------VALSDTC  336 (430)
Q Consensus       265 ~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~  336 (430)
                      +||+.+   ++|+||+|+|++++.+|.+.|+||+.....+.....     ...+..|.|||....        -.++.+.
T Consensus       160 ~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~  231 (288)
T PF14531_consen  160 NLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFAT  231 (288)
T ss_dssp             HHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred             HHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeecc
Confidence            999555   999999999999999999999999887665332111     234577999996543        2478899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCC
Q 014140          337 DIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR  415 (430)
Q Consensus       337 Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R  415 (430)
                      |.|+||+++|.|+||..||+...+......                     .+..+. +.++.+..|+..+|+.+|.+|
T Consensus       232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  232 DAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999999875433111110                     223344 666779999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=6.2e-22  Score=173.34  Aligned_cols=154  Identities=16%  Similarity=0.124  Sum_probs=111.7

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchh---hh------c---cCCchhhHHHHHHHHHHHHHhccCCC
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---LI------K---KDSEPLHHKMIQIRSEIITAGQVRHR  206 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~---~~------~---~~~~~~~~~~~~~~~E~~~l~~l~hp  206 (430)
                      ...||+|++|.||+|...  +|+.||||++.........   ..      .   ...............|+..+.++.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            468999999999999875  8999999999764322110   00      0   00001111123445699999999888


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCcEE
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~Dlkp~Nil  285 (430)
                      ++.....+..  ...+|||||++++++...+.    ....++......++.|++.+|.|+ |+.   +|+||||||+|||
T Consensus        80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl  150 (190)
T cd05147          80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL  150 (190)
T ss_pred             CCCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence            8754443322  22389999999887765532    234688999999999999999999 644   4999999999999


Q ss_pred             eCCCCceEEeecCCcccCC
Q 014140          286 IDDDMEARISEFGLAKRIP  304 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~  304 (430)
                      ++ ++.++|+|||+|....
T Consensus       151 i~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EE-CCcEEEEEccccccCC
Confidence            98 4789999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2.3e-22  Score=178.09  Aligned_cols=179  Identities=13%  Similarity=0.163  Sum_probs=131.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+++|.|+||.||++..   ++..+|||.+.............     -.....+.+|+..+.+++||+|..+.
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~-----f~~g~~~e~Ea~~l~rL~~~GI~~~~  101 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKS-----FVKGDYYENLIVQTDRVRSEGLASLN  101 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHh-----hhhhHHHHHHHHHHHHHHHCCCCcce
Confidence            67899999999999999999754   56689999985543322111000     00012368999999999999999999


Q ss_pred             eEEEeC--------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          213 ARMVRR--------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       213 ~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      .++...        +..++||||++|.+|.++..        ++.    ....+++.++..+|   ..|++|||++|+||
T Consensus       102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Ni  166 (232)
T PRK10359        102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNF  166 (232)
T ss_pred             EeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHE
Confidence            886643        35789999999999988741        222    24568999999999   44599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHH
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV  349 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell  349 (430)
                      +++.++ ++|+|||............              .+.....|..++|+||||+++..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            999988 9999999887653221111              0333334667899999999986543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=4.8e-22  Score=192.50  Aligned_cols=216  Identities=24%  Similarity=0.375  Sum_probs=163.4

Q ss_pred             HhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EecC
Q 014140          200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRI-IHRD  278 (430)
Q Consensus       200 l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-iH~D  278 (430)
                      |+.+.|.|+.+++|.+.+....+.|.+||..|+|.|.+..   ....+++.-...++.+++.||.|||..   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            4678999999999999999999999999999999999964   456689999999999999999999944   35 9999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-------CCcchhHHHHHHHHHHHHhC
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-------LSDTCDIYSFGVLLAVLVIG  351 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~ell~g  351 (430)
                      ++++|++++....+|++|||+.................-..-|.|||.+.+..       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            99999999999999999999988775311111111122356799999988741       46779999999999999999


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +.||+..........++..+...  ...+   +-|.+....  +....+..++..||..+|.+||++..|...++.+
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~~--~~~~---~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKKG--GSNP---FRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cCccccccccCChHHHHHHHHhc--CCCC---cCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99998654433333344443331  1111   111111010  2223588899999999999999999999888765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=6e-21  Score=167.66  Aligned_cols=156  Identities=15%  Similarity=0.150  Sum_probs=114.0

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccch---hhhc------cC---CchhhHHHHHHHHHHHHHhccCCC
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA---ELIK------KD---SEPLHHKMIQIRSEIITAGQVRHR  206 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~---~~~~------~~---~~~~~~~~~~~~~E~~~l~~l~hp  206 (430)
                      ...||+|++|.||+|...  +|+.||||++........   +.+.      ..   ..........+..|...+.++.|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            468999999999999875  899999999976532110   0000      00   001111123456899999999999


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++.....+...  ..+|||||++|+++.....    ....++......++.+++.++.++|+.  .|++||||||+||++
T Consensus        80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll  151 (190)
T cd05145          80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILY  151 (190)
T ss_pred             CCCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEE
Confidence            88655554433  2489999999876544321    123577888999999999999999961  359999999999999


Q ss_pred             CCCCceEEeecCCcccCCC
Q 014140          287 DDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~  305 (430)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3.7e-20  Score=160.64  Aligned_cols=188  Identities=16%  Similarity=0.075  Sum_probs=135.4

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhh-HHHHHHHHHHHHHhccC-CCCccccee
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLH-HKMIQIRSEIITAGQVR-HRNIVPLLA  213 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~  213 (430)
                      +.+...|++|+||+||.+..   .+..++.+.+......           .. -....+.+|+++|++|. |+++.++++
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~-----------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~   69 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWW-----------LRGVAWWLARREALALRQLDGLPRTPRLLH   69 (218)
T ss_pred             cccceeecCCCcceEEEeec---CCceeeecccccchhh-----------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEE
Confidence            34578899999999997753   6777887766322111           00 01225789999999995 588999888


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCcEEeCCCCce
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI-QPANVLIDDDMEA  292 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~  292 (430)
                      +    +..+++|||+.|.+|...+.    .       ....++.+++.+|.++|..   ||+|||| ||+|||++.++.+
T Consensus        70 ~----~~~~lvmeyI~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i  131 (218)
T PRK12274         70 W----DGRHLDRSYLAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSP  131 (218)
T ss_pred             E----cCEEEEEeeecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCE
Confidence            5    45689999999999865431    1       1134778999999999955   5999999 7999999999999


Q ss_pred             EEeecCCcccCCCCCCc----c-------eeeccccccccccccccCCC-CCC-cchhHHHHHHHHHHHHhCCCCC
Q 014140          293 RISEFGLAKRIPDGHTR----T-------TTWSLAGTVGYIAPECHQTV-ALS-DTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      +|+|||++.........    .       .......++.|++|+...-. ..+ ...+.++-|..+|.++|+..|.
T Consensus       132 ~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        132 AVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             EEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            99999999865433210    0       01112356777777743322 223 4679999999999999999874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.2e-20  Score=193.10  Aligned_cols=195  Identities=20%  Similarity=0.249  Sum_probs=158.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv  209 (430)
                      .+.|.+-..||.|+||+||+|...  +|+.||+|+-.++...+                 |.-=.+++.+|+   -+-|.
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WE-----------------fYI~~q~~~RLk~~~~~~~~  757 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWE-----------------FYICLQVMERLKPQMLPSIM  757 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCcee-----------------eeehHHHHHhhchhhhcchH
Confidence            467889999999999999999876  69999999986665442                 222223333443   34566


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC--
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID--  287 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--  287 (430)
                      .+.....-.+..++|+||.+.|||.++++    ..+.+++.....++.|++..+..||..   +||||||||+|+||.  
T Consensus       758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  758 HISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRRE  830 (974)
T ss_pred             HHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecc
Confidence            66666677788899999999999999994    567899999999999999999999955   599999999999994  


Q ss_pred             -----CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 014140          288 -----DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF  353 (430)
Q Consensus       288 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~  353 (430)
                           ++..++|+|||.+..+.--..........+|-.+--+|+..|.+|+...|.|.|+.+++.|+.|+.
T Consensus       831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence                 345699999999986653322233335678999999999999999999999999999999999984

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.5e-21  Score=189.06  Aligned_cols=229  Identities=22%  Similarity=0.248  Sum_probs=175.5

Q ss_pred             ccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeEEEe
Q 014140          141 KIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVR  217 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  217 (430)
                      .+|.|.||+|++.+-.  ...|..+|.|++.......           .. ......|-.++...+ ||.+|++...+..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~-----------~~-~~~t~~er~il~~~~~~~f~v~lhyafqt   68 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV-----------RD-RTHTKQERIILAFVHNTPFLVKLHYAFQT   68 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccc-----------cc-ccccccHHHHHhhccCCCceeeeeeeecc
Confidence            3689999999977532  1246778888875432211           00 114556778888887 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ....+++++|..||.|...+    .....+.+.....+...++-+++++|+.   +++|||+|++||+++.+|++++.||
T Consensus        69 ~~kl~l~ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdf  141 (612)
T KOG0603|consen   69 DGKLYLILDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDF  141 (612)
T ss_pred             ccchhHhhhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCc
Confidence            99999999999999998887    4455678888888899999999999955   5999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcC
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS  377 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~  377 (430)
                      |+++........      +||..|||||++.  +....+|.||||++.+||++|..||..           +..+.++..
T Consensus       142 glske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~  202 (612)
T KOG0603|consen  142 GLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA  202 (612)
T ss_pred             hhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh
Confidence            999876544321      7999999999998  567789999999999999999999865           223333322


Q ss_pred             CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ..           ..+.+....+.+++..++..+|..|.-.
T Consensus       203 ~~-----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 EL-----------EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cc-----------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            11           1222333346677777888888888655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=6.9e-20  Score=167.95  Aligned_cols=198  Identities=19%  Similarity=0.273  Sum_probs=137.6

Q ss_pred             CCCCcccceeEEEeC---------------------------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 014140          204 RHRNIVPLLARMVRR---------------------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIA  256 (430)
Q Consensus       204 ~hpniv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  256 (430)
                      +|||||++.++|.++                           ..+|+||...+. +|..++-     ....+..++.-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence            599999999988652                           245899998866 9999983     2456777888899


Q ss_pred             HHHHHHHHHHhhcCCCCeEecCCCCCcEEeC--CCC--ceEEeecCCcccCCCCCC----cceeeccccccccccccccC
Q 014140          257 QGIASGLEYLHMSHRPRIIHRDIQPANVLID--DDM--EARISEFGLAKRIPDGHT----RTTTWSLAGTVGYIAPECHQ  328 (430)
Q Consensus       257 ~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~  328 (430)
                      .|+++|+.|||   +.||.|||+|++|||+.  +++  .+.|+|||.+---.....    ..-.....|.-..||||+..
T Consensus       348 aQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999   55599999999999994  443  578999998754322111    11111245788899999877


Q ss_pred             CCC------CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHH
Q 014140          329 TVA------LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK  402 (430)
Q Consensus       329 ~~~------~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  402 (430)
                      ..+      .-.|+|.|+.|.+.||+++...||-..  +....+...+....+          +.+    +..++..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~Yqe~qL----------Pal----p~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRTYQESQL----------PAL----PSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheechhhhhhhhC----------CCC----cccCChHHHH
Confidence            543      134899999999999999999997541  111222222111111          111    1222233777


Q ss_pred             HHHhcccCCCCCCCCHHHHHHHHh
Q 014140          403 IACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       403 l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ++...|+.||++|||..-....|.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            888889999999999876665553

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4.5e-19  Score=156.69  Aligned_cols=136  Identities=13%  Similarity=0.143  Sum_probs=102.6

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-----CCCCcccc
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-----RHRNIVPL  211 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l  211 (430)
                      .....||+|++|.||.  ++. ++.. +||++.....              .....+.+|+.+++.+     .||||+++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~~--------------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~   66 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRGD--------------GGDKEIRRELKYYAHLSRRLIDWSGIPRY   66 (210)
T ss_pred             CCcceecCCCceEEEE--CCC-CcCe-EEEEEecccc--------------chHHHHHHHHHHHHHhhccCCCCccccee
Confidence            4467899999999995  442 4444 7998843211              1235689999999999     57999999


Q ss_pred             eeEEEeCC---eeE-EEEEe--cCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCcE
Q 014140          212 LARMVRRD---CDL-LVYEF--RRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL-EYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       212 ~~~~~~~~---~~~-lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +|++.++.   ..+ +|+||  +++|+|.+++.+     ..+++.  ..++.+++.++ .|||+.+   |+||||||+||
T Consensus        67 yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NI  136 (210)
T PRK10345         67 YGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNI  136 (210)
T ss_pred             eEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHE
Confidence            99998874   333 78999  557999999943     235555  35677888777 9999555   99999999999


Q ss_pred             EeCC----CCceEEeecCCc
Q 014140          285 LIDD----DMEARISEFGLA  300 (430)
Q Consensus       285 ll~~----~~~~kl~Dfg~a  300 (430)
                      |++.    ++.++|+||+.+
T Consensus       137 Ll~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        137 LCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEeccCCCCCcEEEEECCCC
Confidence            9973    347999995444

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.4e-18  Score=157.36  Aligned_cols=160  Identities=16%  Similarity=0.100  Sum_probs=114.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhh--hc--------cCCchhhHHHHHHHHHHHHHhc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAEL--IK--------KDSEPLHHKMIQIRSEIITAGQ  202 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~E~~~l~~  202 (430)
                      .-.|.+.+.||.|++|.||+|.....+|+.||+|.+..........  ..        ............+..|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3468889999999999999997222389999999986543211000  00        0000111122456789999999


Q ss_pred             cCCCC--cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCC
Q 014140          203 VRHRN--IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR-IIHRDI  279 (430)
Q Consensus       203 l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-iiH~Dl  279 (430)
                      +.+.+  +.+++++    ...++||||+++++|.....    ....+.......++.|++.++.+||   ..+ ++|+||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di  175 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDL  175 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence            97533  3333332    23589999999988876541    2234566667899999999999999   667 999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCC
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIP  304 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~  304 (430)
                      ||+||+++ ++.++|+|||.+....
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999 8899999999987643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.9e-18  Score=153.45  Aligned_cols=142  Identities=20%  Similarity=0.248  Sum_probs=114.2

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      +.||+|++|.||+|..   +|..+++|+..........      .........+.+|+.++..++|+++.....++...+
T Consensus         2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPE------LDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE   72 (211)
T ss_pred             cccccCceEEEEEEee---CCCceEEEEeCCcCCcChH------HHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence            5789999999999986   6778999986432211100      011122356889999999999999988888888888


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..++||||++|++|.+++..       ... .+..++.+++.+|.++|+.   +++|+|++|.|||++ ++.++|+|||.
T Consensus        73 ~~~lv~e~~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         73 NFIIVMEYIEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             CCEEEEEEeCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999999843       112 7889999999999999955   599999999999999 78899999998


Q ss_pred             ccc
Q 014140          300 AKR  302 (430)
Q Consensus       300 a~~  302 (430)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=4e-18  Score=151.10  Aligned_cols=139  Identities=19%  Similarity=0.270  Sum_probs=109.4

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCe
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDC  220 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  220 (430)
                      .||+|++|.||+|.+   +|..+++|+.........      .........++.+|+.++..++|+++.....++...+.
T Consensus         1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHP------ELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN   71 (199)
T ss_pred             CCCCCceEEEEEeec---CCccEEEEEecCCcCcCc------hHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence            489999999999985   678899998643221100      00111224678899999999999887777777777778


Q ss_pred             eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCc
Q 014140          221 DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA  300 (430)
Q Consensus       221 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a  300 (430)
                      .++||||++|++|.+++..    ...       .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||.+
T Consensus        72 ~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            8999999999999998742    110       78999999999999   45599999999999999 889999999998


Q ss_pred             ccC
Q 014140          301 KRI  303 (430)
Q Consensus       301 ~~~  303 (430)
                      ...
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.3e-19  Score=172.45  Aligned_cols=174  Identities=24%  Similarity=0.353  Sum_probs=128.5

Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      .+|+.|++|...+|.++|.+. ......++...+.++.|++.|+.|   .   +.+|+|+||.||++..+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            468999999999999999653 334557888899999999999999   4   499999999999999999999999999


Q ss_pred             cccCCCCCC----cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHH
Q 014140          300 AKRIPDGHT----RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       300 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      ........+    ........||..||+||.+.+..|+.++||||||++|+|++. -..+++...          -. ..
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~-~d  471 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TL-TD  471 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hh-hh
Confidence            987765541    112224679999999999999999999999999999999997 333322110          00 01


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD  420 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~e  420 (430)
                      +..+.    +++.....++.     -..|+.+++++.|.+||++.+
T Consensus       472 ~r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  472 IRDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence            11111    11111122222     346788899999999995443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=7.6e-18  Score=171.22  Aligned_cols=145  Identities=19%  Similarity=0.209  Sum_probs=113.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|...+.||+|+||.||+|.+.   +..+++|+........      ...........+.+|+.++..++|++++....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~------~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRH------PELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec---CccceeEEEecccccc------hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            34566889999999999999874   4445555542211110      00011122467889999999999999998888


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++.            ....++.+++.+|.+||+   .+++||||||+|||+ +++.++
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEE
Confidence            8888788899999999999999883            346789999999999995   459999999999999 678999


Q ss_pred             EeecCCcccC
Q 014140          294 ISEFGLAKRI  303 (430)
Q Consensus       294 l~Dfg~a~~~  303 (430)
                      |+|||+++..
T Consensus       468 liDFGla~~~  477 (535)
T PRK09605        468 LIDFGLGKYS  477 (535)
T ss_pred             EEeCcccccC
Confidence            9999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.6e-17  Score=147.12  Aligned_cols=152  Identities=16%  Similarity=0.111  Sum_probs=110.4

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchh------hhcc--CCchhhHHHHHHHHHHHHHhccCCC
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE------LIKK--DSEPLHHKMIQIRSEIITAGQVRHR  206 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~------~~~~--~~~~~~~~~~~~~~E~~~l~~l~hp  206 (430)
                      .|.+.+.||.|+||.||+|...  +|+.||||++..+......      ....  ..............|..++..+.|+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3777899999999999999875  8999999997553311000      0000  0000111223477899999999887


Q ss_pred             C--cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          207 N--IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       207 n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +  +...++    .+..++||||++|++|..+..    .      .....++.+++.++.++|+   .+++|+||+|+||
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Ni  156 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNI  156 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccE
Confidence            4  444433    345689999999999876541    0      2345788999999999995   5599999999999


Q ss_pred             EeCCCCceEEeecCCcccCCC
Q 014140          285 LIDDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~  305 (430)
                      ++++++.++|+|||++.....
T Consensus       157 ll~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEcCCCcEEEEECCccccCCC
Confidence            999999999999999966543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=6.1e-18  Score=172.20  Aligned_cols=212  Identities=22%  Similarity=0.278  Sum_probs=140.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .+++|..++.+..|++|-||+.+++. +.+.+|+ ++.+..                              +--+||..+
T Consensus        81 ~e~df~~IklisngAygavylvrh~~-trqrfa~-kiNkq~------------------------------lilRnilt~  128 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKE-TRQRFAM-KINKQN------------------------------LILRNILTF  128 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccc-cccchhh-cccccc------------------------------hhhhccccc
Confidence            35678999999999999999998864 6778888 442110                              001112222


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      -      ++.+.|      |+=.+.+    ...+.++...        +.+++|||   +.||+|||+||+|.+|..-|+
T Consensus       129 a------~npfvv------gDc~tll----k~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGh  181 (1205)
T KOG0606|consen  129 A------GNPFVV------GDCATLL----KNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGH  181 (1205)
T ss_pred             c------CCccee------chhhhhc----ccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeeccc
Confidence            1      122333      3444444    2333444433        78999999   556999999999999999999


Q ss_pred             eEEeecCCcccCCCCCC------------cc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          292 ARISEFGLAKRIPDGHT------------RT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~------------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +|+.|||+++.......            +. ..+..+||+.|+|||++...+|...+|+|++|+++||.+-|..||.+.
T Consensus       182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            99999999875422111            11 123468999999999999999999999999999999999999998754


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN  417 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps  417 (430)
                      .+.       +.+..++.....    .++.....++    +..+++...|+.+|..|.-
T Consensus       262 tpe-------elfg~visd~i~----wpE~dea~p~----Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  262 TPE-------ELFGQVISDDIE----WPEEDEALPP----EAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             CHH-------HHHhhhhhhhcc----ccccCcCCCH----HHHHHHHHHHHhChHhhcc
Confidence            221       111111111100    0000112222    3667777888889998843

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=8.6e-17  Score=144.50  Aligned_cols=207  Identities=22%  Similarity=0.277  Sum_probs=146.2

Q ss_pred             HHHHHhccCCCCcccceeEEEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          196 EIITAGQVRHRNIVPLLARMVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       196 E~~~l~~l~hpniv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      -..-|-++.|.|||+++.|+.+..     ...+++|||..|+|..+|++.......+......+++.||..||.|||++ 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            345566678999999999997643     46789999999999999998777778899999999999999999999988 


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCC-CCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHH
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVL  348 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~-~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el  348 (430)
                      .++|+|+++..+.|++..+|-+|++--.-...-.. ..... .+....+.++|.+||+-.....+..+|||+||+..++|
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            79999999999999999999888853211111000 00000 11122467899999988877788899999999999999


Q ss_pred             HhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          349 VIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       349 l~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      -.|...-.....    ...++...     .+....+...+           -..++..|++..|+.||+|++++-
T Consensus       276 ailEiq~tnseS----~~~~ee~i-----a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSES----KVEVEENI-----ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcc----eeehhhhh-----hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            888754211100    00111000     00000011111           235677899999999999998763

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=9.3e-16  Score=139.18  Aligned_cols=149  Identities=16%  Similarity=0.117  Sum_probs=107.4

Q ss_pred             ccccc-cccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc--ccceeEE
Q 014140          139 LEKIR-SCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI--VPLLARM  215 (430)
Q Consensus       139 ~~~lg-~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~  215 (430)
                      ...|| .||.|+||.+..   .+..++||++.....-. +...............+.+|+.++..|+|+++  +..+++.
T Consensus        36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~-kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~  111 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIG-KLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR  111 (239)
T ss_pred             CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHH-hhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence            45788 899999999976   57889999885432110 11111111111234678899999999998875  6677765


Q ss_pred             EeCCe----eEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          216 VRRDC----DLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       216 ~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      .....    .++|||+++| .+|.+++..     ..++..    .+.+++.+|.+||   ..||+|+||||.|||++.++
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence            44322    3599999997 699988742     234443    3578999999999   45599999999999999989


Q ss_pred             ceEEeecCCcccC
Q 014140          291 EARISEFGLAKRI  303 (430)
Q Consensus       291 ~~kl~Dfg~a~~~  303 (430)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=6.2e-16  Score=135.59  Aligned_cols=152  Identities=18%  Similarity=0.114  Sum_probs=100.0

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhh--------ccCC--chhhHHHHHHHHHHHHHhccCCCC-
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI--------KKDS--EPLHHKMIQIRSEIITAGQVRHRN-  207 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~E~~~l~~l~hpn-  207 (430)
                      .+.||+|+||.||+|...  +|+.||||++...........        ....  ............|...+..+.+.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            467999999999999875  799999999865322110000        0000  000001112246677777775443 


Q ss_pred             -cccceeEEEeCCeeEEEEEecCCCCHHHH-HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          208 -IVPLLARMVRRDCDLLVYEFRRNGSLQDI-LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       208 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                       +.+.+++    ...++||||++++++... +...     ... .....++.+++.++.++|..  .+++|+||+|+||+
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nil  147 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNIL  147 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEE
Confidence             4444432    246899999998543321 1110     011 56778999999999999951  45999999999999


Q ss_pred             eCCCCceEEeecCCcccCCC
Q 014140          286 IDDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~  305 (430)
                      ++ ++.++++|||.+.....
T Consensus       148 i~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EE-CCcEEEEECcccccccC
Confidence            99 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=7e-18  Score=171.10  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ..|.+.+.||.|+|+.|-...........+|+|.+......            .....+...|..+-..+. |+|++.++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~------------~~~~~~i~~e~~~~~~~s~h~n~~~~~   87 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS------------EDSSEHIDTETDIQKKLSKHSNTVHMI   87 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc------------cchhhhcCccccccccccccccccccC
Confidence            34777788999999999998765445566677766433211            122455666777777786 99999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCcEEeCCCC-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDM-  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~-  290 (430)
                      +...+.+..+++++|..+|++.+.+..  ......+......++.|+..++.|+| ..+   +.|+|+||+|.+++..+ 
T Consensus        88 ~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~  162 (601)
T KOG0590|consen   88 EPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGS  162 (601)
T ss_pred             CccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCC
Confidence            999999999999999999999988731  12224666677889999999999999 666   99999999999999999 


Q ss_pred             ceEEeecCCcccCCC-CCCcceeecccc-ccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          291 EARISEFGLAKRIPD-GHTRTTTWSLAG-TVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ..+++|||+|..+.. ...........| ++.|.|||...+.. .....|+||.|+++.-+++|..|++......  ...
T Consensus       163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~  240 (601)
T KOG0590|consen  163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRY  240 (601)
T ss_pred             cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccc
Confidence            999999999998876 444444445678 99999999998854 4667999999999999999999987643321  122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ..|...-   .....        ...........++...++..+|..|.+.+++.
T Consensus       241 ~~~~~~~---~~~~~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  241 SSWKSNK---GRFTQ--------LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             eeecccc---ccccc--------CccccCChhhhhcccccccCCchhcccccccc
Confidence            2222111   00000        01111122366777788889999999988764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=9.4e-16  Score=129.05  Aligned_cols=135  Identities=19%  Similarity=0.206  Sum_probs=111.9

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC--CCcccceeEE
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH--RNIVPLLARM  215 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~  215 (430)
                      +++.||.|+++.||++..   ++..+++|.......                ...+..|+.++..++|  +++.+++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~---~~~~~~iK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~   62 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGT---KDEDYVLKINPSREK----------------GADREREVAILQLLARKGLPVPKVLASG   62 (155)
T ss_pred             cceecccccccceEEEEe---cCCeEEEEecCCCCc----------------hhHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            457899999999999986   447899998733211                2468889999999976  5899999888


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ...+..+++|||++++++..+           +......++.+++.+++++|.....+++|+|++|+||++++.+.++++
T Consensus        63 ~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~  131 (155)
T cd05120          63 ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII  131 (155)
T ss_pred             CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEE
Confidence            888889999999998766432           556677889999999999997654679999999999999999999999


Q ss_pred             ecCCccc
Q 014140          296 EFGLAKR  302 (430)
Q Consensus       296 Dfg~a~~  302 (430)
                      |||.+..
T Consensus       132 Df~~~~~  138 (155)
T cd05120         132 DWEYAGY  138 (155)
T ss_pred             ecccccC
Confidence            9998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.3e-13  Score=135.93  Aligned_cols=155  Identities=19%  Similarity=0.276  Sum_probs=103.0

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccch----hhhc-------c----CC-chh----h------HHHHHH
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA----ELIK-------K----DS-EPL----H------HKMIQI  193 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~----~~~~-------~----~~-~~~----~------~~~~~~  193 (430)
                      +.||+|++|.||+|++.  +|+.||||+..+......    ..+.       .    .. ...    .      .....+
T Consensus       123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            57999999999999987  899999999865532211    1000       0    00 000    0      011236


Q ss_pred             HHHHHHHhccC----CCCcccceeEE-EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 014140          194 RSEIITAGQVR----HRNIVPLLARM-VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS-GLEYLH  267 (430)
Q Consensus       194 ~~E~~~l~~l~----hpniv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH  267 (430)
                      .+|+..+.+++    |.+-+.+-.++ ......+|||||++|++|.++.....   ...   .+..++..++. .+..+|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHH
Confidence            66777777763    33333333333 23455789999999999998864311   112   23456666665 467888


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCC
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  305 (430)
                         ..|++|+|++|.||+++.++.++++|||++..++.
T Consensus       275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               44599999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=9.5e-13  Score=129.52  Aligned_cols=167  Identities=17%  Similarity=0.198  Sum_probs=127.8

Q ss_pred             CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHH
Q 014140          158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL  237 (430)
Q Consensus       158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  237 (430)
                      .++.+|.|........              .......+.+..|+.+|||||++++..+...+..|+|+|.+.  .|..++
T Consensus        35 ~~~~~vsVF~~~~~~~--------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l   98 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG--------------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL   98 (690)
T ss_pred             ccCCceEEEEEeCCCc--------------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH
Confidence            3888888887733211              224567788899999999999999999999999999999983  688888


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeecccc
Q 014140          238 YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG  317 (430)
Q Consensus       238 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  317 (430)
                      ..       +........+.||+.||.|||..+  .++|++|.-+.|+++..|..||++|-++........  .......
T Consensus        99 k~-------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~  167 (690)
T KOG1243|consen   99 KE-------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYL  167 (690)
T ss_pred             HH-------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchh
Confidence            44       335666778999999999998554  599999999999999999999999988765543321  1111223


Q ss_pred             ccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 014140          318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF  353 (430)
Q Consensus       318 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~  353 (430)
                      --.|..|+.+....  -..|.|.|||+++|++.|..
T Consensus       168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             hhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            34577777655433  34699999999999999943

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=9.4e-13  Score=113.37  Aligned_cols=131  Identities=19%  Similarity=0.225  Sum_probs=94.7

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc-ceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP-LLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~  217 (430)
                      ++.++.|.++.||+++.   .|..+++|.......               ....+..|+.++..+.+.++++ ++.+  .
T Consensus         3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~P~~~~~--~   62 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE---------------LLINRENEAENSKLAAEAGIGPKLYYF--D   62 (170)
T ss_pred             eeecCCcccCceEEEEE---CCeEEEEEeCCCCcc---------------cccCHHHHHHHHHHHHHhCCCCceEEE--e
Confidence            45788999999999985   577899998733211               0134678899999887655543 4433  3


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEeCCCCceEEe
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH--RPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      ....++||||++|.++.+..         .   ....++.+++++|+.||...  ..+++|+|++|+||+++ ++.++++
T Consensus        63 ~~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~li  129 (170)
T cd05151          63 PETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLI  129 (170)
T ss_pred             CCCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence            33458999999998775430         0   11245678999999999654  22369999999999999 6689999


Q ss_pred             ecCCccc
Q 014140          296 EFGLAKR  302 (430)
Q Consensus       296 Dfg~a~~  302 (430)
                      ||+.+..
T Consensus       130 Df~~a~~  136 (170)
T cd05151         130 DWEYAGM  136 (170)
T ss_pred             ecccccC
Confidence            9998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=1.1e-12  Score=127.87  Aligned_cols=252  Identities=20%  Similarity=0.220  Sum_probs=179.7

Q ss_pred             ccccccccccc--ccCceEEEeec--CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCc
Q 014140          134 DYFASLEKIRS--CWNGEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNI  208 (430)
Q Consensus       134 ~~~~~~~~lg~--G~~g~vy~a~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni  208 (430)
                      ..|.+...+|.  |.+|.+|.+..  . .++..+|+|+-..+....            .....-.+|+.....++ |+|.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p------------~~~~~k~~~~~s~~~i~~~~~~  180 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPP------------LDSKRKLREFLSHHKIDSHENP  180 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCc------------cccccccchhhcccccCccccc
Confidence            45677788999  99999999987  4 378899999854433221            11223345555556664 9999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCcE
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS----GLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ++.+..+...+..++-+|++. .+|.++...   ....++....+.+..+...    |+.++|+.+   ++|-|+||.||
T Consensus       181 v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i  253 (524)
T KOG0601|consen  181 VRDSPAWEGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANI  253 (524)
T ss_pred             cccCcccccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhhe
Confidence            999999999999999999995 688887743   3344777888888888888    999999665   99999999999


Q ss_pred             EeCCC-CceEEeecCCcccCCCCCCcce---eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          285 LIDDD-MEARISEFGLAKRIPDGHTRTT---TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       285 ll~~~-~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      +...+ ..++++|||+...+..+.....   .+...|...|++||...+ -++...|+||+|.++.+..+|..+......
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            99999 8999999999998876543322   223467888999998876 678899999999999999998765332211


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       .....+..            ..+..+.+.....    .+...+.++++.+|-.|++...+..
T Consensus       333 -~~W~~~r~------------~~ip~e~~~~~s~----~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 -SSWSQLRQ------------GYIPLEFCEGGSS----SLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -CCcccccc------------ccCchhhhcCcch----hhhhHHHHhcCcchhhhhHHHHHhc
Confidence             00000000            0011111111111    2444777889999999998876653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=1.4e-12  Score=130.16  Aligned_cols=160  Identities=18%  Similarity=0.205  Sum_probs=98.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccch----hhhc-------c---C------CchhhHHH----
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA----ELIK-------K---D------SEPLHHKM----  190 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~----~~~~-------~---~------~~~~~~~~----  190 (430)
                      .|.. +.||+|++|.||+|+++. +|+.||||+..+......    ..+.       +   .      .+...+..    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            3555 789999999999999873 599999999976532210    0000       0   0      00000111    


Q ss_pred             --HHHHHHHHHHhccC----CCCcccceeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCC--CCCCCHHHHHHHHHHHHH
Q 014140          191 --IQIRSEIITAGQVR----HRNIVPLLARMVR-RDCDLLVYEFRRNGSLQDILYDVSQG--RRELDWLARHRIAQGIAS  261 (430)
Q Consensus       191 --~~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~i~~  261 (430)
                        -.+.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+++.++-.-....  ...+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              23455555555553    4444444444433 45668999999999998753110010  0113333333333443  


Q ss_pred             HHHHHhhcCCCCeEecCCCCCcEEeCCCC----ceEEeecCCcccCCCC
Q 014140          262 GLEYLHMSHRPRIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDG  306 (430)
Q Consensus       262 ~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~  306 (430)
                           +   ..|++|+|++|.||+++.++    .++++|||++..++..
T Consensus       277 -----f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 3   34699999999999999888    9999999999887543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=3.8e-11  Score=104.38  Aligned_cols=153  Identities=15%  Similarity=0.112  Sum_probs=101.4

Q ss_pred             cccccccCceEEEeecCCC-----CCceEEEEEeeccccc---chhhhccC---------CchhhHHHHHHHHHHHHHhc
Q 014140          140 EKIRSCWNGEVYKAELPGS-----SGRVITIKKIIQPLKS---GAELIKKD---------SEPLHHKMIQIRSEIITAGQ  202 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~-----~~~~vavK~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~  202 (430)
                      ..||.|--+.||.|.-...     .+..+|||........   ....+..+         ............+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4689999999999974311     2479999998654221   11111111         01111222334489999999


Q ss_pred             cCC--CCcccceeEEEeCCeeEEEEEecCCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecC
Q 014140          203 VRH--RNIVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRD  278 (430)
Q Consensus       203 l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~D  278 (430)
                      +..  -++...+++    ..-++||||+.++.+.. .+.     ...++......+..+++.+|..| |..   +++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            963  345555543    45679999997644322 221     12345556677889999999999 744   599999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCC
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPD  305 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~  305 (430)
                      |++.||+++ ++.+.|+|||.+.....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            999999997 46899999999876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=1.2e-10  Score=97.95  Aligned_cols=139  Identities=19%  Similarity=0.283  Sum_probs=102.8

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeCC
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD  219 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  219 (430)
                      ..+++|+-+.+|.+.+   -|..+++|. ..+..+..+.+     ...-...+..+|++++.+++--.|.-..=+..+.+
T Consensus         2 ~~i~~GAEa~i~~~~~---~g~~av~K~-Ri~K~YR~p~L-----D~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDF---LGLPAVVKE-RIPKRYRHPEL-----DEKLRRERTRREARILAKAREAGVPVPIVYDVDPD   72 (204)
T ss_pred             chhhCCcceeEEeeec---cCcceEEEe-ecCcccCChHH-----HHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence            3578999999999977   444555553 33333321111     11223467789999999998766666666677888


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ...|+|||.+|..|.+.+...           ...++..+-.-+.-||   ..||+|+||.++||.+.++. +.++|||+
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCc
Confidence            889999999999999888431           2456777778888899   55599999999999998775 99999999


Q ss_pred             ccc
Q 014140          300 AKR  302 (430)
Q Consensus       300 a~~  302 (430)
                      +..
T Consensus       138 g~~  140 (204)
T COG3642         138 GEF  140 (204)
T ss_pred             ccc
Confidence            864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=1.3e-10  Score=97.18  Aligned_cols=151  Identities=20%  Similarity=0.234  Sum_probs=109.1

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      .+..+-+|+-+.|+++.+   .|+.+.||.- ++..+..+.+     ...-...+..+|++.|.+++--.|.-..-++.+
T Consensus        11 ~l~likQGAEArv~~~~~---~Ge~~iIK~R-f~K~YRHP~L-----D~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF---SGEAAIIKER-FSKRYRHPAL-----DQKLTRKRTKQEARLLAKCRALGIPAPRLIFID   81 (229)
T ss_pred             cceeeeccceeeEeeecc---CCceeEEeec-ccccccchHH-----HHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence            567889999999999987   7888888754 2222221111     112235678899999999976666555556777


Q ss_pred             CCeeEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc---eE
Q 014140          218 RDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME---AR  293 (430)
Q Consensus       218 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~k  293 (430)
                      ...-.|+|||++| .++.+++...-.  ..........++..|-+.+.-||..+   +||+||..+||++..++.   +.
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence            7777899999976 478888864221  12222233678899999999999555   999999999999976653   58


Q ss_pred             EeecCCccc
Q 014140          294 ISEFGLAKR  302 (430)
Q Consensus       294 l~Dfg~a~~  302 (430)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=6.7e-12  Score=122.41  Aligned_cols=249  Identities=20%  Similarity=0.195  Sum_probs=174.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ...+|..+..||.|.|+.|+....+..++..|++|.+.+.......            -..-..|+.+...+ .|.+++.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~------------di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS------------DIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh------------hhcchhhhhHhhHhhcccccCC
Confidence            3567888999999999999998765468899999988554333111            12233456666666 5999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC-
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-  289 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-  289 (430)
                      .+..|...+..|+-.|||.++++...+    .....++...++++..|++.++.++|   .+.++|+|++|+||++..+ 
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccch
Confidence            999999999999999999999988776    23345788889999999999999999   5559999999999999886 


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccc--cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI--APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +..+++|||....+.....     ...++-++.  +|.......+..+.|++|||..+.+.++|..--...         
T Consensus       404 ~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------  469 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------  469 (524)
T ss_pred             hhhhccccccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccc---------
Confidence            7889999998865322111     112333444  455555556788999999999999999987431111         


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML  425 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L  425 (430)
                      ..|....  .+...         .. +.....+..++..+...++..||++.++....
T Consensus       470 ~~~~~i~--~~~~p---------~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  470 VQSLTIR--SGDTP---------NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ccceeee--ccccc---------CC-CchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1111000  01000         00 11113466677778889999999988876543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.4e-10  Score=104.29  Aligned_cols=143  Identities=20%  Similarity=0.204  Sum_probs=106.9

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC--CCcccceeEEEe
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH--RNIVPLLARMVR  217 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~  217 (430)
                      +.|+.|..+.+|++...  +|..+++|........             .....+..|+.+++.+++  .++.+++.+...
T Consensus         4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~-------------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~   68 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALL-------------PSAHDVAREYRVLRALAGTGVPVPKVLALCED   68 (223)
T ss_pred             eecCCCccceEEEEEec--CCcceEEEeCCCcccC-------------cccccHHHHHHHHHHhhCCCCCCCCEEEECCC
Confidence            57899999999999874  5689999987432210             013467889999999975  345667777665


Q ss_pred             C---CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------
Q 014140          218 R---DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH------------------------  270 (430)
Q Consensus       218 ~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------  270 (430)
                      .   +..++||||++|.++.+.+.    . ..++......++.+++++|..||+..                        
T Consensus        69 ~~~~~~~~~v~e~i~G~~l~~~~~----~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (223)
T cd05154          69 PSVLGTPFYVMERVDGRVLRDRLL----R-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWR  143 (223)
T ss_pred             CCccCCceEEEEEeCCEecCCCCC----C-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHH
Confidence            4   25689999999988877541    1 34677777788888888888888531                        


Q ss_pred             -----------------------------CCCeEecCCCCCcEEeCC--CCceEEeecCCccc
Q 014140          271 -----------------------------RPRIIHRDIQPANVLIDD--DMEARISEFGLAKR  302 (430)
Q Consensus       271 -----------------------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~a~~  302 (430)
                                                   ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         144 RQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                         245799999999999998  66789999988754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.17  E-value=1.1e-11  Score=127.31  Aligned_cols=253  Identities=23%  Similarity=0.220  Sum_probs=168.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.+.+.+.+.+|.+|.++.+.-.+ .|-..++|+......-..           ........+-.++-..++|-++...
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~-sgh~~~~~v~~~ap~i~~-----------~~~~s~r~~s~~~i~p~~P~v~~~~  870 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAG-SGHTRPSKVHGLAPKIRT-----------NDYESIRSKSNILITPRSPAVVRSF  870 (1205)
T ss_pred             CccceecccccCCCCcccccCCccc-cccccchhhhccchhhcc-----------ccccccCCccCccccCCCCceeccc
Confidence            3567777889999999999997553 665555555422111100           0122223333333334567777666


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      --+......+||++|..+++|...++.    .+..+..........+..+++|||+..   +.|+|++|.|++...++..
T Consensus       871 ~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  871 PSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             CCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCc
Confidence            556667788999999999999999854    234555555666777889999999554   9999999999999999999


Q ss_pred             EEeecCCcccCC------CC--CC---------------------cceeeccccccccccccccCCCCCCcchhHHHHHH
Q 014140          293 RISEFGLAKRIP------DG--HT---------------------RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGV  343 (430)
Q Consensus       293 kl~Dfg~a~~~~------~~--~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~  343 (430)
                      ++.|||......      ..  ..                     ........||+.|.+||.+.+......+|+|++|+
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence            999998433221      00  00                     01122456899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          344 LLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       344 ~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      +++|.++|..||....+.       +.+.+..+...+.        ...+........+++...+..+|.+|-.+.
T Consensus      1024 ~l~e~l~g~pp~na~tpq-------~~f~ni~~~~~~~--------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQ-------QIFENILNRDIPW--------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhcCCCCCCCcchh-------hhhhccccCCCCC--------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999999998765432       1122222221111        111222223356677777788898887665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=1.9e-09  Score=100.97  Aligned_cols=203  Identities=14%  Similarity=0.147  Sum_probs=131.1

Q ss_pred             eEEEEEecCCCC-HHHHHh--hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          221 DLLVYEFRRNGS-LQDILY--DVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       221 ~~lV~E~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ..+.|+.+++.- ..++++  ..+++.....|.-.++.+..++.+.+-||..   |.+-+|+.++|+|+++++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence            567888887642 333332  1245566789999999999999999999944   5999999999999999999999985


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCccccccccccHHH-H
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIG-KFPSDDFFQHTKEMSLVQ-W  370 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~l~~-~  370 (430)
                      ..-..-.++...   ...+|...|.+||.-.     +..-+...|.|.||+++++++.| +.||.+.........-.+ .
T Consensus       162 Dsfqi~~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         162 DSFQINANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             cceeeccCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            543333222222   2347889999999754     33456779999999999999997 899987654333222221 1


Q ss_pred             HHHHhc--CCCCchhccccccCCCcHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMT--SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD--DPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~Rps~~ev~~~L~~l~  429 (430)
                      +....-  .........+.-...........+..+..+|+..  ++.-|||++..+..|..+.
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            111100  0000111111100111112222366666778743  4678999999998887653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=4.1e-09  Score=101.21  Aligned_cols=172  Identities=19%  Similarity=0.265  Sum_probs=128.7

Q ss_pred             cCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe----CCee
Q 014140          146 WNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR----RDCD  221 (430)
Q Consensus       146 ~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~  221 (430)
                      ...++|++... .+|..|++|+++-..         +..     ......-+++.+++.|+|+|++..++..    +..+
T Consensus       288 ~~~Ttyk~~s~-~DG~~YvLkRlhg~r---------~~~-----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl  352 (655)
T KOG3741|consen  288 FSITTYKATSN-VDGNAYVLKRLHGDR---------DQS-----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL  352 (655)
T ss_pred             ccceeEeeeec-cCCceeeeeeecccc---------ccC-----cccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence            34688999765 499999999993211         111     1123345677889999999999998873    4567


Q ss_pred             EEEEEecCC-CCHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          222 LLVYEFRRN-GSLQDILYDVS-----------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       222 ~lV~E~~~~-gsL~~~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++||+|.++ ++|.+......           ..+...++...|.++.|+..||.++|+.+   +.-+-|.|.+|+++.+
T Consensus       353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~  429 (655)
T KOG3741|consen  353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGK  429 (655)
T ss_pred             EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCc
Confidence            899999885 78888765321           12345788999999999999999999665   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      ..++|+.+|....+..+..                +.+.   --.+-|.=.||.+++.|.||...
T Consensus       430 ~RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  430 MRIRISGCGIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ceEEEecccceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            9999999998776644431                1111   12346888999999999999754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=1.6e-08  Score=92.91  Aligned_cols=145  Identities=17%  Similarity=0.137  Sum_probs=97.6

Q ss_pred             CceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc--ccceeEEEe-----CC
Q 014140          147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI--VPLLARMVR-----RD  219 (430)
Q Consensus       147 ~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~-----~~  219 (430)
                      ...|.+..+   +|+.|.||+........  .++... ....-...+.+|+..+.+|..-+|  ...+++...     ..
T Consensus        35 ~rrvvr~~~---~g~~~~vKr~~~~~~~~--~~k~l~-~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         35 GRRTLRFEL---AGKSYFLKWHRGTGWGE--IFKNLL-SLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             CceEEEEEE---CCEEEEEEEecCCcHHH--Hhhhhc-ccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            344667765   67889999774332110  001000 000112347889999988854333  344445433     23


Q ss_pred             eeEEEEEecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-------CCc
Q 014140          220 CDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-------DME  291 (430)
Q Consensus       220 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-------~~~  291 (430)
                      ..++|||++++. +|.+++....  ....+...+..++.+++..+.-||..   ||+|+|++++|||++.       ++.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            468999999885 8999985321  23456677889999999999999955   5999999999999975       467


Q ss_pred             eEEeecCCccc
Q 014140          292 ARISEFGLAKR  302 (430)
Q Consensus       292 ~kl~Dfg~a~~  302 (430)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=9.8e-09  Score=89.00  Aligned_cols=140  Identities=19%  Similarity=0.189  Sum_probs=84.3

Q ss_pred             eEEEeecCCCCCceEEEEEeecccccchh---hhcc---------CCchhhHHHHHHHHHHHHHhccCCC--CcccceeE
Q 014140          149 EVYKAELPGSSGRVITIKKIIQPLKSGAE---LIKK---------DSEPLHHKMIQIRSEIITAGQVRHR--NIVPLLAR  214 (430)
Q Consensus       149 ~vy~a~~~~~~~~~vavK~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~  214 (430)
                      .||.|...  +|..+|+|..........+   ....         .............+|++.|.++..-  ++.+++.+
T Consensus         1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~   78 (188)
T PF01163_consen    1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY   78 (188)
T ss_dssp             EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred             CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence            38999754  8899999998654222111   1111         1122233456788999999999865  34555533


Q ss_pred             EEeCCeeEEEEEecC--CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          215 MVRRDCDLLVYEFRR--NGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY-LHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                        .  .-++||||++  |..+..+...      .++......++.+++..+.. +|   ..|++||||.+.||+++++ .
T Consensus        79 --~--~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   79 --N--RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             --E--TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-C
T ss_pred             --e--CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-e
Confidence              2  3469999998  6555444321      11133445677777775555 57   4459999999999999988 9


Q ss_pred             eEEeecCCcccCC
Q 014140          292 ARISEFGLAKRIP  304 (430)
Q Consensus       292 ~kl~Dfg~a~~~~  304 (430)
                      +.++|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=2.4e-08  Score=89.19  Aligned_cols=150  Identities=21%  Similarity=0.178  Sum_probs=103.1

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhh-----h---ccCCchhhHHHHHHHHHHHHHhccCCC-
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAEL-----I---KKDSEPLHHKMIQIRSEIITAGQVRHR-  206 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~-----~---~~~~~~~~~~~~~~~~E~~~l~~l~hp-  206 (430)
                      ..+...||-|--+.||.|...  .|..+|||.-.-......+.     .   .....+..-......+|..+|..|... 
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            456789999999999999865  89999999775443322211     1   112222333456778999999999654 


Q ss_pred             -CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          207 -NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       207 -niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                       .+.+.++    .+.-.+||||.+|-.|...-         ++....-.++..|++-+.-+-   ..|++|+|+++-||+
T Consensus       171 ~~VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIl  234 (304)
T COG0478         171 VKVPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNIL  234 (304)
T ss_pred             CCCCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEE
Confidence             5666554    34557999999986554432         123333345555555555555   334999999999999


Q ss_pred             eCCCCceEEeecCCcccC
Q 014140          286 IDDDMEARISEFGLAKRI  303 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~  303 (430)
                      ++++|.+.++||-.+...
T Consensus       235 V~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EecCCCEEEEeCcccccC
Confidence            999999999999776543

>PRK09902 hypothetical protein; Provisional

Probab=98.75  E-value=3.4e-07  Score=79.98  Aligned_cols=148  Identities=14%  Similarity=0.084  Sum_probs=103.5

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC--CcccceeEE
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR--NIVPLLARM  215 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~  215 (430)
                      ...--|+||.+.|+...+   .|..+-+|+-..........        ..-...|.+|+..|.+|..-  ++.+.. ++
T Consensus        22 e~pN~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~--------P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~   89 (216)
T PRK09902         22 EEPNYRRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRY--------PFGRPTIVREVAVIKELERAGVIVPKIV-FG   89 (216)
T ss_pred             cCCCcCCCCcceEEEEEe---CCcEEEEEeccCcccccccC--------CCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence            334558899999999887   55578888763221111110        11246799999999999532  244444 22


Q ss_pred             E-eC----CeeEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          216 V-RR----DCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       216 ~-~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      . ..    -..+||+|-++| -||.+++..  ....+.+...+..+..+++..++-||.   .|+.|+|+.+.||+++.+
T Consensus        90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~  164 (216)
T PRK09902         90 EAVKIEGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTE  164 (216)
T ss_pred             eeeccCCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCC
Confidence            2 11    135799997763 689998843  223356788888999999999999994   459999999999999866


Q ss_pred             Cc--eEEeecCCccc
Q 014140          290 ME--ARISEFGLAKR  302 (430)
Q Consensus       290 ~~--~kl~Dfg~a~~  302 (430)
                      +.  +.++||--++.
T Consensus       165 g~~~v~lIDlEk~r~  179 (216)
T PRK09902        165 GKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCeeEEEEEhhccch
Confidence            67  99999976654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=4.4e-08  Score=97.49  Aligned_cols=156  Identities=22%  Similarity=0.270  Sum_probs=100.0

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchh-----------hhccCCc-----hhhH----------HHHHH
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE-----------LIKKDSE-----PLHH----------KMIQI  193 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~-----~~~~----------~~~~~  193 (430)
                      ..|+.++.|.||+|++.  +|+.||||+.+++.....+           .+.....     ....          ..-.+
T Consensus       131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            57999999999999997  7999999999776554321           0111000     0001          11224


Q ss_pred             HHHHHHHhccC-----CCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHh
Q 014140          194 RSEIITAGQVR-----HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL-EYLH  267 (430)
Q Consensus       194 ~~E~~~l~~l~-----hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH  267 (430)
                      ..|...+.+++     .|++.--.=++...+...|+|||++|-.+.+...-.   ...++..   .++..++++. ..+-
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k---~ia~~~~~~f~~q~~  282 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRK---ELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHH---HHHHHHHHHHHHHHH
Confidence            55666666663     344433333333456678999999998888885321   1234422   2333333321 2222


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCC
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG  306 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  306 (430)
                         .-|+.|.|.+|.||+++.+|.+.+.|||+...++..
T Consensus       283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence               236999999999999999999999999999887644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=2.9e-09  Score=105.77  Aligned_cols=151  Identities=17%  Similarity=0.229  Sum_probs=98.9

Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCC-cc------eeeccccccccccccccCCC
Q 014140          258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT-RT------TTWSLAGTVGYIAPECHQTV  330 (430)
Q Consensus       258 ~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~------~~~~~~gt~~y~aPE~~~~~  330 (430)
                      +++.|+.|+|..  .++||++|.|++|.++.++..|+++|+++........ ..      ..........|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            455999999954  3799999999999999999999999999876544211 11      11112346679999999998


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccC
Q 014140          331 ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD  410 (430)
Q Consensus       331 ~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  410 (430)
                      ..+.++|+||+|+++|-+..|..+.-....   ............  +..        ...+..+.+..+.+=+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~---~~~~~~~~~~~~--~~~--------~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG---GLLSYSFSRNLL--NAG--------AFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccC---Ccchhhhhhccc--ccc--------cccccccCcHHHHHHHHHHhcC
Confidence            889999999999999999966555322111   111111111100  000        0111122333466666678889


Q ss_pred             CCCCCCCHHHHHH
Q 014140          411 DPNKRPNSKDVRC  423 (430)
Q Consensus       411 dp~~Rps~~ev~~  423 (430)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999997776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=2.8e-07  Score=81.82  Aligned_cols=106  Identities=23%  Similarity=0.270  Sum_probs=82.1

Q ss_pred             HHHHHHHHHHhccCCC--CcccceeEEEeCC----eeEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 014140          191 IQIRSEIITAGQVRHR--NIVPLLARMVRRD----CDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGL  263 (430)
Q Consensus       191 ~~~~~E~~~l~~l~hp--niv~l~~~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l  263 (430)
                      ....+|...+..|..-  .....+++.....    ..++|+|++++ .+|.+++...    ..++......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            4678888888888533  3455556555432    35899999987 4799998542    2266777889999999999


Q ss_pred             HHHhhcCCCCeEecCCCCCcEEeCCCC---ceEEeecCCcccC
Q 014140          264 EYLHMSHRPRIIHRDIQPANVLIDDDM---EARISEFGLAKRI  303 (430)
Q Consensus       264 ~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~  303 (430)
                      +-||..   |++|+|++++|||++.++   .+.++||+-++..
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999955   599999999999999887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.62  E-value=8.5e-07  Score=79.83  Aligned_cols=143  Identities=13%  Similarity=0.092  Sum_probs=84.9

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC--cccceeEE
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN--IVPLLARM  215 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~  215 (430)
                      ....||.|..+.||+.     .|..+++|......                ......+|.++++.+..-.  +.+.++++
T Consensus         5 ~~~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~----------------~~~~i~~E~~~l~~l~~~glpvP~~~~~~   63 (226)
T TIGR02172         5 DWTQTGEGGNGESYTH-----KTGKWMLKLYNPGF----------------DKETIKREFDASRKVFSLGIPTPHPFDLV   63 (226)
T ss_pred             HheeecCCCCcceeEe-----cCCCEEEEeCCCCC----------------CHHHHHHHHHHHHHHHHcCCCCCceEEEE
Confidence            3467899999999984     24457788763211                1244688999999986433  46677777


Q ss_pred             EeCCeeEEEEEecCCCC-HHHHH------------------hhhcC-CCCCCCHHHHHH-HHH----------HHHH-HH
Q 014140          216 VRRDCDLLVYEFRRNGS-LQDIL------------------YDVSQ-GRRELDWLARHR-IAQ----------GIAS-GL  263 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gs-L~~~l------------------~~~~~-~~~~l~~~~~~~-i~~----------~i~~-~l  263 (430)
                      ...+...+|||+++|.+ +...+                  ...-. .....+...... +..          .+.. ..
T Consensus        64 ~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~  143 (226)
T TIGR02172        64 EDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKAR  143 (226)
T ss_pred             ecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHH
Confidence            77888889999999863 21111                  00000 000111111100 000          0111 12


Q ss_pred             HHHhhc-CCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          264 EYLHMS-HRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       264 ~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      .+|... ..+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus       144 ~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       144 AFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            222211 234579999999999999888 99999987653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.50  E-value=2.3e-06  Score=75.10  Aligned_cols=147  Identities=16%  Similarity=0.194  Sum_probs=90.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpni  208 (430)
                      ..++|...+++-......|.+-..   +|..+++|..........+.+......     ....+.+..+..++   --..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg-----~~~~~l~~~~~~i~~~g~~~~  100 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKG-----SEYSRLINNTDKIRNEGFTEP  100 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhcc-----HHHHHHHHHHHHHHHcCcccc
Confidence            356788888888877776766654   789999998754322211111100000     11223333333332   2333


Q ss_pred             ccceeEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          209 VPLLARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       209 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      ..++.+..-     ....+|+|||++|..|.++..        ++.    .++..+..++.-||..   |+.|+|.+|+|
T Consensus       101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN  165 (229)
T PF06176_consen  101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN  165 (229)
T ss_pred             ccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence            333333322     234568999999988876541        222    2556677889999955   59999999999


Q ss_pred             EEeCCCCceEEeecCCccc
Q 014140          284 VLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~  302 (430)
                      +++++++ +++.||+..+.
T Consensus       166 Flv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  166 FLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EEEECCc-EEEEECccccc
Confidence            9998654 99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.2e-06  Score=87.00  Aligned_cols=157  Identities=17%  Similarity=0.144  Sum_probs=95.1

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchh-----------hhccCCc------hhhHH------HHHHHHH
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE-----------LIKKDSE------PLHHK------MIQIRSE  196 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~------~~~~~------~~~~~~E  196 (430)
                      +.||..+.|.|++|+++  +|+.||||+-++.......           .+.+...      ...+.      .-.|.+|
T Consensus       167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            57999999999999998  7999999998776554321           0111000      00011      1224445


Q ss_pred             HHHHhcc----CCCCc---ccceeEEE-eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 014140          197 IITAGQV----RHRNI---VPLLARMV-RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM  268 (430)
Q Consensus       197 ~~~l~~l----~hpni---v~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  268 (430)
                      .+...+.    .|-+.   |.+=.++. ......|+||||+|..+.|.-.-   ....++......-+.+...-+-+   
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf---  318 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF---  318 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH---
Confidence            5444444    34441   11222222 24566899999999887776422   12235555433333333222222   


Q ss_pred             cCCCCeEecCCCCCcEEeCC----CCceEEeecCCcccCCCC
Q 014140          269 SHRPRIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDG  306 (430)
Q Consensus       269 ~~~~~iiH~Dlkp~Nill~~----~~~~kl~Dfg~a~~~~~~  306 (430)
                        ..|++|+|-+|.||++..    ++.+.+.|||+...+...
T Consensus       319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence              336999999999999984    678999999998877543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.36  E-value=9.6e-06  Score=72.05  Aligned_cols=152  Identities=18%  Similarity=0.161  Sum_probs=97.3

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchh---------hhccCCc-hhhHHHHHHHHHHHHHhccC--CCCc
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------LIKKDSE-PLHHKMIQIRSEIITAGQVR--HRNI  208 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~E~~~l~~l~--hpni  208 (430)
                      .|.+|--++||+|.-.  ++..+|||++.........         .+..... .......-...|+..|.++.  +=.+
T Consensus        55 ~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          55 CISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            5667778899999753  7899999998654332221         1111111 11122344567888888874  3333


Q ss_pred             ccceeEEEeCCeeEEEEEecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      .+.+++.    .-.|||||+... .-.-.|     ..-++.......+..++++.+.-|-..  .+++|+||+.=|||+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~  201 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH  201 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE
Confidence            3334322    346899999653 111111     112233335777888889999888752  3599999999999999


Q ss_pred             CCCceEEeecCCcccCCCC
Q 014140          288 DDMEARISEFGLAKRIPDG  306 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~  306 (430)
                       ++.+.++|||.|....+.
T Consensus       202 -~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CCeEEEEECccccccCCC
Confidence             889999999998776533

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=2.3e-05  Score=68.20  Aligned_cols=105  Identities=20%  Similarity=0.177  Sum_probs=83.4

Q ss_pred             HHHHHHHhccCC-CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          194 RSEIITAGQVRH-RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       194 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      .+|..+|+.+++ +++.+++|+|    ..++|.||...+++...... -..-...+|..|.+||.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            468889999976 6999999998    34679999987766532100 01123479999999999999999999975444


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccC
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  303 (430)
                      .+.-.|++|+|+-+++++.+|+.|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5888999999999999999999999876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.31  E-value=1.2e-07  Score=93.47  Aligned_cols=185  Identities=18%  Similarity=0.135  Sum_probs=132.9

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC-cccceeE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN-IVPLLAR  214 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~  214 (430)
                      +...+..++|+++++|+.+-.  -.+....+.+..                   .....-++++|.+++||| .+..++-
T Consensus       244 s~~fh~fvK~altknpKkRpt--aeklL~h~fvs~-------------------~l~~rl~~eLLdK~n~P~~~v~~~~d  302 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQ-------------------TLSRRLAIELLDKVNNPNPVVRYLED  302 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCC--hhhheeceeecc-------------------chhhHHHHHHHHHccCCCCccccccc
Confidence            444567899999999999753  223333554422                   244667889999999999 7777777


Q ss_pred             EEeCCeeEEEEEecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          215 MVRRDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +..++..+++++++.++ +....+.   ...-.+..-....+...-.+++++||+..   -+|+|    ||+..+ +..+
T Consensus       303 ~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~  371 (829)
T KOG0576|consen  303 YDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVK  371 (829)
T ss_pred             CCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccc
Confidence            77788889999999887 2222211   11112333344556667778999999654   57888    777655 6889


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      .+||+.+..+......   ....+|+.++|||+.....+....|+|++|+-..++--|..|-
T Consensus       372 ~~~~~v~~~L~~~~~~---~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  372 LLDFAVPPQLTRTMKP---RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccccCCcccCccccc---ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            9999998887655422   2457899999999999999999999999998777777777664

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.24  E-value=1.6e-05  Score=83.96  Aligned_cols=198  Identities=18%  Similarity=0.186  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHhccCCCCcccceeEEEeCCee----EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 014140          190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY  265 (430)
Q Consensus       190 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~  265 (430)
                      +.....|...+.+..|+|++.++.|-.+....    .+..|++..-++...++    .-..++..+.+.+..++..||.|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHH
Confidence            44455678888889999999999988765433    34568888888888884    45668899999999999999999


Q ss_pred             HhhcCCCCeEecCCCCC---cEEeCCCCceEEe--ecCCcccCCCCCCcceeeccccccccccccccCCCCCCc--chhH
Q 014140          266 LHMSHRPRIIHRDIQPA---NVLIDDDMEARIS--EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD--TCDI  338 (430)
Q Consensus       266 LH~~~~~~iiH~Dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv  338 (430)
                      +|+..   ..|.-+..+   +--.+..+...++  ||+.+..++.......   ...+..+.+||......++.  ..|+
T Consensus       302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHH
Confidence            99764   555555555   4444566667777  8888887765433222   23456688888877765544  4799


Q ss_pred             HHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          339 YSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       339 ~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      |++|..+..+..|..+-.....                   +...++.    ....    ...+....|+..++++|+++
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~~-------------------~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~  428 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSAV-------------------PVSLLDV----LSTS----ELLDALPKCLDEDSEERLSA  428 (1351)
T ss_pred             HHHHHHHhhhhhcCcccccccc-------------------hhhhhcc----ccch----hhhhhhhhhcchhhhhccch
Confidence            9999999999998765221100                   0000000    0000    25677778999999999999


Q ss_pred             HHHHHH
Q 014140          419 KDVRCM  424 (430)
Q Consensus       419 ~ev~~~  424 (430)
                      .+++..
T Consensus       429 ~~ll~~  434 (1351)
T KOG1035|consen  429 LELLTH  434 (1351)
T ss_pred             hhhhhc
Confidence            998864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.22  E-value=1.7e-05  Score=71.67  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=82.5

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC--CcccceeEEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR--NIVPLLARMV  216 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~  216 (430)
                      ++.++.|..+.||+....  + ..+++|.....                .....+..|..+++.+...  .+.+++.++.
T Consensus         2 i~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~----------------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~   62 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD--D-GRYVLKFYRPP----------------DAAERLRREAAVLRQLAEHGIPVPRVLAFDT   62 (239)
T ss_dssp             EEEEEESSSSEEEEEEET--T-SEEEEEEESSH----------------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEE
T ss_pred             CccCCCCCeeeEEEEEEC--C-cEEEEEEeCCC----------------CCHHHHHHHHHHHHHHHhcCCCCceEEeecc
Confidence            357899999999999864  3 68999987332                2246677888888888533  3456666443


Q ss_pred             e---CCeeEEEEEecCCCCHHH----------------HHh---hhcCCCCCCCHHHH--HH-------H----------
Q 014140          217 R---RDCDLLVYEFRRNGSLQD----------------ILY---DVSQGRRELDWLAR--HR-------I----------  255 (430)
Q Consensus       217 ~---~~~~~lV~E~~~~gsL~~----------------~l~---~~~~~~~~l~~~~~--~~-------i----------  255 (430)
                      .   ....+++|++++|.++..                .+.   ........+.....  ..       .          
T Consensus        63 ~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (239)
T PF01636_consen   63 SDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELF  142 (239)
T ss_dssp             ETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCH
T ss_pred             cccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhh
Confidence            3   335689999999987777                111   11111111111110  00       0          


Q ss_pred             --HHHHHH-HHHHHhh----cCCCCeEecCCCCCcEEeC-CCCceEEeecCCcc
Q 014140          256 --AQGIAS-GLEYLHM----SHRPRIIHRDIQPANVLID-DDMEARISEFGLAK  301 (430)
Q Consensus       256 --~~~i~~-~l~~LH~----~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~a~  301 (430)
                        ...+.. .+..++.    .....++|+|+.|+||+++ +++.+.|+||+.+.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  143 DDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              111222 2333332    1245699999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.16  E-value=2.1e-05  Score=68.32  Aligned_cols=139  Identities=19%  Similarity=0.279  Sum_probs=93.5

Q ss_pred             cccccccccccccC-ceEEEeecCCCCCceEEEEEeecccccchhhhccCC-------chhhHHHHHHHHHHHHHhccC-
Q 014140          134 DYFASLEKIRSCWN-GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDS-------EPLHHKMIQIRSEIITAGQVR-  204 (430)
Q Consensus       134 ~~~~~~~~lg~G~~-g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~-  204 (430)
                      ..++.++.||.|.- |.||+++.   +|+.||+|.+..-............       ........-|..|.+...+|+ 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            56788899999999 99999997   7889999994322111111100000       111234567999999999996 


Q ss_pred             --CCCc--ccceeEEEeCC------------------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 014140          205 --HRNI--VPLLARMVRRD------------------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG  262 (430)
Q Consensus       205 --hpni--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  262 (430)
                        +.++  |+++||..-..                  ...||.||++...             .+.    ..-+.++.+-
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~d  176 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRD  176 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHH
Confidence              3455  99999874321                  1257888876643             122    2234566677


Q ss_pred             HHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCc
Q 014140          263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA  300 (430)
Q Consensus       263 l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a  300 (430)
                      |..+|   ..||+-+|+++.|..     .-+|+|||.+
T Consensus       177 l~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            78889   455999999999987     4589999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.13  E-value=5.3e-05  Score=69.16  Aligned_cols=142  Identities=10%  Similarity=0.033  Sum_probs=83.1

Q ss_pred             ccccccC-ceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeEEEeC
Q 014140          141 KIRSCWN-GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVRR  218 (430)
Q Consensus       141 ~lg~G~~-g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  218 (430)
                      .|-.|.. ..||+...   ++..+.+|......                 ...+..|+.++..+. +-.+.+++++....
T Consensus         5 ~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~-----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   64 (244)
T cd05150           5 RVTEGQSGATVYRLDG---KNPGLYLKIAPSGP-----------------TYELEREAERLRWLAGKLPVPEVIDYGSDD   64 (244)
T ss_pred             ecCCCCCcCeEEEEcC---CCCcEEEEecCCCc-----------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC
Confidence            3445555 78899864   44678888763211                 124667888888884 34455677777666


Q ss_pred             CeeEEEEEecCCCCHHHHH-------------------hhhcCCCCCCCHH--HHHHHHH--------------------
Q 014140          219 DCDLLVYEFRRNGSLQDIL-------------------YDVSQGRRELDWL--ARHRIAQ--------------------  257 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------  257 (430)
                      +..++|||+++|.+|....                   +.......++...  .......                    
T Consensus        65 ~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (244)
T cd05150          65 GRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGW  144 (244)
T ss_pred             CccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCC
Confidence            6789999999997776432                   1100001111100  0000000                    


Q ss_pred             HHHHHHHHHhh----cCCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          258 GIASGLEYLHM----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       258 ~i~~~l~~LH~----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      .+...+..|-.    ...+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus       145 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         145 SAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            01111222211    1245699999999999999987888999987643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=3.4e-05  Score=64.92  Aligned_cols=130  Identities=17%  Similarity=0.156  Sum_probs=88.8

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      ..+...||.|++|.||++.+   .|..+|+|+-..+..                ...+..|+++|..+..-++.+=+-.+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr~ds~----------------r~~l~kEakiLeil~g~~~~p~vy~y   84 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW---RGGEVALKVRRRDSP----------------RRNLEKEAKILEILAGEGVTPEVYFY   84 (201)
T ss_pred             hhhhhhhhcccccEEEEeec---cCceEEEEEecCCcc----------------hhhHHHHHHHHHHhhhcCCCceEEEe
Confidence            45678899999999999998   566899998744322                46788999999999876664422211


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC--CcEEeCCCCceE
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP--ANVLIDDDMEAR  293 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp--~Nill~~~~~~k  293 (430)
                         +..++.|||..|.+|.+.-..       .+...    ...+++.-.-|.   ..||-|+.|.-  .||++++ +.+.
T Consensus        85 ---g~~~i~me~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~  146 (201)
T COG2112          85 ---GEDFIRMEYIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVY  146 (201)
T ss_pred             ---chhhhhhhhhcCcchhhhhhc-------ccHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecC-CcEE
Confidence               223456999999888776521       12222    334445544455   55699999975  3555554 4999


Q ss_pred             EeecCCccc
Q 014140          294 ISEFGLAKR  302 (430)
Q Consensus       294 l~Dfg~a~~  302 (430)
                      |+||..|+.
T Consensus       147 iIDFd~At~  155 (201)
T COG2112         147 IIDFDSATF  155 (201)
T ss_pred             EEEccchhh
Confidence            999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.07  E-value=0.0001  Score=64.47  Aligned_cols=147  Identities=19%  Similarity=0.203  Sum_probs=94.5

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccch----hhhccCCchhhHHHHHHHHHHHHHhccC------CCC
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGA----ELIKKDSEPLHHKMIQIRSEIITAGQVR------HRN  207 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpn  207 (430)
                      ....||+|+.=.||.=  +  +....+||+.........    ....+...  .....+..+|+.-...+.      +.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~E~~~y~~l~~~~~~~~~~   78 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--P--DDPNLCIKVMRPDRGERRRPFKRWLKRLRP--KSRYRQNRRELRYYKQLSLRRGVDWSH   78 (199)
T ss_pred             CCcccccCCCceEEEC--C--CCCCeEEEEEccccccccccchhHHHhhcc--cchhHHHHHHHHHHHHHhhccCCcccc
Confidence            3568999999999853  3  677789999866551110    00111000  112355666666666555      889


Q ss_pred             cccceeEEEeCCeeEEEEEecCC------CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRN------GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP  281 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  281 (430)
                      |.+++|+..++-...+|+|.+.+      .+|.+++..     ..++. ....   .+-+-..||-..+   |+.+|++|
T Consensus        79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~  146 (199)
T PF10707_consen   79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNP  146 (199)
T ss_pred             cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHcC---CeecCCCc
Confidence            99999999999999999998653      368888732     23555 3333   3334445666444   99999999


Q ss_pred             CcEEeCCC--C--ceEEee-cCCccc
Q 014140          282 ANVLIDDD--M--EARISE-FGLAKR  302 (430)
Q Consensus       282 ~Nill~~~--~--~~kl~D-fg~a~~  302 (430)
                      +||++...  +  .+.|+| ||....
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCccc
Confidence            99999633  2  577777 454433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.06  E-value=5.4e-05  Score=81.29  Aligned_cols=80  Identities=8%  Similarity=0.106  Sum_probs=55.0

Q ss_pred             ccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCc--cccee
Q 014140          139 LEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNI--VPLLA  213 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~  213 (430)
                      +..++.|.+..+|+..... .+  ..+++|+.......             .....+.+|+.+|+.+. |+++  .+++.
T Consensus        43 v~~l~gG~sn~ty~l~~~~-~~~~~~~VLR~~p~~~~~-------------~~~~~~~rE~~~l~~L~~~~~vpVP~v~~  108 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGN-GGSVKRYVLRKKPPGKLL-------------QSAHAVEREYQVLRALGEHTDVPVPKVYC  108 (822)
T ss_pred             EEEeCCCCcCceEEEEECC-CCcceeEEEEeCCCCccC-------------ccHHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            5678999999999987642 11  46777765321100             01245789999999995 6664  77777


Q ss_pred             EEEeC---CeeEEEEEecCCCC
Q 014140          214 RMVRR---DCDLLVYEFRRNGS  232 (430)
Q Consensus       214 ~~~~~---~~~~lV~E~~~~gs  232 (430)
                      +|.+.   +..|+||||++|..
T Consensus       109 ~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876        109 LCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             EecCCCcCCCceEEEEecCCcc
Confidence            77654   46789999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.98  E-value=4.9e-05  Score=69.01  Aligned_cols=32  Identities=28%  Similarity=0.527  Sum_probs=26.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      .++++|+|+.|.||+++++...-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            45599999999999998776677999998644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.88  E-value=0.00023  Score=66.99  Aligned_cols=78  Identities=13%  Similarity=0.011  Sum_probs=55.2

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC---CCccccee
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH---RNIVPLLA  213 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~  213 (430)
                      ...+.||.|..+.||.....  +| .+.+|.... ..               ....+..|...|+.|.-   -.+.++++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~-~~---------------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~   77 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QG-NPMPLMARS-FS---------------TPGVAQQEAWKLSMLARSGTVRMPTVYG   77 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CC-CEEEEEecc-cc---------------cchHHHHHHHHHHHHccCCCCCcCcEEE
Confidence            44568999999999998643  44 466666421 00               02468889999998853   36778888


Q ss_pred             EEEe---CCeeEEEEEecCCCCH
Q 014140          214 RMVR---RDCDLLVYEFRRNGSL  233 (430)
Q Consensus       214 ~~~~---~~~~~lV~E~~~~gsL  233 (430)
                      +|..   .+..++|||+++++++
T Consensus        78 ~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         78 VMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             EeccCCcCCCeEEEEeccCCEec
Confidence            7754   3668999999998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.68  E-value=0.00052  Score=62.18  Aligned_cols=32  Identities=13%  Similarity=0.297  Sum_probs=27.3

Q ss_pred             CCCeEecCCCCCcEEeCC-CCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDD-DMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~a~~  302 (430)
                      ..+++|+|+.+.|||+++ ++.+.++||..|..
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            346999999999999998 57899999987643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.56  E-value=0.0012  Score=64.30  Aligned_cols=82  Identities=11%  Similarity=0.058  Sum_probs=52.8

Q ss_pred             ccccccccCceEEEeecCCCCC-ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCcccceeE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSG-RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVPLLAR  214 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~  214 (430)
                      .+.||.|.+..||++...  +| +.++||.-.......       ...-.....+...|...|..+.   ..++.+++.+
T Consensus        31 ~~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~-------g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVV-------GESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eeEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccc-------cccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            467899999999999875  55 589999853211100       0000012456777888888763   2456666665


Q ss_pred             EEeCCeeEEEEEecCCC
Q 014140          215 MVRRDCDLLVYEFRRNG  231 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~g  231 (430)
                        +.+..++||||+++.
T Consensus       102 --D~~~~~lVME~L~~~  116 (401)
T PRK09550        102 --DEELAVTVMEDLSDH  116 (401)
T ss_pred             --CCCCCEEEEecCCCc
Confidence              445678999999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.51  E-value=0.0019  Score=59.43  Aligned_cols=139  Identities=10%  Similarity=0.064  Sum_probs=75.6

Q ss_pred             cccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc-cceeEEEeCCe
Q 014140          142 IRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV-PLLARMVRRDC  220 (430)
Q Consensus       142 lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~  220 (430)
                      +..|-.+.+|+...   +|..+++|........              ......+|..+++.+....++ ++++.+  .  
T Consensus         4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~--------------~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--   62 (256)
T TIGR02721         4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKA--------------LGVDRQREYQILQALSALGLAPKPILVN--E--   62 (256)
T ss_pred             CCCcCcCCeEEEEe---CCccEEEeeCCccccc--------------ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--
Confidence            45577788998863   6778888865221100              001246788888888643332 333332  2  


Q ss_pred             eEEEEEecCCCCHHH--------------HH---hhhcCCCCCCCHHHH-HHHHHH---------HHHHHHHHhhc----
Q 014140          221 DLLVYEFRRNGSLQD--------------IL---YDVSQGRRELDWLAR-HRIAQG---------IASGLEYLHMS----  269 (430)
Q Consensus       221 ~~lV~E~~~~gsL~~--------------~l---~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~~LH~~----  269 (430)
                      .++||||++|..+..              .+   +.......+++.... ..+..+         +...+..+-..    
T Consensus        63 ~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  142 (256)
T TIGR02721        63 HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPA  142 (256)
T ss_pred             CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCC
Confidence            368999999866432              11   111111122222211 111111         11112222111    


Q ss_pred             -CCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          270 -HRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       270 -~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                       ....++|+|+.|.||++++++ +.|+||..+..
T Consensus       143 ~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       143 PLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence             123589999999999999877 78999987754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.48  E-value=0.0029  Score=59.91  Aligned_cols=146  Identities=16%  Similarity=0.142  Sum_probs=80.1

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC--cccceeE-
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN--IVPLLAR-  214 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-  214 (430)
                      ....++.|....+|+...   ++..+++|.......                ...+..|..++..|....  +.+++.. 
T Consensus        26 ~i~~~~~G~~n~~y~v~t---~~~~~vLK~~~~~~~----------------~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT---DVGRYILTLYEKRVK----------------AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             eccccCCccccceEEEEe---CCCcEEEEEecCCCC----------------HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            356677787789998864   334577887632110                123445666666663221  3333331 


Q ss_pred             -----EEeCCeeEEEEEecCCCCHH----H----------HHhhhcCCC-C-------CCCHHHHH------------HH
Q 014140          215 -----MVRRDCDLLVYEFRRNGSLQ----D----------ILYDVSQGR-R-------ELDWLARH------------RI  255 (430)
Q Consensus       215 -----~~~~~~~~lV~E~~~~gsL~----~----------~l~~~~~~~-~-------~l~~~~~~------------~i  255 (430)
                           ....+..++++||++|.++.    +          .++.....- .       .-.|....            ..
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                 12245678999999885431    1          111111110 0       01111100            01


Q ss_pred             HHHHHHHHHHHhh----cCCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          256 AQGIASGLEYLHM----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       256 ~~~i~~~l~~LH~----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ...+...+.++..    ....++||+|+.+.||++++++.+.|+||+.+..
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1123334555532    1246799999999999999988778999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.42  E-value=0.0025  Score=59.96  Aligned_cols=145  Identities=19%  Similarity=0.153  Sum_probs=83.3

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC--ccccee--
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN--IVPLLA--  213 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~--  213 (430)
                      ..+.+..|....+|+...   ++..+++|....  ..               ...+..|+.++..+.+.+  +.+++.  
T Consensus        18 ~i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~--~~---------------~~~~~~e~~~l~~L~~~g~~vp~~i~~~   77 (296)
T cd05153          18 SFEGISAGIENTNYFVTT---DSGRYVLTLFEK--VS---------------AEELPFFLALLDHLAERGLPVPRPIADR   77 (296)
T ss_pred             heecccCccccceEEEEe---CCCcEEEEEcCC--CC---------------hHhccHHHHHHHHHHHCCCCCCccccCC
Confidence            356777788889999864   445788887632  00               234566777777774322  333333  


Q ss_pred             ----EEEeCCeeEEEEEecCCCCHHH----H----------HhhhcCC-C------CCCCHHHHH----------HHHHH
Q 014140          214 ----RMVRRDCDLLVYEFRRNGSLQD----I----------LYDVSQG-R------RELDWLARH----------RIAQG  258 (430)
Q Consensus       214 ----~~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~~-~------~~l~~~~~~----------~i~~~  258 (430)
                          +....+..++|++|++|.++..    .          ++..... .      ....|....          .....
T Consensus        78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  157 (296)
T cd05153          78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL  157 (296)
T ss_pred             CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence                1223456689999999866421    1          1111110 0      111221110          01111


Q ss_pred             HHHHHHHHhh----cCCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          259 IASGLEYLHM----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       259 i~~~l~~LH~----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      +..++.++..    ....++||+|+.|.||++++++.+.|.||+.+..
T Consensus       158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            2334444442    1135699999999999999987789999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.38  E-value=0.0047  Score=58.78  Aligned_cols=32  Identities=28%  Similarity=0.371  Sum_probs=27.3

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..++||+|+.|.||+++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45799999999999999776668999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.34  E-value=0.0003  Score=65.00  Aligned_cols=150  Identities=13%  Similarity=0.100  Sum_probs=98.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhh------hcc--CCchhhHHHHHHHHHHHHHhccCC-
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAEL------IKK--DSEPLHHKMIQIRSEIITAGQVRH-  205 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~E~~~l~~l~h-  205 (430)
                      -+++.+.||-|--+.+|.+-..  .|++.++|...-........      +.+  ...+..-.......|+..|+.|.. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            4678899999999999999765  89999998664333222111      111  111222234556789999998853 


Q ss_pred             C-CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          206 R-NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       206 p-niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      - .+.+.++    .+.-++|||++.|-.|...-+       ..+..+   +...+..-+.-|-   +.|+||+|+.-=||
T Consensus       171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la---~~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLA---NHGLIHGDFNEFNI  233 (465)
T ss_pred             CCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHH---HcCceecccchhee
Confidence            2 2333333    345678999998877755431       122222   3333333444555   56799999999999


Q ss_pred             EeCCCCceEEeecCCcccC
Q 014140          285 LIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~  303 (430)
                      ++.+++.++++||......
T Consensus       234 mv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  234 MVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             EEecCCCEEEeechHhhcc
Confidence            9999999999999765544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.33  E-value=3.5e-05  Score=83.45  Aligned_cols=163  Identities=12%  Similarity=-0.002  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHhccCCCCcccceeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 014140          191 IQIRSEIITAGQVRHRNIVPLLARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM  268 (430)
Q Consensus       191 ~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  268 (430)
                      +....|..-++...|+++...+.-...  +...+.+++|+.+|.+.+.+-......+.+..........+......-+|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            445556666667789988776654432  445689999999999999997644445556665555556654566666665


Q ss_pred             cCC--CCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHH
Q 014140          269 SHR--PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLA  346 (430)
Q Consensus       269 ~~~--~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~  346 (430)
                      ..+  ...+|+++|+.|.+|..+..++++++|+.+...+....  .....+++.|+.|+......++.++|+|+.|+.+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            432  34789999999999999999999999999843322111  11346788899999998888999999999999999


Q ss_pred             HHHhCCCCC
Q 014140          347 VLVIGKFPS  355 (430)
Q Consensus       347 ell~g~~p~  355 (430)
                      +...|..||
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            998888775

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.27  E-value=0.0036  Score=59.10  Aligned_cols=32  Identities=22%  Similarity=0.315  Sum_probs=27.7

Q ss_pred             CCCeEecCCCCCcEEeCCC----CceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDD----MEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  302 (430)
                      ..++||+|+.|.||+++++    +.+.++||..+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            4579999999999999985    8899999987753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.02  E-value=0.008  Score=55.86  Aligned_cols=32  Identities=28%  Similarity=0.595  Sum_probs=26.1

Q ss_pred             CCCeEecCCCCCcEEeCCCCc-eEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDME-ARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~a~~  302 (430)
                      .+.++|+|++|.||++++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            345899999999999997554 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.88  E-value=0.02  Score=54.20  Aligned_cols=158  Identities=16%  Similarity=0.093  Sum_probs=99.1

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccc---h-----hhhccC----CchhhHHHHHHHHHHHHHhccCC
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSG---A-----ELIKKD----SEPLHHKMIQIRSEIITAGQVRH  205 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~----~~~~~~~~~~~~~E~~~l~~l~h  205 (430)
                      +.-.|..|--+.||.|.-.  +|..+|||++.......   .     ++-.+.    .........-.-.|++-|.+|+.
T Consensus       148 inGCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             cccccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3446777888999999754  99999999885543211   0     110111    01111223344568888888865


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      ..|.-.--+...  .-.|||+|+.. +=+..-   .-....++...+..+-.+++.-|.-|.+.|  +++|.||+-=|+|
T Consensus       226 aGIP~PePIlLk--~hVLVM~FlGr-dgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  226 AGIPCPEPILLK--NHVLVMEFLGR-DGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             cCCCCCCceeee--cceEeeeeccC-CCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            443221111111  22589999853 211110   012334667778888889999999998776  6999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCC
Q 014140          286 IDDDMEARISEFGLAKRIPDG  306 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~  306 (430)
                      +. +|.+.|+|-+.+.....+
T Consensus       298 yh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  298 YH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             EE-CCEEEEEEccccccCCCh
Confidence            86 468999998887765443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.88  E-value=0.013  Score=54.98  Aligned_cols=32  Identities=28%  Similarity=0.525  Sum_probs=28.8

Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeecCCcccC
Q 014140          272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  303 (430)
                      +.++|+|+.+.|++++.+.-+=|.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            46999999999999999888999999998764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.80  E-value=0.016  Score=54.79  Aligned_cols=31  Identities=23%  Similarity=0.334  Sum_probs=26.2

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..++||+|+.+.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            357999999999999988 6789999987543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.80  E-value=0.028  Score=54.63  Aligned_cols=80  Identities=10%  Similarity=0.011  Sum_probs=49.3

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCcccceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVPLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~  215 (430)
                      .+.||.|....||+...   .+..++||+-.......       +..-.....+-..|...|+.+.   ..++.+++.++
T Consensus        37 ~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~v-------ga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d  106 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCI-------GESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD  106 (418)
T ss_pred             EEEcCCCceeeEEEEEc---CCccEEEEeCCccccCC-------CccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC
Confidence            56789999999999874   34568898764222110       0000011334445566666553   34677788877


Q ss_pred             EeCCeeEEEEEecCC
Q 014140          216 VRRDCDLLVYEFRRN  230 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~  230 (430)
                      .  +..+++||++++
T Consensus       107 e--d~~vlvME~L~~  119 (418)
T PLN02756        107 R--TMALIGMRYLEP  119 (418)
T ss_pred             C--CCCEEEEeecCC
Confidence            6  446789999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.025  Score=53.99  Aligned_cols=80  Identities=10%  Similarity=0.036  Sum_probs=47.7

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCC-cccceeEEEe
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRN-IVPLLARMVR  217 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~  217 (430)
                      .||.|....||++.... .++.++||.-..-...       ..+.-.....+..-|...|+...  -|. +.+++.  .+
T Consensus         2 EigdGnlN~VfrV~~~~-g~~svIVKQAlp~vRv-------~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D   71 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE-GDRAAIVKQALPYVRV-------VGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FD   71 (370)
T ss_pred             cCCCCceEEEEEEEcCC-CCeeEEEEEcCHHHhh-------cCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ec
Confidence            57999999999998641 2368999976332111       11111122445567777777663  354 333443  35


Q ss_pred             CCeeEEEEEecCC
Q 014140          218 RDCDLLVYEFRRN  230 (430)
Q Consensus       218 ~~~~~lV~E~~~~  230 (430)
                      .+...+|||+++.
T Consensus        72 ~e~~~~vMEdL~~   84 (370)
T TIGR01767        72 TEMAVTVMEDLSH   84 (370)
T ss_pred             cccceehHhhCcc
Confidence            5566799999864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.45  E-value=0.03  Score=52.18  Aligned_cols=75  Identities=17%  Similarity=0.144  Sum_probs=47.4

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCccccee
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVPLLA  213 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~  213 (430)
                      ...+.|+.|....+|... .  +++.+.||.-...                 ....|..|..-|+.|.   .-.+.+.++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~--~~~~~FvK~~~~~-----------------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~   79 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-T--DGGSYFVKVNSES-----------------GRDMFEGEAEGLKALAEANPIRVPKVIA   79 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-T--TS-EEEEEEEEGG-----------------GCCHHHHHHHHHHHHCHTTTSBS--EEE
T ss_pred             eeeEecCCCChhheEEEE-C--CCccEEEEecChh-----------------hHHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            445678888899999987 2  7889999987311                 1245788888888884   345678888


Q ss_pred             EEEeCCeeEEEEEecCCC
Q 014140          214 RMVRRDCDLLVYEFRRNG  231 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~g  231 (430)
                      +....+..+||+||++.+
T Consensus        80 ~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   80 WGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE-SSCCEEEEE-----
T ss_pred             EEeecCCceEEEEeecCC
Confidence            888777889999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.22  E-value=0.011  Score=58.16  Aligned_cols=49  Identities=27%  Similarity=0.272  Sum_probs=39.1

Q ss_pred             HHHHHHHHHHHhccCCCCcccceeEEEeC-CeeEEEEEecCCCCHHHHHhh
Q 014140          190 MIQIRSEIITAGQVRHRNIVPLLARMVRR-DCDLLVYEFRRNGSLQDILYD  239 (430)
Q Consensus       190 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~  239 (430)
                      ..++.-...+++.+.|+|+..++.+-... ....+|+|++ +.||++.+..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            45677788999999999999998876543 4567899999 5599999843

>PLN02236 choline kinase

Probab=96.15  E-value=0.087  Score=50.66  Aligned_cols=144  Identities=18%  Similarity=0.246  Sum_probs=77.7

Q ss_pred             cccccccCceEEEeecCCC---CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc-cceeEE
Q 014140          140 EKIRSCWNGEVYKAELPGS---SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV-PLLARM  215 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~  215 (430)
                      ..+-.|-.-.+|+..+...   .++.|++|.......              . ...-.+|..++..+..-++. ++++.+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--------------~-~idR~~E~~~~~~l~~~gl~P~~~~~~  106 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--------------L-FFDRDDEIRTFECMSRHGQGPRLLGRF  106 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--------------e-eechHHHHHHHHHHHHcCCCCceEEEE
Confidence            3444467778998875321   236788887633210              0 11236688888888543333 445544


Q ss_pred             EeCCeeEEEEEecCCCCHHHH-----------------HhhhcCCCC--CCCHHHHHHHHHH-----------------H
Q 014140          216 VRRDCDLLVYEFRRNGSLQDI-----------------LYDVSQGRR--ELDWLARHRIAQG-----------------I  259 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------i  259 (430)
                      . ++   .|++|+++.+|...                 ++.......  ...+.....+..+                 +
T Consensus       107 ~-~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l  182 (344)
T PLN02236        107 P-NG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL  182 (344)
T ss_pred             C-Cc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence            2 22   58999987665321                 111110111  1122222222211                 1


Q ss_pred             HHHHHHH----hh-cCCCCeEecCCCCCcEEeCC-CCceEEeecCCccc
Q 014140          260 ASGLEYL----HM-SHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKR  302 (430)
Q Consensus       260 ~~~l~~L----H~-~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~a~~  302 (430)
                      ...+..|    .. .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1112222    21 12346899999999999986 46899999987754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.15  E-value=0.11  Score=49.26  Aligned_cols=142  Identities=20%  Similarity=0.297  Sum_probs=79.0

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC------cccceeE
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN------IVPLLAR  214 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~  214 (430)
                      .|.+ .-..+|+.+..  +|+. ++|..... ..               ..++..|...|..|.-..      +..+=|-
T Consensus        33 ~l~s-~eN~~f~~~~~--~g~~-iLki~~~~-~~---------------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~   92 (331)
T COG2334          33 GLNS-EENSNFRVQTE--DGRY-ILKIYRPG-WT---------------RAEIPFELALLQHLAERGIPVPAPLPSLDGE   92 (331)
T ss_pred             cccc-ccCceEEEEec--CCCe-EEEEecCC-CC---------------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcc
Confidence            3444 44568888753  5555 88877443 21               356777788888774211      2222221


Q ss_pred             E--EeCC--eeEEEEEecCCCCHHH------------H---Hhhhc--------CCCCCCCHHH-------------HHH
Q 014140          215 M--VRRD--CDLLVYEFRRNGSLQD------------I---LYDVS--------QGRRELDWLA-------------RHR  254 (430)
Q Consensus       215 ~--~~~~--~~~lV~E~~~~gsL~~------------~---l~~~~--------~~~~~l~~~~-------------~~~  254 (430)
                      .  .-.+  ..+-+++|++|..+..            +   |+...        .......|..             ...
T Consensus        93 ~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~  172 (331)
T COG2334          93 LLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPED  172 (331)
T ss_pred             hhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchh
Confidence            1  1133  6678999999977762            1   11100        0111233320             011


Q ss_pred             HHHHHHHHHHHHhhc----CCCC---eEecCCCCCcEEeCCCCc-eEEeecCCccc
Q 014140          255 IAQGIASGLEYLHMS----HRPR---IIHRDIQPANVLIDDDME-ARISEFGLAKR  302 (430)
Q Consensus       255 i~~~i~~~l~~LH~~----~~~~---iiH~Dlkp~Nill~~~~~-~kl~Dfg~a~~  302 (430)
                      ...++...+..+...    -...   +||+|+.|.||+++.+.. +.+.||+.+..
T Consensus       173 l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         173 LRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            233333444444322    1223   999999999999998884 89999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.02  E-value=0.07  Score=51.00  Aligned_cols=30  Identities=13%  Similarity=0.354  Sum_probs=26.0

Q ss_pred             CeEecCCCCCcEEeCC-CCceEEeecCCccc
Q 014140          273 RIIHRDIQPANVLIDD-DMEARISEFGLAKR  302 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~-~~~~kl~Dfg~a~~  302 (430)
                      ..+|.|+.+.||++++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4899999999999975 57899999988754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.92  E-value=0.12  Score=48.95  Aligned_cols=32  Identities=19%  Similarity=0.290  Sum_probs=28.4

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..++||+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.92  E-value=0.053  Score=52.50  Aligned_cols=81  Identities=11%  Similarity=-0.016  Sum_probs=50.9

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCc-ccceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNI-VPLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpni-v~l~~~~  215 (430)
                      .+.||-|...-||++.... .++.++||.-..-..        ....-.-...+..-|...|+...  .|.. .+++.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~-~~~svIVKQAlp~vR--------v~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ-KNISVIVKQAGDTAR--------ISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC-CCceEEEEeccHhhc--------cCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            5688999999999998632 356799997633221        11111122566777888888773  3544 44443  


Q ss_pred             EeCCeeEEEEEecCC
Q 014140          216 VRRDCDLLVYEFRRN  230 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~  230 (430)
                      .+.+...+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            345556789998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.81  E-value=0.4  Score=45.74  Aligned_cols=30  Identities=27%  Similarity=0.405  Sum_probs=25.1

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45689999999999995 3 578999998754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.68  E-value=0.046  Score=52.52  Aligned_cols=61  Identities=21%  Similarity=0.227  Sum_probs=42.3

Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ...|+=+|+.|.++..++..     ...++..+..++.--+.|+--+-.-.  .++|.|+.|.||++-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            34577789999999998843     33455566666666666654443222  399999999999984

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.39  E-value=0.052  Score=47.82  Aligned_cols=122  Identities=13%  Similarity=0.044  Sum_probs=74.5

Q ss_pred             HHHHHHHHHHhccCCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014140          191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH  270 (430)
Q Consensus       191 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  270 (430)
                      .-+.++.+++++++  .|+++..=  .+-.+.++.|+|.....             .+    ..++..=+.+|.-.|+. 
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N~i~agi~~L~~fH~~-  160 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SNFITAGIKDLMDFHSE-  160 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hHHHHHhHHHHHHhhcc-
Confidence            45678888888864  45666531  22345689999854211             00    11222224667778866 


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI  350 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~  350 (430)
                      +.+.+|||..|+||+-|..|.+||.|-+.--.              .+..|.--|+   ...+.++.+-+|=.-++++..
T Consensus       161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---cccChHHHHHHHHHHHHHHHH
Confidence            56799999999999999999999999764211              1112222111   134566666666666666655


Q ss_pred             C
Q 014140          351 G  351 (430)
Q Consensus       351 g  351 (430)
                      .
T Consensus       224 ~  224 (308)
T PF07387_consen  224 K  224 (308)
T ss_pred             H
Confidence            3

The function of this family is unknown.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=95.27  E-value=0.013  Score=62.91  Aligned_cols=50  Identities=18%  Similarity=0.245  Sum_probs=46.1

Q ss_pred             ChhHHHHHHhHHHhhhchHHHHHHHHHHHHhhhhhhhhHHHhhhHHHHHH
Q 014140            1 MVKINKVLDDAIEKQTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQMM   50 (430)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   50 (430)
                      |..++..++||+.++-...-++.|.+.+++++|+++|+++.+..+....+
T Consensus        37 L~~l~~~l~d~~a~~~~~~~~~~~~e~~~~~~~~~e~~~~~~~v~~~~~~   86 (889)
T KOG4658|consen   37 LKALQSALEDLDAKRDDLERRVNWEEDVGDLVYLAEDIIWLFLVEEIERK   86 (889)
T ss_pred             HHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            45789999999999999999999999999999999999999999987753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.18  E-value=0.089  Score=49.89  Aligned_cols=73  Identities=16%  Similarity=0.135  Sum_probs=56.4

Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      ...|++|++. |+++.- +       ..-.+.+...++.+.+..+.-+...  -+.-|||+.-.||||+ +|++.|+||-
T Consensus       299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence            3456777775 555532 2       3457888899999988877777644  3689999999999999 9999999999


Q ss_pred             CcccC
Q 014140          299 LAKRI  303 (430)
Q Consensus       299 ~a~~~  303 (430)
                      +++.-
T Consensus       367 lsRl~  371 (488)
T COG5072         367 LSRLS  371 (488)
T ss_pred             eeecc
Confidence            99853

>PTZ00384 choline kinase; Provisional

Probab=94.65  E-value=0.26  Score=48.03  Aligned_cols=30  Identities=20%  Similarity=0.151  Sum_probs=24.4

Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          272 PRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ...||.|+-+.||+.++ ..+.++||-.|..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            46899999999998764 4699999976643

>PRK06148 hypothetical protein; Provisional

Probab=94.44  E-value=0.97  Score=50.01  Aligned_cols=32  Identities=31%  Similarity=0.523  Sum_probs=26.8

Q ss_pred             CCCeEecCCCCCcEEeCCCC--ceE-EeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDM--EAR-ISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~--~~k-l~Dfg~a~~  302 (430)
                      ..++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            45799999999999999875  454 999998765

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.08  E-value=0.21  Score=45.63  Aligned_cols=75  Identities=17%  Similarity=0.034  Sum_probs=51.4

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH---HHHhccCCCCcccceeEEE
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI---ITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~~~~~  216 (430)
                      ..+..|..+.|+.++..  +|.+.++|.......                   ...|.   ..|+..+-...|+++..- 
T Consensus         8 ~~~~~g~~s~V~pv~~~--dG~~avLKl~~p~~~-------------------~~~E~~g~~~L~~w~G~GaVrll~~d-   65 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRA--DGTPAVLKLAPPHAE-------------------AEHEARGEAALRWWNGRGAVRLLAAD-   65 (253)
T ss_pred             CCCCCCcceEEEEEEcC--CCCeEEEEecCCccc-------------------chhhhhHHhHhheeCCCCceeeeccc-
Confidence            44567888999999765  899999998743211                   22233   457777778889988854 


Q ss_pred             eCCeeEEEEEec-CCCCHHHHH
Q 014140          217 RRDCDLLVYEFR-RNGSLQDIL  237 (430)
Q Consensus       217 ~~~~~~lV~E~~-~~gsL~~~l  237 (430)
                       .+.-.|++|.+ ++.+|.++.
T Consensus        66 -~~~~AlLLErl~~g~~L~~~~   86 (253)
T PF04655_consen   66 -PERGALLLERLDPGRSLASLP   86 (253)
T ss_pred             -cccchhhhhhccCCCchhhcc
Confidence             33456888988 555776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	430
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-34
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-08
3soa_A	444	Full-Length Human Camkii Length = 444		3e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-04
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		7e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 17/279 (6%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L  + G ++ +K++ +    G EL             Q ++E+       HRN
Sbjct: 52  GKVYKGRL--ADGTLVAVKRLKEERXQGGEL-------------QFQTEVEMISMAVHRN 96
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ L    +     LLVY +  NGS+   L +  + +  LDW  R RIA G A GL YLH
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 156
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
               P+IIHRD++ AN+L+D++ EA + +FGLAK + D        ++ GT+G+IAPE  
Sbjct: 157 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            T   S+  D++ +GV+L  L+ G+   D     +  ++ L+ W++ ++  +     ++ 
Sbjct: 216 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 275
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
            L GN  +E++  ++++A  CT   P +RP   +V  ML
Sbjct: 276 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 146/279 (52%), Gaps = 17/279 (6%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L  + G ++ +K++ +    G EL             Q ++E+       HRN
Sbjct: 44  GKVYKGRL--ADGXLVAVKRLKEERTQGGEL-------------QFQTEVEMISMAVHRN 88
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ L    +     LLVY +  NGS+   L +  + +  LDW  R RIA G A GL YLH
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
               P+IIHRD++ AN+L+D++ EA + +FGLAK + D        ++ G +G+IAPE  
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            T   S+  D++ +GV+L  L+ G+   D     +  ++ L+ W++ ++  +     ++ 
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
            L GN  +E++  ++++A  CT   P +RP   +V  ML
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 23/282 (8%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  +  ++   + +KK+   +    E +K+          Q   EI    + +H N
Sbjct: 45  GVVYKGYVNNTT---VAVKKLAAMVDITTEELKQ----------QFDQEIKVMAKCQHEN 91
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL      D   LVY +  NGSL D L     G   L W  R +IAQG A+G+ +LH
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAGTVGYIAPEC 326
            +H    IHRDI+ AN+L+D+   A+IS+FGLA R  +   +T   S + GT  Y+APE 
Sbjct: 151 ENHH---IHRDIKSANILLDEAFTAKISDFGLA-RASEKFAQTVMXSRIVGTTAYMAPEA 206
Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            +   ++   DIYSFGV+L  ++ G  P+ D  +H +   L+     +   E        
Sbjct: 207 LRG-EITPKSDIYSFGVVLLEIITG-LPAVD--EHREPQLLLDIKEEIEDEEKTIEDYID 262
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           K + +     +  +  +A  C  +  NKRP+ K V+ +L ++
Sbjct: 263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 134/281 (47%), Gaps = 21/281 (7%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  +  ++   + +KK+   +    E +K+          Q   EI    + +H N
Sbjct: 45  GVVYKGYVNNTT---VAVKKLAAMVDITTEELKQ----------QFDQEIKVMAKCQHEN 91
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL      D   LVY +  NGSL D L     G   L W  R +IAQG A+G+ +LH
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            +H    IHRDI+ AN+L+D+   A+IS+FGLA+             + GT  Y+APE  
Sbjct: 151 ENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
           +   ++   DIYSFGV+L  ++ G  P+ D  +H +   L+     +   E        K
Sbjct: 208 RG-EITPKSDIYSFGVVLLEIITG-LPAVD--EHREPQLLLDIKEEIEDEEKTIEDYIDK 263
Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
            + +     +  +  +A  C  +  NKRP+ K V+ +L ++
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 21/281 (7%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  +  ++   + +KK+       A ++   +E L     Q   EI    + +H N
Sbjct: 39  GVVYKGYVNNTT---VAVKKL-------AAMVDITTEELKQ---QFDQEIKVMAKCQHEN 85
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL      D   LVY +  NGSL D L     G   L W  R +IAQG A+G+ +LH
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            +H    IHRDI+ AN+L+D+   A+IS+FGLA+             + GT  Y+APE  
Sbjct: 145 ENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
           +   ++   DIYSFGV+L  ++ G  P+ D  +H +   L+     +   E        K
Sbjct: 202 RG-EITPKSDIYSFGVVLLEIITG-LPAVD--EHREPQLLLDIKEEIEDEEKTIEDYIDK 257
Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
            + +     +  +  +A  C  +  NKRP+ K V+ +L ++
Sbjct: 258 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 21/280 (7%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  +  ++   + +KK+       A ++   +E L  +  Q   EI    + +H N
Sbjct: 36  GVVYKGYVNNTT---VAVKKL-------AAMVDITTEELKQQFDQ---EIKVXAKCQHEN 82
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL      D   LVY +  NGSL D L     G   L W  R +IAQG A+G+ +LH
Sbjct: 83  LVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            +H    IHRDI+ AN+L+D+   A+IS+FGLA+             + GT  Y APE  
Sbjct: 142 ENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
           +   ++   DIYSFGV+L  ++ G  P+ D  +H +   L+     +   E        K
Sbjct: 199 RG-EITPKSDIYSFGVVLLEIITG-LPAVD--EHREPQLLLDIKEEIEDEEKTIEDYIDK 254
Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ 427
              +     +     +A  C  +  NKRP+ K V+ +L +
Sbjct: 255 KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 79/142 (55%), Gaps = 3/142 (2%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           RH ++V L+     R+  +L+Y++  NG+L+  LY        + W  R  I  G A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            YLH      IIHRD++  N+L+D++   +I++FG++K+  +         + GT+GYI 
Sbjct: 153 HYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 324 PECHQTVALSDTCDIYSFGVLL 345
           PE      L++  D+YSFGV+L
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVL 231

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 79/142 (55%), Gaps = 3/142 (2%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           RH ++V L+     R+  +L+Y++  NG+L+  LY        + W  R  I  G A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            YLH      IIHRD++  N+L+D++   +I++FG++K+  +         + GT+GYI 
Sbjct: 153 HYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 324 PECHQTVALSDTCDIYSFGVLL 345
           PE      L++  D+YSFGV+L
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVL 231

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 19/192 (9%)
Query: 163 ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDL 222
           + IK I  P +   E +K+    +H+           + Q+ H+NIV ++      DC  
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHN-----------SSQLSHQNIVSMIDVDEEDDCYY 87
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+    +L +  Y  S G   +D          I  G+++   +H  RI+HRDI+P 
Sbjct: 88  LVMEYIEGPTLSE--YIESHGPLSVDTAIN--FTNQILDGIKH---AHDMRIVHRDIKPQ 140
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           N+LID +   +I +FG+AK + +  + T T  + GTV Y +PE  +  A  +  DIYS G
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG 199
Query: 343 VLLAVLVIGKFP 354
           ++L  +++G+ P
Sbjct: 200 IVLYEMLVGEPP 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I+ EI      RH +I+ L   +       +V E+   G L D  Y    GR E +  A
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD--YICKHGRVE-EMEA 113
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
           R R+ Q I S ++Y    HR  ++HRD++P NVL+D  M A+I++FGL+  + DG    T
Sbjct: 114 R-RLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169
Query: 312 TWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           +    G+  Y APE     +      DI+S GV+L  L+ G  P DD  +H    +L + 
Sbjct: 170 S---CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVP--TLFKK 222
Query: 371 MRN--VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR 422
           +R       E  NR++ + L+       ML V          DP KR   KD+R
Sbjct: 223 IRGGVFYIPEYLNRSVATLLM------HMLQV----------DPLKRATIKDIR 260

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +IR EI      RH +I+ L   +       +V E+   G L D  Y    GR  LD   
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD--YICKNGR--LDEKE 117
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R+ Q I SG++Y    HR  ++HRD++P NVL+D  M A+I++FGL+  + DG     
Sbjct: 118 SRRLFQQILSGVDY---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRX 174
Query: 312 TWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
           +    G+  Y APE     +      DI+S GV+L  L+ G  P DD
Sbjct: 175 S---CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT 199
           EKI +   G V++AE  GS   V    KI+      AE +            +   E+  
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAV----KILMEQDFHAERVN-----------EFLREVAI 87
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI 259
             ++RH NIV  +  + +     +V E+   GSL  +L+  S  R +LD   R  +A  +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDV 146
Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV 319
           A G+ YLH +  P I+HR+++  N+L+D     ++ +FGL++      T  ++ S AGT 
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 320 GYIAPECHQTVALSDTCDIYSFGVLL 345
            ++APE  +    ++  D+YSFGV+L
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVIL 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I+ EI      RH +I+ L   +       +V E+   G L D  Y    GR E +  A
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD--YICKHGRVE-EMEA 113
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
           R R+ Q I S ++Y    HR  ++HRD++P NVL+D  M A+I++FGL+  + DG     
Sbjct: 114 R-RLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD 169
Query: 312 TWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
           +    G+  Y APE     +      DI+S GV+L  L+ G  P DD  +H    +L + 
Sbjct: 170 S---CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVP--TLFKK 222
Query: 371 MRN--VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR 422
           +R       E  NR++ + L+       ML V          DP KR   KD+R
Sbjct: 223 IRGGVFYIPEYLNRSVATLLM------HMLQV----------DPLKRATIKDIR 260

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 31/282 (10%)
Query: 154 ELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA 213
           E+ GS    +       P K    + + + E     M ++  EI    Q  H NIV    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 214 RMVRRDCDLLVYEFRRNGSLQDIL-YDVSQGRRELDWLARHRIA---QGIASGLEYLHMS 269
             V +D   LV +    GS+ DI+ + V++G  +   L    IA   + +  GLEYLH +
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---WSLAGTVGYIAPEC 326
            +   IHRD++  N+L+ +D   +I++FG++  +  G   T      +  GT  ++APE 
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 327 HQTVALSD-TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN 385
            + V   D   DI+SFG+    L  G  P    +     M ++     ++T +N     +
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP----YHKYPPMKVL-----MLTLQN-----D 243
Query: 386 SKLLGNGYEEQMLL------VLKIACFCTLDDPNKRPNSKDV 421
              L  G +++ +L        K+   C   DP KRP + ++
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 31/282 (10%)
Query: 154 ELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA 213
           E+ GS    +       P K    + + + E     M ++  EI    Q  H NIV    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 214 RMVRRDCDLLVYEFRRNGSLQDIL-YDVSQGRRELDWLARHRIA---QGIASGLEYLHMS 269
             V +D   LV +    GS+ DI+ + V++G  +   L    IA   + +  GLEYLH +
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---WSLAGTVGYIAPEC 326
            +   IHRD++  N+L+ +D   +I++FG++  +  G   T      +  GT  ++APE 
Sbjct: 136 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 327 HQTVALSD-TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN 385
            + V   D   DI+SFG+    L  G  P    +     M ++     ++T +N     +
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAP----YHKYPPMKVL-----MLTLQN-----D 238
Query: 386 SKLLGNGYEEQMLL------VLKIACFCTLDDPNKRPNSKDV 421
              L  G +++ +L        K+   C   DP KRP + ++
Sbjct: 239 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT 199
           EKI +   G V++AE  GS   V    KI+      AE +            +   E+  
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAV----KILMEQDFHAERVN-----------EFLREVAI 87
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI 259
             ++RH NIV  +  + +     +V E+   GSL  +L+  S  R +LD   R  +A  +
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDV 146
Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV 319
           A G+ YLH +  P I+HRD++  N+L+D     ++ +FGL++        +     AGT 
Sbjct: 147 AKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX--AAGTP 203
Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            ++APE  +    ++  D+YSFGV+L  L   + P
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 25/235 (10%)
Query: 124 EEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDS 183
           +ED    + E+ F  LEK+     G VYKA +   +G+++ IK++               
Sbjct: 19  DEDSLTKQPEEVFDVLEKLGEGSYGSVYKA-IHKETGQIVAIKQV--------------- 62
Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
            P+   + +I  EI    Q    ++V       +     +V E+   GS+ DI+   ++ 
Sbjct: 63  -PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
             E D +A   I Q    GLEYLH     R IHRDI+  N+L++ +  A++++FG+A ++
Sbjct: 122 LTE-DEIAT--ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 304 PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            D   +     + GT  ++APE  Q +  +   DI+S G+    +  GK P  D 
Sbjct: 176 TDXMAKRN--XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 91/170 (53%), Gaps = 12/170 (7%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +++  EI     +RH +I+ L   +      ++V E+   G L D  Y V + R   D  
Sbjct: 54  MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFD--YIVEKKRMTED-- 108
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
              R  Q I   +EY    HR +I+HRD++P N+L+DD++  +I++FGL+  + DG+   
Sbjct: 109 EGRRFFQQIICAIEY---CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165
Query: 311 TTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF 359
           T+    G+  Y APE  +  +      D++S G++L V+++G+ P DD F
Sbjct: 166 TS---CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
           E +   +  +R E      ++H NI+ L    ++     LV EF R G L  +L   S  
Sbjct: 44  EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGK 100
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME--------ARIS 295
           R   D L    +   IA G+ YLH      IIHRD++ +N+LI   +E         +I+
Sbjct: 101 RIPPDILVNWAVQ--IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +FGLA+       RTT  S AG   ++APE  +    S   D++S+GVLL  L+ G+ P
Sbjct: 159 DFGLARE----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           N ++ K    GS G+V          K   ++I K          +I  EI     +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +I+ L   +  +D  ++V E+  N      L+D    R ++      R  Q I S +EY 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVEY- 128
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              HR +I+HRD++P N+L+D+ +  +I++FGL+  + DG+   T+    G+  Y APE 
Sbjct: 129 --CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEV 183
Query: 327 -HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               +      D++S GV+L V++  + P DD
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           N ++ K    GS G+V          K   ++I K          +I  EI     +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +I+ L   +  +D  ++V E+  N      L+D    R ++      R  Q I S +EY 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVEY- 127
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              HR +I+HRD++P N+L+D+ +  +I++FGL+  + DG+   T+    G+  Y APE 
Sbjct: 128 --CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEV 182
Query: 327 -HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               +      D++S GV+L V++  + P DD
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           N ++ K    GS G+V          K   ++I K          +I  EI     +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +I+ L   +  +D  ++V E+  N      L+D    R ++      R  Q I S +EY 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVEY- 118
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              HR +I+HRD++P N+L+D+ +  +I++FGL+  + DG+   T+    G+  Y APE 
Sbjct: 119 --CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEV 173
Query: 327 -HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               +      D++S GV+L V++  + P DD
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 30/209 (14%)
Query: 167 KIIQPLKSGA----ELIKKDSEPLHHKMIQIRSEIIT-AGQVRHRN-------IV--PLL 212
           +I++ L +G+     LI+      ++ M  ++ EI+    QV H N       IV  P +
Sbjct: 9   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 213 ARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
            RM     D     ++ ++   G L  +L    + +R  + +A+   A+ +   LEYLH 
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAE-VCLALEYLHS 124
Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
                II+RD++P N+L+D +   +I++FG AK +PD      T+ L GT  YIAPE   
Sbjct: 125 KD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVS 176
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
           T   + + D +SFG+L+  ++ G  P  D
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           N ++ K    GS G+V          K   ++I K          +I  EI     +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +I+ L   +  +D  ++V E+  N      L+D    R ++      R  Q I S +EY 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEARRFFQQIISAVEY- 122
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              HR +I+HRD++P N+L+D+ +  +I++FGL+  + DG+   T+    G+  Y APE 
Sbjct: 123 --CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEV 177
Query: 327 -HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               +      D++S GV+L V++  + P DD
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 9/168 (5%)
Query: 190 MIQ-IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
           M+Q +++E+    Q++H +I+ L       +   LV E   NG +   L +  +   E +
Sbjct: 54  MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE 113
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
             ARH + Q I +G+ YLH SH   I+HRD+  +N+L+  +M  +I++FGLA ++   H 
Sbjct: 114 --ARHFMHQ-IITGMLYLH-SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
           +   ++L GT  YI+PE     A     D++S G +   L+IG+ P D
Sbjct: 168 K--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVYK  L  SSG+   +   I+ LK+G             + +    E    GQ  H N
Sbjct: 58  GEVYKGMLKTSSGKK-EVPVAIKTLKAGYT---------EKQRVDFLGEAGIMGQFSHHN 107
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL- 266
           I+ L   + +    +++ E+  NG+L   L    +   E   L    + +GIA+G++YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG-TVGYIAPE 325
           +M++    +HRD+   N+L++ ++  ++S+FGL++ + D    T T S     + + APE
Sbjct: 165 NMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 326 CHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQH 361
                  +   D++SFG+++  V+  G+ P  +   H
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIA 260
           +V  R +V L      +D   LV      G L+  +Y + Q G  E   +     A  I 
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF---YAAEIC 296
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            GLE LH   R RI++RD++P N+L+DD    RIS+ GLA  +P+G    T     GTVG
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVG 350
Query: 321 YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           Y+APE  +    + + D ++ G LL  ++ G+ P    FQ  K+
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQRKK 390

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 46/261 (17%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL     ++ + R+ L
Sbjct: 63  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKAL 118
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 119 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 174
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--------- 356
           G  + T   L GT  YIAPE       S   D++S G ++  L++GK P +         
Sbjct: 175 GERKKT---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 231
Query: 357 -------DFFQHTKEM--SLVQWMRNVMTSENP--NRAINSKLLGNGYEEQMLLVLKIAC 405
                     +H   +  SL+Q M     +  P  N  +N +   +GY   +   L I C
Sbjct: 232 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY---IPARLPITC 288
Query: 406 FC----------TLDDPNKRP 416
                       +LD  N++P
Sbjct: 289 LTIPPRFSIAPSSLDPSNRKP 309

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIA 260
           +V  R +V L      +D   LV      G L+  +Y + Q G  E   +     A  I 
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF---YAAEIC 296
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            GLE LH   R RI++RD++P N+L+DD    RIS+ GLA  +P+G    T     GTVG
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVG 350
Query: 321 YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           Y+APE  +    + + D ++ G LL  ++ G+ P    FQ  K+
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQRKK 390

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 46/261 (17%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL     ++ + R+ L
Sbjct: 59  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKAL 114
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 115 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--------- 356
           G  + T   L GT  YIAPE       S   D++S G ++  L++GK P +         
Sbjct: 171 GERKKT---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227
Query: 357 -------DFFQHTKEM--SLVQWMRNVMTSENP--NRAINSKLLGNGYEEQMLLVLKIAC 405
                     +H   +  SL+Q M     +  P  N  +N +   +GY   +   L I C
Sbjct: 228 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY---IPARLPITC 284
Query: 406 FC----------TLDDPNKRP 416
                       +LD  N++P
Sbjct: 285 LTIPPRFSIAPSSLDPSNRKP 305

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 46/261 (17%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL     ++ + R+ L
Sbjct: 59  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKAL 114
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 115 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 170
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--------- 356
           G  + T   L GT  YIAPE       S   D++S G ++  L++GK P +         
Sbjct: 171 GERKKT---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227
Query: 357 -------DFFQHTKEM--SLVQWMRNVMTSENP--NRAINSKLLGNGYEEQMLLVLKIAC 405
                     +H   +  SL+Q M     +  P  N  +N +   +GY   +   L I C
Sbjct: 228 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY---IPARLPITC 284
Query: 406 FC----------TLDDPNKRP 416
                       +LD  N++P
Sbjct: 285 LTIPPXFSIAPSSLDPSNRKP 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 152/318 (47%), Gaps = 54/318 (16%)
Query: 125 EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSE 184
           E+L F    + +  LEK+     G VYKA+   S GR++ +K+I           + D+E
Sbjct: 12  ENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRI-----------RLDAE 58
Query: 185 PLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR 244
                   IR EI    ++ H NIV L+  +    C  LV+EF     L+ +L +   G 
Sbjct: 59  DEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL 116
Query: 245 RELDW-LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR- 302
           ++    +  +++ +G+A         H+ RI+HRD++P N+LI+ D   ++++FGLA+  
Sbjct: 117 QDSQIKIYLYQLLRGVAH-------CHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 303 -IPDGHTRTTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP--SD 356
            IP    R+ T  +  T+ Y AP+    +   S + DI+S G + A ++ GK  FP  +D
Sbjct: 170 GIP---VRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225
Query: 357 D-----FFQ-----HTKEMSLVQ----WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK 402
           D      F      + +E   VQ    W +   T +   +   S ++    +E + L+  
Sbjct: 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSN 283
Query: 403 IACFCTLDDPNKRPNSKD 420
           + CF    DPNKR +++D
Sbjct: 284 MLCF----DPNKRISARD 297

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 152/318 (47%), Gaps = 54/318 (16%)
Query: 125 EDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSE 184
           E+L F    + +  LEK+     G VYKA+   S GR++ +K+I           + D+E
Sbjct: 12  ENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRI-----------RLDAE 58
Query: 185 PLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR 244
                   IR EI    ++ H NIV L+  +    C  LV+EF     L+ +L +   G 
Sbjct: 59  DEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGL 116
Query: 245 RELDW-LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR- 302
           ++    +  +++ +G+A         H+ RI+HRD++P N+LI+ D   ++++FGLA+  
Sbjct: 117 QDSQIKIYLYQLLRGVAH-------CHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 303 -IPDGHTRTTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP--SD 356
            IP    R+ T  +  T+ Y AP+    +   S + DI+S G + A ++ GK  FP  +D
Sbjct: 170 GIP---VRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225
Query: 357 D-----FFQ-----HTKEMSLVQ----WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK 402
           D      F      + +E   VQ    W +   T +   +   S ++    +E + L+  
Sbjct: 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSN 283
Query: 403 IACFCTLDDPNKRPNSKD 420
           + CF    DPNKR +++D
Sbjct: 284 MLCF----DPNKRISARD 297

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 19/226 (8%)
Query: 133 EDYFASLEKIRSCWNGEVYKA-ELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI 191
           E YF  + K+ S   GEV    E  G S + I + K  Q  K       K+ E  H    
Sbjct: 36  ESYF-KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE--- 91
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I +EI     + H NI+ L      +    LV EF   G L    ++    R + D   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECD 147
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---MEARISEFGLAKRIPDGHT 308
              I + I SG+ YLH   +  I+HRDI+P N+L+++    +  +I +FGL+      + 
Sbjct: 148 AANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                   GT  YIAPE  +    ++ CD++S GV++ +L+ G  P
Sbjct: 205 LRDR---LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G +   L  +S+         
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-------FD 111
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 169
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 170 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 228 FTFPDFVTEGARDLISRLLKHNPSQRPML 256

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 64/105 (60%), Gaps = 8/105 (7%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
           AR+ + Q I  G++YLH +   R+IHRD++  N+ ++DDM+ +I +FGLA +I  DG  +
Sbjct: 144 ARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            T   L GT  YIAPE       S   DI+S G +L  L++GK P
Sbjct: 200 KT---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       L+ E+   G + D  Y V+ GR + +  AR +  Q I S 
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMK-EKEARSKFRQ-IVSA 123
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y    H+ RI+HRD++  N+L+D DM  +I++FG +     G    T     G+  Y 
Sbjct: 124 VQY---CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYA 177
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 219

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 107
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS--SRRT 165
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L+GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 166 T--LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 224 FTFPDFVTEGARDLISRLLKHNPSQRPML 252

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 123
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 124 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 181
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 182 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 239
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 240 FTFPDFVTEGARDLISRLLKHNPSQRPML 268

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 46/261 (17%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL     ++ + R+ L
Sbjct: 81  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKAL 136
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 137 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 192
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--------- 356
           G  +     L GT  YIAPE       S   D++S G ++  L++GK P +         
Sbjct: 193 GERKKV---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 249
Query: 357 -------DFFQHTKEM--SLVQWMRNVMTSENP--NRAINSKLLGNGYEEQMLLVLKIAC 405
                     +H   +  SL+Q M     +  P  N  +N +   +GY   +   L I C
Sbjct: 250 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY---IPARLPITC 306
Query: 406 FC----------TLDDPNKRP 416
                       +LD  N++P
Sbjct: 307 LTIPPRFSIAPSSLDPSNRKP 327

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 165 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/128 (38%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   GSL+D L   S G  +L   A     Q I  G+ YLH  H    IHRD+   
Sbjct: 112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFA-----QQICEGMAYLHAQH---YIHRDLAAR 163
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSF 341
           NVL+D+D   +I +FGLAK +P+GH          + V + APEC +        D++SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 224 GVTLYELL 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 111
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 169
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 170 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 228 FTFPDFVTEGARDLISRLLKHNPSQRPML 256

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 132
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 190
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 191 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 248
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 249 FTFPDFVTEGARDLISRLLKHNPSQRPML 277

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 106 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 163
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 164 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 221
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 222 FTFPDFVTEGARDLISRLLKHNPSQRPML 250

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 110
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 168
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 169 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 226
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNPSQRPML 255

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 46/261 (17%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL     ++ + R+ L
Sbjct: 83  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKAL 138
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 139 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD--------- 356
           G  +     L GT  YIAPE       S   D++S G ++  L++GK P +         
Sbjct: 195 GERKKV---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251
Query: 357 -------DFFQHTKEM--SLVQWMRNVMTSENP--NRAINSKLLGNGYEEQMLLVLKIAC 405
                     +H   +  SL+Q M     +  P  N  +N +   +GY   +   L I C
Sbjct: 252 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY---IPARLPITC 308
Query: 406 FC----------TLDDPNKRP 416
                       +LD  N++P
Sbjct: 309 LTIPPRFSIAPSSLDPSNRKP 329

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 126
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H  +   I+HRD++  N+L+D DM  +I++FG +     G+   T     G+  Y 
Sbjct: 127 VQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYA 180
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV +     A         +V E+    +L+DI++  ++G   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN++I      ++ +FG+A+ I D 
Sbjct: 112 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP----SDD--FF 359
           G++ T T ++ GT  Y++PE  +  ++    D+YS G +L  ++ G+ P    S D   +
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAY 229
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 230 QHVREDPIPPSARH 243

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 103
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 104 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 161
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 162 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 219
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 220 FTFPDFVTEGARDLISRLLKHNPSQRPML 248

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 188 HKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL 247
           H+  ++  EI     + H+++V         D   +V E  R  SL ++     + R+ L
Sbjct: 57  HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL----HKRRKAL 112
Query: 248 -DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-D 305
            +  AR+ + Q I  G +YLH   R R+IHRD++  N+ +++D+E +I +FGLA ++  D
Sbjct: 113 TEPEARYYLRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           G  +     L GT  YIAPE       S   D++S G ++  L++GK P
Sbjct: 169 GERKKV---LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I+ FG +   P   +R T
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS--SRRT 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 108
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I+ FG +   P   +R T
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS--SRRT 166
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 167 T--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 225 FTFPDFVTEGARDLISRLLKHNPSQRPML 253

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+   T     G+  Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+   T     G+  Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 202 QVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           Q+RH N+V LL  +V     L +V E+   GSL D L   S+GR  L      + +  + 
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVC 118
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
             +EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T  L   V 
Sbjct: 119 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVK 170
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           + APE  +  A S   D++SFG+LL  +   G+ P
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H   +  LA       DL LV      G ++  +Y+V +                I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E+LH  +   II+RD++P NVL+DDD   RIS+ GLA  +  G T+T  +  AGT G++A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMA 357
Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE         + D ++ GV L  ++  + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSG----AELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL 212
           GS G+V  ++K+ +P  SG     +++KK +  +  + ++ + E      V H  +V L 
Sbjct: 39  GSFGKVFLVRKVTRP-DSGHLYAMKVLKKATLKVRDR-VRTKMERDILADVNHPFVVKLH 96
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                     L+ +F R G   D+   +S+     +   +  +A+ +A GL++LH     
Sbjct: 97  YAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHSL--- 149
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            II+RD++P N+L+D++   ++++FGL+K   D   +   +S  GTV Y+APE       
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK--AYSFCGTVEYMAPEVVNRQGH 207
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S + D +S+GVL+  ++ G  P
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H   +  LA       DL LV      G ++  +Y+V +                I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E+LH  +   II+RD++P NVL+DDD   RIS+ GLA  +  G T+T  +  AGT G++A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMA 357
Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE         + D ++ GV L  ++  + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H   +  LA       DL LV      G ++  +Y+V +                I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E+LH  +   II+RD++P NVL+DDD   RIS+ GLA  +  G T+T  +  AGT G++A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMA 357
Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE         + D ++ GV L  ++  + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+   T     G+  Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV +     A         +V E+    +L+DI++  ++G   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN++I      ++ +FG+A+ I D 
Sbjct: 112 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP-SDD-----FF 359
           G++ T T ++ GT  Y++PE  +  ++    D+YS G +L  ++ G+ P + D      +
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 230 QHVREDPIPPSARH 243

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H   +  LA       DL LV      G ++  +Y+V +                I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E+LH  +   II+RD++P NVL+DDD   RIS+ GLA  +  G T+T  +  AGT G++A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMA 357
Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE         + D ++ GV L  ++  + P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV +     A         +V E+    +L+DI++  ++G   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN++I      ++ +FG+A+ I D 
Sbjct: 112 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG-VLLAVLV-----IGKFPSDDFF 359
           G++ T T ++ GT  Y++PE  +  ++    D+YS G VL  VL       G  P    +
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 230 QHVREDPIPPSARH 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 63/105 (60%), Gaps = 8/105 (7%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
           AR+ + Q I  G++YLH +   R+IHRD++  N+ ++DDM+ +I +FGLA +I  DG  +
Sbjct: 128 ARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 183
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                L GT  YIAPE       S   DI+S G +L  L++GK P
Sbjct: 184 K---DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   GSL+D L     G  +L   A     Q I  G+ YLH  H    IHR +   
Sbjct: 89  LVMEYVPLGSLRDYLPRHCVGLAQLLLFA-----QQICEGMAYLHAQH---YIHRALAAR 140
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSF 341
           NVL+D+D   +I +FGLAK +P+GH          + V + APEC +        D++SF
Sbjct: 141 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSF 200
Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           GV L  L+   +   +   HTK   L+   +  MT
Sbjct: 201 GVTLYELLT--YCDSNQSPHTKFTELIGHTQGQMT 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   GSL+D L   S G  +L   A     Q I  G+ YLH  H    IHR++   
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLLFA-----QQICEGMAYLHAQH---YIHRNLAAR 146
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSF 341
           NVL+D+D   +I +FGLAK +P+GH          + V + APEC +        D++SF
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 207 GVTLYELL 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLA----RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV + A             +V E+    +L+DI++  ++G   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN++I      ++ +FG+A+ I D 
Sbjct: 112 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG-VLLAVLV-----IGKFPSDDFF 359
           G++ T T ++ GT  Y++PE  +  ++    D+YS G VL  VL       G  P    +
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 230 QHVREDPIPPSARH 243

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   GSL+D L     G  +L   A     Q I  G+ YLH  H    IHR +   
Sbjct: 90  LVMEYVPLGSLRDYLPRHCVGLAQLLLFA-----QQICEGMAYLHAQH---YIHRALAAR 141
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSF 341
           NVL+D+D   +I +FGLAK +P+GH          + V + APEC +        D++SF
Sbjct: 142 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSF 201
Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           GV L  L+   +   +   HTK   L+   +  MT
Sbjct: 202 GVTLYELLT--YCDSNQSPHTKFTELIGHTQGQMT 234

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 107
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P     T 
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT- 166
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 167 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 224 FTFPDFVTEGARDLISRLLKHNPSQRPML 252

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 63/105 (60%), Gaps = 8/105 (7%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
           AR+ + Q I  G++YLH +   R+IHRD++  N+ ++DDM+ +I +FGLA +I  DG  +
Sbjct: 144 ARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                L GT  YIAPE       S   DI+S G +L  L++GK P
Sbjct: 200 K---XLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 63/105 (60%), Gaps = 8/105 (7%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
           AR+ + Q I  G++YLH +   R+IHRD++  N+ ++DDM+ +I +FGLA +I  DG  +
Sbjct: 144 ARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                L GT  YIAPE       S   DI+S G +L  L++GK P
Sbjct: 200 K---DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   GSL+D L   S G  +L   A     Q I  G+ YLH  H    IHR++   
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLLFA-----QQICEGMAYLHSQH---YIHRNLAAR 146
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT-VGYIAPECHQTVALSDTCDIYSF 341
           NVL+D+D   +I +FGLAK +P+GH          + V + APEC +        D++SF
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 207 GVTLYELL 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       L+ E+   G + D  Y V+ GR + +  AR +  Q I S 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMK-EKEARSKFRQ-IVSA 126
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y    H+ RI+HRD++  N+L+D DM  +I++FG +     G       +  G   Y 
Sbjct: 127 VQY---CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFCGAPPYA 180
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 222

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 16/145 (11%)
Query: 192 QIRSEIITAGQVRHRNIVPLLA---RMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRREL 247
           Q   E+ +   ++H NI+  +    R    D DL L+  F   GSL D L         +
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVV 118
Query: 248 DWLARHRIAQGIASGLEYLHM-------SHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            W     IA+ +A GL YLH         H+P I HRDI+  NVL+ +++ A I++FGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPE 325
            +   G +   T    GT  Y+APE
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPE 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 111
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 169
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
           T  L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 170 T--LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 370 WMRNVMTSENPNRAINSKLL 389
           +      +E   R + S+LL
Sbjct: 228 FTFPDFVTEG-ARDLISRLL 246

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 45/282 (15%)
Query: 160 GRVITIKKIIQPLKSGAELIKKDSE---PLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GR++  K ++  +KS   LI  DSE    +  K  + + E+     + H NIV L   M 
Sbjct: 38  GRLVKDKSVVA-IKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             +   +V EF   G L   L D +     + W  + R+   IA G+EY+  +  P I+H
Sbjct: 93  -HNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVH 147
Query: 277 RDIQPANVLIDDDME-----ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC--HQT 329
           RD++  N+ +    E     A++++FGL+++     +  +   L G   ++APE    + 
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEE 202
Query: 330 VALSDTCDIYSFGVLLAVLVIGKFPSDDF-FQHTKEMSLV--QWMRNVMTSENPNRAINS 386
            + ++  D YSF ++L  ++ G+ P D++ +   K ++++  + +R  +  + P R  N 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN- 261
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                           +   C   DP KRP+   +   LS++
Sbjct: 262 ----------------VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV +     A         +V E+    +L+DI++  ++G   
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 128
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN++I      ++ +FG+A+ I D 
Sbjct: 129 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG-VLLAVLV-----IGKFPSDDFF 359
           G++ T T ++ GT  Y++PE  +  ++    D+YS G VL  VL       G  P    +
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 246
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 247 QHVREDPIPPSARH 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 107
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 165
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 166 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 224 FTFPDFVTEGARDLISRLLKHNPSQRPML 252

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 165 --ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 165 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 165 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 123
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 124 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKW 179
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 124
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 125 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKW 180
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 111
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 169
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 170 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 228 FTFPDFVTEGARDLISRLLKHNPSQRPML 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P   +R T
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRT 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 165 X--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G +   L  +S+         
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-------FD 111
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P     + 
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 228 FTFPDFVTEGARDLISRLLKHNPSQRPML 256

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 125 EDLAF--LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKD 182
           E+L F  ++ E+ F  LEKI     GEV+K  +   + +V+ IK I             D
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------D 61
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
            E    ++  I+ EI    Q     +       ++     ++ E+   GS  D+L     
Sbjct: 62  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--- 118
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
               LD      I + I  GL+YLH   +   IHRDI+ ANVL+ +  E ++++FG+A +
Sbjct: 119 --GPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ 173
Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
           + D   +  T+   GT  ++APE  +  A     DI+S G+    L  G+ P  + 
Sbjct: 174 LTDTQIKRNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 135
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 136 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 191
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           ++ R E   A  + H  IV +     A         +V E+    +L+DI++  ++G   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEG--- 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD- 305
              +   R  + IA   + L+ SH+  IIHRD++PAN+LI      ++ +FG+A+ I D 
Sbjct: 112 --PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADS 169
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP-SDD-----FF 359
           G++   T ++ GT  Y++PE  +  ++    D+YS G +L  ++ G+ P + D      +
Sbjct: 170 GNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229
Query: 360 QHTKEMSLVQWMRN 373
           QH +E  +    R+
Sbjct: 230 QHVREDPIPPSARH 243

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 123
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 124 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW 179
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 128 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 183
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 124
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 125 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 180
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++           REL  L+
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY----------RELQKLS 107
Query: 252 R---HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
           R    R A  I      L   H  R+IHRDI+P N+L+  + E +I++FG +   P   +
Sbjct: 108 RFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS--S 165
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG--KFPSDDFFQHTKEMS 366
           R TT  L GT+ Y+ PE  +     +  D++S GVL    ++G   F +  + +  + +S
Sbjct: 166 RRTT--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLV 400
            V++      +E   R + S+LL +   +++ L 
Sbjct: 224 RVEFTFPDFVTEG-ARDLISRLLKHNASQRLTLA 256

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 117/238 (49%), Gaps = 31/238 (13%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSG-AELIKK 181
           KE D++ ++ E    + E    C +G +   +LPG     + IK     LKSG  E  ++
Sbjct: 28  KEIDISCVKIEQVIGAGEFGEVC-SGHL---KLPGKREIFVAIKT----LKSGYTEKQRR 79
Query: 182 DSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS 241
           D            SE    GQ  H N++ L   + +    +++ EF  NGSL   L    
Sbjct: 80  D----------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---R 126
Query: 242 QGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
           Q   +   +    + +GIA+G++YL  M++    +HRD+   N+L++ ++  ++S+FGL+
Sbjct: 127 QNDGQFTVIQLVGMLRGIAAGMKYLADMNY----VHRDLAARNILVNSNLVCKVSDFGLS 182
Query: 301 KRIPDGHTRTT-TWSLAGTVG--YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           + + D  +  T T +L G +   + APE  Q    +   D++S+G+++  V+  G+ P
Sbjct: 183 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 124
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 125 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 180
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 49  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 104
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 105 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 219
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 220 -KEKKTYLNPWKKIDSAPLA 238

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 128 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW 183
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+      +  G   Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD---AFCGAPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 21/168 (12%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL----ARHRIAQG 258
           + H NIV L   +       LV E+   G + D L  V+ G     W+    AR +  Q 
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHG-----WMKEKEARAKFRQ- 114
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+   T     G+
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 168
Query: 319 VGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
             Y APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P     + 
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 162
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
             +L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P     + 
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 165
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
             +L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 166 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 128 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 183
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D DM  +I++FG +     G+         G+  Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD---EFCGSPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 126
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 182
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 128 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 183
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 9/172 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +   E     +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ + 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVV 112
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              +A  I+S +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T 
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTA 168
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
                  + + APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 108
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P       
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX- 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 225 FTFPDFVTEGARDLISRLLKHNPSQRPML 253

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G V+  K  +   +   ++IKK S         +  E+    Q+ H NI+ L     
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 74
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E  R G L D +  + Q   E+D      I + + SG  YLH   +  I+H
Sbjct: 75  DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAV---IMKQVLSGTTYLH---KHNIVH 127
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D   +I +FGL+     G          GT  YIAPE  +     
Sbjct: 128 RDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAPEVLRK-KYD 183
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 184 EKCDVWSCGVILYILLCGYPP 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L+ E+ F  LEKI     GEV+K  +   + +V+ IK I             D E    +
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDE 48
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           +  I+ EI    Q     +       ++     ++ E+   GS  D+L         LD 
Sbjct: 49  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDE 103
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
                I + I  GL+YLH   +   IHRDI+ ANVL+ +  E ++++FG+A ++ D   +
Sbjct: 104 TQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
             T+   GT  ++APE  +  A     DI+S G+    L  G+ P  + 
Sbjct: 161 RNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 105
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 220
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 221 -KEKKTYLNPWKKIDSAPLA 239

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P       
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX- 168
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 169 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            I+ EI     + H N+V         +   L  E+   G L D + +   G  E D   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPD--- 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 312 TWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
              + GT+ Y+APE  +     ++  D++S G++L  ++ G+ P D      +E S   W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DW 221
Query: 371 MRNVMTSENPNRAINSKLLG 390
            +   T  NP + I+S  L 
Sbjct: 222 -KEKKTYLNPWKKIDSAPLA 240

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P     + 
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 162
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 163 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E+ F  LE+I     GEV+K  +   + +V+ IK I             D E    ++
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII-------------DLEEAEDEI 65
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I+ EI    Q     +       ++     ++ E+   GS  D+L          D  
Sbjct: 66  EDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-----AGPFDEF 120
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               + + I  GL+YLH   +   IHRDI+ ANVL+ +  + ++++FG+A ++ D   + 
Sbjct: 121 QIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 177
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            T+   GT  ++APE  Q  A     DI+S G+    L  G+ P+ D
Sbjct: 178 NTF--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 222

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 128 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 183
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 153 AELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ--IRSEIITAGQVRHRNIVP 210
           +EL   +G V+T    +Q   SG  + +K    L H  I+  IR++II   QV H    P
Sbjct: 22  SELGAGNGGVVTK---VQHRPSGLIMARK----LIHLEIKPAIRNQIIRELQVLHECNSP 74
Query: 211 LLARM---VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            +         D ++ +  E    GSL  +L +  +   E+  L +  IA  +  GL YL
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI--LGKVSIA--VLRGLAYL 130
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              H+  I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y+APE 
Sbjct: 131 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMAPER 184
Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            Q    S   DI+S G+ L  L +G++P
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G V+  K  +   +   ++IKK S         +  E+    Q+ H NI+ L     
Sbjct: 32  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 91
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E  R G L D +  + Q   E+D      I + + SG  YLH   +  I+H
Sbjct: 92  DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAV---IMKQVLSGTTYLH---KHNIVH 144
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D   +I +FGL+     G          GT  YIAPE  +     
Sbjct: 145 RDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIAPEVLRK-KYD 200
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 201 EKCDVWSCGVILYILLCGYPP 221

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 132
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P       
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-- 190
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 191 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 248
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 249 FTFPDFVTEGARDLISRLLKHNPSQRPML 277

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           +E     Q+RH N+V LL  +V     L +V E+   GSL D L   S+GR  L      
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLL 105
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           + +  +   +EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T 
Sbjct: 106 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG 159
Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            L   V + APE  +    S   D++SFG+LL  +   G+ P
Sbjct: 160 KLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 202 QVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           Q+RH N+V LL  +V     L +V E+   GSL D L   S+GR  L      + +  + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVC 127
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
             +EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T  L   V 
Sbjct: 128 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VK 179
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           + APE  +    S   D++SFG+LL  +   G+ P
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 160 GRVITIKKIIQPLKSGAELIKKDSE---PLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GR++  K ++  +KS   LI  DSE    +  K  + + E+     + H NIV L   M 
Sbjct: 38  GRLVKDKSVVA-IKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             +   +V EF   G L   L D +     + W  + R+   IA G+EY+  +  P I+H
Sbjct: 93  -HNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVH 147
Query: 277 RDIQPANVLIDDDME-----ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC--HQT 329
           RD++  N+ +    E     A++++FG +++     +  +   L G   ++APE    + 
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-----SVHSVSGLLGNFQWMAPETIGAEE 202
Query: 330 VALSDTCDIYSFGVLLAVLVIGKFPSDDF-FQHTKEMSLV--QWMRNVMTSENPNRAINS 386
            + ++  D YSF ++L  ++ G+ P D++ +   K ++++  + +R  +  + P R  N 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN- 261
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                           +   C   DP KRP+   +   LS++
Sbjct: 262 ----------------VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G VI  K  I   +   ++I K           +  E+    Q+ H NI+ L     
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    +D    R+    +   RI + + SG+ Y+H   + +I+H
Sbjct: 97  DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 149
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-HQTVAL 332
           RD++P N+L++    D   RI +FGL+                GT  YIAPE  H T   
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLHGT--Y 204
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
            + CD++S GV+L +L+ G  P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-------FD 109
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  R+IHRDI+P N+L+    E +I++FG +   P       
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD-- 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
              L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 168 --DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 226 FTFPDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 202 QVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           Q+RH N+V LL  +V     L +V E+   GSL D L   S+GR  L      + +  + 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVC 299
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
             +EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T  L   V 
Sbjct: 300 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLP--VK 351
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           + APE  +    S   D++SFG+LL  +   G+ P
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDD 357
            APE       S   D+++FGVLL   A   +  +P  D
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++           REL  L+
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY----------RELQKLS 107
Query: 252 R---HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
           R    R A  I      L   H  R+IHRDI+P N+L+  + E +I++FG +   P    
Sbjct: 108 RFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR 167
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG--KFPSDDFFQHTKEMS 366
            T    L GT+ Y+ PE  +     +  D++S GVL    ++G   F +  + +  + +S
Sbjct: 168 DT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLV 400
            V++      +E   R + S+LL +   +++ L 
Sbjct: 224 RVEFTFPDFVTEG-ARDLISRLLKHNASQRLTLA 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL-ARHRIAQGI- 259
           +V H NIV L    +   C  LV E+   GSL    Y+V  G   L +  A H ++  + 
Sbjct: 58  RVNHPNIVKLYGACLNPVC--LVMEYAEGGSL----YNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 260 -ASGLEYLHMSHRPRIIHRDIQPANVL-IDDDMEARISEFGLAKRIPDGHTRTTTWSLAG 317
            + G+ YLH      +IHRD++P N+L +      +I +FG A  I    T        G
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----G 166
Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS 377
           +  ++APE  +    S+ CD++S+G++L  ++  + P D+              R +   
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--------FRIMWAV 218
Query: 378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
            N  R    K L    E  M         C   DP++RP+ +++  +++ +
Sbjct: 219 HNGTRPPLIKNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHL 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL-ARHR 254
           E+    +V H NIV L    +   C  LV E+   GSL    Y+V  G   L +  A H 
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSL----YNVLHGAEPLPYYTAAHA 104
Query: 255 IAQGI--ASGLEYLHMSHRPRIIHRDIQPANVL-IDDDMEARISEFGLAKRIPDGHTRTT 311
           ++  +  + G+ YLH      +IHRD++P N+L +      +I +FG A  I    T   
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
                G+  ++APE  +    S+ CD++S+G++L  ++  + P D+              
Sbjct: 165 -----GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--------F 211
Query: 372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           R +    N  R    K L    E  M         C   DP++RP+ +++  +++ +
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHL 261

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 160 GRVITIKKIIQPLKSGAELIKKDSE---PLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GR++  K ++  +KS   LI  DSE    +  K  + + E+     + H NIV L   M 
Sbjct: 38  GRLVKDKSVVA-IKS---LILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             +   +V EF   G L   L D +     + W  + R+   IA G+EY+  +  P I+H
Sbjct: 93  -HNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVH 147
Query: 277 RDIQPANVLIDDDME-----ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC--HQT 329
           RD++  N+ +    E     A++++F L+++     +  +   L G   ++APE    + 
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFSLSQQ-----SVHSVSGLLGNFQWMAPETIGAEE 202
Query: 330 VALSDTCDIYSFGVLLAVLVIGKFPSDDF-FQHTKEMSLV--QWMRNVMTSENPNRAINS 386
            + ++  D YSF ++L  ++ G+ P D++ +   K ++++  + +R  +  + P R  N 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN- 261
Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                           +   C   DP KRP+   +   LS++
Sbjct: 262 ----------------VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 14/166 (8%)
Query: 193 IRSEIITAGQVRHRNIVPLLARM---VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD 248
           IR++II   QV H    P +         D ++ +  E    GSL  +L     GR    
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 131
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            L +  IA  +  GL YL   H+  I+HRD++P+N+L++   E ++ +FG++ ++ D   
Sbjct: 132 ILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 184
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            +   S  GT  Y++PE  Q    S   DI+S G+ L  + +G++P
Sbjct: 185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R E+     +RH NI+ L           L+ E+   G++   L  +S+         
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-------FD 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  I      L   H  ++IHRDI+P N+L+    E +I++FG +   P     + 
Sbjct: 107 EQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 162
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHT-KEMSLVQ 369
             +L GT+ Y+ PE  +     +  D++S GVL    ++GK P + + +Q T K +S V+
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVE 222
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQML 398
           +      +E     I+  L  N  +  ML
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPML 251

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDD 357
            APE       S   D+++FGVLL   A   +  +P  D
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 36  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 89
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 90  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 144
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y++PE  Q    
Sbjct: 145 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 199
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G VI  K  I   +   ++I K           +  E+    Q+ H NI+ L     
Sbjct: 60  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 119
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    +D    R+    +   RI + + SG+ Y+H   + +I+H
Sbjct: 120 DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 172
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-HQTVAL 332
           RD++P N+L++    D   RI +FGL+                GT  YIAPE  H T   
Sbjct: 173 RDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLHGT--Y 227
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
            + CD++S GV+L +L+ G  P
Sbjct: 228 DEKCDVWSTGVILYILLSGCPP 249

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A + R +   ++ E+   GSL D L     G+  L  L     +  IA G
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEG 122
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + Y+    R   IHRD++ ANVL+ + +  +I++FGLA+ I D +  T        + + 
Sbjct: 123 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 178
Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE       +   D++SFG+LL  ++  GK P
Sbjct: 179 APEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G VI  K  I   +   ++I K           +  E+    Q+ H NI+ L     
Sbjct: 61  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 120
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    +D    R+    +   RI + + SG+ Y+H   + +I+H
Sbjct: 121 DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 173
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-HQTVAL 332
           RD++P N+L++    D   RI +FGL+                GT  YIAPE  H T   
Sbjct: 174 RDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLHGT--Y 228
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
            + CD++S GV+L +L+ G  P
Sbjct: 229 DEKCDVWSTGVILYILLSGCPP 250

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           ++ E+ F  L++I     GEVYK  +   +  V+ IK I             D E    +
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKII-------------DLEEAEDE 60
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           +  I+ EI    Q     I       ++     ++ E+   GS  D+L     G  E  +
Sbjct: 61  IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETY 117
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           +A   I + I  GL+YLH     R IHRDI+ ANVL+ +  + ++++FG+A ++ D   +
Sbjct: 118 IAT--ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
              +   GT  ++APE  +  A     DI+S G+    L  G+ P+ D 
Sbjct: 173 RNXF--VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 14/166 (8%)
Query: 193 IRSEIITAGQVRHRNIVPLLARM---VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD 248
           IR++II   QV H    P +         D ++ +  E    GSL  +L     GR    
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 166
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            L +  IA  +  GL YL   H+  I+HRD++P+N+L++   E ++ +FG++ ++ D   
Sbjct: 167 ILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 219
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            +   S  GT  Y++PE  Q    S   DI+S G+ L  + +G++P
Sbjct: 220 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G VI  K  I   +   ++I K           +  E+    Q+ H NI+ L     
Sbjct: 43  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 102
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    +D    R+    +   RI + + SG+ Y+H   + +I+H
Sbjct: 103 DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 155
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-HQTVAL 332
           RD++P N+L++    D   RI +FGL+                GT  YIAPE  H T   
Sbjct: 156 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPEVLHGT--Y 210
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
            + CD++S GV+L +L+ G  P
Sbjct: 211 DEKCDVWSTGVILYILLSGCPP 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDD 357
            APE       S   D+++FGVLL   A   +  +P  D
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +    S  GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     + S + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 24/173 (13%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGL 263
           H +I+ L+          LV++  R G L D L + V+   +E   + R        S L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR--------SLL 210
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E +   H   I+HRD++P N+L+DD+M+ R+S+FG +  +  G        L GT GY+A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLA 267
Query: 324 PECHQTVALSDT-------CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE  +  ++ +T        D+++ GV+L  L+ G  P    F H +++ +++
Sbjct: 268 PEILK-CSMDETHPGYGKEVDLWACGVILFTLLAGSPP----FWHRRQILMLR 315

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH----------- 205
           G+ G+V+  +  +       + I+   E    K+  I SE++    + H           
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 206 --RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY--DVSQGRRELDWLARHRIAQGIAS 261
             RN V  +  + ++    +  E+  NG+L D+++  +++Q R E  W    R+ + I  
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-W----RLFRQILE 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--------------PDGH 307
            L Y+H      IIHRD++P N+ ID+    +I +FGLAK +              P   
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 308 TRTTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS 366
              T  S  GT  Y+A E    T   ++  D+YS G++   ++   +P   F    + ++
Sbjct: 185 DNLT--SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YP---FSTGMERVN 236
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           +++ +R+V     P+   N          +M +  KI       DPNKRP ++
Sbjct: 237 ILKKLRSVSIEFPPDFDDN----------KMKVEKKIIRLLIDHDPNKRPGAR 279

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H N++  +  + +      + E+ + G+L+ I+  +     +  W  R   A+ IASG
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASG 120
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT------------RT 310
           + YLH  +   IIHRD+   N L+ ++    +++FGLA+ + D  T            R 
Sbjct: 121 MAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHTKEMSLVQ 369
             +++ G   ++APE     +  +  D++SFG++L   +IG+  +D D+   T +  L  
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE-IIGRVNADPDYLPRTMDFGLN- 235
Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
            +R  +    P     S              + + C C L DP KRP+
Sbjct: 236 -VRGFLDRYCPPNCPPS-----------FFPITVRC-CDL-DPEKRPS 269

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 70  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 126
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 127 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 182
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
            APE       +   D++SFG+LL  +V  G+ P                M N    +N 
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------------MTNPEVIQNL 229
Query: 381 NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
            R        N  EE    + ++   C  + P  RP    +R +L
Sbjct: 230 ERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 73  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 129
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 130 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 185
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           + H NIV L   +       LV E+   G + D L  V+ GR + +  AR +  Q I S 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL--VAHGRXK-EKEARAKFRQ-IVSA 125
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++Y H      I+HRD++  N+L+D D   +I++FG +     G+      +  G   Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD---AFCGAPPYA 179
Query: 323 APECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           APE  Q         D++S GV+L  LV G  P D   Q+ KE+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKEL 221

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
            APE       +   D++SFG+LL  +V  G+ P                M N    +N 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------------MTNPEVIQNL 223
Query: 381 NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
            R        N  EE    + ++   C  + P  RP    +R +L
Sbjct: 224 ERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 72  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 128
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 129 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 184
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 65  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 121
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 122 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 177
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E++ +    +A  I+S
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISS 368
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHR++   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 369 AMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 424
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 466

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 66  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 123 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 24/229 (10%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L+ E+ F  LEKI     GEV+K  +   + +V+ IK I             D E    +
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDE 48
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           +  I+ EI    Q     +       ++     ++ E+   GS  D+L         LD 
Sbjct: 49  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDE 103
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
                I + I  GL+YLH   +   IHRDI+ ANVL+ +  E ++++FG+A ++ D   +
Sbjct: 104 TQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
              +   GT  ++APE  +  A     DI+S G+    L  G+ P  + 
Sbjct: 161 RNXF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 70
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 125
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y++PE  Q    
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 180
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 70
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 125
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y++PE  Q    
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 180
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 69  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 126 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 66
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+T   
Sbjct: 127 -----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 175
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 70  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 126
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 127 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 182
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 70
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 125
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y++PE  Q    
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 180
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 17  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 70
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 125
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D    +   S  GT  Y++PE  Q    
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 180
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 74  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 130
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 131 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 186
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/339 (24%), Positives = 143/339 (42%), Gaps = 64/339 (18%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIK 166
           GS DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +K
Sbjct: 1   GSEDRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVK 48
Query: 167 KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLL 223
           K    L+   E   +D E           EI     ++H NIV    +     RR+  L+
Sbjct: 49  K----LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 94
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           + E+   GSL+D L    + +  +D +   +    I  G+EYL      R IHRD+   N
Sbjct: 95  M-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRN 147
Query: 284 VLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           +L++++   +I +FGL K +P D             + + APE       S   D++SFG
Sbjct: 148 ILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 207
Query: 343 VLLAVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLG 390
           V+L  L       K P  +F +              L++ ++N      P          
Sbjct: 208 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---------- 257
Query: 391 NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
           +G  +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 258 DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 120
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 176
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 14/166 (8%)
Query: 193 IRSEIITAGQVRHRNIVPLLARM---VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD 248
           IR++II   QV H    P +         D ++ +  E    GSL  +L     GR    
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 104
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            L +  IA  +  GL YL   H+  I+HRD++P+N+L++   E ++ +FG++ ++ D   
Sbjct: 105 ILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            +   S  GT  Y++PE  Q    S   DI+S G+ L  + +G++P
Sbjct: 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 59  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 115
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHRD++ AN+L+ D +  +I++FGLA+ I D    T        + +
Sbjct: 116 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 171
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL    R     ++ EF   G+L D L + +  R+E+  +    +A  I+S
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 329
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHR++   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 330 AMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 385
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A + + +   ++ EF   GSL D L     G+  L  L     +  IA G
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEG 121
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + Y+    R   IHRD++ ANVL+ + +  +I++FGLA+ I D +  T        + + 
Sbjct: 122 MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 177
Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE       +   +++SFG+LL  ++  GK P
Sbjct: 178 APEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 31/241 (12%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSG-AELIKK 181
           KE D++ ++ E    + E    C +G +   +LPG     + IK     LKSG  E  ++
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVC-SGHL---KLPGKREIFVAIKT----LKSGYTEKQRR 53
Query: 182 DSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS 241
           D            SE    GQ  H N++ L   + +    +++ EF  NGSL   L    
Sbjct: 54  D----------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---R 100
Query: 242 QGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
           Q   +   +    + +GIA+G++YL  M++    +HR +   N+L++ ++  ++S+FGL+
Sbjct: 101 QNDGQFTVIQLVGMLRGIAAGMKYLADMNY----VHRALAARNILVNSNLVCKVSDFGLS 156
Query: 301 KRIPDGHTRTT-TWSLAGTVG--YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
           + + D  +  T T +L G +   + APE  Q    +   D++S+G+++  V+  G+ P  
Sbjct: 157 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 216
Query: 357 D 357
           D
Sbjct: 217 D 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 115/242 (47%), Gaps = 33/242 (13%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIK 180
           KE D+++++ E+   + E       GEV +  L  PG     + IK     LK G     
Sbjct: 9   KEIDVSYVKIEEVIGAGE------FGEVCRGRLKAPGKKESCVAIKT----LKGGYT--- 55
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
                   +  +  SE    GQ  H NI+ L   +      +++ EF  NG+L   L  +
Sbjct: 56  ------ERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RL 108
Query: 241 SQGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
           + G+  +  L    + +GIASG+ YL  MS+    +HRD+   N+L++ ++  ++S+FGL
Sbjct: 109 NDGQFTVIQLVG--MLRGIASGMRYLAEMSY----VHRDLAARNILVNSNLVCKVSDFGL 162
Query: 300 AKRIPDGHTRTT-TWSLAGTVG--YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPS 355
           ++ + +  +  T T SL G +   + APE       +   D +S+G+++  V+  G+ P 
Sbjct: 163 SRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 222
Query: 356 DD 357
            D
Sbjct: 223 WD 224

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + R    ++V E+  NGSL D       G+  +  L    
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVG-- 155
Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRT 310
           + +G+ +G+ YL  + +    +HRD+   NVL+D ++  ++S+FGL++ +   PD    T
Sbjct: 156 MLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT 211
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           T   +   + + APE       S   D++SFGV++  VL  G+ P
Sbjct: 212 TGGKIP--IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G VI  K  I   +   ++I K           +  E+    Q+ H NI  L     
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFE 96
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    +D    R+    +   RI + + SG+ Y    H+ +I+H
Sbjct: 97  DKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITY---XHKNKIVH 149
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-HQTVAL 332
           RD++P N+L++    D   RI +FGL+                GT  YIAPE  H T   
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIAPEVLHGT--Y 204
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
            + CD++S GV+L +L+ G  P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 86/354 (24%), Positives = 148/354 (41%), Gaps = 66/354 (18%)
Query: 96  LTTTSRILAAGRGGS--RDRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVY 151
           + TT  +   G  GS   DR P  F    +E  L FL++  +  F S+E  R        
Sbjct: 14  IPTTENLYFQGAMGSAFEDRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY------- 62
Query: 152 KAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP- 210
              L  ++G V+ +KK    L+   E   +D E           EI     ++H NIV  
Sbjct: 63  -DPLQDNTGEVVAVKK----LQHSTEEHLRDFE----------REIEILKSLQHDNIVKY 107
Query: 211 --LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
             +     RR+  L++ E+   GSL+D L    + +  +D +   +    I  G+EYL  
Sbjct: 108 KGVCYSAGRRNLKLIM-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECH 327
               R IHRD+   N+L++++   +I +FGL K +P D             + + APE  
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 328 QTVALSDTCDIYSFGVLLAVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVM 375
                S   D++SFGV+L  L       K P  +F +              L++ ++N  
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
               P          +G  +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 281 RLPRP----------DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 185 PLHHKM-IQIRSEIITAGQVRHRNIVPLLARMVRRDCDL-----LVYEFRRNGSLQDILY 238
           PL  K   Q   EI +   ++H N++  +A   +R  +L     L+  F   GSL D L 
Sbjct: 47  PLQDKQSWQSEREIFSTPGMKHENLLQFIA-AEKRGSNLEVELWLITAFHDKGSLTDYLK 105
Query: 239 DVSQGRRELDWLARHRIAQGIASGLEYLHM--------SHRPRIIHRDIQPANVLIDDDM 290
                   + W     +A+ ++ GL YLH          H+P I HRD +  NVL+  D+
Sbjct: 106 G-----NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDL 160
Query: 291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
            A +++FGLA R   G     T    GT  Y+APE  +             D+Y+ G++L
Sbjct: 161 TAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 220
Query: 346 AVLV 349
             LV
Sbjct: 221 WELV 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 24/142 (16%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS------HRPRII 275
           LLV E+  NGSL   L          DW++  R+A  +  GL YLH        ++P I 
Sbjct: 88  LLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142
Query: 276 HRDIQPANVLIDDDMEARISEFGLAKRIPD------GHTRTTTWSLAGTVGYIAPECHQ- 328
           HRD+   NVL+ +D    IS+FGL+ R+        G       S  GT+ Y+APE  + 
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 329 TVALSDT------CDIYSFGVL 344
            V L D        D+Y+ G++
Sbjct: 203 AVNLRDXESALKQVDMYALGLI 224

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 24/173 (13%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGL 263
           H NI+ L           LV++  + G L D L + V+   +E   + R        + L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR--------ALL 134
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E +   H+  I+HRD++P N+L+DDDM  ++++FG + ++  G       S+ GT  Y+A
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLA 191
Query: 324 PECHQTVALSDT-------CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE  +  +++D         D++S GV++  L+ G  P    F H K+M +++
Sbjct: 192 PEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLR 239

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 14/165 (8%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + R    ++V E+  NGSL D       G+  +  L    
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVG-- 155
Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRT 310
           + +G+ +G+ YL  + +    +HRD+   NVL+D ++  ++S+FGL++ +   PD    T
Sbjct: 156 MLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           T   +   + + APE       S   D++SFGV++  VL  G+ P
Sbjct: 212 TGGKIP--IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 115/242 (47%), Gaps = 33/242 (13%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIK 180
           KE D+++++ E+   + E       GEV +  L  PG     + IK     LK G     
Sbjct: 11  KEIDVSYVKIEEVIGAGEF------GEVCRGRLKAPGKKESCVAIKT----LKGGY---- 56
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
                   +  +  SE    GQ  H NI+ L   +      +++ EF  NG+L   L  +
Sbjct: 57  -----TERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-L 110
Query: 241 SQGRRELDWLARHRIAQGIASGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
           + G+  +  L    + +GIASG+ YL  MS+    +HRD+   N+L++ ++  ++S+FGL
Sbjct: 111 NDGQFTVIQLVG--MLRGIASGMRYLAEMSY----VHRDLAARNILVNSNLVCKVSDFGL 164
Query: 300 AKRIPDGHTRTT-TWSLAGTVG--YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPS 355
           ++ + +  +  T T SL G +   + APE       +   D +S+G+++  V+  G+ P 
Sbjct: 165 SRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 224
Query: 356 DD 357
            D
Sbjct: 225 WD 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +    S  GT
Sbjct: 138 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 149 EVYKAELPGSSGRVITIKKIIQPLKSGAE--------LIKKDSEPLHHKMIQIRSEIITA 200
           E+ K    GS G+V  +KKI     SG++        ++KK +  +  + ++ + E    
Sbjct: 28  ELLKVLGQGSFGKVFLVKKI-----SGSDARQLYAMKVLKKATLKVRDR-VRTKMERDIL 81
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
            +V H  IV L           L+ +F R G   D+   +S+     +   +  +A+ +A
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAE-LA 137
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
             L++LH      II+RD++P N+L+D++   ++++FGL+K   D   +   +S  GTV 
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 192
Query: 321 YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           Y+APE       + + D +SFGVL+  ++ G  P
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 157 GSSGRVITIKKIIQPLKSGAE--------LIKKDSEPLHHKMIQIRSEIITAGQVRHRNI 208
           GS G+V  +KKI     SG++        ++KK +  +  + ++ + E     +V H  I
Sbjct: 35  GSFGKVFLVKKI-----SGSDARQLYAMKVLKKATLKVRDR-VRTKMERDILVEVNHPFI 88
Query: 209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM 268
           V L           L+ +F R G   D+   +S+     +   +  +A+ +A  L++LH 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS 144
Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
                II+RD++P N+L+D++   ++++FGL+K   D   +   +S  GTV Y+APE   
Sbjct: 145 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 199
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFP 354
               + + D +SFGVL+  ++ G  P
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 149 EVYKAELPGSSGRVITIKKIIQPLKSGAE--------LIKKDSEPLHHKMIQIRSEIITA 200
           E+ K    GS G+V  +KKI     SG++        ++KK +  +  + ++ + E    
Sbjct: 27  ELLKVLGQGSFGKVFLVKKI-----SGSDARQLYAMKVLKKATLKVRDR-VRTKMERDIL 80
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
            +V H  IV L           L+ +F R G   D+   +S+     +   +  +A+ +A
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAE-LA 136
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
             L++LH      II+RD++P N+L+D++   ++++FGL+K   D   +   +S  GTV 
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 191
Query: 321 YIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           Y+APE       + + D +SFGVL+  ++ G  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +    S  GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 150 VYKAELPGSS--GRVITIKKIIQPLKSGAELIK----KDSEPLHHKMIQIRSEIITAGQV 203
           V K E+ G    G+V   ++    LK  A++IK    KD E       ++++EI    Q+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQL 143
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
            H N++ L      ++  +LV E+   G L D + D S    ELD +      + I  G+
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL---FMKQICEGI 200
Query: 264 EYLHMSHRPRIIHRDIQPANVLI--DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            ++H  +   I+H D++P N+L    D  + +I +FGLA+R          +   GT  +
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEF 254
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE      +S   D++S GV+  +L+ G  P
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E+ F  LEKI     GEV+K  +   + +V+ IK I             D E    ++
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDEI 64
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I+ EI    Q     +       ++     ++ E+   GS  D+L         LD  
Sbjct: 65  EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDET 119
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               I + I  GL+YLH   +   IHRDI+ ANVL+ +  E ++++FG+A ++ D   + 
Sbjct: 120 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
             +   GT  ++APE  +  A     DI+S G+    L  G+ P  + 
Sbjct: 177 NXF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 6/170 (3%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           SE+    +++H NIV    R++ R    L  V E+   G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 253 HRIAQGIASGLEYLHMSHRP--RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
            R+   +   L+  H        ++HRD++PANV +D     ++ +FGLA+ +   H  +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTS 171
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
              +  GT  Y++PE    ++ ++  DI+S G LL  L     P   F Q
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G V+  K  I   +   ++I K S   +     I  E+    ++ H NI+ L   + 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
                 +V E    G L    +D    R+        RI + + SG+ Y+H   +  I+H
Sbjct: 92  DSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D + +I +FGL+         T      GT  YIAPE  +     
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRG-TYD 200
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 6/170 (3%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           SE+    +++H NIV    R++ R    L  V E+   G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 253 HRIAQGIASGLEYLHMSHRP--RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
            R+   +   L+  H        ++HRD++PANV +D     ++ +FGLA+ +   H  +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTS 171
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
              +  GT  Y++PE    ++ ++  DI+S G LL  L     P   F Q
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 23  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 67
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHR+I+  N+L+  D   ++++FG   +I P+   R+T   
Sbjct: 128 -----QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 176
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 13/175 (7%)
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR 245
           L  K   I +EI    +++H NIV L       +   LV +    G L D +  V +G  
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKG-- 115
Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKR 302
              +      +  I   L+ ++  HR  I+HRD++P N+L    D++ +  IS+FGL+K 
Sbjct: 116 ---FYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172
Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
              G   +T     GT GY+APE       S   D +S GV+  +L+ G  P  D
Sbjct: 173 EGKGDVMSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           Q++H+ +V L A +V ++   ++ E+  NGSL D L   S  +  ++ L    +A  IA 
Sbjct: 60  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAE 116
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ ++   +    IHR+++ AN+L+ D +  +I++FGLA+ I D +  T        + +
Sbjct: 117 GMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKW 172
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  +V  G+ P
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 66
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+    
Sbjct: 127 -----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---E 175
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGL 263
           H NI+ L           LV++  + G L D L + V+   +E   + R        + L
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR--------ALL 121
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E +   H+  I+HRD++P N+L+DDDM  ++++FG + ++  G        + GT  Y+A
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLA 178
Query: 324 PECHQTVALSDT-------CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE  +  +++D         D++S GV++  L+ G  P    F H K+M +++
Sbjct: 179 PEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLR 226

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 23  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 67
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+    
Sbjct: 128 -----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--- 176
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 11/165 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R EI     +RH NI+ +      R    L+ EF   G L    Y   Q     D   
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--- 113
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  +    + LH  H  ++IHRDI+P N+L+    E +I++FG +   P    R  
Sbjct: 114 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX- 172
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
              + GT+ Y+ PE  +     +  D++  GVL    ++G  P D
Sbjct: 173 ---MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +   EKI    +G VY A +  ++G+ + I+++    +   ELI               +
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELII--------------N 66
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI+   + ++ NIV  L   +  D   +V E+   GSL D++ +      ++  + R  +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWS 314
                  LE+LH +   ++IHRDI+  N+L+  D   ++++FG   +I P+   R+    
Sbjct: 127 -----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---X 175
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           + GT  ++APE     A     DI+S G++   ++ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 11/165 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R EI     +RH NI+ +      R    L+ EF   G L    Y   Q     D   
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--- 112
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             R A  +    + LH  H  ++IHRDI+P N+L+    E +I++FG +   P    R  
Sbjct: 113 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX- 171
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
              + GT+ Y+ PE  +     +  D++  GVL    ++G  P D
Sbjct: 172 ---MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +    +  GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW LAGT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H  +V L A +V  +   +V E+   GSL D L D  +GR  L       +A  +A+
Sbjct: 60  KLKHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKD-GEGR-ALKLPNLVDMAAQVAA 116
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   IHRD++ AN+L+ + +  +I++FGLA+ I D +  T        + +
Sbjct: 117 GMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIED-NEXTARQGAKFPIKW 172
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  LV  G+ P
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 244 RRELDWLARHRIAQGIASGL-EYLHMSHRPRIIHRDIQPANVLI--DDDMEARISEFGLA 300
           R  LD++ R ++   I   +   LH  H   I HRDI+P N L   +   E ++ +FGL+
Sbjct: 158 RESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS 217
Query: 301 K---RIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPS 355
           K   ++ +G     T + AGT  ++APE   T   +    CD +S GVLL +L++G  P 
Sbjct: 218 KEFYKLNNGEYYGMT-TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP- 275
Query: 356 DDFFQHTKEMSLVQWMRNVMTSENPNRAINSKL 388
             F       ++ Q +   +  ENPN  + S L
Sbjct: 276 --FPGVNDADTISQVLNKKLCFENPNYNVLSPL 306

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           +++H N+V LL          +V E+   G+L D L + +  R E+  +    +A  I+S
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN--REEVTAVVLLYMATQISS 141
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            +EYL    +   IHRD+   N L+ ++   ++++FGL+ R+  G T T        + +
Sbjct: 142 AMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 197
Query: 322 IAPECHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDDFFQ 360
            APE       S   D+++FGVLL   A   +  +P  D  Q
Sbjct: 198 TAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 44/292 (15%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L G +    T    I+ LK  AE       PL     + R E +   +++H N
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAE------GPLRE---EFRHEAMLRARLQHPN 73
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ----GRRELDWLAR---------HR 254
           +V LL  + +     +++ +  +G L + L   S     G  + D   +         H 
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           +AQ IA+G+EYL   H   ++H+D+   NVL+ D +  +IS+ GL + +          +
Sbjct: 134 VAQ-IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
               + ++APE       S   DI+S+GV+L  V   G  P    +       +V+ +RN
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSNQDVVEMIRN 245
Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
                 P+                +  L I C+     P++RP  KD+   L
Sbjct: 246 RQVLPCPDDC-----------PAWVYALMIECWNEF--PSRRPRFKDIHSRL 284

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 142/341 (41%), Gaps = 66/341 (19%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITI 165
           G   DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +
Sbjct: 4   GAFEDRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAV 51
Query: 166 KKIIQPLKSGAELIKKDSEPL----HHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD 221
           KK+    +      +++ E L    H  +++ +    +AG+   RN+             
Sbjct: 52  KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLK------------ 96
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
            L+ E+   GSL+D L    + +  +D +   +    I  G+EYL      R IHRD+  
Sbjct: 97  -LIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 149
Query: 282 ANVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
            N+L++++   +I +FGL K +P D             + + APE       S   D++S
Sbjct: 150 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWS 209
Query: 341 FGVLLAVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKL 388
           FGV+L  L       K P  +F +              L++ ++N      P        
Sbjct: 210 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP-------- 261
Query: 389 LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
             +G  +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 262 --DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 297

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-VSQGRRELDWLARHRIAQGIASGL 263
           H NI+ L           LV++  + G L D L + V+   +E   + R        + L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR--------ALL 134
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           E +   H+  I+HRD++P N+L+DDDM  ++++FG + ++  G        + GT  Y+A
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLA 191
Query: 324 PECHQTVALSDT-------CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE  +  +++D         D++S GV++  L+ G  P    F H K+M +++
Sbjct: 192 PEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLR 239

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 44/292 (15%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L G +    T    I+ LK  AE       PL     + R E +   +++H N
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAE------GPLRE---EFRHEAMLRARLQHPN 90
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ----GRRELDWLAR---------HR 254
           +V LL  + +     +++ +  +G L + L   S     G  + D   +         H 
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           +AQ IA+G+EYL   H   ++H+D+   NVL+ D +  +IS+ GL + +          +
Sbjct: 151 VAQ-IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
               + ++APE       S   DI+S+GV+L  V   G  P   +        +V+ +RN
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDVVEMIRN 262
Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
                 P+                +  L I C+     P++RP  KD+   L
Sbjct: 263 RQVLPCPDDC-----------PAWVYALMIECWNEF--PSRRPRFKDIHSRL 301

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 27/192 (14%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V EF   G   D+++ + + RR  +  AR   A+ I S L +LH      II+RD++ 
Sbjct: 100 FFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-IISALMFLH---DKGIIYRDLKL 152
Query: 282 ANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
            NVL+D +   ++++FG+ K  I +G    TT +  GT  YIAPE  Q +      D ++
Sbjct: 153 DNVLLDHEGHCKLADFGMCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWA 209
Query: 341 FGVLLAVLVIGKFP-----SDDFFQH--TKEMSLVQWMRNVMT-------SENPNRAINS 386
            GVLL  ++ G  P      DD F+     E+    W+    T       ++NP   + S
Sbjct: 210 MGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGS 269
Query: 387 KLLGNGYEEQML 398
             L  G E  +L
Sbjct: 270 --LTQGGEHAIL 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/340 (24%), Positives = 142/340 (41%), Gaps = 64/340 (18%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITI 165
           G   DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +
Sbjct: 2   GAFEDRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAV 49
Query: 166 KKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDL 222
           KK    L+   E   +D E           EI     ++H NIV    +     RR+  L
Sbjct: 50  KK----LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKL 95
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           ++ E+   GSL+D L    + +  +D +   +    I  G+EYL      R IHRD+   
Sbjct: 96  IM-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATR 148
Query: 283 NVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           N+L++++   +I +FGL K +P D             + + APE       S   D++SF
Sbjct: 149 NILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSF 208
Query: 342 GVLLAVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLL 389
           GV+L  L       K P  +F +              L++ ++N      P         
Sbjct: 209 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP--------- 259
Query: 390 GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            +G  +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 260 -DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 295

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 182
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW+L GT  Y+APE   +   +
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGATWTLCGTPEYLAPEIILSKGYN 237
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 238 KAVDWWALGVLIYEMAAGYPP 258

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM- 215
           G+ G V  +      L    +LI  + +P       IR++II   QV H    P +    
Sbjct: 20  GNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFY 73
Query: 216 --VRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                D ++ +  E    GSL  +L     GR     L +  IA  +  GL YL   H+ 
Sbjct: 74  GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK- 128
Query: 273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
            I+HRD++P+N+L++   E ++ +FG++ ++ D           GT  Y++PE  Q    
Sbjct: 129 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMSPERLQGTHY 183
Query: 333 SDTCDIYSFGVLLAVLVIGKFP 354
           S   DI+S G+ L  + +G++P
Sbjct: 184 SVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 91/186 (48%), Gaps = 24/186 (12%)
Query: 179 IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY 238
           I K  +P   +    R+E+    + RH NI+  +  M + D   +V ++    SL   L+
Sbjct: 65  ILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLH 123
Query: 239 DVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 298
            V + + ++  L    IA+  A G++YLH  +   IIHRD++  N+ + + +  +I +FG
Sbjct: 124 -VQETKFQMFQLID--IARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG 177
Query: 299 LAKRIPDGHTRTTTWSLA-------GTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVL 348
           LA       T  + WS +       G+V ++APE          S   D+YS+G++L  L
Sbjct: 178 LA-------TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL 230
Query: 349 VIGKFP 354
           + G+ P
Sbjct: 231 MTGELP 236

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 149 EVYKAELPGSSGRVI--TIKKI-----IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAG 201
           E++K    GS G+V     KK      I+ LK    L+  D E     M++ R   + + 
Sbjct: 21  ELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKR---VLSL 74
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
              H  +  +      ++    V E+   G   D++Y + Q   + D       A  I  
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHI-QSCHKFDLSRATFYAAEIIL 130
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL++LH      I++RD++  N+L+D D   +I++FG+ K    G  +T      GT  Y
Sbjct: 131 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--EFCGTPDY 185
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           IAPE       + + D +SFGVLL  ++IG+ P
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G V+  K  I   +   ++I K S   +     I  E+    ++ H NI+ L   + 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
                 +V E    G L    +D    R+        RI + + SG+ Y+H   +  I+H
Sbjct: 92  DSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D + +I +FGL+         T      GT  YIAPE  +     
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRG-TYD 200
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           GS G V+  K  I   +   ++I K S   +     I  E+    ++ H NI+ L   + 
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
                 +V E    G L    +D    R+        RI + + SG+ Y+H   +  I+H
Sbjct: 92  DSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D + +I +FGL+         T      GT  YIAPE  +     
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRG-TYD 200
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 6/170 (3%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           SE+    +++H NIV    R++ R    L  V E+   G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 253 HRIAQGIASGLEYLHMSHRP--RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
            R+   +   L+  H        ++HRD++PANV +D     ++ +FGLA+ +   H   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDED 171
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
                 GT  Y++PE    ++ ++  DI+S G LL  L     P   F Q
Sbjct: 172 FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 138 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 235 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 291
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 347
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+  S+
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH-ASE 114
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
            + E+  L    IA+  A G++YLH      IIHRD++  N+ + +D   +I +FGLA  
Sbjct: 115 TKFEMKKLID--IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA-- 167
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE      +   S   D+Y+FG++L  L+ G+
Sbjct: 168 -----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
Query: 353 FP 354
            P
Sbjct: 223 LP 224

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 235 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 291
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 347
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 25/185 (13%)
Query: 211 LLARMVRRDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------AQG 258
           +L+ +   DC  +V   Y F     L  IL D+  G      L++H +         A  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA       ++    +  GT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGT 353
Query: 319 VGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQWMRNVMT 376
            GY+APE  Q  VA   + D +S G +L  L+ G  P   F QH TK+   +  M   M 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMA 410
Query: 377 SENPN 381
            E P+
Sbjct: 411 VELPD 415

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 25/185 (13%)
Query: 211 LLARMVRRDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------AQG 258
           +L+ +   DC  +V   Y F     L  IL D+  G      L++H +         A  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA       ++    +  GT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGT 353
Query: 319 VGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQWMRNVMT 376
            GY+APE  Q  VA   + D +S G +L  L+ G  P   F QH TK+   +  M   M 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMA 410
Query: 377 SENPN 381
            E P+
Sbjct: 411 VELPD 415

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 125/293 (42%), Gaps = 60/293 (20%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH----------- 205
           G+ G+V+  +  +       + I+   E    K+  I SE++    + H           
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 206 --RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY--DVSQGRRELDWLARHRIAQGIAS 261
             RN V  +  + ++    +  E+  N +L D+++  +++Q R E  W    R+ + I  
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY-W----RLFRQILE 127
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--------------PDGH 307
            L Y+H      IIHRD++P N+ ID+    +I +FGLAK +              P   
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 308 TRTTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS 366
              T  S  GT  Y+A E    T   ++  D+YS G++   ++   +P   F    + ++
Sbjct: 185 DNLT--SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YP---FSTGMERVN 236
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           +++ +R+V     P+   N          +M +  KI       DPNKRP ++
Sbjct: 237 ILKKLRSVSIEFPPDFDDN----------KMKVEKKIIRLLIDHDPNKRPGAR 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 25/185 (13%)
Query: 211 LLARMVRRDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------AQG 258
           +L+ +   DC  +V   Y F     L  IL D+  G      L++H +         A  
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAE 299
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA       ++    +  GT
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGT 352
Query: 319 VGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQWMRNVMT 376
            GY+APE  Q  VA   + D +S G +L  L+ G  P   F QH TK+   +  M   M 
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMA 409
Query: 377 SENPN 381
            E P+
Sbjct: 410 VELPD 414

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L Y F+ N +L  ++  V  G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 25/185 (13%)
Query: 211 LLARMVRRDCDLLV---YEFRRNGSLQDILYDVSQGRRELDWLARHRI---------AQG 258
           +L+ +   DC  +V   Y F     L  IL D+  G      L++H +         A  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GLE++H      +++RD++PAN+L+D+    RIS+ GLA       ++    +  GT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGT 353
Query: 319 VGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-TKEMSLVQWMRNVMT 376
            GY+APE  Q  VA   + D +S G +L  L+ G  P   F QH TK+   +  M   M 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMA 410
Query: 377 SENPN 381
            E P+
Sbjct: 411 VELPD 415

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L Y F+ N +L  ++  V  G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 76  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 128
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDNDYGRA 185
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 62  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 118
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 119 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 174
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L Y F+ N +L  ++  V  G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 76  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 128
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDNDYGRA 185
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 59  KLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 115
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D    T        + +
Sbjct: 116 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKW 171
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 3/96 (3%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      IIHRD++P N+L+++DM  +I++FG AK +     +       GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
             Y++PE     +   + D+++ G ++  LV G  P
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 19  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 78
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 79  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 131
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 132 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDNDYGRA 188
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 189 VDWWGLGVVMYEMMCGRLP 207

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 219 THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 272
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRA 329
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 330 VDWWGLGVVMYEMMCGRLP 348

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 156
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 212 KAVDWWALGVLIYEMAAGYPP 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 148
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID+    ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 204 KAVDWWALGVLIYEMAAGYPP 224

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 221
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 222 THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 275
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG T  T     GT  Y+APE  +       
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRA 332
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 333 VDWWGLGVVMYEMMCGRLP 351

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G VYKA+   + G    +KKI          ++K+ E +    I+   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    +++H NIV L   +  +   +LV+E   +  L+ +L DV +G  E    A+  +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLL-DVCEGGLE-SVTAKSFL 106
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTTTW 313
            Q + +G+ Y    H  R++HRD++P N+LI+ + E +I++FGLA+   IP    R  T 
Sbjct: 107 LQ-LLNGIAY---CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKYTH 159
Query: 314 SLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
            +  T+ Y AP+    +   S T DI+S G + A +V G   FP 
Sbjct: 160 EIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 235 KLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 291
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 347
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FGLAKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 182
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 238 KAVDWWALGVLIYEMAAGYPP 258

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    +A  IAS
Sbjct: 318 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIAS 374
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 375 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 430
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 11  GSMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 66
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 67  LSKPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 115 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 166
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 167 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 222 GCIMAELLTGRTLFPGTD---HIDQLKLI 247

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 91
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 92  --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 142
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW+L GT  Y+APE
Sbjct: 143 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPE 194
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 107 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 157
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW+L GT  Y+APE
Sbjct: 158 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPE 209
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 107 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEY 157
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 158 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 209
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G VYKA+   + G    +KKI          ++K+ E +    I+   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    +++H NIV L   +  +   +LV+E   +  L+ +L DV +G  E    A+  +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLL-DVCEGGLE-SVTAKSFL 106
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTTTW 313
            Q + +G+ Y    H  R++HRD++P N+LI+ + E +I++FGLA+   IP    R  T 
Sbjct: 107 LQ-LLNGIAY---CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKYTH 159
Query: 314 SLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
            +  T+ Y AP+    +   S T DI+S G + A +V G   FP 
Sbjct: 160 EVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 157 GSSGRVI--TIKKI-----IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV 209
           GS G+V     KK      I+ LK    L+  D E     M++ R   + +    H  + 
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKR---VLSLAWEHPFLT 81
Query: 210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS 269
            +      ++    V E+   G   D++Y + Q   + D       A  I  GL++LH  
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGG---DLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
               I++RD++  N+L+D D   +I++FG+ K    G  +T  +   GT  YIAPE    
Sbjct: 138 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF--CGTPDYIAPEILLG 192
Query: 330 VALSDTCDIYSFGVLLAVLVIGKFP 354
              + + D +SFGVLL  ++IG+ P
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 40/268 (14%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKI 168
           G    RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+
Sbjct: 11  GMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 66
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLL 223
            +P +S           +H K  +   E+     ++H N++ LL     AR +    D+ 
Sbjct: 67  SRPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 114
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N
Sbjct: 115 LVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSN 166
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G
Sbjct: 167 LAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 343 VLLAVLVIGK--FPSDDFFQHTKEMSLV 368
            ++A L+ G+  FP  D   H  ++ L+
Sbjct: 222 CIMAELLTGRTLFPGTD---HIDQLKLI 246

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G VYKA+   + G    +KKI          ++K+ E +    I+   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    +++H NIV L   +  +   +LV+E   +  L+ +L DV +G  E    A+  +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLL-DVCEGGLE-SVTAKSFL 106
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTTTW 313
            Q + +G+ Y    H  R++HRD++P N+LI+ + E +I++FGLA+   IP    R  T 
Sbjct: 107 LQ-LLNGIAY---CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKYTH 159
Query: 314 SLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
            +  T+ Y AP+    +   S T DI+S G + A +V G   FP 
Sbjct: 160 EVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPG 203

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 1   GSMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 56
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 57  LSRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 105 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 156
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 157 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 212 GCIMAELLTGRTLFPGTD---HIDQLKLI 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 41  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 99
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 100 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 151
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 152 -----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
Query: 353 FPSDD 357
            P  +
Sbjct: 207 LPYSN 211

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 11  GSMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 66
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 67  LSRPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 115 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 166
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 167 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 222 GCIMAELLTGRTLFPGTD---HIDQLKLI 247

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 1   GSHSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 56
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 57  LSRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 105 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPS 156
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 157 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 212 GCIMAELLTGRTLFPGTD---HIDQLKLI 237

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 140 EKIR-SCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII 198
           EKIR  C+  E+ +    G  G+V  ++K+     +GA   K  +  +  K + +R+   
Sbjct: 12  EKIRPECF--ELLRVLGKGGYGKVFQVRKV-----TGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR------RE---LDW 249
           TA     RNI+  +      D   L+Y F+  G L  IL  +S G       RE   ++ 
Sbjct: 65  TAHTKAERNILEEVKHPFIVD---LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHT 308
            A   +A+ I+  L +LH      II+RD++P N++++     ++++FGL K  I DG  
Sbjct: 122 TACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-- 175
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            T T +  GT+ Y+APE       +   D +S G L+  ++ G  P
Sbjct: 176 -TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 11  GSMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 66
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 67  LSRPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 114
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 115 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 166
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 167 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 221
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 222 GCIMAELLTGRTLFPGTD---HIDQLKLI 247

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIA 260
           +++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q   
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEAD--ASHCIQQI-- 137
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTW-SLA 316
             LE +   H   I+HR+++P N+L+    +    ++++FGLA  + D    +  W   A
Sbjct: 138 --LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----SEAWHGFA 191
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
           GT GY++PE  +    S   DI++ GV+L +L++G  P  D  QH
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 127
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 128 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 179
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 180 -----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234
Query: 353 FP 354
            P
Sbjct: 235 LP 236

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 40/268 (14%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKI 168
           G    RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+
Sbjct: 11  GMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 66
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLL 223
            +P +S           +H K  +   E+     ++H N++ LL     AR +    D+ 
Sbjct: 67  SRPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 114
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N
Sbjct: 115 LVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSN 166
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G
Sbjct: 167 LAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 343 VLLAVLVIGK--FPSDDFFQHTKEMSLV 368
            ++A L+ G+  FP  D   H  ++ L+
Sbjct: 222 CIMAELLTGRTLFPGTD---HIDQLKLI 246

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 28/181 (15%)
Query: 220 CDLLVYEFRRNGSLQDILYDVSQGRR--ELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           C  +  EF   G+L+  +    + RR  +LD +    + + I  G++Y+H     ++IHR
Sbjct: 108 CLFIQMEFCDKGTLEQWI----EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHR 160
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           D++P+N+ + D  + +I +FGL   + +   RT +    GT+ Y++PE   +       D
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVD 217
Query: 338 IYSFGVLLAVLV--------IGKFPSD-------DFFQHTKEMSLVQWMRNVMTSENPNR 382
           +Y+ G++LA L+          KF +D       D F   KE +L+Q + +    + PN 
Sbjct: 218 LYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK-KEKTLLQKLLSKKPEDRPNT 276
Query: 383 A 383
           +
Sbjct: 277 S 277

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYQMAAGYPP 237

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 141/336 (41%), Gaps = 64/336 (19%)
Query: 112 DRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKII 169
           DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +KK  
Sbjct: 5   DRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK-- 50
Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYE 226
             L+   E   +D E           EI     ++H NIV    +     RR+  L++ E
Sbjct: 51  --LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-E 97
Query: 227 FRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
           +   GSL+D L    + +  +D +   +    I  G+EYL      R IHRD+   N+L+
Sbjct: 98  YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 151
Query: 287 DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +++   +I +FGL K +P D             + + APE       S   D++SFGV+L
Sbjct: 152 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 211
Query: 346 AVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             L       K P  +F +              L++ ++N      P          +G 
Sbjct: 212 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGC 261
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 262 PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 294

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 162
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 218 KAVDWWALGVLIYEMAAGYPP 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FGLAKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 19/222 (8%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    Q+ H N++   A  +  +   +V E    G L  ++    + +R +      + 
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              + S LE++H     R++HRDI+PANV I      ++ + GL +        T   SL
Sbjct: 142 FVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSL 196
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM 375
            GT  Y++PE       +   DI+S G LL  +   + P      +  +M+L    + + 
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIE 251
Query: 376 TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
             + P       L  + Y E++  ++ +   C   DP KRP+
Sbjct: 252 QCDYP------PLPSDHYSEELRQLVNM---CINPDPEKRPD 284

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIA 260
           +++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q   
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEAD--ASHCIQQI-- 114
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTW-SLA 316
             LE +   H   I+HR+++P N+L+    +    ++++FGLA  + D    +  W   A
Sbjct: 115 --LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----SEAWHGFA 168
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
           GT GY++PE  +    S   DI++ GV+L +L++G  P  D  QH
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 1   GSMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 56
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 57  LSRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 105 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 156
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 157 NLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 212 GCIMAELLTGRTLFPGTD---HIDQLKLI 237

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 1   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 56
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 57  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 105 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 157 DCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 212 LLTGRTLFPGTD---HIDQLKLI 231

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+  S+
Sbjct: 45  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH-ASE 102
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
            + E+  L    IA+  A G++YLH      IIHRD++  N+ + +D   +I +FGLA  
Sbjct: 103 TKFEMKKLID--IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA-- 155
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE      +   S   D+Y+FG++L  L+ G+
Sbjct: 156 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210
Query: 353 FP 354
            P
Sbjct: 211 LP 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 61  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 119
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 120 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 171
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 172 -----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226
Query: 353 FP 354
            P
Sbjct: 227 LP 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 141/336 (41%), Gaps = 64/336 (19%)
Query: 112 DRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKII 169
           DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +KK  
Sbjct: 7   DRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK-- 52
Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYE 226
             L+   E   +D E           EI     ++H NIV    +     RR+  L++ E
Sbjct: 53  --LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-E 99
Query: 227 FRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
           +   GSL+D L    + +  +D +   +    I  G+EYL      R IHRD+   N+L+
Sbjct: 100 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 153
Query: 287 DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +++   +I +FGL K +P D             + + APE       S   D++SFGV+L
Sbjct: 154 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 213
Query: 346 AVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             L       K P  +F +              L++ ++N      P          +G 
Sbjct: 214 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGC 263
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 264 PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 296

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V  G          R  +  AR   AQ I    EYLH      
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHSLD--- 154
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 210 KAVDWWALGVLIYEMAAGYPP 230

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    ++  IAS
Sbjct: 66  KLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD--MSAQIAS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 123 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 107 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 157
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 158 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 209
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D    T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +          +V ++    SL   L+  S+
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH-ASE 114
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
            + E+  L    IA+  A G++YLH      IIHRD++  N+ + +D   +I +FGLA  
Sbjct: 115 TKFEMKKLID--IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA-- 167
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE      +   S   D+Y+FG++L  L+ G+
Sbjct: 168 -----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
Query: 353 FP 354
            P
Sbjct: 223 LP 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  I S   G V  A     +G  + +KK+ +P +
Sbjct: 10  RPTFYR---QELNKTIWEVPERYQNLSPIGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 65
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 66  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 114 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 165
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 166 DXELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 221 LLTGRTLFPGTD---HIDQLKLI 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH-QTVALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 136 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 186
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV--PLLAR 214
           GS GRV+ +K +        +++ K       K+++++    T  + R    V  P L +
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDK------QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEY 265
                   L + F+ N +L  ++  V  G          R  +  AR   AQ I    EY
Sbjct: 106 --------LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEY 156
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH      +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPE 208
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              +   +   D ++ GVL+  +  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKK 167
           G     RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK
Sbjct: 1   GPMSQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 56
Query: 168 IIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDL 222
           + +P +S           +H K  +   E+     ++H N++ LL     AR +    D+
Sbjct: 57  LSRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 104
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+
Sbjct: 105 YLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPS 156
Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSF 341
           N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S 
Sbjct: 157 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 211
Query: 342 GVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
           G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 212 GCIMAELLTGRTLFPGTD---HIDQLKLI 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 40/270 (14%)
Query: 107 RGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIK 166
           +  +   RP  +    +E +    E  + + +L  + S   G V  A     +G  + +K
Sbjct: 21  QSNASQERPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVK 76
Query: 167 KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCD 221
           K+ +P +S           +H K  +   E+     ++H N++ LL     AR +    D
Sbjct: 77  KLSRPFQS----------IIHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 124
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
           + +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P
Sbjct: 125 VYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKP 176
Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYS 340
           +N+ +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S
Sbjct: 177 SNLAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWS 231
Query: 341 FGVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
            G ++A L+ G+  FP  D   H  ++ L+
Sbjct: 232 VGCIMAELLTGRTLFPGTD---HIDQLKLI 258

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L   +     L  L    ++  IAS
Sbjct: 66  KLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD--MSAQIAS 122
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 123 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEWTARQGAKFPIKW 178
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 25  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 80
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 81  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 129 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 181 DCELKILDFGLAR-----HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 236 LLTGRTLFPGTD---HIDQLKLI 255

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIA 260
           +++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q   
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEAD--ASHCIQQI-- 114
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTW-SLA 316
             LE +   H   I+HR+++P N+L+    +    ++++FGLA  + D    +  W   A
Sbjct: 115 --LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----SEAWHGFA 168
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
           GT GY++PE  +    S   DI++ GV+L +L++G  P  D  QH
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 76  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 128
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 60  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 116
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 117 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 172
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 25  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 80
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 81  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 129 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 181 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 236 LLTGRTLFPGTD---HIDQLKLI 255

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIA 260
           +++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q   
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEAD--ASHCIQQI-- 113
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTW-SLA 316
             LE +   H   I+HR+++P N+L+    +    ++++FGLA  + D    +  W   A
Sbjct: 114 --LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----SEAWHGFA 167
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
           GT GY++PE  +    S   DI++ GV+L +L++G  P  D  QH
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 212

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G V  +++    L+   + I KD   +   M QI +EI     + H NI+ +     
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
                 +V E    G L + +       + L       + + + + L Y H  H   ++H
Sbjct: 91  DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVH 147
Query: 277 RDIQPANVLIDDD---MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +D++P N+L  D       +I +FGLA+        T     AGT  Y+APE  +   ++
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPEVFKR-DVT 203
Query: 334 DTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             CDI+S GV++  L+ G  P    F  T     ++ ++   T + PN A+  + L    
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLP----FTGTS----LEEVQQKATYKEPNYAVECRPLT--- 252
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             Q + +LK        DP +RP++  V
Sbjct: 253 -PQAVDLLKQML---TKDPERRPSAAQV 276

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KG 194
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 1   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 56
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 57  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 105 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 157 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 212 LLTGRTLFPGTD---HIDQLKLI 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 24  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 79
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 80  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 127
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 128 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 179
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 180 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 235 LLTGRTLFPGTD---HIDQLKLI 254

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N+LID     ++++FG AKR+     + 
Sbjct: 164 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KG 214
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 41/254 (16%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H N++ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFP--------------------SDDFFQHTKEMSLV 368
              L    D++S GV+  +L+ G  P                     ++FF HT E++  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-K 250
Query: 369 QWMRNVMTSENPNR 382
            ++R ++  E   R
Sbjct: 251 DFIRKLLVKETRKR 264

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDI--LYDVSQGRREL 247
           Q+  EI    ++ H N+V L+  +   + D   +V+E    G + ++  L  +S+ +   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARF 141
Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
            +       Q +  G+EYLH     +IIHRDI+P+N+L+ +D   +I++FG++       
Sbjct: 142 YF-------QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 308 TRTTTWSLAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
              +  +  GT  ++APE     + +      D+++ GV L   V G+ P  D
Sbjct: 192 ALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           GQ  H N+V L   + R    ++V EF  NG+L D       G+  +  L    + +GIA
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVG--MLRGIA 155
Query: 261 SGLEYL-HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAGT 318
           +G+ YL  M +    +HRD+   N+L++ ++  ++S+FGL++ I D      TT      
Sbjct: 156 AGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
           V + APE  Q    +   D++S+G+++  V+  G+ P  D
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 28/226 (12%)
Query: 140 EKIR-SCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII 198
           EKIR  C+  E+ +    G  G+V  ++K+     +GA   K  +  +  K + +R+   
Sbjct: 12  EKIRPECF--ELLRVLGKGGYGKVFQVRKV-----TGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR------RE---LDW 249
           TA     RNI+  +      D   L+Y F+  G L  IL  +S G       RE   ++ 
Sbjct: 65  TAHTKAERNILEEVKHPFIVD---LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHT 308
            A   +A+ I+  L +LH      II+RD++P N++++     ++++FGL K  I DG  
Sbjct: 122 TACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-- 175
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            T T    GT+ Y+APE       +   D +S G L+  ++ G  P
Sbjct: 176 -TVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 58  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 114
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 115 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 170
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 41/254 (16%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H N++ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFP--------------------SDDFFQHTKEMSLV 368
              L    D++S GV+  +L+ G  P                     ++FF HT E++  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-K 250
Query: 369 QWMRNVMTSENPNR 382
            ++R ++  E   R
Sbjct: 251 DFIRKLLVKETRKR 264

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KXQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DXELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 21  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 80
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 81  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 133
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 134 RDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 191 VDWWGLGVVMYEMMCGRLP 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 11  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 66
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 67  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 115 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 167 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 222 LLTGRTLFPGTD---HIDQLKLI 241

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 46  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII-- 102
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 103 -ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 156
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 157 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211
Query: 353 FP 354
            P
Sbjct: 212 LP 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 41/254 (16%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H N++ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFP--------------------SDDFFQHTKEMSLV 368
              L    D++S GV+  +L+ G  P                     ++FF HT E++  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-K 250
Query: 369 QWMRNVMTSENPNR 382
            ++R ++  E   R
Sbjct: 251 DFIRKLLVKETRKR 264

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 68  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 126
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 127 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 178
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 179 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233
Query: 353 FP 354
            P
Sbjct: 234 LP 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 15  RPTFYR---QELNKTIWEVPERYQNLAPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 70
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 71  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 118
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 119 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 170
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 171 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 225
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 226 LLTGRTLFPGTD---HIDQLKLI 245

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD+  AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+  RV T   +I   +   ++I+K  +P H +    R   +      HRN++ L+    
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D   LV+E  R GS+   ++     RR  + L    + Q +AS L++LH      I H
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH---NKGIAH 134
Query: 277 RDIQPANVLIDDDME---ARISEFGLAKRIP---DGHTRTTTWSL--AGTVGYIAPECHQ 328
           RD++P N+L +   +    +I +FGL   I    D    +T   L   G+  Y+APE  +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 329 TVALSDT-----CDIYSFGVLLAVLVIGKFP 354
             +   +     CD++S GV+L +L+ G  P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 41/268 (15%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKI 168
           GS++R P  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+
Sbjct: 1   GSQER-PTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 55
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLL 223
            +P +S           +H K  +   E+     ++H N++ LL     AR +    D+ 
Sbjct: 56  SRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N
Sbjct: 104 LVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSN 155
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G
Sbjct: 156 LAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 343 VLLAVLVIGK--FPSDDFFQHTKEMSLV 368
            ++A L+ G+  FP  D   H  ++ L+
Sbjct: 211 CIMAELLTGRTLFPGTD---HIDQLKLI 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 10  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 65
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 66  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 114 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 165
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 166 DXELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 221 LLTGRTLFPGTD---HIDQLKLI 240

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 43  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 101
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 102 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 153
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 154 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208
Query: 353 FPSDD 357
            P  +
Sbjct: 209 LPYSN 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 127
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 128 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 179
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 180 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234
Query: 353 FP 354
            P
Sbjct: 235 LP 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +    + V ++    SL   L+ +  
Sbjct: 41  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHIIET 99
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 100 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 151
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 152 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
Query: 353 FPSDD 357
            P  +
Sbjct: 207 LPYSN 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           + P   ++   ++E+    + RH NI+  +    +     +V ++    SL   L+ +  
Sbjct: 46  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET 104
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
              + + +    IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA  
Sbjct: 105 ---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-- 156
Query: 303 IPDGHTRTTTWS-------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGK 352
                T  + WS       L+G++ ++APE          S   D+Y+FG++L  L+ G+
Sbjct: 157 -----TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211
Query: 353 FPSDD 357
            P  +
Sbjct: 212 LPYSN 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 76  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 128
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL+Y+H +    IIHRD++P+NV +++D E RI +FGLA++  +  T         T  Y
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-----GYVATRWY 186
Query: 322 IAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
            APE     +  + T DI+S G ++A L+ GK  FP  D+    K +
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 233

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELD 248
           IQI  ++     V  R +   L ++   D  LL  E+   G L+  L  ++   G +E  
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG- 121
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPD 305
                 +   I+S L YLH +   RIIHRD++P N+++    +    +I + G AK +  
Sbjct: 122 --PIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           G   T      GT+ Y+APE  +    + T D +SFG L    + G  P    +Q     
Sbjct: 177 GELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---- 229
Query: 366 SLVQWMRNVMTSENPNRAINSKLLG 390
             VQW   V    N +  +   L G
Sbjct: 230 --VQWHGKVREKSNEHIVVYDDLTG 252

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KXQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +++         ++++K+      ++    +E       RH  +  L     
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S LEYLH      +++
Sbjct: 76  THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 128
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RDI+  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGLA+ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL+Y+H +    IIHRD++P+NV +++D E RI +FGLA++  +  T         T  Y
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVATRWY 194
Query: 322 IAPECHQT-VALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
            APE     +  + T DI+S G ++A L+ GK  FP  D+    K +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 12  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 67
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 68  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 116 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 168 DCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 223 LLTGRTLFPGTD---HIDQLKLI 242

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 12  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 67
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 68  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 116 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 168 DCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 223 LLTGRTLFPGTD---HIDQLKLI 242

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 12  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 67
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 68  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 116 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 168 DCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 223 LLTGRTLFPGTD---HIDQLKLI 242

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 113/239 (47%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S GV++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   AQ I    EYLH      +I+RD++P N++ID     ++++FG AKR+     + 
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KG 193
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TW L GT  Y+APE   +   +   D ++ GVL+  +  G  P
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 12  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 67
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 68  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 116 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 168 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 223 LLTGRTLFPGTD---HIDQLKLI 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELD 248
           IQI  ++     V  R +   L ++   D  LL  E+   G L+  L  ++   G +E  
Sbjct: 64  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG- 122
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPD 305
                 +   I+S L YLH +   RIIHRD++P N+++    +    +I + G AK +  
Sbjct: 123 --PIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           G   T      GT+ Y+APE  +    + T D +SFG L    + G  P    +Q     
Sbjct: 178 GELCT---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---- 230
Query: 366 SLVQWMRNVMTSENPNRAINSKLLG 390
             VQW   V    N +  +   L G
Sbjct: 231 --VQWHGKVREKSNEHIVVYDDLTG 253

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 2   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 57
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 58  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 105
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 106 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 157
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 158 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 213 LLTGRTLFPGTD---HIDQLKLI 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 11  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 66
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 67  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 115 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 166
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 167 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 222 LLTGRTLFPGTD---HIDQLKLI 241

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYSYNPSHNPEEQL 188
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 246 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 360 QHTKE 364
           +  KE
Sbjct: 304 KLLKE 308

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL+Y+H +    IIHRD++P+NV +++D E RI +FGLA++  +  T         T  Y
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVATRWY 194
Query: 322 IAPECHQT-VALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
            APE     +  + T DI+S G ++A L+ GK  FP  D+    K +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 10  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 65
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 66  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 114 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 165
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 166 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 221 LLTGRTLFPGTD---HIDQLKLI 240

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 69/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N++ID     ++++FG AKR+     +  TW L GT  Y+APE   +   +
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 3   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 58
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 59  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 106
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 107 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 158
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 159 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 213
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 214 LLTGRTLFPGTD---HIDQLKLI 233

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 24  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 79
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 80  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 127
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 128 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 179
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 180 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 235 LLTGRTLFPGTD---HIDQLKLI 254

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 113/239 (47%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S GV++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 11  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 66
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 67  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 115 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 167 DSELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 222 LLTGRTLFPGTD---HIDQLKLI 241

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 25  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 80
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 81  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 129 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 180
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 181 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 236 LLTGRTLFPGTD---HIDQLKLI 255

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 28  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 83
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 84  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 131
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 132 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 183
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 184 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 239 LLTGRTLFPGTD---HIDQLKLI 258

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 10  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 65
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 66  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 114 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 165
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 166 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 221 LLTGRTLFPGTD---HIDQLKLI 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 4   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 59
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 60  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 107
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 108 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 159
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 160 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 214
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 215 LLTGRTLFPGTD---HIDQLKLI 234

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + +    +++ E+  NGSL D     + GR  +  L    
Sbjct: 64  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVG-- 120
Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT 312
           + +GI SG++YL  MS+    +HRD+   N+L++ ++  ++S+FG+++ + D      TT
Sbjct: 121 MLRGIGSGMKYLSDMSY----VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 176
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
                 + + APE       +   D++S+G+++  V+  G+ P  D 
Sbjct: 177 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 223

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 1   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 56
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 57  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 105 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 156
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 157 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 212 LLTGRTLFPGTD---HIDQLKLI 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFGLAR-----HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
           E L  K   + +EI    +++H NIV L           L+ +    G L D +  V +G
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKG 111
Query: 244 -RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL---IDDDMEARISEFGL 299
              E D     R+   +   ++YLH      I+HRD++P N+L   +D+D +  IS+FGL
Sbjct: 112 FYTERD---ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 165
Query: 300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
           +K    G   +T     GT GY+APE       S   D +S GV+  +L+ G  P  D
Sbjct: 166 SKMEDPGSVLSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + +    +++ E+  NGSL D     + GR  +  L    
Sbjct: 58  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVG-- 114
Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT 312
           + +GI SG++YL  MS+    +HRD+   N+L++ ++  ++S+FG+++ + D      TT
Sbjct: 115 MLRGIGSGMKYLSDMSY----VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 170
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDF 358
                 + + APE       +   D++S+G+++  V+  G+ P  D 
Sbjct: 171 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 39/259 (15%)
Query: 120 PLIKEEDLA--FLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE 177
           P    ++LA    E  + + +L  + S   G V  A     +G  + +KK+ +P +S   
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSI-- 58
Query: 178 LIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGS 232
                   +H K  +   E+     ++H N++ LL     AR +    D+ +        
Sbjct: 59  --------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 108
Query: 233 LQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA 292
           L +I+         + +L    I Q I  GL+Y+H +    IIHRD++P+N+ +++D E 
Sbjct: 109 LNNIVKCAKLTDDHVQFL----IYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIG 351
           +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A L+ G
Sbjct: 161 KILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 352 K--FPSDDFFQHTKEMSLV 368
           +  FP  D   H  ++ L+
Sbjct: 216 RTLFPGTD---HIDQLKLI 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 2   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 57
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 58  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 105
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 106 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 157
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 158 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 213 LLTGRTLFPGTD---HIDQLKLI 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 140/336 (41%), Gaps = 64/336 (19%)
Query: 112 DRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKII 169
           DR P  F    +E  L FL +  +  F S+E  R           L  ++G V+ +KK  
Sbjct: 4   DRDPTQF----EERHLKFLRQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK-- 49
Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYE 226
             L+   E   +D E           EI     ++H NIV    +     RR+  L++ E
Sbjct: 50  --LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-E 96
Query: 227 FRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
           F   GSL++ L    + +  +D +   +    I  G+EYL      R IHRD+   N+L+
Sbjct: 97  FLPYGSLREYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 150
Query: 287 DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +++   +I +FGL K +P D             + + APE       S   D++SFGV+L
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 210
Query: 346 AVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             L       K P  +F +              L++ ++N      P          +G 
Sbjct: 211 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGC 260
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 261 PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYSYNPSHNPEEQL 139
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 140 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 197 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 360 QHTKE 364
           +  KE
Sbjct: 255 KLLKE 259

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYSYNPSHNPEEQL 147
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 205 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 360 QHTKE 364
           +  KE
Sbjct: 263 KLLKE 267

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYSYNPSHNPEEQL 136
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 137 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 194 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 360 QHTKE 364
           +  KE
Sbjct: 252 KLLKE 256

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYSYNPSHNPEEQL 140
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 141 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 198 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 360 QHTKE 364
           +  KE
Sbjct: 256 KLLKE 260

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 19  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 78
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 79  THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVY 132
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 190 VDWWGLGVVMYEMMCGRLP 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 54
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 55  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 103
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 104 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 158 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 265
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 266 -TECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
           E L  K   + +EI    +++H NIV L           L+ +    G L D +  V +G
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKG 111
Query: 244 -RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL---IDDDMEARISEFGL 299
              E D     R+   +   ++YLH      I+HRD++P N+L   +D+D +  IS+FGL
Sbjct: 112 FYTERD---ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 165
Query: 300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
           +K    G   +T     GT GY+APE       S   D +S GV+  +L+ G  P  D
Sbjct: 166 SKMEDPGSVLSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 54
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 55  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 103
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 104 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 158 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 265
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 266 -TECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR--------- 254
           +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H          
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 255 ---IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
               A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D + +
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F+  K
Sbjct: 209 TTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 364 E 364
           E
Sbjct: 267 E 267

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 11  RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 66
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 67  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 115 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 167 DCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 222 LLTGRTLFPGTD---HIDQLKLI 241

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 72
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 73  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 121
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 122 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 175
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 283
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 284 -TECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 53
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 54  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 102
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 103 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 156
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 157 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 216
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 217 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 264
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 265 -TECWNNNVNQRPSFRDLALRVDQIR 289

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 52
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 53  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 101
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 102 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 155
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 156 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 215
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 216 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 263
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 264 -TECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 21  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 80
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 81  THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 134
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 192 VDWWGLGVVMYEMMCGRLP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G+VI +K+         +++KK+      ++    +E       RH  +  L     
Sbjct: 20  GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 79
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D    V E+   G L    + +S+ R   +  AR   A+ I S L+YLH      +++
Sbjct: 80  THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVY 133
Query: 277 RDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           RD++  N+++D D   +I++FGL K  I DG    T     GT  Y+APE  +       
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 336 CDIYSFGVLLAVLVIGKFP 354
            D +  GV++  ++ G+ P
Sbjct: 191 VDWWGLGVVMYEMMCGRLP 209

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 72
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 73  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 121
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 122 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 175
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 283
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 284 -TECWNNNVNQRPSFRDLALRVDQIR 308

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q    
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEAD--ASHCIQQI--- 112
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE +   H+  ++HRD++P N+L+    +    ++++FGLA  +     +   +  AGT
Sbjct: 113 -LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--DQQAWFGFAGT 169
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +  A     DI++ GV+L +L++G  P  D  QH
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQH 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I  E+    ++RH NI+ L      +   +L+ E    G L D L        E + L 
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------AEKESLT 113
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGH 307
                Q +   L+ +H  H  RI H D++P N+++ D    +   ++ +FG+A +I  G+
Sbjct: 114 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
                +   GT  ++APE      L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 174 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETL 227
Query: 368 VQ 369
Sbjct: 228 TN 229

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   GSL D L         L  L    +A  IAS
Sbjct: 236 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIAS 292
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGL + I D +  T        + +
Sbjct: 293 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIED-NEYTARQGAKFPIKW 348
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
           E L  K   + +EI    +++H NIV L           L+ +    G L D +  V +G
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKG 111
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL---IDDDMEARISEFGLA 300
                +      ++ I   L+ +   H   I+HRD++P N+L   +D+D +  IS+FGL+
Sbjct: 112 -----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
           K    G   +T     GT GY+APE       S   D +S GV+  +L+ G  P  D
Sbjct: 167 KMEDPGSVLSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 141/336 (41%), Gaps = 64/336 (19%)
Query: 112 DRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKII 169
           DR P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +KK  
Sbjct: 4   DRDPTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK-- 49
Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYE 226
             L+   E   +D E           EI     ++H NIV    +     RR+  L++ E
Sbjct: 50  --LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-E 96
Query: 227 FRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
           +   GSL+D L   ++    +D +   +    I  G+EYL      R IHRD+   N+L+
Sbjct: 97  YLPYGSLRDYLQAHAE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 150
Query: 287 DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +++   +I +FGL K +P D             + + APE       S   D++SFGV+L
Sbjct: 151 ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 210
Query: 346 AVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             L       K P  +F +              L++ ++N      P          +G 
Sbjct: 211 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGC 260
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 261 PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I  E+    ++RH NI+ L      +   +L+ E    G L D L        E + L 
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------AEKESLT 127
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGH 307
                Q +   L+ +H  H  RI H D++P N+++ D    +   ++ +FG+A +I  G+
Sbjct: 128 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
                +   GT  ++APE      L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 188 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETL 241
Query: 368 VQ 369
Sbjct: 242 TN 243

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 126
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 127 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 143
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 144 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   G L D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 82/339 (24%), Positives = 143/339 (42%), Gaps = 66/339 (19%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIK 166
           GSRD  P  F    +E  L FL++  +  F S+E  R           L  ++G V+ +K
Sbjct: 1   GSRD--PTQF----EERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVK 46
Query: 167 KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLL 223
           K    L+   E   +D E           EI     ++H NIV    +     RR+  L+
Sbjct: 47  K----LQHSTEEHLRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 92
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           + E+   GSL+D L    + +  +D +   +    I  G+EYL      R IHR++   N
Sbjct: 93  M-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRN 145
Query: 284 VLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           +L++++   +I +FGL K +P D             + + APE       S   D++SFG
Sbjct: 146 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 205
Query: 343 VLLAVLVI----GKFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLG 390
           V+L  L       K P  +F +              L++ ++N      P          
Sbjct: 206 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---------- 255
Query: 391 NGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
           +G  +++ +++     C  ++ N+RP+ +D+   + QI+
Sbjct: 256 DGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQIR 291

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 123/268 (45%), Gaps = 41/268 (15%)
Query: 109 GSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKI 168
           GS++R P  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+
Sbjct: 1   GSQER-PTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 55
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLL 223
            +P +S           +H K  +   E+     ++H N++ LL     AR +    D+ 
Sbjct: 56  SRPFQSI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 103
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           +        L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N
Sbjct: 104 LVTHLMGADLNNIV----KSQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSN 155
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGL +     HT         T  Y APE     +  + T DI+S G
Sbjct: 156 LAVNEDSELKILDFGLCR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 343 VLLAVLVIGK--FPSDDFFQHTKEMSLV 368
            ++A L+ G+  FP  D   H  ++ L+
Sbjct: 211 CIMAELLTGRTLFPGTD---HIDQLKLI 235

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I  E+    ++RH NI+ L      +   +L+ E    G L D L        E + L 
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------AEKESLT 106
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGH 307
                Q +   L+ +H  H  RI H D++P N+++ D    +   ++ +FG+A +I  G+
Sbjct: 107 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
                +   GT  ++APE      L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 167 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETL 220
Query: 368 VQ 369
Sbjct: 221 TN 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           + +EI    +++H NIV L           LV +    G L D + +    R        
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDA 108
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTR 309
             + Q + S ++YLH +    I+HRD++P N+L    +++ +  I++FGL+K   +G   
Sbjct: 109 SLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK 363
           T      GT GY+APE       S   D +S GV+  +L+ G  P   F++ T+
Sbjct: 166 TA----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP---FYEETE 212

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 170 QPLKSGAELI------KKDSEPLHHKMIQIRSEIITAGQVR-------HRNIVPLLARMV 216
           +PL  G+  I      KK ++    K+I  R E  T  ++        H NIV L     
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E    G L    ++  + ++         I + + S + ++H      ++H
Sbjct: 77  DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVH 129
Query: 277 RDIQPANVLI---DDDMEARISEFGLAK-RIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
           RD++P N+L    +D++E +I +FG A+ + PD     T      T+ Y APE       
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP---CFTLHYAAPELLNQNGY 186
Query: 333 SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM---SLVQWMRNV 374
            ++CD++S GV+L  ++ G+ P   F  H + +   S V+ M+ +
Sbjct: 187 DESCDLWSLGVILYTMLSGQVP---FQSHDRSLTCTSAVEIMKKI 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 60/113 (53%), Gaps = 20/113 (17%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           IA+  A G++YLH      IIHRD++  N+ + +D+  +I +FGLA       T  + WS
Sbjct: 109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA-------TVKSRWS 158
Query: 315 -------LAGTVGYIAPEC---HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
                  L+G++ ++APE          S   D+Y+FG++L  L+ G+ P  +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 50/273 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP 
Sbjct: 174 R------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPG 227
Query: 356 DDFFQHTKEMSLVQWMRNVMTSENPNRAINSKL 388
            D+          QW + +     P  A   KL
Sbjct: 228 RDYID--------QWNKVIEQLGTPCPAFMKKL 252

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++RH  +V L A +V  +   +V E+   G L D L         L  L    +A  IAS
Sbjct: 69  KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD--MAAQIAS 125
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+ Y+    R   +HRD++ AN+L+ +++  ++++FGLA+ I D +  T        + +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 181
Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP 354
            APE       +   D++SFG+LL  L   G+ P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT  Y+AP    +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 153
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 154 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEFSFNPSHNPEEQL 147
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
              +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 205 XXKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 360 QHTKE 364
           +  KE
Sbjct: 263 KLLKE 267

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I ++GLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDYGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+ G V+  +  +  ++   ++I+K S        ++  E+     + H NI+ L     
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS-KLLEEVAVLKLLDHPNIMKLYDFFE 106
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
            +    LV E  + G L    +D    R + + +    I + + SG+ YLH   +  I+H
Sbjct: 107 DKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 277 RDIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           RD++P N+L++    D   +I +FGL+    +   +       GT  YIAPE  +     
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPEVLRK-KYD 215
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
           + CD++S GV+L +L+ G  P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL      + +    D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 356 DDF 358
            D+
Sbjct: 228 RDY 230

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL + + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I  FGLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILGFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 60/326 (18%)
Query: 122 IKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI 179
            +E  L FL++  +  F S+E  R           L  ++G V+ +KK    L+   E  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRY--------DPLQDNTGEVVAVKK----LQHSTEEH 54
Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVP---LLARMVRRDCDLLVYEFRRNGSLQDI 236
            +D E           EI     ++H NIV    +     RR+  L++ E+   GSL+D 
Sbjct: 55  LRDFE----------REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDY 103
Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +  +D +   +    I  G+EYL      R IHRD+   N+L++++   +I +
Sbjct: 104 L---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157
Query: 297 FGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI----G 351
           FGL K +P D             + + APE       S   D++SFGV+L  L       
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 352 KFPSDDFFQHTKE--------MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKI 403
           K P  +F +              L++ ++N      P          +G  +++ +++  
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----------DGCPDEIYMIM-- 265
Query: 404 ACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              C  ++ N+RP+ +D+   + QI+
Sbjct: 266 -TECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL      + +    D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 356 DDF 358
            D+
Sbjct: 228 RDY 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E+  NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAG 317
           IASG++YL        +HRD+   N+LI+ ++  ++S+FGL++ + D      TT     
Sbjct: 156 IASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H N++ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 227

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIAQGIASG 262
           +H NI+ L           LV E  R G L D IL       RE  +     +   I   
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKT 133
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEA----RISEFGLAK--RIPDGHTRTTTWSLA 316
           +EYLH      ++HRD++P+N+L  D+       RI +FG AK  R  +G   T  +   
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--- 187
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            T  ++APE  +     + CDI+S G+LL  ++ G  P
Sbjct: 188 -TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSE-IITAGQVRHRNIVPLLARM 215
           GS G+V+  +   + +    ++++K +     +   I SE  +    V+H  +V L    
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRII 275
              D    V ++   G L    Y + + R  L+  AR   A+ IAS L YLH  +   I+
Sbjct: 109 QTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IV 161
Query: 276 HRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           +RD++P N+L+D      +++FGL K   +    +TT +  GT  Y+APE         T
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT 219
Query: 336 CDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
            D +  G +L  ++ G  P   + ++T EM
Sbjct: 220 VDWWCLGAVLYEMLYGLPPF--YSRNTAEM 247

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+EF     L+D + D S     L  +    I
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFM-DASA----LTGIPLPLI 105
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHE 163
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYCYNPSHNPEEQL 147
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 205 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 360 QHTKE 364
           +  KE
Sbjct: 263 KLLKE 267

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 33/185 (17%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLARHR----- 254
           +H+NI+ LL    +     ++ E+   G+L++ L    Q RR    E  +   H      
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRPPGLEYCYNPSHNPEEQL 132
Query: 255 -------IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--D 305
                   A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFF 359
            + +TT   L   V ++APE       +   D++SFGVLL  +  +G       P ++ F
Sbjct: 190 YYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 360 QHTKE 364
           +  KE
Sbjct: 248 KLLKE 252

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 104 LIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 160
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 160
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 49/264 (18%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE----- 177
           K+ D++++ K  Y  S  K+    + + Y  E+  S+  V+   + ++P+ SGA+     
Sbjct: 26  KQVDVSYIAKH-YNMSKSKV----DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCA 80
Query: 178 ----------LIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC----- 220
                      IKK S P  ++    R+  E++    V H+NI+ LL     +       
Sbjct: 81  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 221 -DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI 279
              LV E       Q I       + ELD      +   +  G+++LH +    IIHRD+
Sbjct: 141 DVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDL 190
Query: 280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTC 336
           +P+N+++  D   +I +FGLA+      T  T++ +   V    Y APE    +   +  
Sbjct: 191 KPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 337 DIYSFGVLLAVLVIGK--FPSDDF 358
           DI+S G ++  +V  K  FP  D+
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDY 268

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 49/264 (18%)
Query: 123 KEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE----- 177
           K+ D++++ K  Y  S  K+    + + Y  E+  S+  V+   + ++P+ SGA+     
Sbjct: 26  KQVDVSYIAKH-YNMSKSKV----DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCA 80
Query: 178 ----------LIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC----- 220
                      IKK S P  ++    R+  E++    V H+NI+ LL     +       
Sbjct: 81  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 221 -DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI 279
              LV E       Q I       + ELD      +   +  G+++LH +    IIHRD+
Sbjct: 141 DVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDL 190
Query: 280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTC 336
           +P+N+++  D   +I +FGLA+      T  T++ +   V    Y APE    +   +  
Sbjct: 191 KPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 337 DIYSFGVLLAVLVIGK--FPSDDF 358
           DI+S G ++  +V  K  FP  D+
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDY 268

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 44/303 (14%)
Query: 135 YFASLEKIRSCW------NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
           YF S+EK  +         G V K      +GR++ IKK ++      +++KK       
Sbjct: 20  YFQSMEKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLE--SDDDKMVKK------- 69
Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
             I +R EI    Q+RH N+V LL    ++    LV+EF  +     IL D+      LD
Sbjct: 70  --IAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLD 122
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
           +    +    I +G+ + H SH   IIHRDI+P N+L+      ++ +FG A+ +     
Sbjct: 123 YQVVQKYLFQIINGIGFCH-SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAP 177
Query: 309 RTTTWSLAGTVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSD---DFFQHT 362
                    T  Y APE     V      D+++ G L+  + +G+  FP D   D   H 
Sbjct: 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237
Query: 363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQML---------LVLKIACFCTLDDPN 413
             M L   +       N N       L    E + L         +V+ +A  C   DP+
Sbjct: 238 M-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296
Query: 414 KRP 416
           KRP
Sbjct: 297 KRP 299

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           SE    GQ  H NI+ L   + +    +++ E+  NGSL D     + GR  +  L    
Sbjct: 79  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVG-- 135
Query: 255 IAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT 312
           + +GI SG++YL  MS     +HRD+   N+L++ ++  ++S+FG+++ + D      TT
Sbjct: 136 MLRGIGSGMKYLSDMSA----VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 191
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
                 + + APE       +   D++S+G+++  V+  G+ P
Sbjct: 192 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 53
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+EF  +  L+D + D S     L  +    I
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASA----LTGIPLPLI 107
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHE 165
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 159
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 104
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 161
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 162 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 12  FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 58
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 110
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 111 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 168 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 19/139 (13%)
Query: 223 LVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
           LV E  R G L D IL       RE  +     +   I   +EYLH      ++HRD++P
Sbjct: 98  LVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQ---GVVHRDLKP 149
Query: 282 ANVLIDDDMEA----RISEFGLAK--RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT 335
           +N+L  D+       RI +FG AK  R  +G   T  +    T  ++APE  +     + 
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY----TANFVAPEVLKRQGYDEG 205
Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CDI+S G+LL  ++ G  P
Sbjct: 206 CDIWSLGILLYTMLAGYTP 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 160
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H N++ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 227

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 159
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 160
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 THEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 43  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 88
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 89  GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 198
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+EF  +  L+D + D S     L  +    I
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASA----LTGIPLPLI 108
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHE 166
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 12  FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 58
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 110
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 111 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 167
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 168 THEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 47  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 92
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 93  GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 202
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A +V ++   ++ EF   GSL D L      ++ L  L     +  IA G
Sbjct: 67  LQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 123
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + ++   +    IHRD++ AN+L+   +  +I++FGLA+ I D    T        + + 
Sbjct: 124 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWT 179
Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE     + +   D++SFG+LL  ++  G+ P
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   RI++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG-R 244
           L  K   + +EI    +++H NIV L           L+ +    G L D +  V +G  
Sbjct: 56  LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFY 113
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL---IDDDMEARISEFGLAK 301
            E D     R+   +   ++YLH      I+HRD++P N+L   +D+D +  IS+FGL+K
Sbjct: 114 TERD---ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               G   +T     GT GY+APE       S   D +S GV+  +L+ G  P  D
Sbjct: 168 MEDPGSVLSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMI---QIRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +   +I  E+    QV H NI+ L 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                R   +L+ E    G L D L   +Q     +  A   I Q I  G+ YLH     
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ-ILDGVNYLHTK--- 134
Query: 273 RIIHRDIQPANVLIDDDM----EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        ++ +FGLA  I DG       ++ GT  ++APE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVN 191
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 227

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 9   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 55
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 107
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 108 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 164
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 165 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q    
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEAD--ASHCIHQI--- 139
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE ++  H+  I+HRD++P N+L+    +    ++++FGLA  +     +   +  AGT
Sbjct: 140 -LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--EQQAWFGFAGT 196
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +        DI++ GV+L +L++G  P  D  QH
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQH 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 54  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 99
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 100 GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 209
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 52  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 97
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 98  GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 207
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 63  NQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 119
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 120 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGL 172
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 173 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 355 SDDF 358
             D+
Sbjct: 227 GRDY 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQG- 243
           ++    R+  E++    V H+NI+ LL     +     + EF+    + +++  ++SQ  
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVI 119
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-- 174
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP  D
Sbjct: 175 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +E++     +H N+V +    +  +   ++ EF + G+L DI   VSQ R   + +A   
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT-- 145
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   L YLH      +IHRDI+  ++L+  D   ++S+FG   +I     +     
Sbjct: 146 VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX-- 200
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV 374
           L GT  ++APE       +   DI+S G+++  +V G+ P   +F      S VQ M+ +
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP---YFSD----SPVQAMKRL 253
Query: 375 MTSENPN 381
             S  P 
Sbjct: 254 RDSPPPK 260

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 18/141 (12%)
Query: 223 LVYEFRRNGSLQDILYDVSQGR---------RELDWLARHRIAQGIASGLEYLHMSHRPR 273
           L + F+ N +L  ++  V+ G          R  +  AR   AQ I    EYLH      
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD--- 161
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           +I+RD++P N+LID     ++++FG AKR+     +  TW L GT   +APE   +   +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEALAPEIILSKGYN 216
Query: 334 DTCDIYSFGVLLAVLVIGKFP 354
              D ++ GVL+  +  G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL      + +    D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 227
Query: 356 DDF 358
            D+
Sbjct: 228 RDY 230

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A +V ++   ++ EF   GSL D L      ++ L  L     +  IA G
Sbjct: 240 LQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 296
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + ++   +    IHRD++ AN+L+   +  +I++FGLA+ I D +  T        + + 
Sbjct: 297 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT 352
Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE     + +   D++SFG+LL  ++  G+ P
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV 216
           G+  RV T   +I   +   ++I+K  +P H +    R   +      HRN++ L+    
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
             D   LV+E  R GS+   ++     RR  + L    + Q +AS L++LH      I H
Sbjct: 82  EEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH---NKGIAH 134
Query: 277 RDIQPANVLIDDDME---ARISEFGLAKRIP---DGHTRTTTWSL--AGTVGYIAPECHQ 328
           RD++P N+L +   +    +I +F L   I    D    +T   L   G+  Y+APE  +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 329 TVALSDT-----CDIYSFGVLLAVLVIGKFP 354
             +   +     CD++S GV+L +L+ G  P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 27/199 (13%)
Query: 173 KSGAEL-IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-L 223
           +SG ++ IKK S P   ++   R+  E++    ++H N++ LL     A  +R   D  L
Sbjct: 65  RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           V  F +   LQ I+  +     ++ +L    +      GL+Y+H +    ++HRD++P N
Sbjct: 125 VMPFMQT-DLQKIM-GMEFSEEKIQYLVYQML-----KGLKYIHSAG---VVHRDLKPGN 174
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGLA+     H          T  Y APE   + +  + T DI+S G
Sbjct: 175 LAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG 229
Query: 343 VLLAVLVIGK--FPSDDFF 359
            ++A ++ GK  F   D+ 
Sbjct: 230 CIMAEMLTGKTLFKGKDYL 248

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 32/179 (17%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-----DDMEARISEFGLAKRIPDG-HT 308
           + Q   SGL +LH  +   I+HRD++P N+LI        ++A IS+FGL K++  G H+
Sbjct: 123 LLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 309 RTTTWSLAGTVGYIAPE-----CHQTVALSDTCDIYSFG-VLLAVLVIGKFPSDDFFQHT 362
            +    + GT G+IAPE     C +      T DI+S G V   V+  G  P     Q  
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTY--TVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             + L     + +  E     I  +L+     E+M+ +          DP KRP++K V
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELI-----EKMIAM----------DPQKRPSAKHV 281

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 27/198 (13%)
Query: 173 KSGAEL-IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-L 223
           +SG ++ IKK S P   ++   R+  E++    ++H N++ LL     A  +R   D  L
Sbjct: 47  RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106
Query: 224 VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN 283
           V  F +   LQ I+  +     ++ +L    +      GL+Y+H +    ++HRD++P N
Sbjct: 107 VMPFMQT-DLQKIM-GLKFSEEKIQYLVYQML-----KGLKYIHSA---GVVHRDLKPGN 156
Query: 284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFG 342
           + +++D E +I +FGLA+     H          T  Y APE   + +  + T DI+S G
Sbjct: 157 LAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 343 VLLAVLVIGK--FPSDDF 358
            ++A ++ GK  F   D+
Sbjct: 212 CIMAEMLTGKTLFKGKDY 229

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E   NGSL   L  +D      +L  + R     G
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 126
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 127 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 42/283 (14%)
Query: 96  LTTTSRILAAGRGG-----SRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEV 150
           L +TS    AG        S   RP  +    +E +    E  + + +L  + S   G V
Sbjct: 11  LESTSLYKKAGSAAAPFTMSHKERPTFYR---QELNKTIWEVPERYQTLSPVGSGAYGSV 67
Query: 151 YKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP 210
             +     SG  I +KK+ +P +S           +H K  +   E+     ++H N++ 
Sbjct: 68  CSS-YDVKSGLKIAVKKLSRPFQSI----------IHAK--RTYRELRLLKHMKHENVIG 114
Query: 211 LL-----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           LL     A  +    D+ +        L +I+    + ++  D   +  I Q I  GL+Y
Sbjct: 115 LLDVFTPATSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKY 169
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           +H +    IIHRD++P+N+ +++D E +I +FGLA+     HT         T  Y APE
Sbjct: 170 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 221
Query: 326 CH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
                +  + T DI+S G ++A L+ G+  FP  D     +++
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I +F LA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDFYLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 42/243 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 8   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 67
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 68  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 124
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 125 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 178
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  D++S G ++  +V  K  FP 
Sbjct: 179 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPG 232
Query: 356 DDF 358
            D+
Sbjct: 233 RDY 235

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D++Y + Q  R  +  A    A+ IA GL +L       II+RD++  
Sbjct: 98  FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---IIYRDLKLD 150
Query: 283 NVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NV++D +   +I++FG+ K  I DG    TT    GT  YIAPE         + D ++F
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 342 GVLLAVLVIGKFP-----SDDFFQHTKEMSLV 368
           GVLL  ++ G+ P      D+ FQ   E ++ 
Sbjct: 208 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 161
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D++Y + Q  R  +  A    A+ IA GL +L       II+RD++  
Sbjct: 419 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---IIYRDLKLD 471
Query: 283 NVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NV++D +   +I++FG+ K  I DG    TT    GT  YIAPE         + D ++F
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 342 GVLLAVLVIGKFP-----SDDFFQHTKEMSLV 368
           GVLL  ++ G+ P      D+ FQ   E ++ 
Sbjct: 529 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 560

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 97  SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 142
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 143 GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 252
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 10/157 (6%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           GQ  H NI+ L   + +    ++V E+  NGSL D     + G+  +  L    + +GI+
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVG--MLRGIS 134
Query: 261 SGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAGT 318
           +G++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT      
Sbjct: 135 AGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           + + APE       +   D++S+G+++  V+  G+ P
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 42/243 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  D++S G ++  +V  K  FP 
Sbjct: 174 R------TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPG 227
Query: 356 DDF 358
            D+
Sbjct: 228 RDY 230

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 160
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E   NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLH-MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLA 316
           IASG++YL  M +    +HRD+   N+LI+ ++  ++S+FGL++ + D      TT    
Sbjct: 156 IASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 160
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 53
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 105
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYX 163
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 161
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 104
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 162
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 106
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 164
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 53
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 105
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 163
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 106
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 164
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 161
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 205 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 262
Query: 364 E 364
           E
Sbjct: 263 E 263

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 53
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 105
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 163
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 161
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 5   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 64
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 65  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 121
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 122 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 175
Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           +      T         T  Y APE    +   +  DI+S G ++  ++ G   FP  D
Sbjct: 176 R---TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 104
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 162
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 104
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 105 LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYX 162
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 42/242 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 120
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 121 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP 
Sbjct: 175 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 356 DD 357
            D
Sbjct: 229 TD 230

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKTFMDASA----LTGIPLP 106
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 107 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 164
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 8/162 (4%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E  T  ++ H  +V       +     +V E+  NG L + L    +G      L    +
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL---EM 109
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +  G+ +L  SH+   IHRD+   N L+D D+  ++S+FG+ + + D    ++    
Sbjct: 110 CYDVCEGMAFLE-SHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GT 165
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
              V + APE       S   D+++FG+L+  V  +GK P D
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 42/242 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 356 DD 357
            D
Sbjct: 228 TD 229

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEAD--ASHCIQQI--- 112
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE ++  H   I+HRD++P N+L+    +    ++++FGLA  +     +   +  AGT
Sbjct: 113 -LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGT 169
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +        D+++ GV+L +L++G  P  D  QH
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 146 LVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 203 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 260
Query: 364 E 364
           E
Sbjct: 261 E 261

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 151 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 208 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 265
Query: 364 E 364
           E
Sbjct: 266 E 266

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 42/242 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP 
Sbjct: 174 R------TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 356 DD 357
            D
Sbjct: 228 TD 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 42/242 (17%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           RS  +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDV 240
           ++    R+  E++    V H+NI+ LL     +       D+ +     + +L  ++   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--- 119
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
              + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 301 KRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           +      T  T++ +   V    Y APE    +   +  DI+S G ++  ++ G   FP 
Sbjct: 174 R------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227
Query: 356 DD 357
            D
Sbjct: 228 TD 229

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 9   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 55
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 107
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T  
Sbjct: 108 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYX 165
Query: 314 SLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
               T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 166 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 42/238 (17%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMIQ 192
            + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++   
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 193 IRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR 245
            R+  E++    V H+NI+ LL      + +    D+ +     + +L  ++      + 
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QM 114
Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+    
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---- 167
Query: 306 GHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
             T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP  D+
Sbjct: 168 --TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 119
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 120 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 173 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 355 SDDF 358
             D+
Sbjct: 227 GRDY 230

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 2   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 61
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 62  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 118
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 119 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 171
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 172 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 225
Query: 355 SDDF 358
             D+
Sbjct: 226 GRDY 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       LV++    G L +DI+    +   E D  A H I Q    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AREYYSEAD--ASHCIQQI--- 112
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE ++  H   I+HRD++P N+L+    +    ++++FGLA  +     +   +  AGT
Sbjct: 113 -LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGT 169
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +        D+++ GV+L +L++G  P  D  QH
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 212

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 65/120 (54%), Gaps = 14/120 (11%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  I   LE+LH   +  +IHRD++P+NVLI+   + ++ +FG++  + D   +T   
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID- 213
Query: 314 SLAGTVGYIA-----PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF---FQHTKEM 365
             AG   Y+A     PE +Q    S   DI+S G+ +  L I +FP D +   FQ  K++
Sbjct: 214 --AGCKPYMAPERINPELNQK-GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 31/242 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+PLH        EI     ++H+NIV  L          +  E    GSL  +L     
Sbjct: 63  SQPLHE-------EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAK 301
             ++ +        Q I  GL+YLH +   +I+HRDI+  NVLI+      +IS+FG +K
Sbjct: 116 PLKDNEQTIGFYTKQ-ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
Query: 302 RIPDGHTRTTTWSLAGTVGYIAPEC--HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF 359
           R+   +  T T++  GT+ Y+APE             DI+S G  +  +  GK P  +  
Sbjct: 172 RLAGINPCTETFT--GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           +    M  V   +           ++ ++  +   E    +LK    C   DP+KR  + 
Sbjct: 230 EPQAAMFKVGMFK-----------VHPEIPESMSAEAKAFILK----CFEPDPDKRACAN 274
Query: 420 DV 421
           D+
Sbjct: 275 DL 276

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 63
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 120
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 121 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 174 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 227
Query: 355 SDDF 358
             D+
Sbjct: 228 GRDY 231

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 63
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 64  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 120
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 121 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 174 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 227
Query: 355 SDDF 358
             D+
Sbjct: 228 GRDY 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       L+++    G L +DI+    +   E D  A H I Q    
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEAD--ASHCIQQI--- 130
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE +   H+  ++HRD++P N+L+   ++    ++++FGLA  +     +   +  AGT
Sbjct: 131 -LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGT 187
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +        D+++ GV+L +L++G  P  D  QH
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 230

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR 217
           SSG+++ +KK+        +L K+    L      + +E++     +H N+V +    + 
Sbjct: 174 SSGKLVAVKKM--------DLRKQQRREL------LFNEVVIMRDYQHENVVEMYNSYLV 219
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
            D   +V EF   G+L DI   V+  R     +   +IA    + L+ L + H   +IHR
Sbjct: 220 GDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           DI+  ++L+  D   ++S+FG   ++     R     L GT  ++APE    +      D
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVD 329
Query: 338 IYSFGVLLAVLVIGKFP 354
           I+S G+++  +V G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 88/181 (48%), Gaps = 28/181 (15%)
Query: 220 CDLLVYEFRRNGSLQDILYDVSQGRR--ELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           C  +  EF   G+L+  +    + RR  +LD +    + + I  G++Y+H     ++I+R
Sbjct: 94  CLFIQMEFCDKGTLEQWI----EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINR 146
Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCD 337
           D++P+N+ + D  + +I +FGL   + +   R  +    GT+ Y++PE   +       D
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KGTLRYMSPEQISSQDYGKEVD 203
Query: 338 IYSFGVLLAVLV--------IGKFPSD-------DFFQHTKEMSLVQWMRNVMTSENPNR 382
           +Y+ G++LA L+          KF +D       D F   KE +L+Q + +    + PN 
Sbjct: 204 LYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK-KEKTLLQKLLSKKPEDRPNT 262
Query: 383 A 383
           +
Sbjct: 263 S 263

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 143 RSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLH 187
           +S  + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 62
Query: 188 HKMIQIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYD 239
           ++    R+  E++    V H+NI+ LL     +          LV E       Q I   
Sbjct: 63  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 119
Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
               + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGL
Sbjct: 120 ----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 300 AKRIPDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
           A+      T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP
Sbjct: 173 AR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 355 SDDF 358
             D+
Sbjct: 227 GRDY 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I + GLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDAGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 262 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319
Query: 364 E 364
           E
Sbjct: 320 E 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 44/240 (18%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMI 191
           + + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++  
Sbjct: 1   DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 60
Query: 192 QIRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYDVSQG 243
             R+  E++    V H+NI+ LL     +          LV E       Q I       
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------- 113
Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
           + ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+  
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-- 168
Query: 304 PDGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
               T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP  D+
Sbjct: 169 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I + GLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDGGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 31/242 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+PLH        EI     ++H+NIV  L          +  E    GSL  +L     
Sbjct: 49  SQPLH-------EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 101
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAK 301
             ++ +        Q I  GL+YLH +   +I+HRDI+  NVLI+      +IS+FG +K
Sbjct: 102 PLKDNEQTIGFYTKQ-ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 157
Query: 302 RIPDGHTRTTTWSLAGTVGYIAPEC--HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF 359
           R+   +  T T++  GT+ Y+APE             DI+S G  +  +  GK P  +  
Sbjct: 158 RLAGINPCTETFT--GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 215
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           +    M  V   +           ++ ++  +   E    +LK    C   DP+KR  + 
Sbjct: 216 EPQAAMFKVGMFK-----------VHPEIPESMSAEAKAFILK----CFEPDPDKRACAN 260
Query: 420 DV 421
           D+
Sbjct: 261 DL 262

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 40/263 (15%)
Query: 114 RPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLK 173
           RP  +    +E +    E  + + +L  + S   G V  A     +G  + +KK+ +P +
Sbjct: 5   RPTFYR---QELNKTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ 60
Query: 174 SGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFR 228
           S           +H K  +   E+     ++H N++ LL     AR +    D+ +    
Sbjct: 61  SI----------IHAK--RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
               L +I+    + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++
Sbjct: 109 MGADLNNIV----KCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNE 160
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAV 347
           D E +I + GLA+     HT         T  Y APE     +  + T DI+S G ++A 
Sbjct: 161 DCELKILDRGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 348 LVIGK--FPSDDFFQHTKEMSLV 368
           L+ G+  FP  D   H  ++ L+
Sbjct: 216 LLTGRTLFPGTD---HIDQLKLI 235

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 33/231 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  LEK+ +     VYK  L  ++G  + +K++           K DSE        IR 
Sbjct: 7   FKQLEKLGNGTYATVYKG-LNKTTGVYVALKEV-----------KLDSEE-GTPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR----ELDWLA 251
           EI    +++H NIV L   +   +   LV+EF  N  L+  +   + G      EL+ + 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 252 --RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
             + ++ QG+A         H  +I+HRD++P N+LI+   + ++ +FGLA+    G   
Sbjct: 112 YFQWQLLQGLA-------FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPV 162
Query: 310 TTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
            T  S   T+ Y AP+    +   S + DI+S G +LA ++ GK  FP  +
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 201 GQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
           GQ  H NI+ L   + +    ++V E   NGSL   L  +D      +L  + R     G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR-----G 155
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAG 317
           IASG++YL        +HRD+   N+LI+ ++  ++S+FGL++ + D      TT     
Sbjct: 156 IASGMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            + + +PE       +   D++S+G++L  V+  G+ P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D   +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 42/239 (17%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMI 191
           +   Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++  
Sbjct: 1   DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 60
Query: 192 QIRS--EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDVSQGR 244
             R+  E++    V H+NI+ LL     +       D+ +     + +L  ++      +
Sbjct: 61  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------Q 114
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
            ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+   
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 168
Query: 305 DGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
              T  T++ +   V    Y APE    +   +  D++S G ++  +V  K  FP  D+
Sbjct: 169 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDY 224

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           + ++ EI      RHRNI+ L       +  ++++EF    S  DI   ++    EL+  
Sbjct: 46  VLVKKEISILNIARHRNILHLHESFESMEELVMIFEF---ISGLDIFERINTSAFELNER 102
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA--RISEFGLAKRIPDGHT 308
                   +   L++LH SH   I H DI+P N++      +  +I EFG A+++  G  
Sbjct: 103 EIVSYVHQVCEALQFLH-SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV 368
               ++      Y APE HQ   +S   D++S G L+ VL+ G  P   F   T +    
Sbjct: 160 FRLLFTAPE---YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---FLAETNQ---- 209
Query: 369 QWMRNVMTSE 378
           Q + N+M +E
Sbjct: 210 QIIENIMNAE 219

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D   +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ + KI           + D+E        IR 
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKI-----------RLDTETEGVPSTAIR- 51
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 103
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 160
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 161 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ + KI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+EF      QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 159
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H+    +IIHRDI+P+N+L+D     ++ +FG++ ++ D   +T     AG   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPER 196
Query: 327 HQTVALSDT----CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
               A         D++S G+ L  L  G+FP      + K  S+   +  V+  + P  
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP------YPKWNSVFDQLTQVVKGDPPQ- 249
Query: 383 AINSKLLGNGYEEQM-LLVLKIACFCTLDDPNKRPNSKDV 421
                 L N  E +     +     C   D +KRP  K++
Sbjct: 250 ------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMIQ 192
            + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++   
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 193 IRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYDVSQGR 244
            R+  E++    V H+NI+ LL     +          LV E       Q I       +
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 113
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
            ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 167
Query: 305 DGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
              T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP  D+
Sbjct: 168 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMIQ 192
            + Y  E+  S+  V+   + ++P+ SGA+                IKK S P  ++   
Sbjct: 2   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 61
Query: 193 IRS--EIITAGQVRHRNIVPLLARMVRRDC------DLLVYEFRRNGSLQDILYDVSQGR 244
            R+  E++    V H+NI+ LL     +          LV E       Q I       +
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 114
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
            ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+   
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 168
Query: 305 DGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
              T  T++ +   V    Y APE    +   +  DI+S G ++  +V  K  FP  D+
Sbjct: 169 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 224

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 11/163 (6%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           Q+R EI     + H NI+ L      R    L+ E+   G L    Y   Q     D   
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQR 124
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              I + +A  L Y H     ++IHRDI+P N+L+    E +I++FG +   P    +T 
Sbjct: 125 TATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT- 180
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              + GT+ Y+ PE  +    ++  D++  GVL   L++G  P
Sbjct: 181 ---MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++ E+   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 34/238 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  L+ + S   G V  A + G +G  + IKK+ +P +S  EL  K          +   
Sbjct: 27  YRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQS--ELFAK----------RAYR 73
Query: 196 EIITAGQVRHRNIVPLLARMVRRDC-----DLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           E+     +RH N++ LL      +      D  +        L  ++     G   + +L
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 133
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               +      GL Y+H +    IIHRD++P N+ +++D E +I +FGLA++       +
Sbjct: 134 VYQML-----KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADS 180
Query: 311 TTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
                  T  Y APE     +  + T DI+S G ++A ++ GK  F   D     KE+
Sbjct: 181 EMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 45/238 (18%)
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY--DVSQGRRELDWLARHRIAQ 257
           A  +  RN V     + ++    +  E+  N +L D+++  +++Q R E  W    R+ +
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY-W----RLFR 123
Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-------------- 303
            I   L Y+H      IIHR+++P N+ ID+    +I +FGLAK +              
Sbjct: 124 QILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 304 PDGHTRTTTWSLAGTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
           P      T  S  GT  Y+A E    T   ++  D YS G++    +   +P   F    
Sbjct: 181 PGSSDNLT--SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YP---FSTGX 232
Query: 363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD-DPNKRPNSK 419
           + +++++ +R+V     P+           +++    V K      +D DPNKRP ++
Sbjct: 233 ERVNILKKLRSVSIEFPPD-----------FDDNKXKVEKKIIRLLIDHDPNKRPGAR 279

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 205 HRNIVPLLARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG 258
           HRNI       +++      D   LV EF   GS+ D++ +      + +W+A   I + 
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICRE 137
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I  GL +LH     ++IHRDI+  NVL+ ++ E ++ +FG++ ++     R  T+   GT
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGT 192
Query: 319 VGYIAPE---CHQT--VALSDTCDIYSFGVLLAVLVIGKFP 354
             ++APE   C +          D++S G+    +  G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 11/135 (8%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D++Y + Q  +  +  A    A+ I+ GL +LH   +  II+RD++  
Sbjct: 97  FVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAE-ISIGLFFLH---KRGIIYRDLKLD 149
Query: 283 NVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NV++D +   +I++FG+ K  + DG    TT    GT  YIAPE         + D +++
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDG---VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAY 206
Query: 342 GVLLAVLVIGKFPSD 356
           GVLL  ++ G+ P D
Sbjct: 207 GVLLYEMLAGQPPFD 221

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 52
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+EF  +  L+  + D S     L  +    I
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASA----LTGIPLPLI 106
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 107 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHE 164
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+EF  +  L+  + D S     L  +    I
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASA----LTGIPLPLI 108
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHE 166
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 131 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 185
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 242
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 243 SCDMWSLGVIMYILLCGYPP 262

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 137 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 191
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 192 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 248
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 249 SCDMWSLGVIMYILLCGYPP 268

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 17/186 (9%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +E++      H N+V + +  +  D   +V EF   G+L DI   V+  R   + +A   
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT-- 145
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           +   +   L YLH      +IHRDI+  ++L+  D   ++S+FG   ++     +     
Sbjct: 146 VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX-- 200
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV 374
           L GT  ++APE    +      DI+S G+++  ++ G+ P   +F        +Q MR +
Sbjct: 201 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPP----LQAMRRI 253
Query: 375 MTSENP 380
             S  P
Sbjct: 254 RDSLPP 259

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 13/102 (12%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDM----EARISEFGLAK--RIPDGHTRTTT 312
           I   +EYLH      ++HRD++P+N+L  D+       RI +FG AK  R  +G   T  
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +    T  ++APE  +       CDI+S GVLL  ++ G  P
Sbjct: 182 Y----TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 124
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 125 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS 181
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 182 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 92  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 146
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 203
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 204 SCDMWSLGVIMYILLCGYPP 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 109
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 110 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 167 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 224

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 87  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 141
Query: 278 DIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L          ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 198
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 199 SCDMWSLGVIMYILLCGYPP 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 14/176 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ-DILYDVSQGRRELDWLA 251
           ++ E      ++H +IV LL          +V+EF     L  +I+     G    + +A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHT 308
            H + Q     LE L   H   IIHRD++P NVL+   ++    ++ +FG+A ++  G +
Sbjct: 133 SHYMRQI----LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GES 186
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
                   GT  ++APE  +        D++  GV+L +L+ G  P    F  TKE
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKE 238

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 24/180 (13%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR------- 254
            + H  +V L     ++    ++ E+  NG L + L       RE+    RHR       
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLL 123
Query: 255 -IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
            + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  
Sbjct: 124 EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
           S    V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 181 S-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 87  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 141
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 198
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 199 SCDMWSLGVIMYILLCGYPP 218

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 91  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 145
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 202
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 203 SCDMWSLGVIMYILLCGYPP 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 93  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 147
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 204
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 205 SCDMWSLGVIMYILLCGYPP 224

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           L+ EF  +GSL++ L    + + +++   + + A  I  G++YL      + +HRD+   
Sbjct: 102 LIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAAR 155
Query: 283 NVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL++ + + +I +FGL K I  D    T        V + APEC          D++SF
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 216 GVTLHELL 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 85  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 139
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 196
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 197 SCDMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 86  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 140
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 141 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 197
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 198 SCDMWSLGVIMYILLCGYPP 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           L+ EF  +GSL++ L    + + +++   + + A  I  G++YL      + +HRD+   
Sbjct: 90  LIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAAR 143
Query: 283 NVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL++ + + +I +FGL K I  D    T        V + APEC          D++SF
Sbjct: 144 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 203
Query: 342 GVLLAVLV 349
           GV L  L+
Sbjct: 204 GVTLHELL 211

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 115
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 116 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 173 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 230

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 104
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 105 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 162 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 219

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D    +
Sbjct: 136 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXS 189
Query: 311 TTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL 367
                     V ++A E  QT   +   D++SFGVLL  L+  G  P  D       + L
Sbjct: 190 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249
Query: 368 VQWMRNVMTSENPN 381
           +Q  R +     P+
Sbjct: 250 LQGRRLLQPEYCPD 263

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 108
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 109 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 166 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           +R+EI    ++ H NI+ L           LV E    G L D +  V +G     + + 
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI--VEKG-----YYSE 147
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---DMEARISEFGLAKRIPDGHTR 309
              A  +   LE +   H   I+HRD++P N+L      D   +I++FGL+K +     +
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQ 204
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               ++ GT GY APE  +  A     D++S G++  +L+ G  P  D
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 117/267 (43%), Gaps = 46/267 (17%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMI 191
           + + Y  ++  S+  V+   + ++P+ SGA+                +KK S P  ++  
Sbjct: 5   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 64
Query: 192 QIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR 244
             R+  E++    V H+NI+ LL      + +    D+ +     + +L  +++      
Sbjct: 65  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH------ 118
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
            ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+   
Sbjct: 119 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 172
Query: 305 DGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
              T +T + +   V    Y APE    +   +  DI+S G ++  LV G       FQ 
Sbjct: 173 ---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQG 225
Query: 362 TKEMSLVQWMRNVMTSENPNRAINSKL 388
           T  +   QW + +     P+    + L
Sbjct: 226 TDHID--QWNKVIEQLGTPSAEFMAAL 250

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 101 RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 155
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 212
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 213 SCDMWSLGVIMYILLCGYPP 232

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++  +   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI--LYDVSQGRRELDWLARH 253
           EI    ++ H NIV LL  +   +   LV+E       QD+    D S     L  +   
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH----QDLKTFMDASA----LTGIPLP 102
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRTT 311
            I   +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+   +P    RT 
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTY 159
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
           T  +  T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 160 THEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 110
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV LL         L++ E+   G L + L   S   R L+      IA   AS  + L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS---RVLETDPAFAIANSTASTRDLL 167
Query: 267 HMSHR----------PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
           H S +             IHRD+   NVL+ +   A+I +FGLA+ I +        +  
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQ 369
             V ++APE       +   D++S+G+LL  +  +G  P      ++K   LV+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 137 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 190
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 191 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 248 VYLLQGRRLLQPEYCPD 264

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 69  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 128
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 129 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 182
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 183 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 239
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 240 VYLLQGRRLLQPEYCPD 256

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q  R +  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 126
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                +   ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 184 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q  R +  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 126
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                +   ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 184 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D    +
Sbjct: 135 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 188
Query: 311 TTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL 367
                     V ++A E  QT   +   D++SFGVLL  L+  G  P  D       + L
Sbjct: 189 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248
Query: 368 VQWMRNVMTSENPN 381
           +Q  R +     P+
Sbjct: 249 LQGRRLLQPEYCPD 262

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q  R +  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 116
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                +   ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 117 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 174 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 96  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 155
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 156 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 209
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 210 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 246

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAE---------------LIKKDSEPLHHKMI 191
           + + Y  E+  S+  V+   + ++P+ SGA+                +KK S P  ++  
Sbjct: 7   DNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 66
Query: 192 QIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR 244
             R+  E++    V H+NI+ LL      + +    D+ +     + +L  +++      
Sbjct: 67  AKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH------ 120
Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
            ELD      +   +  G+++LH +    IIHRD++P+N+++  D   +I +FGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 174
Query: 305 DGHTRTTTWSLAGTV---GYIAPECHQTVALSDTCDIYSFGVLLAVLVIG 351
              T  T + +   V    Y APE    +  +   DI+S G ++  LV G
Sbjct: 175 ---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR-------- 254
           + H  +V L     ++    ++ E+  NG L + L       RE+    RHR        
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-------REM----RHRFQTQQLLE 109
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           + + +   +EYL      + +HRD+   N L++D    ++S+FGL++ + D    ++  S
Sbjct: 110 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGS 166
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMR 372
               V +  PE       S   DI++FGVL+  +  +GK P + F        + Q +R
Sbjct: 167 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 224

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 134 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 187
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 188 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 245 VYLLQGRRLLQPEYCPD 261

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 72  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 132 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 186 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 243 VYLLQGRRLLQPEYCPD 259

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 95  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 154
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 155 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 208
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 209 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 265
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 266 VYLLQGRRLLQPEYCPD 282

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 136 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 189
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKE 364
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D       
Sbjct: 190 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 246
Query: 365 MSLVQWMRNVMTSENPN 381
           + L+Q  R +     P+
Sbjct: 247 VYLLQGRRLLQPEYCPD 263

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 111
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 112 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 168 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 107
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 108 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 164 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 200

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q  R +  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 124
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                +   ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 125 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 182 YKAQTHGKW----PVKWYAPECINYYKFSSKSDVWSFGVLM 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 105
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 106 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 162 YKAQTHGKWP----VKWYAPECINYYKFSSKSDVWSFGVLM 198

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G++YL      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 137 G---FGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 190
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDD 357
            H +T        V ++A E  QT   +   D++SFGVLL  L+  G  P  D
Sbjct: 191 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-QDILYDVSQGRRELDWLARHRIAQGIAS 261
           ++H NIV L   +       L+++    G L +DI+    +   E D  A H I Q    
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEAD--ASHCIQQI--- 119
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGT 318
            LE +   H+  ++HR+++P N+L+   ++    ++++FGLA  +     +   +  AGT
Sbjct: 120 -LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGT 176
Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
            GY++PE  +        D+++ GV+L +L++G  P  D  QH
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRE-LDWLA 251
           +H+NI+ LL    +     ++  +   G+L++ L           YD+++   E + +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP--DGHTR 309
                  +A G+EYL      + IHRD+   NVL+ ++   +I++FGLA+ I   D + +
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIG-----KFPSDDFFQHTK 363
           TT   L   V ++APE       +   D++SFGVL+  +  +G       P ++ F+  K
Sbjct: 216 TTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 364 E 364
           E
Sbjct: 274 E 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 23/221 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
              L    D++S GV+  +L+ G  P   F   TK+ +L  
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLAN 228

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AE          I   ++ LK  ++  +KD            +E++T   ++H +
Sbjct: 27  GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--------FHREAELLT--NLQHEH 76
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYD-------VSQGR--RELDWLARHRIAQG 258
           IV      V  D  ++V+E+ ++G L   L         +++G    EL       IAQ 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG- 317
           IA+G+ YL   H    +HRD+   N L+ +++  +I +FG+++ +      T  + + G 
Sbjct: 137 IAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDV----YSTDYYRVGGH 189
Query: 318 ---TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++ PE       +   D++S GV+L  +   GK P
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           ++   I   L YL   H   +IHRD++P+N+L+D+  + ++ +FG++ R+ D   +  + 
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS- 184
Query: 314 SLAGTVGYIAPE----CHQTVALSDT-CDIYSFGVLLAVLVIGKFP 354
             AG   Y+APE       T    D   D++S G+ L  L  G+FP
Sbjct: 185 --AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH--RIAQGIASGLEYLHMSHRPRII 275
           + C L++ E    G L    +   Q R +  +  R    I + I + +++LH SH   I 
Sbjct: 98  KRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHN--IA 150
Query: 276 HRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
           HRD++P N+L    + D   ++++FG AK       +T  +    T  Y+APE       
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVLGPEKY 206
Query: 333 SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
             +CD++S GV++ +L+ G FP   F+ +T +
Sbjct: 207 DKSCDMWSLGVIMYILLCG-FPP--FYSNTGQ 235

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDM----EARISEFGLAK--RIPDGHTRTTT 312
           I   +EYLH      ++HRD++P+N+L  D+       RI +FG AK  R  +G   T  
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +    T  ++APE  +       CDI+S GVLL   + G  P
Sbjct: 182 Y----TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  I   LE+LH   +  +IHRD++P+NVLI+   + ++ +FG++  + D   +    
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID- 169
Query: 314 SLAGTVGYIA-----PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF---FQHTKEM 365
             AG   Y+A     PE +Q    S   DI+S G+ +  L I +FP D +   FQ  K++
Sbjct: 170 --AGCKPYMAPERINPELNQK-GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 80  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 132
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 189
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 225

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 19/150 (12%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH--RIAQGIASGLEYLHMSHRPRII 275
           + C L++ E    G L    +   Q R +  +  R    I + I + +++LH SH   I 
Sbjct: 79  KRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHN--IA 131
Query: 276 HRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL 332
           HRD++P N+L    + D   ++++FG AK       +T  +    T  Y+APE       
Sbjct: 132 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVLGPEKY 187
Query: 333 SDTCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
             +CD++S GV++ +L+ G FP   F+ +T
Sbjct: 188 DKSCDMWSLGVIMYILLCG-FPP--FYSNT 214

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV+EF  +G L D L      R +    A   +      
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 111
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 112 VCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 164
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 80  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 132
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 189
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+  +G L+D L    + R  LD       +  I  G+EYL      R +HRD+   
Sbjct: 87  LVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 140
Query: 283 NVLIDDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           N+L++ +   +I++FGLAK +P D             + + APE       S   D++SF
Sbjct: 141 NILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 200
Query: 342 GVLLAVL 348
           GV+L  L
Sbjct: 201 GVVLYEL 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIK-KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM 215
           G+ G+V   K       + A++I+ K  E L   +++I  EI+      H  IV LL   
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI--EIL--ATCDHPYIVKLLGAY 77
Query: 216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRII 275
                  ++ EF   G++  I+ ++ +G      L   +I       LE L+  H  RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 276 HRDIQPANVLIDDDMEARISEFGL-AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           HRD++  NVL+  + + R+++FG+ AK +     R    S  GT  ++APE      + D
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFIGTPYWMAPEVVMCETMKD 188
Query: 335 T-----CDIYSFGVLL 345
           T      DI+S G+ L
Sbjct: 189 TPYDYKADIWSLGITL 204

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
              L    D++S GV+  +L+ G  P   F   TK+ +L
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETL 226

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 157 GSSGRVITIKKIIQPLKSGAELIK-KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM 215
           G+ G+V   K       + A++I+ K  E L   +++I  EI+      H  IV LL   
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI--EIL--ATCDHPYIVKLLGAY 85
Query: 216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRII 275
                  ++ EF   G++  I+ ++ +G      L   +I       LE L+  H  RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 276 HRDIQPANVLIDDDMEARISEFGL-AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           HRD++  NVL+  + + R+++FG+ AK +     R    S  GT  ++APE      + D
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFIGTPYWMAPEVVMCETMKD 196
Query: 335 T-----CDIYSFGVLL 345
           T      DI+S G+ L
Sbjct: 197 TPYDYKADIWSLGITL 212

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 28/134 (20%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKRIPD 305
           IASG+ +LH     +IIHRD++P N+L+              +++   IS+FGL K++  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 306 GHT--RTTTWSLAGTVGYIAPECHQTVA-------LSDTCDIYSFG-VLLAVLVIGKFPS 355
           G +  RT   + +GT G+ APE  +          L+ + DI+S G V   +L  GK P 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 356 DDFFQHTKEMSLVQ 369
            D  ++++E ++++
Sbjct: 241 GD--KYSRESNIIR 252

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 11/157 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 111
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHT 308
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K +  D + 
Sbjct: 112 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                     V + APEC      S   D++SFGVL+
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 131 RKCLLIVXECLDGGELFSRIQD--RGDQAFTEREASEIXKSIGEAIQYLHSIN---IAHR 185
Query: 278 DIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L          ++++FG AK     ++ TT      T  Y+APE         
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDK 242
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD +S GV+  +L+ G  P
Sbjct: 243 SCDXWSLGVIXYILLCGYPP 262

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 39/269 (14%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L  ED++  + ++     G+VYKA+   +S  V+   K+I           K  E L   
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETS--VLAAAKVID---------TKSEEELEDY 81
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           M+    EI       H NIV LL      +   ++ EF   G++  ++ ++ +       
Sbjct: 82  MV----EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------ 131
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           L   +I       L+ L+  H  +IIHRD++  N+L   D + ++++FG++ +    +TR
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTR 187
Query: 310 TTTW--SLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
           T     S  GT  ++APE        D       D++S G+ L  +   + P        
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------- 240
Query: 363 KEMSLVQWMRNVMTSENPNRAINSKLLGN 391
            E++ ++ +  +  SE P  A  S+   N
Sbjct: 241 HELNPMRVLLKIAKSEPPTLAQPSRWSSN 269

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV+EF  +G L D L      R +    A   +      
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 109
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 162
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV+EF  +G L D L      R +    A   +      
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 111
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 112 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 164
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV+EF  +G L D L      R +    A   +      
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 114
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 115 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 167
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 24/130 (18%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKRIPD 305
           IASG+ +LH     +IIHRD++P N+L+              +++   IS+FGL K++  
Sbjct: 142 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 306 GHT--RTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFG-VLLAVLVIGKFPSDDFF 359
           G    R    + +GT G+ APE  +      L+ + DI+S G V   +L  GK P  D  
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-- 256
Query: 360 QHTKEMSLVQ 369
           ++++E ++++
Sbjct: 257 KYSRESNIIR 266

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 159 SGRVITIKKIIQP---LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLL 212
           SG+   +KK  +    L+  A+ IKK       + +    I  E+    +++H N++ L 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRP 272
                +   +L+ E    G L D L +    +  L         + I +G+ YLH     
Sbjct: 81  EVYENKTDVILIGELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--- 133
Query: 273 RIIHRDIQPANVLIDD----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
           +I H D++P N+++ D        +I +FGLA +I  G+     +   GT  ++APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVN 190
Query: 329 TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV 368
              L    D++S GV+  +L+ G  P   F   TK+ +L 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLA 227

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           IQI   + +   V++R +     R   R    LV E+  +G L+D L    + R  LD  
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLR----LVMEYLPSGCLRDFL---QRHRARLDAS 114
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
                +  I  G+EYL      R +HRD+   N+L++ +   +I++FGLAK +P D    
Sbjct: 115 RLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 171
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV 349
                    + + APE       S   D++SFGV+L  L 
Sbjct: 172 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV+EF  +G L D L      R +    A   +      
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 131
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 132 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 184
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 185 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 469
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 470 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 526 YKAQTHGKW----PVKWYAPECINYYKFSSKSDVWSFGVLM 562

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 137 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 190
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 191 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 227

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 135 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 188
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 189 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 225

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 138 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDS 191
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 192 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 228

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      +V E+   G L + +   + GR   D  A
Sbjct: 60  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDE-A 116
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q I SG+ Y H     ++ HRD++  N L+D     R  I +FG +K        
Sbjct: 117 RFFFQQLI-SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH 169
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +   S  GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 170 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQD----- 235
           KD      K  Q  +E++T   ++H +IV         D  ++V+E+ ++G L       
Sbjct: 54  KDPTLAARKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 236 -----ILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
                IL D    Q + EL       IA  IASG+ YL   H    +HRD+   N L+  
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGA 168
Query: 289 DMEARISEFGLAKRIPDGHTRTTTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVL 344
           ++  +I +FG+++ +      T  + + G     + ++ PE       +   D++SFGV+
Sbjct: 169 NLLVKIGDFGMSRDV----YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 345 L-AVLVIGKFP 354
           L  +   GK P
Sbjct: 225 LWEIFTYGKQP 235

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 24/130 (18%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKRIPD 305
           IASG+ +LH     +IIHRD++P N+L+              +++   IS+FGL K++  
Sbjct: 142 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 306 GHT--RTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFG-VLLAVLVIGKFPSDDFF 359
           G    R    + +GT G+ APE  +      L+ + DI+S G V   +L  GK P  D  
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-- 256
Query: 360 QHTKEMSLVQ 369
           ++++E ++++
Sbjct: 257 KYSRESNIIR 266

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 137 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 190
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 191 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 227

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           ++ E++    V  +   P + RM+     +  +LV E    G L   L    Q R   D 
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDK 470
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDGH 307
                + Q ++ G++YL  S+    +HRD+   NVL+     A+IS+FGL+K  R  + +
Sbjct: 471 NIIELVHQ-VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526
Query: 308 TRTTT---WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            +  T   W     V + APEC      S   D++SFGVL+
Sbjct: 527 YKAQTHGKW----PVKWYAPECINYYKFSSKSDVWSFGVLM 563

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           F  +EKI     G VYKA     +G V+ +KKI           + D+E        IR 
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI-----------RLDTETEGVPSTAIR- 54
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           EI    ++ H NIV LL  +   +   LV+E   +  L+  + D S     L  +    I
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFE-HVDQDLKKFM-DASA----LTGIPLPLI 108
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +   L+ L   H  R++HRD++P N+LI+ +   ++++FGLA+    G    T    
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHE 166
Query: 316 AGTVGYIAPECHQTVALSDTC-DIYSFGVLLAVLVIGK--FPSD 356
             T+ Y APE         T  DI+S G + A +V  +  FP D
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           IQI   + +   V++R +     R   R    LV E+  +G L+D L    + R  LD  
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLR----LVMEYLPSGCLRDFL---QRHRARLDAS 115
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
                +  I  G+EYL      R +HRD+   N+L++ +   +I++FGLAK +P D    
Sbjct: 116 RLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 172
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV 349
                    + + APE       S   D++SFGV+L  L 
Sbjct: 173 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 138 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 191
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 192 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 82  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 141
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 142 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 195
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 196 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 232

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      +V E+   G L + +   + GR   D  A
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDE-A 117
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q I SG+ Y H     ++ HRD++  N L+D     R  I++FG +K        
Sbjct: 118 RFFFQQLI-SGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLH 170
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +   S  GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 171 SQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      +V E+   G L + +   + GR   D  A
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDE-A 117
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q I SG+ Y H     ++ HRD++  N L+D     R  I +FG +K        
Sbjct: 118 RFFFQQLI-SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH 170
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +   S  GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 171 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 11/140 (7%)
Query: 218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
           R C L+V E    G L   + D  +G +         I + I   ++YLH  +   I HR
Sbjct: 85  RKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 139
Query: 278 DIQPANVLIDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++P N+L      +   ++++FG AK     ++ T       T  Y+APE         
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEP---CYTPYYVAPEVLGPEKYDK 196
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
           +CD++S GV++ +L+ G  P
Sbjct: 197 SCDMWSLGVIMYILLCGYPP 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           IQI   + +   V++R +     R   R    LV E+  +G L+D L    + R  LD  
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLR----LVMEYLPSGCLRDFL---QRHRARLDAS 127
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP-DGHTR 309
                +  I  G+EYL      R +HRD+   N+L++ +   +I++FGLAK +P D    
Sbjct: 128 RLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV 349
                    + + APE       S   D++SFGV+L  L 
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +   L+YL      RIIHRD++P N+L+D+     I++F +A  +P   T+ TT  +AGT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT--MAGT 177
Query: 319 VGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFP 354
             Y+APE   +      S   D +S GV    L+ G+ P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           Q  +E I      H N++ LL   +R +   L+V  + ++G L++ + + +      D +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---- 306
                   +A G+++L      + +HRD+   N ++D+    ++++FGLA+ + D     
Sbjct: 196 G---FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 307 -HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
            H +T        V ++A E  QT   +   D++SFGVLL
Sbjct: 250 VHNKTGA---KLPVKWMALESLQTQKFTTKSDVWSFGVLL 286

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 30/172 (17%)
Query: 195 SEIITAGQVRHRNIVPLLAR-MVRRDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +E+     +RH NI+  +A  M  R       L+  +   GSL D L   +     LD +
Sbjct: 80  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTV 134
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           +  RI   IASGL +LH+       +P I HRD++  N+L+  + +  I++ GLA     
Sbjct: 135 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--- 191
Query: 306 GHTRTTTW------SLAGTVGYIAPECHQTVALSDT------CDIYSFGVLL 345
            H+++T           GT  Y+APE        D        DI++FG++L
Sbjct: 192 -HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 242

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 30/172 (17%)
Query: 195 SEIITAGQVRHRNIVPLLAR-MVRRDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +E+     +RH NI+  +A  M  R       L+  +   GSL D L   +     LD +
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTV 105
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           +  RI   IASGL +LH+       +P I HRD++  N+L+  + +  I++ GLA     
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--- 162
Query: 306 GHTRTTTW------SLAGTVGYIAPECHQTVALSDT------CDIYSFGVLL 345
            H+++T           GT  Y+APE        D        DI++FG++L
Sbjct: 163 -HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMV 216
           +G ++ IKKI               EP    +  +R+  EI      +H NI+ +   + 
Sbjct: 35  TGEIVAIKKI---------------EPFDKPLFALRTLREIKILKHFKHENIITIF-NIQ 78
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
           R D       F     +Q+++            L+   I   I   L  + + H   +IH
Sbjct: 79  RPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 277 RDIQPANVLIDDDMEARISEFGLAKRI---------PDGHTRTTTWSLAGTVGYIAPECH 327
           RD++P+N+LI+ + + ++ +FGLA+ I         P G     T  +A T  Y APE  
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA-TRWYRAPEVM 194
Query: 328 QTVA-LSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
            T A  S   D++S G +LA L + +  FP  D+
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 30/172 (17%)
Query: 195 SEIITAGQVRHRNIVPLLAR-MVRRDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +E+     +RH NI+  +A  M  R       L+  +   GSL D L   +     LD +
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTV 105
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           +  RI   IASGL +LH+       +P I HRD++  N+L+  + +  I++ GLA     
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--- 162
Query: 306 GHTRTTTW------SLAGTVGYIAPECHQTVALSDT------CDIYSFGVLL 345
            H+++T           GT  Y+APE        D        DI++FG++L
Sbjct: 163 -HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 172 LKSGAELIKKDSEPLHHKMIQ---IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFR 228
           L+  A+ IKK       + +    I  E+    +++H N++ L      +   +L+ E  
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 229 RNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD 288
             G L D L +    +  L         + I +G+ YLH     +I H D++P N+++ D
Sbjct: 97  AGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD 149
Query: 289 ----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVL 344
                   +I +FGLA +I  G+     +   GT  ++APE      L    D++S GV+
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 345 LAVLVIGKFPSDDFFQHTKEMSL 367
             +L+ G  P   F   TK+ +L
Sbjct: 207 TYILLSGASP---FLGDTKQETL 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVY 225
           I+ LK G E  K D+E           E++   Q+ H+   P + R++   + +  +LV 
Sbjct: 42  IKVLKQGTE--KADTE-----------EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88
Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E    G L   L      R E+       +   ++ G++YL   +    +HRD+   NVL
Sbjct: 89  EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVL 142
Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGV 343
           + +   A+IS+FGL+K +    +  T  S AG   + + APEC      S   D++S+GV
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARS-AGKWPLKWYAPECINFRKFSSRSDVWSYGV 201
Query: 344 -LLAVLVIGKFP 354
            +   L  G+ P
Sbjct: 202 TMWEALSYGQKP 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 24/234 (10%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 110
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV LL         L++ E+   G L + L   S   R L+      IA    S  + L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS---RVLETDPAFAIANSTLSTRDLL 167
Query: 267 HMSHR----------PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
           H S +             IHRD+   NVL+ +   A+I +FGLA+ I +        +  
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQ 369
             V ++APE       +   D++S+G+LL  +  +G  P      ++K   LV+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 203 VRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++H  +V L A +V ++   ++ EF   GSL D L      ++ L  L     +  IA G
Sbjct: 234 LQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 290
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           + ++   +    IHRD++ AN+L+   +  +I++FGLA+    G      W+        
Sbjct: 291 MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV---GAKFPIKWT-------- 336
Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           APE     + +   D++SFG+LL  ++  G+ P
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 20/230 (8%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 52  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 102
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR------RELDWLARHRIAQGIA 260
           NIV LL         L++ E+   G L + L   ++        R L+       +  +A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ +L   +    IHRD+   NVL+ +   A+I +FGLA+ I +        +    V 
Sbjct: 163 QGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQ 369
           ++APE       +   D++S+G+LL  +  +G  P      ++K   LV+
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMV 216
           +G ++ IKKI               EP    +  +R+  EI      +H NI+ +   + 
Sbjct: 35  TGEIVAIKKI---------------EPFDKPLFALRTLREIKILKHFKHENIITIF-NIQ 78
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
           R D       F     +Q+++            L+   I   I   L  + + H   +IH
Sbjct: 79  RPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 277 RDIQPANVLIDDDMEARISEFGLAKRI---------PDGHTRTTTWSLAGTVGYIAPECH 327
           RD++P+N+LI+ + + ++ +FGLA+ I         P G     T  +A T  Y APE  
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA-TRWYRAPEVM 194
Query: 328 QTVA-LSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
            T A  S   D++S G +LA L + +  FP  D+
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 20/230 (8%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 110
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR------RELDWLARHRIAQGIA 260
           NIV LL         L++ E+   G L + L   ++        R L+       +  +A
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ +L   +    IHRD+   NVL+ +   A+I +FGLA+ I +        +    V 
Sbjct: 171 QGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQ 369
           ++APE       +   D++S+G+LL  +  +G  P      ++K   LV+
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++ 
Sbjct: 129 FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKL 181
Query: 282 ANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYS 340
            NVL+D +   +++++G+ K  +  G T +T     GT  YIAPE  +      + D ++
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 341 FGVLLAVLVIGKFPSD 356
            GVL+  ++ G+ P D
Sbjct: 239 LGVLMFEMMAGRSPFD 254

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      +V E+   G L + +   + GR   D  A
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDE-A 117
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q I SG+ Y H     ++ HRD++  N L+D     R  I  FG +K        
Sbjct: 118 RFFFQQLI-SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLH 170
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +   S  GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 171 SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/124 (25%), Positives = 63/124 (50%), Gaps = 14/124 (11%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
           I + + +   Y+H  +   I HRD++P+N+L+D +   ++S+FG ++ + D   + +   
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 315 LAGTVGYIAPE--CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR 372
             GT  ++ PE   +++       DI+S G+ L V+     P       + ++SLV+   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP------FSLKISLVELFN 263
Query: 373 NVMT 376
           N+ T
Sbjct: 264 NIRT 267

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++    T     S  G V Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE +H  H+  I+H D++PAN LI D M  ++ +FG+A ++          S  GTV Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 323 APECHQTVALS-----------DTCDIYSFGVLLAVLVIGKFP 354
            PE  + ++ S              D++S G +L  +  GK P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           DY+  LE++ S   G V++  +  ++GRV   K I  P             PL      +
Sbjct: 51  DYYDILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPY------------PL--DKYTV 95
Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           ++EI    Q+ H  ++ L      +   +L+ EF   G L D +        E + +   
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA--RISEFGLAKRI-PDGHTRT 310
           R A     GL+++H      I+H DI+P N++ +    +  +I +FGLA ++ PD   + 
Sbjct: 156 RQA---CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           TT     T  + APE      +    D+++ GVL  VL+ G  P
Sbjct: 210 TT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 195 SEIITAGQVRHRNIVPLLAR-MVRRDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A  M  R+      L+  +  +GSL D L      R+ L+  
Sbjct: 51  TEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPH 105
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              R+A   A GL +LH+       +P I HRD +  NVL+  +++  I++ GLA     
Sbjct: 106 LALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQ 165
Query: 306 G--HTRTTTWSLAGTVGYIAPECHQTVALSDT------CDIYSFGVLL 345
           G  +         GT  Y+APE       +D        DI++FG++L
Sbjct: 166 GSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVL 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 9/135 (6%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++ 
Sbjct: 97  FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKL 149
Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
            NVL+D +   +++++G+ K         TT    GT  YIAPE  +      + D ++ 
Sbjct: 150 DNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 207
Query: 342 GVLLAVLVIGKFPSD 356
           GVL+  ++ G+ P D
Sbjct: 208 GVLMFEMMAGRSPFD 222

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMV 216
           +G ++ IKKI               EP    +  +R+  EI      +H NI+ +   + 
Sbjct: 35  TGEIVAIKKI---------------EPFDKPLFALRTLREIKILKHFKHENIITIF-NIQ 78
Query: 217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH 276
           R D       F     +Q+++            L+   I   I   L  + + H   +IH
Sbjct: 79  RPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 277 RDIQPANVLIDDDMEARISEFGLAKRI---------PDGHTRTTTWSLAGTVGYIAPECH 327
           RD++P+N+LI+ + + ++ +FGLA+ I         P G  ++       T  Y APE  
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ-QSGMVEFVATRWYRAPEVM 194
Query: 328 QTVA-LSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
            T A  S   D++S G +LA L + +  FP  D+
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      ++ E+   G L + +   + GR   D  A
Sbjct: 62  NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDE-A 118
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q + SG+ Y H     +I HRD++  N L+D     R  I +FG +K        
Sbjct: 119 RF-FFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH 171
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +   S  GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
           K+ ++  EI    +V H NI+ +L     +    LV E  ++GS  D+   + +  R  +
Sbjct: 72  KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDE 129
Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            LA +   Q + S + YL +     IIHRDI+  N++I +D   ++ +FG A  +  G  
Sbjct: 130 PLASYIFRQ-LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK- 184
Query: 309 RTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFP 354
               ++  GT+ Y APE            +++S GV L  LV  + P
Sbjct: 185 --LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 148 GEVYKAE----LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V+ AE    LP     ++ +K     LK  +E  ++D         Q  +E++T   +
Sbjct: 32  GKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQD--------FQREAELLT--ML 77
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY-------------DVSQGRRELDWL 250
           +H++IV            L+V+E+ R+G L   L              DV+ G   L  L
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               +A  +A+G+ YL   H    +HRD+   N L+   +  +I +FG+++ I      T
Sbjct: 138 LA--VASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YST 188
Query: 311 TTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + G     + ++ PE       +   D++SFGV+L  +   GK P
Sbjct: 189 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 148 GEVYKAE----LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V+ AE    LP     ++ +K     LK  +E  ++D         Q  +E++T   +
Sbjct: 26  GKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQD--------FQREAELLT--ML 71
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY-------------DVSQGRRELDWL 250
           +H++IV            L+V+E+ R+G L   L              DV+ G   L  L
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               +A  +A+G+ YL   H    +HRD+   N L+   +  +I +FG+++ I      T
Sbjct: 132 LA--VASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YST 182
Query: 311 TTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + G     + ++ PE       +   D++SFGV+L  +   GK P
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L  ED++  + ++     G+VYKA+   +S  V+   K+I           K  E L   
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETS--VLAAAKVID---------TKSEEELEDY 81
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           M+    EI       H NIV LL      +   ++ EF   G++  ++ ++ +       
Sbjct: 82  MV----EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------ 131
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           L   +I       L+ L+  H  +IIHRD++  N+L   D + ++++FG++ +    +TR
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTR 187
Query: 310 TTTW--SLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
                 S  GT  ++APE        D       D++S G+ L
Sbjct: 188 XIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 148 GEVYKAE----LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V+ AE    LP     ++ +K     LK  +E  ++D         Q  +E++T   +
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQD--------FQREAELLT--ML 100
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY-------------DVSQGRRELDWL 250
           +H++IV            L+V+E+ R+G L   L              DV+ G   L  L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
               +A  +A+G+ YL   H    +HRD+   N L+   +  +I +FG+++ I      T
Sbjct: 161 LA--VASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YST 211
Query: 311 TTWSLAG----TVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             + + G     + ++ PE       +   D++SFGV+L  +   GK P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 202 QVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI---AQG 258
           ++ H  +V L    + +    LV EF  +G L D L      R +    A   +      
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLD 112
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL  +    +IHRD+   N L+ ++   ++S+FG+ + + D    ++T    GT
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GT 165
Query: 319 ---VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDD 357
              V + +PE       S   D++SFGVL+  V   GK P ++
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 9/135 (6%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++ 
Sbjct: 82  FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKL 134
Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
            NVL+D +   +++++G+ K         TT    GT  YIAPE  +      + D ++ 
Sbjct: 135 DNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 192
Query: 342 GVLLAVLVIGKFPSD 356
           GVL+  ++ G+ P D
Sbjct: 193 GVLMFEMMAGRSPFD 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 9/135 (6%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
             V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++ 
Sbjct: 86  FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKL 138
Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
            NVL+D +   +++++G+ K         TT    GT  YIAPE  +      + D ++ 
Sbjct: 139 DNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWAL 196
Query: 342 GVLLAVLVIGKFPSD 356
           GVL+  ++ G+ P D
Sbjct: 197 GVLMFEMMAGRSPFD 211

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
           H+   +HRDI+P NVL+D +   R+++FG   ++ D  T  ++ ++ GT  YI+PE  Q 
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQA 266
Query: 330 V-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE 378
           +          CD +S GV +  ++ G+ P   F+      SLV+    +M  E
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAE----SLVETYGKIMNHE 313

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
           H+   +HRDI+P NVL+D +   R+++FG   ++ D  T  ++ ++ GT  YI+PE  Q 
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQA 250
Query: 330 V-----ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE 378
           +          CD +S GV +  ++ G+ P   F+      SLV+    +M  E
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAE----SLVETYGKIMNHE 297

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 22/234 (9%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 110
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NIV LL         L++ E+   G L + L        E  +   H   + ++S  + L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS-RDLL 169
Query: 267 HMSHR----------PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
           H S +             IHRD+   NVL+ +   A+I +FGLA+ I +        +  
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQ 369
             V ++APE       +   D++S+G+LL  +  +G  P      ++K   LV+
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 283

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ-DILYDVSQGRRELDWLA 251
           ++ E      ++H +IV LL          +V+EF     L  +I+     G    + +A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHT 308
            H + Q     LE L   H   IIHRD++P  VL+   ++    ++  FG+A ++  G +
Sbjct: 135 SHYMRQI----LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GES 188
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
                   GT  ++APE  +        D++  GV+L +L+ G  P    F  TKE
Sbjct: 189 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKE 240

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ-DILYDVSQGRRELDWLA 251
           ++ E      ++H +IV LL          +V+EF     L  +I+     G    + +A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHT 308
            H + Q     LE L   H   IIHRD++P  VL+   ++    ++  FG+A ++  G +
Sbjct: 133 SHYMRQI----LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GES 186
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
                   GT  ++APE  +        D++  GV+L +L+ G  P    F  TKE
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKE 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 69/134 (51%), Gaps = 28/134 (20%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKRIPD 305
           IASG+ +LH     +IIHRD++P N+L+              +++   IS+FGL K++  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 306 GHT--RTTTWSLAGTVGYIAPECHQTVA-------LSDTCDIYSFG-VLLAVLVIGKFPS 355
           G    R    + +GT G+ APE  +          L+ + DI+S G V   +L  GK P 
Sbjct: 181 GQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 356 DDFFQHTKEMSLVQ 369
            D  ++++E ++++
Sbjct: 241 GD--KYSRESNIIR 252

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 179
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 228

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 178
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 227

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 179
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 228

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 179
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 228

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 14/120 (11%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           +IA  I   LE+LH   +  +IHRD++P+NVLI+   + +  +FG++  + D   +    
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 314 SLAGTVGYIA-----PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF---FQHTKEM 365
             AG   Y A     PE +Q    S   DI+S G+    L I +FP D +   FQ  K++
Sbjct: 197 --AGCKPYXAPERINPELNQK-GYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EII    +RH NIV     ++      +V E+   G L + +   + GR   D  A
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDE-A 117
Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTR 309
           R    Q I SG+ Y H     ++ HRD++  N L+D     R  I  FG +K        
Sbjct: 118 RFFFQQLI-SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLH 170
Query: 310 TTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDD 357
           +      GT  YIAPE            D++S GV L V+++G +P +D
Sbjct: 171 SQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 185
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W AR   A+ + +    L   H    IHRD++
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPEK-----W-ARFYTAEVVLA----LDAIHSMGFIHRDVK 200
Query: 281 PANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++  +G  R  T    GT  YI+PE  ++          
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 259 CDWWSVGVFLYEMLVGDTP 277

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+       SGR+     ++  +KS  E +  D   L  K +Q   E     Q  H N
Sbjct: 128 GEVF-------SGRLRADNTLVA-VKSCRETLPPD---LKAKFLQ---EARILKQYSHPN 173
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+    ++    +V E  + G     L   ++G R L      ++    A+G+EYL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGAR-LRVKTLLQMVGDAAAGMEYLE 230
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                  IHRD+   N L+ +    +IS+FG+++   DG    +       V + APE  
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 328 QTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF-QHTKEM 365
                S   D++SFG+LL     +G  P  +   Q T+E 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 188 HKMIQIRSEIITAGQVR-HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
           H   ++  E+ T  Q + ++NI+ L+          LV+E  + GS   IL  + Q ++ 
Sbjct: 52  HSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGS---ILAHI-QKQKH 107
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME---ARISEF--GLAK 301
            +     R+ + +A+ L++LH      I HRD++P N+L +   +    +I +F  G   
Sbjct: 108 FNEREASRVVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGM 164
Query: 302 RIPDGHTRTTTWSL---AGTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGKF 353
           ++ +  T  TT  L    G+  Y+APE       Q       CD++S GV+L +++ G  
Sbjct: 165 KLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224
Query: 354 P 354
           P
Sbjct: 225 P 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 30/247 (12%)
Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII-TAGQVRH 205
           N E+ K    G+ G+V  ++KI     SG      D+  L+   +  ++ I+  A    H
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKI-----SG-----HDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 206 RNIVPLLARMVRRDCDLLV--YEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG----- 258
                 +   +R+   L+   Y F+    L  IL  ++ G        R R  +      
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 259 ---IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              I   LE+LH   +  II+RDI+  N+L+D +    +++FGL+K      T    +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 220
Query: 316 AGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
            GT+ Y+AP+  +          D +S GVL+  L+ G  P   F    ++ S  +  R 
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRR 277
Query: 374 VMTSENP 380
           ++ SE P
Sbjct: 278 ILKSEPP 284

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 14  LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 55
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 56  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 113
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 114 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 169 RALPQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   ++ H+N
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKLNHQN 95
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 208
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   ++ H+N
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKLNHQN 109
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 222
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W AR   A+ + +    L   H    IHRD++
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEK-----W-ARFYTAEVVLA----LDAIHSMGFIHRDVK 195
Query: 281 PANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++  +G  R  T    GT  YI+PE  ++          
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 254 CDWWSVGVFLYEMLVGDTP 272

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 304
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 353

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W AR   A+ + +    L   H    IHRD++
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPEK-----W-ARFYTAEVVLA----LDAIHSMGFIHRDVK 200
Query: 281 PANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++  +G  R  T    GT  YI+PE  ++          
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 259 CDWWSVGVFLYEMLVGDTP 277

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 121
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 265 YLHMSHRPRIIHRDIQPANVLID---DDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 234
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 272

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 15/112 (13%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
            ++YLH +    IIHRD++P NVL+   ++D   +I++FG +K +  G T +   +L GT
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET-SLMRTLCGT 318
Query: 319 VGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
             Y+APE   +V  +      D +S GV+L + + G  P   F +H  ++SL
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 367

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+       SGR+     ++  +KS  E +  D   L  K +Q   E     Q  H N
Sbjct: 128 GEVF-------SGRLRADNTLVA-VKSCRETLPPD---LKAKFLQ---EARILKQYSHPN 173
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+    ++    +V E  + G     L   ++G R L      ++    A+G+EYL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGAR-LRVKTLLQMVGDAAAGMEYLE 230
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                  IHRD+   N L+ +    +IS+FG+++   DG    +       V + APE  
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 328 QTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF-QHTKEM 365
                S   D++SFG+LL     +G  P  +   Q T+E 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 61/107 (57%), Gaps = 11/107 (10%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD---GHTRTTTWSL 315
           I  GL+Y+H ++   ++HRD++P+N+LI+   + +I +FGLA RI D    HT   T  +
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLA-RIADPEHDHTGFLTEXV 208
Query: 316 AGTVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           A T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 209 A-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 109
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 222
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 4   LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 45
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 46  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 103
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 104 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 159 RALPQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 130 LEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           L  ED++  + ++     G+VYKA+   +S  V+   K+I           K  E L   
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETS--VLAAAKVID---------TKSEEELEDY 81
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDW 249
           M+    EI       H NIV LL      +   ++ EF   G++  ++ ++ +       
Sbjct: 82  MV----EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------ 131
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
           L   +I       L+ L+  H  +IIHRD++  N+L   D + ++++FG++ +    +TR
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTR 187
Query: 310 TTTW--SLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGKFPSDDFFQHT 362
                    GT  ++APE        D       D++S G+ L  +   + P        
Sbjct: 188 XIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------- 240
Query: 363 KEMSLVQWMRNVMTSENPNRAINSKLLGN 391
            E++ ++ +  +  SE P  A  S+   N
Sbjct: 241 HELNPMRVLLKIAKSEPPTLAQPSRWSSN 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 8   LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 49
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 50  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 107
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 108 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 162
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 163 RALPQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 208

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 51  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 101
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 162 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 214
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 252

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 135
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVG 320
           YL  +H    IHRDI   N L+        A+I +FG+A+ I   G+ R    ++   V 
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-PVK 251
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 94
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 207
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A  ++         L+ ++  NGSL D L   +     LD  
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAK 134
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLA-KRIP 304
           +  ++A    SGL +LH        +P I HRD++  N+L+  +    I++ GLA K I 
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 305 D-GHTRTTTWSLAGTVGYIAPEC---------HQTVALSDTCDIYSFGVLL 345
           D         +  GT  Y+ PE           Q+  ++   D+YSFG++L
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA---DMYSFGLIL 242

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 111
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 172 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 224
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 262

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 94
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 207
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 14  LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 55
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 56  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 113
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 114 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 169 RALPQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 62  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 112
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIP-DGHTRTTTWSLAGTVG 320
           YL  +H    IHRDI   N L+        A+I +FG+A+ I   G+ R    ++   V 
Sbjct: 173 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-PVK 228
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 263

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 95
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 208
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ 234
             +++K+++ P   ++  + SE     QV H +++ L     +    LL+ E+ + GSL+
Sbjct: 57  AVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 235 DILYD---VSQG-----------------RRELDWLARHRIAQGIASGLEYLHMSHRPRI 274
             L +   V  G                  R L        A  I+ G++YL      ++
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171
Query: 275 IHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           +HRD+   N+L+ +  + +IS+FGL++ + +  +          V ++A E       + 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 335 TCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             D++SFGVLL  ++ +G  P    +       L   ++     E P+         N  
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRMERPD---------NCS 278
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           EE   L+L+    C   +P+KRP   D+
Sbjct: 279 EEMYRLMLQ----CWKQEPDKRPVFADI 302

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ 234
             +++K+++ P   ++  + SE     QV H +++ L     +    LL+ E+ + GSL+
Sbjct: 57  AVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 235 DILYD---VSQG-----------------RRELDWLARHRIAQGIASGLEYL-HMSHRPR 273
             L +   V  G                  R L        A  I+ G++YL  MS    
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---- 170
Query: 274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS 333
           ++HRD+   N+L+ +  + +IS+FGL++ + +  +          V ++A E       +
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 334 DTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNG 392
              D++SFGVLL  ++ +G  P    +       L   ++     E P+         N 
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRMERPD---------NC 277
Query: 393 YEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
            EE   L+L+    C   +P+KRP   D+
Sbjct: 278 SEEMYRLMLQ----CWKQEPDKRPVFADI 302

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV---RRDCDLLVY 225
           I+ LK G E  K D+E           E++   Q+ H+   P + R++   + +  +LV 
Sbjct: 368 IKVLKQGTE--KADTE-----------EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414
Query: 226 EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
           E    G L   L      R E+       +   ++ G++YL   +    +HR++   NVL
Sbjct: 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVL 468
Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAG--TVGYIAPECHQTVALSDTCDIYSFGV 343
           + +   A+IS+FGL+K +    +  T  S AG   + + APEC      S   D++S+GV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARS-AGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 344 LL-AVLVIGKFP 354
            +   L  G+ P
Sbjct: 528 TMWEALSYGQKP 539

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVYSEQDE------LDFLMEALIISKFNHQN 109
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 222
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 4   LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 45
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 46  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 103
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 104 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 159 RALPQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 4   LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 45
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 46  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 103
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 104 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 159 RALPQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 204

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 36  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 86
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 87  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 147 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKGGCAML 199
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 237

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ 234
             +++K+++ P   ++  + SE     QV H +++ L     +    LL+ E+ + GSL+
Sbjct: 57  AVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 235 DILYD---VSQG-----------------RRELDWLARHRIAQGIASGLEYLHMSHRPRI 274
             L +   V  G                  R L        A  I+ G++YL      ++
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171
Query: 275 IHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           +HRD+   N+L+ +  + +IS+FGL++ + +  +          V ++A E       + 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 335 TCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGY 393
             D++SFGVLL  ++ +G  P    +       L   ++     E P+         N  
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNP----YPGIPPERLFNLLKTGHRMERPD---------NCS 278
Query: 394 EEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           EE   L+L+    C   +P+KRP   D+
Sbjct: 279 EEMYRLMLQ----CWKQEPDKRPVFADI 302

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           LI E+DL  LEK         +     G V + E    SG+ +++           + +K
Sbjct: 8   LIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSV---------AVKCLK 49
Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
            D       M     E+     + HRN++ L   ++     + V E    GSL D L   
Sbjct: 50  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK- 107
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
            QG   L  L+R+ +   +A G+ YL      R IHRD+   N+L+      +I +FGL 
Sbjct: 108 HQGHFLLGTLSRYAVQ--VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 162
Query: 301 KRIP--DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + +P  D H             + APE  +T   S   D + FGV L
Sbjct: 163 RALPQNDDHYVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTL 208

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L    E+  +  E      +    E +   +  H+N
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDE------LDFLMEALIISKFNHQN 95
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH---RIAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGT--- 318
           YL  +H    IHRDI   N L+        A+I +FG+A+ I     R + +   G    
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI----YRASYYRKGGCAML 208
Query: 319 -VGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
            V ++ PE       +   D +SFGVLL  +  +G  P
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           +R EI T   +RH  +V L       +  +++YEF   G L + + D      E + +  
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DMEARISEFGLAKRI-PDGHTR 309
            R    +  GL ++H ++    +H D++P N++       E ++ +FGL   + P    +
Sbjct: 261 MR---QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TT    GT  + APE  +   +    D++S GVL  +L+ G  P
Sbjct: 315 VTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 38/226 (16%)
Query: 135 YFASLEK---IRSCWNGEVYKAELPGSS--GRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
           YF S+EK   ++    G   KA L  S+  GR   IK+I     + + +  K+ E     
Sbjct: 19  YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-----NISRMSSKERE----- 68
Query: 190 MIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSL-------QDILYDVSQ 242
             + R E+     ++H NIV             +V ++   G L       + +L+   Q
Sbjct: 69  --ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 243 GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR 302
               LDW  +  +A         L   H  +I+HRDI+  N+ +  D   ++ +FG+A+ 
Sbjct: 127 ---ILDWFVQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVL 348
           +    T     +  GT  Y++PE  +    ++  DI++ G +L  L
Sbjct: 175 L--NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           +R EI T   +RH  +V L       +  +++YEF   G L + + D      E + +  
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DMEARISEFGLAKRI-PDGHTR 309
            R    +  GL ++H ++    +H D++P N++       E ++ +FGL   + P    +
Sbjct: 155 MR---QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 208
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            TT    GT  + APE  +   +    D++S GVL  +L+ G  P
Sbjct: 209 VTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 26/184 (14%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLA--RMVRRDCDLLVYEFRRNGSLQDILYDVSQ--GRRE 246
           +Q+R E     ++ H+NIV L A          +L+ EF   GSL  +L + S   G  E
Sbjct: 53  VQMR-EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL--IDDDMEA--RISEFGLAKR 302
            ++L    + + +  G+ +L  +    I+HR+I+P N++  I +D ++  ++++FG A+ 
Sbjct: 112 SEFLI---VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVAL--------SDTCDIYSFGVLLAVLVIGKFP 354
           + D        SL GT  Y+ P+ ++   L          T D++S GV       G  P
Sbjct: 166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
Query: 355 SDDF 358
              F
Sbjct: 223 FRPF 226

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 12/111 (10%)
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG-LAKRIPDGHT 308
           +AR  +A+ + + ++ +H  H    +HRDI+P N+L+D +   R+++FG   K + DG  
Sbjct: 176 MARFYLAEMVIA-IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 309 RTTTWSLAGTVGYIAPECHQTVA-----LSDTCDIYSFGVLLAVLVIGKFP 354
           +++     GT  YI+PE  Q +          CD +S GV +  ++ G+ P
Sbjct: 232 QSSV--AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +             V 
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +             V 
Sbjct: 138 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVL 219

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDW 249
            ++ EI    ++RH+N++ L+  +   +     +V E+   G +Q++L  V + R  +  
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPV-- 108
Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
              H     +  GLEYLH      I+H+DI+P N+L+      +IS  G+A+ +      
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLLAVLVIGKFP 354
            T  +  G+  +  PE    +   DT      DI+S GV L  +  G +P
Sbjct: 166 DTCRTSQGSPAFQPPEIANGL---DTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 109/260 (41%), Gaps = 47/260 (18%)
Query: 104 AAGRGGSRDRRPIIFSPLIKEEDLAFL----EKEDYFASLEKIRSCWNGEVYKAELPGSS 159
           A GR GS           +K+ D+A L    + E  F+ L +I     G VY A    +S
Sbjct: 31  AGGRAGS-----------LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS 79
Query: 160 GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRD 219
             V+ IKK+    K   E           K   I  E+    ++RH N +      +R  
Sbjct: 80  -EVVAIKKMSYSGKQSNE-----------KWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI 279
              LV E+   GS  D+L    +  +E++  A   +  G   GL YLH SH   +IHRD+
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH-SHN--MIHRDV 180
Query: 280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD----- 334
           +  N+L+ +    ++ +FG A  +   +         GT  ++APE    +A+ +     
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEV--ILAMDEGQYDG 232
Query: 335 TCDIYSFGVLLAVLVIGKFP 354
             D++S G+    L   K P
Sbjct: 233 KVDVWSLGITCIELAERKPP 252

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +             V 
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 64/113 (56%), Gaps = 10/113 (8%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSLAGT 318
           GL+Y+H +   ++IHRD++P+N+L++++ E +I +FG+A+ +   P  H    T  +A T
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA-T 225
Query: 319 VGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
             Y APE   ++   +   D++S G +   ++  +  FP  ++    + + +V
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS-LAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T   +    
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 431 SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 482
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 540 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 593
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 594 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 640
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 641 ELKAQLSTI 649

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 64/113 (56%), Gaps = 10/113 (8%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSLAGT 318
           GL+Y+H +   ++IHRD++P+N+L++++ E +I +FG+A+ +   P  H    T  +A T
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA-T 226
Query: 319 VGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLV 368
             Y APE   ++   +   D++S G +   ++  +  FP  ++    + + +V
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 45/249 (18%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +A   G       +K  ++ LKS A   +K++         + SE+ I +   +H 
Sbjct: 45  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---------LMSELKIMSHLGQHE 95
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG-------- 258
           NIV LL         L++ E+   G L + L      RR+ + +    +A G        
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFL------RRKAEAMLGPSLAPGQDPEGLDK 149
Query: 259 -----------------IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
                            +A G+ +L   +    IHRD+   NVL+ +   A+I +FGLA+
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQ 360
            I +        +    V ++APE       +   D++S+G+LL  +  +G  P      
Sbjct: 207 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 266
Query: 361 HTKEMSLVQ 369
           ++K   LV+
Sbjct: 267 NSKFYKLVK 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRT 310
           RI + + S + Y    H+  + HRD++P N L      D   ++ +FGLA R   G    
Sbjct: 127 RIMKDVLSAVAY---CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           T     GT  Y++P+  + +     CD +S GV++ VL+ G  P
Sbjct: 184 TK---VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 223

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 172 LKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCD-----LLVYE 226
           LK   + +K D+     ++ +  SE        H N++ LL   +          +++  
Sbjct: 63  LKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 227 FRRNGSLQD-ILYD-VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV 284
           F + G L   +LY  +  G + +      +    IA G+EYL  S+R   +HRD+   N 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNR-NFLHRDLAARNC 178
Query: 285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVL 344
           ++ DDM   +++FGL+K+I  G            V +IA E       +   D+++FGV 
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 345 L 345
           +
Sbjct: 239 M 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 17/149 (11%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG--- 317
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I      T  +   G   
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI----YETAYYRKGGKGL 193
Query: 318 -TVGYIAPECHQTVALSDTCDIYSFGVLL 345
             V ++APE  +    + + D++SFGV+L
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 93  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 193
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRT 310
           RI + + S + Y    H+  + HRD++P N L      D   ++ +FGLA R   G    
Sbjct: 110 RIMKDVLSAVAY---CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           T     GT  Y++P+  + +     CD +S GV++ VL+ G  P
Sbjct: 167 TK---VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 47  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 105
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 106 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 206
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 54  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 105
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 106 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 163 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 216
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 217 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 263
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 264 ELKAQLSTI 272

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW-SLAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T        
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW-SLAG 317
           I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H  T        
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 318 TVGYIAPECH-QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFF 359
           T  Y APE    +   + + DI+S G +LA ++  +  FP   + 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 35  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 93
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 94  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 194
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +             V 
Sbjct: 140 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVL 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 93  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 193
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG- 317
           +A G+EYL      + +HRD+   N ++D+    ++++FGLA+ I D    +        
Sbjct: 133 VARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 318 -TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
             V + A E  QT   +   D++SFGVLL  L+    P    ++H     L  ++
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDLTHFL 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 93  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 193
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 53  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 104
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 105 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 162 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 215
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 216 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 262
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 263 ELKAQLSTI 271

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAEL-------IKKDSEPLHHKMIQIRSEIIT 199
           G+V+KA    + GR + +K++ +Q  + G  L       + +  E   H  +    ++ T
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNG----SLQDILYDVSQGRRELDWLARHRI 255
             +      + L+   V +D    + +    G    +++D+++                 
Sbjct: 85  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ---------------- 128
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +  GL++LH SHR  ++HRD++P N+L+    + ++++FGLA RI       T  S+
Sbjct: 129 ---LLRGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT--SV 179
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
             T+ Y APE     + +   D++S G + A
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 38  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 96
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 97  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 197
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 230

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAEL-------IKKDSEPLHHKMIQIRSEIIT 199
           G+V+KA    + GR + +K++ +Q  + G  L       + +  E   H  +    ++ T
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNG----SLQDILYDVSQGRRELDWLARHRI 255
             +      + L+   V +D    + +    G    +++D+++                 
Sbjct: 85  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ---------------- 128
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +  GL++LH SHR  ++HRD++P N+L+    + ++++FGLA RI       T  S+
Sbjct: 129 ---LLRGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT--SV 179
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
             T+ Y APE     + +   D++S G + A
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPL----HHKMIQIRSEIITAGQV 203
           G VY+A+L   SG ++ IKK++Q    G     ++ + +    H  ++++R    ++G+ 
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           +    + L+   V       VY   R+          S+ ++ L  +        +   L
Sbjct: 89  KDEVYLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
            Y+H      I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y 
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYR 189
Query: 323 APE-CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
           APE        + + D++S G +LA L++G+  FP D
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 53  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 111
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 112 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 212
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 245

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 39  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 97
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 98  YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 198
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 42  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 100
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 101 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 201
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 46  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 104
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 105 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 205
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HRD+   N ++  D   +I +FG+ + I +             V 
Sbjct: 141 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 46  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 104
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 105 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 205
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAEL-------IKKDSEPLHHKMIQIRSEIIT 199
           G+V+KA    + GR + +K++ +Q  + G  L       + +  E   H  +    ++ T
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 200 AGQVRHRNIVPLLARMVRRDCDLLVYEFRRNG----SLQDILYDVSQGRRELDWLARHRI 255
             +      + L+   V +D    + +    G    +++D+++                 
Sbjct: 85  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ---------------- 128
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +  GL++LH SHR  ++HRD++P N+L+    + ++++FGLA RI       T  S+
Sbjct: 129 ---LLRGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALT--SV 179
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
             T+ Y APE     + +   D++S G + A
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR 206
           G+V  A   G S   ++I+  ++ LK  A+  ++++         + SE+    Q+  H 
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA---------LMSELKMMTQLGSHE 109
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--GRRELDWLARHRI--------- 255
           NIV LL          L++E+   G L + L    +     E+++  + R+         
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 256 --------AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
                   A  +A G+E+L        +HRD+   NVL+      +I +FGLA+ I    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                 +    V ++APE       +   D++S+G+LL
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 48  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 99
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 157 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 210
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 211 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 257
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 258 ELKAQLSTI 266

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 62  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 120
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 121 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 221
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 222 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 254

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPL----HHKMIQIRSEIITAGQV 203
           G VY+A+L   SG ++ IKK++Q    G     ++ + +    H  ++++R    ++G+ 
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           +    + L+   V       VY   R+          S+ ++ L  +        +   L
Sbjct: 89  KDEVYLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
            Y+H      I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y 
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYR 189
Query: 323 APE-CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
           APE        + + D++S G +LA L++G+  FP D
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 56  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 107
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 165 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 218
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 219 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 265
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 266 ELKAQLSTI 274

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 79  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 130
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 131 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 188 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 241
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 242 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 288
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 289 ELKAQLSTI 297

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 51  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 102
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 160 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 213
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 214 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 260
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 261 ELKAQLSTI 269

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 51  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 102
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 103 VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 160 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 213
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 214 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 260
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 261 ELKAQLSTI 269

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 68  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 127 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 227
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 150 VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV 209
           VYKA    ++ +++ IKKI    K G     KD   ++   ++   EI    ++ H NI+
Sbjct: 26  VYKAR-DKNTNQIVAIKKI----KLGHRSEAKDG--INRTALR---EIKLLQELSHPNII 75
Query: 210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS--GLEYLH 267
            LL     +    LV++F     L+ I+ D S     L     H  A  + +  GLEYLH
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PD---GHTRTTTWSLAGTVGYI 322
                 I+HRD++P N+L+D++   ++++FGLAK    P+    H   T W       Y 
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW-------YR 179
Query: 323 APECHQTVALSDT-CDIYSFGVLLAVLVI 350
           APE      +     D+++ G +LA L++
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLL 208

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 26/184 (14%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLA--RMVRRDCDLLVYEFRRNGSLQDILYDVSQ--GRRE 246
           +Q+R E     ++ H+NIV L A          +L+ EF   GSL  +L + S   G  E
Sbjct: 53  VQMR-EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL--IDDDMEA--RISEFGLAKR 302
            ++L    + + +  G+ +L  +    I+HR+I+P N++  I +D ++  ++++FG A+ 
Sbjct: 112 SEFLI---VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 303 IPDGHTRTTTWSLAGTVGYIAPECHQTVAL--------SDTCDIYSFGVLLAVLVIGKFP 354
           + D         L GT  Y+ P+ ++   L          T D++S GV       G  P
Sbjct: 166 LEDDEQFVX---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
Query: 355 SDDF 358
              F
Sbjct: 223 FRPF 226

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPL----HHKMIQIRSEIITAGQV 203
           G VY+A+L   SG ++ IKK++Q    G     ++ + +    H  ++++R    ++G+ 
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           +    + L+   V       VY   R+          S+ ++ L  +        +   L
Sbjct: 89  KDEVYLNLVLDYV----PATVYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
            Y+H      I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y 
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYR 189
Query: 323 APE-CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
           APE        + + D++S G +LA L++G+  FP D
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 70  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 128
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 129 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 229
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 262

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 68  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 127 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 227
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+   ++
Sbjct: 34  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE--KKD 90
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L   +V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 91  VVYL--NLVLDYVPETVYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRYYRAPEL 193
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 16/140 (11%)
Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           LV E+   G L  +L     G R    +AR  +A+ + +    +   HR   +HRDI+P 
Sbjct: 138 LVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMA----IDSVHRLGYVHRDIKPD 191
Query: 283 NVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPECHQTVALSDT------ 335
           N+L+D     R+++FG   ++  DG  R+      GT  Y++PE  Q V           
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 336 -CDIYSFGVLLAVLVIGKFP 354
            CD ++ GV    +  G+ P
Sbjct: 250 ECDWWALGVFAYEMFYGQTP 269

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ LL     R    L  E+  +G+L D L    +  R L+      IA   AS L 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLS 140
Query: 265 YLHMSH-------------RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              + H             + + IHRD+   N+L+ ++  A+I++FGL+ R  + + + T
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKT 199
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   V ++A E       +   D++S+GVLL  ++ +G  P
Sbjct: 200 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 72  GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 130
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 131 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 231
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 232 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 264

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q  +     ++   +  H  ++++R    ++G+ +   
Sbjct: 113 GVVYQAKL-CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 171
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            + L+   V       VY   R+          S+ ++ L  +        +   L Y+H
Sbjct: 172 YLNLVLDYVPET----VYRVARH---------YSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
                 I HRDI+P N+L+D D    ++ +FG AK++  G       S   +  Y APE 
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPEL 272
Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSD 356
                  + + D++S G +LA L++G+  FP D
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 305

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 31/248 (12%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 51  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 102
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+  +   ++ +FGL++
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQ 360
            + D  T          + ++APE       +   D++ FGV +  +L+ G  P    FQ
Sbjct: 160 YMEDS-TXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQ 214
Query: 361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
             K   ++  + N      P     +           L  L   C+    DP++RP   +
Sbjct: 215 GVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFTE 261
Query: 421 VRCMLSQI 428
           ++  LS I
Sbjct: 262 LKAQLSTI 269

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ LL     R    L  E+  +G+L D L    +  R L+      IA   AS L 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLS 130
Query: 265 YLHMSH-------------RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              + H             + + IHRD+   N+L+ ++  A+I++FGL+ R  + + + T
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKT 189
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   V ++A E       +   D++S+GVLL  ++ +G  P
Sbjct: 190 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 431 SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 482
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+      ++ +FGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 540 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 593
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 594 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 640
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 641 ELKAQLSTI 649

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 38/176 (21%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 139
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R   
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--- 196
Query: 306 GHTRTTTWSLA-----GTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             + T T  +A     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 247

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 100
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R  D
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HD 159
Query: 306 GHTRTTTWS---LAGTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             T T   +     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 208

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 223 LVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ 280
           +V E+   G L +++  YDV +      W A+   A+ + +    L   H   +IHRD++
Sbjct: 152 MVMEYMPGGDLVNLMSNYDVPE-----KW-AKFYTAEVVLA----LDAIHSMGLIHRDVK 201
Query: 281 PANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPECHQTVA----LSDT 335
           P N+L+D     ++++FG   ++ + G     T    GT  YI+PE  ++          
Sbjct: 202 PDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT--AVGTPDYISPEVLKSQGGDGYYGRE 259
Query: 336 CDIYSFGVLLAVLVIGKFP 354
           CD +S GV L  +++G  P
Sbjct: 260 CDWWSVGVFLFEMLVGDTP 278

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 72  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 126
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R  D
Sbjct: 127 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HD 185
Query: 306 GHTRTTTWS---LAGTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             T T   +     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 186 SATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 234

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 58  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 117
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 118 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 174
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 175 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 30/198 (15%)
Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR 218
           +G+++ IKK ++       +IKK         I +R EI    Q++H N+V LL    R+
Sbjct: 27  TGQIVAIKKFLE--SEDDPVIKK---------IALR-EIRMLKQLKHPNLVNLLEVFRRK 74
Query: 219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD 278
               LV+E+        +L+++ + +R +     H +       L+ ++  H+   IHRD
Sbjct: 75  RRLHLVFEY----CDHTVLHELDRYQRGV---PEHLVKSITWQTLQAVNFCHKHNCIHRD 127
Query: 279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT--- 335
           ++P N+LI      ++ +FG A R+  G +      +A T  Y +PE    + + DT   
Sbjct: 128 VKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA-TRWYRSPE----LLVGDTQYG 181
Query: 336 --CDIYSFGVLLAVLVIG 351
              D+++ G + A L+ G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 47  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 101
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R  D
Sbjct: 102 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HD 160
Query: 306 GHTRTTTWS---LAGTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             T T   +     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 161 SATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 209

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 52  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 106
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R  D
Sbjct: 107 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HD 165
Query: 306 GHTRTTTWS---LAGTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             T T   +     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 166 SATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 214

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWL 250
           +EI     +RH NI+  +A   + +       LV ++  +GSL D L      R  +   
Sbjct: 49  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVE 103
Query: 251 ARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
              ++A   ASGL +LHM       +P I HRD++  N+L+  +    I++ GLA R  D
Sbjct: 104 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HD 162
Query: 306 GHTRTTTWS---LAGTVGYIAPECHQTVALSDT-----------CDIYSFGVLL 345
             T T   +     GT  Y+APE      L D+            DIY+ G++ 
Sbjct: 163 SATDTIDIAPNHRVGTKRYMAPE-----VLDDSINMKHFESFKRADIYAMGLVF 211

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 184 ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 224

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 183 SEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ 242
           S+ +  K +Q   E +T  Q  H +IV L+  ++  +   ++ E    G L+  L    Q
Sbjct: 51  SDSVREKFLQ---EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL----Q 102
Query: 243 GRR-ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK 301
            R+  LD  +    A  +++ L YL      R +HRDI   NVL+      ++ +FGL++
Sbjct: 103 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 302 RIPDG-HTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFF 359
            + D  + + +   L   + ++APE       +   D++ FGV +  +L+ G  P    F
Sbjct: 160 YMEDSTYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----F 213
Query: 360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK 419
           Q  K   ++  + N      P     +           L  L   C+    DP++RP   
Sbjct: 214 QGVKNNDVIGRIENGERLPMPPNCPPT-----------LYSLMTKCWAY--DPSRRPRFT 260
Query: 420 DVRCMLSQI 428
           +++  LS I
Sbjct: 261 ELKAQLSTI 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HR++   N ++  D   +I +FG+ + I +             V 
Sbjct: 141 DGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------SQGRRELDWLARHRIAQGIA 260
           ++V LL  + +    L+V E   +G L+  L  +      + GR         ++A  IA
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            G+ YL+     + +HR++   N ++  D   +I +FG+ + I +             V 
Sbjct: 142 DGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
           ++APE  +    + + D++SFGV+L
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVL 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 19/173 (10%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E++    +    IVPL   +       +  E    GSL  ++ +  QG    D  A + +
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE--QGCLPED-RALYYL 191
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRI-PDGHTRT--T 311
            Q +  GLEYLH     RI+H D++  NVL+  D   A + +FG A  + PDG  ++  T
Sbjct: 192 GQAL-EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLT 247
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC----DIYSFGVLLAVLVIGKFPSDDFFQ 360
              + GT  ++APE    V L  +C    D++S   ++  ++ G  P   FF+
Sbjct: 248 GDYIPGTETHMAPE----VVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFR 296

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 32/229 (13%)
Query: 131 EKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKM 190
           + E  F+ L +I     G VY A    +S  V+ IKK+    K   E           K 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNE-----------KW 59
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
             I  E+    ++RH N +      +R     LV E+   GS  D+L    +  +E++  
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA 118
Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A   +  G   GL YLH SH   +IHRD++  N+L+ +    ++ +FG A  +   +   
Sbjct: 119 A---VTHGALQGLAYLH-SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-- 170
Query: 311 TTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGKFP 354
                 GT  ++APE    +A+ +       D++S G+    L   K P
Sbjct: 171 ----FVGTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 203 VRHRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIA 256
           ++H NIV       + +  + C +LV E   +G+L+  L  + V + +    W       
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------C 135
Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSL 315
           + I  GL++LH +  P IIHRD++  N+ I       +I + GLA        +    ++
Sbjct: 136 RQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AV 190
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM 375
            GT  + APE ++     ++ D+Y+FG         ++P      +++  +  Q  R V 
Sbjct: 191 IGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYP------YSECQNAAQIYRRVT 243
Query: 376 TSENP 380
           +   P
Sbjct: 244 SGVKP 248

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 92
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I           
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 23/167 (13%)
Query: 205 HRNIVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RH 253
           H N+V LL    +    L+V  EF + G+L   L         Y V+      D+L   H
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 254 RIAQG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHT 308
            I     +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + 
Sbjct: 187 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV 242
Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
           R     L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 243 RKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E++    +    IVPL   +       +  E    GSL  ++       +++  L   R 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 166
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRI-PDGHTRT--T 311
              +   LE L   H  RI+H D++  NVL+  D   A + +FG A  + PDG  ++  T
Sbjct: 167 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 226
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
              + GT  ++APE           DI+S   ++  ++ G  P   +F+
Sbjct: 227 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 275

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 32  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 83
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I           
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 92
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTT 311
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R  
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 208
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 209 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 32  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 83
Query: 208 IVPLLARMVRRDCDLLVY-EFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTT 311
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 199
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 200 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 32  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 83
Query: 208 IVPLLARMVRRDCDLLVY-EFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I           
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E++    +    IVPL   +       +  E    GSL  ++       +++  L   R 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 152
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRI-PDGHTRT--T 311
              +   LE L   H  RI+H D++  NVL+  D   A + +FG A  + PDG  ++  T
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
              + GT  ++APE           DI+S   ++  ++ G  P   +F+
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ LL     R    L  E+  +G+L D L    +  R L+      IA   AS L 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLS 137
Query: 265 YLHMSH-------------RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
              + H             + + IHR++   N+L+ ++  A+I++FGL+ R  + + + T
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLS-RGQEVYVKKT 196
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   V ++A E       +   D++S+GVLL  ++ +G  P
Sbjct: 197 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 32  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 83
Query: 208 IVPLLARMVRRDCDLLVY-EFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTT 311
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 199
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 200 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 176
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 217

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E++    +    IVPL   +       +  E    GSL  ++       +++  L   R 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 168
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRI-PDGHTRT--T 311
              +   LE L   H  RI+H D++  NVL+  D   A + +FG A  + PDG  ++  T
Sbjct: 169 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 228
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
              + GT  ++APE           DI+S   ++  ++ G  P   +F+
Sbjct: 229 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 277

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 184 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 183 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 223

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
           ++A  IA G+ YL+ +   + +HRD+   N ++ +D   +I +FG+ + I +        
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                V +++PE  +    +   D++SFGV+L
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 252

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 25/221 (11%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 92
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y V+      D+L   H I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I           
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
               + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 110/243 (45%), Gaps = 43/243 (17%)
Query: 205 HRNIVPLLARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQ--- 257
           H NI+ L+A  +R    +    L+  F + G+L +   ++ + + + ++L   +I     
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN---EIERLKDKGNFLTEDQILWLLL 141
Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP---DGHTRTTT-- 312
           GI  GLE +H        HRD++P N+L+ D+ +  + + G   +     +G  +  T  
Sbjct: 142 GICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 313 -WSLA-GTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
            W+    T+ Y APE         + +  D++S G +L  ++ G+ P D  FQ    ++L
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 368 -VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
            VQ   ++  S   + A+   L        M+ V          DP++RP+   +  +LS
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLL------NSMMTV----------DPHQRPH---IPLLLS 299
Query: 427 QIQ 429
           Q++
Sbjct: 300 QLE 302

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E++    +    IVPL   +       +  E    GSL  ++ +  QG    D  A + +
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE--QGCLPED-RALYYL 172
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRI-PDGHTR--TT 311
            Q +  GLEYLH     RI+H D++  NVL+  D   A + +FG A  + PDG  +   T
Sbjct: 173 GQAL-EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT 228
Query: 312 TWSLAGTVGYIAPECHQTVALSDTC----DIYSFGVLLAVLVIGKFPSDDFFQ 360
              + GT  ++APE    V L  +C    D++S   ++  ++ G  P   FF+
Sbjct: 229 GDYIPGTETHMAPE----VVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFR 277

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---EARISEFGLAKRIPDGHTRT 310
           R+ + I  G+ YLH ++   I+H D++P N+L+       + +I +FG++++I  GH   
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHA-C 188
Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
               + GT  Y+APE      ++   D+++ G++  +L+    P
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
           S G   L    +  IA+ +A+G+ YL  S R + +HRD+   N L+ ++M  +I++FGL+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 301 KRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           + I          + A  + ++ PE       +   D++++GV+L
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP 185
           +  F ++   +  L KI     GEV+KA     +G+ + +KK+         L++ + E 
Sbjct: 10  ECPFCDEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKV---------LMENEKEG 59
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLL------ARMVRRDCD---LLVYEFRRN---GSL 233
                I    EI     ++H N+V L+      A    R C     LV++F  +   G L
Sbjct: 60  FP---ITALREIKILQLLKHENVVNLIEICRTKASPYNR-CKGSIYLVFDFCEHDLAGLL 115
Query: 234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
            ++L   +    +       R+ Q + +GL Y+H   R +I+HRD++ ANVLI  D   +
Sbjct: 116 SNVLVKFTLSEIK-------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK 165
Query: 294 ISEFGLAK 301
           +++FGLA+
Sbjct: 166 LADFGLAR 173

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP 185
           +  F ++   +  L KI     GEV+KA     +G+ + +KK+         L++ + E 
Sbjct: 10  ECPFCDEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKV---------LMENEKEG 59
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLL------ARMVRRDCD---LLVYEFRRN---GSL 233
                I    EI     ++H N+V L+      A    R C     LV++F  +   G L
Sbjct: 60  FP---ITALREIKILQLLKHENVVNLIEICRTKASPYNR-CKASIYLVFDFCEHDLAGLL 115
Query: 234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
            ++L   +    +       R+ Q + +GL Y+H   R +I+HRD++ ANVLI  D   +
Sbjct: 116 SNVLVKFTLSEIK-------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK 165
Query: 294 ISEFGLAK 301
           +++FGLA+
Sbjct: 166 LADFGLAR 173

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 21/184 (11%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKRIPDGHTRT- 310
           +A  + S +EY+H  +    IHRD++P N L+    +     I +FGLAK+  D  T   
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS 366
                  +L GT  Y +   H  +  S   D+ S G +L    +G  P       TK   
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
             +     M++         ++L  GY  +    L        DD   +P+   +R +  
Sbjct: 227 YERISEKKMSTP-------IEVLCKGYPSEFATYLNFCRSLRFDD---KPDYSYLRQLFR 276
Query: 427 QIQH 430
            + H
Sbjct: 277 NLFH 280

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 18/104 (17%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PD----GHTRTT 311
           +A G+E+L  S R + IHRD+   N+L+ ++   +I +FGLA+ I   PD    G TR  
Sbjct: 208 VARGMEFL--SSR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
                  + ++APE       S   D++S+GVLL  +  +G  P
Sbjct: 264 ------PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP 301

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP 185
           +  F ++   +  L KI     GEV+KA     +G+ + +KK+         L++ + E 
Sbjct: 10  ECPFCDEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKV---------LMENEKEG 59
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLL------ARMVRRDCD---LLVYEFRRN---GSL 233
                I    EI     ++H N+V L+      A    R C     LV++F  +   G L
Sbjct: 60  FP---ITALREIKILQLLKHENVVNLIEICRTKASPYNR-CKGSIYLVFDFCEHDLAGLL 115
Query: 234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
            ++L   +    +       R+ Q + +GL Y+H   R +I+HRD++ ANVLI  D   +
Sbjct: 116 SNVLVKFTLSEIK-------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK 165
Query: 294 ISEFGLAK 301
           +++FGLA+
Sbjct: 166 LADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 36/188 (19%)
Query: 126 DLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEP 185
           +  F ++   +  L KI     GEV+KA     +G+ + +KK+         L++ + E 
Sbjct: 9   ECPFCDEVSKYEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKV---------LMENEKEG 58
Query: 186 LHHKMIQIRSEIITAGQVRHRNIVPLL------ARMVRRDCD---LLVYEFRRN---GSL 233
                I    EI     ++H N+V L+      A    R C     LV++F  +   G L
Sbjct: 59  FP---ITALREIKILQLLKHENVVNLIEICRTKASPYNR-CKGSIYLVFDFCEHDLAGLL 114
Query: 234 QDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR 293
            ++L   +    +       R+ Q + +GL Y+H   R +I+HRD++ ANVLI  D   +
Sbjct: 115 SNVLVKFTLSEIK-------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLK 164
Query: 294 ISEFGLAK 301
           +++FGLA+
Sbjct: 165 LADFGLAR 172

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 21/184 (11%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKRIPDGHTRT- 310
           +A  + S +EY+H  +    IHRD++P N L+    +     I +FGLAK+  D  T   
Sbjct: 108 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS 366
                  +L GT  Y +   H  +  S   D+ S G +L    +G  P       TK   
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
             +     M++         ++L  GY  +    L        DD   +P+   +R +  
Sbjct: 225 YERISEKKMSTP-------IEVLCKGYPSEFATYLNFCRSLRFDD---KPDYSYLRQLFR 274
Query: 427 QIQH 430
            + H
Sbjct: 275 NLFH 278

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 6/136 (4%)
Query: 222 LLVYEFRRNGSLQDILYDVSQGRRELDWLARH--RIAQGIASGLEYLHMSHRPRIIHRDI 279
           +++  F ++G L   L     G    +   +   R    IA G+EYL  S R   IHRD+
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSR-NFIHRDL 163
Query: 280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIY 339
              N ++ +DM   +++FGL+++I  G       +    V ++A E       +   D++
Sbjct: 164 AARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVW 223
Query: 340 SFGVLL-AVLVIGKFP 354
           +FGV +  ++  G+ P
Sbjct: 224 AFGVTMWEIMTRGQTP 239

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 9/161 (5%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWL 250
           I+  +E     +    ++V LL  + +    L++ E    G L+  L  +         L
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 251 ARH------RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
           A        ++A  IA G+ YL+ +   + +HRD+   N  + +D   +I +FG+ + I 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           +             V +++PE  +    +   D++SFGV+L
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 14/170 (8%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY---DVSQGRREL 247
           ++   E +    + H ++V LL   +     L V +   +G L + ++   D    +  L
Sbjct: 62  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
           +W  +      IA G+ YL      R++HRD+   NVL+      +I++FGLA+ +    
Sbjct: 121 NWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 171
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
                      + ++A EC      +   D++S+GV +  ++  G  P D
Sbjct: 172 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 21/184 (11%)
Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKRIPDGHTRT- 310
           +A  + S +EY+H  +    IHRD++P N L+    +     I +FGLAK+  D  T   
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS 366
                  +L GT  Y +   H  +  S   D+ S G +L    +G  P       TK   
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
             +     M++         ++L  GY  +    L        DD   +P+   +R +  
Sbjct: 227 YERISEKKMSTP-------IEVLCKGYPSEFSTYLNFCRSLRFDD---KPDYSYLRQLFR 276
Query: 427 QIQH 430
            + H
Sbjct: 277 NLFH 280

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G V+KA+    +  ++ +K++          +  D E +    ++   
Sbjct: 4   YEKLEKIGEGTYGTVFKAK-NRETHEIVALKRV---------RLDDDDEGVPSSALR--- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDI--LYDVSQGRRELDWLAR 252
           EI    +++H+NIV  L  ++  D  L LV+EF      QD+   +D   G  +LD    
Sbjct: 51  EICLLKELKHKNIV-RLHDVLHSDKKLTLVFEF----CDQDLKKYFDSCNG--DLDPEIV 103
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
                 +  GL + H  +   ++HRD++P N+LI+ + E ++++FGLA+    G      
Sbjct: 104 KSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCY 158
Query: 313 WSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGK---FPSDD 357
            +   T+ Y  P+      L S + D++S G + A L       FP +D
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGND 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 14/170 (8%)
Query: 191 IQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY---DVSQGRREL 247
           ++   E +    + H ++V LL   +     L V +   +G L + ++   D    +  L
Sbjct: 85  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLL 143
Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
           +W  +      IA G+ YL      R++HRD+   NVL+      +I++FGLA+ +    
Sbjct: 144 NWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 194
Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSD 356
                      + ++A EC      +   D++S+GV +  ++  G  P D
Sbjct: 195 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 39/209 (18%)
Query: 158 SSGRVITIKKIIQ-PLKSGAEL-IKKDSEPLHH-KMIQIRSEIITAGQVRHRNI-----V 209
           S+G  + IKK+IQ P     EL I +D   LHH  ++Q++S   T G+   R+I     +
Sbjct: 46  STGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105
Query: 210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS 269
             +   + R C      +RR  +   IL  V              + Q I S +  LH+ 
Sbjct: 106 EYVPDTLHRCCRNY---YRRQVAPPPILIKVF-------------LFQLIRS-IGCLHLP 148
Query: 270 HRPRIIHRDIQPANVLIDD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC-- 326
               + HRDI+P NVL+++ D   ++ +FG AK++          +   +  Y APE   
Sbjct: 149 SV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIF 204
Query: 327 ---HQTVALSDTCDIYSFGVLLAVLVIGK 352
              H T A+    DI+S G + A +++G+
Sbjct: 205 GNQHYTTAV----DIWSVGCIFAEMMLGE 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 41  GQVIEADAFGIDKTATXRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 92
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDILYDVSQGRREL--------DWLA-RHRIAQ 257
           +V LL    +    L+V  EF + G+L   L      R E         D+L   H I  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 258 G--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTT 312
              +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R   
Sbjct: 150 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 205
Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
             L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 206 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 25/166 (15%)
Query: 205 HRNIVPLLARMVRRDCDLLV-YEFRRNGSLQDILYDVSQGRREL--------DWLA-RHR 254
           H N+V LL    +    L+V  EF + G+L   L      R E         D+L   H 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKDLYKDFLTLEHL 146
Query: 255 IAQG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTR 309
           I     +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R
Sbjct: 147 IXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD-YVR 202
Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
                L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 203 KGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           E+     ++H NIV L   +       LV+E+  +  L+  L D        + +  H +
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG------NIINMHNV 102
Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL--AKRIPDGHTRTTTW 313
              +   L  L   HR +++HRD++P N+LI++  E ++++FGL  AK IP   T+T   
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDN 159
Query: 314 SLAGTVGYIAPE-CHQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
            +  T+ Y  P+    +   S   D++  G +   +  G+  FP
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 32/229 (13%)
Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           +  LEKI     G V+KA+    +  ++ +K++          +  D E +    ++   
Sbjct: 4   YEKLEKIGEGTYGTVFKAK-NRETHEIVALKRV---------RLDDDDEGVPSSALR--- 50
Query: 196 EIITAGQVRHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDI--LYDVSQGRRELDWLAR 252
           EI    +++H+NIV  L  ++  D  L LV+EF      QD+   +D   G  +LD    
Sbjct: 51  EICLLKELKHKNIV-RLHDVLHSDKKLTLVFEF----CDQDLKKYFDSCNG--DLDPEIV 103
Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
                 +  GL + H  +   ++HRD++P N+LI+ + E +++ FGLA+    G      
Sbjct: 104 KSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCY 158
Query: 313 WSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLV-IGK--FPSDD 357
            +   T+ Y  P+      L S + D++S G + A L   G+  FP +D
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 31/224 (13%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 43  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 94
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLA-RHRIA 256
           +V LL    +    L+V  EF + G+L   L         Y  +      D+L   H I 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 257 QG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTT 311
               +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R  
Sbjct: 155 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 210
Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              L   + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 211 DARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 24/220 (10%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V +A+  G           ++ LK GA      +   H  ++     +I  G   H N
Sbjct: 42  GQVIEADAFGIDKTATCRTVAVKMLKEGA------THSEHRALMSELKILIHIGH--HLN 93
Query: 208 IVPLLARMVRRDCDLLV-YEFRRNGSLQDIL---------YDVSQGRRELDWLARHRIAQ 257
           +V LL    +    L+V  EF + G+L   L         Y   +   +      H I  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 258 G--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I            
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 205 HRNIVPLLARMVRRDCDLLV-YEFRRNGSLQDILYD-----VSQGRREL--DWLA-RHRI 255
           H N+V LL    +    L+V  EF + G+L   L       V     +L  D+L   H I
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 256 AQG--IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW 313
                +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I          
Sbjct: 152 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
                + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL++LH +    I+HRD++P N+L+      ++++FGLA+       +   + +  T+ Y
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWY 177
Query: 322 IAPECHQTVALSDTCDIYSFGVLLA 346
            APE       +   D++S G + A
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFA 202

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 13/101 (12%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL--- 315
           IA  +E+LH      ++HRD++P+N+    D   ++ +FGL   +       T  +    
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 316 -------AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLV 349
                   GT  Y++PE     + S   DI+S G++L  L+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+K+ +   +G V+ +KKI    ++  +  +   E      I I +E+  +G   H N
Sbjct: 23  GIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE------IMILTEL--SG---HEN 70
Query: 208 IVPLLARMVRRDCD---LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           IV LL  ++R D D    LV+++     ++  L+ V +    L+ + +  +   +   ++
Sbjct: 71  IVNLL-NVLRADNDRDVYLVFDY-----METDLHAVIRANI-LEPVHKQYVVYQLIKVIK 123
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA-------- 316
           YLH      ++HRD++P+N+L++ +   ++++FGL++   +    T    L+        
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 317 -----------GTVGYIAPEC-HQTVALSDTCDIYSFGVLLAVLVIGK--FP 354
                       T  Y APE    +   +   D++S G +L  ++ GK  FP
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL--- 315
           IA  +E+LH      ++HRD++P+N+    D   ++ +FGL   +       T  +    
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 316 -------AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV 368
                   GT  Y++PE       S   DI+S G++L  L+         +  + +M  V
Sbjct: 230 YATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---------YSFSTQMERV 280
Query: 369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           + + +V   + P       L    Y ++ ++V  +        P +RP + D+
Sbjct: 281 RIITDVRNLKFP------LLFTQKYPQEHMMVQDMLS----PSPTERPEATDI 323

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 157
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 158 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 214
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 215 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 269
Query: 381 NRAIN 385
           N  +N
Sbjct: 270 NAYLN 274

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R     L
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 262
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 263 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 38/262 (14%)
Query: 179 IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY 238
           I++D+E    ++   + E++   Q RH N+V  +   +      ++    +  +L  ++ 
Sbjct: 65  IERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 239 DVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG 298
           D    +  LD     +IAQ I  G+ YLH      I+H+D++  NV  D+  +  I++FG
Sbjct: 122 D---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFG 174
Query: 299 L---AKRIPDGHTRTTTWSLAGTVGYIAPEC---------HQTVALSDTCDIYSFGVLLA 346
           L   +  +  G          G + ++APE             +  S   D+++ G +  
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 347 VLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACF 406
            L   ++P       T+    + W   + T   PN +     +G G E     +  I  F
Sbjct: 235 ELHAREWPFK-----TQPAEAIIW--QMGTGMKPNLS----QIGMGKE-----ISDILLF 278
Query: 407 CTLDDPNKRPNSKDVRCMLSQI 428
           C   +  +RP    +  ML ++
Sbjct: 279 CWAFEQEERPTFTKLMDMLEKL 300

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 137
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 194
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 195 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 249
Query: 381 NRAIN 385
           N  +N
Sbjct: 250 NVYLN 254

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R     L
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 264
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 265 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 138
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 139 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 195
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 196 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 250
Query: 381 NRAIN 385
           N  +N
Sbjct: 251 NVYLN 255

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 136
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 193
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 194 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 248
Query: 381 NRAIN 385
           N  +N
Sbjct: 249 NVYLN 253

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R     L
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 255
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 256 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI---PDGHTRTTTWSL 315
           +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I   PD + R     L
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARL 257
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFP 354
              + ++APE       +   D++SFGVLL  +  +G  P
Sbjct: 258 P--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 205 HRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           H N++P+L            L+  +   GSL ++L++ +     +D     + A  +A G
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARG 123
Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS--EFGLAKRIPDGHTRTTTWSLAGTVG 320
           + +LH +  P I    +   +V+ID+DM ARIS  +   + + P G      W       
Sbjct: 124 MAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-GRMYAPAW------- 174
Query: 321 YIAPECHQTVALSDT----CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
            +APE  Q     DT     D++SF VLL  LV  + P    F     M +   M+  + 
Sbjct: 175 -VAPEALQKKP-EDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIG--MKVALE 226
Query: 377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
              P        +  G    +  ++KI   C  +DP KRP    +  +L ++Q
Sbjct: 227 GLRPT-------IPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 207 NIVPLL--ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NIV LL   R        L++E+  N   + +LY           L  + I   I   L+
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---------LTDYDIRYYIYELLK 137
Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            L   H   I+HRD++P NV+ID ++ + R+ ++GLA+    G           +  +  
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 194
Query: 324 PECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
           PE    V L D   + D++S G + A ++  K P   F+ H     LV+ +  V+ ++  
Sbjct: 195 PEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVK-IAKVLGTDGL 249
Query: 381 NRAIN 385
           N  +N
Sbjct: 250 NVYLN 254

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI----- 259
           H NIV LL         L++ E+   G L + L      RR+ D     + +  I     
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 162
Query: 260 ---------------ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
                          A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I 
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTK 363
           +        +    V ++APE       +   D++S+G+ L  +  +G  P       +K
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 279
Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +++    +++ E+                +M  ++K    C   DP KRP  K +
Sbjct: 280 FYKMIKEGFRMLSPEHA-------------PAEMYDIMKT---CWDADPLKRPTFKQI 321

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 45/286 (15%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+       G  I +   ++  K    L  K+         +  SE +    + H +
Sbjct: 22  GEVYEGVYTNHKGEKINVA--VKTCKKDCTLDNKE---------KFMSEAVIMKNLDHPH 70
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+  ++  +   ++ E    G L   L    + +  L  L     +  I   + YL 
Sbjct: 71  IVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPEC 326
             +    +HRDI   N+L+      ++ +FGL++ I D  + + +   L   + +++PE 
Sbjct: 127 SIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPES 181
Query: 327 HQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN---VMTSENPNR 382
                 +   D++ F V +  +L  GK P   FF          W+ N   +   E  +R
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQP---FF----------WLENKDVIGVLEKGDR 228
Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                L        +L  L   C+    DP+ RP   ++ C LS +
Sbjct: 229 LPKPDLC-----PPVLYTLMTRCWDY--DPSDRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 45/286 (15%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+       G  I +   ++  K    L  K+         +  SE +    + H +
Sbjct: 26  GEVYEGVYTNHKGEKINVA--VKTCKKDCTLDNKE---------KFMSEAVIMKNLDHPH 74
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+  ++  +   ++ E    G L   L    + +  L  L     +  I   + YL 
Sbjct: 75  IVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPEC 326
             +    +HRDI   N+L+      ++ +FGL++ I D  + + +   L   + +++PE 
Sbjct: 131 SIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPES 185
Query: 327 HQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN---VMTSENPNR 382
                 +   D++ F V +  +L  GK P   FF          W+ N   +   E  +R
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP---FF----------WLENKDVIGVLEKGDR 232
Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                L        +L  L   C+    DP+ RP   ++ C LS +
Sbjct: 233 LPKPDLC-----PPVLYTLMTRCWDY--DPSDRPRFTELVCSLSDV 271

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           GL++LH +    I+HRD++P N+L+      ++++FGLA RI       T   +  T+ Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQMALT--PVVVTLWY 185
Query: 322 IAPECHQTVALSDTCDIYSFGVLLA 346
            APE       +   D++S G + A
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFA 210

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 16/90 (17%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA----- 316
           GL++LH +    I+HRD++P N+L+      ++++FGLA        R  ++ +A     
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA--------RIYSYQMALAPVV 172
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
            T+ Y APE       +   D++S G + A
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFA 202

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 16/90 (17%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA----- 316
           GL++LH +    I+HRD++P N+L+      ++++FGLA        R  ++ +A     
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA--------RIYSYQMALDPVV 172
Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLA 346
            T+ Y APE       +   D++S G + A
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFA 202

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 45/286 (15%)
Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+       G  I +   ++  K    L  K+         +  SE +    + H +
Sbjct: 38  GEVYEGVYTNHKGEKINVA--VKTCKKDCTLDNKE---------KFMSEAVIMKNLDHPH 86
Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+  ++  +   ++ E    G L   L    + +  L  L     +  I   + YL 
Sbjct: 87  IVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYIAPEC 326
             +    +HRDI   N+L+      ++ +FGL++ I D  + + +   L   + +++PE 
Sbjct: 143 SIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPES 197
Query: 327 HQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRN---VMTSENPNR 382
                 +   D++ F V +  +L  GK P   FF          W+ N   +   E  +R
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQP---FF----------WLENKDVIGVLEKGDR 244
Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                L        +L  L   C+    DP+ RP   ++ C LS +
Sbjct: 245 LPKPDLC-----PPVLYTLMTRCWDY--DPSDRPRFTELVCSLSDV 283

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 45/104 (43%), Gaps = 24/104 (23%)
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--------------------PDGHTR 309
           H   IIHRD++PAN L++ D   +I +FGLA+ I                    P  H +
Sbjct: 148 HESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNK 207
Query: 310 TTTWSLAGTV---GYIAPE-CHQTVALSDTCDIYSFGVLLAVLV 349
                L   V    Y APE        +++ DI+S G + A L+
Sbjct: 208 NLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI----- 259
           H NIV LL         L++ E+   G L + L      RR+ D     + +  I     
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 157
Query: 260 ---------------ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
                          A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I 
Sbjct: 158 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 214
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTK 363
           +        +    V ++APE       +   D++S+G+ L  +  +G  P       +K
Sbjct: 215 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 274
Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +++    +++ E+                +M  ++K    C   DP KRP  K +
Sbjct: 275 FYKMIKEGFRMLSPEHA-------------PAEMYDIMKT---CWDADPLKRPTFKQI 316

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI----- 259
           H NIV LL         L++ E+   G L + L      RR+ D     + +  I     
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 155
Query: 260 ---------------ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
                          A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I 
Sbjct: 156 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 212
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTK 363
           +        +    V ++APE       +   D++S+G+ L  +  +G  P       +K
Sbjct: 213 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 272
Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +++    +++ E+                +M  ++K    C   DP KRP  K +
Sbjct: 273 FYKMIKEGFRMLSPEHA-------------PAEMYDIMKT---CWDADPLKRPTFKQI 314

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI----- 259
           H NIV LL         L++ E+   G L + L      RR+ D     + +  I     
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 139
Query: 260 ---------------ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
                          A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTK 363
           +        +    V ++APE       +   D++S+G+ L  +  +G  P       +K
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +++    +++ E+                +M  ++K    C   DP KRP  K +
Sbjct: 257 FYKMIKEGFRMLSPEHA-------------PAEMYDIMKT---CWDADPLKRPTFKQI 298

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 46/238 (19%)
Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI----- 259
           H NIV LL         L++ E+   G L + L      RR+ D     + +  I     
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 162
Query: 260 ---------------ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
                          A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I 
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTK 363
           +        +    V ++APE       +   D++S+G+ L  +  +G  P       +K
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 279
Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +++    +++ E+                +M  ++K    C   DP KRP  K +
Sbjct: 280 FYKMIKEGFRMLSPEHA-------------PAEMYDIMKT---CWDADPLKRPTFKQI 321

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 29/114 (25%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PDG------------- 306
           G++Y+H +    I+HRD++PAN L++ D   ++ +FGLA+ +  P+              
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 307 -------HTRTTTWSLAGTV---GYIAPE-CHQTVALSDTCDIYSFGVLLAVLV 349
                  HT+     L G V    Y APE        ++  D++S G + A L+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 21/101 (20%)
Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-----------------PDGHTRTTT 312
           H   IIHRD++PAN L++ D   ++ +FGLA+ I                 P  H +   
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 313 WSLAGTV---GYIAPE-CHQTVALSDTCDIYSFGVLLAVLV 349
             L   V    Y APE        + + DI+S G + A L+
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 63/129 (48%), Gaps = 13/129 (10%)
Query: 263 LEYLHMSHRPRIIHRDIQPANVLID--DDMEARISEFGLAKR-IPDGHTR----TTTWSL 315
           LEY+H +     +H DI+ AN+L+   +  +  ++++GL+ R  P+G+ +          
Sbjct: 164 LEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM 375
            GT+ + + + H+ VALS   D+   G  +   + GK P +   Q+ K+   VQ  +  +
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE---QNLKDPVAVQTAKTNL 277
Query: 376 TSENPNRAI 384
             E P   +
Sbjct: 278 LDELPQSVL 286

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 262 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
           GL+Y+H ++   ++HRD++PAN+ I+ +D+  +I +FGLA RI D H         G V 
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA-RIMDPHYSHKGHLSEGLVT 187
Query: 321 --YIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGK 352
             Y +P    +    +   D+++ G + A ++ GK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 12/86 (13%)
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR----IPDGHTRTTTWSLAGTVGY 321
           LH+ H   ++HRD+ P N+L+ D+ +  I +F LA+         H  T  W       Y
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-------Y 199
Query: 322 IAPE-CHQTVALSDTCDIYSFGVLLA 346
            APE   Q    +   D++S G ++A
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMA 225

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 12/86 (13%)
Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR----IPDGHTRTTTWSLAGTVGY 321
           LH+ H   ++HRD+ P N+L+ D+ +  I +F LA+         H  T  W       Y
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-------Y 199
Query: 322 IAPE-CHQTVALSDTCDIYSFGVLLA 346
            APE   Q    +   D++S G ++A
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMA 225

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            ++ LL    R D  +L+ E  R   +QD+   +++     + LAR    Q     LE +
Sbjct: 75  GVIRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQV----LEAV 128
Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
              H   ++HRDI+  N+LID +  E ++ +FG    + D    T      GT  Y  PE
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPE 184
Query: 326 C---HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ-WMRNVMTSE 378
               H+    S    ++S G+LL  +V G  P    F+H +E+   Q + R  ++SE
Sbjct: 185 WIRYHRYHGRSAA--VWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSSE 235

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            ++ LL    R D  +L+ E  R   +QD+   +++     + LAR    Q     LE +
Sbjct: 90  GVIRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQV----LEAV 143
Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
              H   ++HRDI+  N+LID +  E ++ +FG    + D    T      GT  Y  PE
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPE 199
Query: 326 C---HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ-WMRNVMTSE 378
               H+    S    ++S G+LL  +V G  P    F+H +E+   Q + R  ++SE
Sbjct: 200 WIRYHRYHGRSAA--VWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSSE 250

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	430
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-64
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-62
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-05
4fev_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  243 bits (622), Expect = 1e-77
 Identities = 89/279 (31%), Positives = 148/279 (53%), Gaps = 17/279 (6%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L    G ++ +K++ +    G EL             Q ++E+       HRN
Sbjct: 44  GKVYKGRLA--DGTLVAVKRLKEERTQGGEL-------------QFQTEVEMISMAVHRN 88

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ L    +     LLVY +  NGS+   L +  + +  LDW  R RIA G A GL YLH
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
               P+IIHRD++ AN+L+D++ EA + +FGLAK +    T  TT ++ GT+G+IAPE  
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYL 207

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSD-DFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            T   S+  D++ +GV+L  L+ G+   D     +  ++ L+ W++ ++  +     ++ 
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
            L GN  +E++  ++++A  CT   P +RP   +V  ML
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  208 bits (532), Expect = 2e-64
 Identities = 87/283 (30%), Positives = 132/283 (46%), Gaps = 23/283 (8%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  +       + +KK    L +  +     +E L     Q   EI    + +H N
Sbjct: 45  GVVYKGYVNN---TTVAVKK----LAAMVD---ITTEELKQ---QFDQEIKVMAKCQHEN 91

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL      D   LVY +  NGSL D L     G   L W  R +IAQG A+G+ +LH
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLH 150

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAGTVGYIAPEC 326
            +H    IHRDI+ AN+L+D+   A+IS+FGLA+       T  T+  + GT  Y+APE 
Sbjct: 151 ENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS-RIVGTTAYMAPEA 206

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
                ++   DIYSFGV+L  ++ G    D   +H +   L+     +   E        
Sbjct: 207 -LRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDEEKTIEDYID 262

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
           K + +     +  +  +A  C  +  NKRP+ K V+ +L ++ 
Sbjct: 263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  203 bits (518), Expect = 3e-62
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 22/284 (7%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L    G  + +K+       G E              +  +EI T    RH +
Sbjct: 53  GKVYKGVLRD--GAKVALKRRTPESSQGIE--------------EFETEIETLSFCRHPH 96

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L+     R+  +L+Y++  NG+L+  LY        + W  R  I  G A GL YL 
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL- 155

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTTWSLAGTVGYIAPEC 326
             H   IIHRD++  N+L+D++   +I++FG++K+  +   T  +T  + GT+GYI PE 
Sbjct: 156 --HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEY 212

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
                L++  D+YSFGV+L  ++  +          + ++L +W      +    + ++ 
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESHNNGQLEQIVDP 271

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
            L      E +      A  C       RP+  DV   L     
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  165 bits (420), Expect = 7e-48
 Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 50/319 (15%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
              LE       G V+KA+L       + +K                      +  Q   
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLN---EYVAVKIF---------------PIQDKQSWQNEY 67

Query: 196 EIITAGQVRHRNIVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           E+ +   ++H NI+  +    R         L+  F   GSL D L         + W  
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNE 122

Query: 252 RHRIAQGIASGLEYLHM-------SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIP 304
              IA+ +A GL YLH         H+P I HRDI+  NVL+ +++ A I++FGLA +  
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 305 DGHTRTTTWSLAGTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD-- 357
            G +   T    GT  Y+APE      +         D+Y+ G++L  L      +D   
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 358 ------FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDD 411
                 F +   +   ++ M+ V+  +     +      +     M ++ +    C   D
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCETIEECWDHD 299

Query: 412 PNKRPNSKDVRCMLSQIQH 430
              R ++  V   ++Q+Q 
Sbjct: 300 AEARLSAGCVGERITQMQR 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  135 bits (342), Expect = 1e-36
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 26/227 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++AE     G  + +K +             + +    ++ +   E+    ++RH N
Sbjct: 51  GTVHRAEW---HGSDVAVKIL------------MEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV  +  + +     +V E+   GSL  +L+  S  R +LD   R  +A  +A G+ YLH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            +  P I+HR+++  N+L+D     ++ +FGL++        +   S AGT  ++APE  
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVL 211

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV 374
           +    ++  D+YSFGV+L  L   + P  +       ++  Q +  V
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGN-------LNPAQVVAAV 251

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  135 bits (342), Expect = 1e-36
 Identities = 67/317 (21%), Positives = 109/317 (34%), Gaps = 59/317 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK  L     R + +K       +    I +               I     + H N
Sbjct: 27  GAVYKGSL---DERPVAVKVF--SFANRQNFINE-------------KNIYRVPLMEHDN 68

Query: 208 IVPLLARMVRRDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           I   +    R   D     LLV E+  NGSL   L          DW++  R+A  +  G
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRG 123

Query: 263 LEYLHMS------HRPRIIHRDIQPANVLIDDDMEARISEFGLAKR------IPDGHTRT 310
           L YLH        ++P I HRD+   NVL+ +D    IS+FGL+ R      +  G    
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 311 TTWSLAGTVGYIAPE-------CHQTVALSDTCDIYSFGVLL---AVLVIGKFPSDD--- 357
              S  GT+ Y+APE            +     D+Y+ G++     +     FP +    
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243

Query: 358 ----FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPN 413
               F          + M+ +++ E            N     +  + +    C   D  
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVRSLKETIEDCWDQDAE 301

Query: 414 KRPNSKDVRCMLSQIQH 430
            R  ++     ++++  
Sbjct: 302 ARLTAQXAEERMAELMM 318

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (339), Expect = 2e-36
 Identities = 66/326 (20%), Positives = 132/326 (40%), Gaps = 55/326 (16%)

Query: 113 RRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPL 172
             P    P + + ++ + ++         I     G V+K  L      V+ IK +I   
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ---------IGKGGFGLVHKGRLV-KDKSVVAIKSLILGD 56

Query: 173 KSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGS 232
             G   + +  +       + + E+     + H NIV L   M       +V EF   G 
Sbjct: 57  SEGETEMIEKFQ-------EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGD 107

Query: 233 LQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID----- 287
           L   L D       + W  + R+   IA G+EY+  +  P I+HRD++  N+ +      
Sbjct: 108 LYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDEN 163

Query: 288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE--CHQTVALSDTCDIYSFGVLL 345
             + A++++FGL++      +  +   L G   ++APE    +  + ++  D YSF ++L
Sbjct: 164 APVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218

Query: 346 AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKL---LGNGYEEQMLLVLK 402
             ++ G+ P D++         ++++  +             L   +      ++  V++
Sbjct: 219 YTILTGEGPFDEY-----SYGKIKFINMI---------REEGLRPTIPEDCPPRLRNVIE 264

Query: 403 IACFCTLDDPNKRPNSKDVRCMLSQI 428
           +   C   DP KRP+   +   LS++
Sbjct: 265 L---CWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  133 bits (337), Expect = 5e-36
 Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 43/283 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V KA+      + + IK+I           K               E+    +V H N
Sbjct: 22  GVVCKAKW---RAKDVAIKQIESE-----SERK-----------AFIVELRQLSRVNHPN 62

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L    +   C  LV E+   GSL ++L+  ++                 + G+ YLH
Sbjct: 63  IVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 268 MSHRPRIIHRDIQPANVLIDDDME-ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                 +IHRD++P N+L+       +I +FG A  I    T        G+  ++APE 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEV 174

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            +    S+ CD++S+G++L  ++  + P D+           + M  V     P      
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEI-----GGPAFRIMWAVHNGTRPP----- 224

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
             L     + +  ++     C   DP++RP+ +++  +++ + 
Sbjct: 225 --LIKNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLM 262

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (320), Expect = 6e-34
 Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 52/292 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VY+A      G  + +K              ++          +R E      ++H N
Sbjct: 21  GKVYRAFW---IGDEVAVKAARHDPDEDISQTIEN----------VRQEAKLFAMLKHPN 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ L    ++     LV EF R G L  +L       + +        A  IA G+ YLH
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLH 122

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEAR--------ISEFGLAKRIPDGHTRTTTWSLAGTV 319
                 IIHRD++ +N+LI   +E          I++FGLA+       RTT  S AG  
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAAGAY 178

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            ++APE  +    S   D++S+GVLL  L+ G+ P          +  +     V     
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-------IDGLAVAYGV----- 226

Query: 380 PNRAINSKL---LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                 +KL   + +   E    +++    C   DP+ RP+  ++   L+ I
Sbjct: 227 ----AMNKLALPIPSTCPEPFAKLMED---CWNPDPHSRPSFTNILDQLTTI 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  127 bits (321), Expect = 9e-34
 Identities = 58/296 (19%), Positives = 112/296 (37%), Gaps = 52/296 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+  K     + G V+ +K++I+      E  +               E+     + H N
Sbjct: 24  GQAIKVTHRET-GEVMVMKELIRF---DEETQR-----------TFLKEVKVMRCLEHPN 68

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++  +  + +      + E+ + G+L+ I+        +  W  R   A+ IASG+ YLH
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG------------HTRTTTWSL 315
             +   IIHRD+   N L+ ++    +++FGLA+ + D               R   +++
Sbjct: 126 SMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW--MRN 373
            G   ++APE     +  +  D++SFG++L  ++       D+   T +  L     +  
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242

Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
                 P                      I   C   DP KRP+   +   L  ++
Sbjct: 243 YCPPNCPPS-----------------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  126 bits (319), Expect = 9e-34
 Identities = 61/290 (21%), Positives = 106/290 (36%), Gaps = 52/290 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GE++K       G  I +K +            K  +    K      E        H N
Sbjct: 24  GELWKGRW---QGNDIVVKVL------------KVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 208 IVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           ++P+L             +  +   GSL ++L++       +D     + A  +A G+ +
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAF 126

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH +  P I    +   +V+ID+DM ARIS   +        +  +         ++APE
Sbjct: 127 LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSP-GRMYAPAWVAPE 178

Query: 326 C---HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
                       + D++SF VLL  LV  + P  D       +S ++    V        
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-------LSNMEIGMKV-------- 223

Query: 383 AINSKL---LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
                L   +  G    +  ++KI   C  +DP KRP    +  +L ++Q
Sbjct: 224 -ALEGLRPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQ 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  125 bits (315), Expect = 1e-32
 Identities = 58/307 (18%), Positives = 110/307 (35%), Gaps = 50/307 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+  +     G  + +K                            +EI     +RH N
Sbjct: 51  GEVWMGKW---RGEKVAVKVFFTT---------------EEASWFRETEIYQTVLMRHEN 92

Query: 208 IVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           I+  +A  ++         L+ ++  NGSL D L         LD  +  ++A    SGL
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGL 147

Query: 264 EYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS--LA 316
            +LH        +P I HRD++  N+L+  +    I++ GLA +                
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 317 GTVGYIAPEC-HQTVALSDT-----CDIYSFGVLLAVLVIGKFPSDD-------FFQHTK 363
           GT  Y+ PE   +++  +        D+YSFG++L  +                +     
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC 423
                + MR ++  +    +  ++   +    QM  ++     C   +P  R  +  V+ 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKK 324

Query: 424 MLSQIQH 430
            L+++  
Sbjct: 325 TLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  124 bits (313), Expect = 2e-32
 Identities = 61/307 (19%), Positives = 112/307 (36%), Gaps = 50/307 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV++ +     G  + +K                      +     +EI     +RH N
Sbjct: 56  GEVWRGKW---RGEEVAVKIFSSR---------------EERSWFREAEIYQTVMLRHEN 97

Query: 208 IVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           I+  +A   + +       LV ++  +GSL D L      R  +      ++A   ASGL
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGL 152

Query: 264 EYLHM-----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS--LA 316
            +LHM       +P I HRD++  N+L+  +    I++ GLA R                
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 317 GTVGYIAPEC-HQTVALSDT-----CDIYSFGVLLAVLVIGKFPSDD-------FFQHTK 363
           GT  Y+APE    ++ +         DIY+ G++   +                ++    
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC 423
               V+ MR V+  +     I ++         M  +++  C+    +   R  +  ++ 
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYA--NGAARLTALRIKK 329

Query: 424 MLSQIQH 430
            LSQ+  
Sbjct: 330 TLSQLSQ 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (304), Expect = 2e-31
 Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 50/305 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV++       G  + +K                      K     +E+     +RH N
Sbjct: 22  GEVWRGSW---QGENVAVKIFSSR---------------DEKSWFRETELYNTVMLRHEN 63

Query: 208 IVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           I+  +A  +          L+  +   GSL D L         LD ++  RI   IASGL
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGL 118

Query: 264 EYLHM-----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW--SLA 316
            +LH+       +P I HRD++  N+L+  + +  I++ GLA        +         
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 317 GTVGYIAPE--CHQTVALSDT----CDIYSFGVLLAVLVIGKFPSDD-------FFQHTK 363
           GT  Y+APE                 DI++FG++L  +      +         F+    
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC 423
                + MR V+  +     I ++   +     +  ++K    C   +P+ R  +  ++ 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKK 295

Query: 424 MLSQI 428
            L++I
Sbjct: 296 TLTKI 300

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  120 bits (304), Expect = 4e-31
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            + ++      +  V   K           ++ K      H+  ++  EI     + H++
Sbjct: 55  AKCFEISDA-DTKEVFAGK-----------IVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           +V         D   +V E  R  SL ++     +    E    AR+ + Q I  G +YL
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTE--PEARYYLRQ-IVLGCQYL 157

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPE 325
           H  +R  +IHRD++  N+ +++D+E +I +FGLA ++  DG  +     L GT  YIAPE
Sbjct: 158 H-RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPE 211

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
                  S   D++S G ++  L++GK P +      KE 
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKET 249

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (300), Expect = 5e-31
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VY+AE    +G  + IK +I   K    + K           ++++E+    Q++H +
Sbjct: 25  AGVYRAESI-HTGLEVAIK-MID--KK--AMYKAGMVQ------RVQNEVKIHCQLKHPS 72

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ L       +   LV E   NG +   L   ++ +   +  ARH + Q I +G+ YLH
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQ-IITGMLYLH 129

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPEC 326
            SH   I+HRD+  +N+L+  +M  +I++FGLA ++        T   L GT  YI+PE 
Sbjct: 130 -SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEI 183

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
               A     D++S G +   L+IG+ P D 
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (299), Expect = 8e-31
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            + ++      +  V   K           ++ K      H+  ++  EI     + H++
Sbjct: 29  AKCFEISDA-DTKEVFAGK-----------IVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V         D   +V E  R  SL ++     +        AR+ + Q I  G +YLH
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEP-EARYYLRQ-IVLGCQYLH 132

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGHTRTTTWSLAGTVGYIAPEC 326
             +R  +IHRD++  N+ +++D+E +I +FGLA ++  DG  +     L GT  YIAPE 
Sbjct: 133 -RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEV 186

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
                 S   D++S G ++  L++GK P +      KE 
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKET 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (291), Expect = 9e-30
 Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 25/211 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI-QIRSEIITAGQVRHR 206
           G VY A     S  ++ +K           ++ K ++     +  Q+R E+     +RH 
Sbjct: 23  GNVYLAREK-QSKFILALK-----------VLFK-AQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NI+ L           L+ E+   G++   L      + + +      I + +A+ L Y 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTATYITE-LANALSYC 125

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      +IHRDI+P N+L+    E +I++FG +   P          L GT+ Y+ PE 
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPPEM 178

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            +     +  D++S GVL    ++GK P + 
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  115 bits (291), Expect = 1e-29
 Identities = 58/294 (19%), Positives = 111/294 (37%), Gaps = 56/294 (19%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK +     G V  +K +              + P   ++   ++E+    + RH N
Sbjct: 38  GTVYKGKW---HGDV-AVKML------------NVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+  +          +V ++    SL   L+       + +      IA+  A G++YLH
Sbjct: 82  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH 137

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE-- 325
                 IIHRD++  N+ + +D   +I +FGLA              L+G++ ++APE  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 326 -CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
               +   S   D+Y+FG++L  L+ G+ P    + +      +  M             
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEM------------- 237

Query: 385 NSKLLGNGYEEQMLLVLKIAC---------FCTLDDPNKRPNSKDVRCMLSQIQ 429
               +G G     L  ++  C          C     ++RP+   +   + ++ 
Sbjct: 238 ----VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (284), Expect = 9e-29
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI-QIRSEIITAGQVRHR 206
           G VY A     +  ++ +K           ++ K S+     +  Q+R EI     +RH 
Sbjct: 28  GNVYLAREK-QNKFIMALK-----------VLFK-SQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NI+ +      R    L+ EF   G L   L     GR + +  +   + + +A  L Y 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFMEE-LADALHYC 130

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H      +IHRDI+P N+L+    E +I++FG +   P    RT    + GT+ Y+ PE 
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPPEM 183

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            +     +  D++  GVL    ++G  P D 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  113 bits (284), Expect = 2e-28
 Identities = 44/219 (20%), Positives = 84/219 (38%), Gaps = 35/219 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VY        G V  I+ I                    ++   + E++   Q RH N
Sbjct: 47  GQVYHGRW---HGEV-AIRLI------------DIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V  +   +      ++    +  +L  ++ D    +  LD     +IAQ I  G+ YLH
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK---RIPDGHTRTTTWSLAGTVGYIAP 324
                 I+H+D++  NV   D+ +  I++FGL      +  G          G + ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 325 ECHQTVALSDT---------CDIYSFGVLLAVLVIGKFP 354
           E  + ++              D+++ G +   L   ++P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (285), Expect = 2e-28
 Identities = 38/217 (17%), Positives = 86/217 (39%), Gaps = 14/217 (6%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            ++   E       +   +K +   K        D   +  K    ++E+     +++  
Sbjct: 45  NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----YDVSQGRRELDWLARHRIAQGIASG 262
            +     +   D   ++YE+  N S+          D +        + +  I   + + 
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS-VLNS 163

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
             Y+H + +  I HRD++P+N+L+D +   ++S+FG ++ + D   + +     GT  ++
Sbjct: 164 FSYIH-NEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----RGTYEFM 217

Query: 323 APE--CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
            PE   +++       DI+S G+ L V+     P   
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (272), Expect = 2e-26
 Identities = 31/246 (12%), Positives = 71/246 (28%), Gaps = 32/246 (13%)

Query: 148 GEVYKAELPGSSGRVITIK----------KIIQPLKSGAELIKKDSEPLHHKMIQIRSEI 197
               +A     +G    +             I+ +K     ++      + K  ++    
Sbjct: 92  YAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150

Query: 198 ITAGQVRHRNIVPLLARMVRRDCDLLVYEF-----RRNGSLQDI---LYDVSQGRRELDW 249
           I    +        + R+   + D+ V        R   +LQ     L   S   + L  
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
            AR ++   +   L  LH      ++H  ++P ++++D      ++ F    R       
Sbjct: 211 HARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AV 266

Query: 310 TTTWSLAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           +            A        H    ++   D ++ G+ +  +     P          
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAA 322

Query: 365 MSLVQW 370
           +   +W
Sbjct: 323 LGGSEW 328

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  105 bits (264), Expect = 7e-26
 Identities = 64/300 (21%), Positives = 109/300 (36%), Gaps = 64/300 (21%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V KA       R   IKKI           +   E    K+  I SE++    + H+ 
Sbjct: 20  GQVVKAR-NALDSRYYAIKKI-----------RHTEE----KLSTILSEVMLLASLNHQY 63

Query: 208 IVPLLARMVRRDCDL-------------LVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
           +V   A  + R   +             +  E+  NG+L D++   S+   +        
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
             Q I   L Y+H      IIHRD++P N+ ID+    +I +FGLAK +          S
Sbjct: 122 FRQ-ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 315 LA------------GTVGYIAPE-CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
                         GT  Y+A E    T   ++  D+YS G++   ++            
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230

Query: 362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              M  V  ++ +    + +         N  + +  ++          DPNKRP ++ +
Sbjct: 231 --GMERVNILKKLR---SVSIEFPPDFDDNKMKVEKKIIRL--LIDH--DPNKRPGARTL 281

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (264), Expect = 9e-26
 Identities = 52/304 (17%), Positives = 103/304 (33%), Gaps = 61/304 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V   E     G    +K+I+   +   E  ++              E        H N
Sbjct: 43  SYVDLVE-GLHDGHFYALKRILCHEQQDREEAQR--------------EADMHRLFNHPN 87

Query: 208 IVPLLARMVRRDCD----LLVYEFRRNGSLQDILYDVSQGRRELD----WLARHRIAQGI 259
           I+ L+A  +R         L+  F + G+L + +  +      L           +  GI
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLLLGI 143

Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA--- 316
             GLE +H        HRD++P N+L+ D+ +  + + G   +       +         
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 317 ----GTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
                T+ Y APE         + +  D++S G +L  ++ G+ P    +          
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMVF------ 250

Query: 370 WMRNVMTSENPNRAINSKL---LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
                   ++   A+ ++L       +   +  +L  +      DP++RP+   +   L 
Sbjct: 251 -----QKGDSVALAVQNQLSIPQSPRHSSALWQLLN-SMMTV--DPHQRPHIPLLLSQLE 302

Query: 427 QIQH 430
            +Q 
Sbjct: 303 ALQP 306

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (262), Expect = 2e-25
 Identities = 54/292 (18%), Positives = 100/292 (34%), Gaps = 41/292 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V++      +G +  IK                S      +     E     ++ H+N
Sbjct: 23  ANVFRGRHK-KTGDLFAIKVF-----------NNIS--FLRPVDVQMREFEVLKKLNHKN 68

Query: 208 IVPLLARMVRRDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           IV L A           L+ EF   GSL  +L + S      +      +   +  G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-VVGGMNH 127

Query: 266 LHMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           L       I+HR+I+P N++     D     ++++FG A+ + D     +   L GT  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEY 181

Query: 322 IAPECHQTVALSD--------TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
           + P+ ++   L          T D++S GV       G  P   F          + M  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYK 238

Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
           ++T +        +   NG  +       +   C+L    +   +  +  +L
Sbjct: 239 IITGKPSGAISGVQKAENGPID---WSGDMPVSCSLSRGLQVLLTPVLANIL 287

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  104 bits (261), Expect = 2e-25
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)

Query: 148 GEVYKAE---LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
             VY AE   L       + IK I  P +   E +K+              E+  + Q+ 
Sbjct: 25  STVYLAEDTIL----NIKVAIKAIFIPPREKEETLKR-----------FEREVHNSSQLS 69

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H+NIV ++      DC  LV E+    +L + +    +    L           I  G++
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIK 125

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           +   +H  RI+HRDI+P N+LID +   +I +FG+A +     + T T  + GTV Y +P
Sbjct: 126 H---AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           E  +  A  +  DIYS G++L  +++G+ P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  105 bits (264), Expect = 2e-25
 Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 52/311 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V++      +G +  IK                S      +     E     ++ H+N
Sbjct: 23  ANVFRGRHK-KTGDLFAIKVF-----------NNIS--FLRPVDVQMREFEVLKKLNHKN 68

Query: 208 IVPLLARMVRRDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           IV L A           L+ EF   GSL  +L + S      +      +   +  G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-VVGGMNH 127

Query: 266 LHMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           L   +   I+HR+I+P N++     D     ++++FG A+ + D     +   L GT  Y
Sbjct: 128 LR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEY 181

Query: 322 IAPECHQTVALSD--------TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
           + P+ ++   L          T D++S GV       G  P   F          + M  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPRRNKEVMYK 238

Query: 374 VMTSENPNRAINSKLLGNG---YEEQMLLVLKIACFCTLD-----------DPNKRPNSK 419
           ++T +        +   NG   +   M +   ++    +            D  K     
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298

Query: 420 DVRCMLSQIQH 430
                 S I H
Sbjct: 299 QFFAETSDILH 309

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  102 bits (256), Expect = 2e-24
 Identities = 62/336 (18%), Positives = 119/336 (35%), Gaps = 50/336 (14%)

Query: 111 RDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQ 170
            +++       + ++      K+D F  + ++ +   G V+K      SG V+  K I  
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLI-- 66

Query: 171 PLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRN 230
            L+    +             QI  E+    +     IV             +  E    
Sbjct: 67  HLEIKPAIRN-----------QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
           GSL  +L     GR     L +  ++  +  GL YL   H+  I+HRD++P+N+L++   
Sbjct: 116 GSLDQVLKKA--GRIPEQILGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRG 169

Query: 291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI 350
           E ++ +FG++ ++ D    +      GT  Y++PE  Q    S   DI+S G+ L  + +
Sbjct: 170 EIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225

Query: 351 GKFP--SDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACF-- 406
           G++P    D  +               T   P                 + + ++  +  
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285

Query: 407 ----------------------CTLDDPNKRPNSKD 420
                                 C + +P +R + K 
Sbjct: 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  100 bits (252), Expect = 4e-24
 Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 38/232 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            +V++        ++  IK +         L + D++     +   R+EI    +++  +
Sbjct: 42  SKVFQVL--NEKKQIYAIKYV--------NLEEADNQ----TLDSYRNEIAYLNKLQQHS 87

Query: 208 --IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIAQGIASGLE 264
             I+ L    +      +V E   N  L   L    + ++ +D W  +      +   + 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKN-MLEAVH 141

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
            +H  H   I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+ P
Sbjct: 142 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 325 E-----------CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           E                 +S   D++S G +L  +  GK P         ++
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (254), Expect = 4e-24
 Identities = 35/304 (11%), Positives = 73/304 (24%), Gaps = 59/304 (19%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V+             +K      ++    ++           ++      A ++   +
Sbjct: 76  SVVFLVRDV-ERLEDFALKVFTMGAENSRSELE-----------RLHEATFAAARLLGES 123

Query: 208 IV--------------------PLLARMVRRDCD------LLVYEF--RRNGSLQDILYD 239
                                 P  A++     D      LL+          L   L  
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
           V   R +   LA H +   +      L       ++H    P N+ I  D    + +   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 300 AKRIPDGHTRTTTWSLAGTVGYIAPEC--HQTVALSDTCDIYSFGVLLAVLVIGKFPSDD 357
             +   G         +  V Y   E     T   +   + +  G+ +  +     P   
Sbjct: 241 LWK--VGTRGPA---SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--- 292

Query: 358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN 417
            F          W R  +       ++         +    L+ +   F    D  +R  
Sbjct: 293 -FGLVTPGIKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGRFLNF----DRRRRLL 346

Query: 418 SKDV 421
             + 
Sbjct: 347 PLEA 350

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  101 bits (253), Expect = 5e-24
 Identities = 31/252 (12%), Positives = 80/252 (31%), Gaps = 43/252 (17%)

Query: 148 GEVYKAELPGSSGRVITIK----------KIIQPLKSGAELIKKDSEPLHHKMIQIRSEI 197
               +A     +G    +             I+ +K     ++      + K  ++    
Sbjct: 87  YAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145

Query: 198 ITAGQVRHRNIVPLLARMVRRDCD------LLVYEFRR--NGSLQDILYDVSQGRRELDW 249
           I    +        + R+   + D        +Y   +    +  ++L   S   + L  
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205

Query: 250 LARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR 309
            AR ++   +   L  LH      ++H  ++P ++++D      ++ F    R  DG   
Sbjct: 206 HARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARV 260

Query: 310 TTTWSLAGTVGYIAPE-----------CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF 358
            ++     + G+  PE             +   ++ + D ++ G+++  +     P    
Sbjct: 261 VSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---- 312

Query: 359 FQHTKEMSLVQW 370
                 +   +W
Sbjct: 313 ITKDAALGGSEW 324

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 5e-24
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 15/193 (7%)

Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLL--VYEF 227
           +P   G              + Q+  EI    ++ H N+V L+  +   + D L  V+E 
Sbjct: 60  RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119

Query: 228 RRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID 287
              G + ++    +      D  AR    Q +  G+EYLH     +IIHRDI+P+N+L+ 
Sbjct: 120 VNQGPVMEV---PTLKPLSED-QAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVG 171

Query: 288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS---DTCDIYSFGVL 344
           +D   +I++FG++          +     GT  ++APE              D+++ GV 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

Query: 345 LAVLVIGKFPSDD 357
           L   V G+ P  D
Sbjct: 230 LYCFVFGQCPFMD 242

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (258), Expect = 6e-24
 Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 40/255 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V +      +G  + IK+  Q      EL  K+ E       +   EI    ++ H N
Sbjct: 28  GYVLRWIHQ-DTGEQVAIKQCRQ------ELSPKNRE-------RWCLEIQIMKKLNHPN 73

Query: 208 IVPLLA------RMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGI 259
           +V          ++   D  LL  E+   G L+  L  ++   G +E     R  ++  I
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IRTLLSD-I 130

Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKRIPDGHTRTTTWSLA 316
           +S L YLH +    IIHRD++P N+++    +     I + G AK +  G   T      
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FV 184

Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           GT+ Y+APE  +    + T D +SFG L    + G  P    +Q       VQW   V  
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVRE 238

Query: 377 SENPNRAINSKLLGN 391
             N +  +   L G 
Sbjct: 239 KSNEHIVVYDDLTGA 253

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  100 bits (252), Expect = 6e-24
 Identities = 60/318 (18%), Positives = 111/318 (34%), Gaps = 46/318 (14%)

Query: 107 RGGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIK 166
              + D   ++ +  +K  D  + E+  +     ++     GEV++      +G    +K
Sbjct: 31  GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAVK 89

Query: 167 KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYE 226
           K+         L     E           E++    +    IVPL   +       +  E
Sbjct: 90  KV--------RLEVFRVE-----------ELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 227 FRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
               GSL  ++    Q     +  A + + Q    GLEYLH     RI+H D++  NVL+
Sbjct: 131 LLEGGSLGQLI---KQMGCLPEDRALYYLGQ-ALEGLEYLHTR---RILHGDVKADNVLL 183

Query: 287 DDD-MEARISEFGLAKRIPD---GHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
             D   A + +FG A  +     G +  T   + GT  ++APE           DI+S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 343 VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLK 402
            ++  ++ G  P   +F+             + +   P R I                ++
Sbjct: 244 CMMLHMLNGCHPWTQYFR-------GPLCLKIASEPPPIREIPPSC-----APLTAQAIQ 291

Query: 403 IACFCTLDDPNKRPNSKD 420
                   +P  R ++ +
Sbjct: 292 -EGLRK--EPVHRASAME 306

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 52/278 (18%), Positives = 108/278 (38%), Gaps = 43/278 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VYK  L   +   +   ++            +D +    +  + + E      ++H N
Sbjct: 40  KTVYKG-LDTETTVEVAWCEL------------QDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 208 IVPLL---ARMVRRDCDLLVY-EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           IV         V+    +++  E   +G+L+  L    +  + +         + I  GL
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGL 142

Query: 264 EYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++LH +  P IIHRD++  N+ I       +I + GLA        +    ++ GT  ++
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFM 197

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
           APE ++     ++ D+Y+FG+ +  +   ++P  +        +  Q  R V TS     
Sbjct: 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC------QNAAQIYRRV-TSGVKPA 249

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
           + +         E   ++    C     + ++R + KD
Sbjct: 250 SFDKVA----IPEVKEIIEG--CIRQ--NKDERYSIKD 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  100 bits (251), Expect = 7e-24
 Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 38/232 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-- 205
            +V++        ++  IK +         L + D++ L       R+EI    +++   
Sbjct: 23  SKVFQVL--NEKKQIYAIKYV--------NLEEADNQTLD----SYRNEIAYLNKLQQHS 68

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIAQGIASGLE 264
             I+ L    +      +V E   N  L   L    + ++ +D W  +      +   + 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKN-MLEAVH 122

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
            +H  H   I+H D++PAN LI D M  ++ +FG+A ++    T     S  GTV Y+ P
Sbjct: 123 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 325 E-----------CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           E                 +S   D++S G +L  +  GK P         ++
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (252), Expect = 2e-23
 Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 48/284 (16%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
            G +    +     R + +K+I   L        +  E      +Q+  E        H 
Sbjct: 37  EGTIVYRGM--FDNRDVAVKRI---LPECFSFADR--E------VQLLRES-----DEHP 78

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           N++        R    +  E     +LQ+ +         L+      + Q   SGL +L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134

Query: 267 HMSHRPRIIHRDIQPANVLI-----DDDMEARISEFGLAKRIPDGHTRTTTWS-LAGTVG 320
           H S    I+HRD++P N+LI        ++A IS+FGL K++  G    +  S + GT G
Sbjct: 135 H-SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 321 YIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS 377
           +IAPE          + T DI+S G +   ++         F  + +      +    + 
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGKSLQRQA-NILLGACSL 247

Query: 378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           +  +   +  ++     E+M+ +          DP KRP++K V
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAM----------DPQKRPSAKHV 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 44/219 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VY+AE      R++ +K + + L S      +           ++ E  TAG+++  +
Sbjct: 48  GDVYEAEDT-VRERIVALKLMSETLSSDPVFRTR-----------MQREARTAGRLQEPH 95

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARH---------RI 255
           +VP             +++F   G +   LY   +   G      L R           I
Sbjct: 96  VVP-------------IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI 139

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
            + I S L+    +H     HRD++P N+L+  D  A + +FG+A         T   + 
Sbjct: 140 VRQIGSALDA---AHAAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNT 195

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            GT+ Y+APE       +   DIY+   +L   + G  P
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 148 GEVYKAE---LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
            EV+ A          R + +K +   L        +            R E   A  + 
Sbjct: 26  SEVHLARDLRD----HRDVAVKVLRADLARDPSFYLR-----------FRREAQNAAALN 70

Query: 205 HRNIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIA 260
           H  IV +     A         +V E+    +L+DI+         +       +     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADAC 126

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTV 319
             L +   SH+  IIHRD++PAN++I      ++ +FG+A+ I D G++ T T ++ GT 
Sbjct: 127 QALNF---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
            Y++PE  +  ++    D+YS G +L  ++ G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 55/282 (19%), Positives = 111/282 (39%), Gaps = 44/282 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G   K     S G+++  K++         + + + +        + SE+    +++H N
Sbjct: 20  GRCQKIRRK-SDGKILVWKEL-----DYGSMTEAEKQ-------MLVSEVNLLRELKHPN 66

Query: 208 IVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELD----WLARHRIAQGIAS 261
           IV    R++ R    L  V E+   G L  ++   ++ R+ LD         R+   +  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTL 122

Query: 262 GLEYLHMSHRP--RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV 319
            L+  H        ++HRD++PANV +D     ++ +FGLA+ +    +   T    GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTP 180

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            Y++PE    ++ ++  DI+S G LL  L     P    F    +  L      +   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAG---KIREGKF 233

Query: 380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                    +   Y +++  ++             RP+ +++
Sbjct: 234 RR-------IPYRYSDELNEIIT-RMLNL--KDYHRPSVEEI 265

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 99.9 bits (249), Expect = 3e-23
 Identities = 47/232 (20%), Positives = 88/232 (37%), Gaps = 38/232 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-- 205
            +V++        ++  IK +         L + D++     +   R+EI    +++   
Sbjct: 70  SKVFQVL--NEKKQIYAIKYV--------NLEEADNQ----TLDSYRNEIAYLNKLQQHS 115

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIAQGIASGLE 264
             I+ L    +      +V E   N  L   L      ++ +D W  +      +   + 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKSYWKN-MLEAVH 169

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
            +H  H   I+H D++PAN LI D M  ++ +FG+A ++    T     S  G V Y+ P
Sbjct: 170 TIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 325 E-----------CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           E                 +S   D++S G +L  +  GK P         ++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.4 bits (243), Expect = 7e-23
 Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 29/213 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V+K      +G VI +K++                    +  +I  ++ +        
Sbjct: 39  GQVWKMRF-RKTGHVIAVKQM-------------RRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            IV      +      +  E     +  + L    QG      L +  +   I   L YL
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGK--MTVAIVKALYYL 140

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
              H   +IHRD++P+N+L+D+  + ++ +FG++ R+ D   +  +   AG   Y+APE 
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPER 195

Query: 327 HQTVALSDT-----CDIYSFGVLLAVLVIGKFP 354
                 +        D++S G+ L  L  G+FP
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 54/198 (27%), Positives = 81/198 (40%), Gaps = 24/198 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY      S+   I IK+I  P +                   +  EI     ++H+N
Sbjct: 36  GIVYAG-RDLSNQVRIAIKEI--PERDSRYSQ------------PLHEEIALHKHLKHKN 80

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV  L          +  E    GSL  +L       ++ +        Q I  GL+YLH
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYLH 139

Query: 268 MSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE- 325
            +   +I+HRDI+  NVLI+      +IS+FG +KR+   +  T   +  GT+ Y+APE 
Sbjct: 140 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEI 194

Query: 326 -CHQTVALSDTCDIYSFG 342
                       DI+S G
Sbjct: 195 IDKGPRGYGKAADIWSLG 212

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 41/279 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
            EVY+A      G  + +KK+ I  L                       EI    Q+ H 
Sbjct: 46  SEVYRA-ACLLDGVPVALKKVQIFDLMDAKARA------------DCIKEIDLLKQLNHP 92

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD----WLARHRIAQGIASG 262
           N++   A  +  +   +V E    G L  ++    + +R +     W    +    + S 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSA 148

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LE++H     R++HRDI+PANV I      ++ + GL +        T   SL GT  Y+
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 203

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
           +PE       +   DI+S G LL  +   + P   F  +  +M+L    + +   + P  
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---F--YGDKMNLYSLCKKIEQCDYP-- 256

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                L  + Y E++  ++   C     DP KRP+   V
Sbjct: 257 ----PLPSDHYSEELRQLVN-MCINP--DPEKRPDVTYV 288

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 49/206 (23%), Positives = 77/206 (37%), Gaps = 36/206 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+   L   +  V  +K      +            L  K +Q   E     Q  H N
Sbjct: 128 GEVFSGRLRADNTLV-AVKS----CRETL------PPDLKAKFLQ---EARILKQYSHPN 173

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L+    ++    +V E  + G     L         L      ++    A+G+EYL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT-------WSLAGTV 319
                  IHRD+   N L+ +    +IS+FG+++   DG +  +         W+     
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----- 282

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLL 345
              APE       S   D++SFG+LL
Sbjct: 283 ---APEALNYGRYSSESDVWSFGILL 305

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 26/199 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+     G+  RV  IK +            K         +Q   E     ++RH  
Sbjct: 281 GEVWMGTWNGT-TRVA-IKTL------------KPGTMSPEAFLQ---EAQVMKKLRHEK 323

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V  +   +V E+   GSL D L    +  + L       +A  IASG+ Y+ 
Sbjct: 324 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH-TRTTTWSLAGTVGYIAPEC 326
              R   +HRD++ AN+L+ +++  ++++FGLA+ I D   T          + + APE 
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEA 435

Query: 327 HQTVALSDTCDIYSFGVLL 345
                 +   D++SFG+LL
Sbjct: 436 ALYGRFTIKSDVWSFGILL 454

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 22/198 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+      S  V  +K + +      E +K               E     +++H N
Sbjct: 234 GEVYEGVWKKYSLTVA-VKTLKEDTMEVEEFLK---------------EAAVMKEIKHPN 277

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL    R     ++ EF   G+L D L      R+E+  +    +A  I+S +EYL 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
             +    IHR++   N L+ ++   ++++FGL+ R+  G T T        + + APE  
Sbjct: 336 KKN---FIHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 328 QTVALSDTCDIYSFGVLL 345
                S   D+++FGVLL
Sbjct: 392 AYNKFSIKSDVWAFGVLL 409

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 30/219 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G V K      SG+++ +K+I              S     +  Q+  ++ +        
Sbjct: 36  GSVNKMVHK-PSGQIMAVKRI-------------RSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDIL---YDVSQGRRELDWLARHRIAQGIASGL 263
            IV     + R     +  E   + S        Y V       + L +  I       L
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKAL 138

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            +L  + +  IIHRDI+P+N+L+D     ++ +FG++ ++ D   +T     AG   Y+A
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMA 193

Query: 324 PECHQTVALSDT----CDIYSFGVLLAVLVIGKFPSDDF 358
           PE     A         D++S G+ L  L  G+FP   +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 35/223 (15%), Positives = 73/223 (32%), Gaps = 33/223 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            +VY+A   G        +K +  LK    + K  +    +   Q+   +          
Sbjct: 79  AQVYEAT-QGDLNDAKNKQKFV--LK----VQKPANPWEFYIGTQLMERL---KPSMQHM 128

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQGIASGLEY 265
            +   +  + ++  +LV E    G+L + +  Y  +  +     L      + +   +E 
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-MLYMIEQ 187

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEA-----------RISEFGLA---KRIPDGHTRTT 311
           +   H   IIH DI+P N ++ +                + + G +   K  P G   T 
Sbjct: 188 V---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                 T G+   E       +   D +     +  ++ G + 
Sbjct: 245 KC---ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 55/278 (19%), Positives = 105/278 (37%), Gaps = 45/278 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+    +     GR   IK+I     + + +  K+ E       + R E+     ++H N
Sbjct: 38  GKAILVK-STEDGRQYVIKEI-----NISRMSSKERE-------ESRREVAVLANMKHPN 84

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RE---LDWLARHRIAQGIASGL 263
           IV             +V ++   G L   +        +E   LDW       Q I   L
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV-----Q-ICLAL 138

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           +++H     +I+HRDI+  N+ +  D   ++ +FG+A+ +             GT  Y++
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLS 193

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRA 383
           PE  +    ++  DI++ G +L  L   K      F+     +LV     +++   P   
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVL---KIISGSFPP-- 244

Query: 384 INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                +   Y   +  ++    F    +P  RP+   +
Sbjct: 245 -----VSLHYSYDLRSLVS-QLFKR--NPRDRPSVNSI 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 39/198 (19%), Positives = 67/198 (33%), Gaps = 23/198 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+K       GR+  +K+ + P +   +  +K +E                   +H  
Sbjct: 71  GEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAE-----------VGSHEKVGQHPC 118

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            V L           L  E     SLQ        G    +      +       L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRD-TLLALAHLH 174

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 ++H D++PAN+ +      ++ +FGL   +             G   Y+APE  
Sbjct: 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELL 228

Query: 328 QTVALSDTCDIYSFGVLL 345
           Q        D++S G+ +
Sbjct: 229 QGSY-GTAADVFSLGLTI 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 37/213 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G +Y A     +GR + +K ++            D+E          +E     +V H +
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHS---------GDAEAQA----MAMAERQFLAEVVHPS 140

Query: 208 IVPLL--ARMVRRDCDLLVY---EFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           IV +        R  D + Y   E+    SL+          ++L           I   
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPA 194

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           L YLH      +++ D++P N+++ ++ + ++ + G   RI       +   L GT G+ 
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQ 244

Query: 323 APECHQ-TVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE        +   DIY+ G  LA L +    
Sbjct: 245 APE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 29/214 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G V K      SG+++ +K+I              +     +  ++  ++ I+   V   
Sbjct: 21  GVVEKMRHV-PSGQIMAVKRI-------------RATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRREL--DWLARHRIAQGIASGLE 264
             V     + R     +  E   + SL      V    + +  D L +  IA  I   LE
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           +LH      +IHRD++P+NVLI+   + ++ +FG++  + D   +      AG   Y+AP
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AGCKPYMAP 178

Query: 325 E----CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           E           S   DI+S G+ +  L I +FP
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 65/303 (21%)

Query: 147 NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           +G V         GR + +K++   L    ++   +        I++ +E        H 
Sbjct: 28  SGTVVFQGS--FQGRPVAVKRM---LIDFCDIALME--------IKLLTESD-----DHP 69

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDIL---YDVSQGRRELDWLARHRIAQGIASGL 263
           N++             +  E   N +LQD++       +  +         + + IASG+
Sbjct: 70  NVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 264 EYLHMSHRPRIIHRDIQPANVLID-------------DDMEARISEFGLAKRIPDGHT-- 308
            +LH S +  IIHRD++P N+L+              +++   IS+FGL K++  G +  
Sbjct: 129 AHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 309 RTTTWSLAGTVGYIAPE-------CHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQ 360
           RT   + +GT G+ APE             L+ + DI+S G +   +L  GK P  D + 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245

Query: 361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYE--EQMLLVLKIACFCTLDDPNKRPNS 418
               +     +R + + +      +  L+    +   QM+            DP KRP +
Sbjct: 246 RESNI-----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDH----------DPLKRPTA 290

Query: 419 KDV 421
             V
Sbjct: 291 MKV 293

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 54/274 (19%), Positives = 98/274 (35%), Gaps = 61/274 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++A+          IK+I  P +          E       ++  E+    ++ H  
Sbjct: 19  GVVFEAKN-KVDDCNYAIKRIRLPNRE------LARE-------KVMREVKALAKLEHPG 64

Query: 208 IV---------PLLARMVRRDCDLLVY---EFRRNGSLQDILYDVSQGRRELDWLARHRI 255
           IV             ++      + +Y   +  R  +L+D + +      E +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHI 123

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              IA  +E+LH      ++HRD++P+N+    D   ++ +FGL   +       T  + 
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 316 A----------GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI--------------- 350
                      GT  Y++PE     + S   DI+S G++L  L+                
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240

Query: 351 --GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
              KFP     ++  E  +VQ     M S +P  
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQD----MLSPSPME 270

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.8 bits (241), Expect = 6e-22
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 26/199 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+     G+  RV  IK +            K         +Q   E     ++RH  
Sbjct: 198 GEVWMGTWNGT-TRVA-IKTL------------KPGTMSPEAFLQ---EAQVMKKLRHEK 240

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V  +   +V E+   GSL D L    +  + L       +A  IASG+ Y+ 
Sbjct: 241 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH-TRTTTWSLAGTVGYIAPEC 326
             +    +HRD++ AN+L+ +++  ++++FGLA+ I D   T          + + APE 
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEA 352

Query: 327 HQTVALSDTCDIYSFGVLL 345
                 +   D++SFG+LL
Sbjct: 353 ALYGRFTIKSDVWSFGILL 371

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 25/186 (13%)

Query: 187 HHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-R 245
              + ++  E+     + H NIV L   +       L+ E+   G + D  Y V+ GR +
Sbjct: 55  PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMK 112

Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           E +  AR    + I S ++Y H   + RI+HRD++  N+L+D DM  +I++FG +     
Sbjct: 113 EKE--AR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166

Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFPSDDFF 359
           G          G   Y APE                 D++S GV+L  LV G  P D   
Sbjct: 167 GGKLDAF---CGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-- 216

Query: 360 QHTKEM 365
           Q+ KE+
Sbjct: 217 QNLKEL 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 53/239 (22%), Positives = 103/239 (43%), Gaps = 48/239 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+KA+     G+   IK++           K ++E       +   E+    ++ H N
Sbjct: 25  GQVFKAKHR-IDGKTYVIKRV-----------KYNNE-------KAEREVKALAKLDHVN 65

Query: 208 IV---------------PLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD-WL 250
           IV                       +   L +  EF   G+L+  +    +   +LD  L
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVL 123

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A     Q I  G++Y+H     ++I+RD++P+N+ + D  + +I +FGL   + +   RT
Sbjct: 124 ALELFEQ-ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
            +    GT+ Y++PE   +       D+Y+ G++LA L+         F+ +K  + ++
Sbjct: 180 RS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLR 232

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 157 GSSGRVITIKKI-------IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV 209
           GS   V+  +++       I+ L+    +IK++      K+  +  E     ++ H   V
Sbjct: 41  GSFSTVVLARELATSREYAIKILEK-RHIIKEN------KVPYVTRERDVMSRLDHPFFV 93

Query: 210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS 269
            L       +       + +NG L   L  + +     +   R   A+ I S LEYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAE-IVSALEYLHGK 149

Query: 270 HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT 329
               IIHRD++P N+L+++DM  +I++FG AK +     +    S  GT  Y++PE    
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 330 VALSDTCDIYSFGVLLAVLVIGKFP 354
            +   + D+++ G ++  LV G  P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPP 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 22/220 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV   ++  + G++   KK    L+   + IKK             +E     +V  R 
Sbjct: 198 GEVCACQVRAT-GKMYACKK----LEK--KRIKKRKGEAM-----ALNEKQILEKVNSRF 245

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L      +D   LV      G L+  +Y + Q        A    A+ I  GLE LH
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAAE-ICCGLEDLH 303

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
              R RI++RD++P N+L+DD    RIS+ GLA  +P+G    T     GTVGY+APE  
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVV 357

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           +    + + D ++ G LL  ++ G+  F         +E+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 31/222 (13%)

Query: 133 EDYFASLEKIRSCWN--GEVYKA-ELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHK 189
              +  L  I   +     V  A   P  +G  +T+++I             + E   ++
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI-------------NLEACSNE 68

Query: 190 MIQ-IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
           M+  ++ E+  +    H NIVP  A  +  +   +V  F   GS +D++           
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
            +A   I QG+   L+Y+H       +HR ++ +++LI  D +  +S       +     
Sbjct: 129 AIAY--ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 309 RTTT-----WSLAGTVGYIAPE-CHQTVALSDT-CDIYSFGV 343
           R              + +++PE   Q +   D   DIYS G+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 55/310 (17%), Positives = 106/310 (34%), Gaps = 70/310 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HR 206
             VY+A+    SGR   +K+++   +     I +              E+    ++  H 
Sbjct: 42  AFVYEAQ-DVGSGREYALKRLLSNEEEKNRAIIQ--------------EVCFMKKLSGHP 86

Query: 207 NIVPLLA-------RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR--ELDWLARHRIAQ 257
           NIV   +              + L+      G L + L  +           L   +I  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL---KIFY 143

Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA---KRIPDGHTRTTTWS 314
                ++++H   +P IIHRD++  N+L+ +    ++ +FG A      PD        +
Sbjct: 144 QTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 315 LA-------GTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           L         T  Y  PE    +    + +  DI++ G +L +L   + P    F+   +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAK 258

Query: 365 MSLV----QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
           + +V        +       +  I +          ML V          +P +R +  +
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRA----------MLQV----------NPEERLSIAE 298

Query: 421 VRCMLSQIQH 430
           V   L +I  
Sbjct: 299 VVHQLQEIAA 308

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 5e-21
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 21/221 (9%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+  ++  + G++   KK    L    + +KK              E     +V  R 
Sbjct: 199 GEVFACQMKAT-GKLYACKK----LNK--KRLKKRKGYQG-----AMVEKKILAKVHSRF 246

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD-WLARHRIAQGIASGLEYL 266
           IV L      +    LV      G ++  +Y+V +         A    AQ I SGLE+L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHL 305

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H   +  II+RD++P NVL+DDD   RIS+ GLA  +  G T+T     AGT G++APE 
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPEL 360

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
                   + D ++ GV L  ++  +  F +       KE+
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 27/199 (13%)

Query: 167 KIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYE 226
           K I+  K     + +D      K+ ++  EI    +V H NI+ +L     +    LV E
Sbjct: 55  KFIKKEK-----VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109

Query: 227 FRRNGS-LQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL 285
              +G  L    +     R +   LA +   Q + S + YL       IIHRDI+  N++
Sbjct: 110 KHGSGLDLFA--FIDRHPRLDEP-LASYIFRQ-LVSAVGYLR---LKDIIHRDIKDENIV 162

Query: 286 IDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT------CDIY 339
           I +D   ++ +FG A  +  G    T     GT+ Y APE      L          +++
Sbjct: 163 IAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPE-----VLMGNPYRGPELEMW 214

Query: 340 SFGVLLAVLVIGKFPSDDF 358
           S GV L  LV  + P  + 
Sbjct: 215 SLGVTLYTLVFEENPFCEL 233

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.7 bits (226), Expect = 9e-21
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 33/220 (15%)

Query: 157 GSSGRVITIKKIIQPLKSGAE----LIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL 212
           G+ G+V    KI +   +G +    ++ +        + +I+ EI      RH +I+ L 
Sbjct: 22  GTFGKV----KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYLHMSHR 271
             +       +V E+   G L D  Y    GR  E++  AR    Q I S ++Y H   R
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEME--ARRLFQQ-ILSAVDYCH---R 129

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA 331
             ++HRD++P NVL+D  M A+I++FGL+  + DG    T+    G+  Y APE      
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-----V 181

Query: 332 LSD------TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           +S         DI+S GV+L  L+ G  P DD  +H   +
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--EHVPTL 219

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 45/239 (18%), Positives = 82/239 (34%), Gaps = 52/239 (21%)

Query: 120 PLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKIIQPLKS 174
            ++KE +   ++      F           G VYK        +V     IK+    L+ 
Sbjct: 10  RILKETEFKKIKVLGSGAF-----------GTVYKGLWIPEGEKVKIPVAIKE----LRE 54

Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ 234
                   S   + +++    E      V + ++  LL  +       L+ +    G L 
Sbjct: 55  AT------SPKANKEILD---EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLL 104

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 294
           D +    + +  +           IA G+ YL    R  ++HRD+   NVL+      +I
Sbjct: 105 DYV---REHKDNIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKI 158

Query: 295 SEFGLAKRIPDGHTRTTT--------WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           ++FGLAK +                 W        +A E       +   D++S+GV +
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKW--------MALESILHRIYTHQSDVWSYGVTV 209

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 38/208 (18%)

Query: 148 GEVYKAELPGSSGRV-ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G V K           + +K     LK+ A     +   L  +++    E     Q+ + 
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKI----LKNEA-----NDPALKDELLA---EANVMQQLDNP 78

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            IV ++  +   +  +LV E    G L   L    Q  R +       +   ++ G++YL
Sbjct: 79  YIVRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---------WSLAG 317
                   +HRD+   NVL+     A+IS+FGL+K +                  W    
Sbjct: 134 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY--- 187

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL 345
                APEC      S   D++SFGVL+
Sbjct: 188 -----APECINYYKFSSKSDVWSFGVLM 210

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 35/223 (15%)

Query: 187 HHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE 246
              M     +I        +N V  L     +    +  +  R  +L+D + +      +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM-NRRCSLED 160

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
            +      I   IA  +E+LH      ++HRD++P+N+    D   ++ +FGL   +   
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 307 HTRTTTWSLA----------GTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI------ 350
               T  +            GT  Y++PE       S   DI+S G++L  L+       
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277

Query: 351 -----------GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
                       KFP     ++ +E  +VQ     M S +P  
Sbjct: 278 ERVRIITDVRNLKFPLLFTQKYPQEHMMVQD----MLSPSPTE 316

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 48/208 (23%), Positives = 81/208 (38%), Gaps = 38/208 (18%)

Query: 148 GEVYKAELPGSSGRV-ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G V +        ++ + IK     LK G E    +         ++  E     Q+ + 
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKV----LKQGTEKADTE---------EMMREAQIMHQLDNP 70

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            IV L+  + + +  +LV E    G L   L      R E+       +   ++ G++YL
Sbjct: 71  YIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL 126

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---------WSLAG 317
                   +HRD+   NVL+ +   A+IS+FGL+K +    +  T          W    
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY--- 180

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL 345
                APEC      S   D++S+GV +
Sbjct: 181 -----APECINFRKFSSRSDVWSYGVTM 203

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 50/212 (23%), Positives = 77/212 (36%), Gaps = 42/212 (19%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G V                 +KK    L+   E   +D             EI     ++
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRD----------FEREIEILKSLQ 69

Query: 205 HRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           H NIV               L+ E+   GSL+D L    + +  +D +   +    I  G
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 126

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT--RTTT-------W 313
           +EYL      R IHRD+   N+L++++   +I +FGL K +P      +          W
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                    APE       S   D++SFGV+L
Sbjct: 184 Y--------APESLTESKFSVASDVWSFGVVL 207

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           +  +   EKI    +G VY A +  ++G+ + I+++         L ++  + L      
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA-MDVATGQEVAIRQM--------NLQQQPKKEL------ 63

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I +EI+   + ++ NIV  L   +  D   +V E+   GSL D+   V++   +   +A 
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA 120

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             + +     LE+LH +    +IHRDI+  N+L+  D   ++++FG   +I    ++ +T
Sbjct: 121 --VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
             + GT  ++APE     A     DI+S G+
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E+ F  LEKI     GEV+K  +   + +V+ IK I             D E    ++  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------DLEEAEDEIED 66

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I+ EI    Q     +       ++     ++ E+   GS  D+L     G  +   +A 
Sbjct: 67  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT 123

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             I + I  GL+YLH     + IHRDI+ ANVL+ +  E ++++FG+A ++ D   +  T
Sbjct: 124 --ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
           +   GT  ++APE  +  A     DI+S G+
Sbjct: 179 F--VGTPFWMAPEVIKQSAYDSKADIWSLGI 207

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 33/208 (15%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G+V                 +K +           K +S   H   ++   EI     + 
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSL-----------KPESGGNHIADLK--KEIEILRNLY 81

Query: 205 HRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           H NIV           +   L+ EF  +GSL++ L    + + +++   + + A  I  G
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKG 138

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++YL  S +   +HRD+   NVL++ + + +I +FGL K I       T           
Sbjct: 139 MDYLG-SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDS 191

Query: 323 -----APECHQTVALSDTCDIYSFGVLL 345
                APEC          D++SFGV L
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTL 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 50/212 (23%), Positives = 77/212 (36%), Gaps = 42/212 (19%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G V                 +KK    L+   E   +D             EI     ++
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRD----------FEREIEILKSLQ 100

Query: 205 HRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           H NIV               L+ E+   GSL+D L    + +  +D +   +    I  G
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKG 157

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT--RTTT-------W 313
           +EYL      R IHRD+   N+L++++   +I +FGL K +P      +          W
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                    APE       S   D++SFGV+L
Sbjct: 215 Y--------APESLTESKFSVASDVWSFGVVL 238

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 4e-20
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 25/232 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY      + G++  +K +         +  K  E     + + R  +          
Sbjct: 203 GEVYGCRKADT-GKMYAMKCL-----DKKRIKMKQGE--TLALNE-RIMLSLVSTGDCPF 253

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV +       D    + +    G   D+ Y +SQ     +   R   A+ I  GLE++H
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAE-IILGLEHMH 309

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE-C 326
                 +++RD++PAN+L+D+    RIS+ GLA             +  GT GY+APE  
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVL 362

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE 378
            + VA   + D +S G +L  L+ G  P    F+  K     +  R  +T  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMA 410

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 48/205 (23%), Positives = 82/205 (40%), Gaps = 38/205 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+ A       +V  +K +     S    +                E      ++H  
Sbjct: 202 GEVWMATYNKH-TKVA-VKTMKPGSMSVEAFLA---------------EANVMKTLQHDK 244

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V ++   ++ EF   GSL D L   S    +         +  IA G+ ++ 
Sbjct: 245 LVKLHA-VVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGTVG 320
              +   IHRD++ AN+L+   +  +I++FGLA+ I D              W+      
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 352

Query: 321 YIAPECHQTVALSDTCDIYSFGVLL 345
             APE     + +   D++SFG+LL
Sbjct: 353 --APEAINFGSFTIKSDVWSFGILL 375

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 25/211 (11%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
                S  KI     G V  A     SGR + +K +        +L K+    L      
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA-REKHSGRQVAVKMM--------DLRKQQRREL------ 88

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           + +E++     +H N+V +    +  +   ++ EF + G+L DI   VSQ R   + +A 
Sbjct: 89  LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT 145

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             + + +   L YLH      +IHRDI+  ++L+  D   ++S+FG   +I     +  +
Sbjct: 146 --VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
             L GT  ++APE       +   DI+S G+
Sbjct: 201 --LVGTPYWMAPEVISRSLYATEVDIWSLGI 229

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 38/209 (18%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           GEV    L     R +   IK     LK+G       +E      +    E    GQ  H
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKA----LKAGY------TERQRRDFLS---EASIMGQFDH 109

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            NI+ L   + R    ++V E+  NGSL   L        +   +    + +G+ +G+ Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRY 166

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH--TRTTT-------WSLA 316
           L        +HRD+   NVL+D ++  ++S+FGL++ + D      TTT       W+  
Sbjct: 167 LSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221

Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                 APE       S   D++SFGV++
Sbjct: 222 ------APEAIAFRTFSSASDVWSFGVVM 244

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E+ F  LEK+     G VYKA     +G+++ IK++  P++S  + I K           
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAI-HKETGQIVAIKQV--PVESDLQEIIK----------- 73

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
              EI    Q    ++V       +     +V E+   GS+ DI+   ++   E D +A 
Sbjct: 74  ---EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIAT 129

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             I Q    GLEYLH       IHRDI+  N+L++ +  A++++FG+A ++ D   +  T
Sbjct: 130 --ILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGV 343
             + GT  ++APE  Q +  +   DI+S G+
Sbjct: 185 --VIGTPFWMAPEVIQEIGYNCVADIWSLGI 213

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 91.2 bits (226), Expect = 7e-20
 Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 38/208 (18%)

Query: 148 GEVYKAELPGSSGRV-ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G V +        ++ + IK     LK G E    +         ++  E     Q+ + 
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKV----LKQGTEKADTE---------EMMREAQIMHQLDNP 396

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            IV L+  + + +  +LV E    G L   L      R E+       +   ++ G++YL
Sbjct: 397 YIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL 452

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---------WSLAG 317
                   +HR++   NVL+ +   A+IS+FGL+K +    +  T          W    
Sbjct: 453 E---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY--- 506

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL 345
                APEC      S   D++S+GV +
Sbjct: 507 -----APECINFRKFSSRSDVWSYGVTM 529

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 38/209 (18%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           GEV    L   S + I+  IK     LK G       +E      +    E    GQ  H
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKT----LKVGY------TEKQRRDFLG---EASIMGQFDH 105

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            NI+ L   + +    ++V E+  NGSL   L    +   +   +    + +GIASG++Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH--TRTTT-------WSLA 316
           L        +HRD+   N+LI+ ++  ++S+FGL + + D      TT        W+  
Sbjct: 163 LSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217

Query: 317 GTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                 +PE       +   D++S+G++L
Sbjct: 218 ------SPEAIAYRKFTSASDVWSYGIVL 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 39/210 (18%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEVYK  L  SSG+      IK     LK+G       +E      +    E    GQ  
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKT----LKAGY------TEKQRVDFLG---EAGIMGQFS 104

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ L   + +    +++ E+  NG+L   L    +   E   L    + +GIA+G++
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT---------WSL 315
           YL   +    +HRD+   N+L++ ++  ++S+FGL++ + D    T T         W+ 
Sbjct: 162 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT- 217

Query: 316 AGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                  APE       +   D++SFG+++
Sbjct: 218 -------APEAISYRKFTSASDVWSFGIVM 240

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 50/212 (23%), Positives = 76/212 (35%), Gaps = 42/212 (19%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G V                 +K+    L+      ++D           + EI     + 
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRD----------FQREIQILKALH 82

Query: 205 HRNIVPLLA--RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
              IV          R    LV E+  +G L+D L    + R  LD       +  I  G
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKG 139

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT--RTTT-------W 313
           +EYL  S R   +HRD+   N+L++ +   +I++FGLAK +P                 W
Sbjct: 140 MEYLG-SRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 314 SLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                    APE       S   D++SFGV+L
Sbjct: 197 --------YAPESLSDNIFSRQSDVWSFGVVL 220

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 27/228 (11%)

Query: 125 EDLAFLEKEDYFASLEKIRSCWNGEVYKA-ELPGSSGRVITIKKIIQPLKSGAELIKKDS 183
             L +    D +   E I S     V  A   P      + IK+I             + 
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRI-------------NL 50

Query: 184 EPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-YDVSQ 242
           E     M ++  EI    Q  H NIV      V +D   LV +    GS+ DI+ + V++
Sbjct: 51  EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAK 110

Query: 243 GRRELDWLARHRIA---QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
           G  +   L    IA   + +  GLEYLH   +   IHRD++  N+L+ +D   +I++FG+
Sbjct: 111 GEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167

Query: 300 AKRIPDGHTRTTTW---SLAGTVGYIAPECHQTVALSDT-CDIYSFGV 343
           +  +  G   T      +  GT  ++APE  + V   D   DI+SFG+
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 45/294 (15%), Positives = 90/294 (30%), Gaps = 61/294 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+K  +    G +  IK+  +PL    +               +R     A   +H +
Sbjct: 25  GSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQN-----------ALREVYAHAVLGQHSH 72

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V   +     D  L+  E+   GSL D + +  +            +   +  GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 268 MSHRPRIIHRDIQPANVLIDDD-------------------MEARISEFGLAKRIPDGHT 308
                 ++H DI+P+N+ I                      +  +I + G   RI     
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 309 RTTTWSLAGTVGYIAPE-CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
                   G   ++A E   +        DI++  + +      +    +          
Sbjct: 190 EE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--------- 234

Query: 368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                 +     P        +     ++   +LK        DP +RP++  +
Sbjct: 235 -DQWHEIRQGRLPR-------IPQVLSQEFTELLK-VMIHP--DPERRPSAMAL 277

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 20/185 (10%)

Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHR--NIVPLLARMVRRDCDLLVYEF-RRNGSLQDI 236
           +           ++  E++   +V      ++ LL    R D  +L+ E       L D 
Sbjct: 80  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD- 138

Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARIS 295
            +   +G  + + LAR      +   + + H      ++HRDI+  N+LID +  E ++ 
Sbjct: 139 -FITERGALQEE-LAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI 192

Query: 296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGK 352
           +FG    + D           GT  Y  PE    H+    S    ++S G+LL  +V G 
Sbjct: 193 DFGSGALLKDTVYTDF----DGTRVYSPPEWIRYHRYHGRS--AAVWSLGILLYDMVCGD 246

Query: 353 FPSDD 357
            P + 
Sbjct: 247 IPFEH 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 59/238 (24%), Positives = 86/238 (36%), Gaps = 50/238 (21%)

Query: 121 LIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVIT--IKKIIQPLKSGA 176
           LI E+DL  LEK  +  F           G V + E    SG+ ++  +K     LK   
Sbjct: 14  LIGEKDLRLLEKLGDGSF-----------GVVRRGEWDAPSGKTVSVAVKC----LKPDV 58

Query: 177 ELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDI 236
                         I+   E+     + HRN++ L   +V      +V E    GSL D 
Sbjct: 59  L----SQPEAMDDFIR---EVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDR 110

Query: 237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE 296
           L    + +         R A  +A G+ YL        IHRD+   N+L+      +I +
Sbjct: 111 L---RKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164

Query: 297 FGLAKRIPDGHTRTTT---------WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           FGL + +P                 W         APE  +T   S   D + FGV L
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWC--------APESLKTRTFSHASDTWMFGVTL 214

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 60/181 (33%), Positives = 87/181 (48%), Gaps = 25/181 (13%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 250
           +IR EI      RH +I+ L   +       +V E+   G L D  Y    GR  E +  
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKE-- 117

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           +R    Q I SG++Y H   R  ++HRD++P NVL+D  M A+I++FGL+  + DG    
Sbjct: 118 SRRLFQQ-ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173

Query: 311 TTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
           T+    G+  Y APE      +S         DI+S GV+L  L+ G  P DD   H   
Sbjct: 174 TS---CGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFDD--DHVPT 223

Query: 365 M 365
           +
Sbjct: 224 L 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 37/207 (17%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G+V++          +   IK      K+        S+ +  K +Q   E +T  Q  H
Sbjct: 29  GDVHQGIYMSPENPALAVAIKT----CKNCT------SDSVREKFLQ---EALTMRQFDH 75

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            +IV L+  ++  +   ++ E    G L+  L      +  LD  +    A  +++ L Y
Sbjct: 76  PHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAY 131

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGT 318
           L      R +HRDI   NVL+  +   ++ +FGL++ + D      +       W     
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM---- 184

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
               APE       +   D++ FGV +
Sbjct: 185 ----APESINFRRFTSASDVWMFGVCM 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 20/175 (11%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRR-DCDL-LVYEFRRNGSLQDILYD-VSQGR-REL 247
            ++ EI    ++RH+N++ L+  +       + +V E+   G  +  + D V + R    
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPV- 108

Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA---KRIP 304
              A     Q +  GLEYLH      I+H+DI+P N+L+      +IS  G+A       
Sbjct: 109 -CQAHGYFCQ-LIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163

Query: 305 DGHTRTTTWSLAGTVGYIAPECHQTVALSD--TCDIYSFGVLLAVLVIGKFPSDD 357
              T  T+    G+  +  PE    +        DI+S GV L  +  G +P + 
Sbjct: 164 ADDTCRTS---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 45/239 (18%), Positives = 82/239 (34%), Gaps = 52/239 (21%)

Query: 120 PLIKEEDLAFLEK--EDYFASLEKIRSCWNGEVYKAELPGSSGRVIT---IKKIIQPLKS 174
            ++KE +   ++      F           G VYK        +V     IK+    L+ 
Sbjct: 10  RILKETEFKKIKVLGSGAF-----------GTVYKGLWIPEGEKVKIPVAIKE----LRE 54

Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQ 234
                   S   + +++    E      V + ++  LL  +       L+ +    G L 
Sbjct: 55  AT------SPKANKEILD---EAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLL 104

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI 294
           D +    + +  +           IA G+ YL    R  ++HRD+   NVL+      +I
Sbjct: 105 DYV---REHKDNIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKI 158

Query: 295 SEFGLAKRIPDGHTRTTT--------WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           ++FGLAK +                 W        +A E       +   D++S+GV +
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKW--------MALESILHRIYTHQSDVWSYGVTV 209

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 5e-19
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 20/173 (11%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 250
            I+ EI     + H N+V         +   L  E+   G L D           E D  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPD-- 106

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A+ R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +   
Sbjct: 107 AQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 311 TTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFPSDD 357
               + GT+ Y+APE      L          D++S G++L  ++ G+ P D 
Sbjct: 163 LLNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 29/229 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV  A     + + + IK II   K         S       + + +EI    ++ H  
Sbjct: 24  GEVKLAFE-RKTCKKVAIK-IISKRK-----FAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ +       D   +V E    G L D    V   R +E     +    Q +   ++YL
Sbjct: 77  IIKIKNFFDAEDY-YIVLELMEGGELFD--KVVGNKRLKEAT--CKLYFYQ-MLLAVQYL 130

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H  +   IIHRD++P NVL+   ++D   +I++FG +K + +     T   L GT  Y+A
Sbjct: 131 H-ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLA 184

Query: 324 PE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE      T   +   D +S GV+L + + G  P   F +H  ++SL  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKD 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 13/117 (11%)

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
            +  I + +   L+YL       IIHRD++P N+L+D+     I++F +A  +P     T
Sbjct: 117 VKLFICE-LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---T 169

Query: 311 TTWSLAGTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE 364
              ++AGT  Y+APE     +    S   D +S GV    L+ G+ P   +   +  
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP---YHIRSST 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV  A     + + + I+ II   K         S       + + +EI    ++ H  
Sbjct: 149 GEVKLAFER-KTCKKVAIR-IISKRK-----FAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ +       D   +V E    G L D    V   R +E     +    Q +   ++YL
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFD--KVVGNKRLKEAT--CKLYFYQ-MLLAVQYL 255

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H      IIHRD++P NVL+   ++D   +I++FG +K + +     T   L GT  Y+A
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLA 309

Query: 324 PE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           PE      T   +   D +S GV+L + + G  P   F +H  ++SL  
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKD 355

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 46/210 (21%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+      S  V  +K + +      E +                E     +++H N
Sbjct: 27  GEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFL---------------KEAAVMKEIKHPN 70

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL    R     ++ EF   G+L D L      R+E+  +    +A  I+S +EYL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGTVG 320
             +    IHRD+   N L+ ++   ++++FGL++ +                W+      
Sbjct: 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------ 179

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
             APE     +L+        D+++FGVLL
Sbjct: 180 --APE-----SLAYNKFSIKSDVWAFGVLL 202

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 20/173 (11%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 250
            I+ EI     + H N+V         +   L  E+   G L D           E D  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPD-- 106

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           A+ R    + +G+ YLH      I HRDI+P N+L+D+    +IS+FGLA      +   
Sbjct: 107 AQ-RFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 311 TTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFPSDD 357
               + GT+ Y+APE      L          D++S G++L  ++ G+ P D 
Sbjct: 163 LLNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 39/190 (20%), Positives = 69/190 (36%), Gaps = 28/190 (14%)

Query: 180 KKDSEPLHHKMIQIRSEIITAGQVR----HRNIVPLLARMVRRDCDLLVYEFRRNGS-LQ 234
           +          +    E+    +V     H  ++ LL     ++  +LV E       L 
Sbjct: 68  RVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127

Query: 235 DILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EAR 293
           D  Y   +G       +R      + + +++ H      ++HRDI+  N+LID     A+
Sbjct: 128 D--YITEKGPLGEG-PSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180

Query: 294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAV 347
           + +FG    + D           GT  Y  PE      +S          ++S G+LL  
Sbjct: 181 LIDFGSGALLHDEPYTDF----DGTRVYSPPE-----WISRHQYHALPATVWSLGILLYD 231

Query: 348 LVIGKFPSDD 357
           +V G  P + 
Sbjct: 232 MVCGDIPFER 241

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 28/216 (12%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
            + +  + ++     G+VYKA     +G +   K I    KS  EL              
Sbjct: 18  NEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVI--ETKSEEELE------------D 62

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
              EI       H  IV LL          ++ EF   G++  I+ ++ +G  E   +  
Sbjct: 63  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV 121

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             + + +   L +LH      IIHRD++  NVL+  + + R+++FG++ +      +  +
Sbjct: 122 --VCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176

Query: 313 WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGV 343
               GT  ++APE      + DT      DI+S G+
Sbjct: 177 --FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 42/207 (20%), Positives = 73/207 (35%), Gaps = 37/207 (17%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           GEVY+       G  I   +K      K    L  K+         +  SE +    + H
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKT----CKKDCTLDNKE---------KFMSEAVIMKNLDH 72

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            +IV L+  ++  +   ++ E    G L   L    + +  L  L     +  I   + Y
Sbjct: 73  PHIVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGT 318
           L        +HRDI   N+L+      ++ +FGL++ I D      +       W     
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM---- 181

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
               +PE       +   D++ F V +
Sbjct: 182 ----SPESINFRRFTTASDVWMFAVCM 204

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 48/208 (23%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGA---ELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G+V   +     G  + +K     +K+ A     +                E     Q+R
Sbjct: 207 GDVMLGDY---RGNKVAVKC----IKNDATAQAFLA---------------EASVMTQLR 244

Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           H N+V LL  +V     L +V E+   GSL D L   S+GR  L      + +  +   +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT------WSLAG 317
           EYL  ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T      W+   
Sbjct: 303 EYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT--- 353

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLL 345
                APE  +    S   D++SFG+LL
Sbjct: 354 -----APEALREKKFSTKSDVWSFGILL 376

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 24/215 (11%)

Query: 157 GSSGRVITIKKIIQPLKSGAE----LIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL 212
           GS G+V    K+    K+  +     I +         +++  EI     +RH +I+ L 
Sbjct: 20  GSFGKV----KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYLHMSHR 271
             +      ++V E+   G L D  Y V + R  E +   R    Q I   +EY H   R
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFD--YIVEKKRMTEDE--GRRFFQQ-IICAIEYCH---R 126

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA 331
            +I+HRD++P N+L+DD++  +I++FGL+  + DG+   T+    G+  Y APE      
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKL 183

Query: 332 -LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
                 D++S G++L V+++G+ P DD  +    +
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDD--EFIPNL 216

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 23/200 (11%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G+V++          +   IK      K+        S+ +  K +Q   E +T  Q  H
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKT----CKNCT------SDSVREKFLQ---EALTMRQFDH 450

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            +IV L+  ++  +   ++ E    G L+  L      +  LD  +    A  +++ L Y
Sbjct: 451 PHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAY 506

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           L      R +HRDI   NVL+  +   ++ +FGL++ + D      +      + ++APE
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562

Query: 326 CHQTVALSDTCDIYSFGVLL 345
                  +   D++ FGV +
Sbjct: 563 SINFRRFTSASDVWMFGVCM 582

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 56/213 (26%), Positives = 80/213 (37%), Gaps = 45/213 (21%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGA-ELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V       ++        +K     LK+ A    +             + EI     +
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKA----LKADAGPQHRSG----------WKQEIDILRTL 90

Query: 204 RHRNIVPLLARMVRRDCD--LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
            H +I+               LV E+   GSL+D L      R  +        AQ I  
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICE 145

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT--RTTT------- 312
           G+ YLH       IHRD+   NVL+D+D   +I +FGLAK +P+GH   R          
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
           W         APEC +        D++SFGV L
Sbjct: 203 W--------YAPECLKEYKFYYASDVWSFGVTL 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 25/175 (14%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWL 250
            ++ EII    +RH NIV     ++      ++ E+   G L +     + GR  E +  
Sbjct: 62  NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDE-- 117

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHT 308
           AR    Q + SG+ Y H     +I HRD++  N L+D     R  I +FG +K       
Sbjct: 118 ARFFFQQ-LLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSD------TCDIYSFGVLLAVLVIGKFPSDD 357
             +T    GT  YIAPE      L          D++S GV L V+++G +P +D
Sbjct: 174 PKST---VGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 44/219 (20%), Positives = 80/219 (36%), Gaps = 44/219 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AE          +   ++ LK  +E  ++D           + E      ++H++
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKALKEASESARQD----------FQREAELLTMLQHQH 104

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL-----------YDVSQGRRELDWLARHRIA 256
           IV            L+V+E+ R+G L   L                    L       +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 257 QGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLA 316
             +A+G+ YL   H    +HRD+   N L+   +  +I +FG+++ I             
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----V 216

Query: 317 GTVGYI-----APECHQTVALSDT-----CDIYSFGVLL 345
           G    +      PE     ++         D++SFGV+L
Sbjct: 217 GGRTMLPIRWMPPE-----SILYRKFTTESDVWSFGVVL 250

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 82.2 bits (204), Expect = 6e-18
 Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 21/158 (13%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
            E     ++ H  +V L    + +    LV EF  +G L D L      R          
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLG 108

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-- 312
           +   +  G+ YL  +    +IHRD+   N L+ ++   ++S+FG+ + + D    ++T  
Sbjct: 109 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165

Query: 313 -----WSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
                W+        +PE       S   D++SFGVL+
Sbjct: 166 KFPVKWA--------SPEVFSFSRYSSKSDVWSFGVLM 195

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 55/223 (24%)

Query: 148 GEVYKAELPGSSGRVIT-IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH 205
           G+V KA +     R+   IK+    +K  A      S+  H        E+    ++  H
Sbjct: 39  GQVLKARIKKDGLRMDAAIKR----MKEYA------SKDDHRDFA---GELEVLCKLGHH 85

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRELDWLARH 253
            NI+ LL     R    L  E+  +G+L D L               +     L      
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT- 312
             A  +A G++YL  S + + IHRD+   N+L+ ++  A+I++FGL+ R  + + + T  
Sbjct: 146 HFAADVARGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMG 201

Query: 313 -----WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLL 345
                W        +A E     +L+ +      D++S+GVLL
Sbjct: 202 RLPVRW--------MAIE-----SLNYSVYTTNSDVWSYGVLL 231

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 29/228 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
             V +      + +   +K I              +E +         E+ I      H 
Sbjct: 31  SVVRRCIHK-PTCKEYAVKII-----DVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEY 265
           NI+ L           LV++  + G L D L    +    E +   R  +   +   +  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE--TRKIMRA-LLEVICA 139

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           LH  +   I+HRD++P N+L+DDDM  ++++FG + ++  G        + GT  Y+APE
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPE 193

Query: 326 ------CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
                            D++S GV++  L+ G  P    F H K+M +
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLM 237

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 37/227 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VY+ +    + +   +K +    K        D +        +R+EI    ++ H N
Sbjct: 67  SIVYRCK-QKGTQKPYALKVL---KK------TVDKK-------IVRTEIGVLLRLSHPN 109

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIAQGIASGLEY 265
           I+ L           LV E    G L D I   V +G   E D  A   + Q I   + Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERD--AADAVKQ-ILEAVAY 163

Query: 266 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LH  +   I+HRD++P N+L      D   +I++FGL+K +       T   + GT GY 
Sbjct: 164 LH-ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYC 217

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           APE  +  A     D++S G++  +L+ G  P   F+    +  + +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP---FYDERGDQFMFR 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 43/211 (20%), Positives = 74/211 (35%), Gaps = 40/211 (18%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G VY  E    +   I   IK     L    E      +           E +    + H
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKS----LSRITE----MQQV-----EAFLREGLLMRGLNH 81

Query: 206 RNIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
            N++ L+  M+  +    ++  +  +G L   +      +R             +A G+E
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGME 138

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI-- 322
           YL        +HRD+   N ++D+    ++++FGLA+ I     R            +  
Sbjct: 139 YLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPV 192

Query: 323 ---APECHQTVALSDTC-----DIYSFGVLL 345
              A E     +L         D++SFGVLL
Sbjct: 193 KWTALE-----SLQTYRFTTKSDVWSFGVLL 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 35/223 (15%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
              F  +E + +   G+VYK      +G++  IK +        ++   + E       +
Sbjct: 23  AGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVM--------DVTGDEEE-------E 66

Query: 193 IRSEI-ITAGQVRHRNIVPLLARMVRRDCDL------LVYEFRRNGSLQDILYDVSQGRR 245
           I+ EI +      HRNI       ++++         LV EF   GS+ D++ +      
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126

Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
           + +W+A   I + I  GL +LH   + ++IHRDI+  NVL+ ++ E ++ +FG++ ++  
Sbjct: 127 KEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

Query: 306 GHTRTTTWSLAGTVGYIAPECHQTVALSDT-----CDIYSFGV 343
              R  T+   GT  ++APE        D       D++S G+
Sbjct: 182 TVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 40/204 (19%), Positives = 77/204 (37%), Gaps = 29/204 (14%)

Query: 148 GEVYKAELPGSSGRVIT---IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           G V+K         +     IK     ++  +                +   ++  G + 
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKV----IEDKSGRQSFQ---------AVTDHMLAIGSLD 73

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H +IV LL  +       LV ++   GSL D +    Q R  L           IA G+ 
Sbjct: 74  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMY 129

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT---VGY 321
           YL       ++HR++   NVL+    + ++++FG+A  +P    +      +     + +
Sbjct: 130 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY---SEAKTPIKW 183

Query: 322 IAPECHQTVALSDTCDIYSFGVLL 345
           +A E       +   D++S+GV +
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTV 207

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 48/210 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V   +  G           I+ +K G+            + I+   E      + H  
Sbjct: 38  GVVKYGKWRG------QYDVAIKMIKEGS------MSE--DEFIE---EAKVMMNLSHEK 80

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L     ++    ++ E+  NG L + L    + R          + + +   +EYL 
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGTVG 320
                  +HRD+   N L++D    ++S+FGL++ + D    ++        WS      
Sbjct: 138 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------ 188

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
              PE      L  +      DI++FGVL+
Sbjct: 189 --PPE-----VLMYSKFSSKSDIWAFGVLM 211

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 30/206 (14%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G VY   L  + G+ I   +K     L    +      E     + Q  +E I      H
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKS----LNRITD----IGE-----VSQFLTEGIIMKDFSH 149

Query: 206 RNIVPLLARMVRRDCDLL-VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
            N++ LL   +R +   L V  + ++G L++ + +                   +A G++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 206

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI-- 322
           +L  + + + +HRD+   N ++D+    ++++FGLA+ +   + +        T   +  
Sbjct: 207 FL--ASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPV 260

Query: 323 ---APECHQTVALSDTCDIYSFGVLL 345
              A E  QT   +   D++SFGVLL
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLL 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 28/214 (13%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E  F+ L +I     G VY A     +  V+ IKK+               +  + K   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFA-RDVRNSEVVAIKKM-----------SYSGKQSNEKWQD 100

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I  E+    ++RH N +      +R     LV E+   GS  D+L    +  +E   +A 
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAA 158

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             +  G   GL YLH  +   +IHRD++  N+L+ +    ++ +FG A  +        +
Sbjct: 159 --VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS 209

Query: 313 WSLAGTVGYIAPE---CHQTVALSDTCDIYSFGV 343
           +   GT  ++APE              D++S G+
Sbjct: 210 F--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 48/210 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+     G   +V  +K + Q   S    +                E     Q++H+ 
Sbjct: 27  GEVWMGYYNGH-TKV-AVKSLKQGSMSPDAFLA---------------EANLMKQLQHQR 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V ++   ++ E+  NGSL D L   +    +L       +A  IA G+ ++ 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-------WSLAGTVG 320
             +    IHRD++ AN+L+ D +  +I++FGLA+ I D              W+      
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT------ 177

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
             APE     A++        D++SFG+LL
Sbjct: 178 --APE-----AINYGTFTIKSDVWSFGILL 200

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 30/206 (14%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G VY   L  + G+ I   +K     L    ++          ++ Q  +E I      H
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKS----LNRITDI---------GEVSQFLTEGIIMKDFSH 85

Query: 206 RNIVPLLARMVRRDCDLL-VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
            N++ LL   +R +   L V  + ++G L++ + +                   +A G++
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 142

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI-- 322
           YL        +HRD+   N ++D+    ++++FGLA+ +   + +        T   +  
Sbjct: 143 YLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPV 196

Query: 323 ---APECHQTVALSDTCDIYSFGVLL 345
              A E  QT   +   D++SFGVLL
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLL 222

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 52/210 (24%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V   +  G+    + +K     +K+ A    +             +E     Q+RH N
Sbjct: 35  GDVMLGDYRGNK---VAVKC----IKNDAT--AQA----------FLAEASVMTQLRHSN 75

Query: 208 IVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +V LL  +V     L +V E+   GSL D L   S+GR  L      + +  +   +EYL
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT------WSLAGTVG 320
             ++    +HRD+   NVL+ +D  A++S+FGL K   +  +   T      W+      
Sbjct: 134 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------ 181

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
             APE     AL +       D++SFG+LL
Sbjct: 182 --APE-----ALREKKFSTKSDVWSFGILL 204

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 26/215 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV   +   +      IK +I+  +        D++ +     +I +EI     + H N
Sbjct: 50  GEVLLCKEK-NGHSEKAIK-VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L      +    LV EF   G L + +  +++ +  E D  A + + Q I SG+ YL
Sbjct: 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECD--AANIMKQ-ILSGICYL 162

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H  +   I+HRDI+P N+L+   +  +  +I +FGL+      +         GT  YIA
Sbjct: 163 HKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIA 216

Query: 324 PECHQTVAL----SDTCDIYSFGVLLAVLVIGKFP 354
           PE      L    ++ CD++S GV++ +L+ G  P
Sbjct: 217 PE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 31/163 (19%)

Query: 195 SEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR 254
            E  T  ++ H  +V       +     +V E+  NG L + L       + L+      
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLE 108

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT-- 312
           +   +  G+ +L        IHRD+   N L+D D+  ++S+FG+ + + D    ++   
Sbjct: 109 MCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165

Query: 313 -----WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLL 345
                WS        APE                D+++FG+L+
Sbjct: 166 KFPVKWS--------APE-----VFHYFKYSSKSDVWAFGILM 195

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 51/223 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AE    S     +   ++ LK      +KD           + E      ++H +
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD----------FQREAELLTNLQHEH 78

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRELDWLARHRI 255
           IV         D  ++V+E+ ++G L   L                Q + EL       I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG-HTRTTT-- 312
           A  IASG+ YL   H    +HRD+   N L+  ++  +I +FG+++ +    + R     
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 313 -----WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLL 345
                W          PE     ++         D++SFGV+L
Sbjct: 196 MLPIRWM--------PPE-----SIMYRKFTTESDVWSFGVIL 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 33/212 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            EV+  +    +G++  +K I +        ++ +   L                ++H N
Sbjct: 23  SEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK--------------IKHEN 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIAQGIASGLEY 265
           IV L           LV +    G L D I   + +G   E D  A   I Q + S ++Y
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKD--ASLVIQQ-VLSAVKY 121

Query: 266 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LH  +   I+HRD++P N+L    +++ +  I++FGL+K   +G   T      GT GY+
Sbjct: 122 LH-ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYV 174

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE       S   D +S GV+  +L+ G  P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 43/217 (19%), Positives = 79/217 (36%), Gaps = 44/217 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+    G        +  I+ +   A      S     + +    E     +    +
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAA------SMRERIEFLN---EASVMKEFNCHH 89

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL------YDVSQGRRELDWLARHRIAQGIAS 261
           +V LL  + +    L++ E    G L+  L         +            ++A  IA 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT-RTTT-------W 313
           G+ YL+ +     +HRD+   N ++ +D   +I +FG+ + I +    R          W
Sbjct: 150 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 314 SLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
                   ++PE     +L D       D++SFGV+L
Sbjct: 207 --------MSPE-----SLKDGVFTTYSDVWSFGVVL 230

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 79.2 bits (196), Expect = 8e-17
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 36/216 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+  E   SSG    IK I    K      +   E       QI +EI     + H N
Sbjct: 36  GDVHLVEER-SSGLERVIKTI---NKD---RSQVPME-------QIEAEIEVLKSLDHPN 81

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGRR--ELDWLARHRIAQGIASGLE 264
           I+ +           +V E    G L + I+   ++G+   E        + Q + + L 
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY--VAELMKQ-MMNALA 138

Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           Y H  H   ++H+D++P N+L          +I +FGLA+        T     AGT  Y
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALY 192

Query: 322 IAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFP 354
           +APE    V    ++  CDI+S GV++  L+ G  P
Sbjct: 193 MAPE----VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 50/220 (22%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G V +  L    G  +   +K     +K      ++  E L        SE        H
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKT----MKLDNSSQREIEEFL--------SEAACMKDFSH 95

Query: 206 RNIVPLLA-----RMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQG 258
            N++ LL              +++  F + G L   L    +  G + +      +    
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI--PDGHTRTTT---- 312
           IA G+EYL   +    +HRD+   N ++ DDM   +++FGL+K+I   D + +       
Sbjct: 156 IALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 313 --WSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLL 345
             W        IA E     +L+D       D+++FGV +
Sbjct: 213 VKW--------IAIE-----SLADRVYTSKSDVWAFGVTM 239

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L          SE      +    E +   +  H+N
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVC------SEQDELDFLM---EALIISKFNHQN 94

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR---IAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 265 YLHMSHRPRIIHRDIQPANVLID---DDMEARISEFGLAKRIPDGH-TRTTTWSLAGTVG 320
           YL  +H    IHRDI   N L+        A+I +FG+A+ I      R    ++   V 
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP-VK 210

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
           ++ PE     A  +       D +SFGVLL
Sbjct: 211 WMPPE-----AFMEGIFTSKTDTWSFGVLL 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 11/165 (6%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            +R EI T   +RH  +V L       +  +++YEF   G L + + D      E +  A
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--A 257

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKRIPDGHTR 309
              + Q +  GL ++H ++    +H D++P N++        +   +FGL   +    + 
Sbjct: 258 VEYMRQ-VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                  GT  + APE  +   +    D++S GVL  +L+ G  P
Sbjct: 314 KV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 44/220 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+VYK  L G +    T    I+ LK  A        PL  +      E +   +++H N
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKA------EGPLREEFRH---EAMLRARLQHPN 73

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRELDWLARHRI 255
           +V LL  + +     +++ +  +G L + L             D    +  L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSL 315
              IA+G+EYL   H   ++H+D+   NVL+ D +  +IS+ GL + +            
Sbjct: 134 VAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK----- 185

Query: 316 AGTVGYI-----APECHQTVALSD-----TCDIYSFGVLL 345
                 +     APE     A+         DI+S+GV+L
Sbjct: 186 LLGNSLLPIRWMAPE-----AIMYGKFSIDSDIWSYGVVL 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRH 205
             V +     ++G    +K + +   +   E +++  E         R E  I      H
Sbjct: 108 SVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVRE-------ATRRETHILRQVAGH 159

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLE 264
            +I+ L+          LV++  R G L D  Y   +    E +   R  +   +   + 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVALSEKE--TRSIMRS-LLEAVS 214

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           +LH ++   I+HRD++P N+L+DD+M+ R+S+FG +  +  G        L GT GY+AP
Sbjct: 215 FLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAP 268

Query: 325 E------CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           E                 D+++ GV+L  L+ G  P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+ ++ G       ++  ++ L          SE      +    E +   +  H+N
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVC------SEQDELDFL---MEALIISKFNHQN 135

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHR---IAQGIASGLE 264
           IV  +   ++     ++ E    G L+  L +      +   LA      +A+ IA G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 265 YLHMSHRPRIIHRDIQPANVLID---DDMEARISEFGLAKRIPDGH-TRTTTWSLAGTVG 320
           YL  +H    IHRDI   N L+        A+I +FG+A+ I      R    ++   V 
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP-VK 251

Query: 321 YIAPECHQTVALSDT-----CDIYSFGVLL 345
           ++ PE     A  +       D +SFGVLL
Sbjct: 252 WMPPE-----AFMEGIFTSKTDTWSFGVLL 276

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 58/212 (27%), Positives = 85/212 (40%), Gaps = 25/212 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V K     S+G     K  I+  +S A       E       +I  E+    QV H N
Sbjct: 26  AIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVCRE-------EIEREVSILRQVLHPN 76

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L      R   +L+ E    G L D L    +    E +  A   I Q I  G+ YL
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--ATSFIKQ-ILDGVNYL 131

Query: 267 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           H      I H D++P N+++          ++ +FGLA  I DG        + GT  ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE      L    D++S GV+  +L+ G  P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 25/212 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V K     S+G     K  I+  +S A       E       +I  E+    QV H N
Sbjct: 26  AIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVSRE-------EIEREVSILRQVLHHN 76

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           ++ L      R   +L+ E    G L D L    +    E +  A   I Q I  G+ YL
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--ATSFIKQ-ILDGVNYL 131

Query: 267 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           H      I H D++P N+++          ++ +FGLA  I DG        + GT  ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFV 185

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE      L    D++S GV+  +L+ G  P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 28/224 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V +      +G+   +K +          + K +         ++ E      ++H +
Sbjct: 38  SVVRRCINR-ETGQQFAVKIV---------DVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGRR--ELDWLARHRIAQGIASGLE 264
           IV LL          +V+EF     L   I+     G    E    A H + Q I   L 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQ-ILEALR 144

Query: 265 YLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           Y H  +   IIHRD++P  VL+   ++    ++  FG+A ++ +           GT  +
Sbjct: 145 YCH-DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHF 199

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM 365
           +APE  +        D++  GV+L +L+ G  P    F  TKE 
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKER 239

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V +     ++G     K I     +  +L  +D +       ++  E     +++H N
Sbjct: 20  SVVRRCVHK-TTGLEFAAKII-----NTKKLSARDFQ-------KLEREARICRKLQHPN 66

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           IV L   +       LV++    G L + +  V++    E D  A H I Q I   + Y 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASHCIQQ-ILESIAYC 121

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H S+   I+HR+++P N+L+         ++++FGLA  + D          AGT GY++
Sbjct: 122 H-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE  +    S   DI++ GV+L +L++G  P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 51/221 (23%)

Query: 148 GEVYKAELPGSSGRVIT--IKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G V +A+L    G  +   +K     LK+         E L         E     +  H
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKM----LKADIIASSDIEEFL--------REAACMKEFDH 84

Query: 206 RNIVPLLA------RMVRRDCDLLVYEFRRNGSLQDIL--YDVSQGRRELDWLARHRIAQ 257
            ++  L+          R    +++  F ++G L   L    + +    L      R   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT-RTTT---- 312
            IA G+EYL   +    IHRD+   N ++ +DM   +++FGL+++I  G   R       
Sbjct: 145 DIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 313 ---WSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLL 345
              W        +A E     +L+D       D+++FGV +
Sbjct: 202 PVKW--------LALE-----SLADNLYTVHSDVWAFGVTM 229

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 37/211 (17%), Positives = 82/211 (38%), Gaps = 37/211 (17%)

Query: 148 GEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
            +++K      G  G++   + +++ L        +                    ++ H
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES----------FFEAASMMSKLSH 71

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           +++V      V  D ++LV EF + GSL   L      +  ++ L +  +A+ +A+ + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEAR--------ISEFGLAKRI-PDGHTRT-TTWSL 315
           L  +    +IH ++   N+L+  + + +        +S+ G++  + P    +    W  
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV- 184

Query: 316 AGTVGYIAPEC-HQTVALSDTCDIYSFGVLL 345
                   PEC      L+   D +SFG  L
Sbjct: 185 -------PPECIENPKNLNLATDKWSFGTTL 208

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 28/211 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV   +    +G+   +K I            K           +  E+    Q+ H N
Sbjct: 40  GEVILCKDK-ITGQECAVKVI-----------SKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L      +    LV E    G L D +  +S+ R  E+D  A   I Q + SG+ Y+
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVD--AARIIRQ-VLSGITYM 142

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H +    I+HRD++P N+L+     D   RI +FGL+                GT  YIA
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIA 196

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE        + CD++S GV+L +L+ G  P
Sbjct: 197 PEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 46/225 (20%), Positives = 83/225 (36%), Gaps = 51/225 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKD---SEPLHHKMIQIRSEIITAGQVR 204
           G+V +A   G       +   ++ LK  A L +++   SE      +++ S +       
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE------LKVLSYL-----GN 85

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL--------------YDVSQGRRELDWL 250
           H NIV LL         L++ E+   G L + L                +      LD  
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
                +  +A G+ +L   +    IHRD+   N+L+      +I +FGLA+ I +     
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 311 TTWSLAGTVGYI-----APECHQTVALSDTC-----DIYSFGVLL 345
                      +     APE     ++ +       D++S+G+ L
Sbjct: 203 -----VKGNARLPVKWMAPE-----SIFNCVYTFESDVWSYGIFL 237

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.2 bits (190), Expect = 8e-16
 Identities = 51/250 (20%), Positives = 81/250 (32%), Gaps = 57/250 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V  A     +  +  IK +            K  +     + +I++E+    ++ H N
Sbjct: 40  GVVRVAIEN-QTRAIRAIKIM---------NKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 208 IVP----------------------LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRR 245
           I                        LL ++     D            Q           
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 246 ELDWL---------------ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
               +                 + + Q I S L YLH      I HRDI+P N L   + 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQ-IFSALHYLHNQG---ICHRDIKPENFLFSTNK 205

Query: 291 EAR--ISEFGLAKRIPDGHT--RTTTWSLAGTVGYIAPE-CHQTVALSDT-CDIYSFGVL 344
                + +FGL+K     +        + AGT  ++APE  + T       CD +S GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 345 LAVLVIGKFP 354
           L +L++G  P
Sbjct: 266 LHLLLMGAVP 275

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.4 bits (189), Expect = 8e-16
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 25/212 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V K      +G+    K  I+  +  +       E       +I  E+    ++RH N
Sbjct: 19  AIVRKCR-QKGTGKEYAAK-FIKKRRLSSSRRGVSRE-------EIEREVNILREIRHPN 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L      +   +L+ E    G L D L    +    E +  A   + Q I  G+ YL
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE--ATQFLKQ-ILDGVHYL 124

Query: 267 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           H      I H D++P N+++      +   ++ +FG+A +I  G+       + GT  ++
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFV 178

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE      L    D++S GV+  +L+ G  P
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 38/202 (18%)

Query: 157 GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH----RNIV--- 209
           GS GRV+ +K             K+       K++    +++   Q+ H    + I+   
Sbjct: 52  GSFGRVMLVKH------------KESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAV 98

Query: 210 --PLLARMVR--RDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
             P L ++    +D   L  V E+   G +   L  +    R  +  AR   AQ I    
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQ-IVLTF 154

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           EYLH      +I+RD++P N+LID     ++++FG AKR+        TW+L GT   +A
Sbjct: 155 EYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALA 206

Query: 324 PECHQTVALSDTCDIYSFGVLL 345
           PE   +   +   D ++ GVL+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLI 228

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 47/221 (21%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGA-ELIKKD--SEPLHHKMIQIRSEIITAGQVR 204
           G+V +A   G       +K  ++ LKS A    K+   SE      ++I S +      +
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE------LKIMSHL-----GQ 108

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL----------YDVSQGRRELDWLARHR 254
           H NIV LL         L++ E+   G L + L             +             
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
            +  +A G+ +L   +    IHRD+   NVL+ +   A+I +FGLA+ I        +  
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI-----MNDSNY 220

Query: 315 LAGTVGYI-----APECHQTVALSDTC-----DIYSFGVLL 345
           +      +     APE     ++ D       D++S+G+LL
Sbjct: 221 IVKGNARLPVKWMAPE-----SIFDCVYTVQSDVWSYGILL 256

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V +     ++G     K I     +  +L  +D +       ++  E     +++H N
Sbjct: 43  SVVRRCVHK-TTGLEFAAKII-----NTKKLSARDFQ-------KLEREARICRKLQHPN 89

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           IV L   +       LV++    G L + +  V++    E D  A H I Q I   + Y 
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASHCIQQ-ILESIAYC 144

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H S+   I+HR+++P N+L+         ++++FGLA  + D          AGT GY++
Sbjct: 145 H-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 198

Query: 324 PECHQTVALSDTCDIYSFGVLLAVL 348
           PE  +    S   DI++ GV+L +L
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYIL 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 29/211 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV        +     IK I         +    +        ++  E+     + H N
Sbjct: 51  GEVLLCRDK-VTHVERAIKII-----RKTSVSTSSNS-------KLLEEVAVLKLLDHPN 97

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L      +    LV E  + G L D +  + + +  E+D  A   I Q + SG+ YL
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVD--AAVIIKQ-VLSGVTYL 152

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H  +   I+HRD++P N+L+   + D   +I +FGL+    +           GT  YIA
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIA 206

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           PE  +     + CD++S GV+L +L+ G  P
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 10/109 (9%)

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR  +A+ +   ++ +H  H    +HRDI+P N+L+D +   R+++FG   ++ +  T  
Sbjct: 177 ARFYLAE-MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 231

Query: 311 TTWSLAGTVGYIAPECHQTVALSD-----TCDIYSFGVLLAVLVIGKFP 354
            +    GT  YI+PE  Q +          CD +S GV +  ++ G+ P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 9/99 (9%)

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
           AR   A+ +   L+ +H       IHRD++P N+L+D     ++++FG   ++       
Sbjct: 170 ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224

Query: 311 TTWSLAGTVGYIAPECHQTVALSD----TCDIYSFGVLL 345
              +  GT  YI+PE  ++          CD +S GV L
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 35/87 (40%), Positives = 53/87 (60%), Gaps = 8/87 (9%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +   LEYLH      II+RD++P N+L+D +   +I++FG AK +PD      T++L GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLL 345
             YIAPE   T   + + D +SFG+L+
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILI 193

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 39/216 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV K +    + +   +K I     + A    KD+         I  E+    ++ H N
Sbjct: 36  GEVLKCK-DRITQQEYAVKVI-----NKASAKNKDTS-------TILREVELLKKLDHPN 82

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIAQGIASGLEY 265
           I+ L   +       +V E    G L D I   + + R  E D  A   I Q + SG+ Y
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHD--AARIIKQ-VFSGITY 136

Query: 266 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           +H  +   I+HRD++P N+L+   + D + +I +FGL+                GT  YI
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYI 190

Query: 323 APECHQTVALSDT----CDIYSFGVLLAVLVIGKFP 354
           APE      L  T    CD++S GV+L +L+ G  P
Sbjct: 191 APE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 56/215 (26%), Positives = 81/215 (37%), Gaps = 39/215 (18%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV  A     +      KKI    K   E + +            + EI     + H N
Sbjct: 23  GEVKIAVQK-GTRIRRAAKKI---PKYFVEDVDR-----------FKQEIEIMKSLDHPN 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L           LV E    G L +    V +   RE D  A   +   + S + Y 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESD--AARIMKD-VLSAVAYC 122

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H  +   + HRD++P N L      D   ++ +FGLA R   G    T     GT  Y++
Sbjct: 123 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVS 176

Query: 324 PECHQTVALSDT----CDIYSFGVLLAVLVIGKFP 354
           P+      L       CD +S GV++ VL+ G  P
Sbjct: 177 PQ-----VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 11/164 (6%)

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           +++EI    Q+ H  ++ L      +   +L+ EF   G L D +        E +    
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VI 152

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKRIPDGHTRT 310
           + + Q    GL+++H      I+H DI+P N++ +    + +   +FGLA ++       
Sbjct: 153 NYMRQ-ACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                  T  + APE      +    D+++ GVL  VL+ G  P
Sbjct: 209 V---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+K E   ++G  +  K I      G +  ++           +++EI    Q+ H N
Sbjct: 103 GQVHKCEET-ATGLKLAAKII---KTRGMKDKEE-----------VKNEISVMNQLDHAN 147

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ L      ++  +LV E+   G L D + D S    ELD      + Q I  G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TILFMKQ-ICEGIRHMH 204

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
                 I+H D++P N+L  +    +I   +FGLA+R              GT  ++APE
Sbjct: 205 -QMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPE 258

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                 +S   D++S GV+  +L+ G  P
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV K +    + +   +K I     + A    KD+         I  E+    ++ H N
Sbjct: 36  GEVLKCKDR-ITQQEYAVKVI-----NKASAKNKDTS-------TILREVELLKKLDHPN 82

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           I+ L   +       +V E    G L D +  + + R  E D  A   I Q + SG+ Y+
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHD--AARIIKQ-VFSGITYM 137

Query: 267 HMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           H  +   I+HRD++P N+L+   + D + +I +FGL+                GT  YIA
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIA 191

Query: 324 PECHQTVALSDT----CDIYSFGVLLAVLVIGKFP 354
           PE      L  T    CD++S GV+L +L+ G  P
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V K     S+G     K  I+  ++ +       E        I  E+    +++H N
Sbjct: 25  AVVKKCR-EKSTGLQYAAK-FIKKRRTKSSRRGVSRE-------DIEREVSILKEIQHPN 75

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGR-RELDWLARHRIAQGIASGLEYL 266
           ++ L      +   +L+ E    G L D L    +    E +  A   + Q I +G+ YL
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEE--ATEFLKQ-ILNGVYYL 130

Query: 267 HMSHRPRIIHRDIQPANVLI----DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           H      I H D++P N+++          +I +FGLA +I  G+       + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE      L    D++S GV+  +L+ G  P
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 157 GSSGRVITIKKIIQPLKSGAEL-----IKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL 211
           G+ G+VI +K+     K+         +KK+      ++    +E       RH  +  L
Sbjct: 159 GTFGKVILVKE-----KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR 271
                  D    V E+   G   ++ + +S+ R   +  AR   A+ I S L+YLH    
Sbjct: 214 KYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN 269

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAGTVGYIAPECHQTV 330
             +++RD++  N+++D D   +I++FGL K  I DG    T  +  GT  Y+APE  +  
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDN 324

Query: 331 ALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                 D +  GV++  ++ G+  F + D
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 50/224 (22%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGA-ELIKKD--SEPLHHKMIQIRSEIITAGQVR 204
           G+V +A+  G           ++ LK GA     +   SE      ++I   I       
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE------LKILIHI-----GH 89

Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDIL------------YDVSQGRRELDWLA 251
           H N+V LL    +    L ++ EF + G+L   L                  +  L    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
               +  +A G+E+L  + R + IHRD+   N+L+ +    +I +FGLA+ I        
Sbjct: 150 LICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205

Query: 312 TWSLAGTVGYI-----APECHQTVALSDTC-----DIYSFGVLL 345
                     +     APE      + D       D++SFGVLL
Sbjct: 206 ----RKGDARLPLKWMAPE-----TIFDRVYTIQSDVWSFGVLL 240

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 46/209 (22%), Positives = 84/209 (40%), Gaps = 29/209 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V +      +G+      I            K      H+ +    E      ++H N
Sbjct: 25  SVVRRCV-KVLAGQEYAAMIIN----------TKKLSARDHQKL--EREARICRLLKHPN 71

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR-RELDWLARHRIAQGIASGLEY 265
           IV L   +       L+++    G L + I   V++    E D  A H I Q I   + +
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEAD--ASHCIQQ-ILEAVLH 125

Query: 266 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
            H      ++HR+++P N+L+         ++++FGLA  +            AGT GY+
Sbjct: 126 CH-QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIG 351
           +PE  +        D+++ GV+L +L++G
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVG 209

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 50/233 (21%), Positives = 87/233 (37%), Gaps = 62/233 (26%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGA-ELIKKD--SEPLHHKMIQIRSEIITAGQVR 204
           G+V  A   G S   ++I+  ++ LK  A    ++   SE      +++ +++       
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE------LKMMTQL-----GS 107

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL-------------------YDVSQGRR 245
           H NIV LL          L++E+   G L + L                    +  +   
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 246 ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD 305
            L +      A  +A G+E+L        +HRD+   NVL+      +I +FGLA+ I  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 306 GH--TRTTT------WSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLL 345
                          W        +APE     +L +       D++S+G+LL
Sbjct: 225 DSNYVVRGNARLPVKW--------MAPE-----SLFEGIYTIKSDVWSYGILL 264

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 65/232 (28%)

Query: 148 GEVYKAELPG----SSGRVIT--IKKIIQPLKSGA-ELIKKD--SEPLHHKMIQIRSEII 198
           G+V  AE  G         +T  +K     LK  A E    D  SE      +++   I 
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSE------MEMMKMI- 97

Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRE 246
                +H+NI+ LL    +     ++ E+   G+L++ L                    +
Sbjct: 98  ----GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           + +         +A G+EYL        IHRD+   NVL+ ++   +I++FGLA+ I + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 307 HT-RTTT-------WSLAGTVGYIAPECHQTVALSD---TC--DIYSFGVLL 345
              + TT       W        +APE     AL D   T   D++SFGVL+
Sbjct: 211 DYYKKTTNGRLPVKW--------MAPE-----ALFDRVYTHQSDVWSFGVLM 249

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 14/112 (12%)

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTR 309
           AR  +A+ I   ++ +H       +HRDI+P N+L+D     R+++FG   +   DG  R
Sbjct: 164 ARFYLAE-IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219

Query: 310 TTTWSLAGTVGYIAPECHQTVALSD-------TCDIYSFGVLLAVLVIGKFP 354
           +      GT  Y++PE  Q V            CD ++ GV    +  G+ P
Sbjct: 220 SLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 58/231 (25%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V KA      GR       ++ LK  A      SE     +  + SE     QV H +
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSE-----LRDLLSEFNVLKQVNHPH 87

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL--------------------YDVSQGRREL 247
           ++ L     +    LL+ E+ + GSL+  L                           R L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
                   A  I+ G++YL       ++HRD+   N+L+ +  + +IS+FGL++ + +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 308 T-RTTT-------WSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLL 345
           +    +       W        +A E     +L D       D++SFGVLL
Sbjct: 205 SYVKRSQGRIPVKW--------MAIE-----SLFDHIYTTQSDVWSFGVLL 242

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 60/269 (22%)

Query: 108 GGSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGE-----VYKAELPGSSGRV 162
           G          S +    +  + +  + + +L  +     GE     V K      +GR+
Sbjct: 2   GHHHHHHS---SGVDLGTENLYFQSMEKYENLGLV-----GEGSYGMVMKCR-NKDTGRI 52

Query: 163 ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDL 222
           + IKK             +  +    K I +R EI    Q+RH N+V LL  + ++    
Sbjct: 53  VAIKKF-----------LESDDDKMVKKIAMR-EIKLLKQLRHENLVNLL-EVCKKKKRW 99

Query: 223 -LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
            LV+EF        IL D+      LD+    +    I +G+ + H SH   IIHRDI+P
Sbjct: 100 YLVFEF----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-SHN--IIHRDIKP 152

Query: 282 ANVLIDDDMEARISEFGLA--KRIPDGHTRT----TTWSLAGTVGYIAPECHQTVALSDT 335
            N+L+      ++ +FG A     P G        T W       Y APE    + + D 
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRW-------YRAPE----LLVGDV 200

Query: 336 C-----DIYSFGVLLAVLVIGK--FPSDD 357
                 D+++ G L+  + +G+  FP D 
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 26/199 (13%)

Query: 189 KMIQIRSEI-ITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR-- 244
                  EI I     +H NI+ L           +V E  + G L D I   + Q    
Sbjct: 58  SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFS 114

Query: 245 -RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA----RISEFGL 299
            RE    A   +   I   +EYLH +    ++HRD++P+N+L  D+       RI +FG 
Sbjct: 115 ERE----ASAVLFT-ITKTVEYLH-AQG--VVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF 359
           AK++   +    T     T  ++APE  +       CDI+S GVLL  ++ G  P    F
Sbjct: 167 AKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP----F 220

Query: 360 QHTKEMSLVQWMRNVMTSE 378
            +  + +  + +  + + +
Sbjct: 221 ANGPDDTPEEILARIGSGK 239

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 55/275 (20%), Positives = 105/275 (38%), Gaps = 44/275 (16%)

Query: 110 SRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKII 169
           S     +   P  K+  +     +DY  S + +    NG+V +      +G+   +K + 
Sbjct: 9   SSGLEVLFQGPEPKKYAV----TDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLL- 62

Query: 170 QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA----RMVRRDCDLLVY 225
                 +   +++ +                      +IV +L         + C L++ 
Sbjct: 63  ----YDSPKARQEVDHHWQAS-------------GGPHIVCILDVYENMHHGKRCLLIIM 105

Query: 226 EFRRNGSLQD-ILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV 284
           E    G L   I     Q   E +  A   +   I + +++LH  +   I HRD++P N+
Sbjct: 106 ECMEGGELFSRIQERGDQAFTERE--AAEIMRD-IGTAIQFLHSHN---IAHRDVKPENL 159

Query: 285 LI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           L    + D   ++++FG AK       +T       T  Y+APE         +CD++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTP----CYTPYYVAPEVLGPEKYDKSCDMWSL 215

Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           GV++ +L+ G  P   F+ +T +       R +  
Sbjct: 216 GVIMYILLCGFPP---FYSNTGQAISPGMKRRIRL 247

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 8/111 (7%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I   LE+LH      II+RDI+  N+L+D +    +++FGL+K      T    +   GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGT 223

Query: 319 VGYIAPE--CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           + Y+AP+             D +S GVL+  L+ G   F  D       E+
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 65/232 (28%)

Query: 148 GEVYKAELPG----SSGRVIT--IKKIIQPLKSGA-ELIKKD--SEPLHHKMIQIRSEII 198
           G+V  AE  G         +T  +K     LK  A E    D  SE      +++   I 
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSE------MEMMKMI- 143

Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRE 246
                +H+NI+ LL    +     ++ E+   G+L++ L                    +
Sbjct: 144 ----GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           + +         +A G+EYL        IHRD+   NVL+ ++   +I++FGLA+ I + 
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 307 HT-RTTT-------WSLAGTVGYIAPECHQTVALSD---TC--DIYSFGVLL 345
              + TT       W        +APE     AL D   T   D++SFGVL+
Sbjct: 257 DYYKKTTNGRLPVKW--------MAPE-----ALFDRVYTHQSDVWSFGVLM 295

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 45/223 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+K      +G+++ IKK             +  +    K I +R EI    Q++H N
Sbjct: 17  GVVFKCR-NRDTGQIVAIKKF-----------LESEDDPVIKKIALR-EIRMLKQLKHPN 63

Query: 208 IVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +V LL  + RR   L LV+E+  + ++   L    +G  E   L +    Q     + + 
Sbjct: 64  LVNLL-EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEH--LVKSITWQ-TLQAVNFC 118

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK--RIPDG---HTRTTTWSLAGTVGY 321
           H  H    IHRD++P N+LI      ++ +FG A+    P         T W       Y
Sbjct: 119 H-KHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-------Y 168

Query: 322 IAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSDD 357
            +PE    + + DT      D+++ G + A L+ G   +P   
Sbjct: 169 RSPE----LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 11/165 (6%)

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
            ++ EI      RHRNI+ L       +  ++++EF     + + +   +    E +   
Sbjct: 47  LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE--I 104

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA--RISEFGLAKRIPDGHTR 309
              + Q +   L++LH  +   I H DI+P N++      +  +I EFG A+++  G   
Sbjct: 105 VSYVHQ-VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                L     Y APE HQ   +S   D++S G L+ VL+ G  P
Sbjct: 161 RL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 41/212 (19%), Positives = 84/212 (39%), Gaps = 27/212 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR- 206
             V +     S+G+    K +           +           +I  EI      +   
Sbjct: 43  AVVRQCI-SKSTGQEYAAKFL-----KKRRRGQDCRA-------EILHEIAVLELAKSCP 89

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            ++ L          +L+ E+   G +    L ++++   E D      I Q I  G+ Y
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIRLIKQ-ILEGVYY 146

Query: 266 LHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           LH ++   I+H D++P N+L+       + +I +FG++++I           + GT  Y+
Sbjct: 147 LHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYL 200

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           APE      ++   D+++ G++  +L+    P
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 58/231 (25%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++A  PG           ++ LK  A      S  +         E     +  + N
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQADFQ---REAALMAEFDNPN 111

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDIL--------------------YDVSQGRREL 247
           IV LL          L++E+   G L + L                       S G   L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 248 DWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGH 307
               +  IA+ +A+G+ YL        +HRD+   N L+ ++M  +I++FGL++ I    
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 308 T-RTTT-------WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLL 345
             +          W        + PE     ++         D++++GV+L
Sbjct: 229 YYKADGNDAIPIRW--------MPPE-----SIFYNRYTTESDVWAYGVVL 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 62/229 (27%), Positives = 88/229 (38%), Gaps = 59/229 (25%)

Query: 148 GEVYKAELPG----SSGRVIT--IKKIIQPLKSGA---ELIKKDSEPLHHKMIQIRSEII 198
           G+V  AE  G       RV    +K     LKS A   +L    SE     M  I     
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISE--MEMMKMIG---- 132

Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL------------YDVSQGRRE 246
                +H+NI+ LL    +     ++ E+   G+L++ L                    +
Sbjct: 133 -----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG 306
           L        A  +A G+EYL        IHRD+   NVL+ +D   +I++FGLA+ I   
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 307 HTRTTTWSLAGTVGYI-----APECHQTVALSDTC-----DIYSFGVLL 345
                      T G +     APE     AL D       D++SFGVLL
Sbjct: 245 DYYK-----KTTNGRLPVKWMAPE-----ALFDRIYTHQSDVWSFGVLL 283

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 30/210 (14%), Positives = 64/210 (30%), Gaps = 56/210 (26%)

Query: 148 GEVYKAE---LPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
            + ++A    L     R + +  +        +++++             S  +   ++ 
Sbjct: 45  LQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQE-----------TLSRTLRLSRID 89

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
              +  +L  +  R   L+V E+ R GSLQ++             +   R  Q +A+  +
Sbjct: 90  KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAAD 143

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
               +HR  +      P+ V +  D        G                       +  
Sbjct: 144 A---AHRAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD 178

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
              Q        DI   G  L  L++ ++P
Sbjct: 179 ANPQD-------DIRGIGASLYALLVNRWP 201

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 17/197 (8%)

Query: 188 HKMIQIRSEIITAGQVR-HRNIVPLLARMVRRDCDLLVYEFRRNGSLQD-ILYDVSQGR- 244
                 + EI        H NIV L      +    LV E    G L + I     +   
Sbjct: 47  RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHF 103

Query: 245 RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAK 301
            E +  A + + + + S + ++H      ++HRD++P N+L    +D++E +I +FG A+
Sbjct: 104 SETE--ASYIMRK-LVSAVSHMH-DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157

Query: 302 RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH 361
             P  +    T     T+ Y APE        ++CD++S GV+L  ++ G+ P     + 
Sbjct: 158 LKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

Query: 362 TKEMSLVQWMRNVMTSE 378
               S V+ M+ +   +
Sbjct: 216 LTCTSAVEIMKKIKKGD 232

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 13/110 (11%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAG 317
           IAS L YLH  +   I++RD++P N+L+D      +++FGL K  I      +TT +  G
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---STTSTFCG 201

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           T  Y+APE         T D +  G +L  ++ G   F S +    T EM
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEM 247

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 9e-14
 Identities = 35/109 (32%), Positives = 59/109 (54%), Gaps = 11/109 (10%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +A  L++LH      II+RD++P N+L+D++   ++++FGL+K   D   +  +    GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           V Y+APE       + + D +SFGVL+  ++ G   F   D     KE 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RKET 234

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 31/217 (14%)

Query: 179 IKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVRRDCDLLVYEFRRNGSLQD-I 236
           I+K   P H +  ++  E+    Q + HRN++ L+      D   LV+E  R GS+   I
Sbjct: 46  IEKQ--PGHIRS-RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI 102

Query: 237 LYDVSQGR-RELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEA 292
                +    EL+  A   +   +AS L++LH      I HRD++P N+L    +     
Sbjct: 103 ---HKRRHFNELE--ASVVVQD-VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153

Query: 293 RISEFGLAKRIPDGHTRTTTWS-----LAGTVGYIAPECHQTVALSDT-----CDIYSFG 342
           +I +F L   I      +   +       G+  Y+APE  +  +   +     CD++S G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213

Query: 343 VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
           V+L +L+ G  P   F                   +N
Sbjct: 214 VILYILLSGYPP---FVGRCGSDCGWDRGEACPACQN 247

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 11/109 (10%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I+  L +LH      II+RD++P N++++     ++++FGL K      T T T    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           + Y+APE       +   D +S G L+  ++ G   F  ++     K+ 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKT 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 54/229 (23%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK++Q                  K  + R E+    ++ H N
Sbjct: 68  GVVYQAKL-CDSGELVAIKKVLQ-----------------DKRFKNR-ELQIMRKLDHCN 108

Query: 208 IVPLLARMV-----RRDCDL-LVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIAQGIA 260
           IV L          + +  L LV ++    ++  +    S+ ++ L     +  + Q + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQ-LF 166

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-RISEFGLAKRIPDGHTRT----TTWSL 315
             L Y+H S    I HRDI+P N+L+D D    ++ +FG AK++  G        + +  
Sbjct: 167 RSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221

Query: 316 AGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                Y APE        T ++    D++S G +LA L++G+  FP D 
Sbjct: 222 -----YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGDS 261

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 40/209 (19%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRN 230
           IKK S P  ++    R+  E++    V H+NI+ LL      + +    D+ LV E    
Sbjct: 92  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL--- 148

Query: 231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
             +   L  V Q   + + +  + + Q +  G+++LH +    IIHRD++P+N+++  D 
Sbjct: 149 --MDANLCQVIQMELDHERM-SYLLYQ-MLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 201

Query: 291 EARISEFGLAKRIPDGHTRT----TTWSLAGTVGYIAPE----CHQTVALSDTCDIYSFG 342
             +I +FGLA+        T    T +       Y APE          +    DI+S G
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRY-------YRAPEVILGMGYKENV----DIWSVG 250

Query: 343 VLLAVLVIGK--FPSDDFF-QHTKEMSLV 368
            ++  +V  K  FP  D+  Q  K +  +
Sbjct: 251 CIMGEMVRHKILFPGRDYIDQWNKVIEQL 279

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)

Query: 189 KMIQ----IRSEI-ITAGQVRHRNIVPLLA----RMVRRDCDLLVYEFRRNGSLQD-ILY 238
           KM+Q     R E+ +     +  +IV ++         R C L+V E    G L   I  
Sbjct: 93  KMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-- 150

Query: 239 DVSQGRR---ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEA 292
              +G +   E +  A   +   I   ++YLH  +   I HRD++P N+L      +   
Sbjct: 151 -QDRGDQAFTERE--ASEIMKS-IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 203

Query: 293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK 352
           ++++FG AK     ++ TT      T  Y+APE         +CD++S GV++ +L+ G 
Sbjct: 204 KLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260

Query: 353 --FPSDDFFQHTKEM 365
             F S+     +  M
Sbjct: 261 PPFYSNHGLAISPGM 275

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 13/110 (11%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-IPDGHTRTTTWSLAG 317
           I  GL++LH      I++RD++  N+L+D D   +I++FG+ K  +        T +  G
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCG 180

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEM 365
           T  YIAPE       + + D +SFGVLL  ++IG+  F   D     +E+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEEL 226

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 52/232 (22%), Positives = 90/232 (38%), Gaps = 54/232 (23%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIR--SEIITAGQVRH 205
           G V   +   S+G  + IKK+IQ                     + R    +     + H
Sbjct: 37  GTVQLGKEK-STGMSVAIKKVIQ-----------------DPRFRNRELQIMQDLAVLHH 78

Query: 206 RNIVPLLARMV----RRDCDL---LVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIAQ 257
            NIV L +       R   D+   +V E+    +L     +  + +      L +  + Q
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRT----TT 312
            +   +  LH      + HRDI+P NVL++  D   ++ +FG AK++           + 
Sbjct: 138 -LIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 313 WSLAGTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           +       Y APE      H T A+    DI+S G + A +++G+  F  D+
Sbjct: 196 Y-------YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGDN 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 11/137 (8%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D++Y + Q  R  +  A    A+ IA GL +L       II+RD++  
Sbjct: 419 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---IIYRDLKLD 471

Query: 283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG 342
           NV++D +   +I++FG+ K        T T    GT  YIAPE         + D ++FG
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPYGKSVDWWAFG 529

Query: 343 VLLAVLVIGK--FPSDD 357
           VLL  ++ G+  F  +D
Sbjct: 530 VLLYEMLAGQAPFEGED 546

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 7/101 (6%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           I S LEYLH      +++RDI+  N+++D D   +I++FGL K          T    GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
             Y+APE  +        D +  GV++  ++ G+  F + D
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 40/209 (19%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRN 230
           IKK S P  ++    R+  E++    V H+NI+ LL      + +    D+ +V E    
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL--- 111

Query: 231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
             +   L  V Q   + + +  + + Q +  G+++LH +    IIHRD++P+N+++  D 
Sbjct: 112 --MDANLCQVIQMELDHERM-SYLLYQ-MLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164

Query: 291 EARISEFGLAKRIPDGHTRT----TTWSLAGTVGYIAPE----CHQTVALSDTCDIYSFG 342
             +I +FGLA+        T    T +       Y APE          +    DI+S G
Sbjct: 165 TLKILDFGLARTAGTSFMMTPYVVTRY-------YRAPEVILGMGYKENV----DIWSVG 213

Query: 343 VLLAVLVIGK--FPSDDFF-QHTKEMSLV 368
            ++  ++ G   FP  D   Q  K +  +
Sbjct: 214 CIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 58/245 (23%)

Query: 134 DYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
             +  L+ +     GE     VYKA    ++ +++ IKKI    K G     KD      
Sbjct: 10  KRYEKLDFL-----GEGQFATVYKARDK-NTNQIVAIKKI----KLGHRSEAKDGIN--- 56

Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
               +R EI    ++ H NI+ LL     +    LV++F     L+ I+ D S       
Sbjct: 57  -RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLV----- 108

Query: 249 WLARHRI----AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR-- 302
            L    I          GLEYLH  H   I+HRD++P N+L+D++   ++++FGLAK   
Sbjct: 109 -LTPSHIKAYMLM-TLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

Query: 303 IPDG---HTRTTTWSLAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK-- 352
            P+    H   T W       Y APE         V +    D+++ G +LA L++    
Sbjct: 164 SPNRAYTHQVVTRW-------YRAPELLFGARMYGVGV----DMWAVGCILAELLLRVPF 212

Query: 353 FPSDD 357
            P D 
Sbjct: 213 LPGDS 217

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 7/101 (6%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           IA GL +L       II+RD++  NV++D +   +I++FG+ K        T T    GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
             YIAPE         + D ++FGVLL  ++ G+  F  +D
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 9/102 (8%)

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAK-RIPDGHTRTTTWSLAG 317
           I S L +LH      II+RD++  NVL+D +   ++++FG+ K  I +G    TT +  G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG---VTTATFCG 186

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           T  YIAPE  Q +      D ++ GVLL  ++ G   F +++
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 37/200 (18%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRN 230
           +KK S P    +   R+  E+     ++H N++ LL     AR +    D+ LV      
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL--- 115

Query: 231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
             +   L ++ + ++  D   +  I Q I  GL+Y+H +    IIHRD++P+N+ +++D 
Sbjct: 116 --MGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 169

Query: 291 EARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALS-----DTCDIYSFGV 343
           E +I +FGLA+   D  T    T W       Y APE    + L+      T DI+S G 
Sbjct: 170 ELKILDFGLARHTADEMTGYVATRW-------YRAPE----IMLNWMHYNQTVDIWSVGC 218

Query: 344 LLAVLVIGK--FPSDDFFQH 361
           ++A L+ G+  FP  D    
Sbjct: 219 IMAELLTGRTLFPGTDHIDQ 238

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++  
Sbjct: 87  FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYRDLKLD 139

Query: 283 NVLIDDDMEARISEFGLAK-RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL+D +   +++++G+ K  +  G    TT +  GT  YIAPE  +      + D ++ 
Sbjct: 140 NVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196

Query: 342 GVLLAVLVIGKFP 354
           GVL+  ++ G+ P
Sbjct: 197 GVLMFEMMAGRSP 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 73/250 (29%), Positives = 115/250 (46%), Gaps = 54/250 (21%)

Query: 125 EDLAFLEKEDYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELI 179
           E+L F    + +  LEK+     GE     VYKA+   S GR++ +K+I    +  AE  
Sbjct: 12  ENLYFQGLMEKYQKLEKV-----GEGTYGVVYKAK--DSQGRIVALKRI----RLDAE-- 58

Query: 180 KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD 239
             +  P       IR EI    ++ H NIV L+  +    C  LV+EF     L+ +L +
Sbjct: 59  -DEGIP----STAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDE 111

Query: 240 VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
              G ++     +  + Q +  G+ + H  HR  I+HRD++P N+LI+ D   ++++FGL
Sbjct: 112 NKTGLQDSQ--IKIYLYQ-LLRGVAHCH-QHR--ILHRDLKPQNLLINSDGALKLADFGL 165

Query: 300 AKR--IPDG---HTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLV 349
           A+   IP     H   T W       Y AP+    V +         DI+S G + A ++
Sbjct: 166 ARAFGIPVRSYTHEVVTLW-------YRAPD----VLMGSKKYSTSVDIWSIGCIFAEMI 214

Query: 350 IGK--FPSDD 357
            GK  FP   
Sbjct: 215 TGKPLFPGVT 224

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 37/200 (18%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEFRRN 230
           IKK   P   ++   R+  E+     +RH N++ LL        +    D  LV  F   
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF--- 111

Query: 231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM 290
             +   L  + +  +  +   +  + Q +  GL Y+H +    IIHRD++P N+ +++D 
Sbjct: 112 --MGTDLGKLMKHEKLGEDRIQFLVYQ-MLKGLRYIHAAG---IIHRDLKPGNLAVNEDC 165

Query: 291 EARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALS-----DTCDIYSFGV 343
           E +I +FGLA++     T    T W       Y APE    V L+      T DI+S G 
Sbjct: 166 ELKILDFGLARQADSEMTGYVVTRW-------YRAPE----VILNWMRYTQTVDIWSVGC 214

Query: 344 LLAVLVIGK--FPSDDFFQH 361
           ++A ++ GK  F   D    
Sbjct: 215 IMAEMITGKTLFKGSDHLDQ 234

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
            V E+   G   D+++ + + R+  +  AR   A+ I+  L YLH      II+RD++  
Sbjct: 130 FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLD 182

Query: 283 NVLIDDDMEARISEFGLAK-RIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
           NVL+D +   +++++G+ K  +  G    TT +  GT  YIAPE  +      + D ++ 
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239

Query: 342 GVLLAVLVIGKFP 354
           GVL+  ++ G+ P
Sbjct: 240 GVLMFEMMAGRSP 252

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 44/230 (19%)

Query: 148 GEVYKA-ELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G VYKA    G   +   +K+I           +         M   R EI    +++H 
Sbjct: 35  GHVYKAKRKDGKDDKDYALKQI-----------EGTGIS----MSACR-EIALLRELKHP 78

Query: 207 NIVPLLARMV-RRDCDL-LVYEFRRN--GSLQDILYDVSQGRRELDWLARHR--IAQGIA 260
           N++ L    +   D  + L++++  +    +          ++ +         +   I 
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR----ISEFGLAKR--IPDGHTRTTTWS 314
            G+ YLH ++   ++HRD++PAN+L+  +   R    I++ G A+    P          
Sbjct: 139 DGIHYLH-ANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL-KPLADLDP 194

Query: 315 LAGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
           +  T  Y APE      H T A+    DI++ G + A L+  +  F    
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSEPIFHCRQ 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 55/229 (24%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++A+L   S  V  IKK++Q                  K  + R E+     V+H N
Sbjct: 54  GVVFQAKLV-ESDEV-AIKKVLQ-----------------DKRFKNR-ELQIMRIVKHPN 93

Query: 208 IVPLLARMV-----RRDCDL-LVYEFRRNGSLQDILYDVSQGRREL-DWLARHRIAQGIA 260
           +V L A        + +  L LV E+    ++       ++ ++ +   L +  + Q + 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ-LL 151

Query: 261 SGLEYLHMSHRPRIIHRDIQPANVLIDDDM-EARISEFGLAKRIPDGHTRT----TTWSL 315
             L Y+H S    I HRDI+P N+L+D      ++ +FG AK +  G        + +  
Sbjct: 152 RSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-- 206

Query: 316 AGTVGYIAPEC-----HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                Y APE      + T  +    DI+S G ++A L+ G+  FP + 
Sbjct: 207 -----YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGES 246

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 59/250 (23%)

Query: 130 LEKEDYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSE 184
           +     F  LEK+     G      VYK  L  ++G  + +K++           K DSE
Sbjct: 1   MSSSSQFKQLEKL-----GNGTYATVYKG-LNKTTGVYVALKEV-----------KLDSE 43

Query: 185 ---PLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS 241
              P       IR EI    +++H NIV L   +   +   LV+EF  +  L+  +   +
Sbjct: 44  EGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRT 97

Query: 242 QGRRELDWLARH--RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL 299
            G                 +  GL + H  ++  I+HRD++P N+LI+   + ++ +FGL
Sbjct: 98  VGNTPRGLELNLVKYFQWQLLQGLAFCH-ENK--ILHRDLKPQNLLINKRGQLKLGDFGL 154

Query: 300 AKR--IPDG---HTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLV 349
           A+   IP         T W       Y AP+    V +         DI+S G +LA ++
Sbjct: 155 ARAFGIPVNTFSSEVVTLW-------YRAPD----VLMGSRTYSTSIDIWSCGCILAEMI 203

Query: 350 IGK--FPSDD 357
            GK  FP  +
Sbjct: 204 TGKPLFPGTN 213

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 49/222 (22%), Positives = 79/222 (35%), Gaps = 41/222 (18%)

Query: 158 SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL--- 212
           S G  + IK++            +    L    +  R   EI       H NI+ L    
Sbjct: 44  SEGIPVAIKRV-----FNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98

Query: 213 -ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH 270
                     L LV E  R   L  +++   Q         ++ +   I  GL  LH + 
Sbjct: 99  VHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYH-ILLGLHVLHEAG 154

Query: 271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT----TTWSLAGTVGYIAPE- 325
              ++HRD+ P N+L+ D+ +  I +F LA+       +T      W       Y APE 
Sbjct: 155 ---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-------YRAPEL 204

Query: 326 ---CHQ-TVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQH 361
                  T  +    D++S G ++A +   K  F    F+  
Sbjct: 205 VMQFKGFTKLV----DMWSAGCVMAEMFNRKALFRGSTFYNQ 242

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 47/228 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT---AGQVR 204
           G+V+KA    + GR + +K++    +       ++  P    +  IR E+          
Sbjct: 25  GKVFKARDLKNGGRFVALKRV----RVQTG---EEGMP----LSTIR-EVAVLRHLETFE 72

Query: 205 HRNIVPLL----ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI 259
           H N+V L          R+  L LV+E   +  L   L  V +     +   +  + Q +
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE-TIKDMMFQ-L 129

Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT----TTWSL 315
             GL++LH SHR  ++HRD++P N+L+    + ++++FGLA+        T    T W  
Sbjct: 130 LRGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW-- 184

Query: 316 AGTVGYIAPE----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                Y APE          +    D++S G + A +   K  F    
Sbjct: 185 -----YRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRKPLFRGSS 223

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 52/240 (21%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           + +  L+K+       VYK +    +  ++ +K+I         L  ++  P       I
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEI--------RLEHEEGAP----CTAI 48

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           R E+     ++H NIV L   +       LV+E+  +  L+  L D          +  H
Sbjct: 49  R-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI------INMH 100

Query: 254 RI----AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA--KRIPDG- 306
            +     Q +  GL Y H   R +++HRD++P N+LI++  E ++++FGLA  K IP   
Sbjct: 101 NVKLFLFQ-LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156

Query: 307 --HTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSDD 357
             +   T W       Y  P+    + L  T      D++  G +   +  G+  FP   
Sbjct: 157 YDNEVVTLW-------YRPPD----ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 56/209 (26%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL-----ARMVRRDCDL-LVYEF--- 227
           IKK S P   ++   R+  E++    ++H N++ LL     A  +R   D  LV  F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113

Query: 228 ------RRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
                     S + I Y V Q                +  GL+Y+H +    ++HRD++P
Sbjct: 114 DLQKIMGLKFSEEKIQYLVYQ----------------MLKGLKYIHSAG---VVHRDLKP 154

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALS-----D 334
            N+ +++D E +I +FGLA+      T    T W       Y APE    V LS      
Sbjct: 155 GNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-------YRAPE----VILSWMHYNQ 203

Query: 335 TCDIYSFGVLLAVLVIGK--FPSDDFFQH 361
           T DI+S G ++A ++ GK  F   D+   
Sbjct: 204 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 62.1 bits (152), Expect = 6e-11
 Identities = 68/241 (28%), Positives = 107/241 (44%), Gaps = 54/241 (22%)

Query: 134 DYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
           + +  LEKI     GE     VYKA+   + G    +KKI    +   E    +  P   
Sbjct: 2   EKYHGLEKI-----GEGTYGVVYKAQ--NNYGETFALKKI----RLEKE---DEGIP--- 44

Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
               IR EI    +++H NIV L   +  +   +LV+E   +  L+ +L     G   + 
Sbjct: 45  -STTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVT 101

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDG 306
             A+  + Q + +G+ Y H   R  ++HRD++P N+LI+ + E +I++FGLA+   IP  
Sbjct: 102 --AKSFLLQ-LLNGIAYCH-DRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155

Query: 307 ---HTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSD 356
              H   T W       Y AP+    V +         DI+S G + A +V G   FP  
Sbjct: 156 KYTHEIVTLW-------YRAPD----VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

Query: 357 D 357
            
Sbjct: 205 S 205

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 38/169 (22%)

Query: 205 HRNIVPLLARMVRRDC---DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
             NI+ L   +V+        LV+E   N   + +   ++      D+  R  + + I  
Sbjct: 90  GPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYE-ILK 141

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRT----TTWSLA 316
            L+Y H S    I+HRD++P NV+ID +  + R+ ++GLA+    G        + +   
Sbjct: 142 ALDYCH-SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195

Query: 317 GTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ 360
               +  PE          +L    D++S G +LA ++  K P   FF 
Sbjct: 196 ----FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP---FFH 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 62/328 (18%), Positives = 114/328 (34%), Gaps = 105/328 (32%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+KA     +G+ + +KK+             ++E     +  +R EI     ++H N
Sbjct: 31  GEVFKA-RHRKTGQKVALKKV-----------LMENEKEGFPITALR-EIKILQLLKHEN 77

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV------------SQGRRELDWLARHRI 255
           +V L+        ++   +       +  +Y V            S    +       R+
Sbjct: 78  VVNLI--------EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 129

Query: 256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDGHTRT--- 310
            Q + +GL Y+H   R +I+HRD++ ANVLI  D   ++++FGLA+   +          
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSDD-- 357
               T W       Y  PE    + L +       D++  G ++A +         +   
Sbjct: 187 NRVVTLW-------YRPPE----LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235

Query: 358 -----FFQ-----------------HTKEMSLVQWMRNVMTSENPNRAINSK---LLGNG 392
                  Q                   +++ LV+  +  +         +     L+   
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI--- 292

Query: 393 YEEQMLLVLKIACFCTLDDPNKRPNSKD 420
                LLVL         DP +R +S D
Sbjct: 293 ---DKLLVL---------DPAQRIDSDD 308

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.8 bits (146), Expect = 3e-10
 Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 42/202 (20%)

Query: 134 DYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
             +  LEKI     GE     V+KA     +  ++ +K++    +   +    +  P   
Sbjct: 2   QKYEKLEKI-----GEGTYGTVFKA-KNRETHEIVALKRV----RLDDD---DEGVP--- 45

Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
               +R EI    +++H+NIV L   +       LV+EF  +  L+      +       
Sbjct: 46  -SSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEI 102

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR--IPDG 306
              +  + Q +  GL + H S    ++HRD++P N+LI+ + E +++ FGLA+   IP  
Sbjct: 103 --VKSFLFQ-LLKGLGFCH-SRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156

Query: 307 ---HTRTTTWSLAGTVGYIAPE 325
                  T W       Y  P+
Sbjct: 157 CYSAEVVTLW-------YRPPD 171

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 47/229 (20%)

Query: 148 GEVYKAELPGSSGRVITIKKI-IQPLKSGAELIKKDSEPLHHKMIQIRSEIIT---AGQV 203
           G VYKA     SG  + +K + +     G   +     P    +  +R E+         
Sbjct: 23  GTVYKA-RDPHSGHFVALKSVRVPNGGGGGGGL-----P----ISTVR-EVALLRRLEAF 71

Query: 204 RHRNIVPLLARMVRRDCDL-----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG 258
            H N+V L+        D      LV+E   +  L+  L          +   +  + Q 
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAE-TIKDLMRQ- 128

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT----TTWS 314
              GL++LH ++   I+HRD++P N+L+      ++++FGLA+        T    T W 
Sbjct: 129 FLRGLDFLH-ANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184

Query: 315 LAGTVGYIAPE----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
                 Y APE          +    D++S G + A +   K  F  + 
Sbjct: 185 ------YRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRKPLFCGNS 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 255 IAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWS 314
            +  +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I           
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254

Query: 315 LAGTVGYIAPECHQTVALSDTCDIYSFGVLL 345
               + ++APE       +   D++SFGVLL
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 26/108 (24%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRT----TTWSLA 316
            + ++H S    I HRDI+P N+L++  D   ++ +FG AK++           + +   
Sbjct: 153 AVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF--- 206

Query: 317 GTVGYIAPE-----CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDD 357
               Y APE        T ++    D++S G +   L++GK  F  + 
Sbjct: 207 ----YRAPELMLGATEYTPSI----DLWSIGCVFGELILGKPLFSGET 246

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 59/246 (23%)

Query: 134 DYFASLEKIRSCWNGE-----VYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
           D +  + K+     GE     VYKA     +   + IK+I    +   E   ++  P   
Sbjct: 34  DRYRRITKL-----GEGTYGEVYKAI-DTVTNETVAIKRI----RLEHE---EEGVP--- 77

Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
               IR E+    +++HRNI+ L + +       L++E+      ++ L        ++ 
Sbjct: 78  -GTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVS 130

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISEFGLAKR- 302
                     + +G+ + H     R +HRD++P N+L+     +      I +FGLA+  
Sbjct: 131 MRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

Query: 303 -IPDG---HTRTTTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK- 352
            IP     H   T W       Y  PE    + L         DI+S   + A +++   
Sbjct: 188 GIPIRQFTHEIITLW-------YRPPE----ILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

Query: 353 -FPSDD 357
            FP D 
Sbjct: 237 LFPGDS 242

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 58/248 (23%)

Query: 136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS 195
           + +L  I     G V  A     +   + IKKI                P  H+    R+
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---------------SPFEHQTYCQRT 72

Query: 196 --EIITAGQVRHRNIVPLL----ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELD 248
             EI    + RH NI+ +     A  + +  D+ +V +      ++  LY + + +   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSN 127

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
               + + Q I  GL+Y+H ++   ++HRD++P+N+L++   + +I +FGLA+     H 
Sbjct: 128 DHICYFLYQ-ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 309 RT--------TTWSLAGTVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--F 353
            T        T W       Y APE    + L+        DI+S G +LA ++  +  F
Sbjct: 184 HTGFLTEYVATRW-------YRAPE----IMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

Query: 354 PSDDFFQH 361
           P   +   
Sbjct: 233 PGKHYLDQ 240

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 58/174 (33%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRH 205
           G V +A       RV+ IKKI                     +   R   EI    ++ H
Sbjct: 67  GHVCEA-YDKLEKRVVAIKKI--------------LRVFEDLIDCKRILREIAILNRLNH 111

Query: 206 RNIVPLL----ARMVRRDCDL-LVYEF---------RRNGSLQD-----ILYDVSQGRRE 246
            ++V +L     + V +  +L +V E          R    L +     +LY        
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY-------- 163

Query: 247 LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
                       +  G++Y+H S    I+HRD++PAN L++ D   ++ +FGLA
Sbjct: 164 ----------N-LLVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 35/177 (19%), Positives = 60/177 (33%), Gaps = 43/177 (24%)

Query: 179 IKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL----ARMVRRDCDL-LVYEF---- 227
           IKK +      +   R   EI    +++   I+ L        + +  +L +V E     
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115

Query: 228 -----RRNGSLQD-----ILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR 277
                +    L +     ILY                    +  G  ++H S    IIHR
Sbjct: 116 LKKLFKTPIFLTEEHIKTILY------------------N-LLLGENFIHESG---IIHR 153

Query: 278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD 334
           D++PAN L++ D   ++ +FGLA+ I           L           +    L+ 
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 50/222 (22%)

Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLL---- 212
           +G ++ IKKI               EP    +  +R+  EI      +H NI+ +     
Sbjct: 35  TGEIVAIKKI---------------EPFDKPLFALRTLREIKILKHFKHENIITIFNIQR 79

Query: 213 ARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHR 271
                   ++ ++ E      +Q  L+ V   +   D   ++ I Q     ++ LH S+ 
Sbjct: 80  PDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ-TLRAVKVLHGSN- 132

Query: 272 PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTV--GYI------A 323
             +IHRD++P+N+LI+ + + ++ +FGLA+ I +     +  +   +    ++      A
Sbjct: 133 --VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190

Query: 324 PE----CHQ-TVALSDTCDIYSFGVLLAVLVIGK--FPSDDF 358
           PE      + + A+    D++S G +LA L + +  FP  D+
Sbjct: 191 PEVMLTSAKYSRAM----DVWSCGCILAELFLRRPIFPGRDY 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 60/231 (25%)

Query: 159 SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRS--EIITAGQVRHRNIVPLLARMV 216
             + + IKKI                 L        +  EI    ++ H NIV +   ++
Sbjct: 35  CDKRVAIKKI----------------VLTDPQSVKHALREIKIIRRLDHDNIVKVFE-IL 77

Query: 217 RRDCDLLVYEFRRNGSLQDI----------LYDVSQGRRELDWLARHRIAQGIASGLEYL 266
                 L  +      L  +          L +V +    L+  AR  + Q +  GL+Y+
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ-LLRGLKYI 136

Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRT--------TTWSLAG 317
           H ++   ++HRD++PAN+ I+ +D+  +I +FGLA+ +   ++          T W    
Sbjct: 137 HSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW---- 189

Query: 318 TVGYIAPECHQTVALSDTC-----DIYSFGVLLAVLVIGK--FPSDDFFQH 361
              Y +P     + LS        D+++ G + A ++ GK  F      + 
Sbjct: 190 ---YRSPR----LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 25/130 (19%), Positives = 53/130 (40%), Gaps = 12/130 (9%)

Query: 232 SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME 291
           SLQ  L      +  L   +  ++A  +   LE+LH +     +H ++   N+ +D + +
Sbjct: 143 SLQSALDV--SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197

Query: 292 ARI--SEFGLAKRIPDGHT-----RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVL 344
           +++  + +G A R             +     G + +I+ + H+    S   D+ S G  
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYC 257

Query: 345 LAVLVIGKFP 354
           +   + G  P
Sbjct: 258 MLKWLYGFLP 267

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 25/123 (20%), Positives = 47/123 (38%), Gaps = 27/123 (21%)

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
            ++YLH      ++HRD++P+N+L++ +   ++++FGL+ R      R T          
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIRRVTNNIPLSINEN 176

Query: 322 IAPECHQTVALSD---------------------TCDIYSFGVLLAVLVIGK--FPSDDF 358
                     L+D                       D++S G +L  ++ GK  FP    
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236

Query: 359 FQH 361
              
Sbjct: 237 MNQ 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 2e-06
 Identities = 71/572 (12%), Positives = 140/572 (24%), Gaps = 218/572 (38%)

Query: 5   NKVLDDAIEKQTKEESVK--IWLGKLQH-----------LAYDVDYLLDEFQTEAFQMML 51
            + +D  I  +          W    +            L  +  +L+   +TE  Q  +
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107

Query: 52  LQD-----------------------ADAMSKVKEVNARLQDIAWQINVLGLKESSG-GK 87
           +                              K+++    L+     + + G+    G GK
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN-VLIDGVL---GSGK 163

Query: 88  STIVGQ--RFLTTTSRI------LAAGRGGSRDRRPIIFSPL------------------ 121
           + +            ++      L      S +    +   L                  
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 122 ------IKEEDLAFLEKEDYFASLEKIRSCWNGEVYKA------------------ELPG 157
                 I+ E    L+ + Y   L  + +  N + + A                   L  
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283

Query: 158 SSGRVITIKKIIQPL--KSGAELIKK--------------DSEPLHHKMI--QIRSEIIT 199
           ++   I++      L       L+ K               + P    +I   IR  + T
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343

Query: 200 AGQVRHRNI----------------------------------VP--LLAR----MVRRD 219
               +H N                                   +P  LL+     +++ D
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403

Query: 220 CDLLVYEFRRNG-----------SLQDILYDVSQGRRELDWLARHR--IAQ-GIASGLE- 264
             ++V +  +             S+  I  ++         L  HR  +    I    + 
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL--HRSIVDHYNIPKTFDS 461

Query: 265 ------------YLHMSHRPRIIH-RDIQPA-------NVLIDDD-MEARISEFGLAKRI 303
                       Y H+ H     H ++I+          V +D   +E +I     A   
Sbjct: 462 DDLIPPYLDQYFYSHIGH-----HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516

Query: 304 PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK 363
                 T    L     YI     +   L     I  F   +   +I           +K
Sbjct: 517 SGSILNTLQ-QLKFYKPYICDNDPKYERL--VNAILDFLPKIEENLI----------CSK 563

Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEE 395
              L++     +     + AI        +EE
Sbjct: 564 YTDLLR-----IALMAEDEAI--------FEE 582

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 10/108 (9%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKRIPDGHTRT- 310
           ++   +   LEY+H +     +H DI+ AN+L+      ++  +++GL+ R         
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211

Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                     GT+ + + + H+ VALS   D+   G  +   + GK P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 15/111 (13%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA---RISEFGLAKRIPDGHTRT 310
            +A  + S +EY+H  +    IHRD++P N L+    +     I +FGLAK+  D  T  
Sbjct: 109 LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

Query: 311 -----TTWSLAGTVGYIAPECHQTVALS--DTCDIYSFGVLLAVLVIGKFP 354
                   +L GT  Y +   H  +  S  D  D+ S G +L    +G  P
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRD--DLESLGYVLMYFNLGSLP 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 32/127 (25%)

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI--DDDMEARISEFGLAKRIPDGHTRT 310
            + A  I   L+ LH   + RIIH D++P N+L+        ++ +FG +          
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT- 258

Query: 311 TTWSLAGTVGYI------APECHQTVAL----SDTCDIYSFGVLLAVLVIGK--FPSDDF 358
                     YI      APE    V L        D++S G +LA L+ G    P +D 
Sbjct: 259 ----------YIQSRFYRAPE----VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

Query: 359 FQHTKEM 365
                 M
Sbjct: 305 GDQLACM 311

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 13/111 (11%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISEFGLAKRIPDGHT 308
             A+ + + ++ +H      +++RDI+P N LI            + +FG+ K   D  T
Sbjct: 110 MAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166

Query: 309 RT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
           +         +L+GT  Y++   H     S   D+ + G +    + G  P
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 10/108 (9%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI--SEFGLAKRIPDGHTRT- 310
           +++  I   LEY+H       +H DI+ +N+L++     ++   ++GLA R         
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 311 ----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP 354
                     GT+ + + + H  VA S   D+   G  +   + G  P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 41/190 (21%), Positives = 73/190 (38%), Gaps = 45/190 (23%)

Query: 189 KMIQIRSEI-ITAGQVRHRNIVPLLA----RMVRRDCDLLVYEFRRNGSLQDILYDVSQG 243
              + R E+ +     +  +IV ++         R C L+V E    G L   +    +G
Sbjct: 53  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRG 110

Query: 244 RR---ELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEF 297
            +   E +  A   +   I   ++YLH S    I HRD++P N+L      +   ++++F
Sbjct: 111 DQAFTERE--ASEIMKS-IGEAIQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK--FPS 355
           G AK                   Y             +CD++S GV++ +L+ G   F S
Sbjct: 165 GFAKET-----------TGE--KY-----------DKSCDMWSLGVIMYILLCGYPPFYS 200

Query: 356 DDFFQHTKEM 365
           +     +  M
Sbjct: 201 NHGLAISPGM 210

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 15/111 (13%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR---ISEFGLAKRIPDGHTRT 310
            +A  + + +E++H       +HRDI+P N L+     A    I +FGLAK+  D  T  
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

Query: 311 -----TTWSLAGTVGYIAPECHQTVALS--DTCDIYSFGVLLAVLVIGKFP 354
                   +L GT  Y +   H  +  S  D  D+ S G +L   + G  P
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRD--DLESLGYVLMYFLRGSLP 212

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.6 bits (107), Expect = 2e-05
 Identities = 29/197 (14%), Positives = 48/197 (24%), Gaps = 29/197 (14%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
            +     EKI     GEV++     +    I I  I  P        K   E L   +I 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 193 IRSEIITAGQV-RHRNIVPLLARMVRRD------CDLLVYEFRRNGSLQDILYDVSQ--- 242
               +++     R    + L +    +            +     GS  D          
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 243 ----------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI 286
                             +         I   + + L         R  HRD+   NVL+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195

Query: 287 DDDMEARISEFGLAKRI 303
                 ++      K  
Sbjct: 196 KKTSLKKLHYTLNGKSS 212

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 23/124 (18%)

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD------DMEARISEFGLAKRIPDG 306
            +I++ +  GL+Y+H      IIH DI+P NVL++        ++ +I++ G A    + 
Sbjct: 134 KQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 307 HTRTTTWSLAGTVGYIAPECHQTVAL----SDTCDIYSFGVLLAVLVIGK--FPSDDFFQ 360
           +T     +   T  Y +PE    V L        DI+S   L+  L+ G   F  D+   
Sbjct: 192 YT-----NSIQTREYRSPE----VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

Query: 361 HTKE 364
           +TK+
Sbjct: 243 YTKD 246

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 29/139 (20%), Positives = 57/139 (41%), Gaps = 20/139 (14%)

Query: 237 LYDVSQ--GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA-- 292
           LYD+ +    R +      + AQ + + L +L  +    IIH D++P N+L+ +   +  
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAI 200

Query: 293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL----SDTCDIYSFGVLLAVL 348
           +I +FG +            +    +  Y +PE    V L        D++S G +L  +
Sbjct: 201 KIVDFGSS-----CQLGQRIYQYIQSRFYRSPE----VLLGMPYDLAIDMWSLGCILVEM 251

Query: 349 VIGK--FPSDDFFQHTKEM 365
             G+  F   +      ++
Sbjct: 252 HTGEPLFSGANEVDQMNKI 270

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 17/113 (15%)

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR-----ISEFGLAKRIPDGHT 308
            IA  + S +EY+H  +   +I+RD++P N LI            I +F LAK   D  T
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165

Query: 309 RT-----TTWSLAGTVGYIAPECHQTVALS--DTCDIYSFGVLLAVLVIGKFP 354
           +         SL GT  Y++   H     S  D  D+ + G +    + G  P
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRD--DLEALGHMFMYFLRGSLP 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 32/181 (17%), Positives = 57/181 (31%), Gaps = 59/181 (32%)

Query: 223 LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA 282
           +V+E   +  L   +   +     L  +   +I Q +  GL+YLH   + RIIH DI+P 
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCV--KKIIQQVLQGLDYLH--TKCRIIHTDIKPE 176

Query: 283 NVLI-------------------------------------------------DDDMEAR 293
           N+L+                                                  + ++ +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236

Query: 294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKF 353
           I++ G A  +    T         T  Y + E       +   DI+S   +   L  G +
Sbjct: 237 IADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

Query: 354 P 354
            
Sbjct: 292 L 292

>4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 13/94 (13%), Positives = 26/94 (27%), Gaps = 4/94 (4%)

Query: 211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH--- 267
            L R+         +   R   L      ++ G  +       R    +    + +H   
Sbjct: 128 FLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187

Query: 268 -MSHRPRIIHRDIQPANVLIDDDMEARISEFGLA 300
             S    + H D    N++ D+       + G  
Sbjct: 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	430
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3qfl_A	115	MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.91
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.59
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.57
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.41
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.28
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.26
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.95
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.85
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.73
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.6
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.55
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.05
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.75
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.9
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.41
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.09
3ro3_B	22	Minsc, peptide of protein inscuteable homolog; asy	82.33

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-57  Score=424.90  Aligned_cols=263  Identities=22%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+++.+.+.||+|+||+||+|++.    ..||||++....            ........|.+|+.+|++++|||||+++
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~------------~~~~~~~~f~~E~~il~~l~HpNIV~l~   98 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVD------------PTPEQFQAFRNEVAVLRKTRHVNILLFM   98 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSS------------CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecC------------CCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            456788899999999999999864    258999984321            1223467899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|.+ +.++||||||++|||.++++.   ....+++..+..|+.|||.||+|||+.+   |+||||||+||||++++.+
T Consensus        99 g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~  171 (307)
T 3omv_A           99 GYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTV  171 (307)
T ss_dssp             EEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEE
T ss_pred             EEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcE
Confidence            98864 568999999999999999964   3456999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ||+|||+|+...............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.....   ...+..
T Consensus       172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~~~~  248 (307)
T 3omv_A          172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQIIF  248 (307)
T ss_dssp             EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHH
T ss_pred             EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHHHHH
Confidence            9999999988765443333345689999999999864   3589999999999999999999999875322   111111


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                      .+......+..         ...+..++..+.+|+..||+.||++|||+.+|++.|+.|++
T Consensus       249 ~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          249 MVGRGYASPDL---------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             HHHTTCCCCCS---------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             HHhcCCCCCCc---------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11111111111         11112233458899999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.4e-58  Score=428.93  Aligned_cols=263  Identities=20%  Similarity=0.307  Sum_probs=211.5

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||+||+|++..    .+|..||||++...              .......|.+|+.+|++++||||
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------------~~~~~~~f~~E~~il~~l~HpnI   77 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------------SDNARKDFHREAELLTNLQHEHI   77 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--------------CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--------------ChHHHHHHHHHHHHHHhCCCCCC
Confidence            4678889999999999999998742    35789999998431              12335779999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS---------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI  279 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  279 (430)
                      |+++|+|.+.+..+||||||++|||.++|+...         .....+++..++.|+.||+.||.|||+.+   |+||||
T Consensus        78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDl  154 (299)
T 4asz_A           78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDL  154 (299)
T ss_dssp             CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCcc
Confidence            999999999999999999999999999997532         23457999999999999999999999655   999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDF  358 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~  358 (430)
                      ||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999987655443333334579999999999999999999999999999999999 89998754


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..    ..+...+.   ....+.          .+..++..+.+|+..||+.||++|||+.+|.+.|+++.
T Consensus       235 ~~----~~~~~~i~---~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          235 SN----NEVIECIT---QGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             CH----HHHHHHHH---HTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CH----HHHHHHHH---cCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            22    22333222   222111          11112334889999999999999999999999998763

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=430.26  Aligned_cols=263  Identities=20%  Similarity=0.281  Sum_probs=204.1

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||+||+|++++    .+++.||||++...              .......|.+|+.+|++++||||
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------------~~~~~~~f~~E~~il~~l~HpnI  105 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------------SESARQDFQREAELLTMLQHQHI  105 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--------------SHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--------------CHHHHHHHHHHHHHHHhCCCCCC
Confidence            4567888999999999999998642    36889999998421              12335789999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-----------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      |+++|+|.+.+..+||||||++|+|.++++....           ...++++..++.|+.||+.||.|||+.+   |+||
T Consensus       106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHR  182 (329)
T 4aoj_A          106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHR  182 (329)
T ss_dssp             CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecc
Confidence            9999999999999999999999999999975321           2356999999999999999999999655   9999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       183 DLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             CCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             cccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999998765444333335679999999999999999999999999999999999 899987


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....    ..+...+..   ..++.          .+..++..+.+|+..||+.||++|||+.||++.|+.+.
T Consensus       263 ~~~~----~~~~~~i~~---g~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          263 QLSN----TEAIDCITQ---GRELE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             SSCH----HHHHHHHHH---TCCCC----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCH----HHHHHHHHc---CCCCC----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            5422    222332222   21111          01112234889999999999999999999999998763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-57  Score=428.47  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=211.3

Q ss_pred             cccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      +.+...+.||+|+||+||+|++.+    .+++.||||++.....             ....+.|.+|+.+|++++|||||
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-------------~~~~~~f~~E~~il~~l~HpNIV   92 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-------------GPLREEFRHEAMLRARLQHPNVV   92 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-------------C-CHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-------------hHHHHHHHHHHHHHHhCCCCCCC
Confidence            356778899999999999998742    3678999999843211             12246799999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      +++|+|.+.+..+||||||++|||.++|.....            ....+++..++.|+.|||.||.|||+.+   |+||
T Consensus        93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHR  169 (308)
T 4gt4_A           93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHK  169 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCC
Confidence            999999999999999999999999999965321            1346999999999999999999999665   9999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       170 DLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             CCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987654433333335679999999999999999999999999999999998 899987


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ...    ...+...+   .....+.          .+..++..+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus       250 ~~~----~~~~~~~i---~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          250 GYS----NQDVVEMI---RNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TCC----HHHHHHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCC----HHHHHHHH---HcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            542    22233332   2222111          11223345889999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-56  Score=424.20  Aligned_cols=254  Identities=19%  Similarity=0.245  Sum_probs=203.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+++.||+|+||+||+|++.. +|+.||||++......            ......+.+|+.+|++|+|||||+++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~~~   89 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMS------------SKEREESRREVAVLANMKHPNIVQYR   89 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETT-TCCEEEEEEEECTTSC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHCC------------HHHHHHHHHHHHHHHHCCCCCCCcEE
Confidence            3579999999999999999998764 8999999999543221            23357899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+++.+|||||||+||+|.+++..  .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        90 ~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~v  164 (350)
T 4b9d_A           90 ESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV  164 (350)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCE
Confidence            999999999999999999999999965  34456899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+.....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....       ..+.+.
T Consensus       165 Kl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~  235 (350)
T 4b9d_A          165 QLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVL  235 (350)
T ss_dssp             EECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHH
T ss_pred             EEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHH
Confidence            9999999987643221  1224679999999999999999999999999999999999999986431       223333


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+.....+.      .....    ...+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~i~~~~~~~------~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          236 KIISGSFPP------VSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHTCCCC------CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCC------CCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            333322211      11112    234889999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.9e-56  Score=415.61  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=208.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+.+|+.+|++++|||||+++
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~   98 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHII-----------KENKVPYVTRERDVMSRLDHPFFVKLY   98 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCC-----------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3579999999999999999999764 8999999999542211           112256799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+.+|||||||+||+|.+++..    .+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~v  171 (311)
T 4aw0_A           99 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI  171 (311)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCE
Confidence            999999999999999999999999954    356999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||....       ..+...
T Consensus       172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~  244 (311)
T 4aw0_A          172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFA  244 (311)
T ss_dssp             EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred             EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHH
Confidence            9999999998765444444445789999999999999999999999999999999999999986421       122222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      .+......   +.    ...+    ..+.+|+.+||+.||++|||+.|++
T Consensus       245 ~i~~~~~~---~p----~~~s----~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          245 KIIKLEYD---FP----EKFF----PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHTCCC---CC----TTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHcCCCC---CC----cccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence            23222111   01    1122    2478999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.8e-55  Score=415.83  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||+||+|++.. +|+.||||++......              ....+.+|+.+|++++|||||+++
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~  137 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY  137 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCS--------------SGGGGHHHHHHHHHCCCTTBCCEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3569999999999999999999874 8999999999542211              124578999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+.+|||||||+||+|.+++..     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus       138 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~v  209 (346)
T 4fih_A          138 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV  209 (346)
T ss_dssp             EEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCE
Confidence            999999999999999999999999853     35999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+.......  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||....    .......+ 
T Consensus       210 Kl~DFGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i-  282 (346)
T 4fih_A          210 KLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMI-  282 (346)
T ss_dssp             EECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHH-
T ss_pred             EEecCcCceecCCCCCcc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHH-
Confidence            999999999875443322  24689999999999999999999999999999999999999986432    12222222 


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        .....+..        .........+.+|+.+||+.||++|||+.|+++
T Consensus       283 --~~~~~~~~--------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          283 --RDNLPPRL--------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             --HHSSCCCC--------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --HcCCCCCC--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              22111110        011112234889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.8e-56  Score=418.08  Aligned_cols=254  Identities=21%  Similarity=0.259  Sum_probs=203.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|...+.||+|+||.||+|++.. +|+.||||++....                   ...+|+.+|+.++|||||++
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~-------------------~~~~E~~il~~l~HpnIV~l  115 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEV-------------------FRVEELVACAGLSSPRIVPL  115 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTT-------------------CCTHHHHTTTTCCCTTBCCE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHH-------------------hHHHHHHHHHhCCCCCCCcE
Confidence            34568888999999999999999864 89999999984311                   12469999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC-
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM-  290 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-  290 (430)
                      ++++.+.+.+|||||||+||+|.+++..    .+.+++..+..++.||+.||.|||+.   +|+||||||+||||+.++ 
T Consensus       116 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~  188 (336)
T 4g3f_A          116 YGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGS  188 (336)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSC
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCC
Confidence            9999999999999999999999999964    34699999999999999999999955   599999999999999987 


Q ss_pred             ceEEeecCCcccCCCCCCcc---eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          291 EARISEFGLAKRIPDGHTRT---TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      .+||+|||+|+.+.......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......    .+
T Consensus       189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~  264 (336)
T 4g3f_A          189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PL  264 (336)
T ss_dssp             CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CC
T ss_pred             EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HH
Confidence            69999999999875432221   222467999999999999999999999999999999999999999754321    11


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ...   +.....+...+        ++.....+.+++.+||+.||.+|||+.|+++.|..
T Consensus       265 ~~~---i~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          265 CLK---IASEPPPIREI--------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             HHH---HHHSCCGGGGS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH---HHcCCCCchhc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            211   12122111111        11223348899999999999999999999988764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6e-55  Score=405.54  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=198.2

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||+|+||+||+|.+.. +|..||+|++......            ......|.+|+.+|++++|||||+++++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~~~~~~   94 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSW   94 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3666789999999999999874 8999999998543211            22357799999999999999999999998


Q ss_pred             Ee----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CC
Q 014140          216 VR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DM  290 (430)
Q Consensus       216 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~  290 (430)
                      .+    .+.+|||||||+||+|.+++..    ...+++..+..++.||+.||.|||+. .++|+||||||+|||+++ ++
T Consensus        95 ~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g  169 (290)
T 3fpq_A           95 ESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTS
T ss_pred             eeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCC
Confidence            75    3458999999999999999964    35699999999999999999999954 234999999999999984 79


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+|+......    ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....      ....
T Consensus       170 ~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~  238 (290)
T 3fpq_A          170 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQI  238 (290)
T ss_dssp             CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHH
T ss_pred             CEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHH
Confidence            99999999998654322    224689999999999875 699999999999999999999999864321      2222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........+ ..++    ...++    .+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~i~~~~~~-~~~~----~~~~~----~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          239 YRRVTSGVKP-ASFD----KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHTTTCCC-GGGG----GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCC-CCCC----ccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            2233222221 1111    12222    3788999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-54  Score=400.02  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=190.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+.+|+.+|++++|||||++++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~~~~   80 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLA-----------KSDMQGRIEREISYLRLLRHPHIIKLYD   80 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcC-----------CHHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence            579999999999999999998764 8999999999543221           1223467999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+||||| +|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        81 ~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vk  152 (275)
T 3hyh_A           81 VIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVK  152 (275)
T ss_dssp             EEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEE
T ss_pred             EEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEE
Confidence            999999999999999 6799999854    356999999999999999999999665   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+|+........   ...+||+.|+|||++.+..| +.++||||+||++|+|++|+.||...       +......
T Consensus       153 l~DFGla~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-------~~~~~~~  222 (275)
T 3hyh_A          153 IADFGLSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-------SIPVLFK  222 (275)
T ss_dssp             ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHH
T ss_pred             EeecCCCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-------CHHHHHH
Confidence            9999999876543322   24689999999999999886 57999999999999999999998642       1222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........   .    ...    ...+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~i~~~~~~~---p----~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          223 NISNGVYTL---P----KFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHTCCCC---C----TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCC---C----CCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            222221110   0    111    234789999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-55  Score=411.69  Aligned_cols=268  Identities=23%  Similarity=0.283  Sum_probs=201.0

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      +|.+.+.||+|+||+||+|++   +|+.||||++....               .....+..|+..+.+++|||||+++|+
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~---------------~~~~~~e~Ei~~~~~l~HpNIv~l~g~   65 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE---------------ERSWFREAEIYQTVMLRHENILGFIAA   65 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc---------------hhhHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            477889999999999999987   68999999984211               112233457777788999999999999


Q ss_pred             EEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCcEE
Q 014140          215 MVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANVL  285 (430)
Q Consensus       215 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp~Nil  285 (430)
                      |.+.+    .+|||||||++|||.++++.     ..+++..+.+++.|++.||+|||+.     +.++|+||||||+|||
T Consensus        66 ~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NIL  140 (303)
T 3hmm_A           66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  140 (303)
T ss_dssp             EEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEE
T ss_pred             EEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEE
Confidence            98764    57999999999999999964     3589999999999999999999965     2347999999999999


Q ss_pred             eCCCCceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          286 IDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTV------ALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       286 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ++.++.+||+|||+|+........  .......||+.|||||++.+.      .++.++|||||||++|||+||..||..
T Consensus       141 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            999999999999999876543322  122245799999999998764      367899999999999999999887643


Q ss_pred             cccc--------cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          358 FFQH--------TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       358 ~~~~--------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....        .............. .......+...   ....+....+.+|+.+||+.||++|||+.||++.|++|.
T Consensus       221 ~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          221 HEDYQLPYYDLVPSDPSVEEMRKVVC-EQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHT-TSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccccchhcccccchHHHHHHHHh-cccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            2110        01112222222222 22111111111   112345567899999999999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6e-55  Score=417.12  Aligned_cols=265  Identities=21%  Similarity=0.278  Sum_probs=212.0

Q ss_pred             cccccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-C
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-R  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p  206 (430)
                      ..++|.+.+.||+|+||+||+|++.+.    .++.||||++.....             ......|.+|+.+|.+++| |
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-------------~~~~~~~~~E~~il~~l~hhp  128 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHHL  128 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------------hHHHHHHHHHHHHHHHcCCCC
Confidence            457899999999999999999987532    346899999843211             2235679999999999965 8


Q ss_pred             CcccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          207 NIVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       207 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||+++|+|.+. +.++||||||++|+|.++|+....            ....+++..++.++.|||.||.|||+.+   
T Consensus       129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---  205 (353)
T 4ase_A          129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  205 (353)
T ss_dssp             TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---
Confidence            999999999764 568999999999999999975322            1345899999999999999999999665   


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      |+||||||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~  285 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  285 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence            99999999999999999999999999998765544444445679999999999999999999999999999999998 89


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .||.....   ...+...+........+         ...    ...+.+++..||+.||++|||+.+|++.|+++
T Consensus       286 ~Pf~~~~~---~~~~~~~i~~g~~~~~p---------~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          286 SPYPGVKI---DEEFCRRLKEGTRMRAP---------DYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CSSTTCCC---SHHHHHHHHHTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHcCCCCCCC---------ccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            99875422   11222222222111111         112    23488999999999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=417.13  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|++.. +|+.||||++......              ....+.+|+.+|+.++|||||+++
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~  214 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY  214 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTTCS--------------SGGGHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCCCceE
Confidence            4679999999999999999999874 8999999999542211              124578999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+.+|||||||+||+|.+++..     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.+|.+
T Consensus       215 ~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~v  286 (423)
T 4fie_A          215 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV  286 (423)
T ss_dssp             EEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence            999999999999999999999999853     35999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+.......  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||....    .......  
T Consensus       287 Kl~DFGla~~~~~~~~~~--~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~--  358 (423)
T 4fie_A          287 KLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKM--  358 (423)
T ss_dssp             EECCCTTCEECCSSCCCB--CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHH--
T ss_pred             EEecCccceECCCCCccc--cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHH--
Confidence            999999999875543322  24689999999999999999999999999999999999999986432    1222222  


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       +.....+...    .....    ...+.+|+.+||+.||++|||+.|+++
T Consensus       359 -i~~~~~~~~~----~~~~~----s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          359 -IRDNLPPRLK----NLHKV----SPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -HHHSCCCCCS----CTTSS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -HHcCCCCCCc----ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             2221111100    00112    234889999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-54  Score=404.42  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=193.1

Q ss_pred             ccccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+++.||+|+||+||+|+..  ..+++.||||++........            ....+.+|+.+|++++|||||+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~   90 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------------DRVRTKMERDILVEVNHPFIVK   90 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE------------ECC------CCCCCCCCTTEEC
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH------------HHHHHHHHHHHHHHCCCCCCCe
Confidence            357999999999999999999863  23678999999965432210            1235788999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.+.+.+|+|||||+||+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        91 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g  163 (304)
T 3ubd_A           91 LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEG  163 (304)
T ss_dssp             EEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTS
T ss_pred             EEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCC
Confidence            99999999999999999999999999954    346999999999999999999999665   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+|+........  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||....       ..+.
T Consensus       164 ~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~  234 (304)
T 3ubd_A          164 HIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-------RKET  234 (304)
T ss_dssp             CEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHH
T ss_pred             CEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-------HHHH
Confidence            9999999999876443322  224689999999999999999999999999999999999999986432       1222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ...+.......       ....    ...+.+|+.+||+.||++|||+
T Consensus       235 ~~~i~~~~~~~-------p~~~----s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          235 MTMILKAKLGM-------PQFL----SPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHHHCCCCC-------CTTS----CHHHHHHHHHHTCSSGGGSTTC
T ss_pred             HHHHHcCCCCC-------CCcC----CHHHHHHHHHHcccCHHHCCCC
Confidence            22332221110       0111    2348899999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-52  Score=391.73  Aligned_cols=253  Identities=20%  Similarity=0.290  Sum_probs=188.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|+... +|+.||||++.....             ......+.+|+.+|++++|||||++++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~-------------~~~~~~~~~E~~il~~l~HpnIV~~~~   70 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNR-------------ELAREKVMREVKALAKLEHPGIVRYFN   70 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECSS-------------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccCC-------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            468999999999999999998764 899999999853221             123467899999999999999999999


Q ss_pred             EEEeCCe------------eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 014140          214 RMVRRDC------------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP  281 (430)
Q Consensus       214 ~~~~~~~------------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  281 (430)
                      +|.+.+.            +|+|||||++|+|.+++... ......++..++.++.||+.||+|||+.+   |+||||||
T Consensus        71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp  146 (299)
T 4g31_A           71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKP  146 (299)
T ss_dssp             EEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred             EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcH
Confidence            9976543            68999999999999999642 12234667788999999999999999665   99999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcc----------eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRT----------TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG  351 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g  351 (430)
                      +|||++.++.+||+|||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++ 
T Consensus       147 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-  225 (299)
T 4g31_A          147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-  225 (299)
T ss_dssp             GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred             HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence            99999999999999999999875432211          1123579999999999999999999999999999999996 


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ||....      .....+........+ ..         .......+.+|+.+||+.||.+|||+.|+++
T Consensus       226 --Pf~~~~------~~~~~~~~~~~~~~p-~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          226 --PFSTQM------ERVRTLTDVRNLKFP-PL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --CCSSHH------HHHHHHHHHHTTCCC-HH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCcc------HHHHHHHHHhcCCCC-CC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              764321      111222222221111 11         1122233678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-50  Score=389.05  Aligned_cols=266  Identities=19%  Similarity=0.250  Sum_probs=200.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+++.||+|+||+||+|++.. +|+.||||++.....            .......+.+|+.+|+.++|||||+++
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~~------------~~~~~~~~~~Ei~il~~l~HpnIv~l~  119 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFD------------VVTNAKRTLRELKILKHFKHDNIIAIK  119 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCeEEEEEEecccCeEEEEEEECC-CCCEEEEEEECcccc------------chHHHHHHHHHHHHHHhcCCCCcceEe
Confidence            3579999999999999999998764 899999999843221            123356788999999999999999999


Q ss_pred             eEEEe------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVR------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++..      .+.+|||||||+ |+|.+++.    ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus       120 ~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~  191 (398)
T 4b99_A          120 DILRPTVPYGEFKSVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLV  191 (398)
T ss_dssp             EECCCSSCTTTCCCEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred             eeeecccccccCCEEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCcccccc
Confidence            98764      357899999996 68999984    4567999999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCC--cceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHT--RTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      +.++.+||+|||+|+.+.....  .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+..    
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~----  267 (398)
T 4b99_A          192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN----  267 (398)
T ss_dssp             CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS----
T ss_pred             CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC----
Confidence            9999999999999987754321  2223356899999999998876 46999999999999999999999986532    


Q ss_pred             cccHHHHHHHHhcCCCCchhc----------cccc--cCCCc-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          364 EMSLVQWMRNVMTSENPNRAI----------NSKL--LGNGY-----EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~----------~~~~--~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......+............-          ...+  ....+     +.....+.+|+.+||+.||++|||+.|+++
T Consensus       268 ~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          268 YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            222222222222111100000          0000  00000     011234789999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-49  Score=377.39  Aligned_cols=199  Identities=24%  Similarity=0.353  Sum_probs=168.5

Q ss_pred             ccccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  209 (430)
                      .+.|.+.+.||+|+||+||+|+.+  ..+++.||||++....                ...++.+|+.+|..+ +|||||
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~E~~~l~~~~~h~nIv   83 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------------HPIRIAAELQCLTVAGGQDNVM   83 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------------CHHHHHHHHHHHHHTCSBTTBC
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------------CHHHHHHHHHHHHHhcCCCCCc
Confidence            467999999999999999999753  2367899999984321                134678899999998 699999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++.+.+..|+|||||++|+|.+++.       .+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        84 ~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~  153 (361)
T 4f9c_A           84 GVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRR  153 (361)
T ss_dssp             CCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred             eEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCC
Confidence            99999999999999999999999999982       3899999999999999999999665   9999999999999876


Q ss_pred             -CceEEeecCCcccCCCCCCc--------------------------ceeeccccccccccccccCCC-CCCcchhHHHH
Q 014140          290 -MEARISEFGLAKRIPDGHTR--------------------------TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSF  341 (430)
Q Consensus       290 -~~~kl~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~sl  341 (430)
                       +.+||+|||+|+........                          ......+||+.|+|||++.+. .|+.++||||+
T Consensus       154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence             79999999999865432211                          111235799999999999876 48999999999


Q ss_pred             HHHHHHHHhCCCCCCc
Q 014140          342 GVLLAVLVIGKFPSDD  357 (430)
Q Consensus       342 G~~l~ell~g~~p~~~  357 (430)
                      ||++|||++|+.||..
T Consensus       234 G~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          234 GVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             HHHHHHHHHTCSSSSC
T ss_pred             HHHHHHHHHCCCCCCC
Confidence            9999999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-48  Score=372.50  Aligned_cols=280  Identities=31%  Similarity=0.535  Sum_probs=237.3

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|++.  +|+.||||++......             .....+.+|+.+++.++||||+++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------------------CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             HhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCc-------------hHHHHHHHHHHHHHhccCCCccce
Confidence            5678999999999999999999865  7999999998543211             112358899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+.++++||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999999765555567999999999999999999999773346999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc-cccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF-QHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~l~~~  370 (430)
                      +||+|||++........... ....||+.|+|||++.+..++.++||||||+++|+|++|..||+... ..........|
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999987754433222 24569999999999998889999999999999999999999987432 22345567777


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      +.............+..............+.+++..||+.||.+|||+.+|++.|+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            777777777777777777777888889999999999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.1e-48  Score=369.07  Aligned_cols=277  Identities=26%  Similarity=0.423  Sum_probs=232.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|++.  +|+.||||++.....              .....+.+|+.+++.++||||+++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESS--------------QGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCS--------------SHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccCh--------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4678999999999999999999975  799999998743211              125678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCC
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCC
Confidence            99999999999999999999999998654333456999999999999999999999654   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+ ........|.
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~~  256 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWA  256 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHHT
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHHh
Confidence            999999999876543322222345689999999999988999999999999999999999999876544 2344566666


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ............+++.............+.+++..||+.||++|||+.+|++.|+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            655555556666666666667788888999999999999999999999999999865

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-48  Score=395.47  Aligned_cols=255  Identities=23%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||+||+|+... +|+.||||++......     .+   ...........++.+++.++|||||+++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~-----~~---~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIK-----MK---QGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----HT---TCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcc-----hh---hhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            3679999999999999999999874 8999999999543211     00   1111223344557788888999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+.+|||||||+||+|.++|..    .+.+++..+..++.||+.||.|||+.   +|+||||||+||||+.+|.+
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            999999999999999999999999964    35699999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||+|+.+.....    ...+||+.|||||++.+ ..|+.++|||||||++|||++|..||.....    .......
T Consensus       332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~  403 (689)
T 3v5w_A          332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEID  403 (689)
T ss_dssp             EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHH
T ss_pred             EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence            9999999988754432    24689999999999975 5799999999999999999999999865322    1222222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVR  422 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~  422 (430)
                      ..........           +......+.+|+..||+.||.+|++     +.||+
T Consensus       404 ~~i~~~~~~~-----------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          404 RMTLTMAVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             HhhcCCCCCC-----------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            2222221110           1111234889999999999999998     56664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-48  Score=395.56  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=206.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+.+. +|+.||+|.+.....              .....+.+|+.+|+.++|||||++++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~~~--------------~~~~~~~~Ei~il~~l~hpnIv~l~~  221 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHE--------------SDKETVRKEIQTMSVLRHPTLVNLHD  221 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSH--------------HHHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEeccch--------------hhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            579999999999999999999874 899999999853221              22467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC--Cc
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--ME  291 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~  291 (430)
                      +|.+.+.+|||||||+||+|.+++..   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.+  +.
T Consensus       222 ~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~  295 (573)
T 3uto_A          222 AFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE  295 (573)
T ss_dssp             EEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCC
T ss_pred             EEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCC
Confidence            99999999999999999999999843   3456999999999999999999999665   9999999999999854  89


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+|+.+.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.....       .+.+
T Consensus       296 vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~  365 (573)
T 3uto_A          296 LKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETL  365 (573)
T ss_dssp             EEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHH
T ss_pred             EEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHH
Confidence            99999999998765433   2345899999999999999999999999999999999999999865321       2222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+......   +........+    ..+.+|+.+||+.||.+|||+.|+++
T Consensus       366 ~~i~~~~~~---~~~~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          366 RNVKSCDWN---MDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHTTCCC---CCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCC---CCcccccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            233222111   1111111222    34789999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=351.00  Aligned_cols=259  Identities=22%  Similarity=0.391  Sum_probs=209.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.+.. +|+.||+|++...              .......+.+|+.++++++||||++++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~--------------~~~~~~~~~~E~~~l~~l~hp~iv~~~   73 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRF--------------DEETQRTFLKEVKVMRCLEHPNVLKFI   73 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCC--------------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECC-CCcEEEEEEeccC--------------CHHHHHHHHHHHHHHHhCCCcCcccEE
Confidence            4679999999999999999999864 8999999988331              123357899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~  147 (310)
T 3s95_A           74 GVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNV  147 (310)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCE
T ss_pred             EEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCE
Confidence            999999999999999999999999964   3456999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcc------------eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          293 RISEFGLAKRIPDGHTRT------------TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ||+|||++..........            ......||+.|+|||++.+..++.++||||||+++|+|++|..|+.....
T Consensus       148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             EECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             EEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence            999999998765432211            11145799999999999999999999999999999999999999875433


Q ss_pred             ccc--cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          361 HTK--EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       361 ~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ...  .............             ...    ...+.+++..||+.||++|||+.++++.|+.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~-------------~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          228 RTMDFGLNVRGFLDRYCP-------------PNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             BCTTSSBCHHHHHHHTCC-------------TTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHhhhhhccccccCC-------------CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            221  1112222111110             011    123888999999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.5e-46  Score=352.97  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+.   +|+.||||++.....            .......+.+|+.++++++||||++++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hp~iv~~~  100 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDF------------HAERVNEFLREVAIMKRLRHPNIVLFM  100 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCC------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCC------------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            46799999999999999999986   688999999854321            123356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCcEEeCCCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR--IIHRDIQPANVLIDDDM  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dlkp~Nill~~~~  290 (430)
                      +++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||   ..+  |+||||||+|||++.++
T Consensus       101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~  176 (309)
T 3p86_A          101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKY  176 (309)
T ss_dssp             EEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTC
T ss_pred             EEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCC
Confidence            99999999999999999999999995411 1124899999999999999999999   556  99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ......
T Consensus       177 ~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~  250 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAA  250 (309)
T ss_dssp             CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHH
T ss_pred             cEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence            9999999999865433221  2235789999999999999999999999999999999999999875322    111211


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +.........            +......+.+++..||+.||.+|||+.++++.|+.+
T Consensus       251 ~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          251 VGFKCKRLEI------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             HHHSCCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCCCCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111111111            111223488999999999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-46  Score=357.56  Aligned_cols=271  Identities=26%  Similarity=0.339  Sum_probs=208.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|++   .|+.||||++....               .....+..|+.++++++||||+++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~~   83 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQD---------------KQSWQNEYEVYSLPGMKHENILQF   83 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             chhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCc---------------hHHHHHHHHHHHHhcCCCCCchhh
Confidence            356799999999999999999986   57999999984321               123455669999999999999999


Q ss_pred             eeEEEeCCe----eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------CCCCeEecCCC
Q 014140          212 LARMVRRDC----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-------HRPRIIHRDIQ  280 (430)
Q Consensus       212 ~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~iiH~Dlk  280 (430)
                      ++++.....    .++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+.       +.++|+|||||
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlk  158 (322)
T 3soc_A           84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK  158 (322)
T ss_dssp             EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCS
T ss_pred             cceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCC
Confidence            999988543    6999999999999999954     3489999999999999999999954       01169999999


Q ss_pred             CCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          281 PANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----ALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       281 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||
T Consensus       159 p~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf  238 (322)
T 3soc_A          159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA  238 (322)
T ss_dssp             GGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred             hHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999877654443333346799999999999873     4567899999999999999999998


Q ss_pred             Cccccccc---------cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          356 DDFFQHTK---------EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       356 ~~~~~~~~---------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ........         ......+........ ....+....   ........+.+++..||+.||++|||+.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            75332111         112222222222111 111111110   11234456899999999999999999999999999


Q ss_pred             ccc
Q 014140          427 QIQ  429 (430)
Q Consensus       427 ~l~  429 (430)
                      +|+
T Consensus       315 ~l~  317 (322)
T 3soc_A          315 QMQ  317 (322)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.5e-46  Score=348.37  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=203.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|.... +|+.||||++......              ....+.+|+.+++.++||||++++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--------------~~~~~~~E~~~l~~l~hp~iv~~~   83 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNYL   83 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeeccccc--------------HHHHHHHHHHHHhcCCCCCCCeEe
Confidence            4679999999999999999998754 8999999998543211              135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~  155 (297)
T 3fxz_A           84 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSV  155 (297)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCE
Confidence            999999999999999999999999954     35899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++..........  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .....
T Consensus       156 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~  226 (297)
T 3fxz_A          156 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALY  226 (297)
T ss_dssp             EECCCTTCEECCSTTCCB--CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH
T ss_pred             EEeeCCCceecCCccccc--CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999998775443322  235799999999999999999999999999999999999999865321       11111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......+...        .+......+.+++..||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          227 LIATNGTPELQ--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHHHCSCCCS--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHhCCCCCCC--------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11111111100        11122334889999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.4e-46  Score=358.71  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=211.5

Q ss_pred             ccccccccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      .++|.+.+.||+|+||.||+|++.+      .++..||||++....             .......+.+|+.+++.+ +|
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h  146 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------------TEKDLSDLVSEMEMMKMIGKH  146 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------------BHHHHHHHHHHHHHHHHSCCC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------------CHHHHHHHHHHHHHHHHhcCC
Confidence            4679999999999999999998631      256789999984321             123357799999999999 89


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      |||++++++|.+.+..|+||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.+   
T Consensus       147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---  223 (370)
T 2psq_A          147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---  223 (370)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            9999999999999999999999999999999976321            1245899999999999999999999655   


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       224 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987765433333334567889999999999999999999999999999999 99


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .||....    ...+...+.......             .+..+...+.+++..||+.||.+||++.++++.|+++
T Consensus       304 ~p~~~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          304 SPYPGIP----VEELFKLLKEGHRMD-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             CSSTTCC----GGGHHHHHHTTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCC----HHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9986532    222332222211111             1111223488999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.5e-46  Score=354.21  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.||||++......            ......+.+|+.+|+.++||||++++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~l~   80 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLN------------PTSLQKLFREVRIMKILNHPNIVKLF   80 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcCC------------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4679999999999999999998764 8999999998543211            23356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~  153 (328)
T 3fe3_A           81 EVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNI  153 (328)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCE
Confidence            999999999999999999999999954    245999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALS-DTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++.........   ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||....       ..+..
T Consensus       154 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~  223 (328)
T 3fe3_A          154 KIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELR  223 (328)
T ss_dssp             EECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH
T ss_pred             EEeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHH
Confidence            99999999876544322   245799999999999988875 78999999999999999999986532       12222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........           +......+.+++..||+.||.+|||+.++++
T Consensus       224 ~~i~~~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          224 ERVLRGKYRI-----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHCCCCC-----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHhCCCCC-----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2222221110           0011234788999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-45  Score=346.40  Aligned_cols=263  Identities=24%  Similarity=0.355  Sum_probs=206.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|.+.....           ........+.+|+.++++++||||++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~iv~~~   77 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPR-----------EKEETLKRFEREVHNSSQLSHQNIVSMI   77 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSS-----------CCHHHHHHHHHHHHHHTTCCBTTBCCEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCcc-----------ccHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence            4679999999999999999998764 899999999854322           1233467899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~  150 (294)
T 4eqm_A           78 DVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTL  150 (294)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             EeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence            999999999999999999999999954    346999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....       .....
T Consensus       151 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~  222 (294)
T 4eqm_A          151 KIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAI  222 (294)
T ss_dssp             EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHH
T ss_pred             EEEeCCCccccccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHH
Confidence            999999998765433222 2245799999999999999999999999999999999999999865321       11122


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-NSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~ev~~~L~~l  428 (430)
                      .......+..  ........    +..+.+++.+||+.||.+|| ++.++.+.|+.+
T Consensus       223 ~~~~~~~~~~--~~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          223 KHIQDSVPNV--TTDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHSSCCCCH--HHHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             HHhhccCCCc--chhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            2222222111  11111122    23488999999999999998 999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-45  Score=341.00  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=209.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.  ++..||+|++......               ...+.+|+.++.+++||||++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~~   69 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS---------------EDEFFQEAQTMMKLSHPKLVKFY   69 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc---------------HHHHHHHHHHHHhCCCCCEeeEE
Confidence            567999999999999999999876  7788999998532211               35688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~  143 (268)
T 3sxs_A           70 GVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCV  143 (268)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCE
T ss_pred             EEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCE
Confidence            9999999999999999999999999652   345999999999999999999999555   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    .   ...
T Consensus       144 ~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~---~~~  215 (268)
T 3sxs_A          144 KVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----S---EVV  215 (268)
T ss_dssp             EECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----H---HHH
T ss_pred             EEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----H---HHH
Confidence            999999998775543322 223456788999999998889999999999999999999 9999865322    1   111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                      ...........   +   ...    ...+.+++..||+.||.+|||+.++++.|+.+++
T Consensus       216 ~~~~~~~~~~~---~---~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          216 LKVSQGHRLYR---P---HLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHHTTCCCCC---C---TTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHcCCCCCC---C---CcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            22221111110   0   011    2248899999999999999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8e-45  Score=343.18  Aligned_cols=272  Identities=31%  Similarity=0.462  Sum_probs=215.1

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||+|+||.||+|..   +++.||||++......          ........+.+|+.++++++||||+++++++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   99 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDI----------TTEELKQQFDQEIKVMAKCQHENLVELLGFS   99 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTS----------CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE---CCceEEEEEEecccCc----------chHHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            34458999999999999986   6889999998543211          1123356799999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          216 VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      .+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~  175 (307)
T 2nru_A          100 SDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS  175 (307)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEe
Confidence            99999999999999999999996532 3456999999999999999999999655   9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHh
Q 014140          296 EFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM  375 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~  375 (430)
                      |||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||........   +..+.....
T Consensus       176 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~  251 (307)
T 2nru_A          176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL---LLDIKEEIE  251 (307)
T ss_dssp             CCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB---TTHHHHHHH
T ss_pred             ecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH---HHHHHHHhh
Confidence            9999987665433333334579999999998876 588999999999999999999999876433221   122222222


Q ss_pred             cCCC-CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          376 TSEN-PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       376 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .... ....++. .....+......+.+++..||+.||.+|||+.+|++.|+++.
T Consensus       252 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          252 DEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            2211 1122222 224456677788999999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-45  Score=351.70  Aligned_cols=258  Identities=23%  Similarity=0.286  Sum_probs=206.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +|+.||+|.+........        ........+.+|+.+|++++||||++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRAS--------RRGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccc--------cchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            4679999999999999999998764 899999999965432210        0001246789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      +++.+.+..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~  154 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP  154 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCC
Confidence            99999999999999999999999994    3457999999999999999999999655   99999999999998877  


Q ss_pred             --ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 --EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                        .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .
T Consensus       155 ~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~  224 (361)
T 2yab_A          155 IPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------Q  224 (361)
T ss_dssp             SCCEEECCCSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------H
T ss_pred             ccCEEEEecCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------H
Confidence              7999999999887654322   235799999999999999999999999999999999999999864321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...........   +++......+    ..+.+++..||+.||.+|||+.++++
T Consensus       225 ~~~~~i~~~~~~---~~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 ETLANITAVSYD---FDEEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHTTCCC---CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhcCCC---CCchhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            222222221110   1111111222    34889999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.3e-46  Score=362.93  Aligned_cols=261  Identities=22%  Similarity=0.288  Sum_probs=209.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|++.. +|+.||||.+....             .......+.+|+.+|++++||||+++
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~hpniv~~  177 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETL-------------PPDLKAKFLQEARILKQYSHPNIVRL  177 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTS-------------CHHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccC-------------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            35678999999999999999999864 78999999984321             11234568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|...+..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus       178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~  251 (377)
T 3cbl_A          178 IGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV  251 (377)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCc
Confidence            9999999999999999999999999964   2345899999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....    ......
T Consensus       252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~~  327 (377)
T 3cbl_A          252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTREF  327 (377)
T ss_dssp             EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHHH
T ss_pred             EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            99999999987544322211112245778999999998889999999999999999998 9999865422    122222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +.   ......          .+..++..+.+++..||+.||++|||+.+|++.|++++
T Consensus       328 ~~---~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          328 VE---KGGRLP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HH---TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH---cCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            21   111110          01112234889999999999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=343.58  Aligned_cols=274  Identities=19%  Similarity=0.222  Sum_probs=212.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +|+.||||++......             .....+.+|+.++++++||||++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~   73 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKLF   73 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC-CCcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCcceEE
Confidence            4679999999999999999999864 7999999998532211             1246678999999999999999999


Q ss_pred             eEEEeCC--eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----
Q 014140          213 ARMVRRD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI----  286 (430)
Q Consensus       213 ~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----  286 (430)
                      +++...+  ..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+|||+    
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~  149 (319)
T 4euu_A           74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGE  149 (319)
T ss_dssp             EEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECT
T ss_pred             EEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccC
Confidence            9998765  7799999999999999996532 2234999999999999999999999655   9999999999999    


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ--------TVALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +.++.+||+|||++..........   ...||+.|+|||++.        +..++.++|||||||++|||++|..||...
T Consensus       150 ~~~~~~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          150 DGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             TSCEEEEECCCTTCEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CCCceEEEccCCCceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            788889999999998876543322   346999999999876        567899999999999999999999998754


Q ss_pred             ccccccccHHHHHHHHhcCCCCchh---------c--cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRA---------I--NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQ  427 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~  427 (430)
                      ............+............         .  ...............+.+++..||+.||++|||+.|+++..++
T Consensus       227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            3322222222222221111110000         0  0011123456777789999999999999999999999987764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=349.23  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=205.8

Q ss_pred             ccccccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .+.|.+.+.||+|+||.||+|++..  ..+..||||++....             .......+.+|+.+++.++||||++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~  114 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------------TERQRRDFLSEASIMGQFDHPNIIR  114 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------------CHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            4679999999999999999999753  134469999984321             1233567999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~  188 (325)
T 3kul_A          115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNL  188 (325)
T ss_dssp             EEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             EEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCC
Confidence            99999999999999999999999999953   3456999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    ..+.
T Consensus       189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~  264 (325)
T 3kul_A          189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVI  264 (325)
T ss_dssp             CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHH
T ss_pred             CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHH
Confidence            99999999998875443222 2223456788999999998899999999999999999999 9999865322    2222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+   .......          .+......+.+++..||+.||.+|||+.+|++.|+.+
T Consensus       265 ~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          265 SSV---EEGYRLP----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             HHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH---HcCCCCC----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            222   2111111          1111223488999999999999999999999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.4e-45  Score=347.92  Aligned_cols=251  Identities=22%  Similarity=0.265  Sum_probs=202.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||+|++......           .......+.+|+.+++.++||||+++++
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~l~~   72 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhh-----------hhhHHHHHHHHHHHHHhCCCCcCcceEE
Confidence            579999999999999999998764 8999999998542111           1122567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        73 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk  145 (337)
T 1o6l_A           73 AFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEE
Confidence            99999999999999999999999854    346899999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||....    .   ......
T Consensus       146 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~---~~~~~~  216 (337)
T 1o6l_A          146 ITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----H---ERLFEL  216 (337)
T ss_dssp             ECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----H---HHHHHH
T ss_pred             EeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----H---HHHHHH
Confidence            999999986443222  1224579999999999999999999999999999999999999986421    1   112222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .......       .....    ...+.+++..||+.||.+||     ++.+|++
T Consensus       217 i~~~~~~-------~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          217 ILMEEIR-------FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHCCCC-------CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHcCCCC-------CCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            2211110       00111    23488999999999999999     8888865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-45  Score=340.91  Aligned_cols=257  Identities=22%  Similarity=0.299  Sum_probs=208.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+.  +++.||+|++......               ...+.+|+.++++++||||+++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~   70 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQL   70 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence            3567999999999999999999976  7888999998543221               3568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~  144 (269)
T 4hcu_A           71 YGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQV  144 (269)
T ss_dssp             EEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGC
T ss_pred             EEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCC
Confidence            9999999999999999999999999954   3456999999999999999999999555   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    ....  
T Consensus       145 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~~--  217 (269)
T 4hcu_A          145 IKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVV--  217 (269)
T ss_dssp             EEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH--
T ss_pred             EEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHHH--
Confidence            999999999876543211 1123456788999999998899999999999999999999 9999865321    1222  


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                       ........+.   .+   ...    ...+.+++..||+.||.+|||+.++++.|+++.
T Consensus       218 -~~~~~~~~~~---~~---~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          218 -EDISTGFRLY---KP---RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             -HHHHTTCCCC---CC---TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHhcCccCC---CC---CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence             2222111110   00   111    234889999999999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=344.28  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=204.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.+|+|.+....               .....+.+|+.+++.++||||++++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~---------------~~~~~~~~E~~~l~~l~hpnIv~~~   67 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG---------------TDQVLVKKEISILNIARHRNILHLH   67 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT---------------HHHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecCc---------------ccHHHHHHHHHHHHhCCCCCCCeEe
Confidence            3679999999999999999998764 89999999984211               1245688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC--CC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DM  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~  290 (430)
                      +++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.  ++
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~  141 (321)
T 1tki_A           68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSS  141 (321)
T ss_dssp             EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCC
T ss_pred             EEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCC
Confidence            999999999999999999999999943   3346999999999999999999999655   999999999999997  78


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....       .+.
T Consensus       142 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~  211 (321)
T 1tki_A          142 TIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQI  211 (321)
T ss_dssp             CEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH
T ss_pred             CEEEEECCCCeECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHH
Confidence            9999999999887654322   235789999999999998899999999999999999999999865321       122


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........   +.......    ...+.+++..||+.||.+|||+.|+++
T Consensus       212 ~~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          212 IENIMNAEYTF---DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHTCCCC---CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCC---ChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22222211110   11111122    234889999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-45  Score=349.85  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......             .....+.+|+.+++.++||||++++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~   71 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFY   71 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEccccc-------------chHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3679999999999999999998764 8999999998432211             1135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++    .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~  144 (323)
T 3tki_A           72 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL  144 (323)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCE
Confidence            9999999999999999999999998    34456999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++..+.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||......  ......+.
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~  222 (323)
T 3tki_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK  222 (323)
T ss_dssp             EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHH
T ss_pred             EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh
Confidence            9999999987654333333334679999999999988775 77899999999999999999998753221  11111111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                          .......         ........+.+|+..||+.||.+|||+.|+++
T Consensus       223 ----~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          223 ----EKKTYLN---------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ----TTCTTST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cccccCC---------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                1111100         00111234788999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=353.41  Aligned_cols=264  Identities=23%  Similarity=0.294  Sum_probs=212.0

Q ss_pred             cccccccccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-C
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-R  204 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  204 (430)
                      ..++|.+.+.||+|+||.||+|++.+      ..+..||||++....             .......+.+|+.+++++ +
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~  133 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------------TEKDLSDLISEMEMMKMIGK  133 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------------CHHHHHHHHHHHHHHHHhcC
Confidence            35689999999999999999998632      244689999984321             123357799999999999 8


Q ss_pred             CCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       205 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      ||||++++++|...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.+  
T Consensus       134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  211 (382)
T 3tt0_A          134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--  211 (382)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            99999999999999999999999999999999976331            1245999999999999999999999655  


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-C
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-G  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g  351 (430)
                       |+||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++++|++ |
T Consensus       212 -ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g  290 (382)
T 3tt0_A          212 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG  290 (382)
T ss_dssp             -CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             -EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987765443333334567899999999999999999999999999999999 9


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..||....    ...+...   .........      ....    ...+.+++..||+.||++|||+.+|++.|+++
T Consensus       291 ~~p~~~~~----~~~~~~~---~~~~~~~~~------~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          291 GSPYPGVP----VEELFKL---LKEGHRMDK------PSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             CCSSTTCC----HHHHHHH---HHTTCCCCC------CSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCC----HHHHHHH---HHcCCCCCC------CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            99986432    1122222   222111110      0112    23488999999999999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.7e-45  Score=351.85  Aligned_cols=265  Identities=20%  Similarity=0.281  Sum_probs=209.1

Q ss_pred             cccccccccccccccCceEEEeec----CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++    ...+++.||||++....             .......+.+|+.++.++ +||
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~hp   86 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------------THSEHRALMSELKILIHIGHHL   86 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------------CHHHHHHHHHHHHHHHhhcCCc
Confidence            467899999999999999999973    22477999999984321             122356799999999999 799


Q ss_pred             CcccceeEEEeCCe-eEEEEEecCCCCHHHHHhhhcCC------------------------------------------
Q 014140          207 NIVPLLARMVRRDC-DLLVYEFRRNGSLQDILYDVSQG------------------------------------------  243 (430)
Q Consensus       207 niv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------  243 (430)
                      ||++++++|.+.+. .++||||+++|+|.+++......                                          
T Consensus        87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            99999999987654 89999999999999999753221                                          


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccC
Q 014140          244 --------------------RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       244 --------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  303 (430)
                                          ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                122899999999999999999999655   999999999999999999999999999877


Q ss_pred             CCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhcCCCCch
Q 014140          304 PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR  382 (430)
Q Consensus       304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (430)
                      .............||+.|+|||++.+..++.++||||||+++|||++ |..||.....   ...+...+........+  
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~~~--  318 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRLKEGTRMRAP--  318 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHHHHHHHTCCCCCC--
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hHHHHHHHHcCCCCCCC--
Confidence            55444333335678999999999999999999999999999999998 9999865322   11122222211111100  


Q ss_pred             hccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                             ...    ...+.+++..||+.||.+|||+.+|++.|+.+
T Consensus       319 -------~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          319 -------DYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             -------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                   111    23488899999999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=355.90  Aligned_cols=264  Identities=22%  Similarity=0.303  Sum_probs=207.5

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|++.+    .++..||||++....             .......+.+|+.++++++||||
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~hpnI  136 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------------SEQDELDFLMEALIISKFNHQNI  136 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-------------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-------------ChhhHHHHHHHHHHHHhCCCCCC
Confidence            4679999999999999999998532    367799999984321             12234578899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++++...+..++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  213 (367)
T 3l9p_A          137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCL  213 (367)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEE
Confidence            9999999999999999999999999999976432   2245999999999999999999999655   999999999999


Q ss_pred             eCCCC---ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          286 IDDDM---EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       286 l~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ++.++   .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....  
T Consensus       214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--  291 (367)
T 3l9p_A          214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--  291 (367)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred             EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence            99555   599999999986533222222224568999999999999999999999999999999998 999986532  


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        ...+..   .......+..          +......+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       292 --~~~~~~---~i~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          292 --NQEVLE---FVTSGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             --HHHHHH---HHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHH---HHHcCCCCCC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              122222   2222211110          1111234889999999999999999999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.5e-45  Score=351.61  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=193.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......               ...+.+|+.+++.++||||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~~~   82 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAI---------------DENVQREIINHRSLRHPNIVRFK   82 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESSTTS---------------CHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCccc---------------cHHHHHHHHHHHhCCCCCCCcEE
Confidence            4679999999999999999999764 8999999998542211               24578999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++. 
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~  155 (361)
T 3uc3_A           83 EVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAP  155 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSC
T ss_pred             EEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCc
Confidence            999999999999999999999999854    346999999999999999999999555   999999999999987765 


Q ss_pred             -eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 -ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       +||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   .....
T Consensus       156 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~  229 (361)
T 3uc3_A          156 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRK  229 (361)
T ss_dssp             CEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHH
T ss_pred             eEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHH
Confidence             99999999975433222   223579999999999988888666 89999999999999999998754321   22333


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+...........   .  ....+    ..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~---~--~~~~s----~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          230 TIQRILSVKYSIP---D--DIRIS----PECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHTTCCCCC---T--TSCCC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhcCCCCCC---C--cCCCC----HHHHHHHHHHccCChhHCcCHHHHHh
Confidence            3333332211100   0  00112    34789999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=350.40  Aligned_cols=265  Identities=20%  Similarity=0.304  Sum_probs=211.1

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..++|.+.+.||+|+||.||+|++.+    .+++.||||.+....             .......+.+|+.++++++|||
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~hp~  111 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------------SADMQADFQREAALMAEFDNPN  111 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            46789999999999999999999753    355899999984321             1233577999999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG--------------------RRELDWLARHRIAQGIASGLEYLH  267 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH  267 (430)
                      |+++++++.+.+..++||||+++|+|.+++......                    ...+++..++.++.|++.||.|||
T Consensus       112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  191 (343)
T 1luf_A          112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  191 (343)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999763211                    257999999999999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.+   |+||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+
T Consensus       192 ~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  268 (343)
T 1luf_A          192 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  268 (343)
T ss_dssp             HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence            655   99999999999999999999999999987644332222234568899999999998899999999999999999


Q ss_pred             HHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          348 LVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       348 ll~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      |++ |..||.....       .+..........+.          .+......+.+++..||+.||.+|||+.+|++.|+
T Consensus       269 l~t~g~~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          269 IFSYGLQPYYGMAH-------EEVIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             HHTTTCCTTTTSCH-------HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcCCCcCCCCCh-------HHHHHHHhCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            999 9999865321       11222222211110          01112234889999999999999999999999999


Q ss_pred             ccc
Q 014140          427 QIQ  429 (430)
Q Consensus       427 ~l~  429 (430)
                      ++.
T Consensus       332 ~~~  334 (343)
T 1luf_A          332 RMC  334 (343)
T ss_dssp             HTT
T ss_pred             HHH
Confidence            874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=344.51  Aligned_cols=257  Identities=24%  Similarity=0.300  Sum_probs=204.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||.||+|.... +|+.||+|.+........        ........+.+|+.+++.++||||+++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccc--------cchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            569999999999999999998764 899999999865432210        00012467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC---
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---  290 (430)
                      ++.+.+..++||||+++|+|.+++.    ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++   
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSS
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCC
Confidence            9999999999999999999999994    3457999999999999999999999655   99999999999999887   


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....    .... 
T Consensus       155 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-  226 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETL-  226 (326)
T ss_dssp             CCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH-
T ss_pred             CCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHH-
Confidence             7999999999877543322   235799999999999999999999999999999999999999864321    1111 


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        .........   +........    ...+.+++..||+.||.+|||+.++++
T Consensus       227 --~~~~~~~~~---~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          227 --ANVSAVNYE---FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --HHHHHTCCC---CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --HHHHhcCCC---cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              111111110   011111112    234789999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.8e-45  Score=348.68  Aligned_cols=258  Identities=21%  Similarity=0.266  Sum_probs=199.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCce----EEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRV----ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.    ||+|.+....             .......+.+|+.++++++||||
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~i   79 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREAT-------------SPKANKEILDEAYVMASVDNPHV   79 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------------------CHHHHHHHHHHHHHCCBTTB
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeeccccc-------------CHHHHHHHHHHHHHHHhCCCCCE
Confidence            5679999999999999999998764 5554    4777663211             11224679999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      ++++++|...+ .++|+||+.+|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        80 v~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~  152 (327)
T 3poz_A           80 CRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKT  152 (327)
T ss_dssp             CCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEE
T ss_pred             eEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECC
Confidence            99999998755 7899999999999999964   3456999999999999999999999655   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....    ..+
T Consensus       153 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~  228 (327)
T 3poz_A          153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEI  228 (327)
T ss_dssp             TTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGH
T ss_pred             CCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HHH
Confidence            99999999999987765444333334567889999999999999999999999999999999 9999875422    223


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+.......             .+......+.+++..||+.||.+|||+.++++.|+.+
T Consensus       229 ~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          229 SSILEKGERLP-------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHHHHTTCCCC-------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCC-------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            32222211111             1111223488999999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-44  Score=352.92  Aligned_cols=254  Identities=20%  Similarity=0.249  Sum_probs=198.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||+|++......           .......+..|..++.++ +||||+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~-----------~~~~~~~~~~E~~il~~~~~hp~Iv~l  118 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVN-----------DDEDIDWVQTEKHVFEQASNHPFLVGL  118 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC---------------CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhcc-----------CHHHHHHHHHHHHHHHhcCCCCCcCee
Confidence            4579999999999999999999874 8999999999643221           112235578899999887 89999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~  191 (396)
T 4dc2_A          119 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH  191 (396)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred             EEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCC
Confidence            9999999999999999999999999964    346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-ccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT-KEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~l~~~  370 (430)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus       192 ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~  269 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  269 (396)
T ss_dssp             EEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred             EEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence            99999999986433222  2224689999999999999999999999999999999999999996432111 01111111


Q ss_pred             H-HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          371 M-RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       371 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      + .........           .+......+.+|+..||+.||.+||++
T Consensus       270 ~~~~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          270 LFQVILEKQIR-----------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHhccccC-----------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1 122211110           011122348899999999999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.5e-45  Score=343.68  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             ccccccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|++   ...+|+.||||++...              .......+.+|+.++++++||||+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv   74 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------------TEEHLRDFEREIEILKSLQHDNIV   74 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--------------CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--------------CHHHHHHHHHHHHHHHhCCCCCEe
Confidence            46799999999999999999984   2347899999998432              123356789999999999999999


Q ss_pred             cceeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          210 PLLARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       210 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++++...  ...++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+|||++
T Consensus        75 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~  148 (295)
T 3ugc_A           75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE  148 (295)
T ss_dssp             CEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             eEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEc
Confidence            999998653  568999999999999999965   2345999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-----
Q 014140          288 DDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-----  361 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-----  361 (430)
                      .++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+......     
T Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~  228 (295)
T 3ugc_A          149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI  228 (295)
T ss_dssp             ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHH
T ss_pred             CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhh
Confidence            9999999999999877543322 1222345788899999999999999999999999999999999997643210     


Q ss_pred             --c-ccccHH-HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          362 --T-KEMSLV-QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       362 --~-~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        . ...... ............          ..+......+.+++..||+.||++|||+.++++.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          229 GNDKQGQMIVFHLIELLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCccccchhHHHHHHHHhccCcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence              0 000011 111111111111          111122345889999999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-44  Score=340.56  Aligned_cols=266  Identities=23%  Similarity=0.273  Sum_probs=201.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....           ........+.+|+.+++.++||||++++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   98 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDL-----------MDAKARADCIKEIDLLKQLNHPNVIKYY   98 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSS-----------CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhc-----------cCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3579999999999999999998754 899999999853211           1123457789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A           99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCE
Confidence            9999999999999999999999999765555677999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....     ........
T Consensus       176 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~  248 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCK  248 (310)
T ss_dssp             EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHHH
T ss_pred             EEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHHH
Confidence            99999999876543221  123568999999999999999999999999999999999999986432     12222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .......+..     .....    ...+.+++..||+.||.+|||+.+|++.|++++
T Consensus       249 ~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          249 KIEQCDYPPL-----PSDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             HHHTTCSCCC-----CTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhcccCCCC-----ccccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            2222111110     00112    234889999999999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=350.29  Aligned_cols=253  Identities=21%  Similarity=0.241  Sum_probs=202.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||+|.+......           .......+.+|+.+|+.++||||+++++
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~hp~Iv~l~~   82 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCV-----------ERNEVRNVFKELQIMQGLEHPFLVNLWY   82 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhcc-----------cHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            579999999999999999998764 8999999998542211           1122567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.+.+..++||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           83 SFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEE
Confidence            99999999999999999999999953    456999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |+|||++.........   ....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.....    ......
T Consensus       156 L~DFG~a~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~  228 (384)
T 4fr4_A          156 ITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEI  228 (384)
T ss_dssp             ECCCTTCEECCTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHH
T ss_pred             EeccceeeeccCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHH
Confidence            9999999877544322   24579999999999874   4589999999999999999999999864322    122222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-SKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~ev~~  423 (430)
                      ..........           .+......+.+++..||+.||.+||+ +.+|.+
T Consensus       229 ~~~~~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          229 VHTFETTVVT-----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHCCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHhhcccC-----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            2222211111           11112234889999999999999999 666553

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-45  Score=346.69  Aligned_cols=265  Identities=20%  Similarity=0.276  Sum_probs=212.3

Q ss_pred             cccccccccccccccCceEEEeec----CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++    ...+++.||||.+.....             ......+.+|+.++.++ +||
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~   87 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------------LTEREALMSELKVLSYLGNHM   87 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCCT
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-------------HHHHHHHHHHHHHHhhcccCC
Confidence            457899999999999999999985    334788999999843211             12357799999999999 999


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------GRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      ||+++++++...+..++||||+++|+|.+++.....              ....+++..++.++.|++.||.|||+.+  
T Consensus        88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--  165 (313)
T 1t46_A           88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--  165 (313)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            999999999999999999999999999999975321              1235899999999999999999999655  


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-C
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-G  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g  351 (430)
                       ++||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       166 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  244 (313)
T 1t46_A          166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG  244 (313)
T ss_dssp             -CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             -eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999988765544333334567889999999999899999999999999999999 9


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..||.....   .......+........             +......+.+++..||+.||.+|||+.++++.|+++
T Consensus       245 ~~p~~~~~~---~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          245 SSPYPGMPV---DSKFYKMIKEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             CCSSTTCCS---SHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccc---hhHHHHHhccCCCCCC-------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            999865422   1112222222111110             111123488999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-44  Score=343.42  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=211.5

Q ss_pred             cccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..++|.+.+.||+|+||.||+|...    ..++..||||.+....             .......+.+|+.+++.++|||
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~hp~   87 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------------SPSELRDLLSEFNVLKQVNHPH   87 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------------CHHHHHHHHHHHHHHhhCCCCc
Confidence            3567999999999999999999863    1256899999984321             1233577899999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------------GRRELDWLARHRIAQGIASGLEYLH  267 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH  267 (430)
                      |+++++++.+.+..++||||+++|+|.+++.....                    ....+++..++.++.|++.||.|||
T Consensus        88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  167 (314)
T 2ivs_A           88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA  167 (314)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999976322                    1234899999999999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.+   ++||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+
T Consensus       168 ~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             HTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             HCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence            655   99999999999999999999999999987765443333334567889999999998889999999999999999


Q ss_pred             HHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          348 LVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       348 ll~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      |++ |..||.....    ..+...+.......             .+......+.+++..||+.||.+|||+.++++.|+
T Consensus       245 l~t~g~~p~~~~~~----~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          245 IVTLGGNPYPGIPP----ERLFNLLKTGHRME-------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             HHTTSCCSSTTCCG----GGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCH----HHHHHHhhcCCcCC-------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999 9999865322    22332222211110             01112234889999999999999999999999998


Q ss_pred             cc
Q 014140          427 QI  428 (430)
Q Consensus       427 ~l  428 (430)
                      ++
T Consensus       308 ~~  309 (314)
T 2ivs_A          308 KM  309 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-45  Score=350.12  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=200.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||.||+|.+.. +|+.||||++......           .......+.+|+.+++.++||||++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~l~   75 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLK-----------KSDMHMRVEREISYLKLLRHPHIIKLY   75 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHcc-----------chhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3679999999999999999999764 8999999998532111           011135688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+ +|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        76 ~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~  147 (336)
T 3h4j_B           76 DVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNV  147 (336)
T ss_dssp             EEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCE
T ss_pred             EEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCE
Confidence            9999999999999999 6799998854    346999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++..........   ...||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........     
T Consensus       148 kl~DFG~s~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----  219 (336)
T 3h4j_B          148 KIADFGLSNIMTDGNFLK---TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----  219 (336)
T ss_dssp             EECCSSCTBTTTTSBTTC---CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----
T ss_pred             EEEEeccceeccCCcccc---cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----
Confidence            999999998765543222   3479999999999998876 7899999999999999999999875322110000     


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         .....          ...+......+.+++..||+.||.+|||+.|+++
T Consensus       220 ---i~~~~----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          220 ---VNSCV----------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CCSSC----------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHcCC----------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               00000          0011112234789999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=351.80  Aligned_cols=247  Identities=23%  Similarity=0.254  Sum_probs=196.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+..|..++..+ +||||+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~~hp~Iv~l   89 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVIL-----------QDDDVECTMTEKRILSLARNHPFLTQL   89 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhc-----------chhHHHHHHHHHHHHHhccCCCceeeE
Confidence            3579999999999999999999764 8999999998542111           112356788999999988 69999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence            9999999999999999999999999954    346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.....       .+..
T Consensus       163 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~  233 (353)
T 3txo_A          163 CKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLF  233 (353)
T ss_dssp             EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred             EEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHH
Confidence            99999999986443322  22246799999999999998999999999999999999999999865321       1222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ..+.......           +......+.+++..||+.||.+||++
T Consensus       234 ~~i~~~~~~~-----------p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          234 EAILNDEVVY-----------PTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             HHHHcCCCCC-----------CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            2222221110           01112347889999999999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9e-45  Score=352.08  Aligned_cols=260  Identities=21%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             ccccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++.  +.++..||||.+....             .......+.+|+.++++++||||++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~niv~  110 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------------TEKQRRDFLGEASIMGQFDHPNIIR  110 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------------CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            467999999999999999999875  2357889999984321             1233567999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       111 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  184 (373)
T 2qol_A          111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNL  184 (373)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred             EEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCC
Confidence            99999999999999999999999999953   3456999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....    ..+.
T Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~  260 (373)
T 2qol_A          185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVI  260 (373)
T ss_dssp             CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHH
T ss_pred             CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence            99999999998775432211 1112345788999999999999999999999999999998 9999865321    1222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.......             .+......+.+++..||+.||.+||++.+|++.|+++
T Consensus       261 ~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          261 KAVDEGYRLP-------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHHHTTEECC-------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCC-------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            2221111111             1112233488999999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.9e-45  Score=365.25  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=210.4

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+.. ++..||||.+.....               ....+.+|+.+|++++||||+++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l  281 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQL  281 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCccc---------------chHHHHHHHHHHHhcCCCCEeeE
Confidence            35678999999999999999999863 689999999843211               14679999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|...+..++|||||++|+|.+++..  .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~  356 (495)
T 1opk_A          282 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHL  356 (495)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCc
Confidence            9999999999999999999999999965  23456899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....    ...+...
T Consensus       357 ~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~----~~~~~~~  431 (495)
T 1opk_A          357 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYEL  431 (495)
T ss_dssp             EEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHH
T ss_pred             EEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHH
Confidence            999999999877543221 1223456789999999998899999999999999999999 999986532    2223333


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +.......             .+..+...+.+|+..||+.||.+|||+.+|++.|+.+
T Consensus       432 ~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          432 LEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             HHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcCCCCC-------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            22211111             1111223488999999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-44  Score=344.60  Aligned_cols=261  Identities=21%  Similarity=0.227  Sum_probs=206.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||.+.....                ...+.+|+.+++.+ +||||+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~~~   70 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKSR----------------APQLHLEYRFYKQLGSGDGIPQV   70 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTCS----------------SCCHHHHHHHHHHHCSCTTSCCE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC-CCcEEEEEEeccccc----------------hHHHHHHHHHHHHhhCCCCCCEE
Confidence            4679999999999999999998653 899999998843211                13478899999999 99999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+ +++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~  143 (330)
T 2izr_A           71 YYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN  143 (330)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGG
T ss_pred             EEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCC
Confidence            99999999999999999 89999999642   457999999999999999999999665   999999999999998887


Q ss_pred             -----eEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 014140          292 -----ARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH  361 (430)
Q Consensus       292 -----~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~  361 (430)
                           +||+|||++..........     ......||+.|+|||++.+..++.++|||||||++|||++|..||..... 
T Consensus       144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-  222 (330)
T 2izr_A          144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-  222 (330)
T ss_dssp             TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-
T ss_pred             CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-
Confidence                 9999999998765433211     12346799999999999999999999999999999999999999876432 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         ....+..........   ...........+    .+.+++..||+.||.+||++.+|.+.|+++
T Consensus       223 ---~~~~~~~~~i~~~~~---~~~~~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          223 ---DTLKERYQKIGDTKR---ATPIEVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             ---SSHHHHHHHHHHHHH---HSCHHHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ---ccHHHHHHHHHhhhc---cCCHHHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence               122222211111000   000000111111    488999999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-44  Score=340.68  Aligned_cols=265  Identities=24%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhc--cCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQ--VRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++   +|+.||||++...                 ....+..|..++..  ++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-----------------~~~~~~~e~~~~~~~~l~h~niv~   66 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR-----------------DEKSWFRETELYNTVMLRHENILG   66 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG-----------------GHHHHHHHHHHHHHTCCCCTTBCC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc-----------------cchhhHHHHHHHHHhhccCcCeee
Confidence            46799999999999999999986   7899999998421                 12345556666655  79999999


Q ss_pred             ceeEEEeC----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCC
Q 014140          211 LLARMVRR----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQP  281 (430)
Q Consensus       211 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp  281 (430)
                      +++++...    ...++||||+++|+|.+++.     ...+++..++.++.|++.||.|||..     +..+|+||||||
T Consensus        67 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp  141 (301)
T 3q4u_A           67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS  141 (301)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG
T ss_pred             EEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh
Confidence            99997653    45789999999999999993     24699999999999999999999921     123499999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcce--eeccccccccccccccCCC------CCCcchhHHHHHHHHHHHHhC--
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRTT--TWSLAGTVGYIAPECHQTV------ALSDTCDIYSFGVLLAVLVIG--  351 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g--  351 (430)
                      +|||++.++.+||+|||++...........  .....||+.|+|||++.+.      .++.++|||||||++|||++|  
T Consensus       142 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~  221 (301)
T 3q4u_A          142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV  221 (301)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence            999999999999999999986654332211  1234799999999999887      455789999999999999999  


Q ss_pred             --------CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          352 --------KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       352 --------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                              ..||.......  .............. ....+...   .........+.+++..||+.||++|||+.+|++
T Consensus       222 ~~~~~~~~~~pf~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          222 SNGIVEDYKPPFYDVVPND--PSFEDMRKVVCVDQ-QRPNIPNR---WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             BTTBCCCCCCTTTTTSCSS--CCHHHHHHHHTTSC-CCCCCCGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CccccccccccccccCCCC--cchhhhhHHHhccC-CCCCCChh---hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                    77776543322  12222222221111 11111111   112245567999999999999999999999999


Q ss_pred             HHhcc
Q 014140          424 MLSQI  428 (430)
Q Consensus       424 ~L~~l  428 (430)
                      .|++|
T Consensus       296 ~L~~i  300 (301)
T 3q4u_A          296 TLTKI  300 (301)
T ss_dssp             HHHHH
T ss_pred             HHhcc
Confidence            99986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=352.22  Aligned_cols=265  Identities=21%  Similarity=0.252  Sum_probs=208.8

Q ss_pred             cccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++.    ..++..||||.+.....             ......+.+|+.++.++ +||
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~hp  109 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------------SSEREALMSELKMMTQLGSHE  109 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCT
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-------------HHHHHHHHHHHHHHHhhcCCC
Confidence            4578999999999999999999862    23667899999853211             12246789999999999 899


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG-------------------RRELDWLARHRIAQGIASGLEYLH  267 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH  267 (430)
                      ||+++++++...+..++||||+++|+|.+++......                   ...+++..++.++.|++.||.|||
T Consensus       110 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  189 (344)
T 1rjb_A          110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  189 (344)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999753211                   134899999999999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.+   |+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+
T Consensus       190 ~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  266 (344)
T 1rjb_A          190 FKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE  266 (344)
T ss_dssp             HTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHH
Confidence            655   99999999999999999999999999987754443333334567889999999998899999999999999999


Q ss_pred             HHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          348 LVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       348 ll~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      |++ |..||.....   ...+...+.......             .+......+.+++..||+.||.+|||+.+|++.|+
T Consensus       267 l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          267 IFSLGVNPYPGIPV---DANFYKLIQNGFKMD-------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             HTTTSCCSSTTCCC---SHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHcCCCCCcccCCc---HHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            998 9999875422   111222222111110             01111234889999999999999999999999998


Q ss_pred             cc
Q 014140          427 QI  428 (430)
Q Consensus       427 ~l  428 (430)
                      .+
T Consensus       331 ~~  332 (344)
T 1rjb_A          331 CQ  332 (344)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-44  Score=344.55  Aligned_cols=254  Identities=21%  Similarity=0.236  Sum_probs=199.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|++.....           ........+.+|..++.++ +||||+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~~~~hp~iv~l   75 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELV-----------NDDEDIDWVQTEKHVFEQASNHPFLVGL   75 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGS-----------CSHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHh-----------cchHHHHHHHHHHHHHHhcCCCCccCeE
Confidence            3579999999999999999999864 899999999954321           1123356788999999988 89999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~  148 (345)
T 3a8x_A           76 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH  148 (345)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCC
Confidence            9999999999999999999999999954    246999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc-c-ccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK-E-MSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-~-~~l~~  369 (430)
                      +||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||........ . .....
T Consensus       149 ~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  226 (345)
T 3a8x_A          149 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  226 (345)
T ss_dssp             EEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred             EEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence            99999999986433222  12246899999999999999999999999999999999999999964321110 0 11111


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ......... ..          .+......+.+++..||+.||.+||++
T Consensus       227 ~~~~i~~~~-~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          227 LFQVILEKQ-IR----------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHCC-CC----------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHcCC-CC----------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111111111 10          011122348889999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=341.78  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||+|++......           .......+.+|..+++.++||||+++++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   73 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVV-----------RLKQVEHTNDERLMLSIVTHPFIIRMWG   73 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHhhCCCCCCceEeE
Confidence            579999999999999999998764 8999999998542111           0122467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        74 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k  146 (318)
T 1fot_A           74 TFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK  146 (318)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence            99999999999999999999999954    34689999999999999999999954   599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||....       .......
T Consensus       147 L~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~  214 (318)
T 1fot_A          147 ITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEK  214 (318)
T ss_dssp             ECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH
T ss_pred             EeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            9999999876432     124579999999999999999999999999999999999999986432       1122222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ........       ....    ...+.+++..||+.||.+||     ++.++++
T Consensus       215 i~~~~~~~-------p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          215 ILNAELRF-------PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHCCCCC-------CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhCCCCC-------CCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            22221110       0111    23488999999999999999     8888764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.7e-44  Score=339.15  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=201.2

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|...+.||+|+||.||+|+... +|+.||||++.....              .....+.+|+.+++.++||||++++++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~  110 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHFNVVEMYKS  110 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTC--------------CSHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccch--------------hHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            46777899999999999998764 899999999853221              114568899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARI  294 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl  294 (430)
                      +...+..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||
T Consensus       111 ~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl  182 (321)
T 2c30_A          111 YLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL  182 (321)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred             EEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEE
Confidence            9999999999999999999999842     46999999999999999999999655   999999999999999999999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....       .+.....
T Consensus       183 ~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~~~~~  253 (321)
T 2c30_A          183 SDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRL  253 (321)
T ss_dssp             CCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHH
T ss_pred             eeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            9999998765433222  245799999999999999999999999999999999999999864321       1112222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+...        ........+.+++..||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          254 RDSPPPKLK--------NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHSSCCCCT--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCCcC--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            211111100        00111234888999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-45  Score=362.63  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=206.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+.  ++..||||.+.....               ....+.+|+.+|++++||||+++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~iv~l  248 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKL  248 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSB---------------CHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCc---------------cHHHHHHHHHHHhhCCCCCEeeE
Confidence            4678999999999999999999986  678899999853211               14679999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++. .+..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       249 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~  322 (454)
T 1qcf_A          249 HAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV  322 (454)
T ss_dssp             EEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCC
T ss_pred             EEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCc
Confidence            99886 66789999999999999999642  2235889999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||+++........ ......+|..|+|||++.+..++.++|||||||++|||++ |..||.....    ..+...
T Consensus       323 ~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~  397 (454)
T 1qcf_A          323 CKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRA  397 (454)
T ss_dssp             EEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHH
T ss_pred             EEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            999999999876543211 1112346788999999998899999999999999999999 9999865321    222222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +........             +..++..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       398 i~~~~~~~~-------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          398 LERGYRMPR-------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             HHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            222211111             1112234889999999999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.6e-44  Score=333.59  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=202.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +++.||+|++.........       ........+.+|+.++++++||||++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGET-------EMIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCH-------HHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hccceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccch-------hHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            4679999999999999999999864 8999999998543322110       0001126789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCcEEeCCCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR--IIHRDIQPANVLIDDDM  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dlkp~Nill~~~~  290 (430)
                      +++.+..  ++||||+++|+|.+.+..   ....+++..++.++.|++.||.|||   ..+  ++||||||+|||++.++
T Consensus        90 ~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           90 GLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             EEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCC
T ss_pred             eeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccC
Confidence            9886554  799999999999998853   4457999999999999999999999   556  99999999999998877


Q ss_pred             c-----eEEeecCCcccCCCCCCcceeeccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          291 E-----ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ--TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       291 ~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      .     +||+|||++......     .....||+.|+|||++.  +..++.++||||||+++|+|++|..||.....  .
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~  234 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--G  234 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC--C
T ss_pred             CCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc--c
Confidence            6     999999999754332     22457899999999984  44578999999999999999999999875322  1


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         -..............     .....    ....+.+++..||+.||.+|||+.++++.|++|
T Consensus       235 ---~~~~~~~~~~~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          235 ---KIKFINMIREEGLRP-----TIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---HHHHHHHHHHSCCCC-----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---HHHHHHHHhccCCCC-----CCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               111111111111110     01111    223488999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-44  Score=340.47  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|+..  +|+.||+|++......            ......+.+|+.++++++||||++++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~~   85 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED------------EGIPSTAIREISLLKELHHPNIVSLI   85 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------------------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccccc------------chhhHHHHHHHHHHHHcCCCCEeeee
Confidence            367999999999999999999875  7999999998432211            12246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~  158 (311)
T 3niz_A           86 DVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGAL  158 (311)
T ss_dssp             EEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             eEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCE
Confidence            999999999999999975 88888853   3456999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++..........  ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....    ......+
T Consensus       159 kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i  232 (311)
T 3niz_A          159 KLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPKI  232 (311)
T ss_dssp             EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHHH
T ss_pred             EEccCcCceecCCCcccc--cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence            999999998765332221  23478999999999877 4689999999999999999999999875432    2223333


Q ss_pred             HHHhcCCCCchhcc--------c---cccCCC-----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAIN--------S---KLLGNG-----YEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~--------~---~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+.....        .   ......     .+.....+.+|+..||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33332221111000        0   000000     0111234789999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-44  Score=335.93  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=201.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||++......            ......+.+|+.++++++||||+++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~   68 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLHD   68 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSS------------TTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCCc------------CCcchHHHHHHHHHhcCCCCCEeeEEe
Confidence            468999999999999999998764 8999999999543221            123467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~k  141 (292)
T 3o0g_A           69 VLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence            99999999999999976 66666643   3456999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++..........  ....||+.|+|||++.+.. ++.++|||||||++|+|++|..|+...   .........+.
T Consensus       142 l~Dfg~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~---~~~~~~~~~i~  216 (292)
T 3o0g_A          142 LANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIF  216 (292)
T ss_dssp             ECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHH
T ss_pred             EeecccceecCCccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHHH
Confidence            99999998765332221  2357899999999998766 899999999999999999998885322   12222222222


Q ss_pred             HHhcCCCCchh--cc-------------ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRA--IN-------------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~--~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........  +.             ........+.....+.+++..||+.||++|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            22211111000  00             00000111123345789999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-44  Score=348.26  Aligned_cols=261  Identities=19%  Similarity=0.235  Sum_probs=205.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... +|+.||||++.......      ..   ......+.+|+.+++.++||||++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~------~~---~~~~~~~~~E~~~l~~l~hpnIv~~~   92 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTS------SP---GLSTEDLKREASICHMLKHPHIVELL   92 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHT------SS---SCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccc------cc---cchHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3579999999999999999998764 89999999984322110      00   01146789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++.+.+..++||||+++|+|.+.+.........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++. 
T Consensus        93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A           93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTT
T ss_pred             EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCC
Confidence            9999999999999999999999988764445566899999999999999999999655   999999999999986654 


Q ss_pred             --eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 --ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                        +||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....     ..+. 
T Consensus       170 ~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~-  241 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLF-  241 (351)
T ss_dssp             CCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHH-
T ss_pred             CcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHH-
Confidence              999999999877654322  123579999999999999999999999999999999999999986521     1111 


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        .........   ..+......    ...+.+++..||+.||++|||+.++++
T Consensus       242 --~~i~~~~~~---~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          242 --EGIIKGKYK---MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --HHHHHTCCC---CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHcCCCC---CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              111111110   011111112    234889999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.4e-44  Score=345.84  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||+|.+......            ......+.+|+.+++.++||||++++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~~~   94 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLS------------ARDFQKLEREARICRKLQHPNIVRLH   94 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3579999999999999999998764 8999999998543211            22356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      +++.+.+..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~  167 (362)
T 2bdw_A           95 DSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG  167 (362)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTT
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCC
Confidence            99999999999999999999999984    3456999999999999999999999655   99999999999998654  


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||....    ...+..
T Consensus       168 ~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~  240 (362)
T 2bdw_A          168 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYA  240 (362)
T ss_dssp             CCEEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH
T ss_pred             CCEEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHH
Confidence             5999999999877643322   23579999999999999999999999999999999999999986432    122222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+...... .+..     ..    ......+.+++..||+.||.+||++.++++
T Consensus       241 ~i~~~~~~-~~~~-----~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          241 QIKAGAYD-YPSP-----EW----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHTCCC-CCTT-----GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCC-CCcc-----cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22211100 0100     00    112234889999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-44  Score=342.29  Aligned_cols=264  Identities=21%  Similarity=0.330  Sum_probs=193.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCc---eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGR---VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..++|.+.+.||+|+||.||+|++.. ++.   .||||.+......            ......+.+|+.++++++||||
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i   87 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQ-EDGSFVKVAVKMLKADIIA------------SSDIEEFLREAACMKEFDHPHV   87 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcc-cCCcceeEEEEEecccccC------------HHHHHHHHHHHHHHHHCCCCce
Confidence            45689999999999999999998764 333   7999998432211            1235779999999999999999


Q ss_pred             ccceeEEEeCCee------EEEEEecCCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 014140          209 VPLLARMVRRDCD------LLVYEFRRNGSLQDILYDVSQ--GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ  280 (430)
Q Consensus       209 v~l~~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  280 (430)
                      +++++++...+..      ++||||+++|+|.+++.....  ....+++..++.++.|++.||.|||+.+   ++|||||
T Consensus        88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dik  164 (323)
T 3qup_A           88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLA  164 (323)
T ss_dssp             CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCC
Confidence            9999999887655      999999999999999965332  2236899999999999999999999655   9999999


Q ss_pred             CCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 014140          281 PANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFF  359 (430)
Q Consensus       281 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~  359 (430)
                      |+|||++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus       165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999999987755443333334467889999999999999999999999999999999 899987532


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .    ......+   .......          .+......+.+++..||+.||.+|||+.++++.|+++
T Consensus       245 ~----~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          245 N----AEIYNYL---IGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             G----GGHHHHH---HTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h----HHHHHHH---hcCCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            2    2222222   1111110          0111223488999999999999999999999999876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=353.27  Aligned_cols=255  Identities=19%  Similarity=0.242  Sum_probs=202.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.+|+|.+.....            .......+.+|+.+++.++||||++++
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~------------~~~~~~~~~~E~~il~~l~hpnIv~l~   76 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKL------------SARDHQKLEREARICRLLKHPNIVRLH   76 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSC------------HHHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccC------------CHHHHHHHHHHHHHHHhCCCcCCCeEE
Confidence            4679999999999999999998764 899999999854321            123356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC---CC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID---DD  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~  289 (430)
                      +++.+.+..++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++   .+
T Consensus        77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~  149 (444)
T 3soa_A           77 DSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKG  149 (444)
T ss_dssp             EEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTT
T ss_pred             EEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCC
Confidence            999999999999999999999999854    356999999999999999999999655   99999999999998   46


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....    ...+..
T Consensus       150 ~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~  223 (444)
T 3soa_A          150 AAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQ  223 (444)
T ss_dssp             CCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHH
T ss_pred             CcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHH
Confidence            78999999999877544322  124579999999999999999999999999999999999999986432    122222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+....... +     .......    ...+.+++..||+.||.+|||+.++++
T Consensus       224 ~i~~~~~~~-~-----~~~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          224 QIKAGAYDF-P-----SPEWDTV----TPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHTCCCC-C-----TTTTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCC-C-----ccccccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            222111000 0     0011112    234889999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-44  Score=334.23  Aligned_cols=258  Identities=26%  Similarity=0.316  Sum_probs=195.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.+   .|..||||++......          ........+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDE----------DISQTIENVRQEAKLFAMLKHPNIIALR   72 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC--------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcc----------cHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            45799999999999999999986   5889999998543221          1112356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC----
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD----  288 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----  288 (430)
                      +++...+..++||||+++++|.+++.     ...+++..++.++.|++.||.|||+.+..+++||||||+||+++.    
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~  147 (271)
T 3dtc_A           73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN  147 (271)
T ss_dssp             EEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred             EEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence            99999999999999999999999983     346999999999999999999999664344999999999999986    


Q ss_pred             ----CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          289 ----DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       289 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                          ++.+||+|||++.........    ...||+.|+|||++.+..++.++||||||+++++|++|+.||.....    
T Consensus       148 ~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  219 (271)
T 3dtc_A          148 GDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----  219 (271)
T ss_dssp             SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----
T ss_pred             ccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence                778999999999876543221    34689999999999998999999999999999999999999865321    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         ..............         ..+......+.+++..||+.||.+|||+.++++.|++|
T Consensus       220 ---~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          220 ---LAVAYGVAMNKLAL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---HHHHHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---HHHHHhhhcCCCCC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               11111111111110         01111223488999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-44  Score=337.04  Aligned_cols=256  Identities=20%  Similarity=0.290  Sum_probs=204.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+.  ++..||+|++......               ...+.+|+.++.+++||||+++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~   84 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQL   84 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC---------------HHHHHHHHHHHhcCCCCCEeeE
Confidence            3567999999999999999999876  7889999998532211               3568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~  158 (283)
T 3gen_A           85 YGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGV  158 (283)
T ss_dssp             EEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSC
T ss_pred             EEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCC
Confidence            9999999999999999999999999954   2346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....    ......
T Consensus       159 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~  233 (283)
T 3gen_A          159 VKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEH  233 (283)
T ss_dssp             EEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH
T ss_pred             EEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHH
Confidence            999999999876543211 1123456788999999998899999999999999999998 9999865322    112222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         .........   +   ...    ...+.+++..||+.+|.+|||+.++++.|+++
T Consensus       234 ---~~~~~~~~~---~---~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          234 ---IAQGLRLYR---P---HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ---HHTTCCCCC---C---TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HhcccCCCC---C---CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence               221111100   0   111    23488999999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-44  Score=336.82  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=211.6

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+.. ++..||+|.+....               .....+.+|+.++++++||||+++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~   74 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT---------------MEVEEFLKEAAVMKEIKHPNLVQL   74 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSCS---------------THHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcCH---------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            35679999999999999999999864 78999999984321               125678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++||||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~  149 (288)
T 3kfa_A           75 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL  149 (288)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCC
Confidence            9999999999999999999999999965  34456999999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....    .......
T Consensus       150 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----~~~~~~~  224 (288)
T 3kfa_A          150 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYEL  224 (288)
T ss_dssp             EEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHH
T ss_pred             EEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH
Confidence            999999999877644332 2224467889999999999899999999999999999999 999986532    2223333


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +........+         ...    ...+.+++..||+.||.+|||+.++++.|+.+
T Consensus       225 ~~~~~~~~~~---------~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          225 LEKDYRMERP---------EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHTTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCCCCC---------CCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            2222111111         112    23488999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6e-44  Score=335.55  Aligned_cols=262  Identities=18%  Similarity=0.173  Sum_probs=206.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.....                ...+.+|+.++..+ +|||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~   71 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNV   71 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCCc----------------cHHHHHHHHHHHHHhcCCCCCeE
Confidence            4679999999999999999998653 899999998843211                13477899999999 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++......++||||+ +++|.+++..   ....+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        72 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~  144 (298)
T 1csn_A           72 YYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNS  144 (298)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSS
T ss_pred             EeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCC
Confidence            99999999999999999 9999999964   23469999999999999999999994   45999999999999987776


Q ss_pred             -----eEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 014140          292 -----ARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH  361 (430)
Q Consensus       292 -----~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~  361 (430)
                           +||+|||++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus       145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  224 (298)
T 1csn_A          145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  224 (298)
T ss_dssp             TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence                 999999999877543322     1123457999999999999999999999999999999999999998764321


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .. ......+......... .    ......+    ..+.+++..||+.||++||++.+|++.|+++
T Consensus       225 ~~-~~~~~~~~~~~~~~~~-~----~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          225 TN-KQKYERIGEKKQSTPL-R----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CH-HHHHHHHHHHHHHSCH-H----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cc-HHHHHHHHhhccCccH-H----HHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            11 1111111111111111 0    1111222    3488999999999999999999999999876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-44  Score=347.31  Aligned_cols=251  Identities=22%  Similarity=0.305  Sum_probs=201.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+..|..++..+ +||||+++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVL-----------MDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhh-----------hhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            4679999999999999999999864 8999999999542111           011245678899999887 89999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~  156 (345)
T 1xjd_A           84 FCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGH  156 (345)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCC
Confidence            9999999999999999999999999954    346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|..||.....    ..+..  
T Consensus       157 vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~--  228 (345)
T 1xjd_A          157 IKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFH--  228 (345)
T ss_dssp             EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH--
T ss_pred             EEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHHHH--
Confidence            999999999865433222  2246899999999999999999999999999999999999999864321    11222  


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK-DVR  422 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~-ev~  422 (430)
                       ........       .    +......+.+++..||+.||.+||++. +|+
T Consensus       229 -~i~~~~~~-------~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          229 -SIRMDNPF-------Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -HHHHCCCC-------C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -HHHhCCCC-------C----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence             22211110       0    011123488999999999999999997 554

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-44  Score=337.79  Aligned_cols=262  Identities=21%  Similarity=0.334  Sum_probs=193.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.    ..+|+|++.....            .......+.+|+.++++++||||++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAP------------TPQQLQAFKNEVGVLRKTRHVNILLFM   86 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSC------------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCC------------CHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence            567999999999999999999853    3599999843221            123457799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++ ..+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           87 GYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             EEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             eec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCE
Confidence            965 56678999999999999999953   3456999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ||+|||++................||+.|+|||++.   +..++.++||||||+++|+|++|+.||.....   ...+..
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~  236 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIE  236 (289)
T ss_dssp             EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---HHHHHH
T ss_pred             EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---HHHHHH
Confidence            999999998765433333333457999999999986   55688999999999999999999999875422   112222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .+..........     ......    ...+.+++..||+.+|.+|||+.++++.|+++.
T Consensus       237 ~~~~~~~~~~~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          237 MVGRGSLSPDLS-----KVRSNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHTSCCCCTT-----SSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HhcccccCcchh-----hccccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            222211111110     111122    234889999999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-44  Score=349.62  Aligned_cols=279  Identities=17%  Similarity=0.164  Sum_probs=205.7

Q ss_pred             cccccccccccccccCceEEEeecCCC----CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGS----SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..+.|.+.+.||+|+||.||+|.+...    .++.||||++..........+.   .........+..|+..+..++|||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~---~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELK---FYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHH---HHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHH---HHHhhhhhHHHHHHHHHhhccCCC
Confidence            356899999999999999999987632    2588999998554321100000   000011134556778889999999


Q ss_pred             cccceeEEEeC----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          208 IVPLLARMVRR----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       208 iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      |+++++++...    ...++||||+ +++|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N  182 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN  182 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence            99999999875    4589999999 9999999964   3457999999999999999999999655   9999999999


Q ss_pred             EEeC--CCCceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          284 VLID--DDMEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       284 ill~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      ||++  .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  88999999999998765332111     1123469999999999999999999999999999999999999997


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhcccccc-CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLL-GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....   .............. .....++..+. ...+    ..+.+++..||+.+|.+||++.+|++.|+++
T Consensus       263 ~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          263 DNLK---DPKYVRDSKIRYRE-NIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             GGTT---CHHHHHHHHHHHHH-CHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccc---CHHHHHHHHHHhhh-hHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            5322   11222222221111 11111211111 1122    3488899999999999999999999999865

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-44  Score=351.37  Aligned_cols=210  Identities=22%  Similarity=0.286  Sum_probs=178.7

Q ss_pred             hcccccccccccccc--cCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          131 EKEDYFASLEKIRSC--WNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       131 ~~~~~~~~~~~lg~G--~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ...++|.+.+.||+|  +||.||+|+... +|+.||||++......            ......+.+|+.+++.++||||
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni   88 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACS------------NEMVTFLQGELHVSKLFNHPNI   88 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEecccccC------------hHHHHHHHHHHHHHHhCCCCCC
Confidence            345789999999999  999999999864 8999999999543211            2345778899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++++.+.+..++|||||++|+|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~  163 (389)
T 3gni_B           89 VPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISV  163 (389)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             CcEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            9999999999999999999999999999965  23356999999999999999999999665   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCC-----cceeeccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          289 DMEARISEFGLAKRIPDGHT-----RTTTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      ++.+||+|||.+........     ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             TCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999875432211     111223478999999999988  57899999999999999999999998753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-44  Score=345.17  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=201.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCce----EEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRV----ITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.    ||+|.+......             .....+.+|+.++++++||||
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i   77 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGR-------------QSFQAVTDHMLAIGSLDHAHI   77 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSC-------------SCBCSCCHHHHHHHTCCCTTB
T ss_pred             HhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccH-------------HHHHHHHHHHHHHhcCCCCCc
Confidence            4679999999999999999998764 5665    666666322111             112346789999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++++. .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        78 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~  150 (325)
T 3kex_A           78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKS  150 (325)
T ss_dssp             CCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESS
T ss_pred             CeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECC
Confidence            99999886 5668899999999999999954   2456899999999999999999999665   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+++...............||..|+|||++.+..++.++||||||+++|+|++ |..||.....    ...
T Consensus       151 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~  226 (325)
T 3kex_A          151 PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AEV  226 (325)
T ss_dssp             SSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----THH
T ss_pred             CCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HHH
Confidence            99999999999998765544333334578889999999999899999999999999999999 9999875322    222


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+........+ ..            ....+.+++..||+.||.+|||+.++++.|+++
T Consensus       227 ~~~~~~~~~~~~~-~~------------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          227 PDLLEKGERLAQP-QI------------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             HHHHHTTCBCCCC-TT------------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCC-Cc------------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222221111111 01            111277899999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.2e-44  Score=354.76  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.+   .|+.||||.+....                ....+.+|+.+|++++||||+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~  251 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQL  251 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCT----------------TSHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCch----------------HHHHHHHHHHHHHhccCCCEEEE
Confidence            356799999999999999999987   57899999984321                13568999999999999999999


Q ss_pred             eeEEEeCC-eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++++...+ ..++|||||++|+|.+++...  ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++
T Consensus       252 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~  326 (450)
T 1k9a_A          252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN  326 (450)
T ss_dssp             EEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTS
T ss_pred             EEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCC
Confidence            99988765 789999999999999999752  3345799999999999999999999665   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+++.......     ...++..|+|||++.+..++.++||||||+++|||++ |..||.....    .....
T Consensus       327 ~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~  397 (450)
T 1k9a_A          327 VAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP  397 (450)
T ss_dssp             CEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHHH
T ss_pred             CEEEeeCCCccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence            999999999986532211     2356889999999999999999999999999999998 9999875422    22333


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .+....   ++.          .+..++..+.+++..||+.||++|||+.+|++.|+.++
T Consensus       398 ~i~~~~---~~~----------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          398 RVEKGY---KMD----------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             HHHTTC---CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCC---CCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            222211   110          11112234889999999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.8e-44  Score=341.54  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=209.0

Q ss_pred             cccccccccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-C
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-R  204 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  204 (430)
                      ..++|.+.+.||+|+||.||+|++.+      .++..||||++....             .......+.+|+.+++++ +
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~   99 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------------TEKDLSDLVSEMEMMKMIGK   99 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------------cHHHHHHHHHHHHHHHHhhc
Confidence            35789999999999999999998642      357889999984321             123357789999999999 8


Q ss_pred             CCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       205 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      ||||+++++++...+..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+  
T Consensus       100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--  177 (334)
T 2pvf_A          100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--  177 (334)
T ss_dssp             CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            999999999999999999999999999999999753211            234899999999999999999999655  


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-C
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-G  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g  351 (430)
                       ++||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       178 -ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  256 (334)
T 2pvf_A          178 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG  256 (334)
T ss_dssp             -EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             -eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987765443333334567889999999988889999999999999999999 9


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..||.....    ..+...+....   ...      .....    ...+.+++..||+.||.+|||+.++++.|+++
T Consensus       257 ~~p~~~~~~----~~~~~~~~~~~---~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          257 GSPYPGIPV----EELFKLLKEGH---RMD------KPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             CCSSTTCCH----HHHHHHHHHTC---CCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcCcCCH----HHHHHHHhcCC---CCC------CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999865321    12222222211   110      01112    23488999999999999999999999999876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.8e-44  Score=344.48  Aligned_cols=248  Identities=21%  Similarity=0.242  Sum_probs=202.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||+|++......           .......+.+|+.+++.++||||+++++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~  108 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVV-----------KLKQIEHTLNEKRILQAVNFPFLVKLEF  108 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhc-----------cHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            579999999999999999999764 8999999998542211           1122567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       109 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k  181 (350)
T 1rdq_E          109 SFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEE
Confidence            99999999999999999999999964    245999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....       ..+....
T Consensus       182 L~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~  249 (350)
T 1rdq_E          182 VTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEK  249 (350)
T ss_dssp             ECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             EcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-------HHHHHHH
Confidence            9999999876432     124579999999999999999999999999999999999999986432       1122222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      .......       .....    ...+.+++..||+.||.+||+     +.+|++
T Consensus       250 i~~~~~~-------~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          250 IVSGKVR-------FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHCCCC-------CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHcCCCC-------CCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2221110       00111    234889999999999999998     777764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.3e-44  Score=331.59  Aligned_cols=255  Identities=24%  Similarity=0.288  Sum_probs=203.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++   .|+.||||++.....            .......+.+|+.++++++||||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   73 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDW------------STRKSRDFNEECPRLRIFSHPNVLPVL   73 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTC------------CHHHHHHHHHHGGGGCCCSCTTEECEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEeccccc------------CHHHHHHHHHHHHHHHhcCCCchhheE
Confidence            35789999999999999999987   588999999854321            123356799999999999999999999


Q ss_pred             eEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCcEEeCC
Q 014140          213 ARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR--IIHRDIQPANVLIDD  288 (430)
Q Consensus       213 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dlkp~Nill~~  288 (430)
                      +++.+.  +..++||||+++|+|.+++..  .....+++..++.++.|++.||.|||   ..+  ++||||||+||+++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~  148 (271)
T 3kmu_A           74 GACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDE  148 (271)
T ss_dssp             EEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECT
T ss_pred             EEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcC
Confidence            999887  778999999999999999964  23346999999999999999999999   555  999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCc---chhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSD---TCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      ++.++|+|||++......       ...||+.|+|||++.+..++.   ++||||||+++|+|++|+.||.....     
T Consensus       149 ~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----  216 (271)
T 3kmu_A          149 DMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----  216 (271)
T ss_dssp             TSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----
T ss_pred             CcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----
Confidence            999999999887653222       246899999999998765544   79999999999999999999865322     


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcccC
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH  430 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~~  430 (430)
                        ..............     ......    ...+.+++..||+.||++|||+.++++.|+++++
T Consensus       217 --~~~~~~~~~~~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          217 --MEIGMKVALEGLRP-----TIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --HHHHHHHHHSCCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --HHHHHHHHhcCCCC-----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              11111111111110     011112    2348899999999999999999999999998863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-44  Score=338.27  Aligned_cols=263  Identities=23%  Similarity=0.280  Sum_probs=197.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+..  +|+.||+|++......            ......+.+|+.+++.++||||+++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~   67 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKED------------EGIPSTTIREISILKELKHSNIVKLYD   67 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGG------------GCCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEeccccc------------cccchhHHHHHHHHHhcCCCCEeeeee
Confidence            46899999999999999999874  7999999998543211            111356789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k  140 (288)
T 1ob3_A           68 VIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK  140 (288)
T ss_dssp             EEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             EEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence            99999999999999976 99999853   3356999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....    ......+.
T Consensus       141 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~  214 (288)
T 1ob3_A          141 IADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIF  214 (288)
T ss_dssp             ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             EeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            9999999876432211  1134689999999998764 589999999999999999999999865321    11111222


Q ss_pred             HHhcCCCCc--------hhccccc-------cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPN--------RAINSKL-------LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~--------~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........        ...++..       ...........+.+++.+||+.||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            211111100        0000000       00001112344789999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=347.58  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=203.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... +|+.||+|.+.....              .....+.+|+.+|+.++||||++++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~--------------~~~~~~~~E~~il~~l~hpnIv~~~  114 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYP--------------LDKYTVKNEISIMNQLHHPKLINLH  114 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccch--------------hhHHHHHHHHHHHHhCCCcCCCeEE
Confidence            3579999999999999999998764 899999999843211              1245688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC--CC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DM  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~  290 (430)
                      +++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.  ++
T Consensus       115 ~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~  188 (387)
T 1kob_A          115 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKAS  188 (387)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCC
Confidence            999999999999999999999999843   3346999999999999999999999655   999999999999974  57


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++..........   ...||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ..... 
T Consensus       189 ~vkL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~-  260 (387)
T 1kob_A          189 SVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQ-  260 (387)
T ss_dssp             CEEECCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHH-
T ss_pred             ceEEEecccceecCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHH-
Confidence            79999999998875543222   34799999999999999999999999999999999999999865321    11222 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ........   ++.......    ...+.+++..||+.||.+|||+.++++
T Consensus       261 --~i~~~~~~---~~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          261 --NVKRCDWE---FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --HHHHCCCC---CCSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --HHHhCCCC---CCccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              22111110   111111122    234889999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=337.43  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=196.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++   .++.||||++...                .....+.+|+.++++++||||++++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----------------~~~~~~~~E~~~l~~l~hp~iv~~~   67 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE----------------SERKAFIVELRQLSRVNHPNIVKLY   67 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSST----------------THHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecCh----------------hHHHHHHHHHHHHhcCCCCCcCeEE
Confidence            35789999999999999999987   5788999998321                1246789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++.  +..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+..+++||||||+|||++.++. 
T Consensus        68 ~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  144 (307)
T 2eva_A           68 GACL--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV  144 (307)
T ss_dssp             EBCT--TTTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred             EEEc--CCcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence            9886  4579999999999999999642 12235789999999999999999999743367999999999999998886 


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....     ......
T Consensus       145 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~  214 (307)
T 2eva_A          145 LKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFRIM  214 (307)
T ss_dssp             EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHHHH
T ss_pred             EEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHHHH
Confidence            7999999997654321     134689999999999999999999999999999999999999875322     111111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ........+.      .....+    ..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       215 ~~~~~~~~~~------~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          215 WAVHNGTRPP------LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             HHHHTTCCCC------CBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             HHHhcCCCCC------cccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1222111111      111222    34889999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-44  Score=332.94  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=194.8

Q ss_pred             ccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|.+...  .+..||+|.+....             .......+.+|+.++++++||||++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~   80 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------------SDSVREKFLQEALTMRQFDHPHIVK   80 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------------SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------------CHHHHHHHHHHHHHHHhCCCCccce
Confidence            46799999999999999999987532  34679999874311             1233577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++ ..+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++
T Consensus        81 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  153 (281)
T 1mp8_A           81 LIGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND  153 (281)
T ss_dssp             EEEEE-CSSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred             EEEEE-ccCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCC
Confidence            99987 45678999999999999999964   2346999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||++........... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    .....
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~~  228 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG  228 (281)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH
T ss_pred             CEEECccccccccCccccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHHH
Confidence            999999999987754332221 13456789999999998899999999999999999997 9999875422    22222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+..   ...+.      ....    ....+.+++..||+.||++|||+.++++.|+++
T Consensus       229 ~i~~---~~~~~------~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          229 RIEN---GERLP------MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HHHT---TCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHc---CCCCC------CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            2221   11110      1111    223488999999999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-44  Score=357.26  Aligned_cols=259  Identities=19%  Similarity=0.200  Sum_probs=202.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||+||+|++.. +|+.||+|++.......           ......+.+|..++..++||||+++
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~-----------~~~~~~~~~E~~il~~~~hp~Iv~l  139 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLK-----------RAETACFREERDVLVNGDSKWITTL  139 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHH-----------TTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhh-----------HHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            46789999999999999999999874 78999999985421110           0112348889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|.+.+..|+|||||++|+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence            9999999999999999999999999954   2456999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +||+|||+++......... .....||+.|+|||++.     +..++.++|||||||++|||++|+.||.....    ..
T Consensus       214 vkL~DFGla~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~  288 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VE  288 (437)
T ss_dssp             EEECCCTTCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HH
T ss_pred             EEEcchhhhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hH
Confidence            9999999998765443322 22457999999999987     45689999999999999999999999865321    11


Q ss_pred             HHHHHHHHh-cCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 014140          367 LVQWMRNVM-TSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~  423 (430)
                      ....+.... ....+      ......+    ..+.+|+..||..+|++  ||++.|+++
T Consensus       289 ~~~~i~~~~~~~~~p------~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          289 TYGKIMNHKERFQFP------TQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHHTHHHHCCCC------SSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHHhhhhccccccCC------cccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            111111100 00001      0001122    33788999999888888  999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.7e-44  Score=354.32  Aligned_cols=251  Identities=27%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.||||++......           .......+.+|+.+++.++||||++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~-----------~~~~~~~~~~Ei~~l~~l~HpnIv~l~   82 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIR-----------SLDVVGKIRREIQNLKLFRHPHIIKLY   82 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhcc-----------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4679999999999999999998764 8999999998542111           112246789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           83 QVISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             EEEECSSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCe
Confidence            99999999999999999999999983    346799999999999999999999954   59999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++.........   ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....    ..+   .
T Consensus       156 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~---~  225 (476)
T 2y94_A          156 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTL---F  225 (476)
T ss_dssp             EECCCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHH---H
T ss_pred             EEEeccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHH---H
Confidence            99999999887554322   23579999999999998765 6899999999999999999999865321    122   2


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........       ....+    ..+.+++..||+.||.+|||+.++++
T Consensus       226 ~~i~~~~~~~-------p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          226 KKICDGIFYT-------PQYLN----PSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHTTCCCC-------CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCcCC-------CccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            2222211100       01112    24789999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.4e-45  Score=348.42  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=209.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCC-----ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSG-----RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RH  205 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  205 (430)
                      ..++|.+.+.||+|+||.||+|.... ++     ..||+|.+....             .......+.+|+.+++.+ +|
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~h  109 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFG-LGKEDAVLKVAVKMLKSTA-------------HADEKEALMSELKIMSHLGQH  109 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETT-CSSSCCCCEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred             CHHHceeeeEeccCCCcceEEEEecC-CCcccchhHHHHHhccccc-------------ChHHHHHHHHHHHHHHhhcCC
Confidence            45789999999999999999998764 33     479999984321             122357799999999999 89


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ----------GRRELDWLARHRIAQGIASGLEYLHMSHRPRII  275 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii  275 (430)
                      |||+++++++.+.+..++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||+.+   |+
T Consensus       110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv  186 (333)
T 2i1m_A          110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CI  186 (333)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cc
Confidence            9999999999999999999999999999999975321          1346899999999999999999999655   99


Q ss_pred             ecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 014140          276 HRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFP  354 (430)
Q Consensus       276 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p  354 (430)
                      ||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       187 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  266 (333)
T 2i1m_A          187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP  266 (333)
T ss_dssp             CSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987654433333334567889999999998899999999999999999999 8999


Q ss_pred             CCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          355 SDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       355 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      |......   ..+............+         ...    ...+.+++..||+.||.+|||+.+|++.|+++
T Consensus       267 ~~~~~~~---~~~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          267 YPGILVN---SKFYKLVKDGYQMAQP---------AFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             STTCCSS---HHHHHHHHHTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Ccccchh---HHHHHHHhcCCCCCCC---------CCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            8654221   1122222221111100         111    23488999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=334.80  Aligned_cols=264  Identities=19%  Similarity=0.252  Sum_probs=196.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhcc------------CCchhhHHHHHHHHHHHHH
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKK------------DSEPLHHKMIQIRSEIITA  200 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l  200 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++..........+..            ...........+.+|+.++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3579999999999999999998764 89999999996543211100000            0001112246789999999


Q ss_pred             hccCCCCcccceeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          201 GQVRHRNIVPLLARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       201 ~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      ++++||||+++++++.+  .+..++||||+++|+|.+++     ....+++..++.++.|++.||.|||+.+   ++|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D  162 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD  162 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence            99999999999999987  56789999999999998864     3357999999999999999999999665   99999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCC
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      |||+|||++.++.+||+|||++.........  .....||+.|+|||++.+..   ++.++|||||||++|+|++|..||
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999999999999999999876543322  22357999999999998765   377899999999999999999998


Q ss_pred             CccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          356 DDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       356 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....       ................     .....+    ..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          241 MDER-------IMCLHSKIKSQALEFP-----DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CCSS-------HHHHHHHHHHCCCCCC-----SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcc-------HHHHHHHHhcccCCCC-----CccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            6431       1111122211111000     001122    34889999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-44  Score=342.73  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=197.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|++.. +|+.||||++.....             ......+.+|+.++++++||||+++++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~~~~   71 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNR-------------ELAREKVMREVKALAKLEHPGIVRYFN   71 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCST-------------TTHHHHHHHHHHHHTSCCCTTBCCEEE
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCCc-------------hhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            578999999999999999999864 899999999853221             123567899999999999999999999


Q ss_pred             EEEeCCe---------------------------------------------------------eEEEEEecCCCCHHHH
Q 014140          214 RMVRRDC---------------------------------------------------------DLLVYEFRRNGSLQDI  236 (430)
Q Consensus       214 ~~~~~~~---------------------------------------------------------~~lV~E~~~~gsL~~~  236 (430)
                      +|.+.+.                                                         .++||||+++|+|.++
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  151 (332)
T 3qd2_B           72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW  151 (332)
T ss_dssp             EEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHH
T ss_pred             EEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHH
Confidence            9876542                                                         7999999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCc-------
Q 014140          237 LYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTR-------  309 (430)
Q Consensus       237 l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------  309 (430)
                      +... ......++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........       
T Consensus       152 ~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~  227 (332)
T 3qd2_B          152 MNRR-CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM  227 (332)
T ss_dssp             HHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------
T ss_pred             Hhcc-cCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccc
Confidence            9753 23345677789999999999999999655   999999999999999999999999999887654221       


Q ss_pred             ---ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccc
Q 014140          310 ---TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS  386 (430)
Q Consensus       310 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  386 (430)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...         ............+ .    
T Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~~~-~----  293 (332)
T 3qd2_B          228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLKFP-L----  293 (332)
T ss_dssp             ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTCCC-H----
T ss_pred             cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccCCC-c----
Confidence               1122356999999999999999999999999999999999987763211         1111111111111 0    


Q ss_pred             cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       387 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                           ........+.+++..||+.||.+|||+.++++
T Consensus       294 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          294 -----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             -----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             -----ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                 11222334788999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-44  Score=341.98  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=180.9

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  217 (430)
                      .+.||+|+||.||+|.+.. +|+.||||++...                 ....+.+|+.++..+. ||||+++++++.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~-----------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK-SNQAFAVKIISKR-----------------MEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT-TCCEEEEEEEEGG-----------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECC-CCCEEEEEEEChh-----------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            3789999999999999864 8999999998421                 1356778999999997 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC---ceEE
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---EARI  294 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl  294 (430)
                      .+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEE
T ss_pred             CCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEE
Confidence            9999999999999999999954    356999999999999999999999655   99999999999997665   8999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.............+.....
T Consensus       151 ~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i  228 (325)
T 3kn6_A          151 IDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI  228 (325)
T ss_dssp             CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred             eccccceecCCCCCcc--cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence            9999998765433221  23568999999999999999999999999999999999999997644322223333444333


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......   ....    .......+.+++..||+.||.+|||+.++++
T Consensus       229 ~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          229 KKGDFSF---EGEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTTCCCC---CSHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HcCCCCC---Cccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            3222110   0000    0112345889999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=341.06  Aligned_cols=260  Identities=21%  Similarity=0.270  Sum_probs=197.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceE----EEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVI----TIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..++|.+.+.||+|+||.||+|++.. +|+.+    |+|.+.....             ......+.+|+.+++.++|||
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~   78 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH   78 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSS-------------CCCHHHHHHHHHHHTTCCBTT
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence            35679999999999999999998764 56655    5555532111             112467899999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      |+++++++...+ .++|+||+.+|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++
T Consensus        79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~  151 (327)
T 3lzb_A           79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK  151 (327)
T ss_dssp             BCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred             eeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEc
Confidence            999999998765 7899999999999999964   3456999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMS  366 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~  366 (430)
                      .++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....    ..
T Consensus       152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~  227 (327)
T 3lzb_A          152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE  227 (327)
T ss_dssp             ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred             CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HH
Confidence            999999999999988755433333334567889999999999999999999999999999999 9999875422    22


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +...+........             +......+.+++..||+.||.+|||+.++++.|+++.
T Consensus       228 ~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          228 ISSILEKGERLPQ-------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             HHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3332222111110             1112234889999999999999999999999998763

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.9e-44  Score=360.25  Aligned_cols=255  Identities=25%  Similarity=0.308  Sum_probs=205.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|++......           .......+.+|+.++++++||||++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~-----------~~~~~~~~~~E~~iL~~l~hp~Iv~l~  251 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLK-----------KRKGYQGAMVEKKILAKVHSRFIVSLA  251 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhh-----------hhHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            4679999999999999999999864 8999999998542211           112246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..|+||||++||+|.+++.........+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~v  328 (543)
T 3c4z_A          252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV  328 (543)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCE
Confidence            9999999999999999999999999764444567999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++..........  ....||+.|+|||++.+..++.++|||||||++|||++|..||.......   .......
T Consensus       329 kL~DFGla~~~~~~~~~~--~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~  403 (543)
T 3c4z_A          329 RISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQ  403 (543)
T ss_dssp             EECCCTTCEECCTTCCCB--CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHH
T ss_pred             EEeecceeeeccCCCccc--ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHH
Confidence            999999998875543322  23589999999999999999999999999999999999999987542211   1222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ........           .+......+.+++..||+.||.+||++
T Consensus       404 ~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          404 RVLEQAVT-----------YPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHCCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             HHhhcccC-----------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            22221110           011122348889999999999999976

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-44  Score=343.28  Aligned_cols=247  Identities=21%  Similarity=0.218  Sum_probs=198.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+..|..++..+ +||||+++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~~~~hp~iv~l   86 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVI-----------QDDDVECTMVEKRVLALPGKPPFLTQL   86 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhh-----------cchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence            4679999999999999999999864 7899999998543211           112246788999999988 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||++||+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCc
Confidence            9999999999999999999999999964    246999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+..
T Consensus       160 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~  230 (353)
T 2i0e_A          160 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELF  230 (353)
T ss_dssp             EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred             EEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHH
Confidence            99999999986433222  22246799999999999999999999999999999999999999864321       1222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ..+......           .+......+.+++..||+.||.+||++
T Consensus       231 ~~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          231 QSIMEHNVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             HHHHhCCCC-----------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            222221111           001122348899999999999999964

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.4e-43  Score=333.74  Aligned_cols=263  Identities=22%  Similarity=0.265  Sum_probs=189.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||+|.+......             .....+.+|+.++++++||||++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~   69 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDSEE-------------GTPSTAIREISLMKELKHENIVRLY   69 (317)
T ss_dssp             ---------------CEEEEEECSS-SCCEEEEEEEECCSTT-------------CSCHHHHHHHHHHTTCCBTTBCCEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeeccccc-------------ccHHHHHHHHHHHHhcCCCCcceEE
Confidence            4579999999999999999998764 8999999998543211             1135678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++...+..++||||++ |+|.+++....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~  145 (317)
T 2pmi_A           70 DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRG  145 (317)
T ss_dssp             EEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred             EEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCC
Confidence            99999999999999998 59999986532  22345899999999999999999999555   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....    .....
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~  219 (317)
T 2pmi_A          146 QLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLK  219 (317)
T ss_dssp             CEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred             CEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Confidence            9999999999876533221  1234789999999998874 689999999999999999999999865322    12222


Q ss_pred             HHHHHhcCCCCc------------------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPN------------------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..........                        ..+.+.....    ....+.+++..||+.||++|||+.++++
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            222222111100                        0000000011    1235889999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-44  Score=354.17  Aligned_cols=257  Identities=18%  Similarity=0.243  Sum_probs=201.6

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||+||+|++.. +|+.||+|++......     ..      .....+.+|+.+++.++||||+++
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~-----~~------~~~~~~~~E~~il~~l~hp~Iv~l  134 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMI-----KR------SDSAFFWEERDIMAFANSPWVVQL  134 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----HT------CCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhh-----hh------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence            35689999999999999999999874 8999999998542111     00      112347889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|.+.+..|+||||++||+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          135 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence            9999999999999999999999999854     35899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA----LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +||+|||+++........ ......||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....       
T Consensus       207 ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------  278 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------  278 (410)
T ss_dssp             EEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred             EEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-------
Confidence            999999999876544322 222468999999999998765    78999999999999999999999864321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNK--RPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--Rps~~ev~~  423 (430)
                      ......+......   +........    ...+.+|+..||+.+|.+  ||++.||++
T Consensus       279 ~~~~~~i~~~~~~---~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          279 VGTYSKIMNHKNS---LTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHTHHHH---CCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hhHHHHHHhcccc---ccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1112222111000   000000111    234888999999999988  999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-43  Score=334.99  Aligned_cols=265  Identities=20%  Similarity=0.309  Sum_probs=198.3

Q ss_pred             cccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ..++|.+.+.||+|+||.||+|.+...  ++..||+|.+.....            .......+.+|+.++++++||||+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv   99 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------------SQREIEEFLSEAACMKDFSHPNVI   99 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------------CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------------chhHHHHHHHHHHHHhcCCCCCee
Confidence            467899999999999999999987532  456899999853321            123357789999999999999999


Q ss_pred             cceeEEEeCCe-----eEEEEEecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          210 PLLARMVRRDC-----DLLVYEFRRNGSLQDILYDVS--QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       210 ~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      ++++++.+.+.     .++||||+++|+|.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+
T Consensus       100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~  176 (313)
T 3brb_A          100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAAR  176 (313)
T ss_dssp             CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGG
T ss_pred             eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcc
Confidence            99999987653     499999999999999985422  2345699999999999999999999954   5999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... 
T Consensus       177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  255 (313)
T 3brb_A          177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-  255 (313)
T ss_dssp             GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-
Confidence            99999999999999999987754433233323467889999999999999999999999999999999 8889865322 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         ......+..   ...+.      .....    ...+.+++..||+.||.+|||+.++++.|+++
T Consensus       256 ---~~~~~~~~~---~~~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          256 ---HEMYDYLLH---GHRLK------QPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ---GGHHHHHHT---TCCCC------CBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHc---CCCCC------CCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               222222221   11110      01112    23488999999999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.7e-44  Score=336.44  Aligned_cols=268  Identities=19%  Similarity=0.291  Sum_probs=207.6

Q ss_pred             ccccccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ...|.+.+.||+|+||.||+|++   ...+|+.||||++.....             ......+.+|+.+++.++||||+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~   86 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------------GNHIADLKKEIEILRNLYHENIV   86 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------------chhHHHHHHHHHHHHhCCCCCee
Confidence            35689999999999999999984   234889999999853221             11246789999999999999999


Q ss_pred             cceeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          210 PLLARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       210 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++++...  +..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus        87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~  160 (302)
T 4e5w_A           87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE  160 (302)
T ss_dssp             CEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred             eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEc
Confidence            999999876  6689999999999999999542   345999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc------
Q 014140          288 DDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ------  360 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------  360 (430)
                      .++.++|+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.....      
T Consensus       161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  240 (302)
T 4e5w_A          161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI  240 (302)
T ss_dssp             ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence            9999999999999887654332 222245688899999999998999999999999999999999988653211      


Q ss_pred             --ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          361 --HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       361 --~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        ....................          ..+......+.+++..||+.||.+|||+.++++.|+.+-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          241 GPTHGQMTVTRLVNTLKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CSCCGGGHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccCHHHHHHHHhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence              01111122222222211111          111122344889999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-44  Score=357.01  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|.+.  .+..||||.+.....               ....+.+|+.+|++++||||+++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hp~iv~~  244 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQL  244 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCC---------------CHHHHHHHHHHHHhCCCCCEeeE
Confidence            4567899999999999999999986  567899999853221               13568999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+ +..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.
T Consensus       245 ~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~  318 (452)
T 1fmk_A          245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV  318 (452)
T ss_dssp             EEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCC
Confidence            999876 7789999999999999999642  2345899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....    ..... 
T Consensus       319 ~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~-  392 (452)
T 1fmk_A          319 CKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLD-  392 (452)
T ss_dssp             EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHH-
T ss_pred             EEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHHH-
Confidence            999999999876543221 1123457889999999998899999999999999999999 9999865322    12222 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        .........          .+..++..+.+++..||+.||++|||+.+|++.|+.+
T Consensus       393 --~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          393 --QVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             --HHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             --HHHcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              222111110          1112233488999999999999999999999999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-43  Score=345.80  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=190.4

Q ss_pred             cccccc-cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhc-cCCCCcccc
Q 014140          134 DYFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQ-VRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~-~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l  211 (430)
                      ++|.+. +.||.|+||+||+|.... +|+.||||++..                   ...+.+|+.++.+ .+||||+++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~-------------------~~~~~~E~~~~~~~~~hp~iv~l  120 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVRI  120 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             ccceeccceeeeccCeEEEEEEECC-CCCEEEEEEeCc-------------------chhHHHHHHHHHHhcCCCCcceE
Confidence            456665 689999999999998764 899999999832                   1346678888744 489999999


Q ss_pred             eeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++..    .+..|+|||||++|+|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus       121 ~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~  195 (400)
T 1nxk_A          121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT  195 (400)
T ss_dssp             EEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEES
T ss_pred             eEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEe
Confidence            999876    5678999999999999999964  22346999999999999999999999655   99999999999999


Q ss_pred             C---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 D---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .   ++.+||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       196 ~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  272 (400)
T 1nxk_A          196 SKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_dssp             SSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred             cCCCCccEEEEecccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            7   789999999999876543221   2357899999999999999999999999999999999999998754332222


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+...... .+.     .....    ....+.+|+..||+.||++|||+.++++
T Consensus       273 ~~~~~~i~~~~~~-~~~-----~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          273 PGMKTRIRMGQYE-FPN-----PEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CSHHHHHHHTCCC-CCT-----TTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCccc-CCC-----ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2222222211100 000     00111    2234889999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-43  Score=335.89  Aligned_cols=258  Identities=23%  Similarity=0.297  Sum_probs=205.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +|+.||+|.+.........        .......+.+|+.++++++||||++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASR--------RGVSREEIEREVSILRQVLHHNVITLH   81 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCS--------SSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccc--------cchhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3579999999999999999998764 8999999998654322100        011246789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      +++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++  
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCC
Confidence            999999999999999999999999943    456899999999999999999999655   99999999999999888  


Q ss_pred             --ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 --EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                        .+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .
T Consensus       155 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~  224 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------Q  224 (321)
T ss_dssp             SCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------H
T ss_pred             cCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------H
Confidence              7999999999877654322   234689999999999999999999999999999999999999864321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...........   .++......+    ..+.+++..||+.||.+|||+.++++
T Consensus       225 ~~~~~i~~~~~~---~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          225 ETLANITSVSYD---FDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHHTTCCC---CCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhcccc---cChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            122222211110   1111111222    34889999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=342.37  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=188.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +++.||||++....                ....+.+|+.++++++||||++++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~  114 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTV----------------DKKIVRTEIGVLLRLSHPNIIKLK  114 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC--------------------------CHHHHHCCCTTBCCEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccch----------------hHHHHHHHHHHHHhCCCCCCccee
Confidence            4679999999999999999999864 78999999985321                134578899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---C
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---D  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~  289 (430)
                      +++...+..++||||+++|+|.+++.    ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~  187 (349)
T 2w4o_A          115 EIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPD  187 (349)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTT
T ss_pred             eeEecCCeEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCC
Confidence            99999999999999999999999984    3456999999999999999999999655   999999999999975   8


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .   ..
T Consensus       188 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~---~~  258 (349)
T 2w4o_A          188 APLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---D---QF  258 (349)
T ss_dssp             CCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---H---HH
T ss_pred             CCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---c---HH
Confidence            8999999999987644322   1235789999999999999999999999999999999999999864321   1   11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ............   .....    ......+.+++..||+.||++|||+.++++
T Consensus       259 ~~~~i~~~~~~~---~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          259 MFRRILNCEYYF---ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHTTCCCC---CTTTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCCcc---CCchh----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122222211110   00111    112234889999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6e-44  Score=330.14  Aligned_cols=256  Identities=22%  Similarity=0.285  Sum_probs=206.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.+.  ++..||+|.+......               ...+.+|+.++++++||||++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~   69 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQLY   69 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC---------------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC---------------HHHHHHHHHHHHhCCCCCEeeEE
Confidence            467999999999999999999876  7889999998542211               35688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~  143 (267)
T 3t9t_A           70 GVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI  143 (267)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCE
T ss_pred             EEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCE
Confidence            999999999999999999999999964   2356899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....       .+..
T Consensus       144 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~  215 (267)
T 3t9t_A          144 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVV  215 (267)
T ss_dssp             EECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred             EEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHH
Confidence            99999999876432111 1113457789999999998899999999999999999999 8999865321       1122


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..........   .+   ...    ...+.+++..||+.||.+|||+.++++.|+++.
T Consensus       216 ~~i~~~~~~~---~~---~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          216 EDISTGFRLY---KP---RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             HHHHTTCCCC---CC---TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCCcCC---CC---ccC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2222211110   00   111    234889999999999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4e-44  Score=355.98  Aligned_cols=252  Identities=20%  Similarity=0.253  Sum_probs=194.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......           .......+.+|+.+++.++||||++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~l~  214 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIV-----------AKDEVAHTLTENRVLQNSRHPFLTALK  214 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC------------------------CCCCCSCTTSCCEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhh-----------hhHHHHHHHHHHHHHHhCCCCeEeeEE
Confidence            3579999999999999999998764 8999999998542111           112245678899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEeCCCCc
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHM-SHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++|...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.
T Consensus       215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~  287 (446)
T 4ejn_A          215 YSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGH  287 (446)
T ss_dssp             EEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSC
T ss_pred             EEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCC
Confidence            999999999999999999999999854    3469999999999999999999996 4   4999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ....
T Consensus       288 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~  358 (446)
T 4ejn_A          288 IKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLF  358 (446)
T ss_dssp             EEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred             EEEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHH
Confidence            999999999865433221  2246799999999999999999999999999999999999999864321       1122


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      .........       .....    ...+.+++..||+.||.+||     ++.++++
T Consensus       359 ~~i~~~~~~-------~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          359 ELILMEEIR-------FPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHCCCC-------CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHhCCCC-------CCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            222211110       00111    23488999999999999999     9999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=349.79  Aligned_cols=272  Identities=20%  Similarity=0.247  Sum_probs=211.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|++.. +|+.||||++.....             ......+.+|+.++++++||||++++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnIv~~~   73 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISF-------------LRPVDVQMREFEVLKKLNHKNIVKLF   73 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGG-------------GSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEeccccc-------------cchHHHHHHHHHHHHhcCCCCCCeEE
Confidence            4679999999999999999999864 799999999853211             11246678999999999999999999


Q ss_pred             eEEEeCC--eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----
Q 014140          213 ARMVRRD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI----  286 (430)
Q Consensus       213 ~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----  286 (430)
                      +++...+  ..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+|||+    
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  149 (396)
T 4eut_A           74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGE  149 (396)
T ss_dssp             EEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECT
T ss_pred             EeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecC
Confidence            9998765  6799999999999999996432 2234999999999999999999999665   9999999999999    


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT--------VALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +.++.+||+|||+++........   ....||+.|+|||++.+        ..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          150 DGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (396)
T ss_dssp             TSCEEEEECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CCceeEEEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            78888999999999876543222   23579999999999865        46788999999999999999999998754


Q ss_pred             ccccccccHHHHHHHHhcCCCCchh------------c--cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRA------------I--NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      .......   +.+........+...            .  +..............+.+++..||+.||++||++.++++.
T Consensus       227 ~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          227 EGPRRNK---EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCTTTCH---HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchH---HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3322222   222222222111000            0  0011123346777789999999999999999999999999


Q ss_pred             Hhcc
Q 014140          425 LSQI  428 (430)
Q Consensus       425 L~~l  428 (430)
                      |..+
T Consensus       304 l~~i  307 (396)
T 4eut_A          304 TSDI  307 (396)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=338.29  Aligned_cols=264  Identities=20%  Similarity=0.262  Sum_probs=197.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++.....            .......+.+|+.++++++||||+++++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~   69 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESED------------DPVIKKIALREIRMLKQLKHPNLVNLLE   69 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCCC-------------HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeecccc------------chHHHHHHHHHHHHHHhCCCCCccchhh
Confidence            578999999999999999999764 799999998844221            1233567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  142 (311)
T 4agu_A           70 VFRRKRRLHLVFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIK  142 (311)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             eeecCCeEEEEEEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEE
Confidence            9999999999999999999999874    3456999999999999999999999555   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++..........  ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....    ......+.
T Consensus       143 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~  216 (311)
T 4agu_A          143 LCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD----VDQLYLIR  216 (311)
T ss_dssp             ECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             EeeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            99999998765432221  23478999999999876 5689999999999999999999999865322    11111111


Q ss_pred             HHhcCCCCc--------------hhccccccCC---CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPN--------------RAINSKLLGN---GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~--------------~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .......+.              ...++.....   ..+.....+.+++..||+.||.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            111110000              0000000000   00112334889999999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.3e-44  Score=359.94  Aligned_cols=257  Identities=24%  Similarity=0.321  Sum_probs=205.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......           .......+.+|+.+|+.++||||++++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~-----------~~~~~~~~~~E~~iL~~l~hp~Iv~l~  250 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIK-----------KRKGEAMALNEKQILEKVNSRFVVSLA  250 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhh-----------hhHHHHHHHHHHHHHHHcCCCCEeeEE
Confidence            5679999999999999999999864 8999999998542111           111245688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..|+||||++||+|.+++..  .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       251 ~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~v  325 (576)
T 2acx_A          251 YAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI  325 (576)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCe
Confidence            999999999999999999999999964  22345999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|||++|..||...........+...+ 
T Consensus       326 KL~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i-  401 (576)
T 2acx_A          326 RISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-  401 (576)
T ss_dssp             EECCCTTCEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-
T ss_pred             EEEecccceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-
Confidence            99999999887654322   23589999999999999899999999999999999999999987543211111122221 


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                        ......       .....    ...+.+|+..||+.||.+||     ++.||++
T Consensus       402 --~~~~~~-------~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 --KEVPEE-------YSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --HHCCCC-------CCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --hccccc-------CCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              111110       00111    23488999999999999999     6777764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-44  Score=340.11  Aligned_cols=258  Identities=20%  Similarity=0.236  Sum_probs=194.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.....           ........+.+|+.++++++||||++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~   78 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLA-----------RDPSFYLRFRREAQNAAALNHPAIVAVY   78 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTT-----------TSHHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCcccc-----------CCHHHHHHHHHHHHHHHcCCCCCcceEE
Confidence            4679999999999999999999764 899999999854221           1223457789999999999999999999


Q ss_pred             eEEEeCCe----eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          213 ARMVRRDC----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       213 ~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++...+.    .++||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~  151 (311)
T 3ork_A           79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA  151 (311)
T ss_dssp             EEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred             EeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcC
Confidence            99877554    3999999999999999954    346999999999999999999999655   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....       
T Consensus       152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------  224 (311)
T 3ork_A          152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------  224 (311)
T ss_dssp             TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------
T ss_pred             CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------
Confidence            999999999999876543221 222245689999999999999999999999999999999999999865321       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .................   .....    ...+.+++..||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~---~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          225 VSVAYQHVREDPIPPSA---RHEGL----SADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHHHHHHCCCCCHHH---HSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHHHHHHhcCCCCCccc---ccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            11122222221111100   01112    234889999999999999997766553

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-43  Score=332.43  Aligned_cols=261  Identities=20%  Similarity=0.208  Sum_probs=198.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||.||+|+... +|+.||+|++.....           ........+.+|+.++.+++||||++++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~iv~~~  100 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLS-----------SDPVFRTRMQREARTAGRLQEPHVVPIH  100 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGG-----------GSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccc-----------cCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            3679999999999999999998764 789999999843221           1223357789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus       101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A          101 DFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             EEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             EEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCE
Confidence            999999999999999999999999964    246999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    .    .+.
T Consensus       174 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~----~~~  244 (309)
T 2h34_A          174 YLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S----VMG  244 (309)
T ss_dssp             EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H----HHH
T ss_pred             EEecCccCcccccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H----HHH
Confidence            999999998765432221 1235689999999999999999999999999999999999999865321    1    111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-NSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~ev~~~L~~l  428 (430)
                      .......+...   ......    ...+.+++..||+.||++|| ++.++++.|+++
T Consensus       245 ~~~~~~~~~~~---~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          245 AHINQAIPRPS---TVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             HHHHSCCCCGG---GTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             HHhccCCCCcc---ccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            11111111100   011112    22488899999999999999 999999999865

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.9e-44  Score=331.91  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.||+|.+....                  ..+.+|+.++++++||||++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~~   70 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNN------------------EKAEREVKALAKLDHVNIVHYN   70 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCS------------------GGGHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccceeeeeccCCceEEEEEEEcC-CCeEEEEEEecccc------------------HHHHHHHHHHHhCCCCCEEEEe
Confidence            3579999999999999999998764 89999999985321                  2366899999999999999999


Q ss_pred             eEEEe----------------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 014140          213 ARMVR----------------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIH  276 (430)
Q Consensus       213 ~~~~~----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH  276 (430)
                      +++..                ....++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+   ++|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H  145 (284)
T 2a19_B           71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LIN  145 (284)
T ss_dssp             EEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             eeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            98864                44579999999999999999652  2356999999999999999999999655   999


Q ss_pred             cCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          277 RDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       277 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      +||||+||+++.++.+||+|||++..........   ...||+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus       146 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             SCCSGGGEEEEETTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             ccCCHHHEEEcCCCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999999999999999999999998775543221   3468999999999999999999999999999999999998853


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ...         ....... ......        ..+    ..+.+++..||+.||.+|||+.++++.|..++
T Consensus       223 ~~~---------~~~~~~~-~~~~~~--------~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          223 ETS---------KFFTDLR-DGIISD--------IFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHH---------HHHHHHH-TTCCCT--------TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             hHH---------HHHHHhh-cccccc--------cCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            211         1111111 111111        112    23788999999999999999999999998875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-43  Score=330.07  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=199.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... ++..||+|++......           .......+.+|+.+++.++||||++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~   75 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLE-----------KAGVEHQLRREVEIQSHLRHPNILRLY   75 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HHTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccc-----------hhhHHHHHHHHHHHHHcCCCCCCcchh
Confidence            4679999999999999999998764 7899999998542211           112246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCE
T ss_pred             heEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCE
Confidence            999999999999999999999999954    245899999999999999999999   4559999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....    .....   
T Consensus       149 ~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~---  217 (279)
T 3fdn_A          149 KIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYK---  217 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH---
T ss_pred             EEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH----HHHHH---
Confidence            9999999866543322    235789999999999999999999999999999999999999864321    11111   


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........           .+......+.+++..||+.||.+|||+.++++
T Consensus       218 ~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          218 RISRVEFT-----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHHTCCC-----------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCC-----------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111110           01111234788999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-43  Score=328.35  Aligned_cols=254  Identities=21%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||.+.....             ......+.+|+.+++.++||||+++++
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~   72 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRA-------------VDCPENIKKEICINKMLNHENVVKFYG   72 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGC-------------TTHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccc-------------hhhhHHHHHHHHHHHhcCCCCceeeee
Confidence            579999999999999999998764 889999999853221             122467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+++++|.+++.    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k  145 (276)
T 2yex_A           73 HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK  145 (276)
T ss_dssp             EEEETTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEcCCEEEEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEE
Confidence            9999999999999999999999883    3456999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||......  ......+. 
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-  222 (276)
T 2yex_A          146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK-  222 (276)
T ss_dssp             ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHH-
T ss_pred             EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhh-
Confidence            999999987643332222234578999999999988765 77899999999999999999998754321  11111111 


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         .......         ........+.+++..||+.||.+|||+.++++
T Consensus       223 ---~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          223 ---EKKTYLN---------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TTCTTST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hcccccC---------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               1111000         00111234788999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.3e-44  Score=344.30  Aligned_cols=251  Identities=24%  Similarity=0.235  Sum_probs=192.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHH-HhccCCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIIT-AGQVRHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l  211 (430)
                      .++|.+.+.||+|+||+||+|+... +++.||||++......           .......+..|..+ ++.++||||+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~-----------~~~~~~~~~~e~~~ll~~~~hp~Iv~l  104 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAIL-----------KKKEEKHIMSERNVLLKNVKHPFLVGL  104 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC------------------------CCBCCCCCTTBCCE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHHhCCCCCCCCE
Confidence            4679999999999999999999864 8999999999543221           11224556777776 577899999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          105 HFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCC
Confidence            9999999999999999999999999954    346899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||....       ..+..
T Consensus       178 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~  248 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMY  248 (373)
T ss_dssp             EEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHH
T ss_pred             EEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHH
Confidence            99999999986433222  1224689999999999999999999999999999999999999986432       12222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ..+......   +.    ...    ...+.+++..||+.||.+||++.+.+
T Consensus       249 ~~i~~~~~~---~~----~~~----~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          249 DNILNKPLQ---LK----PNI----TNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HHHHHSCCC---CC----SSS----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             HHHHhcccC---CC----CCC----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            222222110   00    111    23488899999999999999986433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-43  Score=328.87  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=203.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||+|++......            ......+.+|+.++++++||||++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~   71 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLS------------ARDFQKLEREARICRKLQHPNIVRLH   71 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccCC------------HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            4679999999999999999998764 8999999998543221            22356788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++...+..++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++. 
T Consensus        72 ~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~  144 (284)
T 3kk8_A           72 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG  144 (284)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTT
T ss_pred             EEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCC
Confidence            999999999999999999999998854    346999999999999999999999655   999999999999986655 


Q ss_pred             --eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 --ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                        +||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    .....
T Consensus       145 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~  217 (284)
T 3kk8_A          145 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYA  217 (284)
T ss_dssp             CCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred             CcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHHH
Confidence              999999999876544322   235789999999999999999999999999999999999999864321    12222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+...... .+.     ......+    ..+.+++..||+.||++|||+.++++
T Consensus       218 ~~~~~~~~-~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          218 QIKAGAYD-YPS-----PEWDTVT----PEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHTCCC-CCT-----TTTTTSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHhcccc-CCc-----hhhcccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            21111100 010     0011122    34889999999999999999999976

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=338.43  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=201.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||.+............      ......+.+|+.++++++||||++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIE------DPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEE------ETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             ccceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccc------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4679999999999999999998764 8999999999654322110000      01123577899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          213 ARMVRRDCDLLVYEFRRNG-SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++.+.+..++||||+.+| +|.+++.    ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence            9999999999999999776 9999984    3456999999999999999999999555   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++..........   ...||+.|+|||++.+..+ +.++|||||||++|+|++|..||......         
T Consensus       169 ~kL~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------  236 (335)
T 3dls_A          169 IKLIDFGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------  236 (335)
T ss_dssp             EEECCCTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred             EEEeecccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence            9999999998776543322   3579999999999988876 78999999999999999999998653221         


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                          .......    +   ...    ...+.+++..||+.||.+|||+.++++.
T Consensus       237 ----~~~~~~~----~---~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----VEAAIHP----P---YLV----SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----TTTCCCC----S---SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HhhccCC----C---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000000    0   011    2348899999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=338.80  Aligned_cols=265  Identities=21%  Similarity=0.269  Sum_probs=206.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|+... +|+.||||++....              ......+.+|+.+++.++||||+++
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv~~   91 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHE--------------QQDREEAQREADMHRLFNHPNILRL   91 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEESS--------------HHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecCC--------------HHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            35679999999999999999998754 89999999884321              1235678999999999999999999


Q ss_pred             eeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++..    ....++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~  168 (317)
T 2buj_A           92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLG  168 (317)
T ss_dssp             CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred             EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence            999973    34788999999999999999775556678999999999999999999999665   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcc-------eeeccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRT-------TTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      .++.+||+|||++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||..
T Consensus       169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            99999999999987654221110       011245799999999987654   68999999999999999999999865


Q ss_pred             cccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .....  .............  +           ........+.+++..||+.||.+|||+.++++.|+.++
T Consensus       249 ~~~~~--~~~~~~~~~~~~~--~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          249 VFQKG--DSVALAVQNQLSI--P-----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHTT--SCHHHHHHCC--C--C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhccc--chhhHHhhccCCC--C-----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            32211  1122111111000  0           00111234889999999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=335.38  Aligned_cols=268  Identities=20%  Similarity=0.225  Sum_probs=198.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv  209 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++........         .......+.+|+.+++.+   +||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~niv   77 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGG---------GGGLPISTVREVALLRRLEAFEHPNVV   77 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTT---------SSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEeccccccc---------ccccchhHHHHHHHHHHHhhcCCCCeE
Confidence            5689999999999999999998764 899999999854322110         001123455666666666   599999


Q ss_pred             cceeEEEeCC-----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          210 PLLARMVRRD-----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       210 ~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++++|....     ..++||||+. |+|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Ni  151 (308)
T 3g33_A           78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI  151 (308)
T ss_dssp             CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTE
T ss_pred             EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence            9999998765     4789999996 599999965  23345999999999999999999999665   99999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      |++.++.+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....    
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----  224 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----  224 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----
T ss_pred             EEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            9999999999999999876543322   235789999999999999999999999999999999999999865322    


Q ss_pred             ccHHHHHHHHhcCCCCch----------hcccccc---CCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNR----------AINSKLL---GNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~----------~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+...........          .+.+...   ....+.....+.+++..||+.||.+|||+.|+++
T Consensus       225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            122222222221111000          0000000   0000112345889999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-43  Score=335.99  Aligned_cols=265  Identities=20%  Similarity=0.262  Sum_probs=209.0

Q ss_pred             cccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++.    ..+++.||||.+....             .......+.+|+.++.++ +||
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~~hp   91 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------------THSEHRALMSELKILIHIGHHL   91 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------------CcHHHHHHHHHHHHHHhcccCC
Confidence            4578999999999999999999742    2477999999984321             122356789999999999 799


Q ss_pred             CcccceeEEEeCC-eeEEEEEecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          207 NIVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQG------------RRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       207 niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      ||+++++++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+   
T Consensus        92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---  168 (316)
T 2xir_A           92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  168 (316)
T ss_dssp             TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            9999999988755 489999999999999999653221            123889999999999999999999655   


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GK  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~  352 (430)
                      ++||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987765444333334568899999999999899999999999999999998 99


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .||.....   ...+...+....   ...      .....    ...+.+++..||+.||.+|||+.++++.|+.+
T Consensus       249 ~p~~~~~~---~~~~~~~~~~~~---~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          249 SPYPGVKI---DEEFCRRLKEGT---RMR------APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CSSTTCCC---SHHHHHHHHHTC---CCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccch---hHHHHHHhccCc---cCC------CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            99865322   111222221111   100      00111    23488899999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.8e-43  Score=329.64  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=203.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.....                ...+.+|+.+++.++|++++..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~   70 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTI   70 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC-------------------CCCHHHHHHHHHHHTTSTTCCCE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeeccccc----------------chHHHHHHHHHHHhcCCCCCCee
Confidence            4679999999999999999998754 899999998643211                13478899999999998887777


Q ss_pred             eEE-EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CC
Q 014140          213 ARM-VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DD  288 (430)
Q Consensus       213 ~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~  288 (430)
                      +.+ ...+..++||||+ +++|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~  143 (296)
T 4hgt_A           71 RWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKK  143 (296)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGG
T ss_pred             eeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCC
Confidence            766 5677889999999 8999999964   2346999999999999999999999665   9999999999999   78


Q ss_pred             CCceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ++.+||+|||++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       144 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  223 (296)
T 4hgt_A          144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  223 (296)
T ss_dssp             TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred             CCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh
Confidence            8999999999998765433211     12245789999999999999999999999999999999999999986543222


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+...........  ..    ......+    ..+.+++..||+.||++|||+.+|++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~--~~----~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          224 RQKYERISEKKMSTP--IE----VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SSHHHHHHHHHHHSC--HH----HHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhhhhcccccch--hh----hhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            222222222221111  00    0111122    3488999999999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=340.42  Aligned_cols=253  Identities=20%  Similarity=0.312  Sum_probs=194.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC--CCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH--RNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~  210 (430)
                      .+.|.+.+.||+|+||.||+|...  +++.||||++.....            .......+.+|+.+|..++|  |||++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~~~~~~iv~   73 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEA------------DNQTLDSYRNEIAYLNKLQQHSDKIIR   73 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeecccc------------chHHHHHHHHHHHHHHhhhhcCCceEE
Confidence            467999999999999999999875  799999999854321            12335778999999999986  99999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+..++|||+ .+|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++ ++
T Consensus        74 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~  144 (343)
T 3dbq_A           74 LYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DG  144 (343)
T ss_dssp             EEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TT
T ss_pred             EeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CC
Confidence            99999999999999995 57899999954    356899999999999999999999655   99999999999997 67


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----------VALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      .+||+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....
T Consensus       145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            899999999988765443333335679999999999864           578999999999999999999999986532


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .      ............... .    .....    ...+.+++..||+.||.+|||+.++++
T Consensus       225 ~------~~~~~~~~~~~~~~~-~----~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          225 N------QISKLHAIIDPNHEI-E----FPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             S------HHHHHHHHHCTTSCC-C----CCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h------HHHHHHHHhcCCccc-C----CcccC----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            2      112222222111110 0    00111    134789999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=341.70  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=194.7

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEE
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  216 (430)
                      ...+.||+|+||.||+|+... +|+.||+|++.....              .....+.+|+.++++++||||+++++++.
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  156 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGM--------------KDKEEVKNEISVMNQLDHANLIQLYDAFE  156 (373)
T ss_dssp             EEEEECC-----CEEEEEETT-TCCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcC-CCcEEEEEEEccccc--------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            336789999999999998764 899999999853211              22467899999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe--CCCCceEE
Q 014140          217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI--DDDMEARI  294 (430)
Q Consensus       217 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill--~~~~~~kl  294 (430)
                      +.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||+  +.++.+||
T Consensus       157 ~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl  230 (373)
T 2x4f_A          157 SKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKI  230 (373)
T ss_dssp             CSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEE
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEE
Confidence            99999999999999999998854   3346999999999999999999999655   9999999999999  67789999


Q ss_pred             eecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHH
Q 014140          295 SEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNV  374 (430)
Q Consensus       295 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~  374 (430)
                      +|||++..........   ...||+.|+|||++.+..++.++|||||||++|||++|..||.....       .+.....
T Consensus       231 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i  300 (373)
T 2x4f_A          231 IDFGLARRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLNNI  300 (373)
T ss_dssp             CCCSSCEECCTTCBCC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHH
T ss_pred             EeCCCceecCCccccc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            9999998875443222   34699999999999998999999999999999999999999865321       1122222


Q ss_pred             hcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          375 MTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......   +........+    ..+.+|+..||+.||.+|||+.++++
T Consensus       301 ~~~~~~---~~~~~~~~~~----~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          301 LACRWD---LEDEEFQDIS----EEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHTCCC---SCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhccCC---CChhhhccCC----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            211110   0111111222    34889999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-43  Score=329.26  Aligned_cols=254  Identities=25%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||.||+|+... +|..+|+|++......             .....+.+|+.++++++||||+++++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~~   87 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQ-------------VPMEQIEAEIEVLKSLDHPNIIKIFE   87 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCC-------------SCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hheeecceeccCCCeEEEEEEEcc-CCceEEEEEeeccccc-------------hhHHHHHHHHHHHHhCCCchHHhHHH
Confidence            579999999999999999998764 8999999998543211             11467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CCCC
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDM  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~  290 (430)
                      ++.+.+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~  164 (285)
T 3is5_A           88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHS  164 (285)
T ss_dssp             EEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTC
T ss_pred             heecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCC
Confidence            999999999999999999999999764444567999999999999999999999655   9999999999999   4567


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++.........   ....||+.|+|||++. ..++.++||||||+++|+|++|..||.....    ..... 
T Consensus       165 ~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----~~~~~-  235 (285)
T 3is5_A          165 PIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----EEVQQ-  235 (285)
T ss_dssp             CEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH-
T ss_pred             CEEEEeeecceecCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH----HHHHh-
Confidence            8999999999876543222   2357899999999886 4689999999999999999999999865321    11111 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ......... ...   ....+    ..+.+++..||+.||.+|||+.|+++
T Consensus       236 --~~~~~~~~~-~~~---~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          236 --KATYKEPNY-AVE---CRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --HHHHCCCCC-CC-----CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --hhccCCccc-ccc---cCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              111111110 000   01122    34778999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=350.73  Aligned_cols=259  Identities=20%  Similarity=0.187  Sum_probs=200.6

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+.+|..++..++||||+++
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~-----------~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDML-----------KRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhh-----------hHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            35689999999999999999999864 8999999998532111           11123457889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..|+||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence            99999999999999999999999999642   246999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-------TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      +||+|||+++......... .....||+.|+|||++.       +..++.++|||||||++|||++|+.||.....    
T Consensus       201 vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----  275 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----  275 (412)
T ss_dssp             EEECCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred             EEEeechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----
Confidence            9999999998775443322 22458999999999987       35689999999999999999999999865321    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR---PNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---ps~~ev~~  423 (430)
                      ......+.........     +......    ...+.+++.+||. +|.+|   |++.++++
T Consensus       276 ~~~~~~i~~~~~~~~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 AETYGKIVHYKEHLSL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHHHTHHHHCCC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHHHhcccCcCC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            1111111110000000     0000112    2348899999999 99998   58888764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.9e-44  Score=337.97  Aligned_cols=264  Identities=19%  Similarity=0.294  Sum_probs=209.4

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ..++|.+.+.||+|+||.||+|.+.+    .+++.||||.+....             .......+.+|+.+++.++|||
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~   89 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------------SMRERIEFLNEASVMKEFNCHH   89 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------------CHHHHHHHHHHHHHGGGCCCTT
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------------CHHHHHHHHHHHHHHHhcCCCC
Confidence            35689999999999999999998642    357899999984321             1123467899999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP  281 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  281 (430)
                      |+++++++.+.+..++||||+++|+|.+++.....      ....+++..++.++.|++.||.|||+.+   |+||||||
T Consensus        90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp  166 (322)
T 1p4o_A           90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAA  166 (322)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSG
T ss_pred             EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCcc
Confidence            99999999999999999999999999999975321      1245799999999999999999999655   99999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQ  360 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~  360 (430)
                      +||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  246 (322)
T 1p4o_A          167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  246 (322)
T ss_dssp             GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence            999999999999999999987644332222223457889999999998899999999999999999999 8899765321


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                             .+..........+.          .+......+.+++..||+.||.+|||+.++++.|+++
T Consensus       247 -------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          247 -------EQVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             -------HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -------HHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                   12222222221110          0111223488999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=333.45  Aligned_cols=247  Identities=18%  Similarity=0.216  Sum_probs=191.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  212 (430)
                      ++|.+.+.||+|+||+||+|++.. +|+.||||++......            ......+..|+..+..+ +||||++++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~~~~~~~h~~iv~l~  123 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRG------------PKDRARKLAEVGSHEKVGQHPCCVRLE  123 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCS------------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccC------------hHHHHHHHHHHHHHHHhcCCCcEEEEE
Confidence            579999999999999999998864 8999999987432221            12234455566666555 899999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+..++||||+ +++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~  196 (311)
T 3p1a_A          124 QAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRC  196 (311)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCE
T ss_pred             EEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCE
Confidence            9999999999999999 67999998653   346999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|||++|..|+.....          ..
T Consensus       197 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~  262 (311)
T 3p1a_A          197 KLGDFGLLVELGTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQ  262 (311)
T ss_dssp             EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HH
T ss_pred             EEccceeeeecccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HH
Confidence            99999999876543322   23469999999999886 799999999999999999999766432110          11


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ... ......    ......    ...+.+++..||+.||++|||+.++++
T Consensus       263 ~~~-~~~~~~----~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          263 QLR-QGYLPP----EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHT-TTCCCH----HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHh-ccCCCc----ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111 111111    111112    234889999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=342.29  Aligned_cols=278  Identities=18%  Similarity=0.176  Sum_probs=200.5

Q ss_pred             ccccccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|....  .++..+|||++...........   ..........+.+|+..+..++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~---~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSEL---KFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHH---HHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHH---HHHHHHhhhHHHHHHHhhccccccCcce
Confidence            4679999999999999999998752  2578999999865432110000   0000011245778999999999999999


Q ss_pred             ceeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          211 LLARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       211 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++++..    ....++||||+ +++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  184 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence            9999988    67899999999 9999999843    337999999999999999999999655   9999999999999


Q ss_pred             CCCC--ceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          287 DDDM--EARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       287 ~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      +.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8877  9999999999876432111     11124579999999999999999999999999999999999999986432


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..   ...............+............    ...+.+++..||+.||++|||+.+|++.|+++
T Consensus       265 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          265 KD---PVAVQTAKTNLLDELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             TC---HHHHHHHHHHHHHTTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             cc---cHHHHHHHHhhcccccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            21   1111111111111111111000000012    23488999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=335.98  Aligned_cols=266  Identities=23%  Similarity=0.349  Sum_probs=199.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc--CCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV--RHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++   .|+.||||++....                 ...+..|..++..+  +||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-----------------EASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-----------------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             ccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-----------------cchhhhHHHHHHHHhhcCCCeee
Confidence            36799999999999999999986   58999999984311                 23344455555554  8999999


Q ss_pred             ceeEEEeC----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCC
Q 014140          211 LLARMVRR----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH-----RPRIIHRDIQP  281 (430)
Q Consensus       211 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dlkp  281 (430)
                      +++++...    +..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+..     .++|+||||||
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence            99999887    788999999999999999954     35899999999999999999999550     12699999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcc--eeeccccccccccccccCCCCCCcc------hhHHHHHHHHHHHHhC--
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVALSDT------CDIYSFGVLLAVLVIG--  351 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~~l~ell~g--  351 (430)
                      +|||++.++.+||+|||++..........  ......||+.|+|||++.+..++..      +|||||||++|||++|  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            99999999999999999998765432221  1123579999999999988776665      9999999999999999  


Q ss_pred             --------CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          352 --------KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       352 --------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                              ..||.......  ..... .............+...   .....+...+.+++..||+.||.+|||+.+|++
T Consensus       251 ~~~~~~~~~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSD--PSYED-MREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSS--CCHHH-HHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccccccccHhhhcCCC--Cchhh-hHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence                    56655433221  11222 12222111111111111   012255667999999999999999999999999


Q ss_pred             HHhccc
Q 014140          424 MLSQIQ  429 (430)
Q Consensus       424 ~L~~l~  429 (430)
                      .|+++.
T Consensus       325 ~L~~l~  330 (337)
T 3mdy_A          325 TLAKMS  330 (337)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-43  Score=330.75  Aligned_cols=251  Identities=18%  Similarity=0.244  Sum_probs=199.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCC-------ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG-------RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  205 (430)
                      .++|.+.+.||+|+||.||+|+... ++       ..||+|.+....              ......+.+|+.++++++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~~va~K~~~~~~--------------~~~~~~~~~E~~~l~~l~h   71 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRRE-VGDYGQLHETEVLLKVLDKAH--------------RNYSESFFEAASMMSKLSH   71 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEE-ECGGGCEEEEEEEEEEECGGG--------------GGGHHHHHHHHHHHHTSCC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEec-ccccccccchhhhhhhccccc--------------HHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999999998763 34       579999884321              1224678999999999999


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      |||+++++++.+.+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        72 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl  145 (289)
T 4fvq_A           72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNIL  145 (289)
T ss_dssp             TTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             CCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEE
Confidence            9999999999999999999999999999999964   2345999999999999999999999655   999999999999


Q ss_pred             eCCCCc--------eEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCC-CC
Q 014140          286 IDDDME--------ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKF-PS  355 (430)
Q Consensus       286 l~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~-p~  355 (430)
                      ++.++.        +||+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|+|++|.. |+
T Consensus       146 l~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          146 LIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             EEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence            998887        999999998765322      12468899999999988 679999999999999999999654 44


Q ss_pred             CccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          356 DDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       356 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ....    ......   ............            ...+.+++..||+.||.+|||+.++++.|+++.
T Consensus       220 ~~~~----~~~~~~---~~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          220 SALD----SQRKLQ---FYEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             TTSC----HHHHHH---HHHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             cccc----hHHHHH---HhhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3221    111111   111111111111            112788999999999999999999999999873

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-43  Score=338.37  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|...+.||+|+||.||+|+... +|+.||||++.....           ........+.+|+.++++++||||++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpniv~~~  120 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGK-----------QSNEKWQDIIKEVRFLQKLRHPNTIQYR  120 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSS-----------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccc-----------cchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4568999999999999999998753 899999999854321           1223357789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+. |+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       121 ~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  193 (348)
T 1u5q_A          121 GCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV  193 (348)
T ss_dssp             EEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEE
T ss_pred             EEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence            99999999999999997 588888854   2356999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ||+|||++......      ....||+.|+|||++.   +..++.++|||||||++|||++|..||.....       ..
T Consensus       194 kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~  260 (348)
T 1u5q_A          194 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS  260 (348)
T ss_dssp             EECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH
T ss_pred             EEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HH
Confidence            99999999876432      1357899999999884   55789999999999999999999999864321       11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........+..  .   ....    ...+.+++..||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~--~---~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          261 ALYHIAQNESPAL--Q---SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHHHHHSCCCCC--C---CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCCCCC--C---CCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2222222221110  0   0111    234788999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-43  Score=329.18  Aligned_cols=260  Identities=21%  Similarity=0.265  Sum_probs=202.7

Q ss_pred             cccccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..|...+.||+|+||.||+|.+..  .++..+|+|.+...             ........+.+|+.+++.++||||+++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~~   87 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-------------TEMQQVEAFLREGLLMRGLNHPNVLAL   87 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-------------CSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-------------ccHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence            346777999999999999998642  23347999988431             112335788999999999999999999


Q ss_pred             eeEEEeCCee-EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVRRDCD-LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~~~~~-~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++++.+.+.. ++||||+.+|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        88 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~  161 (298)
T 3pls_A           88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESF  161 (298)
T ss_dssp             CEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTC
T ss_pred             EEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence            9999876655 999999999999999953   3456899999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||++.........  .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...   .....+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~---~~~~~~~  238 (298)
T 3pls_A          162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH---IDPFDLT  238 (298)
T ss_dssp             CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCGGGHH
T ss_pred             cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc---CCHHHHH
Confidence            9999999999876543211  1222356789999999999999999999999999999999966553221   1222333


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+........             +......+.+++..||+.||.+|||+.++++.|+++
T Consensus       239 ~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          239 HFLAQGRRLPQ-------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             HHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCCCC-------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            33322211111             011123488999999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-43  Score=327.67  Aligned_cols=262  Identities=23%  Similarity=0.285  Sum_probs=205.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.....                ...+.+|+.+++.++|++++..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~   70 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTI   70 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCSS----------------CCHHHHHHHHHHHHTTSTTCCCE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCcc----------------hhHHHHHHHHHHHhhcCCCCCcc
Confidence            4689999999999999999998753 899999998843221                13588999999999998877777


Q ss_pred             eEE-EeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC---C
Q 014140          213 ARM-VRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID---D  288 (430)
Q Consensus       213 ~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~  288 (430)
                      .++ ...+..++||||+ +++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+|||++   .
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~  143 (296)
T 3uzp_A           71 RWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKK  143 (296)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGG
T ss_pred             ccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCC
Confidence            666 5567789999999 8999999963   2356999999999999999999999655   99999999999994   8


Q ss_pred             CCceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ++.+||+|||++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  223 (296)
T 3uzp_A          144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  223 (296)
T ss_dssp             TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred             CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence            8899999999998765443211     12245799999999999999999999999999999999999999986443222


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+...........  ..    .+....+    ..+.+++..||+.||.+|||+.+|++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~--~~----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          224 RQKYERISEKKMSTP--IE----VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SSHHHHHHHHHHHSC--HH----HHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhhhcccccCCc--hH----HHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            222222222221111  00    0111122    3488999999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-43  Score=330.23  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=203.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|...  ++..||||.+.....               ....+.+|+.+++.++||||+++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~   73 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM---------------SPDAFLAEANLMKQLQHQRLVRL   73 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCcc---------------cHHHHHHHHHHHHhCCCcCcceE
Confidence            3567999999999999999999875  678899999843221               13568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++. .+..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        74 ~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~  147 (279)
T 1qpc_A           74 YAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLS  147 (279)
T ss_dssp             EEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             EEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCC
Confidence            99876 55689999999999999998531  1236899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||++.......... .....++..|+|||++.+..++.++||||||+++++|++ |..||.....    ..+.. 
T Consensus       148 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~-  221 (279)
T 1qpc_A          148 CKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQ-  221 (279)
T ss_dssp             EEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHH-
T ss_pred             EEECCCcccccccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHHH-
Confidence            9999999998775433221 123456889999999998889999999999999999999 8999865321    12222 


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        .........      .....    ...+.+++..||+.||++|||+.++++.|+.+
T Consensus       222 --~~~~~~~~~------~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          222 --NLERGYRMV------RPDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             --HHHTTCCCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHhcccCCC------Ccccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              222111110      00112    23488999999999999999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-44  Score=342.35  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=204.0

Q ss_pred             ccccccccccccCceEEEeecC---CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELP---GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .|.+.+.||+|+||+||++.+.   ..+|+.||||++....             .......+.+|+.++++++||||+++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------------GPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------------ChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            3589999999999999887643   2378899999984321             12335778999999999999999999


Q ss_pred             eeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++.+.  ...++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~  170 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDND  170 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCC
Confidence            9999884  578999999999999999843     34999999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc------
Q 014140          290 MEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT------  362 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~------  362 (430)
                      +.+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++|..||.......      
T Consensus       171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            999999999999876543321 2224567889999999999889999999999999999999999976432100      


Q ss_pred             --ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          363 --KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       363 --~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        ........ .........         ...+......+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       251 ~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          251 AQGQMTVLRL-TELLERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             CCHHHHHHHH-HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccchhHHHH-HHHHhcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence              00011111 111111110         1111122345889999999999999999999999999764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-43  Score=335.48  Aligned_cols=254  Identities=19%  Similarity=0.237  Sum_probs=192.0

Q ss_pred             ccccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|+..  ..+|+.||+|++......          ........+.+|+.+++.++||||++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~   85 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----------RNAKDTAHTKAERNILEEVKHPFIVD   85 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------HHHHHHHCCCTTBCC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh----------hhhhHHHHHHHHHHHHHhCCCCCccc
Confidence            467999999999999999999863  237899999998543211          01122456788999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           86 LIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             EEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTS
T ss_pred             eeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCC
Confidence            99999999999999999999999999954    346899999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....       ...
T Consensus       159 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~  229 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKT  229 (327)
T ss_dssp             CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHH
T ss_pred             cEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHH
Confidence            999999999986543222  12245799999999999999999999999999999999999999865321       111


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ..........           .+......+.+++..||+.||.+||     ++.++++
T Consensus       230 ~~~i~~~~~~-----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          230 IDKILKCKLN-----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHTCCC-----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHhCCCC-----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            2222211110           0011123488999999999999999     6667664

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=327.73  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=182.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||.+......           .......+.+|+.++++++||||++++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~   77 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMY-----------KAGMVQRVQNEVKIHCQLKHPSILELY   77 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTBCCTTBCCEE
T ss_pred             cccceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhh-----------hhhHHHHHHHHHHHHHhCCCCCeEeEE
Confidence            4579999999999999999998753 8999999998432211           111246789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~  151 (278)
T 3cok_A           78 NYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNI  151 (278)
T ss_dssp             EEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCE
T ss_pred             EEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCE
Confidence            999999999999999999999999953   3457999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++..........  ....||+.|+|||.+.+..++.++||||||+++|+|++|..||......    ..   ..
T Consensus       152 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---~~  222 (278)
T 3cok_A          152 KIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----NT---LN  222 (278)
T ss_dssp             EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------
T ss_pred             EEEeecceeeccCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----HH---HH
Confidence            999999998765332211  2357899999999999989999999999999999999999998653211    00   01


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......       ...    +......+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~-------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          223 KVVLAD-------YEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCSSC-------CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhhcc-------cCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            111000       000    1112234789999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.3e-43  Score=343.17  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=195.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~  210 (430)
                      ...|.+.+.||+|+||.||+|...  +|+.||||++.....            .......+.+|+.+|.+++  ||||++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~------------~~~~~~~~~~Ei~~l~~l~~~~~~iv~  120 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEA------------DNQTLDSYRNEIAYLNKLQQHSDKIIR  120 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccc------------cHHHHHHHHHHHHHHHHcccCCCeEEE
Confidence            346999999999999999999875  699999999854221            1234578999999999996  599999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+..++||| +.+++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++
T Consensus       121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~  191 (390)
T 2zmd_A          121 LYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG  191 (390)
T ss_dssp             EEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SS
T ss_pred             EEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CC
Confidence            9999999999999999 457899999964    34689999999999999999999954   599999999999995 58


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----------VALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      .+||+|||++..+.............||+.|+|||++.+           ..++.++|||||||++|||++|..||....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            999999999988765433333334679999999999865           368999999999999999999999986532


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .      ....+........... +.    ...    ...+.+++..||+.||.+|||+.++++
T Consensus       272 ~------~~~~~~~~~~~~~~~~-~~----~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          272 N------QISKLHAIIDPNHEIE-FP----DIP----EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             C------HHHHHHHHHCTTSCCC-CC----CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H------HHHHHHHHhCccccCC-CC----ccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1      1222222322111100 00    011    234789999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-43  Score=343.35  Aligned_cols=266  Identities=20%  Similarity=0.294  Sum_probs=190.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|.+.. +|+.||||++......            ......+.+|+.++..+. ||||+++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~------------~~~~~~~~~E~~~l~~l~~h~niv~l   74 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQN------------STDAQRTFREIMILTELSGHENIVNL   74 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETT-TCCEEEEEEECC--CC------------HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccccC------------hHHHHHHHHHHHHHHhccCCCCCCee
Confidence            3579999999999999999998764 8999999998432211            233567889999999997 9999999


Q ss_pred             eeEEEeCC--eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVRRD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++...+  ..|+|||||+ |+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~  145 (388)
T 3oz6_A           75 LNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE  145 (388)
T ss_dssp             EEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred             eeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCC
Confidence            99998654  6899999997 599999854     36899999999999999999999665   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCC-------------------cceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHH
Q 014140          290 MEARISEFGLAKRIPDGHT-------------------RTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLV  349 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell  349 (430)
                      +.+||+|||+++.+.....                   ........||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus       146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            9999999999987643111                   111223579999999999887 57899999999999999999


Q ss_pred             hCCCCCCccccccccccHHHHHHHHhcCCCCchhc-----------c---------ccccCCCcH-------------HH
Q 014140          350 IGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI-----------N---------SKLLGNGYE-------------EQ  396 (430)
Q Consensus       350 ~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-----------~---------~~~~~~~~~-------------~~  396 (430)
                      +|+.||.....    ......+......+......           .         ........+             ..
T Consensus       226 ~g~~pf~~~~~----~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (388)
T 3oz6_A          226 CGKPIFPGSST----MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC  301 (388)
T ss_dssp             HSSCSCCCSSH----HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred             hCCCCCCCCCH----HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence            99999865321    11122221221111100000           0         000000000             11


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          397 MLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       397 ~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                      ...+.+|+.+||+.||++|||+.|+++.
T Consensus       302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          302 NEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            2348899999999999999999998763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-44  Score=343.71  Aligned_cols=267  Identities=21%  Similarity=0.252  Sum_probs=208.4

Q ss_pred             cccccccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      ..++|.+.+.||+|+||.||+|++   ...+++.||||++....              ......+.+|+.++++++||||
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~i   86 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------------PDQQRDFQREIQILKALHSDFI   86 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------------HHHHHHHHHHHHHHHhcCCCce
Confidence            356799999999999999999984   23488999999984321              2235678999999999999999


Q ss_pred             ccceeEEE--eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          209 VPLLARMV--RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       209 v~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++++++.  ..+..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   ++||||||+|||+
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~  160 (327)
T 3lxl_A           87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILV  160 (327)
T ss_dssp             CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEE
Confidence            99999987  456689999999999999999652   235999999999999999999999555   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc----
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH----  361 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~----  361 (430)
                      +.++.+||+|||++.......... ......||..|+|||++.+..++.++||||||+++|+|++|..||......    
T Consensus       161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~  240 (327)
T 3lxl_A          161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM  240 (327)
T ss_dssp             EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred             CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence            999999999999998876443322 222346888999999999988999999999999999999999997643210    


Q ss_pred             ----cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 ----TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                          ..................          ...+......+.+++..||+.||.+|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          241 MGCERDVPALSRLLELLEEGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             CC----CCHHHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             cccccccccHHHHHHHhhcccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                000111111111111111          111122234488999999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-43  Score=334.15  Aligned_cols=260  Identities=22%  Similarity=0.362  Sum_probs=199.7

Q ss_pred             ccccccccccccccCceEEEeecCCCC---CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSS---GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .+.|.+.+.||+|+||.||+|.+...+   +..||||.+....             .......+.+|+.+++.++||||+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv  109 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------------TEKQRVDFLGEAGIMGQFSHHNII  109 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------------CHHHHHHHHHHHHHHHhCCCCCCC
Confidence            467889999999999999999876322   3469999984321             122356789999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++...+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~  183 (333)
T 1mqb_A          110 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSN  183 (333)
T ss_dssp             CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred             cEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCC
Confidence            999999999999999999999999999964   3456999999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      +.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    ..+
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~  259 (333)
T 1mqb_A          184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEV  259 (333)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH
T ss_pred             CcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHH
Confidence            999999999998775432211 1222356889999999999899999999999999999999 9999865321    122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..   .......+..          +......+.+++..||+.||.+||++.++++.|+++
T Consensus       260 ~~---~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          260 MK---AINDGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HH---HHHTTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HH---HHHCCCcCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22   2221111110          111223488999999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.2e-43  Score=327.79  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=204.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +++.+|+|.+......           .......+.+|+.+++.++||||++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~   81 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLL-----------KPHQREKMSMEISIHRSLAHQHVVGFH   81 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCC-----------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhcc-----------CHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence            4679999999999999999999764 7899999998543211           123357789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~  154 (294)
T 2rku_A           82 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV  154 (294)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCE
Confidence            999999999999999999999999854    346899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .+...
T Consensus       155 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~  225 (294)
T 2rku_A          155 KIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYL  225 (294)
T ss_dssp             EECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred             EEEeccCceecccCcccc--ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            999999998765332222  235789999999999998899999999999999999999999865321       11112


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........       .....    ...+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~-------~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          226 RIKKNEYS-------IPKHI----NPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHTTCCC-------CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHhhccCC-------Ccccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            22211110       00111    234788999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-43  Score=326.50  Aligned_cols=260  Identities=18%  Similarity=0.265  Sum_probs=202.6

Q ss_pred             cccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ..++|.+.+.||+|+||.||+|.+...  ++..||+|.+....             .......+.+|+.+++.++||||+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~i~   76 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------------TLDNKEKFMSEAVIMKNLDHPHIV   76 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------------CHHHHHHHHHHHHHHHHHCCTTBC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------------CchHHHHHHHHHHHHHhCCCCCcc
Confidence            356799999999999999999986432  34569999884321             123357799999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++.+ +..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~  149 (281)
T 3cc6_A           77 KLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASP  149 (281)
T ss_dssp             CEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEET
T ss_pred             eEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCC
Confidence            99998764 556899999999999999964   2345899999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      +.+||+|||++........... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....    ....
T Consensus       150 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~  224 (281)
T 3cc6_A          150 ECVKLGDFGLSRYIEDEDYYKA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVI  224 (281)
T ss_dssp             TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHH
T ss_pred             CcEEeCccCCCccccccccccc-ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHH
Confidence            9999999999987654332221 23457889999999998899999999999999999998 9999864322    2233


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ..+........+         ...    ...+.+++..||+.||++|||+.++++.|+++.
T Consensus       225 ~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          225 GVLEKGDRLPKP---------DLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HHHHHTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCC---------CCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            222221111100         111    234889999999999999999999999998763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-43  Score=340.04  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=197.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||.+.....                  ...+|+.++.++ +||||+++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~------------------~~~~E~~~l~~~~~hp~iv~~   81 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKR------------------DPTEEIEILLRYGQHPNIITL   81 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTC------------------CCHHHHHHHHHHTTSTTBCCE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccC------------------ChHHHHHHHHHhcCCCCcCeE
Confidence            4579999999999999999998764 899999999843211                  134677888888 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC--
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--  289 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--  289 (430)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+.++  
T Consensus        82 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~  154 (342)
T 2qr7_A           82 KDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESG  154 (342)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSC
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCC
Confidence            9999999999999999999999999853    456999999999999999999999665   9999999999998543  


Q ss_pred             --CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 --MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                        +.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ...
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~  228 (342)
T 2qr7_A          155 NPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTP  228 (342)
T ss_dssp             SGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCH
T ss_pred             CcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCH
Confidence              35999999999876543222  1235789999999999888899999999999999999999999864321    122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+...........   +.    ..........+.+++..||+.||.+||++.++++
T Consensus       229 ~~~~~~i~~~~~~---~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          229 EEILARIGSGKFS---LS----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHCCCC---CC----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCCcc---cC----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2222222211111   00    0111122234889999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-42  Score=335.95  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-----CCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-----HRN  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpn  207 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++...               ......+..|+.+++.++     |||
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNI---------------KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC---------------HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccc---------------hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            5789999999999999999999864 8899999998421               122456778999999996     999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      |+++++++...+..++||||+ +++|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~  171 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD  171 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence            999999999999999999999 8899999965  33346999999999999999999999555   99999999999998


Q ss_pred             C-------------------------CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHH
Q 014140          288 D-------------------------DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG  342 (430)
Q Consensus       288 ~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG  342 (430)
                      .                         ++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            5                         7899999999998754332     135789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhcc------------cc-c---cC--CCc-----------
Q 014140          343 VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN------------SK-L---LG--NGY-----------  393 (430)
Q Consensus       343 ~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~------------~~-~---~~--~~~-----------  393 (430)
                      |++|+|++|+.||.....    ......+....... +.....            .. .   ..  ...           
T Consensus       247 ~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  321 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEH----MEHLAMMESIIQPI-PKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL  321 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSH----HHHHHHHHHHTCCC-CHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred             HHHHHHHHCCCCCCCCcH----HHHHHHHHHhcCCC-CHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence            999999999999865321    12222222221111 100000            00 0   00  000           


Q ss_pred             ----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          394 ----EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       394 ----~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                          ......+.+|+..||+.||++|||+.|+++
T Consensus       322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000145779999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-43  Score=338.80  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||.||+|+... +|+.||||++.....            .......+.+|+.++++++||||++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   90 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDD------------DKMVKKIAMREIKLLKQLRHENLVNLL   90 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCSS------------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCCC------------chHHHHHHHHHHHHHhhCCCCCEeeEE
Confidence            4679999999999999999998764 799999999854321            123356688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~  163 (331)
T 4aaa_A           91 EVCKKKKRWYLVFEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVV  163 (331)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             EEeecCCEEEEEEecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcE
Confidence            99999999999999999998988863    3456999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......    .....+
T Consensus       164 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~  237 (331)
T 4aaa_A          164 KLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHI  237 (331)
T ss_dssp             EECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHH
T ss_pred             EEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHH
Confidence            99999999876543221  1234689999999999876 6899999999999999999999998653221    111111


Q ss_pred             HHHhcCCCC------------chhccccccCCC-----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENP------------NRAINSKLLGNG-----YEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~------------~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+            .....+......     .+.....+.+++..||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111100000            000000000000     0122345889999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-43  Score=339.68  Aligned_cols=265  Identities=22%  Similarity=0.221  Sum_probs=199.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.... +++.||+|++......         .........+.+|+.++++++||||+++
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIR---------QINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH---------C---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhc---------ccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            35679999999999999999998764 8999999998543211         0011235779999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC------------------------------------CCCCCHHHHHHH
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQG------------------------------------RRELDWLARHRI  255 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i  255 (430)
                      ++++.+.+..++||||+++|+|.+++......                                    ...+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            99999999999999999999999998421110                                    223467788899


Q ss_pred             HHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--ceEEeecCCcccCCCCCCc--ceeeccccccccccccccCC--
Q 014140          256 AQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--EARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQT--  329 (430)
Q Consensus       256 ~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--  329 (430)
                      +.|++.||.|||+.+   |+||||||+|||++.++  .+||+|||++..+......  .......||+.|+|||++.+  
T Consensus       174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            999999999999665   99999999999998776  8999999999865432211  12224579999999999875  


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhccc
Q 014140          330 VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTL  409 (430)
Q Consensus       330 ~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  409 (430)
                      ..++.++||||||+++|+|++|..||.....       .+.............   ......    ....+.+++..||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-------ADTISQVLNKKLCFE---NPNYNV----LSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCTT---SGGGGG----SCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcccccC---Cccccc----CCHHHHHHHHHHcC
Confidence            5789999999999999999999999865322       122222222211110   000011    12348899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 014140          410 DDPNKRPNSKDVRC  423 (430)
Q Consensus       410 ~dp~~Rps~~ev~~  423 (430)
                      .||.+|||+.++++
T Consensus       317 ~~p~~Rps~~~~l~  330 (345)
T 3hko_A          317 RNVDERFDAMRALQ  330 (345)
T ss_dssp             SCTTTSCCHHHHHH
T ss_pred             CChhHCCCHHHHhc
Confidence            99999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.7e-43  Score=325.99  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=201.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||+|.+........        ........+.+|+.++++++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSS--------RRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhcccccc--------ccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            568999999999999999998764 799999999865432210        00112467899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC---
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM---  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---  290 (430)
                      ++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++   
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~  148 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPN  148 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSS
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCC
Confidence            99999999999999999999999954    346899999999999999999999555   99999999999999877   


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       .+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .+
T Consensus       149 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~  218 (283)
T 3bhy_A          149 PRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QE  218 (283)
T ss_dssp             CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH
T ss_pred             CceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HH
Confidence             8999999999876543322   234689999999999999999999999999999999999999865321       11


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........   .........    ...+.+++..||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~---~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          219 TLTNISAVNYD---FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHHTTCCC---CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhHhcccC---CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11222111110   011111122    234889999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-42  Score=344.20  Aligned_cols=203  Identities=25%  Similarity=0.278  Sum_probs=168.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+|+.++||||++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~nIv~l~   91 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFE------------DLIDCKRILREITILNRLKSDYIIRLY   91 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTTT------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchhc------------ChHHHHHHHHHHHHHHHcCCCCcceEE
Confidence            5789999999999999999998764 899999999953221            123357889999999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     +..|+||||+. |+|.+++.    ....+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~  163 (432)
T 3n9x_A           92 DLIIPDDLLKFDELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLN  163 (432)
T ss_dssp             EECCCSCTTTCCCEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred             EEEecCCCCcCCeEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEEC
Confidence            999876     56899999996 59999984    3456999999999999999999999665   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCc--------------------ceeecccccccccccccc-CCCCCCcchhHHHHHHHHH
Q 014140          288 DDMEARISEFGLAKRIPDGHTR--------------------TTTWSLAGTVGYIAPECH-QTVALSDTCDIYSFGVLLA  346 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~  346 (430)
                      .++.+||+|||+++........                    .......||+.|+|||++ .+..++.++|||||||++|
T Consensus       164 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~  243 (432)
T 3n9x_A          164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA  243 (432)
T ss_dssp             TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence            9999999999999877543211                    112356799999999986 5556999999999999999


Q ss_pred             HHHhCCCCCC
Q 014140          347 VLVIGKFPSD  356 (430)
Q Consensus       347 ell~g~~p~~  356 (430)
                      ||++|..||.
T Consensus       244 ell~g~~p~~  253 (432)
T 3n9x_A          244 ELLNMLQSHI  253 (432)
T ss_dssp             HHHTTCTTTC
T ss_pred             HHHhcccccc
Confidence            9999766654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=327.17  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=205.0

Q ss_pred             cccccccc-ccccccCceEEEeecC-CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLE-KIRSCWNGEVYKAELP-GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~-~lg~G~~g~vy~a~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.. .||+|+||.||+|.+. ..++..||||.+....             .......+.+|+.++++++||||++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~i~~   74 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------------EKADTEEMMREAQIMHQLDNPYIVR   74 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------------chhHHHHHHHHHHHHHhCCCCCEeE
Confidence            35566666 9999999999999853 2367889999985421             1234577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++ ..+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        75 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~  147 (287)
T 1u59_A           75 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRH  147 (287)
T ss_dssp             EEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETT
T ss_pred             EEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCC
Confidence            99998 56678999999999999999953   3456999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .++|+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    ..+.
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~  223 (287)
T 1u59_A          148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVM  223 (287)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHH
T ss_pred             CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHH
Confidence            99999999998775433221 2223456899999999988889999999999999999998 9999865322    2222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.   ....+.          .+......+.+++..||+.||.+||++.++++.|+.+
T Consensus       224 ~~i~---~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          224 AFIE---QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             HHHH---TTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHh---cCCcCC----------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222   111110          1111223488999999999999999999999999876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.8e-43  Score=335.72  Aligned_cols=263  Identities=22%  Similarity=0.309  Sum_probs=201.7

Q ss_pred             ccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|++.    ..++..||||.+....             .......+.+|+.++++++||||
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~i   95 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------------SEQDELDFLMEALIISKFNHQNI   95 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------------chhhHHHHHHHHHHHhhCCCCCC
Confidence            467999999999999999999853    2367899999984321             12235678899999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG---RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++++++...+..++||||+++|+|.+++......   ...+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIl  172 (327)
T 2yfx_A           96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCL  172 (327)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEE
Confidence            99999999999999999999999999999763321   245899999999999999999999655   999999999999


Q ss_pred             eCC---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          286 IDD---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       286 l~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                      ++.   +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..... 
T Consensus       173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  251 (327)
T 2yfx_A          173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-  251 (327)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-
Confidence            994   44699999999976543332222224567899999999998899999999999999999998 9999864321 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                         ......   ......+.      .....    ...+.+++..||+.||.+||++.+|++.|+.+
T Consensus       252 ---~~~~~~---~~~~~~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          252 ---QEVLEF---VTSGGRMD------PPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ---HHHHHH---HHTTCCCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHH---HhcCCCCC------CCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               122222   22211111      00112    23488999999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=341.31  Aligned_cols=259  Identities=21%  Similarity=0.295  Sum_probs=193.3

Q ss_pred             cccccccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..|.+.+.||+|+||.||+|++...++  ..||||.+....             .......+.+|+.++++++||||+++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~il~~l~hpnIv~~  155 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------------DIGEVSQFLTEGIIMKDFSHPNVLSL  155 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-------------CSHHHHHHHHHHTTSTTCCCTTBCCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-------------CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            357788999999999999998753233  468999874311             12335789999999999999999999


Q ss_pred             eeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          212 LARMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       212 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++|.. .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  229 (373)
T 3c1x_A          156 LGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF  229 (373)
T ss_dssp             CEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred             EEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCC
Confidence            998765 4578999999999999999953   3456899999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc--eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          291 EARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      .+||+|||+++.........  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....    ....
T Consensus       230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~----~~~~  305 (373)
T 3c1x_A          230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDI  305 (373)
T ss_dssp             CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----SSCH
T ss_pred             CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC----HHHH
Confidence            99999999998764432211  1223457889999999999999999999999999999999 677775432    2223


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+...   ..+.   .       +......+.+++..||+.||++|||+.++++.|+.+
T Consensus       306 ~~~~~~~---~~~~---~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          306 TVYLLQG---RRLL---Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             HHHHHTT---CCCC---C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcC---CCCC---C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            3222211   1110   0       011123488999999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-43  Score=329.40  Aligned_cols=262  Identities=21%  Similarity=0.274  Sum_probs=205.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|.+......            ......+.+|+.++++++||||++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~   71 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMT------------EAEKQMLVSEVNLLRELKHPNIVRYY   71 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence            4679999999999999999998764 8999999998543211            23357799999999999999999999


Q ss_pred             eEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEeCC
Q 014140          213 ARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH--RPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       213 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~  288 (430)
                      +++..  .+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+  ..+++|+||||+||+++.
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS
T ss_pred             EEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC
Confidence            98865  56789999999999999999765455566999999999999999999999553  123999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ++.+||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ..+.
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~  225 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELA  225 (279)
T ss_dssp             SSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred             CCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHH
Confidence            999999999999876543221  1134689999999999998999999999999999999999999865321    1222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      ..+...   ..+      .+....    ...+.+++..||+.||.+|||+.+|++.+.
T Consensus       226 ~~i~~~---~~~------~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          226 GKIREG---KFR------RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHHT---CCC------CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHHhhc---ccc------cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            222211   110      011112    234889999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-43  Score=343.94  Aligned_cols=260  Identities=22%  Similarity=0.262  Sum_probs=192.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +++.||||++.......      ...........+.+|+.+|++++||||++++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  206 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAI------GSAREADPALNVETEIEILKKLNHPCIIKIK  206 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTT------C--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcc------cccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            5789999999999999999998764 88999999986532211      0011112234588999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      +++. .+..++||||+++|+|.+++    .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus       207 ~~~~-~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          207 NFFD-AEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             EEEE-SSEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred             EEEe-cCceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence            9875 55689999999999999988    34567999999999999999999999655   99999999999997544  


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                       .+||+|||+++.......   .....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.....   ...
T Consensus       279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~  352 (419)
T 3i6u_A          279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVS  352 (419)
T ss_dssp             CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCC
T ss_pred             ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHH
Confidence             599999999988754322   224579999999999864   5688899999999999999999999875322   222


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...+......  .    .+......    ...+.+++..||+.||.+|||+.++++
T Consensus       353 ~~~~i~~~~~~--~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 LKDQITSGKYN--F----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHHTTCCC--C----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCC--C----Cchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            32222211100  0    01111112    234889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=338.49  Aligned_cols=255  Identities=11%  Similarity=0.069  Sum_probs=201.7

Q ss_pred             cccccccccccccccCceEEEeec----CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAEL----PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---  204 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---  204 (430)
                      ..+.|.+.+.||+|+||.||+|.+    ...+++.||||++....                 ...+..|+.++..++   
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~l~~~~  125 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------------PWEFYIGTQLMERLKPSM  125 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------------HHHHHHHHHHHHHSCGGG
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------------hhHHHHHHHHHHHhhhhh
Confidence            356799999999999999999952    22378999999984321                 345777788877776   


Q ss_pred             CCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-GRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       205 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      |+||+++++++...+..++|||||++|+|.+++..... ....+++..++.++.|++.||.|||+.   +|+||||||+|
T Consensus       126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~N  202 (365)
T 3e7e_A          126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDN  202 (365)
T ss_dssp             GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGG
T ss_pred             hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHH
Confidence            99999999999999999999999999999999975333 356799999999999999999999954   59999999999


Q ss_pred             EEeCC-----------CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 014140          284 VLIDD-----------DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK  352 (430)
Q Consensus       284 ill~~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~  352 (430)
                      ||++.           ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  282 (365)
T 3e7e_A          203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT  282 (365)
T ss_dssp             EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            99998           8999999999997654333333334567999999999999999999999999999999999999


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR-PNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-ps~~ev~~~L~~l  428 (430)
                      .||.........                   ....+ ...+  ....+.+++..|++.+|.+| |++.++.+.|+++
T Consensus       283 ~pf~~~~~~~~~-------------------~~~~~-~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          283 YMKVKNEGGECK-------------------PEGLF-RRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             CCCEEEETTEEE-------------------ECSCC-TTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             CccccCCCCcee-------------------echhc-cccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            998543221000                   00000 0001  12347788889999999999 6788888877754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.8e-43  Score=328.06  Aligned_cols=257  Identities=22%  Similarity=0.316  Sum_probs=190.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.....            .......+..+...++.++||||++++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------------~~~~~~~~~~~~~~~~~~~h~~iv~~~   72 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVN------------SQEQKRLLMDLDISMRTVDCPFTVTFY   72 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---C------------HHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccC------------cHHHHHHHHHHHHHHHhCCCCeEEEEe
Confidence            4679999999999999999999764 899999999853221            112234555666678889999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++ +|.+++.........+++..++.++.|++.||.|||+..  +++||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           73 GALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             EEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCE
T ss_pred             eeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCE
Confidence            999999999999999974 998888765456678999999999999999999999650  49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeecccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH----QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      ||+|||++..........   ...||+.|+|||++    .+..++.++||||||+++|+|++|..||.....     . .
T Consensus       150 kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-~  220 (290)
T 3fme_A          150 KMCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----P-F  220 (290)
T ss_dssp             EBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----H-H
T ss_pred             EEeecCCccccccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----h-H
Confidence            999999998765443222   24689999999996    556789999999999999999999999864221     1 1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........+...         .......+.+++..||+.||++|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          221 QQLKQVVEEPSPQLP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHSCCCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhccCCCCcc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            112222222211110         0111234889999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.4e-43  Score=328.71  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=199.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      ...|.+.+.||+|+||.||+|++...++  ..+|+|.+...             ........+.+|+.++++++||||++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~   90 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------------TDIGEVSQFLTEGIIMKDFSHPNVLS   90 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-------------CSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-------------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence            4468999999999999999998753232  36888887431             11233577999999999999999999


Q ss_pred             ceeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          211 LLARMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       211 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +++++.. .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        91 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~  164 (298)
T 3f66_A           91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK  164 (298)
T ss_dssp             CCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred             eeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCC
Confidence            9998654 5678999999999999999953   3456899999999999999999999555   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG-KFPSDDFFQHTKEMS  366 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~  366 (430)
                      +.+||+|||++.........  .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...    ....
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~  240 (298)
T 3f66_A          165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFD  240 (298)
T ss_dssp             CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS----CTTT
T ss_pred             CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC----CHHH
Confidence            99999999999876543221  122234678899999999999999999999999999999994 5565432    2222


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .............+         ...    ...+.+++..||+.||.+|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~---------~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          241 ITVYLLQGRRLLQP---------EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             HHHHHHTTCCCCCC---------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCC---------ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22222211111000         111    23488999999999999999999999999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-42  Score=345.68  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=195.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|.... +|+.||||++.....            .......+.+|+.+|+.++||||++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpnIv~l~  127 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQ------------NQTHAKRAYRELVLMKCVNHKNIISLL  127 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGGG------------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECcccc------------ChHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4679999999999999999998764 899999999954321            123357788999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+      ..|+||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus       128 ~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll  197 (464)
T 3ttj_A          128 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV  197 (464)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             EEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEE
Confidence            9997653      56999999976 5777762      24899999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||+++.......   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...    ..
T Consensus       198 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~  270 (464)
T 3ttj_A          198 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----ID  270 (464)
T ss_dssp             CTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HH
T ss_pred             eCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence            9999999999999987654322   2235799999999999999999999999999999999999999865321    11


Q ss_pred             HHHHHHHHhcCCCC-------------------------chhccccccCCC---cHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          367 LVQWMRNVMTSENP-------------------------NRAINSKLLGNG---YEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       367 l~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ....+......+.+                         ...+........   .......+.+|+.+||+.||++|||+
T Consensus       271 ~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  350 (464)
T 3ttj_A          271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  350 (464)
T ss_dssp             HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence            11111111111100                         000000011111   11124568999999999999999999


Q ss_pred             HHHHH
Q 014140          419 KDVRC  423 (430)
Q Consensus       419 ~ev~~  423 (430)
                      .|+++
T Consensus       351 ~e~L~  355 (464)
T 3ttj_A          351 DDALQ  355 (464)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-42  Score=323.78  Aligned_cols=251  Identities=24%  Similarity=0.281  Sum_probs=200.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... ++..+|+|++......              ....+.+|+.++++++||||++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~   72 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVE--------------DVDRFKQEIEIMKSLDHPNIIRLY   72 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhccc--------------hHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3579999999999999999998764 7889999998543221              146788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDD  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~  289 (430)
                      +++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||++   +.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  145 (277)
T 3f3z_A           73 ETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPD  145 (277)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTT
T ss_pred             EEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCC
Confidence            999999999999999999999999854    345899999999999999999999655   9999999999999   788


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.++|+|||++..........   ...||+.|+|||++.+. ++.++||||||+++|+|++|..||.....    ...  
T Consensus       146 ~~~~l~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~--  215 (277)
T 3f3z_A          146 SPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEV--  215 (277)
T ss_dssp             CCEEECCCTTCEECCTTSCBC---CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--
T ss_pred             CcEEEEecccceeccCccchh---ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH----HHH--
Confidence            999999999998765443222   34789999999998764 89999999999999999999999865321    111  


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ............   .......    ...+.+++..||+.||.+|||+.++++
T Consensus       216 -~~~~~~~~~~~~---~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          216 -MLKIREGTFTFP---EKDWLNV----SPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -HHHHHHCCCCCC---HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -HHHHHhCCCCCC---chhhhcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111111111100   0000111    234889999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-42  Score=325.94  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||+|+||.||+|.... ++..||+|.+......            ......+.+|+.+++.++||||++++
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~   91 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFY   91 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhhC------------HHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            3458888999999999999998764 8899999998543221            23357789999999999999999999


Q ss_pred             eEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCcEEe
Q 014140          213 ARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR--IIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dlkp~Nill  286 (430)
                      +++..    ....++||||+++|+|.+++..    ...+++..++.++.|++.||.|||   ..+  ++|+||||+|||+
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~  164 (290)
T 1t4h_A           92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFI  164 (290)
T ss_dssp             EEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEE
T ss_pred             eeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEE
Confidence            99876    3568999999999999999954    246899999999999999999999   555  9999999999999


Q ss_pred             C-CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 D-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      + .++.+||+|||++........    ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....     
T Consensus       165 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----  234 (290)
T 1t4h_A          165 TGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----  234 (290)
T ss_dssp             SSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----
T ss_pred             ECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----
Confidence            8 789999999999976543322    23568999999998875 599999999999999999999999865321     


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       .............+ ..++    ...+    ..+.+++..||+.||.+|||+.++++
T Consensus       235 -~~~~~~~~~~~~~~-~~~~----~~~~----~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          235 -AAQIYRRVTSGVKP-ASFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -HHHHHHHHTTTCCC-GGGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHhccCCc-cccC----CCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence             22222222222111 1111    1122    23889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.2e-43  Score=333.67  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +++.+|+|.+.....           ........+.+|+.+++.++||||++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~  107 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLL-----------LKPHQREKMSMEISIHRSLAHQHVVGFH  107 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGC-----------CSHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhh-----------cCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4679999999999999999998764 789999999854321           1123457789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  180 (335)
T 2owb_A          108 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV  180 (335)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred             EEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCE
Confidence            999999999999999999999999854    346899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||++..........  ....||..|+|||++.+..++.++||||||+++|+|++|..||.....       .+...
T Consensus       181 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~  251 (335)
T 2owb_A          181 KIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYL  251 (335)
T ss_dssp             EECCCTTCEECCSTTCCB--CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred             EEeeccCceecccCcccc--cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHH
Confidence            999999998765332221  235789999999999998999999999999999999999999865321       11111


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........       .....    ...+.+++..||+.||++|||+.++++
T Consensus       252 ~~~~~~~~-------~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          252 RIKKNEYS-------IPKHI----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHTCCC-------CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHhcCCCC-------CCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111110       00111    224788999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3e-43  Score=340.06  Aligned_cols=201  Identities=25%  Similarity=0.408  Sum_probs=174.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +|..||+|++....             .......+.+|+.+++.++||||++++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   97 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEI-------------KPAIRNQIIRELQVLHECNSPYIVGFY   97 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCC-------------CHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECC-CCcEEEEEEecccc-------------CHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence            4679999999999999999999864 89999999985421             123357789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++|+|.+++..    ...+++..+..++.+++.||.|||+.+  +|+||||||+|||++.++.+
T Consensus        98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~  171 (360)
T 3eqc_A           98 GAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI  171 (360)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCE
Confidence            999999999999999999999999964    245899999999999999999999641  49999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      ||+|||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       172 kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          172 KLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             EECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             EEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999998754322    11235789999999999999999999999999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=338.17  Aligned_cols=269  Identities=25%  Similarity=0.327  Sum_probs=194.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHH--HHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIR--SEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|+.   +|+.||||++....                 ...+.  .|+..+..++||||++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~~~h~~i~~   71 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN-----------------RQNFINEKNIYRVPLMEHDNIAR   71 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG-----------------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             hHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc-----------------hhhHHHHHHHHHHHhccCcchhh
Confidence            46799999999999999999976   78999999984321                 12233  3444455689999999


Q ss_pred             ceeEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCC
Q 014140          211 LLARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH------RPRIIHRDI  279 (430)
Q Consensus       211 l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiH~Dl  279 (430)
                      +++.+..     ....++||||+++|+|.+++..     ...++..++.++.|++.||.|||+..      .++|+||||
T Consensus        72 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Di  146 (336)
T 3g2f_A           72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL  146 (336)
T ss_dssp             EEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSC
T ss_pred             heecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeeccc
Confidence            9986643     2356899999999999999954     23589999999999999999999550      116999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCCCCCC------cceeeccccccccccccccCC-------CCCCcchhHHHHHHHHH
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIPDGHT------RTTTWSLAGTVGYIAPECHQT-------VALSDTCDIYSFGVLLA  346 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~  346 (430)
                      ||+|||++.++.+||+|||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|
T Consensus       147 kp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~  226 (336)
T 3g2f_A          147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW  226 (336)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHH
Confidence            99999999999999999999987654321      111224569999999999987       35677899999999999


Q ss_pred             HHHhCCCCCCcccccccc-cc---------HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC
Q 014140          347 VLVIGKFPSDDFFQHTKE-MS---------LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP  416 (430)
Q Consensus       347 ell~g~~p~~~~~~~~~~-~~---------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp  416 (430)
                      ||++|..|+......... ..         .................+...  ..........+.+++..||+.||++||
T Consensus       227 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp  304 (336)
T 3g2f_A          227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARL  304 (336)
T ss_dssp             HHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             HHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCc
Confidence            999998765432111110 00         011111111111111111111  111233556799999999999999999


Q ss_pred             CHHHHHHHHhcc
Q 014140          417 NSKDVRCMLSQI  428 (430)
Q Consensus       417 s~~ev~~~L~~l  428 (430)
                      |+.++++.|+++
T Consensus       305 s~~e~l~~L~~l  316 (336)
T 3g2f_A          305 TAQXAEERMAEL  316 (336)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             chHHHHHHHHHH
Confidence            999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.7e-43  Score=328.58  Aligned_cols=259  Identities=21%  Similarity=0.258  Sum_probs=203.2

Q ss_pred             cccccccc-ccccccCceEEEeecC-CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLE-KIRSCWNGEVYKAELP-GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~-~lg~G~~g~vy~a~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .+.|.+.+ .||+|+||.||+|.+. ..+++.||||.+.....            .......+.+|+.+++.++||||++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~   82 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------------DPALKDELLAEANVMQQLDNPYIVR   82 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc------------CHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            45688888 9999999999999542 23678999999853211            1233577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++ ..+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           83 MIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             EEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             EEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCC
Confidence            99998 67778999999999999999954    346999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....    ..+.
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~  230 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVT  230 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHH
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHH
Confidence            99999999998775443322 1223356789999999998889999999999999999999 9999865322    1222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.   ....+.          .+......+.+++..||+.||.+|||+.++++.|+++
T Consensus       231 ~~~~---~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          231 AMLE---KGERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHH---TTCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHH---cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2221   111110          1111223488999999999999999999999999876

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.5e-43  Score=325.98  Aligned_cols=250  Identities=23%  Similarity=0.286  Sum_probs=202.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... ++..||+|.+......           .......+.+|+.+++.++||||++++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~   80 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLE-----------KEGVEHQLRREIEIQSHLRHPNILRMY   80 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccc-----------hHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence            3579999999999999999998764 7899999998542211           011246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCE
T ss_pred             EEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCE
Confidence            999999999999999999999999964    2468999999999999999999994   459999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      +|+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .....
T Consensus       154 kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~  222 (284)
T 2vgo_A          154 KIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHR  222 (284)
T ss_dssp             EECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred             EEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHH
Confidence            9999999876543221    235789999999999999999999999999999999999999864321       11122


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........       .    +......+.+++..||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~-------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          223 RIVNVDLK-------F----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHTTCCC-------C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccccC-------C----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            22221110       0    0111234789999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-42  Score=346.10  Aligned_cols=198  Identities=24%  Similarity=0.345  Sum_probs=154.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|++.. +|+.||||++.....            .......+.+|+.+|+.++||||++++
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~l~  118 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFE------------DLIDCKRILREIAILNRLNHDHVVKVL  118 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC---CEEEEEEECSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhhc------------CHHHHHHHHHHHHHHHhCCCCCCCceE
Confidence            4679999999999999999998764 899999999843221            123357789999999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     +..|+||||+ +|+|.+++.    ....+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       119 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~  190 (458)
T 3rp9_A          119 DIVIPKDVEKFDELYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVN  190 (458)
T ss_dssp             EECCCSCTTTCCCEEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEEC
T ss_pred             EEEecCCcccCceEEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEEC
Confidence            999543     5689999998 469999984    3456999999999999999999999665   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCc-------------------------ceeecccccccccccccc-CCCCCCcchhHHHH
Q 014140          288 DDMEARISEFGLAKRIPDGHTR-------------------------TTTWSLAGTVGYIAPECH-QTVALSDTCDIYSF  341 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~sl  341 (430)
                      .++.+||+|||+++........                         ......+||+.|+|||++ .+..|+.++|||||
T Consensus       191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence            9999999999999876532111                         112245789999999976 45679999999999


Q ss_pred             HHHHHHHHhC
Q 014140          342 GVLLAVLVIG  351 (430)
Q Consensus       342 G~~l~ell~g  351 (430)
                      ||++|||++|
T Consensus       271 G~il~elltg  280 (458)
T 3rp9_A          271 GCIFAELLNM  280 (458)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHHh
Confidence            9999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-42  Score=326.16  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|.... +|+.||||.+......             .....+.+|+.+++.++||||+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~   85 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKY   85 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTCS-------------TTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECC-CCcEEEEEEecccccH-------------HHHHHHHHHHHHHHhCCCCCEeEE
Confidence            34679999999999999999998754 8999999998543211             125678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++++|.+++.     ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  157 (303)
T 3a7i_A           86 YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGE  157 (303)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             EEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCC
Confidence            999999999999999999999999983     246999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ......+
T Consensus       158 ~kl~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~  231 (303)
T 3a7i_A          158 VKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLI  231 (303)
T ss_dssp             EEECCCTTCEECBTTBCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHH
T ss_pred             EEEeecccceecCcccccc--CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHh
Confidence            9999999998765432221  235789999999999999999999999999999999999999865322    1111111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM  424 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~  424 (430)
                         .....+      ......+    ..+.+++..||+.||.+|||+.++++.
T Consensus       232 ---~~~~~~------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          232 ---PKNNPP------TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---HHSCCC------CCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---hcCCCC------CCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               111111      1111222    338899999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-43  Score=334.99  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=202.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceE--EEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVI--TIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|+... +|..+  |+|.+.....             ......+.+|+.++.++ +||||+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~hp~iv   89 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNII   89 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred             HHHccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccc-------------hHHHHHHHHHHHHHHhccCCCchh
Confidence            3578999999999999999998764 66654  8888843211             12245688999999999 899999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVS------------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                      ++++++.+.+..++||||+++|+|.+++....            .....+++..++.++.|++.||.|||+.+   ++||
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~  166 (327)
T 1fvr_A           90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHR  166 (327)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence            99999999999999999999999999996532            22357999999999999999999999555   9999


Q ss_pred             CCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 014140          278 DIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSD  356 (430)
Q Consensus       278 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~  356 (430)
                      ||||+|||++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          167 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             CCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999875432211   112356889999999998889999999999999999998 999986


Q ss_pred             ccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ....       .+..........+.          .+......+.+++..||+.||.+|||+.++++.|+++
T Consensus       244 ~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          244 GMTC-------AELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             TCCH-------HHHHHHGGGTCCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcH-------HHHHHHhhcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5321       11222222111110          0111223488999999999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=338.86  Aligned_cols=263  Identities=14%  Similarity=0.137  Sum_probs=202.7

Q ss_pred             ccccccccccccccCceEEEeecCCC-------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS-------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH  205 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  205 (430)
                      .++|.+.+.||+|+||.||+|+....       +++.||||.+...                   ..+.+|+.++++++|
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------------~~~~~E~~~l~~l~h  101 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------------GRLFNEQNFFQRAAK  101 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------------STHHHHHHHHHHHCC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------------chHHHHHHHHHHhcc
Confidence            46799999999999999999998642       4889999998431                   347889999999999


Q ss_pred             CCccc---------------ceeEEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 014140          206 RNIVP---------------LLARMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS  269 (430)
Q Consensus       206 pniv~---------------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  269 (430)
                      |||++               +++++.. .+..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||+.
T Consensus       102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~  178 (352)
T 2jii_A          102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN  178 (352)
T ss_dssp             HHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            99887               6777776 77889999999 99999999652  235799999999999999999999966


Q ss_pred             CCCCeEecCCCCCcEEeCCCC--ceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHH
Q 014140          270 HRPRIIHRDIQPANVLIDDDM--EARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFG  342 (430)
Q Consensus       270 ~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG  342 (430)
                      +   |+||||||+|||++.++  .+||+|||++..+......     .......||+.|+|||++.+..++.++||||||
T Consensus       179 ~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  255 (352)
T 2jii_A          179 E---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG  255 (352)
T ss_dssp             T---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred             C---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence            5   99999999999999998  8999999999876532211     111235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccc-cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 014140          343 VLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKL-LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV  421 (430)
Q Consensus       343 ~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev  421 (430)
                      |++|+|++|+.||.....  ....+............  ....... ....+    ..+.+++..||+.||++|||+.+|
T Consensus       256 ~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          256 YCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVDKPG--PFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             HHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHHSCC--CEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HHHHHHHhCCCCcccCCc--CHHHHHHHHHhccCChh--hhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHH
Confidence            999999999999876432  11122222222221111  1111000 01112    348899999999999999999999


Q ss_pred             HHHHhcc
Q 014140          422 RCMLSQI  428 (430)
Q Consensus       422 ~~~L~~l  428 (430)
                      ++.|+++
T Consensus       328 ~~~L~~~  334 (352)
T 2jii_A          328 RNNLEAL  334 (352)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=358.82  Aligned_cols=256  Identities=23%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|.+.  .+..||||++.....               ....|.+|+.+|++++||||+++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~  327 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQL  327 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             chhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCC---------------CHHHHHHHHHHHHhCCCCCEeeE
Confidence            3567899999999999999999986  567899999853221               13568999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+ +..++|||||++|+|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       328 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~  401 (535)
T 2h8h_A          328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV  401 (535)
T ss_dssp             EEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCc
Confidence            999876 6789999999999999999642  2345899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....    ..+...
T Consensus       402 ~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~~~  476 (535)
T 2h8h_A          402 CKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQ  476 (535)
T ss_dssp             EEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHHHH
T ss_pred             EEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            99999999987653211 11113456789999999998899999999999999999999 8999865322    122222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +   .......          .+..+...+.+|+..||+.||++|||+.+|++.|+.+
T Consensus       477 i---~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          477 V---ERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             H---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H---HcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2   2111110          1112233488999999999999999999999999976

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4e-43  Score=327.90  Aligned_cols=249  Identities=20%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||.+......            ......+.+|+..+..+ +||||+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~~~~l~~h~~iv~~   76 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAG------------SVDEQNALREVYAHAVLGQHSHVVRY   76 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTT------------SHHHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccc------------cHHHHHHHHHHHHHHHhCCCCCeeee
Confidence            4679999999999999999998764 8999999998543221            12356788999999999 89999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC--
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--  289 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--  289 (430)
                      ++++.+.+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   |+||||||+|||++.+  
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~  153 (289)
T 1x8b_A           77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSI  153 (289)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred             eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCC
Confidence            99999999999999999999999999764433467999999999999999999999655   9999999999999844  


Q ss_pred             -----------------CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhC
Q 014140          290 -----------------MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIG  351 (430)
Q Consensus       290 -----------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g  351 (430)
                                       ..++|+|||.+.......      ...||+.|+|||++.+. .++.++||||||+++++|++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~  227 (289)
T 1x8b_A          154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA  227 (289)
T ss_dssp             ----------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred             CcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence                             479999999998765432      23589999999999876 567899999999999999999


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..|+...       ....   .......+      ......    ...+.+++..||+.||++|||+.++++
T Consensus       228 ~~~~~~~-------~~~~---~~~~~~~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          228 EPLPRNG-------DQWH---EIRQGRLP------RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCSSS-------HHHH---HHHTTCCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCcch-------hHHH---HHHcCCCC------CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            8775321       1111   11111110      011112    234889999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-42  Score=348.41  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=199.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||+||+|+... +|+.||||++......            ......+.+|+.++++++||||+++++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~   88 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAK------------NKDTSTILREVELLKKLDHPNIMKLFE   88 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHB------------CSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEeccccc------------chHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999998764 8999999998542211            011467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC---CCC
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID---DDM  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~  290 (430)
                      ++.+.+..++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++   .++
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  161 (486)
T 3mwu_A           89 ILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC  161 (486)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTC
T ss_pred             EEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCC
Confidence            99999999999999999999999854    246999999999999999999999665   99999999999995   456


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....    ..+.  
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~--  231 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDIL--  231 (486)
T ss_dssp             CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH--
T ss_pred             CEEEEECCcCeECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH--
Confidence            7999999999876544322   23579999999999976 599999999999999999999999865321    1222  


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ...........   .....    .....+.+++..||+.||.+|||+.++++
T Consensus       232 -~~i~~~~~~~~---~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          232 -KRVETGKYAFD---LPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -HHHHHTCCCSC---SGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -HHHHhCCCCCC---CcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             22221111100   00011    11234889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-43  Score=332.14  Aligned_cols=268  Identities=23%  Similarity=0.318  Sum_probs=206.4

Q ss_pred             ccccccccccccccCceEEEeec---CCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAEL---PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|++   ...+|+.||||++....              ......+.+|+.++++++||||+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv  105 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------------EEHLRDFEREIEILKSLQHDNIV  105 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------------SHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCCCee
Confidence            45789999999999999999984   23478999999984321              12356789999999999999999


Q ss_pred             cceeEEEeCC--eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          210 PLLARMVRRD--CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       210 ~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++++...+  ..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus       106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~  179 (326)
T 2w1i_A          106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE  179 (326)
T ss_dssp             CEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE
T ss_pred             eEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEc
Confidence            9999987654  78999999999999999964   2346999999999999999999999555   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-----
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH-----  361 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-----  361 (430)
                      .++.+||+|||++........... .....++..|+|||.+.+..++.++||||||+++++|++|..|+......     
T Consensus       180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~  259 (326)
T 2w1i_A          180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI  259 (326)
T ss_dssp             ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred             CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence            999999999999988765433211 22345778899999999888999999999999999999999987542110     


Q ss_pred             --ccc-ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          362 --TKE-MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       362 --~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                        ... ......+..........         ..+......+.+++..||+.||++|||+.+|++.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          260 GNDKQGQMIVFHLIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchhhhHHHHHHHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              000 00111111111111100         011122345889999999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-42  Score=328.00  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=194.6

Q ss_pred             ccccccc-cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          133 EDYFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~-~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      .+.|.+. +.||+|+||.||+|+... +|+.||||++.....              .....+.+|+.++.++ +||||++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~~~~h~~i~~   75 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPG--------------HIRSRVFREVEMLYQCQGHRNVLE   75 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSS-SCCEEEEEEEECCSS--------------CCHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             ceeEEecCceecCCceEEEEEEEEcC-CCcEEEEEEEeeCcc--------------hhHHHHHHHHHHHHHhcCCCCeee
Confidence            3567774 789999999999998764 899999999854211              1146788999999985 7999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~  148 (316)
T 2ac3_A           76 LIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPN  148 (316)
T ss_dssp             EEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSS
T ss_pred             EEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCC
Confidence            99999999999999999999999999964    246899999999999999999999665   99999999999999877


Q ss_pred             c---eEEeecCCcccCCCCCC-----cceeeccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          291 E---ARISEFGLAKRIPDGHT-----RTTTWSLAGTVGYIAPECHQT-----VALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       291 ~---~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      .   +||+|||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||..
T Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  228 (316)
T 2ac3_A          149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG  228 (316)
T ss_dssp             SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence            6   99999999986643211     111123469999999999875     4588999999999999999999999976


Q ss_pred             ccccccccc--------HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          358 FFQHTKEMS--------LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       358 ~~~~~~~~~--------l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........        ..............   +........    ...+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          229 RCGSDCGWDRGEACPACQNMLFESIQEGKYE---FPDKDWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCCSCSCC----CCHHHHHHHHHHHHHCCCC---CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccccccccchhHHHHHHHHHhccCcc---cCchhcccC----CHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            432110000        01111111111110   000000111    234889999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=334.97  Aligned_cols=259  Identities=22%  Similarity=0.311  Sum_probs=194.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+++.++||||++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpnIv~l~   90 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQ------------SELFAKRAYRELRLLKHMRHENVIGLL   90 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTS------------SHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCcccc------------CHHHHHHHHHHHHHHHhCCCcCCCCce
Confidence            4679999999999999999998764 899999999844221            123357789999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+      ..|+||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  161 (367)
T 1cm8_A           91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAV  161 (367)
T ss_dssp             EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEE
Confidence            9997753      459999999 7899999854     35899999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||+++||++|+.||.....    .
T Consensus       162 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~  232 (367)
T 1cm8_A          162 NEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----L  232 (367)
T ss_dssp             CTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred             cCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            999999999999998764321     23578999999999887 6799999999999999999999999865321    1


Q ss_pred             cHHHHHHHHhcCCCCchhc------------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAI------------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+....... +...+                  ...............+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~l~~i~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          233 DQLKEIMKVTGTP-PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHHHHHCCC-CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhcCCC-CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            1111111111110 00000                  000000111122345889999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.3e-43  Score=326.60  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=195.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+.   .|+.||||.+....                ....+.+|+.++++++||||++++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~~iv~~~   80 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLL   80 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh----------------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence            46799999999999999999986   68899999984321                146789999999999999999999


Q ss_pred             eEEEeC-CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          213 ARMVRR-DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       213 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++.+. +..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  155 (278)
T 1byg_A           81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV  155 (278)
T ss_dssp             EEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             EEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCc
Confidence            997654 4789999999999999999652  2234889999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ++|+|||++........     ...+++.|+|||++.+..++.++||||||+++|+|++ |..||.....    ......
T Consensus       156 ~~l~Dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~  226 (278)
T 1byg_A          156 AKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPR  226 (278)
T ss_dssp             EEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHH
T ss_pred             EEEeecccccccccccc-----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            99999999876543211     2357889999999998899999999999999999998 9999865321    222222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +   .....+      ......    ...+.+++..||+.||.+|||+.++++.|++++
T Consensus       227 ~---~~~~~~------~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          227 V---EKGYKM------DAPDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             H---TTTCCC------CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---hcCCCC------CCcccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            1   111111      011122    234889999999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-42  Score=321.88  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=194.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.||||.+......           .......+.+|+.+++.++||||++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~   77 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIR-----------SLDVVGKIKREIQNLKLFRHPHIIKLY   77 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECC-CCceEEEEEecccccc-----------chhHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            4679999999999999999998764 8999999998542211           112246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~  150 (276)
T 2h6d_A           78 QVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA  150 (276)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCE
T ss_pred             EEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCE
Confidence            999999999999999999999999954    245899999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +|+|||++.........   ....||+.|+|||.+.+..+ +.++||||||+++++|++|..||.....    ......+
T Consensus       151 ~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~  223 (276)
T 2h6d_A          151 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKI  223 (276)
T ss_dssp             EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             EEeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHh
Confidence            99999999877544322   23468999999999988765 6899999999999999999999864321    1122211


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..   ....       ....    ....+.+++..||+.||.+|||+.++++
T Consensus       224 ~~---~~~~-------~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          224 RG---GVFY-------IPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HH---CCCC-------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hc---Cccc-------Cchh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11   1100       0011    1234788999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8e-43  Score=332.92  Aligned_cols=264  Identities=20%  Similarity=0.225  Sum_probs=191.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......            ......+.+|+.++++++||||++++
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHEE------------EGVPGTAIREVSLLKELQHRNIIELK   99 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC--------------------CHHHHHHGGGCCCTTBCCEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECC-CCceEEEEEEcccccc------------cccchhHHHHHHHHHHcCCCCcceEE
Confidence            3579999999999999999998764 8999999998543211            12245678999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe-----C
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI-----D  287 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-----~  287 (430)
                      +++.+.+..++||||+++ +|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||+     +
T Consensus       100 ~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~  171 (329)
T 3gbz_A          100 SVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDAS  171 (329)
T ss_dssp             EEEEETTEEEEEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC----
T ss_pred             EEEecCCEEEEEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCC
Confidence            999999999999999975 99999854    345999999999999999999999655   9999999999999     4


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      .++.+||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....    ..
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~  245 (329)
T 3gbz_A          172 ETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----ID  245 (329)
T ss_dssp             -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH
T ss_pred             ccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HH
Confidence            5556999999999876433221  1234689999999999875 489999999999999999999999865321    11


Q ss_pred             HHHHHHHHhcCCCCch--hc---------cccccCCCcH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNR--AI---------NSKLLGNGYE-----EQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~--~~---------~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+...........  ..         .+........     .....+.+|+..||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111111111111000  00         0000000000     02245789999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-42  Score=332.28  Aligned_cols=266  Identities=24%  Similarity=0.312  Sum_probs=205.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhc--cCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQ--VRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++   +|+.||||.+...                 ....+..|..++..  ++||||++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~-----------------~~~~~~~e~~~~~~~~l~h~ni~~  100 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR-----------------EERSWFREAEIYQTVMLRHENILG  100 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG-----------------GHHHHHHHHHHHHHSCCCCTTBCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch-----------------hHHHHHHHHHHHHHhhcCCCcEEE
Confidence            35799999999999999999986   6899999998321                 13457788888887  78999999


Q ss_pred             ceeEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCC
Q 014140          211 LLARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQP  281 (430)
Q Consensus       211 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp  281 (430)
                      +++++...+    ..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||..     +..+++||||||
T Consensus       101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp  175 (342)
T 1b6c_B          101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS  175 (342)
T ss_dssp             EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG
T ss_pred             EEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH
Confidence            999998876    78999999999999999954     3589999999999999999999921     022499999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcc--eeeccccccccccccccCCCC------CCcchhHHHHHHHHHHHHhC--
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVA------LSDTCDIYSFGVLLAVLVIG--  351 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g--  351 (430)
                      +|||++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|||++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999998765433221  122457899999999988763      34689999999999999999  


Q ss_pred             --------CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          352 --------KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       352 --------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                              ..||.....  .......+........ ....+....   ........+.+++..||+.||++|||+.+|++
T Consensus       256 ~~~~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVP--SDPSVEEMRKVVCEQK-LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             BTTBCCCCCCTTTTTSC--SSCCHHHHHHHHTTSC-CCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCcccccccCccccCc--CcccHHHHHHHHHHHH-hCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                    677765432  1222333333332211 111111110   12345667999999999999999999999999


Q ss_pred             HHhccc
Q 014140          424 MLSQIQ  429 (430)
Q Consensus       424 ~L~~l~  429 (430)
                      .|+++.
T Consensus       330 ~L~~i~  335 (342)
T 1b6c_B          330 TLSQLS  335 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.5e-43  Score=327.35  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=198.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++...+++  .||||.+.....           ........+.+|+.++++++||||++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~   85 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----------SQPEAMDDFIREVNAMHSLDHRNLIR   85 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-----------CCHHHHHHHHHHHHHHHhCCCCCccc
Confidence            46799999999999999999986533444  689998843221           11234678999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++...+ .++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++
T Consensus        86 ~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           86 LYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD  158 (291)
T ss_dssp             EEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred             EEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCC
Confidence            999987655 88999999999999999652   346899999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....       .
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~  231 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------S  231 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------H
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------H
Confidence            99999999998876543322 2223457889999999998889999999999999999999 9999865321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +.............         .+......+.+++..||+.||.+|||+.++++.|++++
T Consensus       232 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          232 QILHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             HHHHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHccCCCCC---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            22222222211110         01112234889999999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-43  Score=343.20  Aligned_cols=248  Identities=11%  Similarity=0.068  Sum_probs=188.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHH---HHHhccCCCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI---ITAGQVRHRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpni  208 (430)
                      ..+.|.+.+.||+|+||.||+|++.. +|+.||||++......           .......+.+|+   .+++.++||||
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~l~hpni  138 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERP-----------PSNAIKQMKEEVLRLRLLRGIKNQKQ  138 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-C-----------CTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred             CCceEEEcceeecCCCEEEEEEEECC-CCcEEEEEEEeecccc-----------chHHHHHHHHHHHHHHhccccCCHHH
Confidence            35679999999999999999999753 7999999999543211           112357789999   55556689999


Q ss_pred             ccce-------eEEEeCC-----------------eeEEEEEecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHH
Q 014140          209 VPLL-------ARMVRRD-----------------CDLLVYEFRRNGSLQDILYDVSQ---GRRELDWLARHRIAQGIAS  261 (430)
Q Consensus       209 v~l~-------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~  261 (430)
                      |+++       +++...+                 ..++||||+ +|+|.+++.....   ....+++..++.++.|++.
T Consensus       139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~  217 (377)
T 3byv_A          139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR  217 (377)
T ss_dssp             HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence            9998       6655543                 278999999 6799999975321   1123456888999999999


Q ss_pred             HHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-----------
Q 014140          262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-----------  330 (430)
Q Consensus       262 ~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------  330 (430)
                      ||.|||+.+   |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           
T Consensus       218 aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             HHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence            999999665   99999999999999999999999999986432     2224567 999999999887           


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccC
Q 014140          331 ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLD  410 (430)
Q Consensus       331 ~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  410 (430)
                      .++.++|||||||++|||++|+.||........                ......  .....+    ..+.+++..||+.
T Consensus       289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~--~~~~~~----~~~~~li~~~L~~  346 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFR--SCKNIP----QPVRALLEGFLRY  346 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCCC------CC----------------SGGGGS--SCCCCC----HHHHHHHHHHTCS
T ss_pred             cCChhhhHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh--hccCCC----HHHHHHHHHHcCC
Confidence            899999999999999999999999865322110                000000  001222    3488999999999


Q ss_pred             CCCCCCCHHHHHH
Q 014140          411 DPNKRPNSKDVRC  423 (430)
Q Consensus       411 dp~~Rps~~ev~~  423 (430)
                      ||++|||+.++++
T Consensus       347 dp~~Rpt~~e~l~  359 (377)
T 3byv_A          347 PKEDRLLPLQAME  359 (377)
T ss_dssp             SGGGCCCHHHHHT
T ss_pred             CchhCCCHHHHhh
Confidence            9999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=332.41  Aligned_cols=263  Identities=17%  Similarity=0.224  Sum_probs=194.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++.......             ....+.+|+.+++.++||||+++++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~~   67 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLHD   67 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC-------------------CCCCCCCHHHHSCCCCTTBCCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccccc-------------cchhHHHHHHHHHhcCCCCCCeeee
Confidence            468999999999999999998764 88999999985332110             0123457999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++||||++ |+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        68 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k  140 (324)
T 3mtl_A           68 IIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK  140 (324)
T ss_dssp             EEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEE
T ss_pred             EEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEE
Confidence            9999999999999997 599998864   3456999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||++.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....    ......+.
T Consensus       141 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~  214 (324)
T 3mtl_A          141 LADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIF  214 (324)
T ss_dssp             ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             EccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            9999999865433221  123468999999999877 4689999999999999999999999865322    22223333


Q ss_pred             HHhcCCCCch---hccc---------cccCC----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNR---AINS---------KLLGN----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~---~~~~---------~~~~~----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........   ....         .....    ..+.....+.+|+..||+.||.+|||+.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            3222211100   0000         00000    00112234789999999999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-42  Score=339.09  Aligned_cols=262  Identities=18%  Similarity=0.229  Sum_probs=196.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|+... +|+.||||++.....                  ...+|+.+|+.++||||+++
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l   65 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPR------------------YKNRELDIMKVLDHVNIIKL   65 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCTT------------------SCCHHHHHHTTCCCTTBCCE
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCcc------------------hHHHHHHHHHHcCCCCccch
Confidence            35679999999999999999998764 899999999854211                  12369999999999999999


Q ss_pred             eeEEEeC--------------------------------------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHH
Q 014140          212 LARMVRR--------------------------------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH  253 (430)
Q Consensus       212 ~~~~~~~--------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  253 (430)
                      ++++...                                      ...++||||++ |+|.+.+.........+++..+.
T Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~  144 (383)
T 3eb0_A           66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS  144 (383)
T ss_dssp             EEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred             hheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH
Confidence            9998543                                      34789999998 59988887655566789999999


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC-CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-C
Q 014140          254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-A  331 (430)
Q Consensus       254 ~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~  331 (430)
                      .++.|++.||.|||+.   +|+||||||+|||++ .++.+||+|||++..........   ...||+.|+|||++.+. .
T Consensus       145 ~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~  218 (383)
T 3eb0_A          145 IYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATE  218 (383)
T ss_dssp             HHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCC
Confidence            9999999999999954   599999999999997 68899999999998765443222   34789999999998875 4


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCch----------hccccccCC-----CcHHH
Q 014140          332 LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR----------AINSKLLGN-----GYEEQ  396 (430)
Q Consensus       332 ~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~  396 (430)
                      ++.++|||||||++|+|++|+.||.....    ......+......+....          ...+.....     .+...
T Consensus       219 ~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (383)
T 3eb0_A          219 YTPSIDLWSIGCVFGELILGKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT  294 (383)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred             CCcchhhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence            89999999999999999999999875322    111111111111110000          000000000     11112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          397 MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       397 ~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...+.+|+.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            334889999999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=356.06  Aligned_cols=257  Identities=19%  Similarity=0.260  Sum_probs=198.6

Q ss_pred             cccccc-ccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          135 YFASLE-KIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       135 ~~~~~~-~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ++.+.. .||+|+||.||+|.+.. .++..||||++.....             ......+.+|+.+|++++|||||+++
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~il~~l~hpniv~l~  402 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------------KADTEEMMREAQIMHQLDNPYIVRLI  402 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-------------STTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-------------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            344444 79999999999998752 2567899999854211             12256799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.. +..++|||||++|+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       403 ~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~v  475 (613)
T 2ozo_A          403 GVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYA  475 (613)
T ss_dssp             EEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred             EEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcE
Confidence            99875 568999999999999999953   3456999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          293 RISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      ||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....    ..+...
T Consensus       476 kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~  551 (613)
T 2ozo_A          476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAF  551 (613)
T ss_dssp             EECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHHHHH
T ss_pred             EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHH
Confidence            99999999877543221 11212345789999999998899999999999999999998 9999875422    223322


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +..   ...+.          .+..+...+.+++..||+.+|++||++.+|++.|+.+
T Consensus       552 i~~---~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          552 IEQ---GKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHT---TCCCC----------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHc---CCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            222   11110          1112233488999999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-42  Score=348.04  Aligned_cols=252  Identities=24%  Similarity=0.316  Sum_probs=196.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||+||+|+... ++..||+|++.......            .....+.+|+.+++.++||||+++++
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~  103 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVST------------SSNSKLLEEVAVLKLLDHPNIMKLYD  103 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC-----------------CTTHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCc------------hHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            569999999999999999999764 89999999985432211            11356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---C
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---M  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~  290 (430)
                      +|.+.+..++|||||++|+|.+.+..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++..   +
T Consensus       104 ~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  176 (494)
T 3lij_A          104 FFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA  176 (494)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCC
Confidence            99999999999999999999998854    246899999999999999999999655   9999999999999764   4


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....    ..+.  
T Consensus       177 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~--  246 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEIL--  246 (494)
T ss_dssp             CEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH--
T ss_pred             cEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHH--
Confidence            599999999987654322   223579999999999864 699999999999999999999999865321    1222  


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       .........   +........+    ..+.+++..||+.||.+|||+.++++
T Consensus       247 -~~i~~~~~~---~~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          247 -RKVEKGKYT---FDSPEWKNVS----EGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -HHHHHTCCC---CCSGGGTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHhCCCC---CCchhcccCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence             222211111   0111111222    34889999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.8e-43  Score=328.26  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=186.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|.... +|+.||||.+.....             ......+.+|+.++++++||||+++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~   78 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKC-------------QTSMDELLKEIQAMSQCHHPNIVSY   78 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------------------CCCCCCCTTBCCE
T ss_pred             chhhhhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhhc-------------chhHHHHHHHHHHHhhcCCCCEeeE
Confidence            35689999999999999999998753 789999998843211             1224668899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVS----QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++...+..++||||+++|+|.+++....    .....+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~  155 (303)
T 2vwi_A           79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLG  155 (303)
T ss_dssp             EEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred             EEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEc
Confidence            999999999999999999999999986421    12456999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCC---cceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHT---RTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      .++.+||+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......  
T Consensus       156 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  233 (303)
T 2vwi_A          156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--  233 (303)
T ss_dssp             TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--
T ss_pred             CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--
Confidence            999999999999987654321   111223578999999999876 46899999999999999999999998754321  


Q ss_pred             cccHHHHHHHHhcCCCC---chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          364 EMSLVQWMRNVMTSENP---NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ....   .......+   ....+.......+    ..+.+++..||+.||.+|||+.++++
T Consensus       234 --~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          234 --KVLM---LTLQNDPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --GHHH---HHHTSSCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --hHHH---HHhccCCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence              1111   11111111   1111111122223    34788999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=332.75  Aligned_cols=268  Identities=22%  Similarity=0.215  Sum_probs=196.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.......         ........+.+|+.+++.++||||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSE---------AKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcch---------hhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            4679999999999999999998764 79999999985432211         0011124678999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++ +|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCE
Confidence            999999999999999976 89888843   3456899999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||++..........  ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....    ......+
T Consensus       152 kl~Dfg~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i  225 (346)
T 1ua2_A          152 KLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRI  225 (346)
T ss_dssp             EECCCGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             EEEecccceeccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence            999999998765432221  235789999999998765 589999999999999999999999765321    1112222


Q ss_pred             HHHhcCCCCchh---------ccccccCCCc-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRA---------INSKLLGNGY-----EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~---------~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ............         +........+     ......+.+++..||+.||.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            121111110000         0000000000     112245889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=323.96  Aligned_cols=252  Identities=26%  Similarity=0.366  Sum_probs=197.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|.... +|+.||||.+....                ....+.+|+.++..++||||+++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~----------------~~~~~~~e~~~l~~l~h~~i~~~   89 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVES----------------DLQEIIKEISIMQQCDSPHVVKY   89 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETTS----------------CCHHHHHHHHHHHTCCCTTBCCE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCchH----------------HHHHHHHHHHHHHhCCCCCCccE
Confidence            35679999999999999999998764 79999999985321                13568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  163 (314)
T 3com_A           90 YGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGH  163 (314)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred             EEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCC
Confidence            9999999999999999999999999853   2356999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ++|+|||++..........  ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       ....
T Consensus       164 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~  234 (314)
T 3com_A          164 AKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAI  234 (314)
T ss_dssp             EEECCCTTCEECBTTBSCB--CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred             EEEeecccchhhhhhcccc--CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHH
Confidence            9999999998765432211  235789999999999999999999999999999999999999865321       1111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........+.. .       .+......+.+++..||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~-~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          235 FMIPTNPPPTF-R-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHSCCCCC-S-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHhcCCCccc-C-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111110 0       01111234889999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=320.54  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|.....||+|+||.||+|.... ++..||||.+.....              .....+.+|+.+++.++||||++++++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~   87 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDS--------------RYSQPLHEEIALHKHLKHKNIVQYLGS   87 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT-TCCEEEEEEEECCCC-----------------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECC-CCeEEEEEEccCCch--------------HHHHHHHHHHHHHHhCCCCCEeeEeeE
Confidence            45556689999999999998764 889999999853211              224678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-CCceE
Q 014140          215 MVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-DMEAR  293 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~k  293 (430)
                      +...+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++. ++.+|
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~k  163 (295)
T 2clq_A           88 FSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK  163 (295)
T ss_dssp             EEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEE
T ss_pred             EEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEE
Confidence            99999999999999999999999652 22345778999999999999999999655   999999999999987 89999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA--LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      |+|||++.........  .....||+.|+|||++.+..  ++.++||||||+++|+|++|..||......    . ....
T Consensus       164 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~-~~~~  236 (295)
T 2clq_A          164 ISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----Q-AAMF  236 (295)
T ss_dssp             ECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----H-HHHH
T ss_pred             EeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----h-HHHH
Confidence            9999999876543221  12357899999999987654  889999999999999999999998643211    1 1111


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........      +......    ...+.+++..||+.||++||++.++++
T Consensus       237 ~~~~~~~~------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          237 KVGMFKVH------PEIPESM----SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHCCC------CCCCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             hhcccccc------ccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11110110      0111112    234788999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.5e-42  Score=348.31  Aligned_cols=254  Identities=23%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +|+.||||++......           .......+.+|+.++++++||||++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~~   92 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVK-----------QKTDKESLLREVQLLKQLDHPNIMKLY   92 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCC-----------BSSCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhcc-----------cchHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3579999999999999999998764 8999999998543221           111256789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDD  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~  289 (430)
                      +++.+.+..++||||+.+|+|.+.+..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.+
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  165 (484)
T 3nyv_A           93 EFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKD  165 (484)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCC
Confidence            999999999999999999999999843    456999999999999999999999665   9999999999999   567


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.+||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....    ..+..
T Consensus       166 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~  237 (484)
T 3nyv_A          166 ANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDILK  237 (484)
T ss_dssp             CCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred             CcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence            89999999999877554332   23579999999999876 699999999999999999999999865321    22222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .   .........   ....    ......+.+++..||+.||.+|||+.++++
T Consensus       238 ~---i~~~~~~~~---~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          238 K---VEKGKYTFE---LPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             H---HHHCCCCCC---SGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHcCCCCCC---Cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            2   221111100   0000    112234889999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-43  Score=336.76  Aligned_cols=260  Identities=22%  Similarity=0.294  Sum_probs=201.4

Q ss_pred             ccccccccccccccCceEEEeecCC--CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG--SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|+...  .+|+.||||++........          ......+.+|+.++..+ +||||+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~~h~~iv  122 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLV  122 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh----------hhHHHHHHHHHHHHHHccCCCcee
Confidence            3679999999999999999998732  3789999999854321100          01123466789999999 699999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          123 TLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN  195 (355)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             EEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence            999999999999999999999999999964    246899999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      +.+||+|||+++......... .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......   ...
T Consensus       196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~  271 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQ  271 (355)
T ss_dssp             SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCH
T ss_pred             CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc---chH
Confidence            999999999998764332222 2245799999999999863  4789999999999999999999998653221   122


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRCM  424 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~~  424 (430)
                      .............           .+......+.+++..||+.||.+||     ++.++++.
T Consensus       272 ~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          272 AEISRRILKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHHhccCCC-----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            2222222222111           1111223478999999999999999     89988764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.2e-42  Score=331.70  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=200.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.......            .....+.+|+.+++.++||||++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~   82 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVNLI   82 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCSS------------SSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCcccHh
Confidence            4679999999999999999999764 89999999985432211            1134678899999999999999999


Q ss_pred             eEEEe--------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          213 ARMVR--------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       213 ~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++..        .+..++||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        83 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NI  155 (351)
T 3mi9_A           83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV  155 (351)
T ss_dssp             EEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred             heeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHE
Confidence            99987        3468999999975 88887743   3456999999999999999999999655   99999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH  361 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~  361 (430)
                      |++.++.+||+|||++.........  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... 
T Consensus       156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-  234 (351)
T 3mi9_A          156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-  234 (351)
T ss_dssp             EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred             EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence            9999999999999999876532221  122245789999999998764 589999999999999999999999875322 


Q ss_pred             cccccHHHHHHHHhcCCCCch--hccc-ccc---------CCCcHHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          362 TKEMSLVQWMRNVMTSENPNR--AINS-KLL---------GNGYEEQ------MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~--~~~~-~~~---------~~~~~~~------~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         ......+........+..  ..+. ...         .......      ...+.+|+.+||+.||++|||+.|+++
T Consensus       235 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          235 ---QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             ---HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence               222222322222111110  0000 000         0000111      234789999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-42  Score=327.88  Aligned_cols=261  Identities=19%  Similarity=0.230  Sum_probs=198.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  210 (430)
                      ..++|.+.+.||+|+||.||+|+... +|+.||||++...                 ....+.+|+.+++.++ ||||++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----------------~~~~~~~E~~~l~~l~~~~~i~~   95 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPV-----------------KKKKIKREIKILENLRGGPNIIT   95 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC-----------------CHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECC-CCcEEEEEEeccc-----------------chHHHHHHHHHHHHcCCCCCEEE
Confidence            35689999999999999999998764 8999999998421                 1356889999999997 999999


Q ss_pred             ceeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          211 LLARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       211 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++++.+  ....++||||+++++|.+++.       .+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~  165 (330)
T 3nsz_A           96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH  165 (330)
T ss_dssp             EEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred             eeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcC
Confidence            9999988  667899999999999999873       3889999999999999999999655   999999999999997


Q ss_pred             CC-ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--
Q 014140          289 DM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE--  364 (430)
Q Consensus       289 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~--  364 (430)
                      ++ .+||+|||++..........   ...||..|+|||++.+ ..++.++|||||||++|+|++|..||.........  
T Consensus       166 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          166 EHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             TTTEEEECCCTTCEECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             CCCEEEEEeCCCceEcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            76 89999999998765443322   3478999999999887 56899999999999999999999998532211000  


Q ss_pred             --------ccHHHHHHHHhcCCC----------CchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 --------MSLVQWMRNVMTSEN----------PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 --------~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                              ..+..++........          ....................+.+|+..||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    001111111000000          00000000001111112345889999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.9e-42  Score=346.85  Aligned_cols=264  Identities=24%  Similarity=0.325  Sum_probs=199.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||+||+|+... +++.||||++.......... .............+.+|+.++++++||||++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRY-SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccc-cccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4679999999999999999999764 88999999996543221100 000011112356789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      +++.+.+..++|||||++|+|.+.+..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence            999999999999999999999999854    346999999999999999999999655   99999999999998776  


Q ss_pred             -ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          291 -EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                       .+||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....    ..+  
T Consensus       186 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~--  255 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDI--  255 (504)
T ss_dssp             SSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--
T ss_pred             ccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHH--
Confidence             6999999999877554322   23579999999999875 689999999999999999999999865321    122  


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ...........   +.......    ...+.+++..||+.||.+|||+.++++
T Consensus       256 -~~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 -IKKVEKGKYYF---DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -HHHHHHCCCCC---CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHcCCCCC---CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             22222111110   00111112    234889999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.7e-42  Score=323.82  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|+... +|+.||+|.+.....              .....+.+|+.+++.++||||++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~   72 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPA--------------FRDSSLENEIAVLKKIKHENIVTLE   72 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC--------------------HHHHHHHHHHHCCCTTBCCEE
T ss_pred             hccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEecccc--------------cchHHHHHHHHHHHhCCCCCeeehh
Confidence            3579999999999999999998764 899999999854221              1134688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDD  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~  289 (430)
                      +++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+||++   +.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~  145 (304)
T 2jam_A           73 DIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEEN  145 (304)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTT
T ss_pred             hhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCC
Confidence            999999999999999999999999854    246899999999999999999999655   9999999999999   788


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.++|+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ..+..
T Consensus       146 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~  217 (304)
T 2jam_A          146 SKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFE  217 (304)
T ss_dssp             CCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHH
T ss_pred             CCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence            9999999999976543221    134689999999999999999999999999999999999999865321    12222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..   ....   +.......    ....+.+++..||+.||++|||+.++++
T Consensus       218 ~i~~---~~~~---~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          218 KIKE---GYYE---FESPFWDD----ISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHH---CCCC---CCTTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHc---CCCC---CCcccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2211   1110   00111111    2234889999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=332.39  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=185.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      ..+|.+.+.||+|+||.||+|++.. +|+.||||++....              ......+.+|+.++.++. ||||+++
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~~h~~iv~~   91 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNE--------------EEKNRAIIQEVCFMKKLSGHPNIVQF   91 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEESS--------------HHHHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             CceEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCCc--------------hHHHHHHHHHHHHHHHhccCCChhhc
Confidence            4579999999999999999999764 89999999884321              123567889999999996 9999999


Q ss_pred             eeEEEe--------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCC
Q 014140          212 LARMVR--------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPR--IIHRDIQP  281 (430)
Q Consensus       212 ~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dlkp  281 (430)
                      ++++..        ....++||||+. |+|.+++.... ....+++..++.++.|++.||.|||   ..+  ++||||||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp  166 (337)
T 3ll6_A           92 CSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKV  166 (337)
T ss_dssp             EEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCG
T ss_pred             cccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCc
Confidence            999953        345789999996 69999986532 3456999999999999999999999   556  99999999


Q ss_pred             CcEEeCCCCceEEeecCCcccCCCCCCcc----------eeecccccccccccccc---CCCCCCcchhHHHHHHHHHHH
Q 014140          282 ANVLIDDDMEARISEFGLAKRIPDGHTRT----------TTWSLAGTVGYIAPECH---QTVALSDTCDIYSFGVLLAVL  348 (430)
Q Consensus       282 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el  348 (430)
                      +|||++.++.+||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|
T Consensus       167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el  246 (337)
T 3ll6_A          167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL  246 (337)
T ss_dssp             GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred             ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence            99999999999999999998775432211          11134689999999998   566789999999999999999


Q ss_pred             HhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          349 VIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       349 l~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ++|..||.....    .   .......... ..        ...+    ..+.+++..||+.||.+|||+.++++.|+.+
T Consensus       247 ~~g~~p~~~~~~----~---~~~~~~~~~~-~~--------~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          247 CFRQHPFEDGAK----L---RIVNGKYSIP-PH--------DTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             HHSSCCC-------------------CCCC-TT--------CCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCcchhH----H---HhhcCcccCC-cc--------cccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999864321    0   1111111100 00        0111    1277899999999999999999999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3e-42  Score=357.82  Aligned_cols=247  Identities=21%  Similarity=0.212  Sum_probs=200.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++......           .......+..|..++..+ +||||+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~-----------~~~~~~~~~~E~~~l~~~~~~~~i~~l  407 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVI-----------QDDDVECTMVEKRVLALPGKPPFLTQL  407 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHH-----------HTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEeccccc-----------cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            4679999999999999999999874 8999999998542111           112246688899999988 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+.+|+||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       408 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~  480 (674)
T 3pfq_A          408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH  480 (674)
T ss_dssp             EEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSC
T ss_pred             EEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCc
Confidence            9999999999999999999999999964    246999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.......  ......||+.|+|||++.+..|+.++|||||||++|||++|..||....       ..+..
T Consensus       481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-------~~~~~  551 (674)
T 3pfq_A          481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELF  551 (674)
T ss_dssp             EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH
T ss_pred             EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-------HHHHH
Confidence            99999999986443322  2234689999999999999999999999999999999999999986532       12223


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ..+......           .+......+.+|+..||+.||++||++
T Consensus       552 ~~i~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          552 QSIMEHNVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHSSCCC-----------CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             HHHHhCCCC-----------CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            333332211           011122348899999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.8e-42  Score=330.14  Aligned_cols=256  Identities=16%  Similarity=0.253  Sum_probs=198.5

Q ss_pred             ccccccc-cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccc
Q 014140          133 EDYFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVP  210 (430)
Q Consensus       133 ~~~~~~~-~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  210 (430)
                      .+.|.+. +.||+|+||.||+|.... +|+.||+|++......            ......+.+|+.++..++ ||||++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRG------------QDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETT------------EECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcc------------hHHHHHHHHHHHHHHhccCCCCEEE
Confidence            3556776 889999999999998764 8999999998543221            112467889999999995 699999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC--
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--  288 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--  288 (430)
                      +++++...+..++||||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+|||++.  
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBT
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCC
Confidence            99999999999999999999999999843  23467999999999999999999999555   999999999999998  


Q ss_pred             -CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          289 -DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                       ++.+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ...
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~  241 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QET  241 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH
T ss_pred             CCCcEEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHH
Confidence             789999999999877543222   235799999999999999999999999999999999999999865321    111


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...+.... ...+.     ..    .......+.+++..||+.||.+|||+.++++
T Consensus       242 ~~~i~~~~-~~~~~-----~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          242 YLNISQVN-VDYSE-----ET----FSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHTC-CCCCT-----TT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcc-cccCc-----hh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            11111111 11110     11    1112234889999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.5e-42  Score=330.37  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=203.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      .++|.+.+.||.|+||.||+|++.. +|+.||||++.......      ...........+.+|+.++..+ +||||+++
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERL------SPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCC------CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhhcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEcccccc------CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            4679999999999999999998764 79999999985533210      0011223356788999999999 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999954    346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT------VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      ++|+|||++..+......   ....||+.|+|||++.+      ..++.++|||||||++|+|++|..||.....    .
T Consensus       239 ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~  311 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----I  311 (365)
T ss_dssp             EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred             EEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----H
Confidence            999999999877644322   23579999999998863      3588899999999999999999999864321    1


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..   ...........   ........    ...+.+++..||+.||++|||+.++++
T Consensus       312 ~~---~~~i~~~~~~~---~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LM---LRMIMEGQYQF---SSPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH---HHHHHHTCCCC---CHHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH---HHHHHhCCCCC---CCcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11   11111111100   00001111    234889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.9e-43  Score=344.19  Aligned_cols=261  Identities=22%  Similarity=0.258  Sum_probs=194.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||+|+||.||+|++.. +|+.||||++.....                  ...+|+.+|+.++||||++++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~~------------------~~~~E~~il~~l~hpniv~l~  113 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLR  113 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccch------------------hHHHHHHHHHHcCCCCcccee
Confidence            4569999999999999999999864 799999999853211                  123699999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++|....      ..++||||+++ +|.+.+.........+++..++.++.||+.||.|||+   .+|+||||||+|||+
T Consensus       114 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl  189 (420)
T 1j1b_A          114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLL  189 (420)
T ss_dssp             EEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEE
T ss_pred             eEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEE
Confidence            9986522      36789999976 7887776544556779999999999999999999995   459999999999999


Q ss_pred             CCC-CceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          287 DDD-MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       287 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      +.+ +.+||+|||+++.+......   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   .
T Consensus       190 ~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~  263 (420)
T 1j1b_A          190 DPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---V  263 (420)
T ss_dssp             ETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred             eCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---H
Confidence            955 67899999999876544322   235789999999998775 699999999999999999999999875321   1


Q ss_pred             ccHHHHHHHHhcCCC----------CchhccccccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSEN----------PNRAINSKLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~----------~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+...+. .+....          ......+.....     ........+.+|+.+||+.||.+||++.|+++
T Consensus       264 ~~l~~i~~-~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          264 DQLVEIIK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHHH-HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHH-HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11222211 111100          000000000000     01112345889999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-42  Score=336.47  Aligned_cols=264  Identities=18%  Similarity=0.195  Sum_probs=202.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--------
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--------  204 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  204 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++...               ......+.+|+.+++.++        
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~   99 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSA---------------EHYTETALDEIRLLKSVRNSDPNDPN   99 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecC---------------CcchHHHHHHHHHHHHHhhcCCCCCC
Confidence            3679999999999999999998764 8999999998421               123567889999999996        


Q ss_pred             CCCcccceeEEE----eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 014140          205 HRNIVPLLARMV----RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ  280 (430)
Q Consensus       205 hpniv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  280 (430)
                      ||||+++++++.    .....++||||+ +++|.+.+..  .....+++..++.++.|++.||.|||+.+  +|+|||||
T Consensus       100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDik  174 (397)
T 1wak_A          100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIK  174 (397)
T ss_dssp             GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCS
T ss_pred             cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCC
Confidence            788999999987    456789999999 5677777754  23356999999999999999999999651  49999999


Q ss_pred             CCcEEeCCCC-------------------------------------------------ceEEeecCCcccCCCCCCcce
Q 014140          281 PANVLIDDDM-------------------------------------------------EARISEFGLAKRIPDGHTRTT  311 (430)
Q Consensus       281 p~Nill~~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~  311 (430)
                      |+|||++.++                                                 .+||+|||++.......    
T Consensus       175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----  250 (397)
T 1wak_A          175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----  250 (397)
T ss_dssp             GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----
T ss_pred             HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----
Confidence            9999999775                                                 79999999998764331    


Q ss_pred             eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc--cccHHHHHHHHhcCCCCchh------
Q 014140          312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK--EMSLVQWMRNVMTSENPNRA------  383 (430)
Q Consensus       312 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~------  383 (430)
                       ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .......+....... +...      
T Consensus       251 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~  328 (397)
T 1wak_A          251 -TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV-PRKLIVAGKY  328 (397)
T ss_dssp             -CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC-CHHHHHHCTT
T ss_pred             -ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC-ChHHhhcccc
Confidence             134789999999999999999999999999999999999999975432211  111112222221111 1000      


Q ss_pred             ----cccc-------------------ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          384 ----INSK-------------------LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       384 ----~~~~-------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                          +...                   .....+......+.+|+.+||+.||++|||+.|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                0000                   001234566778999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=319.43  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=198.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.... +|+.||+|.+......          ........+.+|+.+++.++||||+++++
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   73 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLR----------RIPNGEANVKKEIQLLRRLRHKNVIQLVD   73 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHH----------HSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECC-CCcEEEEEEecccccc----------ccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            579999999999999999998764 8899999998542211          00123567899999999999999999999


Q ss_pred             EEE--eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          214 RMV--RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       214 ~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++.  +.+..++||||++++ |.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           74 VLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             EEECC---CEEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEcCCCCeEEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCc
Confidence            985  455789999999875 8787765  23457999999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA--LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +||+|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||....       ..+
T Consensus       148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~  220 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYK  220 (305)
T ss_dssp             EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHH
T ss_pred             EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHH
Confidence            9999999998776443333333567999999999988754  3789999999999999999999986431       111


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........       .....+    ..+.+++.+||+.||.+|||+.++++
T Consensus       221 ~~~~i~~~~~~-------~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          221 LFENIGKGSYA-------IPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHCCCC-------CCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCC-------CCCccC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22222111110       111122    34788999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=326.06  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ..+.|.+.+.||+|+||.||+|++.. +|+.||||++.....               ....+.+|+.+++++ +||||++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTGD---------------EEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSS---------------TTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecCcc---------------cHHHHHHHHHHHHhccCCCCeee
Confidence            45789999999999999999999764 899999999843211               135688999999999 7999999


Q ss_pred             ceeEEEe------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          211 LLARMVR------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       211 l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++++..      .+..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NI  160 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV  160 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHE
Confidence            9999987      46789999999999999999652  2356899999999999999999999655   99999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFF  359 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~  359 (430)
                      +++.++.+||+|||++.........  .....||+.|+|||++.     +..++.++|||||||++|+|++|..||....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999876533221  12357899999999987     5568999999999999999999999986532


Q ss_pred             cccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          360 QHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .       ............+. ..    ....+    ..+.+++..||+.||.+||++.++++
T Consensus       239 ~-------~~~~~~~~~~~~~~-~~----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 P-------MRALFLIPRNPAPR-LK----SKKWS----KKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             H-------HHHHHHHHHSCCCC-CS----CSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H-------HHHHHHhhcCcccc-CC----ccccC----HHHHHHHHHHhccChhhCCCHHHHhh
Confidence            2       11111111111110 00    01122    34889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-42  Score=337.11  Aligned_cols=257  Identities=10%  Similarity=0.018  Sum_probs=180.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc--CCCCcccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV--RHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l  211 (430)
                      ..|.+.+.||+|+||.||+|++.. +|+.||||++.....           ........+.+|+.++..|  +||||+++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~~~~l~~~hp~iv~~  129 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAE-----------NSRSELERLHEATFAAARLLGESPEEARD  129 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCST-----------THHHHHHHHHHHHHHHHHHHC--------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEeccc-----------ccccHHHHHHHHHHHHHHhcccChhhhhh
Confidence            458999999999999999999764 899999999955322           1223456778885544444  69998775


Q ss_pred             e-------eEEEeC-----------------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHH------HHHHHHHHH
Q 014140          212 L-------ARMVRR-----------------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR------HRIAQGIAS  261 (430)
Q Consensus       212 ~-------~~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~  261 (430)
                      +       +++...                 ...++|||||+ |+|.+++...   ...+++..+      ..++.|++.
T Consensus       130 ~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~  205 (371)
T 3q60_A          130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIR  205 (371)
T ss_dssp             --CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHH
Confidence            5       444433                 33799999998 7999999753   223455566      788899999


Q ss_pred             HHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC--CCCCcchhHH
Q 014140          262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT--VALSDTCDIY  339 (430)
Q Consensus       262 ~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~  339 (430)
                      ||+|||+.+   |+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||
T Consensus       206 aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~Diw  277 (371)
T 3q60_A          206 LAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAW  277 (371)
T ss_dssp             HHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred             HHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHH
Confidence            999999655   9999999999999999999999999998764221     13467799999999987  6799999999


Q ss_pred             HHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          340 SFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       340 slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      ||||++|||++|+.||....+.....         +........................+.+++..||+.||++|||+.
T Consensus       278 SlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          278 QLGLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             HHHHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             HHHHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            99999999999999997653211000         000000000000000011112234588999999999999999999


Q ss_pred             HHHH
Q 014140          420 DVRC  423 (430)
Q Consensus       420 ev~~  423 (430)
                      ++++
T Consensus       349 e~l~  352 (371)
T 3q60_A          349 EAME  352 (371)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-42  Score=326.48  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|+... +|+.||+|.+.....              .....+.+|+.+++.++||||+++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~   81 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSE--------------EELEDYIVEIEILATCDHPYIVKL   81 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC------------------CCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccceeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCCCH--------------HHHHHHHHHHHHHhcCCCCCEeee
Confidence            35679999999999999999999864 789999999843211              124678899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  155 (302)
T 2j7t_A           82 LGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGD  155 (302)
T ss_dssp             EEEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSC
T ss_pred             eeeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCC
Confidence            99999999999999999999999998642   346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeecccccccccccccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH-----QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +||+|||++.......  .......||+.|+|||++     .+..++.++||||||+++|+|++|..||.....      
T Consensus       156 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------  227 (302)
T 2j7t_A          156 IRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------  227 (302)
T ss_dssp             EEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             EEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------
Confidence            9999999875432110  111234689999999988     466789999999999999999999999865322      


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ............+....        +......+.+++..||+.||.+|||+.++++
T Consensus       228 -~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          228 -MRVLLKIAKSDPPTLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -HHHHHHHHHSCCCCCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -HHHHHHHhccCCcccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             11122222222111100        1112234889999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-41  Score=329.90  Aligned_cols=260  Identities=21%  Similarity=0.235  Sum_probs=199.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +++.||||++....             .......+.+|+.++.+++||||++++
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~niv~~~   91 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFE-------------HQTYCQRTLREIKILLRFRHENIIGIN   91 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTT-------------CHHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC-CCeEEEEEEecccc-------------CcHHHHHHHHHHHHHHhcCCCCCccce
Confidence            4579999999999999999998764 88999999984311             123356789999999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     ...++||||+. |+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~  162 (364)
T 3qyz_A           92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN  162 (364)
T ss_dssp             EEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred             eEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEEC
Confidence            999765     36899999997 599999853     35999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      .++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....    .
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~  238 (364)
T 3qyz_A          163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----L  238 (364)
T ss_dssp             TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG----G
T ss_pred             CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh----H
Confidence            99999999999998765432211 12245799999999986554 589999999999999999999999865322    2


Q ss_pred             cHHHHHHHHhcCCCCc---------------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPN---------------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+..........                     ..-........    ...+.+|+..||+.||.+|||+.++++
T Consensus       239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2222222221111100                     00000111112    234889999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-41  Score=338.54  Aligned_cols=262  Identities=22%  Similarity=0.252  Sum_probs=203.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-CCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-RNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|++.. +|+.||||++.....                ...+..|+.+++.++| +++..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----------------~~~~~~E~~il~~L~~~~~i~~i   68 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----------------HPQLLYESKIYRILQGGTGIPNV   68 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTCS----------------SCCHHHHHHHHHHTTTSTTCCCE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEeccccc----------------cHHHHHHHHHHHHhcCCCCCCeE
Confidence            4679999999999999999998753 899999998743221                1247889999999987 556666


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---CC
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DD  288 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~  288 (430)
                      ..++...+..++||||+ +++|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.
T Consensus        69 ~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~  141 (483)
T 3sv0_A           69 RWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR  141 (483)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGG
T ss_pred             EEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCC
Confidence            66677788899999999 8999999964   2356999999999999999999999655   9999999999999   58


Q ss_pred             CCceEEeecCCcccCCCCCCcc-----eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ++.+||+|||+++.+.......     ......||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~  221 (483)
T 3sv0_A          142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK  221 (483)
T ss_dssp             TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred             CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence            8999999999998765433211     12246799999999999999999999999999999999999999976433211


Q ss_pred             cccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+......... ...     ..+....+    ..+.+++..||+.+|.+||++.+|++.|+++
T Consensus       222 ~~~~~~i~~~~~~-~~~-----~~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          222 KQKYEKISEKKVA-TSI-----EALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHHHHHHHHHH-SCH-----HHHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhcccc-ccH-----HHHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111111111111 100     01111222    3488999999999999999999999999876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-42  Score=356.05  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=196.1

Q ss_pred             cccccccCceEEEeecC-CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELP-GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||.||+|.+. ..+++.||||++......            ......+.+|+.+|++++|||||+++++|. .
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  441 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIVRMIGICE-A  441 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC------------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            47999999999999653 225789999998543211            123577999999999999999999999986 4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++|||||++|+|.+++..    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence            568899999999999999953    356999999999999999999999655   9999999999999999999999999


Q ss_pred             CcccCCCCCCc-ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhc
Q 014140          299 LAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMT  376 (430)
Q Consensus       299 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~  376 (430)
                      +++.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....    ..+...+..   
T Consensus       515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~---  587 (635)
T 4fl3_A          515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEK---  587 (635)
T ss_dssp             HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---
T ss_pred             CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc---
Confidence            99877543321 12223456889999999999999999999999999999998 9999865422    122222221   


Q ss_pred             CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .....          .+..+...+.+++..||+.||++||++.+|++.|+++
T Consensus       588 ~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             TCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11110          1111224488999999999999999999999999876

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-42  Score=338.14  Aligned_cols=260  Identities=22%  Similarity=0.248  Sum_probs=192.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      ...|.+.+.||+|+||.||+|++.  .+..+|+|++.....                  ...+|+.+++.++||||++++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~------------------~~~~E~~il~~l~h~niv~l~   98 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR------------------FKNRELQIMRIVKHPNVVDLK   98 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc------------------hHHHHHHHHHhCCCCCcceEE
Confidence            457999999999999999999986  445589998854221                  123699999999999999999


Q ss_pred             eEEEeCCe------eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++|...+.      .++||||+++ ++...+.........+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        99 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill  174 (394)
T 4e7w_A           99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLL  174 (394)
T ss_dssp             EEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             EEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEE
Confidence            99976543      7899999987 555555443344567999999999999999999999655   9999999999999


Q ss_pred             C-CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          287 D-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       287 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      + .++.+||+|||+++.........   ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   .
T Consensus       175 ~~~~~~~kL~DFG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~  248 (394)
T 4e7w_A          175 DPPSGVLKLIDFGSAKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---I  248 (394)
T ss_dssp             ETTTTEEEECCCTTCEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred             cCCCCcEEEeeCCCcccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---H
Confidence            9 79999999999998775443322   35789999999998775 589999999999999999999999875321   1


Q ss_pred             ccHHHHHHHHhcCCCCch--hcc--------ccccCC-----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNR--AIN--------SKLLGN-----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~--~~~--------~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+...+ .....+....  .+.        +.....     ........+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          249 DQLVEII-KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHH-HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHH-HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1111111 1111100000  000        000000     01112235889999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-41  Score=335.17  Aligned_cols=199  Identities=20%  Similarity=0.243  Sum_probs=170.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc------CCC
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV------RHR  206 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp  206 (430)
                      ..+|.+.+.||+|+||.||+|.... +|+.||||++...               ......+.+|+.+++.+      .||
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~  159 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNE---------------KRFHRQAAEEIRILEHLRKQDKDNTM  159 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHTTCTTSCS
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCc---------------cchHHHHHHHHHHHHHHhhccccCCc
Confidence            4579999999999999999998764 7999999998432               12245677788888777      577


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ||+++++++...+..++||||+. ++|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus       160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl  233 (429)
T 3kvw_A          160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILL  233 (429)
T ss_dssp             CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEE
T ss_pred             CEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence            99999999999999999999996 599999865  33345999999999999999999999665   9999999999999


Q ss_pred             CCCCc--eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          287 DDDME--ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       287 ~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +.++.  +||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99887  9999999997654322     1357899999999999999999999999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.3e-42  Score=331.26  Aligned_cols=261  Identities=21%  Similarity=0.256  Sum_probs=191.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+++.++||||++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpniv~~~   90 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQ------------NQTHAKRAYRELVLMKCVNHKNIIGLL   90 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC-CCceEEEEEeccccC------------ChHHHHHHHHHHHHHHhcCCCCccceE
Confidence            3679999999999999999998764 899999999854221            123356788999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+      ..++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~  160 (371)
T 2xrw_A           91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV  160 (371)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             EeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEE
Confidence            9997765      67999999975 7888883      24899999999999999999999655   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ..
T Consensus       161 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~  233 (371)
T 2xrw_A          161 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----ID  233 (371)
T ss_dssp             CTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HH
T ss_pred             cCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HH
Confidence            9999999999999987653322   1235789999999999999999999999999999999999999865321    11


Q ss_pred             HHHHHHHHhcCC-------------------CC------chhccccccCC---CcHHHHHHHHHHHHhcccCCCCCCCCH
Q 014140          367 LVQWMRNVMTSE-------------------NP------NRAINSKLLGN---GYEEQMLLVLKIACFCTLDDPNKRPNS  418 (430)
Q Consensus       367 l~~~~~~~~~~~-------------------~~------~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~Rps~  418 (430)
                      ....+.......                   ..      ...+.......   ........+.+|+.+||+.||.+|||+
T Consensus       234 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  313 (371)
T 2xrw_A          234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  313 (371)
T ss_dssp             HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence            111110000000                   00      00000000001   012234568999999999999999999


Q ss_pred             HHHHH
Q 014140          419 KDVRC  423 (430)
Q Consensus       419 ~ev~~  423 (430)
                      .++++
T Consensus       314 ~e~l~  318 (371)
T 2xrw_A          314 DEALQ  318 (371)
T ss_dssp             HHHHH
T ss_pred             HHHhC
Confidence            99986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-41  Score=320.38  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=203.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||.+........     ...........+.+|+.+++++. ||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSF-----SAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTC-----CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhccceeeeecCCCceEEEEEEEcC-cCceEEEEEEeccccccc-----CHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4679999999999999999998864 899999999854321100     00111233567889999999996 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence            9999999999999999999999999954    346999999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ------TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +||+|||++.........   ....||+.|+|||++.      ...++.++||||||+++++|++|..||.....     
T Consensus       163 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----  234 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----  234 (298)
T ss_dssp             EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             EEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----
Confidence            999999999876544322   2346899999999875      45688999999999999999999999864321     


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ...............   .    .........+.+++..||+.||.+|||+.++++
T Consensus       235 --~~~~~~~~~~~~~~~---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 --MLMLRMIMSGNYQFG---S----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHHHHTCCCCC---T----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHhcCCcccC---c----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              111222221111100   0    011122334889999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-42  Score=326.62  Aligned_cols=260  Identities=23%  Similarity=0.281  Sum_probs=196.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||.+........      ..........+.+|+.+++.++||||++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   81 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIG------SAREADPALNVETEIEILKKLNHPCIIKIK   81 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhc------ccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence            3579999999999999999998764 889999999854322100      001112235688999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc-
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME-  291 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-  291 (430)
                      +++...+ .++||||+++|+|.+++.    ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++. 
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence            9987655 899999999999999983    4567999999999999999999999655   999999999999987664 


Q ss_pred             --eEEeecCCcccCCCCCCcceeeccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 --ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ---TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                        +||+|||++........   .....||+.|+|||++.   +..++.++|||||||++|+|++|..||.....   ...
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~  227 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVS  227 (322)
T ss_dssp             CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSC
T ss_pred             CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHH
Confidence              99999999987654321   12346899999999874   45789999999999999999999999875322   122


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...+......  .    .+......    ...+.+++..||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~--~----~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKDQITSGKYN--F----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHTCCC--C----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCccc--c----Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            32222221100  0    01111112    234889999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7e-42  Score=330.94  Aligned_cols=256  Identities=22%  Similarity=0.310  Sum_probs=182.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+++.++||||++++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpnIv~~~   94 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQ------------SIIHAKRTYRELRLLKHMKHENVIGLL   94 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETT-TTEEEEEEECSSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCcccc------------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4689999999999999999998654 899999999854221            123356788999999999999999999


Q ss_pred             eEEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...      ...++|+||+ +++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll  165 (367)
T 2fst_X           95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAV  165 (367)
T ss_dssp             EEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             EEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEE
Confidence            998754      5679999999 6799998842     46999999999999999999999655   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....    .
T Consensus       166 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~  236 (367)
T 2fst_X          166 NEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----I  236 (367)
T ss_dssp             CTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----H
T ss_pred             CCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            99999999999999875432     123578999999999887 6789999999999999999999999865321    1


Q ss_pred             cHHHHHHHHhcCCCCc---------------------hhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPN---------------------RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+......+...                     ..-........    ...+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA----NPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCC----CHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            2222222221111000                     00000011111    234889999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.3e-42  Score=329.46  Aligned_cols=265  Identities=18%  Similarity=0.201  Sum_probs=189.2

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+.+.||+|+||.||+|++.. +|+.||||++......               ......++..+..++||||+++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~~~~~l~~l~h~niv~~   84 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPRF---------------RNRELQIMQDLAVLHHPNIVQL   84 (360)
T ss_dssp             HHTTEEEC----------CEEEEETT-TCCEEEEEEEECCTTC---------------CCHHHHHHHHHHHHCCTTBCCE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecCccc---------------cHHHHHHHHHHHhcCCCCcccH
Confidence            35689999999999999999999764 8999999988543211               1346678888899999999999


Q ss_pred             eeEEEeCCe-------eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCC
Q 014140          212 LARMVRRDC-------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH--MSHRPRIIHRDIQPA  282 (430)
Q Consensus       212 ~~~~~~~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~Dlkp~  282 (430)
                      ++++...+.       .++||||+++ +|.+.+.........+++..+..++.|++.||.|||  +.+   |+||||||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~  160 (360)
T 3e3p_A           85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPH  160 (360)
T ss_dssp             EEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGG
T ss_pred             HHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHH
Confidence            999976443       7899999976 666666544455677999999999999999999999  555   999999999


Q ss_pred             cEEeCC-CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          283 NVLIDD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       283 Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      |||++. ++.+||+|||++..........   ...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus       161 NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          161 NVLVNEADGTLKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             GEEEETTTTEEEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEEeCCCCcEEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence            999996 8999999999998776443222   357899999999987654 89999999999999999999999875322


Q ss_pred             ccccccHHHHHHHHhcCCC------------Cchhcc------ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSEN------------PNRAIN------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~------------~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                          ......+........            ......      ..............+.+|+..||+.||.+|||+.|++
T Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  313 (360)
T 3e3p_A          238 ----AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL  313 (360)
T ss_dssp             ----HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             ----HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence                111111111111100            000000      0001111112345688999999999999999999997


Q ss_pred             H
Q 014140          423 C  423 (430)
Q Consensus       423 ~  423 (430)
                      +
T Consensus       314 ~  314 (360)
T 3e3p_A          314 C  314 (360)
T ss_dssp             T
T ss_pred             c
Confidence            5

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-41  Score=322.69  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=202.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC------
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR------  206 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------  206 (430)
                      .++|.+.+.||+|+||.||+|.....+|+.||||++...               ......+.+|+.+++.++|+      
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~~~~   77 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------------DRYCEAARSEIQVLEHLNTTDPNSTF   77 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------------HHHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------------CchhHHHHHHHHHHHHhhhcCCCCce
Confidence            367999999999999999999875458899999998421               12246788899999988765      


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++++++++...+..++||||+ +++|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~  151 (339)
T 1z57_A           78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILF  151 (339)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            4999999999999999999999 8899999965  33346899999999999999999999655   9999999999999


Q ss_pred             CC-------------------CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          287 DD-------------------DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       287 ~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.                   ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  226 (339)
T 1z57_A          152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE  226 (339)
T ss_dssp             SCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred             eccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence            87                   6689999999998754322     13578999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccccccHHHHHHHHhcCCCCchhcc-------------------------------ccccCCCcHHH
Q 014140          348 LVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN-------------------------------SKLLGNGYEEQ  396 (430)
Q Consensus       348 ll~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~  396 (430)
                      |++|..||.....    ......+....... +.....                               ...........
T Consensus       227 l~~g~~pf~~~~~----~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (339)
T 1z57_A          227 YYLGFTVFPTHDS----KEHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE  301 (339)
T ss_dssp             HHHSSCSCCCSCH----HHHHHHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred             HHhCCCCCCCCCh----HHHHHHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhh
Confidence            9999999865321    11222222222110 100000                               00001122344


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          397 MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       397 ~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...+.+++..||+.||.+|||+.|+++
T Consensus       302 ~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          302 HERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            567899999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.6e-41  Score=328.07  Aligned_cols=201  Identities=22%  Similarity=0.252  Sum_probs=170.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CC-----
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HR-----  206 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----  206 (430)
                      .++|.+.+.||+|+||+||+|.... +|+.||||++...               ......+..|+.++..++ |+     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~~~~  116 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNK---------------KAFLNQAQIEVRLLELMNKHDTEMKY  116 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSS---------------HHHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEecc---------------HHHHHHHHHHHHHHHHHHhcccccce
Confidence            4689999999999999999998764 8899999998421               122456778888888885 55     


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++++++++...+..++||||++ |+|.+++..  .....+++..+..++.|++.||.|||+. ..+|+||||||+|||+
T Consensus       117 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          117 YIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL  192 (382)
T ss_dssp             GBCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred             eEEEeeeeeccCCceEEEEecCC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence            49999999999999999999996 599999965  2335699999999999999999999953 3469999999999999


Q ss_pred             C--CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          287 D--DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       287 ~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +  .++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            5  57889999999998764332     2357899999999999999999999999999999999999998753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.3e-41  Score=328.10  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=194.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+++.++||||++++
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~  107 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQ------------SEIFAKRAYRELLLLKHMQHENVIGLL  107 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC-CCCEEEEEEeccccc------------chhHHHHHHHHHHHHHhcCCCCchhhh
Confidence            5689999999999999999998764 899999999854321            123357788999999999999999999


Q ss_pred             eEEEeCCee------EEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+..      ++||||+. ++|.+++.      ..+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus       108 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll  177 (371)
T 4exu_A          108 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAV  177 (371)
T ss_dssp             EEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             hheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEE
Confidence            999887665      99999997 58888762      34999999999999999999999655   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+||+|||++.......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....    .
T Consensus       178 ~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~  248 (371)
T 4exu_A          178 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----L  248 (371)
T ss_dssp             CTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----H
T ss_pred             CCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence            999999999999998654321     23578999999999887 6789999999999999999999999875321    1


Q ss_pred             cHHHHHHHHhcCCCCchhcc-----------ccc---cCC----CcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAIN-----------SKL---LGN----GYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~-----------~~~---~~~----~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+........ .....           ...   ...    ..+.....+.+|+..||+.||.+|||+.++++
T Consensus       249 ~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          249 DQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHHHCCCC-HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCc-HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            11111111111000 00000           000   000    00112345889999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=326.86  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=195.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+..    ..+|+|++.......            .....+.+|+.++++++||||++++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNE------------DQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCC------------CCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCH------------HHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            567999999999999999999864    249999985432211            1123467799999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++ ++.+
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~  168 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKV  168 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CC
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCE
Confidence            999999999999999999999999843   3346899999999999999999999655   99999999999998 6799


Q ss_pred             EEeecCCcccCCCCCC---cceeeccccccccccccccCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          293 RISEFGLAKRIPDGHT---RTTTWSLAGTVGYIAPECHQT---------VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      +|+|||++........   ........||+.|+|||++.+         ..++.++||||||+++|+|++|..||.....
T Consensus       169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  248 (319)
T 2y4i_B          169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA  248 (319)
T ss_dssp             EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred             EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999876542211   111223468999999999875         3578899999999999999999999865321


Q ss_pred             ccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                          .   ...........+.. ...    ..+    ..+.+++..||+.||.+|||+.++++.|+++.
T Consensus       249 ----~---~~~~~~~~~~~~~~-~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          249 ----E---AIIWQMGTGMKPNL-SQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             ----H---HHHHHHHTTCCCCC-CCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             ----H---HHHHHhccCCCCCC-CcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                1   11122221111110 000    111    23889999999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-41  Score=350.20  Aligned_cols=258  Identities=20%  Similarity=0.272  Sum_probs=201.6

Q ss_pred             ccccccccccccccCceEEEeecCCC--CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|.+...  .+..||||.+....             .......+.+|+.++++++||||++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~HpnIv~  455 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------------SDSVREKFLQEALTMRQFDHPHIVK  455 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------------CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            45688889999999999999987532  35679999874311             1233577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++. .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       456 l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~  528 (656)
T 2j0j_A          456 LIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND  528 (656)
T ss_dssp             EEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCC
Confidence            999984 5678999999999999999964   3346899999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+++.......... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||.....    .....
T Consensus       529 ~vkL~DFG~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~  603 (656)
T 2j0j_A          529 CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG  603 (656)
T ss_dssp             EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH
T ss_pred             CEEEEecCCCeecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHH
Confidence            999999999988754432222 13457889999999998899999999999999999997 9999865322    12222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+..   ...+.          .+......+.+++..||+.||.+|||+.+|++.|+++
T Consensus       604 ~i~~---~~~~~----------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          604 RIEN---GERLP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             HHHH---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHc---CCCCC----------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2221   11110          0111223488999999999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-41  Score=322.64  Aligned_cols=267  Identities=19%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpni  208 (430)
                      ..++|.+.+.||+|+||.||+|+....+|+.||+|++........            ....+.+|+.+++.+   +||||
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~~i   76 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNV   76 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTB
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc------------CCchhhHHHHHHHhhhccCCCCe
Confidence            457899999999999999999987545789999999854322110            012355666666665   89999


Q ss_pred             ccceeEEE-----eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          209 VPLLARMV-----RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       209 v~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      +++++++.     .....++||||++ |+|.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~N  150 (326)
T 1blx_A           77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN  150 (326)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred             EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHH
Confidence            99999987     4567899999997 599999965  23345899999999999999999999655   9999999999


Q ss_pred             EEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      |+++.++.+||+|||++.......   ......||..|+|||++.+..++.++||||||+++|+|++|..||.....   
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---  224 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---  224 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             eEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---
Confidence            999999999999999998764322   12235789999999999999999999999999999999999999875322   


Q ss_pred             cccHHHHHHHHhcCCCCc----------hhccc---cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          364 EMSLVQWMRNVMTSENPN----------RAINS---KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~----------~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ......+..........          ..+..   .............+.+++.+||+.||.+|||+.++++
T Consensus       225 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          225 -VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             -HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             11222222211111000          00000   0000011122345789999999999999999999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-41  Score=329.38  Aligned_cols=273  Identities=19%  Similarity=0.208  Sum_probs=194.9

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.|.+.+.||+|+||.||+|...  +|..||||++..........   ...........+.+|+.++++++||||+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTV---NILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCE---EGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchh---hhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            4678999999999999999999875  69999999986543321110   001122335789999999999999999999


Q ss_pred             eeEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          212 LARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       212 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++++...     ...++||||++ |+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999653     35799999997 588888853   3457999999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+||+|||++.........   ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....    .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~  240 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF----Y  240 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----H
T ss_pred             cCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH----H
Confidence            99999999999999865433222   23578999999999887 6789999999999999999999999875321    1


Q ss_pred             cHHHHHHHHhcCCCCchh------------------ccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRA------------------INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+............                  ..........+.....+.+++..||+.||.+|||+.++++
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111111111111110000                  0000000000111234889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-41  Score=319.82  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=193.7

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCcc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNIV  209 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv  209 (430)
                      ..+.|.+.+.||+|+||.||+|...  +|+.||||++.....            .......+.+|+.++.+++  ||||+
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~~~~~~iv   91 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEA------------DNQTLDSYRNEIAYLNKLQQHSDKII   91 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSC------------CHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccc------------cccchHHHHHHHHHHHhccccCCceE
Confidence            3467999999999999999999875  689999999854221            1234578899999999997  59999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++++...+..++||| +.+++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++ 
T Consensus        92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-  162 (313)
T ss_dssp             CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred             EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence            99999999999999999 457899999954    346899999999999999999999655   999999999999964 


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-----------VALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      +.+||+|||++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            8999999999987755433333334578999999999876           46888999999999999999999998653


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..      ...............     ......    ...+.+++..||+.||.+|||+.++++
T Consensus       243 ~~------~~~~~~~~~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          243 IN------QISKLHAIIDPNHEI-----EFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CS------HHHHHHHHHCTTSCC-----CCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH------HHHHHHHHHhccccc-----CCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            22      112222222211110     000111    234888999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=331.53  Aligned_cols=270  Identities=20%  Similarity=0.216  Sum_probs=182.3

Q ss_pred             ccccc-ccccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          134 DYFAS-LEKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~-~~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      +.|.+ .++||+|+||.||+|++.. .+++.||||++.....                ...+.+|+.+|+.++||||+++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~E~~~l~~l~hpniv~~   83 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISL   83 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------------CHHHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------------CHHHHHHHHHHHhcCCCCeeeE
Confidence            34665 4589999999999998642 3688999999843211                2457889999999999999999


Q ss_pred             eeEEEe--CCeeEEEEEecCCCCHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          212 LARMVR--RDCDLLVYEFRRNGSLQDILYDVS-----QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       212 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      ++++..  ....++||||+.+ +|.+++....     .....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NI  159 (405)
T 3rgf_A           84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANI  159 (405)
T ss_dssp             CEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             eeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHe
Confidence            999965  6788999999965 8888875322     12235999999999999999999999665   99999999999


Q ss_pred             Ee----CCCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          285 LI----DDDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       285 ll----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      |+    +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       160 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          160 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99    67789999999999877543221 222245789999999999875 5899999999999999999999999643


Q ss_pred             cccc-----ccccHHHHHHHHhcCCCCchhcc---------------ccccCCCcH---------HHHHHHHHHHHhccc
Q 014140          359 FQHT-----KEMSLVQWMRNVMTSENPNRAIN---------------SKLLGNGYE---------EQMLLVLKIACFCTL  409 (430)
Q Consensus       359 ~~~~-----~~~~l~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~---------~~~~~l~~l~~~cl~  409 (430)
                      ....     ........+...+........-.               .........         .....+.+|+..||+
T Consensus       240 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~  319 (405)
T 3rgf_A          240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT  319 (405)
T ss_dssp             C------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSC
T ss_pred             cccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHcc
Confidence            2210     00111222222221111100000               000000000         002347899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 014140          410 DDPNKRPNSKDVRC  423 (430)
Q Consensus       410 ~dp~~Rps~~ev~~  423 (430)
                      .||.+|||+.|+++
T Consensus       320 ~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          320 MDPIKRITSEQAMQ  333 (405)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CCcccCCCHHHHhc
Confidence            99999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.5e-41  Score=327.98  Aligned_cols=264  Identities=19%  Similarity=0.223  Sum_probs=199.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--------
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--------  204 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  204 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++....               .....+.+|+.++++++        
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~   81 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK---------------VYTEAAEDEIKLLQRVNDADNTKED   81 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCCc---------------cchhhhhHHHHHHHHhhcccccchh
Confidence            4679999999999999999998764 89999999984211               12456788999999886        


Q ss_pred             ---CCCcccceeEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 014140          205 ---HRNIVPLLARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHR  277 (430)
Q Consensus       205 ---hpniv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  277 (430)
                         ||||+++++++...+    ..++||||+ +++|.+++...  ....+++..+..++.|++.||.|||+..  +|+||
T Consensus        82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~  156 (373)
T 1q8y_A           82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHT  156 (373)
T ss_dssp             HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECS
T ss_pred             ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEec
Confidence               899999999998754    789999999 88999999652  3345999999999999999999999651  49999


Q ss_pred             CCCCCcEEeC------CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC
Q 014140          278 DIQPANVLID------DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG  351 (430)
Q Consensus       278 Dlkp~Nill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g  351 (430)
                      ||||+|||++      ..+.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       157 Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  231 (373)
T 1q8y_A          157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG  231 (373)
T ss_dssp             CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhC
Confidence            9999999994      44589999999998764332     134789999999999999999999999999999999999


Q ss_pred             CCCCCccccccc--cccHHHHHHHHhcCCCCchhc----------c-----------------c--cccCCCcHHHHHHH
Q 014140          352 KFPSDDFFQHTK--EMSLVQWMRNVMTSENPNRAI----------N-----------------S--KLLGNGYEEQMLLV  400 (430)
Q Consensus       352 ~~p~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~----------~-----------------~--~~~~~~~~~~~~~l  400 (430)
                      ..||........  .......+...... .+....          .                 .  ......+......+
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (373)
T 1q8y_A          232 DFLFEPDEGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI  310 (373)
T ss_dssp             SCCC---------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred             CCCCCCCcccccCChHHHHHHHHHhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHH
Confidence            999975432111  11111111111111 010000          0                 0  00112345667789


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHH
Q 014140          401 LKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       401 ~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+|+..||+.||++|||+.++++
T Consensus       311 ~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          311 SDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHHHhccCccccCCHHHHhh
Confidence            99999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.2e-41  Score=323.99  Aligned_cols=260  Identities=20%  Similarity=0.234  Sum_probs=196.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++....             .......+.+|+.+++.++||||++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   75 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFD-------------KPLFALRTLREIKILKHFKHENIITIF   75 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCS-------------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccc-------------cchHHHHHHHHHHHHHhCcCCCcCCee
Confidence            4679999999999999999998764 79999999984211             123356788999999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     ...++||||+. |+|.+++..     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++
T Consensus        76 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~  146 (353)
T 2b9h_A           76 NIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLIN  146 (353)
T ss_dssp             EECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             eeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEc
Confidence            988764     67899999997 599999854     36899999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcc--------eeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRT--------TTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      .++.+||+|||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus       147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999998765332111        1123478999999998765 67899999999999999999999998753


Q ss_pred             ccccccccHHHHHHHHhcCCCCchhc----------------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCC
Q 014140          359 FQHTKEMSLVQWMRNVMTSENPNRAI----------------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP  416 (430)
Q Consensus       359 ~~~~~~~~l~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp  416 (430)
                      ..    ......+.............                      ......    .....+.+++..||+.||.+||
T Consensus       227 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rp  298 (353)
T 2b9h_A          227 DY----RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP----RVNPKGIDLLQRMLVFDPAKRI  298 (353)
T ss_dssp             SH----HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHST----TSCHHHHHHHHHHSCSSGGGSC
T ss_pred             Cc----HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcc----cCCHHHHHHHHHhcCcCcccCC
Confidence            21    11111111111111000000                      000011    1233478999999999999999


Q ss_pred             CHHHHHH
Q 014140          417 NSKDVRC  423 (430)
Q Consensus       417 s~~ev~~  423 (430)
                      |+.++++
T Consensus       299 t~~ell~  305 (353)
T 2b9h_A          299 TAKEALE  305 (353)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.2e-41  Score=316.53  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=191.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||.+...               ......+.+|+.++++++||||++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------------~~~~~~~~~E~~~l~~l~h~~i~~~~   68 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHT---------------EEKLSTILSEVMLLASLNHQYVVRYY   68 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEEE---------------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccchhhheeccCCcEEEEEEEEcC-CCeEEEEEEEecc---------------HHHHHHHHHHHHHHHhcCchHHHHHH
Confidence            3579999999999999999998764 8999999998421               12356789999999999999999999


Q ss_pred             eEEEe-------------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 014140          213 ARMVR-------------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDI  279 (430)
Q Consensus       213 ~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  279 (430)
                      +++.+             .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl  142 (303)
T 1zy4_A           69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDL  142 (303)
T ss_dssp             EEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             HHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccC
Confidence            99865             3567899999999999999964   3346788999999999999999999665   999999


Q ss_pred             CCCcEEeCCCCceEEeecCCcccCCCCCC------------cceeeccccccccccccccCCC-CCCcchhHHHHHHHHH
Q 014140          280 QPANVLIDDDMEARISEFGLAKRIPDGHT------------RTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLA  346 (430)
Q Consensus       280 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~  346 (430)
                      ||+||+++.++.+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|
T Consensus       143 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  222 (303)
T 1zy4_A          143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF  222 (303)
T ss_dssp             CGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHH
T ss_pred             CHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHH
Confidence            99999999999999999999987653211            1112245689999999999865 6899999999999999


Q ss_pred             HHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          347 VLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       347 ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +|++   ||....   .   .............   .+.+.    .+......+.+++..||+.||.+|||+.++++
T Consensus       223 ~l~~---p~~~~~---~---~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          223 EMIY---PFSTGM---E---RVNILKKLRSVSI---EFPPD----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHS---CCSSHH---H---HHHHHHHHHSTTC---CCCTT----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHh---ccCCch---h---HHHHHHhcccccc---ccCcc----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            9998   543211   1   1111222211110   01111    11222334789999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-41  Score=322.97  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=178.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHH-HHhccCCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII-TAGQVRHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l  211 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....             ......+..|+. +++.++||||+++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~~~~h~niv~~   86 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVD-------------EKEQKQLLMDLDVVMRSSDCPYIVQF   86 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCCC-------------HHHHHHHHHHHHHHHSSCCCTTBCCE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC-CCCEEEEEEeecccC-------------chHHHHHHHHHHHHHHcCCCCcEeee
Confidence            4679999999999999999998764 899999999854211             112344555555 7788899999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDV-SQGRRELDWLARHRIAQGIASGLEYLHMS-HRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++...+..++||||+++ +|.+++... ......+++..+..++.|++.||.|||+. +   ++||||||+||+++.+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~  162 (327)
T 3aln_A           87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRS  162 (327)
T ss_dssp             EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETT
T ss_pred             eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCC
Confidence            9999999999999999975 888887532 12356799999999999999999999965 5   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeecccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH----QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.+||+|||++..........   ...||+.|+|||++    .+..++.++||||||+++|+|++|..||......    
T Consensus       163 ~~~kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  235 (327)
T 3aln_A          163 GNIKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----  235 (327)
T ss_dssp             TEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred             CCEEEccCCCceecccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----
Confidence            999999999998765432221   23689999999998    4567899999999999999999999998653210    


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        .+..........+  .+........    ...+.+++..||+.||.+|||+.++++
T Consensus       236 --~~~~~~~~~~~~~--~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          236 --FDQLTQVVKGDPP--QLSNSEEREF----SPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------CCCCCSCCC--CCCCCSSCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHhcCCCC--CCCCcccccC----CHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              1111111111111  0111111112    234889999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.5e-41  Score=314.47  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=200.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||+|++......            ......+.+|+.++++++||||++++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~   87 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAK------------NKDTSTILREVELLKKLDHPNIMKLF   87 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBS------------SSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccc------------hHHHHHHHHHHHHHHhccCCCccEEE
Confidence            4679999999999999999998764 8899999998543221            11246788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC---
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD---  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---  289 (430)
                      +++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+   
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~  160 (287)
T 2wei_A           88 EILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD  160 (287)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTT
T ss_pred             EEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCc
Confidence            999999999999999999999998854    246899999999999999999999655   9999999999999764   


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.+||+|||++..........   ...||+.|+|||++.+ .++.++||||||+++|+|++|..||.....    ..+. 
T Consensus       161 ~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~-  231 (287)
T 2wei_A          161 CDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDIL-  231 (287)
T ss_dssp             CCEEECSTTGGGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH-
T ss_pred             ccEEEeccCcceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHHH-
Confidence            469999999998765433221   3468999999999876 489999999999999999999999865321    1122 


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        ..........   +.......    ...+.+++..||+.||.+|||+.++++
T Consensus       232 --~~~~~~~~~~---~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          232 --KRVETGKYAF---DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --HHHHHCCCCC---CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHcCCCCC---Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence              2222111110   00011112    234889999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-41  Score=324.84  Aligned_cols=272  Identities=18%  Similarity=0.258  Sum_probs=204.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhh---ccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI---KKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      .++|.+.+.||+|+||.||+|+.   +|+.||||.+...........   .............+.+|+.++++++||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            46899999999999999999987   899999999965432211100   000000111237799999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHH------HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDI------LYDVSQGRRELDWLARHRIAQGIASGLEYLHM-SHRPRIIHRDIQPA  282 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~  282 (430)
                      ++++++.+.+..++||||+++|+|.++      +..  .....+++..++.++.|++.||.|||+ .   +++||||+|+
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~  181 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS  181 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence            999999999999999999999999998      422  225679999999999999999999996 4   5999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSD-TCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ||+++.++.++|+|||++......    ......||..|+|||++.+. .++. ++||||||+++|+|++|..||.....
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999876443    22245789999999999987 5666 99999999999999999999875322


Q ss_pred             ccccccHHHHHHHHhcCCCCchhcc-----ccc----cCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          361 HTKEMSLVQWMRNVMTSENPNRAIN-----SKL----LGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .   ..+   ....... ......+     ...    ...........+.+++..||+.||.+|||+.++++
T Consensus       258 ~---~~~---~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          258 L---VEL---FNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             S---HHH---HHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H---HHH---HHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1   112   2222211 1110000     000    00001222345889999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-40  Score=318.99  Aligned_cols=260  Identities=16%  Similarity=0.205  Sum_probs=199.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC-----
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN-----  207 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----  207 (430)
                      .++|.+.+.||+|+||.||+|.....+++.||+|++...               ......+.+|+.+++.++|++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~   82 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------------GKYREAARLEINVLKKIKEKDKENKF   82 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------------ccchhHHHHHHHHHHHHhhcCCCCce
Confidence            467999999999999999999876544579999998421               122467888999999997765     


Q ss_pred             -cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          208 -IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       208 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                       ++.+++++...+..++||||+ +++|.+++..  .....+++..++.++.|++.||.|||+.   +|+||||||+|||+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll  156 (355)
T 2eu9_A           83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILF  156 (355)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEE
T ss_pred             eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence             899999999999999999999 6678887754  2335699999999999999999999954   59999999999999


Q ss_pred             -------------------CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          287 -------------------DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       287 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                                         +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE  231 (355)
T ss_dssp             SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             ecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence                               567899999999998754332     13578999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccc-------------------------------cccCCCcHHH
Q 014140          348 LVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS-------------------------------KLLGNGYEEQ  396 (430)
Q Consensus       348 ll~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~  396 (430)
                      |++|..||.....    ......+...... .+......                               ..........
T Consensus       232 l~~g~~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (355)
T 2eu9_A          232 YYRGFTLFQTHEN----REHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE  306 (355)
T ss_dssp             HHHSSCSCCCSSH----HHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred             HHhCCCCCCCCCH----HHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence            9999999875321    1122222222211 11100000                               0000112233


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          397 MLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       397 ~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...+.+|+..||+.||++|||+.++++
T Consensus       307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          307 HVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            456889999999999999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.3e-41  Score=321.23  Aligned_cols=253  Identities=19%  Similarity=0.262  Sum_probs=170.0

Q ss_pred             cccccccc-ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          133 EDYFASLE-KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~-~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .++|.+.. .||+|+||.||+|.... +|+.||||++....                  .........++.+.||||+++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~------------------~~~~e~~~~~~~~~h~~i~~~   87 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSP------------------KARQEVDHHWQASGGPHIVCI   87 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESSH------------------HHHHHHHHHHHHTTSTTBCCE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECC-CCCEEEEEEecCcH------------------HHHHHHHHHHHhcCCCChHHH
Confidence            45788854 69999999999998764 89999999984311                  111222334566799999999


Q ss_pred             eeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++..    ....++||||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+|||++
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~  162 (336)
T 3fhr_A           88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYT  162 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             HHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE
Confidence            999976    4458999999999999999964  23356999999999999999999999655   99999999999998


Q ss_pred             C---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 D---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .   ++.+||+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus       163 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  238 (336)
T 3fhr_A          163 SKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS  238 (336)
T ss_dssp             CSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh
Confidence            6   45599999999987653322    2346899999999998888999999999999999999999998654321111


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+.    ....  .+.......    ....+.+++..||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~----~~~~--~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          239 PGMKRRIR----LGQY--GFPNPEWSE----VSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------------------CCCTTTSTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHhhh----cccc--ccCchhhcc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111110    0000  000001111    2234889999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=321.27  Aligned_cols=259  Identities=22%  Similarity=0.277  Sum_probs=194.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||||++.....            .......+.+|+.+++.++||||++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   89 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQ------------SEIFAKRAYRELLLLKHMQHENVIGLL   89 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC-CCCEEEEEEeccccc------------chHHHHHHHHHHHHHHhcCCCCcccHh
Confidence            4679999999999999999998764 899999999854221            123356789999999999999999999


Q ss_pred             eEEEeCCe------eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRDC------DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      +++...+.      .++||||+. |+|.+++.      ..+++..+..++.|++.||.|||+.+   ++||||||+||++
T Consensus        90 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~  159 (353)
T 3coi_A           90 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAV  159 (353)
T ss_dssp             EEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEE
T ss_pred             heEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeE
Confidence            99987654      499999997 58888762      24999999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+||+|||++.......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....    .
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~  230 (353)
T 3coi_A          160 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----L  230 (353)
T ss_dssp             CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----H
T ss_pred             CCCCcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            999999999999998754321     13478999999999887 6789999999999999999999999875321    1


Q ss_pred             cHHHHHHHHhcCCCCc--------------hhc---cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPN--------------RAI---NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~--------------~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .....+..........              ..+   ...............+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111111111000000              000   000001111223345889999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=314.65  Aligned_cols=263  Identities=19%  Similarity=0.240  Sum_probs=189.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.... +|+.||+|++....              ......+.+|+.++++++||||++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~   74 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTD--------------PQSVKHALREIKIIRRLDHDNIVKVF   74 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT-TTEEEEEEEEECCS--------------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecCC--------------hHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            4679999999999999999998764 79999999884321              23357789999999999999999999


Q ss_pred             eEEE--------------eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          213 ARMV--------------RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       213 ~~~~--------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      +++.              +.+..++||||++ |+|.+++.     ...+++..++.++.|++.||.|||+.+   ++|||
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d  145 (320)
T 2i6l_A           75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRD  145 (320)
T ss_dssp             EEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred             EeccccccccccccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence            9873              3467899999997 59999983     246899999999999999999999655   99999


Q ss_pred             CCCCcEEeC-CCCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          279 IQPANVLID-DDMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       279 lkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                      |||+||+++ +++.+||+|||++......... .......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||
T Consensus       146 lkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  225 (320)
T 2i6l_A          146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF  225 (320)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence            999999997 5679999999999876533221 11223467999999998765 57899999999999999999999998


Q ss_pred             CccccccccccHHHHHHHHhcCCC----------Cchhcccccc-CC-----CcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          356 DDFFQHTKEMSLVQWMRNVMTSEN----------PNRAINSKLL-GN-----GYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       356 ~~~~~~~~~~~l~~~~~~~~~~~~----------~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      .....    ......+........          ....+..... ..     ........+.+++..||+.||.+|||+.
T Consensus       226 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (320)
T 2i6l_A          226 AGAHE----LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE  301 (320)
T ss_dssp             CCSSH----HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CCCCH----HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence            75322    111111111100000          0000000000 00     0011234588999999999999999999


Q ss_pred             HHHH
Q 014140          420 DVRC  423 (430)
Q Consensus       420 ev~~  423 (430)
                      ++++
T Consensus       302 ell~  305 (320)
T 2i6l_A          302 EALS  305 (320)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=314.09  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=181.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||.||+|++.. +|+.||||++......            ......+..+..+++.++||||++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~~~~~~~~~~h~~i~~~~   90 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNK------------EENKRILMDLDVVLKSHDCPYIVQCF   90 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT-TCCEEEEEEEETTSCH------------HHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hccccccceeeecCCeeEEEEEEec-CCeEEEEEEecccccc------------hHHHHHHHHHHHHHHhcCCCceeeEE
Confidence            4679999999999999999999864 8999999998543211            12234455666678888999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++...+..++||||+ ++.+..+...   ....+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~  164 (318)
T 2dyl_A           91 GTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI  164 (318)
T ss_dssp             EEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCE
T ss_pred             EEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCE
Confidence            9999999999999999 5566665532   235689999999999999999999964  149999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ||+|||++.........   ....||+.|+|||++.     +..++.++||||||+++|+|++|..||.....      .
T Consensus       165 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~  235 (318)
T 2dyl_A          165 KLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------D  235 (318)
T ss_dssp             EECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------H
T ss_pred             EEEECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------c
Confidence            99999999776543222   2346899999999985     45688999999999999999999999865321      1


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .+..........+....    ....+    ..+.+++..||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          236 FEVLTKVLQEEPPLLPG----HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHHSCCCCCCS----SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhccCCCCCCc----cCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence            12222222222111000    01122    34888999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-40  Score=327.20  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=185.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  212 (430)
                      +.|.+.+.||+|+||+||.+...  +|+.||||++...                 ....+.+|+.++..+ +||||++++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~-----------------~~~~~~~E~~~l~~l~~HpnIv~~~   75 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID-----------------FCDIALMEIKLLTESDDHPNVIRYY   75 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES--SSSEEEEEEEEGG-----------------GHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHH-----------------HHHHHHHHHHHHHhccCCCCcCeEE
Confidence            45677789999999999866443  7999999998431                 134578899999887 899999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRE---LDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +++.+.+..++|||||. |+|.+++.........   .++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        76 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~  151 (434)
T 2rio_A           76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTS  151 (434)
T ss_dssp             EEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECC
T ss_pred             EEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecC
Confidence            99999999999999996 6999999653221111   133345789999999999999655   9999999999999754


Q ss_pred             -------------CceEEeecCCcccCCCCCCcc--eeeccccccccccccccCC-------CCCCcchhHHHHHHHHHH
Q 014140          290 -------------MEARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQT-------VALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       290 -------------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~e  347 (430)
                                   +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e  231 (434)
T 2rio_A          152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY  231 (434)
T ss_dssp             HHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred             cccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence                         489999999999876543221  1224579999999999876       568999999999999999


Q ss_pred             HHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          348 LVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       348 ll~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      |++ |..||......     ..............        ...........+.+++..||+.||.+|||+.+|++
T Consensus       232 llt~g~~Pf~~~~~~-----~~~i~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          232 ILSKGKHPFGDKYSR-----ESNIIRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHTTSCCTTCSTTTH-----HHHHHHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCCCCCchhh-----HHHHhcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999 99998653221     11111111111111        11123445567899999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-41  Score=319.11  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=197.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||.+...........        .....+.+|+.++++++  ||||++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGEL--------PNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEEC--------TTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhh--------hhhhHHHHHHHHHHhhccCCCCceE
Confidence            4679999999999999999998764 899999999965432211000        01234667999999996  599999


Q ss_pred             ceeEEEeCCeeEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC-C
Q 014140          211 LLARMVRRDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-D  288 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~  288 (430)
                      +++++...+..++|||++.+ ++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++ +
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN  185 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence            99999999999999999976 899999954    346899999999999999999999655   99999999999999 7


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||++........    ....||+.|+|||++.+..+ +.++||||||+++|||++|..||.....       
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------  254 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------  254 (320)
T ss_dssp             TTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             CCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence            89999999999987654322    23468999999999887765 6789999999999999999999864211       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                            .......       .....+    ..+.+++..||+.||.+|||+.+|++
T Consensus       255 ------~~~~~~~-------~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ------IIRGQVF-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------HHHCCCC-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------hhccccc-------ccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0101000       001122    34889999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=315.02  Aligned_cols=247  Identities=19%  Similarity=0.207  Sum_probs=189.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc----CCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV----RHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpni  208 (430)
                      .++|.+.+.||+|+||.||+|+... +|+.||||++.........        .......+.+|+.++.++    +||||
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWS--------PLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC----------------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccc--------cchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            4679999999999999999998764 8899999998543221100        001123456788888888    89999


Q ss_pred             ccceeEEEeCCeeEEEEEe-cCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          209 VPLLARMVRRDCDLLVYEF-RRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++++++...+..++|||| +.+++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILID  173 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEE
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEe
Confidence            9999999999999999999 789999999964    345999999999999999999999665   99999999999999


Q ss_pred             -CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          288 -DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       288 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                       .++.+||+|||++........    ....||..|+|||++.+..+ +.++||||||+++|+|++|+.||.....     
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----  244 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----  244 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             CCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence             889999999999987754322    23568999999999887766 4589999999999999999999864211     


Q ss_pred             cHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                          ....   ....        ....    ...+.+++..||+.||++|||+.++++
T Consensus       245 ----~~~~---~~~~--------~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ----ILEA---ELHF--------PAHV----SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHT---CCCC--------CTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----Hhhh---ccCC--------cccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000   0000        0111    234788999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.9e-40  Score=338.33  Aligned_cols=261  Identities=23%  Similarity=0.266  Sum_probs=196.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|.+.. +|+.||||++....             .......+.+|+.++++++||||+++++
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~-------------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~   79 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQEL-------------SPKNRERWCLEIQIMKKLNHPNVVSARE   79 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCC-------------CHHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccC-------------CHHHHHHHHHHHHHHHhCCCCCCCceee
Confidence            579999999999999999998764 89999999884321             1233577899999999999999999999


Q ss_pred             EEEe------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          214 RMVR------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       214 ~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++..      .+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        80 v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~  155 (676)
T 3qa8_A           80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQ  155 (676)
T ss_dssp             CCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEE
T ss_pred             eecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEee
Confidence            8765      677899999999999999996532 2346899999999999999999999655   99999999999999


Q ss_pred             CCCc---eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 DDME---ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .++.   +||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....    
T Consensus       156 ~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----  228 (676)
T 3qa8_A          156 PGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----  228 (676)
T ss_dssp             CCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----
T ss_pred             cCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----
Confidence            7665   999999999887554322   235789999999999999999999999999999999999999864311    


Q ss_pred             ccHHHHHHHHhc--------CCCCchh--ccc--cccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 014140          365 MSLVQWMRNVMT--------SENPNRA--INS--KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV  421 (430)
Q Consensus       365 ~~l~~~~~~~~~--------~~~~~~~--~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev  421 (430)
                        ...|......        .......  +..  .............+.+++..||+.||++|||+.++
T Consensus       229 --~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          229 --PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             --HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             --hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence              1111100000        0000000  000  00112333455678999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=321.57  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=183.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      ...|.+.+.||+|+||+|+.....  +|+.||||++.....                 ..+.+|+.+|+.+ +||||+++
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~-----------------~~~~~E~~~l~~l~~HpnIv~l   83 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF-----------------SFADREVQLLRESDEHPNVIRY   83 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE-----------------EECHHHHHHHHHSCCCTTBCCE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH-----------------HHHHHHHHHHHhccCCCCcCeE
Confidence            456899999999999996544333  889999999843211                 1245799999999 79999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---  288 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---  288 (430)
                      ++++.+.+..++|||||. |+|.+++..   ....+....++.++.|++.||.|||+.+   |+||||||+|||++.   
T Consensus        84 ~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~  156 (432)
T 3p23_A           84 FCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNA  156 (432)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBT
T ss_pred             EEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCC
Confidence            999999999999999996 599999964   2233455566789999999999999665   999999999999953   


Q ss_pred             --CCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 014140          289 --DMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQH  361 (430)
Q Consensus       289 --~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~  361 (430)
                        ...+||+|||+++........ .......||+.|+|||++.+   ..++.++|||||||++|||++ |..||..... 
T Consensus       157 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-  235 (432)
T 3p23_A          157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-  235 (432)
T ss_dssp             TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-
T ss_pred             CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-
Confidence              335889999999887643221 22234579999999999984   567889999999999999999 8999854321 


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                             ............ ....      ........+.+|+..||+.||.+|||+.+|++
T Consensus       236 -------~~~~~~~~~~~~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          236 -------RQANILLGACSL-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -------HHHHHHTTCCCC-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHHhccCCc-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                   111111111111 1110      11223345789999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.4e-39  Score=298.51  Aligned_cols=234  Identities=13%  Similarity=0.101  Sum_probs=181.1

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||.||+|+... +|+.||||++......           .......+.+|+.++.+++||||+++++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~iv~~~~   98 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVL-----------PDDVLQETLSRTLRLSRIDKPGVARVLD   98 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCS-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECccccc-----------CHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence            579999999999999999998763 7999999999543221           1234578999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..|+||||++|++|.+++..     . .....+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~k  169 (286)
T 3uqc_A           99 VVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVV  169 (286)
T ss_dssp             EEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEE
T ss_pred             EEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEE
Confidence            99999999999999999999999832     1 355678899999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+++|                      |++       .++.++|||||||++|+|++|+.||.............    .
T Consensus       170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~  216 (286)
T 3uqc_A          170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----R  216 (286)
T ss_dssp             ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----B
T ss_pred             EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----H
Confidence            98443                      333       36889999999999999999999987643211000000    0


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ......+.   ........    ...+.+++.+||+.||.+| |+.++++.|+++.
T Consensus       217 ~~~~~~~~---~~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          217 DTAGQPIE---PADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             CTTSCBCC---HHHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             HhccCCCC---hhhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            00000000   00111112    2348899999999999999 9999999998753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-39  Score=338.02  Aligned_cols=241  Identities=20%  Similarity=0.239  Sum_probs=191.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|.+...+|+.||||++....             .......+.+|+.++.+++||||++++
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~E~~~l~~l~hp~iv~~~  145 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------------DAEAQAMAMAERQFLAEVVHPSIVQIF  145 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-------------CHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-------------CHHHHHHHHHHHHHHHhcCCCCcCeEe
Confidence            4689999999999999999998764478999999884321             123356789999999999999999999


Q ss_pred             eEEEeCCe-----eEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRRDC-----DLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...+.     .|+||||+++++|.+++.      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~  216 (681)
T 2pzi_A          146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLT  216 (681)
T ss_dssp             EEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             eeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEe
Confidence            99988765     699999999999998773      26999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      .+ .+||+|||++......      ....||+.|+|||++.+. ++.++|||||||++++|++|..||........    
T Consensus       217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----  284 (681)
T 2pzi_A          217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----  284 (681)
T ss_dssp             SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----
T ss_pred             CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----
Confidence            85 8999999999876543      235799999999998765 48899999999999999999988764322100    


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHhc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-SKDVRCMLSQ  427 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-~~ev~~~L~~  427 (430)
                                  +.        ..........+.+++.+||+.||.+||+ +.++...|..
T Consensus       285 ------------~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 ------------PE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------------CT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------------cc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                        00        0000112235889999999999999995 5556665543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-38  Score=299.79  Aligned_cols=231  Identities=19%  Similarity=0.291  Sum_probs=175.7

Q ss_pred             cccccc-cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHH-hccCCCCcccc
Q 014140          134 DYFASL-EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITA-GQVRHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~-~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l  211 (430)
                      ++|.+. +.||+|+||.||+|.... +|+.||+|++..                   ...+.+|+.++ +.++||||+++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~-------------------~~~~~~e~~~~~~~~~h~~i~~~   76 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVRI   76 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC-CCcEEEEEEecc-------------------cHHHHHHHHHHHHhccCCCchhH
Confidence            457776 789999999999998764 899999999832                   23467788887 55589999999


Q ss_pred             eeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      ++++..    .+..++||||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+|||++
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  151 (299)
T 3m2w_A           77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT  151 (299)
T ss_dssp             EEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEES
T ss_pred             HhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEe
Confidence            999987    6778999999999999999975  33456999999999999999999999655   99999999999999


Q ss_pred             C---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 D---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .   ++.+||+|||++....                        +..++.++|||||||++|+|++|..||.........
T Consensus       152 ~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  207 (299)
T 3m2w_A          152 SKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  207 (299)
T ss_dssp             SSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred             cCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence            8   7889999999986532                        234678899999999999999999998653221000


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...    ........  ..+.......    ....+.+++..||+.||.+|||+.++++
T Consensus       208 ~~~----~~~~~~~~--~~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 PGM----KTRIRMGQ--YEFPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCS----CCSSCTTC--CSSCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHH----HHHHhhcc--ccCCchhccc----CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000    00000000  0000000011    2335889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-38  Score=311.98  Aligned_cols=247  Identities=14%  Similarity=0.098  Sum_probs=181.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-CCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-RNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l  211 (430)
                      ...|...+.||+|+||.||+|++.. +|+.||||++......           .......+.+|+.+++.++| +|...+
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~-----------~~~~~~~~~~E~~~~~~l~~~~~~~~~  144 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERP-----------PSNAIKQMKEEVLRLRLLRGIKNQKQA  144 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC---------------CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred             ceeEEEecccccCCCEEEEEEEecC-CCCceEEEEEecCCCc-----------cHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence            3457888999999999999999764 8999999988532221           11224678999999999987 322111


Q ss_pred             ---------eeE------------EEe-----CCeeEEEEEecCCCCHHHHHhhh---cCCCCCCCHHHHHHHHHHHHHH
Q 014140          212 ---------LAR------------MVR-----RDCDLLVYEFRRNGSLQDILYDV---SQGRRELDWLARHRIAQGIASG  262 (430)
Q Consensus       212 ---------~~~------------~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~  262 (430)
                               ...            +..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a  223 (413)
T 3dzo_A          145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL  223 (413)
T ss_dssp             HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence                     111            111     12356777776 67999998532   2334568889999999999999


Q ss_pred             HHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeecccccccccccccc----------CCCCC
Q 014140          263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH----------QTVAL  332 (430)
Q Consensus       263 l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~  332 (430)
                      |.|||+.+   |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..+
T Consensus       224 L~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          224 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             HHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             HHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC
Confidence            99999555   999999999999999999999999998875432     224567 999999998          55568


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCC
Q 014140          333 SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDP  412 (430)
Q Consensus       333 ~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp  412 (430)
                      +.++|||||||++|||++|+.||..........       ..+..           ....+    ..+.+++..||+.||
T Consensus       295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-------~~~~~-----------~~~~~----~~~~~li~~~l~~dP  352 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-------WIFRS-----------CKNIP----QPVRALLEGFLRYPK  352 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-------GGGSS-----------CCCCC----HHHHHHHHHHTCSSG
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-------HHHhh-----------cccCC----HHHHHHHHHHccCCh
Confidence            899999999999999999999987542211000       00100           01122    348899999999999


Q ss_pred             CCCCCHHHHHH
Q 014140          413 NKRPNSKDVRC  423 (430)
Q Consensus       413 ~~Rps~~ev~~  423 (430)
                      ++||++.++++
T Consensus       353 ~~Rpt~~~~l~  363 (413)
T 3dzo_A          353 EDRLLPLQAME  363 (413)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCcCHHHHHh
Confidence            99999887754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-38  Score=304.02  Aligned_cols=250  Identities=15%  Similarity=0.106  Sum_probs=183.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--------
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--------  204 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  204 (430)
                      .++|.+.+.||+|+||.||+|+.   +|+.||||++.........      .........+.+|+.+++.++        
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVN------GSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBT------TBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccc------cccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            45789999999999999999986   6899999999654321000      001122466888888888885        


Q ss_pred             -CCCcccceeEEE-----------------e-------------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHH
Q 014140          205 -HRNIVPLLARMV-----------------R-------------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH  253 (430)
Q Consensus       205 -hpniv~l~~~~~-----------------~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  253 (430)
                       ||||+++.+++.                 +             .+..++||||+++|++.+.+.     ...+++..++
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~  164 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAK  164 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHH
Confidence             777776666543                 2             678999999999997766662     2468999999


Q ss_pred             HHHHHHHHHHHHHh-hcCCCCeEecCCCCCcEEeCCCC--------------------ceEEeecCCcccCCCCCCccee
Q 014140          254 RIAQGIASGLEYLH-MSHRPRIIHRDIQPANVLIDDDM--------------------EARISEFGLAKRIPDGHTRTTT  312 (430)
Q Consensus       254 ~i~~~i~~~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~  312 (430)
                      .++.||+.||.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....      
T Consensus       165 ~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 787   99999999999999887                    8999999999876432      


Q ss_pred             eccccccccccccccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCC
Q 014140          313 WSLAGTVGYIAPECHQTVALSDTCDIYSFGVL-LAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGN  391 (430)
Q Consensus       313 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~-l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                       ...||+.|+|||++.+.. +.++||||||++ .+++++|..||.....      ................    .....
T Consensus       236 -~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~----~~~~~  303 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQMTFKT----KCNTP  303 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTCCCSS----CCCSH
T ss_pred             -cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhhccCc----ccchh
Confidence             247999999999998766 889999998777 7788889988643100      0001111111100000    00011


Q ss_pred             CcHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 014140          392 GYEEQMLLVLKIACFCTLDDPNKRPNSKDVR  422 (430)
Q Consensus       392 ~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~  422 (430)
                      ........+.+|+.+||+.|     |+.|++
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            22345667999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.6e-32  Score=275.08  Aligned_cols=196  Identities=19%  Similarity=0.090  Sum_probs=133.2

Q ss_pred             ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccceeEEEeCC
Q 014140          141 KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRRD  219 (430)
Q Consensus       141 ~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  219 (430)
                      ..+.|++|....++.. ..|+.++||.+........    ......+....+|.+|+.+|+++ .|+||+++++++.+++
T Consensus       241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGI----LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             C-C--------CCEEE-EECSSEEEEEEESSCSTTC----SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             ccccCCcccccccccc-cccceeEEEEEeccccccc----chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            3556777766665533 3789999999965432211    11122334467899999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCC
Q 014140          220 CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGL  299 (430)
Q Consensus       220 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~  299 (430)
                      ..||||||++|++|.++|..    .++++..   .|+.||+.||.|+|+.+   |+||||||+|||++.++.+||+|||+
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl  385 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS  385 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence            99999999999999999953    3456654   58999999999999555   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          300 AKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       300 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      |+.........  ...+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus       386 Ar~~~~~~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          386 IVTTPQDCSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             EESCC---CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CeeCCCCCccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            98776543322  24689999999999976 466789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=7.1e-29  Score=250.87  Aligned_cols=194  Identities=15%  Similarity=0.093  Sum_probs=149.2

Q ss_pred             ccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEE
Q 014140          137 ASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       137 ~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  216 (430)
                      ...+.||+|+||.||+|..   .+..+++|+.........      ..........+.+|+.++++++||||+++..++.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~------~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  409 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDE------RLDENIRKSRTAREARYLALVKDFGIPAPYIFDV  409 (540)
T ss_dssp             ---------CCEEEEEEEC---SSCEEEEEEECCCTTSCH------HHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccch------hhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence            4467899999999999965   678899998754221100      0111123567899999999999999998777777


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEee
Q 014140          217 RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISE  296 (430)
Q Consensus       217 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D  296 (430)
                      ..+..++||||+++|+|.+++..            +..++.|++.||.|||+.+   |+||||||+|||++.  .+||+|
T Consensus       410 ~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          410 DLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             ETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred             eCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence            88889999999999999999832            5689999999999999655   999999999999999  999999


Q ss_pred             cCCcccCCCCCCcc-----eeeccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          297 FGLAKRIPDGHTRT-----TTWSLAGTVGYIAPECHQT--VALSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       297 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      ||+++.........     ......||+.|+|||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99999875532211     1124679999999999987  568888999999999998888877653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.4e-24  Score=199.01  Aligned_cols=162  Identities=12%  Similarity=0.013  Sum_probs=119.8

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhcc----CCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKK----DSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      ....|.+.+.||+|+||.||+|..  .+|+.||||.+.............    ...........+.+|+.+|++++  |
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             CCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            345677889999999999999998  389999999985432211000000    00111123567899999999999  5


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                       +++.+++.. +..++||||++||+|.+ +.    .      .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence             777775544 56699999999999988 41    1      123469999999999999555   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCC
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT  329 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  329 (430)
                       ++.+||+|||+++.               +..+.|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999853               345788888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=6.3e-20  Score=168.15  Aligned_cols=154  Identities=16%  Similarity=0.156  Sum_probs=108.1

Q ss_pred             ccccccccccccCceEEEeecCCCCCce--EEEEEeecccccch---hhh------ccC-CchhhHHHHHHHHHHHHHhc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRV--ITIKKIIQPLKSGA---ELI------KKD-SEPLHHKMIQIRSEIITAGQ  202 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~--vavK~~~~~~~~~~---~~~------~~~-~~~~~~~~~~~~~E~~~l~~  202 (430)
                      .|.+.+.||+|+||.||+|.... +|+.  ||||++........   ..+      ... ..........+.+|+.+|..
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            36788999999999999998732 7888  99998754321100   000      000 00011223568899999999


Q ss_pred             cCCCCcccceeEEEeCCeeEEEEEecCC-C----CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEe
Q 014140          203 VRHRNIVPLLARMVRRDCDLLVYEFRRN-G----SLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH-MSHRPRIIH  276 (430)
Q Consensus       203 l~hpniv~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH  276 (430)
                      ++|+++....-+..  +..++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.+   |+|
T Consensus       127 l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          127 AKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            99886522222222  356899999942 3    67666421       234456789999999999999 777   999


Q ss_pred             cCCCCCcEEeCCCCceEEeecCCcccC
Q 014140          277 RDIQPANVLIDDDMEARISEFGLAKRI  303 (430)
Q Consensus       277 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~  303 (430)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=9e-19  Score=167.08  Aligned_cols=155  Identities=11%  Similarity=0.051  Sum_probs=104.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchh------hhccCCchh--hHHHHHHHHHHHHHhccCC
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE------LIKKDSEPL--HHKMIQIRSEIITAGQVRH  205 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~~~--~~~~~~~~~E~~~l~~l~h  205 (430)
                      .-|.+...||.|++|.||+|...  +|+.||||++.........      .........  .........|...|.++.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            34899999999999999999875  8999999988543221100      000000000  0111223467778888865


Q ss_pred             CCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 014140          206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVL  285 (430)
Q Consensus       206 pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil  285 (430)
                      +++....-+...  ..+|||||++|++|..+.    .    .  .....++.|++.+|.|||..+   ||||||||.|||
T Consensus       173 ~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~----~----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          173 EGFPVPEPIAQS--RHTIVMSLVDALPMRQVS----S----V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             TTCSCCCEEEEE--TTEEEEECCSCEEGGGCC----C----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             cCCCCCeeeecc--CceEEEEecCCccHhhhc----c----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            554332222222  237999999998886543    1    1  123568899999999999555   999999999999


Q ss_pred             eCCCC----------ceEEeecCCcccCCC
Q 014140          286 IDDDM----------EARISEFGLAKRIPD  305 (430)
Q Consensus       286 l~~~~----------~~kl~Dfg~a~~~~~  305 (430)
                      +++++          .+.|+||+.+.....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCCC
Confidence            98776          389999998876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=2.2e-12  Score=118.05  Aligned_cols=142  Identities=12%  Similarity=0.085  Sum_probs=109.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ..|.+...++.|+.+.||++..   .|..+++|........              ....+.+|+.+++.+. +.++.+++
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~vP~v~   76 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKG--------------TTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTT--------------STTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCC--------------CHHHHHHHHHHHHHHhcCCCCCeEE
Confidence            3577888889899999999974   5788999988432110              0124788999999985 67788999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH----------------------  270 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------  270 (430)
                      +++...+..|+||||++|.+|.+.+.         +......++.+++.+|..||+..                      
T Consensus        77 ~~~~~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           77 HFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEecCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            99998899999999999999887631         11223468889999999999710                      


Q ss_pred             ----------------------------------CCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          271 ----------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       271 ----------------------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                                                        ..+++|+|++|.||+++++..+.|+||+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                              1459999999999999876666799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=7.5e-11  Score=107.38  Aligned_cols=137  Identities=12%  Similarity=0.145  Sum_probs=97.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC--cccce
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN--IVPLL  212 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~  212 (430)
                      .+.+..+.+.|..+.||++...  +|..+++|......                 ...+..|+.+++.+.+.+  +.+++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~~vP~~~   81 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAVL   81 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT--TSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCEE
T ss_pred             CCceEecccCCCCceEEEEecC--CCCeEEEEeCCccc-----------------chhhhHHHHHHHHHHhCCCCCCeEE
Confidence            3444444445666999999753  67889999873310                 134678999999886544  45688


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH----------------------  270 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------  270 (430)
                      +++...+..++||||++|.+|.  ..   .    ..   ...++.+++..|..||+..                      
T Consensus        82 ~~~~~~~~~~~v~e~i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~  149 (264)
T 1nd4_A           82 DVVTEAGRDWLLLGEVPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME  149 (264)
T ss_dssp             EEEECSSCEEEEEECCSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred             EeccCCCCCEEEEEecCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence            8888778889999999998884  21   1    11   2256777788888888542                      


Q ss_pred             ---------------------------------CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 ---------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ---------------------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                                                       ..+++|+|++|.||++++++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                             12399999999999998776677999998643

>3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare}

Probab=99.17  E-value=4.5e-11  Score=93.99  Aligned_cols=48  Identities=19%  Similarity=0.365  Sum_probs=44.4

Q ss_pred             ChhHHHHHHhHHHh--hhchHHHHHHHHHHHHhhhhhhhhHHHhhhHHHH
Q 014140            1 MVKINKVLDDAIEK--QTKEESVKIWLGKLQHLAYDVDYLLDEFQTEAFQ   48 (430)
Q Consensus         1 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   48 (430)
                      |..|+++|.|||++  |.+|+.|+.|+++||+++||+||+||+|.+++-.
T Consensus        35 L~~m~a~L~da~~~~~~~~d~~vk~W~~~vrdlaYD~ED~iD~f~~~~~~   84 (115)
T 3qfl_A           35 LESMNAALIKIGEVPREQLDSQDKLWADEVRELSYVIEDVVDKFLVQVDG   84 (115)
T ss_dssp             HHHHHHHHHHHTTSCGGGCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            46899999999999  7799999999999999999999999999998743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=2e-10  Score=109.91  Aligned_cols=143  Identities=13%  Similarity=0.147  Sum_probs=106.4

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEee--cccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCccccee
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKII--QPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNIVPLLA  213 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~  213 (430)
                      .++.++.|.++.||+...   .+..+++|+..  .....             .....+.+|+.+++.+.  +.++.+++.
T Consensus        42 ~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~~-------------~~~~~~~~E~~~l~~L~~~~vpvP~~~~  105 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKLL-------------PSAHAIEREYRVMDALAGTDVPVAKMYA  105 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC---SSCEEEEECCCC-----------------------CHHHHHHHHHHHTTSSSCCCCEEE
T ss_pred             eEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCCC-------------CcHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            467789999999999975   45678888764  21100             11245778999999997  456788888


Q ss_pred             EEEeC---CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------
Q 014140          214 RMVRR---DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH--------------------  270 (430)
Q Consensus       214 ~~~~~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------  270 (430)
                      ++.+.   +..++||||++|.++.+..      ...++...+..++.+++..|+.||...                    
T Consensus       106 ~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3dxp_A          106 LCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQI  179 (359)
T ss_dssp             EECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHH
T ss_pred             ECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHH
Confidence            88766   4589999999998775421      234778888899999999999999731                    


Q ss_pred             -----------------------------------CCCeEecCCCCCcEEeCCCCc--eEEeecCCccc
Q 014140          271 -----------------------------------RPRIIHRDIQPANVLIDDDME--ARISEFGLAKR  302 (430)
Q Consensus       271 -----------------------------------~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~a~~  302 (430)
                                                         ..+++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          180 ERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                               256999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=4.7e-10  Score=104.81  Aligned_cols=187  Identities=15%  Similarity=0.138  Sum_probs=119.9

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCC--cccceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRN--IVPLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~  215 (430)
                      ++.++.|....||+..      ..+++|.....                .....+..|+.+|+.+. +..  +.+++...
T Consensus        25 i~~~~~G~~n~v~~v~------~~~vlR~~~~~----------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~   82 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------RDFIFKFPKHS----------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTG   82 (304)
T ss_dssp             CCEEEECSSEEEEEST------TSEEEEEESSH----------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC
T ss_pred             eEecCCCCcceEEEEC------CEEEEEecCCc----------------chHHHHHHHHHHHHHHHhcCCCCCCceEeec
Confidence            4568899999999873      34888875211                22467889999998884 332  33444433


Q ss_pred             EeCC---eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------
Q 014140          216 VRRD---CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH----------------------  270 (430)
Q Consensus       216 ~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------  270 (430)
                      ...+   ..|+|||+++|.+|.+...      ..++...+..++.+++..+..||...                      
T Consensus        83 ~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~  156 (304)
T 3sg8_A           83 MPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKK  156 (304)
T ss_dssp             CCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHH
T ss_pred             CCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHH
Confidence            3332   3489999999988875432      23677777888888888888888521                      


Q ss_pred             ---------------------------------CCCeEecCCCCCcEEeCC--CCceEEeecCCcccCCCCCCccee---
Q 014140          271 ---------------------------------RPRIIHRDIQPANVLIDD--DMEARISEFGLAKRIPDGHTRTTT---  312 (430)
Q Consensus       271 ---------------------------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~---  312 (430)
                                                       .+.++|+|++|.||++++  ...+.|+||+.+............   
T Consensus       157 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~  236 (304)
T 3sg8_A          157 IKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED  236 (304)
T ss_dssp             HHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT
T ss_pred             HHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh
Confidence                                             145899999999999998  556889999988653221000000   


Q ss_pred             ---------ecccccccccc-ccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 014140          313 ---------WSLAGTVGYIA-PECHQTVALSDTCDIYSFGVLLAVLVIGKFPS  355 (430)
Q Consensus       313 ---------~~~~gt~~y~a-PE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~  355 (430)
                               ......++... |+....  .....+.|++|.+++.+.+|..+|
T Consensus       237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          237 DEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     00001111122 222111  122368999999999999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=4.9e-07  Score=82.52  Aligned_cols=135  Identities=13%  Similarity=0.086  Sum_probs=94.8

Q ss_pred             ccccccCc-eEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccceeEEEeC
Q 014140          141 KIRSCWNG-EVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLARMVRR  218 (430)
Q Consensus       141 ~lg~G~~g-~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  218 (430)
                      .+..|..| .||+.... .++..+++|+-...                 ....+..|...|+.+. +-.+.++++++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~-----------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~   92 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK-PNAPELFLKHGKGS-----------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP   92 (272)
T ss_dssp             EEECSSSSCEEEEEECC-TTCCCEEEEEEETH-----------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             EccCCCcCCeEEEEEec-CCCeEEEEEECCCC-----------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence            34445544 68987654 26678999976321                 1356788999998885 33467788889999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH----------------------------  270 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------  270 (430)
                      +..++|||+++|.++.+....        .......++.+++..|.-||...                            
T Consensus        93 ~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (272)
T 4gkh_A           93 DDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA  164 (272)
T ss_dssp             TEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred             CeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence            999999999999888776522        11223345666666666666321                            


Q ss_pred             ---------------------------CCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          271 ---------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       271 ---------------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                                                 .+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                       1137999999999999988777899998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=9.5e-07  Score=82.31  Aligned_cols=136  Identities=18%  Similarity=0.117  Sum_probs=90.7

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC---CcccceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR---NIVPLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~  215 (430)
                      ++.++.|....||+.      |..+++|....                ......+..|+.+|+.+.+.   .+.+.+.++
T Consensus        24 v~~l~~G~~n~v~~v------g~~~VlR~~~~----------------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~   81 (306)
T 3tdw_A           24 VESLGEGFRNYAILV------NGDWVFRFPKS----------------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIG   81 (306)
T ss_dssp             EEEEEECSSEEEEEE------TTTEEEEEESS----------------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEE
T ss_pred             eeecCCCcceeEEEE------CCEEEEEecCC----------------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeec
Confidence            456788888889987      35578887411                12246788999999999753   245556665


Q ss_pred             E-eCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------
Q 014140          216 V-RRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-------------------------  269 (430)
Q Consensus       216 ~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------  269 (430)
                      . ..+..++||||++|.+|.+...      ..++...+..++.+++..|..||..                         
T Consensus        82 ~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~  155 (306)
T 3tdw_A           82 KRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEA  155 (306)
T ss_dssp             ECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHH
T ss_pred             ccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHH
Confidence            4 3456789999999988876321      1133444444455555555544432                         


Q ss_pred             --------------------------------CCCCeEecCCCCCcEEeCC---CCc-eEEeecCCccc
Q 014140          270 --------------------------------HRPRIIHRDIQPANVLIDD---DME-ARISEFGLAKR  302 (430)
Q Consensus       270 --------------------------------~~~~iiH~Dlkp~Nill~~---~~~-~kl~Dfg~a~~  302 (430)
                                                      ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       156 ~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          156 VEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                            2335799999999999997   355 58999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=2.9e-06  Score=80.74  Aligned_cols=86  Identities=2%  Similarity=-0.064  Sum_probs=52.8

Q ss_pred             ccccc-ccccCceEEEeecC--CC---CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-C--CCc
Q 014140          138 SLEKI-RSCWNGEVYKAELP--GS---SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-H--RNI  208 (430)
Q Consensus       138 ~~~~l-g~G~~g~vy~a~~~--~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pni  208 (430)
                      ..+.| +.|....+|+....  ..   ++..+++|........  ...   .      ...+..|+.+++.+. +  -.+
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~--~~~---~------~~~~~~E~~~l~~L~~~~~vpv   92 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV--PVF---P------TYRLDHQFEVIRLVGELTDVPV   92 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC--CSS---S------CCCHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc--ccC---c------hhHHHHHHHHHHHHhhcCCCCC
Confidence            34667 78888899988642  00   1677888876322100  000   0      123667888888774 2  346


Q ss_pred             ccceeEEEeC---CeeEEEEEecCCCCHH
Q 014140          209 VPLLARMVRR---DCDLLVYEFRRNGSLQ  234 (430)
Q Consensus       209 v~l~~~~~~~---~~~~lV~E~~~~gsL~  234 (430)
                      .+++.++.+.   +..++||||++|.++.
T Consensus        93 P~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           93 PRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             CcEEEEccCCCccCCceEEEEecCCCChh
Confidence            6777776554   3568999999986654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.07  E-value=4.4e-05  Score=71.78  Aligned_cols=31  Identities=16%  Similarity=0.414  Sum_probs=27.8

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                      ..++||+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5679999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.02  E-value=2.3e-05  Score=75.67  Aligned_cols=83  Identities=13%  Similarity=0.052  Sum_probs=48.8

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC--CCcc-cceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH--RNIV-PLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv-~l~~~~  215 (430)
                      .+.+|.|..+.||++.... +++.++||.......    ......   ......+..|..+|+.+..  |..+ +++.+ 
T Consensus        35 ~~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r----~~~~~~---~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAK----VVGESW---PLTIDRARIESSALIRQGEHVPHLVPRVFYS-  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-----CEEEEEEECCC-----------C---CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred             EEECCCCceEEEEEEEECC-CCcEEEEEecchhhc----ccCCCC---cCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-
Confidence            5678999999999997642 568899998643211    000000   0012346678888887742  4333 44433 


Q ss_pred             EeCCeeEEEEEecCCC
Q 014140          216 VRRDCDLLVYEFRRNG  231 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~g  231 (430)
                       +.+..++|||++++.
T Consensus       106 -d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 -DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             -ETTTTEEEECCCTTS
T ss_pred             -cCCccEEEEEeCCCc
Confidence             455678999999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.91  E-value=9.4e-05  Score=68.74  Aligned_cols=140  Identities=16%  Similarity=0.145  Sum_probs=90.6

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---CCCcccceeE
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---HRNIVPLLAR  214 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~  214 (430)
                      ..+.|+.|....+|+...   ++..+++|.....                 ....+..|...|+.|.   ...+.+++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~-----------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~   99 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND---EVQTVFVKINERS-----------------YRSMFRAEADQLALLAKTNSINVPLVYGI   99 (312)
T ss_dssp             EEEEECCSSSSEEEEEES---SSCEEEEEEEEGG-----------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred             eeEEeCCccceeeeEEEE---CCCeEEEEeCCcc-----------------cHHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence            356789999999999974   5678888876321                 1356788999998884   3567888888


Q ss_pred             EEeCCeeEEEEEecCCCCHH--------H---HHhhhcC-CC-----------------CCCCHHHHH---HHH------
Q 014140          215 MVRRDCDLLVYEFRRNGSLQ--------D---ILYDVSQ-GR-----------------RELDWLARH---RIA------  256 (430)
Q Consensus       215 ~~~~~~~~lV~E~~~~gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~------  256 (430)
                      +...+..++||||+++.++.        .   .|+.... ..                 ..-+|....   ++.      
T Consensus       100 ~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a  179 (312)
T 3jr1_A          100 GNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQIC  179 (312)
T ss_dssp             EECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHH
T ss_pred             eecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHH
Confidence            88888899999999987642        1   2222211 00                 011343321   111      


Q ss_pred             ----------HHHHHHH-HHHhh-cCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          257 ----------QGIASGL-EYLHM-SHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       257 ----------~~i~~~l-~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                                ..++..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       180 ~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          180 KEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                      1111112 23421 2256799999999999999887 8888873

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.59  E-value=0.00031  Score=64.48  Aligned_cols=78  Identities=14%  Similarity=0.148  Sum_probs=53.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC---Ccccc
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR---NIVPL  211 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l  211 (430)
                      ....++.+|.|..+.||+.+..  +|+.|++|+.......              ....|..|+..|+.|.-.   .+.++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~--------------~~~~~~~Ea~~L~~L~~~~~vpvP~v   79 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPA--------------LDGLFRAEALGLDWLGRSFGSPVPQV   79 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCC--------------CTTHHHHHHHHHHHHTCSTTCCSCCE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcc--------------hhhHHHHHHHHHHHHHhhCCCCcceE
Confidence            3556788999999999999876  8999999976322111              013477899999888422   23444


Q ss_pred             eeEEEeCCeeEEEEEecCCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGS  232 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gs  232 (430)
                      +++    +..++||||++++.
T Consensus        80 ~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           80 AGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEE----ETTEEEEECCCCCC
T ss_pred             Eec----cCceEEEEeecccC
Confidence            443    23478999998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.57  E-value=0.00046  Score=67.03  Aligned_cols=80  Identities=15%  Similarity=0.081  Sum_probs=48.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC---CCcchhHHHHHHHHHH
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA---LSDTCDIYSFGVLLAV  347 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~e  347 (430)
                      .+.++|+|++|.|||++.++ +.|+||+.+..-......... ...-...|++|+......   ......+.+....+++
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            56799999999999999876 999999988653211000000 000123467776554211   1223455677878887


Q ss_pred             HHhCC
Q 014140          348 LVIGK  352 (430)
Q Consensus       348 ll~g~  352 (430)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.41  E-value=0.0017  Score=60.59  Aligned_cols=143  Identities=13%  Similarity=0.124  Sum_probs=78.1

Q ss_pred             cccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC--cccceeE---
Q 014140          140 EKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN--IVPLLAR---  214 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~---  214 (430)
                      ..++ |....||+....  +|+.+++|........               ...+..|..++..+....  +.+++..   
T Consensus        32 ~~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~~~---------------~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~   93 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE--DRRRFVVKFYRPERWT---------------ADQILEEHQFALQLVNDEVPVAAPVAFNGQ   93 (328)
T ss_dssp             EEEC-CSSSEEEEECCT--TCCCEEEEEECTTTSC---------------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTB
T ss_pred             Eeec-CcccceEEEEcC--CCCEEEEEEcCCCCCC---------------HHHHHHHHHHHHHHHHcCCeecceeecCCc
Confidence            4566 778899988653  6778999987422111               234566777777774211  3333332   


Q ss_pred             --EEeCCeeEEEEEecCCCCHH-----H------H---HhhhcCC-----CCCCCHHHH----HHH--------------
Q 014140          215 --MVRRDCDLLVYEFRRNGSLQ-----D------I---LYDVSQG-----RRELDWLAR----HRI--------------  255 (430)
Q Consensus       215 --~~~~~~~~lV~E~~~~gsL~-----~------~---l~~~~~~-----~~~l~~~~~----~~i--------------  255 (430)
                        ....+..++||+|++|.++.     .      .   ++.....     ....++...    ..+              
T Consensus        94 ~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  173 (328)
T 1zyl_A           94 TLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAA  173 (328)
T ss_dssp             SCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHH
T ss_pred             EEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHH
Confidence              22355668899999874431     1      1   1111110     111222211    000              


Q ss_pred             -HHHHHHHHHHHhhc----CCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          256 -AQGIASGLEYLHMS----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       256 -~~~i~~~l~~LH~~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                       ...+...+..+...    ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       174 ~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          174 FLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             11111222233211    245689999999999999 4 899999987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.28  E-value=0.00081  Score=62.02  Aligned_cols=31  Identities=19%  Similarity=0.122  Sum_probs=25.7

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ...++|+|+.|.||+ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5566789999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.26  E-value=0.0014  Score=61.36  Aligned_cols=33  Identities=24%  Similarity=0.270  Sum_probs=28.2

Q ss_pred             CCCeEecCCCCCcEEeCCC----CceEEeecCCcccC
Q 014140          271 RPRIIHRDIQPANVLIDDD----MEARISEFGLAKRI  303 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~a~~~  303 (430)
                      ...++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999875    68999999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.16  E-value=0.0043  Score=57.57  Aligned_cols=145  Identities=13%  Similarity=0.112  Sum_probs=77.5

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-----CCCcccce-
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-----HRNIVPLL-  212 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-  212 (430)
                      .+.|+.|....+|+....  +| .+++|.......                ...+..|+.++..|.     -|.++... 
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~~~----------------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~   87 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KD-PLILTLYEKRVE----------------KNDLPFFLGLMQHLAAKGLSCPLPLPRKD   87 (322)
T ss_dssp             EEEECC---EEEEEEEES--SC-CEEEEEECC-------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             eeccCCCcccceEEEEeC--Cc-cEEEEEeCCCCC----------------HHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence            456777888899998753  34 688888743100                123455677766663     23333211 


Q ss_pred             e--EEEeCCeeEEEEEecCCCCHHH--------------HHhhhcCC-CCC----C---CHHHHHH------------HH
Q 014140          213 A--RMVRRDCDLLVYEFRRNGSLQD--------------ILYDVSQG-RRE----L---DWLARHR------------IA  256 (430)
Q Consensus       213 ~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~-~~~----l---~~~~~~~------------i~  256 (430)
                      |  +....+..+++++|++|.++..              .++..... ..+    .   .|.....            +.
T Consensus        88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~  167 (322)
T 2ppq_A           88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  167 (322)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence            1  1123466789999999854311              12211111 000    1   1221100            01


Q ss_pred             HHHHHHHHHHhhc----CCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          257 QGIASGLEYLHMS----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       257 ~~i~~~l~~LH~~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..+...+..++..    ...+++|+|+.+.||+++++..+.|+||+.+..
T Consensus       168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1234445555432    134699999999999999876668999987643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.95  E-value=0.0034  Score=59.78  Aligned_cols=145  Identities=13%  Similarity=0.154  Sum_probs=79.7

Q ss_pred             ccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC-cccc
Q 014140          139 LEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN-IVPL  211 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l  211 (430)
                      ++.+..|-...+|+.....      .++..+++|+.....               .....+.+|..+++.|...+ ..++
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---------------~~~~~~~rE~~vl~~L~~~gv~P~l  119 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---------------QGVDSLVLESVMFAILAERSLGPQL  119 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------------CCHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---------------chHHHHHHHHHHHHHHHhcCCCCeE
Confidence            3466677788899987631      134778888752110               01344568999998885222 3455


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHH--------------HH---hhhcC-CCCCCC--HHHHHHHHHHHHH----------
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQD--------------IL---YDVSQ-GRRELD--WLARHRIAQGIAS----------  261 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~--------------~l---~~~~~-~~~~l~--~~~~~~i~~~i~~----------  261 (430)
                      ++++.  +  .+||||++|.+|..              .|   +.... ......  +....++..++..          
T Consensus       120 l~~~~--~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~  195 (379)
T 3feg_A          120 YGVFP--E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMN  195 (379)
T ss_dssp             EEEET--T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCC
T ss_pred             EEEcC--C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhh
Confidence            55543  2  38999999855421              11   11100 111222  3344444433321          


Q ss_pred             ---------HHHHH----hhc-CCCCeEecCCCCCcEEeCCC----CceEEeecCCccc
Q 014140          262 ---------GLEYL----HMS-HRPRIIHRDIQPANVLIDDD----MEARISEFGLAKR  302 (430)
Q Consensus       262 ---------~l~~L----H~~-~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  302 (430)
                               .+..|    ... ....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       196 ~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          196 LLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                     22333    221 23469999999999999876    7899999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.95  E-value=0.011  Score=51.03  Aligned_cols=103  Identities=17%  Similarity=0.092  Sum_probs=68.5

Q ss_pred             CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcc
Q 014140          231 GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT  310 (430)
Q Consensus       231 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  310 (430)
                      -||.++|..   .+.++++..+|.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+-+.+ +.+.         
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence            379999965   456899999999999999998776211111  1333456899999999988764 1110         


Q ss_pred             eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       311 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                           .....+.|||... ...+.+.=|||||+++|.-+-...|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1123467888764 3456788999999999999987766

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.85  E-value=0.0018  Score=62.97  Aligned_cols=74  Identities=9%  Similarity=0.149  Sum_probs=46.5

Q ss_pred             ccccccccCceEEEeecCCC------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc-ccc
Q 014140          139 LEKIRSCWNGEVYKAELPGS------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI-VPL  211 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l  211 (430)
                      ++.|+.|....+|+......      ++..+++|+.....             .   ...+..|..+++.|...++ .++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-------------~---~~~li~E~~~l~~L~~~g~~P~l  141 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-------------T---ESHLVAESVIFTLLSERHLGPKL  141 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-------------C---HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-------------c---HHHHHHHHHHHHHHHhCCCCCcE
Confidence            45677888889999976421      25778888772210             0   1234468888888853334 456


Q ss_pred             eeEEEeCCeeEEEEEecCCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGS  232 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gs  232 (430)
                      ++.+.  +  .+|+||++|.+
T Consensus       142 ~~~~~--~--g~v~e~l~G~~  158 (429)
T 1nw1_A          142 YGIFS--G--GRLEEYIPSRP  158 (429)
T ss_dssp             EEEET--T--EEEECCCCEEE
T ss_pred             EEEeC--C--CEEEEEeCCcc
Confidence            66543  2  38999998633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.73  E-value=0.0075  Score=58.99  Aligned_cols=75  Identities=13%  Similarity=0.050  Sum_probs=45.3

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc-ccceeEEEe
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI-VPLLARMVR  217 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~  217 (430)
                      ++.|+.|-...+|+....+ .+..+++|+.......               ......|..+++.|...++ .++++++  
T Consensus       113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~---------------~idR~~E~~vl~~L~~~gl~P~ll~~~--  174 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE---------------IINREREKKISCILYNKNIAKKIYVFF--  174 (458)
T ss_dssp             EEEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS---------------CSCHHHHHHHHHHHTTSSSBCCEEEEE--
T ss_pred             EEEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh---------------hcCHHHHHHHHHHHHhcCCCCCEEEEe--
Confidence            4567778888999998642 2477888876321100               0012578888888865555 4566655  


Q ss_pred             CCeeEEEEEecCCCCH
Q 014140          218 RDCDLLVYEFRRNGSL  233 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL  233 (430)
                      .+  .+||||++|.+|
T Consensus       175 ~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          175 TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             TT--EEEEECCCSEEC
T ss_pred             CC--eEEEEeeCCccC
Confidence            22  359999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.60  E-value=0.0031  Score=59.90  Aligned_cols=31  Identities=19%  Similarity=0.321  Sum_probs=25.2

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..+++|+|+.+.|||++++. +.|+||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            34699999999999998655 89999987653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.55  E-value=0.015  Score=54.49  Aligned_cols=32  Identities=22%  Similarity=0.347  Sum_probs=27.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.75  E-value=0.11  Score=50.19  Aligned_cols=30  Identities=20%  Similarity=0.353  Sum_probs=26.2

Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          272 PRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46899999999999 7788999999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.90  E-value=0.63  Score=39.98  Aligned_cols=120  Identities=13%  Similarity=0.077  Sum_probs=81.0

Q ss_pred             CCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       204 ~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      .||+++.. .+-.+.+.+.+.++.-+  +..++-     .-..++...+++++.+|+....+++     .-+|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence            68988876 45566666656555543  222221     1234889999999999988875554     14788999999


Q ss_pred             EEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 014140          284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQ  360 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~  360 (430)
                      ++++.++.+++.--|+...+                   +|.     .++...=.-.+=+++..+++++.+|+....
T Consensus       110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~  162 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVE  162 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred             EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence            99999999999876654332                   222     122222344677888899999998876544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.41  E-value=2.1  Score=36.80  Aligned_cols=117  Identities=17%  Similarity=0.175  Sum_probs=77.6

Q ss_pred             CCCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCC
Q 014140          204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE-YLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       204 ~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~Dlkp~  282 (430)
                      .||++  -..+-.+.+.+.+.++.-+++-=...+       ..++...+++++.+++.... +++     .-+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57888  444456677777777765433222233       24788999999999887655 443     3578899999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDF  358 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~  358 (430)
                      |++++.++.+++.-.|+-..                   ++|.-+     +..-=.-++=|++..++.++..|+..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999999987665332                   333221     11112335677888888888877653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.09  E-value=0.15  Score=49.74  Aligned_cols=64  Identities=5%  Similarity=-0.095  Sum_probs=18.0

Q ss_pred             cccccccccCceEEEeecCCCCCceEEE------EEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITI------KKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..+.||   ||.||+|.+.. ...+|||      |......            ........+.+|..++..++|||+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~------------~~~e~~~~~~rea~l~~~~~H~niv~~  209 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDG------------VSEKRLTSLVRRATLKENEQIPKYEKI  209 (463)
T ss_dssp             STTTSS---BCCC----------CCBGGGC-----------------------------------------------CBC
T ss_pred             ccccCC---chhhhcccccc-cCCchhhhhccCcccccccc------------ccccccccccccccccccccccccCCC
Confidence            345565   99999999863 3467888      5442211            111234568889999999999999999


Q ss_pred             eeEEEe
Q 014140          212 LARMVR  217 (430)
Q Consensus       212 ~~~~~~  217 (430)
                      +++...
T Consensus       210 h~f~~~  215 (463)
T 3cxl_A          210 HNFKVH  215 (463)
T ss_dssp             CCEEEE
T ss_pred             cceEEe
Confidence            997654

>3ro3_B Minsc, peptide of protein inscuteable homolog; asymmetric cell division, protein binding; 1.10A {Mus musculus}

Probab=82.33  E-value=0.81  Score=22.80  Aligned_cols=13  Identities=31%  Similarity=0.782  Sum_probs=11.0

Q ss_pred             HHHHHHHHHHHHh
Q 014140           19 ESVKIWLGKLQHL   31 (430)
Q Consensus        19 ~~~~~~~~~~~~~   31 (430)
                      .+|+.|+++||..
T Consensus         8 DSV~rWmeDLr~M   20 (22)
T 3ro3_B            8 DSVQRWMEDLKLM   20 (26)
T ss_pred             HHHHHHHHHHHhh
Confidence            5799999999854

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	430
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-40
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-38
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-30
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-25
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 54/285 (18%), Positives = 111/285 (38%), Gaps = 38/285 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYK +  G     + +K +              + P   ++   ++E+    + RH N
Sbjct: 22  GTVYKGKWHGD----VAVKML------------NVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+  +          +V ++    SL   L+ +     + + +    IA+  A G++YLH
Sbjct: 66  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 IIHRD++  N+ + +D+  +I +FGLA              L+G++ ++APE  
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 328 QT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
           +       S   D+Y+FG++L  L+ G+ P    + +      + +M            +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            S             + ++   C     ++RP    +   +  + 
Sbjct: 235 RSNCPKA--------MKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-44
 Identities = 58/302 (19%), Positives = 118/302 (39%), Gaps = 29/302 (9%)

Query: 132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI 191
           K+D F  + ++ +   G V+K      SG V+  K I             + +P      
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLI-----------HLEIKPAIRN-- 49

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           QI  E+    +     IV             +  E    GSL  +L         +    
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 105

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
             +++  +  GL YL    + +I+HRD++P+N+L++   E ++ +FG++ ++ D    + 
Sbjct: 106 LGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
                GT  Y++PE  Q    S   DI+S G+ L  + +G++P         E+     +
Sbjct: 164 ----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

Query: 372 RNVMTSENPNRAINSKLLGNGYEEQ--MLLVLKIACFCTLDDPNKRPN---SKDVRCMLS 426
                   P      + L +   +    + + ++  +   + P K P+   S + +  ++
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

Query: 427 QI 428
           + 
Sbjct: 280 KC 281

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 43/294 (14%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           ED++  + ++     G+VYKA+    +  +   K I              SE    ++  
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVI-----------DTKSE---EELED 55

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
              EI       H NIV LL      +   ++ EF   G++  ++ +     R L     
Sbjct: 56  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQI 112

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             + +     L YLH     +IIHRD++  N+L   D + ++++FG++ +      R  +
Sbjct: 113 QVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

Query: 313 WSLAGTVGYIAPECHQTVALSDT-----CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL 367
           +   GT  ++APE        D       D++S G+ L  +   + P  +       ++ 
Sbjct: 170 F--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-------LNP 220

Query: 368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           ++ +  +  SE P  A  S+   N  +     + K    C   + + R  +  +
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDARWTTSQL 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-42
 Identities = 60/278 (21%), Positives = 109/278 (39%), Gaps = 36/278 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G   K     S G+++  K++     + AE               + SE+    +++H N
Sbjct: 18  GRCQKIRRK-SDGKILVWKELDYGSMTEAE------------KQMLVSEVNLLRELKHPN 64

Query: 208 IVPLLARMVRRDCDLL--VYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
           IV    R++ R    L  V E+   G L  ++   ++ R+ LD     R+   +   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 266 LHMSHR--PRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
            H        ++HRD++PANV +D     ++ +FGLA+ +    +        GT  Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRA 383
           PE    ++ ++  DI+S G LL  L     P    F    +  L   +R       P R 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRRIPYRY 238

Query: 384 INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
             S  L         ++ +            RP+ +++
Sbjct: 239 --SDELNE-------IITR----MLNLKDYHRPSVEEI 263

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-41
 Identities = 61/303 (20%), Positives = 108/303 (35%), Gaps = 44/303 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV++ +     G  + +K                 E    +     +EI     +RH N
Sbjct: 17  GEVWRGKW---RGEEVAVKIF-----------SSREE----RSWFREAEIYQTVMLRHEN 58

Query: 208 IVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           I+  +A   + +       LV ++  +GSL D L      R  +      ++A   ASGL
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGL 113

Query: 264 EYLHMS-----HRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG--HTRTTTWSLA 316
            +LHM       +P I HRD++  N+L+  +    I++ GLA R                
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 317 GTVGYIAPEC------HQTVALSDTCDIYSFGVLLAVLVIGKFPSD---DFFQHTKEMSL 367
           GT  Y+APE        +        DIY+ G++   +           D+     ++  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 368 VQWMRNVMTSENPNRAINSKLLGNGYE-EQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
                  M      + +   +       E + ++ KI   C   +   R  +  ++  LS
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

Query: 427 QIQ 429
           Q+ 
Sbjct: 294 QLS 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-40
 Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 40/281 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+     G     + +K +           K+ S           +E     Q++H+ 
Sbjct: 27  GEVWMGYYNG--HTKVAVKSL-----------KQGSMSPD----AFLAEANLMKQLQHQR 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V ++   ++ E+  NGSL D L        +L       +A  IA G+ ++ 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                  IHRD++ AN+L+ D +  +I++FGLA+ I D             + + APE  
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAI 182

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
                +   D++SFG+LL  +V         +       ++Q +        P+      
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLERGYRMVRPDNCPEE- 238

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                       + ++   C  + P  RP    +R +L   
Sbjct: 239 ------------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-40
 Identities = 59/274 (21%), Positives = 107/274 (39%), Gaps = 41/274 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY A     S  ++ +K +            K          Q+R E+     +RH N
Sbjct: 20  GNVYLAREK-QSKFILALKVL-----------FKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ L           L+ E+   G++   L    Q   + D          +A+ L Y H
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 123

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                R+IHRDI+P N+L+    E +I++FG +   P     +   +L GT+ Y+ PE  
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMI 176

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
           +     +  D++S GVL    ++GK P +         +  +  + +   E       ++
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQETYKRISRVEFTFPDFVTE 229

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
              +       L+ +        +P++RP  ++V
Sbjct: 230 GARD-------LISR----LLKHNPSQRPMLREV 252

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (362), Expect = 3e-40
 Identities = 54/305 (17%), Positives = 110/305 (36%), Gaps = 56/305 (18%)

Query: 148 GEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G V++A  PG        ++ +K +           K+++          + E     + 
Sbjct: 27  GRVFQARAPGLLPYEPFTMVAVKML-----------KEEASADMQA--DFQREAALMAEF 73

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD--------------------VSQG 243
            + NIV LL          L++E+   G L + L                       S G
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 244 RRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
              L    +  IA+ +A+G+ YL      + +HRD+   N L+ ++M  +I++FGL++ I
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 304 PDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK 363
                     + A  + ++ PE       +   D++++GV+L  +          +    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMA 247

Query: 364 EMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC 423
              ++ ++R+      P             E   L +  +   C    P  RP+   +  
Sbjct: 248 HEEVIYYVRDGNILACP-------------ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 424 MLSQI 428
           +L ++
Sbjct: 295 ILQRM 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 5e-40
 Identities = 61/276 (22%), Positives = 105/276 (38%), Gaps = 37/276 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV  A     +   + +K +                    +   I+ EI     + H N
Sbjct: 19  GEVQLAVNR-VTEEAVAVKIV-----------DMKRAVDCPE--NIKKEICINKMLNHEN 64

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V         +   L  E+   G L D +    +    +      R    + +G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 I HRDI+P N+L+D+    +IS+FGLA      +       + GT+ Y+APE  
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 328 QTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
           +         D++S G++L  ++ G+ P   + Q +         +   T  NP + I+S
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR 422
             L         L+ KI       +P+ R    D++
Sbjct: 235 APLA--------LLHKILVE----NPSARITIPDIK 258

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 53/282 (18%), Positives = 101/282 (35%), Gaps = 42/282 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V   +  G     + IK I           K+ S        +   E      + H  
Sbjct: 18  GVVKYGKWRG--QYDVAIKMI-----------KEGSMSED----EFIEEAKVMMNLSHEK 60

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L     ++    ++ E+  NG L + L    + R          + + +   +EYL 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                + +HRD+   N L++D    ++S+FGL++ + D    ++       V +  PE  
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVL 173

Query: 328 QTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
                S   DI++FGVL+  +  +GK P    ++        + +   +    P+ A   
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                        V  I   C  +  ++RP  K +   +  +
Sbjct: 230 -------------VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 1e-39
 Identities = 65/283 (22%), Positives = 106/283 (37%), Gaps = 46/283 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V   +     G  + +K I           K D+           +E     Q+RH N
Sbjct: 21  GDVMLGDY---RGNKVAVKCI-----------KNDAT-----AQAFLAEASVMTQLRHSN 61

Query: 208 IVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           +V LL  +V     L +V E+   GSL D L   S+GR  L      + +  +   +EYL
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                   +HRD+   NVL+ +D  A++S+FGL K            +    V + APE 
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA 171

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
            +    S   D++SFG+LL  +          +       +V  +      + P+    +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228

Query: 387 KLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
                        V ++   C   D   RP+   +R  L  I+
Sbjct: 229 -------------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 1e-39
 Identities = 48/279 (17%), Positives = 111/279 (39%), Gaps = 43/279 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VYK     +    +   ++            +D +    +  + + E      ++H N
Sbjct: 23  KTVYKGLDTET-TVEVAWCEL------------QDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 208 IVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           IV       + +  + C +LV E   +G+L+  L    +  + +         + I  GL
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGL 125

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDD-DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           ++LH +  P IIHRD++  N+ I       +I + GLA        +     + GT  ++
Sbjct: 126 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 180

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
           APE ++     ++ D+Y+FG+ +  +   ++P   + +      + + + + +   + ++
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDK 236

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
               ++             +I   C   + ++R + KD+
Sbjct: 237 VAIPEV------------KEIIEGCIRQNKDERYSIKDL 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 42/287 (14%)

Query: 148 GEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           GEV    L  PG     + IK +              S     +     SE    GQ  H
Sbjct: 40  GEVCSGHLKLPGKREIFVAIKTL-------------KSGYTEKQRRDFLSEASIMGQFDH 86

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            N++ L   + +    +++ EF  NGSL   L    Q   +   +    + +GIA+G++Y
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG---HTRTTTWSLAGTVGYI 322
           L        +HRD+   N+L++ ++  ++S+FGL++ + D     T T+       + + 
Sbjct: 144 LAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 323 APECHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN 381
           APE  Q    +   D++S+G+++  V+  G+ P    +       ++  +        P 
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTNQDVINAIEQDYRLPPP- 255

Query: 382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                        +    + ++   C   D N RP    +   L ++
Sbjct: 256 ------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 59/292 (20%), Positives = 107/292 (36%), Gaps = 44/292 (15%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
           E  F+ L +I     G VY A     +  V+ IKK+               +  + K   
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKM-----------SYSGKQSNEKWQD 61

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           I  E+    ++RH N +      +R     LV E+    +   +       ++ L  +  
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI 117

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTT 312
             +  G   GL YLH      +IHRD++  N+L+ +    ++ +FG A  +   ++    
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---- 170

Query: 313 WSLAGTVGYIAPE---CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
               GT  ++APE              D++S G+    L   K P  +       M+ + 
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMS 221

Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
            + ++  +E+P       L    + E     +     C    P  RP S+ +
Sbjct: 222 ALYHIAQNESP------ALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 57/302 (18%), Positives = 111/302 (36%), Gaps = 38/302 (12%)

Query: 129 FLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHH 188
           FL++++   +  ++     G V +        ++    K++          K+ +E    
Sbjct: 4   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL----------KQGTEKADT 53

Query: 189 KMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELD 248
           +  ++  E     Q+ +  IV L+         +LV E    G L   L      R E+ 
Sbjct: 54  E--EMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIP 107

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI-PDGH 307
                 +   ++ G++YL        +HRD+   NVL+ +   A+IS+FGL+K +  D  
Sbjct: 108 VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164

Query: 308 TRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLA-VLVIGKFPSDDFFQHTKEMS 366
             T   +    + + APEC      S   D++S+GV +   L  G+ P    ++  K   
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPE 220

Query: 367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS 426
           ++ ++      E P                   +  +   C +     RP+   V   + 
Sbjct: 221 VMAFIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267

Query: 427 QI 428
             
Sbjct: 268 AC 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-38
 Identities = 50/286 (17%), Positives = 103/286 (36%), Gaps = 36/286 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY   L  + G+ I               + + ++    ++ Q  +E I      H N
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKS---------LNRITDI--GEVSQFLTEGIIMKDFSHPN 89

Query: 208 IVPLLARMVRRD-CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           ++ LL   +R +   L+V  + ++G L++ +                     +A G+   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM--- 143

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDG--HTRTTTWSLAGTVGYIAP 324
                 + +HRD+   N ++D+    ++++FGLA+ + D    +          V ++A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 325 ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
           E  QT   +   D++SFGVLL  L+    P    +       +  ++        P    
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           +              + ++   C       RP+  ++   +S I  
Sbjct: 261 DP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 56/285 (19%), Positives = 114/285 (40%), Gaps = 39/285 (13%)

Query: 148 GEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR 204
           GEVYK  L  SSG     + IK +              +     + +    E    GQ  
Sbjct: 21  GEVYKGMLKTSSGKKEVPVAIKTL-------------KAGYTEKQRVDFLGEAGIMGQFS 67

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           H NI+ L   + +    +++ E+  NG+L   L +      E   L    + +GIA+G++
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIA 323
           Y         +HRD+   N+L++ ++  ++S+FGL++ + D    T TT      + + A
Sbjct: 125 Y---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 324 PECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRA 383
           PE       +   D++SFG+++  ++         +       +++ + +      P   
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAINDGFRLPTP--- 235

Query: 384 INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                      +    + ++   C   +  +RP   D+  +L ++
Sbjct: 236 ----------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 55/284 (19%), Positives = 94/284 (33%), Gaps = 40/284 (14%)

Query: 148 GEVYKAELP-GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR 206
           G V K         + + +K +       A               ++ +E     Q+ + 
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPAL------------KDELLAEANVMQQLDNP 68

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
            IV ++  +   +  +LV E    G L   L       R +       +   ++ G++YL
Sbjct: 69  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL 123

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT-RTTTWSLAGTVGYIAPE 325
             S+    +HRD+   NVL+     A+IS+FGL+K +                V + APE
Sbjct: 124 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 326 CHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
           C      S   D++SFGVL+      G+ P    ++  K   +   +        P    
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERMGCPAGCP 236

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                          +  +   C   D   RP    V   L   
Sbjct: 237 RE-------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 49/338 (14%)

Query: 109 GSRDRRPIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKI 168
           GS D           E DL +    +     + + S   G+V  A   G S   ++I+  
Sbjct: 12  GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71

Query: 169 IQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRRDCDLLVYEF 227
           ++ LK  A+           +   + SE+    Q+  H NIV LL          L++E+
Sbjct: 72  VKMLKEKAD---------SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122

Query: 228 RRNGSLQDILY-------------------DVSQGRRELDWLARHRIAQGIASGLEYLHM 268
              G L + L                    +  +    L +      A  +A G+E+L  
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181

Query: 269 SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ 328
                 +HRD+   NVL+      +I +FGLA+ I          +    V ++APE   
Sbjct: 182 --FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239

Query: 329 TVALSDTCDIYSFGVLLAVLV-IGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
               +   D++S+G+LL  +  +G  P   +     + +  + ++N    + P  A    
Sbjct: 240 EGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPVDANFYKLIQNGFKMDQPFYATEE- 295

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCML 425
                       +  I   C   D  KRP+  ++   L
Sbjct: 296 ------------IYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 55/281 (19%), Positives = 107/281 (38%), Gaps = 38/281 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEVY+          + +K +           K+D+  +     +   E     +++H N
Sbjct: 31  GEVYEGVWKKY-SLTVAVKTL-----------KEDTMEVE----EFLKEAAVMKEIKHPN 74

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V LL    R     ++ EF   G+L D L +    R+E+  +    +A  I+S +EYL 
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
              +   IHRD+   N L+ ++   ++++FGL++ +               + + APE  
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESL 188

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
                S   D+++FGVLL  +          +       + + +      E P       
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERP------- 238

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                 E     V ++   C   +P+ RP+  ++      +
Sbjct: 239 ------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-38
 Identities = 54/291 (18%), Positives = 104/291 (35%), Gaps = 40/291 (13%)

Query: 139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEII 198
           +++I S   G V+       +   + IK I           ++ +            E  
Sbjct: 10  VQEIGSGQFGLVHLGYWL--NKDKVAIKTI-----------REGAMSEE----DFIEEAE 52

Query: 199 TAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQG 258
              ++ H  +V L    + +    LV+EF  +G L D    +   R          +   
Sbjct: 53  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLD 109

Query: 259 IASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGT 318
           +  G+ YL       +IHRD+   N L+ ++   ++S+FG+ + + D    T++      
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFP 165

Query: 319 VGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSE 378
           V + +PE       S   D++SFGVL+  +          +++     +V+ +       
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLY 222

Query: 379 NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ 429
            P  A                V +I   C  + P  RP    +   L++I 
Sbjct: 223 KPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-38
 Identities = 57/281 (20%), Positives = 104/281 (37%), Gaps = 40/281 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+     G     + IK +           K  +            E     ++RH  
Sbjct: 31  GEVWMGTWNG--TTRVAIKTL-----------KPGTM----SPEAFLQEAQVMKKLRHEK 73

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L A +V  +   +V E+   GSL D  +   +  + L       +A  IASG+ Y+ 
Sbjct: 74  LVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                  +HRD++ AN+L+ +++  ++++FGLA+ I D             + + APE  
Sbjct: 131 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAA 186

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
                +   D++SFG+LL  L          +       ++  +        P     S 
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPPECPES- 242

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                       +  + C C   +P +RP  + ++  L   
Sbjct: 243 ------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-38
 Identities = 60/274 (21%), Positives = 117/274 (42%), Gaps = 40/274 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY A    ++G+ + I+++               +P   K   I +EI+   + ++ N
Sbjct: 34  GTVYTAMDV-ATGQEVAIRQM-----------NLQQQP---KKELIINEILVMRENKNPN 78

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV  L   +  D   +V E+   GSL D++         +D      + +     LE+LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                ++IHRDI+  N+L+  D   ++++FG   +I    ++ +T    GT  ++APE  
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVV 188

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
              A     DI+S G++   ++ G+ P  +        + ++ +  + T+  P      K
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATNGTPELQNPEK 241

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           L     +     + +    C   D  KR ++K++
Sbjct: 242 LSAIFRD----FLNR----CLDMDVEKRGSAKEL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 63/327 (19%), Positives = 116/327 (35%), Gaps = 57/327 (17%)

Query: 115 PIIFSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKS 174
           P I+ P++   D+ F +          I     G+V KA +     R+    K ++   S
Sbjct: 1   PTIY-PVLDWNDIKFQDV---------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 50

Query: 175 GAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPLLARMVRRDCDLLVYEFRRNGSL 233
                                E+    ++  H NI+ LL     R    L  E+  +G+L
Sbjct: 51  ------------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98

Query: 234 QDILYD------------VSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQP 281
            D L               +     L        A  +A G++YL    + + IHRD+  
Sbjct: 99  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAA 155

Query: 282 ANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSF 341
            N+L+ ++  A+I++FGL++       +T        V ++A E       +   D++S+
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSY 212

Query: 342 GVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVL 401
           GVLL  +V         +       L + +      E P    +              V 
Sbjct: 213 GVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE-------------VY 256

Query: 402 KIACFCTLDDPNKRPNSKDVRCMLSQI 428
            +   C  + P +RP+   +   L+++
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRM 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 37/283 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V  A    ++ R   IK +           +K      +K+  +  E     ++ H  
Sbjct: 22  STVVLAREL-ATSREYAIKIL-----------EKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            V L       +       + +NG L   +  +                   A  +  L 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-------FDETCTRFYTAEIVSALE 122

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
             H   IIHRD++P N+L+++DM  +I++FG AK +     +    S  GT  Y++PE  
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
              +   + D+++ G ++  LV G  P    F+   E  +    + ++  E        K
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI---FQKIIKLEYD---FPEK 232

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
                + +   LV K      + D  KR   +++        H
Sbjct: 233 F----FPKARDLVEK----LLVLDATKRLGCEEMEGYGPLKAH 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 55/300 (18%), Positives = 101/300 (33%), Gaps = 50/300 (16%)

Query: 148 GEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V +A   G     +   + +K +           K  +     +   + SE+     +
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKML-----------KPSAHLTERE--ALMSELKVLSYL 83

Query: 204 -RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYD--------------VSQGRRELD 248
             H NIV LL         L++ E+   G L + L                +      LD
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
                  +  +A G+ +L        IHRD+   N+L+      +I +FGLA+ I +   
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV 368
                +    V ++APE       +   D++S+G+ L  L         +     +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--PYPGMPVDSKFY 258

Query: 369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           + ++      +P  A                +  I   C   DP KRP  K +  ++ + 
Sbjct: 259 KMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 55/299 (18%), Positives = 104/299 (34%), Gaps = 33/299 (11%)

Query: 132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMI 191
           KE  F  ++ + S   G VYK       G  + I   I+        +++ + P  +K  
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIK-------ELREATSPKANK-- 56

Query: 192 QIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLA 251
           +I  E      V + ++  LL  +       L+ +    G L D +    + +  +    
Sbjct: 57  EILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVR---EHKDNIGSQY 112

Query: 252 RHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTT 311
                  IA G+ YL      R++HRD+   NVL+      +I++FGLAK +        
Sbjct: 113 LLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
                  + ++A E       +   D++S+GV +  L+         +       +   +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSIL 226

Query: 372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
                   P                   V  I   C + D + RP  +++    S++  
Sbjct: 227 EKGERLPQPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 68/314 (21%), Positives = 107/314 (34%), Gaps = 43/314 (13%)

Query: 118 FSPLIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAE 177
            + LI E+DL  LEK         +     G V + E    SG+ +++            
Sbjct: 1   LTCLIGEKDLRLLEK---------LGDGSFGVVRRGEWDAPSGKTVSVAVKC-------- 43

Query: 178 LIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDIL 237
            +K D       M     E+     + HRN++ L   +V      +V E    GSL D L
Sbjct: 44  -LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL 101

Query: 238 YDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF 297
                 +         R A  +A G+ YL      R IHRD+   N+L+      +I +F
Sbjct: 102 RK---HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDF 155

Query: 298 GLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL-AVLVIGKFPS 355
           GL + +P                 + APE  +T   S   D + FGV L  +   G+ P 
Sbjct: 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

Query: 356 DDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKR 415
                    ++  Q +  +                   E+    +  +   C    P  R
Sbjct: 216 IG-------LNGSQILHKIDKEGERLPRP---------EDCPQDIYNVMVQCWAHKPEDR 259

Query: 416 PNSKDVRCMLSQIQ 429
           P    +R  L + Q
Sbjct: 260 PTFVALRDFLLEAQ 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 51/300 (17%)

Query: 148 GEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAG 201
           G+V  AE  G      +    + +K +              S+     +  + SE+    
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKML-------------KSDATEKDLSDLISEMEMMK 73

Query: 202 QV-RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILY------------DVSQGRRELD 248
            + +H+NI+ LL    +     ++ E+   G+L++ L                    +L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 249 WLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHT 308
                  A  +A G+EYL      + IHRD+   NVL+ +D   +I++FGLA+ I     
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 309 RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV 368
              T +    V ++APE       +   D++SFGVLL  +          +       L 
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEELF 247

Query: 369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           + ++     + P+   N              +  +   C    P++RP  K +   L +I
Sbjct: 248 KLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 46/293 (15%), Positives = 104/293 (35%), Gaps = 42/293 (14%)

Query: 148 GEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G VY+    G         + IK +             +      + I+  +E     + 
Sbjct: 34  GMVYEGVAKGVVKDEPETRVAIKTV-------------NEAASMRERIEFLNEASVMKEF 80

Query: 204 RHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQG------RRELDWLARHRIAQ 257
              ++V LL  + +    L++ E    G L+  L  +                   ++A 
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 258 GIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAG 317
            IA G+ YL+     + +HRD+   N ++ +D   +I +FG+ + I +            
Sbjct: 141 EIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS 377
            V +++PE  +    +   D++SFGV+L  +          +Q      +++++      
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGLL 254

Query: 378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQH 430
           + P+   +              + ++   C   +P  RP+  ++   + +   
Sbjct: 255 DKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  125 bits (316), Expect = 3e-33
 Identities = 54/276 (19%), Positives = 104/276 (37%), Gaps = 40/276 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++     ++G     K ++ P +S  E               +R EI T   +RH  
Sbjct: 40  GVVHRVTER-ATGNNFAAKFVMTPHESDKE--------------TVRKEIQTMSVLRHPT 84

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L       +  +++YEF   G L + + D      ++         + +  GL ++ 
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM- 140

Query: 268 MSHRPRIIHRDIQPANVLI--DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
             H    +H D++P N++       E ++ +FGL   +    +   T    GT  + APE
Sbjct: 141 --HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 195

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN 385
             +   +    D++S GVL  +L+ G  P    F    +   ++ +++       +  ++
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSC------DWNMD 245

Query: 386 SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                   E+    + K      L DPN R      
Sbjct: 246 DSAFSGISEDGKDFIRK----LLLADPNTRMTIHQA 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 38/273 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+ AE    + +   IK + + +    + ++            +  + + +    H  
Sbjct: 16  GKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVEC----------TMVEKRVLSLAWEHPF 64

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +  +      ++    V E+   G L   +    Q   + D       A  I  GL++LH
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 I++RD++  N+L+D D   +I++FG+ K    G  +T T+   GT  YIAPE  
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEIL 175

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
                + + D +SFGVLL  ++IG+ P    F    E  L   +R            ++ 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM-----------DNP 220

Query: 388 LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD 420
                 E++   +L    F    +P KR   + 
Sbjct: 221 FYPRWLEKEAKDLLV-KLFVR--EPEKRLGVRG 250

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 4e-32
 Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 41/284 (14%)

Query: 148 GEVYKAEL--PGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH 205
           G+V++     P +    + IK             K  +     +  +   E +T  Q  H
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTC-----------KNCTSDSVRE--KFLQEALTMRQFDH 67

Query: 206 RNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEY 265
            +IV L+  ++  +   ++ E    G L+  L      +  LD  +    A  +++ L Y
Sbjct: 68  PHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAY 123

Query: 266 LHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           L      R +HRDI   NVL+  +   ++ +FGL++ + D      +      + ++APE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPE 179

Query: 326 CHQTVALSDTCDIYSFGVLL-AVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
                  +   D++ FGV +  +L+ G  P      +     +    R  M    P    
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           +             L+ K    C   DP++RP   +++  LS I
Sbjct: 240 S-------------LMTK----CWAYDPSRRPRFTELKAQLSTI 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 7e-32
 Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 41/276 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V++     SS +    K +           K          + ++ EI      RHRN
Sbjct: 19  GIVHRCVET-SSKKTYMAKFV-----------KVKGT----DQVLVKKEISILNIARHRN 62

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ L       +  ++++EF     + + +   +    EL+          +   L++LH
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEAR--ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
                 I H DI+P N++      +   I EFG A+++  G      +       Y APE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPE 173

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN 385
            HQ   +S   D++S G L+ VL+ G  P    F       +++ +       N     +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIM------NAEYTFD 223

Query: 386 SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
            +       E M  V +      + +   R  + + 
Sbjct: 224 EEAFKEISIEAMDFVDR----LLVKERKSRMTASEA 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-32
 Identities = 53/298 (17%), Positives = 106/298 (35%), Gaps = 47/298 (15%)

Query: 148 GEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV 203
           G+V +A+  G    ++ R + +K +           K+ +    H+ + +    I     
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKML-----------KEGATHSEHRAL-MSELKILIHIG 74

Query: 204 RHRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYD------------VSQGRRELDWL 250
            H N+V LL    +    L ++ EF + G+L   L                  +  L   
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 251 ARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRT 310
                +  +A G+E+L      + IHRD+   N+L+ +    +I +FGLA+ I       
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 311 TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW 370
                   + ++APE       +   D++SFGVLL  +         +     +    + 
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRR 249

Query: 371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
           ++       P+                  + +    C   +P++RP   ++   L  +
Sbjct: 250 LKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  121 bits (305), Expect = 9e-32
 Identities = 57/290 (19%), Positives = 106/290 (36%), Gaps = 40/290 (13%)

Query: 134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQI 193
           DY+  LE++ S   G V++     ++GRV   K I  P                     +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKY--------------TV 73

Query: 194 RSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARH 253
           ++EI    Q+ H  ++ L      +   +L+ EF   G L D +   +    ++      
Sbjct: 74  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVI 130

Query: 254 RIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID--DDMEARISEFGLAKRIPDGHTRTT 311
              +    GL+++   H   I+H DI+P N++ +       +I +FGLA ++        
Sbjct: 131 NYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---I 184

Query: 312 TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM 371
                 T  + APE      +    D+++ GVL  VL+ G  P    F    ++  +Q +
Sbjct: 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNV 240

Query: 372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           +        +   +     +   E    +          +P KR    D 
Sbjct: 241 KRC------DWEFDEDAFSSVSPEAKDFIKN----LLQKEPRKRLTVHDA 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  119 bits (298), Expect = 2e-31
 Identities = 58/281 (20%), Positives = 109/281 (38%), Gaps = 37/281 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HR 206
             V +      + +   +K I              +E +         E+    +V  H 
Sbjct: 17  SVVRRCIHK-PTCKEYAVKII-----DVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70

Query: 207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYL 266
           NI+ L           LV++  + G L D L      +  L      +I + +   +  L
Sbjct: 71  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICAL 126

Query: 267 HMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
           H   +  I+HRD++P N+L+DDDM  ++++FG + ++  G          GT  Y+APE 
Sbjct: 127 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEI 180

Query: 327 HQTVALSDT------CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
            +     +        D++S GV++  L+ G  P    F H K+M +++ +       + 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLRMIM------SG 230

Query: 381 NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           N    S    +  +    LV +      +  P KR  +++ 
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (295), Expect = 5e-31
 Identities = 61/289 (21%), Positives = 117/289 (40%), Gaps = 39/289 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
            EV+ A       R + +K +           + D        ++ R E   A  + H  
Sbjct: 21  SEVHLARDL-RLHRDVAVKVL-----------RADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 208 IVPLLARMVRRDCDL----LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
           IV +               +V E+    +L+DI++        +       +       L
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQAL 124

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPD-GHTRTTTWSLAGTVGYI 322
            + H   +  IIHRD++PAN++I      ++ +FG+A+ I D G++ T T ++ GT  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
           +PE  +  ++    D+YS G +L  ++ G+ P    F     +S+    ++V     P  
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSV--AYQHVREDPIPPS 235

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS-KDVRCMLSQIQH 430
           A +  L  +       +VLK        +P  R  +  ++R  L ++ +
Sbjct: 236 ARHEGLSADLDA----VVLK----ALAKNPENRYQTAAEMRADLVRVHN 276

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (297), Expect = 6e-31
 Identities = 65/292 (22%), Positives = 110/292 (37%), Gaps = 41/292 (14%)

Query: 133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ 192
            D +   + + +    EV  AE    + +++ IK I               + L  K   
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCI-------------AKKALEGKEGS 53

Query: 193 IRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR 252
           + +EI    +++H NIV L           L+ +    G L D + +    +        
Sbjct: 54  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDA 109

Query: 253 HRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTR 309
            R+   +   ++YLH      I+HRD++P N+L    D+D +  IS+FGL+K    G   
Sbjct: 110 SRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166

Query: 310 TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ 369
           +T     GT GY+APE       S   D +S GV+  +L+ G  P   F+         Q
Sbjct: 167 ST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQ 220

Query: 370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
            ++     ++P     S    +        +          DP KR   +  
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKD-------FIRH----LMEKDPEKRFTCEQA 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 28/226 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+       +GR   +K +           KK+      ++     E +    V H  
Sbjct: 18  GRVHLIRSR-HNGRYYAMKVL-----------KKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ +           ++ ++   G L  +L    + +R  + +A+   A+ +   LEYLH
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAE-VCLALEYLH 121

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 II+RD++P N+L+D +   +I++FG AK +PD        +L GT  YIAPE  
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVV 173

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
            T   + + D +SFG+L+  ++ G  P    F  +  M   + + N
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILN 215

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-30
 Identities = 65/305 (21%), Positives = 120/305 (39%), Gaps = 42/305 (13%)

Query: 121 LIKEEDLAFLEKEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIK 180
           + ++E++     +DY+ + E++ S     V K     S+G     K I        +  +
Sbjct: 2   VFRQENV-----DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFI--------KKRR 47

Query: 181 KDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDV 240
             S         I  E+    +++H N++ L      +   +L+ E    G L D L + 
Sbjct: 48  TKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE- 106

Query: 241 SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR----ISE 296
              +  L         + I +G+   +  H  +I H D++P N+++ D    +    I +
Sbjct: 107 ---KESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160

Query: 297 FGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSD 356
           FGLA +I  G+     +   GT  ++APE      L    D++S GV+  +L+ G  P  
Sbjct: 161 FGLAHKIDFGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-- 215

Query: 357 DFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP 416
            F   TK+ +L          E+   +  S L  +        + +      + DP KR 
Sbjct: 216 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD-------FIRR----LLVKDPKKRM 263

Query: 417 NSKDV 421
             +D 
Sbjct: 264 TIQDS 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  115 bits (288), Expect = 7e-30
 Identities = 45/291 (15%), Positives = 99/291 (34%), Gaps = 43/291 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G +++      + + + IK                  P      Q+R E  T   +    
Sbjct: 19  GVIFEGTNL-LNNQQVAIKFE----------------PRRSDAPQLRDEYRTYKLLAGCT 61

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            +P +    +     ++       SL+D+L       R+         A+ + + ++ +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 268 MSHRPRIIHRDIQPANVLIDDDME-----ARISEFGLAKRIPDGHTRTTTW-----SLAG 317
                 +++RDI+P N LI            + +FG+ K   D  T+         +L+G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 318 TVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTS 377
           T  Y++   H     S   D+ + G +    + G       +Q  K  +  Q    +   
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL----PWQGLKAATNKQKYERIG-- 229

Query: 378 ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
               ++   + L  G+ E+    +           +  P+   ++ + S++
Sbjct: 230 -EKKQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKV 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (283), Expect = 4e-29
 Identities = 54/289 (18%), Positives = 95/289 (32%), Gaps = 41/289 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G++Y      ++G  + IK                   +  K  Q+  E      ++   
Sbjct: 21  GDIYLGTDI-AAGEEVAIKLE----------------CVKTKHPQLHIESKIYKMMQGGV 63

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
            +P +          ++       SL       +   R+        +A  + S +EY+H
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 268 MSHRPRIIHRDIQPANVLI---DDDMEARISEFGLAKRIPDGHTRTTTW-----SLAGTV 319
                  IHRD++P N L+          I +FGLAK+  D  T          +L GT 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            Y +   H  +  S   D+ S G +L    +G  P       TK     +     M+   
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 234

Query: 380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI 428
                  ++L  GY  +    L     C     + +P+   +R +   +
Sbjct: 235 ----TPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 5e-29
 Identities = 55/288 (19%), Positives = 110/288 (38%), Gaps = 32/288 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V+KA    + GR + +K++          ++   E +    I+  + +       H N
Sbjct: 21  GKVFKARDLKNGGRFVALKRV---------RVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 208 IVPLLARMVRRDCD-----LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           +V L         D      LV+E         +          +       +   +  G
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRG 128

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           L++LH     R++HRD++P N+L+    + ++++FGLA+        T+      T+ Y 
Sbjct: 129 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYR 182

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFP---SDDFFQHTKEMSLV------QWMRN 373
           APE     + +   D++S G + A +   K     S D  Q  K + ++       W R+
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           V        + +++ +     +   L   +   C   +P KR ++   
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 6e-29
 Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 30/285 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             VYKA    ++ +++ IKKI          +   SE           EI    ++ H N
Sbjct: 12  ATVYKARDK-NTNQIVAIKKI---------KLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ LL     +    LV++F        I          L              GLEYLH
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
              +  I+HRD++P N+L+D++   ++++FGLAK     +   T      T  Y APE  
Sbjct: 118 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELL 172

Query: 328 QTVALSDT-CDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
               +     D+++ G +LA L++     P D        +             +     
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 385 NSKLLGNGYEEQMLLVLKIACFCTLD--------DPNKRPNSKDV 421
           +     +     +  +   A    LD        +P  R  +   
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  111 bits (279), Expect = 5e-28
 Identities = 62/275 (22%), Positives = 95/275 (34%), Gaps = 42/275 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--- 204
           GEVY       +G++  +K +            K    +        +E I    V    
Sbjct: 18  GEVYGCRKA-DTGKMYAMKCL-----------DKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
              IV +       D    + +    G L   L                  A  I  GLE
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLE 121

Query: 265 YLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAP 324
           ++H      +++RD++PAN+L+D+    RIS+ GLA          +     GT GY+AP
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAP 174

Query: 325 ECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRA 383
           E  Q  VA   + D +S G +L  L+ G  P    F+  K     +  R  +T       
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPD 230

Query: 384 INSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS 418
             S  L +       L+          D N+R   
Sbjct: 231 SFSPELRS-------LLEG----LLQRDVNRRLGC 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 6e-28
 Identities = 54/277 (19%), Positives = 93/277 (33%), Gaps = 43/277 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY      S    + IK + +      + I    E  +   + +   ++         
Sbjct: 18  GSVYSGIRV-SDNLPVAIKHVEK------DRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ LL    R D  +L+ E          L+D    R  L           +   + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127

Query: 268 MSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPEC 326
                 ++HRDI+  N+LID +  E ++ +FG    + D    T      GT  Y  PE 
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEW 180

Query: 327 HQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAIN 385
            +          ++S G+LL  +V G  P    F+H +E+   Q       S      I 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRVSSECQHLIR 236

Query: 386 SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVR 422
                                C    P+ RP  ++++
Sbjct: 237 W--------------------CLALRPSDRPTFEEIQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 45/226 (19%), Positives = 80/226 (35%), Gaps = 25/226 (11%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G+V       ++GR   +K +           +K+      ++    +E       RH  
Sbjct: 19  GKVILVREK-ATGRYYAMKIL-----------RKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +  L       D    V E+   G L   L                R     A  +  L 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSALE 119

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
             H   +++RDI+  N+++D D   +I++FGL K         T  +  GT  Y+APE  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPEVL 177

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
           +        D +  GV++  ++ G+ P    F +     L + +  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILM 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 6e-27
 Identities = 54/282 (19%), Positives = 101/282 (35%), Gaps = 46/282 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
           G+V +      +     +K +                       + R E+ +     +  
Sbjct: 26  GKVLQIFNK-RTQEKFALKML-------------------QDCPKARREVELHWRASQCP 65

Query: 207 NIVPLL----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           +IV ++         R C L+V E    G L   + D  +G +         I + I   
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEA 123

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDME---ARISEFGLAKRIPDGHTRTTTWSLAGTV 319
           ++YLH      I HRD++P N+L          ++++FG AK     ++ TT      T 
Sbjct: 124 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TP 177

Query: 320 GYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
            Y+APE         +CD++S GV++ +L+ G  P    F     +++   M+  +    
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQ 233

Query: 380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                 +       EE  +L+          +P +R    + 
Sbjct: 234 YE--FPNPEWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 8e-27
 Identities = 56/297 (18%), Positives = 107/297 (36%), Gaps = 49/297 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V  A     +   + IKKI                  + +  +   EI    + RH N
Sbjct: 22  GMVCSAYDN-VNKVRVAIKKI-----------SPFEHQTYCQ--RTLREIKILLRFRHEN 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           I+ +   +     + +   +     +   LY + + +  L           I  GL+Y+H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 126

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW-SLAGTVGYIAPEC 326
                 ++HRD++P+N+L++   + +I +FGLA+     H  T        T  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 327 HQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP----- 380
                      DI+S G +LA ++  +      F     +  +  +  ++ S +      
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI----FPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 381 ----------------NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
                           N+   ++L  N   + + L+ K+  F    +P+KR   +  
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF----NPHKRIEVEQA 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-26
 Identities = 57/287 (19%), Positives = 104/287 (36%), Gaps = 42/287 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VY+A+L   SG ++ IKK+            +D             E+    ++ H N
Sbjct: 34  GVVYQAKLC-DSGELVAIKKV-----------LQDKR-------FKNRELQIMRKLDHCN 74

Query: 208 IVPLLARMVRRDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           IV L                 LV ++      +      S+ ++ L  +        +  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFR 133

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDD-MEARISEFGLAKRIPDGHTRTTTWSLAGTVG 320
            L Y+   H   I HRDI+P N+L+D D    ++ +FG AK++  G    +      +  
Sbjct: 134 SLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRY 187

Query: 321 YIAP-ECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSEN 379
           Y AP         + + D++S G +LA L++G+      F     +  +  +  V+ +  
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPT 243

Query: 380 PNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD-VRCML 425
             +          Y E     +K   +  +  P   P +      +L
Sbjct: 244 REQIREMN---PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (264), Expect = 4e-26
 Identities = 47/226 (20%), Positives = 81/226 (35%), Gaps = 28/226 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V   +    SG    +K +            K       ++    +E      V    
Sbjct: 55  GRVMLVKHK-ESGNHYAMKIL-----------DKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +V L           +V E+   G +   L                  A  I    EYLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                 +I+RD++P N+LID     ++++FG AKR+         W+L GT   +APE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEII 210

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN 373
            +   +   D ++ GVL+  +  G  P    F   + + + + + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVS 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 8e-25
 Identities = 55/290 (18%), Positives = 106/290 (36%), Gaps = 36/290 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           GEV+KA     +G+ + +KK++           ++ +           EI     ++H N
Sbjct: 24  GEVFKARHR-KTGQKVALKKVL----------MENEKEGFPI--TALREIKILQLLKHEN 70

Query: 208 IVPLL--------ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGI 259
           +V L+             +    LV++F  +     +         +       R+ Q +
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQML 126

Query: 260 ASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTW--SLAG 317
            +GL Y+H   R +I+HRD++ ANVLI  D   ++++FGLA+              +   
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 318 TVGYIAPECHQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT 376
           T+ Y  PE            D++  G ++A +           Q   E   +  +  +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALISQLCG 239

Query: 377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKD-VRCML 425
           S  P    N        + +++   K      L    + P + D +  +L
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  100 bits (250), Expect = 1e-24
 Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 35/286 (12%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYKA+     G    +KKI          ++K+ E +         EI    +++H N
Sbjct: 16  GVVYKAQNN--YGETFALKKI---------RLEKEDEGIPS---TTIREISILKELKHSN 61

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L   +  +   +LV+E       + +          L+ +        + +G+ Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH 117

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
                R++HRD++P N+LI+ + E +I++FGLA+    G           T+ Y AP+  
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVL 172

Query: 328 Q-TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINS 386
             +   S T DI+S G + A +V G        +  + M + + +    +   PN     
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 387 KLLGNGYEEQMLLVLKIACFCTLD-----------DPNKRPNSKDV 421
           K   N    + L                       DPN+R  +K  
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 4e-24
 Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 41/290 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G VYKA     +G V+ +KKI           + D+E           EI    ++ H N
Sbjct: 16  GVVYKARNK-LTGEVVALKKI-----------RLDTET-EGVPSTAIREISLLKELNHPN 62

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV LL  +   +   LV+EF      + +    +     +           +  GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE-C 326
                R++HRD++P N+LI+ +   ++++FGLA+         T      T+ Y APE  
Sbjct: 120 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEIL 174

Query: 327 HQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAI 384
                 S   DI+S G + A +V  +  FP D        +       + +         
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 385 N-------------SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDV 421
           +             SK++    E+   L+ ++  +    DPNKR ++K  
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY----DPNKRISAKAA 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.1 bits (243), Expect = 9e-24
 Identities = 49/289 (16%), Positives = 103/289 (35%), Gaps = 39/289 (13%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V+KA+    +  ++ +K++            +  +           EI    +++H+N
Sbjct: 16  GTVFKAKNR-ETHEIVALKRV------------RLDDDDEGVPSSALREICLLKELKHKN 62

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           IV L   +       LV+EF      QD+         +LD          +  GL + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
             +   ++HRD++P N+LI+ + E +++ FGLA+       R  +  +            
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVM--TSENPNRAIN 385
                S + D++S G + A L     P    F        ++ +  ++   +E    ++ 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 386 SKLLGNGYEEQMLLVLKIACFCTLD-------------DPNKRPNSKDV 421
                  Y         +     L+             +P +R ++++ 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 58/277 (20%), Positives = 107/277 (38%), Gaps = 39/277 (14%)

Query: 148 GEVYKAELPGS--SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQ-IRSEIITAGQVR 204
           G+V+         +G++  +K +           KK +     K  +  R+E      +R
Sbjct: 38  GKVFLVRKISGHDTGKLYAMKVL-----------KKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 205 HRNIVPLLARMVRRDCDL-LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGL 263
               +  L    + +  L L+ ++   G L   L        + +    H +   +   +
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-------SQRERFTEHEVQIYVGEIV 139

Query: 264 EYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
             L   H+  II+RDI+  N+L+D +    +++FGL+K      T    +   GT+ Y+A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMA 198

Query: 324 PECHQTVALSDT--CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPN 381
           P+  +          D +S GVL+  L+ G  P   F    ++ S  +  R ++ SE P 
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRILKSEPPY 255

Query: 382 RAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNS 418
               S L  +       L+ +      + DP KR   
Sbjct: 256 PQEMSALAKD-------LIQR----LLMKDPKKRLGC 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 2e-22
 Identities = 49/291 (16%), Positives = 98/291 (33%), Gaps = 41/291 (14%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V  A     +G  + IKK+ +P +S                 +   E+     +RH N
Sbjct: 32  GAVCSAVDG-RTGAKVAIKKLYRPFQSELFAK------------RAYRELRLLKHMRHEN 78

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           ++ LL      +      +F                  +L       +   +  GL Y+H
Sbjct: 79  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECH 327
            +      HRD++P N+ +++D E +I +FGLA++     T                   
Sbjct: 139 AAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT----RWYRAPEVIL 191

Query: 328 QTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSK 387
             +  + T DI+S G ++A ++ GK      F+ +  +  ++ +  V  +         +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 388 LLGNGYEEQMLLVLKIACFCTLD-----------------DPNKRPNSKDV 421
                   + L  L+   F ++                  D  +R  + + 
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 90.7 bits (224), Expect = 7e-21
 Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 39/243 (16%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEI-ITAGQVRHR 206
            EV++A    ++   + +K +           K        K  +I+ EI I        
Sbjct: 49  SEVFEAINI-TNNEKVVVKIL-----------KPV------KKKKIKREIKILENLRGGP 90

Query: 207 NIVPLLARMVRRDCDL--LVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLE 264
           NI+ L   +         LV+E   N   + +        + L           I   L+
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALD 143

Query: 265 YLHMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIA 323
           Y H      I+HRD++P NV+ID +  + R+ ++GLA+    G           +  +  
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKG 197

Query: 324 PECHQTVALSDT-CDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
           PE      + D   D++S G +LA ++  K P   FF        +  +  V+ +E+   
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 383 AIN 385
            I+
Sbjct: 255 YID 257

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.5 bits (210), Expect = 6e-19
 Identities = 47/256 (18%), Positives = 96/256 (37%), Gaps = 11/256 (4%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V+ A+    +   + +K I++  K   E  + + + L        ++      +   +
Sbjct: 27  STVWLAKDM-VNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVN---DADNTKEDSMGANH 81

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLAR-HRIAQGIASGLEYL 266
           I+ LL     +  + +          +++L  + +       L    +I++ +  GL+Y+
Sbjct: 82  ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141

Query: 267 HMSHRPRIIHRDIQPANVLID-DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPE 325
           H   R  IIH DI+P NVL++  D    + +  +A             +   T  Y +PE
Sbjct: 142 H--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPE 199

Query: 326 CHQTVALSDTCDIYSFGVLLAVLVIGK--FPSDDFFQHTKEMSLVQWMRNVMTSENPNRA 383
                      DI+S   L+  L+ G   F  D+   +TK+   +  +  ++        
Sbjct: 200 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259

Query: 384 INSKLLGNGYEEQMLL 399
            N K     +  + LL
Sbjct: 260 RNGKYTRTFFNSRGLL 275

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.0 bits (209), Expect = 9e-19
 Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 36/239 (15%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V  A       R + IKK+ +P ++                 +   E++    V H+N
Sbjct: 31  GIVCAAYDA-VLDRNVAIKKLSRPFQNQTH------------AKRAYRELVLMKCVNHKN 77

Query: 208 IVPLLARMVRRDCD------LLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIAS 261
           I+ LL     +          LV E       Q I       + ELD      +   +  
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLC 130

Query: 262 GLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGY 321
           G+++LH +     IHRD++P+N+++  D   +I +FGLA+        T       T  Y
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYY 184

Query: 322 IAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENP 380
            APE    +   +  DI+S G ++  +V  K      F     +     +   + +  P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVIEQLGTPCP 239

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 6e-18
 Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 51/296 (17%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
           G V  A     +G  + +KK+ +P +S                 +   E+     ++H N
Sbjct: 32  GSVCAAFDT-KTGLRVAVKKLSRPFQSIIH------------AKRTYRELRLLKHMKHEN 78

Query: 208 IVPLL-----ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASG 262
           ++ LL     AR +    D+ +        L +I+       ++L       +   I  G
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRG 133

Query: 263 LEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYI 322
           L+Y+H      IIHRD++P+N+ +++D E +I +FGLA+   D  T              
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRA 186

Query: 323 APECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMTSENPNR 382
                  +  + T DI+S G ++A L+ G+      F  T  +  ++ +  ++ +     
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLILRLVGTPGAEL 242

Query: 383 AINSKLLGNGYEEQMLLVLKIACFCTLD-----------------DPNKRPNSKDV 421
                        Q L  +    F  +                  D +KR  +   
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 58.3 bits (140), Expect = 1e-10
 Identities = 23/156 (14%), Positives = 46/156 (29%), Gaps = 17/156 (10%)

Query: 148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN 207
             V+             +K      K G    KK  E   +  +      I + +   R 
Sbjct: 14  SAVFNCYSE--KFGECVVKF----HKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLH 267
           +  L    V +      Y +  N  L +     ++    +       +   I   +   +
Sbjct: 68  LQKLQGLAVPKV-----YAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRI 303
                 I+H D+   NVL+  +    I +F  +  +
Sbjct: 121 ---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	430
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.93

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=405.20  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|++.+.||+|+||+||+|+++. +|+.||||++......             .....+.+|+.+|++++|||||++++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~-------------~~~~~~~~Ei~~l~~l~HpnIv~~~~   70 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFYG   70 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC--------------------CHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcc-------------hHHHHHHHHHHHHHhCCCCCEeeEee
Confidence            579999999999999999999864 8999999998542211             12356889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+++..|+|||||++|+|.+++.    ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+|
T Consensus        71 ~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~K  143 (271)
T d1nvra_          71 HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK  143 (271)
T ss_dssp             EEEETTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred             eeccCceeEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEE
Confidence            9999999999999999999999983    4567999999999999999999999665   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......   .....   
T Consensus       144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~---  217 (271)
T d1nvra_         144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYS---  217 (271)
T ss_dssp             ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---SHHHH---
T ss_pred             EccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---HHHHH---
Confidence            999999998765443333445689999999999988876 57899999999999999999998653221   11111   


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........         ........+.+|+.+||+.||++|||+.|+++
T Consensus       218 ~~~~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWKEKKTYLN---------PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHTTCTTST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCCCC---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111111100         00111234778999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=401.82  Aligned_cols=256  Identities=21%  Similarity=0.289  Sum_probs=198.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|...+.||+|+||+||+|++.  +++.||||++......               ..+|.+|+.++++++|||||+++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~   66 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQLY   66 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc---------------HHHHHHHHHHHHhcCCCCccccc
Confidence            457899999999999999999986  7889999998432211               35689999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|.+++..++|||||++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        67 g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~  140 (263)
T d1sm2a_          67 GVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI  140 (263)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCE
T ss_pred             ceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCe
Confidence            999999999999999999999999853   3456899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK-FPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||+++.......... ....||+.|+|||++.+..|+.++|||||||++|||+|+. +||...    ....+...+
T Consensus       141 Kl~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~----~~~~~~~~i  215 (263)
T d1sm2a_         141 KVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDI  215 (263)
T ss_dssp             EECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC----CHHHHHHHH
T ss_pred             EecccchheeccCCCceee-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC----CHHHHHHHH
Confidence            9999999987755433222 2457899999999999999999999999999999999954 444321    222233333


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ........+         ...    ...+.+++..||+.||++|||+++|++.|+++.
T Consensus       216 ~~~~~~~~p---------~~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         216 STGFRLYKP---------RLA----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HHTCCCCCC---------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCCCCc---------ccc----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            222111111         111    234889999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=404.65  Aligned_cols=262  Identities=21%  Similarity=0.328  Sum_probs=201.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|+++    ..||||++......            ......|.+|+.+|++++|||||+++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~   70 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPT------------PQQLQAFKNEVGVLRKTRHVNILLFM   70 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCC------------TTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCCCEeeee
Confidence            467899999999999999999864    35999998543221            12357899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++. .+..++|||||++|+|.+++..   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus        71 ~~~~-~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~  143 (276)
T d1uwha_          71 GYST-APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTV  143 (276)
T ss_dssp             EEEC-SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSE
T ss_pred             EEEe-ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCE
Confidence            9875 4568999999999999999954   3356999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV---ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      ||+|||+|+...............||+.|+|||++.+.   .|+.++|||||||++|||+||+.||.....   ...+..
T Consensus       144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~~  220 (276)
T d1uwha_         144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIF  220 (276)
T ss_dssp             EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHH
T ss_pred             EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HHHHHH
Confidence            99999999887654443333456899999999998653   489999999999999999999999875422   111222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      .+......+..     .......    +..+.+|+.+||+.||++|||+.+|++.|+.|+
T Consensus       221 ~~~~~~~~p~~-----~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         221 MVGRGYLSPDL-----SKVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             HHHHTSCCCCG-----GGSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCcc-----hhccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            22221111111     1111122    234889999999999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-55  Score=404.24  Aligned_cols=259  Identities=20%  Similarity=0.281  Sum_probs=210.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|++.. +|+.||||++.....               ..++|.+|+.+|++++|||||+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~---------------~~~~~~~E~~il~~l~HpnIv~~~   79 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLL   79 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTTCS---------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCccc---------------hHHHHHHHHHHHHhCCCCCEecCC
Confidence            4678999999999999999999864 789999999843211               145789999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      ++|.+.+..++|||||++|+|.+++..  .....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~  154 (287)
T d1opja_          80 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLV  154 (287)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             ccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcE
Confidence            999999999999999999999999965  34567999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+......... .....||+.|+|||++.+..|+.++|||||||++|||++|..|+....   ....+.+.+.
T Consensus       155 Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~i~  230 (287)
T d1opja_         155 KVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLE  230 (287)
T ss_dssp             EECCCCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHH
T ss_pred             EEccccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHHHHHh
Confidence            999999999876543322 224568999999999999999999999999999999999877653221   1122222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      ...   .+.          .+...+..+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus       231 ~~~---~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         231 KDY---RME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             TTC---CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCC---CCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111   111          11112234889999999999999999999999998763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=397.26  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=205.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|++.. +|+.||+|++......           .......+.+|+.+++.++|||||++++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~~~~   73 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLE-----------KAGVEHQLRREVEIQSHLRHPNILRLYG   73 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHcc-----------ChHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            469999999999999999999864 8999999998542211           1122467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+++..++|||||++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        74 ~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~k  146 (263)
T d2j4za1          74 YFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELK  146 (263)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred             EEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEe
Confidence            99999999999999999999999954    346999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||....       ..+....
T Consensus       147 l~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~  215 (263)
T d2j4za1         147 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKR  215 (263)
T ss_dssp             ECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH
T ss_pred             ecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHH
Confidence            999999987654432    24579999999999999999999999999999999999999986432       1222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........           +......+.+|+.+||+.||++|||+.|+++
T Consensus       216 i~~~~~~~-----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         216 ISRVEFTF-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHTTCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            22222110           0111234788999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=396.79  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||++......              ....+.+|+.+|++++|||||++++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~~~   84 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNYLD   84 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccCh--------------HHHHHHHHHHHHHhCCCCCEeeEeE
Confidence            469999999999999999998764 8999999998542211              1356899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+|||||++|+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vk  156 (293)
T d1yhwa1          85 SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVK  156 (293)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEE
T ss_pred             EEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEe
Confidence            99999999999999999999998753     35999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|+.+.......  ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.....       .+.+..
T Consensus       157 l~DFG~a~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~  227 (293)
T d1yhwa1         157 LTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYL  227 (293)
T ss_dssp             ECCCTTCEECCSTTCCB--CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHH
T ss_pred             eccchhheeeccccccc--cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHH
Confidence            99999999875443322  245799999999999999999999999999999999999999864321       111222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+....        +......+.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         228 IATNGTPELQN--------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHCSCCCSS--------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHhCCCCCCCC--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22221111111        1112234889999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-55  Score=399.92  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||.+......            ......+.+|+.+|++++|||||++++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~   70 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMT------------EAEKQMLVSEVNLLRELKHPNIVRYYD   70 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTSC------------HHHHHHHHHHHHHTTSCCCTTBCCEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhCC------------HHHHHHHHHHHHHHHHCCCCCEeeEEE
Confidence            579999999999999999998764 8999999998543221            233567899999999999999999999


Q ss_pred             EEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEeCCC
Q 014140          214 RMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH--RPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       214 ~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++.+  ++.+|+|||||++|+|.+++.........+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.+
T Consensus        71 ~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~  150 (269)
T d2java1          71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK  150 (269)
T ss_dssp             EEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT
T ss_pred             EEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC
Confidence            9865  45689999999999999999765445667999999999999999999999753  2359999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHH
Q 014140          290 MEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~  369 (430)
                      +.+||+|||+++.+......  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....    ..+..
T Consensus       151 ~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~~~  224 (269)
T d2java1         151 QNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAG  224 (269)
T ss_dssp             SCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred             CcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHHHH
Confidence            99999999999987544322  2246799999999999999999999999999999999999999865321    12222


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                         .+.....+.      +....+    ..+.+|+.+||+.||++|||+.|+++
T Consensus       225 ---~i~~~~~~~------~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 ---KIREGKFRR------IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---HHHHTCCCC------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHcCCCCC------CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               222111110      111122    34889999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=398.99  Aligned_cols=256  Identities=22%  Similarity=0.314  Sum_probs=204.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||.||+|+++  +++.||||++.....               ..+.|.+|+.+|++++|||||+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~---------------~~~~~~~E~~~l~~l~HpnIv~~~   74 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSM---------------SPDAFLAEANLMKQLQHQRLVRLY   74 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcC---------------CHHHHHHHHHHHHhCCCCCEeEEE
Confidence            467999999999999999999986  788999999843221               135699999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |++. .+..++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+
T Consensus        75 g~~~-~~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~  148 (272)
T d1qpca_          75 AVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSC  148 (272)
T ss_dssp             EEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred             eeec-cCCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccce
Confidence            9875 45679999999999999987542  2345999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+....... .....||+.|+|||++.+..++.++|||||||++|||+||..|+....   ....+...  
T Consensus       149 Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~--  222 (272)
T d1qpca_         149 KIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN--  222 (272)
T ss_dssp             EECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHH--
T ss_pred             eeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHH--
Confidence            999999999876543322 224578999999999999899999999999999999999765543221   11222222  


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                       +....++..          +...+..+.+|+..||+.||++|||+.+|++.|+.+
T Consensus       223 -i~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         223 -LERGYRMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHhcCCCCC----------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence             222211110          111223488999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-54  Score=399.69  Aligned_cols=260  Identities=21%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             ccccccccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||+||+|++...++  ..||||.+....             .....+.|.+|+.+|++++|||||+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~HpnIv~   91 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------------TEKQRRDFLSEASIMGQFDHPNVIH   91 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------------CHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            4578889999999999999999864222  368888874321             1233567999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|+|.+.+..++|||||++|+|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        92 l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~  165 (299)
T d1jpaa_          92 LEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNL  165 (299)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred             EEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCC
Confidence            99999999999999999999999998853   3456999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcce---eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 014140          291 EARISEFGLAKRIPDGHTRTT---TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMS  366 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~  366 (430)
                      .+||+|||+++.+........   .....||+.|+|||++.+..++.++|||||||++|||+| |..||.....    ..
T Consensus       166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~  241 (299)
T d1jpaa_         166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QD  241 (299)
T ss_dssp             CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH
T ss_pred             cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HH
Confidence            999999999998764432221   223457999999999999999999999999999999998 8999865322    22


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      +...   +.....+.          .+...+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       242 ~~~~---i~~~~~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         242 VINA---IEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHH---HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHH---HHcCCCCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2222   22222211          1112234488999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=387.72  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=209.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|...+.||+|+||+||+|+++  +++.||||++......               ...|.+|+.++++++||||++++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~---------------~~~~~~Ev~~~~~l~HpnIv~~~   65 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQLY   65 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC---------------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC---------------HHHHHHHHHHHHhcCCCceeeEE
Confidence            467899999999999999999986  7889999998542211               35689999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|.+.+..++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~  139 (258)
T d1k2pa_          66 GVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV  139 (258)
T ss_dssp             EEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCE
T ss_pred             EEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcE
Confidence            999999999999999999999999754   3456899999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      ||+|||+++.......... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....    ..+... 
T Consensus       140 kl~DfG~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~~-  213 (258)
T d1k2pa_         140 KVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEH-  213 (258)
T ss_dssp             EECCCSSCCBCSSSSCCCC-CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHH-
T ss_pred             EECcchhheeccCCCceee-cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHHH-
Confidence            9999999987765433222 24578999999999999999999999999999999998 8999875422    222222 


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        +....++.   .+   ...    ...+.+|+..||+.||++|||+.+|++.|.+|
T Consensus       214 --i~~~~~~~---~p---~~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         214 --IAQGLRLY---RP---HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --HHTTCCCC---CC---TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --HHhCCCCC---Cc---ccc----cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              22221111   11   112    23488999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=398.49  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=203.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+.+|+.+|++++|||||+++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~   74 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHII-----------KENKVPYVTRERDVMSRLDHPFFVKLY   74 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHcc-----------CHHHHHHHHHHHHHHHHcCCCCeeEEE
Confidence            3579999999999999999998764 8999999998532211           112246799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+.+..|+|||||++|+|.+++..    .+.+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~v  147 (288)
T d1uu3a_          75 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI  147 (288)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceE
Confidence            999999999999999999999999854    356999999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+|+.+.............||+.|+|||++.+..|+.++|||||||++|||++|+.||....       ..+...
T Consensus       148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~  220 (288)
T d1uu3a_         148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EYLIFQ  220 (288)
T ss_dssp             EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred             EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-------HHHHHH
Confidence            9999999998765444333335689999999999999999999999999999999999999986431       112222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........   +.    ...+    ..+.+|+.+||+.||++|||+.|+++
T Consensus       221 ~i~~~~~~---~p----~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         221 KIIKLEYD---FP----EKFF----PKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHTTCCC---CC----TTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHcCCCC---CC----ccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            22222111   00    1122    34789999999999999999998743

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=403.49  Aligned_cols=202  Identities=26%  Similarity=0.419  Sum_probs=176.6

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      ..++|.+++.||+|+||+||+|++.. +|+.||+|++.....             ......+.+|+.+|++++|||||++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~-------------~~~~~~~~~Ei~il~~l~HpnIv~l   69 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGF   69 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCCC-------------TTHHHHHHHHGGGGGGCCCTTBCCE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhhC-------------HHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            35789999999999999999999764 899999999854221             1224678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++|.+.+..|+|||||++|+|.+++..    ...+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.
T Consensus        70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~  143 (322)
T d1s9ja_          70 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE  143 (322)
T ss_dssp             EEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCC
T ss_pred             EEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCC
Confidence            9999999999999999999999999964    346999999999999999999999641  4999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDD  357 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~  357 (430)
                      +||+|||+|+......    ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       144 vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         144 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             EEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             EEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999998754321    2246899999999999999999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=396.25  Aligned_cols=254  Identities=21%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      .++.|++.+.||+|+||+||+|++.. +|+.||||++.....              .....+.+|+.+|++++|||||++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~l   74 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSE--------------EELEDYMVEIDILASCDHPNIVKL   74 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECSSS--------------GGGGGTHHHHHHHHHCCCTTBCCE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcCCH--------------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence            34578999999999999999999764 899999999854221              113568899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      ++++.+.+..++|||||++|+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~  148 (288)
T d2jfla1          75 LDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGD  148 (288)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             EEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCC
Confidence            9999999999999999999999999854   2356999999999999999999999665   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQ-----TVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      +||+|||+|........  ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.....    ..
T Consensus       149 ~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~  222 (288)
T d2jfla1         149 IKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MR  222 (288)
T ss_dssp             EEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GG
T ss_pred             EEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HH
Confidence            99999999976533211  112357999999999984     44689999999999999999999999875422    12


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..   ........+...        .+......+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~---~~i~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         223 VL---LKIAKSEPPTLA--------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HH---HHHHHSCCCCCS--------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HH---HHHHcCCCCCCC--------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22   222222211111        11112234889999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=394.23  Aligned_cols=261  Identities=22%  Similarity=0.337  Sum_probs=199.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCC---ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG---RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIV  209 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  209 (430)
                      ++.|...++||+|+||.||+|.++..++   ..||||++.....             ......|.+|+.+|++++|||||
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~il~~l~H~nIv   72 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------------EKQRVDFLGEAGIMGQFSHHNII   72 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-------------hHHHHHHHHHHHHHHhcCCCCEe
Confidence            4568889999999999999999864332   4799999843211             12346789999999999999999


Q ss_pred             cceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          210 PLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       210 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      +++|+|.+.+..++|||||.+|++.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~  146 (283)
T d1mqba_          73 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSN  146 (283)
T ss_dssp             CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred             eeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCC
Confidence            999999999999999999999999998854   3457999999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....   ....+.
T Consensus       147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~  223 (283)
T d1mqba_         147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVM  223 (283)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH
T ss_pred             CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHHH
Confidence            999999999998875443222 2223568999999999999999999999999999999999766643221   112222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .   .+....++.          .+...+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       224 ~---~i~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         224 K---AINDGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             H---HHHTTCCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             H---HHhccCCCC----------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            2   222221111          1111224488999999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=403.83  Aligned_cols=263  Identities=22%  Similarity=0.271  Sum_probs=206.9

Q ss_pred             cccccccccccccccCceEEEeecCCCC----CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSS----GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||+||+|++.+.+    +..||+|.+.....             ......+.+|+.+|.++ +||
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~Hp  101 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------------SSEREALMSELKMMTQLGSHE  101 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCT
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------------HHHHHHHHHHHHHHHHhcCCC
Confidence            3467999999999999999999875422    23689998843211             12246789999999998 899


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ-------------------GRRELDWLARHRIAQGIASGLEYLH  267 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH  267 (430)
                      |||+++++|.+.+..++|||||++|+|.++++....                   ....+++..++.++.|++.||.|||
T Consensus       102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH  181 (325)
T d1rjba_         102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  181 (325)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             cEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999975321                   1245899999999999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.+   |+||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++||
T Consensus       182 ~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~e  258 (325)
T d1rjba_         182 FKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE  258 (325)
T ss_dssp             HTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHH
Confidence            665   99999999999999999999999999987765544444435678999999999999999999999999999999


Q ss_pred             HHh-CCCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          348 LVI-GKFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       348 ll~-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      |+| |..||.....   ...+...+....   ++.          .+......+.+|+..||+.||++|||+.||++.|.
T Consensus       259 mlt~g~~Pf~~~~~---~~~~~~~~~~~~---~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         259 IFSLGVNPYPGIPV---DANFYKLIQNGF---KMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HTTTSCCSSTTCCC---SHHHHHHHHTTC---CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCH---HHHHHHHHhcCC---CCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            998 8999875322   112222222211   110          11112234889999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-53  Score=389.67  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=205.1

Q ss_pred             ccccccccc-cccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEK-IRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~-lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+. ||+|+||.||+|.++. .++..||||++....             .......|.+|+.+|++++|||||+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~~E~~il~~l~HpnIv~   73 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------------EKADTEEMMREAQIMHQLDNPYIVR   73 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence            456777774 9999999999998753 245689999984321             1233578999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|+|.. +..|+|||||++|+|.+++..   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        74 l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~  146 (285)
T d1u59a_          74 LIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRH  146 (285)
T ss_dssp             EEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETT
T ss_pred             Eeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCC
Confidence            9998864 568999999999999999843   3457999999999999999999999665   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....    ..+.
T Consensus       147 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~~  222 (285)
T d1u59a_         147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVM  222 (285)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHH
T ss_pred             ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HHHH
Confidence            99999999999876543322 2224568999999999999999999999999999999998 8999875422    2222


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..+.   ...++.          .+...+..+.+|+..||+.||++|||+.+|.+.|+.+
T Consensus       223 ~~i~---~~~~~~----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         223 AFIE---QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHH---TTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH---cCCCCC----------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2222   222111          1111223488999999999999999999999998754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=385.66  Aligned_cols=250  Identities=21%  Similarity=0.312  Sum_probs=197.1

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEE
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARM  215 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  215 (430)
                      |...+.||+|+||+||+|++.. ++..||+|++......            ......+.+|+.+|++++|||||+++++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~   77 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSW   77 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3566789999999999998764 8899999998542211            22356799999999999999999999998


Q ss_pred             Ee----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC-CCC
Q 014140          216 VR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID-DDM  290 (430)
Q Consensus       216 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~  290 (430)
                      .+    ....++|||||++|+|.+++..    ...+++..+..++.||+.||.|||+. .++|+||||||+|||++ +++
T Consensus        78 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~  152 (270)
T d1t4ha_          78 ESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG  152 (270)
T ss_dssp             EEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTS
T ss_pred             eeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCC
Confidence            75    3457999999999999999954    34699999999999999999999944 23499999999999997 578


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+|+......    .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....      ....
T Consensus       153 ~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~~  221 (270)
T d1t4ha_         153 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQI  221 (270)
T ss_dssp             CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHH
T ss_pred             CEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHHH
Confidence            99999999998654332    224689999999999876 699999999999999999999999864321      1222


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........+ ..++    ...++    .+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~i~~~~~~-~~~~----~~~~~----~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         222 YRRVTSGVKP-ASFD----KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHTTTCCC-GGGG----GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCC-cccC----ccCCH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence            2233222221 1111    12222    3788999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-53  Score=394.43  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=201.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|+.++.||+|+||+||+|+... +|+.||||++.....           ........+.+|+.+|++++|||||++++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~-----------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~   82 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGK-----------QSNEKWQDIIKEVRFLQKLRHPNTIQYRG   82 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSS-----------CHHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhc-----------cCHHHHHHHHHHHHHHHHCCCCCEeeEEE
Confidence            459999999999999999998764 899999999854322           22334577999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+|||||++|+|..++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~K  155 (309)
T d1u5ra_          83 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK  155 (309)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEE
T ss_pred             EEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEE
Confidence            99999999999999999999776633    356999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT---VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      |+|||+|......      ....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.....       .+.
T Consensus       156 l~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~  222 (309)
T d1u5ra_         156 LGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA  222 (309)
T ss_dssp             ECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH
T ss_pred             EeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHH
Confidence            9999999875432      23579999999999865   3589999999999999999999999864321       122


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +........+..  .+   ...    ...+.+|+.+||+.||.+|||+.|+++
T Consensus       223 ~~~i~~~~~~~~--~~---~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         223 LYHIAQNESPAL--QS---GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHSCCCCC--SC---TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCCCC--CC---CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            222222222110  00   112    234889999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-53  Score=393.87  Aligned_cols=252  Identities=25%  Similarity=0.297  Sum_probs=189.3

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||+||+|+... +|+.||||++......             .....+.+|+.+|++++|||||++++
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~~   74 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALE-------------GKEGSMENEIAVLHKIKHPNIVALDD   74 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC-----------------------CHHHHHHHTCCCTTBCCEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhh-------------hHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            569999999999999999999764 8999999998543211             11356789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC---CCC
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID---DDM  290 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~  290 (430)
                      ++.+++..|+|||||+||+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+.   +++
T Consensus        75 ~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~  147 (307)
T d1a06a_          75 IYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDS  147 (307)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTC
T ss_pred             EEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCc
Confidence            99999999999999999999999953    457999999999999999999999655   99999999999995   578


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~  370 (430)
                      .+||+|||+|+........   ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....    ..+   
T Consensus       148 ~vkl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~---  217 (307)
T d1a06a_         148 KIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKL---  217 (307)
T ss_dssp             CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH---
T ss_pred             eEEEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHH---
Confidence            9999999999876544322   235799999999999999999999999999999999999999865321    112   


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........   .......    ....+.+|+..||+.||++|||+.|+++
T Consensus       218 ~~~i~~~~~~~---~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         218 FEQILKAEYEF---DSPYWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHTTCCCC---CTTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCC---CCccccC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            22222221110   1111111    2234889999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=387.71  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=198.5

Q ss_pred             cccccccCceEEEeecCC-CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEeC
Q 014140          140 EKIRSCWNGEVYKAELPG-SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVRR  218 (430)
Q Consensus       140 ~~lg~G~~g~vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  218 (430)
                      +.||+|+||+||+|.+.. .+++.||||++.....            .......+.+|+.+|++++|||||+++|+|. .
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~   79 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------------DPALKDELLAEANVMQQLDNPYIVRMIGICE-A   79 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC------------CHHHHHHHHHHHHHHHhCCCCCCceEEEEec-c
Confidence            469999999999998642 3567899999843211            1233578999999999999999999999985 4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeecC
Q 014140          219 DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEFG  298 (430)
Q Consensus       219 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg  298 (430)
                      +..++|||||++|+|.+++..    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFG  152 (277)
T d1xbba_          80 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  152 (277)
T ss_dssp             SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchh
Confidence            567899999999999999854    456999999999999999999999665   9999999999999999999999999


Q ss_pred             CcccCCCCCCcc-eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHHHHHHhc
Q 014140          299 LAKRIPDGHTRT-TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQWMRNVMT  376 (430)
Q Consensus       299 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~~~~~~~  376 (430)
                      +++.+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....    ..+...+   ..
T Consensus       153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i---~~  225 (277)
T d1xbba_         153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAML---EK  225 (277)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH---HT
T ss_pred             hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHH---Hc
Confidence            998876543322 2234578999999999999999999999999999999998 8999875321    2222222   22


Q ss_pred             CCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          377 SENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..++.          .+..++..+.+|+.+||+.||++|||+.+|.+.|+.+
T Consensus       226 ~~~~~----------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCC----------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            22111          1111223488999999999999999999999988764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-52  Score=391.47  Aligned_cols=266  Identities=20%  Similarity=0.305  Sum_probs=211.2

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRN  207 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  207 (430)
                      +.++|.+.+.||+|+||+||+|++++    .+++.||||++....             .......|.+|+.+|++++|||
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------------~~~~~~~~~~E~~il~~l~h~n   77 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------------SADMQADFQREAALMAEFDNPN   77 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------------ChHHHHHHHHHHHHHHhcCCCC
Confidence            45789999999999999999998643    356899999984321             1233577999999999999999


Q ss_pred             cccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc--------------------CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 014140          208 IVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS--------------------QGRRELDWLARHRIAQGIASGLEYLH  267 (430)
Q Consensus       208 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH  267 (430)
                      |++++++|...+..++||||+++|+|.++++...                    .....+++..++.++.|++.||+|||
T Consensus        78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH  157 (301)
T d1lufa_          78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  157 (301)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence            9999999999999999999999999999996422                    11335899999999999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 014140          268 MSHRPRIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAV  347 (430)
Q Consensus       268 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  347 (430)
                      +.+   ++||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++||
T Consensus       158 ~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         158 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             cCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence            655   99999999999999999999999999987654433333334678999999999999999999999999999999


Q ss_pred             HHhCC-CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 014140          348 LVIGK-FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLS  426 (430)
Q Consensus       348 ll~g~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~  426 (430)
                      |++|. .||....    ...+.   ..+.....+.      .....    +..+.+|+..||+.+|++|||+.||+++|+
T Consensus       235 ll~~~~~p~~~~~----~~e~~---~~v~~~~~~~------~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         235 IFSYGLQPYYGMA----HEEVI---YYVRDGNILA------CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             HHTTTCCTTTTSC----HHHHH---HHHHTTCCCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHccCCCCCCCCC----HHHHH---HHHHcCCCCC------CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            99996 5655432    12222   2222222211      01112    234889999999999999999999999999


Q ss_pred             cccC
Q 014140          427 QIQH  430 (430)
Q Consensus       427 ~l~~  430 (430)
                      +|.+
T Consensus       298 ~i~~  301 (301)
T d1lufa_         298 RMCE  301 (301)
T ss_dssp             HTTC
T ss_pred             HhcC
Confidence            9864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=385.74  Aligned_cols=258  Identities=24%  Similarity=0.306  Sum_probs=206.4

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+.+.||+|+||+||+|++.. +|+.||||++........        ........+.+|+.+|++++|||||+++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchh--------hhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3579999999999999999999764 899999999965432211        1111256799999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC--
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM--  290 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--  290 (430)
                      ++|.+.+..|+|||||++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSS
T ss_pred             EEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCc
Confidence            999999999999999999999999954    346999999999999999999999665   99999999999998776  


Q ss_pred             --ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 --EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                        .+|++|||++..........   ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .
T Consensus       153 ~~~vkl~DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~  222 (293)
T d1jksa_         153 KPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------Q  222 (293)
T ss_dssp             SCCEEECCCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H
T ss_pred             ccceEecchhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------H
Confidence              49999999998875443322   35789999999999999999999999999999999999999864321       1


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +............   ........    ...+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         223 ETLANVSAVNYEF---EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHHTTCCCC---CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCC---CchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222222221110   01111112    234789999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=384.90  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=198.5

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .++|.+.+.||+|+||+||+|+++  +++.||||++......               .+.|.+|+.+|++++|||||+++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~---------------~~~~~~E~~~l~~l~h~nIv~~~   78 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQLY   78 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC---------------HHHHHHHHHHHHhcccCCEeEEE
Confidence            457999999999999999999986  6678999998432211               35689999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      |+|. .+..++|||||++|+|..++...  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+
T Consensus        79 g~~~-~~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~  152 (285)
T d1fmka3          79 AVVS-EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVC  152 (285)
T ss_dssp             EEEC-SSSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEe-cCCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcE
Confidence            9985 55689999999999999998652  2346999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|..|+....   ....+...+ 
T Consensus       153 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i-  227 (285)
T d1fmka3         153 KVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-  227 (285)
T ss_dssp             EECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHH-
T ss_pred             EEcccchhhhccCCCcee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHH-
Confidence            999999998775443322 224578999999999999999999999999999999999766643321   122222222 


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                        .....+.          .+......+.+++.+||+.||++|||+.+|+++|+.+
T Consensus       228 --~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         228 --ERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             --HTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             --HhcCCCC----------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence              2221111          1111223488999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-51  Score=391.55  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=204.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++....              ......+.+|+.+|++++|||||++++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~~--------------~~~~~~~~~E~~il~~l~HpnIv~~~~   90 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPH--------------ESDKETVRKEIQTMSVLRHPTLVNLHD   90 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCCS--------------HHHHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEcccc--------------hhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            479999999999999999998764 89999999984321              122467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC--CCc
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD--DME  291 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~  291 (430)
                      ++.+.+..|+|||||+||+|.+++..   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.
T Consensus        91 ~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~  164 (350)
T d1koaa2          91 AFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE  164 (350)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCC
T ss_pred             EEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCe
Confidence            99999999999999999999999843   3456999999999999999999999665   999999999999964  678


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+++.+......   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....       ..+.+
T Consensus       165 vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~  234 (350)
T d1koaa2         165 LKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETL  234 (350)
T ss_dssp             EEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHH
T ss_pred             EEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-------HHHHH
Confidence            999999999987654332   23589999999999999999999999999999999999999986432       12222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..........   ........    ...+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         235 RNVKSCDWNM---DDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHTCCCS---CCGGGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCC---CcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2222211100   01111111    234789999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-51  Score=391.89  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=204.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      +.|.+.+.||+|+||+||+|+... +|+.||||++.....              .....+.+|+.+|++++|||||++++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~~~~   93 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYP--------------LDKYTVKNEISIMNQLHHPKLINLHD   93 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCSTTBCCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcch--------------hHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            469999999999999999998764 899999999853221              12456889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC--CCCc
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID--DDME  291 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~  291 (430)
                      +|.+++..|+|||||+||+|.+.+.   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++  .++.
T Consensus        94 ~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~  167 (352)
T d1koba_          94 AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASS  167 (352)
T ss_dssp             EEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCC
T ss_pred             EEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCe
Confidence            9999999999999999999998873   23456999999999999999999999655   99999999999998  6789


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||+|..+.......   ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||.....    ..+   +
T Consensus       168 vkL~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~---~  237 (352)
T d1koba_         168 VKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LET---L  237 (352)
T ss_dssp             EEECCCTTCEECCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHH---H
T ss_pred             EEEeecccceecCCCCcee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH---H
Confidence            9999999999876543322   35799999999999999999999999999999999999999865321    122   2


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .........   +........    ...+.+|+..||+.||.+|||+.|+++
T Consensus       238 ~~i~~~~~~---~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         238 QNVKRCDWE---FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHCCCC---CCSSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCC---CCcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222221111   011111122    234789999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=387.80  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             ccccccccccccccCceEEEeecCCCCCc----eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGR----VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|++++.||+|+||+||+|++.. +|+    .||+|++.....             ....+.+.+|+.+|++++||||
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnI   73 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPHV   73 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-----------------CTHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCCE
Confidence            4579999999999999999998764 554    578887743211             1225679999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      |+++|+|.++ ..++++||+.+|+|.+++..   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        74 v~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~  146 (317)
T d1xkka_          74 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKT  146 (317)
T ss_dssp             CCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEE
T ss_pred             eeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCC
Confidence            9999999865 56788999999999998864   4567999999999999999999999655   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||+| |..||+....    ..+
T Consensus       147 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~~  222 (317)
T d1xkka_         147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEI  222 (317)
T ss_dssp             TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GGH
T ss_pred             CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH----HHH
Confidence            99999999999998765554444445678999999999999999999999999999999998 7888865422    223


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ...+........             +..+...+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       223 ~~~i~~~~~~~~-------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         223 SSILEKGERLPQ-------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHHHHTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCC-------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            333322211111             111223488999999999999999999999998765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=386.96  Aligned_cols=251  Identities=22%  Similarity=0.261  Sum_probs=203.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|+... +|+.||||++......           .......+.+|+.+|++++||||+++++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~-----------~~~~~~~~~~E~~il~~l~hp~Iv~l~~   72 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhcc-----------CHHHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence            579999999999999999999764 8999999999542211           1122567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+.+|+|||||+||+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.+|.+|
T Consensus        73 ~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vk  145 (337)
T d1o6la_          73 AFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             eeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEE
Confidence            99999999999999999999999854    356899999999999999999999555   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|+........  ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....    ..+.   ..
T Consensus       146 l~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~---~~  216 (337)
T d1o6la_         146 ITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLF---EL  216 (337)
T ss_dssp             ECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH---HH
T ss_pred             EeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHHH---HH
Confidence            9999999876543222  2246899999999999999999999999999999999999999865321    1122   22


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      .......       .....+    ..+.+|+..||+.||.+||+     +.++++
T Consensus       217 i~~~~~~-------~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         217 ILMEEIR-------FPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHCCCC-------CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HhcCCCC-------CCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            2221110       001122    34789999999999999995     677764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.2e-51  Score=380.03  Aligned_cols=263  Identities=21%  Similarity=0.262  Sum_probs=203.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|++.. +|+.||||++.....           ........+.+|+.+|+.++|||||++++
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~-----------~~~~~~~~~~~E~~~l~~~~hpniv~~~~   74 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLA-----------RDPSFYLRFRREAQNAAALNHPAIVAVYD   74 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTT-----------TCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhc-----------cCHHHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            579999999999999999998764 899999999854322           22334577999999999999999999999


Q ss_pred             EEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          214 RMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       214 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++...+    ..|+||||++||+|.+++..    .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~  147 (277)
T d1o6ya_          75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT  147 (277)
T ss_dssp             EEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             eeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcc
Confidence            998754    37899999999999998854    346999999999999999999999655   9999999999999999


Q ss_pred             CceEEeecCCcccCCCCCC-cceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          290 MEARISEFGLAKRIPDGHT-RTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      +..+++|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.....       .
T Consensus       148 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~  220 (277)
T d1o6ya_         148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------V  220 (277)
T ss_dssp             SCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------H
T ss_pred             ccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------H
Confidence            9999999999876643322 2223346799999999999999999999999999999999999999865321       2


Q ss_pred             HHHHHHhcCCCC-chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcccC
Q 014140          369 QWMRNVMTSENP-NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-NSKDVRCMLSQIQH  430 (430)
Q Consensus       369 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-s~~ev~~~L~~l~~  430 (430)
                      +........... .....    ...+    ..+.+++.+||+.||.+|| |+.++++.|.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         221 SVAYQHVREDPIPPSARH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHHHHHCCCCCGGGTS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcCCCCCchhc----cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            222223322221 11111    1122    3488999999999999999 89999999988764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=380.31  Aligned_cols=263  Identities=23%  Similarity=0.284  Sum_probs=199.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|++.+.||+|+||.||+|++...++  ..||||++.....           ......+.|.+|+.+|++++|||||+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-----------~~~~~~~~~~~Ei~~l~~l~H~nIv~   75 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----------SQPEAMDDFIREVNAMHSLDHRNLIR   75 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-----------CCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            4568999999999999999998764444  3789998843322           12234578999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|+|.+ +..++|||||++|+|.+.+..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        76 ~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          76 LYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD  148 (273)
T ss_dssp             EEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred             EEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccc
Confidence            9999965 567899999999999998864   2346999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcce-eeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRTT-TWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||.....       .
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~  221 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------S  221 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------H
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------H
Confidence            999999999998765544332 223467889999999999999999999999999999998 8999865321       2


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +........+...     ......+    ..+.+|+.+||+.||++|||+.+|.+.|++.+
T Consensus       222 ~~~~~i~~~~~~~-----~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         222 QILHKIDKEGERL-----PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             HHHHHHHTSCCCC-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCC-----CCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            2222332222111     0111222    34889999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=378.64  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+.+.||+|+||.||+|++   .|+.||||++....                ..+.+.+|+.++++++||||++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~----------------~~~~~~~E~~~l~~l~HpnIv~~~   66 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLL   66 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHH----------------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence            35688899999999999999997   57889999984311                135689999999999999999999


Q ss_pred             eEEEe-CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          213 ARMVR-RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       213 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      |+|.+ .+..++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        67 g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~  141 (262)
T d1byga_          67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNV  141 (262)
T ss_dssp             EEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             EEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCC
Confidence            99965 45689999999999999999652  2335899999999999999999999655   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQW  370 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~~  370 (430)
                      +|++|||+++......     ....+|..|+|||++.+..++.++|||||||++|||+| |+.||...    ....+...
T Consensus       142 ~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~  212 (262)
T d1byga_         142 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPR  212 (262)
T ss_dssp             EEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHH
T ss_pred             EeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHHH
Confidence            9999999998754322     13467899999999999999999999999999999998 67776543    22334433


Q ss_pred             HHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          371 MRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                      +...   .++.      .....+    ..+.+|+.+||+.||.+|||+.+|++.|++++
T Consensus       213 i~~~---~~~~------~~~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         213 VEKG---YKMD------APDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HTTT---CCCC------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcC---CCCC------CCccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            3221   1111      111222    34789999999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-51  Score=384.02  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=203.4

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|+.+. +|+.||||++......           .......+.+|+.+|++++|||||++++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~~~~   71 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVV-----------RLKQVEHTNDERLMLSIVTHPFIIRMWG   71 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHcc-----------CHHHHHHHHHHHHHHHhccCcChhheee
Confidence            469999999999999999999764 8999999998542211           1122567899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+|||||+||+|..++..    ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vk  144 (316)
T d1fota_          72 TFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIK  144 (316)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEE
T ss_pred             eEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEE
Confidence            99999999999999999999999853    4568899999999999999999994   4599999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|+......     ....||+.|+|||++.+..|+.++|||||||++|||++|+.||....       ..+....
T Consensus       145 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~  212 (316)
T d1fota_         145 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEK  212 (316)
T ss_dssp             ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH
T ss_pred             EecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHH
Confidence            99999998865432     24689999999999999999999999999999999999999986532       1222233


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ........       ....    ...+.+++.+||+.||.+||     |+.++++
T Consensus       213 i~~~~~~~-------p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         213 ILNAELRF-------PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHCCCCC-------CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHcCCCCC-------CCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            33222111       0111    23478999999999999996     8888875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=374.68  Aligned_cols=258  Identities=20%  Similarity=0.281  Sum_probs=195.4

Q ss_pred             ccccccccccccccCceEEEeecCCCC--CceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSS--GRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  210 (430)
                      .++|.+.+.||+|+||.||+|++...+  +..||||.+....             .......+.+|+.+|++++|||||+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------------~~~~~~~~~~E~~~l~~l~HpnIv~   72 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------------SDSVREKFLQEALTMRQFDHPHIVK   72 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------------SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence            467999999999999999999876433  3568888773211             1233577999999999999999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      ++|++. .+..++||||+++|+|.+++..   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        73 l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~  145 (273)
T d1mp8a_          73 LIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSND  145 (273)
T ss_dssp             EEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred             EEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCC
Confidence            999985 5678999999999999998754   3456999999999999999999999655   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccHHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-GKFPSDDFFQHTKEMSLVQ  369 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~l~~  369 (430)
                      .+||+|||+|+.......... ....||+.|+|||++.+..++.++|||||||++|||++ |.+||.....    ..+..
T Consensus       146 ~~Kl~DfG~a~~~~~~~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~~  220 (273)
T d1mp8a_         146 CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG  220 (273)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH
T ss_pred             cEEEccchhheeccCCcceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----HHHHH
Confidence            999999999987654433222 24568999999999999999999999999999999998 8899875432    23333


Q ss_pred             HHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          370 WMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+..   ...+.      .    +...+..+.+|+..||+.||++|||+.+|++.|+.+
T Consensus       221 ~i~~---~~~~~------~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         221 RIEN---GERLP------M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             HHHT---TCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHc---CCCCC------C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            3222   22111      1    111223488999999999999999999999999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=379.16  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=199.1

Q ss_pred             cccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++..    .+++.||||++.....             ......+..|..++.++ +||
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------------~~~~~~~~~e~~~l~~~~~h~   77 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHHL   77 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------------HHHHHHHHHHHHHHHHHCCCT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------------cHHHHHHHHHHHHHHhhcCCC
Confidence            34679999999999999999998642    2457899999843211             12346678888888877 689


Q ss_pred             CcccceeEEEeC-CeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014140          207 NIVPLLARMVRR-DCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRPR  273 (430)
Q Consensus       207 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  273 (430)
                      ||+.+++++.+. +..++|||||++|+|.++++....            ....+++..++.++.||+.||.|||+.+   
T Consensus        78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---  154 (299)
T d1ywna1          78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  154 (299)
T ss_dssp             TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            999999998765 468999999999999999975322            1345899999999999999999999655   


Q ss_pred             eEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-
Q 014140          274 IIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK-  352 (430)
Q Consensus       274 iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-  352 (430)
                      |+||||||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. 
T Consensus       155 ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~  234 (299)
T d1ywna1         155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  234 (299)
T ss_dssp             CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence            9999999999999999999999999998776554443333567999999999999999999999999999999999975 


Q ss_pred             CCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          353 FPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       353 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .||.....   ...+...+....   .+.      .....    ...+.+++.+||+.||++|||+.||++.|+++
T Consensus       235 ~p~~~~~~---~~~~~~~~~~~~---~~~------~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         235 SPYPGVKI---DEEFCRRLKEGT---RMR------APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CSSTTCCC---SHHHHHHHHHTC---CCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHhcCC---CCC------CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            56654321   112222222221   110      00112    23488999999999999999999999999876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-50  Score=371.28  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=205.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  212 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||++.........     ..........+.+|+.+|++++ ||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFS-----AEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCC-----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchh-----HHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            579999999999999999998764 8999999999654332110     1112234567899999999997 99999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+++..|||||||++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence            999999999999999999999999954    346999999999999999999999655   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT------VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ||+|||++..+......   ....||+.|+|||++.+      ..++.++||||+||++|+|++|+.||.....      
T Consensus       150 kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------  220 (277)
T d1phka_         150 KLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------  220 (277)
T ss_dssp             EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred             EEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------
Confidence            99999999987654332   23579999999998763      3468899999999999999999999875321      


Q ss_pred             HHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ...............   .    .........+.+|+.+||+.||++|||+.||++
T Consensus       221 -~~~~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 -MLMLRMIMSGNYQFG---S----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HHHHHHHHHTCCCCC---T----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHHhCCCCCC---C----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             111222222211100   0    011112234889999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=379.01  Aligned_cols=256  Identities=20%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             ccccccccCceEEEeecCCCCC--ceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSG--RVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMV  216 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  216 (430)
                      .++||+|+||+||+|++...++  ..||||++...             ........|.+|+.+|++++|||||+++|+|.
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   98 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL   98 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence            4689999999999999864333  36899988421             12234678999999999999999999999987


Q ss_pred             eC-CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 014140          217 RR-DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARIS  295 (430)
Q Consensus       217 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~  295 (430)
                      +. +..++|||||++|+|.+++..   ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+
T Consensus        99 ~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~  172 (311)
T d1r0pa_          99 RSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA  172 (311)
T ss_dssp             ETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEe
Confidence            64 578999999999999999853   4456889999999999999999999555   9999999999999999999999


Q ss_pred             ecCCcccCCCCCCcc--eeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          296 EFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       296 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |||+++.........  ......||+.|+|||++.+..++.++||||||+++|||+||..||.....   ...+...+  
T Consensus       173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~i--  247 (311)
T d1r0pa_         173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYL--  247 (311)
T ss_dssp             SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH--
T ss_pred             cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHHH--
Confidence            999999876443222  22235689999999999999999999999999999999998887654221   11222222  


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhccc
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQIQ  429 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l~  429 (430)
                       ....++.   .+   ...    ...+.+|+..||+.||++|||+.||++.|+++.
T Consensus       248 -~~g~~~~---~p---~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         248 -LQGRRLL---QP---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             -HTTCCCC---CC---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HcCCCCC---Cc---ccC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             2222211   11   111    234889999999999999999999999998774

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=377.18  Aligned_cols=264  Identities=23%  Similarity=0.291  Sum_probs=207.3

Q ss_pred             cccccccccccccccCceEEEeecCCC------CCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-C
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGS------SGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-R  204 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  204 (430)
                      ..++|.+.+.||+|+||.||+|+..+.      ++..||||++....             .......+.+|...+.++ +
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~~e~~~l~~~~~   77 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------------TEKDLSDLISEMEMMKMIGK   77 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------------ChHHHHHHHHHHHHHHHhcC
Confidence            356899999999999999999986532      23579999984322             123357789999999888 8


Q ss_pred             CCCcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          205 HRNIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ------------GRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       205 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      |||||+++++|.+++..++|||||++|+|.+++.....            ....+++..++.++.|++.||.|||+.+  
T Consensus        78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--  155 (299)
T d1fgka_          78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--  155 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--
Confidence            99999999999999999999999999999999975321            2346899999999999999999999665  


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-C
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVI-G  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g  351 (430)
                       |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |
T Consensus       156 -ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             -CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             -EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence             99999999999999999999999999998766554444445678999999999999999999999999999999998 6


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..||.....    ..+...+.   ....+.      .....    ...+.+|+.+||+.||++|||+.||++.|++|
T Consensus       235 ~~p~~~~~~----~~~~~~i~---~~~~~~------~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         235 GSPYPGVPV----EELFKLLK---EGHRMD------KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             CCSSTTCCH----HHHHHHHH---TTCCCC------CCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCH----HHHHHHHH---cCCCCC------CCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            888764321    22222222   111111      00112    23488999999999999999999999999876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-50  Score=383.01  Aligned_cols=248  Identities=21%  Similarity=0.231  Sum_probs=203.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||.||+|+++. +|+.||||++......           .......+.+|+.+|+.++|||||++++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~~~~  108 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVV-----------KLKQIEHTLNEKRILQAVNFPFLVKLEF  108 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHcc-----------CHHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence            469999999999999999998764 8999999998532211           1122467899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..++||||+.+|+|..++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       109 ~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ik  181 (350)
T d1rdqe_         109 SFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             ccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEE
Confidence            99999999999999999999999954    346999999999999999999999665   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRN  373 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~  373 (430)
                      |+|||+|+.+....     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......
T Consensus       182 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~  249 (350)
T d1rdqe_         182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEK  249 (350)
T ss_dssp             ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             eeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-------HHHHHHH
Confidence            99999998875332     23579999999999999999999999999999999999999986431       1222222


Q ss_pred             HhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 014140          374 VMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRP-----NSKDVRC  423 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rp-----s~~ev~~  423 (430)
                      ........       ....    ...+.+++..||+.||.+|+     |+.++++
T Consensus       250 i~~~~~~~-------p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         250 IVSGKVRF-------PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHCCCCC-------CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HhcCCCCC-------CccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            22221110       0112    23488999999999999994     8888875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=375.80  Aligned_cols=269  Identities=24%  Similarity=0.297  Sum_probs=201.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ..|...+.||+|+||.||+|++   +|+.||||++....               ........|+..+.+++|||||++++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~---------------~~~~~~e~ei~~~~~~~HpnIv~~~~   64 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE---------------ERSWFREAEIYQTVMLRHENILGFIA   64 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc---------------hhHHHHHHHHHHHhhCCCCcCcceEE
Confidence            3577888999999999999986   78999999984211               11122334666677889999999999


Q ss_pred             EEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCcE
Q 014140          214 RMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMS-----HRPRIIHRDIQPANV  284 (430)
Q Consensus       214 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp~Ni  284 (430)
                      +|.+.+    .+++|||||++|+|.++++.     ..+++..++.++.|++.||+|||+.     ++++|+||||||+||
T Consensus        65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI  139 (303)
T d1vjya_          65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred             EEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence            998754    57899999999999999964     3589999999999999999999964     235799999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCcc--eeeccccccccccccccCCCC------CCcchhHHHHHHHHHHHHhCCCCCC
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTRT--TTWSLAGTVGYIAPECHQTVA------LSDTCDIYSFGVLLAVLVIGKFPSD  356 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g~~p~~  356 (430)
                      ||+.++.+||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+.
T Consensus       140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99999999999999998775433221  223467999999999987653      5778999999999999999998875


Q ss_pred             ccccc--------cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          357 DFFQH--------TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       357 ~~~~~--------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .....        ..... .+..............+...   ....+....+.+|+.+||+.||++|||+.||++.|++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         220 IHEDYQLPYYDLVPSDPS-VEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             BCCCCCCTTTTTSCSSCC-HHHHHHHHTTSCCCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccchhhcccccch-HHHHHHHHhccccCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            32111        01112 22222222222211111111   11223456688999999999999999999999999987


Q ss_pred             c
Q 014140          429 Q  429 (430)
Q Consensus       429 ~  429 (430)
                      .
T Consensus       296 ~  296 (303)
T d1vjya_         296 S  296 (303)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=376.03  Aligned_cols=265  Identities=20%  Similarity=0.256  Sum_probs=211.0

Q ss_pred             cccccccccccccccCceEEEeecC----CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCC
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELP----GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHR  206 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  206 (430)
                      ..++|.+.+.||+|+||.||+|++.    ..+++.||||++....             .......+.+|+.++.++ +||
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------------~~~~~~~~~~E~~~~~~l~~Hp   87 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------------HLTEREALMSELKVLSYLGNHM   87 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-------------CHHHHHHHHHHHHHHHhccCCC
Confidence            3568899999999999999999863    3467899999984321             123356799999999999 699


Q ss_pred             CcccceeEEEeCCeeEEEEEecCCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 014140          207 NIVPLLARMVRRDCDLLVYEFRRNGSLQDILYDVSQ--------------GRRELDWLARHRIAQGIASGLEYLHMSHRP  272 (430)
Q Consensus       207 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  272 (430)
                      |||+++++|.+.+..++|||||++|+|.++++....              ....+++..+..++.||+.||.|||+.+  
T Consensus        88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--  165 (311)
T d1t46a_          88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--  165 (311)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            999999999999999999999999999999975321              2346899999999999999999999555  


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-
Q 014140          273 RIIHRDIQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIG-  351 (430)
Q Consensus       273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-  351 (430)
                       ++||||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ 
T Consensus       166 -ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         166 -CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             -CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             -eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence             999999999999999999999999999988765554444456899999999999999999999999999999999995 


Q ss_pred             CCCCCccccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          352 KFPSDDFFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       352 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .+||....   ....+...+........             +......+.+|+.+||+.||.+|||+.+|+++|+++
T Consensus       245 ~p~~~~~~---~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         245 SSPYPGMP---VDSKFYKMIKEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             CCSSTTCC---SSHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCC---HHHHHHHHHhcCCCCCC-------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            45443321   11122222222221111             111223488999999999999999999999999853

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=379.00  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=199.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHh-ccCCCCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAG-QVRHRNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~  212 (430)
                      ++|.+.+.||+|+||+||+|+... +|+.||||++......           .......+..|..++. .++|||||+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~-----------~~~~~~~~~~e~~~l~~~~~hp~Iv~~~   69 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVL-----------MDDDVECTMVEKRVLSLAWEHPFLTHMF   69 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhcc-----------ChHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence            469999999999999999999874 8999999999532111           1112455667777665 68999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCce
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEA  292 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~  292 (430)
                      +++.+++..|+|||||++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+
T Consensus        70 ~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~  142 (320)
T d1xjda_          70 CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI  142 (320)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred             EEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCce
Confidence            999999999999999999999999954    346899999999999999999999665   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          293 RISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       293 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ||+|||+++.........  ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....    ..+.   .
T Consensus       143 kl~DFG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~---~  213 (320)
T d1xjda_         143 KIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELF---H  213 (320)
T ss_dssp             EECCCTTCBCCCCTTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH---H
T ss_pred             eccccchhhhcccccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----HHHH---H
Confidence            999999998765433322  235799999999999999999999999999999999999999865321    1222   2


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSK-DVR  422 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~-ev~  422 (430)
                      .........       ....    ...+.+|+.+||+.||++||++. +++
T Consensus       214 ~i~~~~~~~-------p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         214 SIRMDNPFY-------PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHHHCCCCC-------CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHcCCCCC-------CccC----CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            222111110       0111    23488999999999999999995 665

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8e-50  Score=382.38  Aligned_cols=255  Identities=23%  Similarity=0.242  Sum_probs=199.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||.||+|+... +|+.||||++.......     .   ...........|+.+++.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~-----~---~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKM-----K---QGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHH-----H---TCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcch-----h---hHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            579999999999999999999764 89999999985322110     0   01111233445678888889999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+.+..|+|||||+||+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEE
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEE
Confidence            99999999999999999999999954    356899999999999999999999555   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||+|+.+.....    ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....    ........
T Consensus       148 l~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~  219 (364)
T d1omwa3         148 ISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDR  219 (364)
T ss_dssp             ECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHHH
T ss_pred             EeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence            999999987754432    23579999999999875 4689999999999999999999999875322    22222222


Q ss_pred             HHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          373 NVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      ........       .....+    ..+.+|+..||+.||++|||     +.++++
T Consensus       220 ~~~~~~~~-------~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 MTLTMAVE-------LPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSSSCCCC-------CCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             hcccCCCC-------CCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            22211111       001122    34889999999999999999     577764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=373.95  Aligned_cols=251  Identities=21%  Similarity=0.267  Sum_probs=202.8

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+.+.||+|+||+||+|.... +|+.||||.+....               .....+.+|+.+|+.++|||||++++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~~~~   68 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG---------------TDQVLVKKEISILNIARHRNILHLHE   68 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT---------------HHHHHHHHHHHHHHHSCCTTBCCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCc---------------ccHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            569999999999999999998764 89999999984321               11345789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC--Cc
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD--ME  291 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~  291 (430)
                      ++.+.+..|+|||||+||+|.+++..   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.+  ..
T Consensus        69 ~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~  142 (321)
T d1tkia_          69 SFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSST  142 (321)
T ss_dssp             EEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCC
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceE
Confidence            99999999999999999999999943   3346999999999999999999999655   9999999999999854  58


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWM  371 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~  371 (430)
                      +||+|||++.........   ....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.....       .+..
T Consensus       143 ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~  212 (321)
T d1tkia_         143 IKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQII  212 (321)
T ss_dssp             EEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHH
T ss_pred             EEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence            999999999887554332   235789999999999999999999999999999999999999865321       1222


Q ss_pred             HHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          372 RNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..+......   ++.......+    ..+.+|+..||+.||++|||+.|+++
T Consensus       213 ~~i~~~~~~---~~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         213 ENIMNAEYT---FDEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCC---CCHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCC---CChhhccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222222111   1111111122    34789999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=378.19  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=202.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCc--eEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGR--VITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  210 (430)
                      ++|.+.+.||+|+||.||+|+++. +|.  .||||++.....             ......+.+|+.+|.++ +|||||+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~HpnIv~   75 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNIIN   75 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccC-------------hHHHHHHHHHHHHHHhccCCCCEee
Confidence            568888999999999999999874 555  467777632111             12245799999999999 7999999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhh------------cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDV------------SQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRD  278 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  278 (430)
                      ++|+|.+.+..++||||+++|+|.++++..            ......+++..+..++.||+.||.|||+.+   |+|||
T Consensus        76 ~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrD  152 (309)
T d1fvra_          76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD  152 (309)
T ss_dssp             EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             EEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccc
Confidence            999999999999999999999999999642            123467999999999999999999999655   99999


Q ss_pred             CCCCcEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCc
Q 014140          279 IQPANVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK-FPSDD  357 (430)
Q Consensus       279 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-~p~~~  357 (430)
                      |||+|||++.++.+||+|||+++........   ....||..|+|||.+.+..++.++|||||||++|||++|. +||..
T Consensus       153 lkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         153 LAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             CSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence            9999999999999999999999865433222   2346899999999999999999999999999999999976 46543


Q ss_pred             cccccccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          358 FFQHTKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      .    .   ..+....+....++..          +......+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       230 ~----~---~~~~~~~i~~~~~~~~----------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         230 M----T---CAELYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             C----C---HHHHHHHGGGTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----C---HHHHHHHHHhcCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2    1   2222222222222111          111223488999999999999999999999999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=378.59  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             ccccccc-ccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc-CCCCcccc
Q 014140          134 DYFASLE-KIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV-RHRNIVPL  211 (430)
Q Consensus       134 ~~~~~~~-~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  211 (430)
                      ++|.+.. .||+|+||+||+|++.. +|+.||||++..                   ...+.+|+.++.++ +|||||++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~-------------------~~~~~~E~~~~~~~~~hpnIv~l   70 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVRI   70 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECC-CCCEEEEEEECC-------------------cHHHHHHHHHHHHhcCCCCCCeE
Confidence            5688775 69999999999998764 899999999832                   24567899887655 89999999


Q ss_pred             eeEEEe----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          212 LARMVR----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       212 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++|.+    ...+|+|||||+||+|.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        71 ~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~  145 (335)
T d2ozaa1          71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT  145 (335)
T ss_dssp             EEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEES
T ss_pred             EEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccc
Confidence            999875    4668999999999999999964  23456999999999999999999999655   99999999999998


Q ss_pred             C---CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          288 D---DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       288 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      .   ++.+||+|||+|+.........   ...||+.|+|||++.+..|+.++|||||||++|+|+||+.||.....    
T Consensus       146 ~~~~~~~~Kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~----  218 (335)
T d2ozaa1         146 SKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----  218 (335)
T ss_dssp             CSSTTCCEEECCCTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC----
T ss_pred             cccccccccccccceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH----
Confidence            5   5679999999998776543322   35799999999999999999999999999999999999999865322    


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ......+..........      ............+.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         219 LAISPGMKTRIRMGQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             C--------CCCSCSSS------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111111111111100      000111223445889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=374.82  Aligned_cols=263  Identities=19%  Similarity=0.289  Sum_probs=211.6

Q ss_pred             ccccccccccccccCceEEEeecCC----CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPG----SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI  208 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  208 (430)
                      .++|...+.||+|+||+||+|.+++    .++..||||++....             .......|.+|+.++++++||||
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------------~~~~~~~~~~E~~il~~l~h~nI   85 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------------SMRERIEFLNEASVMKEFNCHHV   85 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-------------ChHHHHHHHHHHHHHHHcCCCCE
Confidence            4678999999999999999998742    246789999984321             12235678999999999999999


Q ss_pred             ccceeEEEeCCeeEEEEEecCCCCHHHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 014140          209 VPLLARMVRRDCDLLVYEFRRNGSLQDILYDVS------QGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPA  282 (430)
Q Consensus       209 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  282 (430)
                      |+++|+|...+..++|||||++|+|.+++....      .....+++..+..++.|++.||.|||+.+   |+||||||+
T Consensus        86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~  162 (308)
T d1p4oa_          86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR  162 (308)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred             eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCC
Confidence            999999999999999999999999999986432      12345799999999999999999999665   999999999


Q ss_pred             cEEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccc
Q 014140          283 NVLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGK-FPSDDFFQH  361 (430)
Q Consensus       283 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~-~p~~~~~~~  361 (430)
                      |||+++++.+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||...   
T Consensus       163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---  239 (308)
T d1p4oa_         163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---  239 (308)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---
T ss_pred             ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---
Confidence            9999999999999999998775544433333457899999999999999999999999999999999985 666442   


Q ss_pred             cccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          362 TKEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                          +..+....+.....+.          .+...+..+.+++..||+.+|++|||+.+|++.|++.
T Consensus       240 ----~~~~~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         240 ----SNEQVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ----CHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ----CHHHHHHHHHhCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                2233333333322211          0111223589999999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=372.06  Aligned_cols=263  Identities=21%  Similarity=0.184  Sum_probs=195.9

Q ss_pred             cccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeEEEe
Q 014140          138 SLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLARMVR  217 (430)
Q Consensus       138 ~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  217 (430)
                      .+++||+|+||+||+|++.. +|+.||||++.......         ........+.+|+.+|++++|||||++++++.+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~---------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~   71 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSE---------AKDGINRTALREIKLLQELSHPNIIGLLDAFGH   71 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS-CCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cceEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhh---------hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            35789999999999998764 89999999985432211         111123568899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceEEeec
Q 014140          218 RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEARISEF  297 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df  297 (430)
                      ++..|+||||+.++++..+.    .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          72 KSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             TTCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccC
Confidence            99999999999987766555    34567999999999999999999999655   999999999999999999999999


Q ss_pred             CCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHHHHhc
Q 014140          298 GLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMRNVMT  376 (430)
Q Consensus       298 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~~~~~  376 (430)
                      |+++.........  ....||+.|+|||++.+. .|+.++|||||||++|||++|..||....    ..+....+.....
T Consensus       145 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~  218 (299)
T d1ua2a_         145 GLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLG  218 (299)
T ss_dssp             GGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHC
T ss_pred             ccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC----HHHHHHHHHHhcC
Confidence            9998765543222  235799999999998755 57999999999999999999999986432    2222222222221


Q ss_pred             CCCCchhc---------cccccCCCc-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          377 SENPNRAI---------NSKLLGNGY-----EEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       377 ~~~~~~~~---------~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ........         ........+     ......+.+|+.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            11110000         000000001     111245889999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=369.76  Aligned_cols=270  Identities=22%  Similarity=0.255  Sum_probs=201.0

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|++.. +|+.||||++......            .....++.+|+.+|++++|||||++++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~   68 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTET------------EGVPSTAIREISLLKELNHPNIVKLLD   68 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC-------------------CCHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcC------------hHHHHHHHHHHHHHHhCCCCcEEEecc
Confidence            479999999999999999999764 8999999998432211            112467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++.+++..|+||||+.+ ++.+++..  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~k  142 (298)
T d1gz8a_          69 VIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIK  142 (298)
T ss_dssp             EEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             ccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcce
Confidence            99999999999999976 55555533  34567999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.|+........  .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.....    ......+.
T Consensus       143 l~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~  216 (298)
T d1gz8a_         143 LADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIF  216 (298)
T ss_dssp             ECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             eccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHH
Confidence            9999999876543322  22357999999999877765 58899999999999999999999865321    11111111


Q ss_pred             HHhcCCC--Cchhcc--cc-------ccCCC----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hhcc
Q 014140          373 NVMTSEN--PNRAIN--SK-------LLGNG----YEEQMLLVLKIACFCTLDDPNKRPNSKDVRCM--LSQI  428 (430)
Q Consensus       373 ~~~~~~~--~~~~~~--~~-------~~~~~----~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~--L~~l  428 (430)
                      .......  ......  +.       .....    .......+.+|+.+||+.||++|||+.|+++-  |+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             HHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            1111100  000000  00       00000    01112457899999999999999999999873  5443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=363.78  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=195.9

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC--CCCccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR--HRNIVP  210 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~  210 (430)
                      .++|.+.+.||+|+||+||+|+... +|+.||||++...........        ....++.+|+.+|++++  |||||+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~--------~~~~~~~~E~~il~~l~~~h~nIv~   73 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGEL--------PNGTRVPMEVVLLKKVSSGFSGVIR   73 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEEC--------TTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhh--------hHHHHHHHHHHHHHHhccCCCCccE
Confidence            3579999999999999999998764 899999999965432211100        01234668999999996  899999


Q ss_pred             ceeEEEeCCeeEEEEEecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC-
Q 014140          211 LLARMVRRDCDLLVYEFRRN-GSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD-  288 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-  288 (430)
                      +++++.+.+..++||||+.+ +++.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++. 
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          74 LLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN  146 (273)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred             EEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecC
Confidence            99999999999999999976 688888753    356999999999999999999999655   999999999999985 


Q ss_pred             CCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          289 DMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVAL-SDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      ++.+||+|||+|........    ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....       
T Consensus       147 ~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------  215 (273)
T d1xwsa_         147 RGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------  215 (273)
T ss_dssp             TTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             CCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------
Confidence            57999999999987644322    24579999999999987765 5679999999999999999999864211       


Q ss_pred             HHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          368 VQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                            .......       .....+    ..+.+|+.+||+.||++|||+.|+++
T Consensus       216 ------i~~~~~~-------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 ------IIRGQVF-------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------HHHCCCC-------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HhhcccC-------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  1111100       011122    34889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=363.55  Aligned_cols=267  Identities=19%  Similarity=0.236  Sum_probs=196.5

Q ss_pred             cccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhcc---CCCCc
Q 014140          132 KEDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQV---RHRNI  208 (430)
Q Consensus       132 ~~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpni  208 (430)
                      ..++|.+++.||+|+||+||+|++...+++.||||++........            ....+.+|+.+|+.|   +||||
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~~l~~l~~~~HpnI   72 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNV   72 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTB
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch------------HHHHHHHHHHHHHHHhhcCCCCc
Confidence            357899999999999999999997654678899999855332210            012345666666655   89999


Q ss_pred             ccceeEEEe-----CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 014140          209 VPLLARMVR-----RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPAN  283 (430)
Q Consensus       209 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  283 (430)
                      ++++++|..     ....+++|||++++++.....   .....+++..+..++.|++.||+|||+.+   |+||||||+|
T Consensus        73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~N  146 (305)
T d1blxa_          73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN  146 (305)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred             ceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccE
Confidence            999999864     246789999998876654442   34567999999999999999999999655   9999999999


Q ss_pred             EEeCCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 014140          284 VLIDDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTK  363 (430)
Q Consensus       284 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~  363 (430)
                      ||++.++.+||+|||++........   .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.....   
T Consensus       147 ILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---  220 (305)
T d1blxa_         147 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---  220 (305)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             EEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---
Confidence            9999999999999999886543322   2246799999999999999999999999999999999999999865321   


Q ss_pred             cccHHHHHHHHhcCCCCc----------hhcccc---ccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          364 EMSLVQWMRNVMTSENPN----------RAINSK---LLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                       ......+..........          ..+...   ............+.+|+.+||+.||++|||+.|+++
T Consensus       221 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         221 -VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             -HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             11222222221111000          000000   000011122335788999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.7e-48  Score=358.85  Aligned_cols=263  Identities=22%  Similarity=0.243  Sum_probs=197.7

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|+++  +|+.||||++......            ......+.+|+.+|++++|||||++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~~~~   67 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKED------------EGIPSTTIREISILKELKHSNIVKLYD   67 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGG------------GCCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcC------------hHHHHHHHHHHHHHHhCCCCcEEeeee
Confidence            47999999999999999999876  8899999998543211            122467899999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      ++...+..++++||+.++++..+.    .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        68 ~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~k  140 (286)
T d1ob3a_          68 VIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK  140 (286)
T ss_dssp             EEECSSCEEEEEECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             ecccCCceeEEEEeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEE
Confidence            999999999999999886666665    34567999999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      ++|||.+..........  ....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.....    ......+.
T Consensus       141 l~DfG~a~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~  214 (286)
T d1ob3a_         141 IADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIF  214 (286)
T ss_dssp             ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             ecccccceecccCcccc--ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHH
Confidence            99999998765433222  234689999999998765 569999999999999999999999875322    11111111


Q ss_pred             HHhcCCCCchhc---------------cccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRAI---------------NSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ............               ...............+.+|+.+||+.||++|||++|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111000000               000000011112235789999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=354.97  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=197.0

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      -++|.+++.||+|+||+||+|++.. +|+.||||++......            .....++.+|+.+|++++|||+++++
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~h~nii~~~   75 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEK------------EGFPITALREIKILQLLKHENVVNLI   75 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----CT------------TSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcc------------hHHHHHHHHHHHHHHHhcCCCccceE
Confidence            4689999999999999999999764 8999999998543221            11246688999999999999999999


Q ss_pred             eEEEe--------CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 014140          213 ARMVR--------RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANV  284 (430)
Q Consensus       213 ~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni  284 (430)
                      +++..        .+..++||||+.++++....    .....++...++.++.|++.||.|||+.+   |+||||||+||
T Consensus        76 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NI  148 (318)
T d3blha1          76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV  148 (318)
T ss_dssp             EEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred             eeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchhe
Confidence            99865        34579999999876655443    44567999999999999999999999655   99999999999


Q ss_pred             EeCCCCceEEeecCCcccCCCCCCc--ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 014140          285 LIDDDMEARISEFGLAKRIPDGHTR--TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQH  361 (430)
Q Consensus       285 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~  361 (430)
                      |++.++.+||+|||++.........  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....  
T Consensus       149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--  226 (318)
T d3blha1         149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--  226 (318)
T ss_dssp             EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred             eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--
Confidence            9999999999999999876543221  222245799999999998766 68999999999999999999999986532  


Q ss_pred             cccccHHHHHHHHhcCCCCch--hcccc--------cc--CCCcHH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          362 TKEMSLVQWMRNVMTSENPNR--AINSK--------LL--GNGYEE------QMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~--~~~~~--------~~--~~~~~~------~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                        .......+...........  .....        ..  ......      ....+.+|+.+||+.||++|||+.|+++
T Consensus       227 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         227 --EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             --HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence              2222222323222111100  00000        00  000111      1234678999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=361.84  Aligned_cols=260  Identities=22%  Similarity=0.238  Sum_probs=191.7

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccceeE
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLAR  214 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  214 (430)
                      .|...++||+|+||+||+|++.. +|+.||||++.....                  .+.+|+.+|++++||||++++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~------------------~~~~Ei~il~~l~h~niv~~~~~   81 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLRYF   81 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSS------------------SCCHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccch------------------HHHHHHHHHHhcCCCCCCcEEEE
Confidence            58889999999999999999874 899999999854221                  12369999999999999999999


Q ss_pred             EEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          215 MVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       215 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      |...      ...++|||||+++ +.+.+.........+++..+..++.||+.||+|||+.   +|+||||||+|||++.
T Consensus        82 ~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~  157 (350)
T d1q5ka_          82 FYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDP  157 (350)
T ss_dssp             EEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECT
T ss_pred             EEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEec
Confidence            8653      2478999999865 4444433334556799999999999999999999954   5999999999999997


Q ss_pred             CC-ceEEeecCCcccCCCCCCcceeeccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          289 DM-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQT-VALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       289 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ++ .+||+|||++..........   ...||..|+|||.+.+ ..++.++||||+||++|||++|+.||......   ..
T Consensus       158 ~~~~~kl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~  231 (350)
T d1q5ka_         158 DTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQ  231 (350)
T ss_dssp             TTCCEEECCCTTCEECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HH
T ss_pred             CCCceeEecccchhhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HH
Confidence            75 89999999998775543322   3579999999998775 46899999999999999999999998643211   11


Q ss_pred             HHHHH-----------HHHhcC---CCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWM-----------RNVMTS---ENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~-----------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      +...+           ......   ......................+.+|+.+||+.||++|||+.|+++
T Consensus       232 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111           111000   0000000000000111122334889999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=354.82  Aligned_cols=261  Identities=21%  Similarity=0.235  Sum_probs=193.7

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +++|.+++.||+|+||+||+|+... +|+.||||++....             .......+.+|+.+|++++||||++++
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~-------------~~~~~~~~~~Ei~il~~l~hp~iv~~~   72 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFE-------------HQTYCQRTLREIKILLRFRHENIIGIN   72 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTT-------------CHHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhc-------------ChHHHHHHHHHHHHHHHcCCCCCCcEE
Confidence            3579999999999999999998764 89999999984321             123356789999999999999999999


Q ss_pred             eEEEeCC----eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC
Q 014140          213 ARMVRRD----CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD  288 (430)
Q Consensus       213 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~  288 (430)
                      +++....    ..+++++|+.+|+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++
T Consensus        73 ~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~  144 (345)
T d1pmea_          73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNT  144 (345)
T ss_dssp             EEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred             EEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECC
Confidence            9997653    23455566779999999953     35999999999999999999999655   999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCCc-ceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          289 DMEARISEFGLAKRIPDGHTR-TTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       289 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      ++.+||+|||++......... .......||+.|+|||++... .++.++||||+||++|+|++|+.||.....    ..
T Consensus       145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~----~~  220 (345)
T d1pmea_         145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LD  220 (345)
T ss_dssp             TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH----HH
T ss_pred             CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH----HH
Confidence            999999999999876543221 122345799999999998554 578999999999999999999999865321    11


Q ss_pred             HHHHHHHHhcCCCC---------------------chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENP---------------------NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ..............                     ............    ...+.+|+.+||+.||.+|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111111100                     000000011111    124789999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-46  Score=348.15  Aligned_cols=261  Identities=23%  Similarity=0.267  Sum_probs=197.5

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccc-e
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL-L  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l-~  212 (430)
                      ++|.+.+.||+|+||.||+|++.. +|+.||||.+.....                ..++..|+.+++.++|+|++.. .
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----------------~~~~~~E~~i~~~l~~~~~i~~~~   69 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTIR   69 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCTT----------------SCCHHHHHHHHHHSTTSTTCCCEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhcc----------------CHHHHHHHHHHHHccCCCcccEEE
Confidence            569999999999999999998764 899999998743211                1247789999999987775555 5


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC---C
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD---D  289 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~  289 (430)
                      +++.+.+..++||||+ +|+|.+.+..   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.   +
T Consensus        70 ~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~  142 (299)
T d1ckia_          70 WCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKG  142 (299)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGT
T ss_pred             EEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCC
Confidence            5557788889999999 5577777643   3457999999999999999999999665   999999999999864   4


Q ss_pred             CceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 014140          290 MEARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKE  364 (430)
Q Consensus       290 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~  364 (430)
                      ..++|+|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~  222 (299)
T d1ckia_         143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  222 (299)
T ss_dssp             TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence            57999999999987543322     1223467999999999999999999999999999999999999999765432222


Q ss_pred             ccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          365 MSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..............  ..    ......+    ..+.+++..||+.+|++||++.++.+.|+++
T Consensus       223 ~~~~~~~~~~~~~~--~~----~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         223 QKYERISEKKMSTP--IE----VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             --HHHHHHHHHHSC--HH----HHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHhhcccCCCC--hh----HhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            22222222111111  11    1111222    3388899999999999999999999988764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=347.20  Aligned_cols=265  Identities=19%  Similarity=0.193  Sum_probs=204.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|++.. +|+.||||++.....            ......++.+|+.+|+.++||||+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~------------~~~~~~~~~~E~~il~~l~h~niv~~~~   68 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDD------------DEGVPSSALREICLLKELKHKNIVRLHD   68 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCS------------STTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhhC------------ChHHHHHHHHHHHHHHhcCcCCEEeecc
Confidence            469999999999999999999764 899999999854321            1233678999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCceE
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDMEAR  293 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k  293 (430)
                      +|.+.+..++|+|++.+++|..++.    ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~iv~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~k  141 (292)
T d1unla_          69 VLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EEECSSEEEEEEECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEE
T ss_pred             ccccccceeEEeeeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCcee
Confidence            9999999999999999998888774    3467899999999999999999999655   99999999999999999999


Q ss_pred             EeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccHHHHHH
Q 014140          294 ISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLVQWMR  372 (430)
Q Consensus       294 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~~~~~  372 (430)
                      |+|||.++..........  ...+++.|+|||++.+.. ++.++|||||||++|||++|+.||...   .........+.
T Consensus       142 l~DFG~a~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~---~~~~~~~~~~~  216 (292)
T d1unla_         142 LANFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIF  216 (292)
T ss_dssp             ECCCTTCEECCSCCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHH
T ss_pred             eeecchhhcccCCCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC---CCHHHHHHHHH
Confidence            999999988765433222  346788999999988765 689999999999999999999996432   12222222222


Q ss_pred             HHhcCCCCchh--------------cc-ccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          373 NVMTSENPNRA--------------IN-SKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       373 ~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ...........              .. ..............+.+|+.+||+.||.+|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22221110000              00 00001111222345788999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=355.56  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=192.1

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      .+.|.+++.||+|+||+||+|+... +|+.||||++.....            .......+.+|+.+|++++|||||+++
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~------------~~~~~~~~~~Ei~il~~l~hpniv~l~   83 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQ------------SELFAKRAYRELRLLKHMRHENVIGLL   83 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT-TCCEEEEEECSSTTS------------SHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhhc------------ChHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            4689999999999999999998764 899999999843221            123457889999999999999999999


Q ss_pred             eEEEeCC------eeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 014140          213 ARMVRRD------CDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLI  286 (430)
Q Consensus       213 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill  286 (430)
                      ++|...+      ..|+||||+ +++|..++..     ..+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        84 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~  154 (346)
T d1cm8a_          84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAV  154 (346)
T ss_dssp             EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             EEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhc
Confidence            9998755      469999999 5688887743     45999999999999999999999665   9999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 014140          287 DDDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEM  365 (430)
Q Consensus       287 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~  365 (430)
                      +.++.+|++|||+|+.......     ...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.....    .
T Consensus       155 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~  225 (346)
T d1cm8a_         155 NEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----L  225 (346)
T ss_dssp             CTTCCEEECCCTTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred             ccccccccccccceeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----H
Confidence            9999999999999987654322     35789999999998765 568999999999999999999999865321    1


Q ss_pred             cHHHHHHHHhcCC---------------------CCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          366 SLVQWMRNVMTSE---------------------NPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       366 ~l~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      .............                     .....-........    ...+.+|+.+||+.||.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA----SPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCC----CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111111111000                     00000000111112    234788999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-45  Score=343.86  Aligned_cols=261  Identities=18%  Similarity=0.186  Sum_probs=203.2

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-CCcccce
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-RNIVPLL  212 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~  212 (430)
                      ++|.+.+.||+|+||+||+|++.. +|+.||||++.....                ...+.+|++.+..++| +|++.++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~~   67 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNVY   67 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEccccC----------------cHHHHHHHHHHHHhcCCCCCCEEE
Confidence            579999999999999999999764 899999998743211                1246788899999965 8999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCC----
Q 014140          213 ARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDD----  288 (430)
Q Consensus       213 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----  288 (430)
                      +++......++||||+ +|+|.+++..   ....++..++..++.|++.||.|||   +.+|+||||||+|||++.    
T Consensus        68 ~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~  140 (293)
T d1csna_          68 YFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSK  140 (293)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSST
T ss_pred             EEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccc
Confidence            9999999999999999 6899999854   3456999999999999999999999   455999999999999974    


Q ss_pred             -CCceEEeecCCcccCCCCCCc-----ceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 014140          289 -DMEARISEFGLAKRIPDGHTR-----TTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHT  362 (430)
Q Consensus       289 -~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~  362 (430)
                       ++.+||+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~  220 (293)
T d1csna_         141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT  220 (293)
T ss_dssp             TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred             cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence             578999999999876543221     12234679999999999999999999999999999999999999997543321


Q ss_pred             ccccHHHHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcc
Q 014140          363 KEMSLVQWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRCMLSQI  428 (430)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~~L~~l  428 (430)
                      ..... ..+....... +.    ..+....+    ..+.+++..|++.+|++||++..+.+.|+++
T Consensus       221 ~~~~~-~~i~~~~~~~-~~----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         221 NKQKY-ERIGEKKQST-PL----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHH-HHHHHHHHHS-CH----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHH-HHHHhccCCC-Ch----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11111 1111111111 11    11112233    2378899999999999999999999888764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-45  Score=350.37  Aligned_cols=260  Identities=20%  Similarity=0.242  Sum_probs=195.2

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCcccc
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPL  211 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  211 (430)
                      .++|.+++.||+|+||+||+|+... +|+.||||++...                 ...++.+|+.+|++++ ||||+++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~-----------------~~~~~~~Ei~il~~l~~hpnIv~~   95 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPV-----------------KKKKIKREIKILENLRGGPNIITL   95 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSS-----------------CHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECHH-----------------HHHHHHHHHHHHHhccCCCCCcEE
Confidence            4679999999999999999999764 8999999998421                 1356889999999995 9999999


Q ss_pred             eeEEEe--CCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCC
Q 014140          212 LARMVR--RDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDD  289 (430)
Q Consensus       212 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~  289 (430)
                      ++++..  ....++|||||++|+|..+.       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~  165 (328)
T d3bqca1          96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE  165 (328)
T ss_dssp             EEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             EEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCC
Confidence            999975  45689999999999987654       35999999999999999999999655   9999999999999865


Q ss_pred             C-ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-
Q 014140          290 M-EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV-ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS-  366 (430)
Q Consensus       290 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-  366 (430)
                      + .+||+|||+|.........   ....||+.|+|||.+.+. .++.++||||+||++++|++|+.||........... 
T Consensus       166 ~~~vkl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         166 HRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             TTEEEECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CCeeeecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence            5 6999999999877654332   235789999999998776 479999999999999999999999865322111000 


Q ss_pred             ---------HHHHHHHHhcCCCC----------chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 ---------LVQWMRNVMTSENP----------NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 ---------l~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                               ...+.........+          ...................+.+|+.+||+.||.+|||++|+++
T Consensus       243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     00111000000000          0000000001111122345889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=352.68  Aligned_cols=258  Identities=22%  Similarity=0.306  Sum_probs=199.6

Q ss_pred             cccccccccccccCceEEEeecC--CCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC-CCccc
Q 014140          134 DYFASLEKIRSCWNGEVYKAELP--GSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH-RNIVP  210 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~  210 (430)
                      ++|.+++.||+|+||+||+|+..  ..+|+.||||.+........          ......+.+|+.+|++++| |||++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~~E~~il~~l~h~pnIv~   93 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVT   93 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc----------hHHHHHHHHHHHHHHhccCCCeEEE
Confidence            46999999999999999999763  23689999999854322110          0113457889999999976 89999


Q ss_pred             ceeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCC
Q 014140          211 LLARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDM  290 (430)
Q Consensus       211 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~  290 (430)
                      +++++.+.+..++||||+.+|+|.+++..    ...+++.....++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~  166 (322)
T d1vzoa_          94 LHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNG  166 (322)
T ss_dssp             EEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred             eeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCC
Confidence            99999999999999999999999999954    345788999999999999999999665   99999999999999999


Q ss_pred             ceEEeecCCcccCCCCCCcceeeccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccHH
Q 014140          291 EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTV--ALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSLV  368 (430)
Q Consensus       291 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l~  368 (430)
                      .+||+|||+++.+....... .....|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......   ...
T Consensus       167 ~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~  242 (322)
T d1vzoa_         167 HVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQA  242 (322)
T ss_dssp             CEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHH
T ss_pred             CEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            99999999998765433322 2246799999999998765  46889999999999999999999987643321   122


Q ss_pred             HHHHHHhcCCCCchhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 014140          369 QWMRNVMTSENPNRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPN-----SKDVRC  423 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps-----~~ev~~  423 (430)
                      ...........+           .+......+.+|+.+||++||++|||     +.|+++
T Consensus       243 ~i~~~~~~~~~~-----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         243 EISRRILKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHhcccCCCC-----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            222222211111           11112234889999999999999995     778775

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=348.24  Aligned_cols=260  Identities=23%  Similarity=0.278  Sum_probs=188.9

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCccccee
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLLA  213 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  213 (430)
                      ++|.+++.||+|+||+||+|++.. +|+.||||++......            ......+.+|+.+|++++|||||++++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~l~hpnIv~~~~   83 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIISLLN   83 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhhcC------------HHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            579999999999999999998764 8999999999543221            233567899999999999999999999


Q ss_pred             EEEeC------CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          214 RMVRR------DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       214 ~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +|...      ..+|+|||||.+ ++.+.+.      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        84 ~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~  153 (355)
T d2b1pa1          84 VFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK  153 (355)
T ss_dssp             EECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             EEecccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccc
Confidence            99643      678999999976 4555552      35899999999999999999999555   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccH
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMSL  367 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~l  367 (430)
                      .++.++++|||+++.........   ...||+.|+|||++.+..++.++||||+||++++|++|+.||.....    ...
T Consensus       154 ~~~~~kl~df~~~~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~  226 (355)
T d2b1pa1         154 SDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQ  226 (355)
T ss_dssp             TTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH
T ss_pred             cccceeeechhhhhccccccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHH
Confidence            99999999999988765543322   35789999999999999999999999999999999999999864321    111


Q ss_pred             HHHHHH-------------------HhcCCC-C-----chhccccccCC---CcHHHHHHHHHHHHhcccCCCCCCCCHH
Q 014140          368 VQWMRN-------------------VMTSEN-P-----NRAINSKLLGN---GYEEQMLLVLKIACFCTLDDPNKRPNSK  419 (430)
Q Consensus       368 ~~~~~~-------------------~~~~~~-~-----~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~Rps~~  419 (430)
                      ...+..                   ...... .     ...+.......   ........+.+|+.+||+.||++|||++
T Consensus       227 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~  306 (355)
T d2b1pa1         227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  306 (355)
T ss_dssp             HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            111111                   011000 0     00111111111   1223455689999999999999999999


Q ss_pred             HHHH
Q 014140          420 DVRC  423 (430)
Q Consensus       420 ev~~  423 (430)
                      |+++
T Consensus       307 elL~  310 (355)
T d2b1pa1         307 DALQ  310 (355)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=344.31  Aligned_cols=257  Identities=22%  Similarity=0.298  Sum_probs=192.8

Q ss_pred             ccccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCcccce
Q 014140          133 EDYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNIVPLL  212 (430)
Q Consensus       133 ~~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  212 (430)
                      +++|.+++.||+|+||+||+|+... +|+.||||++......            ......+.+|+.+|++++|||+|+++
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~------------~~~~~~~~~Ei~il~~l~h~~iv~~~   83 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQS------------IIHAKRTYRELRLLKHMKHENVIGLL   83 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchhcC------------hHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            5679999999999999999998764 8999999998532211            22356788999999999999999999


Q ss_pred             eEEEeC-----CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeC
Q 014140          213 ARMVRR-----DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLID  287 (430)
Q Consensus       213 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~  287 (430)
                      +++...     ...+++++|+.+|+|.+++..     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~  155 (348)
T d2gfsa1          84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN  155 (348)
T ss_dssp             EEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             EEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccc
Confidence            998643     344677788889999999842     46999999999999999999999655   99999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCCcceeeccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 014140          288 DDMEARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVA-LSDTCDIYSFGVLLAVLVIGKFPSDDFFQHTKEMS  366 (430)
Q Consensus       288 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~  366 (430)
                      .++.+|++|||++......     .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.....    ..
T Consensus       156 ~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~  226 (348)
T d2gfsa1         156 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----ID  226 (348)
T ss_dssp             TTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HH
T ss_pred             ccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HH
Confidence            9999999999999765322     22457899999999877764 68899999999999999999999864321    11


Q ss_pred             HHHHHHHHhcCCCC---------------------chhccccccCCCcHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 014140          367 LVQWMRNVMTSENP---------------------NRAINSKLLGNGYEEQMLLVLKIACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       367 l~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      ....+.........                     ...-.......    ....+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG----ANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC----CCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            11111111111000                     00000000011    1234789999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.6e-40  Score=313.44  Aligned_cols=264  Identities=19%  Similarity=0.192  Sum_probs=189.6

Q ss_pred             cccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC---------
Q 014140          134 DYFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR---------  204 (430)
Q Consensus       134 ~~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------  204 (430)
                      ++|.+++.||+|+||+||+|+... +|+.||||++....               .....+.+|+.+++.++         
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~---------------~~~~~~~~Ei~~l~~l~~~~~~~~~~   76 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK---------------VYTEAAEDEIKLLQRVNDADNTKEDS   76 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccc---------------cchHHHHHHHHHHHHhcchhhhhhhh
Confidence            459999999999999999998764 89999999984321               12356778888888775         


Q ss_pred             --CCCcccceeEEEeC--CeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 014140          205 --HRNIVPLLARMVRR--DCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQ  280 (430)
Q Consensus       205 --hpniv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  280 (430)
                        ||||+++++++...  ...+++++++..+........ ......+++..+..++.|++.||.|||+.  .+|+|||||
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlK  153 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIK  153 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCS
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCC
Confidence              57899999988653  456677777655443333222 24556789999999999999999999962  259999999


Q ss_pred             CCcEEeCCCC------ceEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 014140          281 PANVLIDDDM------EARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLLAVLVIGKFP  354 (430)
Q Consensus       281 p~Nill~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p  354 (430)
                      |+|||++.++      .++++|||.+.......     ....||+.|+|||++.+..++.++||||+||++++|++|+.|
T Consensus       154 p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p  228 (362)
T d1q8ya_         154 PENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  228 (362)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             hhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence            9999998665      39999999998654322     245799999999999999999999999999999999999999


Q ss_pred             CCcccccccccc---HHHHHHHHhcCCCCchhc----------c---------c----------cccCCCcHHHHHHHHH
Q 014140          355 SDDFFQHTKEMS---LVQWMRNVMTSENPNRAI----------N---------S----------KLLGNGYEEQMLLVLK  402 (430)
Q Consensus       355 ~~~~~~~~~~~~---l~~~~~~~~~~~~~~~~~----------~---------~----------~~~~~~~~~~~~~l~~  402 (430)
                      |...........   +...+. .+.. .+....          +         .          .............+.+
T Consensus       229 F~~~~~~~~~~~~~~~~~~~~-~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  306 (362)
T d1q8ya_         229 FEPDEGHSYTKDDDHIAQIIE-LLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD  306 (362)
T ss_dssp             C---------CHHHHHHHHHH-HHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred             CCCCccccccchhHHHHHHHH-HhCC-CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence            875422111111   111111 1100 000000          0         0          0011234566678999


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 014140          403 IACFCTLDDPNKRPNSKDVRC  423 (430)
Q Consensus       403 l~~~cl~~dp~~Rps~~ev~~  423 (430)
                      |+.+||..||.+|||+.|+++
T Consensus       307 ll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         307 FLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=9e-25  Score=189.08  Aligned_cols=184  Identities=13%  Similarity=0.020  Sum_probs=122.3

Q ss_pred             cccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhh----ccCCchhhHHHHHHHHHHHHHhccCCCCcccc
Q 014140          136 FASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELI----KKDSEPLHHKMIQIRSEIITAGQVRHRNIVPL  211 (430)
Q Consensus       136 ~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  211 (430)
                      +.+.+.||+|+||+||+|+..  +|+.||||++...........    ................|...+.++.|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            356789999999999999875  899999998754322211100    00001112233556779999999999999988


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEeCCCCc
Q 014140          212 LARMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSHRPRIIHRDIQPANVLIDDDME  291 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~  291 (430)
                      +++.    ..+++|||++++.+.+           ++......++.|++.+|.|||+.+   |+||||||+|||++++ .
T Consensus        80 ~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          80 YAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             EEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-E
T ss_pred             EEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-C
Confidence            7653    2379999998865432           334445679999999999999655   9999999999999865 5


Q ss_pred             eEEeecCCcccCCCCCCcceeeccccccccccccccCCCCCCcchhHHHHHHHH
Q 014140          292 ARISEFGLAKRIPDGHTRTTTWSLAGTVGYIAPECHQTVALSDTCDIYSFGVLL  345 (430)
Q Consensus       292 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l  345 (430)
                      ++|+|||.|............   ...... -.+.+ ...|+.++|+||..--+
T Consensus       141 ~~liDFG~a~~~~~~~~~~~l---~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWREIL---ERDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEECCCTTCEETTSTTHHHHH---HHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHHHH---HHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            899999999776433221100   000000 01111 24578889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.59  E-value=1.2e-07  Score=84.01  Aligned_cols=141  Identities=12%  Similarity=0.079  Sum_probs=92.6

Q ss_pred             ccccccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-CCCccccee
Q 014140          135 YFASLEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-HRNIVPLLA  213 (430)
Q Consensus       135 ~~~~~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  213 (430)
                      .|.+....+-++.+.||+...   +++.+++|+.......              ....+..|...+..+. +-.+.+++.
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~--------------~~~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKG--------------TTYDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTT--------------STTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCccc--------------chhhHHHHHHHHHHHhccCCCCcEEE
Confidence            455555544455678998863   6677888877432211              1223667888877774 333566778


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------
Q 014140          214 RMVRRDCDLLVYEFRRNGSLQDILYDVSQGRRELDWLARHRIAQGIASGLEYLHMSH-----------------------  270 (430)
Q Consensus       214 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------  270 (430)
                      ++..++..++||++++|.++.+....         ......++.+++..++.||+..                       
T Consensus        78 ~~~~~~~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          78 FERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EEEETTEEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             EEecCCceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence            88888899999999999887654311         1112234555555555666321                       


Q ss_pred             ---------------------------------CCCeEecCCCCCcEEeCCCCceEEeecCCcc
Q 014140          271 ---------------------------------RPRIIHRDIQPANVLIDDDMEARISEFGLAK  301 (430)
Q Consensus       271 ---------------------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~  301 (430)
                                                       ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                             1137999999999999987777799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=1e-05  Score=70.69  Aligned_cols=74  Identities=11%  Similarity=0.103  Sum_probs=49.6

Q ss_pred             cccccc-CceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCC--CCcccceeEEEe
Q 014140          141 KIRSCW-NGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRH--RNIVPLLARMVR  217 (430)
Q Consensus       141 ~lg~G~-~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~  217 (430)
                      .+..|. .+.||+....  ++..+++|......                 ...+..|...++.+..  -.+.++++++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~-----------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~   77 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAVLDVVTE   77 (255)
T ss_dssp             ECSCTTSSCEEEEEECT--TSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC--CCCEEEEEeCCccC-----------------HhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence            334444 4678998764  67778888753211                 1235667777777642  335667888888


Q ss_pred             CCeeEEEEEecCCCCH
Q 014140          218 RDCDLLVYEFRRNGSL  233 (430)
Q Consensus       218 ~~~~~lV~E~~~~gsL  233 (430)
                      .+..++||++++|.++
T Consensus        78 ~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          78 AGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SSCEEEEEECCSSEET
T ss_pred             ccceEEEEEeeecccc
Confidence            8889999999988554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=1.5e-05  Score=74.57  Aligned_cols=84  Identities=14%  Similarity=0.024  Sum_probs=47.7

Q ss_pred             ccccccccCceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccC-C-C-CcccceeEE
Q 014140          139 LEKIRSCWNGEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVR-H-R-NIVPLLARM  215 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~  215 (430)
                      .+.||.|....||+..... +|+.++||.-........+       .......+...|...|+.+. + | .+.+++.  
T Consensus        31 ~~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~-------~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGE-------SWPLTIDRARIESSALIRQGEHVPHLVPRVFY--  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--C-------CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--
T ss_pred             EEEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCC-------CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--
Confidence            4568999999999998653 5778999965322111000       00001233556777777662 2 3 3444443  


Q ss_pred             EeCCeeEEEEEecCCCC
Q 014140          216 VRRDCDLLVYEFRRNGS  232 (430)
Q Consensus       216 ~~~~~~~lV~E~~~~gs  232 (430)
                      .+.+..++|||++++..
T Consensus       101 ~d~~~~~lvmE~L~~~~  117 (392)
T d2pula1         101 SDTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             EETTTTEEEECCCTTSE
T ss_pred             EcCCCCEEEEeccCCcc
Confidence            45666789999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00081  Score=60.58  Aligned_cols=136  Identities=13%  Similarity=0.095  Sum_probs=75.4

Q ss_pred             ceEEEeecCCCCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCC-----Ccccc--eeEEEeCCe
Q 014140          148 GEVYKAELPGSSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHR-----NIVPL--LARMVRRDC  220 (430)
Q Consensus       148 g~vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-----niv~l--~~~~~~~~~  220 (430)
                      -.||+++..  +|+.|++|........               ..++..|...+..|...     ..+..  -..+...+.
T Consensus        36 N~vy~v~~~--dg~~~VlK~~rp~~~s---------------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~   98 (325)
T d1zyla1          36 NRVYQFQDE--DRRRFVVKFYRPERWT---------------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF   98 (325)
T ss_dssp             SEEEEECCT--TCCCEEEEEECTTTSC---------------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred             ceeEEEEcC--CCCEEEEEEeCCCCCC---------------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeE
Confidence            479999875  8999999987543222               35577788888777422     11221  112344666


Q ss_pred             eEEEEEecCCCCHH-----H---------HHhhhcC-----CCCCCCHH-------------------HHHHHHHHHHHH
Q 014140          221 DLLVYEFRRNGSLQ-----D---------ILYDVSQ-----GRRELDWL-------------------ARHRIAQGIASG  262 (430)
Q Consensus       221 ~~lV~E~~~~gsL~-----~---------~l~~~~~-----~~~~l~~~-------------------~~~~i~~~i~~~  262 (430)
                      .+.++++++|..+.     .         .++....     .....++.                   .+..+...+...
T Consensus        99 ~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (325)
T d1zyla1          99 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL  178 (325)
T ss_dssp             EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred             EEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHH
Confidence            78899999863211     1         1111100     01111211                   111122222223


Q ss_pred             HHHHhh----cCCCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          263 LEYLHM----SHRPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       263 l~~LH~----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      +..+..    ....++||+|+.|.|||++++  ..++||+.+..
T Consensus       179 ~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         179 IAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            333322    224578999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.96  E-value=0.01  Score=54.65  Aligned_cols=74  Identities=9%  Similarity=0.177  Sum_probs=44.2

Q ss_pred             ccccccccCceEEEeecCC------CCCceEEEEEeecccccchhhhccCCchhhHHHHHHHHHHHHHhccCCCCc-ccc
Q 014140          139 LEKIRSCWNGEVYKAELPG------SSGRVITIKKIIQPLKSGAELIKKDSEPLHHKMIQIRSEIITAGQVRHRNI-VPL  211 (430)
Q Consensus       139 ~~~lg~G~~g~vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l  211 (430)
                      ++.|+.|-.=.+|+.....      ..++.|.++.....  .          .    .....+|..+++.+.-.++ .++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~----------~----~idr~~E~~i~~~ls~~gl~Pkl  110 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E----------T----ESHLVAESVIFTLLSERHLGPKL  110 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C----------C----HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c----------h----hhHHHHHHHHHHHHHhCCCCCeE
Confidence            3567777777899987642      12345666554211  0          0    1234578888888853344 466


Q ss_pred             eeEEEeCCeeEEEEEecCCCC
Q 014140          212 LARMVRRDCDLLVYEFRRNGS  232 (430)
Q Consensus       212 ~~~~~~~~~~~lV~E~~~~gs  232 (430)
                      ++++.  +  .+|+||++|.+
T Consensus       111 l~~~~--~--g~I~efi~g~~  127 (395)
T d1nw1a_         111 YGIFS--G--GRLEEYIPSRP  127 (395)
T ss_dssp             EEEET--T--EEEECCCCEEE
T ss_pred             EEEcC--C--ceEEEEecccc
Confidence            66653  2  68999998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.93  E-value=0.013  Score=51.79  Aligned_cols=32  Identities=25%  Similarity=0.316  Sum_probs=27.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeecCCccc
Q 014140          271 RPRIIHRDIQPANVLIDDDMEARISEFGLAKR  302 (430)
Q Consensus       271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~a~~  302 (430)
                      ..|+||+|+.++||+++++...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            45799999999999999988889999998743